Psyllid ID: psy13988

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------36
Protein Sequence
GFSGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF
Secondary Structure (PSIPRED)
ccccccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHcccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccEEEEEEEcccccEEEEEEEcccccccccccHHHHHHHHHHHcccccccccccEEEccccccccccccccEEEEEEccHHcHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEEccccEEEccccccccccccccccccccccEEEEccccccccccccccccHHHHHHHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccHHHHHHHHHHHHHcccccccccccccccccccccccccccHHHHHHcccccHHHHHHHHHHccccHHHcccHHHHHccHHHcccccHHHccccccccccccHHHHHHHHHHHccccccHccccccccccccccccccccEcccccEEEEEEEcccccccEEEEEEEEcccccccccHHHHHHHHHHHccccccEccEEEEEccccccHHcccccccEEEEEEEcHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEcccccccEcccccccEcccccccccccccHHHHccccccccHHHHHHHHHHHHHHHHccccc
Coil and Loop (DISEMBL)
gfsggrgnsgwANIELLQLEVISKlcgtptpavwpaviklplwhtikpkkihrrrlreefslmppgALDLLDKMLELDPERRITAEQALKSVWlknvhpesmpppqlptwqdCHELWSKKRRrqlrgdpmemqaaapiqsnstnnssrplmeplaagglslnnfsVSLFTDELVALKKVRLenekegfpitAVREIKILRQLNHKNIVNLREIVtdksdaldfrkdkgSFYLVFEYMDHDLMGLLEsgmvdfnevnNASIMRQLLDGLsychkrnflhrdikcsnilmnnrgevkladfGLARlynaedrqrpytnkvitlwyrppelllgeerygpaidvwscgcilgelfvkkplf
Flexible Loop (DISEMBL)
gfsggrgnsgWANIELLQLEVISKLCGTPTPAVWPAViklplwhtikpkkihrrrlreefslmppgALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDpmemqaaapiqsnstnnsSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVrlenekegfpitavREIKIlrqlnhknivnlreivtdksdaldfrKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLynaedrqrpytnkvitlwyrppELLLGEERYGPAIDVWSCGCILGELFVKKPLF
Low Complexity Region (SEG)
GFSGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF
Disordered region (IsUnstruct)
*********GWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELD**RRITAEQALKSVWLKN*************WQDCHEL***************************************AGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK****
Disordered Region (DISOPRED)
*FSGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF
Disordered Region (DISEMBL)
********SGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF
Disordered Region (DISPRO)
***********ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCH**WSKKR******************SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
GFSGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	358	2.2.26 [Sep-21-2011]
Q9VP22	1157	Cyclin-dependent kinase 1	yes	N/A	0.519	0.160	0.9	1e-104
Q69ZA1	1511	Cyclin-dependent kinase 1	yes	N/A	0.525	0.124	0.814	3e-93
Q14004	1512	Cyclin-dependent kinase 1	yes	N/A	0.525	0.124	0.814	4e-93
E1BB52	1512	Cyclin-dependent kinase 1	yes	N/A	0.525	0.124	0.814	5e-93
Q9NYV4	1490	Cyclin-dependent kinase 1	no	N/A	0.525	0.126	0.809	8e-93
Q14AX6	1484	Cyclin-dependent kinase 1	no	N/A	0.525	0.126	0.809	9e-93
D2H526	1491	Cyclin-dependent kinase 1	no	N/A	0.525	0.126	0.809	1e-92
E1BB50	1264	Cyclin-dependent kinase 1	no	N/A	0.525	0.148	0.809	2e-92
Q3MJK5	1484	Cyclin-dependent kinase 1	no	N/A	0.525	0.126	0.809	2e-92
B5DE93	1239	Cyclin-dependent kinase 1	yes	N/A	0.525	0.151	0.809	3e-92

>sp|Q9VP22|CDK12_DROME Cyclin-dependent kinase 12 OS=Drosophila melanogaster GN=Cdk12 PE=1 SV=1

 Score =  377 bits (968), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 171/190 (90%), Positives = 186/190 (97%)

Query: 169  FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
             T+++VALKKVRLE+EKEGFPITAVREIKILRQLNH+NIVNL EIVTDK DA++FRKDKG
Sbjct: 825  HTNDMVALKKVRLEHEKEGFPITAVREIKILRQLNHRNIVNLHEIVTDKQDAVEFRKDKG 884

Query: 229  SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            SFYLVFEYMDHDLMGLLESGMVDFNE NNASIM+QLLDGL+YCHK+NFLHRDIKCSNILM
Sbjct: 885  SFYLVFEYMDHDLMGLLESGMVDFNEENNASIMKQLLDGLNYCHKKNFLHRDIKCSNILM 944

Query: 289  NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
            NNRG+VKLADFGLARLYNA+DR+RPYTNKVITLWYRPPELLLGEERYGP+IDVWSCGCIL
Sbjct: 945  NNRGKVKLADFGLARLYNADDRERPYTNKVITLWYRPPELLLGEERYGPSIDVWSCGCIL 1004

Query: 349  GELFVKKPLF 358
            GELFVK+PLF
Sbjct: 1005 GELFVKRPLF 1014

Cyclin-dependent kinase which displays CTD kinase activity: hyperphosphorylates the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit, thereby acting as a key regulator of transcription elongation.
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3

 Score =  342 bits (877), Expect = 3e-93,   Method: Compositional matrix adjust.
 Identities = 154/189 (81%), Positives = 176/189 (93%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKKVRL+NEKEGFPITA+REIKILRQL H++I+N++EIVTDK DALDF+KDKG+
Sbjct: 727 TGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGA 786

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V FNE +  S MRQL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct: 787 FYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLN 846

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           NRG++KLADFGLARLY++E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct: 847 NRGQIKLADFGLARLYSSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 905

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 906 ELFTKKPIF 914

Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q14004|CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2

 Score =  341 bits (875), Expect = 4e-93,   Method: Compositional matrix adjust.
 Identities = 154/189 (81%), Positives = 176/189 (93%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKKVRL+NEKEGFPITA+REIKILRQL H++I+N++EIVTDK DALDF+KDKG+
Sbjct: 727 TGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGA 786

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V FNE +  S MRQL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct: 787 FYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLN 846

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           NRG++KLADFGLARLY++E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct: 847 NRGQIKLADFGLARLYSSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 905

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 906 ELFTKKPIF 914

Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|E1BB52|CDK13_BOVIN Cyclin-dependent kinase 13 OS=Bos taurus GN=CDK13 PE=3 SV=1

 Score =  341 bits (874), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 154/189 (81%), Positives = 176/189 (93%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKKVRL+NEKEGFPITA+REIKILRQL H++I+N++EIVTDK DALDF+KDKG+
Sbjct: 728 TGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGA 787

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V FNE +  S MRQL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct: 788 FYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLN 847

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           NRG++KLADFGLARLY++E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct: 848 NRGQIKLADFGLARLYSSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 906

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 907 ELFTKKPIF 915

Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2

 Score =  340 bits (873), Expect = 8e-93,   Method: Compositional matrix adjust.
 Identities = 153/189 (80%), Positives = 175/189 (92%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ELVALKKVRL+NEKEGFPITA+REIKILRQL H+++VN++EIVTDK DALDF+KDKG+
Sbjct: 749 TGELVALKKVRLDNEKEGFPITAIREIKILRQLIHRSVVNMKEIVTDKQDALDFKKDKGA 808

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V F+E +  S M+QL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct: 809 FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLEYCHKKNFLHRDIKCSNILLN 868

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           N G++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct: 869 NSGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 927

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 928 ELFTKKPIF 936

Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2

 Score =  340 bits (872), Expect = 9e-93,   Method: Compositional matrix adjust.
 Identities = 153/189 (80%), Positives = 175/189 (92%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ELVALKKVRL+NEKEGFPITA+REIKILRQL H+++VN++EIVTDK DALDF+KDKG+
Sbjct: 745 TGELVALKKVRLDNEKEGFPITAIREIKILRQLVHQSVVNMKEIVTDKQDALDFKKDKGA 804

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V F+E +  S M+QL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct: 805 FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLN 864

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           N G++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct: 865 NSGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 923

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 924 ELFTKKPIF 932

Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1

 Score =  340 bits (871), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 153/189 (80%), Positives = 175/189 (92%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ELVALKKVRL+NEKEGFPITA+REIKILRQL H+++VN++EIVTDK DALDF+KDKG+
Sbjct: 750 TGELVALKKVRLDNEKEGFPITAIREIKILRQLIHRSVVNMKEIVTDKQDALDFKKDKGA 809

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V F+E +  S M+QL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct: 810 FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLN 869

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           N G++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct: 870 NSGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 928

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 929 ELFTKKPIF 937

Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors.

Ailuropoda melanoleuca (taxid: 9646)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|E1BB50|CDK12_BOVIN Cyclin-dependent kinase 12 OS=Bos taurus GN=CDK12 PE=3 SV=1

 Score =  339 bits (870), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 153/189 (80%), Positives = 175/189 (92%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ELVALKKVRL+NEKEGFPITA+REIKILRQL H+++VN++EIVTDK DALDF+KDKG+
Sbjct: 749 TGELVALKKVRLDNEKEGFPITAIREIKILRQLIHRSVVNMKEIVTDKQDALDFKKDKGA 808

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V F+E +  S M+QL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct: 809 FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLN 868

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           N G++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct: 869 NSGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 927

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 928 ELFTKKPIF 936

Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1

 Score =  339 bits (870), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 153/189 (80%), Positives = 175/189 (92%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ELVALKKVRL+NEKEGFPITA+REIKILRQL H+++VN++EIVTDK DALDF+KDKG+
Sbjct: 745 TGELVALKKVRLDNEKEGFPITAIREIKILRQLVHQSVVNMKEIVTDKQDALDFKKDKGA 804

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V F+E +  S M+QL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct: 805 FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKKNFLHRDIKCSNILLN 864

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           N G++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct: 865 NSGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 923

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 924 ELFTKKPIF 932

Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1

 Score =  338 bits (868), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 153/189 (80%), Positives = 175/189 (92%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ELVALKKVRL+NEKEGFPITA+REIKILRQL HK++VN++EIVTDK DALDF+KDKG+
Sbjct: 732 TGELVALKKVRLDNEKEGFPITAIREIKILRQLIHKSVVNMKEIVTDKQDALDFKKDKGA 791

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V F+E +  S M+QL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct: 792 FYLVFEYMDHDLMGLLESGLVQFSEDHIKSFMKQLMEGLEYCHKKNFLHRDIKCSNILLN 851

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           N G++KLADFGLARLY++E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct: 852 NSGQIKLADFGLARLYSSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 910

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 911 ELFTKKPIF 919

Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2.

Xenopus tropicalis (taxid: 8364)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	358
350398704	1479	PREDICTED: hypothetical protein LOC10074	0.519	0.125	0.956	1e-105
270013169	1227	hypothetical protein TcasGA2_TC011738 [T	0.488	0.142	0.957	1e-104
383857058	1480	PREDICTED: uncharacterized protein LOC10	0.519	0.125	0.956	1e-104
158297875	1254	AGAP004780-PA [Anopheles gambiae str. PE	0.527	0.150	0.936	1e-104
189241298	1057	PREDICTED: similar to AGAP004780-PA [Tri	0.522	0.176	0.957	1e-104
307175619	1493	Cell division cycle 2-like protein kinas	0.519	0.124	0.951	1e-104
345493802	1172	PREDICTED: cyclin-dependent kinase 12-li	0.519	0.158	0.940	1e-104
322783487	1363	hypothetical protein SINV_02771 [Solenop	0.519	0.136	0.951	1e-104
328783895	1479	PREDICTED: hypothetical protein LOC40996	0.519	0.125	0.946	1e-104
332019896	1502	Cell division cycle 2-like protein kinas	0.519	0.123	0.951	1e-103

>gi|350398704|ref|XP_003485281.1| PREDICTED: hypothetical protein LOC100747750 [Bombus impatiens]

 Score =  386 bits (992), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 178/186 (95%), Positives = 183/186 (98%)

Query: 173  LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
            LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK DALDFRKDKGSFYL
Sbjct: 904  LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKQDALDFRKDKGSFYL 963

Query: 233  VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            VFEYMDHDLMGLLESGMVDFNE+NNASIM+QLLDGL+YCH +NFLHRDIKCSNILMNN+G
Sbjct: 964  VFEYMDHDLMGLLESGMVDFNEMNNASIMKQLLDGLNYCHSKNFLHRDIKCSNILMNNKG 1023

Query: 293  EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF
Sbjct: 1024 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 1083

Query: 353  VKKPLF 358
             KKPLF
Sbjct: 1084 SKKPLF 1089

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270013169|gb|EFA09617.1| hypothetical protein TcasGA2_TC011738 [Tribolium castaneum]

 Score =  385 bits (990), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 179/187 (95%), Positives = 185/187 (98%)

Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK DA+DFRKDKGSFY
Sbjct: 725 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKQDAVDFRKDKGSFY 784

Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           LVFEYMDHDLMGLLESGMVDFNE+NNA IM+QLLDGL+YCHK+NFLHRDIKCSNILMNNR
Sbjct: 785 LVFEYMDHDLMGLLESGMVDFNEMNNACIMKQLLDGLNYCHKKNFLHRDIKCSNILMNNR 844

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL
Sbjct: 845 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 904

Query: 352 FVKKPLF 358
           F+KKPLF
Sbjct: 905 FLKKPLF 911

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383857058|ref|XP_003704023.1| PREDICTED: uncharacterized protein LOC100879265 [Megachile rotundata]

 Score =  385 bits (988), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 178/186 (95%), Positives = 183/186 (98%)

Query: 173  LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
            LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK DALDFRKDKGSFYL
Sbjct: 905  LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKQDALDFRKDKGSFYL 964

Query: 233  VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            VFEYMDHDLMGLLESGMVDFNE+NNASIM+QLLDGL+YCH +NFLHRDIKCSNILMNN+G
Sbjct: 965  VFEYMDHDLMGLLESGMVDFNEMNNASIMKQLLDGLNYCHSKNFLHRDIKCSNILMNNKG 1024

Query: 293  EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF
Sbjct: 1025 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 1084

Query: 353  VKKPLF 358
             KKPLF
Sbjct: 1085 SKKPLF 1090

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|158297875|ref|XP_318036.4| AGAP004780-PA [Anopheles gambiae str. PEST] gi|157014537|gb|EAA13162.4| AGAP004780-PA [Anopheles gambiae str. PEST]

 Score =  385 bits (988), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 177/189 (93%), Positives = 187/189 (98%)

Query: 170  TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            T+ELVALKKVRLE+EKEGFPITAVREIKILRQLNH+NIVNLREIVTDK DAL+FRKDKGS
Sbjct: 911  TNELVALKKVRLEHEKEGFPITAVREIKILRQLNHQNIVNLREIVTDKQDALEFRKDKGS 970

Query: 230  FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            FYLVFEYMDHDLMGLLESGMVDFNE NNASIMRQLLDGL+YCHK+NFLHRDIKCSNILMN
Sbjct: 971  FYLVFEYMDHDLMGLLESGMVDFNEQNNASIMRQLLDGLNYCHKKNFLHRDIKCSNILMN 1030

Query: 290  NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
            NRGEVKLADFGLARLYNA++R+RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG
Sbjct: 1031 NRGEVKLADFGLARLYNADNRERPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 1090

Query: 350  ELFVKKPLF 358
            ELF+KKPLF
Sbjct: 1091 ELFLKKPLF 1099

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|189241298|ref|XP_975145.2| PREDICTED: similar to AGAP004780-PA [Tribolium castaneum]

 Score =  385 bits (988), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 179/187 (95%), Positives = 185/187 (98%)

Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK DA+DFRKDKGSFY
Sbjct: 725 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKQDAVDFRKDKGSFY 784

Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           LVFEYMDHDLMGLLESGMVDFNE+NNA IM+QLLDGL+YCHK+NFLHRDIKCSNILMNNR
Sbjct: 785 LVFEYMDHDLMGLLESGMVDFNEMNNACIMKQLLDGLNYCHKKNFLHRDIKCSNILMNNR 844

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL
Sbjct: 845 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 904

Query: 352 FVKKPLF 358
           F+KKPLF
Sbjct: 905 FLKKPLF 911

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307175619|gb|EFN65528.1| Cell division cycle 2-like protein kinase 5 [Camponotus floridanus]

 Score =  384 bits (987), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 177/186 (95%), Positives = 183/186 (98%)

Query: 173  LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
            LVALKKVRLENEKEGFP+TAVREIKILRQLNHKNIVNLREIVTDK DALDFRKDKGSFYL
Sbjct: 944  LVALKKVRLENEKEGFPVTAVREIKILRQLNHKNIVNLREIVTDKQDALDFRKDKGSFYL 1003

Query: 233  VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            VFEYMDHDLMGLLESGMVDFNE+NNASIM+QLLDGL+YCH +NFLHRDIKCSNILMNN+G
Sbjct: 1004 VFEYMDHDLMGLLESGMVDFNEMNNASIMKQLLDGLNYCHSKNFLHRDIKCSNILMNNKG 1063

Query: 293  EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF
Sbjct: 1064 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 1123

Query: 353  VKKPLF 358
             KKPLF
Sbjct: 1124 SKKPLF 1129

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345493802|ref|XP_003427156.1| PREDICTED: cyclin-dependent kinase 12-like [Nasonia vitripennis]

 Score =  384 bits (987), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 175/186 (94%), Positives = 183/186 (98%)

Query: 173  LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
            +VALKKVRLENEK+GFPITAVREIKILRQLNHKNIVNLREIVTDK DALDFR DKGSFYL
Sbjct: 826  IVALKKVRLENEKDGFPITAVREIKILRQLNHKNIVNLREIVTDKQDALDFRNDKGSFYL 885

Query: 233  VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            VFEYMDHDLMGLLESGMVDFNE+NNASIM+QLLDGL+YCH +NFLHRDIKCSNILMNN+G
Sbjct: 886  VFEYMDHDLMGLLESGMVDFNEMNNASIMKQLLDGLNYCHSKNFLHRDIKCSNILMNNKG 945

Query: 293  EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF
Sbjct: 946  EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 1005

Query: 353  VKKPLF 358
            +KKPLF
Sbjct: 1006 LKKPLF 1011

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322783487|gb|EFZ10951.1| hypothetical protein SINV_02771 [Solenopsis invicta]

 Score =  384 bits (985), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 177/186 (95%), Positives = 183/186 (98%)

Query: 173  LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
            +VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK DALDFRKDKGSFYL
Sbjct: 1018 MVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKQDALDFRKDKGSFYL 1077

Query: 233  VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            VFEYMDHDLMGLLESGMVDFNE+NNASIM+QLLDGL+YCH +NFLHRDIKCSNILMNN+G
Sbjct: 1078 VFEYMDHDLMGLLESGMVDFNEMNNASIMKQLLDGLNYCHSKNFLHRDIKCSNILMNNKG 1137

Query: 293  EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF
Sbjct: 1138 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 1197

Query: 353  VKKPLF 358
             KKPLF
Sbjct: 1198 SKKPLF 1203

Source: Solenopsis invicta

Species: Solenopsis invicta

Genus: Solenopsis

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328783895|ref|XP_397595.4| PREDICTED: hypothetical protein LOC409965 [Apis mellifera]

 Score =  383 bits (984), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 176/186 (94%), Positives = 182/186 (97%)

Query: 173  LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
            LVALKKVRLENEKEGFP+TAVREIKILRQLNHKNIVNLREIVTDK D LDFRKDKGSFYL
Sbjct: 905  LVALKKVRLENEKEGFPVTAVREIKILRQLNHKNIVNLREIVTDKQDVLDFRKDKGSFYL 964

Query: 233  VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            VFEYMDHDLMGLLESGMVDFNE+NNASIM+QLLDGL+YCH +NFLHRDIKCSNILMNN+G
Sbjct: 965  VFEYMDHDLMGLLESGMVDFNEMNNASIMKQLLDGLNYCHSKNFLHRDIKCSNILMNNKG 1024

Query: 293  EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF
Sbjct: 1025 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 1084

Query: 353  VKKPLF 358
             KKPLF
Sbjct: 1085 SKKPLF 1090

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332019896|gb|EGI60357.1| Cell division cycle 2-like protein kinase [Acromyrmex echinatior]

 Score =  382 bits (982), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 177/186 (95%), Positives = 183/186 (98%)

Query: 173  LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
            +VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK DALDFRKDKGSFYL
Sbjct: 939  MVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKQDALDFRKDKGSFYL 998

Query: 233  VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            VFEYMDHDLMGLLESGMVDFNE+NNASIM+QLLDGL+YCH +NFLHRDIKCSNILMNN+G
Sbjct: 999  VFEYMDHDLMGLLESGMVDFNEMNNASIMKQLLDGLNYCHSKNFLHRDIKCSNILMNNKG 1058

Query: 293  EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF
Sbjct: 1059 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 1118

Query: 353  VKKPLF 358
             KKPLF
Sbjct: 1119 SKKPLF 1124

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	358
FB|FBgn0037093	1157	Cdk12 [Drosophila melanogaster	0.527	0.163	0.904	3.3e-96
ZFIN|ZDB-GENE-030131-4975	1289	cdk13 "cyclin-dependent kinase	0.525	0.145	0.830	2.8e-86
ZFIN|ZDB-GENE-081104-294	1293	cdk12 "cyclin-dependent kinase	0.525	0.145	0.814	2e-85
UNIPROTKB|F1NBD9	1257	CDK13 "Uncharacterized protein	0.525	0.149	0.830	2.5e-85
UNIPROTKB|J3QSD7	1201	CDK12 "Cyclin-dependent kinase	0.525	0.156	0.809	1e-84
UNIPROTKB|J9P287	1504	CDK13 "Uncharacterized protein	0.525	0.125	0.814	2.4e-84
MGI|MGI:1916812	1511	Cdk13 "cyclin-dependent kinase	0.525	0.124	0.814	2.5e-84
UNIPROTKB|E1BB52	1512	CDK13 "Cyclin-dependent kinase	0.525	0.124	0.814	2.5e-84
UNIPROTKB|Q14004	1512	CDK13 "Cyclin-dependent kinase	0.525	0.124	0.814	2.5e-84
UNIPROTKB|J9NYW8	1129	CDK13 "Uncharacterized protein	0.525	0.166	0.814	2.7e-84

FB|FBgn0037093 Cdk12 [Drosophila melanogaster (taxid:7227)]

 Score = 928 (331.7 bits), Expect = 3.3e-96, Sum P(2) = 3.3e-96
 Identities = 171/189 (90%), Positives = 186/189 (98%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T+++VALKKVRLE+EKEGFPITAVREIKILRQLNH+NIVNL EIVTDK DA++FRKDKGS
Sbjct:   826 TNDMVALKKVRLEHEKEGFPITAVREIKILRQLNHRNIVNLHEIVTDKQDAVEFRKDKGS 885

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESGMVDFNE NNASIM+QLLDGL+YCHK+NFLHRDIKCSNILMN
Sbjct:   886 FYLVFEYMDHDLMGLLESGMVDFNEENNASIMKQLLDGLNYCHKKNFLHRDIKCSNILMN 945

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             NRG+VKLADFGLARLYNA+DR+RPYTNKVITLWYRPPELLLGEERYGP+IDVWSCGCILG
Sbjct:   946 NRGKVKLADFGLARLYNADDRERPYTNKVITLWYRPPELLLGEERYGPSIDVWSCGCILG 1005

Query:   350 ELFVKKPLF 358
             ELFVK+PLF
Sbjct:  1006 ELFVKRPLF 1014

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0006911 "phagocytosis, engulfment" evidence=IMP

GO:0005703 "polytene chromosome puff" evidence=IDA

GO:0005700 "polytene chromosome" evidence=IDA

GO:0022008 "neurogenesis" evidence=IMP

ZFIN|ZDB-GENE-030131-4975 cdk13 "cyclin-dependent kinase 13" [Danio rerio (taxid:7955)]

 Score = 855 (306.0 bits), Expect = 2.8e-86, Sum P(2) = 2.8e-86
 Identities = 157/189 (83%), Positives = 176/189 (93%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T ELVALKKVRL+NEKEGFPITA+REIKILRQLNHK+I+N++EIVTDK DALDF+ DKG+
Sbjct:   616 TAELVALKKVRLDNEKEGFPITAIREIKILRQLNHKSIINMKEIVTDKEDALDFKNDKGA 675

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESG+V FNE +  S MRQLL+GL YCHK+NFLHRDIKCSNIL+N
Sbjct:   676 FYLVFEYMDHDLMGLLESGLVHFNESHIKSFMRQLLEGLDYCHKKNFLHRDIKCSNILLN 735

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             N+G++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct:   736 NKGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 794

Query:   350 ELFVKKPLF 358
             ELF KKP+F
Sbjct:   795 ELFTKKPIF 803

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

ZFIN|ZDB-GENE-081104-294 cdk12 "cyclin-dependent kinase 12" [Danio rerio (taxid:7955)]

 Score = 846 (302.9 bits), Expect = 2.0e-85, Sum P(2) = 2.0e-85
 Identities = 154/189 (81%), Positives = 175/189 (92%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T ELVALKKVRL+NEKEGFPITA+REIKILRQLNH+++VN++EIVTDK DALDF+KDKG+
Sbjct:   697 TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRSVVNMKEIVTDKQDALDFKKDKGA 756

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESG+V F+  +  S MRQL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct:   757 FYLVFEYMDHDLMGLLESGLVSFSHEHVQSFMRQLMEGLDYCHKKNFLHRDIKCSNILLN 816

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             N G++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct:   817 NSGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYSPAIDVWSCGCILG 875

Query:   350 ELFVKKPLF 358
             ELF KKP+F
Sbjct:   876 ELFTKKPIF 884

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|F1NBD9 CDK13 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 858 (307.1 bits), Expect = 2.5e-85, P = 2.5e-85
 Identities = 157/189 (83%), Positives = 178/189 (94%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T ELVALKKVRL+NEKEGFPITA+REIKILRQLNH++I+N++EIVTDK DALDF+KDKG+
Sbjct:   459 TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHQSIINMKEIVTDKEDALDFKKDKGA 518

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESG+V FNE +  S MRQL++GL+YCHK+NFLHRDIKCSNIL+N
Sbjct:   519 FYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLAYCHKKNFLHRDIKCSNILLN 578

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             NRG++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct:   579 NRGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 637

Query:   350 ELFVKKPLF 358
             ELF KKP+F
Sbjct:   638 ELFTKKPIF 646

GO:0005524 "ATP binding" evidence=IEA

GO:0000380 "alternative mRNA splicing, via spliceosome" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0016607 "nuclear speck" evidence=IEA

GO:0019908 "nuclear cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0030097 "hemopoiesis" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0070816 "phosphorylation of RNA polymerase II C-terminal domain" evidence=IEA

UNIPROTKB|J3QSD7 CDK12 "Cyclin-dependent kinase 12" [Homo sapiens (taxid:9606)]

 Score = 835 (299.0 bits), Expect = 1.0e-84, Sum P(2) = 1.0e-84
 Identities = 153/189 (80%), Positives = 175/189 (92%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T ELVALKKVRL+NEKEGFPITA+REIKILRQL H+++VN++EIVTDK DALDF+KDKG+
Sbjct:   748 TGELVALKKVRLDNEKEGFPITAIREIKILRQLIHRSVVNMKEIVTDKQDALDFKKDKGA 807

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESG+V F+E +  S M+QL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct:   808 FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLEYCHKKNFLHRDIKCSNILLN 867

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             N G++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct:   868 NSGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 926

Query:   350 ELFVKKPLF 358
             ELF KKP+F
Sbjct:   927 ELFTKKPIF 935

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|J9P287 CDK13 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 844 (302.2 bits), Expect = 2.4e-84, Sum P(2) = 2.4e-84
 Identities = 154/189 (81%), Positives = 176/189 (93%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T E+VALKKVRL+NEKEGFPITA+REIKILRQL H++I+N++EIVTDK DALDF+KDKG+
Sbjct:   720 TGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGA 779

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESG+V FNE +  S MRQL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct:   780 FYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLN 839

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             NRG++KLADFGLARLY++E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct:   840 NRGQIKLADFGLARLYSSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 898

Query:   350 ELFVKKPLF 358
             ELF KKP+F
Sbjct:   899 ELFTKKPIF 907

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:1916812 Cdk13 "cyclin-dependent kinase 13" [Mus musculus (taxid:10090)]

 Score = 844 (302.2 bits), Expect = 2.5e-84, Sum P(2) = 2.5e-84
 Identities = 154/189 (81%), Positives = 176/189 (93%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T E+VALKKVRL+NEKEGFPITA+REIKILRQL H++I+N++EIVTDK DALDF+KDKG+
Sbjct:   727 TGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGA 786

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESG+V FNE +  S MRQL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct:   787 FYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLN 846

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             NRG++KLADFGLARLY++E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct:   847 NRGQIKLADFGLARLYSSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 905

Query:   350 ELFVKKPLF 358
             ELF KKP+F
Sbjct:   906 ELFTKKPIF 914

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000380 "alternative mRNA splicing, via spliceosome" evidence=IDA

GO:0002945 "cyclin K-CDK13 complex" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0006397 "mRNA processing" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISO

GO:0008380 "RNA splicing" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016607 "nuclear speck" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019908 "nuclear cyclin-dependent protein kinase holoenzyme complex" evidence=IDA

GO:0030097 "hemopoiesis" evidence=ISO

GO:0030332 "cyclin binding" evidence=ISO;IPI

GO:0070816 "phosphorylation of RNA polymerase II C-terminal domain" evidence=ISO

UNIPROTKB|E1BB52 CDK13 "Cyclin-dependent kinase 13" [Bos taurus (taxid:9913)]

 Score = 844 (302.2 bits), Expect = 2.5e-84, Sum P(2) = 2.5e-84
 Identities = 154/189 (81%), Positives = 176/189 (93%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T E+VALKKVRL+NEKEGFPITA+REIKILRQL H++I+N++EIVTDK DALDF+KDKG+
Sbjct:   728 TGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGA 787

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESG+V FNE +  S MRQL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct:   788 FYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLN 847

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             NRG++KLADFGLARLY++E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct:   848 NRGQIKLADFGLARLYSSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 906

Query:   350 ELFVKKPLF 358
             ELF KKP+F
Sbjct:   907 ELFTKKPIF 915

GO:0019908 "nuclear cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0000380 "alternative mRNA splicing, via spliceosome" evidence=ISS

GO:0030097 "hemopoiesis" evidence=ISS

GO:0070816 "phosphorylation of RNA polymerase II C-terminal domain" evidence=ISS

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISS

GO:0016607 "nuclear speck" evidence=ISS

GO:0030332 "cyclin binding" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q14004 CDK13 "Cyclin-dependent kinase 13" [Homo sapiens (taxid:9606)]

 Score = 844 (302.2 bits), Expect = 2.5e-84, Sum P(2) = 2.5e-84
 Identities = 154/189 (81%), Positives = 176/189 (93%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T E+VALKKVRL+NEKEGFPITA+REIKILRQL H++I+N++EIVTDK DALDF+KDKG+
Sbjct:   727 TGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGA 786

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESG+V FNE +  S MRQL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct:   787 FYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLN 846

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             NRG++KLADFGLARLY++E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct:   847 NRGQIKLADFGLARLYSSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 905

Query:   350 ELFVKKPLF 358
             ELF KKP+F
Sbjct:   906 ELFTKKPIF 914

GO:0005524 "ATP binding" evidence=IEA

GO:0019048 "virus-host interaction" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0070816 "phosphorylation of RNA polymerase II C-terminal domain" evidence=IDA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IDA

GO:0030097 "hemopoiesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0000380 "alternative mRNA splicing, via spliceosome" evidence=ISS;TAS

GO:0016607 "nuclear speck" evidence=IDA

GO:0019908 "nuclear cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0004672 "protein kinase activity" evidence=TAS

GO:0007088 "regulation of mitosis" evidence=TAS

GO:0007275 "multicellular organismal development" evidence=TAS

GO:0002945 "cyclin K-CDK13 complex" evidence=IPI

GO:0030332 "cyclin binding" evidence=IPI

GO:0008284 "positive regulation of cell proliferation" evidence=TAS

UNIPROTKB|J9NYW8 CDK13 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
 Identities = 154/189 (81%), Positives = 176/189 (93%)

Query:   170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             T E+VALKKVRL+NEKEGFPITA+REIKILRQL H++I+N++EIVTDK DALDF+KDKG+
Sbjct:   345 TGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVTDKEDALDFKKDKGA 404

Query:   230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             FYLVFEYMDHDLMGLLESG+V FNE +  S MRQL++GL YCHK+NFLHRDIKCSNIL+N
Sbjct:   405 FYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLHRDIKCSNILLN 464

Query:   290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             NRG++KLADFGLARLY++E+  RPYTNKVITLWYRPPELLLGEERY PAIDVWSCGCILG
Sbjct:   465 NRGQIKLADFGLARLYSSEE-SRPYTNKVITLWYRPPELLLGEERYTPAIDVWSCGCILG 523

Query:   350 ELFVKKPLF 358
             ELF KKP+F
Sbjct:   524 ELFTKKPIF 532

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8W4P1	CDKC2_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.5280	0.5782	0.4035	yes	N/A
E1BB52	CDK13_BOVIN	2, ., 7, ., 1, 1, ., 2, 3	0.8148	0.5251	0.1243	yes	N/A
P46551	CDK12_CAEEL	2, ., 7, ., 1, 1, ., 2, 3	0.6221	0.5977	0.2931	yes	N/A
Q9VP22	CDK12_DROME	2, ., 7, ., 1, 1, ., 2, 3	0.9	0.5195	0.1607	yes	N/A
Q69ZA1	CDK13_MOUSE	2, ., 7, ., 1, 1, ., 2, 3	0.8148	0.5251	0.1244	yes	N/A
B5DE93	CDK12_XENTR	2, ., 7, ., 1, 1, ., 2, 3	0.8095	0.5251	0.1517	yes	N/A
Q14004	CDK13_HUMAN	2, ., 7, ., 1, 1, ., 2, 3	0.8148	0.5251	0.1243	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	358
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-140
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-113
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-92
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-85
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-85
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-84
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-75
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-68
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-68
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-66
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-65
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-64
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-61
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-59
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-58
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-58
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-58
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-58
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-57
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-57
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-55
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-54
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-53
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-53
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-53
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-53
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-52
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-51
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-50
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-49
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-47
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-47
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-44
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-44
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-44
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-43
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-42
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-42
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-41
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-41
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-40
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-40
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-37
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-37
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-36
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-36
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-35
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-35
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-34
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-34
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-33
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-32
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-31
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-28
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-27
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-27
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-26
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-26
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-26
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-24
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-21
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-17
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-16
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-15
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-14
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-07
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-06
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	7e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.001
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	0.002
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	0.002
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	0.004

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  400 bits (1030), Expect = e-140
 Identities = 159/189 (84%), Positives = 179/189 (94%), Gaps = 1/189 (0%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ELVALKKVRL+NEKEGFPITA+REIKILRQLNH+NIVNL+EIVTDK DALDF+KDKG+
Sbjct: 31  TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA 90

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFEYMDHDLMGLLESG+V F+E +  S M+QLL+GL+YCHK+NFLHRDIKCSNIL+N
Sbjct: 91  FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN 150

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           N+G++KLADFGLARLYN+E+  RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG
Sbjct: 151 NKGQIKLADFGLARLYNSEE-SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 209

Query: 350 ELFVKKPLF 358
           ELF KKP+F
Sbjct: 210 ELFTKKPIF 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  331 bits (852), Expect = e-113
 Identities = 121/189 (64%), Positives = 139/189 (73%), Gaps = 9/189 (4%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ELVALKK+R+ENEKEGFPITA+REIK+L++L H NIV L+EIVT K         KGS
Sbjct: 23  TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK--------GKGS 74

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y+VFEYMDHDL GLL+S  V F E      M+QLL+GL Y H    LHRDIK SNIL+N
Sbjct: 75  IYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN 134

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           N G +KLADFGLAR Y        YTN+VITLWYRPPELLLG  RYGP +D+WS GCIL 
Sbjct: 135 NDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILA 193

Query: 350 ELFVKKPLF 358
           ELF+ KP+F
Sbjct: 194 ELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  277 bits (710), Expect = 3e-92
 Identities = 93/189 (49%), Positives = 120/189 (63%), Gaps = 12/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKK+RL+NE+EG P TA+REI +L++L H NIV L +++  +            
Sbjct: 23  TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER----------K 72

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLVFEY D DL   L+      +     SIM QLL GL+YCH    LHRD+K  NIL+N
Sbjct: 73  LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN 132

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI  
Sbjct: 133 RDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFA 190

Query: 350 ELFVKKPLF 358
           E+   KPLF
Sbjct: 191 EMITGKPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  259 bits (664), Expect = 5e-85
 Identities = 97/203 (47%), Positives = 136/203 (66%), Gaps = 11/203 (5%)

Query: 165 SVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           +  + T  +VALKK+ + NEK+GFPITA+REIKIL++L H N+V L ++  ++ D    +
Sbjct: 27  ARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD--KSK 84

Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           + +GS Y+V  YMDHDL GLLE+  V   E      M QLL+G++Y H+ + LHRDIK +
Sbjct: 85  RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAA 144

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQ---------RPYTNKVITLWYRPPELLLGEERY 335
           NIL++N+G +K+ADFGLAR Y+              R YTN V+T WYRPPELLLGE RY
Sbjct: 145 NILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204

Query: 336 GPAIDVWSCGCILGELFVKKPLF 358
             A+D+W  GC+  E+F ++P+ 
Sbjct: 205 TTAVDIWGIGCVFAEMFTRRPIL 227

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  258 bits (661), Expect = 9e-85
 Identities = 95/189 (50%), Positives = 125/189 (66%), Gaps = 10/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKK+++E EKEGFPIT++REI IL +L H NIV ++E+V           +   
Sbjct: 29  TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS--------NLDK 80

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y+V EY++HDL  L+E+    F +     +M QLL G+++ H    LHRD+K SN+L+N
Sbjct: 81  IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN 140

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           NRG +K+ DFGLAR Y      +PYT  V+TLWYR PELLLG + Y  AID+WS GCI  
Sbjct: 141 NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFA 198

Query: 350 ELFVKKPLF 358
           EL  KKPLF
Sbjct: 199 ELLTKKPLF 207

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  256 bits (657), Expect = 6e-84
 Identities = 104/190 (54%), Positives = 136/190 (71%), Gaps = 4/190 (2%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++VALKKV +ENEKEGFPITA+REIKIL+ L H+N+VNL EI   K+    + + KGS
Sbjct: 36  TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP--YNRYKGS 93

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLVFE+ +HDL GLL +  V F       +M+ LL+GL Y H+   LHRD+K +NIL+ 
Sbjct: 94  FYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT 153

Query: 290 NRGEVKLADFGLARLYNAEDRQRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             G +KLADFGLAR ++     +P  YTN+V+TLWYRPPELLLGE  YGP ID+W  GCI
Sbjct: 154 KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCI 213

Query: 348 LGELFVKKPL 357
           + E++ + P+
Sbjct: 214 MAEMWTRSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  234 bits (598), Expect = 4e-75
 Identities = 93/189 (49%), Positives = 124/189 (65%), Gaps = 10/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + E+VALKKVR++NE++G PI+++REI +L  L H NIV L+E+V  K   LD      S
Sbjct: 31  SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH--LD------S 82

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +LV EY + DL  LL++    F+E     +M QLL GL Y H+   +HRD+K SN+L+ 
Sbjct: 83  IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT 142

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           ++G +K+ADFGLAR Y      +P T KV+TLWYR PELLLG   Y  AID+W+ GCIL 
Sbjct: 143 DKGCLKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILA 200

Query: 350 ELFVKKPLF 358
           EL   KPL 
Sbjct: 201 ELLAHKPLL 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  216 bits (553), Expect = 2e-68
 Identities = 76/192 (39%), Positives = 113/192 (58%), Gaps = 15/192 (7%)

Query: 170 TDELVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T  +VA+KK++L   +  K+G   TA+REIK+L++L H NI+ L ++   KS        
Sbjct: 24  TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS-------- 75

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             +  LVFE+M+ DL  +++   +     +  S M   L GL Y H    LHRD+K +N+
Sbjct: 76  --NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL 133

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+ + G +KLADFGLAR + + +  R  T++V+T WYR PELL G   YG  +D+WS GC
Sbjct: 134 LIASDGVLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGC 191

Query: 347 ILGELFVKKPLF 358
           I  EL ++ P  
Sbjct: 192 IFAELLLRVPFL 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  213 bits (545), Expect = 8e-68
 Identities = 76/190 (40%), Positives = 105/190 (55%), Gaps = 17/190 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T +LVA+K ++ +  K+      +REIKIL++L H NIV L           D  +D+  
Sbjct: 23  TGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNIVRL----------YDVFEDEDK 71

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            YLV EY +  DL  LL+      +E      +RQ+L  L Y H +  +HRD+K  NIL+
Sbjct: 72  LYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL 130

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  G VKLADFGLAR  +  ++   +   V T  Y  PE+LLG + YG A+D+WS G IL
Sbjct: 131 DEDGHVKLADFGLARQLDPGEKLTTF---VGTPEYMAPEVLLG-KGYGKAVDIWSLGVIL 186

Query: 349 GELFVKKPLF 358
            EL   KP F
Sbjct: 187 YELLTGKPPF 196

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  211 bits (539), Expect = 2e-66
 Identities = 90/192 (46%), Positives = 121/192 (63%), Gaps = 12/192 (6%)

Query: 167 SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
              T E+VA+KK++L  E EG P TA+REIK+L++LNH NI+ L ++   K D       
Sbjct: 20  DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD------- 72

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
               YLVFE+MD DL  L++       E    S + QLL GL++CH    LHRD+K  N+
Sbjct: 73  ---LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL 129

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+N  G +KLADFGLAR + +    RPYT+ V+T WYR PELLLG++ Y   +D+WS GC
Sbjct: 130 LINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGC 187

Query: 347 ILGELFVKKPLF 358
           I  EL  ++PLF
Sbjct: 188 IFAELLSRRPLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  208 bits (531), Expect = 2e-65
 Identities = 87/193 (45%), Positives = 122/193 (63%), Gaps = 13/193 (6%)

Query: 167 SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
              T E+VALKK+RLE E EG P TA+REI +L++LNH NIV L ++V  ++        
Sbjct: 20  DKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN-------- 71

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVD-FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
               YLVFE++D DL   ++S  +   +     S + QLL G++YCH    LHRD+K  N
Sbjct: 72  --KLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQN 129

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +L++  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG  +Y   +D+WS G
Sbjct: 130 LLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG 187

Query: 346 CILGELFVKKPLF 358
           CI  E+  ++PLF
Sbjct: 188 CIFAEMVNRRPLF 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  205 bits (524), Expect = 3e-64
 Identities = 80/189 (42%), Positives = 107/189 (56%), Gaps = 11/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E VALKKV L   + G P  A+REIK L+   H  +V L ++    S           
Sbjct: 24  TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS----------G 73

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           F LV EYM  DL  +L        E    S MR LL G++Y H    +HRD+K +N+L++
Sbjct: 74  FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS 133

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             G +K+ADFGLARL++ E+  R Y+++V T WYR PELL G  +Y P +D+W+ GCI  
Sbjct: 134 ADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFA 192

Query: 350 ELFVKKPLF 358
           EL    PLF
Sbjct: 193 ELLNGSPLF 201

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  197 bits (503), Expect = 2e-61
 Identities = 80/191 (41%), Positives = 102/191 (53%), Gaps = 16/191 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++VA+K ++  +EK     TA REI+ILR+L+H NIV L +   DK            
Sbjct: 23  TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH---------- 72

Query: 230 FYLVFEYMDH-DLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
            YLV EY +  DL   L   G +  +E     I  Q+L GL Y H    +HRD+K  NIL
Sbjct: 73  LYLVMEYCEGGDLFDYLSRGGPLSEDEA--KKIALQILRGLEYLHSNGIIHRDLKPENIL 130

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           ++  G VK+ADFGLA+           T  V T WY  PE+LLG   YGP +DVWS G I
Sbjct: 131 LDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188

Query: 348 LGELFVKKPLF 358
           L EL   KP F
Sbjct: 189 LYELLTGKPPF 199

Length = 260

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  193 bits (492), Expect = 1e-59
 Identities = 87/193 (45%), Positives = 125/193 (64%), Gaps = 18/193 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++VA+KK+RLE+E+EG P TA+REI +L++L H NIV L++++  +S           
Sbjct: 24  TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES----------R 73

Query: 230 FYLVFEYMDHDLMGLLES----GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
            YL+FE++  DL   L+S      +D   V   S + Q+L G+ +CH R  LHRD+K  N
Sbjct: 74  LYLIFEFLSMDLKKYLDSLPKGQYMDAELVK--SYLYQILQGILFCHSRRVLHRDLKPQN 131

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +L++N+G +KLADFGLAR +      R YT++V+TLWYR PE+LLG  RY   +D+WS G
Sbjct: 132 LLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG 189

Query: 346 CILGELFVKKPLF 358
            I  E+  KKPLF
Sbjct: 190 TIFAEMATKKPLF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  191 bits (486), Expect = 1e-58
 Identities = 89/198 (44%), Positives = 126/198 (63%), Gaps = 23/198 (11%)

Query: 166 VSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIV-TDKSDALDFR 224
            S  T +LVALK++RLE+E EG P TA+RE  +L+ L H NIV L +I+ T K+      
Sbjct: 25  RSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKT------ 77

Query: 225 KDKGSFYLVFEYMDHDLMGLLE---SGMVDFNEVNNASI-MRQLLDGLSYCHKRNFLHRD 280
                  LVFEY+D DL   ++    G+     ++N  + + QLL GL+YCH+R  LHRD
Sbjct: 78  -----LTLVFEYLDTDLKQYMDDCGGGL----SMHNVRLFLFQLLRGLAYCHQRRVLHRD 128

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +K  N+L++ RGE+KLADFGLAR  +   +   Y+N+V+TLWYRPP++LLG   Y  ++D
Sbjct: 129 LKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLD 186

Query: 341 VWSCGCILGELFVKKPLF 358
           +W  GCI  E+   +PLF
Sbjct: 187 MWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  190 bits (484), Expect = 2e-58
 Identities = 90/192 (46%), Positives = 121/192 (63%), Gaps = 17/192 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALK+VRL+++ EG P +A+REI +L++L HKNIV L +++               
Sbjct: 24  THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK----------K 73

Query: 230 FYLVFEYMDHDLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             LVFEY D DL    +S  G +D   V   S M QLL GL++CH  N LHRD+K  N+L
Sbjct: 74  LTLVFEYCDQDLKKYFDSCNGDIDPEIVK--SFMFQLLKGLAFCHSHNVLHRDLKPQNLL 131

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  GE+KLADFGLAR +    R   Y+ +V+TLWYRPP++L G + Y  +ID+WS GCI
Sbjct: 132 INKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 189

Query: 348 LGELFVK-KPLF 358
             EL    +PLF
Sbjct: 190 FAELANAGRPLF 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  190 bits (484), Expect = 3e-58
 Identities = 85/191 (44%), Positives = 115/191 (60%), Gaps = 15/191 (7%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK +   + E    TA+RE+K+LRQL H+NIVNL           +  + KG 
Sbjct: 25  TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL----------KEAFRRKGR 74

Query: 230 FYLVFEYMDHDLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
            YLVFEY++  L+ LLE+  G +  + V   S + QLL  ++YCH  N +HRDIK  NIL
Sbjct: 75  LYLVFEYVERTLLELLEASPGGLPPDAVR--SYIWQLLQAIAYCHSHNIIHRDIKPENIL 132

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           ++  G +KL DFG AR         P T+ V T WYR PELL+G+  YG  +DVW+ GCI
Sbjct: 133 VSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191

Query: 348 LGELFVKKPLF 358
           + EL   +PLF
Sbjct: 192 MAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  189 bits (481), Expect = 7e-58
 Identities = 82/197 (41%), Positives = 115/197 (58%), Gaps = 21/197 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQL---NHKNIVNLREIVTDKSDALDFRKD 226
           T   VALKKVR+   +EG P++ +REI +L+QL    H NIV L ++          R D
Sbjct: 23  TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP------RTD 76

Query: 227 KG-SFYLVFEYMDHDLMGLLE----SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
           +     LVFE++D DL   L      G+     + +  +MRQLL G+ + H    +HRD+
Sbjct: 77  RELKLTLVFEHVDQDLATYLSKCPKPGL-PPETIKD--LMRQLLRGVDFLHSHRIVHRDL 133

Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           K  NIL+ + G+VK+ADFGLAR+Y     +   T+ V+TLWYR PE+LL    Y   +D+
Sbjct: 134 KPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLWYRAPEVLLQSS-YATPVDM 189

Query: 342 WSCGCILGELFVKKPLF 358
           WS GCI  ELF ++PLF
Sbjct: 190 WSVGCIFAELFRRRPLF 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  187 bits (477), Expect = 2e-57
 Identities = 85/192 (44%), Positives = 118/192 (61%), Gaps = 17/192 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L +++            +  
Sbjct: 24  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI----------HTENK 73

Query: 230 FYLVFEYMDHDL---MGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
            YLVFE++  DL   M       +    +   S + QLL GL++CH    LHRD+K  N+
Sbjct: 74  LYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHRVLHRDLKPQNL 131

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+N  G +KLADFGLAR +      R YT++V+TLWYR PE+LLG + Y  A+D+WS GC
Sbjct: 132 LINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 189

Query: 347 ILGELFVKKPLF 358
           I  E+  ++ LF
Sbjct: 190 IFAEMVTRRALF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  187 bits (478), Expect = 7e-57
 Identities = 78/193 (40%), Positives = 113/193 (58%), Gaps = 13/193 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITA---VREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T   VA+KK+    +     I A   +REIK+LR L H+NI+ L +I+   S      +D
Sbjct: 24  TGRKVAIKKISNVFDD---LIDAKRILREIKLLRHLRHENIIGLLDILRPPS-----PED 75

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
               Y+V E M+ DL  +++S      + +    + Q+L GL Y H  N +HRD+K SNI
Sbjct: 76  FNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNI 134

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L+N+  ++K+ DFGLAR  + ++ ++ + T  V+T WYR PELLL   RY  AID+WS G
Sbjct: 135 LVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG 194

Query: 346 CILGELFVKKPLF 358
           CI  EL  +KPLF
Sbjct: 195 CIFAELLTRKPLF 207

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  182 bits (464), Expect = 2e-55
 Identities = 85/193 (44%), Positives = 125/193 (64%), Gaps = 19/193 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALK++ L+ E EG P TA+REI ++++L H+NIV L +++  ++  +        
Sbjct: 24  TGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM-------- 74

Query: 230 FYLVFEYMDHDLMGLLES----GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
             LVFEYMD DL   +++    G +D N V   S   QLL G+++CH+   LHRD+K  N
Sbjct: 75  --LVFEYMDKDLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCHENRVLHRDLKPQN 130

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +L+N RGE+KLADFGLAR +        ++N+V+TLWYR P++LLG   Y  +ID+WS G
Sbjct: 131 LLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG 188

Query: 346 CILGELFVKKPLF 358
           CI+ E+   +PLF
Sbjct: 189 CIMAEMITGRPLF 201

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  180 bits (457), Expect = 2e-54
 Identities = 93/194 (47%), Positives = 127/194 (65%), Gaps = 17/194 (8%)

Query: 167 SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIV-TDKSDALDFRK 225
           S  T+ LVALK++RLE+E EG P TA+RE+ +L+ L H NIV L +I+ T++        
Sbjct: 26  SKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERC------- 77

Query: 226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASI-MRQLLDGLSYCHKRNFLHRDIKCS 284
                 LVFEY+D DL   L++   +   ++N  I M QLL GLSYCHKR  LHRD+K  
Sbjct: 78  ----LTLVFEYLDSDLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQ 132

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L+N +GE+KLADFGLAR  +   +   Y+N+V+TLWYRPP++LLG   Y   ID+W  
Sbjct: 133 NLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV 190

Query: 345 GCILGELFVKKPLF 358
           GCIL E+   +P+F
Sbjct: 191 GCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  177 bits (450), Expect = 4e-53
 Identities = 94/193 (48%), Positives = 123/193 (63%), Gaps = 15/193 (7%)

Query: 167 SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIV-TDKSDALDFRK 225
           S  TD LVALK++RLE+E EG P TA+RE+ +L+ L H NIV L +I+ T+KS       
Sbjct: 27  SKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS------- 78

Query: 226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
                 LVFEY+D DL   L+      N  N    + QLL GL+YCH+R  LHRD+K  N
Sbjct: 79  ----LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQN 134

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +L+N RGE+KLADFGLAR  +   +   Y+N+V+TLWYRPP++LLG   Y   ID+W  G
Sbjct: 135 LLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 192

Query: 346 CILGELFVKKPLF 358
           CI  E+   +PLF
Sbjct: 193 CIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  176 bits (449), Expect = 4e-53
 Identities = 86/193 (44%), Positives = 122/193 (63%), Gaps = 16/193 (8%)

Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T+E +ALKK+RLE E EG P TA+REI +L+++ H NIV L+++V           +K 
Sbjct: 25  VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV---------HSEK- 74

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNN--ASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             YLVFEY+D DL   ++S   DF +      + + Q+L G++YCH    LHRD+K  N+
Sbjct: 75  RLYLVFEYLDLDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133

Query: 287 LMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ R   +KLADFGLAR +      R +T++V+TLWYR PE+LLG   Y   +D+WS G
Sbjct: 134 LIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG 191

Query: 346 CILGELFVKKPLF 358
           CI  E+  +KPLF
Sbjct: 192 CIFAEMVNQKPLF 204

Length = 294

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  176 bits (449), Expect = 4e-53
 Identities = 81/194 (41%), Positives = 115/194 (59%), Gaps = 22/194 (11%)

Query: 170 TDELVALKKV--RLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKD 226
           T ELVA+KK+  +  + +E      +RE+K LR+LN H NIV L+E+           ++
Sbjct: 23  TGELVAIKKMKKKFYSWEE---CMNLREVKSLRKLNEHPNIVKLKEVF----------RE 69

Query: 227 KGSFYLVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
               Y VFEYM+ +L  L++      F+E    SI+ Q+L GL++ HK  F HRD+K  N
Sbjct: 70  NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPEN 129

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           +L++    VK+ADFGLAR    E R R PYT+ V T WYR PE+LL    Y   +D+W+ 
Sbjct: 130 LLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWAL 185

Query: 345 GCILGELFVKKPLF 358
           GCI+ EL+  +PLF
Sbjct: 186 GCIMAELYTLRPLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  176 bits (449), Expect = 8e-53
 Identities = 76/200 (38%), Positives = 115/200 (57%), Gaps = 18/200 (9%)

Query: 169 FTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
              +  A+KK + + E+  G   +A REI +LR+L H+N+V+L E+  + +D        
Sbjct: 25  KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD-------- 76

Query: 228 GSFYLVFEYMDHDLMGLL----ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
            S YL+F+Y +HDL  ++    ++  V        S++ Q+L+G+ Y H    LHRD+K 
Sbjct: 77  KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKP 136

Query: 284 SNILM----NNRGEVKLADFGLARLYNAEDRQRPYTNK-VITLWYRPPELLLGEERYGPA 338
           +NIL+      RG VK+ D GLARL+NA  +     +  V+T+WYR PELLLG   Y  A
Sbjct: 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKA 196

Query: 339 IDVWSCGCILGELFVKKPLF 358
           ID+W+ GCI  EL   +P+F
Sbjct: 197 IDIWAIGCIFAELLTLEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  176 bits (447), Expect = 1e-52
 Identities = 92/193 (47%), Positives = 123/193 (63%), Gaps = 15/193 (7%)

Query: 167 SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIV-TDKSDALDFRK 225
           S  T+ LVALK++RLE+E EG P TA+RE+ +L+ L H NIV L +IV TDKS       
Sbjct: 27  SKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS------- 78

Query: 226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
                 LVFEY+D DL   ++      +  N    + Q+L GL+YCH+R  LHRD+K  N
Sbjct: 79  ----LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQN 134

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +L+N RGE+KLADFGLAR  +   +   Y+N+V+TLWYRPP++LLG   Y   ID+W  G
Sbjct: 135 LLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG 192

Query: 346 CILGELFVKKPLF 358
           CI  E+   +PLF
Sbjct: 193 CIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  173 bits (440), Expect = 3e-51
 Identities = 77/213 (36%), Positives = 115/213 (53%), Gaps = 35/213 (16%)

Query: 170 TDELVALKKVRLENEKE------------GFPITAVREIKILRQLNHKNIVNLREIVTDK 217
           T ++VA+KKV++                 G   T +RE+KI+ ++ H+NI+ L ++  + 
Sbjct: 33  TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92

Query: 218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
               DF        LV + M  DL  +++   +   E     I+ Q+L+GL+  HK  F+
Sbjct: 93  ----DF------INLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFM 141

Query: 278 HRDIKCSNILMNNRGEVKLADFGLARLY------------NAEDRQRPYTNKVITLWYRP 325
           HRD+  +NI +N++G  K+ADFGLAR Y                R+   T+KV+TLWYR 
Sbjct: 142 HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRA 201

Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           PELL+G E+Y  A+D+WS GCI  EL   KPLF
Sbjct: 202 PELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234

Length = 335

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  168 bits (427), Expect = 8e-51
 Identities = 68/184 (36%), Positives = 99/184 (53%), Gaps = 15/184 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VA+K ++ E+         +REI+IL++LNH NIV L  +           +D+  
Sbjct: 17  TGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVF----------EDENH 65

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            YLV EY +   L  LL+      +E     I+ Q+L+GL Y H    +HRD+K  NIL+
Sbjct: 66  LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL 125

Query: 289 NNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           ++  G+VKLADFGL++L  ++         V T  Y  PE+LLG+  Y    D+WS G I
Sbjct: 126 DSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVI 183

Query: 348 LGEL 351
           L EL
Sbjct: 184 LYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  169 bits (431), Expect = 2e-50
 Identities = 80/191 (41%), Positives = 116/191 (60%), Gaps = 18/191 (9%)

Query: 170 TDELVALKKVRLENEKEGFPIT---AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T ++VA+KK  +E+E +  P+    A+REI++L+QL H N+VNL E+         FR+ 
Sbjct: 25  TGQIVAIKKF-VESEDD--PVIKKIALREIRMLKQLKHPNLVNLIEV---------FRR- 71

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           K   +LVFEY DH ++  LE       E     I+ Q L  +++CHK N +HRD+K  NI
Sbjct: 72  KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI 131

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+  +G++KL DFG AR+         YT+ V T WYR PELL+G+ +YGP +DVW+ GC
Sbjct: 132 LITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGC 189

Query: 347 ILGELFVKKPL 357
           +  EL   +PL
Sbjct: 190 VFAELLTGQPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  166 bits (423), Expect = 2e-49
 Identities = 78/189 (41%), Positives = 114/189 (60%), Gaps = 12/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++VA+KK     + +     A+REI++L+QL H+N+VNL E+         FR+ K  
Sbjct: 25  TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV---------FRRKK-R 74

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLVFE++DH ++  LE      +E      + Q+L G+ +CH  N +HRDIK  NIL++
Sbjct: 75  LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS 134

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             G VKL DFG AR   A      YT+ V T WYR PELL+G+ +YG A+D+W+ GC++ 
Sbjct: 135 QSGVVKLCDFGFARTLAAP--GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVT 192

Query: 350 ELFVKKPLF 358
           E+   +PLF
Sbjct: 193 EMLTGEPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  162 bits (411), Expect = 2e-47
 Identities = 81/195 (41%), Positives = 119/195 (61%), Gaps = 13/195 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN-IVNLREIVTDKSDALDFRKDKG 228
           T +LVALKK RLE ++EG P TA+REI +L+ L+    IV L ++   +         K 
Sbjct: 25  TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK-----NGKP 79

Query: 229 SFYLVFEYMDHDLMGLLES-GMVDFNEVNNASI---MRQLLDGLSYCHKRNFLHRDIKCS 284
           S YLVFEY+D DL   ++S G      +   +I   M QLL G+++CHK   +HRD+K  
Sbjct: 80  SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQ 139

Query: 285 NILMNNRGEV-KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +  + K+AD GL R ++   +   YT++++TLWYR PE+LLG   Y   +D+WS
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197

Query: 344 CGCILGELFVKKPLF 358
            GCI  E+  K+PLF
Sbjct: 198 VGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  161 bits (410), Expect = 9e-47
 Identities = 88/198 (44%), Positives = 119/198 (60%), Gaps = 24/198 (12%)

Query: 170 TDELVALKKV--RLENEKEG---FPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDF 223
           T E+VALKK+     N  +    F     REI  L++L +H NIV L  ++  ++D    
Sbjct: 31  TKEVVALKKIFDAFRNATDAQRTF-----REIMFLQELGDHPNIVKLLNVIKAEND---- 81

Query: 224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
            KD    YLVFEYM+ DL  ++ + ++   +V+   IM QLL  L Y H  N +HRD+K 
Sbjct: 82  -KD---IYLVFEYMETDLHAVIRANIL--EDVHKRYIMYQLLKALKYIHSGNVIHRDLKP 135

Query: 284 SNILMNNRGEVKLADFGLARLYNA--EDRQRP-YTNKVITLWYRPPELLLGEERYGPAID 340
           SNIL+N+   VKLADFGLAR  +   E+ + P  T+ V T WYR PE+LLG  RY   +D
Sbjct: 136 SNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVD 195

Query: 341 VWSCGCILGELFVKKPLF 358
           +WS GCILGE+ + KPLF
Sbjct: 196 MWSVGCILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  154 bits (391), Expect = 1e-44
 Identities = 83/215 (38%), Positives = 119/215 (55%), Gaps = 13/215 (6%)

Query: 144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN 203
             +S   +E L  G  +     +S    +LVALK + ++ E EG P TA+RE  +L+ L 
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLK 61

Query: 204 HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQ 263
           H NIV L +I+  K           +   VFEYM  DL   +       +  N    M Q
Sbjct: 62  HANIVLLHDIIHTKE----------TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ 111

Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
           LL GL+Y H ++ LHRD+K  N+L++  GE+KLADFGLAR  +   +   Y+++V+TLWY
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWY 169

Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           RPP++LLG   Y  A+D+W  GCI  E+   +P F
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  154 bits (390), Expect = 7e-44
 Identities = 72/192 (37%), Positives = 103/192 (53%), Gaps = 19/192 (9%)

Query: 174 VALKKVRLENEKEGF--PITA---VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           VA+KK+        F  P  A   +RE+KILR   H NI+ +R+I+       DF+    
Sbjct: 33  VAIKKI-----PHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA--DFK---- 81

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             Y+V + M+ DL  ++ S      E +    + QLL GL Y H  N +HRD+K SN+L+
Sbjct: 82  DVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV 140

Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           N   E+++ DFG+AR    +  + +   T  V T WYR PELLL    Y  AID+WS GC
Sbjct: 141 NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGC 200

Query: 347 ILGELFVKKPLF 358
           I  E+  ++ LF
Sbjct: 201 IFAEMLGRRQLF 212

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  152 bits (385), Expect = 9e-44
 Identities = 81/192 (42%), Positives = 117/192 (60%), Gaps = 15/192 (7%)

Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQL---NHKNIVNLREI-VTDKSDALDFRKDK 227
             VALK VR++  ++G P++ VRE+ +L++L   +H NIV L ++  T ++D    R+ K
Sbjct: 26  HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD----RETK 81

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
            +  LVFE++D DL   L+              +MRQ L GL + H    +HRD+K  NI
Sbjct: 82  VT--LVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 139

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+ + G+VKLADFGLAR+Y+    Q   T  V+TLWYR PE+LL +  Y   +D+WS GC
Sbjct: 140 LVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGC 195

Query: 347 ILGELFVKKPLF 358
           I  E+F +KPLF
Sbjct: 196 IFAEMFRRKPLF 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  152 bits (386), Expect = 3e-43
 Identities = 77/191 (40%), Positives = 111/191 (58%), Gaps = 12/191 (6%)

Query: 170 TDELVALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T+E VA+KK+    +N  +      +REIK+LR L+H+N++ +++I+         R+  
Sbjct: 29  TNEKVAIKKIANAFDNRIDA--KRTLREIKLLRHLDHENVIAIKDIMPPPH-----REAF 81

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              Y+V+E MD DL  ++ S     ++ +    + QLL GL Y H  N LHRD+K SN+L
Sbjct: 82  NDVYIVYELMDTDLHQIIRSSQTLSDD-HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL 140

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N   ++K+ DFGLAR  + +      T  V+T WYR PELLL    Y  AIDVWS GCI
Sbjct: 141 LNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCI 198

Query: 348 LGELFVKKPLF 358
             EL  +KPLF
Sbjct: 199 FAELLGRKPLF 209

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  149 bits (378), Expect = 1e-42
 Identities = 58/83 (69%), Positives = 68/83 (81%)

Query: 12  ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLL 71
           AN EL QLE+IS+LCG+P PAVWP VIKLP ++T+KPKK +RRRLREEFS +P  ALDLL
Sbjct: 220 ANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLL 279

Query: 72  DKMLELDPERRITAEQALKSVWL 94
           D ML LDP +R TAE+AL S WL
Sbjct: 280 DHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  149 bits (379), Expect = 3e-42
 Identities = 73/190 (38%), Positives = 109/190 (57%), Gaps = 9/190 (4%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T   VA+KK+    E + F    +REIKILR+  H+NI+ + +I+  +  + +   D   
Sbjct: 29  TGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILDII--RPPSFESFND--- 82

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y+V E M+ DL  L+++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N
Sbjct: 83  VYIVQELMETDLYKLIKTQHLSNDHI--QYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 140

Query: 290 NRGEVKLADFGLARLY-NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              ++K+ DFGLAR+     D     T  V T WYR PE++L  + Y  AID+WS GCIL
Sbjct: 141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL 200

Query: 349 GELFVKKPLF 358
            E+   +PLF
Sbjct: 201 AEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  145 bits (368), Expect = 3e-41
 Identities = 83/193 (43%), Positives = 119/193 (61%), Gaps = 19/193 (9%)

Query: 173 LVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREIVT-DKSDALDFRKDKG 228
            VALK+VR++  +EG P++ +RE+ +LR L    H N+V L ++ T  ++D    R+ K 
Sbjct: 29  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD----RETK- 83

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASI---MRQLLDGLSYCHKRNFLHRDIKCSN 285
              LVFE++D DL   L+   V    V   +I   M QLL GL + H    +HRD+K  N
Sbjct: 84  -LTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 140

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           IL+ + G++KLADFGLAR+Y+    Q   T+ V+TLWYR PE+LL +  Y   +D+WS G
Sbjct: 141 ILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVG 196

Query: 346 CILGELFVKKPLF 358
           CI  E+F +KPLF
Sbjct: 197 CIFAEMFRRKPLF 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  145 bits (366), Expect = 7e-41
 Identities = 83/201 (41%), Positives = 116/201 (57%), Gaps = 13/201 (6%)

Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           +E L  G  +      S    +LVALK +RL+ E+EG P TA+RE  +L+ L H NIV L
Sbjct: 10  LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ-EEEGTPFTAIREASLLKGLKHANIVLL 68

Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            +I+  K           +  LVFEY+  DL   ++      +  N    + QLL GLSY
Sbjct: 69  HDIIHTKE----------TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118

Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H+R  LHRD+K  N+L+++ GE+KLADFGLAR  +       Y+N+V+TLWYRPP++LL
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT--YSNEVVTLWYRPPDVLL 176

Query: 331 GEERYGPAIDVWSCGCILGEL 351
           G   Y   +D+W  GCI  E+
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  145 bits (367), Expect = 2e-40
 Identities = 82/214 (38%), Positives = 115/214 (53%), Gaps = 10/214 (4%)

Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + PL  G   L   +V    D+ VA+KK+ L + +      A+REIKI+R+L+H NIV +
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALREIKIIRRLDHDNIVKV 67

Query: 211 REIVTDK-SDALDFRKDKGSF---YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLD 266
            E++    SD  +           Y+V EYM+ DL  +LE G +          M QLL 
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR--LFMYQLLR 125

Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEV-KLADFGLARLYNAEDRQRPY-TNKVITLWYR 324
           GL Y H  N LHRD+K +N+ +N    V K+ DFGLAR+ +     + Y +  ++T WYR
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185

Query: 325 PPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            P LLL    Y  AID+W+ GCI  E+   KPLF
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  143 bits (363), Expect = 5e-40
 Identities = 76/193 (39%), Positives = 105/193 (54%), Gaps = 14/193 (7%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNL--REIVTDKSDALDFRKDK 227
           +E VA+KK+     K+     A+RE+K+LR    HKNI  L   +IV       +     
Sbjct: 27  EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF--PGNFN----- 79

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              YL  E M+ DL  ++ SG     + +  S + Q+L GL Y H  N LHRD+K  N+L
Sbjct: 80  -ELYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLL 137

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +N   E+K+ DFGLAR ++    +     T  V T WYR PE++L  + Y  AIDVWS G
Sbjct: 138 VNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG 197

Query: 346 CILGELFVKKPLF 358
           CIL EL  +KP+F
Sbjct: 198 CILAELLGRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  140 bits (354), Expect = 3e-39
 Identities = 82/189 (43%), Positives = 112/189 (59%), Gaps = 12/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK +   E E    T +RE+K+LR L  +NIV L+E          FR+ +G 
Sbjct: 25  TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA---------FRR-RGK 74

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLVFEY++ +++ LLE            S + QL+  + +CHK + +HRDIK  N+L++
Sbjct: 75  LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           +   +KL DFG AR   +E     YT  V T WYR PELLLG   YG A+D+WS GCILG
Sbjct: 135 HNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILG 192

Query: 350 ELFVKKPLF 358
           EL   +PLF
Sbjct: 193 ELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  136 bits (344), Expect = 5e-38
 Identities = 63/195 (32%), Positives = 96/195 (49%), Gaps = 25/195 (12%)

Query: 167 SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
              T + VA+K ++LE++++   I  + EI+IL++  H NIV        K         
Sbjct: 21  HKRTGKEVAIKVIKLESKEKKEKI--INEIQILKKCKHPNIVKYYGSYLKK--------- 69

Query: 227 KGSFYLVFEYMDHDLMG----LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
               ++V E+      G    LL+S      E   A + ++LL GL Y H    +HRDIK
Sbjct: 70  -DELWIVMEFCS---GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIK 125

Query: 283 CSNILMNNRGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
            +NIL+ + GEVKL DFGL+ +L + + R       V T ++  PE++ G + Y    D+
Sbjct: 126 AANILLTSDGEVKLIDFGLSAQLSDTKARNTM----VGTPYWMAPEVING-KPYDYKADI 180

Query: 342 WSCGCILGELFVKKP 356
           WS G    EL   KP
Sbjct: 181 WSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  134 bits (341), Expect = 2e-37
 Identities = 66/194 (34%), Positives = 93/194 (47%), Gaps = 19/194 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             +L  LK++ L N  E     A+ E+KIL++LNH NI+   E          F ++KG 
Sbjct: 24  DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE---------SF-EEKGK 73

Query: 230 FYLVFEYMDH-DLMGLLESGMVD---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
             +V EY D  DL   ++    +   F E        QL   L Y H R  LHRDIK  N
Sbjct: 74  LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSC 344
           I + + G VKL DFG++++ ++          V+ T +Y  PEL    + Y    D+WS 
Sbjct: 134 IFLTSNGLVKLGDFGISKVLSSTV---DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSL 189

Query: 345 GCILGELFVKKPLF 358
           GC+L EL   K  F
Sbjct: 190 GCVLYELCTLKHPF 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  136 bits (344), Expect = 4e-37
 Identities = 65/189 (34%), Positives = 100/189 (52%), Gaps = 11/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T   VA+KK+    +         RE+++L+ ++H+N++ L ++ T  S   DF+     
Sbjct: 39  TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ----D 94

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLV   M  DL  +++   +  + +    ++ Q+L GL Y H    +HRD+K SNI +N
Sbjct: 95  VYLVTHLMGADLNNIVKCQKLSDDHIQ--FLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 152

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
              E+K+ DFGLAR  + E      T  V T WYR PE++L    Y   +D+WS GCI+ 
Sbjct: 153 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 207

Query: 350 ELFVKKPLF 358
           EL   K LF
Sbjct: 208 ELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  133 bits (338), Expect = 1e-36
 Identities = 63/183 (34%), Positives = 95/183 (51%), Gaps = 17/183 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VA+KK+RL  + +      + EI I++   H NIV+            D       
Sbjct: 43  TGKEVAIKKMRLRKQNKE---LIINEILIMKDCKHPNIVDY----------YDSYLVGDE 89

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            ++V EYMD   L  ++    V  NE   A + R++L GL Y H +N +HRDIK  NIL+
Sbjct: 90  LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  G VKLADFG A     E  +R   + V T ++  PE++  ++ YGP +D+WS G + 
Sbjct: 150 SKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMC 206

Query: 349 GEL 351
            E+
Sbjct: 207 IEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  132 bits (335), Expect = 2e-36
 Identities = 66/170 (38%), Positives = 91/170 (53%), Gaps = 13/170 (7%)

Query: 190 ITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           +  +REI+ LR+L+ H NI+ L E++ D+          G   LVFE MD +L  L++  
Sbjct: 42  VNNLREIQALRRLSPHPNILRLIEVLFDRK--------TGRLALVFELMDMNLYELIKGR 93

Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
                E    S M QLL  L + H+    HRDIK  NIL+ +   +KLADFG  R     
Sbjct: 94  KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCR---GI 149

Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             + PYT  + T WYR PE LL +  YGP +D+W+ GC+  E+    PLF
Sbjct: 150 YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF 199

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (331), Expect = 5e-36
 Identities = 71/192 (36%), Positives = 105/192 (54%), Gaps = 19/192 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T EL+A+K V L  + E   + A+ REI+IL  L H NIV  R   +++       ++K 
Sbjct: 24  TGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHPNIV--RYYGSERD------EEKN 74

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASI---MRQLLDGLSYCHKRNFLHRDIKCSN 285
           +  +  EY+     G L S +  F ++    I    RQ+L+GL+Y H    +HRDIK +N
Sbjct: 75  TLNIFLEYVS---GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGAN 131

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSC 344
           IL+++ G VKLADFG A+     +     T  V  T ++  PE++ GEE YG A D+WS 
Sbjct: 132 ILVDSDGVVKLADFGCAKRLGDIE-TGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSL 189

Query: 345 GCILGELFVKKP 356
           GC + E+   KP
Sbjct: 190 GCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  130 bits (330), Expect = 6e-36
 Identities = 62/189 (32%), Positives = 96/189 (50%), Gaps = 17/189 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VA+K++ LE  KE    + ++EI +L+ L H NIV            +   +   S
Sbjct: 24  TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY----------IGSIETSDS 73

Query: 230 FYLVFEYMDH-DLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
            Y++ EY ++  L  +++  G   F E   A  + Q+L GL+Y H++  +HRDIK +NIL
Sbjct: 74  LYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANIL 131

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
               G VKLADFG+A   N   +     + V T ++  PE++        A D+WS GC 
Sbjct: 132 TTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGA-STASDIWSLGCT 188

Query: 348 LGELFVKKP 356
           + EL    P
Sbjct: 189 VIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  132 bits (333), Expect = 1e-35
 Identities = 70/197 (35%), Positives = 104/197 (52%), Gaps = 18/197 (9%)

Query: 165 SVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           ++   T E VA+KK+    + E F   A RE+ +L+ + H+N++ L ++ T      +F+
Sbjct: 34  AIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93

Query: 225 KDKGSFYLVFEYMDHDL---MGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
                FYLV  YM  DL   MG         +E     ++ Q+L GL Y H    +HRD+
Sbjct: 94  ----DFYLVMPYMQTDLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDL 143

Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           K  N+ +N   E+K+ DFGLAR  +AE      T  V+T WYR PE++L    Y   +D+
Sbjct: 144 KPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDI 198

Query: 342 WSCGCILGELFVKKPLF 358
           WS GCI+ E+   K LF
Sbjct: 199 WSVGCIMAEMLTGKTLF 215

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  129 bits (326), Expect = 9e-35
 Identities = 72/213 (33%), Positives = 110/213 (51%), Gaps = 26/213 (12%)

Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAV-----REIKILRQLNHK 205
           ++P+  G   L   +    T + VA+KK+      + F    +     RE+K+L+ L H+
Sbjct: 15  LQPVGMGAFGLVCSARDQLTGQNVAIKKIM-----KPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NI++L +I         F       Y V E +  DL  LL S  ++   +     + Q+L
Sbjct: 70  NIISLSDI---------FISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQ--YFLYQIL 118

Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
            GL Y H    +HRD+K SNIL+N   ++K+ DFGLAR+   +D Q   T  V T +YR 
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQ--MTGYVSTRYYRA 173

Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           PE++L  ++Y   +D+WS GCI  E+   KPLF
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  129 bits (326), Expect = 1e-34
 Identities = 76/197 (38%), Positives = 108/197 (54%), Gaps = 10/197 (5%)

Query: 165 SVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           ++   T E VA+KK+    E        +REIK+LR L H +IV ++ I+   S     R
Sbjct: 19  AIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-----R 73

Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           ++    Y+VFE M+ DL  ++++   D    ++   + QLL  L Y H  N  HRD+K  
Sbjct: 74  REFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPK 132

Query: 285 NILMNNRGEVKLADFGLARL-YNAEDRQRPYTNKVITLWYRPPELLLGE--ERYGPAIDV 341
           NIL N   ++K+ DFGLAR+ +N       +T+ V T WYR PE L G    +Y PAID+
Sbjct: 133 NILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDI 191

Query: 342 WSCGCILGELFVKKPLF 358
           WS GCI  E+   KPLF
Sbjct: 192 WSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (323), Expect = 5e-34
 Identities = 73/199 (36%), Positives = 95/199 (47%), Gaps = 22/199 (11%)

Query: 172 ELVALKKVRLE-NEKEGFPITAVREIKILRQLNH-KNIVNLREIVTDKSDALDFRKDKGS 229
           +LVALK +  +   K       +REI+IL  LNH  NIV L           DF +D+GS
Sbjct: 23  KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL----------YDFFQDEGS 72

Query: 230 FYLVFEYMD-HDLMGLLESGM--VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
            YLV EY+D   L  LL+        +E     I+ Q+L  L Y H +  +HRDIK  NI
Sbjct: 73  LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENI 132

Query: 287 LMN-NRGEVKLADFGLARLYNAED----RQRPYTNKVITLWYRPPELLLG--EERYGPAI 339
           L++ +   VKL DFGLA+L              +  V T  Y  PE+LLG        + 
Sbjct: 133 LLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSS 192

Query: 340 DVWSCGCILGELFVKKPLF 358
           D+WS G  L EL    P F
Sbjct: 193 DIWSLGITLYELLTGLPPF 211

Length = 384

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  127 bits (320), Expect = 5e-34
 Identities = 77/208 (37%), Positives = 116/208 (55%), Gaps = 39/208 (18%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           D   ALK++    E  G  ++A REI +LR+L H N+++L+++    +D    RK     
Sbjct: 28  DRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQKVFLSHAD----RK----V 75

Query: 231 YLVFEYMDHDLMGLLESGMVDFNEVNNA-------------SIMRQLLDGLSYCHKRNFL 277
           +L+F+Y +HDL  +++     F+  + A             S++ Q+LDG+ Y H    L
Sbjct: 76  WLLFDYAEHDLWHIIK-----FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 130

Query: 278 HRDIKCSNILM----NNRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLL 330
           HRD+K +NIL+      RG VK+AD G ARL+N+    +P  +    V+T WYR PELLL
Sbjct: 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSP--LKPLADLDPVVVTFWYRAPELLL 188

Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y  AID+W+ GCI  EL   +P+F
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  126 bits (318), Expect = 2e-33
 Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 11/208 (5%)

Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++ + +G       ++   T   VA+KK+    + E F   A RE+++L+ + H+N++ L
Sbjct: 20  LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79

Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T       F      FYLV  +M  DL  L++      +E     ++ Q+L GL Y
Sbjct: 80  LDVFTPDLSLDRFH----DFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKY 133

Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K  N+ +N   E+K+ DFGLAR  ++E      T  V+T WYR PE++L
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVIL 188

Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ E+   KPLF
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  125 bits (316), Expect = 2e-33
 Identities = 77/204 (37%), Positives = 114/204 (55%), Gaps = 39/204 (19%)

Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           ALK++    E  G  ++A REI +LR+L H N++ L+++    SD    RK     +L+F
Sbjct: 32  ALKQI----EGTGISMSACREIALLRELKHPNVIALQKVFLSHSD----RK----VWLLF 79

Query: 235 EYMDHDLMGLLESGMVDFNEVNNA-------------SIMRQLLDGLSYCHKRNFLHRDI 281
           +Y +HDL  +++     F+  + A             S++ Q+LDG+ Y H    LHRD+
Sbjct: 80  DYAEHDLWHIIK-----FHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDL 134

Query: 282 KCSNILM----NNRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEER 334
           K +NIL+      RG VK+AD G ARL+N+    +P  +    V+T WYR PELLLG   
Sbjct: 135 KPANILVMGEGPERGRVKIADMGFARLFNSP--LKPLADLDPVVVTFWYRAPELLLGARH 192

Query: 335 YGPAIDVWSCGCILGELFVKKPLF 358
           Y  AID+W+ GCI  EL   +P+F
Sbjct: 193 YTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  122 bits (308), Expect = 1e-32
 Identities = 66/189 (34%), Positives = 94/189 (49%), Gaps = 23/189 (12%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++ ALKK+ + +  E F    +RE+K LR      +V        +          G 
Sbjct: 25  TGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE----------GE 73

Query: 230 FYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH-KRNFLHRDIKCS 284
             +V EYMD     DL+  +        E   A I RQ+L GL Y H KR+ +HRDIK S
Sbjct: 74  ISIVLEYMDGGSLADLLKKVGK----IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPS 129

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L+N++GEVK+ADFG+++    E+        V T+ Y  PE + GE  Y  A D+WS 
Sbjct: 130 NLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGES-YSYAADIWSL 186

Query: 345 GCILGELFV 353
           G  L E  +
Sbjct: 187 GLTLLECAL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  117 bits (296), Expect = 6e-31
 Identities = 64/200 (32%), Positives = 90/200 (45%), Gaps = 28/200 (14%)

Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL--REIVTDKSDALDFRKDKGS 229
           +++  K++   N  E      V E+ ILR+L H NIV    R I               +
Sbjct: 26  KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ----------T 75

Query: 230 FYLVFEYMDH-DLMGLL-----ESGMVDFNEVNNASIMRQLLDGLSYCHKRN-----FLH 278
            Y+V EY +  DL  L+     E   ++   +    I+ QLL  L  CH R+      LH
Sbjct: 76  LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI--WRILTQLLLALYECHNRSDPGNTVLH 133

Query: 279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPA 338
           RD+K +NI ++    VKL DFGLA++    D     T  V T +Y  PE L     Y   
Sbjct: 134 RDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTY-VGTPYYMSPEQLN-HMSYDEK 190

Query: 339 IDVWSCGCILGELFVKKPLF 358
            D+WS GC++ EL    P F
Sbjct: 191 SDIWSLGCLIYELCALSPPF 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  118 bits (298), Expect = 3e-30
 Identities = 60/170 (35%), Positives = 95/170 (55%), Gaps = 13/170 (7%)

Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-- 249
             RE+K+L    H N+++  +I+  +   +D  ++    Y+V E M  DL  ++ S    
Sbjct: 46  VFRELKMLCFFKHDNVLSALDIL--QPPHIDPFEE---IYVVTELMQSDLHKIIVSPQPL 100

Query: 250 -VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
             D  +V     + Q+L GL Y H    LHRDIK  N+L+N+   +K+ DFGLAR+   +
Sbjct: 101 SSDHVKV----FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156

Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + +   T +V+T +YR PE+L+G   Y  A+D+WS GCI  EL  ++ LF
Sbjct: 157 ESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 3e-30
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 29/196 (14%)

Query: 170 TDELVALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
               VA+K ++    E E++ F    ++E +++++L H N+V L  + T++         
Sbjct: 22  KTTEVAVKTLKEDASEEERKDF----LKEARVMKKLGHPNVVRLLGVCTEE--------- 68

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASI-MRQLLD-------GLSYCHKRNFL 277
               YLV EYM+  DL+  L      F     +++ ++ LL        G+ Y   + F+
Sbjct: 69  -EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFV 127

Query: 278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN-KVITLWYRPPELLLGEERYG 336
           HRD+   N L+     VK++DFGL+R    +D  R  T  K+   W   PE L  +  + 
Sbjct: 128 HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-APESLK-DGIFT 185

Query: 337 PAIDVWSCGCILGELF 352
              DVWS G +L E+F
Sbjct: 186 SKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  114 bits (288), Expect = 9e-30
 Identities = 57/188 (30%), Positives = 93/188 (49%), Gaps = 21/188 (11%)

Query: 170 TDELVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
            +  VA+K ++    E + E F    +RE +I+R+L+H NIV L  + T++         
Sbjct: 27  KEVEVAVKTLKEDASEQQIEEF----LREARIMRKLDHPNIVKLLGVCTEE--------- 73

Query: 227 KGSFYLVFEYMDH-DLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
                +V EYM   DL+  L ++   + +  +  S   Q+  G+ Y   +NF+HRD+   
Sbjct: 74  -EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAAR 132

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N L+     VK++DFGL+R    +D  +    K+   W   PE L  E ++    DVWS 
Sbjct: 133 NCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLK-EGKFTSKSDVWSF 190

Query: 345 GCILGELF 352
           G +L E+F
Sbjct: 191 GVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  113 bits (285), Expect = 2e-29
 Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 20/187 (10%)

Query: 170 TDELVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
               VA+K ++    E + E F    +RE +I+R+L+H N+V L  + T++         
Sbjct: 27  KKVEVAVKTLKEDASEQQIEEF----LREARIMRKLDHPNVVKLLGVCTEE--------- 73

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
               Y+V EYM+  DL+  L       +  +  S   Q+  G+ Y   +NF+HRD+   N
Sbjct: 74  -EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARN 132

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
            L+     VK++DFGL+R    +D  R    K+   W   PE L  E ++    DVWS G
Sbjct: 133 CLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLK-EGKFTSKSDVWSFG 190

Query: 346 CILGELF 352
            +L E+F
Sbjct: 191 VLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  111 bits (280), Expect = 1e-28
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 24/198 (12%)

Query: 166 VSLFTDELVALKKVRLENEKEGFPITAV----REIKILRQLNHKNIVNLREIVTDKSDAL 221
           ++L   +  A+K+V L ++       AV    +EI +L +L H NIV  + + T++ +  
Sbjct: 20  LNLDDGDFFAVKEVSLADD-GQTGQEAVKQLEQEIALLSKLQHPNIV--QYLGTEREE-- 74

Query: 222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASI---MRQLLDGLSYCHKRNFLH 278
                  + Y+  E +     G L   +  +       I    RQ+L GL Y H RN +H
Sbjct: 75  ------DNLYIFLELVP---GGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125

Query: 279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPA 338
           RDIK +NIL++  G VKLADFG+A+        + +     + ++  PE++  +  YG A
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKG---SPYWMAPEVIAQQGGYGLA 182

Query: 339 IDVWSCGCILGELFVKKP 356
            D+WS GC + E+   KP
Sbjct: 183 ADIWSLGCTVLEMATGKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  112 bits (283), Expect = 3e-28
 Identities = 63/189 (33%), Positives = 104/189 (55%), Gaps = 11/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VA+KK+    +       A RE+ +++ +NHKNI+ L  + T +    +F+     
Sbjct: 40  TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ----D 95

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLV E MD +L  +++   +D +    + ++ Q+L G+ + H    +HRD+K SNI++ 
Sbjct: 96  VYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 152

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           +   +K+ DFGLAR         PY   V+T +YR PE++LG   Y   +D+WS GCI+G
Sbjct: 153 SDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILGMG-YKENVDIWSVGCIMG 208

Query: 350 ELFVKKPLF 358
           E+     LF
Sbjct: 209 EMIRGTVLF 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 1e-27
 Identities = 46/80 (57%), Positives = 60/80 (75%), Gaps = 1/80 (1%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS-LMPPGALDLLDK 73
           EL QLE I +LCG+PT   WP V KLP +  +KPKK ++RRLRE F  L+ P ALDLLDK
Sbjct: 207 ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDK 266

Query: 74  MLELDPERRITAEQALKSVW 93
           +L LDP++RI+A+QAL+  +
Sbjct: 267 LLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  107 bits (271), Expect = 2e-27
 Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 21/188 (11%)

Query: 170 TDELVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T+  VA+K ++    E E+E F    + E  I+++L+H NIV L  + T           
Sbjct: 27  TETKVAVKTLKEGASEEEREEF----LEEASIMKKLSHPNIVRLLGVCTQG--------- 73

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
               Y+V EYM   DL+  L          +   +  Q+  G+ Y   +NF+HRD+   N
Sbjct: 74  -EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARN 132

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGEERYGPAIDVWSC 344
            L+     VK++DFGL+R    +D  R      + + W   PE L  + ++    DVWS 
Sbjct: 133 CLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APESLK-DGKFTSKSDVWSF 190

Query: 345 GCILGELF 352
           G +L E+F
Sbjct: 191 GVLLWEIF 198

Length = 258

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  109 bits (274), Expect = 3e-27
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)

Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81

Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 82  LNVFTPQKSLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 134

Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 191

Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 192 GMG-YKENVDIWSVGCIMGEMVRHKILF 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  108 bits (270), Expect = 1e-26
 Identities = 58/168 (34%), Positives = 92/168 (54%), Gaps = 17/168 (10%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFN 253
           RE+++L+ + H+N++ L ++ T  +   +F +     YLV   M  DL     + +V   
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNE----VYLVTNLMGADL-----NNIVKCQ 113

Query: 254 EVNNASI---MRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           ++++  +   + QLL GL Y H    +HRD+K SN+ +N   E+++ DFGLAR  + E  
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-- 171

Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
               T  V T WYR PE++L    Y   +D+WS GCI+ EL   K LF
Sbjct: 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  107 bits (267), Expect = 4e-26
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)

Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88

Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 141

Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198

Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  107 bits (267), Expect = 4e-26
 Identities = 62/185 (33%), Positives = 103/185 (55%), Gaps = 11/185 (5%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    + +     A RE+ +L+ +NHKNI++L  + T +    +F+      YLV
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ----DVYLV 104

Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            E MD +L  ++    ++ +    + ++ Q+L G+ + H    +HRD+K SNI++ +   
Sbjct: 105 MELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 161

Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +K+ DFGLAR         PY   V+T +YR PE++LG   Y   +D+WS GCI+GEL  
Sbjct: 162 LKILDFGLARTACTNFMMTPY---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVK 217

Query: 354 KKPLF 358
              +F
Sbjct: 218 GSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  105 bits (263), Expect = 1e-25
 Identities = 57/165 (34%), Positives = 90/165 (54%), Gaps = 11/165 (6%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFN 253
           RE+++L+ + H+N++ L ++ T      +F       YLV   M  DL  +++   +  +
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDD 120

Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            V    ++ Q+L GL Y H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E     
Sbjct: 121 HVQ--FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----- 173

Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            T  V T WYR PE++L    Y   +D+WS GCI+ EL   + LF
Sbjct: 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  102 bits (256), Expect = 3e-25
 Identities = 62/198 (31%), Positives = 91/198 (45%), Gaps = 38/198 (19%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++VA+K V +E + +      ++EI IL+Q +   IV                K  GS
Sbjct: 27  TGQVVAIKVVPVEEDLQEI----IKEISILKQCDSPYIV----------------KYYGS 66

Query: 230 FY------LVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           ++      +V EY       D+M +         E   A+I+ Q L GL Y H    +HR
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHSNKKIHR 123

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPA 338
           DIK  NIL+N  G+ KLADFG++        +R   N VI T ++  PE++  E  Y   
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR---NTVIGTPFWMAPEVIQ-EIGYNNK 179

Query: 339 IDVWSCGCILGELFVKKP 356
            D+WS G    E+   KP
Sbjct: 180 ADIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  101 bits (253), Expect = 1e-24
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 41/214 (19%)

Query: 170 TDELVALK---KVRLENE-KEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFR 224
           T++  A+K   K +L  E K  +      E ++L +LN H  I+ L    T       F 
Sbjct: 25  TNKEYAIKILDKRQLIKEKKVKY---VKIEKEVLTRLNGHPGIIKL--YYT-------F- 71

Query: 225 KDKGSFYLVFEYMDH-DLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
           +D+ + Y V EY  + +L+  +   G +D           ++L  L Y H +  +HRD+K
Sbjct: 72  QDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YAAEILLALEYLHSKGIIHRDLK 129

Query: 283 CSNILMNNRGEVKLADFGLARLYNAED---------------RQRPYTNK---VITLWYR 324
             NIL++    +K+ DFG A++ +                   ++        V T  Y 
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189

Query: 325 PPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            PE LL E+  G + D+W+ GCI+ ++   KP F
Sbjct: 190 SPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 99.1 bits (248), Expect = 4e-24
 Identities = 63/195 (32%), Positives = 91/195 (46%), Gaps = 24/195 (12%)

Query: 170 TDELVALK-----KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           T +L A+K     K+    E E      + E  IL ++NH  IV L       +    F 
Sbjct: 17  TGKLYAMKVLKKKKIIKRKEVE----HTLTERNILSRINHPFIVKLH-----YA----F- 62

Query: 225 KDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           + +   YLV EY    +L   L      F+E        +++  L Y H    ++RD+K 
Sbjct: 63  QTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
            NIL++  G +KL DFGLA+   + +  R  T    T  Y  PE+LLG+  YG A+D WS
Sbjct: 122 ENILLDADGHIKLTDFGLAK-ELSSEGSRTNT-FCGTPEYLAPEVLLGKG-YGKAVDWWS 178

Query: 344 CGCILGELFVKKPLF 358
            G +L E+   KP F
Sbjct: 179 LGVLLYEMLTGKPPF 193

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 4e-24
 Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 30/199 (15%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ELVA+K ++LE   + F I   +EI +L++  H NIV               R+DK  
Sbjct: 27  TGELVAIKVIKLE-PGDDFEII-QQEISMLKECRHPNIVAYF--------GSYLRRDK-- 74

Query: 230 FYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
            ++V EY       D+  +    +   +E+  A + R+ L GL+Y H+   +HRDIK +N
Sbjct: 75  LWIVMEYCGGGSLQDIYQVTRGPL---SELQIAYVCRETLKGLAYLHETGKIHRDIKGAN 131

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEER--YGPAIDVW 342
           IL+   G+VKLADFG++    A   +R      I T ++  PE+   E +  Y    D+W
Sbjct: 132 ILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPYWMAPEVAAVERKGGYDGKCDIW 188

Query: 343 SCG--CI-LGELFVKKPLF 358
           + G   I L EL  + P+F
Sbjct: 189 ALGITAIELAEL--QPPMF 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.9 bits (247), Expect = 5e-24
 Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 22/199 (11%)

Query: 166 VSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           V+L T EL+A+K++R+++           E+K+L  L H N+V        K   ++  +
Sbjct: 20  VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV--------KYYGVEVHR 71

Query: 226 DKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMR---QLLDGLSYCHKRNFLHRDI 281
           +K   Y+  EY     L  LLE G +    V    I     QLL+GL+Y H    +HRDI
Sbjct: 72  EK--VYIFMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 282 KCSNILMNNRGEVKLADFGLA-RLYNAEDRQRPYTNKVI-TLWYRPPELLLGEER--YGP 337
           K +NI +++ G +KL DFG A +L N           +  T  Y  PE++ G +   +G 
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185

Query: 338 AIDVWSCGCILGELFVKKP 356
           A D+WS GC++ E+   K 
Sbjct: 186 AADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 9e-24
 Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 21/190 (11%)

Query: 170 TDELVALKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T+++VA+K + LE  ++   I  + +EI+ L Q     I          S          
Sbjct: 25  TNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRSPYITKYYGSFLKGS---------- 72

Query: 229 SFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             +++ EY      + LL+ G    +E   A I+R++L GL Y H+   +HRDIK +NIL
Sbjct: 73  KLWIIMEYCGGGSCLDLLKPGK--LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANIL 130

Query: 288 MNNRGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           ++  G+VKLADFG++ +L +   ++  +   V T ++  PE++     Y    D+WS G 
Sbjct: 131 LSEEGDVKLADFGVSGQLTSTMSKRNTF---VGTPFWMAPEVIKQSG-YDEKADIWSLGI 186

Query: 347 ILGELFVKKP 356
              EL   +P
Sbjct: 187 TAIELAKGEP 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 86/285 (30%), Positives = 128/285 (44%), Gaps = 45/285 (15%)

Query: 99  PESMPPPQLPTWQDCHELWSKKRRRQLRGDPM---EMQAAAPI-------QSNSTNNSSR 148
           P   PP         H   S+ RRR     P+   +   A P+        S+S+++SS 
Sbjct: 3   PIQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSA 62

Query: 149 PLMEPLAAGGLS----LNNFS----------VSLFTDELVALKKVRLENEKEGFPITAVR 194
               P AA  LS    +N             +   T  L ALK V   N ++       R
Sbjct: 63  SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVRRQICR 121

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI+ILR +NH N+V             D     G   ++ E+MD    G LE   +  +E
Sbjct: 122 EIEILRDVNHPNVVKCH----------DMFDHNGEIQVLLEFMDG---GSLEGTHIA-DE 167

Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
              A + RQ+L G++Y H+R+ +HRDIK SN+L+N+   VK+ADFG++R+        P 
Sbjct: 168 QFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPC 225

Query: 315 TNKVITLWYRPPELL---LGEERY-GPAIDVWSCGCILGELFVKK 355
            + V T+ Y  PE +   L    Y G A D+WS G  + E ++ +
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 30/202 (14%)

Query: 170 TDELVALKKV-----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           T ++ A+K +       +N+ +      + E  IL Q     +V L      K       
Sbjct: 17  TGDIYAIKVIKKADMIRKNQVD----QVLTERDILSQAQSPYVVKLYYSFQGKK------ 66

Query: 225 KDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
               + YLV EY+   DL  LLE+ +   +E      + +++  L Y H    +HRD+K 
Sbjct: 67  ----NLYLVMEYLPGGDLASLLEN-VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121

Query: 284 SNILMNNRGEVKLADFGLA------RLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYG 336
            NIL+++ G +KL DFGL+      R  N  D ++    +++ T  Y  PE++LG+  + 
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDYIAPEVILGQG-HS 179

Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D WS GCIL E  V  P F
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPF 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.9 bits (236), Expect = 4e-22
 Identities = 71/204 (34%), Positives = 101/204 (49%), Gaps = 30/204 (14%)

Query: 164 FSVSLFTDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD 219
           F+  + T+E+VA+KK+    +  NEK       ++E++ L+QL H N +  +     +  
Sbjct: 33  FARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQQLRHPNTIEYKGCYLREHT 89

Query: 220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           A          +LV EY       +LE       EV  A+I    L GL+Y H    +HR
Sbjct: 90  A----------WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGP 337
           DIK  NIL+   G VKLADFG A L +      P  + V T ++  PE++L   E +Y  
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVS------PANSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 338 AIDVWSCG--CILGELFVKK-PLF 358
            +DVWS G  CI  EL  +K PLF
Sbjct: 194 KVDVWSLGITCI--ELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 94.3 bits (234), Expect = 6e-22
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 25/199 (12%)

Query: 164 FSVSLFTDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD 219
           F+ +  T+E+VA+KK+    +  NEK       ++E+K L+QL H N +  +     +  
Sbjct: 39  FATNSHTNEVVAVKKMSYSGKQTNEKWQ---DIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95

Query: 220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           A          +LV EY       LLE       EV  A+I    L GL+Y H  N +HR
Sbjct: 96  A----------WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGP 337
           DIK  NIL+   G+VKLADFG A   +      P  + V T ++  PE++L   E +Y  
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMDEGQYDG 199

Query: 338 AIDVWSCGCILGELFVKKP 356
            +DVWS G    EL  +KP
Sbjct: 200 KVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.4 bits (232), Expect = 7e-22
 Identities = 61/194 (31%), Positives = 102/194 (52%), Gaps = 18/194 (9%)

Query: 170 TDELVALKKVRL----ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T  L+A+K+V       +E+E       +EI+++ +LNH +I+ +          L    
Sbjct: 24  TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRM----------LGATC 73

Query: 226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           +   F L  E+M    +  L S    F E    +   QLL GLSY H+   +HRD+K +N
Sbjct: 74  EDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGAN 133

Query: 286 ILMNNRGE-VKLADFGLA-RLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVW 342
           +L+++ G+ +++ADFG A RL         +  +++ T+ +  PE+L GE+ YG + DVW
Sbjct: 134 LLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVW 192

Query: 343 SCGCILGELFVKKP 356
           S GC++ E+   KP
Sbjct: 193 SVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.2 bits (232), Expect = 7e-22
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L+E +  G  ++   ++ L  +E VA+K++ LE  +        +E++ + Q NH N+V 
Sbjct: 5   LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVK 63

Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMD----HDLM--GLLESGMVDFNEVNNASIMRQ 263
                                +LV  Y+      D+M       G    +E   A+++++
Sbjct: 64  YYTSFVVGD----------ELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKE 110

Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTNKVI-TL 321
           +L GL Y H    +HRDIK  NIL+   G VK+ADFG+ A L +  DR R      + T 
Sbjct: 111 VLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 322 WYRPPELLLGEERYGPAIDVWSCG 345
            +  PE++     Y    D+WS G
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFG 194

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 29/197 (14%)

Query: 170 TDELVALKKVRL--ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T    A K +++  E E E F +    EI IL +  H NIV L E    ++         
Sbjct: 29  TGLFAAAKIIQIESEEELEDFMV----EIDILSECKHPNIVGLYEAYFYENK-------- 76

Query: 228 GSFYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
              +++ E+ D      +M  LE G     E     + RQ+L+ L++ H    +HRD+K 
Sbjct: 77  --LWILIEFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKA 131

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAI 339
            NIL+   G+VKLADFG++   N    Q+  T  + T ++  PE++  E      Y    
Sbjct: 132 GNILLTLDGDVKLADFGVSAK-NKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPYDYKA 189

Query: 340 DVWSCGCILGELFVKKP 356
           D+WS G  L EL   +P
Sbjct: 190 DIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 93.2 bits (231), Expect = 5e-21
 Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 27/228 (11%)

Query: 141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILR 200
           N + N S  L   +  G   +   ++ + T E VA+KKV  +      P    RE+ I++
Sbjct: 61  NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMK 114

Query: 201 QLNHKNIVNLREIVTDKSDALDFRKDKGSFYL--VFEYMDHDLMGLLESGMVDFNEVNNA 258
            LNH NI+ L++    +     F+K++ + +L  V E++   +       M  +   N+A
Sbjct: 115 NLNHINIIFLKDYYYTEC----FKKNEKNIFLNVVMEFIPQTV----HKYMKHYARNNHA 166

Query: 259 SIM-------RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE-VKLADFGLARLYNAEDR 310
             +        QL   L+Y H +   HRD+K  N+L++     +KL DFG A+   A  R
Sbjct: 167 LPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226

Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
              Y   + + +YR PEL+LG   Y   ID+WS GCI+ E+ +  P+F
Sbjct: 227 SVSY---ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271

Length = 440

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 90.3 bits (224), Expect = 8e-21
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 26/199 (13%)

Query: 170 TDELVALKKVRL-------ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD 222
           + EL+A+K+V L       ++ K        REI +L++L H+NIV            L 
Sbjct: 24  SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY----------LG 73

Query: 223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
              D     +  EY+    +  L +    F E    + +RQ+L GL+Y H R  +HRDIK
Sbjct: 74  SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIK 133

Query: 283 CSNILMNNRGEVKLADFGLAR------LYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
            +NIL++N+G +K++DFG+++      L    +  RP      ++++  PE ++ +  Y 
Sbjct: 134 GANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG--SVFWMAPE-VVKQTSYT 190

Query: 337 PAIDVWSCGCILGELFVKK 355
              D+WS GC++ E+   K
Sbjct: 191 RKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 58/190 (30%), Positives = 84/190 (44%), Gaps = 15/190 (7%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           D LV  K+V L    E     A+ EI IL  L H NI+             +   D  + 
Sbjct: 25  DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY----------YNHFMDDNTL 74

Query: 231 YLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +  EY +   +   ++      F E      + Q++  +SY HK   LHRDIK  NI +
Sbjct: 75  LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL 134

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              G +KL DFG++++  +E         V T +Y  PEL  G + Y    D+W+ GC+L
Sbjct: 135 TKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVL 191

Query: 349 GELFVKKPLF 358
            EL   K  F
Sbjct: 192 YELLTLKRTF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.0 bits (220), Expect = 5e-20
 Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 25/199 (12%)

Query: 164 FSVSLFTDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD 219
           F+  + T+E+VA+KK+    +  NEK       ++E+K L+++ H N +  +     +  
Sbjct: 43  FARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVKFLQRIKHPNSIEYKGCYLREHT 99

Query: 220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           A          +LV EY       LLE       EV  A+I    L GL+Y H  N +HR
Sbjct: 100 A----------WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGP 337
           DIK  NIL+   G+VKLADFG A + +      P  + V T ++  PE++L   E +Y  
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIAS------PANSFVGTPYWMAPEVILAMDEGQYDG 203

Query: 338 AIDVWSCGCILGELFVKKP 356
            +DVWS G    EL  +KP
Sbjct: 204 KVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 87.6 bits (217), Expect = 7e-20
 Identities = 60/194 (30%), Positives = 90/194 (46%), Gaps = 27/194 (13%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           +A+K++   + +   P+    EI +   L H+NIV      ++             F+ +
Sbjct: 36  IAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIVQYLGSDSE-----------NGFFKI 82

Query: 234 FEYMDH----DLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
           F  M+      L  LL S  G +  NE       +Q+L+GL Y H    +HRDIK  N+L
Sbjct: 83  F--MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVL 140

Query: 288 MNN-RGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELL-LGEERYGPAIDVWSC 344
           +N   G VK++DFG + RL         +T    TL Y  PE++  G   YG   D+WS 
Sbjct: 141 VNTYSGVVKISDFGTSKRLAGINPCTETFTG---TLQYMAPEVIDKGPRGYGAPADIWSL 197

Query: 345 GCILGELFVKKPLF 358
           GC + E+   KP F
Sbjct: 198 GCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 25/199 (12%)

Query: 164 FSVSLFTDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD 219
           F+  +   E+VA+KK+    +  NEK       ++E++ L++L H N +  R     +  
Sbjct: 33  FARDVRNSEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQKLRHPNTIQYRGCYLREHT 89

Query: 220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           A          +LV EY       LLE       EV  A++    L GL+Y H  N +HR
Sbjct: 90  A----------WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGP 337
           D+K  NIL++  G VKL DFG A +        P    V T ++  PE++L   E +Y  
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 338 AIDVWSCGCILGELFVKKP 356
            +DVWS G    EL  +KP
Sbjct: 194 KVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 20/197 (10%)

Query: 170 TDELVALKKVRL-------ENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDAL 221
           T E++A+K+V L        + ++   + A+R EI+ L+ L+H NIV            L
Sbjct: 25  TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQY----------L 74

Query: 222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
            F   +    +  EY+    +G        F E        Q+L+GL+Y H +  LHRD+
Sbjct: 75  GFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDL 134

Query: 282 KCSNILMNNRGEVKLADFGLARLY-NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           K  N+L++  G  K++DFG+++   +  D  +  + +    W  P  +    + Y   +D
Sbjct: 135 KADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVD 194

Query: 341 VWSCGCILGELFV-KKP 356
           +WS GC++ E+F  ++P
Sbjct: 195 IWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 29/194 (14%)

Query: 174 VALKKVRLENE-----KEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           +A+K+V  + +     KE   + A+  EI++L+ L H+ IV     + D           
Sbjct: 30  LAVKQVPFDPDSPETKKE---VNALECEIQLLKNLQHERIVQYYGCLRDD---------- 76

Query: 228 GSFYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
            +  +  EYM      D +    +      E       RQ+L+G+ Y H    +HRDIK 
Sbjct: 77  ETLSIFMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSNMIVHRDIKG 132

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVW 342
           +NIL ++ G VKL DFG ++              V  T ++  PE++ GE  YG   DVW
Sbjct: 133 ANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVW 191

Query: 343 SCGCILGELFVKKP 356
           S GC + E+  +KP
Sbjct: 192 SVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 28/200 (14%)

Query: 173 LVALKKVRLENEKEGFPITA--------VREIKILR-QLNHKNIVNLREIVTDKSDALDF 223
           L+ALK++ + N   G             V E+ I++ QL H NIV   +   + +D L  
Sbjct: 28  LLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-NDRL-- 84

Query: 224 RKDKGSFYLVFEYMDHDLMGLLESGMVD----FNEVNNASIMRQLLDGLSYCHKRNFL-H 278
                  Y+V + ++   +G   + + +    F E    +I  Q++  L Y HK   + H
Sbjct: 85  -------YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVH 137

Query: 279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPA 338
           RD+  +NI++    +V + DFGLA+    E +    T+ V T+ Y  PE++  E  YG  
Sbjct: 138 RDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILYSCPEIVKNEP-YGEK 193

Query: 339 IDVWSCGCILGELFVKKPLF 358
            DVW+ GCIL ++   +P F
Sbjct: 194 ADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 19/192 (9%)

Query: 170 TDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            +   ALK V+  +  E G       E +IL + NH  IV L      ++    F KDK 
Sbjct: 17  KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY-----RT----F-KDKK 66

Query: 229 SFYLVFEYMD-HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             Y++ EY    +L  +L + G+  F+E      +  ++    Y H R  ++RD+K  N+
Sbjct: 67  YIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENL 124

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++ G VKL DFG A+    +  Q+ +T    T  Y  PE++L +  Y  ++D WS G 
Sbjct: 125 LLDSNGYVKLVDFGFAK--KLKSGQKTWT-FCGTPEYVAPEIILNKG-YDFSVDYWSLGI 180

Query: 347 ILGELFVKKPLF 358
           +L EL   +P F
Sbjct: 181 LLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.5 bits (204), Expect = 4e-18
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 40/215 (18%)

Query: 153 PLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITA-------VREIKILRQLNHK 205
            +  G  S+   ++ L    +VALKKV++      F +         ++EI +L+QL+H 
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQI------FEMMDAKARQDCLKEIDLLKQLDHP 62

Query: 206 NIV---------NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVN 256
           N++         N   IV + +DA D  +               ++   +       E  
Sbjct: 63  NVIKYLASFIENNELNIVLELADAGDLSR---------------MIKHFKKQKRLIPERT 107

Query: 257 NASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN 316
                 QL   L + H +  +HRDIK +N+ +   G VKL D GL R ++++       +
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HS 165

Query: 317 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
            V T +Y  PE  + E  Y    D+WS GC+L E+
Sbjct: 166 LVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 38/94 (40%), Positives = 50/94 (53%), Gaps = 3/94 (3%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           ++ QL  I +  GTPT   WP V  LP +   KP       L++ F      ALDLL ++
Sbjct: 208 DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFP--PTPLKQIFPAASDDALDLLQRL 265

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
           L L+P +RITA QAL+  +  N  P   PP QLP
Sbjct: 266 LTLNPNKRITARQALEHPYFSND-PAPTPPSQLP 298

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 15/189 (7%)

Query: 170 TDELVALKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T  +VALK + L+       ++ + RE+ +L QL      N   I       L       
Sbjct: 25  TGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPN---ITKYYGSYLK----GP 75

Query: 229 SFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             +++ EY +   +  L+++G +   E   + I+R++L  L Y HK   +HRDIK +NIL
Sbjct: 76  RLWIIMEYAEGGSVRTLMKAGPIA--EKYISVIIREVLVALKYIHKVGVIHRDIKAANIL 133

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + N G VKL DFG+A L N    +R  +  V T ++  PE++   + Y    D+WS G  
Sbjct: 134 VTNTGNVKLCDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGIT 191

Query: 348 LGELFVKKP 356
           + E+    P
Sbjct: 192 IYEMATGNP 200

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 54/168 (32%), Positives = 81/168 (48%), Gaps = 17/168 (10%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLE-SGMVDF 252
           REI IL+ ++H+ I+NL          +   + K +  +V      DL   ++ SG +  
Sbjct: 135 REIDILKTISHRAIINL----------IHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPL 184

Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNAEDRQ 311
            +    +I R+LL+ L+Y H R  +HRD+K  NI ++      L DFG A +L    D  
Sbjct: 185 EQA--ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242

Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK-PLF 358
           + Y     TL    PE LL  + Y    D+WS G +L E+ VK   LF
Sbjct: 243 QCY-GWSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Length = 392

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 18/193 (9%)

Query: 165 SVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           ++ + T + VA+K++ L+ + +   I  + EI ++R+  H NIVN           LD  
Sbjct: 38  AIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNY----------LDSY 85

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
                 ++V EY+    L  ++    +D  ++  A++ R+ L  L + H    +HRDIK 
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLHSNQVIHRDIKS 143

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
            NIL+   G VKL DFG       E  +R  +  V T ++  PE++   + YGP +D+WS
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT-RKAYGPKVDIWS 200

Query: 344 CGCILGELFVKKP 356
            G +  E+   +P
Sbjct: 201 LGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 36/80 (45%), Positives = 52/80 (65%), Gaps = 2/80 (2%)

Query: 12  ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS--LMPPGALD 69
            N E  QL +IS+LCG+ TP VWP V KL L+  ++  +  +R+++E     +  P ALD
Sbjct: 226 GNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALD 285

Query: 70  LLDKMLELDPERRITAEQAL 89
           L+DK+L LDP +RI A+ AL
Sbjct: 286 LIDKLLVLDPAKRIDADTAL 305

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 67/194 (34%), Positives = 94/194 (48%), Gaps = 38/194 (19%)

Query: 170 TDELVALKKVRLE-NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T +++A+K +RLE NE     I  +RE+ IL + N   IV              F    G
Sbjct: 25  TGKIMAVKTIRLEINEAIQKQI--LRELDILHKCNSPYIV-------------GFY---G 66

Query: 229 SFY------LVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH-KRNFLHRD 280
           +FY      +  EYMD   L  +L+       E     I   +L GL+Y H K   +HRD
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126

Query: 281 IKCSNILMNNRGEVKLADFGLA-RLYN--AEDRQRPYTNKVITLWYRPPELLLGEERYGP 337
           +K SNIL+N+RG++KL DFG++ +L N  A+         V T  Y  PE + G + Y  
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-------FVGTSSYMAPERIQGND-YSV 178

Query: 338 AIDVWSCGCILGEL 351
             D+WS G  L EL
Sbjct: 179 KSDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 19/171 (11%)

Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM- 249
           + +E+ +L  + H NIV  +E            ++ G+ Y+V +Y +  DL   + +   
Sbjct: 46  SRKEVAVLSNMKHPNIVQYQESF----------EENGNLYIVMDYCEGGDLYKKINAQRG 95

Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE- 308
           V F E        Q+   L + H R  LHRDIK  NI +   G +KL DFG+AR+ N+  
Sbjct: 96  VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155

Query: 309 DRQRPYTNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFVKKPLF 358
           +  R     + T +Y  PE+   E R Y    D+W+ GC+L E+   K  F
Sbjct: 156 ELAR---TCIGTPYYLSPEIC--ENRPYNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 80.2 bits (198), Expect = 2e-17
 Identities = 59/188 (31%), Positives = 88/188 (46%), Gaps = 19/188 (10%)

Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           ALK+V L +  +     AV EI+IL  +NH NI++ +E        LD  K      +V 
Sbjct: 29  ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE------AFLDGNK----LCIVM 78

Query: 235 EYMD-HDLMGLLESGMVDFNEVNNASIMR---QLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           EY    DL   +         +    I R   QLL GL   H++  LHRD+K +NIL+  
Sbjct: 79  EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA 138

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              VK+ D G++++     ++     ++ T  Y  PE+  G   Y    D+WS GC+L E
Sbjct: 139 NDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYE 193

Query: 351 LFVKKPLF 358
           +    P F
Sbjct: 194 MATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 16/164 (9%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI  L +LNH+NI+ + EI+  +++           Y++ +  D DL   +     D+ +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANT----------YMITQKYDFDLYSFMYDEAFDWKD 262

Query: 255 V----NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
                   +IM+QLL  + Y H +  +HRDIK  NI +N  G++ L DFG A  +  E  
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322

Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
              Y   V T+    PE+L G+  Y    D+WSCG IL ++   
Sbjct: 323 AFDY-GWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 48/203 (23%)

Query: 170 TDELVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E VA+K +     E  +  F     REI+ILR L+H+NIV  + +             
Sbjct: 32  TGEQVAVKSLNHSGEEQHRSDFE----REIEILRTLDHENIVKYKGVCEKPG-------- 79

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDF------NEVNNASIMR---QLLDGLSYCHKRNFL 277
             S  L+ EY        L SG +        +++N   ++    Q+  G+ Y   + ++
Sbjct: 80  GRSLRLIMEY--------LPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYI 131

Query: 278 HRDIKCSNILMNNRGEVKLADFGLARL--------YNAEDRQRPYTNKVITLWYRPPELL 329
           HRD+   NIL+ +   VK++DFGLA++        Y  E  + P        WY P    
Sbjct: 132 HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP------IFWYAPE--C 183

Query: 330 LGEERYGPAIDVWSCGCILGELF 352
           L   ++  A DVWS G  L ELF
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 79.7 bits (197), Expect = 4e-17
 Identities = 52/168 (30%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLE---SGM 249
           + E +IL++LNH  +VNL     D+ +           YLV + +   L G L    S  
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDEEN----------MYLVVDLL---LGGDLRYHLSQK 94

Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
           V F+E      + +++  L Y H +  +HRDIK  NIL++ +G V + DF +A       
Sbjct: 95  VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--- 151

Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE-LFVKKP 356
                T+   T  Y  PE+L  +  Y  A+D WS G    E L  K+P
Sbjct: 152 PDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 79.6 bits (196), Expect = 4e-17
 Identities = 65/188 (34%), Positives = 90/188 (47%), Gaps = 24/188 (12%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           +D+  A+K++RL          + +E  +L ++ H NIV  +E          F  D G 
Sbjct: 24  SDQKYAMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPNIVAFKE---------SFEAD-GH 72

Query: 230 FYLVFEYMDH-DLMGL--LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
            Y+V EY D  DLM    L+ G + F E        Q+  G+ + H++  LHRDIK  NI
Sbjct: 73  LYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYT---NKVITLWYRPPELLLGEERYGPAIDVWS 343
            +   G+VKL DFG ARL  +     P       V T +Y PPE+      Y    D+WS
Sbjct: 132 FLTQNGKVKLGDFGSARLLTS-----PGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWS 185

Query: 344 CGCILGEL 351
            GCIL EL
Sbjct: 186 LGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 22/190 (11%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E VA+K ++ E+          +EI+ILR L H+NIV  + I T+             
Sbjct: 32  TGEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGN--------G 82

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR---QLLDGLSYCHKRNFLHRDIKCSNI 286
             L+ E++      L E    + N++N    ++   Q+  G+ Y   R ++HRD+   N+
Sbjct: 83  IKLIMEFLPSG--SLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 140

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNK----VITLWYRPPELLLGEERYGPAIDVW 342
           L+ +  +VK+ DFGL +    E  +  YT K        WY P  L+  + ++  A DVW
Sbjct: 141 LVESEHQVKIGDFGLTK--AIETDKEYYTVKDDLDSPVFWYAPECLI--QSKFYIASDVW 196

Query: 343 SCGCILGELF 352
           S G  L EL 
Sbjct: 197 SFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 5e-17
 Identities = 60/189 (31%), Positives = 86/189 (45%), Gaps = 26/189 (13%)

Query: 170 TDELVALK--KVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKD 226
           T +LVA+K   +  + E+E        E  ILR+  NH NI         K+       +
Sbjct: 30  TGQLVAIKIMDIIEDEEEE-----IKEEYNILRKYSNHPNIATFYGAFIKKNP----PGN 80

Query: 227 KGSFYLVFEYMDH----DLM-GLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
               +LV E        DL+ GL + G     E   A I+R+ L GL+Y H+   +HRDI
Sbjct: 81  DDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLHENKVIHRDI 139

Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAI- 339
           K  NIL+    EVKL DFG++      D      N  I T ++  PE++  +E+   +  
Sbjct: 140 KGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYD 196

Query: 340 ---DVWSCG 345
              DVWS G
Sbjct: 197 ARSDVWSLG 205

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.4 bits (196), Expect = 6e-17
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 34/206 (16%)

Query: 172 ELVA---LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           ELVA   LK+    + ++ F     RE ++L    H+NIV    + T+            
Sbjct: 36  ELVAVKTLKETASNDARKDFE----REAELLTNFQHENIVKFYGVCTEG----------D 81

Query: 229 SFYLVFEYMDH-DLMGLLESGMVDFN----------EVNNASIMR---QLLDGLSYCHKR 274
              +VFEYM+H DL   L S   D            E+  + +++   Q+  G+ Y   +
Sbjct: 82  PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141

Query: 275 NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER 334
           +F+HRD+   N L+     VK+ DFG++R     D  R   + ++ + + PPE ++   +
Sbjct: 142 HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-YRK 200

Query: 335 YGPAIDVWSCGCILGELFV--KKPLF 358
           +    DVWS G +L E+F   K+P +
Sbjct: 201 FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 17/187 (9%)

Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           A+K++ L          A+ E ++L +L+   I+   E   DK          G   +V 
Sbjct: 29  AMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK----------GKLNIVM 78

Query: 235 EYMDH-DLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           EY ++ DL  LL+        E        Q+L GL++ H +  LHRDIK  N+ ++   
Sbjct: 79  EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD 138

Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
            VK+ D G+A+L +       + N ++ T +Y  PE L  ++ Y    DVW+ G +L E 
Sbjct: 139 NVKIGDLGVAKLLSD---NTNFANTIVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYEC 194

Query: 352 FVKKPLF 358
              K  F
Sbjct: 195 CTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 77.9 bits (193), Expect = 2e-16
 Identities = 33/85 (38%), Positives = 48/85 (56%), Gaps = 6/85 (7%)

Query: 6   RGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPP 65
            G+S     E+ QL  I ++ GTPT   WP V KLP +    PK    + L +    + P
Sbjct: 200 PGDS-----EIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK-FPPKDLEKVLPRLDP 253

Query: 66  GALDLLDKMLELDPERRITAEQALK 90
             +DLL KML+ +P +RI+A++ALK
Sbjct: 254 EGIDLLSKMLQYNPAKRISAKEALK 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 33/84 (39%), Positives = 46/84 (54%), Gaps = 8/84 (9%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGAL-----D 69
           E+ QL  I KL GTPT  +WP   +LP        K    +LR++F   P  +L     D
Sbjct: 212 EIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKF---PALSLSDNGFD 268

Query: 70  LLDKMLELDPERRITAEQALKSVW 93
           LL+++L  DP +RI+AE ALK  +
Sbjct: 269 LLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 38/175 (21%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG---- 248
           +E +I+++L H  +V L  + +++             Y+V EYM    L+  L+SG    
Sbjct: 50  QEAQIMKKLRHDKLVQLYAVCSEEE----------PIYIVTEYMSKGSLLDFLKSGEGKK 99

Query: 249 -----MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR 303
                +VD           Q+ +G++Y   RN++HRD+   NIL+      K+ADFGLAR
Sbjct: 100 LRLPQLVDM--------AAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR 151

Query: 304 LYNAEDRQRPYT----NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           L   ED +  YT     K    W  P     G  R+    DVWS G +L E+   
Sbjct: 152 LI--EDDE--YTAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTY 200

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.2 bits (190), Expect = 4e-16
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 38/197 (19%)

Query: 170 TDELVALKKVRLEN---EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E+VA+K ++ E       G+     +EI IL+ L H+NIV  +   +++         
Sbjct: 32  TGEMVAVKTLKRECGQQNTSGW----KKEINILKTLYHENIVKYKGCCSEQGGK------ 81

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKC 283
                L+ EY+   L  L +   +  +++N A ++   +Q+ +G++Y H ++++HRD+  
Sbjct: 82  --GLQLIMEYVP--LGSLRD--YLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAA 135

Query: 284 SNILMNNRGEVKLADFGLAR------LYN--AEDRQRPYTNKVITLWYRPPELLLGEERY 335
            N+L++N   VK+ DFGLA+       Y    ED   P        WY      L E ++
Sbjct: 136 RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAVE--CLKENKF 187

Query: 336 GPAIDVWSCGCILGELF 352
             A DVWS G  L EL 
Sbjct: 188 SYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 25/191 (13%)

Query: 170 TDELVALKKVRLENEK--EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T E+VA+KK++    +    F     REI+IL+ L H NIV  + +         +   +
Sbjct: 32  TGEVVAVKKLQHSTAEHLRDFE----REIEILKSLQHDNIVKYKGVC--------YSAGR 79

Query: 228 GSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
            +  LV EY+    L   L+      +         Q+  G+ Y   + ++HRD+   NI
Sbjct: 80  RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNI 139

Query: 287 LMNNRGEVKLADFGLARLYNAEDR-----QRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           L+ +   VK+ DFGL ++   +D+     + P  + +   WY P    L E ++  A DV
Sbjct: 140 LVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPI--FWYAPES--LTESKFSVASDV 194

Query: 342 WSCGCILGELF 352
           WS G +L ELF
Sbjct: 195 WSFGVVLYELF 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 76.6 bits (188), Expect = 5e-16
 Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 10/163 (6%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI++L+ L H+ IV     + D+++         +  +  EYM    +           E
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEK--------TLTIFMEYMPGGSVKDQLKAYGALTE 105

Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNAEDRQRP 313
                  RQ+L+G+SY H    +HRDIK +NIL ++ G VKL DFG + RL         
Sbjct: 106 SVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165

Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP 356
             +   T ++  PE++ GE  YG   DVWS GC + E+  +KP
Sbjct: 166 IRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.1 bits (189), Expect = 6e-16
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 18/186 (9%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K++ L+ + +   I  + EI ++++L + NIVN           LD        ++V
Sbjct: 47  VAIKQINLQKQPKKELI--INEILVMKELKNPNIVNF----------LDSFLVGDELFVV 94

Query: 234 FEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            EY+    L  ++    +D  E   A++ R+ L  L + H    +HRDIK  N+L+   G
Sbjct: 95  MEYLAGGSLTDVVTETCMD--EAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG 152

Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            VKL DFG       E  +R  +  V T ++  PE++   + YGP +D+WS G +  E+ 
Sbjct: 153 SVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMV 209

Query: 353 VKKPLF 358
             +P +
Sbjct: 210 EGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 77.0 bits (190), Expect = 7e-16
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 28/195 (14%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T+ LVA+KK+ L++  +       +EI   RQL H NI+         S+          
Sbjct: 24  TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE---------- 73

Query: 230 FYLVFEYMDH----DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
            Y+V   M +    DL+           E+  A I++ +L+ L Y H + F+HR +K S+
Sbjct: 74  LYVVSPLMAYGSCEDLLK--THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASH 131

Query: 286 ILMNNRGEVKLADFGLAR-LYNAEDRQRPY----TNKVITLWYRPPELL----LGEERYG 336
           IL++  G+V L+    +  +     RQR       + V  L +  PE+L     G   Y 
Sbjct: 132 ILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG---YN 188

Query: 337 PAIDVWSCGCILGEL 351
              D++S G    EL
Sbjct: 189 EKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 76.3 bits (188), Expect = 8e-16
 Identities = 53/165 (32%), Positives = 74/165 (44%), Gaps = 21/165 (12%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYM-----DHDLMGLLES 247
           +RE++I +      IV       D+S          S  +  EY      D     + + 
Sbjct: 47  LRELEINKSCKSPYIVKYYGAFLDESS--------SSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 248 GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYN 306
           G     E     I   +L GLSY H R  +HRDIK SNIL+  +G+VKL DFG++  L N
Sbjct: 99  GGR-IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157

Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +      +T    T +Y  PE + G+  Y    DVWS G  L E+
Sbjct: 158 SLAGT--FTG---TSFYMAPERIQGKP-YSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 33/79 (41%), Positives = 44/79 (55%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           ++ QL +I KLCGTPT   WP    LP    +     + R L E F  + P  LDLL K+
Sbjct: 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKL 291

Query: 75  LELDPERRITAEQALKSVW 93
           L LDP +R+TA  AL+  +
Sbjct: 292 LSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 59/169 (34%), Positives = 80/169 (47%), Gaps = 18/169 (10%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM-VD 251
           +E+ +L ++ H NIV                ++ G  ++V EY D  DLM  +     V 
Sbjct: 48  KEVILLAKMKHPNIVTF----------FASFQENGRLFIVMEYCDGGDLMKRINRQRGVL 97

Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEV-KLADFGLARLYNAEDR 310
           F+E    S   Q+  GL + H R  LHRDIK  NI ++  G V KL DFG+AR  N  D 
Sbjct: 98  FSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DS 155

Query: 311 QRPYTNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFVKKPLF 358
                  V T +Y  PE+   + R Y    D+WS GC+L EL   K  F
Sbjct: 156 MELAYTCVGTPYYLSPEIC--QNRPYNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 25/167 (14%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF 252
           + E K++ +L+H N+V L  + T +             ++V EYM +   G L + + + 
Sbjct: 47  IEEAKVMMKLSHPNLVQLYGVCTKQ----------RPIFIVTEYMAN---GCLLNYLRER 93

Query: 253 NEVNNASIM----RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
                   +      + + + Y     F+HRD+   N L+     VK++DFGLAR Y  +
Sbjct: 94  KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLD 152

Query: 309 DRQRPYTNKVITLW---YRPPELLLGEERYGPAIDVWSCGCILGELF 352
           D+   YT+   T +   + PPE+     R+    DVWS G ++ E+F
Sbjct: 153 DQ---YTSSQGTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVF 195

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 49/159 (30%), Positives = 73/159 (45%), Gaps = 13/159 (8%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF 252
             E  ILR +NH +I+ L+   T                L+      DL   L +   + 
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC----------LILPRYKTDLYCYL-AAKRNI 179

Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
              +  +I R +L  + Y H+   +HRDIK  NI +N+ G+V L DFG A  +  +    
Sbjct: 180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINAN 238

Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
            Y     T+    PE LL  + YGPA+D+WS G +L E+
Sbjct: 239 KYYGWAGTIATNAPE-LLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 18/195 (9%)

Query: 165 SVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           ++ + T + VA+K++ L+ + +   I  + EI ++R+  + NIVN           LD  
Sbjct: 38  AIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPNIVNY----------LDSY 85

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
                 ++V EY+    L  ++    +D  ++  A++ R+ L  L + H    +HRDIK 
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALDFLHSNQVIHRDIKS 143

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
            NIL+   G VKL DFG       E  +R  +  V T ++  PE++   + YGP +D+WS
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT-RKAYGPKVDIWS 200

Query: 344 CGCILGELFVKKPLF 358
            G +  E+   +P +
Sbjct: 201 LGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 56/165 (33%), Positives = 68/165 (41%), Gaps = 38/165 (23%)

Query: 226 DKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMR----QLLDGLSYCHKRNFLHRD 280
           D+   YLV EYM   DLM LL      F E       R    +L+  L   HK  F+HRD
Sbjct: 72  DEEHLYLVMEYMPGGDLMNLL-IRKDVFPE----ETARFYIAELVLALDSVHKLGFIHRD 126

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP--------------- 325
           IK  NIL++  G +KLADFGL +  N    +  Y N    L +R                
Sbjct: 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186

Query: 326 ------------PELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                       PE+L G   YG   D WS G IL E+    P F
Sbjct: 187 ANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 61/188 (32%), Positives = 93/188 (49%), Gaps = 17/188 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++VA+K + LE E E       +EI +L Q +   +               + KD   
Sbjct: 28  TQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYG---------SYLKDT-K 76

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ EY+     + LLE G +D  E   A+I+R++L GL Y H    +HRDIK +N+L+
Sbjct: 77  LWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 134

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  GEVKLADFG+A      D Q      V T ++  PE ++ +  Y    D+WS G   
Sbjct: 135 SEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGITA 191

Query: 349 GELFVKKP 356
            EL   +P
Sbjct: 192 IELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 73.7 bits (181), Expect = 5e-15
 Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 19/184 (10%)

Query: 171 DELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
              VA+K ++ +  E E F    ++E  +++++ H N+V L  + T +            
Sbjct: 31  SLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP----------P 76

Query: 230 FYLVFEYMDHD--LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
           FY++ E+M +   L  L E    + N V    +  Q+   + Y  K+NF+HRD+   N L
Sbjct: 77  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 136

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +     VK+ADFGL+RL   +        K    W  P    L   ++    DVW+ G +
Sbjct: 137 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES--LAYNKFSIKSDVWAFGVL 194

Query: 348 LGEL 351
           L E+
Sbjct: 195 LWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.0 bits (181), Expect = 6e-15
 Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 18/195 (9%)

Query: 165 SVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           ++ + T + VA++++ L+ + +   I  + EI ++R+  + NIVN           LD  
Sbjct: 39  AMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY----------LDSY 86

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
                 ++V EY+    L  ++    +D  ++  A++ R+ L  L + H    +HRDIK 
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLHSNQVIHRDIKS 144

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
            NIL+   G VKL DFG       E  +R  +  V T ++  PE++   + YGP +D+WS
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT-RKAYGPKVDIWS 201

Query: 344 CGCILGELFVKKPLF 358
            G +  E+   +P +
Sbjct: 202 LGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 29/175 (16%)

Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM        +  
Sbjct: 45  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMS-------KGS 86

Query: 249 MVDFNEVNNASIMR--QLLD-------GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           ++DF +      +R  QL+D       G++Y  + N++HRD++ +NIL+      K+ADF
Sbjct: 87  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 146

Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           GLARL    +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 199

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 56/181 (30%), Positives = 89/181 (49%), Gaps = 17/181 (9%)

Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV ++  K G   P + + E +I+++L H  +V L  +V+++             Y+V E
Sbjct: 32  KVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEP-----------IYIVTE 80

Query: 236 YMDH-DLMGLLESGMVDFNEVNNASIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
           YM    L+  L+ G     ++ N   M  Q+  G++Y  + N++HRD++ +NIL+ +   
Sbjct: 81  YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV 140

Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
            K+ADFGLARL    +       K    W  P   L G  R+    DVWS G +L EL  
Sbjct: 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVT 198

Query: 354 K 354
           K
Sbjct: 199 K 199

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 1/99 (1%)

Query: 12  ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLL 71
              E+ QL++I +L GTP  ++WP    LPL       K     L+ +F  +    L LL
Sbjct: 211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLL 270

Query: 72  DKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTW 110
           + +L  DP++R TAE+AL+S + K   P    P  +PT+
Sbjct: 271 NFLLMYDPKKRATAEEALESSYFKE-KPLPCEPEMMPTF 308

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 24/185 (12%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K ++    E +++ F    + E  I+ Q +H NI+ L  +VT    A+         
Sbjct: 36  VAIKTLKPGYTEKQRQDF----LSEASIMGQFSHHNIIRLEGVVTKFKPAM--------- 82

Query: 231 YLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            ++ EYM++  L   L     +F+      ++R +  G+ Y    N++HRD+   NIL+N
Sbjct: 83  -IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN 141

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +  E K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 142 SNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEA--IAYRKFTSASDVWSFGI 198

Query: 347 ILGEL 351
           ++ E+
Sbjct: 199 VMWEV 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 17/181 (9%)

Query: 178 KVRLENEKEG--FPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV ++  K G   P   ++E +I+++L H  +V L  +V+++             Y+V E
Sbjct: 32  KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP-----------IYIVTE 80

Query: 236 YMDH-DLMGLLESGMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
           +M    L+  L+ G   + ++     +  Q+ DG++Y  + N++HRD++ +NIL+ +   
Sbjct: 81  FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV 140

Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
            K+ADFGLARL    +       K    W  P   L G  R+    DVWS G +L EL  
Sbjct: 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVT 198

Query: 354 K 354
           K
Sbjct: 199 K 199

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 18/199 (9%)

Query: 165 SVSLFTDELVALKKVRL-ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
           +  L   + VALKKV++ E          V+EI +L+QLNH N++            LD 
Sbjct: 21  ATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY----------LDS 70

Query: 224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMR---QLLDGLSYCHKRNFLHR 279
             +     +V E  D  DL  +++        +   ++ +   QL   + + H R  +HR
Sbjct: 71  FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR 130

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAI 339
           DIK +N+ +   G VKL D GL R ++++       + V T +Y  PE  + E  Y    
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPE-RIHENGYNFKS 187

Query: 340 DVWSCGCILGELFVKKPLF 358
           D+WS GC+L E+   +  F
Sbjct: 188 DIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 35/199 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN-IVNLREIVT-DKSDAL-----D 222
           T E+VALK  R++               +L +LN    ++  R+I+T  KS+ L      
Sbjct: 25  TGEIVALK--RMKK-------------SLLFKLNEVRHVLTERDILTTTKSEWLVKLLYA 69

Query: 223 FRKDKGSFYLVFEYM-DHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
           F +D    YL  EY+   D   LL   G++  +       M ++ + +   H+  ++HRD
Sbjct: 70  F-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR--FYMAEMFEAVDALHELGYIHRD 126

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAI 339
           +K  N L++  G +KL DFGL++          Y N V+ +  Y  PE+L G+  Y   +
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIVT------YANSVVGSPDYMAPEVLRGKG-YDFTV 179

Query: 340 DVWSCGCILGELFVKKPLF 358
           D WS GC+L E     P F
Sbjct: 180 DYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 52/191 (27%), Positives = 94/191 (49%), Gaps = 20/191 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE--IVTDKSDALDFRKDK 227
           T   VA+KK+ L  ++    +    E+ I+R   H NIV +    +V D+          
Sbjct: 43  TGRQVAVKKMDLRKQQRRELL--FNEVVIMRDYQHPNIVEMYSSYLVGDE---------- 90

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              ++V E+++   +  + +     NE   A++   +L  LS+ H +  +HRDIK  +IL
Sbjct: 91  --LWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSIL 147

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + + G VKL+DFG     + E  +R   + V T ++  PE ++    YG  +D+WS G +
Sbjct: 148 LTSDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIM 204

Query: 348 LGELFVKKPLF 358
           + E+   +P +
Sbjct: 205 VIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 11/169 (6%)

Query: 185 KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGL 244
           K G+  ++V E ++LR+L+H  ++ L          LD R   G   LV      DL   
Sbjct: 200 KAGWYASSVHEARLLRRLSHPAVLAL----------LDVRVVGGLTCLVLPKYRSDLYTY 249

Query: 245 LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL 304
           L + +         ++ RQLL  + Y H    +HRDIK  N+L+N   ++ L DFG A  
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF 309

Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
                    +     T+    PE+L G+  Y P++D+WS G ++ E  V
Sbjct: 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAV 357

Length = 461

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 71.1 bits (174), Expect = 4e-14
 Identities = 46/164 (28%), Positives = 87/164 (53%), Gaps = 19/164 (11%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVD 251
           + E K++ +L+H+ +V L  + T +             Y+V EYM +  L+  L      
Sbjct: 47  IEEAKVMMKLSHEKLVQLYGVCTKQR----------PIYIVTEYMSNGCLLNYLREHGKR 96

Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F       + + + +G++Y   + F+HRD+   N L++++G VK++DFGL+R Y  +D  
Sbjct: 97  FQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDE- 154

Query: 312 RPYTNKVITLW---YRPPELLLGEERYGPAIDVWSCGCILGELF 352
             YT+ V + +   + PPE+LL   ++    DVW+ G ++ E++
Sbjct: 155 --YTSSVGSKFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVY 195

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 26/77 (33%), Positives = 40/77 (51%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLEL 77
           QL ++ +  GTP    WP +  LP ++ I   +     L E F    P ALDLL  +L  
Sbjct: 209 QLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVY 268

Query: 78  DPERRITAEQALKSVWL 94
           DP +R++A +AL+  + 
Sbjct: 269 DPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 31/195 (15%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREI-VTDKSDALDFRKDKG 228
           T ++VA+K + LE  ++        EI+ ++Q          EI V  + D+    K  G
Sbjct: 28  TQQVVAIKIIDLEEAED--------EIEDIQQ----------EITVLSQCDSPYVTKYYG 69

Query: 229 SF------YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
           S+      +++ EY+     + LL +G   F+E   A++++++L GL Y H    +HRDI
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127

Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           K +N+L++ +G+VKLADFG+A      D Q      V T ++  PE ++ +  Y    D+
Sbjct: 128 KAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADI 184

Query: 342 WSCGCILGELFVKKP 356
           WS G    EL   +P
Sbjct: 185 WSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 23/187 (12%)

Query: 170 TDELVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
            +  VA+K ++    + ++  F    + E  I+ Q +H NI+ L  +VT     +     
Sbjct: 31  KEIDVAIKTLKAGSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVTKSRPVM----- 81

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
                ++ EYM++  L   L      F       ++R +  G+ Y  + N++HRD+   N
Sbjct: 82  -----IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARN 136

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNK--VITLWYRPPELLLGEERYGPAIDVWS 343
           IL+N+    K++DFGL+R    ED +  YT K   I + +  PE  +   ++  A DVWS
Sbjct: 137 ILVNSNLVCKVSDFGLSRR--LEDSEATYTTKGGKIPIRWTAPE-AIAYRKFTSASDVWS 193

Query: 344 CGCILGE 350
            G ++ E
Sbjct: 194 FGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 22/188 (11%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K V  EN      I  + E  ++++ N  ++V L  +V+     L          +V
Sbjct: 39  VAIKTVN-ENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL----------VV 87

Query: 234 FEYMDH-DLMGLLESGMVDFNEVNN-ASIMRQLL--------DGLSYCHKRNFLHRDIKC 283
            E M   DL   L S   +            Q          DG++Y   + F+HRD+  
Sbjct: 88  MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAA 147

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
            N ++     VK+ DFG+ R     D  R     ++ + +  PE L  +  +    DVWS
Sbjct: 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTKSDVWS 206

Query: 344 CGCILGEL 351
            G +L E+
Sbjct: 207 FGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.3 bits (172), Expect = 6e-14
 Identities = 57/190 (30%), Positives = 95/190 (50%), Gaps = 17/190 (8%)

Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE-IVTDKSDALDFRKDKGSF 230
           +LV +K++ +E   +   + A  E ++L+ L+H NI+   E  + DK+  +      G  
Sbjct: 26  KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG- 84

Query: 231 YLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             + EY+      LL E  ++ F          Q+L  L + H +  LHRD+K  NIL++
Sbjct: 85  -TLAEYIQKRCNSLLDEDTILHF--------FVQILLALHHVHTKLILHRDLKTQNILLD 135

Query: 290 NRGEV-KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
               V K+ DFG++++ ++  + + YT  V T  Y  PEL  G+  Y    D+W+ GC+L
Sbjct: 136 KHKMVVKIGDFGISKILSS--KSKAYT-VVGTPCYISPELCEGKP-YNQKSDIWALGCVL 191

Query: 349 GELFVKKPLF 358
            EL   K  F
Sbjct: 192 YELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 44/172 (25%), Positives = 71/172 (41%), Gaps = 35/172 (20%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDF------------RKDKGSFYLVFEYMDHDL 241
           +E  I+  L+H+N++ L  +V      +              RKD    +L+        
Sbjct: 45  KEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLI-------- 96

Query: 242 MGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL 301
                S + D+          Q+ +G+ Y   + F+HRD+   NIL+ +  +VK+ DFGL
Sbjct: 97  -----STLCDYAV--------QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGL 143

Query: 302 AR-LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            R L   ED      +  +   +  PE  L    +  A DVW  G  L E+F
Sbjct: 144 MRALPQNEDHYVMEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEMF 194

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.6 bits (173), Expect = 8e-14
 Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 33/181 (18%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES----- 247
           RE  ++ + +H NIV L  +                  L+FEYM + DL   L       
Sbjct: 57  REAALMAEFDHPNIVKLLGVCAVGK----------PMCLLFEYMAYGDLNEFLRHRSPRA 106

Query: 248 ----------------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
                             +  +      I +Q+  G++Y  +R F+HRD+   N L+   
Sbjct: 107 QCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN 166

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             VK+ADFGL+R   + D  +   N  I + + PPE +    RY    DVW+ G +L E+
Sbjct: 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEI 225

Query: 352 F 352
           F
Sbjct: 226 F 226

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.5 bits (177), Expect = 9e-14
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 40/218 (18%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E    K +     KE      V E+ ++R+L HKNIV   +   +K++          
Sbjct: 37  TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ--------K 88

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIM---RQLLDGLSYCHK-------RNFLH 278
            Y++ E+ D  DL   ++     F ++   +I+   RQLL  L+YCH           LH
Sbjct: 89  LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH 148

Query: 279 RDIKCSNIL-----------------MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL 321
           RD+K  NI                  +N R   K+ DFGL++    E       + V T 
Sbjct: 149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTP 205

Query: 322 WYRPPELLLGEER-YGPAIDVWSCGCILGELFVKKPLF 358
           +Y  PELLL E + Y    D+W+ GCI+ EL   K  F
Sbjct: 206 YYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 10/163 (6%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI++L+ L H+ IV     + D  +         +  +  E+M    +           E
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMER--------TLSIFMEHMPGGSIKDQLKSYGALTE 105

Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                  RQ+L+G+SY H    +HRDIK +NIL ++ G VKL DFG ++           
Sbjct: 106 NVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165

Query: 315 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP 356
              V  T ++  PE++ GE  YG   D+WS GC + E+  +KP
Sbjct: 166 MKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 20/189 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE--IVTDKSDALDFRKDK 227
           + +LVA+KK+ L  ++    +    E+ I+R   H+N+V +    +V D+          
Sbjct: 44  SGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNSYLVGDE---------- 91

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              ++V E+++   +  + +     NE   A++   +L  LS  H +  +HRDIK  +IL
Sbjct: 92  --LWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSIL 148

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + + G VKL+DFG     + E  +R   + V T ++  PE L+    YGP +D+WS G +
Sbjct: 149 LTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPE-LISRLPYGPEVDIWSLGIM 205

Query: 348 LGELFVKKP 356
           + E+   +P
Sbjct: 206 VIEMVDGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 29/200 (14%)

Query: 170 TDELVALKKVRLEN------EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
             +L+A+K+V L+       EKE   +    E+ +L+ L H NIV       D +     
Sbjct: 23  QGQLIAVKQVELDTSNVLAAEKEYEKLQ--EEVDLLKSLKHVNIVQYLGTCLDDN----- 75

Query: 224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFN---EVNNASIMRQLLDGLSYCHKRNFLHRD 280
                    +  +M+    G + S +  F    E       +Q+LDG++Y H    +HRD
Sbjct: 76  --------TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRD 127

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYG 336
           IK +N+++   G +KL DFG AR          ++N + ++    ++  PE ++ E  YG
Sbjct: 128 IKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINESGYG 186

Query: 337 PAIDVWSCGCILGELFVKKP 356
              D+WS GC + E+   KP
Sbjct: 187 RKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 25/182 (13%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           LK+  +   K+ F    +RE  ++ QL+H  IV L  I   K +            LV E
Sbjct: 31  LKQEHIAAGKKEF----LREASVMAQLDHPCIVRL--IGVCKGE---------PLMLVME 75

Query: 236 YMDHDLMGLLESGMVDFNEVNNASI---MRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
                 +G L   +    E+  + +     Q+  G++Y   ++F+HRD+   N+L+ NR 
Sbjct: 76  LAP---LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH 132

Query: 293 EVKLADFGLARLYNA-EDRQRPYT-NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
           + K++DFG++R   A  D  R  T  +    WY P  +  G  ++    DVWS G  L E
Sbjct: 133 QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWE 190

Query: 351 LF 352
            F
Sbjct: 191 AF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 50/166 (30%), Positives = 75/166 (45%), Gaps = 16/166 (9%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI++L+ L H  IV     + D  +            +  EYM    +           E
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEK--------KLSIFVEYMPGGSIKDQLKAYGALTE 105

Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR----LYNAEDR 310
                  RQ+L G+SY H    +HRDIK +NIL ++ G VKL DFG ++    +  +   
Sbjct: 106 NVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165

Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP 356
            +  T    T ++  PE++ GE  YG   DVWS  C + E+  +KP
Sbjct: 166 IKSVTG---TPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 18/181 (9%)

Query: 174 VALKKVRL-ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K +      +E F    + E K++ +L+H  +V L  + T +             Y+
Sbjct: 31  VAIKAINEGAMSEEDF----IEEAKVMMKLSHPKLVQLYGVCTQQK----------PLYI 76

Query: 233 VFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           V E+M++  L+  L       ++    S+ + + +G+ Y  + +F+HRD+   N L+++ 
Sbjct: 77  VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST 136

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           G VK++DFG+ R Y  +D     +     + + PPE+     +Y    DVWS G ++ E+
Sbjct: 137 GVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEV 194

Query: 352 F 352
           F
Sbjct: 195 F 195

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 29/176 (16%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLL------- 245
           +E +++  L H NIV L  + T +              ++FEY+ H DL   L       
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQ----------PTCMLFEYLAHGDLHEFLVRNSPHS 106

Query: 246 --ESGMVDFNEVNNA-------SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL 296
              +   D   V ++        I  Q+  G+ Y    +F+HRD+   N L+     VK+
Sbjct: 107 DVGAESGD-ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKI 165

Query: 297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +DFGL+R   + D  R  +  ++ + + PPE +L   ++    D+WS G +L E+F
Sbjct: 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 21/180 (11%)

Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H  +V L  +VT           +   Y++ E
Sbjct: 32  KVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----------QEPIYIITE 80

Query: 236 YMDH----DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           YM++    D +   E   +  N++ + +   Q+ +G+++  ++N++HRD++ +NIL++  
Sbjct: 81  YMENGSLVDFLKTPEGIKLTINKLIDMAA--QIAEGMAFIERKNYIHRDLRAANILVSET 138

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
              K+ADFGLARL    +       K    W  P  +  G   +    DVWS G +L E+
Sbjct: 139 LCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 39/203 (19%)

Query: 164 FSVSLFTDELVALKKVRLE---NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA 220
           +   L  +  VA+K  R     + K  F    ++E +IL+Q +H NIV L  +   K   
Sbjct: 12  YKGVLKGNTEVAVKTCRSTLPPDLKRKF----LQEAEILKQYDHPNIVKLIGVCVQKQ-- 65

Query: 221 LDFRKDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLD---GLSYCHKRNF 276
                     Y+V E +    L+  L       N +    +++  LD   G+ Y   +N 
Sbjct: 66  --------PIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKNC 114

Query: 277 LHRDIKCSNILMNNRGEVKLADFGLAR-----LYNAED--RQRPYTNKVITLWYRPPELL 329
           +HRD+   N L+     +K++DFG++R     +Y   D  +Q P        W  P  L 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK------WTAPEALN 168

Query: 330 LGEERYGPAIDVWSCGCILGELF 352
            G  RY    DVWS G +L E F
Sbjct: 169 YG--RYTSESDVWSYGILLWETF 189

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 3/94 (3%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E+ QL  I +L GTP    WP   KLPL+    P+K   + L+  F      A+DLL  +
Sbjct: 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRK--PKDLKTIFPNASDDAIDLLQSL 296

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
           L+L+P  RI+A++ALK  + K+  P    P QLP
Sbjct: 297 LKLNPLERISAKEALKHEYFKS-DPLPCDPSQLP 329

Length = 335

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 42/134 (31%), Positives = 60/134 (44%), Gaps = 11/134 (8%)

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           K   YLV EY++      L   +    E      + +++ G+   H+R  +HRDIK  N+
Sbjct: 69  KDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENL 128

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSC 344
           L++  G +KL DFGL+R            NK    T  Y  PE +LG        D WS 
Sbjct: 129 LIDQTGHLKLTDFGLSRN--------GLENKKFVGTPDYLAPETILGVGD-DKMSDWWSL 179

Query: 345 GCILGELFVKKPLF 358
           GC++ E     P F
Sbjct: 180 GCVIFEFLFGYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 14/167 (8%)

Query: 185 KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGL 244
           K G   T + E  +L+ +NH +++ +++ +                 +V  +   DL   
Sbjct: 97  KIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG----------AITCMVLPHYSSDLYTY 146

Query: 245 LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL 304
           L              I +Q+L+GL Y H +  +HRD+K  NI +N+  +V + D G A+ 
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206

Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                        V T     PE +L  ++Y    D+WS G +L E+
Sbjct: 207 PVVAPAFLGLAGTVET---NAPE-VLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 68.4 bits (167), Expect = 3e-13
 Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 20/185 (10%)

Query: 171 DELVALKKVRLENEKEGFPITA--VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
              VA+K +R     EG       + E +++ +L+H  +V L  + T++S          
Sbjct: 28  KRKVAIKTIR-----EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS---------- 72

Query: 229 SFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              LVFE+M+H  L   L +    F++     +   + +G++Y    N +HRD+   N L
Sbjct: 73  PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCL 132

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +     VK++DFG+ R    +        K    W  P        +Y    DVWS G +
Sbjct: 133 VGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVL 190

Query: 348 LGELF 352
           + E+F
Sbjct: 191 MWEVF 195

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 29/169 (17%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLL---ESG 248
            +E++ L++L HK++++L  + +               Y++ E M+   L+  L   E  
Sbjct: 50  QKEVQALKRLRHKHLISLFAVCSVGE----------PVYIITELMEKGSLLAFLRSPEGQ 99

Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL---- 304
           ++    + +  +  Q+ +G++Y  ++N +HRD+   NIL+      K+ADFGLARL    
Sbjct: 100 VLPVASLID--MACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157

Query: 305 -YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            Y + D++ PY       W  P         +    DVWS G +L E+F
Sbjct: 158 VYLSSDKKIPYK------WTAPEA--ASHGTFSTKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 58/188 (30%), Positives = 92/188 (48%), Gaps = 17/188 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+K + LE E E       +EI +L Q +   I          +           
Sbjct: 28  TKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT----------K 76

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ EY+     + LL+ G ++  E   A+I+R++L GL Y H    +HRDIK +N+L+
Sbjct: 77  LWIIMEYLGGGSALDLLKPGPLE--ETYIATILREILKGLDYLHSERKIHRDIKAANVLL 134

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           + +G+VKLADFG+A      D Q      V T ++  PE ++ +  Y    D+WS G   
Sbjct: 135 SEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKADIWSLGITA 191

Query: 349 GELFVKKP 356
            EL   +P
Sbjct: 192 IELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 17/192 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T EL A+K ++LE   E F +   +EI +++   H NIV               R+DK  
Sbjct: 33  TGELAAIKVIKLE-PGEDFAVVQ-QEIIMMKDCKHSNIVAYF--------GSYLRRDK-- 80

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            ++  E+     +  +       +E   A + R+ L GL Y H +  +HRDIK +NIL+ 
Sbjct: 81  LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCI 347
           + G VKLADFG++    A   +R   + + T ++  PE+   E +  Y    D+W+ G  
Sbjct: 141 DNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGIT 198

Query: 348 LGELF-VKKPLF 358
             EL  ++ P+F
Sbjct: 199 AIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 21/197 (10%)

Query: 167 SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           +L T EL A+K ++LE   + F +   +EI ++++  H NIV                  
Sbjct: 30  NLHTGELAAVKIIKLE-PGDDFSLIQ-QEIFMVKECKHCNIVAY----------FGSYLS 77

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           +   ++  EY     +  +       +E+  A + R+ L GL+Y H +  +HRDIK +NI
Sbjct: 78  REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANI 137

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER--YGPAIDVWSC 344
           L+ + G+VKLADFG+A    A   +R   + + T ++  PE+   E+   Y    D+W+ 
Sbjct: 138 LLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195

Query: 345 GCI---LGELFVKKPLF 358
           G     L EL  + P+F
Sbjct: 196 GITAIELAEL--QPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 46/133 (34%), Positives = 64/133 (48%), Gaps = 7/133 (5%)

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +DK + YLV EY    DL+ LL      F+E      + +L+  +   H+  ++HRDIK 
Sbjct: 71  QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKP 130

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL-----GEERYGPA 338
            N+L++  G +KLADFG A    A          V T  Y  PE+L      G+  YG  
Sbjct: 131 ENVLIDRTGHIKLADFGSAARLTANKMVNS-KLPVGTPDYIAPEVLTTMNGDGKGTYGVE 189

Query: 339 IDVWSCGCILGEL 351
            D WS G I  E+
Sbjct: 190 CDWWSLGVIAYEM 202

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 34/203 (16%)

Query: 169 FTDE--LVALKKVRLE---NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
           F  +  LVA+K +R +     +  F    ++EIKI+ +L + NI+ L  +     D L  
Sbjct: 40  FDGQPVLVAVKMLRADVTKTARNDF----LKEIKIMSRLKNPNIIRLLGVCV-SDDPL-- 92

Query: 224 RKDKGSFYLVFEYMDH-DLMGLL-----ESGMVDFNEVNNASIMR------QLLDGLSYC 271
                   ++ EYM++ DL   L     ES     N + + SI        Q+  G+ Y 
Sbjct: 93  -------CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145

Query: 272 HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLL 330
              NF+HRD+   N L+ N   +K+ADFG++R   + D  R     V+ + W     +LL
Sbjct: 146 ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205

Query: 331 GEERYGPAIDVWSCGCILGELFV 353
           G  ++  A DVW+ G  L E+F 
Sbjct: 206 G--KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 35/188 (18%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++ +   + F    + E  ++ QL H N+V L  ++ +         +KG  Y+V
Sbjct: 32  VAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVE---------EKGGLYIV 78

Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIM---------RQLLDGLSYCHKRNFLHRDIKCS 284
            EYM        +  +VD+      S++           + + + Y    NF+HRD+   
Sbjct: 79  TEYM-------AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAAR 131

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++     K++DFGL +    E      T K+   W  P  L   E+++    DVWS 
Sbjct: 132 NVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALR--EKKFSTKSDVWSF 185

Query: 345 GCILGELF 352
           G +L E++
Sbjct: 186 GILLWEIY 193

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 18/184 (9%)

Query: 173 LVALKKVRLENEKEGFP-ITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
            VALKKV++ +  +       ++EI +L+QLNH N++       + ++            
Sbjct: 29  PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE----------LN 78

Query: 232 LVFEYMDH-DLMGLLESGMVDFNEVNNASIMR---QLLDGLSYCHKRNFLHRDIKCSNIL 287
           +V E  D  DL  +++        +   ++ +   QL   L + H R  +HRDIK +N+ 
Sbjct: 79  IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +   G VKL D GL R +++  +     + V T +Y  PE  + E  Y    D+WS GC+
Sbjct: 139 ITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCL 195

Query: 348 LGEL 351
           L E+
Sbjct: 196 LYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 29/183 (15%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG---- 248
           RE ++L  L H++IV    +  D  D L          +VFEYM H DL   L +     
Sbjct: 56  REAELLTNLQHEHIVKFYGVCGD-GDPL---------IMVFEYMKHGDLNKFLRAHGPDA 105

Query: 249 --MVDFNEVNNAS---------IMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA 297
             +VD                 I  Q+  G+ Y   ++F+HRD+   N L+     VK+ 
Sbjct: 106 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 165

Query: 298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV--KK 355
           DFG++R   + D  R   + ++ + + PPE ++   ++    DVWS G IL E+F   K+
Sbjct: 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQ 224

Query: 356 PLF 358
           P F
Sbjct: 225 PWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.6 bits (165), Expect = 7e-13
 Identities = 38/89 (42%), Positives = 51/89 (57%), Gaps = 7/89 (7%)

Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITLW 322
           ++ GL+Y      LHRD+K SN+L+N RG+VKL DFG++  L N+  +    TN      
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA----- 158

Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           Y  PE + GE+ YG   DVWS G    EL
Sbjct: 159 YMAPERISGEQ-YGIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 11/85 (12%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMP---------PGAL 68
           QLE I ++ GTPT   WP + K+P + T+   K  + +     SL               
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLM--KDFKTKTYPSNSLAKWMEKHKKPDSQGF 290

Query: 69  DLLDKMLELDPERRITAEQALKSVW 93
           DLL K+LE DP +RITAE+AL+  +
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 22/187 (11%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           + L  LK++ +        + A +E ++L +L+H  IV       ++           +F
Sbjct: 28  ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD----------AF 77

Query: 231 YLVFEY-----MDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
            ++ EY     +D  L  L  +G    +E        QLL G+ Y H+R  LHRD+K  N
Sbjct: 78  CIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKN 136

Query: 286 ILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           I + N   +K+ DFG++R L  + D    +T    T +Y  PE  L  + Y    D+WS 
Sbjct: 137 IFLKN-NLLKIGDFGVSRLLMGSCDLATTFTG---TPYYMSPE-ALKHQGYDSKSDIWSL 191

Query: 345 GCILGEL 351
           GCIL E+
Sbjct: 192 GCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 24/185 (12%)

Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K ++    E ++  F    + E  I+ Q +H NI++L  +VT     +         
Sbjct: 35  VAIKTLKAGYTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKSKPVM--------- 81

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 82  -IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN 140

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 141 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTAPEA--IAYRKFTSASDVWSYGI 197

Query: 347 ILGEL 351
           ++ E+
Sbjct: 198 VMWEV 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 32/203 (15%)

Query: 173 LVALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           LVA+K ++   +N ++ F     RE ++L  L H++IV    +  +  D L         
Sbjct: 37  LVAVKTLKDASDNARKDFH----REAELLTNLQHEHIVKFYGVCVE-GDPL--------- 82

Query: 231 YLVFEYMDH-DLMGLLESGMVD------------FNEVNNASIMRQLLDGLSYCHKRNFL 277
            +VFEYM H DL   L +   D              +     I +Q+  G+ Y   ++F+
Sbjct: 83  IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFV 142

Query: 278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGP 337
           HRD+   N L+     VK+ DFG++R   + D  R   + ++ + + PPE ++   ++  
Sbjct: 143 HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTT 201

Query: 338 AIDVWSCGCILGELFV--KKPLF 358
             DVWS G +L E+F   K+P +
Sbjct: 202 ESDVWSLGVVLWEIFTYGKQPWY 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 34/205 (16%)

Query: 173 LVALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           LVA+K ++   E+ ++ F     RE ++L  L H++IV    + T+    L         
Sbjct: 37  LVAVKALKEASESARQDFQ----REAELLTVLQHQHIVRFYGVCTEGRPLL--------- 83

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNA--------------SIMRQLLDGLSYCHKRN 275
            +VFEYM H DL   L S   D   +                 +I  Q+  G+ Y    +
Sbjct: 84  -MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH 142

Query: 276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           F+HRD+   N L+     VK+ DFG++R   + D  R     ++ + + PPE +L   ++
Sbjct: 143 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKF 201

Query: 336 GPAIDVWSCGCILGELFV--KKPLF 358
               D+WS G +L E+F   K+P +
Sbjct: 202 TTESDIWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 32/85 (37%), Positives = 51/85 (60%), Gaps = 2/85 (2%)

Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPE 327
           L + H+   ++RDIK  NIL+++ G V L DFGL++ + AE+ +R Y+    T+ Y  PE
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPE 176

Query: 328 LLLGEER-YGPAIDVWSCGCILGEL 351
           ++ G    +  A+D WS G +  EL
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFEL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 23/182 (12%)

Query: 174 VALKKVRLE-NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +    + F    + E  ++  L H N+V L  +V   +            Y+
Sbjct: 32  VAVKCLKDDSTAAQAF----LAEASVMTTLRHPNLVQLLGVVLQGN----------PLYI 77

Query: 233 VFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           V EYM    L+  L S G               + +G+ Y  ++NF+HRD+   N+L++ 
Sbjct: 78  VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE 137

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
               K++DFGLA+    E  Q   + K+   W  P  L     ++    DVWS G +L E
Sbjct: 138 DLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWE 191

Query: 351 LF 352
           ++
Sbjct: 192 IY 193

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 28/168 (16%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF 252
           + E +I+++L H  ++ L  + T +             Y+V E M +         ++++
Sbjct: 49  LAEAQIMKKLRHPKLIQLYAVCTLEE----------PIYIVTELMKY-------GSLLEY 91

Query: 253 --NEVNNASIMRQLLD-------GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR 303
                  A  + QL+D       G++Y   +N++HRD+   N+L+      K+ADFGLAR
Sbjct: 92  LQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151

Query: 304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +   +  +     K    W  P   L    R+    DVWS G +L E+
Sbjct: 152 VIKEDIYEAREGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 51/189 (26%), Positives = 97/189 (51%), Gaps = 20/189 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE--IVTDKSDALDFRKDK 227
           T + VA+KK+ L  ++    +    E+ I+R  +H+N+V++    +V D+          
Sbjct: 46  TGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHENVVDMYNSYLVGDE---------- 93

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              ++V E+++   +  + +     NE   A++   +L  LSY H +  +HRDIK  +IL
Sbjct: 94  --LWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSIL 150

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + + G +KL+DFG     + E  +R   + V T ++  PE ++    YG  +D+WS G +
Sbjct: 151 LTSDGRIKLSDFGFCAQVSKEVPKR--KSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIM 207

Query: 348 LGELFVKKP 356
           + E+   +P
Sbjct: 208 VIEMIDGEP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 56/183 (30%), Positives = 89/183 (48%), Gaps = 19/183 (10%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++ ENEK       +RE +I+ QL++  IV  R I   +++AL          LV
Sbjct: 25  VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIV--RMIGVCEAEAL---------MLV 72

Query: 234 FEYMDHDLMGLLESGMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            E      +    SG  D   V+N   +M Q+  G+ Y   +NF+HRD+   N+L+ N+ 
Sbjct: 73  MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH 132

Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVITLW---YRPPELLLGEERYGPAIDVWSCGCILG 349
             K++DFGL++   A+D    Y  +    W   +  PE +    ++    DVWS G  + 
Sbjct: 133 YAKISDFGLSKALGADDSY--YKARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGITMW 189

Query: 350 ELF 352
           E F
Sbjct: 190 EAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 33/85 (38%), Positives = 55/85 (64%), Gaps = 1/85 (1%)

Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPE 327
           L + HK   ++RDIK  NIL+++ G V L DFGL++ + +E+++R Y+    T+ Y  PE
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF-CGTIEYMAPE 176

Query: 328 LLLGEERYGPAIDVWSCGCILGELF 352
           ++ G+  +G A+D WS G ++ EL 
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 28/76 (36%), Positives = 45/76 (59%), Gaps = 1/76 (1%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLEL 77
           QL  I ++ GTPT + WP + +LP +    P+   +  L++ F    P  +DLL ++L+L
Sbjct: 209 QLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQD-LQQLFPHADPLGIDLLHRLLQL 267

Query: 78  DPERRITAEQALKSVW 93
           +PE RI+A  AL+  W
Sbjct: 268 NPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 31/167 (18%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES------ 247
           E  +++ L H  +V L  +VT           K   Y++ E+M    L+  L+S      
Sbjct: 51  EANVMKTLQHDKLVKLHAVVT-----------KEPIYIITEFMAKGSLLDFLKSDEGSKQ 99

Query: 248 ---GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL 304
               ++DF+         Q+ +G+++  +RN++HRD++ +NIL++     K+ADFGLAR+
Sbjct: 100 PLPKLIDFSA--------QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 151

Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
               +       K    W  P  +  G   +    DVWS G +L E+
Sbjct: 152 IEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEI 196

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 65.5 bits (159), Expect = 6e-12
 Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 12/191 (6%)

Query: 179 VRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD----ALDFR-KDKGSFYLV 233
           V+L+N  + F +  + + ++L++         R+++ +  +     L +  +D+ + YLV
Sbjct: 20  VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79

Query: 234 FEY-MDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            +Y +  DL+ LL        E      + +++  +   H+ +++HRDIK  NILM+  G
Sbjct: 80  MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 139

Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL----GEERYGPAIDVWSCG-CI 347
            ++LADFG + L   ED     +  V T  Y  PE+L     G+ +YGP  D WS G C+
Sbjct: 140 HIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCM 198

Query: 348 LGELFVKKPLF 358
              L+ + P +
Sbjct: 199 YEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 37/198 (18%)

Query: 174 VALKKVRLENE---KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K  +       +E F    ++E  I+RQ +H +IV L  ++T+              
Sbjct: 37  VAVKTCKNCTSPSVREKF----LQEAYIMRQFDHPHIVKLIGVITENP-----------V 81

Query: 231 YLVFEYMDHDLMGLLESGMVDFNEVNNASI--------MRQLLDGLSYCHKRNFLHRDIK 282
           ++V E     L  L E     + +VN  S+          QL   L+Y   + F+HRDI 
Sbjct: 82  WIVME-----LAPLGELRS--YLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIA 134

Query: 283 CSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
             N+L+++   VKL DFGL+R    E   +    K+   W  P  +     R+  A DVW
Sbjct: 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF--RRFTSASDVW 192

Query: 343 SCGCILGELFV--KKPLF 358
             G  + E+ +   KP  
Sbjct: 193 MFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 25/195 (12%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  L A K +  ++E+E      + EI+IL   NH  IV L          L      G 
Sbjct: 36  TGALAAAKVIETKSEEE--LEDYMVEIEILATCNHPYIVKL----------LGAFYWDGK 83

Query: 230 FYLVFEYMDHDLMGLLESGMVDFN----EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
            +++ E+      G +++ M++ +    E     I RQ+L+ L Y H    +HRD+K  N
Sbjct: 84  LWIMIEFCPG---GAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGN 140

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER----YGPAIDV 341
           +L+   G++KLADFG++   N +  QR   + + T ++  PE+++ E      Y    D+
Sbjct: 141 VLLTLDGDIKLADFGVSA-KNVKTLQR-RDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 198

Query: 342 WSCGCILGELFVKKP 356
           WS G  L E+   +P
Sbjct: 199 WSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 27/188 (14%)

Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           AL+K + EN +  F     RE+ + R+L+HKN+V L  +  +              Y++ 
Sbjct: 42  ALQKTKDENLQSEFR----RELDMFRKLSHKNVVRLLGLCREAE----------PHYMIL 87

Query: 235 EYMD-HDLMGLLE--SGMVDFNEVNNAS------IMRQLLDGLSYCHKRNFLHRDIKCSN 285
           EY D  DL   L       +  +    S      +  Q+  G+ +     F+HRD+   N
Sbjct: 88  EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARN 147

Query: 286 ILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
            L++++ EVK++   L++ +YN+E       N +I L +  PE +  E+ +    DVWS 
Sbjct: 148 CLVSSQREVKVSLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSF 204

Query: 345 GCILGELF 352
           G ++ E+F
Sbjct: 205 GVLMWEVF 212

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 18/180 (10%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           LK     +E+E      + E+KI+  L NH+NIVNL    T            G   ++ 
Sbjct: 73  LKPTAHSSEREAL----MSELKIMSHLGNHENIVNLLGACTIG----------GPILVIT 118

Query: 235 EYMDH-DLMGLLESGMVDFNEVNNA-SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           EY  + DL+  L      F  + +  S   Q+  G+++   +N +HRD+   N+L+ +  
Sbjct: 119 EYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK 178

Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            VK+ DFGLAR    +       N  + + +  PE +     Y    DVWS G +L E+F
Sbjct: 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIF 237

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 30/193 (15%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           +KK+ L N        A +E ++L QL H NIV  RE          +  + G  Y+V  
Sbjct: 30  IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE---------SWEGEDGLLYIVMG 80

Query: 236 YMD-----HDLMG-----LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           + +     H L       L E+ +V++          Q+   L Y H+++ LHRD+K  N
Sbjct: 81  FCEGGDLYHKLKEQKGKLLPENQVVEW--------FVQIAMALQYLHEKHILHRDLKTQN 132

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           + +     +K+ D G+AR+   E++    +  + T +Y  PE L   + Y    DVW+ G
Sbjct: 133 VFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPE-LFSNKPYNYKSDVWALG 189

Query: 346 CILGELFVKKPLF 358
           C + E+   K  F
Sbjct: 190 CCVYEMATLKHAF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 49/140 (35%), Positives = 67/140 (47%), Gaps = 8/140 (5%)

Query: 223 FRKDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
           F+ DK   Y+V EYM   DL+ L+ +   D  E        +++  L   H   F+HRD+
Sbjct: 112 FQDDK-YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDV 168

Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---GEERYGPA 338
           K  N+L++  G +KLADFG     +A    R  T  V T  Y  PE+L    G+  YG  
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 339 IDVWSCGCILGELFVKKPLF 358
            D WS G  L E+ V    F
Sbjct: 228 CDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 57/173 (32%), Positives = 84/173 (48%), Gaps = 38/173 (21%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY------LVFEYMDH---DLMG 243
           +RE+K+L + N   IV                   G+FY      +  E+MD    D + 
Sbjct: 47  IRELKVLHECNSPYIVGFY----------------GAFYSDGEISICMEHMDGGSLDQV- 89

Query: 244 LLESGMVDFNEVNNASIMRQLLDGLSYCH-KRNFLHRDIKCSNILMNNRGEVKLADFGLA 302
           L ++G +  N +   SI   +L GL+Y   K   +HRD+K SNIL+N+RGE+KL DFG++
Sbjct: 90  LKKAGRIPENILGKISIA--VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147

Query: 303 -RLYNAEDRQRPYTNK-VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
            +L ++        N  V T  Y  PE L G   Y    D+WS G  L E+ +
Sbjct: 148 GQLIDS------MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAI 193

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 35/76 (46%), Positives = 41/76 (53%), Gaps = 2/76 (2%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           EL QL  I KL GTPT  VWP V KL  WH     +   + L      + P  LDLL KM
Sbjct: 217 ELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF--PQWKPQDLSRAVPDLSPEGLDLLQKM 274

Query: 75  LELDPERRITAEQALK 90
           L  DP +RI+A+ AL 
Sbjct: 275 LRYDPAKRISAKAALT 290

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHT---IKPKKIHRRR-LREEFSLMPPGALDLLDK 73
           QL+ I  L GTP   +   + K+        I+      ++  +E FS   P A+DLL+K
Sbjct: 224 QLKRIMNLVGTPDEEL---LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEK 280

Query: 74  MLELDPERRITAEQALKSVWLKNVH-PESMPPPQL 107
           ML LDP++RITA +AL   +L   H PE  P    
Sbjct: 281 MLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPP 315

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 31/195 (15%)

Query: 173 LVALKKVRLE---NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           LVA+K +R +   N +  F    ++EIKI+ +L   NI+ L  +    SD L        
Sbjct: 48  LVAVKMLREDANKNARNDF----LKEIKIMSRLKDPNIIRLLAVCIT-SDPL-------- 94

Query: 230 FYLVFEYMD----------HDLMGLLESGMVDFNEVNNASIM-RQLLDGLSYCHKRNFLH 278
             ++ EYM+          H+     E   V     +    M  Q+  G+ Y    NF+H
Sbjct: 95  -CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153

Query: 279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGEERYGP 337
           RD+   N L+     +K+ADFG++R   + D  R     V+ + W     +LLG  ++  
Sbjct: 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTT 211

Query: 338 AIDVWSCGCILGELF 352
           A DVW+ G  L E+ 
Sbjct: 212 ASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 41/134 (30%), Positives = 73/134 (54%), Gaps = 7/134 (5%)

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           K   + V EY++  DLM  ++S    F+E        +++ GL + HK+  ++RD+K  N
Sbjct: 68  KEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDN 126

Query: 286 ILMNNRGEVKLADFGLARL-YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           +L++  G +K+ADFG+ +   N E +   +     T  Y  PE+L G ++Y  ++D WS 
Sbjct: 127 VLLDKDGHIKIADFGMCKENMNGEGKASTFCG---TPDYIAPEILKG-QKYNESVDWWSF 182

Query: 345 GCILGELFVKKPLF 358
           G +L E+ + +  F
Sbjct: 183 GVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 45/171 (26%), Positives = 68/171 (39%), Gaps = 39/171 (22%)

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D+   YL+ EY+   D+M LL        E     I   +L  +   HK  ++HRDIK 
Sbjct: 71  QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL-AIDSIHKLGYIHRDIKP 129

Query: 284 SNILMNNRGEVKLADFGL-------------------ARLYNAEDRQRPYTNK-VITLW- 322
            N+L++ +G +KL+DFGL                         +   +P ++K     W 
Sbjct: 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWK 189

Query: 323 ---------------YRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                          Y  PE+ L +  Y    D WS G I+ E+ V  P F
Sbjct: 190 RNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 19/163 (11%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFN 253
           E  I+ Q +H NI++L  +VT     +          ++ E+M++  L   L      F 
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSRPVM----------IITEFMENGALDSFLRQNDGQFT 104

Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            +    ++R +  G+ Y  + N++HRD+   NIL+N+    K++DFGL+R +  +D   P
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDP 163

Query: 314 -YTN----KVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
            YT+    K+   W  P  +     ++  A DVWS G ++ E+
Sbjct: 164 TYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEV 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 63.3 bits (155), Expect = 2e-11
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 34/175 (19%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-------HDLMGLL 245
           + E +IL+ + H  +VNL              +D  + YLV EY+            G  
Sbjct: 49  LNEKRILQSIRHPFLVNL----------YGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF 98

Query: 246 ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY 305
              +  F     A+   Q++  L Y H  + ++RD+K  N+L+++ G +K+ DFG A+  
Sbjct: 99  PEPVARFY----AA---QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151

Query: 306 NAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
               + R YT   +  T  Y  PE++L +  YG A+D W+ G ++ E+    P F
Sbjct: 152 ----KGRTYT---LCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 48/189 (25%), Positives = 88/189 (46%), Gaps = 30/189 (15%)

Query: 172 ELVALKKVR-LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           E++ LK+ + + NEK            +L++++H  I+ L               D+   
Sbjct: 38  EVIRLKQEQHVHNEKR-----------VLKEVSHPFIIRL----------FWTEHDQRFL 76

Query: 231 YLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           Y++ EY+   +L   L +    F+         +++  L Y H +  ++RD+K  NIL++
Sbjct: 77  YMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD 135

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             G +KL DFG A+    + R R +T    T  Y  PE ++  + +  A+D W+ G ++ 
Sbjct: 136 KEGHIKLTDFGFAK----KLRDRTWT-LCGTPEYLAPE-VIQSKGHNKAVDWWALGILIY 189

Query: 350 ELFVKKPLF 358
           E+ V  P F
Sbjct: 190 EMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 5/97 (5%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNAEDRQRPYTNKVITL 321
           Q++ GL + H+R  ++RD+K  N+L++N G V+++D GLA  L + + + + Y     T 
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG---TP 161

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            +  PELL GEE Y  ++D ++ G  L E+   +  F
Sbjct: 162 GFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 29/89 (32%), Positives = 51/89 (57%), Gaps = 4/89 (4%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q++ GL + H+R  ++RD+K  N+L+++ G V+++D GLA         +    +  T  
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPG 159

Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           Y  PE+L GE  Y  ++D ++ GC L E+
Sbjct: 160 YMAPEVLQGEV-YDFSVDWFALGCTLYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 30/169 (17%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG--- 248
           + E  +++ L H  +V L  +VT +             Y++ EYM    L+  L+S    
Sbjct: 49  LEEANLMKTLQHDKLVRLYAVVTKEE----------PIYIITEYMAKGSLLDFLKSDEGG 98

Query: 249 ------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA 302
                 ++DF+         Q+ +G++Y  ++N++HRD++ +N+L++     K+ADFGLA
Sbjct: 99  KVLLPKLIDFSA--------QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150

Query: 303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           R+    +       K    W  P  +  G   +    DVWS G +L E+
Sbjct: 151 RVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 31/76 (40%), Positives = 41/76 (53%), Gaps = 1/76 (1%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E+ QL  I +  GTP   VWP V  LP +    PK   R+ L +    +    LDLL KM
Sbjct: 205 EIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK-WARQDLSKVVPNLDEDGLDLLSKM 263

Query: 75  LELDPERRITAEQALK 90
           L  DP +RI+A+ AL+
Sbjct: 264 LVYDPAKRISAKAALQ 279

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 35/213 (16%)

Query: 158 GLSLNNFSVSLFTDE--LVALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLRE 212
             S   F+ +   D   LVA+K +R    +N +E F    ++E+KIL +L+  NI  L  
Sbjct: 31  DFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF----LKEVKILSRLSDPNIARLLG 86

Query: 213 I-VTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLL-ESGMVDFNEVNNAS---------I 260
           +   D               ++ EYM++ DL   L +          N+          +
Sbjct: 87  VCTVDPP-----------LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYM 135

Query: 261 MRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVI 319
             Q+  G+ Y    NF+HRD+   N L+     +K+ADFG++R LY + D  R      +
Sbjct: 136 ATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY-SSDYYRVQGRAPL 194

Query: 320 TLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            + +   E +L   ++    DVW+ G  L E+ 
Sbjct: 195 PIRWMAWESVLL-GKFTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 55/168 (32%), Positives = 81/168 (48%), Gaps = 20/168 (11%)

Query: 195 EIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-----LMGLLESG 248
           E  IL+ L NH N+V    +   K+D L      G  +LV E  +       + GLL  G
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFY-KADKLV----GGQLWLVLELCNGGSVTELVKGLLICG 122

Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL-ARLYNA 307
               +E   + I+   L GL + H    +HRD+K +NIL+   G VKL DFG+ A+L + 
Sbjct: 123 Q-RLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPA----IDVWSCGCILGEL 351
             R+      V T ++  PE++  E++Y  +     DVWS G    EL
Sbjct: 182 RLRR---NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 20/183 (10%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K  + E+  +   I  + E +IL+Q +H NIV L  + T +             Y+V
Sbjct: 22  VAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ----------PIYIV 70

Query: 234 FEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLD---GLSYCHKRNFLHRDIKCSNILMN 289
            E +   D +  L       +E+    +++  LD   G++Y   +N +HRD+   N L+ 
Sbjct: 71  MELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG 127

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
               +K++DFG++R  +          ++   W  P  L  G  RY    DVWS G +L 
Sbjct: 128 ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLW 185

Query: 350 ELF 352
           E F
Sbjct: 186 ETF 188

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 29/198 (14%)

Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           +LVA+K ++  N  + +     +E  ++ +L+H NIV L  +VT +              
Sbjct: 35  QLVAIKTLKDINNPQQWG-EFQQEASLMAELHHPNIVCLLGVVTQEQPVC---------- 83

Query: 232 LVFEYMDH-DLMGLL--------------ESGMV--DFNEVNNASIMRQLLDGLSYCHKR 274
           ++FEY++  DL   L              E G V    +  +   I  Q+  G+ Y    
Sbjct: 84  MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143

Query: 275 NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER 334
            F+H+D+   NIL+  +  VK++D GL+R   + D  R     ++ + + PPE ++   +
Sbjct: 144 FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-YGK 202

Query: 335 YGPAIDVWSCGCILGELF 352
           +    D+WS G +L E+F
Sbjct: 203 FSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 5/93 (5%)

Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRP 325
           GL + H+R  ++RD+K  N+L+++ G +K+ADFG+ +           T+    T  Y  
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVT--TSTFCGTPDYIA 164

Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           PE+L  +  YGPA+D W+ G +L E+   +  F
Sbjct: 165 PEILSYQP-YGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 33/76 (43%), Positives = 39/76 (51%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E+ QL  I +  GTP P VWP    L   +     K     L + F    P ALDLL +M
Sbjct: 204 EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQM 263

Query: 75  LELDPERRITAEQALK 90
           L  DP +RITAEQAL 
Sbjct: 264 LHYDPHKRITAEQALA 279

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 14/133 (10%)

Query: 231 YLVFEY-MDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             V EY    DLM  + + +  F+E         ++ GL Y H+   ++RD+K  N+L++
Sbjct: 78  CFVMEYAAGGDLMMHIHTDV--FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP----PELLLGEERYGPAIDVWSCG 345
             G VK+ADFGL +    E     + ++  T    P    PE+L  E  Y  A+D W  G
Sbjct: 136 TEGFVKIADFGLCK----EGMG--FGDRTSTFCGTPEFLAPEVLT-ETSYTRAVDWWGLG 188

Query: 346 CILGELFVKKPLF 358
            ++ E+ V +  F
Sbjct: 189 VLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 28/169 (16%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG------ 248
           E+ I+R   H+N+V +      KS            YLV E +   LM  L+ G      
Sbjct: 68  EVVIMRDYQHQNVVEMY-----KS------------YLVGEEL-WVLMEFLQGGALTDIV 109

Query: 249 -MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA 307
                NE   A++   +L  L Y H +  +HRDIK  +IL+   G VKL+DFG     + 
Sbjct: 110 SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169

Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP 356
           +  +R   + V T ++  PE ++    YG  +D+WS G ++ E+   +P
Sbjct: 170 DVPKR--KSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 18/178 (10%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           L+K R++  K      A+ E +IL ++N + +VNL      K DAL          LV  
Sbjct: 33  LEKKRIKKRKG--ESMALNEKQILEKVNSQFVVNLAYAYETK-DAL---------CLVLT 80

Query: 236 YMDH-DL-MGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            M+  DL   +   G   F E        ++L GL   H+ N ++RD+K  NIL+++ G 
Sbjct: 81  IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH 140

Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           ++++D GLA      +  R    +V T+ Y  PE +L  +RY  + D W  GC++ E+
Sbjct: 141 IRISDLGLAVKIPEGESIR---GRVGTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 37/131 (28%), Positives = 69/131 (52%), Gaps = 9/131 (6%)

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           Y V EY++  DLM  ++  +  F E +      ++  GL + H +  ++RD+K  N++++
Sbjct: 77  YFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCI 347
             G +K+ADFG+ +    E+     T +    T  Y  PE++  +  YG ++D W+ G +
Sbjct: 136 AEGHIKIADFGMCK----ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVL 190

Query: 348 LGELFVKKPLF 358
           L E+   +P F
Sbjct: 191 LYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 40/108 (37%), Positives = 56/108 (51%), Gaps = 5/108 (4%)

Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+         +LL  L   HK N ++RD+K  NIL++ +G + L DFGL +L   +D +
Sbjct: 90  FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK 149

Query: 312 RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
              TN    T  Y  PELLLG   Y  A+D W+ G +L E+    P F
Sbjct: 150 ---TNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 26/188 (13%)

Query: 170 TDELVALKKVRL-ENEKEGFPITAVREIKILRQLNH-KNIVNLREIVTDKSDALDFRKDK 227
           T +L A+K + + E+E+E   +    EI +L++ +H +NI         KS         
Sbjct: 40  TGQLAAIKVMDVTEDEEEEIKL----EINMLKKYSHHRNIATYYGAFIKKSPP----GHD 91

Query: 228 GSFYLVFEYMDH----DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
              +LV E+       DL+   +       E   A I R++L GL++ H    +HRDIK 
Sbjct: 92  DQLWLVMEFCGAGSVTDLVKNTKGNA--LKEDWIAYICREILRGLAHLHAHKVIHRDIKG 149

Query: 284 SNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEER----YGP 337
            N+L+    EVKL DFG+ A+L    DR     N  I T ++  PE++  +E     Y  
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY 205

Query: 338 AIDVWSCG 345
             D+WS G
Sbjct: 206 RSDIWSLG 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 41/134 (30%), Positives = 72/134 (53%), Gaps = 7/134 (5%)

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           K + + V EY++  DLM  ++S    F+         +++ GL + H +  ++RD+K  N
Sbjct: 68  KENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDN 126

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSC 344
           IL++  G +K+ADFG+ +     D +   T     T  Y  PE+LLG ++Y  ++D WS 
Sbjct: 127 ILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPEILLG-QKYNTSVDWWSF 182

Query: 345 GCILGELFVKKPLF 358
           G +L E+ + +  F
Sbjct: 183 GVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 27/183 (14%)

Query: 182 ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDL 241
           E E E + +    EI IL   +H NIV L          LD    + + +++ E+     
Sbjct: 43  EEELEDYMV----EIDILASCDHPNIVKL----------LDAFYYENNLWILIEFCAG-- 86

Query: 242 MGLLESGMVDF----NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA 297
            G +++ M++      E     + +Q L+ L+Y H+   +HRD+K  NIL    G++KLA
Sbjct: 87  -GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLA 145

Query: 298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER----YGPAIDVWSCGCILGELFV 353
           DFG++   N    QR   + + T ++  PE+++ E      Y    DVWS G  L E+  
Sbjct: 146 DFGVSA-KNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203

Query: 354 KKP 356
            +P
Sbjct: 204 IEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 16/169 (9%)

Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DL-MGLLESGM 249
           A+ E +IL ++N + +V+L      K DAL          LV   M+  DL   +   G 
Sbjct: 47  ALNEKQILEKVNSRFVVSLAYAYETK-DAL---------CLVLTLMNGGDLKFHIYNMGN 96

Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
             F+E        ++  GL   H+   ++RD+K  NIL+++ G ++++D GLA      +
Sbjct: 97  PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156

Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             R    +V T+ Y  PE ++  ERY  + D W  GC++ E+   K  F
Sbjct: 157 TIR---GRVGTVGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 38/132 (28%), Positives = 69/132 (52%), Gaps = 9/132 (6%)

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            Y V EY++  DLM  ++  +  F E        ++  GL + H+R  ++RD+K  N+++
Sbjct: 76  LYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGC 346
           ++ G +K+ADFG+ +    E      T +    T  Y  PE ++  + YG ++D W+ G 
Sbjct: 135 DSEGHIKIADFGMCK----EHMVDGVTTRTFCGTPDYIAPE-IIAYQPYGKSVDWWAYGV 189

Query: 347 ILGELFVKKPLF 358
           +L E+   +P F
Sbjct: 190 LLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 28/177 (15%)

Query: 193 VREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY-----MDHDLMGLLE 246
           V E+++++ +  HKNI+NL    T            G  Y++ EY     +   L     
Sbjct: 68  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 117

Query: 247 SGM---VDFNEVNN--------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D   V +         S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMK 177

Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIF 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 5/98 (5%)

Query: 262 RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYT-NKVIT 320
            Q+  G+SY  ++  +HRD+   N+L+     VK+ DFGLA+L + ++++      KV  
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175

Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
            W     +L     Y    DVWS G  + EL  F  KP
Sbjct: 176 KWMALESILHRI--YTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 23/79 (29%), Positives = 35/79 (44%), Gaps = 2/79 (2%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS--LMPPGALDLLDKML 75
           QL  I ++ GTPT   WP V   P +          R L          P   +L  K L
Sbjct: 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFL 272

Query: 76  ELDPERRITAEQALKSVWL 94
           + +P++RI+A +A+K  + 
Sbjct: 273 QYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 39/137 (28%), Positives = 67/137 (48%), Gaps = 15/137 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T   +A+K++RLE ++  F    + E+ IL +     IV+       +          G+
Sbjct: 25  TGVTMAMKEIRLELDESKFN-QIIMELDILHKAVSPYIVDFYGAFFIE----------GA 73

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNN---ASIMRQLLDGLSYCHKR-NFLHRDIKCSN 285
            Y+  EYMD   +  L +G V    +       I   ++ GL +  +  N +HRD+K +N
Sbjct: 74  VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133

Query: 286 ILMNNRGEVKLADFGLA 302
           +L+N  G+VKL DFG++
Sbjct: 134 VLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 18/167 (10%)

Query: 195 EIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD-- 251
           E  IL+ L +H N+V    +   K       K+    +LV E  +   +  L  G +   
Sbjct: 64  EYNILKALSDHPNVVKFYGMYYKKD-----VKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118

Query: 252 --FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL-ARLYNAE 308
               E   A I+ + L GL + H    +HRD+K +NIL+   G VKL DFG+ A+L +  
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178

Query: 309 DRQRPYTNKVITLWYRPPELLLGEER----YGPAIDVWSCGCILGEL 351
            R+      V T ++  PE++  E++    Y    DVWS G    EL
Sbjct: 179 LRR---NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 4/90 (4%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TL 321
           +L+  L + HK + ++RD+K  NIL++  G + L DFGL++    +++    TN    T 
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTT 160

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL 351
            Y  PE+LL E+ Y   +D WS G ++ E+
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 35/124 (28%), Positives = 67/124 (54%), Gaps = 2/124 (1%)

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +L+ +Y++   +    S    F E        +++  L + HK   ++RDIK  NIL++
Sbjct: 80  LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL-GEERYGPAIDVWSCGCIL 348
           + G V L DFGL++ ++ ++ +R Y +   T+ Y  P+++  G+  +  A+D WS G ++
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAY-SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198

Query: 349 GELF 352
            EL 
Sbjct: 199 YELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 54/194 (27%), Positives = 82/194 (42%), Gaps = 20/194 (10%)

Query: 164 FSVSLFTDE-LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD 222
           FS  L  D   VA+K  R E          ++E +IL+Q +H NIV L  + T K     
Sbjct: 12  FSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ---- 66

Query: 223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
                   Y+V E +   D +  L +            ++     G+ Y   ++ +HRD+
Sbjct: 67  ------PIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYT---NKVITLWYRPPELLLGEERYGPA 338
              N L+  +  +K++DFG++R    ED     T    ++   W  P  L  G  RY   
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYG--RYSSE 176

Query: 339 IDVWSCGCILGELF 352
            DVWS G +L E F
Sbjct: 177 SDVWSFGILLWEAF 190

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 59.5 bits (145), Expect = 6e-10
 Identities = 28/112 (25%), Positives = 50/112 (44%), Gaps = 5/112 (4%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRR-LREEFSLMPPGALDLLDKMLE 76
           QL +I ++ GTP+      +      + +K      ++ L + F    P A+DLL+KML 
Sbjct: 215 QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLV 274

Query: 77  LDPERRITAEQALKSVWLKNVHPES--MPPPQLPTWQDCHELWSKKRRRQLR 126
            DP++RITA++AL   +L  +H             +        +    +L+
Sbjct: 275 FDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDF--FDDDELTEEELK 324

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 7/140 (5%)

Query: 225 KDKGSFYLVFEY-MDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D+   YLV +Y +  DL+ LL        E      + +++  +   H+ +++HRDIK 
Sbjct: 71  QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE----RYGPAI 339
            N+L++  G ++LADFG + L   +D     +  V T  Y  PE+L   E    +YGP  
Sbjct: 131 DNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189

Query: 340 DVWSCG-CILGELFVKKPLF 358
           D WS G C+   L+ + P +
Sbjct: 190 DWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 47/133 (35%), Positives = 64/133 (48%), Gaps = 7/133 (5%)

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D    Y+V EYM   DL+ L+ +   D  E        +++  L   H   F+HRD+K 
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---GEERYGPAID 340
            N+L++  G +KLADFG     N E   R  T  V T  Y  PE+L    G+  YG   D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECD 229

Query: 341 VWSCGCILGELFV 353
            WS G  L E+ V
Sbjct: 230 WWSVGVFLYEMLV 242

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 29/189 (15%)

Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           +T + VA+K ++ +   + F    + E  ++ +L+HKN+V L  ++              
Sbjct: 27  YTGQKVAVKNIKCDVTAQAF----LEETAVMTKLHHKNLVRLLGVILHNG---------- 72

Query: 229 SFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLD---GLSYCHKRNFLHRDIKC 283
             Y+V E M   +L+  L + G      V+   +++  LD   G+ Y   +  +HRD+  
Sbjct: 73  -LYIVMELMSKGNLVNFLRTRGRA---LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAA 128

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
            NIL++  G  K++DFGLAR+           +K+   W  P    L  +++    DVWS
Sbjct: 129 RNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEA--LKHKKFSSKSDVWS 182

Query: 344 CGCILGELF 352
            G +L E+F
Sbjct: 183 YGVLLWEVF 191

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.9 bits (141), Expect = 1e-09
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 28/155 (18%)

Query: 203 NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYM-DHDLMGLLES-GMVDFNEVNNASI 260
           ++ N + L   VT     +          L+ +Y+ D DL  LL+  G +   EV    I
Sbjct: 67  DNPNFIKLYYSVTTLKGHV----------LIMDYIKDGDLFDLLKKEGKLSEAEV--KKI 114

Query: 261 MRQLLDGLSYCHKRNFLHRDIKCSNILMN-NRGEVKLADFGLARLYNAE---DRQRPYTN 316
           +RQL++ L+  HK N +H DIK  N+L +  +  + L D+GL ++       D       
Sbjct: 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG------ 168

Query: 317 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
              TL Y  PE + G   Y  + D W+ G +  EL
Sbjct: 169 ---TLDYFSPEKIKG-HNYDVSFDWWAVGVLTYEL 199

Length = 267

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 51/176 (28%), Positives = 70/176 (39%), Gaps = 44/176 (25%)

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +DK + Y V +Y+   D+M LL   +  F E      + +L   +   HK  F+HRDIK 
Sbjct: 71  QDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP 129

Query: 284 SNILMNNRGEVKLADFGLA--------------------------RLYNAEDRQRPYTNK 317
            NIL++  G +KL DFGL                             ++  DR R    +
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLE 189

Query: 318 ---------------VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                          V T  Y  PE+LL    Y    D WS G IL E+ V +P F
Sbjct: 190 RRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 17/166 (10%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMVDF 252
           E  IL  + H  IV+L            F+   G  YL+ EY+      M L   G+  F
Sbjct: 50  ERNILEAVKHPFIVDL---------IYAFQTG-GKLYLILEYLSGGELFMHLEREGI--F 97

Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
            E      + ++   L + H++  ++RD+K  NIL++ +G VKL DFGL +  +  +   
Sbjct: 98  MEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTV 156

Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            +T    T+ Y  PE+L+    +G A+D WS G ++ ++    P F
Sbjct: 157 THTF-CGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 40/133 (30%), Positives = 66/133 (49%), Gaps = 5/133 (3%)

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           K   + V EY++  DLM  ++     F+E  +     ++   L + H+   ++RD+K  N
Sbjct: 68  KDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDN 126

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           IL++  G  KLADFG+ +           T    T  Y  PE +L E  YGP++D W+ G
Sbjct: 127 ILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPDYIAPE-ILQELEYGPSVDWWALG 183

Query: 346 CILGELFVKKPLF 358
            ++ E+   +P F
Sbjct: 184 VLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 46/227 (20%)

Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLR---EIVTDKSDALDFR-----KD 226
           A  +VRL  +K+   I A++ ++    L  + + ++R   +I+ +   A   +     +D
Sbjct: 13  AFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD 72

Query: 227 KGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           K + YL+ E++   D+M LL        E     I   +L  +   H+  F+HRDIK  N
Sbjct: 73  KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQLGFIHRDIKPDN 131

Query: 286 ILMNNRGEVKLADFGL----------------------------------ARLYNAEDRQ 311
           +L++ +G VKL+DFGL                                  A  +    RQ
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191

Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             Y+  V T  Y  PE+ + +  Y    D WS G I+ E+ +  P F
Sbjct: 192 LAYST-VGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 22/183 (12%)

Query: 177 KKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY 236
           KKV     K       +RE++I+ +     IV+      ++++            +  E+
Sbjct: 35  KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC----------MCMEF 84

Query: 237 MDHD-LMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCH-KRNFLHRDIKCSNILMNNRGE 293
           MD   L  +  + G +    +    I   +++GL+Y +     +HRDIK SNIL+N+RG+
Sbjct: 85  MDCGSLDRIYKKGGPIPVEIL--GKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ 142

Query: 294 VKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +KL DFG++  L N+          V T  Y  PE + G  +Y    DVWS G  + EL 
Sbjct: 143 IKLCDFGVSGELINS-----IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELA 196

Query: 353 VKK 355
           + K
Sbjct: 197 LGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 18/165 (10%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY-MDHDLMGLLESGMVDFN 253
           E  IL +L+H  IVN+          +   +D+   Y + E+ +  +L   L       N
Sbjct: 68  EKSILMELSHPFIVNM----------MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN 117

Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
           +V        +L    Y H ++ ++RD+K  N+L++N+G VK+ DFG A+    +   R 
Sbjct: 118 DVAKFYHAELVL-AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRT 172

Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +T    T  Y  PE ++  + +G A+D W+ G +L E     P F
Sbjct: 173 FT-LCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.2 bits (139), Expect = 3e-09
 Identities = 30/89 (33%), Positives = 43/89 (48%), Gaps = 4/89 (4%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTI--KPKKIHRRRLREEFSLMPPGALDLLDKML 75
           QLE I ++ G P+       IK P   T+        R+ L E        ALDLL K+L
Sbjct: 221 QLEKIIEVIGPPSAEDI-ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279

Query: 76  ELDPERRITAEQALKSVWLKNVH-PESMP 103
             +P +R+TAE+AL+  ++   H P   P
Sbjct: 280 VFNPNKRLTAEEALEHPYVAQFHNPSDEP 308

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 27/172 (15%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVD 251
           ++E  I++  +H N+++L  I             +GS  +V  YM H DL   +      
Sbjct: 44  LKEGIIMKDFSHPNVLSLLGICLP---------SEGSPLVVLPYMKHGDLRNFIR----- 89

Query: 252 FNEVNNASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-L 304
            +E +N ++        Q+  G+ Y   + F+HRD+   N +++    VK+ADFGLAR +
Sbjct: 90  -SETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148

Query: 305 YNAE--DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           Y+ E          K+   W       L  +++    DVWS G +L EL  +
Sbjct: 149 YDKEYYSVHNHTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 24/168 (14%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG--LLESGMV 250
           +RE+++L + N   IV              F  D G   +  E+MD   +   L ++G +
Sbjct: 51  IRELQVLHECNSPYIVGFYGA---------FYSD-GEISICMEHMDGGSLDQVLKKAGRI 100

Query: 251 DFNEVNNASIMRQLLDGLSYC-HKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNAE 308
               +   SI   ++ GL+Y   K   +HRD+K SNIL+N+RGE+KL DFG++ +L ++ 
Sbjct: 101 PEQILGKVSI--AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157

Query: 309 DRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK 355
                  N  + T  Y  PE L G   Y    D+WS G  L E+ + +
Sbjct: 158 -----MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 50/172 (29%), Positives = 76/172 (44%), Gaps = 29/172 (16%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFN 253
           E  I+ + NH+NIV L          + F  ++   +++ E M   DL   L        
Sbjct: 59  EALIMSKFNHQNIVRLI--------GVSF--ERLPRFILLELMAGGDLKSFLRENR---P 105

Query: 254 EVNNAS--IMRQLL-------DGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGL 301
                S   M+ LL        G  Y  + +F+HRDI   N L+  +G     K+ADFG+
Sbjct: 106 RPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165

Query: 302 AR-LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           AR +Y A    R     ++ + + PPE  L +  +    DVWS G +L E+F
Sbjct: 166 ARDIYRA-SYYRKGGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIF 215

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 39/203 (19%)

Query: 173 LVALKKVRLE---NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           LVA+K +R +   N +  F    ++E+KIL +L   NI+ L  +  D  D L        
Sbjct: 48  LVAVKILRPDANKNARNDF----LKEVKILSRLKDPNIIRLLGVCVD-EDPL-------- 94

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNA------------------SIMRQLLDGLSY 270
             ++ EYM++ DL   L S  +D  E N                     +  Q+  G+ Y
Sbjct: 95  -CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153

Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELL 329
               NF+HRD+   N L+     +K+ADFG++R   A D  R     V+ + W     +L
Sbjct: 154 LSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213

Query: 330 LGEERYGPAIDVWSCGCILGELF 352
           +G  ++  A DVW+ G  L E+ 
Sbjct: 214 MG--KFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 14/137 (10%)

Query: 225 KDKGSFYLVFEY-MDHDLMGLLESGMVDFNEVNNASIMR----QLLDGLSYCHKRNFLHR 279
           +D+ + YLV +Y +  DL+ LL      F +     + R    +++  +   H+  ++HR
Sbjct: 71  QDENNLYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL----GEERY 335
           DIK  N+L++  G ++LADFG      A+   +     V T  Y  PE+L     G+ RY
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYISPEILQAMEDGKGRY 185

Query: 336 GPAIDVWSCGCILGELF 352
           GP  D WS G  + E+ 
Sbjct: 186 GPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 14/104 (13%)

Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR---------LY--NAEDRQRPYTN 316
           L Y H    +HRD+K  N+L+ + G +KL DFGL++         LY  + E   R + +
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 317 KVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           K +  T  Y  PE++L  + YG  +D W+ G IL E  V    F
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 18/185 (9%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           L+K R++  K      A+ E +IL ++N + +V+L      K DAL          LV  
Sbjct: 33  LEKKRIKKRKG--ESMALNEKQILEKVNSRFVVSLAYAYETK-DAL---------CLVLT 80

Query: 236 YMDH-DL-MGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            M+  DL   +   G   F E        ++  GL   H+   ++RD+K  NIL+++ G 
Sbjct: 81  LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH 140

Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           ++++D GLA ++  E +      +V T+ Y  PE ++  ERY  + D W+ GC+L E+  
Sbjct: 141 IRISDLGLA-VHVPEGQT--IKGRVGTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIA 196

Query: 354 KKPLF 358
            +  F
Sbjct: 197 GQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 20/166 (12%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG--LLESGMV 250
           +RE+++L + N   IV              F  D G   +  E+MD   +   L E+  +
Sbjct: 51  IRELQVLHECNSPYIVGFYGA---------FYSD-GEISICMEHMDGGSLDQVLKEAKRI 100

Query: 251 DFNEVNNASIMRQLLDGLSYC-HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
               +   SI   +L GL+Y   K   +HRD+K SNIL+N+RGE+KL DFG++     + 
Sbjct: 101 PEEILGKVSI--AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQL 154

Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK 355
                 + V T  Y  PE L G   Y    D+WS G  L EL + +
Sbjct: 155 IDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 44/185 (23%), Positives = 84/185 (45%), Gaps = 15/185 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           +++ VA+K ++ +N         +RE  +++QL++  IV +  I            +  S
Sbjct: 21  SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----------EAES 69

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           + LV E  +   +           E N   ++ Q+  G+ Y  + NF+HRD+   N+L+ 
Sbjct: 70  WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV 129

Query: 290 NRGEVKLADFGLARLYNAEDR--QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
            +   K++DFGL++   A++   +     K    WY P    +   ++    DVWS G +
Sbjct: 130 TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--CMNYYKFSSKSDVWSFGVL 187

Query: 348 LGELF 352
           + E F
Sbjct: 188 MWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 57/197 (28%), Positives = 84/197 (42%), Gaps = 21/197 (10%)

Query: 170 TDELVALKKVR-LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T   VA+K +R    E+E       RE  +  +L H NIV L     D  +A       G
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPP-----G 52

Query: 229 SFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             + VFEY+    L  +L +            +M Q+LD L+  H +  +HRD+K  NI+
Sbjct: 53  LLFAVFEYVPGRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIM 111

Query: 288 MNNRG---EVKLADFGLARL---YNAEDRQR-PYTNKVI-TLWYRPPELLLGEERYGPAI 339
           ++  G     K+ DFG+  L       D      T +V+ T  Y  PE L GE    P  
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNS 170

Query: 340 DVWSCGCILGELFVKKP 356
           D+++ G I  E    + 
Sbjct: 171 DLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 32/183 (17%)

Query: 193 VREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY--------------- 236
           V E+++++ +  HKNI+NL    T            G  Y++ EY               
Sbjct: 65  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVLVEYASKGNLREYLRARRP 114

Query: 237 --MDHDLMGL-LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
             MD+      L    + F ++   S   Q+  G+ Y   +  +HRD+   N+L+     
Sbjct: 115 PGMDYSFDTCKLPEEQLTFKDL--VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV 172

Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +K+ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFT 231

Query: 354 KKP 356
              
Sbjct: 232 LGG 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 8/109 (7%)

Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA---E 308
           F E     +  Q+L  + + H ++ +HRDIK +NIL+ + G VKL DFG +++Y A   +
Sbjct: 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199

Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF-VKKP 356
           D  R +     T +Y  PE+    + Y    D++S G +L EL  +K+P
Sbjct: 200 DVGRTFCG---TPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 31/83 (37%), Positives = 45/83 (54%), Gaps = 1/83 (1%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E+ +L  I ++ GTP    WP V  LP + +  PK    + L      + P  +DLL KM
Sbjct: 209 EIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPK-WPPKDLATVVPTLEPAGVDLLSKM 267

Query: 75  LELDPERRITAEQALKSVWLKNV 97
           L LDP +RITA  AL+  + K++
Sbjct: 268 LRLDPSKRITARAALEHEYFKDL 290

Length = 294

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 1/101 (0%)

Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F E     +  Q++  L   H R  +HRD+K +NI +   G +KL DFG ++ Y+     
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225

Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
              ++   T +Y  PE L   +RY    D+WS G IL EL 
Sbjct: 226 DVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELL 265

Length = 478

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 53/180 (29%), Positives = 71/180 (39%), Gaps = 48/180 (26%)

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +DK + Y V +Y+   D+M LL   M  F EV     + +L   +   HK  F+HRDIK 
Sbjct: 71  QDKDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKP 129

Query: 284 SNILMNNRGEVKLADFGLA---------------------------------------RL 304
            NIL++  G +KL DFGL                                        RL
Sbjct: 130 DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRL 189

Query: 305 YNAEDRQRPYTNKVI------TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
              E R      + +      T  Y  PE+LL  + Y    D WS G IL E+ V +P F
Sbjct: 190 KTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.9 bits (134), Expect = 7e-09
 Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 8/104 (7%)

Query: 258 ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTN 316
           A I R++L GLS+ H+   +HRDIK  N+L+    EVKL DFG+ A+L     R+  +  
Sbjct: 114 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 173

Query: 317 KVITLWYRPPELLLGEER----YGPAIDVWSCGCILGELFVKKP 356
              T ++  PE++  +E     Y    D+WS G    E+    P
Sbjct: 174 ---TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 23/195 (11%)

Query: 170 TDELVALKKVRLE--NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T+ + A+K V+ E  N+ E        +    +  NH  +V L      +S         
Sbjct: 19  TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--------- 69

Query: 228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
              + V EY++  DLM  ++       E +      ++   L+Y H+R  ++RD+K  N+
Sbjct: 70  -RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 127

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI---TLWYRPPELLLGEERYGPAIDVWS 343
           L+++ G +KL D+G+ +     +  RP         T  Y  PE+L GE+ YG ++D W+
Sbjct: 128 LLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWA 181

Query: 344 CGCILGELFVKKPLF 358
            G ++ E+   +  F
Sbjct: 182 LGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 27/85 (31%), Positives = 37/85 (43%), Gaps = 25/85 (29%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLP------------LWHTIKPKKIHRRRLREEFSLMPP 65
           QL+ I +L GTPT   WP V KLP                + PK             +  
Sbjct: 209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPK-------------LNS 255

Query: 66  GALDLLDKMLELDPERRITAEQALK 90
              DLL  +L  +P +RI+AE+AL+
Sbjct: 256 TGRDLLQNLLVCNPVQRISAEEALQ 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 22/53 (41%), Positives = 30/53 (56%)

Query: 53  RRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPP 105
           R+     F    P A+DLL+KML  DP +RIT E+AL   +L ++H  S  P 
Sbjct: 253 RQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV 305

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 29/196 (14%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ ++  E      V E+++++ +  HKNI+NL  + T           +G  Y+
Sbjct: 45  VAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT----------QEGPLYV 93

Query: 233 VFEYMDH-DLMGLLESG---MVDFNEVNN------------ASIMRQLLDGLSYCHKRNF 276
           V EY  H +L   L +        +  +              S   Q+  G+ +   +  
Sbjct: 94  VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKC 153

Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRD+   N+L+     +K+ADFGLAR  +  D  R  TN  + + +  PE L  +  Y 
Sbjct: 154 IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-DRVYT 212

Query: 337 PAIDVWSCGCILGELF 352
              DVWS G +L E+F
Sbjct: 213 HQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 46/227 (20%)

Query: 175 ALKKVRLENEKEG---FPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK------ 225
           A  +VRL  +K+    + +  +R+  +L +    +I   R+I+ + +D+L   K      
Sbjct: 13  AFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVKMFYSFQ 71

Query: 226 DKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           DK + YL+ E++   D+M LL        E     I   +L  +   H+  F+HRDIK  
Sbjct: 72  DKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIHQLGFIHRDIKPD 130

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTN---------------------------- 316
           N+L++++G VKL+DFGL        R   Y N                            
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190

Query: 317 -----KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PE+ + +  Y    D WS G I+ E+ +  P F
Sbjct: 191 QLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 9/126 (7%)

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            + V E+++  DLM  ++     F+E        ++   L + H +  ++RD+K  N+L+
Sbjct: 71  LFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGC 346
           ++ G  KLADFG+ +    E      T      T  Y  PE +L E  YGP++D W+ G 
Sbjct: 130 DHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGV 184

Query: 347 ILGELF 352
           +L E+ 
Sbjct: 185 LLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 5/97 (5%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ-RPYTNKVITL 321
           Q+  G++Y  +R  +HRD+   N+L+     VK+ DFGLA+L  A++++      KV   
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           W     +L     Y    DVWS G  + EL  F  KP
Sbjct: 177 WMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 47/180 (26%), Positives = 71/180 (39%), Gaps = 48/180 (26%)

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D    YL+ E++   DLM +L      F+E      M + +  +   HK  F+HRDIK 
Sbjct: 71  QDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129

Query: 284 SNILMNNRGEVKLADFGLA----RLYNAEDRQRPYTNKV--------------------- 318
            NIL++  G +KL+DFGL+    + +++   Q+    K                      
Sbjct: 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189

Query: 319 ----ITLW----------------YRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
               I  W                Y  PE+ L +  YG   D WS G I+ E  +  P F
Sbjct: 190 SKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPPF 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 51/180 (28%), Positives = 70/180 (38%), Gaps = 48/180 (26%)

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +DK + Y V +Y+   D+M LL   M  F E      + +L   +   HK  F+HRDIK 
Sbjct: 71  QDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKP 129

Query: 284 SNILMNNRGEVKLADFGL---------ARLYNAEDRQRPYTNKVITLW------------ 322
            NIL++  G +KL DFGL         ++ Y + D  R  +      W            
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRL 189

Query: 323 ------------------------YRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                                   Y  PE+LL    Y    D WS G IL E+ V +P F
Sbjct: 190 KPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 32/76 (42%), Positives = 43/76 (56%), Gaps = 1/76 (1%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E+ QL  I ++ GTPT  VWP V  LP +    PK   +  LR     +    LDLL+KM
Sbjct: 207 EIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK-WKKGSLRSAVKNLDEDGLDLLEKM 265

Query: 75  LELDPERRITAEQALK 90
           L  DP +RI+A++AL 
Sbjct: 266 LIYDPAKRISAKKALN 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 28/177 (15%)

Query: 193 VREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--------- 242
           + E+++++ +  HKNI+NL    T            G  Y++ EY     +         
Sbjct: 71  ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 120

Query: 243 -GLLESGMVDFNEVNNASI------MRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+              S         Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 180

Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIF 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 32/179 (17%)

Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY--------------- 236
           + E+++++ +  HKNI+NL  + T +          G  Y++ EY               
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQE----------GPLYVIVEYAAKGNLREFLRARRP 114

Query: 237 --MDHDLMGL-LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
              D+      +    + F ++   S   Q+  G+ Y   R  +HRD+   N+L+     
Sbjct: 115 PGPDYTFDITKVPEEQLSFKDL--VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV 172

Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ADFGLAR  +  D  +  +N  + + +  PE L  +  Y    DVWS G ++ E+F
Sbjct: 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 31/190 (16%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           L+K   + EK+ F    ++E  ++   NH NIV L  +                 Y++ E
Sbjct: 34  LRKGATDQEKKEF----LKEAHLMSNFNHPNIVKLLGVCLLNE----------PQYIIME 79

Query: 236 YMDH-DLMGLLESGMVDFNEVNNASIMRQLLD-------GLSYCHKRNFLHRDIKCSNIL 287
            M+  DL+  L    V+       ++ ++LLD       G  Y  + +F+HRD+   N L
Sbjct: 80  LMEGGDLLSYLRDARVERFGPPLLTL-KELLDICLDVAKGCVYLEQMHFIHRDLAARNCL 138

Query: 288 MNNRGE-----VKLADFGLAR-LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           ++ +G      VK+ DFGLAR +Y ++  ++     +   W  P  LL G  ++    DV
Sbjct: 139 VSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDV 196

Query: 342 WSCGCILGEL 351
           WS G ++ E+
Sbjct: 197 WSFGVLMWEI 206

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 44/189 (23%), Positives = 84/189 (44%), Gaps = 21/189 (11%)

Query: 174 VALKKVRLEN----EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++L+     E E F    + E   ++  +H N++ L  +  + S      K    
Sbjct: 30  VAVKTMKLDIHTYSEIEEF----LSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP--- 82

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVN--NASIMRQLLD---GLSYCHKRNFLHRDIKC 283
             ++  +M H DL   L    +          ++++ ++D   G+ Y   RNF+HRD+  
Sbjct: 83  -MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAA 141

Query: 284 SNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
            N ++     V +ADFGL++ +Y+ +  ++    K+   W       L +  Y    DVW
Sbjct: 142 RNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES--LADRVYTSKSDVW 199

Query: 343 SCGCILGEL 351
           + G  + E+
Sbjct: 200 AFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 18/178 (10%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           L+K R++  K      A+ E +IL ++N + +V+L      K DAL          LV  
Sbjct: 33  LEKKRIKKRKG--EAMALNEKRILEKVNSRFVVSLAYAYETK-DAL---------CLVLT 80

Query: 236 YMDH-DL-MGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            M+  DL   +   G   F+E        +L  GL    +   ++RD+K  NIL+++RG 
Sbjct: 81  IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH 140

Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           ++++D GLA      +  R    +V T+ Y  PE ++  E+Y  + D W  GC++ E+
Sbjct: 141 IRISDLGLAVQIPEGETVR---GRVGTVGYMAPE-VINNEKYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 9/132 (6%)

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            Y V EY++  DLM  ++  +  F E +      ++  GL + H +  ++RD+K  N+++
Sbjct: 76  LYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGC 346
           ++ G +K+ADFG+ +    E+     T K    T  Y  PE ++  + YG ++D W+ G 
Sbjct: 135 DSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGV 189

Query: 347 ILGELFVKKPLF 358
           +L E+   +  F
Sbjct: 190 LLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 3/91 (3%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL 321
           Q+  G+ +   R  +HRD+   NIL++    VK+ DFGLAR +Y   D  R  + ++   
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           W  P  +   ++ Y    DVWS G +L E+F
Sbjct: 242 WMAPESIF--DKVYTTQSDVWSFGVLLWEIF 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 18/96 (18%)

Query: 265 LDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADFGLA-RLYN--AEDRQ---RPYTNK 317
           +  L+Y  +    +HRD+K SNIL++  G +KL DFG++ +L +  A+ R    RPY   
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM-- 174

Query: 318 VITLWYRPPELLLGEERYGPAI--DVWSCGCILGEL 351
                   PE +    R G  +  DVWS G  L E+
Sbjct: 175 -------APERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 44/133 (33%), Positives = 62/133 (46%), Gaps = 7/133 (5%)

Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D    Y+V EYM   DL+ L+ +   D  E        +++  L   H    +HRD+K 
Sbjct: 113 QDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKP 170

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---GEERYGPAID 340
            N+L++  G +KLADFG     +     R  T  V T  Y  PE+L    G+  YG   D
Sbjct: 171 DNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECD 229

Query: 341 VWSCGCILGELFV 353
            WS G  L E+ V
Sbjct: 230 WWSVGVFLFEMLV 242

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 3/91 (3%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL 321
           Q+  G+ +   R  +HRD+   NIL++    VK+ DFGLAR +Y   D  R    ++   
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           W  P  +   +  Y    DVWS G +L E+F
Sbjct: 247 WMAPETIF--DRVYTIQSDVWSFGVLLWEIF 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H R+ ++RDIK  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGT 158

Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 159 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 32/101 (31%), Positives = 58/101 (57%), Gaps = 4/101 (3%)

Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++ GL + H R  ++RD+K +NIL++  G V+++D GLA  ++   ++
Sbjct: 94  FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KK 150

Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +P+ + V T  Y  PE+L     Y  + D +S GC+L +L 
Sbjct: 151 KPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 28/75 (37%), Positives = 38/75 (50%), Gaps = 1/75 (1%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E+ QL  I +  GTP   VWP V  LP +    PK   R+   +    +     DLL +M
Sbjct: 206 EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWA-RQDFSKVVPPLDEDGRDLLSQM 264

Query: 75  LELDPERRITAEQAL 89
           L  DP +RI+A+ AL
Sbjct: 265 LHYDPNKRISAKAAL 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 3/91 (3%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL 321
           Q+  G+ +   R  +HRD+   NIL++    VK+ DFGLAR +Y   D  R    ++   
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           W  P  +   ++ Y    DVWS G +L E+F
Sbjct: 241 WMAPESIF--DKVYTTQSDVWSFGVLLWEIF 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRP 325
           L Y H  N ++RD+K  NIL++++G V L DFGL +    E  +   T      T  Y  
Sbjct: 109 LGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLA 164

Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           PE+L  +  Y   +D W  G +L E+    P F
Sbjct: 165 PEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 7/91 (7%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H  + ++RD+K  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGT 158

Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 159 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 36/136 (26%), Positives = 72/136 (52%), Gaps = 11/136 (8%)

Query: 227 KGSFYLVFEYMDH-DLM-GLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           K   + V E+++  DLM  + + G  D       +   +++ GL + H +  ++RD+K  
Sbjct: 68  KEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYA--AEIVCGLQFLHSKGIIYRDLKLD 125

Query: 285 NILMNNRGEVKLADFGLAR--LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
           N++++  G +K+ADFG+ +  ++  ++R   +     T  Y  PE+L G  +Y  ++D W
Sbjct: 126 NVMLDRDGHIKIADFGMCKENVF-GDNRASTFCG---TPDYIAPEILQG-LKYTFSVDWW 180

Query: 343 SCGCILGELFVKKPLF 358
           S G +L E+ + +  F
Sbjct: 181 SFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 52.6 bits (126), Expect = 7e-08
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 12/134 (8%)

Query: 230 FYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMR---QLLDGLSYCHKRNFLHRDIKCSN 285
           + LVFEY +  DL   L              + R   ++  G+++ HK NFLH D+   N
Sbjct: 70  YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRN 129

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL-------LLGEERYGPA 338
             + +   VK+ D+G+      ED      +K + L +  PEL       L+  E+  P+
Sbjct: 130 CFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPS 189

Query: 339 IDVWSCGCILGELF 352
            +VW+ G  L ELF
Sbjct: 190 -NVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.6 bits (126), Expect = 7e-08
 Identities = 30/86 (34%), Positives = 52/86 (60%), Gaps = 4/86 (4%)

Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPP 326
           GL + H R  ++RD+K +NIL++  G V+++D GLA  ++   +++P+ + V T  Y  P
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHAS-VGTHGYMAP 164

Query: 327 ELLLGEERYGPAIDVWSCGCILGELF 352
           E+L     Y  + D +S GC+L +L 
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.4 bits (126), Expect = 8e-08
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 27/105 (25%)

Query: 259 SIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADFG--------LARLYNAED 309
           SI++     L Y H + + +HRD+K SN+L+N  G+VKL DFG        +A+  +A  
Sbjct: 111 SIVK----ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGC 166

Query: 310 RQRPYTNKVITLWYRPPELLLGE---ERYGPAIDVWSCGCILGEL 351
           +            Y  PE +  E   + Y    DVWS G  + EL
Sbjct: 167 KP-----------YMAPERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 52.6 bits (127), Expect = 9e-08
 Identities = 24/76 (31%), Positives = 36/76 (47%), Gaps = 3/76 (3%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E  QL+ I  + G P+   WP  + LP   +        R  +     +    LDLL KM
Sbjct: 211 EADQLDKIFDVIGLPSEEEWPRNVSLP-RSSFPSY--TPRSFKSFVPEICEEGLDLLKKM 267

Query: 75  LELDPERRITAEQALK 90
           L  +P +RI+A +AL+
Sbjct: 268 LTFNPHKRISAFEALQ 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 18/165 (10%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY-MDHDLMGLLESGMVDFN 253
           E KIL  +NH   VNL              KD+   YLV E+ +  +    L       N
Sbjct: 81  ERKILNYINHPFCVNLYGSF----------KDESYLYLVLEFVIGGEFFTFLRRNKRFPN 130

Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
           +V       Q++    Y    N ++RD+K  N+L++  G +K+ DFG A++ +     R 
Sbjct: 131 DVG-CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----RT 185

Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           YT    T  Y  PE+LL    +G A D W+ G  + E+ V  P F
Sbjct: 186 YT-LCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI---TLWY 323
            L++ H+R  ++RD+K  N+L++  G +KL D+G+ +     +   P         T  Y
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNY 162

Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             PE+L GEE YG ++D W+ G ++ E+   +  F
Sbjct: 163 IAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 5/97 (5%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ-RPYTNKVITL 321
           Q+  G+SY  +   +HRD+   N+L+ +   VK+ DFGLARL + ++ +      KV   
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           W     +L    R+    DVWS G  + EL  F  KP
Sbjct: 177 WMALESIL--HRRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 21/189 (11%)

Query: 174 VALKKVRL----ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K +++     +E E F    + E   +++ +H N++ L  +     +     +   S
Sbjct: 29  VAVKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVE----SEGYPS 80

Query: 230 FYLVFEYMDH-DLMG-LLESGMVD----FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
             ++  +M H DL   LL S + D             M  +  G+ Y   ++F+HRD+  
Sbjct: 81  PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAA 140

Query: 284 SNILMNNRGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
            N ++N    V +ADFGL+ ++YN +  ++    K+   W       L +  Y    DVW
Sbjct: 141 RNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES--LADRVYTTKSDVW 198

Query: 343 SCGCILGEL 351
           S G  + E+
Sbjct: 199 SFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 50/185 (27%), Positives = 80/185 (43%), Gaps = 18/185 (9%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           L+K  +  +KE   I A R + +L+ L H  +V L            F+  +   Y V +
Sbjct: 28  LQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGLH---------YSFQTAE-KLYFVLD 76

Query: 236 YMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
           Y++   +         F E        ++   + Y H  N ++RD+K  NIL++++G V 
Sbjct: 77  YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVV 136

Query: 296 LADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           L DFGL +    E  +   T      T  Y  PE +L +E Y   +D W  G +L E+  
Sbjct: 137 LTDFGLCK----EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLY 191

Query: 354 KKPLF 358
             P F
Sbjct: 192 GLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 43/186 (23%), Positives = 79/186 (42%), Gaps = 26/186 (13%)

Query: 173 LVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            VA+  +R    + ++ GF    + E   L Q +H NIV L  ++T  +          +
Sbjct: 35  PVAIHTLRAGCSDKQRRGF----LAEALTLGQFDHSNIVRLEGVITRGN----------T 80

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS----YCHKRNFLHRDIKCSN 285
             +V EYM +   G L+S +        A  +  +L GL+    Y  +  ++H+ +    
Sbjct: 81  MMIVTEYMSN---GALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHK 137

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +L+N+    K++ F   +   +E      + K   LW  P  +      +  A DVWS G
Sbjct: 138 VLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFG 195

Query: 346 CILGEL 351
            ++ E+
Sbjct: 196 IVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 55/179 (30%), Positives = 79/179 (44%), Gaps = 41/179 (22%)

Query: 195 EIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMV-- 250
           E+++L +L  H NI+NL          L   + +G  YL  EY  H +L+  L    V  
Sbjct: 57  ELEVLCKLGHHPNIINL----------LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 106

Query: 251 ---DFNEVNN-ASIM--RQLLD-------GLSYCHKRNFLHRDIKCSNILMNNRGEVKLA 297
               F   N+ AS +  +QLL        G+ Y  ++ F+HRD+   NIL+      K+A
Sbjct: 107 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166

Query: 298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER-----YGPAIDVWSCGCILGEL 351
           DFGL+R       Q  Y  K +    R P   +  E      Y    DVWS G +L E+
Sbjct: 167 DFGLSR------GQEVYVKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 3/89 (3%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIK--PKKIHRRRLREEFSLMPPGALDLLDKML 75
           Q  +I+ L GTP   V   +        ++  PK+       E+F    P A+DLL+KML
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKR-EPVPFSEKFKNADPSAIDLLEKML 272

Query: 76  ELDPERRITAEQALKSVWLKNVHPESMPP 104
             DP++RI+A +AL   +L   H  +  P
Sbjct: 273 VFDPQKRISAAEALAHPYLAPYHDPTDEP 301

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 53/189 (28%), Positives = 91/189 (48%), Gaps = 26/189 (13%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           L K RL+  K+     A+ E +IL ++N   IVNL         A  F + K    LV  
Sbjct: 26  LDKKRLK--KKSGEKMALLEKEILEKVNSPFIVNL---------AYAF-ESKTHLCLVMS 73

Query: 236 YMD-----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
            M+     + +  + E G+ +   V + S   Q+  G+ + H  + ++RD+K  N+L+++
Sbjct: 74  LMNGGDLKYHIYNVGERGL-EMERVIHYSA--QITCGILHLHSMDIVYRDMKPENVLLDD 130

Query: 291 RGEVKLADFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           +G  +L+D GLA     E +  +  T +  T  Y  PE+L  EE Y   +D ++ GC + 
Sbjct: 131 QGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPEILK-EEPYSYPVDWFAMGCSIY 185

Query: 350 ELFVKKPLF 358
           E+   +  F
Sbjct: 186 EMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 15/158 (9%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYM-DHDLMGLLESGMVDFN 253
           E  IL ++NH  IV L              + +G  YL+ +++   DL   L S  V F 
Sbjct: 48  ERDILAEVNHPFIVKLHYAF----------QTEGKLYLILDFLRGGDLFTRL-SKEVMFT 96

Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
           E +    + +L   L + H    ++RD+K  NIL++  G +KL DFGL++   + D ++ 
Sbjct: 97  EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKK 154

Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             +   T+ Y  PE ++    +  + D WS G ++ E+
Sbjct: 155 AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEM 191

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 4/76 (5%)

Query: 231 YLVFEYM-DHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           YLV EY+   D+  LL   G   F+E      + ++   L Y H+   +HRD+K  N+L+
Sbjct: 80  YLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137

Query: 289 NNRGEVKLADFGLARL 304
           +N G +KL DFGL+++
Sbjct: 138 SNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.5 bits (120), Expect = 4e-07
 Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 35/193 (18%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +K+   +++   F      E+++L +L +H NI+NL          L   + +G  YL  
Sbjct: 30  MKEYASKDDHRDF----AGELEVLCKLGHHPNIINL----------LGACEHRGYLYLAI 75

Query: 235 EYMDH----DLMG---LLESGMVDFNEVNNASIM--RQLL-------DGLSYCHKRNFLH 278
           EY  H    D +    +LE+        + AS +  +QLL        G+ Y  ++ F+H
Sbjct: 76  EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 135

Query: 279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPA 338
           RD+   NIL+      K+ADFGL+R    E   +    ++   W       L    Y   
Sbjct: 136 RDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIES--LNYSVYTTN 191

Query: 339 IDVWSCGCILGEL 351
            DVWS G +L E+
Sbjct: 192 SDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 31/83 (37%), Positives = 44/83 (53%), Gaps = 8/83 (9%)

Query: 273 KRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELLLG 331
           K   +HRD+K SNIL++  G VKL DFG++ RL +++ + R          Y  PE +  
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA----YMAPERIDP 188

Query: 332 EE---RYGPAIDVWSCGCILGEL 351
            +   +Y    DVWS G  L EL
Sbjct: 189 PDPNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 7/93 (7%)

Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRP 325
           L++ H+R  ++RD+K  N+L++  G +KL D+G+ +    E  +   T      T  Y  
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYIA 164

Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           PE+L GE+ YG ++D W+ G ++ E+   +  F
Sbjct: 165 PEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 32/199 (16%)

Query: 172 ELVALKKVRLENEKEGFPITAVREIKILR-QLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           + VA+K   L+++ EG      +   ++R +L H NIV L  +VT         K++   
Sbjct: 36  QAVAIKT--LKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT---------KEQ-PL 83

Query: 231 YLVFEYMDH-DLMGLL-------ESGMVDFNEVNNAS--------IMRQLLDGLSYCHKR 274
            ++F Y  H DL   L       + G  D ++   ++        I+ Q+  G+ +    
Sbjct: 84  SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH 143

Query: 275 NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGEE 333
           + +H+D+   N+L+ ++  VK++D GL R   A D  +   N ++ + W  P  ++ G  
Sbjct: 144 HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-- 201

Query: 334 RYGPAIDVWSCGCILGELF 352
           ++    D+WS G +L E+F
Sbjct: 202 KFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 61/207 (29%), Positives = 86/207 (41%), Gaps = 47/207 (22%)

Query: 174 VALKKVR---LENE--KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           VALKK+R    EN   K+ F    +RE KI   L H  IV +  I +D            
Sbjct: 30  VALKKIREDLSENPLLKKRF----LREAKIAADLIHPGIVPVYSICSDGD---------- 75

Query: 229 SFYLVFEYMD-HDLMGLL------ESGMVDFNEVNNA----SIMRQLLDGLSYCHKRNFL 277
             Y    Y++ + L  LL      ES   +  E  +     SI  ++   + Y H +  L
Sbjct: 76  PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVL 135

Query: 278 HRDIKCSNILMNNRGEVKLADFGLARLYNAED----------RQRPYTNKVI------TL 321
           HRD+K  NIL+   GEV + D+G A     E+          R   Y++  I      T 
Sbjct: 136 HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTP 195

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCIL 348
            Y  PE LLG      + D+++ G IL
Sbjct: 196 DYMAPERLLGVPA-SESTDIYALGVIL 221

Length = 932

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 24/99 (24%)

Query: 18  QLEVISKLCGTP---------TPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMP---P 65
           QL  I ++ GTP         +P     +  LP    I  K           S+ P   P
Sbjct: 218 QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLP---NIPKKPFE--------SIFPNANP 266

Query: 66  GALDLLDKMLELDPERRITAEQALKSVWLKNVH-PESMP 103
            ALDLL+K+L  DP +RI+ E+AL+  +L   H P+  P
Sbjct: 267 LALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEP 305

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 35/193 (18%)

Query: 176 LKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           LK+   EN+   F      E+++L +L +H NI+NL          L   +++G  Y+  
Sbjct: 37  LKEFASENDHRDF----AGELEVLCKLGHHPNIINL----------LGACENRGYLYIAI 82

Query: 235 EYMDH----DLMG---LLESGMVDFNEVNNASIM--RQLL-------DGLSYCHKRNFLH 278
           EY  +    D +    +LE+      E   AS +  +QLL        G+ Y  ++ F+H
Sbjct: 83  EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIH 142

Query: 279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPA 338
           RD+   N+L+      K+ADFGL+R    E   +    ++   W       L    Y   
Sbjct: 143 RDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVRWMAIES--LNYSVYTTK 198

Query: 339 IDVWSCGCILGEL 351
            DVWS G +L E+
Sbjct: 199 SDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 19/65 (29%), Positives = 27/65 (41%), Gaps = 9/65 (13%)

Query: 39  KLPLWHTIK--PKKIHRRRLR-------EEFSLMPPGALDLLDKMLELDPERRITAEQAL 89
           K P          ++ RR L         ++S     A DL+ K L  DP +R TAE+ L
Sbjct: 196 KPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Query: 90  KSVWL 94
           +  W 
Sbjct: 256 QHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 31/91 (34%), Positives = 42/91 (46%), Gaps = 22/91 (24%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKL--------PLWHTIKPKKIHRRRLREEFSLMP-- 64
           E+ QL  I  + GTPT   WP   KL        P      P  +H+        L+P  
Sbjct: 204 EIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP---QFAPTSLHQ--------LIPNA 252

Query: 65  -PGALDLLDKMLELDPERRITAEQALKSVWL 94
            P A+DL+  ML  DP++R TA QAL+  + 
Sbjct: 253 SPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 6/117 (5%)

Query: 18  QLEVISKLCGTPTPAVWPAV--IKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKML 75
           QL++I+ L GTP+P     V   K   + +   KK       ++F    P AL LL+++L
Sbjct: 216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKK-QPVPFSQKFPNADPLALRLLERLL 274

Query: 76  ELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEM 132
             DP+ R TAE+AL   + K +      P   P  +   E    +RRR  + D  E+
Sbjct: 275 AFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEF---ERRRLTKEDVREL 328

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 7/98 (7%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           ++   L Y H  N ++RD+K  NIL++++G + L DFGL +    E+ +   T      T
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGT 159

Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             Y  PE +L ++ Y   +D W  G +L E+    P F
Sbjct: 160 PEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 3/90 (3%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN-KVITL 321
           Q+  G+ Y  +   +HR++   NIL+ +   V++ADFG+A L   +D++  Y+  K    
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           W     +L G  RY    DVWS G  + E+
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 25/171 (14%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFN 253
           E +  R L H N++      T+ +           + LV E+    DL G L S      
Sbjct: 45  EAQPYRSLQHSNLLQCLGQCTEVT----------PYLLVMEFCPLGDLKGYLRSCRKAEL 94

Query: 254 EVNNASIMRQL----LDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
              + + ++++      GL + HK NF+H D+   N L+     VK+ D+GL+     ED
Sbjct: 95  MTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154

Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAI--------DVWSCGCILGELF 352
                    + L +  PEL+  +E +G  +        +VWS G  + ELF
Sbjct: 155 YYVTPDQLWVPLRWIAPELV--DEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 7/98 (7%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H    ++RD+K  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGT 158

Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             Y  PE +L +  YG A+D W  G ++ E+   +  F
Sbjct: 159 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 263 QLLDGLSYCH-KRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-- 319
           +++  L Y H ++N ++RD+K  N++++  G +K+ DFGL +    E  +   T K    
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCG 158

Query: 320 TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           T  Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 159 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 3/96 (3%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G+ Y  +R  +HRD+   N+L+ +   VK+ DFGLARL   ++++       + + 
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E  +   ++    DVWS G  + EL  F  KP
Sbjct: 177 WMALE-CIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 27/177 (15%)

Query: 190 ITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG 248
           +  ++E++  R+LNH N++       +    L          LV E+    DL   L S 
Sbjct: 40  LLFLQEVQPYRELNHPNVLQCLGQCIESIPYL----------LVLEFCPLGDLKNYLRSN 89

Query: 249 MVDFNEVNNASIMRQL----LDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL 304
                ++    +++++      GL + H+ +F+H D+   N  +     VK+ D+GLA  
Sbjct: 90  RGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE 149

Query: 305 YNAEDRQRPYTNKVITLWYRPPELL---------LGEERYGPAIDVWSCGCILGELF 352
              ED         + L +  PEL+           + +     ++WS G  + ELF
Sbjct: 150 QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS---NIWSLGVTMWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 19/187 (10%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREI--VTDKSDALDFRKDKGSFY 231
           V  KK+ L N KE   I A R + +L+ + H  +V L      T+K             Y
Sbjct: 27  VLQKKIVL-NRKEQKHIMAERNV-LLKNVKHPFLVGLHYSFQTTEK------------LY 72

Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
            V ++++   +         F E        ++   L Y H  N ++RD+K  NIL++++
Sbjct: 73  FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ 132

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           G V L DFGL +      +    T    T  Y  PE++  ++ Y   +D W  G +L E+
Sbjct: 133 GHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEM 189

Query: 352 FVKKPLF 358
               P F
Sbjct: 190 LYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 45/181 (24%), Positives = 72/181 (39%), Gaps = 35/181 (19%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLL-ESGMV-- 250
           E  +L+Q+NH +++ L    +            G   L+ EY  +  L   L ES  V  
Sbjct: 53  EFNLLKQVNHPHVIKLYGACS----------QDGPLLLIVEYAKYGSLRSFLRESRKVGP 102

Query: 251 -------------DFNEVNNASIMRQLLD-------GLSYCHKRNFLHRDIKCSNILMNN 290
                          N    A  M  L+        G+ Y  +   +HRD+   N+L+  
Sbjct: 103 SYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAE 162

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
             ++K++DFGL+R    ED     +   I + +   E L  +  Y    DVWS G +L E
Sbjct: 163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWE 221

Query: 351 L 351
           +
Sbjct: 222 I 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 1/90 (1%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G+S+   +N +HRD+   NIL+ +    K+ DFGLAR    +       N  + + 
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281

Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +  PE +     Y    DVWS G +L E+F
Sbjct: 282 WMAPESIF-NCVYTFESDVWSYGILLWEIF 310

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 37/115 (32%), Positives = 55/115 (47%), Gaps = 10/115 (8%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKP----KKIHRRRLREEFSLMPPGALDLLDK 73
           QL +I  + GTP+      +I L   + IK      K+   +L   F    P ALDLLDK
Sbjct: 218 QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKL---FPNADPKALDLLDK 274

Query: 74  MLELDPERRITAEQALKSVWLKNVH-PESMP--PPQLPTWQDCHELWSKKRRRQL 125
           ML  +P +RIT E+AL   +L+  H P   P      P   +  +   K++ ++L
Sbjct: 275 MLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKEL 329

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 10/103 (9%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGA----LDLLDK 73
           QL  I K+ G P P     V KL         K   +  R++FS + P A    +DLL+K
Sbjct: 223 QLTQILKVTGVPGPEF---VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEK 279

Query: 74  MLELDPERRITAEQALKSVWLKNVH-PESMPPPQLPTWQDCHE 115
           MLELD ++R+TA +AL+  +  +    +     Q   + D  E
Sbjct: 280 MLELDVDKRLTATEALEHPYFDSFRDADEETEQQ--PYDDSLE 320

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 46.8 bits (112), Expect = 6e-06
 Identities = 15/37 (40%), Positives = 23/37 (62%)

Query: 58  EEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWL 94
                + P A DL+ K+L  DPE+R+TAE+AL+  + 
Sbjct: 218 PPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.4 bits (112), Expect = 7e-06
 Identities = 21/44 (47%), Positives = 29/44 (65%)

Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA 302
            +MRQ+L GL   H+   +HRDIK  N+L+   G+VK+ DFG A
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 25/89 (28%), Positives = 48/89 (53%), Gaps = 1/89 (1%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           ++ DG++Y + + F+HRD+   N ++ +   VK+ DFG+ R     D  R     ++ + 
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +  PE  L +  +  + D+WS G +L E+
Sbjct: 187 WMAPE-SLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 1/94 (1%)

Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKV 318
           S   Q+  G+ +   +N +HRD+   N+L+     VK+ DFGLAR    +       +  
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 319 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           + + +  PE +  +  Y    DVWS G +L E+F
Sbjct: 301 LPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIF 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 1/90 (1%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G+ +   +N +HRD+   N+L+ +    K+ DFGLAR    +       N  + + 
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279

Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +  PE +  +  Y    DVWS G +L E+F
Sbjct: 280 WMAPESIF-DCVYTVQSDVWSYGILLWEIF 308

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 19/169 (11%)

Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF---YLVFEYMDH-DLMGLLESG 248
           +RE   +++ +H N++ L  +           + KG      ++  +M H DL   L   
Sbjct: 49  LREAACMKEFDHPNVIKLIGVSLR-------SRAKGRLPIPMVILPFMKHGDLHTFLLMS 101

Query: 249 MVDFNEVN--NASIMRQLLD---GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR 303
            +          +++R ++D   G+ Y   +NF+HRD+   N ++N    V +ADFGL++
Sbjct: 102 RIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Query: 304 -LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
            +Y+ +  ++   +K+   W       L +  Y    DVW+ G  + E+
Sbjct: 162 KIYSGDYYRQGCASKLPVKWLALES--LADNVYTTHSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 1/89 (1%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           ++ DG++Y +   F+HRD+   N ++     VK+ DFG+ R     D  R     ++ + 
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +  PE  L +  +    DVWS G +L E+
Sbjct: 187 WMSPE-SLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 26/78 (33%), Positives = 37/78 (47%), Gaps = 5/78 (6%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRR--RLREEFSLMPPGALDLLD 72
           EL Q+  I  + GTP   V   + K      +      ++   LR+         LDLL 
Sbjct: 204 ELDQIAKIHDVLGTPDAEV---LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLK 260

Query: 73  KMLELDPERRITAEQALK 90
           K+L  DP+ RITA+QAL+
Sbjct: 261 KLLAYDPDERITAKQALR 278

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 2/88 (2%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKP-KKIHRRRLREEFSLMPPGALDLLDKMLE 76
           QL++I +L GTP   +   +      + I+   ++ +      F    P A+DLL+KML 
Sbjct: 226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 285

Query: 77  LDPERRITAEQALKSVWLKNVH-PESMP 103
           LD ++RITA QAL   +    H P+  P
Sbjct: 286 LDSDKRITAAQALAHAYFAQYHDPDDEP 313

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 1/90 (1%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+ +G+ +   +N +HRD+   N+L+     VK+ DFGLAR    +       +  + L 
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306

Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +  PE +     Y    DVWS G +L E+F
Sbjct: 307 WMAPESIF-NNLYTTLSDVWSFGILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 15/96 (15%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNA------EDRQRPYT 315
           Q+  G+SY HKR  +H+DI   N +++   +VK+ D  L+R L+        ++  RP  
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP-- 182

Query: 316 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                + +   E L+ +E Y  A DVWS G +L EL
Sbjct: 183 -----VKWMALESLVNKE-YSSASDVWSFGVLLWEL 212

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 29/79 (36%), Positives = 39/79 (49%), Gaps = 12/79 (15%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLP-------LWHTIKPKKIHRRRLREEFSLMPPGALDL 70
           QLE I  + G PT   WP V KLP       L    +  ++  +RL       PP A DL
Sbjct: 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSR-----PPKAEDL 267

Query: 71  LDKMLELDPERRITAEQAL 89
             +ML + P+ RI+A+ AL
Sbjct: 268 ASQMLMMFPKDRISAQDAL 286

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)

Query: 16  LLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMP---PGALDLLD 72
           L QL  I K+ GTP+      +      + +K  K+ R R ++  SL+P   P A+++L+
Sbjct: 222 LDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK--KLPRFRKKDFRSLLPNANPLAVNVLE 279

Query: 73  KMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQD 112
           KML LD E RITA +AL   + +  H +     + P + D
Sbjct: 280 KMLVLDAESRITAAEALAHPYFEEFH-DPEDETEAPPYDD 318

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 39/124 (31%), Positives = 56/124 (45%), Gaps = 23/124 (18%)

Query: 252 FNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILM----------NNRG------EV 294
           F+  + A I+ Q    L Y H   + +H D+K  NILM           NR        V
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           ++ D G        D +   T  V T  YR PE++LG   +  + D+WS GCI+ EL+  
Sbjct: 288 RICDLG-----GCCDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTG 341

Query: 355 KPLF 358
           K L+
Sbjct: 342 KLLY 345

Length = 467

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 32/95 (33%), Positives = 43/95 (45%), Gaps = 27/95 (28%)

Query: 18  QLEVISKLCGTPTPAVWPAVI-------------KLPL-WHTIKPKKIHRRRLREEFSLM 63
           QL++I  + G+P+  V   +              K P+ W  I PK              
Sbjct: 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKA------------- 266

Query: 64  PPGALDLLDKMLELDPERRITAEQALKSVWLKNVH 98
            P ALDLL +ML+ DPE RIT EQAL+  +L   H
Sbjct: 267 SPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 34/198 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  LV ++   LEN  E        E+ +     H NI+    + T            GS
Sbjct: 24  TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----------TGS 72

Query: 230 F------YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +      ++ +   +  L      GM   +E    +I+   L GL+Y H+  ++HR+IK 
Sbjct: 73  WLWVISPFMAYGSANSLLKTYFPEGM---SEALIGNILFGALRGLNYLHQNGYIHRNIKA 129

Query: 284 SNILMNNRGEVKLADFGLARLY---NAEDRQR-----PYTNKVITLWYRPPELLLGEERY 335
           S+IL++  G V L+  GL+ LY       + +     P  +  +  W  P   LL ++ Y
Sbjct: 130 SHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE--LLRQDLY 185

Query: 336 GPAI--DVWSCGCILGEL 351
           G  +  D++S G    EL
Sbjct: 186 GYNVKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 32/197 (16%)

Query: 170 TDELVALKKVRLE---NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E V ++++ LE   NE   F      E+ + +  NH NIV  R      ++       
Sbjct: 24  TGEYVTVRRINLEACTNEMVTFLQG---ELHVSKLFNHPNIVPYRATFIADNE------- 73

Query: 227 KGSFYLVFEYMDH----DLMGL-LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
               ++V  +M +    DL+      GM   +E+  A I++ +L  L Y H   ++HR +
Sbjct: 74  ---LWVVTSFMAYGSAKDLICTHFMDGM---SELAIAYILQGVLKALDYIHHMGYVHRSV 127

Query: 282 KCSNILMNNRGEVKLADF-GLARLYNAEDRQR------PYTNKVITLWYRPPELLLGEER 334
           K S+IL++  G+V L+       + N   R R       Y+ KV+  W  P  L    + 
Sbjct: 128 KASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQG 186

Query: 335 YGPAIDVWSCGCILGEL 351
           Y    D++S G    EL
Sbjct: 187 YDAKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 24/99 (24%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMP------------P 65
           QL+ I ++ GTP+P V             K    H R+  +    MP            P
Sbjct: 224 QLKRIMEVVGTPSPEV-----------LKKISSEHARKYIQSLPHMPQQDLKKIFRGANP 272

Query: 66  GALDLLDKMLELDPERRITAEQALKSVWLKNVH-PESMP 103
            A+DLL+KML LD ++RI+A +AL   +    H PE  P
Sbjct: 273 LAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEP 311

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 21/73 (28%), Positives = 36/73 (49%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLEL 77
           QL  I ++ GTPT   WP ++    + +    K     L      +     +LL K+L+ 
Sbjct: 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQF 272

Query: 78  DPERRITAEQALK 90
           +  +RI+AE+A+K
Sbjct: 273 EGRKRISAEEAMK 285

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 43/213 (20%)

Query: 170 TDELVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T +L ALK +  +   +   +  V  E +IL  L+H  +  L            F+ +  
Sbjct: 25  TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA---------SFQTET- 74

Query: 229 SFYLVFEY-MDHDLMGLLE--SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
              LV +Y    +L  LL+   G    +E        ++L  L Y H    ++RD+K  N
Sbjct: 75  YLCLVMDYCPGGELFRLLQRQPGKC-LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPY--------------------------TNK-V 318
           IL++  G + L+DF L++  + E                                +N  V
Sbjct: 134 ILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFV 193

Query: 319 ITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
            T  Y  PE++ G+  +G A+D W+ G +L E+
Sbjct: 194 GTEEYIAPEVISGDG-HGSAVDWWTLGILLYEM 225

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 20/44 (45%), Positives = 27/44 (61%), Gaps = 5/44 (11%)

Query: 67  ALDLLDKMLELDPERRITAEQALK----SVWLKNVHPESMPPPQ 106
           A DLL KML +DPE+RI+ + AL+    +VW      E+ PPP 
Sbjct: 287 ARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEA-PPPA 329

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 20/45 (44%), Positives = 30/45 (66%), Gaps = 5/45 (11%)

Query: 67  ALDLLDKMLELDPERRITAEQALK----SVWLKNVHPESMPPPQL 107
           A DLL KML +DP++RI+ ++AL+    +VW      E+ PPPQ+
Sbjct: 291 ARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEA-PPPQI 334

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 11/129 (8%)

Query: 233 VFEYMDHDLMGLLESGMVDFNEVNNASIMR---QLLDGLSYCHKRNFLHRDIKCSNILMN 289
           VF  + H   G L S +  F  +    + R   +++  L   H+   + RD+  +NIL++
Sbjct: 60  VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL-LLGEERYGPAIDVWSCGCIL 348
           +RG ++L  F   R    ED       + +   Y  PE+  + EE    A D WS G IL
Sbjct: 120 DRGHIQLTYFS--RWSEVEDS---CDGEAVENMYCAPEVGGISEET--EACDWWSLGAIL 172

Query: 349 GELFVKKPL 357
            EL   K L
Sbjct: 173 FELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 25/84 (29%), Positives = 42/84 (50%), Gaps = 2/84 (2%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMP--PGALDLLDKML 75
           QLE I  + GTP    WP V  LP +   +      + LR+ ++ +     A DL  K+L
Sbjct: 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLL 272

Query: 76  ELDPERRITAEQALKSVWLKNVHP 99
           +  P+ R++A+ AL   +  ++ P
Sbjct: 273 QCFPKNRLSAQAALSHEYFSDLPP 296

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.7 bits (93), Expect = 5e-04
 Identities = 33/158 (20%), Positives = 58/158 (36%), Gaps = 33/158 (20%)

Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNI----VNLRE 212
           GGL+   + +    ++ V LK     N          RE+ IL+ L  K +    V    
Sbjct: 8   GGLTNRVYLLGTKDEDYV-LKI----NPSREKGADREREVAILQLLARKGLPVPKV---- 58

Query: 213 IVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYC 271
                   L   +  G  YL+ E+++   L         + +E     I  QL + L+  
Sbjct: 59  --------LASGESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKL 102

Query: 272 HKRN---FLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
           H+       H D+   NIL+++   + + D+  A    
Sbjct: 103 HQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.9 bits (96), Expect = 9e-04
 Identities = 18/45 (40%), Positives = 25/45 (55%), Gaps = 1/45 (2%)

Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-RGEVKLADFGLA 302
           +IMRQ+L  L   H    +HRD+K  NI+ +   G  K+ D G A
Sbjct: 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 14/96 (14%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTI-----KPKKI--HRRRLREEFSLMPPGALDL 70
           +L +I +L GTPT   WP +     +        KP+ +  H  RL  E        ++L
Sbjct: 213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTE-------GIEL 265

Query: 71  LDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQ 106
           L K L+ + ++RI+AE+A+K  + +++       P+
Sbjct: 266 LTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPE 301

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 19/78 (24%), Positives = 34/78 (43%), Gaps = 2/78 (2%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIK-PKKIHRRRLREEFS-LMPPGALDLLD 72
           ++ QL +I K  G   P+        P +  +  P+      L   +   +   ALD L 
Sbjct: 207 DIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLK 266

Query: 73  KMLELDPERRITAEQALK 90
             L +DP+ R+T ++ L+
Sbjct: 267 ACLRMDPKERLTCDELLQ 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 17/43 (39%), Positives = 27/43 (62%)

Query: 53  RRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLK 95
           RR LR+    + P ALD L+++L  +P  R+TAE+AL   ++ 
Sbjct: 262 RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 38.3 bits (90), Expect = 0.004
 Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 45  TIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN-VHPESMP 103
            I  K I   +  E++S   P   D L+K L  DPE+R +AE+ L+  +LK     E   
Sbjct: 227 LITTKGIPPLKNPEKWS---PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFA 283

Query: 104 P 104
           P
Sbjct: 284 P 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	358
KOG0595|consensus	429		100.0
KOG0598|consensus	357		100.0
KOG0593|consensus	396		100.0
KOG0600|consensus	560		100.0
KOG0575|consensus	592		100.0
KOG0591|consensus	375		100.0
KOG0659|consensus	318		100.0
KOG0615|consensus	475		100.0
KOG0616|consensus	355		100.0
KOG0663|consensus	419		100.0
KOG0581|consensus	364		100.0
KOG0661|consensus	538		100.0
KOG0592|consensus	604		100.0
KOG0605|consensus	550		100.0
KOG0583|consensus	370		100.0
KOG0597|consensus	808		100.0
KOG0594|consensus	323		100.0
KOG0585|consensus	576		100.0
KOG0660|consensus	359		100.0
KOG0611|consensus	668		100.0
KOG0588|consensus	786		100.0
KOG0578|consensus	550		100.0
KOG0694|consensus	694		100.0
KOG0192|consensus	362		100.0
KOG0198|consensus	313		100.0
KOG0582|consensus	516		100.0
KOG0658|consensus	364		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0033|consensus	355		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0667|consensus	586		100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0589|consensus	426		100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG4717|consensus	864		100.0
KOG0201|consensus	467		100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0610|consensus	459		100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0197|consensus	468		100.0
KOG0599|consensus	411		100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0032|consensus	382		100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG1035|consensus	1351		100.0
KOG0580|consensus	281		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0193|consensus	678		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0662|consensus	292		100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG1187|consensus	361		100.0
KOG0666|consensus	438		100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0690|consensus	516		100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG4250|consensus	732		100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0596|consensus	677		100.0
KOG0607|consensus	463		100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0586|consensus	596		100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG2345|consensus	302		100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0577|consensus	948		100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0669|consensus	376		100.0
KOG0612|consensus	1317		100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0574|consensus	502		100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG1989|consensus	738		100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG4721|consensus	904		100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG4236|consensus	888		100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0603|consensus	612		100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0604|consensus	400		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0986|consensus	591		100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG4279|consensus	1226		100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0696|consensus	683		100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0584|consensus	632		100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG1151|consensus	775		100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0614|consensus	732		100.0
KOG0664|consensus	449		100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0579|consensus	1187		100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0608|consensus	1034		100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0695|consensus	593		100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG4645|consensus	1509		100.0
KOG0671|consensus	415		100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG1026|consensus	774		100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0194|consensus	474		100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG1095|consensus	1025		100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG1152|consensus	772		100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0983|consensus	391		100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1006|consensus	361		100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG1094|consensus	807		100.0
KOG0984|consensus	282		100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0668|consensus	338		100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG3653|consensus	534		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG1290|consensus	590		99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0587|consensus	953		99.97
KOG0196|consensus	996		99.97
KOG0665|consensus	369		99.97
KOG4257|consensus	974		99.97
KOG0670|consensus	752		99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG2052|consensus	513		99.97
KOG0199|consensus	1039		99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG1025|consensus	1177		99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG4278|consensus	1157		99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1167|consensus	418		99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1345|consensus	378		99.96
KOG1027|consensus	903		99.96
KOG0200|consensus	609		99.95
KOG0576|consensus	829		99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG1164|consensus	322		99.94
KOG1163|consensus	341		99.93
KOG1165|consensus	449		99.93
KOG0590|consensus	601		99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG1024|consensus	563		99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
KOG1166|consensus	974		99.86
KOG0603|consensus	612		99.85
smart00090	237	RIO RIO-like kinase.	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG4158|consensus	598		99.81
KOG1240|consensus	1431		99.79
KOG0659|consensus	318		99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
KOG0195|consensus	448		99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
KOG0660|consensus	359		99.74
KOG0606|consensus	1205		99.72
KOG0663|consensus	419		99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
KOG0600|consensus	560		99.72
KOG0590|consensus	601		99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG1033|consensus	516		99.64
KOG0662|consensus	292		99.64
KOG0661|consensus	538		99.63
KOG1023|consensus	484		99.58
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.57
KOG1243|consensus	690		99.55
KOG0601|consensus	524		99.53
KOG0658|consensus	364		99.52
KOG0594|consensus	323		99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
KOG0666|consensus	438		99.37
KOG0593|consensus	396		99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
KOG3087|consensus	229		99.34
KOG0601|consensus	524		99.26
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.26
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.21
KOG3741|consensus	655		99.19
KOG0665|consensus	369		99.14
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.12
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.09
KOG0606|consensus	1205		99.08
KOG1266|consensus	458		99.05
KOG0667|consensus	586		99.05
KOG0668|consensus	338		99.05
PRK09902	216	hypothetical protein; Provisional	99.04
COG4248	637	Uncharacterized protein with protein kinase and he	99.01
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	98.95
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.93
KOG0669|consensus	376		98.89
KOG0671|consensus	415		98.84
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	98.81
PTZ00036	440	glycogen synthase kinase; Provisional	98.79
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	98.75
KOG0615|consensus	475		98.72
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.72
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	98.71
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	98.66
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	98.64
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.57
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	98.54
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	98.54
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	98.53
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.5
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	98.49
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	98.49
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	98.49
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	98.45
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.44
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	98.42
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	98.38
KOG1290|consensus	590		98.37
PTZ00024	335	cyclin-dependent protein kinase; Provisional	98.37
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	98.36
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	98.36
KOG0599|consensus	411		98.36
KOG2137|consensus	700		98.35
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	98.35
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.35
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	98.34

>KOG0595|consensus

Probab=100.00  E-value=4.7e-49  Score=337.70  Aligned_cols=202  Identities=28%  Similarity=0.428  Sum_probs=178.2

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...++|.+.+.||.|+|++||+++++.++..||||.+..........+....|+.+|+.++|||||.++++..+      
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~------   80 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED------   80 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec------
Confidence            45578889999999999999999999999999999998876555556667899999999999999999776655      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC------CcEEE
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR------GEVKL  296 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~------~~~~l  296 (358)
                          ++++|+|||||.|+.+..+....+.+++..++.++.||+.||++||+++|+||||||+|||++..      -.+||
T Consensus        81 ----~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   81 ----DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             ----CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence                66999999999976666666666689999999999999999999999999999999999999875      35899


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .|||+|+...+....   ...+|+|-|||||++.... |+.|+|+||+|+++|++++|++||
T Consensus       157 ADFGfAR~L~~~~~a---~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf  214 (429)
T KOG0595|consen  157 ADFGFARFLQPGSMA---ETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPF  214 (429)
T ss_pred             cccchhhhCCchhHH---HHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCc
Confidence            999999998766544   4556799999999998554 999999999999999999999998

>KOG0598|consensus

Probab=100.00  E-value=1e-47  Score=326.47  Aligned_cols=204  Identities=25%  Similarity=0.362  Sum_probs=179.3

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ......|.+++.||+|+||.|++++...+++.||+|++++..-... .......|..+|..++||.||+++..|++    
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt----   96 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT----   96 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc----
Confidence            3456789999999999999999999999999999999987753332 45677899999999999999999776665    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            ...+|+|+||+.|+.+....++.+.+++..++-++..|+.||.|||++||+||||||+|||+|.+|+++|+|||
T Consensus        97 ------~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFg  170 (357)
T KOG0598|consen   97 ------EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFG  170 (357)
T ss_pred             ------CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccc
Confidence                  56999999999987666666667789999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.......  .....+||+.|||||++.+.+ |+.++|+||||+++|+||+|.+||
T Consensus       171 L~k~~~~~~~--~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF  225 (357)
T KOG0598|consen  171 LCKEDLKDGD--ATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPF  225 (357)
T ss_pred             cchhcccCCC--ccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCC
Confidence            9985433322  234578899999999999876 999999999999999999999998

>KOG0593|consensus

Probab=100.00  E-value=1.8e-47  Score=315.66  Aligned_cols=201  Identities=38%  Similarity=0.643  Sum_probs=182.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|..+..+|+|+||+|++|+++.||+.||||++...........-.++|+++|++++|+|+|.++++|..         
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr---------   72 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR---------   72 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh---------
Confidence            35788899999999999999999999999999998766555555567899999999999999999888876         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       .+.+++|+|||+...++.++.....+++..+.++++|++.|+.|+|+++++||||||+|||++.+|.+||||||+|+..
T Consensus        73 -krklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   73 -KRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             -cceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence             5689999999999999999988888999999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..+.  ..++..+.|.+|+|||.+.+...|...+|||++||++.||++|.+.|
T Consensus       152 ~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~  202 (396)
T KOG0593|consen  152 SAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW  202 (396)
T ss_pred             cCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence            6432  33566778999999999999878999999999999999999999987

>KOG0600|consensus

Probab=100.00  E-value=3.2e-47  Score=333.91  Aligned_cols=206  Identities=59%  Similarity=0.981  Sum_probs=191.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|..++.||+|.||.||++++..+|+.||+|++..+....++..-..+||.+|++|+||||+++.++..+.      
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~------  188 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK------  188 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec------
Confidence            44567889999999999999999999999999999999998888888889999999999999999999988774      


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ..+.+|+|+||++.+|...+......|++.++..+++||+.||+|||++||+|||||..|||||.+|.+||+|||+|+
T Consensus       189 --~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr  266 (560)
T KOG0600|consen  189 --LSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLAR  266 (560)
T ss_pred             --CCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecccccee
Confidence              256899999999999999998888899999999999999999999999999999999999999999999999999999


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++...... .++..+.|.+|+|||.+.+...|+.++|+||.||||.||++|++.|
T Consensus       267 ~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~  320 (560)
T KOG0600|consen  267 FYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL  320 (560)
T ss_pred             eccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence            88765443 3678889999999999999988999999999999999999999986

>KOG0575|consensus

Probab=100.00  E-value=5e-47  Score=340.35  Aligned_cols=200  Identities=30%  Similarity=0.420  Sum_probs=179.3

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+... .....+.+.+||++.++|+|||||+++++|++        
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--------   89 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--------   89 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--------
Confidence            789999999999999999999999999999999987543 33445678899999999999999999777766        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ..++|||+|+|..+.+..+.+..++++|.+++.+++||+.||.|||+.+|+|||||..|+|++++.++||+|||+|..
T Consensus        90 --s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   90 --SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             --CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeee
Confidence              558999999999877777766888999999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ....+|||.|.|||++...+ ++..+||||+||++|.||+|+|||
T Consensus       168 le~~~Er--k~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPF  218 (592)
T KOG0575|consen  168 LEYDGER--KKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPF  218 (592)
T ss_pred             ecCcccc--cceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCc
Confidence            8755322  24557799999999998665 899999999999999999999999

>KOG0591|consensus

Probab=100.00  E-value=2.8e-47  Score=311.55  Aligned_cols=205  Identities=30%  Similarity=0.427  Sum_probs=177.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .....|+|++.||+|+||.||++.+..+|..||.|.++.+.......+....|+.+|++|+|||||++++.-..      
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~------   89 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI------   89 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh------
Confidence            44567999999999999999999999999999999999877766667788899999999999999999873222      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHH---hcCCCCCChHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCEEecCCCcE
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLL---ESGMVDFNEVNNASIMRQLLDGLSYCHK--RN--FLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~--i~H~Dlkp~Nill~~~~~~  294 (358)
                        ++...++||||+|++ +|.+.+   +.....++|..+++++.|++.||.++|+  ..  |+||||||.||+++.+|.+
T Consensus        90 --~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv  167 (375)
T KOG0591|consen   90 --EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV  167 (375)
T ss_pred             --ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence              123458999999996 444444   3455679999999999999999999998  44  9999999999999999999


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+|||+++.+.....  ...+.+|||.||+||.+.+.+ |+.++||||+||++|||+.-++||
T Consensus       168 KLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF  228 (375)
T KOG0591|consen  168 KLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPF  228 (375)
T ss_pred             eeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCc
Confidence            9999999998865543  235678999999999999877 999999999999999999999998

>KOG0659|consensus

Probab=100.00  E-value=4.1e-45  Score=296.61  Aligned_cols=201  Identities=39%  Similarity=0.737  Sum_probs=186.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|...+.||+|.||.||+++|..+|+.||||+++.....+.......+|+..|+.++|+||+.++++|..         
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~---------   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH---------   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC---------
Confidence            47888999999999999999999999999999999998888888899999999999999999999887765         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       .+.+-+|+||++-+|...+++....++..++..++.++++|++|||++.|+||||||.|+|++.+|.+||+|||+++.+
T Consensus        73 -~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   73 -KSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             -CCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence             5588999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........  ..+.|..|+|||.+.|.+.|+..+||||.|||+.||+-|.|.|
T Consensus       152 ~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f  202 (318)
T KOG0659|consen  152 GSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF  202 (318)
T ss_pred             CCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence            87665543  3477999999999999989999999999999999999998876

>KOG0615|consensus

Probab=100.00  E-value=3.2e-46  Score=320.06  Aligned_cols=204  Identities=28%  Similarity=0.441  Sum_probs=171.9

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-----CchhHHHHHHHHHhCCCCcccchhhhhc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-----FPITAVREIKILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~  215 (358)
                      .......|.+.+.||.|+||.|-+|....+|+.||||+++.......     ....+.+|+++|++++|||||+++++|.
T Consensus       167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~  246 (475)
T KOG0615|consen  167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE  246 (475)
T ss_pred             cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence            34477888899999999999999999999999999999987643321     1223468999999999999999977776


Q ss_pred             ccCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC---
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---  291 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~---  291 (358)
                      .          ....||||||++| +|++.+.. .+.+.+..-..+++||+.|+.|||++||+||||||+|||+..+   
T Consensus       247 ~----------~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~  315 (475)
T KOG0615|consen  247 V----------PDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED  315 (475)
T ss_pred             c----------CCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc
Confidence            6          4478999999997 56666644 4568888889999999999999999999999999999999876   


Q ss_pred             CcEEEeecccceeccccCCCCCCCCccccccccccccccCCC--CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE--RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       292 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..+||+|||+|+..+.....   ...+|||.|.|||++.+.+  .+..++||||+||++|-+|+|.+||
T Consensus       316 ~llKItDFGlAK~~g~~sfm---~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPF  381 (475)
T KOG0615|consen  316 CLLKITDFGLAKVSGEGSFM---KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPF  381 (475)
T ss_pred             eEEEecccchhhccccceeh---hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCc
Confidence            57999999999988644443   4567799999999997543  3556899999999999999999999

>KOG0616|consensus

Probab=100.00  E-value=1.3e-45  Score=303.93  Aligned_cols=200  Identities=21%  Similarity=0.335  Sum_probs=177.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..-.+|.++++||.|+||.|.+++++.+|..||+|+++...-. -...++...|..+|+.+.||.++++.+.+.+     
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-----  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-----  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-----
Confidence            5567789999999999999999999999999999999876422 2234567789999999999999999666654     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           .+.+|+||||++|+-+..+....+++++..++-++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+
T Consensus       116 -----~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGF  190 (355)
T KOG0616|consen  116 -----NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGF  190 (355)
T ss_pred             -----CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccc
Confidence                 669999999999877776666777899999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+.....     ....+|||.|+|||++...+ ++.++|+|+||+++|||+.|.+||
T Consensus       191 AK~v~~r-----T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF  241 (355)
T KOG0616|consen  191 AKRVSGR-----TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPF  241 (355)
T ss_pred             eEEecCc-----EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCC
Confidence            9987544     24567899999999998776 999999999999999999999998

>KOG0663|consensus

Probab=100.00  E-value=3.5e-45  Score=305.89  Aligned_cols=205  Identities=45%  Similarity=0.781  Sum_probs=188.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|..+..|++|+||.||+++|+.+++.||+|+++.+....++....++||.+|.+++|||||.+.++..-..     
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~-----  148 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN-----  148 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc-----
Confidence            445688899999999999999999999999999999999988999999999999999999999999988776533     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         -+.+|+|||||+.++...+..-..++...++..++.|+++|++|||.+.|+|||||++|+|+...|.+||+|||+|+
T Consensus       149 ---~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  149 ---MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             ---cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence               55799999999998888887766789999999999999999999999999999999999999999999999999999


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .++.+  ...++..+.|.+|+|||.+.+...|+.+.||||+|||+.||+++++.|
T Consensus       226 ~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf  278 (419)
T KOG0663|consen  226 EYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF  278 (419)
T ss_pred             hhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence            98766  345677788999999999999999999999999999999999999987

>KOG0581|consensus

Probab=100.00  E-value=2.1e-45  Score=312.40  Aligned_cols=200  Identities=30%  Similarity=0.391  Sum_probs=176.5

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+...+..||+|..|+||+++++.+++.+|+|.+... .......++.+|++++++++||+||.++++|....     
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~-----  150 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG-----  150 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC-----
Confidence            344666788999999999999999999999999999543 34444567899999999999999999999887632     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         . ..+|+||||+|+.++.+....+.++|....+++.++++||.|||+ .+|+||||||.|||+..+|++||||||.+
T Consensus       151 ---~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  151 ---E-EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             ---c-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccccc
Confidence               1 599999999998777777666889999999999999999999995 89999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..+.+.    ....++||..|||||.+.+.. |+.++||||||++++|+.+|+.||
T Consensus       227 ~~lvnS----~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~  277 (364)
T KOG0581|consen  227 GILVNS----IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPY  277 (364)
T ss_pred             HHhhhh----hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCC
Confidence            877655    235678899999999999876 999999999999999999999997

>KOG0661|consensus

Probab=100.00  E-value=3.9e-45  Score=318.61  Aligned_cols=203  Identities=39%  Similarity=0.664  Sum_probs=183.8

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  221 (358)
                      ....+|.+++.||.|+||.||+|..+.+++.||||+++..-.. +....-+||+..|++|+ ||||+++.+++.+..   
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~---   82 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDND---   82 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC---
Confidence            4567899999999999999999999999999999998865433 33334579999999997 999999999998743   


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                            +.+|+||||++.+|.+.++.++..+++..++.|+.||++||+|+|++|+.|||+||+|||+..+..+||+|||+
T Consensus        83 ------~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   83 ------RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             ------ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccc
Confidence                  38999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+.....   .+++..+.|.+|+|||++.....|+.+.|||++|||++|+.+-++.|
T Consensus       157 ARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF  210 (538)
T KOG0661|consen  157 AREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF  210 (538)
T ss_pred             ccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence            9987644   45677888999999999988888999999999999999999999887

>KOG0592|consensus

Probab=100.00  E-value=1.7e-44  Score=319.27  Aligned_cols=204  Identities=31%  Similarity=0.475  Sum_probs=174.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  220 (358)
                      ....+|.+.+.||.|+|++|++|++..+++.||||++.+.-- .+....-+..|-++|..| .||.|++++..|++    
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD----  145 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD----  145 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec----
Confidence            345688999999999999999999999999999999876532 222334567899999999 99999999666655    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            +..+|+|+||+++ +|++.+.. .+.+++..++.++.+|+.||+|||++|||||||||+|||+|.+++++|.||
T Consensus       146 ------~~sLYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  146 ------EESLYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             ------ccceEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeec
Confidence                  6689999999986 56666644 468999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCC---------CC--CCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQ---------RP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~---------~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |.|+.+.+....         ..  ...++||..|.+||++.... .+..+|||+||||+|+|+.|++||
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPF  287 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPF  287 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCC
Confidence            999987643222         11  25689999999999998655 899999999999999999999999

>KOG0605|consensus

Probab=100.00  E-value=4.1e-44  Score=316.88  Aligned_cols=204  Identities=27%  Similarity=0.374  Sum_probs=176.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+|.+++.||+|+||.||+|+.+.||+.+|+|++++...- ....+.+..|-++|....+|.||+++..|++      
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD------  212 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD------  212 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC------
Confidence            567899999999999999999999999999999999877532 3345677889999999999999999777766      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ..++||||||++|+....+.-....+++..++.++.+++.|++.||+.|++||||||+|+|||..|++||+|||++
T Consensus       213 ----~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  213 ----KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             ----CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecccccc
Confidence                5599999999999777777666778999999999999999999999999999999999999999999999999998


Q ss_pred             eeccccC---------------------CCC------------------------CCCCccccccccccccccCCCCCCC
Q psy13988        303 RLYNAED---------------------RQR------------------------PYTNKVITLWYRPPELLLGEERYGP  337 (358)
Q Consensus       303 ~~~~~~~---------------------~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~  337 (358)
                      .-+....                     ...                        ..-+.+|||.|+|||++.+.+ |+.
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~  367 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGK  367 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCc
Confidence            6432100                     000                        001347899999999999887 999


Q ss_pred             cchHHHHHHHHHHHhhCCCCC
Q psy13988        338 AIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       338 ~~DiwslG~~l~~lltg~~pF  358 (358)
                      .+|+||||||+||||.|.|||
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF  388 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPF  388 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999

>KOG0583|consensus

Probab=100.00  E-value=2.4e-43  Score=316.62  Aligned_cols=204  Identities=31%  Similarity=0.497  Sum_probs=178.0

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC---CCCchhHHHHHHHHHhCC-CCcccchhhhhccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK---EGFPITAVREIKILRQLN-HKNIVNLREIVTDK  217 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  217 (358)
                      ....+.|.+.+.||+|+||.|+++.+..+++.||+|+++.....   ......+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            35677899999999999999999999999999999987765222   123456678999999998 99999998888764


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVK  295 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~  295 (358)
                      .          .+|+||||+.| +|++.+.+ .+++.|.+++.+++||+.|++|||++||+||||||+||+++.+ +++|
T Consensus        93 ~----------~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   93 T----------KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             C----------eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEE
Confidence            3          69999999997 78888877 7789999999999999999999999999999999999999999 9999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCC-CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++....  .........+||+.|+|||++.+.. +-..++||||+|+++|.|++|+.||
T Consensus       162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF  223 (370)
T KOG0583|consen  162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPF  223 (370)
T ss_pred             EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence            99999999874  1222345667899999999999877 5568999999999999999999998

>KOG0597|consensus

Probab=100.00  E-value=1.1e-43  Score=315.06  Aligned_cols=199  Identities=33%  Similarity=0.486  Sum_probs=178.3

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|.+.+.||+|+||.||+++.+.+.+.||+|.+.+....+.....+.+|+++++.++||||+.+++.|+.         
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt---------   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET---------   72 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc---------
Confidence            46889999999999999999999999999999998877766666678899999999999999999777765         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ..++|+|+||+.|+|...+. .++.++|+.++.++.|++.||.|||+++|+|||+||.||+++..|.+|+||||+|+.+
T Consensus        73 -~~~~~vVte~a~g~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   73 -SAHLWVVTEYAVGDLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             -cceEEEEehhhhhhHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence             56899999999997666664 4568999999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..+..  ..+...|||-|||||.+.+.. |+..+|+||+||++||+++|+|||
T Consensus       151 ~~~t~--vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF  200 (808)
T KOG0597|consen  151 STNTS--VLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPF  200 (808)
T ss_pred             ccCce--eeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCc
Confidence            65543  234556899999999998655 999999999999999999999998

>KOG0594|consensus

Probab=100.00  E-value=1.1e-42  Score=295.54  Aligned_cols=208  Identities=44%  Similarity=0.770  Sum_probs=184.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc-ccchhhhhcccCccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN-IVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~  223 (358)
                      ...|..++.||+|+||+||+|++..+|+.||+|++..+...+.......+|+.+++.++|+| |+.+++++.....    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~----   85 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN----   85 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc----
Confidence            45577889999999999999999999999999999988766667778899999999999999 9999998876431    


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCC---CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGM---VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                      ....+.+++|+||++.++...+....   ..++...+..+++||+.||+|||+++|+||||||+||+++++|.+||+|||
T Consensus        86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence            33456899999999999999887655   357778999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+...-+  ...++..++|..|.|||++.+...|+...||||+|||+.||+++++.|
T Consensus       166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF  221 (323)
T KOG0594|consen  166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF  221 (323)
T ss_pred             hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence            99966533  344678889999999999999888999999999999999999999887

>KOG0585|consensus

Probab=100.00  E-value=6.1e-43  Score=304.75  Aligned_cols=208  Identities=27%  Similarity=0.428  Sum_probs=175.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC------------CchhHHHHHHHHHhCCCCcccch
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG------------FPITAVREIKILRQLNHKNIVNL  210 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~~  210 (358)
                      ..-+.|++++.||.|.||.|-++++..+++.||||++.+......            ..+.+.+||.+++++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345679999999999999999999999999999999977642211            12477899999999999999999


Q ss_pred             hhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC
Q psy13988        211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN  290 (358)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~  290 (358)
                      +++.-++.        ...+|||+|||..+-....-.....+++.+++.++++++.||+|||.+||+||||||.|+|+++
T Consensus       174 iEvLDDP~--------s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  174 IEVLDDPE--------SDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEeecCcc--------cCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence            99998865        5689999999997666655444444999999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceeccccCCC---CCCCCccccccccccccccCC---CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        291 RGEVKLADFGLARLYNAEDRQ---RPYTNKVITLWYRPPELLLGE---ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|.+||+|||.+.........   ......+|||.|+|||...+.   ...+.+.||||+||+||+|+.|+.||
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            999999999999877433111   112346789999999998762   23567899999999999999999998

>KOG0660|consensus

Probab=100.00  E-value=5.9e-43  Score=296.33  Aligned_cols=210  Identities=39%  Similarity=0.614  Sum_probs=183.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .....|..++.||.|++|.|..+.+..+|+.||||++...-...-...+..+|+.+|+.++|+||+.+.+++..+.    
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~----   94 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS----   94 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc----
Confidence            4566777789999999999999999999999999999866555555678899999999999999999999987622    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                       ...-+.+|+|+|+++.+|.+.++.+ ..+++..+.-+++||++||+|+|+.+++||||||.|++++.+..+||+|||+|
T Consensus        95 -~~~f~DvYiV~elMetDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   95 -RDKFNDVYLVFELMETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             -ccccceeEEehhHHhhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence             2334679999999987777766544 46999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +...........+..+.|..|.|||++.....|+.+.||||.|||+.|||+|++.|
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF  228 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF  228 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence            98865533444577788999999999988778999999999999999999999987

>KOG0611|consensus

Probab=100.00  E-value=2e-42  Score=296.21  Aligned_cols=215  Identities=27%  Similarity=0.440  Sum_probs=186.4

Q ss_pred             ccccccccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccc
Q psy13988        131 EMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVN  209 (358)
Q Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  209 (358)
                      .+..+.+.........+|.+.+.||+|.||.|-++++...|+.||||.++.+.-.+ .....+.+|++++..|+||||+.
T Consensus        38 k~~gvkrhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~  117 (668)
T KOG0611|consen   38 KMSGVKRHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQ  117 (668)
T ss_pred             ccccccccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceee
Confidence            34455556666677889999999999999999999999999999999998765332 22345679999999999999999


Q ss_pred             hhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec
Q psy13988        210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN  289 (358)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~  289 (358)
                      ++++|+..          +...|||||..++.+..+......+++.+++++++||+.|+.|||+++++|||||.+|||+|
T Consensus       118 IyEVFENk----------dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD  187 (668)
T KOG0611|consen  118 IYEVFENK----------DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD  187 (668)
T ss_pred             hhhhhcCC----------ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec
Confidence            99888764          48899999998754444445566899999999999999999999999999999999999999


Q ss_pred             CCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       290 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .++++||.|||++..+......   ..++|+|-|++||++.+..+-.+.+|.||||+++|.|..|..||
T Consensus       188 ~N~NiKIADFGLSNly~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF  253 (668)
T KOG0611|consen  188 QNNNIKIADFGLSNLYADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF  253 (668)
T ss_pred             CCCCeeeeccchhhhhccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc
Confidence            9999999999999988766554   45667999999999999987889999999999999999999998

>KOG0588|consensus

Probab=100.00  E-value=4.2e-42  Score=310.47  Aligned_cols=202  Identities=32%  Similarity=0.500  Sum_probs=178.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecc-ccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLE-NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..-+-|++.+.||.|+.|.|.+|.+..||+.+|||++... ...+.....+.+|+.+|+.+.|||++++++++++     
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-----   83 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-----   83 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-----
Confidence            3456789999999999999999999999999999999876 3444445567899999999999999999888876     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           ..++|+|.||++| .|++.+. ..+++++.++.++++||+.|+.|||..+|+|||+||+|+|+|.++++||+|||
T Consensus        84 -----~~~lylvlEyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   84 -----KQHLYLVLEYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             -----CceEEEEEEecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccc
Confidence                 4589999999997 5666554 44589999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|..-..+...   ...+|+|.|+|||++.+..+.+.++||||+|+|||.||||+.||
T Consensus       158 MAsLe~~gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF  212 (786)
T KOG0588|consen  158 MASLEVPGKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF  212 (786)
T ss_pred             eeecccCCccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC
Confidence            99876555444   34567999999999999998899999999999999999999999

>KOG0578|consensus

Probab=100.00  E-value=1.1e-41  Score=303.58  Aligned_cols=207  Identities=29%  Similarity=0.479  Sum_probs=182.0

Q ss_pred             cccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhc
Q psy13988        136 APIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  215 (358)
                      ..+...+.....|...+.||+|+.|.||.+....+++.||||++.......  .+.++.|+.+++..+|+|||++++.|.
T Consensus       263 ~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Syl  340 (550)
T KOG0578|consen  263 KRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYL  340 (550)
T ss_pred             heeccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhc
Confidence            345567788889999999999999999999999999999999998765443  456789999999999999999988887


Q ss_pred             ccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                      .          .+.+|+||||++|+.+..+.... .++|.++..|++++++||+|||.+||+|||||.+|||++.+|.+|
T Consensus       341 v----------~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vK  409 (550)
T KOG0578|consen  341 V----------GDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVK  409 (550)
T ss_pred             c----------cceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEE
Confidence            5          35899999999986665554333 499999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||+|..+......  ...-+|||.|||||++.... |+.++||||||++++||+-|.+||
T Consensus       410 ltDFGFcaqi~~~~~K--R~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPY  469 (550)
T KOG0578|consen  410 LTDFGFCAQISEEQSK--RSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPY  469 (550)
T ss_pred             EeeeeeeeccccccCc--cccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCc
Confidence            9999999988655433  34567899999999998655 999999999999999999999998

>KOG0694|consensus

Probab=100.00  E-value=8.3e-42  Score=310.39  Aligned_cols=203  Identities=24%  Similarity=0.319  Sum_probs=176.1

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccc-cCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLEN-EKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSD  219 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  219 (358)
                      ......|.++++||+|+||.|+++..+.+++.||||.+++.. ......+..+.|.+++... +||.+++++++|+.   
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT---  440 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT---  440 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc---
Confidence            445677889999999999999999999999999999998774 3344456778888888877 69999999888877   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ..++|+||||+.|+.+.. ......+++..++-++..++.||.|||++||+|||||.+|||+|.+|.+||+||
T Consensus       441 -------~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADF  512 (694)
T KOG0694|consen  441 -------KEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADF  512 (694)
T ss_pred             -------CCeEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccc
Confidence                   448999999999977333 334457999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+++.--..  .......+|||.|+|||++.+.. |+.++|+|||||+|||||.|..||
T Consensus       513 GlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF  568 (694)
T KOG0694|consen  513 GLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPF  568 (694)
T ss_pred             ccccccCCC--CCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCC
Confidence            999854322  23456778899999999999776 999999999999999999999998

>KOG0192|consensus

Probab=100.00  E-value=1.8e-41  Score=301.70  Aligned_cols=202  Identities=29%  Similarity=0.388  Sum_probs=170.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcE-EEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDEL-VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ......+.+.||.|+||+||.+..  .|.. ||||++............+.+|+.+|.+++|||||++++++.++.    
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----  112 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----  112 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----
Confidence            344445667799999999998775  5666 999999877655544668899999999999999999999887643    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcC--CCCCChHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEecCCC-cEEEee
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESG--MVDFNEVNNASIMRQLLDGLSYCHKRN-FLHRDIKCSNILMNNRG-EVKLAD  298 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~Dlkp~Nill~~~~-~~~l~D  298 (358)
                           +.+++||||++++.+..+...  ...++...+..++.||++|+.|||+++ |+||||||+|||++.++ ++||+|
T Consensus       113 -----~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D  187 (362)
T KOG0192|consen  113 -----GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD  187 (362)
T ss_pred             -----CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence                 168999999997666655433  678999999999999999999999999 99999999999999998 999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+++......  .......||+.|||||++.+. ..++.++||||||+++|||+||+.||
T Consensus       188 FGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf  246 (362)
T KOG0192|consen  188 FGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPF  246 (362)
T ss_pred             Cccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCC
Confidence            99998775432  222346789999999999852 45999999999999999999999998

>KOG0198|consensus

Probab=100.00  E-value=1.5e-41  Score=293.46  Aligned_cols=204  Identities=31%  Similarity=0.455  Sum_probs=170.0

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|...+.||+|+||+||++.+..+|+..|||.+.......  .+.+.+|+.+|++++|||||++++......      
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~------   87 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRE------   87 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCcccccc------
Confidence            456888999999999999999999999999999987763222  456789999999999999999988754422      


Q ss_pred             cCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEeecccc
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-RGEVKLADFGLA  302 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~-~~~~~l~Dfg~~  302 (358)
                        +..+++.|||+.++ +.+.+....+.+++..++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus        88 --~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   88 --NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             --CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccc
Confidence              13799999999975 55555544448999999999999999999999999999999999999999 799999999999


Q ss_pred             eeccc-cCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNA-EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..... ...........||+.|||||++........++|||||||++.||+||++||
T Consensus       166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW  222 (313)
T KOG0198|consen  166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPW  222 (313)
T ss_pred             cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcc
Confidence            87664 222233345678999999999985322335999999999999999999997

>KOG0582|consensus

Probab=100.00  E-value=9.5e-41  Score=289.19  Aligned_cols=209  Identities=26%  Similarity=0.416  Sum_probs=180.2

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      .........|.+.+.||.|..++||+|+...+++.||||+++.+..... ...+.+|+..++.++||||++++..|..  
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--   95 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--   95 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--
Confidence            3455678899999999999999999999999999999999999876654 5678899999999999999999998886  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                              +..+|+||.|+.+ ++++.+... ...++|..+..|++++++||.|||++|.+|||||+.||||+.+|.++|
T Consensus        96 --------~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkL  167 (516)
T KOG0582|consen   96 --------DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKL  167 (516)
T ss_pred             --------cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEE
Confidence                    5589999999986 666665432 234999999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCC-CCC-CCcccccccccccccc-CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQ-RPY-TNKVITLWYRPPELLL-GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~-~~~-~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||.+..+...... ... ...+||+.|||||++. ....|+.|+||||||++..||.+|..||
T Consensus       168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf  232 (516)
T KOG0582|consen  168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF  232 (516)
T ss_pred             cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence            999988766544322 111 4568899999999953 3445999999999999999999999998

>KOG0658|consensus

Probab=100.00  E-value=9.7e-42  Score=289.47  Aligned_cols=201  Identities=31%  Similarity=0.545  Sum_probs=173.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..-.|.-.+.+|.|+||.||.+....+++.||||++..+..-.      .+|+.+|+.++|||||++.-+|....+.   
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~---   92 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTES---   92 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCC---
Confidence            3445777899999999999999999999999999987554322      4799999999999999998888764421   


Q ss_pred             ccCCCeEEEEeeccccChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEeec
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADF  299 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~l~Df  299 (358)
                        +.-+..+||||++.++.+.+..   .+..++...+.-+.+||++||.|||+.||+||||||.|+|+|.+ |.+|||||
T Consensus        93 --d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   93 --DEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             --chhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccC
Confidence              2346789999999988888763   35578888999999999999999999999999999999999987 89999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |.|+....+...   .....|..|+|||.+.+...|+.+.||||.||++.||+-|++.|
T Consensus       171 GSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF  226 (364)
T KOG0658|consen  171 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF  226 (364)
T ss_pred             CcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence            999988766543   44566999999999999888999999999999999999999987

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.6e-40  Score=292.67  Aligned_cols=201  Identities=42%  Similarity=0.716  Sum_probs=173.6

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|.+++.||.|+||.||++.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.+        
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------   74 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--------   74 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--------
Confidence            36799999999999999999999999999999998755322 223456789999999999999999777654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        +...++||||+++++.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus        75 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          75 --KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             --CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence              558999999999999988877667799999999999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  .......+++.|+|||++.+...++.++||||+||++|+|++|.+||
T Consensus       153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  204 (303)
T cd07869         153 KSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF  204 (303)
T ss_pred             ccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            43222  22234567899999999876666889999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.5e-40  Score=289.56  Aligned_cols=200  Identities=47%  Similarity=0.804  Sum_probs=172.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|.+++.||.|+||.||++.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++..         
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------   74 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT---------   74 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC---------
Confidence            569999999999999999999999999999999875432 2233467789999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++..++||||+++++...+......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus        75 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          75 -ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             -CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence             5589999999999888887666666899999999999999999999999999999999999999999999999998765


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  .......+++.|+|||++.+...++.++||||+||++|+|+||++||
T Consensus       154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf  204 (288)
T cd07871         154 SVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF  204 (288)
T ss_pred             cCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence            4322  12234567899999999876656899999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.1e-40  Score=300.85  Aligned_cols=201  Identities=24%  Similarity=0.317  Sum_probs=167.6

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      +|++++.||+|+||.||++.+..+++.||||++...... ......+.+|+.++..++|+||+++++.+.+         
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~---------   72 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD---------   72 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec---------
Confidence            688999999999999999999999999999999754322 2223456789999999999999999776654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ...+|+||||++|+.+..+......+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||+++..
T Consensus        73 -~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          73 -KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             -CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence             5589999999987555444444567999999999999999999999999999999999999999999999999998754


Q ss_pred             cccCCC---------------------------------CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHh
Q psy13988        306 NAEDRQ---------------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF  352 (358)
Q Consensus       306 ~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll  352 (358)
                      ......                                 ......+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell  230 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHH
Confidence            321100                                 0012346899999999998655 889999999999999999


Q ss_pred             hCCCCC
Q psy13988        353 VKKPLF  358 (358)
Q Consensus       353 tg~~pF  358 (358)
                      +|++||
T Consensus       231 ~G~~Pf  236 (363)
T cd05628         231 IGYPPF  236 (363)
T ss_pred             hCCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-39  Score=287.50  Aligned_cols=201  Identities=40%  Similarity=0.685  Sum_probs=174.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ++|.+.+.||+|++|.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++..         
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR---------   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec---------
Confidence            36899999999999999999999999999999998665444445677899999999999999999877754         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++.+|+||||++++++..+......+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus        72 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          72 -RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             -CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence             5589999999999888887666667999999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..... .......+++.|+|||++.+.. ++.++||||+||++|+|++|++||
T Consensus       151 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf  201 (287)
T cd07848         151 SEGSN-ANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLF  201 (287)
T ss_pred             ccccc-ccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCC
Confidence            43322 1223346789999999997655 889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0033|consensus

Probab=100.00  E-value=1.3e-41  Score=273.28  Aligned_cols=202  Identities=31%  Similarity=0.479  Sum_probs=177.1

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ......|.+.+.||+|.|+.|+++.+..+|+.+|+|+++.........+++.+|+.+-+.|+||||+++.+.+..     
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-----   81 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----   81 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-----
Confidence            345677899999999999999999999999999999998887777677888999999999999999999777654     


Q ss_pred             ccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~~l~  297 (358)
                           .+..|+|+|+++|+ +...+..+ .-++|..+.+.++||++||.|+|.++|||||+||+|+++-.+.   -+||+
T Consensus        82 -----~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   82 -----ESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             -----cceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeec
Confidence                 66899999999984 44444333 3588999999999999999999999999999999999996543   69999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++.....   .....+..|||+|||||++...+ |+..+|||+.|+++|-||.|++||
T Consensus       156 ~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF  212 (355)
T KOG0033|consen  156 DFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPF  212 (355)
T ss_pred             ccceEEEeCC---ccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCC
Confidence            9999998873   34457888999999999998766 999999999999999999999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-40  Score=289.01  Aligned_cols=197  Identities=21%  Similarity=0.334  Sum_probs=166.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|++++.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+        
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------   72 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--------   72 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--------
Confidence            3688999999999999999999999999999998754322 1223457789999999999999999877654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ++.+|+||||+.++.+..+......+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..
T Consensus        73 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          73 --QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             --CCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence              558999999998754444434445789999999999999999999999999999999999999999999999999886


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....     ....|++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       151 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf  198 (291)
T cd05612         151 LRDRT-----WTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPF  198 (291)
T ss_pred             ccCCc-----ccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            54321     2345799999999987655 789999999999999999999997

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0667|consensus

Probab=100.00  E-value=3.4e-40  Score=299.43  Aligned_cols=199  Identities=32%  Similarity=0.499  Sum_probs=172.0

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-C-----Ccccchhhhh
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-H-----KNIVNLREIV  214 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~  214 (358)
                      .+....+|.+.+.||+|+||.|.+|.|..|++.||||+++...   .+..+...|+.+|..|+ |     -|+|+++++|
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            4455568889999999999999999999999999999998543   33456678999999996 4     3899997776


Q ss_pred             cccCcccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-
Q psy13988        215 TDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-  292 (358)
Q Consensus       215 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-  292 (358)
                      ..          .+++|||+|.++-+|.+.++.+. ..++...++.|+.||+.||.+||+.+|||+||||+||||...+ 
T Consensus       258 ~f----------r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r  327 (586)
T KOG0667|consen  258 YF----------RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR  327 (586)
T ss_pred             cc----------ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc
Confidence            54          67999999999999999997543 4589999999999999999999999999999999999998654 


Q ss_pred             -cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        293 -EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       293 -~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                       .+||+|||.++......     ...+.+..|+|||++.+.+ |+.+.||||||||+.||++|.+.|
T Consensus       328 ~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  328 SRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             CceeEEecccccccCCcc-----eeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCcccc
Confidence             79999999998765443     2456688999999999877 999999999999999999999887

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.6e-40  Score=300.12  Aligned_cols=201  Identities=30%  Similarity=0.379  Sum_probs=166.3

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|.+++.||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++|+||+++++++.+         
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~---------   72 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD---------   72 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec---------
Confidence            588999999999999999999999999999999764322 2233467889999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus        73 -~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          73 -KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             -CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence             5589999999987554444444457899999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCC---------------------------------------------CCCCCccccccccccccccCCCCCCCcch
Q psy13988        306 NAEDRQ---------------------------------------------RPYTNKVITLWYRPPELLLGEERYGPAID  340 (358)
Q Consensus       306 ~~~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  340 (358)
                      ......                                             ......+||+.|+|||++.+.. ++.++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~D  230 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCD  230 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccc
Confidence            110000                                             0012346899999999987655 889999


Q ss_pred             HHHHHHHHHHHhhCCCCC
Q psy13988        341 VWSCGCILGELFVKKPLF  358 (358)
Q Consensus       341 iwslG~~l~~lltg~~pF  358 (358)
                      ||||||++|+|++|.+||
T Consensus       231 iwSlG~il~elltG~~Pf  248 (381)
T cd05626         231 WWSVGVILFEMLVGQPPF  248 (381)
T ss_pred             eeehhhHHHHHHhCCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-40  Score=298.59  Aligned_cols=202  Identities=26%  Similarity=0.358  Sum_probs=168.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|++++.||.|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.+        
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--------   72 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--------   72 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--------
Confidence            3688999999999999999999999999999999754321 2223456789999999999999999777665        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        +..+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus        73 --~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          73 --ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             --CCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence              568999999998765555444455799999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCC------------------------------------CCCCccccccccccccccCCCCCCCcchHHHHHHHH
Q psy13988        305 YNAEDRQR------------------------------------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL  348 (358)
Q Consensus       305 ~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l  348 (358)
                      +.......                                    .....+||+.|+|||++.+.. ++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHH
Confidence            43221100                                    011235899999999987655 89999999999999


Q ss_pred             HHHhhCCCCC
Q psy13988        349 GELFVKKPLF  358 (358)
Q Consensus       349 ~~lltg~~pF  358 (358)
                      |+|++|.+||
T Consensus       230 ~el~~G~~Pf  239 (364)
T cd05599         230 YEMLVGYPPF  239 (364)
T ss_pred             HHhhcCCCCC
Confidence            9999999998

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-40  Score=300.73  Aligned_cols=201  Identities=25%  Similarity=0.343  Sum_probs=165.3

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|.+++.||.|+||.||++.+..+++.||||++..... .......+.+|+++++.++||||+++++++.+         
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~---------   72 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD---------   72 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc---------
Confidence            68899999999999999999999999999999865432 22223456789999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       +..+|+||||++|+.+..+......+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||+++.+
T Consensus        73 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          73 -AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             -CCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence             5589999999986544444334457899999999999999999999999999999999999999999999999998643


Q ss_pred             cccCCC------------C---------------------------------CCCCccccccccccccccCCCCCCCcch
Q psy13988        306 NAEDRQ------------R---------------------------------PYTNKVITLWYRPPELLLGEERYGPAID  340 (358)
Q Consensus       306 ~~~~~~------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~D  340 (358)
                      ......            .                                 .....+||+.|+|||++.+.. ++.++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~D  230 (377)
T cd05629         152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECD  230 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCcee
Confidence            211000            0                                 001246899999999987654 899999


Q ss_pred             HHHHHHHHHHHhhCCCCC
Q psy13988        341 VWSCGCILGELFVKKPLF  358 (358)
Q Consensus       341 iwslG~~l~~lltg~~pF  358 (358)
                      ||||||++|+|++|.+||
T Consensus       231 iwSlGvil~elltG~~Pf  248 (377)
T cd05629         231 WWSLGAIMFECLIGWPPF  248 (377)
T ss_pred             eEecchhhhhhhcCCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-39  Score=291.88  Aligned_cols=199  Identities=25%  Similarity=0.330  Sum_probs=169.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....|.+.+.||.|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.+      
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------   89 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD------   89 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc------
Confidence            45679999999999999999999999999999999875432 22233467889999999999999999777654      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ++..|+||||+.|+.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus        90 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  165 (329)
T PTZ00263         90 ----ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA  165 (329)
T ss_pred             ----CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCc
Confidence                5589999999987544444334457899999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......     ....|++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       166 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf  215 (329)
T PTZ00263        166 KKVPDRT-----FTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPF  215 (329)
T ss_pred             eEcCCCc-----ceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCC
Confidence            8764322     2345799999999998665 789999999999999999999998

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-39  Score=291.61  Aligned_cols=206  Identities=36%  Similarity=0.590  Sum_probs=170.6

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|+||.||++.+..++..||||++............+.+|+.+++.++||||+++++++.....     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----~~   75 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-----RE   75 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC-----CC
Confidence            5889999999999999999999999999999987543333334467899999999999999999888754321     12


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ...+|+||||+++++.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus        76 ~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          76 FKDIYVVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             CceEEEEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            3468999999998887776543 468999999999999999999999999999999999999999999999999998653


Q ss_pred             ccCC-CCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDR-QRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .... ........+++.|+|||++.+. ..++.++|||||||++|+|++|++||
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf  208 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF  208 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC
Confidence            2221 1222345679999999988652 34889999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0589|consensus

Probab=100.00  E-value=4.7e-40  Score=291.25  Aligned_cols=202  Identities=32%  Similarity=0.498  Sum_probs=178.9

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ...|..++.+|+|+||.+++++++.++..|++|.+..............+|+.++++++|||||.+.+++...       
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-------   75 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-------   75 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-------
Confidence            3578999999999999999999999999999999999887777777889999999999999999998888763       


Q ss_pred             cCCCeEEEEeeccccChH-HHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        225 KDKGSFYLVFEYMDHDLM-GLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~-~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                        +..++|||+||+|+.+ +.+... ..-+++..+..|+.||+.|+.|||+++|+|||||+.|||++.++.++|+|||+|
T Consensus        76 --~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGla  153 (426)
T KOG0589|consen   76 --GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLA  153 (426)
T ss_pred             --CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhh
Confidence              2349999999998544 445443 367999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.+.....  .....+||+.||+||++.+.. |+.++|||||||++|||++-+++|
T Consensus       154 K~l~~~~~--~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF  206 (426)
T KOG0589|consen  154 KILNPEDS--LASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAF  206 (426)
T ss_pred             hhcCCchh--hhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhccccc
Confidence            99876652  224567899999999998776 999999999999999999999987

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=293.14  Aligned_cols=197  Identities=26%  Similarity=0.378  Sum_probs=169.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      +.|.+++.||.|+||.||++.+..+++.||||++...... ......+.+|+.++..++||||+++++++.+        
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--------   72 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--------   72 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--------
Confidence            3689999999999999999999999999999999765322 1223467789999999999999999776654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ++..|+||||++|+.+..+......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus        73 --~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          73 --DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             --CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence              558999999998765555555556789999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...     ......|++.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf  198 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPF  198 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCC
Confidence            543     223456799999999998764 899999999999999999999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-39  Score=298.88  Aligned_cols=201  Identities=29%  Similarity=0.367  Sum_probs=165.2

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|.+++.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++|+||+++++++.+         
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~---------   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD---------   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe---------
Confidence            58899999999999999999999999999999875432 12223467789999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++.+|+||||++++.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+
T Consensus        73 -~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          73 -KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence             5589999999987544444334457899999999999999999999999999999999999999999999999997532


Q ss_pred             cccCC---------------------------------------------CCCCCCccccccccccccccCCCCCCCcch
Q psy13988        306 NAEDR---------------------------------------------QRPYTNKVITLWYRPPELLLGEERYGPAID  340 (358)
Q Consensus       306 ~~~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  340 (358)
                      .....                                             .......+||+.|+|||++.+.. ++.++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~D  230 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCD  230 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeee
Confidence            11000                                             00011246799999999997665 899999


Q ss_pred             HHHHHHHHHHHhhCCCCC
Q psy13988        341 VWSCGCILGELFVKKPLF  358 (358)
Q Consensus       341 iwslG~~l~~lltg~~pF  358 (358)
                      ||||||++|+|++|++||
T Consensus       231 iwSlGvil~elltG~~Pf  248 (382)
T cd05625         231 WWSVGVILYEMLVGQPPF  248 (382)
T ss_pred             EEechHHHHHHHhCCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-39  Score=298.66  Aligned_cols=202  Identities=29%  Similarity=0.371  Sum_probs=166.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      +.|++++.||+|+||.||++.+..+++.||||++..... .......+.+|+.+++.++|+||+++++.+.+        
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--------   72 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--------   72 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--------
Confidence            468999999999999999999999999999999865422 12234567789999999999999999766654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ++.+|+||||++++.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus        73 --~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          73 --KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence              568999999998755544444445789999999999999999999999999999999999999999999999999753


Q ss_pred             ccccCC-----------------------------------------CCCCCCccccccccccccccCCCCCCCcchHHH
Q psy13988        305 YNAEDR-----------------------------------------QRPYTNKVITLWYRPPELLLGEERYGPAIDVWS  343 (358)
Q Consensus       305 ~~~~~~-----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  343 (358)
                      +.....                                         ........||+.|+|||++.+.. ++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeee
Confidence            311000                                         00011346899999999997655 889999999


Q ss_pred             HHHHHHHHhhCCCCC
Q psy13988        344 CGCILGELFVKKPLF  358 (358)
Q Consensus       344 lG~~l~~lltg~~pF  358 (358)
                      |||++|+|++|++||
T Consensus       230 lGvilyell~G~~Pf  244 (376)
T cd05598         230 VGVILYEMLVGQPPF  244 (376)
T ss_pred             ccceeeehhhCCCCC
Confidence            999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-39  Score=291.86  Aligned_cols=205  Identities=25%  Similarity=0.320  Sum_probs=170.8

Q ss_pred             cccCCCCCCCCcccccccCCcceeeEeeeeecCC-cEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhc
Q psy13988        138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTD-ELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       138 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  215 (358)
                      ..........|.+.+.||+|+||.||++.+..++ ..||+|.+..... .......+.+|+.+++.++||||+++++++.
T Consensus        22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            3344456678999999999999999999976655 7899999875432 2223446778999999999999999987775


Q ss_pred             ccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                      +          ++.+|+||||+.++.+..+......+++..+..++.||+.||+|||++||+||||||+||+++.++.++
T Consensus       102 ~----------~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ik  171 (340)
T PTZ00426        102 D----------ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIK  171 (340)
T ss_pred             e----------CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEE
Confidence            4          558999999998755544444455799999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++.......     ....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus       172 L~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf  228 (340)
T PTZ00426        172 MTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPF  228 (340)
T ss_pred             EecCCCCeecCCCc-----ceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCC
Confidence            99999998764321     2346799999999997655 789999999999999999999998

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.1e-39  Score=290.78  Aligned_cols=194  Identities=22%  Similarity=0.322  Sum_probs=162.5

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF  230 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~  230 (358)
                      +.||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++..          ++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----------~~~~   70 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT----------HDRL   70 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc----------CCEE
Confidence            4689999999999999999999999998754321 2223456789999999999999999776654          5689


Q ss_pred             EEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       231 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                      |+||||++++.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++...... 
T Consensus        71 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  149 (323)
T cd05571          71 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence            9999999986555444445578999999999999999999999999999999999999999999999999987532221 


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf  195 (323)
T cd05571         150 -ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  195 (323)
T ss_pred             -CcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCC
Confidence             1123456799999999997655 899999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4717|consensus

Probab=100.00  E-value=2.4e-39  Score=284.92  Aligned_cols=206  Identities=29%  Similarity=0.493  Sum_probs=185.2

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..+.+.+-|.+-+.||+|.|.+|-++++..+|++||||++.+.........++++|++-++.++|||||++|++...   
T Consensus        12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT---   88 (864)
T KOG4717|consen   12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT---   88 (864)
T ss_pred             cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc---
Confidence            34556778999999999999999999999999999999999888777777788999999999999999999888765   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEe
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLA  297 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~l~  297 (358)
                             +..+|+|+|+-++ ++.+++......+.|..+.+++.||+.|+.|+|+..+|||||||+||++.+. |-+||.
T Consensus        89 -------QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLT  161 (864)
T KOG4717|consen   89 -------QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLT  161 (864)
T ss_pred             -------cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEee
Confidence                   4589999999986 8889988777789999999999999999999999999999999999977654 789999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++..+.++...   ...+|+..|.|||++.+..+-.+++||||||||+|.|.||++||
T Consensus       162 DFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF  219 (864)
T KOG4717|consen  162 DFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF  219 (864)
T ss_pred             eccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc
Confidence            99999988776654   44567999999999999987778999999999999999999998

>KOG0201|consensus

Probab=100.00  E-value=5.5e-40  Score=284.10  Aligned_cols=202  Identities=28%  Similarity=0.383  Sum_probs=177.7

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .....|+.++.||+|+||.||++.+..+++.||||++..+... ...+.+.+|+.+|.+++++||.++++.|..      
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~------   82 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLK------   82 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheee------
Confidence            3455688889999999999999999999999999999987544 345678899999999999999999999876      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          +..++++|||+.|+....+......+++..+.-++++++.|+.|||..+.+|||||+.||++..+|.+||+|||.+
T Consensus        83 ----g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa  158 (467)
T KOG0201|consen   83 ----GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVA  158 (467)
T ss_pred             ----cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEeccee
Confidence                4489999999998655555555556689999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .........+  ..++|||.|||||++.... |+.++||||||++.+||++|.+||
T Consensus       159 ~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~  211 (467)
T KOG0201|consen  159 GQLTNTVKRR--KTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPH  211 (467)
T ss_pred             eeeechhhcc--ccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCC
Confidence            8876554443  6778999999999999655 999999999999999999999997

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=293.41  Aligned_cols=201  Identities=32%  Similarity=0.416  Sum_probs=170.1

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|.+++.||.|+||.||++.+..+++.||||++....... .....+.+|+.++..++|+||+++++++.+        
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--------   72 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--------   72 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--------
Confidence            36899999999999999999999999999999997653222 334567789999999999999999877754        


Q ss_pred             cCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ++.+|+||||+.++ |.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus        73 --~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          73 --EEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             --CCeEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence              55899999999874 5554443 3679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccC---------------------------CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCC
Q psy13988        304 LYNAED---------------------------RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP  356 (358)
Q Consensus       304 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~  356 (358)
                      ......                           .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCC
Confidence            665432                           011223456799999999998764 8999999999999999999999


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       229 Pf  230 (350)
T cd05573         229 PF  230 (350)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=296.62  Aligned_cols=204  Identities=29%  Similarity=0.460  Sum_probs=169.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||||++....      ....+|+.+++.++||||+++++++....  +..
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~--~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTEC--FKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecc--ccc
Confidence            4567999999999999999999999999999999885432      23457999999999999999988765422  222


Q ss_pred             ccCCCeEEEEeeccccChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeec
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADF  299 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Df  299 (358)
                      ......+++||||+++++...+.   .....+++..++.++.||+.||+|||+.+|+||||||+||+++.++ .+||+||
T Consensus       136 ~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            23345688999999998776653   3455789999999999999999999999999999999999999765 6999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+++.+.....   .....+|+.|+|||++.+...++.++|||||||++|+|++|.+||
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf  271 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF  271 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99986643322   223466899999999877666899999999999999999999998

>KOG0610|consensus

Probab=100.00  E-value=9.8e-39  Score=274.48  Aligned_cols=209  Identities=25%  Similarity=0.276  Sum_probs=175.0

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      .........+++++.||.|.-|+||+++...++..+|+|++.+.... .....++..|-++|+.++||.++.+|..++. 
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-  148 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-  148 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-
Confidence            34455667889999999999999999999999999999999876533 2233456779999999999999999888765 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHh--cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLE--SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                               +...|+|||||.|+.+..+.  +....+++..++-++..++.||+|||-.|||+|||||+||||-++|++.
T Consensus       149 ---------~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIM  219 (459)
T KOG0610|consen  149 ---------DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIM  219 (459)
T ss_pred             ---------cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEE
Confidence                     55899999999986666553  3345699999999999999999999999999999999999999999999


Q ss_pred             Eeecccceecccc---------------------------------CC---------------------CCCCCCccccc
Q psy13988        296 LADFGLARLYNAE---------------------------------DR---------------------QRPYTNKVITL  321 (358)
Q Consensus       296 l~Dfg~~~~~~~~---------------------------------~~---------------------~~~~~~~~~~~  321 (358)
                      |+||.++......                                 ..                     ......++||-
T Consensus       220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh  299 (459)
T KOG0610|consen  220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH  299 (459)
T ss_pred             eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence            9999986533110                                 00                     01123557899


Q ss_pred             cccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        322 WYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       322 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .|.|||++.+.+ .+.++|+|+||+++||||.|..||
T Consensus       300 EYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPF  335 (459)
T KOG0610|consen  300 EYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPF  335 (459)
T ss_pred             ccccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCc
Confidence            999999999887 899999999999999999999998

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-38  Score=280.29  Aligned_cols=204  Identities=38%  Similarity=0.683  Sum_probs=169.0

Q ss_pred             CCCcccccccCCcceeeEeeeeec-CCcEEEEEEeeccccCCCCchhHHHHHHHHHhC---CCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLF-TDELVALKKVRLENEKEGFPITAVREIKILRQL---NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~  221 (358)
                      .+|++++.||+|+||.||++.+.. ++..||+|.+............+.+|+.+++.+   +||||+++++++....   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~---   77 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR---   77 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc---
Confidence            368999999999999999999854 568899999876654444445567788877766   6999999988875321   


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                        ...+..+++|||++++++.+.+... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||
T Consensus        78 --~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          78 --TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             --CCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence              1235579999999999888877543 3458999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.......   ......+++.|+|||.+.+.. ++.++|||||||++|+|++|++||
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f  209 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLF  209 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCc
Confidence            998765332   223445799999999987654 889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-38  Score=286.20  Aligned_cols=194  Identities=24%  Similarity=0.343  Sum_probs=162.2

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF  230 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~  230 (358)
                      +.||+|+||.||++.+..++..||+|++...... ......+.+|+.+++.++||||+++++++..          ++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----------~~~~   70 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----------HDRL   70 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec----------CCEE
Confidence            4689999999999999999999999998764321 2223456789999999999999999777654          5589


Q ss_pred             EEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       231 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                      |+||||++++.+.........+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        71 ~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-  149 (323)
T cd05595          71 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-
Confidence            9999999976555544445578999999999999999999999999999999999999999999999999987532221 


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                       .......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf  195 (323)
T cd05595         150 -ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  195 (323)
T ss_pred             -CccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCC
Confidence             1123345799999999987654 899999999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-38  Score=289.30  Aligned_cols=205  Identities=31%  Similarity=0.506  Sum_probs=173.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+++.||.|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----   93 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK----   93 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC----
Confidence            4567899999999999999999999999999999998765444444556789999999999999999998876532    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      .......+|+||||+++++...+..   .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus        94 ~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          94 SLEEFQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             CccccceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            1123346899999999988877643   4788999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......   ......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf  222 (359)
T cd07876         171 RTACTNF---MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIF  222 (359)
T ss_pred             cccccCc---cCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCC
Confidence            7543322   123446689999999997655 889999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.3e-39  Score=292.77  Aligned_cols=204  Identities=24%  Similarity=0.286  Sum_probs=168.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ....+|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.+     
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----  114 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-----  114 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence            3456899999999999999999999999999999998753222 2223456789999999999999999776654     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           +..+|+||||++|+.+..+... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus       115 -----~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         115 -----DKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             -----CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccc
Confidence                 5689999999987544444333 2588999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCC---CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEE---RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +........ .......||+.|+|||++.+..   .++.++||||+||++|+|++|++||
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf  247 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF  247 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence            987643322 1123456799999999986532   3788999999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.8e-39  Score=292.84  Aligned_cols=201  Identities=24%  Similarity=0.334  Sum_probs=167.1

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|.+++.||+|+||.||++.+..+++.||+|++..... .......+.+|+.++..++|+||+++++.+.+         
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~---------   72 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD---------   72 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc---------
Confidence            68889999999999999999999999999999875432 22234466789999999999999999766654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++.+|+||||++|+.+..+......+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus        73 -~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          73 -KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             -CCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence             5689999999987555444444457999999999999999999999999999999999999999999999999998754


Q ss_pred             cccCCC---------------------------------CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHh
Q psy13988        306 NAEDRQ---------------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF  352 (358)
Q Consensus       306 ~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll  352 (358)
                      ......                                 ......+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~  230 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecc
Confidence            321100                                 0112346899999999988655 889999999999999999


Q ss_pred             hCCCCC
Q psy13988        353 VKKPLF  358 (358)
Q Consensus       353 tg~~pF  358 (358)
                      +|++||
T Consensus       231 tG~~Pf  236 (360)
T cd05627         231 IGYPPF  236 (360)
T ss_pred             cCCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-38  Score=289.68  Aligned_cols=195  Identities=28%  Similarity=0.414  Sum_probs=166.9

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .....|.+++.||+|+||.||++.+..+++.||+|....        ..+.+|+++++.++||||+++++++..      
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~------  154 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY------  154 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE------
Confidence            455679999999999999999999999999999996432        245789999999999999999877654      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          +...++|+|++.+++...+... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus       155 ----~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a  229 (391)
T PHA03212        155 ----NKFTCLILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA  229 (391)
T ss_pred             ----CCeeEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence                4578999999998888777544 46889999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       230 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~  283 (391)
T PHA03212        230 CFPVDIN-ANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSL  283 (391)
T ss_pred             ccccccc-ccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCc
Confidence            7543221 12223456899999999987654 899999999999999999998775

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-38  Score=286.12  Aligned_cols=194  Identities=22%  Similarity=0.334  Sum_probs=162.4

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF  230 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~  230 (358)
                      +.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++..          ++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------~~~~   70 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT----------KDRL   70 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----------CCEE
Confidence            4689999999999999999999999999764322 2233467789999999999999999766654          5689


Q ss_pred             EEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       231 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                      |+||||++++.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        71 ~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-  149 (328)
T cd05593          71 CFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-  149 (328)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence            9999999976555444445579999999999999999999999999999999999999999999999999987543221 


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf  195 (328)
T cd05593         150 -ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  195 (328)
T ss_pred             -cccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCC
Confidence             1123346799999999987655 889999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.8e-38  Score=278.74  Aligned_cols=198  Identities=25%  Similarity=0.363  Sum_probs=165.8

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....... .....+.+|+.+++.++|+||+++++++.+         
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~---------   71 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET---------   71 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc---------
Confidence            3778899999999999999999999999999987543221 223356789999999999999999766654         


Q ss_pred             CCCeEEEEeeccccChHH-HHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        226 DKGSFYLVFEYMDHDLMG-LLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~-~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                       ++..++||||+.++.+. .+.. ....+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus        72 -~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~  150 (285)
T cd05631          72 -KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV  150 (285)
T ss_pred             -CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence             55899999999975444 4432 33468999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......   .....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf  201 (285)
T cd05631         151 QIPEGET---VRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPF  201 (285)
T ss_pred             EcCCCCe---ecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCC
Confidence            7543221   23446799999999998654 899999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.5e-38  Score=281.41  Aligned_cols=201  Identities=45%  Similarity=0.787  Sum_probs=172.6

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|.+++.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..        
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------   75 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT--------   75 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--------
Confidence            35789999999999999999999999999999998765332 233456789999999999999999777654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ++..++||||+++++...+......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus        76 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  153 (309)
T cd07872          76 --DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (309)
T ss_pred             --CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence              558999999999998888876666789999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......+++.|+|||++.+...++.++||||||+++|+|+||++||
T Consensus       154 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf  205 (309)
T cd07872         154 KSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF  205 (309)
T ss_pred             cCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            533221  1233456899999999876666899999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0197|consensus

Probab=100.00  E-value=7.4e-39  Score=284.64  Aligned_cols=248  Identities=25%  Similarity=0.379  Sum_probs=192.5

Q ss_pred             hhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCCCCCCCCCCCCchhhHHHHHHhhhcccCCCccccccccccccCCCC
Q psy13988         65 PGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTN  144 (358)
Q Consensus        65 ~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (358)
                      ...++.|..|..+.+.++...-..|..|=-..-+..    |..+...                          .......
T Consensus       155 ~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~~----p~~~~~~--------------------------~d~wei~  204 (468)
T KOG0197|consen  155 RELFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHTK----PQTPDLA--------------------------RDPWEIP  204 (468)
T ss_pred             HHhhhhHHHHHhhhhccCcchhhcccCchhccCCCC----CCCCccc--------------------------cCCeeec
Confidence            356888999999999988877666655433211100    0000000                          1122234


Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ...+++++.||+|-||.||.+... ....||+|.++...   ...+.+.+|+.++++|+|+|||++++++..        
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~--------  272 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTK--------  272 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEec--------
Confidence            445678899999999999999972 33489999988653   334678899999999999999999888765        


Q ss_pred             cCCCeEEEEeeccc-cChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        225 KDKGSFYLVFEYMD-HDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       225 ~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                        ++.+||||||+. |+|++.+.. ....+...+.+.++.||++|++||+++++|||||...||||+++..+||+|||++
T Consensus       273 --~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  273 --QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             --CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccc
Confidence              447999999998 578888876 5667999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +...+.... ......-...|.|||++.... ++.+|||||||++||||+| |+.||
T Consensus       351 r~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py  405 (468)
T KOG0197|consen  351 RLIGDDEYT-ASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPY  405 (468)
T ss_pred             cccCCCcee-ecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCC
Confidence            955444322 122223367899999998655 9999999999999999998 78775

>KOG0599|consensus

Probab=100.00  E-value=3.2e-39  Score=263.41  Aligned_cols=199  Identities=30%  Similarity=0.488  Sum_probs=170.4

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCc------hhHHHHHHHHHhC-CCCcccchhhhhcccC
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFP------ITAVREIKILRQL-NHKNIVNLREIVTDKS  218 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  218 (358)
                      ..|.-.+.||.|..++|..+....+|..+|+|++..........      +...+|+.+|+++ .||+|+.+.++|+.  
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--   94 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--   94 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence            34556789999999999999999999999999997764332221      2345799999999 89999999888876  


Q ss_pred             cccccccCCCeEEEEeeccc-cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                              +..+++|+|.++ |.|.+.+. ....+++...+.+++|++.|++|||.++||||||||+|||++++.+++|+
T Consensus        95 --------~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   95 --------DAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             --------cchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEe
Confidence                    448999999998 56666664 44579999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCcccccccccccccc-----CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLL-----GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||+++.+..+...   ...+|||+|+|||.+.     +...|+..+|+|++|+++|.||.|++||
T Consensus       166 DFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF  228 (411)
T KOG0599|consen  166 DFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF  228 (411)
T ss_pred             ccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence            99999998877654   4556799999999874     3345888999999999999999999998

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.4e-38  Score=287.75  Aligned_cols=205  Identities=31%  Similarity=0.500  Sum_probs=171.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|.+.+.||.|+||.||++.+..+++.||||++............+.+|+.+++.++|+||+++++++.....     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~   75 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI-----DP   75 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc-----cc
Confidence            3678899999999999999999999999999986543332234567899999999999999999988875431     11


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ....|+||||+.+++...+.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus        76 ~~~~~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          76 FEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             cceEEEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            236899999999888777654 3478999999999999999999999999999999999999999999999999998654


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .... .......+++.|+|||.+.+...++.++||||+||++|+|++|++||
T Consensus       155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  205 (372)
T cd07853         155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF  205 (372)
T ss_pred             cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC
Confidence            3321 22234456889999999987666899999999999999999999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.6e-38  Score=287.53  Aligned_cols=205  Identities=30%  Similarity=0.515  Sum_probs=174.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+.+.||+|+||.||.+.+..+++.||||++............+.+|+.+++.++||||+++++++....    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~----   96 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK----   96 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccc----
Confidence            3467899999999999999999999999999999998765444444556788999999999999999998876532    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      .......+|+||||+++++...+..   .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus        97 ~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875          97 SLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            2233457899999999988877743   4788899999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.......   .....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       174 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf  225 (364)
T cd07875         174 RTAGTSFM---MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLF  225 (364)
T ss_pred             cccCCCCc---ccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCC
Confidence            86543321   23446799999999998655 899999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=283.35  Aligned_cols=192  Identities=28%  Similarity=0.363  Sum_probs=160.7

Q ss_pred             ccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEE
Q psy13988        154 LAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL  232 (358)
Q Consensus       154 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~l  232 (358)
                      ||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++..          .+..|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------~~~~~l   70 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS----------PEKLYL   70 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec----------CCeEEE
Confidence            7999999999999999999999999875432 22223456789999999999999999776654          558999


Q ss_pred             EeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCC
Q psy13988        233 VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR  312 (358)
Q Consensus       233 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~  312 (358)
                      ||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.......  
T Consensus        71 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  148 (312)
T cd05585          71 VLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--  148 (312)
T ss_pred             EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--
Confidence            999999755544434455799999999999999999999999999999999999999999999999999875432221  


Q ss_pred             CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf  193 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPF  193 (312)
T ss_pred             ccccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCc
Confidence            123446799999999998655 899999999999999999999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0032|consensus

Probab=100.00  E-value=3.2e-38  Score=283.25  Aligned_cols=203  Identities=33%  Similarity=0.486  Sum_probs=177.3

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCC-CCcccchhhhhccc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLN-HKNIVNLREIVTDK  217 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  217 (358)
                      ........|.+.+.||.|.||.||.+.++.+|+.+|+|.+........ ....+.+|+.+|+++. ||||+.++++|++ 
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-  107 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-  107 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-
Confidence            455677889999999999999999999999999999999987654332 3457789999999998 9999999888876 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC----C
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR----G  292 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~----~  292 (358)
                               ...+++|||++.| .|++.+...  .+++..+..++.|++.|++|||+.||+||||||+|+|+...    +
T Consensus       108 ---------~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~  176 (382)
T KOG0032|consen  108 ---------PDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSG  176 (382)
T ss_pred             ---------CCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCC
Confidence                     4489999999996 677777665  39999999999999999999999999999999999999654    4


Q ss_pred             cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       293 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .++++|||++......   ......+||+.|+|||++.... |+..+||||+|+++|.|++|.+||
T Consensus       177 ~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF  238 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPF  238 (382)
T ss_pred             cEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCC
Confidence            7999999999988762   3345678899999999998655 999999999999999999999998

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-38  Score=289.80  Aligned_cols=205  Identities=26%  Similarity=0.302  Sum_probs=168.9

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ......|.+++.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+    
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~----  114 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD----  114 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----
Confidence            34457899999999999999999999999999999998753221 1123346789999999999999999776654    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            ++.+|+||||++|+.+..+... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||
T Consensus       115 ------~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 ------DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             ------CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence                  5689999999987544444333 358899999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCC---CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEE---RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++......... ......||+.|+|||++.+..   .++.++|||||||++|+|++|++||
T Consensus       188 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf  247 (371)
T cd05622         188 TCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  247 (371)
T ss_pred             ceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence            99876433221 123456799999999986532   3788999999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-38  Score=287.18  Aligned_cols=205  Identities=31%  Similarity=0.526  Sum_probs=173.9

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|++++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----   89 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK----   89 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc----
Confidence            3557899999999999999999999999999999998765444444456778999999999999999998876532    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      ........|+||||+++++...+..   .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus        90 ~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          90 SLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            1223456899999999988877643   4788999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.......   .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       167 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf  218 (355)
T cd07874         167 RTAGTSFM---MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_pred             ccCCCccc---cCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            86543322   23446799999999997655 889999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-38  Score=283.92  Aligned_cols=204  Identities=30%  Similarity=0.525  Sum_probs=172.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+++.||.|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++....    .
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~   88 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT----S   88 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc----c
Confidence            456899999999999999999999999999999998755333333445778999999999999999999886532    1


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      .......|++++++++++...+..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          89 IENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             ccccCcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccce
Confidence            223356899999998877666543  368999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....     .....+++.|+|||++.+...++.++|||||||++|+|++|+.||
T Consensus       167 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  216 (343)
T cd07878         167 QADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF  216 (343)
T ss_pred             ecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence            65432     234467999999999987556899999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=283.96  Aligned_cols=202  Identities=25%  Similarity=0.349  Sum_probs=167.5

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|.+++.||+|+||.||++.+..+++.||+|++..... .......+.+|+.++..++|+||+++++++.+        
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--------   72 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--------   72 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--------
Confidence            368899999999999999999999999999999875322 22223456789999999999999999776654        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ++.+|+||||+.| +|.+.+......+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++.
T Consensus        73 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          73 --ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             --CCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence              5689999999986 5555555545678999999999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........ ......||+.|+|||++..    ...++.++||||+||++|+|++|+.||
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf  208 (331)
T cd05597         151 RLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF  208 (331)
T ss_pred             ecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCC
Confidence            65433221 1122457999999999863    234788999999999999999999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG1035|consensus

Probab=100.00  E-value=1.4e-38  Score=304.56  Aligned_cols=277  Identities=27%  Similarity=0.362  Sum_probs=205.3

Q ss_pred             hHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCCCCCCCCCCCCchhhHHHHHHhhhcccCCCccccccccccccCCCCC
Q psy13988         66 GALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNN  145 (358)
Q Consensus        66 ~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (358)
                      ...|++.+|+.-++++|+++.+++.|+|.+...... .....+    ...    ...+............ .....+...
T Consensus       409 ~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~-~~~~~~----~~~----~~~~~~~~r~~~~~s~-~~r~~SRY~  478 (1351)
T KOG1035|consen  409 ELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNE-SSEFAP----NDE----TSVPQFRLRFSGAMSP-LQRQFSRYL  478 (1351)
T ss_pred             hhhhhhhhhcchhhhhccchhhhhhchhcccccccc-cccccC----ccc----cccCccCCCCccccCc-cccchhhHh
Confidence            578899999999999999999999999997521111 111111    000    0011111111111100 011113345


Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc-----
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA-----  220 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-----  220 (358)
                      .+|..++.||+||||.||+++++.+|+.||||++.... .......+.+|+..+.+|+|||||+++..+......     
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            56678899999999999999999999999999999876 444556788999999999999999999755442210     


Q ss_pred             -------------------------------------------cccc--------------------cC-----------
Q psy13988        221 -------------------------------------------LDFR--------------------KD-----------  226 (358)
Q Consensus       221 -------------------------------------------~~~~--------------------~~-----------  226 (358)
                                                                 ....                    ++           
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                       0000                    00           


Q ss_pred             ----------------------C--------CeEEEEeeccccChHHHHhcCCCCC-ChHHHHHHHHHHHHHHHHHHhCC
Q psy13988        227 ----------------------K--------GSFYLVFEYMDHDLMGLLESGMVDF-NEVNNASIMRQLLDGLSYCHKRN  275 (358)
Q Consensus       227 ----------------------~--------~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~qi~~al~~LH~~~  275 (358)
                                            .        -.+||-||||+..+++.+.+.+... ....+++++++|++||.|+|+.|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                  1        4579999999999999887766554 57788999999999999999999


Q ss_pred             ceecCCCCCCEEecCCCcEEEeecccceecc----------------ccCCCCCCCCccccccccccccccCCC--CCCC
Q psy13988        276 FLHRDIKCSNILMNNRGEVKLADFGLARLYN----------------AEDRQRPYTNKVITLWYRPPELLLGEE--RYGP  337 (358)
Q Consensus       276 i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~  337 (358)
                      |+||||||.|||+++++.+||+|||+++...                .+......++.+||..|+|||++.+..  .|+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999998721                011222446778999999999998776  6999


Q ss_pred             cchHHHHHHHHHHHhh
Q psy13988        338 AIDVWSCGCILGELFV  353 (358)
Q Consensus       338 ~~DiwslG~~l~~llt  353 (358)
                      |+||||||+|++||+.
T Consensus       798 KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             hhhhHHHHHHHHHHhc
Confidence            9999999999999985

>KOG0580|consensus

Probab=100.00  E-value=7.4e-39  Score=256.51  Aligned_cols=200  Identities=32%  Similarity=0.468  Sum_probs=173.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...++.+.+.||+|.||.||+++...++-.||+|++.++.- ......++.+|+++-+.|+||||++++++|-+      
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd------   93 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD------   93 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec------
Confidence            34568899999999999999999999999999999876542 23334567889999999999999999888766      


Q ss_pred             cccCCCeEEEEeeccc-cChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMD-HDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                          ....|+++||.. |+++..+.. ...++++..+..+++|++.|+.|+|.++++||||||+|+|++.++.+|++|||
T Consensus        94 ----~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   94 ----SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             ----cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence                558999999998 567777764 44569999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      -+...+ ....   ...+||..|.+||...+.. ++..+|+|++|++.||+|.|.+||
T Consensus       170 wsV~~p-~~kR---~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppF  222 (281)
T KOG0580|consen  170 WSVHAP-SNKR---KTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPF  222 (281)
T ss_pred             ceeecC-CCCc---eeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCch
Confidence            887654 2222   3456799999999998776 899999999999999999999998

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.7e-38  Score=282.28  Aligned_cols=199  Identities=22%  Similarity=0.343  Sum_probs=163.4

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCC-cccchhhhhcccCcccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHK-NIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  224 (358)
                      +|.+++.||+|+||.||++.+..+++.||||++..... .......+..|..++..+.|+ +|+++++++..        
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--------   72 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--------   72 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--------
Confidence            47889999999999999999999999999999876432 222334567899999999765 57778666654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        .+.+|+||||++|+.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus        73 --~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          73 --MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             --CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence              558999999998755544444445789999999999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  .......||+.|+|||++.+.. ++.++||||+||++|+|+||+.||
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf  201 (324)
T cd05587         151 NIFGG--KTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPF  201 (324)
T ss_pred             cCCCC--CceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCC
Confidence            32221  1123345799999999998655 889999999999999999999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.5e-38  Score=288.62  Aligned_cols=204  Identities=25%  Similarity=0.318  Sum_probs=168.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....|.+.+.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+     
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-----  114 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-----  114 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            3456899999999999999999999999999999998754322 1223346789999999999999999766654     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           +..+|+||||++|+.+..+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+
T Consensus       115 -----~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         115 -----DKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             -----CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence                 5689999999987544444333 3588999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCC---CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGE---ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +........ .......||+.|+|||++.+.   ..++.++|||||||++|+|++|++||
T Consensus       189 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf  247 (370)
T cd05596         189 CMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  247 (370)
T ss_pred             eeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence            987643322 122345679999999998653   23788999999999999999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.2e-38  Score=280.87  Aligned_cols=194  Identities=23%  Similarity=0.383  Sum_probs=159.4

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||||.++..... .........|..++... +||||+++++++..          ++.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----------~~~   70 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT----------KEH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc----------CCE
Confidence            4699999999999999999999999999765321 22233445677776654 89999999776654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||++|+.+.........+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          71 LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            99999999876555544445579999999999999999999999999999999999999999999999999997643322


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf  196 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             --CccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCC
Confidence              1223446799999999987655 889999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0193|consensus

Probab=100.00  E-value=1.5e-38  Score=285.08  Aligned_cols=207  Identities=20%  Similarity=0.316  Sum_probs=174.5

Q ss_pred             cccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       138 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ....+...+...+.+.||.|+||+||++..   --.||||+++.+.......+.|+.|+.++++-+|.||+-+.+++..+
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            345556666677889999999999999986   35799999999887777788899999999999999999999999875


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                      .           +.||+.+|+| +|+..+....-.+.-...+.|++||++|+.|||.++|+|+|||..|||+.+++.+||
T Consensus       461 ~-----------~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkI  529 (678)
T KOG0193|consen  461 P-----------LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKI  529 (678)
T ss_pred             c-----------eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEE
Confidence            4           4899999999 566666555667899999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCC--CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++..-..-..........+...|||||+++..  ..|+..+||||||+++|||+||..||
T Consensus       530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy  593 (678)
T KOG0193|consen  530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY  593 (678)
T ss_pred             ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence            999998754322222222334457889999998643  35899999999999999999999997

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-37  Score=274.28  Aligned_cols=200  Identities=44%  Similarity=0.741  Sum_probs=173.7

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|++|.||++.+..+|+.||+|.+............+.+|+.+++.++|+||+++++++.+          
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----------   70 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS----------   70 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc----------
Confidence            4888999999999999999999999999999997665444445567889999999999999999888765          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ....++|+||+++++...+......+++..++.++.||++||.|||+.+++|+||||+||+++.++.++|+|||++....
T Consensus        71 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          71 DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             CCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            45799999999999988887666779999999999999999999999999999999999999999999999999988654


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...  .......+++.|+|||.+.+...++.++||||||+++|+|+||..||
T Consensus       151 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~  200 (284)
T cd07839         151 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  200 (284)
T ss_pred             CCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence            322  22234456889999999877666789999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.7e-38  Score=284.01  Aligned_cols=201  Identities=24%  Similarity=0.321  Sum_probs=164.5

Q ss_pred             CCcccccccCCcceeeEeeeee---cCCcEEEEEEeecccc--CCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENE--KEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  220 (358)
                      +|.+++.||+|+||.||++.+.   .+++.||+|++.....  .......+.+|+.+++.+ +|+||+++++++..    
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----   76 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT----   76 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence            4789999999999999998864   5789999999875432  122234567899999999 58999999766654    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            ++.+++||||+.++.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||
T Consensus        77 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          77 ------EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             ------CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCc
Confidence                  56899999999975444333344578999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++......... ......||+.|+|||++.+...++.++|||||||++|+|+||+.||
T Consensus       151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf  207 (332)
T cd05614         151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF  207 (332)
T ss_pred             CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCC
Confidence            98865433222 1223467999999999986655788999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-37  Score=274.80  Aligned_cols=203  Identities=38%  Similarity=0.694  Sum_probs=169.0

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC---CCCcccchhhhhcccCccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL---NHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~  223 (358)
                      +|.+++.||+|++|.||++.+..+++.||+|.+..............+|+.+++.+   +||||+++++++....     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~-----   75 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR-----   75 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc-----
Confidence            58899999999999999999999999999999876544443344566777777665   7999999998876422     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      .......++|||++.+++...+... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          76 TDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             CCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            1234578999999999888777543 335899999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........   .....+++.|+|||++.+.. ++.++||||+||++|+|++|++||
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f  207 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLF  207 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCc
Confidence            87643322   22345688999999987655 899999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.9e-38  Score=281.49  Aligned_cols=199  Identities=21%  Similarity=0.323  Sum_probs=163.2

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      +|.+++.||+|+||.||++.+..+++.||||.+...... .........|..++..+ +|++|+++++++..        
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--------   72 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--------   72 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--------
Confidence            478899999999999999999999999999998865322 22223456678888777 57889988766654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        .+.+|+||||++++.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..
T Consensus        73 --~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          73 --MDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             --CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence              558999999998754444434445789999999999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......||+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf  201 (323)
T cd05616         151 NMWDGV--TTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPF  201 (323)
T ss_pred             cCCCCC--ccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCC
Confidence            432211  123446799999999998655 899999999999999999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0662|consensus

Probab=100.00  E-value=3.5e-38  Score=242.44  Aligned_cols=200  Identities=45%  Similarity=0.776  Sum_probs=182.2

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|.-.+.||+|.+|+|++++...+++.||+|++..+...+......++|+-+++.++|.|||+++++.-.          
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs----------   72 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----------   72 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc----------
Confidence            4666789999999999999999999999999999999888899999999999999999999999887754          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      +..+-+|+|||+.++...+.+-++.++.+.++.++.|+++||.++|+.+++|||+||.|.++..+|++|+.|||+++.++
T Consensus        73 dkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   73 DKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             CceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            56899999999999999998888899999999999999999999999999999999999999999999999999999775


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      -+.  ..+...+.|..|.+|.++-+.+-|+...|+||-||++.|+.. |++.|
T Consensus       153 ipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf  203 (292)
T KOG0662|consen  153 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_pred             Cce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence            443  344556679999999999998889999999999999999985 66655

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=293.26  Aligned_cols=215  Identities=26%  Similarity=0.315  Sum_probs=174.8

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ......+|.+.+.||+|+||.||++.+..+++.||||++............+.+|+..+..++|+||++++..+..... 
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~-  105 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP-  105 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc-
Confidence            3345679999999999999999999999999999999997664443334567789999999999999998877654321 


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                       ........+++||||+.+ +|.+.+..   ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|
T Consensus       106 -~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        106 -RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             -cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence             011112357899999986 55555543   2346899999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||+++.+.............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf  245 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPF  245 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999998765433222233456799999999998655 899999999999999999999998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.8e-38  Score=283.50  Aligned_cols=204  Identities=25%  Similarity=0.353  Sum_probs=161.9

Q ss_pred             CCCCCcccccccCCcceeeEeeee-----ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVS-----LFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      ...+|++.+.||.|+||.||++.+     ..+++.||||++.... .......+.+|+.++..+ +||||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            346799999999999999999975     3445789999987432 222334678999999999 899999998876542


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcC------------------------------------------------
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESG------------------------------------------------  248 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------------------------------------------------  248 (358)
                               ++.+++||||+++ +|.+.+...                                                
T Consensus        84 ---------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (338)
T cd05102          84 ---------NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTS  154 (338)
T ss_pred             ---------CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccC
Confidence                     3468999999986 454444321                                                


Q ss_pred             -------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCC
Q psy13988        249 -------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYT  315 (358)
Q Consensus       249 -------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~  315 (358)
                                   ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++............
T Consensus       155 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~  234 (338)
T cd05102         155 GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  234 (338)
T ss_pred             cccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhccc
Confidence                         1236778889999999999999999999999999999999999999999999998654332222222


Q ss_pred             CccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        316 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       316 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ...+++.|+|||++.+.. ++.++||||||+++|+|++ |..||
T Consensus       235 ~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf  277 (338)
T cd05102         235 SARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPY  277 (338)
T ss_pred             CCCCCccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCC
Confidence            334467899999987654 8999999999999999997 99987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.3e-38  Score=283.95  Aligned_cols=202  Identities=24%  Similarity=0.335  Sum_probs=167.3

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|.+++.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.++..++|+||+++++++.+        
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--------   72 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--------   72 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--------
Confidence            368899999999999999999999999999999875321 12223346788999999999999999776654        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ++..|+||||+.| +|...+......+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus        73 --~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          73 --ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEecccee
Confidence              5689999999987 4555555545678999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCC----CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........ ......|++.|+|||++.+.    ..++.++||||||+++|+|++|+.||
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf  208 (331)
T cd05624         151 KMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF  208 (331)
T ss_pred             eccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCc
Confidence            76433221 11234579999999988642    34788999999999999999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.9e-38  Score=283.71  Aligned_cols=194  Identities=22%  Similarity=0.327  Sum_probs=161.8

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF  230 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~  230 (358)
                      +.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++..          ++..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~----------~~~~   70 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----------HDRL   70 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc----------CCEE
Confidence            4689999999999999999999999999765322 2223456789999999999999999766654          5589


Q ss_pred             EEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       231 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      |+||||++++.+.........+++..+..++.||+.||+|||+ .||+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          71 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence            9999999986555554455579999999999999999999997 799999999999999999999999999987543221


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf  196 (325)
T cd05594         151 A--TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  196 (325)
T ss_pred             c--ccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCC
Confidence            1  122345799999999987654 899999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-38  Score=280.60  Aligned_cols=195  Identities=26%  Similarity=0.360  Sum_probs=160.6

Q ss_pred             cccccCCcceeeEeeeee---cCCcEEEEEEeecccc--CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        151 MEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENE--KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ++.||+|+||.||++.+.   .+++.||+|.+.....  .......+..|+.+++.++||||+++++++..         
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~---------   71 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT---------   71 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec---------
Confidence            368999999999999874   5789999999875432  11223456789999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++.+|+||||+.++.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus        72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          72 -GGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             -CCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence             5589999999998555544444557889999999999999999999999999999999999999999999999998754


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf  200 (323)
T cd05584         151 IHEGT--VTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPF  200 (323)
T ss_pred             ccCCC--cccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCC
Confidence            32221  122345799999999987655 789999999999999999999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.2e-38  Score=281.07  Aligned_cols=197  Identities=24%  Similarity=0.287  Sum_probs=161.7

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHH---HhCCCCcccchhhhhcccCccccc
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKIL---RQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      |++++.||+|++|.||++.+..+++.||||+++..... ......+.+|+.++   +.++||||+++++++.+       
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-------   73 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-------   73 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-------
Confidence            67889999999999999999999999999999754321 22234556666555   45689999999877654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         .+..|+||||++|+.+...... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus        74 ---~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          74 ---EDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             ---CCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence               5589999999998655544433 468999999999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  .......|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||
T Consensus       150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf  201 (324)
T cd05589         150 EGMGFG--DRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPF  201 (324)
T ss_pred             cCCCCC--CcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCC
Confidence            533221  1123456799999999987654 889999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.8e-38  Score=285.81  Aligned_cols=202  Identities=28%  Similarity=0.335  Sum_probs=168.7

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..|.+.+.||+|+||.||++.+..+++.||+|+++.... .......+.+|+.+++.++|+||+++++++.+        
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--------   72 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--------   72 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--------
Confidence            368899999999999999999999999999999986543 22233456789999999999999999776654        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ....|+||||+++ +|.+.+......+++..+..++.||+.||+|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus        73 --~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          73 --KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             --CCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence              5589999999986 5555555544679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccC-----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLG-----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........ ......+|+.|+|||++..     ...++.++|||||||++|+|++|+.||
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf  209 (330)
T cd05601         151 RLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF  209 (330)
T ss_pred             ECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCC
Confidence            76543222 1223457999999999863     334788999999999999999999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG1187|consensus

Probab=100.00  E-value=6.2e-38  Score=281.05  Aligned_cols=194  Identities=28%  Similarity=0.383  Sum_probs=160.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|.-...||+|+||.||++... ++..||||++.......  ..+|..|+.++.+++|||+|++++||.+          
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e----------  142 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLE----------  142 (361)
T ss_pred             CCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEec----------
Confidence            3444468999999999999864 44999999887654432  3459999999999999999999888775          


Q ss_pred             CC-eEEEEeecccc-ChHHHHhcCCC-CCChHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEecCCCcEEEeecc
Q psy13988        227 KG-SFYLVFEYMDH-DLMGLLESGMV-DFNEVNNASIMRQLLDGLSYCHKRN---FLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       227 ~~-~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~---i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                      .+ ..++|+||+.+ +|.+.+..... +++|..+.+|+.++|+||+|||...   |+|||||+.|||+|++.++||+|||
T Consensus       143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG  222 (361)
T KOG1187|consen  143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG  222 (361)
T ss_pred             CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence            34 58999999995 66666655554 8999999999999999999999854   9999999999999999999999999


Q ss_pred             cceeccc-cCCCCCCCCc-cccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        301 LARLYNA-EDRQRPYTNK-VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       301 ~~~~~~~-~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      +|+.... ....   ... .||.+|++||.+.. +..+.++||||||++++||+||+.+
T Consensus       223 La~~~~~~~~~~---~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~  277 (361)
T KOG1187|consen  223 LAKLGPEGDTSV---STTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKA  277 (361)
T ss_pred             CcccCCccccce---eeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcc
Confidence            9965543 2111   111 67999999998875 4489999999999999999999975

>KOG0666|consensus

Probab=100.00  E-value=2.4e-38  Score=262.67  Aligned_cols=204  Identities=37%  Similarity=0.642  Sum_probs=179.4

Q ss_pred             CCCcccccccCCcceeeEeeeeecCC----cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTD----ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..|+++..||+|.||.||++....+.    ..+|||+++.+..........-+|+.+++.++|||++.+..++..     
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~-----   98 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS-----   98 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc-----
Confidence            46888999999999999999665443    379999999887777777888999999999999999999998875     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhc----CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC----Cc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLES----GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR----GE  293 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~----~~  293 (358)
                          .++.+++++||.+.+|+..+..    ....++...+.+++.||+.|+.|||++=|+||||||.|||+..+    |.
T Consensus        99 ----~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   99 ----HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             ----cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCe
Confidence                2568999999999999998743    22468999999999999999999999999999999999999887    89


Q ss_pred             EEEeecccceeccccCCCC-CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        294 VKLADFGLARLYNAEDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       294 ~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +||+|||+++.+.+.-... .....+.|..|+|||.+.+...|+.+.|||++|||+.||||-.+.|
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF  240 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF  240 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence            9999999999987665443 4455667999999999999999999999999999999999999887

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.4e-38  Score=281.33  Aligned_cols=194  Identities=23%  Similarity=0.345  Sum_probs=161.2

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||+|++....... .....+.+|+.++.++ +||||+++++++..          ++.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~----------~~~   70 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----------ESR   70 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe----------CCE
Confidence            46999999999999999999999999998653222 2234566788888777 89999999877655          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      .|+||||+.++.+.........+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+++......
T Consensus        71 ~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          71 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            99999999976555444445579999999999999999999999999999999999999999999999999987532221


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .  ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf  196 (329)
T cd05618         151 D--TTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF  196 (329)
T ss_pred             C--ccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCC
Confidence            1  123456799999999998655 889999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-37  Score=279.38  Aligned_cols=194  Identities=22%  Similarity=0.342  Sum_probs=160.8

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||||++..... .......+..|..++..+ +||||+++++++..          .+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~----------~~~   70 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT----------PDR   70 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc----------CCE
Confidence            468999999999999999999999999875432 222334566788888876 79999999777654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||++++.+.........+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          71 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            99999999975555444444579999999999999999999999999999999999999999999999999987543222


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf  196 (320)
T cd05590         151 K--TTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPF  196 (320)
T ss_pred             C--cccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCC
Confidence            1  123446799999999987654 889999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.2e-38  Score=280.33  Aligned_cols=194  Identities=25%  Similarity=0.359  Sum_probs=160.5

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||||++...... ......+..|..++..+ +||||+++++++..          ++.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~----------~~~   70 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT----------KDR   70 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----------CCe
Confidence            4699999999999999999999999998764321 22234566788888866 89999999777754          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||++++.+.........+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          71 LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            99999999975554443444578999999999999999999999999999999999999999999999999987543222


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .  ......|++.|+|||++.+.. ++.++||||||+++|+|++|++||
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf  196 (321)
T cd05591         151 V--TTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPF  196 (321)
T ss_pred             c--cccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCC
Confidence            1  123446799999999987654 889999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-37  Score=277.16  Aligned_cols=196  Identities=36%  Similarity=0.655  Sum_probs=162.0

Q ss_pred             cccccCCcceeeEeeeee--cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCC
Q psy13988        151 MEPLAAGGLSLNNFSVSL--FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      ...||+|+||.||++.+.  .+++.||+|.+....    ......+|+.+++.++||||+++++++....        +.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~   73 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA--------DR   73 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCC--------Cc
Confidence            468999999999999965  467899999886432    2345678999999999999999988876532        45


Q ss_pred             eEEEEeeccccChHHHHhcC--------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCCCcEEE
Q psy13988        229 SFYLVFEYMDHDLMGLLESG--------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM----NNRGEVKL  296 (358)
Q Consensus       229 ~~~lv~e~~~~~l~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill----~~~~~~~l  296 (358)
                      .+|+||||+++++...+...        ...+++..++.++.||+.||.|||++||+||||||+||++    +.++.+||
T Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07868          74 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence            78999999999887766421        2358899999999999999999999999999999999999    45578999


Q ss_pred             eecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++......... .......+|+.|+|||++.+...++.++||||+||++|+|++|++||
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f  216 (317)
T cd07868         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  216 (317)
T ss_pred             eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence            999999876543221 22234567999999999987666899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0690|consensus

Probab=100.00  E-value=9.7e-39  Score=266.58  Aligned_cols=202  Identities=23%  Similarity=0.330  Sum_probs=173.5

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....|..+++||+|.||.|.+++.+.+++.||||+++++.- ........+.|-++|+..+||.+..+.-.|+.      
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt------  239 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT------  239 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc------
Confidence            44567789999999999999999999999999999987632 23334566789999999999999998766655      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ++++|+||||..|+.+-...++...+++..++-+...|+.||.|||+++||+||||.+|.|+|.+|++||.|||++
T Consensus       240 ----~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  240 ----QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             ----CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccc
Confidence                5689999999998766555555667999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.--..  ......++|||.|+|||++.... |..++|+|.+|+++|||+||+.||
T Consensus       316 KE~I~~--g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPF  368 (516)
T KOG0690|consen  316 KEEIKY--GDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPF  368 (516)
T ss_pred             hhcccc--cceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcc
Confidence            853221  22345678899999999998765 999999999999999999999998

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.7e-38  Score=280.98  Aligned_cols=194  Identities=21%  Similarity=0.321  Sum_probs=161.0

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||+|+++...... .....+.+|..+++.+ +||||+++++++.+          .+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~----------~~~   70 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT----------ESR   70 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc----------CCE
Confidence            46899999999999999999999999998653222 2234567899999888 79999999777654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||++|+.+.........+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          71 LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            99999999875444443344579999999999999999999999999999999999999999999999999987432111


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        .......||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf  196 (329)
T cd05588         151 --DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF  196 (329)
T ss_pred             --CccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCc
Confidence              1223456799999999998655 889999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG4250|consensus

Probab=100.00  E-value=4.5e-38  Score=286.92  Aligned_cols=208  Identities=30%  Similarity=0.354  Sum_probs=173.2

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..+..|..-+.||+|+||.||+++++.+|+.||||.++... ...-.+...+|++++++++|+|||+++++-....  . 
T Consensus        10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~--~-   85 (732)
T KOG4250|consen   10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKF--L-   85 (732)
T ss_pred             CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccc--c-
Confidence            34456667789999999999999999999999999998754 2333456679999999999999999988766532  1 


Q ss_pred             cccCCCeEEEEeeccccChHH-HHhc--CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC--CC--cEE
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMG-LLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN--RG--EVK  295 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~-~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~--~~--~~~  295 (358)
                       .-..+...+|||||.|+.+. .+.+  +-..+++.+.+.++.++..||.|||++||+||||||+||++..  +|  ..|
T Consensus        86 -~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   86 -GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             -CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEe
Confidence             12345678999999975554 4432  3345999999999999999999999999999999999999843  34  479


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||.|+....+.   ...+..||..|.+||.+...+.|+..+|.|||||++|+..||..||
T Consensus       165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF  224 (732)
T KOG4250|consen  165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPF  224 (732)
T ss_pred             eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCC
Confidence            99999999887665   4567788999999999986567999999999999999999999998

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-37  Score=279.10  Aligned_cols=199  Identities=22%  Similarity=0.357  Sum_probs=162.6

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCcccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  224 (358)
                      +|.+.+.||+|+||.||++.+..+++.||+|++..... .......+..|..++..+. |++|+++++++.+        
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--------   72 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--------   72 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--------
Confidence            36778999999999999999999999999999876432 1222345667888888885 5677778666554        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        .+.+|+||||++|+.+.........+++.++..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..
T Consensus        73 --~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          73 --VDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             --CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence              458999999998755554444455799999999999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......||+.|+|||++.+.. ++.++||||+||++|+|++|++||
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf  201 (323)
T cd05615         151 HMVDGV--TTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPF  201 (323)
T ss_pred             cCCCCc--cccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCC
Confidence            432211  122345799999999987654 889999999999999999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.8e-38  Score=280.32  Aligned_cols=194  Identities=22%  Similarity=0.321  Sum_probs=157.7

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHH-HHHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREI-KILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||+|++...... ......+..|. .+++.++||||+++++++..          ++.
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~----------~~~   70 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----------ADK   70 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc----------CCe
Confidence            4699999999999999999999999998754321 11122334444 35678899999999776654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||+.++.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          71 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            99999999986555554445578899999999999999999999999999999999999999999999999987542221


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf  196 (325)
T cd05602         151 --GTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPF  196 (325)
T ss_pred             --CCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCC
Confidence              1223456799999999988654 889999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.4e-37  Score=274.00  Aligned_cols=201  Identities=46%  Similarity=0.804  Sum_probs=172.3

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ...|.+++.||.|++|.||++.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++..        
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--------   75 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--------   75 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--------
Confidence            45789999999999999999999999999999998754322 223456789999999999999999877654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        .+..++||||+++++...+......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        76 --~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          76 --EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             --CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence              558999999999988888876666789999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......+++.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       154 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f  205 (301)
T cd07873         154 KSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF  205 (301)
T ss_pred             cCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC
Confidence            533221  2233456889999999876656888999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.4e-38  Score=280.19  Aligned_cols=194  Identities=22%  Similarity=0.336  Sum_probs=158.3

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHH-HHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIK-ILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||||++...... ......+..|.. +++.++||||+++++++.+          ...
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~----------~~~   70 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----------ADK   70 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe----------CCE
Confidence            4689999999999999999999999998754322 112233445544 5678899999999776654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      .|+||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          71 LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            99999999986555444445679999999999999999999999999999999999999999999999999987532221


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf  196 (323)
T cd05575         151 --KTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPF  196 (323)
T ss_pred             --CccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCC
Confidence              1223446799999999987655 889999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.3e-37  Score=271.18  Aligned_cols=200  Identities=43%  Similarity=0.771  Sum_probs=171.0

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|++++.||.|++|.||++.+..++..||+|.+............+.+|+.+++.++||||+++++++.+          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------   70 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ----------   70 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee----------
Confidence            4788999999999999999999999999999987654444444567889999999999999999877754          


Q ss_pred             CCeEEEEeeccccChHHHHhcC--CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESG--MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ++.+|+||||+.+++.+.+...  ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        71 ~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          71 ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             CCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence            5589999999998887776542  25689999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  .......+++.|+|||++.+...++.++||||||+++|+|+||++||
T Consensus       151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~  202 (285)
T cd07861         151 FGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF  202 (285)
T ss_pred             cCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCC
Confidence            54332  22234456889999999876666788999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.8e-38  Score=279.90  Aligned_cols=194  Identities=23%  Similarity=0.324  Sum_probs=157.9

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHH-HHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIK-ILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||+|++...... ......+..|.. +++.++||||+++++++.+          .+.
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~----------~~~   70 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT----------AEK   70 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc----------CCE
Confidence            4699999999999999999999999998754321 112234445554 6788899999999766654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      .|+||||++|+.+.........+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          71 LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            99999999975554444445578999999999999999999999999999999999999999999999999987532221


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        .......+++.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf  196 (321)
T cd05603         151 --ETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPF  196 (321)
T ss_pred             --CccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCC
Confidence              1123446799999999987654 889999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-37  Score=280.50  Aligned_cols=201  Identities=25%  Similarity=0.343  Sum_probs=166.8

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      +|.+++.||+|+||.||++.+..+++.||+|++..... .......+.+|+.++..++|+||+++++++.+         
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---------   72 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD---------   72 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec---------
Confidence            68899999999999999999999999999999865322 12223346789999999999999999776654         


Q ss_pred             CCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                       ...+|+||||+.+ +|.+.+......+++..++.++.||+.||+|||+.+|+||||||+||+++.++.++|+|||++..
T Consensus        73 -~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          73 -ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             -CCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence             5589999999986 56666655456789999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...... .......||+.|+|||++..    ...++.++|||||||++|+|++|+.||
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf  208 (332)
T cd05623         152 LMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF  208 (332)
T ss_pred             cccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCC
Confidence            533221 11223467999999999862    344788999999999999999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.6e-37  Score=277.31  Aligned_cols=199  Identities=27%  Similarity=0.359  Sum_probs=169.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+++.||+|+||.||++.+..++..||+|.+..... ......+.+|+++++.++||||+++++++..       
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------   74 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------   74 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-------
Confidence            35689999999999999999999999999999999875422 2233467899999999999999999877654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         ++..++||||++++.+..+......+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++
T Consensus        75 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  151 (331)
T cd06649          75 ---DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (331)
T ss_pred             ---CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence               558999999999855555544455789999999999999999999986 6999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......    .....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       152 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~  202 (331)
T cd06649         152 GQLIDSM----ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPI  202 (331)
T ss_pred             ccccccc----cccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence            7654322    22345799999999988655 899999999999999999999997

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-37  Score=290.78  Aligned_cols=201  Identities=26%  Similarity=0.342  Sum_probs=167.6

Q ss_pred             CCCCcccccccCCcceeeEeeeeecC-CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFT-DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...|.+.+.||+|++|.||++.+..+ +..||+|.+.....  .....+.+|+.+++.++||||+++++++..       
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-------  136 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--RQAAYARSELHCLAACDHFGIVKHFDDFKS-------  136 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-------
Confidence            44599999999999999999998877 78899997654322  223456779999999999999999777654       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                         ++.+|+||||++| +|.+.+.   ....++++..+..++.||+.||+|||+.+|+||||||+||+++.++.++|+||
T Consensus       137 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DF  213 (478)
T PTZ00267        137 ---DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDF  213 (478)
T ss_pred             ---CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeC
Confidence               5689999999986 4544443   23456899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+++...............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf  271 (478)
T PTZ00267        214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPF  271 (478)
T ss_pred             cCceecCCccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCC
Confidence            9998765443322334456899999999987654 899999999999999999999997

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.5e-38  Score=280.41  Aligned_cols=194  Identities=22%  Similarity=0.326  Sum_probs=158.4

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHH-HHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIK-ILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||+|++...... ......+..|.. +++.++||||+++++++..          .+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~----------~~~   70 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----------TEK   70 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec----------CCE
Confidence            4689999999999999999999999998754321 112234445554 5677899999999766654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      .|+||||+.|+.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          71 LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            99999999986555444455679999999999999999999999999999999999999999999999999987532221


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        .......|++.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf  196 (325)
T cd05604         151 --DTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPF  196 (325)
T ss_pred             --CCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCC
Confidence              1223446799999999987655 889999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.4e-37  Score=276.58  Aligned_cols=194  Identities=21%  Similarity=0.324  Sum_probs=158.8

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||+|.++..... .........|..++... +||||+++++++.+          ++.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----------~~~   70 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT----------KEH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe----------CCE
Confidence            4699999999999999999999999999764321 12233456677777754 89999999776654          568


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||+.++.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          71 LFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             EEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            99999999875444443444578999999999999999999999999999999999999999999999999987432211


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf  196 (316)
T cd05620         151 --NRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             --CceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCC
Confidence              1223456799999999998655 899999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-37  Score=282.95  Aligned_cols=197  Identities=27%  Similarity=0.350  Sum_probs=168.2

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee--cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL--FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ....+|.+++.||.|++|.||++...  .+++.||+|.+...       ....+|+.+++.++||||+++++++..    
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~----  157 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW----  157 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee----
Confidence            34568999999999999999999753  45688999987642       134689999999999999999776654    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            +...|+|||++.+++...+ .....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||
T Consensus       158 ------~~~~~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        158 ------KSTVCMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             ------CCEEEEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCc
Confidence                  5589999999999888887 344579999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++................||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf  287 (392)
T PHA03207        231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTL  287 (392)
T ss_pred             cccccCcccccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCC
Confidence            998765443333334556899999999987655 889999999999999999999997

>KOG0596|consensus

Probab=100.00  E-value=5.7e-38  Score=278.29  Aligned_cols=204  Identities=27%  Similarity=0.370  Sum_probs=175.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ..+..|.+++.||.||.+.||++.. .+...||+|++...........-+..|+..|.+| .|.+|+++++|-.      
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv------  430 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV------  430 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec------
Confidence            4678899999999999999999996 4456778887777766666677889999999999 6899999966544      


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          .++.+|+|||+-+.+|-..+......++.-.++.+..||+.|+.++|+.||||.||||.|+++- +|.+||+|||+
T Consensus       431 ----~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGI  505 (677)
T KOG0596|consen  431 ----TDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGI  505 (677)
T ss_pred             ----cCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeech
Confidence                4779999999999999999987666566557888999999999999999999999999999985 58999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCC----------CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEE----------RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |..+......-.....+||+.|||||.+....          ..++++||||||||+|+|+.|++||
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf  572 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF  572 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence            99887776665667889999999999985332          2567999999999999999999998

>KOG0607|consensus

Probab=100.00  E-value=1.3e-37  Score=259.14  Aligned_cols=202  Identities=28%  Similarity=0.396  Sum_probs=166.0

Q ss_pred             CCCCCccc-ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLM-EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ...-|++. +.||+|+++.|-.+....+|..||||++.+..  .....++.+|++++.++ .|+||+.++++|++     
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-----  147 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFED-----  147 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-----
Confidence            33445543 68999999999999999999999999998763  33456789999999999 79999999666655     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~~l~  297 (358)
                           +..+|+|||-+.| .++..+. ....+++.++.++.++|+.||+|||.+||.|||+||+|||.....   .+|||
T Consensus       148 -----d~~FYLVfEKm~GGplLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  148 -----DTRFYLVFEKMRGGPLLSHIQ-KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             -----cceEEEEEecccCchHHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeee
Confidence                 6689999999997 4666554 445799999999999999999999999999999999999997655   58999


Q ss_pred             ecccceeccccCC-----CCCCCCcccccccccccccc---C-CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDR-----QRPYTNKVITLWYRPPELLL---G-EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~---~-~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||.++.-+.....     .......+|+..|||||+..   + ...|+.++|.||||+|+|.||+|.+||
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF  291 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF  291 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence            9998765432221     22334567899999999863   2 235889999999999999999999998

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-37  Score=284.96  Aligned_cols=195  Identities=26%  Similarity=0.351  Sum_probs=168.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+..|.+.+.||.|+||.||++.+..+++.||||....        ....+|++++++++|+||+++++++..       
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~-------  231 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV-------  231 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE-------
Confidence            46689999999999999999999999999999995331        245689999999999999999776654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ++..++|||++.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus       232 ---~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~  308 (461)
T PHA03211        232 ---GGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC  308 (461)
T ss_pred             ---CCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence               56889999999999988887666679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      ...............||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus       309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~  361 (461)
T PHA03211        309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTAS  361 (461)
T ss_pred             ecccccccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCC
Confidence            764432222223456799999999997655 89999999999999999998754

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-38  Score=280.82  Aligned_cols=194  Identities=25%  Similarity=0.357  Sum_probs=161.3

Q ss_pred             cccccCCcceeeEeeeee---cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        151 MEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      ++.||+|+||.||++.+.   .+++.||+|++............+.+|++++++++||||+++++++.+          +
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------~   70 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT----------E   70 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc----------C
Confidence            367999999999999873   578999999998654333334456789999999999999999776654          5


Q ss_pred             CeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        228 GSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       228 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      +..|+||||++++ +.+.+ .....+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        71 ~~~~lv~e~~~~~~L~~~l-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          71 GKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             CEEEEEEcCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            6899999999864 54444 444578999999999999999999999999999999999999999999999999987654


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       150 ~~~~--~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~  198 (318)
T cd05582         150 DHEK--KAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPF  198 (318)
T ss_pred             CCCC--ceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCC
Confidence            3321  123446799999999987654 789999999999999999999997

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0586|consensus

Probab=100.00  E-value=1.5e-37  Score=279.64  Aligned_cols=205  Identities=27%  Similarity=0.483  Sum_probs=182.1

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..+...+.|.+.++||+|.|+.|.++++..++..||||.+.+........+.+.+|+++++.++|||||+++.+...   
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t---  126 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET---  126 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee---
Confidence            45566778999999999999999999999999999999999887666666778899999999999999999888765   


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                             ...+|+||||+.++ +.+++. ..+.+.+..++.++.|++.|++|||+++|+|||||.+||+|+.+.++||+|
T Consensus       127 -------~~~lylV~eya~~ge~~~yl~-~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaD  198 (596)
T KOG0586|consen  127 -------EATLYLVMEYASGGELFDYLV-KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIAD  198 (596)
T ss_pred             -------cceeEEEEEeccCchhHHHHH-hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeec
Confidence                   45899999999875 555554 445677899999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++..+......   ...+|++.|+|||++.+..+.++.+|+||+|+++|-|++|..||
T Consensus       199 fgfS~~~~~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF  255 (596)
T KOG0586|consen  199 FGFSTFFDYGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF  255 (596)
T ss_pred             cccceeecccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence            9999998765544   45567999999999999888889999999999999999999998

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.9e-37  Score=275.12  Aligned_cols=194  Identities=23%  Similarity=0.380  Sum_probs=158.8

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||||.+...... .........|..++... +||||+++++++.+          ++.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~----------~~~   70 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT----------KEN   70 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe----------CCE
Confidence            4689999999999999999999999998765321 22234456677777764 99999999777654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||++++.+.........+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          71 LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            99999999875444444444578999999999999999999999999999999999999999999999999987532221


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .  ......||+.|+|||++.+.. ++.++||||+||++|+|++|+.||
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf  196 (316)
T cd05619         151 A--KTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             C--ceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCC
Confidence            1  123445799999999987655 899999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-37  Score=277.95  Aligned_cols=194  Identities=22%  Similarity=0.333  Sum_probs=161.3

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+..+++.||+|++...... ......+.+|+.++.++ +||||+++++++.+          .+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------~~~   70 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT----------TSR   70 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe----------CCE
Confidence            4699999999999999999999999999865322 22234567899998888 69999999777654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||++|+.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            99999999875554444444579999999999999999999999999999999999999999999999999987532211


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf  196 (327)
T cd05617         151 --DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPF  196 (327)
T ss_pred             --CceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCC
Confidence              1123456799999999987655 889999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.1e-37  Score=269.48  Aligned_cols=192  Identities=28%  Similarity=0.349  Sum_probs=159.6

Q ss_pred             ccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEE
Q psy13988        154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL  232 (358)
Q Consensus       154 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~l  232 (358)
                      ||+|+||.||++.+..+++.||+|.+........ ....+..|+.+++.++|+||+++.+++..          +...|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----------~~~~~l   70 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT----------KTDLCL   70 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC----------CCeEEE
Confidence            7999999999999999999999999875432221 22456789999999999999999766654          557999


Q ss_pred             EeeccccChHH-HHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecccc
Q psy13988        233 VFEYMDHDLMG-LLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE  308 (358)
Q Consensus       233 v~e~~~~~l~~-~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~  308 (358)
                      ||||++++.+. .+.   .....+++..+..++.||+.||+|||+++|+|+||||+||+++.++.++|+|||++......
T Consensus        71 v~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             EEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            99999875554 332   23456899999999999999999999999999999999999999999999999999766433


Q ss_pred             CCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..  ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       151 ~~--~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf  197 (280)
T cd05608         151 QS--KTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPF  197 (280)
T ss_pred             Cc--cccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCC
Confidence            22  123346789999999998655 889999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG2345|consensus

Probab=100.00  E-value=2.3e-37  Score=249.11  Aligned_cols=209  Identities=28%  Similarity=0.383  Sum_probs=174.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .++++|+|.+.||+|||+.|+++....+++.||+|++.....  +..+..++|++..++++|||+++++++.....    
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~----   91 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREE----   91 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh----
Confidence            578999999999999999999999999999999999987652  33567889999999999999999998876532    


Q ss_pred             cccCCCeEEEEeeccc-cChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEEE
Q psy13988        223 FRKDKGSFYLVFEYMD-HDLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~~~~~~~l  296 (358)
                       .......|++++|+. |++++.+..   ....+++.+++.|+.++++||++||+..  ++||||||.||++.+.+.++|
T Consensus        92 -~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   92 -KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             -ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence             112346899999987 568887742   3446999999999999999999999998  999999999999999999999


Q ss_pred             eecccceeccccCCC-------CCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQ-------RPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .|||.++...-....       ........|..|+|||.+.-  ....+.++|||||||++|.|+.|.-||
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPf  241 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPF  241 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcc
Confidence            999998865432211       11233345889999998853  234788999999999999999999998

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.2e-37  Score=274.73  Aligned_cols=194  Identities=25%  Similarity=0.373  Sum_probs=160.9

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||.|+||.||++.+..++..||||++...... ......+.+|..++..+ +||||+++++++..          .+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~----------~~~   70 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT----------KDR   70 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----------CCE
Confidence            4699999999999999999999999999865321 22234566788888888 79999999877654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||+.|+.+.........+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          71 LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            99999999876555444445579999999999999999999999999999999999999999999999999987532221


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .  ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       151 ~--~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf  196 (318)
T cd05570         151 V--TTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPF  196 (318)
T ss_pred             C--cccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCC
Confidence            1  122345799999999997655 889999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=276.67  Aligned_cols=198  Identities=30%  Similarity=0.447  Sum_probs=162.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|.+++.||.|+||.||++.+..+++.||||++.... .......+.+|+++++.++|+||+++++++..       
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------  143 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH-------  143 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-------
Confidence            3456788899999999999999999999999999986432 22223467899999999999999999776654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ++.+++||||+.++.+..    ....++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus       144 ---~~~~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~  216 (353)
T PLN00034        144 ---NGEIQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR  216 (353)
T ss_pred             ---CCeEEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccce
Confidence               568999999999865432    2245677888999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCC----CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......|+..|+|||.+...    ...+.++|||||||++|+|++|+.||
T Consensus       217 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf  273 (353)
T PLN00034        217 ILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF  273 (353)
T ss_pred             ecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            7643321  12334679999999987432    23456899999999999999999998

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-37  Score=269.09  Aligned_cols=198  Identities=25%  Similarity=0.351  Sum_probs=165.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|++.+.||+|+||.||++.+..+++.||+|.+........ ....+.+|+.+++.++||||+++++++..         
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET---------   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC---------
Confidence            47889999999999999999999999999999875432221 22356789999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChH-HHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        226 DKGSFYLVFEYMDHDLM-GLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~-~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                       +..+++||||+.++.+ ..+.. ....+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++.
T Consensus        72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~  150 (285)
T cd05605          72 -KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAV  150 (285)
T ss_pred             -CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCce
Confidence             4589999999987544 44433 23468999999999999999999999999999999999999999999999999988


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......   .....+++.|+|||++.+.. ++.++||||+|+++|+|++|+.||
T Consensus       151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf  201 (285)
T cd05605         151 EIPEGET---IRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPF  201 (285)
T ss_pred             ecCCCCc---cccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCC
Confidence            7643322   22346789999999987654 889999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0577|consensus

Probab=100.00  E-value=1.1e-38  Score=284.61  Aligned_cols=205  Identities=31%  Similarity=0.457  Sum_probs=179.0

Q ss_pred             cccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       138 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      +-..++....|.-++.||.|+||.||.++|..+.+.||||+++..... ....+.+++|+..|.+++|||++.+.++|..
T Consensus        18 LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr   97 (948)
T KOG0577|consen   18 LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR   97 (948)
T ss_pred             HHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence            334455566777889999999999999999999999999999876533 2334568899999999999999999999976


Q ss_pred             cCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                      .          -..|+|||||=|+--+.+.-..+++.+.++..|+.+.+.||+|||+.+.+|||||..|||+++.|.+||
T Consensus        98 e----------~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKL  167 (948)
T KOG0577|consen   98 E----------HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKL  167 (948)
T ss_pred             c----------chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeee
Confidence            3          368999999999877777666678999999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCcccccccccccccc--CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL--GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||.+..+.+.      ..++|||.|||||++.  +.+.|+-++||||||++..+|.-.+||+
T Consensus       168 aDFGSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl  225 (948)
T KOG0577|consen  168 ADFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  225 (948)
T ss_pred             ccccchhhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence            999999877544      4678899999999984  4567999999999999999999999884

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.8e-36  Score=270.44  Aligned_cols=205  Identities=45%  Similarity=0.789  Sum_probs=174.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|++.+.||.|++|.||++.+..+++.||+|.+..............+|+.++++++|+||+++++++....     
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----   79 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH-----   79 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC-----
Confidence            456799999999999999999999999999999998765544444445678999999999999999988875422     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         .+..++||||+++++...+......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus        80 ---~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          80 ---LDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             ---CCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceee
Confidence               34689999999998888776655679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......+++.|+|||.+.+...++.++||||||+++|+|++|++||
T Consensus       157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f  209 (309)
T cd07845         157 TYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL  209 (309)
T ss_pred             ecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC
Confidence            7654321  1223344788999999876666889999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-36  Score=269.82  Aligned_cols=214  Identities=75%  Similarity=1.234  Sum_probs=183.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|.+.+.||.|++|.||++.+..+++.||+|.++...........+.+|+.+++.++||||+++++++.+..+...+
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            44678899999999999999999999999999999986654444455677899999999999999999999876655666


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ..+++.+++|+||+++++...+......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||.+.
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence            67777999999999998888887665679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....... .......++..|+|||.+.+...++.++||||||+++|+|++|++||
T Consensus       165 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~  218 (302)
T cd07864         165 LYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF  218 (302)
T ss_pred             cccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            7644332 12223345778999998876555789999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-36  Score=266.59  Aligned_cols=201  Identities=38%  Similarity=0.684  Sum_probs=173.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++.+.||.|++|.||++.+..+++.||+|++............+.+|+.+++.++|+|++++++++..         
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---------   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR---------   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee---------
Confidence            36889999999999999999999999999999987554333344567889999999999999999877654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ....++||||++++++..+......+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        72 -~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          72 -KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             -CCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceec
Confidence             4589999999999988888766667999999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  ......++..|+|||.+.+...++.++|+||||+++|+|++|++||
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~  201 (286)
T cd07847         151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW  201 (286)
T ss_pred             CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence            54321  1223345788999999876556889999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-36  Score=273.77  Aligned_cols=199  Identities=27%  Similarity=0.353  Sum_probs=167.5

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++.+.||.|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++|+||+++++++.+       
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------   74 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------   74 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-------
Confidence            4578999999999999999999999999999999887542 22223467899999999999999999877764       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         ++..++||||+.++.+..+......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus        75 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~  151 (333)
T cd06650          75 ---DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (333)
T ss_pred             ---CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence               558999999998754444444445689999999999999999999975 7999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......    .....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||
T Consensus       152 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~  202 (333)
T cd06650         152 GQLIDSM----ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPI  202 (333)
T ss_pred             hhhhhhc----cccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence            7653321    12335689999999987654 889999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0669|consensus

Probab=100.00  E-value=3.8e-38  Score=254.40  Aligned_cols=213  Identities=47%  Similarity=0.841  Sum_probs=191.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..+.|.-+..+|+|.||.||+++...++++||+|++-.++....+.+..++|+.+|..++|+|++.++++|.....  ..
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T--p~   92 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT--PT   92 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC--Cc
Confidence            4567777889999999999999999999999999998888888999999999999999999999999999987542  23


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ..+...+|+|+++|+.+|...+.+....++..++..++.++.+||.|+|.+.|+|||+|++|++|+.+|.++|.|||+++
T Consensus        93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            34567799999999999999887777789999999999999999999999999999999999999999999999999997


Q ss_pred             eccc--cCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNA--EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .+..  +.....++..+.|..|++||.+.+.+.|+.+.|||.-||++.+|.|+.+.|
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim  229 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM  229 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence            6543  334455778888999999999999999999999999999999999998865

>KOG0612|consensus

Probab=100.00  E-value=1.1e-37  Score=296.21  Aligned_cols=204  Identities=25%  Similarity=0.299  Sum_probs=173.5

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+|.|++.||+|+||.|.+++.+.+++.||+|++++-..- .....-|..|-.++..-+.+=|+.++-.|++      
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD------  146 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD------  146 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC------
Confidence            446799999999999999999999999999999999864322 2234456778889988888999999877765      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ++++|+||||+.|+.+-.+.....++++..++-++..|+.||+.||+.|+|||||||+|||+|..|++||.|||.|
T Consensus       147 ----~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  147 ----ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ----ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence                6699999999997544444444448999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      -.+...+.. .....+|||.|.|||++..    .+.|+..+|+||+||++||||+|..||
T Consensus       223 lkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF  281 (1317)
T KOG0612|consen  223 LKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF  281 (1317)
T ss_pred             HhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence            888754433 3456789999999999852    245899999999999999999999998

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.7e-36  Score=269.29  Aligned_cols=213  Identities=49%  Similarity=0.864  Sum_probs=178.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..++|.+.+.||.|++|.||++.+..+++.||||.+............+.+|+.++++++||||+++++++.....  ..
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~   87 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT--PY   87 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc--cc
Confidence            4457999999999999999999999999999999987654444444456789999999999999999988776442  12


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      .......++||||+++++.+.+......+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          88 NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             cCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence            33456789999999998888887666679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCC--CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQ--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........  .......++..|+|||.+.+...++.++||||||+++|+|++|++||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~  224 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM  224 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence            66443221  12233456788999998876655788999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.1e-36  Score=270.99  Aligned_cols=195  Identities=36%  Similarity=0.663  Sum_probs=160.8

Q ss_pred             ccccCCcceeeEeeeeec--CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLF--TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      ..||+|+||.||++....  ++..||+|.+....    ....+.+|+.+++.++||||+++++++....        +..
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~~   74 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHS--------DRK   74 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC--------CCe
Confidence            579999999999999653  66899999886432    2335778999999999999999988775432        457


Q ss_pred             EEEEeeccccChHHHHhc--------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCCCcEEEe
Q psy13988        230 FYLVFEYMDHDLMGLLES--------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM----NNRGEVKLA  297 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill----~~~~~~~l~  297 (358)
                      .++||||+++++...+..        ....+++..++.++.||+.||.|||+.+|+||||||+||++    +.++.++|+
T Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07867          75 VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence            899999999988777632        12358899999999999999999999999999999999999    456789999


Q ss_pred             ecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||+++........ .......+|+.|+|||++.+...++.++|||||||++|+|+||++||
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f  216 (317)
T cd07867         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  216 (317)
T ss_pred             eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence            99999876543221 22234567899999999877666899999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.4e-36  Score=266.27  Aligned_cols=200  Identities=42%  Similarity=0.721  Sum_probs=170.4

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|.+++.||.|++|.||++.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++++..         
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---------   74 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT---------   74 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec---------
Confidence            679999999999999999999999999999999875533 2233456789999999999999999776654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       +...|+||||+.++++..+......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++..
T Consensus        75 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          75 -KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             -CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence             5589999999999988887665567888899999999999999999999999999999999999999999999998764


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  ......+++.|+|||.+.+...++.++||||||+++|+|++|+.||
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f  204 (291)
T cd07870         154 SIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF  204 (291)
T ss_pred             CCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            33221  1233456889999999876555788999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0574|consensus

Probab=100.00  E-value=1.9e-38  Score=262.28  Aligned_cols=196  Identities=26%  Similarity=0.425  Sum_probs=173.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .-|.+++.||+|+||.||++.++.+|..||||.+..+..    .+++.+|+.++.+++.|++|++|+.|....       
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK~s-------  101 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFKHS-------  101 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhccCC-------
Confidence            346688999999999999999999999999999887543    457889999999999999999999887644       


Q ss_pred             CCCeEEEEeeccc-cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                         .+|+|||||+ |+.-+.+..+++++++.++..+++..++||+|||...-+|||||..|||+..+|..||.|||.+..
T Consensus       102 ---DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  102 ---DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ  178 (502)
T ss_pred             ---ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccch
Confidence               6999999998 566677777888999999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.+..-.  ....+|||.|||||++..-+ |+.++||||||++..||.-|++||
T Consensus       179 LTDTMAK--RNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPY  229 (502)
T KOG0574|consen  179 LTDTMAK--RNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPY  229 (502)
T ss_pred             hhhhHHh--hCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCc
Confidence            6544322  24567899999999998655 899999999999999999999997

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=278.47  Aligned_cols=193  Identities=24%  Similarity=0.308  Sum_probs=156.6

Q ss_pred             ccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC---CCCcccchhhhhcccCcccccccCCCe
Q psy13988        154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL---NHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       154 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      ||+|+||.||++.+..+++.||||++...... .........|..++...   +||||+++++++..          ...
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~----------~~~   70 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT----------DSD   70 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec----------CCe
Confidence            79999999999999999999999998754221 11223345566666655   69999999776654          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|+||||+.++.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        71 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          71 LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            99999999875444443445579999999999999999999999999999999999999999999999999987543222


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf  197 (330)
T cd05586         151 K--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF  197 (330)
T ss_pred             C--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCC
Confidence            1  1234467999999999876655889999999999999999999997

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4e-36  Score=265.12  Aligned_cols=200  Identities=39%  Similarity=0.687  Sum_probs=172.4

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|++.+.||.|++|.||++.+..+++.||+|++............+.+|+++++.++||||+++++++..          
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------   71 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR----------   71 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc----------
Confidence            6889999999999999999999899999999987654443344567889999999999999999888754          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ++..|+|+||++++++..+......+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            55899999999998888776655568999999999999999999999999999999999999999999999999988764


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  ......++..|+|||.+.+...++.++||||||+++|+|++|++||
T Consensus       152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~  201 (286)
T cd07846         152 APGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF  201 (286)
T ss_pred             CCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC
Confidence            4322  2233456889999999876666788999999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.6e-37  Score=267.24  Aligned_cols=198  Identities=34%  Similarity=0.496  Sum_probs=167.9

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      |++++.||+|+||+||++.+..+++.||+|++..............+|+.++++++||||+++++++.+          .
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------~   70 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD----------D   70 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE----------S
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc----------c
Confidence            678999999999999999999999999999998775444333334569999999999999999777765          5


Q ss_pred             CeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       228 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ...++|||++.+ ++.+.+. ....+++..+..++.||++||++||+++++|+||||+||+++.++.++|+|||.+....
T Consensus        71 ~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   71 NYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             SEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred             cccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            589999999998 5555555 44578999999999999999999999999999999999999999999999999998641


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        ..........++..|+|||++.....++.++|+||||+++|+|++|..||
T Consensus       150 --~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~  199 (260)
T PF00069_consen  150 --ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPF  199 (260)
T ss_dssp             --STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSS
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence              11222344566899999999873445899999999999999999999987

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG1989|consensus

Probab=100.00  E-value=4.2e-37  Score=287.75  Aligned_cols=209  Identities=25%  Similarity=0.375  Sum_probs=166.8

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhh-hcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREI-VTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~~~~~  220 (358)
                      ....+++|.+.|++|||+.||+|.+...|..||+|++-..  .+.....+.+|+++++.|+ |+|||.+++. .....  
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~--  109 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS--  109 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc--
Confidence            3455677889999999999999999998899999988765  3333556789999999995 9999999984 33221  


Q ss_pred             cccccC-CCeEEEEeeccc-cChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEE
Q psy13988        221 LDFRKD-KGSFYLVFEYMD-HDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       221 ~~~~~~-~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~~~~~~~  295 (358)
                         ... .-.++|.||||. |+|.+.+.. -...|++.++++|++|+++|+.+||...  |+|||||-+||||+.+|..|
T Consensus       110 ---~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  110 ---SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             ---CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence               112 247899999999 589988853 2334999999999999999999999987  99999999999999999999


Q ss_pred             EeecccceeccccCCCCCC-------CCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPY-------TNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||||.++..-........       ....-|+.|+|||++.-  ...++.|+|||+|||+||.|+....||
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PF  258 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPF  258 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCc
Confidence            9999998744322210000       00112999999998742  233889999999999999999999998

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.9e-36  Score=265.21  Aligned_cols=201  Identities=40%  Similarity=0.697  Sum_probs=173.7

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|++.+.||.|++|.||++.+..++..||+|++............+.+|+.+++.++||||+++++++..          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------   70 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH----------   70 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec----------
Confidence            4889999999999999999999999999999998765444455678899999999999999999777654          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      +...++|+||+.+++...+......+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        71 ~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          71 GSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             CCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            56899999999667777776655679999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .... .......++..|+|||.+.+...++.++||||+|+++|+|++|.+||
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~  201 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF  201 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence            4332 22334567899999999876665789999999999999999998876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG4721|consensus

Probab=100.00  E-value=1.4e-37  Score=276.54  Aligned_cols=184  Identities=24%  Similarity=0.399  Sum_probs=162.8

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      -++-||.|+.|.||+++.  .++.||||+++...         ..+|.-|++|+|+||+.+.++|.+..          +
T Consensus       128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsP----------c  186 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSP----------C  186 (904)
T ss_pred             hhhhhccCcccceeeeec--cCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCc----------e
Confidence            356799999999999985  78999999876322         35899999999999999999998755          8


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      +|||||||..+-+..+......+.......|..+|+.|+.|||.+.|+|||||.-||||..+..+||+|||.++..... 
T Consensus       187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-  265 (904)
T KOG4721|consen  187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-  265 (904)
T ss_pred             eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence            9999999997666666666668999999999999999999999999999999999999999999999999999876543 


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        .+...+.||..|||||++.+.. .+.|+|||||||+|||||||..||
T Consensus       266 --STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPY  311 (904)
T KOG4721|consen  266 --STKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPY  311 (904)
T ss_pred             --hhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCc
Confidence              4556788899999999999766 999999999999999999999987

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.4e-36  Score=292.90  Aligned_cols=202  Identities=27%  Similarity=0.347  Sum_probs=164.0

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ++|.+++.||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.+        
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--------   73 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--------   73 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--------
Confidence            5799999999999999999999999999999998754322 1223467889999999999999999766654        


Q ss_pred             cCCCeEEEEeeccccChHH-HHhcC----------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q psy13988        225 KDKGSFYLVFEYMDHDLMG-LLESG----------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE  293 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~-~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~  293 (358)
                        ++..|+||||++|+.+. .+...          ....+...+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus        74 --~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~  151 (932)
T PRK13184         74 --GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE  151 (932)
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC
Confidence              56899999999975444 33221          123456677899999999999999999999999999999999999


Q ss_pred             EEEeecccceeccccCC----------------CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        294 VKLADFGLARLYNAEDR----------------QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       294 ~~l~Dfg~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      ++|+|||++........                ........||+.|+|||.+.+.. ++.++|||||||++|+|+||+.|
T Consensus       152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCC
Confidence            99999999986621110                00112246899999999987655 89999999999999999999999


Q ss_pred             C
Q psy13988        358 F  358 (358)
Q Consensus       358 F  358 (358)
                      |
T Consensus       231 F  231 (932)
T PRK13184        231 Y  231 (932)
T ss_pred             C
Confidence            7

>KOG4236|consensus

Probab=100.00  E-value=1.6e-37  Score=274.03  Aligned_cols=199  Identities=27%  Similarity=0.362  Sum_probs=176.5

Q ss_pred             CCCccc--ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        146 SSRPLM--EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       146 ~~~~~~--~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .-|+|.  ++||.|.||+||-+.+..+|+.||||++.+.............|+.+|..+.||.||.+...++.++     
T Consensus       562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-----  636 (888)
T KOG4236|consen  562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-----  636 (888)
T ss_pred             HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-----
Confidence            334444  6899999999999999999999999999988777666678889999999999999999988887654     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEeec
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EVKLADF  299 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~~l~Df  299 (358)
                           .+|+|||-+.|+.+..+.. ..+++++....-++.||+.||.|||-++|+|+||||+|||+....   .+|||||
T Consensus       637 -----rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDF  711 (888)
T KOG4236|consen  637 -----RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDF  711 (888)
T ss_pred             -----eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccc
Confidence                 8999999999999988754 456799999999999999999999999999999999999997653   7999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|+.++.....   ...+|||.|+|||++...+ |+...|+||.|+|+|.-|+|..||
T Consensus       712 GfARiIgEksFR---rsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPF  766 (888)
T KOG4236|consen  712 GFARIIGEKSFR---RSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPF  766 (888)
T ss_pred             cceeecchhhhh---hhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccC
Confidence            999999766544   3457899999999999776 999999999999999999999998

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=265.58  Aligned_cols=201  Identities=44%  Similarity=0.789  Sum_probs=170.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ...|.+.+.||.|++|.||++.+..+++.||||.+...... .....+.+|+.+++.++|+||+++++++.+        
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------   74 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT--------   74 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec--------
Confidence            35788999999999999999999999999999998764322 223356789999999999999999877654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        +...++||||+.+++.+.+......+++..+..++.|+++||.|||+++++|+||||+||+++.++.++|+|||++..
T Consensus        75 --~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          75 --KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             --CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence              558999999999988887766556789999999999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......++..|+|||.+.+...++.++||||+|+++|+|++|++||
T Consensus       153 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~  204 (291)
T cd07844         153 KSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF  204 (291)
T ss_pred             cCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence            432211  1223345788999999876555889999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.6e-36  Score=266.52  Aligned_cols=212  Identities=47%  Similarity=0.850  Sum_probs=178.3

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|.+.+.||.|++|.||++.+..+++.||||.+............+.+|+++++.++|+||+++++++.+...  ...
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD--KSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc--ccc
Confidence            578999999999999999999999999999999987665544444567789999999999999999988765431  112


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .....+++|+||+.+++...+......+++..+..++.|+++||+|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence            34567899999999988888876666899999999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCC---------CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQ---------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......         .......+++.|+|||.+.+...++.++||||||+++|+|++|++||
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~  227 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL  227 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence            5433221         11223355788999998876655889999999999999999999987

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0603|consensus

Probab=100.00  E-value=2.1e-36  Score=273.69  Aligned_cols=273  Identities=27%  Similarity=0.406  Sum_probs=196.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCH-----hhhhcCcccccCCCC-----CCCCCCCCCchh-hHHHHHHh-hhcccCCC-
Q psy13988         62 LMPPGALDLLDKMLELDPERRITA-----EQALKSVWLKNVHPE-----SMPPPQLPTWQD-CHELWSKK-RRRQLRGD-  128 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~-----~~~l~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~-  128 (358)
                      ..++.+.+++..|+..+|.+|.-+     .++.+|+||..+...     ...++.-|.... .+...... -..+.... 
T Consensus       209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~ds  288 (612)
T KOG0603|consen  209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADS  288 (612)
T ss_pred             hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccC
Confidence            478899999999999999999854     789999999865321     111111111111 00000000 00000000 


Q ss_pred             c------cc------cccccccc--c--CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhH
Q psy13988        129 P------ME------MQAAAPIQ--S--NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITA  192 (358)
Q Consensus       129 ~------~~------~~~~~~~~--~--~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~  192 (358)
                      +      .+      ..-.++..  .  .......|.+...+|.|+|+.|..+.+..++...++|++.....      ..
T Consensus       289 p~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~  362 (612)
T KOG0603|consen  289 PLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DN  362 (612)
T ss_pred             CCCCCCccccchhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheecccccc------cc
Confidence            0      00      00000100  1  11345678888899999999999999999999999999987622      23


Q ss_pred             HHHHHHHHhC-CCCcccchhhhhcccCcccccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHH
Q psy13988        193 VREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSY  270 (358)
Q Consensus       193 ~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~  270 (358)
                      .+|+.++... +||||+++.+++.+          +.+.|+|||.+.|. +++.+... ..+ ..++..|+++|+.|+.|
T Consensus       363 ~~e~~~~~~~~~h~niv~~~~v~~~----------~~~~~~v~e~l~g~ell~ri~~~-~~~-~~e~~~w~~~lv~Av~~  430 (612)
T KOG0603|consen  363 QDEIPISLLVRDHPNIVKSHDVYED----------GKEIYLVMELLDGGELLRRIRSK-PEF-CSEASQWAAELVSAVDY  430 (612)
T ss_pred             ccccchhhhhcCCCcceeecceecC----------CceeeeeehhccccHHHHHHHhc-chh-HHHHHHHHHHHHHHHHH
Confidence            4566555555 89999999777765          66899999999985 44444433 223 37888999999999999


Q ss_pred             HHhCCceecCCCCCCEEe-cCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHH
Q psy13988        271 CHKRNFLHRDIKCSNILM-NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG  349 (358)
Q Consensus       271 LH~~~i~H~Dlkp~Nill-~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~  349 (358)
                      ||++|++||||||+|||+ +..++++|+|||.++.....     ....+.|..|.|||++...+ ++.++||||||++||
T Consensus       431 LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy  504 (612)
T KOG0603|consen  431 LHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLY  504 (612)
T ss_pred             HHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCC-CCcchhhHHHHHHHH
Confidence            999999999999999999 58899999999999877655     23445589999999998655 999999999999999


Q ss_pred             HHhhCCCCC
Q psy13988        350 ELFVKKPLF  358 (358)
Q Consensus       350 ~lltg~~pF  358 (358)
                      +||+|+.||
T Consensus       505 ~ML~G~tp~  513 (612)
T KOG0603|consen  505 EMLTGRTLF  513 (612)
T ss_pred             HHHhCCCcc
Confidence            999999997

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.6e-36  Score=265.75  Aligned_cols=203  Identities=47%  Similarity=0.812  Sum_probs=173.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|.+.+.||.|++|.||++.+..+++.|++|.++...........+.+|+.++++++||||+++++++....       
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-------   77 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN-------   77 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC-------
Confidence            4788999999999999999999999999999999866544444446678999999999999999988775431       


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       .+..|+||||+++++...+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        78 -~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          78 -LDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             -CCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence             3689999999998887777665557999999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  .......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||
T Consensus       157 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f  207 (293)
T cd07843         157 GSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF  207 (293)
T ss_pred             cCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC
Confidence            5432  12233456888999999876665789999999999999999999987

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-36  Score=283.83  Aligned_cols=196  Identities=25%  Similarity=0.369  Sum_probs=160.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc------ccchhhhhccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN------IVNLREIVTDK  217 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~  217 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||||+++...   ........|+.+++.++|.+      ++++++++.. 
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc-
Confidence            4578999999999999999999999999999999986432   12234556788887776554      6666555543 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCC----
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRG----  292 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~----  292 (358)
                              +.+++|+|||++++++++.+... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++    
T Consensus       203 --------~~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        203 --------ETGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             --------CCceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccc
Confidence                    24579999999988888887654 478999999999999999999998 5999999999999998765    


Q ss_pred             ------------cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        293 ------------EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       293 ------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                                  .+||+|||.+.....     ......+|+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence                        499999998754321     123456799999999998765 899999999999999999999998

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-36  Score=293.12  Aligned_cols=208  Identities=30%  Similarity=0.473  Sum_probs=171.2

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..+....+|.+++.||.|+||.||++.+..++..||+|.+............+..|+.+++.++||||+++++++.+.. 
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~-   85 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA-   85 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC-
Confidence            3455667899999999999999999999999999999998866544444567889999999999999999988775432 


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCEEe
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKR-------NFLHRDIKCSNILM  288 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~-------~i~H~Dlkp~Nill  288 (358)
                             ...+||||||+++ +|...+..   ....+++..++.|+.||+.||.|||+.       +|+|+||||+||||
T Consensus        86 -------~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL  158 (1021)
T PTZ00266         86 -------NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL  158 (1021)
T ss_pred             -------CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence                   4579999999986 55555533   235699999999999999999999984       49999999999999


Q ss_pred             cCC-----------------CcEEEeecccceeccccCCCCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHH
Q psy13988        289 NNR-----------------GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGE  350 (358)
Q Consensus       289 ~~~-----------------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~  350 (358)
                      +..                 +.++|+|||++..+.....   .....+|+.|+|||++.+. ..++.++|||||||++|+
T Consensus       159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             ecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence            642                 3489999999986643322   2234679999999998643 347889999999999999


Q ss_pred             HhhCCCCC
Q psy13988        351 LFVKKPLF  358 (358)
Q Consensus       351 lltg~~pF  358 (358)
                      |+||..||
T Consensus       236 LLTGk~PF  243 (1021)
T PTZ00266        236 LCSGKTPF  243 (1021)
T ss_pred             HHHCCCCC
Confidence            99999998

>KOG0604|consensus

Probab=100.00  E-value=3.7e-37  Score=254.31  Aligned_cols=197  Identities=28%  Similarity=0.409  Sum_probs=164.9

Q ss_pred             CCCCccc-ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        145 NSSRPLM-EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       145 ~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      -.+|.+. ++||-|-.|.|..+.++.+++++|+|++...       .+..+|+++.-.. .|||||.++++|++.     
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs-----  127 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENS-----  127 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhh-----
Confidence            3455543 6899999999999999999999999988643       2556888876555 799999999999863     


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEe
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EVKLA  297 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~~l~  297 (358)
                       +....++.+|||.++| +|+..+.+ +...++|.++..|++||..|+.|||+.+|.||||||+|+|....+   .+||+
T Consensus       128 -~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  128 -YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             -ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence             3457899999999997 56666654 445699999999999999999999999999999999999997654   69999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||+|+....+..   ....+.||.|.|||++...+ |+..+|+||+||++|.||+|.+||
T Consensus       207 DfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPF  263 (400)
T KOG0604|consen  207 DFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF  263 (400)
T ss_pred             ccccccccCCCcc---ccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcc
Confidence            9999987654332   23445599999999987555 999999999999999999999998

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.4e-36  Score=275.80  Aligned_cols=204  Identities=26%  Similarity=0.358  Sum_probs=162.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecC-----CcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFT-----DELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  216 (358)
                      ....+|.+.+.||+|+||.||++.+..+     +..||+|++...... .....+.+|+++++.+ +|+||+++++++..
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            3455788999999999999999986443     357999998754322 2234678899999999 89999999777654


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcC-----------------------------------------------
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG-----------------------------------------------  248 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------------------------------------------  248 (358)
                                .+.+++||||+.+ +|.+.+...                                               
T Consensus       114 ----------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (374)
T cd05106         114 ----------GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE  183 (374)
T ss_pred             ----------CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence                      5589999999986 555544221                                               


Q ss_pred             ----------------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        249 ----------------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       249 ----------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                                            ..++++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~  263 (374)
T cd05106         184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM  263 (374)
T ss_pred             cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeecc
Confidence                                  1247788899999999999999999999999999999999999999999999998654


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ............++..|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       264 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf  315 (374)
T cd05106         264 NDSNYVVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPY  315 (374)
T ss_pred             CCcceeeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCC
Confidence            332211112223456799999987554 8999999999999999997 99997

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-35  Score=261.76  Aligned_cols=200  Identities=43%  Similarity=0.797  Sum_probs=170.6

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|++++.||.|++|.||++.+..++..||||.+............+.+|++++++++||||+++++++.+          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------   70 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----------   70 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc----------
Confidence            3788999999999999999999999999999987655444444578899999999999999999887754          


Q ss_pred             CCeEEEEeeccccChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        227 KGSFYLVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      ++..++||||+.+++...+.. ....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        71 ~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          71 ENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             CCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            558999999998887776644 3356899999999999999999999999999999999999999999999999998765


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  .......+++.|+|||.+.+...++.++||||||+++|+|+||+.||
T Consensus       151 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~  201 (284)
T cd07860         151 GVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF  201 (284)
T ss_pred             ccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            4332  12233455888999998876665788999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-36  Score=271.80  Aligned_cols=191  Identities=23%  Similarity=0.356  Sum_probs=164.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ...|.+++.||.|+||.||++.+..+++.||+|.....        ....|+.+++.++|+||+++++++..        
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~--------  128 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS--------  128 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe--------
Confidence            34699999999999999999999999999999974321        23579999999999999999887765        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        +...++|||++.+++...+......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus       129 --~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        129 --GAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             --CCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence              457899999999999998877777899999999999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      .....   ......||+.|+|||++.+.. ++.++|||||||++|+|+++..|
T Consensus       207 ~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        207 PVVAP---AFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             cccCc---ccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCc
Confidence            33221   123445799999999987655 89999999999999999986443

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.7e-36  Score=262.48  Aligned_cols=191  Identities=26%  Similarity=0.317  Sum_probs=158.4

Q ss_pred             ccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEE
Q psy13988        154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL  232 (358)
Q Consensus       154 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~l  232 (358)
                      ||+|+||.||++.+..+|+.||+|.+........ ....+..|+++++.++||||+++++++..          +..+|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~----------~~~~~l   70 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES----------KTHLCL   70 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec----------CCeEEE
Confidence            7999999999999999999999999875432221 12345679999999999999999766654          558999


Q ss_pred             EeeccccChH-HHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        233 VFEYMDHDLM-GLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       233 v~e~~~~~l~-~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                      ||||+.|+.+ ..+.. ....+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        71 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~  150 (277)
T cd05607          71 VMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT  150 (277)
T ss_pred             EEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence            9999987544 44432 334588999999999999999999999999999999999999999999999999887643321


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                         .....+++.|+|||++.+.. ++.++|+||+||++|+|++|+.||
T Consensus       151 ---~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~  194 (277)
T cd05607         151 ---ITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPF  194 (277)
T ss_pred             ---eeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCC
Confidence               12345689999999998766 899999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.2e-36  Score=271.73  Aligned_cols=205  Identities=31%  Similarity=0.512  Sum_probs=173.0

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|++++.||+|++|.||++.+..+++.||||.+............+.+|+.+++.++|+||+++++++....    
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   88 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK----   88 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC----
Confidence            3567899999999999999999999999999999998754333333456778999999999999999998876532    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      ...+....|+||||+.+++...+...   +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          89 SLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CccccCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            12234568999999999888877543   889999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........   .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus       166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf  217 (353)
T cd07850         166 RTAGTSFM---MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLF  217 (353)
T ss_pred             eeCCCCCC---CCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCC
Confidence            87644322   22345688999999987655 899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-36  Score=262.92  Aligned_cols=202  Identities=43%  Similarity=0.738  Sum_probs=175.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ++|.+.+.||.|++|.||++.+..+++.||+|.++...........+.+|+++++.++|+||+++++++..         
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------   71 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR---------   71 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE---------
Confidence            36889999999999999999999999999999987655444455678899999999999999999887765         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++..++||||++++++..+......+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        72 -~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          72 -KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             -CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence             4589999999999888877666667999999999999999999999999999999999999999999999999998876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..... .......++..|+|||++.+...++.++|+||||+++|+|++|++||
T Consensus       151 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~  202 (288)
T cd07833         151 RARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF  202 (288)
T ss_pred             CCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            54432 12234556888999999987645889999999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=258.58  Aligned_cols=202  Identities=27%  Similarity=0.430  Sum_probs=167.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC---CchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG---FPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..|.+.+.||.|++|.||.+.+..+++.||+|.+........   ....+.+|++++++++||||+++++++..      
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD------   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc------
Confidence            358899999999999999999999999999999875432221   23457789999999999999999777754      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          +...++|+|++++..+.........+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        76 ----~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          76 ----DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             ----CCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence                4589999999987555444444457899999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......... .......++..|+|||.+.+.. ++.++||||+|+++|+|++|+.||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~  207 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW  207 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCc
Confidence            765432211 1112334578899999998765 889999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.4e-36  Score=273.28  Aligned_cols=203  Identities=27%  Similarity=0.351  Sum_probs=162.2

Q ss_pred             CCCCCcccccccCCcceeeEeeee-----ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVS-----LFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      ...+|.+.+.||+|+||.||++..     ..++..||||+++.... ......+.+|+.+++.+ +||||+++++++.. 
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-  110 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV-  110 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-
Confidence            345789999999999999999974     34567899999874432 22334678899999999 89999999777654 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcC------------------------------------------------
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESG------------------------------------------------  248 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------------------------------------------------  248 (358)
                               ++..++||||+++ +|.+.+...                                                
T Consensus       111 ---------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  181 (375)
T cd05104         111 ---------GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT  181 (375)
T ss_pred             ---------CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence                     5578999999986 555555321                                                


Q ss_pred             --------------------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        249 --------------------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       249 --------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                                                ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a  261 (375)
T cd05104         182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA  261 (375)
T ss_pred             ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccc
Confidence                                      124678889999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +...............++..|+|||++.+.. ++.++||||||+++|+|++ |..||
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~  317 (375)
T cd05104         262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPY  317 (375)
T ss_pred             eeccCcccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            8764433222122223456799999987654 8999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.7e-35  Score=258.33  Aligned_cols=204  Identities=27%  Similarity=0.406  Sum_probs=166.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC---CchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG---FPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..|.+.+.||+|++|.||.+.+..+++.||||.+........   ....+.+|+.+++.++||||+++++++.+..    
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   77 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM----   77 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC----
Confidence            468899999999999999999999999999998865432221   1235678999999999999999988765432    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          +..+++||||++++.+.........+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+|||++
T Consensus        78 ----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          78 ----ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             ----CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence                3478899999987544444334456889999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~  209 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPW  209 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCC
Confidence            765322111 1122334688999999987654 889999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-35  Score=267.41  Aligned_cols=207  Identities=34%  Similarity=0.593  Sum_probs=174.2

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|.+.+.||.|++|.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++....      
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------   77 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG------   77 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC------
Confidence            46789999999999999999999999999999998765444344556778999999999999999998876432      


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ......|+||||+++++.+.+... ..+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++..
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          78 ADFKDVYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             CCCceEEEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            235678999999998777766543 4699999999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCC--CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQ--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  .......++..|+|||.+.+...++.++||||||+++|+|++|++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf  212 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF  212 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc
Confidence            6433221  11124467889999999876555889999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.6e-36  Score=266.56  Aligned_cols=203  Identities=27%  Similarity=0.403  Sum_probs=159.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeec----------------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLF----------------TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNI  207 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  207 (358)
                      ...+|.+.+.||+|+||.||++.+..                ++..||+|.+..... ......+.+|+.++++++||||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCe
Confidence            34678899999999999999998532                345799998875422 2223467899999999999999


Q ss_pred             cchhhhhcccCcccccccCCCeEEEEeecccc-ChHHHHhcCC------------------CCCChHHHHHHHHHHHHHH
Q psy13988        208 VNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM------------------VDFNEVNNASIMRQLLDGL  268 (358)
Q Consensus       208 v~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------------~~~~~~~~~~~~~qi~~al  268 (358)
                      +++++++.+          .+..++||||+.+ ++.+.+....                  ..+++..+..++.||+.||
T Consensus        82 v~~~~~~~~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al  151 (304)
T cd05096          82 IRLLGVCVD----------EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM  151 (304)
T ss_pred             eEEEEEEec----------CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999877754          4578999999986 4555443211                  2367778899999999999


Q ss_pred             HHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHH
Q psy13988        269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL  348 (358)
Q Consensus       269 ~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l  348 (358)
                      .|||+.||+|+||||+||+++.++.++|+|||+++...............++..|+|||++.+.. ++.++||||||+++
T Consensus       152 ~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l  230 (304)
T cd05096         152 KYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTL  230 (304)
T ss_pred             HHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHH
Confidence            99999999999999999999999999999999998664433222222334477899999987654 89999999999999


Q ss_pred             HHHhh--CCCCC
Q psy13988        349 GELFV--KKPLF  358 (358)
Q Consensus       349 ~~llt--g~~pF  358 (358)
                      |+|++  +..||
T Consensus       231 ~el~~~~~~~p~  242 (304)
T cd05096         231 WEILMLCKEQPY  242 (304)
T ss_pred             HHHHHccCCCCC
Confidence            99986  45565

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.5e-36  Score=267.15  Aligned_cols=202  Identities=20%  Similarity=0.327  Sum_probs=164.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCc----EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDE----LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ...+|++.+.||+|+||.||++.+..+++    .||+|.++... .......+.+|+.+++.++||||+++++++..   
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---   80 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---   80 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---
Confidence            34678999999999999999999866665    48999886432 22234567889999999999999999887753   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                              ...++|+|++.+ ++.+.+......+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|
T Consensus        81 --------~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~D  152 (316)
T cd05108          81 --------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITD  152 (316)
T ss_pred             --------CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcc
Confidence                    246789999885 67777766556788999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||+++................+..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       153 fG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~  212 (316)
T cd05108         153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPY  212 (316)
T ss_pred             ccccccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCC
Confidence            99998765433222222333467899999987654 8999999999999999997 99887

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.9e-35  Score=262.41  Aligned_cols=200  Identities=39%  Similarity=0.693  Sum_probs=168.7

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC---CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK---EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      +|.+.+.||.|++|.||++.+..+++.||||.+......   ......+..|+.+++.++|+||+++++++.+       
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------   73 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-------   73 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-------
Confidence            478889999999999999999999999999999766443   2233456789999999999999999887765       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         +...++||||+.+++...+......+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        74 ---~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          74 ---KSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             ---CCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeee
Confidence               45899999999667777665544479999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~  203 (298)
T cd07841         151 SFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL  203 (298)
T ss_pred             eccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc
Confidence            7654322  1223345788999998876556889999999999999999998775

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-35  Score=261.65  Aligned_cols=198  Identities=26%  Similarity=0.357  Sum_probs=164.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|++.+.||+|+||.||++.+..+++.||+|.+........ ....+.+|+.+++.++|+||+++++.+.+         
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~---------   71 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET---------   71 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec---------
Confidence            36778899999999999999999999999999875433222 22346789999999999999999766654         


Q ss_pred             CCCeEEEEeeccccC-hHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        226 DKGSFYLVFEYMDHD-LMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                       ++..++||||+.|+ +.+.+.. ....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus        72 -~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~  150 (285)
T cd05630          72 -KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV  150 (285)
T ss_pred             -CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeecccee
Confidence             55899999999875 4444432 33468999999999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......   .....+++.|+|||++.+.. ++.++||||+|+++|+|++|+.||
T Consensus       151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf  201 (285)
T cd05630         151 HVPEGQT---IKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPF  201 (285)
T ss_pred             ecCCCcc---ccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCC
Confidence            6543221   12346799999999997655 899999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.7e-36  Score=269.32  Aligned_cols=205  Identities=26%  Similarity=0.366  Sum_probs=163.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  216 (358)
                      ....+|++.+.||.|+||.||++.+.     .+++.||+|++...... .....+.+|+.++.++ +|+||+++++++..
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            34568999999999999999999753     34589999998754322 2234567899999999 89999999887654


Q ss_pred             cCcccccccCCCeEEEEeeccccC-hHHHHhcC-----------------------------------------------
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDHD-LMGLLESG-----------------------------------------------  248 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~-----------------------------------------------  248 (358)
                      .         +..+++||||++++ +.+.+...                                               
T Consensus        83 ~---------~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (337)
T cd05054          83 P---------GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL  153 (337)
T ss_pred             C---------CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence            2         45789999999974 44444221                                               


Q ss_pred             -------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCC
Q psy13988        249 -------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYT  315 (358)
Q Consensus       249 -------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~  315 (358)
                                   ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+..........
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~  233 (337)
T cd05054         154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  233 (337)
T ss_pred             hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhcc
Confidence                         1257888999999999999999999999999999999999999999999999998764332222222


Q ss_pred             CccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        316 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       316 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ...++..|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus       234 ~~~~~~~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~  276 (337)
T cd05054         234 DARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPY  276 (337)
T ss_pred             CCCCCccccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCC
Confidence            334467899999987655 8999999999999999998 99887

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-35  Score=256.40  Aligned_cols=199  Identities=28%  Similarity=0.408  Sum_probs=168.9

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|.+.+.||+|++|.||++.+..+++.|++|.+............+.+|+.+++.++||||+++++++.+          
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------   70 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD----------   70 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc----------
Confidence            4778899999999999999999999999999987654444445677889999999999999999877654          


Q ss_pred             CCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ++..|+||||+.+ ++.+.+... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~  150 (256)
T cd08529          71 KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL  150 (256)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEccccccee
Confidence            4589999999986 555555443 45789999999999999999999999999999999999999999999999999887


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  .....+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||
T Consensus       151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  201 (256)
T cd08529         151 LSDNTNF--ANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPF  201 (256)
T ss_pred             ccCccch--hhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCC
Confidence            6543221  12345688999999987655 889999999999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0986|consensus

Probab=100.00  E-value=6e-37  Score=265.92  Aligned_cols=202  Identities=26%  Similarity=0.345  Sum_probs=173.9

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC-chhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF-PITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+..-++||+|+||.|+-++-..||+.||.|++.+..-.... ....+.|-.+|++++.+.||.+--.|+.     
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-----  256 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-----  256 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-----
Confidence            3445667778999999999999999999999999988766433222 2346789999999999999999666665     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGM--VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                           .+.+|+|+..+.|+.+.+...+.  ..++++.++-++.+|+.||++||+.+||+||+||+|||+|+.|+++|+|+
T Consensus       257 -----kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  257 -----KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             -----CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeecc
Confidence                 45899999999998777665443  37999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|..+..+..   ..+.+||.+|||||++.+.. |+...|+|||||++|+|+.|+-||
T Consensus       332 GLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPF  386 (591)
T KOG0986|consen  332 GLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPF  386 (591)
T ss_pred             ceEEecCCCCc---cccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCch
Confidence            99998865543   34558899999999998776 999999999999999999999998

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=264.75  Aligned_cols=204  Identities=37%  Similarity=0.641  Sum_probs=170.3

Q ss_pred             CCcccccccCCcceeeEeeeeec--CCcEEEEEEeeccc-cCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLF--TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      +|.+.+.||.|++|.||++.+..  ++..||+|.+.... ........+.+|+.+++.++||||+++++++.+..     
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA-----   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC-----
Confidence            47889999999999999999988  89999999988643 22333456788999999999999999988876532     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhc----CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC----CCcEE
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLES----GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN----RGEVK  295 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~----~~~~~  295 (358)
                         +..+++||||+++++.+.+..    ....+++..++.++.||+.||.|||+.+++|+||||+||+++.    ++.++
T Consensus        76 ---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          76 ---DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             ---CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEE
Confidence               368999999999888776632    2236899999999999999999999999999999999999999    89999


Q ss_pred             EeecccceeccccCC-CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDR-QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++........ ........+++.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~  216 (316)
T cd07842         153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF  216 (316)
T ss_pred             ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence            999999987644322 112233456888999998877666889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=266.78  Aligned_cols=207  Identities=35%  Similarity=0.600  Sum_probs=171.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+.+|.+.+.||+|++|.||++.+..+++.||||.+.... .......+.+|+.+++.++|+||+++++++....     
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----   76 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS-----   76 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc-----
Confidence            3568999999999999999999999999999999986432 2223456778999999999999999998765432     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      +......|+|+|++++++.+.+..  ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.
T Consensus        77 ~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          77 FESFNDVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             ccccceEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence            223457899999999988776644  368999999999999999999999999999999999999999999999999988


Q ss_pred             eccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........ .......+++.|+|||.+.+...++.++||||+|+++|+|++|++||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f  210 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF  210 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            65433221 11233456889999998766555889999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-35  Score=258.05  Aligned_cols=201  Identities=27%  Similarity=0.368  Sum_probs=167.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++.+.||.|+||.||++.+..+++.||+|++......  ....+.+|+.+++.++||||+++++++..       
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-------   77 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLS-------   77 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEe-------
Confidence            456799999999999999999999999999999998754322  23456789999999999999999777654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         +...++||||++++.+..+......+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++.
T Consensus        78 ---~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~  154 (267)
T cd06646          78 ---REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA  154 (267)
T ss_pred             ---CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccce
Confidence               45889999999976555444444578999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......+++.|+|||.+..  ...++.++|+||+|+++|+|++|+.||
T Consensus       155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~  209 (267)
T cd06646         155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM  209 (267)
T ss_pred             eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCc
Confidence            7643221  1223456889999998742  233678999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4279|consensus

Probab=100.00  E-value=1.5e-36  Score=275.67  Aligned_cols=192  Identities=30%  Similarity=0.454  Sum_probs=164.2

Q ss_pred             cccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEE
Q psy13988        153 PLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL  232 (358)
Q Consensus       153 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~l  232 (358)
                      +||+|.||+||-++|..+...+|||-+.....  ...+-+.+|+.+.++++|.|||++++.+..          ++++-|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~se----------nGf~kI  649 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSE----------NGFFKI  649 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCC----------CCeEEE
Confidence            69999999999999999999999998875443  345667899999999999999999777544          678899


Q ss_pred             EeeccccChHH-HHhcCCCCC--ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEeecccceecccc
Q psy13988        233 VFEYMDHDLMG-LLESGMVDF--NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-RGEVKLADFGLARLYNAE  308 (358)
Q Consensus       233 v~e~~~~~l~~-~~~~~~~~~--~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~-~~~~~l~Dfg~~~~~~~~  308 (358)
                      .||-++|+.+. .+....+++  +|..+.-+.+||++||.|||++.|||||||-+||++.. .|.+||+|||.++....-
T Consensus       650 FMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  650 FMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             EeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            99999975444 556667777  78888888999999999999999999999999999964 689999999999876422


Q ss_pred             CCCCCCCCcccccccccccccc-CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        309 DRQRPYTNKVITLWYRPPELLL-GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       309 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        ......+.||..|||||++. |.+.|..++|||||||++.||.||+|||
T Consensus       730 --nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF  778 (1226)
T KOG4279|consen  730 --NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPF  778 (1226)
T ss_pred             --CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCe
Confidence              23345667899999999996 4456999999999999999999999998

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.9e-35  Score=259.88  Aligned_cols=192  Identities=28%  Similarity=0.368  Sum_probs=164.4

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|++++.||.|++|.||++.+..++..||+|.+..... ......+.+|++++++++||||+++++++..          
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------   70 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFV----------   70 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE----------
Confidence            57888999999999999999999999999999875422 2223467789999999999999999877765          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      .+..++||||++++.+...    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        71 ~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          71 ENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             CCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            4578999999998766544    247888899999999999999999999999999999999999999999999998654


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...    .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       147 ~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf  193 (279)
T cd06619         147 NSI----AKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPY  193 (279)
T ss_pred             ccc----ccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCc
Confidence            332    23346789999999987655 889999999999999999999997

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-35  Score=258.39  Aligned_cols=199  Identities=45%  Similarity=0.828  Sum_probs=169.5

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      |++.+.||.|++|.||++.+..+|..||+|++............+.+|+.+++.++|||++++++++.+          +
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~----------~   70 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS----------E   70 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc----------C
Confidence            678899999999999999999999999999998665444444567889999999999999999887754          4


Q ss_pred             CeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        228 GSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      +..|+||||+++++...+.... ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        71 ~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          71 NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             CeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            6899999999887777665433 368999999999999999999999999999999999999999999999999987654


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  ......+++.|+|||++.+...++.++|+||||+++|+|++|++||
T Consensus       151 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  200 (283)
T cd07835         151 VPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF  200 (283)
T ss_pred             CCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence            3321  2233355888999998876555788999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-35  Score=260.54  Aligned_cols=197  Identities=26%  Similarity=0.364  Sum_probs=164.2

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      |++.+.||.|+||.||++.+..+++.||+|.+........ ....+.+|+++++.++|+||+.+.+.+..          
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----------   71 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET----------   71 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec----------
Confidence            6678899999999999999999999999999875432221 22346789999999999999999766654          


Q ss_pred             CCeEEEEeeccccC-hHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        227 KGSFYLVFEYMDHD-LMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       227 ~~~~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ++..++||||+.+. +...+.. ....+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~  151 (285)
T cd05632          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK  151 (285)
T ss_pred             CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence            55899999999975 4444432 334699999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......   .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||
T Consensus       152 ~~~~~~---~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~  201 (285)
T cd05632         152 IPEGES---IRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPF  201 (285)
T ss_pred             cCCCCc---ccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCC
Confidence            543221   22346799999999987654 889999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1e-35  Score=259.84  Aligned_cols=202  Identities=19%  Similarity=0.270  Sum_probs=162.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeee---cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ....|++.+.||+|+||.||++...   ..+..||+|.++..... .....+.+|+.+++.++||||+++++++..    
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----   77 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITR----   77 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEec----
Confidence            3457889999999999999999764   45678999998754322 223467889999999999999999877654    


Q ss_pred             cccccCCCeEEEEeeccccChHHH-HhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGL-LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            ++..++||||++++++.. +......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++++||
T Consensus        78 ------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~df  151 (266)
T cd05064          78 ------GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF  151 (266)
T ss_pred             ------CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCC
Confidence                  457999999999865554 4444457899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |.+........ .......++..|+|||.+.+.. ++.++|||||||++|++++ |..||
T Consensus       152 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~  209 (266)
T cd05064         152 RRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPY  209 (266)
T ss_pred             cccccccccch-hcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCc
Confidence            98765422211 1111223467899999887654 8999999999999999875 99997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.9e-35  Score=260.72  Aligned_cols=201  Identities=43%  Similarity=0.788  Sum_probs=168.3

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|.+.+.||.|++|.||++.+..+++.||+|.+............+.+|+++++.++|+||+++++++.+         
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS---------   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec---------
Confidence            46889999999999999999999999999999987654433344567889999999999999999877754         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEeecccce
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLAR  303 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~l~Dfg~~~  303 (358)
                       +...|+||||+++++...+.... ..+++..+..++.||+.||+|||+++++|+||+|+||+++.+ +.++|+|||++.
T Consensus        73 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         73 -EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             -CCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccc
Confidence             55899999999988888775433 346788888999999999999999999999999999999864 579999999997


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  .......+++.|+|||.+.+...++.++||||+|+++|+|+||++||
T Consensus       152 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf  204 (294)
T PLN00009        152 AFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF  204 (294)
T ss_pred             ccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            654321  12233456889999999876666889999999999999999999987

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-35  Score=259.32  Aligned_cols=201  Identities=25%  Similarity=0.359  Sum_probs=167.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+.+.||.|++|.||++.+..+++.||+|.++.....  ....+.+|+.+++.++||||+++++++..       
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-------   77 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLR-------   77 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEe-------
Confidence            345789999999999999999999999999999998754322  23456789999999999999999777654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         .+.+|+||||++++.+..+......+++..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus        78 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          78 ---RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             ---CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeee
Confidence               55899999999975555554445579999999999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCCCCCCcccccccccccccc--CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLL--GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  .......+++.|+|||++.  ....++.++|+|||||++|+|++|..||
T Consensus       155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~  209 (267)
T cd06645         155 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM  209 (267)
T ss_pred             EccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCc
Confidence            664322  1123446789999999874  2234788999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2e-35  Score=261.24  Aligned_cols=196  Identities=26%  Similarity=0.391  Sum_probs=166.4

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|++.+.||.|++|.||++.+..+++.||+|.+...... ......+.+|+++++.++||||+++++++.+        
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   72 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--------   72 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--------
Confidence            3688999999999999999999999999999998754321 2234567889999999999999999777654        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ++..|+||||+++ ++.+.+.. ...+++..+..++.||+.||++||++|++|+||+|.||+++.++.++|+|||++.
T Consensus        73 --~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          73 --DSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             --CCeEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence              5689999999965 55555543 3579999999999999999999999999999999999999999999999999988


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....     .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       150 ~~~~~-----~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  198 (290)
T cd05580         150 RVKGR-----TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPF  198 (290)
T ss_pred             ccCCC-----CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCC
Confidence            76443     22335689999999887654 788999999999999999999997

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.8e-35  Score=267.10  Aligned_cols=206  Identities=40%  Similarity=0.664  Sum_probs=171.8

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ....+|.+.+.||.|++|.||++.+..+++.||+|++............+.+|+.+++++ +||||+++++++...    
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~----   79 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE----   79 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC----
Confidence            355789999999999999999999999999999998864322222334567899999999 999999998877542    


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          ++...|+||||+++++...+...  .+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||+
T Consensus        80 ----~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~  153 (337)
T cd07852          80 ----NDKDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL  153 (337)
T ss_pred             ----CCceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence                24478999999998887777554  688899999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCC---CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQ---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.........   .......+++.|+|||.+.+...++.++|+||||+++|+|++|++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf  213 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF  213 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC
Confidence            9866433221   22234457889999998876666889999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.1e-35  Score=259.88  Aligned_cols=205  Identities=40%  Similarity=0.710  Sum_probs=170.0

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      +|++.+.||.|++|.||++.+..+++.||||.+............+.+|+.+++.+ +|+||+++++++.....     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~-----~   76 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK-----N   76 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC-----C
Confidence            68899999999999999999999999999999876544444445678899999999 46999999887765321     1


Q ss_pred             CCCeEEEEeeccccChHHHHhcC----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEeecc
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESG----MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-RGEVKLADFG  300 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~-~~~~~l~Dfg  300 (358)
                      .....|+||||+++++.+.+...    ...+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||
T Consensus        77 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          77 GKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            23358999999999887776532    245899999999999999999999999999999999999998 8899999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.......  .......+++.|+|||++.+...++.++|+||||+++|+|++|.+||
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~  212 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF  212 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence            988654322  12233355888999999876555789999999999999999999987

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.6e-35  Score=258.80  Aligned_cols=199  Identities=42%  Similarity=0.791  Sum_probs=169.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|++++.||.|++|.||++.+..+++.||||.+..... ......+.+|+.+++.++|+||+++++++.+          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------   69 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHT----------   69 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEee----------
Confidence            47889999999999999999999999999999876543 2234466789999999999999999877765          


Q ss_pred             CCeEEEEeeccccChHHHHhcCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGM--VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .+..++||||+++++.+.+....  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        70 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~  149 (284)
T cd07836          70 ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARA  149 (284)
T ss_pred             CCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence            45789999999998888775433  4689999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......+++.|+|||.+.+...++.++|+||||+++|+|++|++||
T Consensus       150 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~  201 (284)
T cd07836         150 FGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF  201 (284)
T ss_pred             hcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            543221  2233455888999999876655788999999999999999999987

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.8e-35  Score=261.00  Aligned_cols=206  Identities=26%  Similarity=0.433  Sum_probs=172.1

Q ss_pred             ccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        137 PIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       137 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      ...+.+....+|.+++.||.|++|.||++.+..++..|++|.+......  ....+.+|+.+++.++|+||+++++.+..
T Consensus        11 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~   88 (296)
T cd06654          11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV   88 (296)
T ss_pred             hccccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence            3445667778999999999999999999999999999999998764332  24567889999999999999999777654


Q ss_pred             cCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                                +...|+||||+.++.+..+... ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|
T Consensus        89 ----------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl  157 (296)
T cd06654          89 ----------GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKL  157 (296)
T ss_pred             ----------CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEE
Confidence                      4589999999987544444332 35789999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++.........  .....+++.|+|||.+.+.. ++.++|||||||++|+|++|++||
T Consensus       158 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf  216 (296)
T cd06654         158 TDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPY  216 (296)
T ss_pred             Cccccchhccccccc--cCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCC
Confidence            999998765433211  22345688999999887654 789999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.8e-35  Score=254.13  Aligned_cols=195  Identities=24%  Similarity=0.358  Sum_probs=158.0

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY  231 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~  231 (358)
                      +.||+|++|.||++.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++..          ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------~~~~~   69 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----------KQPIY   69 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC----------CCCeE
Confidence            47999999999999999999999999876432 22233467899999999999999999776654          55789


Q ss_pred             EEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        232 LVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       232 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                      +||||+.++ +.+.+......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        70 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          70 IVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY  149 (252)
T ss_pred             EEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence            999999874 5555544445689999999999999999999999999999999999999999999999999876543221


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .........+..|+|||.+.+.. ++.++||||||+++|+|++ |.+||
T Consensus       150 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~  197 (252)
T cd05084         150 ASTGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPY  197 (252)
T ss_pred             cccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCc
Confidence            11111112246799999887654 8899999999999999998 88886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-35  Score=255.26  Aligned_cols=204  Identities=27%  Similarity=0.401  Sum_probs=166.7

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC---CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK---EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..|.+.+.||+|++|.||++.+..++..||+|.+......   ......+.+|+++++.++|+||+++++++.+..    
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~----   77 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE----   77 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC----
Confidence            4688999999999999999999999999999987643211   222346778999999999999999988775532    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ++.+++|+||+.+..+.........+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus        78 ----~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          78 ----EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             ----CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence                4578999999987544444334446889999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCC-CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDR-QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +....... ........++..|+|||.+.+.. ++.++|+||||+++|+|++|++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  209 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPW  209 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCC
Confidence            86543211 11112345688999999987654 789999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.3e-35  Score=260.16  Aligned_cols=202  Identities=25%  Similarity=0.348  Sum_probs=167.7

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..+..|++++.||.|++|.||++.+..++..|++|.+.....  .....+.+|+.+++.++|+||+++++++..      
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVKLLGAFYW------   80 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCcEeeeEEEEEe------
Confidence            345779999999999999999999999999999999875422  224567789999999999999999777654      


Q ss_pred             cccCCCeEEEEeeccccChHHHH-hcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          ++..|+||||++++++..+ ......+++..+..++.|++.|+.|||+.+++|+||||+||+++.++.++|+|||+
T Consensus        81 ----~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~  156 (292)
T cd06644          81 ----DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV  156 (292)
T ss_pred             ----CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcc
Confidence                5589999999998665544 44455789999999999999999999999999999999999999999999999998


Q ss_pred             ceeccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.......  .......+++.|+|||.+.+    ...++.++|+|||||++|+|++|.+||
T Consensus       157 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  215 (292)
T cd06644         157 SAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH  215 (292)
T ss_pred             ceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCC
Confidence            87543221  11233456889999998852    233678999999999999999999997

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.6e-35  Score=253.74  Aligned_cols=200  Identities=26%  Similarity=0.404  Sum_probs=167.7

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|++++.||.|++|.||++.+..+++.||+|.+............+.+|+++++.++|+|++++++.+..         .
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------~   71 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG---------E   71 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC---------C
Confidence            4889999999999999999999999999999997655444445567889999999999999999766532         2


Q ss_pred             CCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      +..+|+||||+++ ++.+.+... ...+++.++..++.|++.|+++||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~  151 (257)
T cd08223          72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV  151 (257)
T ss_pred             CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEE
Confidence            4468999999986 555555442 34589999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......+++.|+|||++.+.. ++.++|+||+|+++|+|++|+.||
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~  202 (257)
T cd08223         152 LENQCD--MASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAF  202 (257)
T ss_pred             ecccCC--ccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCC
Confidence            643322  123345688999999987654 888999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.1e-35  Score=255.57  Aligned_cols=198  Identities=27%  Similarity=0.368  Sum_probs=169.2

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|++.+.||.|++|.||++.+..++..||+|.+....... .....+.+|++++++++||||+++++++..         
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD---------   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC---------
Confidence            4788999999999999999999999999999998654322 334577889999999999999999887765         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       +...++|+||+.|+.+........++++..+..++.||++||.|||+++++|+||+|+||+++.++.++|+|||.+...
T Consensus        72 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          72 -EENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             -CCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence             4589999999998655555444468999999999999999999999999999999999999999999999999998876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....   .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||
T Consensus       151 ~~~~~---~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~  199 (258)
T cd05578         151 TPDTL---TTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPY  199 (258)
T ss_pred             CCCcc---ccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCC
Confidence            44321   23345688899999987655 889999999999999999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4e-35  Score=256.07  Aligned_cols=204  Identities=28%  Similarity=0.424  Sum_probs=165.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC---CchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG---FPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..|.+.+.||+|++|.||++.+..++..|++|.+........   ....+.+|+.+++.++||||+++++++....    
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   77 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA----   77 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC----
Confidence            468889999999999999999999999999999875532221   2235678999999999999999987765422    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          +..+++++||+++..+.........+++...+.++.|++.||++||+++++|+||+|+||+++.++.++|+|||++
T Consensus        78 ----~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          78 ----EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             ----CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence                4578999999987544444334446899999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCC-CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDR-QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........ ........++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf  209 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW  209 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCc
Confidence            76533211 11112234688999999987654 889999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.7e-35  Score=259.47  Aligned_cols=201  Identities=26%  Similarity=0.420  Sum_probs=163.4

Q ss_pred             CCCcccccccCCcceeeEeeeeecCC-----cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTD-----ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .+|++++.||+|++|.||++.+...+     ..||+|.+.... .......+.+|+.+++.++||||+++++++.+    
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK----   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----
Confidence            46889999999999999999986655     789999886432 22223457889999999999999999777654    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGM---------------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS  284 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~  284 (358)
                            .+..+++|||+++ ++.+.+....               ..+++..+..++.|++.||+|||+++++|+||||+
T Consensus        80 ------~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~  153 (283)
T cd05048          80 ------EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAAR  153 (283)
T ss_pred             ------CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccc
Confidence                  4578999999986 5555553321               35788899999999999999999999999999999


Q ss_pred             CEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       285 Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||+++.++.++|+|||++................+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||
T Consensus       154 Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~  227 (283)
T cd05048         154 NCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPY  227 (283)
T ss_pred             eEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999998664433222233445578899999887654 8999999999999999998 99887

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.6e-35  Score=264.94  Aligned_cols=199  Identities=24%  Similarity=0.331  Sum_probs=160.4

Q ss_pred             ccccccCC--cceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        150 LMEPLAAG--GLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       150 ~~~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      ++++||+|  ++++||++.+..+++.||+|++............+.+|+.+++.++||||+++++++..          +
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----------~   71 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----------D   71 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE----------C
Confidence            57899999  67899999999999999999987654443334566789999999999999999777765          5


Q ss_pred             CeEEEEeeccccChH-HHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        228 GSFYLVFEYMDHDLM-GLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~-~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      +..++||||++++.+ +.+.. ....+++..++.++.|++.||+|||+++|+|+||||+||+++.++.++++||+.+...
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          72 NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            589999999997544 44433 2345899999999999999999999999999999999999999999999999865543


Q ss_pred             cccCCCC-----CCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQR-----PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......     ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  210 (327)
T cd08227         152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  210 (327)
T ss_pred             ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            2211100     11122457789999998753 34889999999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.1e-35  Score=260.79  Aligned_cols=207  Identities=26%  Similarity=0.434  Sum_probs=173.4

Q ss_pred             cccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhc
Q psy13988        136 APIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  215 (358)
                      +.+...+....+|.+++.||.|++|.||++.+..+++.||+|.+......  ....+.+|+.+++.++|+||+++++++.
T Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (297)
T cd06656           9 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYL   86 (297)
T ss_pred             HhhcccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34556677789999999999999999999999999999999998754332  2356778999999999999999977765


Q ss_pred             ccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                      .          ++..|+||||+++..+..+... ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus        87 ~----------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~  155 (297)
T cd06656          87 V----------GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVK  155 (297)
T ss_pred             c----------CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            4          5589999999987555544332 3578999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||.+.........  .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||
T Consensus       156 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf  215 (297)
T cd06656         156 LTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPY  215 (297)
T ss_pred             ECcCccceEccCCccC--cCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999998865433221  12345688999999987654 789999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-35  Score=256.09  Aligned_cols=206  Identities=20%  Similarity=0.252  Sum_probs=163.2

Q ss_pred             CcccccccCCcceeeEeeeeecC---CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFT---DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      |++.+.||+|+||.||.+....+   +..||+|+++...........+.+|+..++.++|+||+++++++....    ..
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~   76 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS----SL   76 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC----cc
Confidence            56889999999999999987653   488999998765443333456788999999999999999988776532    11


Q ss_pred             cCCCeEEEEeeccccC-hHHHHhc-----CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLES-----GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                      ......++|+||+.++ +...+..     ....+++..+..++.|++.||+|||+++++|+||||+||++++++.++|+|
T Consensus        77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence            2334689999999874 4444422     223689999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||+++................+..|+|||.+.+.. ++.++||||||+++|+|++ |.+||
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~  216 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPY  216 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCC
Confidence            99998765443322222223467899999886544 8899999999999999999 88886

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=258.06  Aligned_cols=202  Identities=60%  Similarity=0.994  Sum_probs=173.1

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      |.+++.||.|++|.||++.+..+++.||+|.+............+.+|+.+++.++|+|++++++++....        .
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------~   72 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--------K   72 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--------C
Confidence            67889999999999999999999999999999876534444556788999999999999999988876531        3


Q ss_pred             CeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccc
Q psy13988        228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA  307 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~  307 (358)
                      +..++|+||+++++...+......+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        73 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          73 GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             CcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            68999999999988877766656799999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ... .......++..|+|||.+.+...++.++||||||+++|+|++|+.||
T Consensus       153 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~  202 (287)
T cd07840         153 RNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF  202 (287)
T ss_pred             CCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCC
Confidence            432 12233455788999998876555889999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.1e-35  Score=261.38  Aligned_cols=196  Identities=28%  Similarity=0.355  Sum_probs=165.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|++.+.||+|+||.||++.+..++..||+|.+..... ......+.+|++++++++||||+++++++..          
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------   70 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYS----------   70 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----------
Confidence            58899999999999999999999999999998875422 2223457789999999999999999877754          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      ++.+++||||++++.+..+......+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus        71 ~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          71 DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             CCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            55899999999975555554444678999999999999999999997 69999999999999999999999999998755


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....    .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       151 ~~~~----~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~  198 (308)
T cd06615         151 IDSM----ANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPI  198 (308)
T ss_pred             cccc----cccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCC
Confidence            3322    12345688999999987654 889999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.9e-35  Score=260.00  Aligned_cols=205  Identities=26%  Similarity=0.450  Sum_probs=171.6

Q ss_pred             cccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       138 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      +...+....+|.+++.||.|++|.||++.+..+++.|++|.+......  ....+.+|+.+++.++|+||+++++++.. 
T Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   87 (296)
T cd06655          11 IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLV-   87 (296)
T ss_pred             HHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEec-
Confidence            334455667899999999999999999999999999999998754322  24567889999999999999999877654 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                               +..+|+|+||+.++.+..+... ..+++.++..++.|++.||++||+.|++|+||+|+||+++.++.++|+
T Consensus        88 ---------~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~  157 (296)
T cd06655          88 ---------GDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLT  157 (296)
T ss_pred             ---------CceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEc
Confidence                     5589999999998666655443 358999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++.........  .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||
T Consensus       158 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf  215 (296)
T cd06655         158 DFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPY  215 (296)
T ss_pred             cCccchhccccccc--CCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            99998765433221  12345688999999887654 789999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.8e-35  Score=263.20  Aligned_cols=206  Identities=37%  Similarity=0.636  Sum_probs=172.2

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|.+.+.||.|++|.||++.+..+++.||||.+............+.+|+.+++.++|+||+++++++.....     
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-----   78 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR-----   78 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc-----
Confidence            457999999999999999999999999999999987543333334466789999999999999999988765321     


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ......|+|+||+++++.+.+... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..
T Consensus        79 ~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          79 EAFNDVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cccCcEEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            122468999999998887776543 5799999999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  .......++..|+|||.+.....++.++||||||+++|+|++|++||
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  209 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF  209 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC
Confidence            64332  11233456888999998875445889999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=254.15  Aligned_cols=200  Identities=28%  Similarity=0.394  Sum_probs=168.8

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|.+.+.||.|++|.||++.+..+++.+++|.+......  ....+.+|+.+++.++||||+++++++.+        
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--------   71 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLR--------   71 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEe--------
Confidence            35788999999999999999999999999999998765333  34577899999999999999999877654        


Q ss_pred             cCCCeEEEEeeccccChHHHH-hcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        +..+|++|||++++.+..+ ......+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+.
T Consensus        72 --~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          72 --RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccch
Confidence              5589999999998655554 4444679999999999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCCCCCCccccccccccccccCC--CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......++..|+|||.+.+.  ..++.++|+||||+++|+|++|++||
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~  204 (262)
T cd06613         150 QLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM  204 (262)
T ss_pred             hhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence            6543321  11234568889999998654  24788999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.4e-35  Score=258.56  Aligned_cols=194  Identities=18%  Similarity=0.212  Sum_probs=159.9

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC-chhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF-PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF  230 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~  230 (358)
                      ..+++|+++.||++..  +|+.||||.+......... ...+.+|+.++++++||||+++++++.+..      ++...+
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~------~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV------DDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc------cCCCce
Confidence            4789999999999987  7999999998765332211 345679999999999999999998876511      123578


Q ss_pred             EEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       231 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      ++||||++++.+..+......+++.....++.|++.||.+||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            9999999986555554555678999999999999999999998 499999999999999999999999999988654322


Q ss_pred             CCCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                           ....++..|+|||++.+. ..++.++||||||+++|+|++|+.||
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf  222 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF  222 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCC
Confidence                 234568899999998752 34899999999999999999999998

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9e-35  Score=255.95  Aligned_cols=198  Identities=36%  Similarity=0.570  Sum_probs=166.7

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCcccccccC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      |++++.||.|++|.||++.+..++..||+|+++...... ......+|+.+++++. |+|++++++++.+..        
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--------   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRK--------   71 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCC--------
Confidence            678899999999999999999999999999987543222 2224457888898884 999999988876531        


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      .+..++||||+++++++.+......+++..++.++.|++.||+|||+.|++|+||+|+||+++. +.++|+|||++....
T Consensus        72 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          72 TGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             CCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            3688999999999999888766667999999999999999999999999999999999999999 999999999998664


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....   .....++..|+|||.+.....++.++||||+||++|+|++|.+||
T Consensus       151 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~  199 (282)
T cd07831         151 SKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF  199 (282)
T ss_pred             cCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC
Confidence            3322   123346889999998765555788999999999999999999987

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.4e-35  Score=255.34  Aligned_cols=200  Identities=27%  Similarity=0.420  Sum_probs=165.6

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ++|.+.+.||.|++|.||++.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++.+        
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   73 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--------   73 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--------
Confidence            5789999999999999999999999999999988653322 2223457789999999999999999877654        


Q ss_pred             cCCCeEEEEeeccccChHH-HHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        225 KDKGSFYLVFEYMDHDLMG-LLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~-~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                        .+..++|+||++++.+. .+.   .....+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||
T Consensus        74 --~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          74 --DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             --CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccc
Confidence              45889999999974443 332   233458899999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........  ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||
T Consensus       152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~  206 (267)
T cd08228         152 LGRFFSSKTT--AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPF  206 (267)
T ss_pred             cceeccchhH--HHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCC
Confidence            9887643321  112335688899999987655 788999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.9e-35  Score=256.35  Aligned_cols=200  Identities=21%  Similarity=0.302  Sum_probs=161.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCc----EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDE----LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .+|++++.||.|+||.||++....+++    .|++|.+..... ......+..|+..++.+.||||+++++++..     
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence            467889999999999999999877776    477777653221 1222456678888899999999999876532     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            ...++|+|++.+ ++.+.+......+++..+..++.||+.||+|||+++++|+||||+||+++.++.++|+|||
T Consensus        81 ------~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          81 ------ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             ------CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCc
Confidence                  346789999885 6666666656678999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++...............++..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~  212 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPY  212 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCC
Confidence            998765433322233444577899999987654 8999999999999999998 99887

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.4e-35  Score=267.62  Aligned_cols=204  Identities=25%  Similarity=0.360  Sum_probs=162.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecC-----CcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFT-----DELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  216 (358)
                      ....+|.+.+.||.|+||.||++.+...     +..||||++..... ....+.+.+|+.+++.+. ||||+++++++..
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            4466888999999999999999987433     35799999865432 223456789999999995 9999999777754


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcC-----------------------------------------------
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG-----------------------------------------------  248 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------------------------------------------  248 (358)
                                .+..|+||||+.+ +|.+.+...                                               
T Consensus       113 ----------~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (400)
T cd05105         113 ----------SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ  182 (400)
T ss_pred             ----------CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence                      4579999999986 454444221                                               


Q ss_pred             ------------------------------------------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecC
Q psy13988        249 ------------------------------------------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD  280 (358)
Q Consensus       249 ------------------------------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~D  280 (358)
                                                                      ...+++..+..++.||+.||+|||+++++|+|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~d  262 (400)
T cd05105         183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRD  262 (400)
T ss_pred             ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence                                                            12467788889999999999999999999999


Q ss_pred             CCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       281 lkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |||+||+++.++.++|+|||++................+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~  340 (400)
T cd05105         263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPY  340 (400)
T ss_pred             CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999998664433222223334578899999987654 8899999999999999997 88886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1e-34  Score=258.79  Aligned_cols=204  Identities=31%  Similarity=0.465  Sum_probs=171.9

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      .........|.+.+.||.|++|.||++.+..+++.||+|.+...... ......+.+|+.+++.++||||+++.+++.+ 
T Consensus         8 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-   86 (307)
T cd06607           8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-   86 (307)
T ss_pred             hcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-
Confidence            34455667799999999999999999999999999999998654322 1222457789999999999999999877764 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                               .+..|+|+||+.|++.+.+......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+
T Consensus        87 ---------~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~  157 (307)
T cd06607          87 ---------EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLA  157 (307)
T ss_pred             ---------CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEe
Confidence                     45789999999998888776555679999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++......      ....+++.|+|||++.+  ...++.++||||||+++|+|++|++||
T Consensus       158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~  214 (307)
T cd06607         158 DFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  214 (307)
T ss_pred             ecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCC
Confidence            99998765322      23345788999998742  344788999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=254.73  Aligned_cols=199  Identities=46%  Similarity=0.835  Sum_probs=173.5

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      |.+++.||.|++|.||++.+..+++.+++|.+............+.+|+.+++.++|+||+++++++..          +
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------~   70 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH----------K   70 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc----------C
Confidence            567889999999999999999999999999987665444445677889999999999999999888765          4


Q ss_pred             CeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccc
Q psy13988        228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA  307 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~  307 (358)
                      ...++|+||+++++...+......+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        71 ~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          71 GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             CCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            58999999999988888877666899999999999999999999999999999999999999999999999999987754


Q ss_pred             cCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..  .......++..|+|||.+.+...++.++|+||||+++|+|+||++||
T Consensus       151 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~  199 (283)
T cd05118         151 PV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF  199 (283)
T ss_pred             Cc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            43  12233456888999999877645899999999999999999999887

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0696|consensus

Probab=100.00  E-value=8.1e-36  Score=256.34  Aligned_cols=202  Identities=22%  Similarity=0.332  Sum_probs=169.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ...+|..+.+||+|+||.|.++..+.+.+.||||+++.+.-- +...+-.+.|-++|..- +-|.++++..+|+..+   
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD---  423 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD---  423 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh---
Confidence            345677889999999999999999999999999999876322 11222335577777666 5678999999988754   


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                             .+|+||||+.|+.+-+..++.+.+.|..+.-++..|+.||-+||++||++||||.+|||+|.+|++||.|||+
T Consensus       424 -------RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  424 -------RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             -------heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccc
Confidence                   8999999999876666666777899999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.--..  ..+...++|||.|+|||++.-.. |+.++|+||+|+++||||.|++||
T Consensus       497 cKEni~~--~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPF  550 (683)
T KOG0696|consen  497 CKENIFD--GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPF  550 (683)
T ss_pred             ccccccC--CcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCC
Confidence            9853222  23345678899999999988655 999999999999999999999998

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-34  Score=251.47  Aligned_cols=199  Identities=31%  Similarity=0.431  Sum_probs=170.3

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|++++.||.|++|.|+.+.+..+++.+++|.+............+.+|++++++++|+||+++++++.+          
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------   70 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD----------   70 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec----------
Confidence            5889999999999999999999999999999987665444445677899999999999999999877765          


Q ss_pred             CCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .+..++||||+++ ++.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        71 ~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~  150 (256)
T cd08221          71 DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI  150 (256)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEE
Confidence            4589999999986 565555443 45689999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||
T Consensus       151 ~~~~~~--~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~  201 (256)
T cd08221         151 LGSEYS--MAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTF  201 (256)
T ss_pred             cccccc--cccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCC
Confidence            644432  123345689999999987655 788999999999999999999887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.5e-35  Score=254.77  Aligned_cols=205  Identities=21%  Similarity=0.289  Sum_probs=161.5

Q ss_pred             cccccccCCcceeeEeeeeecCCc--EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        149 PLMEPLAAGGLSLNNFSVSLFTDE--LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       149 ~~~~~lg~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .+.+.||+|+||.||++.+..++.  .||+|.++...........+.+|+.+++.++|+||+++++++.....    ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~   77 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE----SEG   77 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc----ccC
Confidence            467899999999999999877765  69999887654333334567889999999999999999887643221    011


Q ss_pred             CCeEEEEeecccc-ChHHHHhc-----CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLES-----GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                      ....++||||+.+ ++...+..     ....+++..+..++.||+.||+|||+++|+|+||||+||+++.++.++|+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence            2357899999986 45444421     22348899999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++.+.............+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~  215 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPY  215 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCC
Confidence            998765433221122223467899999887654 8999999999999999999 78887

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-34  Score=253.22  Aligned_cols=201  Identities=28%  Similarity=0.485  Sum_probs=165.8

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-------CchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-------FPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      +|.+...||.|++|.||++.+..++..||+|.+........       ....+.+|+.+++.++||||+++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            47788999999999999999999999999998875533221       12356789999999999999999776654   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             .+..++||||+++..+..+......+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+||
T Consensus        78 -------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          78 -------ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             -------CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEeccc
Confidence                   5588999999988655555444567899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCC----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQ----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |.+.........    .......++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  212 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPF  212 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCC
Confidence            998876532211    1112234688899999987654 788999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=254.22  Aligned_cols=198  Identities=28%  Similarity=0.377  Sum_probs=167.6

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++.+.||.|++|.||++.+..+++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+         
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------   70 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLK---------   70 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEE---------
Confidence            368899999999999999999999999999999876532 2233467789999999999999999877654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       +...|+|+||+.++.+..+.... .+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        71 -~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          71 -GSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             -CCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence             45899999999875444443332 7899999999999999999999999999999999999999999999999999877


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  ......+++.|+|||.+.+.. ++.++||||||+++|+|+||++||
T Consensus       149 ~~~~~--~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~  198 (274)
T cd06609         149 TSTMS--KRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPL  198 (274)
T ss_pred             ccccc--ccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCc
Confidence            54421  123345688899999998765 899999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.7e-35  Score=255.43  Aligned_cols=201  Identities=20%  Similarity=0.307  Sum_probs=163.3

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCc----EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDE----LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ..+|.+++.||.|+||.||++....+++    .||+|.+..... ......+.+|+.+++.++|+||+++++++..    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC----
Confidence            4578889999999999999999877776    489998864422 2223467789999999999999999877653    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ...++++|++++ ++.+.+......+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+||
T Consensus        81 -------~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~df  153 (279)
T cd05109          81 -------STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDF  153 (279)
T ss_pred             -------CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCC
Confidence                   246789999985 666666555567899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++...............+++.|+|||...+.. ++.++||||||+++|+|++ |.+||
T Consensus       154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~  212 (279)
T cd05109         154 GLARLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPY  212 (279)
T ss_pred             CceeecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCC
Confidence            9998765432222222233467899999987654 8899999999999999998 88887

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-34  Score=255.50  Aligned_cols=197  Identities=25%  Similarity=0.355  Sum_probs=164.2

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      |++.+.||.|++|.||++.+..++..+++|.+.....  .....+.+|+++++.++|+||+++++++..          +
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----------~   74 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYY----------E   74 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEee----------C
Confidence            6788999999999999999999999999999865432  223467789999999999999999777654          4


Q ss_pred             CeEEEEeeccccChHHHH-hcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        228 GSFYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      +..|+|+||++++.+..+ .....++++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          75 NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccc
Confidence            588999999998666554 4445579999999999999999999999999999999999999999999999999987653


Q ss_pred             ccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...  .......+++.|+|||++..    ...++.++|+||+||++|+|++|++||
T Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~  208 (282)
T cd06643         155 RTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH  208 (282)
T ss_pred             ccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCc
Confidence            221  11233456889999998742    234778999999999999999999997

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.8e-35  Score=256.48  Aligned_cols=202  Identities=28%  Similarity=0.439  Sum_probs=163.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeec-----CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLF-----TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..+|.+.+.||+|++|.||++.+..     +++.||||.+...... .....+.+|+++++.++|+||+++++++..   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTE---   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEec---
Confidence            4568899999999999999998743     4688999998754322 223578899999999999999999877765   


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhcC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLESG-------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN  285 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~-------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~N  285 (358)
                             ....++||||+.++ +.+.+...             ...+++..+..++.|++.|+.+||++|++|+||||+|
T Consensus        80 -------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~n  152 (280)
T cd05049          80 -------GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRN  152 (280)
T ss_pred             -------CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccce
Confidence                   45799999999874 44444322             2347888999999999999999999999999999999


Q ss_pred             EEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       286 ill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++.++.++|+|||++................+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       153 ili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~  225 (280)
T cd05049         153 CLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPW  225 (280)
T ss_pred             EEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCC
Confidence            999999999999999987654332222222334478899999987655 8999999999999999998 99987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.7e-35  Score=252.32  Aligned_cols=198  Identities=32%  Similarity=0.484  Sum_probs=166.9

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|++|.||++.+..++..||+|.++..... ...+.+.+|+.+++.++|+||+++++++.+          
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------   69 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEA----------   69 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEE----------
Confidence            478899999999999999999999999999998754322 234567789999999999999999777654          


Q ss_pred             CCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ++.+|+||||+++ ++...+.. ....+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+..
T Consensus        70 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~  149 (255)
T cd08219          70 DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL  149 (255)
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCccee
Confidence            5689999999986 56665543 344689999999999999999999999999999999999999999999999999886


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  .....+++.|+|||++.+.. ++.++|+||||+++|+|++|..||
T Consensus       150 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~  200 (255)
T cd08219         150 LTSPGAY--ACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPF  200 (255)
T ss_pred             ecccccc--cccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCC
Confidence            6433221  12345688899999987654 889999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=258.74  Aligned_cols=201  Identities=25%  Similarity=0.304  Sum_probs=166.4

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      +|++.+.||.|++|.||++.+..+++.||+|.+....... .....+.+|+++++.++|+||+++++.+.+         
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------   72 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT---------   72 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec---------
Confidence            6888999999999999999999999999999987653332 233467889999999999999999777654         


Q ss_pred             CCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                       +...|+||||+.| ++.+.+... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus        73 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~  151 (316)
T cd05574          73 -ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK  151 (316)
T ss_pred             -CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence             5589999999987 555555432 3568999999999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCC---------------------------CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCC
Q psy13988        304 LYNAEDRQR---------------------------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP  356 (358)
Q Consensus       304 ~~~~~~~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~  356 (358)
                      .........                           ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~  230 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTT  230 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCC
Confidence            653321110                           111235688899999987655 7899999999999999999999


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       231 pf  232 (316)
T cd05574         231 PF  232 (316)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.8e-35  Score=252.31  Aligned_cols=194  Identities=23%  Similarity=0.389  Sum_probs=156.9

Q ss_pred             cccCCcceeeEeeee--ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeE
Q psy13988        153 PLAAGGLSLNNFSVS--LFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF  230 (358)
Q Consensus       153 ~lg~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~  230 (358)
                      .||+|+||.||++..  ..++..||+|+++...........+.+|+.+++.++||||+++++++..           ...
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----------~~~   70 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-----------ESW   70 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----------CCc
Confidence            689999999999864  4567899999987554433344567889999999999999999776532           356


Q ss_pred             EEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       231 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                      ++||||++++.+..+......+++..+..++.|++.||++||++|++|+||||.||+++.++.++|+|||++........
T Consensus        71 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~  150 (257)
T cd05116          71 MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN  150 (257)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence            89999999765544444445789999999999999999999999999999999999999999999999999987644322


Q ss_pred             C-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        311 Q-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       311 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      . .......++..|+|||.+.... ++.++|+||||+++|+|++ |.+||
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~  199 (257)
T cd05116         151 YYKAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPY  199 (257)
T ss_pred             eeeecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCC
Confidence            1 1112223357899999886544 8889999999999999998 99997

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.1e-35  Score=256.78  Aligned_cols=201  Identities=26%  Similarity=0.434  Sum_probs=161.0

Q ss_pred             CCCCcccccccCCcceeeEeeee-----ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVS-----LFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ...|.+.+.||.|+||.||++.+     ..++..||+|.+.....  .....+.+|+.++++++||||+++++++..   
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVE---   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence            35688899999999999999985     33456799998865422  223467889999999999999999777654   


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhcC------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLESG------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI  286 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Ni  286 (358)
                             ++.+++||||+.++ +.+.+...            ...+++..+..++.|++.||+|||++|++||||||+||
T Consensus        79 -------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni  151 (288)
T cd05093          79 -------GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC  151 (288)
T ss_pred             -------CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence                   55789999999864 44444322            12489999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       287 ll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++.++.++|+|||++................++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||
T Consensus       152 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~  223 (288)
T cd05093         152 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPW  223 (288)
T ss_pred             EEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999988654332222222333467899999887654 8899999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-34  Score=262.04  Aligned_cols=205  Identities=30%  Similarity=0.525  Sum_probs=169.9

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+.+.||+|++|.||++.+..+++.||+|++............+.+|+.++++++|+||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~----   89 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR----   89 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc----
Confidence            3457899999999999999999999999999999998764333333456778999999999999999988876432    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      ........|++++++++++...+...  .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        90 ~~~~~~~~~lv~~~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          90 SLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             cccccccEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence            11233468899999977776655433  5899999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......     .....+++.|+|||.+.+...++.++||||||+++|+|++|++||
T Consensus       168 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  218 (345)
T cd07877         168 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  218 (345)
T ss_pred             cccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            764322     123456888999999876555888999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-34  Score=253.01  Aligned_cols=206  Identities=25%  Similarity=0.345  Sum_probs=168.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..+.|.+.+.||.|++|.||++.+..+++.||+|.+....   .....+..|+.+++.+ +|+||+++++++....    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~----   76 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN----   76 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC----
Confidence            4567889999999999999999999999999999987543   2234678899999998 7999999998886532    


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                      ........|+||||+.+ ++...+.. ....+++..+..++.|++.|++|||+++++|+||+|+||+++.++.++|+|||
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCC
Confidence            11123578999999987 45554543 23468999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........  ......+++.|+|||++.+    ...++.++||||+||++|+|++|+.||
T Consensus       157 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~  216 (272)
T cd06637         157 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL  216 (272)
T ss_pred             Cceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9886543221  2234457889999999853    224788999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-35  Score=256.25  Aligned_cols=200  Identities=27%  Similarity=0.378  Sum_probs=166.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|.+++.||.|++|.||++.+..++..||+|.+......  ....+.+|+.++++++|+||+++++++..        
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   73 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEAYFY--------   73 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEec--------
Confidence            34689999999999999999999889999999998754322  23467789999999999999999877654        


Q ss_pred             cCCCeEEEEeeccccChHHHH-hcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        +...|+||||++++.+..+ ......+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus        74 --~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~  151 (280)
T cd06611          74 --ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA  151 (280)
T ss_pred             --CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccch
Confidence              5588999999998555544 4445579999999999999999999999999999999999999999999999999877


Q ss_pred             eccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......+++.|+|||.+..    ...++.++|+||||+++|+|++|++||
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~  208 (280)
T cd06611         152 KNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH  208 (280)
T ss_pred             hhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCc
Confidence            5533221  1233456889999998752    233678999999999999999999997

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.5e-35  Score=256.66  Aligned_cols=201  Identities=26%  Similarity=0.401  Sum_probs=161.4

Q ss_pred             CCCcccccccCCcceeeEeeeee----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSL----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..|++.+.||+|+||.||++...    .++..|++|.+..... ......+.+|+.+++.++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----   78 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----   78 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----
Confidence            46788899999999999999853    4567899999874322 2223467789999999999999999777654     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcC----------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESG----------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS  284 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~----------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~  284 (358)
                           +...|+||||+.+ ++.+.+...                ...+++..+..++.|++.||+|||+++++|+||||+
T Consensus        79 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~  153 (283)
T cd05090          79 -----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR  153 (283)
T ss_pred             -----CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence                 4578999999986 455544211                124788889999999999999999999999999999


Q ss_pred             CEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       285 Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||+++.++.++|+|||+++...............++..|+|||.+.+.. ++.++|+||||+++|+|++ |.+||
T Consensus       154 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~  227 (283)
T cd05090         154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPY  227 (283)
T ss_pred             eEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999998764433222233334467899999887654 8899999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-34  Score=261.05  Aligned_cols=205  Identities=33%  Similarity=0.564  Sum_probs=170.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|++++.||.|++|.||++.+..++..||||++............+.+|+.+++.++||||+++++++.....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   88 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS---   88 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc---
Confidence            35678999999999999999999999999999999986543333334467789999999999999999988865331   


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                       ......+++|||++++++...+..  ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++
T Consensus        89 -~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          89 -LDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             -ccccceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence             111235799999997766665543  36899999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......     ....+++.|+|||.+.+...++.++|+||||+++|+|++|.+||
T Consensus       166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  216 (343)
T cd07880         166 RQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF  216 (343)
T ss_pred             cccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            7654321     23345888999999876555889999999999999999999997

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-34  Score=255.19  Aligned_cols=198  Identities=24%  Similarity=0.366  Sum_probs=161.8

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHH-HHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKI-LRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      +|.+++.||+|+||.||++.+..+|+.||||.++....... ...+..|+.. ++.++||||+++++++..         
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~---------   71 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFR---------   71 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEec---------
Confidence            68899999999999999999999999999999876533222 2345556664 666799999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                       ++..|+||||+++++.+.+..   ....+++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|+|||+
T Consensus        72 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          72 -EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             -CCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence             457999999999877665533   335689999999999999999999997 999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCC---CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGE---ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +........   .....++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||
T Consensus       151 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  207 (283)
T cd06617         151 SGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY  207 (283)
T ss_pred             ccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCC
Confidence            886543221   1224568889999988642   33688999999999999999999997

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.9e-34  Score=259.57  Aligned_cols=211  Identities=38%  Similarity=0.617  Sum_probs=171.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc---
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA---  220 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  220 (358)
                      ...+|.+.+.||.|++|.||++.+..++..||+|.+.....  .....+.+|+++++.++||||+++++++......   
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            46889999999999999999999999999999999876543  2345678899999999999999999887654311   


Q ss_pred             -cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEee
Q psy13988        221 -LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLAD  298 (358)
Q Consensus       221 -~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~l~D  298 (358)
                       +..+.+....|+||||+++++...+..  ..+++..++.++.||+.||.|||+.|++|+||||+||+++.+ +.++|+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence             122334457899999999877766643  368899999999999999999999999999999999999854 5789999


Q ss_pred             cccceeccccCCCC-CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||.+.......... ......++..|+|||.+.....++.++|||||||++|+|++|+.||
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf  219 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF  219 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence            99998654322111 1122346888999998765555888999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.2e-34  Score=250.34  Aligned_cols=200  Identities=27%  Similarity=0.443  Sum_probs=166.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|.+.+.||.|++|.||++.+..+++.||+|.++...... .....+.+|+.++++++|+|++++++++..        
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--------   73 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--------   73 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--------
Confidence            47889999999999999999999999999999887543322 224567899999999999999999887765        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                        ++..++||||+++ ++...+..   ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        74 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          74 --NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             --CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccc
Confidence              4578999999997 45444432   23458999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.........  .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       152 ~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  206 (267)
T cd08224         152 LGRFFSSKTTA--AHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPF  206 (267)
T ss_pred             eeeeccCCCcc--cceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCc
Confidence            98765433211  12345688899999987655 889999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-34  Score=252.56  Aligned_cols=201  Identities=30%  Similarity=0.475  Sum_probs=166.3

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC----CchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG----FPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .|+..+.||+|++|.||++.+..+++.||+|.+........    ....+.+|+.+++.++|+||+++++++.+      
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE------   74 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc------
Confidence            47788999999999999999999999999999875432211    23467889999999999999999877654      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg~  301 (358)
                          .+..++|+||+.+..+..+.....++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.
T Consensus        75 ----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          75 ----DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             ----CCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence                558999999999866655544555789999999999999999999999999999999999998876 599999999


Q ss_pred             ceeccccCCCC--CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQR--PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +..........  ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~  208 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPW  208 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCC
Confidence            88765432111  112335688999999987644 789999999999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-34  Score=254.20  Aligned_cols=197  Identities=26%  Similarity=0.373  Sum_probs=164.1

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|++++.||.|++|.||++.+..++..||+|.+..... ......+.+|+.++++++|+||+++++++..          
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------   70 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFI----------   70 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheec----------
Confidence            68899999999999999999999999999998875422 1223467889999999999999999887765          


Q ss_pred             CCeEEEEeeccccChHHHHhcC---CCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESG---MVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      ++..|+||||++++.+..+...   ...+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            5589999999998655555433   2368999999999999999999996 59999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCC-----CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEE-----RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........    ....+++.|+|||.+.+..     .++.++|+|||||++|+|++|+.||
T Consensus       151 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  207 (286)
T cd06622         151 GNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY  207 (286)
T ss_pred             ccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCC
Confidence            76533221    2334678899999885432     2578999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.4e-34  Score=254.67  Aligned_cols=212  Identities=17%  Similarity=0.160  Sum_probs=159.8

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecC---CcEEEEEEeeccccCCCCc---------hhHHHHHHHHHhCCCCc
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFT---DELVALKKVRLENEKEGFP---------ITAVREIKILRQLNHKN  206 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~n  206 (358)
                      +..+..+.+|++.+.||+|+||.||++.+..+   +..+|+|+...........         .....+...+..+.|+|
T Consensus         5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (294)
T PHA02882          5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG   84 (294)
T ss_pred             eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence            34456778999999999999999999998777   6778888654332211000         01122334455668999


Q ss_pred             ccchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy13988        207 IVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI  286 (358)
Q Consensus       207 iv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Ni  286 (358)
                      ++++++++.....      .....+++++++..++...+.. ....++..+..++.|++.||+|||+.+++||||||+||
T Consensus        85 i~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Ni  157 (294)
T PHA02882         85 IPKYYGCGSFKRC------RMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENI  157 (294)
T ss_pred             CCcEEEeeeEecC------CceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            9999876543221      1224578899887766655543 23467888999999999999999999999999999999


Q ss_pred             EecCCCcEEEeecccceeccccCCC-----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        287 LMNNRGEVKLADFGLARLYNAEDRQ-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       287 ll~~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.++.++|+|||+++.+......     .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~  233 (294)
T PHA02882        158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPW  233 (294)
T ss_pred             EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999876432211     1112345799999999988655 899999999999999999999998

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-34  Score=259.58  Aligned_cols=203  Identities=33%  Similarity=0.574  Sum_probs=169.0

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+.+.||.|++|.||++.+..+++.||||++............+.+|+.+++.++|+||+++++++....    .
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~   88 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV----S   88 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc----c
Confidence            456899999999999999999999999999999998765433334456789999999999999999999886532    1


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ......+|+|+||+..++....   ...+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          89 GDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             CCCCceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            1223467999999987655443   2358899999999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....     .....+++.|+|||.+.+...++.++||||||+++|+|++|+.||
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf  215 (342)
T cd07879         166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF  215 (342)
T ss_pred             CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCC
Confidence            54322     123456888999999876555889999999999999999999997

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-34  Score=254.48  Aligned_cols=204  Identities=21%  Similarity=0.329  Sum_probs=160.2

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ....+|++.+.||+|++|.||++.+.     .++..||||.+..... ......+.+|+.+++.++|+||+++++++.+ 
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-   80 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-   80 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence            34567999999999999999998864     2457899998764321 1223457789999999999999999776643 


Q ss_pred             CcccccccCCCeEEEEeeccccC-hHHHHhcCC---------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHD-LMGLLESGM---------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL  287 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~---------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nil  287 (358)
                               ++..++||||++++ |.+.+....         ..++...+..++.|++.||+|||+.+++|+||||+||+
T Consensus        81 ---------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil  151 (277)
T cd05062          81 ---------GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCM  151 (277)
T ss_pred             ---------CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEE
Confidence                     55889999999874 444443221         23567788899999999999999999999999999999


Q ss_pred             ecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       288 l~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++.++.++|+|||++................+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       152 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~  222 (277)
T cd05062         152 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPY  222 (277)
T ss_pred             EcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999987654332222222234477899999987654 8999999999999999999 67876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0584|consensus

Probab=100.00  E-value=1e-35  Score=268.27  Aligned_cols=201  Identities=24%  Similarity=0.365  Sum_probs=170.3

Q ss_pred             CCCCC-cccccccCCcceeeEeeeeecCCcEEEEEEeeccc--cCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSR-PLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLEN--EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ..++| +.-+.||+|+|-+||+|.|..+|-.||---++...  ......+++..|+.+|+.|+||||+++++++.+..  
T Consensus        37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~--  114 (632)
T KOG0584|consen   37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD--  114 (632)
T ss_pred             CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC--
Confidence            33444 45679999999999999999999999854443332  33333478899999999999999999999998754  


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEecCC-CcEEEe
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR--NFLHRDIKCSNILMNNR-GEVKLA  297 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~Dlkp~Nill~~~-~~~~l~  297 (358)
                            +...-+|+|++.++.+..+...-..++-..+.+|++||++||.|||++  -|+|||||-+||||+.+ |.+||+
T Consensus       115 ------n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  115 ------NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             ------CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence                  467899999999887777777667888999999999999999999987  59999999999999876 799999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|+|+......-    ...+|||.|||||.+.  ..|+..+||||||++++||.|+.+||
T Consensus       189 DLGLAtl~r~s~a----ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPY  243 (632)
T KOG0584|consen  189 DLGLATLLRKSHA----KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPY  243 (632)
T ss_pred             chhHHHHhhcccc----ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCCh
Confidence            9999998754432    3368899999999996  44999999999999999999999997

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-34  Score=251.86  Aligned_cols=202  Identities=26%  Similarity=0.395  Sum_probs=168.6

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++.+.||.|++|.||++....++..|++|++....... ....+.+|+.+++.++|+||+++++.+..         
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------   70 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV---------   70 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee---------
Confidence            36889999999999999999998899999999987544333 44577899999999999999999776654         


Q ss_pred             CCCeEEEEeeccccChHHH-HhcC--CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        226 DKGSFYLVFEYMDHDLMGL-LESG--MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~-~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                       +...++|||+++++.+.. +...  ...+++..+..++.|++.||++||+.|++|+||+|+||++++++.++|+|||++
T Consensus        71 -~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          71 -GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             -CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence             558899999998754444 4332  246899999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCC--CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQR--PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..........  ......++..|+|||.+.....++.++|+||||+++|+|++|+.||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~  207 (267)
T cd06610         150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY  207 (267)
T ss_pred             HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCc
Confidence            8765443221  2233356889999999876645899999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-34  Score=250.08  Aligned_cols=195  Identities=27%  Similarity=0.438  Sum_probs=164.7

Q ss_pred             ccccCCcceeeEeeeeecC---CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCC
Q psy13988        152 EPLAAGGLSLNNFSVSLFT---DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      +.||+|+||.||.+.+...   +..|++|.++...... ....+.+|++.++.++|+||+++++++..          +.
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------~~   69 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE----------EE   69 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC----------CC
Confidence            4789999999999999866   8999999988654433 34577899999999999999999777654          55


Q ss_pred             eEEEEeecccc-ChHHHHhcC--------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        229 SFYLVFEYMDH-DLMGLLESG--------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       229 ~~~lv~e~~~~-~l~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                      .+++||||+.+ ++.+.+...        ...+++..+..++.|++.||++||+++++|+||+|+||+++.++.++|+||
T Consensus        70 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~df  149 (262)
T cd00192          70 PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDF  149 (262)
T ss_pred             ceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccc
Confidence            89999999965 566665554        367999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |.+................+++.|+|||.+... .++.++||||||+++|+|++ |..||
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~  208 (262)
T cd00192         150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPY  208 (262)
T ss_pred             ccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCC
Confidence            999877654322223344568899999988765 48999999999999999999 58887

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=251.12  Aligned_cols=202  Identities=23%  Similarity=0.392  Sum_probs=164.2

Q ss_pred             CCCCcccccccCCcceeeEeeeeecC---CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFT---DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..+|++.+.||+|+||.||++....+   ...||||.+..... ......+.+|+.+++.++||||+++++.+..     
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   76 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----   76 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----
Confidence            35688999999999999999998654   46899998865432 2223467789999999999999999776654     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           ++..++||||+.+ ++.+.+......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||
T Consensus        77 -----~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg  151 (266)
T cd05033          77 -----SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG  151 (266)
T ss_pred             -----CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccc
Confidence                 5578999999987 5555555555578999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++................+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~  209 (266)
T cd05033         152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPY  209 (266)
T ss_pred             hhhcccccccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCC
Confidence            998775222221122233467899999887654 8899999999999999998 98887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3e-34  Score=249.24  Aligned_cols=199  Identities=30%  Similarity=0.429  Sum_probs=166.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC---CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK---EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      +|+..+.||.|++|.||++.+..+++.|++|.+......   ......+.+|+.+++.++|+||+++++++.+       
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------   73 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-------   73 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-------
Confidence            477889999999999999999889999999998764322   2233467889999999999999999776654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         +..+++|+||+++..+..+......+++..+..++.||+.|+++||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        74 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          74 ---EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             ---CCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence               45899999999985555554444568999999999999999999999999999999999999999999999999988


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......   ......+++.|+|||.+.....++.++|+||||+++|+|++|++||
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf  202 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW  202 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence            764433   1233456888999998865444788999999999999999999997

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-34  Score=252.34  Aligned_cols=200  Identities=28%  Similarity=0.421  Sum_probs=166.1

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..|.+.+.||.|++|.||++.+..+++.|+||.+...... ......+.+|+.+++.++|+||+++++++..        
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--------   73 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--------   73 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--------
Confidence            4688999999999999999999999999999988654322 2223467789999999999999999877764        


Q ss_pred             cCCCeEEEEeeccccC-hHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                        ++..++||||+.++ +.+.+.   .....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus        74 --~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          74 --DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             --CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcch
Confidence              45889999999974 444443   234468999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........  ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||
T Consensus       152 ~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  206 (267)
T cd08229         152 LGRFFSSKTT--AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPF  206 (267)
T ss_pred             hhhccccCCc--ccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCc
Confidence            9876643322  122345688999999987655 788999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG1151|consensus

Probab=100.00  E-value=5.4e-36  Score=259.58  Aligned_cols=211  Identities=29%  Similarity=0.483  Sum_probs=178.4

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-----CCCchhHHHHHHHHHhCCCCcccchhhh
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-----EGFPITAVREIKILRQLNHKNIVNLREI  213 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~  213 (358)
                      ....+.+.+|-++..||+|||+.||++-|....++||+|+-......     ..+.....+|..+.+.|.||.||+++++
T Consensus       456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            34456788999999999999999999999999999999986544322     2233455689999999999999999999


Q ss_pred             hcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEecCC
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR--NFLHRDIKCSNILMNNR  291 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~Dlkp~Nill~~~  291 (358)
                      +.-         +...+|-|+|||+|+.++++.....-+++.+++.|+.||+.||.||.+.  .|+|.||||.|||+...
T Consensus       536 fsl---------DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G  606 (775)
T KOG1151|consen  536 FSL---------DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG  606 (775)
T ss_pred             eee---------ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC
Confidence            875         3457899999999999998888888899999999999999999999976  59999999999999543


Q ss_pred             ---CcEEEeecccceeccccCCC-----CCCCCcccccccccccccc-C--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        292 ---GEVKLADFGLARLYNAEDRQ-----RPYTNKVITLWYRPPELLL-G--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       292 ---~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~-~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                         |.+||.|||+++.+......     .......||.+|++||.+. +  .+..+.++||||+|||+|+.|.|+.||
T Consensus       607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF  684 (775)
T KOG1151|consen  607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF  684 (775)
T ss_pred             cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence               68999999999988655332     2334567899999999885 3  245789999999999999999999998

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-34  Score=254.10  Aligned_cols=200  Identities=25%  Similarity=0.352  Sum_probs=159.6

Q ss_pred             CcccccccCCcceeeEeee----eecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        148 RPLMEPLAAGGLSLNNFSV----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      |++++.||+|+||+||++.    ...++..||+|.+..... ......+.+|+++++.++||||+++++++....     
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----   79 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG-----   79 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----
Confidence            3889999999999998765    345778999999875422 223456778999999999999999987765422     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ...+++||||+.++.+..+... ..+++.+++.++.|++.||+|||+++++|+||||+||+++.++.++|+|||++.
T Consensus        80 ---~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          80 ---GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             ---CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccc
Confidence               3468999999997555444332 258999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCC-CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......... ......++..|+|||.+.+.. ++.++||||||+++|+|+||+.||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~  210 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSK  210 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCC
Confidence            765332211 111223356799999887654 889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0614|consensus

Probab=100.00  E-value=4.6e-36  Score=263.69  Aligned_cols=203  Identities=23%  Similarity=0.331  Sum_probs=176.5

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccc-cCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      +..-...+++..||-|+||.|-++........+|+|++++.- ......+++..|-+++..++.|.||++|..|.+    
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd----  491 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD----  491 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc----
Confidence            344556778899999999999999987666678988886542 222334567889999999999999999877765    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            ..++|++||.|=|+.+..+....+.+++..++-++..+++|++|||++||++|||||+|.+++.+|-+||.|||
T Consensus       492 ------~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  492 ------SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             ------chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehh
Confidence                  56899999999887777777777889999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+.+..+....   .++|||.|.|||++.+.+ .+.++|.||||+++||||+|.+||
T Consensus       566 FAKki~~g~KTw---TFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPF  619 (732)
T KOG0614|consen  566 FAKKIGSGRKTW---TFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPF  619 (732)
T ss_pred             hHHHhccCCcee---eecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCC
Confidence            999998776554   456799999999998776 899999999999999999999998

>KOG0664|consensus

Probab=100.00  E-value=5.6e-37  Score=250.48  Aligned_cols=200  Identities=36%  Similarity=0.590  Sum_probs=172.2

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY  231 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~  231 (358)
                      +.||-|.||+||.+.|..+|+.||+|++..-...-.....+.+|+.+|..++|.|++..+++.+.+.  +++++   ..|
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph--~dfFq---EiY  133 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPAN--PSFFQ---ELY  133 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCC--chHHH---HHH
Confidence            5799999999999999999999999988755433334457889999999999999999999887655  55555   478


Q ss_pred             EEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCC
Q psy13988        232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ  311 (358)
Q Consensus       232 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~  311 (358)
                      +|+|.+..+|...+.+ ...++...+..+++||++||+|||+.+|+||||||.|.+++.+..+||||||+++....... 
T Consensus       134 V~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~-  211 (449)
T KOG0664|consen  134 VLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR-  211 (449)
T ss_pred             HHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh-
Confidence            9999999877776644 44799999999999999999999999999999999999999999999999999997765433 


Q ss_pred             CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...+..+.|..|+|||++.+.+.|+.+.||||.|||+.|||..+..|
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF  258 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF  258 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh
Confidence            33456677999999999999999999999999999999999877655

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-34  Score=258.23  Aligned_cols=206  Identities=39%  Similarity=0.636  Sum_probs=174.4

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|++|.||++.+..+++.||||++............+.+|+.+++.++|+||+++.+++.....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----~~   75 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP-----ED   75 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc-----cc
Confidence            5889999999999999999999999999999987654334445678899999999999999999998876431     22


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ....|+||||+++++.+.+... ..+++..++.++.||+.||++||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        76 ~~~~~lv~e~~~~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          76 FNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             ccceEEEecchhhhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            3478999999998777766544 389999999999999999999999999999999999999999999999999998775


Q ss_pred             ccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..... .......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf  207 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF  207 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc
Confidence            44311 12234456889999999987645899999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-34  Score=248.55  Aligned_cols=197  Identities=24%  Similarity=0.394  Sum_probs=161.0

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|.+.+.||.|++|.||++.+. ++..+|+|.+.....   ....+.+|+++++.++|+||+++++++..         
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------   70 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTK---------   70 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcC---------
Confidence            45789999999999999999875 567899998764322   23467889999999999999999776654         


Q ss_pred             CCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                       .+..|+||||+++ ++.+.+......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+++.
T Consensus        71 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~  149 (256)
T cd05059          71 -QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARY  149 (256)
T ss_pred             -CCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCccccee
Confidence             4578999999986 56666655455789999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~  202 (256)
T cd05059         150 VLDDQYT-SSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPY  202 (256)
T ss_pred             ccccccc-ccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCC
Confidence            5432211 111222345799999887654 8899999999999999999 78887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.6e-34  Score=255.92  Aligned_cols=201  Identities=23%  Similarity=0.279  Sum_probs=164.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|.+++.||.|++|.||++.+..+++.|++|.+...... ......+.+|+++++.++||||+++++++..         
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---------   72 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET---------   72 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec---------
Confidence            688899999999999999999999999999998755321 1223466789999999999999999776654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++.+++||||++|+.+..+......+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++..
T Consensus        73 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~  151 (305)
T cd05609          73 -KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG  151 (305)
T ss_pred             -CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence             5589999999998555555444457899999999999999999999999999999999999999999999999988642


Q ss_pred             cccCCC-------------CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQ-------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......             .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf  216 (305)
T cd05609         152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPF  216 (305)
T ss_pred             CcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            111100             0111234578899999987654 889999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-34  Score=259.88  Aligned_cols=204  Identities=25%  Similarity=0.353  Sum_probs=160.5

Q ss_pred             CCCCCcccccccCCcceeeEeeee-----ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVS-----LFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      ...+|++.+.||+|+||.||+|.+     ..+++.||||++...... .....+.+|+.++..+ +|+||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            346799999999999999999984     356789999998754322 2234677899999999 789999998877542


Q ss_pred             CcccccccCCCeEEEEeeccccC-hHHHHhcCC-----------------------------------------------
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHD-LMGLLESGM-----------------------------------------------  249 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-----------------------------------------------  249 (358)
                               +..+++||||++++ |.+.+....                                               
T Consensus        84 ---------~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (343)
T cd05103          84 ---------GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVE  154 (343)
T ss_pred             ---------CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccC
Confidence                     34689999999974 444443211                                               


Q ss_pred             -------------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        250 -------------------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       250 -------------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                                         ..++...+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~  234 (343)
T cd05103         155 EKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD  234 (343)
T ss_pred             CCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc
Confidence                               1367778889999999999999999999999999999999999999999999886533222


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ........+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       235 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~  282 (343)
T cd05103         235 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPY  282 (343)
T ss_pred             hhhcCCCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence            11112223467799999987654 8899999999999999997 88886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.1e-34  Score=248.10  Aligned_cols=197  Identities=28%  Similarity=0.427  Sum_probs=168.3

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|.+.+.||.|++|.||++....++..|++|.+.....    ...+.+|+++++.++|+||+++++++..        
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~--------   69 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFK--------   69 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeec--------
Confidence            3578999999999999999999998899999999875432    4578899999999999999999877765        


Q ss_pred             cCCCeEEEEeeccccChH-HHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHDLM-GLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        +..+|+++|++.+..+ +.+......+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus        70 --~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          70 --NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             --CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccch
Confidence              4589999999997544 4444445678999999999999999999999999999999999999999999999999988


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........  .....++..|+|||.+.+.. ++.++||||||+++|+|++|++||
T Consensus       148 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~  199 (256)
T cd06612         148 QLTDTMAK--RNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPY  199 (256)
T ss_pred             hcccCccc--cccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            76543211  12234588899999987654 889999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.1e-34  Score=250.48  Aligned_cols=202  Identities=25%  Similarity=0.435  Sum_probs=164.8

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC--------CchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG--------FPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+........        ..+.+.+|+.+++.++|+|++++++++..  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence            57788999999999999999999999999998865322111        12356789999999999999999776654  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                              +...++||||+.++.+.........+++..+..++.||+.||.+||+++++|+||+|+||+++.++.++|+|
T Consensus        80 --------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          80 --------EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             --------CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEee
Confidence                    457899999998755554444446789999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCC-CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++................++..|+|||.+.... .++.++|+||||+++|+|++|..||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  212 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW  212 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence            99987654322222223345688999999987543 4788999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.6e-34  Score=254.88  Aligned_cols=198  Identities=24%  Similarity=0.408  Sum_probs=165.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ...|.....||.|+||.||++.+..++..||+|.+......  ....+.+|+.+++.++||||+++++++..        
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--------   89 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLV--------   89 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheee--------
Confidence            34455566899999999999999999999999998754322  24567889999999999999999887764        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ++..|+|+||++++.+..+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        90 --~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659          90 --GEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             --CCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence              4589999999998666555433 4689999999999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......++..|+|||.+.+.. ++.++||||+|+++|+|++|+.||
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~  217 (297)
T cd06659         167 ISKDVP--KRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPY  217 (297)
T ss_pred             cccccc--cccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            543221  123345689999999987655 889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.8e-34  Score=248.44  Aligned_cols=197  Identities=25%  Similarity=0.447  Sum_probs=161.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|++.+.||+|+||.||++... ++..+|+|.+....   .....+.+|+++++.++||||+++++++..         
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------   70 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ---------   70 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEcc---------
Confidence            46788999999999999999764 45689999876432   223567889999999999999999777654         


Q ss_pred             CCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                       .+..++||||+++ ++.+.+......+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        71 -~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~  149 (256)
T cd05114          71 -QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY  149 (256)
T ss_pred             -CCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccc
Confidence             4578999999986 56555555455689999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~  202 (256)
T cd05114         150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPF  202 (256)
T ss_pred             cCCCcee-ccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCC
Confidence            5332211 112223456899999987654 8899999999999999999 89887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3e-34  Score=250.14  Aligned_cols=200  Identities=24%  Similarity=0.387  Sum_probs=164.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|.+.+.||.|++|.||++.+..+++.||+|.+....   .....+.+|+++++.++|+||+++++++..       
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------   73 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-------   73 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC-------
Confidence            3456788899999999999999999999999999886432   223567889999999999999999776654       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                         +..+++||||+++ ++.+.+.. ....+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus        74 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~  150 (263)
T cd05052          74 ---EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL  150 (263)
T ss_pred             ---CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcc
Confidence               4578999999986 55555543 234588999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +......... .......+..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~  206 (263)
T cd05052         151 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY  206 (263)
T ss_pred             ccccccceee-ccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCC
Confidence            9876543221 111222356799999887655 8899999999999999998 88886

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.3e-34  Score=249.40  Aligned_cols=200  Identities=26%  Similarity=0.381  Sum_probs=163.6

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC----CchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG----FPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .|++.+.||.|+||.||++.+ .+++.+|+|.+........    ....+.+|+++++.++|+||+++.+++.+      
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD------   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec------
Confidence            478889999999999999986 5789999998875432211    12356789999999999999999776654      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          .+..++|+||++++.+..+......+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        74 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          74 ----DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             ----CCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhh
Confidence                5689999999988655555444457899999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCC----CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDR----QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........    ........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~  208 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPL  208 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCcc
Confidence            76532111    11112345688999999987655 789999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.1e-34  Score=248.96  Aligned_cols=199  Identities=27%  Similarity=0.445  Sum_probs=167.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|++++.||.|++|.+|++.+..+++.||+|.+............+.+|+.+++.++||||+++.+++.+          
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   70 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE----------   70 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC----------
Confidence            5889999999999999999999999999999987654333334577899999999999999999776654          


Q ss_pred             CCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .+..++|+||+.+ ++.+.+... ...+++..+..++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||.+..
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~  150 (256)
T cd08218          71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV  150 (256)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence            5689999999986 566655443 33578999999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  .....+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||
T Consensus       151 ~~~~~~~--~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~  201 (256)
T cd08218         151 LNSTVEL--ARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAF  201 (256)
T ss_pred             cCcchhh--hhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCc
Confidence            6443221  12234688899999987654 888999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0579|consensus

Probab=100.00  E-value=1.1e-35  Score=267.51  Aligned_cols=200  Identities=24%  Similarity=0.354  Sum_probs=172.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|.|+..||.|+||.||++....++-..|.|++....  ....+.++-||++|..++||+||++++.|..       
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~-------  100 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYF-------  100 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-------
Confidence            3456789999999999999999999999999999887543  3346678889999999999999999887754       


Q ss_pred             ccCCCeEEEEeeccccChHHHH-hcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         ++.++|+.|||+|+-.+.+ ..-...+.+.++..+++|++.||.|||+++|+|||||..|||++-+|.++|.|||.+
T Consensus       101 ---enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVS  177 (1187)
T KOG0579|consen  101 ---ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVS  177 (1187)
T ss_pred             ---cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccc
Confidence               5689999999999877766 344557999999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCcccccccccccccc----CCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLL----GEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      .....  .......++|||.|||||+..    ....|++++||||||+++.+|..+.||
T Consensus       178 AKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP  234 (1187)
T KOG0579|consen  178 AKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP  234 (1187)
T ss_pred             ccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence            64332  223346789999999999874    334599999999999999999999988

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4e-34  Score=251.41  Aligned_cols=192  Identities=23%  Similarity=0.273  Sum_probs=154.7

Q ss_pred             cccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC-chhHHHHHHHHHh---CCCCcccchhhhhcccCcccccccCCC
Q psy13988        153 PLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF-PITAVREIKILRQ---LNHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       153 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      .||+|+||.||++.+..+++.||+|.+......... .....+|..+++.   .+||||+.+++++..          ++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----------~~   70 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT----------PD   70 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec----------CC
Confidence            489999999999999999999999988754332221 1223444444333   479999998766654          45


Q ss_pred             eEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecccc
Q psy13988        229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE  308 (358)
Q Consensus       229 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~  308 (358)
                      ..++||||+.++.+.........+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus        71 ~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          71 KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            89999999998666555445557999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .    .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  196 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF  196 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence            2    123457899999998865445889999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=251.13  Aligned_cols=198  Identities=28%  Similarity=0.418  Sum_probs=166.4

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC---CCcccchhhhhcccCccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~  223 (358)
                      .|++++.||.|++|.||++.+..+++.||+|.+..... ......+.+|+.+++.++   |||++++++++.+       
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-------   73 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-------   73 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-------
Confidence            47888999999999999999999999999999875432 223456778999999996   9999999877654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         +...|+||||+.++.+..+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        74 ---~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          74 ---GPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             ---CCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCcee
Confidence               4578999999987555444433 378999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~  202 (277)
T cd06917         150 LLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY  202 (277)
T ss_pred             ecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCC
Confidence            7654432  1233457889999999876555788999999999999999999997

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-34  Score=255.23  Aligned_cols=202  Identities=23%  Similarity=0.355  Sum_probs=160.6

Q ss_pred             CCCCcccccccCCcceeeEeeeeecC-----CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFT-----DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ...|.+.+.||.|+||.||++.+..+     +..||||+++.... ......+.+|+.++..++||||+++++++..   
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~---   79 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTK---   79 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---
Confidence            34578899999999999999987543     57899999875432 2223457789999999999999999777655   


Q ss_pred             ccccccCCCeEEEEeeccccCh-HHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDL-MGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC  283 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l-~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp  283 (358)
                             ....++++||+.+.. ...+...               ...+++..+..++.|++.||.|||++|++||||||
T Consensus        80 -------~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp  152 (283)
T cd05091          80 -------EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLAT  152 (283)
T ss_pred             -------CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence                   447899999998644 4443211               23478888999999999999999999999999999


Q ss_pred             CCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       284 ~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +||+++.++.++|+|||+++...............+++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||
T Consensus       153 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~  227 (283)
T cd05091         153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPY  227 (283)
T ss_pred             hheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999988664333222223334577899999987554 8899999999999999998 77776

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.2e-34  Score=249.90  Aligned_cols=201  Identities=30%  Similarity=0.476  Sum_probs=168.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+++.||.|++|.||++.+..++..||+|.+............+..|+.+++.++|+||+++++++...        .
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~   72 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR--------S   72 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC--------C
Confidence            47889999999999999999999999999999876544444445677899999999999999998776542        2


Q ss_pred             CCeEEEEeeccccC-hHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCEEecCCCcEEEe
Q psy13988        227 KGSFYLVFEYMDHD-LMGLLES---GMVDFNEVNNASIMRQLLDGLSYCH-----KRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       227 ~~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH-----~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                      +...+++|||++++ +.+.+..   ....+++..++.++.||+.||++||     +.+++|+||+|+||+++.++.++|+
T Consensus        73 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          73 NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             CCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence            45789999999874 4444433   2457899999999999999999999     8999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++.........  .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       153 d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  210 (265)
T cd08217         153 DFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPF  210 (265)
T ss_pred             cccccccccCCccc--ccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcc
Confidence            99999876544321  12345689999999987655 889999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3e-34  Score=254.49  Aligned_cols=203  Identities=24%  Similarity=0.369  Sum_probs=162.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCC----------------cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTD----------------ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNI  207 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  207 (358)
                      ...+|.+++.||+|+||.||++.+..++                ..||+|.+...... .....+.+|+++++.++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCE
Confidence            3467899999999999999999876544                56899988754322 234567789999999999999


Q ss_pred             cchhhhhcccCcccccccCCCeEEEEeeccccC-hHHHHhcCC----------CCCChHHHHHHHHHHHHHHHHHHhCCc
Q psy13988        208 VNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGM----------VDFNEVNNASIMRQLLDGLSYCHKRNF  276 (358)
Q Consensus       208 v~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~~~i  276 (358)
                      +++++++..          ++..++|||++.++ +...+....          ..+++..++.++.|++.||+|||+.|+
T Consensus        82 ~~~~~~~~~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i  151 (296)
T cd05051          82 ARLLGVCTV----------DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF  151 (296)
T ss_pred             eEEEEEEec----------CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence            999776654          45889999999874 444443322          268999999999999999999999999


Q ss_pred             eecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh--C
Q psy13988        277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV--K  354 (358)
Q Consensus       277 ~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt--g  354 (358)
                      +|+||||+||+++.++.++|+|||++................+++.|+|||.+.+.. ++.++||||||+++|+|++  |
T Consensus       152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~  230 (296)
T cd05051         152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCR  230 (296)
T ss_pred             cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCC
Confidence            999999999999999999999999988654433222223334577899999887644 8899999999999999998  6


Q ss_pred             CCCC
Q psy13988        355 KPLF  358 (358)
Q Consensus       355 ~~pF  358 (358)
                      ..||
T Consensus       231 ~~p~  234 (296)
T cd05051         231 EQPY  234 (296)
T ss_pred             CCCC
Confidence            6665

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.1e-34  Score=250.15  Aligned_cols=192  Identities=23%  Similarity=0.273  Sum_probs=155.2

Q ss_pred             cccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC-chhHHHHH---HHHHhCCCCcccchhhhhcccCcccccccCCC
Q psy13988        153 PLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF-PITAVREI---KILRQLNHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       153 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      .||+|+||.||++.+..+++.||+|.+......... ......|.   ..++...||||+.+.+++..          ..
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----------~~   70 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----------PD   70 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec----------CC
Confidence            489999999999999999999999998765322111 11233343   34444589999999777664          45


Q ss_pred             eEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecccc
Q psy13988        229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE  308 (358)
Q Consensus       229 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~  308 (358)
                      ..++||||+.|+.+.........+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus        71 ~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          71 KLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            89999999998666555555567999999999999999999999999999999999999999999999999998755332


Q ss_pred             CCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .    .....++..|+|||.+.+...++.++||||+|+++|+|++|+.||
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~  196 (278)
T cd05606         151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF  196 (278)
T ss_pred             C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCC
Confidence            2    123457899999999875545889999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-34  Score=252.49  Aligned_cols=201  Identities=26%  Similarity=0.420  Sum_probs=161.7

Q ss_pred             CCCcccccccCCcceeeEeee----eecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSV----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .+|++++.||+|+||.||.+.    +..+++.||+|.+.....  .....+.+|+++++.++||||+++++++...    
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----   77 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSA----   77 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccC----
Confidence            478899999999999999987    456789999999875432  2234678899999999999999998766432    


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                          +...+++||||+++ +|.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus        78 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg  153 (284)
T cd05081          78 ----GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG  153 (284)
T ss_pred             ----CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCc
Confidence                24468999999986 5655665555578999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCC-CCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        301 LARLYNAEDRQRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       301 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      ++........... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..|
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~  210 (284)
T cd05081         154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDK  210 (284)
T ss_pred             ccccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCc
Confidence            9987643322111 11112345699999987654 88999999999999999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-34  Score=254.40  Aligned_cols=199  Identities=25%  Similarity=0.425  Sum_probs=165.0

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|.....||.|++|.||++.+..++..||||.+.....  .....+.+|+.+++.++|+||+++++.+..       
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-------   90 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLV-------   90 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheec-------
Confidence            33445556789999999999999999999999998865332  223457789999999999999999887764       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ++..|+||||++++++..+... ..+++..+..++.||+.||+|||+++++|+||||+||+++.++.++|+|||++.
T Consensus        91 ---~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~  166 (292)
T cd06658          91 ---GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA  166 (292)
T ss_pred             ---CCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence               4588999999998666555433 358899999999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||
T Consensus       167 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~  218 (292)
T cd06658         167 QVSKEVP--KRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPY  218 (292)
T ss_pred             hcccccc--cCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            6533221  122345688999999887554 889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-34  Score=253.23  Aligned_cols=198  Identities=27%  Similarity=0.347  Sum_probs=167.9

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|++++.||+|++|.||++.+..++..||+|++..... ......+.+|+++++.++||||+++++++..        
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------   74 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLN--------   74 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEec--------
Confidence            4678999999999999999999999999999998875432 2234567899999999999999999777665        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        .+.+++||||++++.+..+......+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus        75 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~  152 (284)
T cd06620          75 --ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG  152 (284)
T ss_pred             --CCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence              45899999999986666555555678999999999999999999997 689999999999999999999999999987


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......    ....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||
T Consensus       153 ~~~~~~~----~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~  202 (284)
T cd06620         153 ELINSIA----DTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPF  202 (284)
T ss_pred             chhhhcc----CccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCC
Confidence            5432221    234568999999998765 4889999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-34  Score=247.11  Aligned_cols=199  Identities=25%  Similarity=0.408  Sum_probs=162.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++.+.||.|++|.||++.+. ++..||+|.+.....   ....+.+|+.++++++|+||+++++++..       
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------   72 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTL-------   72 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEec-------
Confidence            3467889999999999999999874 457899999875432   24567889999999999999999776544       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                         ++..++|||++.+ ++.+.+.... ..+++..+..++.|++.|+.+||++|++|+||||+||+++.++.++|+|||+
T Consensus        73 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~  149 (261)
T cd05068          73 ---EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGL  149 (261)
T ss_pred             ---CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcce
Confidence               5578999999965 6666664432 4689999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +......... .......+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||
T Consensus       150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~  205 (261)
T cd05068         150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPY  205 (261)
T ss_pred             EEEccCCccc-ccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCC
Confidence            9877533211 112222246799999887654 8899999999999999999 99887

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-34  Score=251.78  Aligned_cols=201  Identities=22%  Similarity=0.340  Sum_probs=164.6

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCc----EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDE----LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ..+|++.+.||+|+||.||++.+..+++    .||+|.+..... ......+.+|+.+++.++||||+++++++..    
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence            4678899999999999999999877765    589998765432 2223467789999999999999999877643    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ...++||||+.+ ++.+.+......+++..+..++.||+.||+|||+++++|+||||+||+++.++.++|+||
T Consensus        81 -------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~df  153 (279)
T cd05057          81 -------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDF  153 (279)
T ss_pred             -------CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCC
Confidence                   368999999985 666666665667999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++...............++..|+|||.+.... ++.++|+||||+++|+|++ |+.||
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~  212 (279)
T cd05057         154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPY  212 (279)
T ss_pred             cccccccCcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCC
Confidence            9998765332222222222356799999886544 8899999999999999998 99987

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-34  Score=249.35  Aligned_cols=199  Identities=48%  Similarity=0.819  Sum_probs=171.9

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      |++.+.||.|++|.||++....+++.||+|.+............+..|+.+++.++|+|++++++++..          .
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------~   70 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT----------E   70 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc----------C
Confidence            567789999999999999999999999999998765444455677889999999999999999888865          3


Q ss_pred             CeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccc
Q psy13988        228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA  307 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~  307 (358)
                      +..++|+|++++++.+.+......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        71 ~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          71 RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             CceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            58999999999988887766545799999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       308 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...  .......+..|+|||.+.+...++.++|+||||+++|+|++|++||
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~  199 (282)
T cd07829         151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF  199 (282)
T ss_pred             Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC
Confidence            322  2233445778999999876646899999999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.9e-34  Score=252.11  Aligned_cols=203  Identities=25%  Similarity=0.362  Sum_probs=161.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeec-----CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLF-----TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ....|.+.+.||+|++|.||++.+..     ++..|++|.+...... .....+.+|+.+++.++|+||+++++++.+  
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   80 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIVRLIGVSFE--   80 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--
Confidence            34568899999999999999999977     7789999987643221 223457889999999999999999776654  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCC------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGM------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR  291 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~  291 (358)
                              ....++||||+.| ++.+.+....      ..+++..+..++.||+.||+|||+++++|+||||+||+++.+
T Consensus        81 --------~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~  152 (277)
T cd05036          81 --------RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCK  152 (277)
T ss_pred             --------CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEecc
Confidence                    4467999999986 5555553322      258889999999999999999999999999999999999876


Q ss_pred             C---cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        292 G---EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       292 ~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +   .++|+|||+++................+..|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf  222 (277)
T cd05036         153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPY  222 (277)
T ss_pred             CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCC
Confidence            5   58999999998763322211122223356799999987655 8999999999999999997 88887

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.6e-34  Score=254.21  Aligned_cols=201  Identities=27%  Similarity=0.416  Sum_probs=161.3

Q ss_pred             CCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..+|.+.+.||+|++|.||++.+.     .++..+++|.+.....  .....+.+|+.+++.++|+||+++++++..   
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   78 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGD---   78 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEcc---
Confidence            356788899999999999999853     3456789998764332  123467889999999999999999777654   


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC  283 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp  283 (358)
                             +...++||||++++ +.+.+...               ...+++..++.++.||+.||+|||++|++|+||||
T Consensus        79 -------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp  151 (291)
T cd05094          79 -------GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLAT  151 (291)
T ss_pred             -------CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCc
Confidence                   55789999999864 54444322               13478899999999999999999999999999999


Q ss_pred             CCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       284 ~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +||+++.++.++|+|||++................++..|+|||.+.+.. ++.++||||||+++|+|+| |+.||
T Consensus       152 ~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~  226 (291)
T cd05094         152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPW  226 (291)
T ss_pred             ceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999987654433222223344578899999887654 8899999999999999998 99987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.1e-34  Score=247.41  Aligned_cols=202  Identities=28%  Similarity=0.411  Sum_probs=169.4

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+............+.+|+.+++.++|+||+++++++..          
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------   70 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH----------   70 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec----------
Confidence            5888999999999999999999999999999988665443455678899999999999999999776544          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ...+++|+||+++..+..+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          71 REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             CCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            55899999999976555554444568899999999999999999999999999999999999999999999999988765


Q ss_pred             ccCCCCC--CCCccccccccccccccCCC--CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRP--YTNKVITLWYRPPELLLGEE--RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  .....+++.|+|||.+.+..  ..+.++||||||+++|+|++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf  206 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW  206 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence            4332211  11245688999999987543  3788999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=252.59  Aligned_cols=203  Identities=23%  Similarity=0.352  Sum_probs=163.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecC-----CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFT-----DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ...+|.+.+.||.|++|.||++.+...     +..||+|.+..... ......+.+|+.+++.++|+||+++++++..  
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   80 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVST--   80 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--
Confidence            345788999999999999999998644     48999999764321 1223467789999999999999999877654  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcC---------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESG---------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM  288 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill  288 (358)
                              ....++||||+++ +|.+.+...         ...+++..+..++.|++.||.|||+++++|+||||+||++
T Consensus        81 --------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill  152 (277)
T cd05032          81 --------GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV  152 (277)
T ss_pred             --------CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE
Confidence                    4578999999986 555554321         2246788899999999999999999999999999999999


Q ss_pred             cCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       289 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +.++.++|+|||+++...............++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~  222 (277)
T cd05032         153 AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPY  222 (277)
T ss_pred             cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCC
Confidence            999999999999988664433222223344578899999887554 8899999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.6e-34  Score=254.25  Aligned_cols=200  Identities=32%  Similarity=0.483  Sum_probs=168.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....|...+.||+|+||.||++.+..++..||+|.+...... ......+.+|+++++.++|+|++++++++.+     
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   96 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----   96 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            3444578889999999999999999999999999998754322 2223467789999999999999999877754     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           +...++||||+.|++.+.+......+++.++..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||+
T Consensus        97 -----~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635          97 -----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             -----CCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCC
Confidence                 457899999999988887766566799999999999999999999999999999999999999999999999998


Q ss_pred             ceeccccCCCCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +......      ....+++.|+|||.+..  ...++.++||||||+++|+|++|++||
T Consensus       172 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~  224 (317)
T cd06635         172 ASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  224 (317)
T ss_pred             ccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            8754322      23356888999998742  334788999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.3e-34  Score=251.79  Aligned_cols=198  Identities=27%  Similarity=0.370  Sum_probs=165.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|.+++.||.|++|.||++.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++..         
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------   73 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLK---------   73 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhccccc---------
Confidence            4577889999999999999999999999999988744322 233467889999999999999999887764         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       +...|+||||++++.+..+... ..+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        74 -~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06642          74 -GTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             -CCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccc
Confidence             4579999999997544444332 46899999999999999999999999999999999999999999999999998765


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~  201 (277)
T cd06642         152 TDTQI--KRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPN  201 (277)
T ss_pred             cCcch--hhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCC
Confidence            43321  112234688899999987654 889999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.6e-34  Score=255.61  Aligned_cols=199  Identities=34%  Similarity=0.578  Sum_probs=168.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+++.||.|++|.||++.+..+++.||||++............+.+|+.+++.++||||+++.+++...      
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------   81 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP------   81 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC------
Confidence            56789999999999999999999999999999998865443333445678899999999999999998877542      


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         +...|+|+||+++++...+..  ..+++..+..++.||+.||.|||+.+++|+||+|.||+++.++.++|+|||.+.
T Consensus        82 ---~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          82 ---LEDIYFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             ---CCcEEEEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence               346899999998877666543  357888889999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......     ....+++.|+|||.+.+...++.++|+||||+++|+|++|++||
T Consensus       157 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f  206 (328)
T cd07856         157 IQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF  206 (328)
T ss_pred             ccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence            543221     23345788999998866455889999999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.4e-34  Score=256.41  Aligned_cols=205  Identities=38%  Similarity=0.578  Sum_probs=168.2

Q ss_pred             CCcccccccCCcceeeEeeeeecC--CcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFT--DELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  223 (358)
                      +|.+.+.||.|+||.||++.+..+  +..||+|++............+.+|+.+++++ +||||+++++......     
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----   75 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-----   75 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-----
Confidence            478899999999999999999888  89999999875433333345677899999999 5999999987653311     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                       .....+|+++++++++|...+.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus        76 -~~~~~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          76 -GNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             -ccCCcEEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence             12346899999999888777754 4468999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCC--CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQ--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........  .......+++.|+|||.+.+...++.++||||+|+++|+|++|++||
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf  210 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF  210 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC
Confidence            66433221  11223467899999998876555889999999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1e-33  Score=250.46  Aligned_cols=209  Identities=25%  Similarity=0.338  Sum_probs=169.0

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccC
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKS  218 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  218 (358)
                      ..+....+|.+.+.||.|++|.||++.+..+++.||+|.+....   .....+.+|+.+++++ +|||++++++++...+
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            34445788999999999999999999999999999999886432   2234567899999999 8999999998886532


Q ss_pred             cccccccCCCeEEEEeeccccChHH-HHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcE
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMG-LLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~-~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~  294 (358)
                      .     ..++..|+||||++++.+. .+.   .....+++..++.++.|++.||++||+.+++|+||||+||+++.++.+
T Consensus        93 ~-----~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          93 K-----LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             c-----cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCE
Confidence            1     1245789999999875444 332   234568999999999999999999999999999999999999999999


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCC----CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE----RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++.........  .....++..|+|||.+....    .++.++||||||+++|+|++|++||
T Consensus       168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~  233 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL  233 (291)
T ss_pred             EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence            99999998865432221  12335688899999876432    2678999999999999999999997

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.9e-34  Score=248.13  Aligned_cols=198  Identities=26%  Similarity=0.413  Sum_probs=160.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+.+.||+|++|.||++.+..+ ..||+|.+.....   ....+.+|+++++.++|+||+++++.+.        
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~--------   71 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS--------   71 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC--------
Confidence            456799999999999999999988655 4699999874322   2346789999999999999999976653        


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                         ....++||||+++ ++.+.+... ...+++..+..++.|++.||++||+++++|+||||+||+++.++.++|+|||.
T Consensus        72 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~  148 (262)
T cd05071          72 ---EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL  148 (262)
T ss_pred             ---CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCc
Confidence               2357899999986 555555432 34578999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +.......... .....++..|+|||...+.. ++.++|+||||+++|+|+| |.+||
T Consensus       149 ~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~  204 (262)
T cd05071         149 ARLIEDNEYTA-RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY  204 (262)
T ss_pred             eeecccccccc-ccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCC
Confidence            98765433211 12233467899999886554 8999999999999999999 78786

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4e-34  Score=252.16  Aligned_cols=202  Identities=26%  Similarity=0.387  Sum_probs=162.7

Q ss_pred             CCCcccccccCCcceeeEeeee----ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVS----LFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..|++++.||+|+||.||++..    ..++..||+|.+..... ......+.+|+.+++.++||||+++.+++....   
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   79 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDG---   79 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence            4578999999999999999974    46788999999865432 223456789999999999999999988775531   


Q ss_pred             ccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           ....++||||++|+ |.+.+......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus        80 -----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          80 -----GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             -----CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCc
Confidence                 35689999999875 444444444568999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        301 LARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       301 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      ++......... .......++..|+|||++.+.. ++.++||||||+++|+|+|++.|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~  211 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDS  211 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCC
Confidence            99876443221 1112334467799999987654 88999999999999999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-34  Score=273.10  Aligned_cols=204  Identities=28%  Similarity=0.399  Sum_probs=157.2

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCC-cEEEEEEeecc---------------ccCCCCchhHHHHHHHHHhCCCC
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTD-ELVALKKVRLE---------------NEKEGFPITAVREIKILRQLNHK  205 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~---------------~~~~~~~~~~~~e~~~l~~l~h~  205 (358)
                      +....+|++++.||+|+||.||++...... ..+++|.+...               .........+.+|+.+++.++|+
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            345578999999999999999998764432 22222211100               01111234567899999999999


Q ss_pred             cccchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCC----CCCChHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy13988        206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM----VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI  281 (358)
Q Consensus       206 niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dl  281 (358)
                      ||+++++++..          .+..|+|++++.++++..+....    .......++.++.||+.||+|||++||+||||
T Consensus       224 nIv~l~~~~~~----------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDL  293 (501)
T PHA03210        224 NILKIEEILRS----------EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI  293 (501)
T ss_pred             CcCcEeEEEEE----------CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            99999777654          45789999999998888775432    12345677889999999999999999999999


Q ss_pred             CCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       282 kp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      ||+|||++.++.++|+|||++..+...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..+
T Consensus       294 KP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        294 KLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCC
Confidence            999999999999999999999876543221 123456799999999998765 89999999999999999998753

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.5e-34  Score=249.82  Aligned_cols=201  Identities=25%  Similarity=0.446  Sum_probs=162.6

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCc---EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDE---LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      +.|++.+.||+|++|.||++.+..+++   .||||.+.... .......+..|+.+++.++||||+++.+++.+      
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------   76 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK------   76 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC------
Confidence            468899999999999999999887765   69999986542 22223567889999999999999999776644      


Q ss_pred             cccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          +...++||||++++ +.+.+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus        77 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~  152 (269)
T cd05065          77 ----SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL  152 (269)
T ss_pred             ----CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcc
Confidence                55789999999875 4445555556789999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCc---cccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNK---VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +...............   ..+..|+|||.+.+.. ++.++||||+|+++|+|++ |..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~  212 (269)
T cd05065         153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPY  212 (269)
T ss_pred             ccccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCC
Confidence            8766433222111111   1245799999987654 8899999999999999886 99887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7e-34  Score=246.90  Aligned_cols=193  Identities=26%  Similarity=0.394  Sum_probs=154.8

Q ss_pred             cccCCcceeeEeeeee--cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeE
Q psy13988        153 PLAAGGLSLNNFSVSL--FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF  230 (358)
Q Consensus       153 ~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~  230 (358)
                      .||+|+||.||++...  ..+..||+|.+.... .....+.+.+|+.++++++|+||+++++++..           ...
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-----------~~~   69 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-----------EAL   69 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-----------CCe
Confidence            4899999999998765  445679999887543 22233567899999999999999999876532           357


Q ss_pred             EEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        231 YLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       231 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      ++||||++++ +.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        70 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          70 MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD  149 (257)
T ss_pred             EEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence            9999999864 555555455679999999999999999999999999999999999999999999999999987654332


Q ss_pred             CC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        310 RQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       310 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .. .......+++.|+|||.+.... ++.++||||||+++|+|++ |..||
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~  199 (257)
T cd05115         150 SYYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPY  199 (257)
T ss_pred             cceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCc
Confidence            21 1112222357899999887554 8899999999999999996 99987

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.8e-34  Score=250.21  Aligned_cols=191  Identities=27%  Similarity=0.364  Sum_probs=158.4

Q ss_pred             ccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEE
Q psy13988        154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL  232 (358)
Q Consensus       154 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~l  232 (358)
                      ||.|+||.||++.+..+++.||+|.+...... ......+..|+++++.++||||+++++++..          .+..|+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------~~~~~l   70 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET----------KDDLCL   70 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec----------CCeEEE
Confidence            68999999999999999999999998754322 1223355789999999999999999776654          558999


Q ss_pred             EeeccccChH-HHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        233 VFEYMDHDLM-GLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       233 v~e~~~~~l~-~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                      ||||+++..+ ..+... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        71 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  149 (277)
T cd05577          71 VMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-  149 (277)
T ss_pred             EEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-
Confidence            9999997544 444332 2368999999999999999999999999999999999999999999999999987654321 


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||
T Consensus       150 --~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  194 (277)
T cd05577         150 --KIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPF  194 (277)
T ss_pred             --ccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCC
Confidence              122345678899999987655 889999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.6e-34  Score=246.93  Aligned_cols=198  Identities=24%  Similarity=0.469  Sum_probs=161.5

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|++++.||+|++|.||.+... .+..||+|.+.....   ....+.+|+.+++.++||||+++++++..        
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   70 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTK--------   70 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEcc--------
Confidence            356889999999999999999764 345699998764322   23567899999999999999999877654        


Q ss_pred             cCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ....++||||+.++ +.+.+......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.++
T Consensus        71 --~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          71 --QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             --CCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccce
Confidence              44689999999864 555555544578999999999999999999999999999999999999999999999999988


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ........ ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~  202 (256)
T cd05113         149 YVLDDEYT-SSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPY  202 (256)
T ss_pred             ecCCCcee-ecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCc
Confidence            65433211 112233467799999987654 8889999999999999998 98887

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.3e-34  Score=250.01  Aligned_cols=196  Identities=31%  Similarity=0.443  Sum_probs=166.3

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+...... .....+.+|+++++.++||||+++++++..          
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------   70 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYN----------   70 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeec----------
Confidence            577889999999999999999999999999998765332 334567889999999999999999777654          


Q ss_pred             CCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .+.+++|+|++++ ++.+.+......+++..+..++.|++.|+++||+ .+++|+||+|+||+++.++.++|+|||.+..
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~  150 (265)
T cd06605          71 NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ  150 (265)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence            4689999999996 4555444433678999999999999999999999 9999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......    ...++..|+|||.+.+.. ++.++||||||+++|+|++|..||
T Consensus       151 ~~~~~~~----~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~  199 (265)
T cd06605         151 LVNSLAK----TFVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPY  199 (265)
T ss_pred             hHHHHhh----cccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            5433211    145688899999987654 889999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.5e-34  Score=248.13  Aligned_cols=199  Identities=25%  Similarity=0.402  Sum_probs=163.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|++|.||++.+ .++..||+|.+.....   ..+.+.+|+.+++.++|+||+++++++..       
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------   72 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTK-------   72 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcC-------
Confidence            456789999999999999999986 4567899998764322   24577899999999999999999766654       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                         .+..++||||+.+ ++.+.+.. ....+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||.
T Consensus        73 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~  149 (261)
T cd05072          73 ---EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGL  149 (261)
T ss_pred             ---CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCcc
Confidence               5578999999986 56555543 345688889999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +......... ......++..|+|||.+.+.. ++.++||||||+++|+|+| |..||
T Consensus       150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~  205 (261)
T cd05072         150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPY  205 (261)
T ss_pred             ceecCCCcee-ccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCC
Confidence            9876543221 122233467899999887654 8889999999999999998 99887

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-34  Score=257.30  Aligned_cols=205  Identities=32%  Similarity=0.547  Sum_probs=172.0

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+.+.||.|++|.||++.+..++..||||++............+.+|+.+++.++|+||+++.+++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   88 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS---   88 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc---
Confidence            45678999999999999999999999999999999987543333334566789999999999999999988765331   


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                       .......++|+|++++++.+.+..  ..+++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        89 -~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          89 -LEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             -ccccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence             122346899999998877776654  36899999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......     .....++..|+|||.+.+...++.++||||||+++|+|++|+.||
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf  216 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF  216 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            866433     123355888999999876555789999999999999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.5e-34  Score=250.36  Aligned_cols=199  Identities=26%  Similarity=0.391  Sum_probs=165.9

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ...|+.++.||.|++|.||.+.+..++..||||.+..... ......+.+|+.+++.+.|+||+++++++.+        
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   73 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--------   73 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--------
Confidence            3568889999999999999999999999999999875422 2223567889999999999999999877754        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        +...|+||||++|+.+..+... .++++.++..++.|++.||++||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        74 --~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~  150 (277)
T cd06640          74 --GTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             --CCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEccccccee
Confidence              5589999999987544443333 3688999999999999999999999999999999999999999999999999976


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  .....++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||
T Consensus       151 ~~~~~~~--~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~  201 (277)
T cd06640         151 LTDTQIK--RNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPN  201 (277)
T ss_pred             ccCCccc--cccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCC
Confidence            6433211  12234688899999987654 889999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.7e-34  Score=254.68  Aligned_cols=198  Identities=23%  Similarity=0.350  Sum_probs=156.8

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcE--EEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDEL--VALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      +.|.+.+.||+|+||.||+|.+..++..  +++|.+.... .......+.+|+.++.++ +|+||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~------   79 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH------   79 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC------
Confidence            4678889999999999999999877764  5777655321 222234677899999999 89999999777654      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI  286 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Ni  286 (358)
                          ++..|+||||+++ ++.+.+...               ...+++..++.++.||+.|++|||++|++|+||||+||
T Consensus        80 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Ni  155 (303)
T cd05088          80 ----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI  155 (303)
T ss_pred             ----CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence                5579999999986 555555322               12578999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       287 ll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++.++.++|+|||++........   ......+..|+|||.+.+.. ++.++||||||+++|+|+| |..||
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~  224 (303)
T cd05088         156 LVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPY  224 (303)
T ss_pred             EecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCc
Confidence            999999999999999864321111   11122356799999886554 8899999999999999998 99987

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.1e-34  Score=250.98  Aligned_cols=201  Identities=27%  Similarity=0.406  Sum_probs=160.1

Q ss_pred             CCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..++.+.+.||+|+||.||++...     .++..+++|.+.....  .....+.+|+++++.++|+||+++++++..   
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   78 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIVRFYGVCTE---   78 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--HHHHHHHHHHHHHhcCCCCCCceEEEEEec---
Confidence            356778899999999999999743     3567899998764322  223467889999999999999999776654   


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhcCC--------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLESGM--------------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS  284 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~--------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~  284 (358)
                             ....++||||++++ +.+.+....              ..+++..+..++.||+.|++|||+.|++|+||||+
T Consensus        79 -------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~  151 (280)
T cd05092          79 -------GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR  151 (280)
T ss_pred             -------CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence                   45789999999864 444443221              24788999999999999999999999999999999


Q ss_pred             CEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       285 Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||++++++.++|+|||++................+++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||
T Consensus       152 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~  225 (280)
T cd05092         152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPW  225 (280)
T ss_pred             hEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999987654332222222233467899999887655 8999999999999999998 89987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-33  Score=245.48  Aligned_cols=198  Identities=26%  Similarity=0.438  Sum_probs=166.4

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+++.||.|++|.||++.+..++..+|+|.+............+.+|+++++.++|||++++++.+..          
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------   70 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE----------   70 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec----------
Confidence            4888999999999999999999999999999998665444445678889999999999999999776653          


Q ss_pred             CCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeecccce
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLAR  303 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg~~~  303 (358)
                      ++..++||||+++ ++.+.+... ...+++..+..++.|++.|+++||++|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~  150 (256)
T cd08220          71 DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK  150 (256)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence            5589999999987 555555443 34589999999999999999999999999999999999998655 57999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........   ....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||
T Consensus       151 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~  201 (256)
T cd08220         151 ILSSKSKA---YTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAF  201 (256)
T ss_pred             ecCCCccc---cccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCc
Confidence            76543221   2345688999999987654 788999999999999999999887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0608|consensus

Probab=100.00  E-value=8.6e-35  Score=261.74  Aligned_cols=205  Identities=29%  Similarity=0.371  Sum_probs=168.7

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ...+-|..++.||.|+||.|.+++...|...||.|.+.+... .......++.|-.+|..-+++=||+++-.|++     
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-----  700 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----  700 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-----
Confidence            344556678899999999999999999999999998876532 22234567789999999999999999666655     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           .+++|+||||++|+.+-.+.-.-+-++|..++-++..+..|+++.|+.|++||||||+|||||.+|++||.|||+
T Consensus       701 -----kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGL  775 (1034)
T KOG0608|consen  701 -----KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL  775 (1034)
T ss_pred             -----CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccc
Confidence                 669999999999855544444455799999999999999999999999999999999999999999999999999


Q ss_pred             ceeccc---------cC--C-----------------------------CCCCCCccccccccccccccCCCCCCCcchH
Q psy13988        302 ARLYNA---------ED--R-----------------------------QRPYTNKVITLWYRPPELLLGEERYGPAIDV  341 (358)
Q Consensus       302 ~~~~~~---------~~--~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  341 (358)
                      |+-+.-         +.  .                             .-.....+||+.|+|||++...+ ++..+|+
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdw  854 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDW  854 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchh
Confidence            864321         00  0                             00112347899999999998776 8999999


Q ss_pred             HHHHHHHHHHhhCCCCC
Q psy13988        342 WSCGCILGELFVKKPLF  358 (358)
Q Consensus       342 wslG~~l~~lltg~~pF  358 (358)
                      ||.|||||+|+.|++||
T Consensus       855 ws~gvil~em~~g~~pf  871 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPF  871 (1034)
T ss_pred             hHhhHHHHHHhhCCCCc
Confidence            99999999999999998

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-33  Score=255.25  Aligned_cols=204  Identities=37%  Similarity=0.654  Sum_probs=167.2

Q ss_pred             CCCCCc-ccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC------------CchhHHHHHHHHHhCCCCcccch
Q psy13988        144 NNSSRP-LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG------------FPITAVREIKILRQLNHKNIVNL  210 (358)
Q Consensus       144 ~~~~~~-~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~~  210 (358)
                      ...+|. +.+.||.|++|.||++.+..+++.||||.+........            ....+.+|+.+++.++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            345665 45779999999999999999999999999865432220            01246789999999999999999


Q ss_pred             hhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC
Q psy13988        211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN  290 (358)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~  290 (358)
                      ++++..          +...++|||++.+++...+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.
T Consensus        86 ~~~~~~----------~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~  154 (335)
T PTZ00024         86 VDVYVE----------GDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINS  154 (335)
T ss_pred             eEEEec----------CCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECC
Confidence            777654          558999999999988777754 346899999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceeccccC------------CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        291 RGEVKLADFGLARLYNAED------------RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.++|+|||.+.......            .........+++.|+|||.+.+...++.++|+||||+++|+|++|++||
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999998665211            0111223345788999999876655789999999999999999999987

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.9e-34  Score=249.11  Aligned_cols=196  Identities=21%  Similarity=0.307  Sum_probs=150.6

Q ss_pred             ccccCCcceeeEeeeeec--CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLF--TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++....  ....+++|.+.... .......+.+|+.+++.++|+||+++++.+..          ...
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~----------~~~   69 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE----------SIP   69 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC----------CCc
Confidence            368999999999996432  44678888776432 22223456789999999999999999776654          457


Q ss_pred             EEEEeecccc-ChHHHHhcCC----CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        230 FYLVFEYMDH-DLMGLLESGM----VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       230 ~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      +|+||||+++ ++.+.+....    ...++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++..
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  149 (269)
T cd05042          70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE  149 (269)
T ss_pred             eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccc
Confidence            8999999987 4555554322    2246777889999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCccccccccccccccC------CCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ..............+++.|+|||++..      ...++.++||||||+++|+|++ |..||
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  210 (269)
T cd05042         150 QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY  210 (269)
T ss_pred             cccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC
Confidence            433222122233344678999998743      2346789999999999999999 77776

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5e-34  Score=254.34  Aligned_cols=205  Identities=26%  Similarity=0.415  Sum_probs=161.8

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeec-------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhh
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLF-------TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREI  213 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  213 (358)
                      .....+|.+.+.||+|+||.||++.+..       +...||+|.+.... .......+.+|+++++.+ +|+||++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3445679999999999999999998743       23579999887542 222234577899999999 89999999777


Q ss_pred             hcccCcccccccCCCeEEEEeecccc-ChHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHHHhCCce
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM---------------VDFNEVNNASIMRQLLDGLSYCHKRNFL  277 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~i~  277 (358)
                      +..          ++..|+||||+.+ +|.+.+....               ..++...++.++.|++.||+|||++|++
T Consensus        93 ~~~----------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~  162 (307)
T cd05098          93 CTQ----------DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI  162 (307)
T ss_pred             Eec----------CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            654          5578999999986 5555554321               2478889999999999999999999999


Q ss_pred             ecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCC
Q psy13988        278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKP  356 (358)
Q Consensus       278 H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~  356 (358)
                      |+||||+||+++.++.++|+|||.+................+++.|+|||++.+.. ++.++|+||||+++|+|++ |.+
T Consensus       163 H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~  241 (307)
T cd05098         163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGS  241 (307)
T ss_pred             cccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999987654322222122223356899999887654 8899999999999999998 888


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       242 p~  243 (307)
T cd05098         242 PY  243 (307)
T ss_pred             CC
Confidence            86

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.7e-34  Score=249.44  Aligned_cols=207  Identities=25%  Similarity=0.345  Sum_probs=167.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ...+.|++.+.||.|+||.||++.+..+++.||+|.+.....   ....+..|+.+++.+ +|+||+++++++....   
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~---   86 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKYSHHRNIATYYGAFIKKS---   86 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH---HHHHHHHHHHHHHHhcCCCcEEEEeeehhccc---
Confidence            455789999999999999999999999999999999865432   234567899999998 7999999998886422   


Q ss_pred             ccccCCCeEEEEeeccccC-hHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        222 DFRKDKGSFYLVFEYMDHD-LMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                       ....+...|+||||++++ +...+.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus        87 -~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          87 -PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             -ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence             112356899999999874 4444433 2345888889999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........  ......+++.|+|||.+..    ...++.++|+||||+++|+|++|..||
T Consensus       166 g~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~  226 (282)
T cd06636         166 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL  226 (282)
T ss_pred             cchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence            99876532221  1233456889999998753    234788999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-34  Score=248.41  Aligned_cols=206  Identities=28%  Similarity=0.366  Sum_probs=169.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..++|.+.+.||.|++|.||++.+..+++.|++|++.....   ....+.+|+.+++++ .|+||+++++++.....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~---   77 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP---   77 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC---
Confidence            45789999999999999999999999999999999875432   235678899999999 79999999998876431   


Q ss_pred             cccCCCeEEEEeeccccChHHHH-hc---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLL-ES---GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~-~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                       ...+..+++||||++++.+..+ ..   ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|
T Consensus        78 -~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          78 -PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             -CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence             0235678999999997544433 22   245789999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCC----CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++........  ......++..|+|||.+...    ..++.++||||||+++|+|++|++||
T Consensus       157 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  218 (275)
T cd06608         157 FGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL  218 (275)
T ss_pred             Cccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCc
Confidence            999876543322  12334568899999987532    34678999999999999999999997

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-34  Score=252.61  Aligned_cols=202  Identities=27%  Similarity=0.391  Sum_probs=158.9

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCC--------------cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccch
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTD--------------ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL  210 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  210 (358)
                      ..+|.+.+.||+|+||.||++.+..++              ..||+|.++... .......+.+|++++++++|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            457899999999999999999875432              358999887442 22223467889999999999999999


Q ss_pred             hhhhcccCcccccccCCCeEEEEeeccccC-hHHHHhcCC-----------CCCChHHHHHHHHHHHHHHHHHHhCCcee
Q psy13988        211 REIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGM-----------VDFNEVNNASIMRQLLDGLSYCHKRNFLH  278 (358)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~LH~~~i~H  278 (358)
                      ++++..          ++..++||||+.+. +.+.+....           ..+++..+..++.|++.||.|||++|++|
T Consensus        83 ~~~~~~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H  152 (295)
T cd05097          83 LGVCVS----------DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVH  152 (295)
T ss_pred             EEEEcC----------CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence            777654          45789999999874 444443211           23678888999999999999999999999


Q ss_pred             cCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh--CCC
Q psy13988        279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV--KKP  356 (358)
Q Consensus       279 ~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt--g~~  356 (358)
                      +||||+||+++.++.++|+|||++................++..|+|||++.+.. ++.++|+||||+++|+|++  |..
T Consensus       153 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~  231 (295)
T cd05097         153 RDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQ  231 (295)
T ss_pred             cccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999987654332222222233467899999887655 8999999999999999988  556


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       232 p~  233 (295)
T cd05097         232 PY  233 (295)
T ss_pred             CC
Confidence            65

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=247.44  Aligned_cols=197  Identities=40%  Similarity=0.677  Sum_probs=167.3

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCcccccccC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      |.+.+.||.|++|.||++.+..+++.|+||++...... .......+|+..+++++ |+|++++++++.+          
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~----------   69 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE----------   69 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc----------
Confidence            67889999999999999999999999999998754332 12224467999999998 9999999888865          


Q ss_pred             CCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      ++..++||||+++++.+.+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        70 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          70 NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence            45889999999888888776543 46899999999999999999999999999999999999999999999999999866


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....   .....++..|+|||++.+...++.++|+||||+++++|++|++||
T Consensus       150 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~  199 (283)
T cd07830         150 RSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF  199 (283)
T ss_pred             cCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence            43322   223456888999998876655889999999999999999999887

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-33  Score=249.11  Aligned_cols=209  Identities=25%  Similarity=0.318  Sum_probs=168.7

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccC
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKS  218 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  218 (358)
                      .......+|.+++.||+|++|.||++.+..+++.||+|.+....   .....+..|+.+++.+ +|+||+++++++....
T Consensus        12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            34456778999999999999999999999999999999876432   1224567899999999 7999999988775321


Q ss_pred             cccccccCCCeEEEEeeccccChHHH-Hh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcE
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGL-LE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~-~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~  294 (358)
                           ..++...++||||++++.+.. +.   .....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+
T Consensus        89 -----~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          89 -----VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             -----cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence                 123567999999998754443 32   233568899999999999999999999999999999999999999999


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCC----CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++........  ......+++.|+|||.+...    ..++.++||||+||++|+|++|+.||
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~  229 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL  229 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence            9999999887643321  12334578999999987532    33788999999999999999999987

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.1e-34  Score=248.75  Aligned_cols=202  Identities=24%  Similarity=0.404  Sum_probs=163.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCc---EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDE---LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..+|++.+.||.|+||.||++.+..++.   .||+|.+..... ......+.+|+.+++.++||||+++++++..     
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   76 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----   76 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            3578899999999999999999865543   799998865322 2223467889999999999999999777654     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           ++..|+||||+++ ++.+.+......+++.++..++.|++.|+.+||+.+++|+||||+||+++.++.++|+|||
T Consensus        77 -----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd05066          77 -----SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFG  151 (267)
T ss_pred             -----CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCC
Confidence                 5578999999987 4555555555578999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++..+...... .......++..|+|||.+.+.. ++.++|+||||+++|++++ |..||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~  210 (267)
T cd05066         152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPY  210 (267)
T ss_pred             cccccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCc
Confidence            99876543221 1112223356899999987654 8999999999999999886 99887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.9e-34  Score=253.36  Aligned_cols=204  Identities=27%  Similarity=0.437  Sum_probs=163.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecC-----CcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFT-----DELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  216 (358)
                      ....+|.+.+.||+|++|.||++.....     ...||+|.+...... .....+.+|+.+++.+ +|+||+++++++..
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            4456788999999999999999997644     378999988754222 2234577899999999 89999999776654


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhc---------------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecC
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLES---------------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD  280 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~D  280 (358)
                                ++.+++||||+.+ ++...+..               ....+++..+..++.|++.||+|||+++++|+|
T Consensus        88 ----------~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d  157 (293)
T cd05053          88 ----------EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD  157 (293)
T ss_pred             ----------CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence                      5578999999986 44444432               234688999999999999999999999999999


Q ss_pred             CCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       281 lkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |||+||+++.++.++|+|||.++.+.............++..|+|||.+.+.. ++.++|||||||++|+|++ |..||
T Consensus       158 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~  235 (293)
T cd05053         158 LAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPY  235 (293)
T ss_pred             cceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCC
Confidence            99999999999999999999998765433222222233467799999886554 8899999999999999997 88886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.8e-34  Score=253.01  Aligned_cols=200  Identities=21%  Similarity=0.331  Sum_probs=161.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCc----EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDE----LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..|++.+.||.|++|.||++.+..++.    .||+|.+..... ......+.+|+.+++.++||||+++++++...    
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            467788999999999999999887776    578888764322 22233577899999999999999998876531    


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                             ..++++|++++ ++.+.+......+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||
T Consensus        82 -------~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          82 -------TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             -------CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccc
Confidence                   35689999985 6666666555568999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++...............++..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~  212 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPY  212 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCC
Confidence            998765433222222334467899999887654 8899999999999999997 88886

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0695|consensus

Probab=100.00  E-value=2.1e-34  Score=241.81  Aligned_cols=206  Identities=22%  Similarity=0.326  Sum_probs=175.6

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      +.+.....|.++++||+|+|+.|.+++...+.+.||+|+++++-..+. ....+..|-.+...- +||.+|.+..+|+. 
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-  322 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-  322 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-
Confidence            445567788999999999999999999999999999999987754433 334556677777666 79999999998876 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                               +..+++|.||+.|+.+-....+...++++.++-+...|..||.|||+.||++||||.+||++|.+|++||.
T Consensus       323 ---------esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghiklt  393 (593)
T KOG0695|consen  323 ---------ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLT  393 (593)
T ss_pred             ---------cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeec
Confidence                     44899999999986555554555689999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|+++.--.+.  .....++|||.|.|||++.+.. |...+|+|+||++++||+.|+.||
T Consensus       394 dygmcke~l~~g--d~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspf  451 (593)
T KOG0695|consen  394 DYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPF  451 (593)
T ss_pred             ccchhhcCCCCC--cccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCc
Confidence            999998532222  2345678899999999999877 999999999999999999999998

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-33  Score=249.91  Aligned_cols=204  Identities=26%  Similarity=0.440  Sum_probs=168.9

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ...+....+|.+++.||.|++|.||++.+..++..|++|.+......  ..+.+.+|+.+++.++||||+++++++..  
T Consensus        12 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--   87 (293)
T cd06647          12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLV--   87 (293)
T ss_pred             eeccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeee--
Confidence            34455568999999999999999999999889999999998644222  24567889999999999999999887765  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                              ....|+|+||++++.+..+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus        88 --------~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~d  158 (293)
T cd06647          88 --------GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTD  158 (293)
T ss_pred             --------CCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEcc
Confidence                    4478999999987555444332 2578889999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++.........  .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       159 fg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf  215 (293)
T cd06647         159 FGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPY  215 (293)
T ss_pred             Ccceecccccccc--cccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9988765433221  12335688899999987654 789999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.4e-34  Score=252.48  Aligned_cols=198  Identities=22%  Similarity=0.331  Sum_probs=156.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCc--EEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDE--LVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      +.|.+.+.||.|+||.||++.+..++.  .+++|.++... .....+.+.+|+.++.++ +||||+++++++..      
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------   74 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACEN------   74 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc------
Confidence            468899999999999999999877764  46888776322 112234678899999999 79999999776654      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGM---------------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI  286 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Ni  286 (358)
                          .+..|+|+||+++ ++.+.+....               ..+++..++.++.||+.||+|||++|++|+||||+||
T Consensus        75 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Ni  150 (297)
T cd05089          75 ----RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNV  150 (297)
T ss_pred             ----CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceE
Confidence                4578999999986 5555553321               2478889999999999999999999999999999999


Q ss_pred             EecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       287 ll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++.++.++|+|||++........   ......+..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       151 ll~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf  219 (297)
T cd05089         151 LVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPY  219 (297)
T ss_pred             EECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999864321111   11112245799999887654 8899999999999999997 99987

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.9e-34  Score=247.95  Aligned_cols=198  Identities=25%  Similarity=0.361  Sum_probs=164.5

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|++++.||.|++|.||++.+.. +..+++|.+......  ....+.+|+.+++.++|+||+++++++.+        
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   73 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSV--------   73 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEec--------
Confidence            3568899999999999999999977 899999998754332  24567889999999999999999766654        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                        ....++||||+++ ++.+.+.. ....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        74 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~  151 (261)
T cd05148          74 --GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA  151 (261)
T ss_pred             --CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccch
Confidence              5578999999987 56555544 3346899999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .........  .....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~  205 (261)
T cd05148         152 RLIKEDVYL--SSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPY  205 (261)
T ss_pred             hhcCCcccc--ccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCC
Confidence            876433221  12333467899999887654 8899999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1e-33  Score=246.78  Aligned_cols=198  Identities=34%  Similarity=0.466  Sum_probs=168.6

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|.+.+.||.|++|.||++.+..+++.|++|++...... .....+.+|+..+..++|+||+++++++..          
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   70 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK----------   70 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc----------
Confidence            578899999999999999999999999999998765432 334578899999999999999999777654          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      .+.+++||||++++.+..+......+++..+..++.|++.|+.+||+ .+++|+||+|+||+++.++.++|+|||.+...
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          71 EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            46899999999975555554444679999999999999999999999 99999999999999999999999999999876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||
T Consensus       151 ~~~~~~~--~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~  200 (264)
T cd06623         151 ENTLDQC--NTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPF  200 (264)
T ss_pred             ccCCCcc--cceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            5433221  234568889999998765 4889999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.5e-34  Score=253.36  Aligned_cols=205  Identities=26%  Similarity=0.338  Sum_probs=163.5

Q ss_pred             CCCCCCCcccccccCCcceeeEeeee-----ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVS-----LFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVT  215 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  215 (358)
                      .....+|.+.+.||+|+||.||++.+     ..++..||+|.++.... ....+.+.+|+.+++++ +|+||+++++++.
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            34556788999999999999999975     33456899998875432 22234678899999999 7999999977765


Q ss_pred             ccCcccccccCCCeEEEEeecccc-ChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE  293 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~  293 (358)
                      .          .+..|+||||+.+ +|...+.... ..+++.++..++.|++.||.|||+++++|+||||+||+++.++.
T Consensus       110 ~----------~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~  179 (302)
T cd05055         110 I----------GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI  179 (302)
T ss_pred             c----------CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe
Confidence            4          4578999999986 5555554332 33899999999999999999999999999999999999999999


Q ss_pred             EEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       294 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++|+|||++................++..|+|||.+.+.. ++.++||||+|+++|+|++ |.+||
T Consensus       180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~  244 (302)
T cd05055         180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPY  244 (302)
T ss_pred             EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCc
Confidence            9999999988654332211112233467899999887655 8899999999999999998 99886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-33  Score=245.22  Aligned_cols=193  Identities=26%  Similarity=0.377  Sum_probs=156.4

Q ss_pred             ccccCCcceeeEeeeeecCC---cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCC
Q psy13988        152 EPLAAGGLSLNNFSVSLFTD---ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      +.||+|++|.||++....++   ..||+|.+...... .....+.+|+.+++.+.|+||+++++++.           ..
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----------~~   68 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-----------GE   68 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----------CC
Confidence            47999999999999876555   79999998755433 23456788999999999999999987653           23


Q ss_pred             eEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccc
Q psy13988        229 SFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA  307 (358)
Q Consensus       229 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~  307 (358)
                      ..++||||+.+ ++.+.+.. ...+++..+..++.|++.||++||+.+++|+||||+||+++.++.++|+|||++.....
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          69 PLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             ceEEEEEeCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence            57999999986 55555544 34789999999999999999999999999999999999999999999999999986644


Q ss_pred             cCCCC-CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        308 EDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       308 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ..... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~  199 (257)
T cd05060         148 GSDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPY  199 (257)
T ss_pred             CCcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCc
Confidence            33211 111222346799999887654 8999999999999999998 99987

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.1e-34  Score=250.70  Aligned_cols=204  Identities=22%  Similarity=0.338  Sum_probs=160.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeec-----CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLF-----TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ....+|.+.+.||+|+||.||++.+..     .+..||+|.+...... .....+.+|+.+++.++|+||+++++++.+ 
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   80 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSK-   80 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence            455789999999999999999997642     3458999987644322 123456789999999999999999877654 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcC---------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESG---------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL  287 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nil  287 (358)
                               ....|+||||+.+ +|.+.+...         ....+...+..++.|++.||.|||+++++|+||||+||+
T Consensus        81 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nil  151 (288)
T cd05061          81 ---------GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM  151 (288)
T ss_pred             ---------CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEE
Confidence                     4478999999986 555555331         123456678899999999999999999999999999999


Q ss_pred             ecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       288 l~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++.++.++|+|||+++...............++..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||
T Consensus       152 i~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~  222 (288)
T cd05061         152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY  222 (288)
T ss_pred             EcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999988654333222222233467899999987654 8899999999999999998 77776

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG4645|consensus

Probab=100.00  E-value=9.8e-36  Score=286.54  Aligned_cols=205  Identities=27%  Similarity=0.409  Sum_probs=174.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..-+|.-...||.|.||.||.+.+..+|+..|+|-+............+.+|..++..|+|||+|+++++-..       
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH------- 1305 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH------- 1305 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-------
Confidence            3445666789999999999999999999999999888776665556677899999999999999999777655       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         +..++|-||||+|+.+..+.......++.....+..|++.|+.|||+.|||||||||.||+++.+|.+|++|||.|.
T Consensus      1306 ---Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1306 ---REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             ---HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeeccccee
Confidence               45789999999988777776666567888888889999999999999999999999999999999999999999999


Q ss_pred             eccccCC--CCCCCCccccccccccccccCCC--CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDR--QRPYTNKVITLWYRPPELLLGEE--RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .+.++..  ........||+.|||||++.+..  ....+.|||||||++.||+||+.||
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch
Confidence            8765531  12223557899999999997643  3567899999999999999999998

>KOG0671|consensus

Probab=100.00  E-value=2.7e-35  Score=250.90  Aligned_cols=205  Identities=28%  Similarity=0.440  Sum_probs=171.5

Q ss_pred             ccccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCC--Cc----cc
Q psy13988        135 AAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH--KN----IV  208 (358)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv  208 (358)
                      .......+....+|.++..||+|.||.|..+.|..++..||||+++.-   ..+.+..+-|+++|.++.+  |+    ++
T Consensus        78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv  154 (415)
T KOG0671|consen   78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCV  154 (415)
T ss_pred             eEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence            334556677799999999999999999999999999999999998743   2344566779999999932  32    45


Q ss_pred             chhhhhcccCcccccccCCCeEEEEeeccccChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy13988        209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL  287 (358)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nil  287 (358)
                      .+          .+|++..++.|||+|.++.++.+.+.. +..+++-.+++.+++|+++++++||+++++|.||||+||+
T Consensus       155 ~m----------~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENIL  224 (415)
T KOG0671|consen  155 QM----------RDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENIL  224 (415)
T ss_pred             ee----------ehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEE
Confidence            55          455666889999999999999999976 4567999999999999999999999999999999999999


Q ss_pred             ecC--------------------CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHH
Q psy13988        288 MNN--------------------RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI  347 (358)
Q Consensus       288 l~~--------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~  347 (358)
                      +.+                    +..++|+|||.|+......     ...+.|..|+|||++.+-+ |+.++||||+|||
T Consensus       225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCI  298 (415)
T KOG0671|consen  225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCI  298 (415)
T ss_pred             EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccC-cCCccCceeeeeE
Confidence            942                    2258999999998754332     3445599999999999887 9999999999999


Q ss_pred             HHHHhhCCCCC
Q psy13988        348 LGELFVKKPLF  358 (358)
Q Consensus       348 l~~lltg~~pF  358 (358)
                      |+||.||...|
T Consensus       299 L~ElytG~~LF  309 (415)
T KOG0671|consen  299 LVELYTGETLF  309 (415)
T ss_pred             EEEeeccceec
Confidence            99999998776

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.9e-34  Score=252.40  Aligned_cols=206  Identities=27%  Similarity=0.415  Sum_probs=163.5

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeee-------cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhh
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSL-------FTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLRE  212 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  212 (358)
                      ......+|.+.+.||+|+||.||++...       ..+..||+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            3455678889999999999999999753       2345799998864322 22235678899999999 8999999977


Q ss_pred             hhcccCcccccccCCCeEEEEeecccc-ChHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCc
Q psy13988        213 IVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNF  276 (358)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i  276 (358)
                      ++..          .+..|+||||+.+ +|.+.+...               ...++...+..++.||+.||.|||++|+
T Consensus        89 ~~~~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~gi  158 (304)
T cd05101          89 ACTQ----------DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC  158 (304)
T ss_pred             EEec----------CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCe
Confidence            7654          4578999999987 455555332               1246778889999999999999999999


Q ss_pred             eecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CC
Q psy13988        277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KK  355 (358)
Q Consensus       277 ~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~  355 (358)
                      +|+||||+||+++.++.++|+|||.++...............+++.|+|||++.+.. ++.++||||||+++|+|++ |.
T Consensus       159 vH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~  237 (304)
T cd05101         159 IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGG  237 (304)
T ss_pred             eecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999998765433322223334567899999987654 8899999999999999998 77


Q ss_pred             CCC
Q psy13988        356 PLF  358 (358)
Q Consensus       356 ~pF  358 (358)
                      .||
T Consensus       238 ~p~  240 (304)
T cd05101         238 SPY  240 (304)
T ss_pred             CCc
Confidence            775

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.6e-34  Score=259.73  Aligned_cols=204  Identities=25%  Similarity=0.383  Sum_probs=161.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  216 (358)
                      ....+|.+.+.||+|+||.||++.+.     .+++.||+|+++..... .....+.+|+.++..+. ||||+++++++..
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            34456778899999999999999853     45578999999754322 22346788999999997 9999999877754


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCC----------------------------------------------
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM----------------------------------------------  249 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------------------------------  249 (358)
                                ++..++||||+.+ +|.+.+....                                              
T Consensus       113 ----------~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (401)
T cd05107         113 ----------GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS  182 (401)
T ss_pred             ----------CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence                      4578999999986 5555553211                                              


Q ss_pred             ---------------------------------------------------CCCChHHHHHHHHHHHHHHHHHHhCCcee
Q psy13988        250 ---------------------------------------------------VDFNEVNNASIMRQLLDGLSYCHKRNFLH  278 (358)
Q Consensus       250 ---------------------------------------------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H  278 (358)
                                                                         ..++...++.++.||+.||+|||+.+++|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH  262 (401)
T cd05107         183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH  262 (401)
T ss_pred             CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence                                                               13566778889999999999999999999


Q ss_pred             cCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCC
Q psy13988        279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPL  357 (358)
Q Consensus       279 ~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~p  357 (358)
                      +||||+||+++.++.++|+|||+++...............++..|+|||.+.+.. ++.++||||||+++|+|++ |..|
T Consensus       263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P  341 (401)
T cd05107         263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTP  341 (401)
T ss_pred             ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999998654332222222334578899999987654 8899999999999999998 8888


Q ss_pred             C
Q psy13988        358 F  358 (358)
Q Consensus       358 F  358 (358)
                      |
T Consensus       342 ~  342 (401)
T cd05107         342 Y  342 (401)
T ss_pred             C
Confidence            6

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1026|consensus

Probab=100.00  E-value=5.3e-35  Score=272.69  Aligned_cols=200  Identities=29%  Similarity=0.462  Sum_probs=167.8

Q ss_pred             CCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .-...+.||+|.||.||+++..     .....||||.++..... ...++|.+|++++..++|||||+++++|..     
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----  560 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCRE-----  560 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----
Confidence            3346789999999999999963     23468999998865433 245689999999999999999999777765     


Q ss_pred             ccccCCCeEEEEeeccc-cChHHHHhcC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy13988        222 DFRKDKGSFYLVFEYMD-HDLMGLLESG-------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL  287 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nil  287 (358)
                           ++.+|+|+||+. |+|..++...             ..+++..+.+.|+.|||.|++||-++.+|||||-..|.|
T Consensus       561 -----~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL  635 (774)
T KOG1026|consen  561 -----GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL  635 (774)
T ss_pred             -----CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence                 668999999998 5666666321             123889999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       288 l~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |.++..+||+|||+++-.-..+..+......-..+|||||.+...+ ++.+|||||+||+|||+++ |+.||
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy  706 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPY  706 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcc
Confidence            9999999999999999776665555444556689999999998655 9999999999999999997 88886

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-33  Score=248.83  Aligned_cols=198  Identities=28%  Similarity=0.357  Sum_probs=164.8

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|...+.||.|++|.||++.+..+++.||+|.+...... .....+.+|+++++.++||||+++++++...        .
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~   72 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDE--------S   72 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc--------C
Confidence            577889999999999999999999999999998754322 2345678999999999999999998887543        2


Q ss_pred             CCeEEEEeeccccC-hHHHH---hcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        227 KGSFYLVFEYMDHD-LMGLL---ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       227 ~~~~~lv~e~~~~~-l~~~~---~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      .+.+|+||||++++ |.+.+   ......+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence            45789999999874 43333   233456889999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........    ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus       153 ~~~~~~~~----~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  203 (287)
T cd06621         153 GELVNSLA----GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPF  203 (287)
T ss_pred             cccccccc----ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            75543221    1234578899999887654 889999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-33  Score=243.13  Aligned_cols=194  Identities=25%  Similarity=0.353  Sum_probs=157.9

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY  231 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~  231 (358)
                      +.||.|++|.||++.+.. ++.||+|.+...... .....+.+|+++++.++|+||+++++++.+          ....+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------~~~~~   68 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ----------KQPIY   68 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec----------CCCeE
Confidence            479999999999999877 999999988754332 234567889999999999999999776654          55789


Q ss_pred             EEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        232 LVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       232 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                      +|||++.+ ++.+.+......+++..+..++.+++.||++||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus        69 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (251)
T cd05041          69 IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY  148 (251)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence            99999986 45555555555788999999999999999999999999999999999999999999999999876542221


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .........+..|+|||.+.+.. ++.++|+||||+++|+|+| |..||
T Consensus       149 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~  196 (251)
T cd05041         149 TVSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPY  196 (251)
T ss_pred             eeccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCC
Confidence            11111222356799999887654 8899999999999999999 78876

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=247.93  Aligned_cols=202  Identities=41%  Similarity=0.696  Sum_probs=166.5

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC---CCCcccchhhhhcccCcccccc
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL---NHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      |++.+.||.|++|.||++.+..++..||+|.+............+.+|+.+++.+   +|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~-----   75 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT-----   75 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC-----
Confidence            6788999999999999999988999999999976544433344566788777666   69999999988876431     


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ......+++||++.+++.+.+.... ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.
T Consensus        76 ~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          76 DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             CCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence            1233589999999988777665432 358999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........   ....++..|+|||.+.+.. ++.++|+||+|+++|+|++|.+||
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~  206 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLF  206 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcc
Confidence            76443221   2234588899999987655 889999999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-33  Score=245.89  Aligned_cols=196  Identities=24%  Similarity=0.330  Sum_probs=153.1

Q ss_pred             ccccCCcceeeEeeeee--cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSL--FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++...  .++..+|+|.+...... .....+.+|+.+++.++||||+++++++.+          ...
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------~~~   69 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTE----------VTP   69 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC----------CCC
Confidence            36899999999999754  45578999988654322 223467789999999999999999776654          446


Q ss_pred             EEEEeecccc-ChHHHHhcC----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        230 FYLVFEYMDH-DLMGLLESG----MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       230 ~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .++||||+++ ++.+.+...    ....++..+..++.|++.|++|||+.+++|+||||+||+++.++.++|+|||.+..
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~  149 (269)
T cd05087          70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHN  149 (269)
T ss_pred             cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcccccc
Confidence            8999999986 555555332    23456777889999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCccccccccccccccCCC------CCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEE------RYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ..............++..|+|||++.+..      .++.++||||||+++|+|++ |+.||
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  210 (269)
T cd05087         150 KYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY  210 (269)
T ss_pred             ccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCC
Confidence            43332222223344578899999886421      25789999999999999996 99987

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-33  Score=249.75  Aligned_cols=200  Identities=23%  Similarity=0.343  Sum_probs=157.6

Q ss_pred             CCcccccccCCcceeeEeeeeec-----CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLF-----TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .|++.+.||+|+||.||++.+..     ....+++|.+...... .....+.+|+.+++.++||||+++++.+..     
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   74 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----   74 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----
Confidence            47788999999999999998753     2357888887644322 223467789999999999999999776654     


Q ss_pred             ccccCCCeEEEEeeccccC-hHHHHhcC-----------------------CCCCChHHHHHHHHHHHHHHHHHHhCCce
Q psy13988        222 DFRKDKGSFYLVFEYMDHD-LMGLLESG-----------------------MVDFNEVNNASIMRQLLDGLSYCHKRNFL  277 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~  277 (358)
                           ++..++|+||+.++ +.+.+...                       ...+++..++.++.|++.||+|||+++++
T Consensus        75 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iv  149 (290)
T cd05045          75 -----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV  149 (290)
T ss_pred             -----CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence                 45789999999964 44443221                       12478889999999999999999999999


Q ss_pred             ecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCC
Q psy13988        278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKP  356 (358)
Q Consensus       278 H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~  356 (358)
                      |+||||+||+++.++.++|+|||+++...............++..|+|||.+.+.. ++.++||||||+++|+|++ |..
T Consensus       150 H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~  228 (290)
T cd05045         150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGN  228 (290)
T ss_pred             hhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999987653332211122233467899999886554 8899999999999999998 988


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       229 p~  230 (290)
T cd05045         229 PY  230 (290)
T ss_pred             CC
Confidence            87

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.8e-33  Score=245.05  Aligned_cols=191  Identities=28%  Similarity=0.400  Sum_probs=160.1

Q ss_pred             ccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEE
Q psy13988        154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL  232 (358)
Q Consensus       154 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~l  232 (358)
                      ||.|++|.||++.+..++..||+|.+...... ......+.+|+.+++.++||||+++++.+.+          +..+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------~~~~~l   70 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD----------KKYIYM   70 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc----------CCccEE
Confidence            68999999999999999999999998754322 2234567889999999999999999776654          558999


Q ss_pred             EeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCC
Q psy13988        233 VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR  312 (358)
Q Consensus       233 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~  312 (358)
                      |+||++++.+..+......+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||++........  
T Consensus        71 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--  148 (262)
T cd05572          71 LMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--  148 (262)
T ss_pred             EEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc--
Confidence            999998754444434445689999999999999999999999999999999999999999999999999987654321  


Q ss_pred             CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       313 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                       .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||
T Consensus       149 -~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  192 (262)
T cd05572         149 -TWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPF  192 (262)
T ss_pred             -cccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCc
Confidence             12235688899999987654 889999999999999999999997

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-34  Score=249.42  Aligned_cols=197  Identities=31%  Similarity=0.464  Sum_probs=158.4

Q ss_pred             ccccccCCcceeeEeeeee----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        150 LMEPLAAGGLSLNNFSVSL----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      +.+.||.|.||.||.|...    ..+..|+||.++... .......+.+|++.+++++||||+++++++..         
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~---------   72 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE---------   72 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES---------
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-ccccceeeeecccccccccccccccccccccc---------
Confidence            5689999999999999987    456789999996432 22224678899999999999999999888764         


Q ss_pred             CCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                       .+..++|+||+.+ +|.+.+... ...+++..+..++.||+.||.|||+++++|+||+++||+++.++.+||+|||++.
T Consensus        73 -~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~  151 (259)
T PF07714_consen   73 -NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSR  151 (259)
T ss_dssp             -SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred             -ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence             4468999999985 666666655 5679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ...................|+|||.+.+.. ++.++||||||+++|||++ |+.||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~  206 (259)
T PF07714_consen  152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPF  206 (259)
T ss_dssp             ETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTT
T ss_pred             cccccccccccccccccccccccccccccc-ccccccccccccccccccccccccc
Confidence            773332222223344578899999987655 8999999999999999999 67776

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.5e-33  Score=243.18  Aligned_cols=197  Identities=30%  Similarity=0.441  Sum_probs=167.2

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|++|.||++.+..+++.+++|.+............+.+|+.+++.++|+||+++.+++..          
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   70 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD----------   70 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc----------
Confidence            4788999999999999999999999999999987655444445567789999999999999999888765          


Q ss_pred             CCeEEEEeeccccC-hHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        227 KGSFYLVFEYMDHD-LMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       227 ~~~~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      ....++|+||+++. +...+..   ....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccch
Confidence            45899999999874 4444433   2346899999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......    .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||
T Consensus       151 ~~~~~~~----~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~  201 (256)
T cd08530         151 KVLKKNM----AKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPF  201 (256)
T ss_pred             hhhccCC----cccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            8765441    12344688999999987654 788999999999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.8e-33  Score=245.81  Aligned_cols=202  Identities=24%  Similarity=0.402  Sum_probs=162.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCc---EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDE---LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..+|...+.||+|++|.||++.+..++.   .+|+|.+..... ....+.+..|+++++.++|+||+++.+++..     
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   77 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-----   77 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----
Confidence            3467788999999999999999876654   799998865422 2223467889999999999999999777654     


Q ss_pred             ccccCCCeEEEEeeccccChH-HHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLM-GLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           .+..++||||++++.+ +.+......+++..+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||
T Consensus        78 -----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg  152 (268)
T cd05063          78 -----FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFG  152 (268)
T ss_pred             -----CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCc
Confidence                 4578999999997544 4444445678999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCC-CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++.......... .......+..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~  211 (268)
T cd05063         153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPY  211 (268)
T ss_pred             cceecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCC
Confidence            988664332211 111122256799999887654 7899999999999999997 99987

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0194|consensus

Probab=100.00  E-value=1.4e-34  Score=261.18  Aligned_cols=205  Identities=25%  Similarity=0.354  Sum_probs=166.6

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCc---E-EEEEEeeccc-cCCCCchhHHHHHHHHHhCCCCcccchhhhhc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDE---L-VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~---~-vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  215 (358)
                      ......+-.+.+.||+|.||.||++.....+.   . ||||..+.+. .......++.+|.++++.++|||||+++|+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33444444566899999999999999876532   3 8999887532 33444567899999999999999999988877


Q ss_pred             ccCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcE
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~  294 (358)
                      .          ...+++|||+|.| +|.+.+......++..+...++.+.+.||+|||+++++||||-..|+|++.++.+
T Consensus       232 ~----------~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  232 L----------EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             C----------CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeE
Confidence            6          4478999999997 6777777776679999999999999999999999999999999999999999999


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||+|||+++.-..-....  ........|+|||.+... .++.++|||||||++||+++ |..||
T Consensus       302 KISDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py  363 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPY  363 (474)
T ss_pred             EeCccccccCCcceeecc--ccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCC
Confidence            999999987543111111  111236889999999866 59999999999999999998 77776

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.4e-33  Score=243.98  Aligned_cols=198  Identities=27%  Similarity=0.459  Sum_probs=160.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|++|.||++.+. ++..||+|.+.....   ....+.+|+.++++++|+|++++++++.        
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~--------   71 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS--------   71 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC--------
Confidence            4457899999999999999999765 567799998875432   2356889999999999999999977653        


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                         ....++||||+.+ ++.+.+... ...+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||+
T Consensus        72 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~  148 (260)
T cd05070          72 ---EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGL  148 (260)
T ss_pred             ---CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCcee
Confidence               2357899999987 555555432 34589999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +......... ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |.+||
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~  204 (260)
T cd05070         149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPY  204 (260)
T ss_pred             eeeccCcccc-cccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCC
Confidence            9876543221 112223456799999886544 8899999999999999999 88887

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-33  Score=249.13  Aligned_cols=196  Identities=33%  Similarity=0.485  Sum_probs=166.1

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|...+.||.|++|.||++.+..++..|++|.+....... .....+.+|+.+++.++|||++++++++.+         
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------   92 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK---------   92 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe---------
Confidence            3666788999999999999999999999999987553322 222456789999999999999999877765         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       +...|+||||+.+++.+.+.....++++..+..++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        93 -~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633          93 -EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             -CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence             4578999999999988888766667999999999999999999999999999999999999999999999999987643


Q ss_pred             cccCCCCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..      .....++..|+|||.+..  ...++.++||||||+++|+|++|.+||
T Consensus       172 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~  220 (313)
T cd06633         172 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  220 (313)
T ss_pred             CC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            21      123456888999999852  344788999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.2e-33  Score=244.26  Aligned_cols=199  Identities=25%  Similarity=0.446  Sum_probs=162.8

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .....|++++.||.|+||.||++.. .+++.||+|.+.....   ....+.+|+.+++.++|+||+++++++.       
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-------   71 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-------   71 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-------
Confidence            3556789999999999999999986 4678899998874432   2457889999999999999999977653       


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                          .+..++|||++.+ ++.+.+.. ....+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||
T Consensus        72 ----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          72 ----QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             ----cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCc
Confidence                2358999999986 56665543 34568999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++......... ......++..|+|||.+.... ++.++||||||+++|+|++ |++||
T Consensus       148 ~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~  204 (260)
T cd05067         148 LARLIEDNEYT-AREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPY  204 (260)
T ss_pred             ceeecCCCCcc-cccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCC
Confidence            99876532211 112223467899999887554 7889999999999999999 99997

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-33  Score=243.83  Aligned_cols=200  Identities=27%  Similarity=0.440  Sum_probs=163.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+.+.||.|++|.||++.+. .+..||||.+.....   ....+.+|+.+++.++|+||+++++++..      
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   72 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSE------   72 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeec------
Confidence            35578999999999999999999975 557899998875432   24568899999999999999999777654      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                          +...++|||++++ ++.+.+.... ..+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||
T Consensus        73 ----~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          73 ----EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             ----CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccc
Confidence                4578999999987 5555554432 468999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .+......... .......+..|+|||.+.+.. ++.++|+||+|+++|+|++ |+.||
T Consensus       149 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~  205 (261)
T cd05034         149 LARLIEDDEYT-AREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPY  205 (261)
T ss_pred             cceeccchhhh-hhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCC
Confidence            98876532111 111222356799999887654 8899999999999999998 99887

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-33  Score=253.48  Aligned_cols=205  Identities=26%  Similarity=0.414  Sum_probs=161.0

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecC-------CcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhh
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFT-------DELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREI  213 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  213 (358)
                      .....+|++.+.||+|+||.||++.+...       +..||+|.+.... .......+.+|+++++++ +||||++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            34456789999999999999999987532       2368999877432 222345678899999999 89999999776


Q ss_pred             hcccCcccccccCCCeEEEEeecccc-ChHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCce
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNFL  277 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~  277 (358)
                      +..          ++..++|+||+.+ ++.+.+...               ...++...+..++.|++.||+|||++|++
T Consensus        87 ~~~----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~giv  156 (334)
T cd05100          87 CTQ----------DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI  156 (334)
T ss_pred             Ecc----------CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            654          5578999999987 455554332               12467788889999999999999999999


Q ss_pred             ecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCC
Q psy13988        278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKP  356 (358)
Q Consensus       278 H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~  356 (358)
                      |+||||+||+++.++.++|+|||+++...............++..|+|||++.+.. ++.++||||||+++|+|++ |..
T Consensus       157 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~  235 (334)
T cd05100         157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGS  235 (334)
T ss_pred             ccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999998664332222222233356799999987654 8899999999999999998 788


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       236 p~  237 (334)
T cd05100         236 PY  237 (334)
T ss_pred             CC
Confidence            76

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-33  Score=249.66  Aligned_cols=198  Identities=22%  Similarity=0.299  Sum_probs=162.8

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|...+.||.|++|.||++.+..++..||+|.+...... .....+.+|+.++.++. |+||+++++++..         
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~---------   74 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR---------   74 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec---------
Confidence            456778999999999999999999999999998754332 22346778999999995 9999999877654         


Q ss_pred             CCCeEEEEeeccccChHHHH----hcCCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEeecc
Q psy13988        226 DKGSFYLVFEYMDHDLMGLL----ESGMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                       .+..+++||++++++....    ......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus        75 -~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  153 (288)
T cd06616          75 -EGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG  153 (288)
T ss_pred             -CCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecc
Confidence             4578999999987654432    12335789999999999999999999975 99999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCC--CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.........   ....+++.|+|||.+.+.  ..++.++||||+|+++|+|++|++||
T Consensus       154 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  210 (288)
T cd06616         154 ISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY  210 (288)
T ss_pred             hhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCc
Confidence            98765433211   223468889999998765  35889999999999999999999997

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-33  Score=248.61  Aligned_cols=205  Identities=24%  Similarity=0.339  Sum_probs=164.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeec----CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLF----TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ....+|.+.+.||+|+||.||.+.+..    ++..|++|.+... ........+.+|+.+++.++|+||+++++++... 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence            345688899999999999999999876    3688999987633 2222345677899999999999999998876542 


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCC-------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGM-------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN  290 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~  290 (358)
                              +...+++++++.+ ++...+....       ..+++..+..++.|++.||+|||+++++|+||||+||+++.
T Consensus        81 --------~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~  152 (280)
T cd05043          81 --------GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE  152 (280)
T ss_pred             --------CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC
Confidence                    3467899999985 5555443321       45899999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++.++|+|||+++.+.............++..|+|||.+.+.. ++.++||||||+++|++++ |++||
T Consensus       153 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~  220 (280)
T cd05043         153 ELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPY  220 (280)
T ss_pred             CCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCc
Confidence            9999999999998654333222222333467799999987654 8899999999999999998 99987

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.3e-33  Score=243.68  Aligned_cols=194  Identities=23%  Similarity=0.359  Sum_probs=158.6

Q ss_pred             ccccCCcceeeEeeeeec-CC--cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCC
Q psy13988        152 EPLAAGGLSLNNFSVSLF-TD--ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      +.||.|++|.||++.+.. .+  ..||||.+...... .....+.+|+.++++++|+||+++++++..           .
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----------~   68 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-----------H   68 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-----------C
Confidence            468999999999999865 33  36999998765443 334577899999999999999999776643           4


Q ss_pred             eEEEEeecccc-ChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        229 SFYLVFEYMDH-DLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       229 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ..++||||+++ ++.+.+.... ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~  148 (257)
T cd05040          69 PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALP  148 (257)
T ss_pred             eEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccc
Confidence            78999999975 5666665544 468999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        307 AEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       307 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ..... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~  201 (257)
T cd05040         149 QNEDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPW  201 (257)
T ss_pred             ccccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCC
Confidence            43211 1112234577899999887654 8899999999999999998 99987

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-33  Score=243.60  Aligned_cols=193  Identities=23%  Similarity=0.421  Sum_probs=158.9

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ...|++.+.||+|++|.||++..  .+..||+|.+....    ....+.+|+.+++.++|+|++++++++..        
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   70 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE--------   70 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEc--------
Confidence            45788999999999999999875  58899999876432    23467889999999999999999876543        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                       .+...++||||+++ ++.+.+.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus        71 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          71 -EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             -CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccc
Confidence             24478999999986 5666655433 34889999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .......     .....+..|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       150 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~  200 (256)
T cd05082         150 KEASSTQ-----DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPY  200 (256)
T ss_pred             eeccccC-----CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCC
Confidence            7553322     1223356799999887654 8899999999999999997 88886

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.8e-33  Score=242.12  Aligned_cols=203  Identities=33%  Similarity=0.482  Sum_probs=170.6

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||+|++|.||++.+..+++.|++|++............+.+|+.++++++|+||+++++.+....        
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   72 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--------   72 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--------
Confidence            477889999999999999999999999999998766543344567889999999999999999977766521        


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ...+++|+|++++..+..+......+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          73 KNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            26899999999765555444444489999999999999999999999999999999999999999999999999998776


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ............++..|+|||.+.+.. .+.++|+||||+++|+|++|..||
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  203 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPW  203 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            554321223445688999999887655 889999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.3e-33  Score=243.52  Aligned_cols=194  Identities=27%  Similarity=0.422  Sum_probs=160.4

Q ss_pred             ccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEE
Q psy13988        154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL  232 (358)
Q Consensus       154 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~l  232 (358)
                      ||.|++|.||++.+..+++.|++|.+...... ......+.+|+++++.++|+||+++++.+..          +...|+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------~~~~~l   70 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG----------KKNLYL   70 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec----------CcEEEE
Confidence            68999999999999999999999998754321 2234567889999999999999999877654          558999


Q ss_pred             EeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC--
Q psy13988        233 VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR--  310 (358)
Q Consensus       233 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~--  310 (358)
                      |+|++.++.+..+......+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++........  
T Consensus        71 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          71 VMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            999998755554444444789999999999999999999999999999999999999999999999999876533321  


Q ss_pred             ----CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        311 ----QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       311 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                          ........++..|+|||...... .+.++|+||||+++|+|++|..||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~  201 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPF  201 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCC
Confidence                11223345678899999987655 888999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-33  Score=250.02  Aligned_cols=202  Identities=26%  Similarity=0.390  Sum_probs=158.5

Q ss_pred             CCCCcccccccCCcceeeEeeeeec----------------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLF----------------TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIV  208 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  208 (358)
                      .++|++.+.||+|+||.||++.+..                +...||+|.+.... .......+.+|+.+++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4578999999999999999986432                34579999887542 222234678999999999999999


Q ss_pred             chhhhhcccCcccccccCCCeEEEEeecccc-ChHHHHhcCC----------CCCChHHHHHHHHHHHHHHHHHHhCCce
Q psy13988        209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM----------VDFNEVNNASIMRQLLDGLSYCHKRNFL  277 (358)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~~~i~  277 (358)
                      ++++++..          ++..++||||+.+ ++...+....          ..+++..+..++.|++.||+|||+.|++
T Consensus        83 ~~~~~~~~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~  152 (296)
T cd05095          83 RLLAVCIT----------SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV  152 (296)
T ss_pred             eEEEEEec----------CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            99777654          4578999999986 5555553321          2366778999999999999999999999


Q ss_pred             ecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh--CC
Q psy13988        278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV--KK  355 (358)
Q Consensus       278 H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt--g~  355 (358)
                      |+||||+||+++.++.++|+|||++..+..............++.|++||...+.. ++.++|+|||||++|+|++  |.
T Consensus       153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~  231 (296)
T cd05095         153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKE  231 (296)
T ss_pred             cccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCC
Confidence            99999999999999999999999988654332222122223367899999876554 8999999999999999998  66


Q ss_pred             CCC
Q psy13988        356 PLF  358 (358)
Q Consensus       356 ~pF  358 (358)
                      .||
T Consensus       232 ~p~  234 (296)
T cd05095         232 QPY  234 (296)
T ss_pred             CCc
Confidence            776

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-33  Score=242.34  Aligned_cols=194  Identities=24%  Similarity=0.406  Sum_probs=162.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|++.+.||.|++|.||++..  .++.||+|.+.....   ...++.+|+.+++.++|+||+++++++.+       
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------   71 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-------   71 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-------
Confidence            356788999999999999999986  489999999875533   34578899999999999999999777654       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                         ....++||||+++ ++.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.
T Consensus        72 ---~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~  148 (256)
T cd05039          72 ---GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL  148 (256)
T ss_pred             ---CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccc
Confidence               4578999999996 5655554332 2689999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +........     ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||
T Consensus       149 ~~~~~~~~~-----~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~  200 (256)
T cd05039         149 AKEASQGQD-----SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPY  200 (256)
T ss_pred             ccccccccc-----cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCC
Confidence            987633221     222356799999887554 8889999999999999997 98887

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.3e-33  Score=250.82  Aligned_cols=203  Identities=26%  Similarity=0.412  Sum_probs=159.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeec-------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLF-------TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVT  215 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  215 (358)
                      ...+|.+.+.||+|++|.||++.+..       ....||+|.+..... ......+.+|+.+++.+ +||||+++++++.
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            44678899999999999999998632       345799998764322 22234577899999999 6999999977665


Q ss_pred             ccCcccccccCCCeEEEEeecccc-ChHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCceec
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHR  279 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~  279 (358)
                      +          ++.+|+||||+.+ ++.+.+...               ...++...+..++.||+.||.|||++|++|+
T Consensus        89 ~----------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~  158 (314)
T cd05099          89 Q----------EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR  158 (314)
T ss_pred             c----------CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            4          5578999999986 455555332               1347888899999999999999999999999


Q ss_pred             CCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       280 Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||||+||+++.++.++|+|||.++...............++..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999998664332211112222356799999987654 8899999999999999999 88876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.8e-33  Score=245.26  Aligned_cols=201  Identities=26%  Similarity=0.424  Sum_probs=167.1

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+|.+.+.||.|++|.||++.+..++..||+|++...... ......+.+|+.++++++ |+||+++++++..       
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-------   73 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-------   73 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-------
Confidence            3688999999999999999999999999999998764321 222345678999999998 9999999888765       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         .+..++|||++.+ ++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        74 ---~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          74 ---EENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             ---CceEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccc
Confidence               4589999999965 55555544 447999999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCC------------------CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQ------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .........                  .......++..|+|||+..... ++.++|+||||+++++|++|+.||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCC
Confidence            866543321                  1222345688999999887654 888999999999999999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.3e-33  Score=246.35  Aligned_cols=200  Identities=23%  Similarity=0.345  Sum_probs=162.4

Q ss_pred             CCcccccccCCcceeeEeeeee---cCCcEEEEEEeecccc--CCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENE--KEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  220 (358)
                      .|++.+.||.|++|.||++.+.   .+|+.||+|++.....  .......+.+|+.+++.+ +|+||+++++++..    
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----   76 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT----   76 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence            4788999999999999999974   4789999999875432  122234667899999999 68999999766654    


Q ss_pred             cccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            ++.+|+||||+++. +.+.+. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus        77 ------~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          77 ------DTKLHLILDYINGGELFTHLS-QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             ------CCeEEEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeC
Confidence                  55889999999974 545444 3456889999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........ .......++..|+|||.+... ..++.++||||||+++|+|++|..||
T Consensus       150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~  208 (290)
T cd05613         150 GLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF  208 (290)
T ss_pred             ccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCC
Confidence            99886643321 112234568899999988643 23678999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1095|consensus

Probab=100.00  E-value=6.7e-34  Score=274.39  Aligned_cols=203  Identities=26%  Similarity=0.419  Sum_probs=167.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCc-----EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDE-----LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ....-.+.+.||+|.||.||.+.......     .||||.++... .......|++|..+++.++|||||++++++.+  
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--  766 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--  766 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--
Confidence            34455677899999999999999765433     48999887553 33455689999999999999999999888876  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcC------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESG------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR  291 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~  291 (358)
                              .+..+|++|||+| +|+.++++.      ...++....+.++.|||+|+.||+++++|||||...|+||+..
T Consensus       767 --------~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~  838 (1025)
T KOG1095|consen  767 --------SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER  838 (1025)
T ss_pred             --------CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc
Confidence                    4578999999996 677777665      5568889999999999999999999999999999999999999


Q ss_pred             CcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       292 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ..+||+|||+|+-+......+......-...|||||.+.. ..++.++|||||||++||++| |..||
T Consensus       839 r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY  905 (1025)
T KOG1095|consen  839 RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPY  905 (1025)
T ss_pred             CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCC
Confidence            9999999999995444433332223233678999999986 459999999999999999998 78887

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4e-33  Score=241.91  Aligned_cols=199  Identities=33%  Similarity=0.488  Sum_probs=169.7

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|++|.||++.+..++..|++|++............+.+|+++++.++|+|++++.+.+..          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----------   70 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE----------   70 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec----------
Confidence            4788999999999999999999999999999998765544455677899999999999999999776654          


Q ss_pred             CCeEEEEeecccc-ChHHHHhcC---CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLESG---MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      +...++|+|++++ ++...+...   ...+++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccce
Confidence            4689999999997 555555443   367999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........  ......+++.|+|||...+.. ++.++|+||+|+++|+|++|+.||
T Consensus       151 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~  203 (258)
T cd08215         151 KVLSSTVD--LAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPF  203 (258)
T ss_pred             eecccCcc--eecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCC
Confidence            87654431  122345688999999887654 889999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-33  Score=240.53  Aligned_cols=199  Identities=32%  Similarity=0.506  Sum_probs=169.9

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+............+.+|++++++++|+|++++++++.+          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   70 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET----------   70 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe----------
Confidence            4788999999999999999999999999999998765433445678899999999999999999776654          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ++..++|||++++..+..+......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          71 SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            55899999999985555554444679999999999999999999999999999999999999999999999999998775


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  .....++..|+|||...+.. ++.++|+||+|+++|+|++|..||
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~  199 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPY  199 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCC
Confidence            44322  22345688999999887655 789999999999999999999987

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.5e-33  Score=245.54  Aligned_cols=197  Identities=26%  Similarity=0.415  Sum_probs=163.1

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|...+.||.|++|.||++.+..+++.|++|.+.....  .....+.+|+.+++.++|+||+++++++..         
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~---------   87 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLV---------   87 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEc---------
Confidence            345556799999999999999999999999998864432  223457889999999999999999877654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++..++|+||+.+..+..+... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        88 -~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          88 -GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             -CCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence             4578999999987555544333 46899999999999999999999999999999999999999999999999988755


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||
T Consensus       166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~  215 (285)
T cd06648         166 SKEVP--RRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPY  215 (285)
T ss_pred             ccCCc--ccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCC
Confidence            43221  112345688999999987654 889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.8e-33  Score=245.32  Aligned_cols=206  Identities=20%  Similarity=0.269  Sum_probs=160.3

Q ss_pred             CcccccccCCcceeeEeeeee---cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      |.+.+.||+|++|.||++...   .++..||||.+..........+.+.+|+.+++.++||||+++++++......    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~----   76 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK----   76 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC----
Confidence            567889999999999999864   3578999999876544433445678899999999999999999877653210    


Q ss_pred             cCCCeEEEEeeccccC-hHHHHhc-----CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLES-----GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                      ......+++++|+.++ +...+..     ....++...+..++.|++.||+|||++||+|+||||+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence            0112457889999864 4444321     122478889999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||+++...............+++.|++||.+.+.. ++.++||||||+++|+|++ |++||
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~  216 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPY  216 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCC
Confidence            99988664333222222333467899999887554 7889999999999999999 88886

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.7e-33  Score=249.71  Aligned_cols=199  Identities=30%  Similarity=0.471  Sum_probs=167.5

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....|...+.||.|++|.||++.+..++..||+|.+...... ......+.+|+++++.++|+|++++.+++..      
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   86 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR------   86 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc------
Confidence            445577889999999999999999999999999998753222 2223456789999999999999999877764      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ....++||||+.|++.+.+......+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        87 ----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  162 (308)
T cd06634          87 ----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA  162 (308)
T ss_pred             ----CCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccc
Confidence                4578999999999888777655567899999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......      ....+++.|+|||.+.+  ...++.++||||||+++|+|++|..||
T Consensus       163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  214 (308)
T cd06634         163 SIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  214 (308)
T ss_pred             eeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCC
Confidence            765432      23346888999998752  234788999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.2e-33  Score=240.43  Aligned_cols=193  Identities=25%  Similarity=0.386  Sum_probs=156.0

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY  231 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~  231 (358)
                      +.||.|++|.||++.. .++..||+|.+..... ......+.+|+++++.++||||+++++++..          .+..+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------~~~~~   68 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQ----------RQPIY   68 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEec----------CCccE
Confidence            4789999999999985 4788999998875432 2223457789999999999999999776654          45789


Q ss_pred             EEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCC
Q psy13988        232 LVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR  310 (358)
Q Consensus       232 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~  310 (358)
                      +||||+++ ++.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        69 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (250)
T cd05085          69 IVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY  148 (250)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc
Confidence            99999986 55555555555688999999999999999999999999999999999999999999999999876543321


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      . ......+++.|+|||.+.+.. ++.++||||||+++|++++ |..||
T Consensus       149 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~  195 (250)
T cd05085         149 S-SSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPY  195 (250)
T ss_pred             c-cCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCC
Confidence            1 111223356799999887544 8899999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.2e-33  Score=241.33  Aligned_cols=197  Identities=27%  Similarity=0.440  Sum_probs=161.6

Q ss_pred             cccccccCCcceeeEeeeeecCC----cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        149 PLMEPLAAGGLSLNNFSVSLFTD----ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       149 ~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ++.+.||.|+||.||++.+...+    ..||+|.+...... .....+.+|+.+++.++|+||+++++++.+        
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   72 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTE--------   72 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcC--------
Confidence            56789999999999999998766    89999998654322 134577889999999999999999776654        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhcCCCC-CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLESGMVD-FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                        .+..++|||++++ ++.+.+...... +++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        73 --~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~  150 (258)
T smart00219       73 --EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS  150 (258)
T ss_pred             --CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCc
Confidence              4589999999987 455555443333 899999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ............ ...+++.|+|||.+.+. .++.++|+||+|+++|+|++ |.+||
T Consensus       151 ~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~  205 (258)
T smart00219      151 RDLYDDDYYKKK-GGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPY  205 (258)
T ss_pred             eecccccccccc-cCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            876544222111 22357889999988644 48899999999999999998 78886

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.1e-33  Score=244.85  Aligned_cols=198  Identities=27%  Similarity=0.389  Sum_probs=164.3

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .-|++++.||.|+||.||++.+..+++.||||.+...... .....+.+|+.+++.++||||+++++++..         
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------   73 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK---------   73 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEe---------
Confidence            3577889999999999999999999999999987644322 233467789999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       +...|+||||++++.+..+... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        74 -~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06641          74 -DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  151 (277)
T ss_pred             -CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence             5589999999997555544333 36899999999999999999999999999999999999999999999999998765


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||
T Consensus       152 ~~~~~~--~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~  201 (277)
T cd06641         152 TDTQIK--RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPH  201 (277)
T ss_pred             ccchhh--hccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCC
Confidence            433211  12235688899999887554 788999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.3e-33  Score=241.84  Aligned_cols=198  Identities=27%  Similarity=0.438  Sum_probs=160.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+.+.||.|++|.||++.+..+ ..||+|.+....   .....+.+|+.+++.++|+|++++++++.        
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--------   71 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS--------   71 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc--------
Confidence            346688999999999999999987554 469999876432   22356788999999999999999976653        


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                         .+..++||||+.+ ++.+.+... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.
T Consensus        72 ---~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~  148 (260)
T cd05069          72 ---EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGL  148 (260)
T ss_pred             ---CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCcc
Confidence               2357899999986 666666543 33578899999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +......... ......++..|+|||...+.. ++.++||||||+++|+|++ |..||
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~  204 (260)
T cd05069         149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPY  204 (260)
T ss_pred             ceEccCCccc-ccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCC
Confidence            9876433221 112223467899999887554 8899999999999999999 88887

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG1152|consensus

Probab=100.00  E-value=4.6e-34  Score=254.62  Aligned_cols=200  Identities=31%  Similarity=0.446  Sum_probs=170.5

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC--CC----chhHHHHHHHHHhCC---CCcccchhhhh
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE--GF----PITAVREIKILRQLN---HKNIVNLREIV  214 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~----~~~~~~e~~~l~~l~---h~niv~~~~~~  214 (358)
                      ....|..++.||.|+||.|++|.++.+...|+||.+.++.--.  |.    .-.+-.|+.+|..++   |+||+++++  
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd--  636 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD--  636 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh--
Confidence            4556899999999999999999999999999999998764211  11    112346999999996   999999954  


Q ss_pred             cccCcccccccCCCeEEEEeecccc--ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC
Q psy13988        215 TDKSDALDFRKDKGSFYLVFEYMDH--DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG  292 (358)
Q Consensus       215 ~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~  292 (358)
                              ++++++++|++||-...  +|.+.++ ....++|.++..|++|++.|+++||+.||+|||||-+||.++.+|
T Consensus       637 --------fFEddd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g  707 (772)
T KOG1152|consen  637 --------FFEDDDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG  707 (772)
T ss_pred             --------eeecCCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC
Confidence                    55567899999998864  5666654 445799999999999999999999999999999999999999999


Q ss_pred             cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       293 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      -+||+|||.+.....+    ++..++||..|+|||++.+..+....-|||+||+++|.++...-||
T Consensus       708 ~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  708 FVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             eEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            9999999999876544    4577889999999999999988889999999999999999888776

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6e-33  Score=242.60  Aligned_cols=193  Identities=30%  Similarity=0.457  Sum_probs=158.0

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY  231 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~  231 (358)
                      ..||+|+||.||++.+..++..|++|.+......  ....+.+|+.+++.++|+||+++++++..          ++..+
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------~~~~~   81 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSE----------NGFFK   81 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeecc----------CCEEE
Confidence            5899999999999999999999999988754322  23467899999999999999999777654          55899


Q ss_pred             EEeecccc-ChHHHHhcCCCCC--ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEeecccceeccc
Q psy13988        232 LVFEYMDH-DLMGLLESGMVDF--NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-RGEVKLADFGLARLYNA  307 (358)
Q Consensus       232 lv~e~~~~-~l~~~~~~~~~~~--~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~-~~~~~l~Dfg~~~~~~~  307 (358)
                      +|+||+.+ +|.+.+......+  ++..+..++.||+.||+|||++||+|+||||+||+++. ++.++|+|||.+.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999987 4555555443445  78888899999999999999999999999999999986 67999999999876543


Q ss_pred             cCCCCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        308 EDRQRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       308 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...  ......+++.|+|||.+.+. ..++.++|+||+|+++|+|++|.+||
T Consensus       162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~  211 (268)
T cd06624         162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF  211 (268)
T ss_pred             CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCC
Confidence            222  12233468899999988643 33788999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-33  Score=243.21  Aligned_cols=189  Identities=21%  Similarity=0.283  Sum_probs=151.5

Q ss_pred             ccccCCcceeeEeeeeec------------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        152 EPLAAGGLSLNNFSVSLF------------TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      +.||+|++|.||++....            ....|++|.+....  ......+.+|+.+++.++||||+++++++..   
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~---   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR---   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence            468999999999998432            22468899876432  2233467788999999999999999887654   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHh-cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc-----
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE-----  293 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~-----  293 (358)
                             ....++||||++++.++.+. .....+++..+..++.||+.||+|||+++|+|+||||+||+++.++.     
T Consensus        76 -------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~  148 (262)
T cd05077          76 -------DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG  148 (262)
T ss_pred             -------CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCC
Confidence                   34678999999986665554 34456899999999999999999999999999999999999987664     


Q ss_pred             --EEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHh-hCCCCC
Q psy13988        294 --VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF-VKKPLF  358 (358)
Q Consensus       294 --~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll-tg~~pF  358 (358)
                        ++++|||++......      ....++..|+|||.+.+...++.++||||||+++|+|+ +|..||
T Consensus       149 ~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  210 (262)
T cd05077         149 PFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL  210 (262)
T ss_pred             ceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence              899999988654322      22345788999998875556899999999999999998 577776

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.8e-33  Score=241.03  Aligned_cols=199  Identities=30%  Similarity=0.457  Sum_probs=165.8

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +|.+.+.||.|++|.||++.+..++..||+|.+............+.+|+.+++.++|+||+++++.+..          
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~----------   70 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE----------   70 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc----------
Confidence            4788999999999999999999999999999987754443444567899999999999999999777654          


Q ss_pred             CCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeecccce
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLAR  303 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg~~~  303 (358)
                      ++..++|+||+.+ ++.+.+... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||.+.
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~  150 (257)
T cd08225          71 NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR  150 (257)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccch
Confidence            5589999999987 555555432 33578999999999999999999999999999999999999886 46999999988


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........  .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||
T Consensus       151 ~~~~~~~~--~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  202 (257)
T cd08225         151 QLNDSMEL--AYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPF  202 (257)
T ss_pred             hccCCccc--ccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            66543221  12234688999999887654 889999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.2e-33  Score=246.92  Aligned_cols=202  Identities=26%  Similarity=0.431  Sum_probs=160.9

Q ss_pred             CCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..+|++.+.||.|+||.||++.+.     .++..||+|.+...... .....+.+|+.+++.++||||+++++++.+   
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPNIVKLLGVCAV---   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-HHHHHHHHHHHHHHhcCCCchheEEEEEcC---
Confidence            456889999999999999999874     36789999988754221 123457789999999999999999776654   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcC---------------------CCCCChHHHHHHHHHHHHHHHHHHhCCce
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESG---------------------MVDFNEVNNASIMRQLLDGLSYCHKRNFL  277 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~  277 (358)
                             +...++||||+++ ++.+.+...                     ...+++..++.++.||+.||++||+++++
T Consensus        80 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~  152 (288)
T cd05050          80 -------GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV  152 (288)
T ss_pred             -------CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence                   4578999999986 555555321                     12477888899999999999999999999


Q ss_pred             ecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCC
Q psy13988        278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKP  356 (358)
Q Consensus       278 H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~  356 (358)
                      |+||||+||+++.++.++|+|||++.................+..|+|||.+.+.. ++.++||||||+++|+|++ |..
T Consensus       153 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~  231 (288)
T cd05050         153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQ  231 (288)
T ss_pred             cccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999987654332222222233466799999887654 8999999999999999997 877


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       232 p~  233 (288)
T cd05050         232 PY  233 (288)
T ss_pred             CC
Confidence            76

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-33  Score=246.51  Aligned_cols=204  Identities=27%  Similarity=0.399  Sum_probs=165.2

Q ss_pred             CCCCcccccccCCcceeeEeeeee----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSL----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ...|++.+.||+|+||.||++...    .++..||||.+...... .....+.+|+.+++.++|+||+++++++....  
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--   79 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG--   79 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC--
Confidence            356788899999999999999864    34789999998755432 23457889999999999999999987765422  


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            +...++||||+++ ++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+||
T Consensus        80 ------~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~df  153 (284)
T cd05038          80 ------GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDF  153 (284)
T ss_pred             ------CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccc
Confidence                  4578999999986 565566555546899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |.+......... .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~  212 (284)
T cd05038         154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPS  212 (284)
T ss_pred             ccccccccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCc
Confidence            999876533221 1111223356699999887654 889999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.7e-33  Score=243.54  Aligned_cols=201  Identities=24%  Similarity=0.353  Sum_probs=161.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecC---CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFT---DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ...+|.+.+.||.|++|.||++.+...   ...|+||....... ....+.+.+|+.+++.++||||+++++++.+    
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----   78 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE----   78 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC----
Confidence            345688899999999999999987544   35789998765432 2233467889999999999999999877653    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ...++||||+++ ++.+.+......+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+||
T Consensus        79 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~  151 (270)
T cd05056          79 -------NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDF  151 (270)
T ss_pred             -------CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccC
Confidence                   246899999986 555555554456899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |++.......... .....++..|+|||.+.... ++.++||||||+++|+|++ |..||
T Consensus       152 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf  209 (270)
T cd05056         152 GLSRYLEDESYYK-ASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPF  209 (270)
T ss_pred             ceeeeccccccee-cCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCC
Confidence            9988664432211 11223356799999886554 8899999999999999996 99997

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-33  Score=242.10  Aligned_cols=190  Identities=26%  Similarity=0.368  Sum_probs=154.8

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHH-HHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKI-LRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||.|++|.||+|.+..+++.||+|.+....... .....+..|..+ ....+|+|++++++++..          ++.
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------~~~   71 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS----------KDY   71 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc----------CCe
Confidence            57999999999999999999999999986543211 111223344443 344589999999877754          558


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      .|+|+||++++.+..+......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... 
T Consensus        72 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  150 (260)
T cd05611          72 LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-  150 (260)
T ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-
Confidence            9999999998666655555557899999999999999999999999999999999999999999999999998754321 


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                           ....+++.|+|||.+.+.. ++.++||||+|+++|+|++|..||
T Consensus       151 -----~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  193 (260)
T cd05611         151 -----KKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPF  193 (260)
T ss_pred             -----ccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCC
Confidence                 2234578899999987665 789999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.6e-33  Score=242.10  Aligned_cols=188  Identities=27%  Similarity=0.411  Sum_probs=153.1

Q ss_pred             CCCcccccc--cCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPL--AAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~l--g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..|.+.+.+  |.|+||.||++.+..++..+|+|.+.......       .|+.....+ +|+||+++++++..      
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~------   80 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT------   80 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec------
Confidence            345565655  99999999999999999999999987543221       123222222 79999999777755      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg  300 (358)
                          ++.+|+||||+++ +|.+.+... ..+++..+..++.||++||.+||+.|++|+||+|+||+++.++ .++|+|||
T Consensus        81 ----~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         81 ----LKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             ----CCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence                4589999999986 555555443 4899999999999999999999999999999999999999998 99999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.......      ...++..|+|||++.+.. ++.++|+||+|+++|+|++|+.||
T Consensus       156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~  206 (267)
T PHA03390        156 LCKIIGTPS------CYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPF  206 (267)
T ss_pred             cceecCCCc------cCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCC
Confidence            987654321      234688999999997655 789999999999999999999997

>KOG0983|consensus

Probab=100.00  E-value=1.4e-33  Score=230.45  Aligned_cols=198  Identities=22%  Similarity=0.275  Sum_probs=162.0

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..+++..||.|+.|.|++++...+|...|||.+...... +...+++..+.++... ..|+||+++++|....       
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-------  164 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-------  164 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-------
Confidence            345678899999999999999999999999998766433 3445677788877665 5899999999888644       


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                         .+++-||.+.-=....++.-..+++|.-+-++...+++||.||.+ +||+|||+||.|||+|+.|++||||||++.+
T Consensus       165 ---dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  165 ---DVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             ---hHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence               577888888743333333444579999999999999999999996 5899999999999999999999999999987


Q ss_pred             ccccCCCCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +-...   ..+...|-+.|||||.+.-  ...|+.++||||||++++||.||+.||
T Consensus       242 lvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy  294 (391)
T KOG0983|consen  242 LVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPY  294 (391)
T ss_pred             eeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCC
Confidence            75443   2345566899999999863  345888999999999999999999998

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.1e-33  Score=244.47  Aligned_cols=201  Identities=32%  Similarity=0.518  Sum_probs=168.5

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +.....|.+.+.||.|++|.||++.+..++..|++|.+.....   ....+.+|+++++.++|+|++++++++..     
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   86 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV-----   86 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----
Confidence            4566678899999999999999999998999999999875433   34567889999999999999999877765     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           +...|+|+||+++ +|.+.+......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        87 -----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~  161 (286)
T cd06614          87 -----GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFG  161 (286)
T ss_pred             -----CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccc
Confidence                 4589999999996 5555554433379999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.........  .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       162 ~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~  216 (286)
T cd06614         162 FAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPY  216 (286)
T ss_pred             hhhhhccchhh--hccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCC
Confidence            88755433211  12234578899999887654 889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.9e-33  Score=241.76  Aligned_cols=187  Identities=21%  Similarity=0.290  Sum_probs=152.9

Q ss_pred             ccccCCcceeeEeeeeecCC----------cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        152 EPLAAGGLSLNNFSVSLFTD----------ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +.||+|+||.||++.+..++          ..|++|.+......   ...+.+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-----   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence            46899999999999998776          45888876644321   4577899999999999999999877654     


Q ss_pred             ccccCCCeEEEEeeccccChHHHH-hcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-------c
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-------E  293 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-------~  293 (358)
                            ...++||||+.++.+..+ ......+++..+..++.||+.||+|||++|++|+||||+||+++.++       .
T Consensus        73 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~  146 (259)
T cd05037          73 ------DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPF  146 (259)
T ss_pred             ------CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCcee
Confidence                  256899999997655544 44444789999999999999999999999999999999999999887       7


Q ss_pred             EEEeecccceeccccCCCCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       294 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++|+|||++......      ....++..|+|||.+.+. ..++.++||||||+++|+|++ |..||
T Consensus       147 ~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~  207 (259)
T cd05037         147 IKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL  207 (259)
T ss_pred             EEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence            999999998865431      223346779999998765 358899999999999999999 46665

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.6e-33  Score=251.06  Aligned_cols=197  Identities=23%  Similarity=0.300  Sum_probs=155.8

Q ss_pred             ccccCC--cceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAG--GLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      ..||.|  ++|+||++.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++..          ++.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----------~~~   73 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT----------GSW   73 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec----------CCc
Confidence            467777  88999999999999999999987654333334567889999999999999999877765          558


Q ss_pred             EEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccc
Q psy13988        230 FYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA  307 (358)
Q Consensus       230 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~  307 (358)
                      .++|+||+.+ ++.+.+... ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++++||+.+.....
T Consensus        74 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~  153 (328)
T cd08226          74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR  153 (328)
T ss_pred             eEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence            8999999997 444444332 23589999999999999999999999999999999999999999999999986543322


Q ss_pred             cCCCCC-----CCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        308 EDRQRP-----YTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       308 ~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......     .....++..|+|||++.+. ..++.++||||+||++|+|++|++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  210 (328)
T cd08226         154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF  210 (328)
T ss_pred             cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            111100     0111235679999998754 34788999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-33  Score=242.76  Aligned_cols=192  Identities=24%  Similarity=0.363  Sum_probs=151.6

Q ss_pred             ccccCCcceeeEeeeeecCCc--EEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCC
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDE--LVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      +.||+|++|.||++.+..++.  .+++|.++... .......+.+|++++.++ +||||+++++++..          .+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----------~~   69 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----------RG   69 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec----------CC
Confidence            468999999999999988775  46888776322 222234677899999999 89999999777654          45


Q ss_pred             eEEEEeecccc-ChHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC
Q psy13988        229 SFYLVFEYMDH-DLMGLLESGM---------------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG  292 (358)
Q Consensus       229 ~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~  292 (358)
                      ..++||||+.+ ++.+.+....               ..+++..+..++.|++.||+|||++|++|+||||+||+++.++
T Consensus        70 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~  149 (270)
T cd05047          70 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  149 (270)
T ss_pred             CceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC
Confidence            78999999986 5655554321               2478899999999999999999999999999999999999999


Q ss_pred             cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       293 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .++|+|||++.........   .....+..|+|||.+.... ++.++||||||+++|+|++ |..||
T Consensus       150 ~~kl~dfgl~~~~~~~~~~---~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf  212 (270)
T cd05047         150 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPY  212 (270)
T ss_pred             eEEECCCCCccccchhhhc---cCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCc
Confidence            9999999998532211111   1112256799999886544 8899999999999999997 99987

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-32  Score=238.76  Aligned_cols=198  Identities=25%  Similarity=0.449  Sum_probs=161.9

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ...|++.+.||.|++|.||++.+. .+..+|+|.+.....   ....+.+|+++++.++|||++++++++..        
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   70 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTE--------   70 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEcc--------
Confidence            357888999999999999999875 477899998864322   23467889999999999999999776654        


Q ss_pred             cCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ....++||||+.++ +.+.+......+++..+..++.|++.|+++||+.+++|+||||+||+++.++.++|+|||.+.
T Consensus        71 --~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          71 --RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCccee
Confidence              45789999999875 444454445568899999999999999999999999999999999999999999999999988


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ........ ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       149 ~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~  202 (256)
T cd05112         149 FVLDDQYT-SSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPY  202 (256)
T ss_pred             ecccCccc-ccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCC
Confidence            65433211 112223467899999887654 8889999999999999998 89887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-32  Score=238.10  Aligned_cols=196  Identities=32%  Similarity=0.481  Sum_probs=166.7

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|.+.+.||.|++|.||++.+..+++.|++|++.....  .....+.+|+++++.++|+|++++++++..          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   68 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK----------   68 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec----------
Confidence            37788999999999999999998999999999876543  234577899999999999999999776654          


Q ss_pred             CCeEEEEeeccccChHH-HHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        227 KGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      ....++++||+++..+. .+......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        69 ~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  148 (253)
T cd05122          69 KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL  148 (253)
T ss_pred             CCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence            45789999999965444 44443357899999999999999999999999999999999999999999999999998876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....   .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus       149 ~~~~~---~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  197 (253)
T cd05122         149 SDTKA---RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPY  197 (253)
T ss_pred             ccccc---ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCC
Confidence            54432   23345688999999987654 789999999999999999999987

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.6e-33  Score=240.75  Aligned_cols=196  Identities=24%  Similarity=0.351  Sum_probs=152.5

Q ss_pred             ccccCCcceeeEeeeeec---CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCC
Q psy13988        152 EPLAAGGLSLNNFSVSLF---TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      +.||+|+||.||++.+..   ....||||.+.... .......+.+|+.+++.++||||+++++++..         .++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------~~~   70 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP---------SEG   70 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeec---------CCC
Confidence            468999999999998754   34679999875322 11223467789999999999999999876543         234


Q ss_pred             eEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccc
Q psy13988        229 SFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA  307 (358)
Q Consensus       229 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~  307 (358)
                      ..++||||+.+ ++.+.+.......++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||+++....
T Consensus        71 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~  150 (262)
T cd05058          71 SPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD  150 (262)
T ss_pred             CcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccC
Confidence            67899999986 55555555445567788889999999999999999999999999999999999999999999876543


Q ss_pred             cCCC--CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhC-CCCC
Q psy13988        308 EDRQ--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK-KPLF  358 (358)
Q Consensus       308 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg-~~pF  358 (358)
                      ....  .......++..|+|||.+.+.. ++.++||||||+++|+|++| .+||
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~  203 (262)
T cd05058         151 KEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPY  203 (262)
T ss_pred             CcceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCC
Confidence            2211  1112233467899999887654 88999999999999999995 5554

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-33  Score=244.22  Aligned_cols=189  Identities=20%  Similarity=0.258  Sum_probs=152.2

Q ss_pred             ccccCCcceeeEeeeeecCCc-------EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDE-------LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      +.||.|+||.||++.+...+.       .|++|.+....  ....+.+.+|+.+++.++||||+++++++..        
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--------   70 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--------   70 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--------
Confidence            479999999999999865443       48888875432  2223467789999999999999999877754        


Q ss_pred             cCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc--------EE
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE--------VK  295 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~--------~~  295 (358)
                        +...++||||++++ +...+......+++..+..++.||+.||+|||++|++||||||+||+++.++.        ++
T Consensus        71 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~  148 (258)
T cd05078          71 --GDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIK  148 (258)
T ss_pred             --CCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEE
Confidence              44789999999875 44555555556899999999999999999999999999999999999987764        69


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCC-CCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK-PLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~-~pF  358 (358)
                      ++|||.+......      ....+++.|+|||++.+...++.++||||||+++|+|++|. +||
T Consensus       149 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~  206 (258)
T cd05078         149 LSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL  206 (258)
T ss_pred             ecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence            9999988654322      12345788999999986555889999999999999999984 554

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.3e-33  Score=242.61  Aligned_cols=201  Identities=24%  Similarity=0.410  Sum_probs=160.7

Q ss_pred             CCCCcccccccCCcceeeEeeeeec-----CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLF-----TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..+|.+++.||.|+||.||++....     +.+.|++|.+..... ......+.+|++++++++|+||+++++++.+   
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   79 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCRE---   79 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECC---
Confidence            3578899999999999999999653     346899998764321 2234568899999999999999999776644   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcCC--------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESGM--------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN  290 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~  290 (358)
                             ....++||||+++ +|.+.+....        ..+++..+..++.|++.||.|||+++++|+||||+||+++.
T Consensus        80 -------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~  152 (275)
T cd05046          80 -------AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS  152 (275)
T ss_pred             -------CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC
Confidence                   4578999999996 4544554322        15899999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++.++++|||++....... ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       153 ~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~  219 (275)
T cd05046         153 QREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPF  219 (275)
T ss_pred             CCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCc
Confidence            9999999999986543221 11223345578899999887654 7889999999999999998 77776

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-32  Score=245.66  Aligned_cols=191  Identities=26%  Similarity=0.323  Sum_probs=154.4

Q ss_pred             cceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEEEeecc
Q psy13988        158 GLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYM  237 (358)
Q Consensus       158 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  237 (358)
                      +++.||++.+..+++.||||+++...........+.+|+.+++.++|+||+++++++.+          +...+++|||+
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~----------~~~~~~~~e~~   81 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV----------DSELYVVSPLM   81 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec----------CCeEEEEEecc
Confidence            45667777777899999999998654444445678899999999999999999887765          45789999999


Q ss_pred             ccChHHHH-hc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCC----
Q psy13988        238 DHDLMGLL-ES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ----  311 (358)
Q Consensus       238 ~~~l~~~~-~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~----  311 (358)
                      +++.+..+ .. ....+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+||+.+.........    
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            97655544 32 2346889999999999999999999999999999999999999999999999988765432211    


Q ss_pred             -CCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        312 -RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       312 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                       .......++..|+|||++... ..++.++|+||+|+++|+|++|+.||
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf  210 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF  210 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence             111223457789999998653 34788999999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-32  Score=244.24  Aligned_cols=201  Identities=22%  Similarity=0.260  Sum_probs=164.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....|.+.+.||.|++|.||++.+..++..||||.++..... .....+.+|+.++... .|+||+++++++.+      
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------   85 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT------   85 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec------
Confidence            446788999999999999999999989999999998754322 2233456677766666 59999999887765      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          ....|+||||+++.+...+......+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus        86 ----~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          86 ----DSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             ----CCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence                45799999999887766665555579999999999999999999997 5999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCC---CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGE---ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +..+.....   .....++..|+|||.+.+.   ..++.++||||||+++|+|++|+.||
T Consensus       162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  218 (296)
T cd06618         162 SGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY  218 (296)
T ss_pred             chhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCC
Confidence            876543221   1223457889999998644   23788999999999999999999997

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.9e-33  Score=242.29  Aligned_cols=195  Identities=26%  Similarity=0.392  Sum_probs=156.3

Q ss_pred             ccccCCcceeeEeeeeecCC------cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        152 EPLAAGGLSLNNFSVSLFTD------ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      +.||.|++|.||++.+....      ..||||.+..... ......+.+|+.+++.++||||+++++++..         
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------   70 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL---------   70 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC---------
Confidence            36899999999999986544      7899998764422 2234567889999999999999999777654         


Q ss_pred             CCCeEEEEeecccc-ChHHHHhc------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-----c
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLES------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-----E  293 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-----~  293 (358)
                       .+..++||||+++ ++.+.+..      ....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++     .
T Consensus        71 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~  149 (269)
T cd05044          71 -NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRV  149 (269)
T ss_pred             -CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcc
Confidence             4578999999986 55555543      223478899999999999999999999999999999999999887     8


Q ss_pred             EEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       294 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++|+|||++................++..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~  214 (269)
T cd05044         150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPY  214 (269)
T ss_pred             eEECCcccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCC
Confidence            9999999987654333222222334577899999987654 8999999999999999998 99887

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.2e-32  Score=243.55  Aligned_cols=197  Identities=26%  Similarity=0.427  Sum_probs=162.7

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|.....||+|++|.||++....+++.||||.+.....  .....+.+|+.+++.++|+||+++++++..         
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------   88 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV---------   88 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEe---------
Confidence            334445789999999999999999999999998754322  234467889999999999999999877654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       +...++||||++++.+..+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        89 -~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657          89 -GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             -CCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence             5589999999998666555433 35889999999999999999999999999999999999999999999999998765


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||
T Consensus       167 ~~~~~--~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~  216 (292)
T cd06657         167 SKEVP--RRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPY  216 (292)
T ss_pred             ccccc--cccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            43221  112345688999999886544 788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-32  Score=238.73  Aligned_cols=199  Identities=24%  Similarity=0.391  Sum_probs=161.9

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+.+.||+|++|.||++.+. .+..+|+|.+....   .....+.+|+++++.++|+||+++++++..      
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   72 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------   72 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------
Confidence            45678999999999999999999854 55679999876432   224567889999999999999999777643      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           ...++||||+++ ++.+.+.. ....++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        73 -----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          73 -----EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             -----CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCc
Confidence                 367999999986 66666644 33457888899999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .+......... ......++..|+|||.+.... ++.++|+||||+++|++++ |..||
T Consensus       148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~  204 (260)
T cd05073         148 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPY  204 (260)
T ss_pred             ceeeccCCCcc-cccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCC
Confidence            99866433221 112233467799999887544 8889999999999999998 89887

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1006|consensus

Probab=100.00  E-value=2e-34  Score=234.53  Aligned_cols=201  Identities=25%  Similarity=0.321  Sum_probs=163.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      .....+-+..||.|+||+|++..++.+|+..|||++..... +....+++.|.+...+- +.||||++++....      
T Consensus        62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~------  134 (361)
T KOG1006|consen   62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS------  134 (361)
T ss_pred             ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc------
Confidence            33445567889999999999999999999999999987654 23345677787755544 78999999888765      


Q ss_pred             cccCCCeEEEEeeccccChHHHHh----cCCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEe
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLE----SGMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                          ++..|+-||.++-++...++    .....++|.-.-+|....+.||.||-.. .|+|||+||+|||++..|.+|||
T Consensus       135 ----EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  135 ----EGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             ----CCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeee
Confidence                56899999999976555442    2334688988889999999999999964 89999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCC-CCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++..+..+--   .+...|-..|||||.+..... |+-++|+||||+++||+.||+.||
T Consensus       211 DFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy  269 (361)
T KOG1006|consen  211 DFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY  269 (361)
T ss_pred             cccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc
Confidence            9999876643321   234456778999999975544 899999999999999999999996

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.3e-33  Score=242.74  Aligned_cols=188  Identities=19%  Similarity=0.254  Sum_probs=149.6

Q ss_pred             cccCCcceeeEeeeeecC------------------------CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCccc
Q psy13988        153 PLAAGGLSLNNFSVSLFT------------------------DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIV  208 (358)
Q Consensus       153 ~lg~G~~g~v~~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  208 (358)
                      .||+|+||.||++....+                        ...|++|.+.....  .....+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence            589999999999874322                        24688898764322  2234677889999999999999


Q ss_pred             chhhhhcccCcccccccCCCeEEEEeeccccChHHHHh-cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy13988        209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL  287 (358)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nil  287 (358)
                      ++++++.+          +...++||||++++.++.+. .....+++..+..++.||+.||+|||+++|+|+||||+||+
T Consensus        80 ~~~~~~~~----------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nil  149 (274)
T cd05076          80 FVHGVCVR----------GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL  149 (274)
T ss_pred             eEEEEEEe----------CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEE
Confidence            99887765          45789999999986665554 44567899999999999999999999999999999999999


Q ss_pred             ecCCC-------cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHh-hCCCCC
Q psy13988        288 MNNRG-------EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF-VKKPLF  358 (358)
Q Consensus       288 l~~~~-------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll-tg~~pF  358 (358)
                      ++..+       .++++|||.+......      ....++..|+|||.+.+...++.++||||||+++|+|+ +|..||
T Consensus       150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~  222 (274)
T cd05076         150 LARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL  222 (274)
T ss_pred             EeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCc
Confidence            97654       3899999987643221      12245778999998876555899999999999999995 688886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-32  Score=238.94  Aligned_cols=190  Identities=25%  Similarity=0.465  Sum_probs=157.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|++.+.||+|++|.||.+.  .+++.||+|.+....    ....+.+|+.+++.++|||++++++++..         
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---------   70 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---------   70 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---------
Confidence            568899999999999999886  478899999886432    23467889999999999999999877643         


Q ss_pred             CCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        +..++||||+.+ ++.+.+... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        71 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          71 --NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             --CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccce
Confidence              236899999986 666665443 3357899999999999999999999999999999999999999999999999987


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ......     .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |++||
T Consensus       149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~  198 (254)
T cd05083         149 VGSMGV-----DNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPY  198 (254)
T ss_pred             eccccC-----CCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCC
Confidence            643221     1223356799999887554 8899999999999999997 99987

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1094|consensus

Probab=100.00  E-value=4.3e-33  Score=248.71  Aligned_cols=203  Identities=28%  Similarity=0.416  Sum_probs=169.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+...+++.||+|-||.|.++.- ..+.+||+|.++...... ....|.+|+++|.+|+||||+.++++|..      
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~------  606 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQ------  606 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeec------
Confidence            3455567889999999999999986 347999999998664443 34688999999999999999999888776      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCCCC-CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVD-FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                          +..+++|+||+++ +|.+++.....+ .......+|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||
T Consensus       607 ----DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfg  682 (807)
T KOG1094|consen  607 ----DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFG  682 (807)
T ss_pred             ----CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcc
Confidence                5589999999996 555556554333 3566677899999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh--CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV--KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt--g~~pF  358 (358)
                      +++.+-.++........+-..+|||+|.+...+ ++.++|+|+||+++||+++  ...||
T Consensus       683 msR~lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py  741 (807)
T KOG1094|consen  683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPY  741 (807)
T ss_pred             cccccccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCch
Confidence            999776666666556666789999999998665 9999999999999999864  45554

>KOG0984|consensus

Probab=100.00  E-value=3.3e-33  Score=219.47  Aligned_cols=199  Identities=22%  Similarity=0.308  Sum_probs=162.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ....-+..||+|++|.|-+.++..+|...|+|++...-.. ....+.++|+++..+. ..|.+|.+++.+.+        
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--------  116 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--------  116 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhc--------
Confidence            3444567899999999999999999999999999866433 2334567788876655 78999999887655        


Q ss_pred             cCCCeEEEEeeccccChHHHH---hcCCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEeecc
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLL---ESGMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                        ++.+++-||.++-++....   ...+..++|.-.-+|+..+++||.|||++ .++|||+||.|||++.+|++|+||||
T Consensus       117 --egdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  117 --EGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             --cccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence              5689999999997655544   45677899999999999999999999976 89999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccC---CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLG---EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++..+.++.-.   +-..|--.|||||.+..   ...|+-++||||||+++.||.+++.||
T Consensus       195 IsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY  252 (282)
T KOG0984|consen  195 ISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY  252 (282)
T ss_pred             cceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence            99876544321   11234567999999853   235899999999999999999999997

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.7e-32  Score=237.58  Aligned_cols=196  Identities=22%  Similarity=0.296  Sum_probs=149.2

Q ss_pred             ccccCCcceeeEeeeeecC--CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFT--DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.....  ...+++|.+..... ......+.+|+.+++.++||||+++++.+.+          ...
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----------~~~   69 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVE----------AIP   69 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecC----------CCc
Confidence            3699999999999975433  34567777654322 2234577889999999999999999877654          457


Q ss_pred             EEEEeecccc-ChHHHHhcC---CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        230 FYLVFEYMDH-DLMGLLESG---MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       230 ~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      .|+||||+.+ +|.+.+...   ....++..+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~  149 (268)
T cd05086          70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSR  149 (268)
T ss_pred             cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEeccccccccc
Confidence            8999999996 555555432   234667778899999999999999999999999999999999999999999987643


Q ss_pred             cccCCCCCCCCccccccccccccccCC------CCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGE------ERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .............++..|+|||++...      ..++.++||||||+++|+|++ |.+||
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  209 (268)
T cd05086         150 YKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY  209 (268)
T ss_pred             CcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence            222222222334568889999987531      125779999999999999997 56676

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.1e-32  Score=238.21  Aligned_cols=198  Identities=29%  Similarity=0.486  Sum_probs=161.8

Q ss_pred             CCcccccccCCcceeeEeeeeec-CCcEEEEEEeeccccC--------CCCchhHHHHHHHHHh-CCCCcccchhhhhcc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLF-TDELVALKKVRLENEK--------EGFPITAVREIKILRQ-LNHKNIVNLREIVTD  216 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~--------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  216 (358)
                      .|++.+.||.|++|.||++.+.. +++.+|+|.+......        ......+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47889999999999999999987 7899999988654321        1122345678887765 699999999776654


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHH---hcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCC
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLL---ESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNR  291 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~  291 (358)
                                ++..++||||+++ ++.+.+   ......+++..++.++.|++.||.+||+ .+++|+||+|+||+++.+
T Consensus        81 ----------~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~  150 (269)
T cd08528          81 ----------NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED  150 (269)
T ss_pred             ----------CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC
Confidence                      5689999999987 444443   2344578999999999999999999996 789999999999999999


Q ss_pred             CcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       292 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.++|+|||.+.......   ......++..|+|||.+.+.. ++.++|+||||+++|+|++|++||
T Consensus       151 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~  213 (269)
T cd08528         151 DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPF  213 (269)
T ss_pred             CcEEEecccceeeccccc---ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcc
Confidence            999999999998765443   223445688999999997654 889999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-32  Score=232.48  Aligned_cols=191  Identities=31%  Similarity=0.450  Sum_probs=160.2

Q ss_pred             ccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEE
Q psy13988        154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL  232 (358)
Q Consensus       154 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~l  232 (358)
                      ||.|++|.||.+.+..+++.||+|.+....... .....+..|+.+++.++|+||+++++.+..          +...++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------~~~~~~   70 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT----------EEKLYL   70 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec----------CCeeEE
Confidence            689999999999998899999999987654322 134467889999999999999999877754          558999


Q ss_pred             Eeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCC
Q psy13988        233 VFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ  311 (358)
Q Consensus       233 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~  311 (358)
                      |||++.+ ++.+.+.. ...+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        71 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-  148 (250)
T cd05123          71 VLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-  148 (250)
T ss_pred             EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence            9999965 55555543 34689999999999999999999999999999999999999999999999999887644321 


Q ss_pred             CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                       ......++..|+|||...+.. .+.++|+||||+++|+|++|..||
T Consensus       149 -~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~  193 (250)
T cd05123         149 -RTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPF  193 (250)
T ss_pred             -cccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCC
Confidence             123345688899999987654 788999999999999999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0668|consensus

Probab=100.00  E-value=3.2e-33  Score=222.86  Aligned_cols=197  Identities=27%  Similarity=0.518  Sum_probs=170.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  221 (358)
                      .....|++++.+|+|.++.|+.+....+.++++||+++...     ...+.+|+.+|..+. ||||++++++..++.   
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---  106 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPE---  106 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCcc---
Confidence            36678999999999999999999999999999999987543     236789999999995 999999999999865   


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg  300 (358)
                           .....+|+|++.+.....+-.   .++.-.++.++.+++.||.|||+.||.|||+||.||++|... .++|+|+|
T Consensus       107 -----SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  107 -----SKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             -----ccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecc
Confidence                 456789999999865555533   477888999999999999999999999999999999999876 69999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|.++.++..-   ...+.+..|--||.+.....|+.+.|+|||||++..|+..+.||
T Consensus       179 LAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF  233 (338)
T KOG0668|consen  179 LAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF  233 (338)
T ss_pred             hHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence            99988765432   33344667788999998888999999999999999999999888

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.5e-32  Score=239.55  Aligned_cols=201  Identities=22%  Similarity=0.297  Sum_probs=161.0

Q ss_pred             CCcccccccCCcceeeEeeeee---cCCcEEEEEEeeccccC--CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENEK--EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  220 (358)
                      .|++.+.||.|++|.||++.+.   .+++.||||.+......  ......+.+|+.++..+ +||||+++++++..    
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~----   76 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT----   76 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence            3788899999999999999864   46789999998754221  22234567899999999 69999999776654    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            +...++||||+.++.+.........+++..+..++.|+++||.|||+.+++|+||+|.||+++.++.++|+|||
T Consensus        77 ------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          77 ------DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             ------CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECc
Confidence                  55889999999874444333334568999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCC-CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++......... ......++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||
T Consensus       151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~  208 (288)
T cd05583         151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF  208 (288)
T ss_pred             ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCc
Confidence            98765433221 112334688999999886532 3678999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG3653|consensus

Probab=100.00  E-value=2.5e-32  Score=238.59  Aligned_cols=197  Identities=25%  Similarity=0.309  Sum_probs=162.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHH--HHHHhCCCCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREI--KILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~--~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ....-++++.+|+|.||.||++..  +++.||||+++....     +.+..|-  ..+-.++|+||++++++-...+   
T Consensus       208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~k-----qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t---  277 (534)
T KOG3653|consen  208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEK-----QSFQNEKNIYSLPGMKHENILQFIGAEKRGT---  277 (534)
T ss_pred             cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHH-----HHHHhHHHHHhccCccchhHHHhhchhccCC---
Confidence            345566789999999999999986  669999999986532     3444444  4445569999999987766533   


Q ss_pred             ccccCCCeEEEEeeccc-cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh---------CCceecCCCCCCEEecCC
Q psy13988        222 DFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK---------RNFLHRDIKCSNILMNNR  291 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---------~~i~H~Dlkp~Nill~~~  291 (358)
                         .++..++||++|.+ |+|.+++..+  .+++....+++..|++||+|||+         ..|+|||||..||||..+
T Consensus       278 ---~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D  352 (534)
T KOG3653|consen  278 ---ADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND  352 (534)
T ss_pred             ---ccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence               12558999999998 5777777654  58899999999999999999995         359999999999999999


Q ss_pred             CcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCC-----CcchHHHHHHHHHHHhhCC
Q psy13988        292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG-----PAIDVWSCGCILGELFVKK  355 (358)
Q Consensus       292 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~~l~~lltg~  355 (358)
                      +.+.|+|||+|..+..........+.+||.+|||||++.+.-.+.     .+.||||+|.++|||++..
T Consensus       353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            999999999999998777777777899999999999998765444     3689999999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=1.1e-31  Score=230.13  Aligned_cols=178  Identities=23%  Similarity=0.291  Sum_probs=146.6

Q ss_pred             CcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEEEeec
Q psy13988        157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY  236 (358)
Q Consensus       157 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~  236 (358)
                      |.++.||++.+..+++.||+|++....       ...+|...+....||||+++++++.+          ....++||||
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~----------~~~~~lv~e~   66 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS----------EDSVFLVLQH   66 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec----------CCeEEEEEec
Confidence            889999999999999999999987543       12345555556679999999887765          4589999999


Q ss_pred             ccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCC
Q psy13988        237 MDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYT  315 (358)
Q Consensus       237 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~  315 (358)
                      +.| +|.+.+.. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++|||.+.......     .
T Consensus        67 ~~~~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~  140 (237)
T cd05576          67 AEGGKLWSHISK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----D  140 (237)
T ss_pred             CCCCCHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----c
Confidence            997 45555543 3468999999999999999999999999999999999999999999999999876554321     2


Q ss_pred             CccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        316 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       316 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||
T Consensus       141 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~  182 (237)
T cd05576         141 GEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTLV  182 (237)
T ss_pred             cCCcCccccCCcccCCCC-CCchhhHHHHHHHHHHHHHCcchh
Confidence            233467799999886544 788999999999999999998765

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1290|consensus

Probab=99.97  E-value=1.1e-31  Score=235.23  Aligned_cols=142  Identities=25%  Similarity=0.366  Sum_probs=122.5

Q ss_pred             cccCCCCC-CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-----C---Cccc
Q psy13988        138 IQSNSTNN-SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-----H---KNIV  208 (358)
Q Consensus       138 ~~~~~~~~-~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv  208 (358)
                      ..-.+... ++|.+.+.||.|-|++||++.|..+.+.||+|+.+.   .+.+.+..+.||.+|++++     |   .+||
T Consensus        69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            33445555 999999999999999999999999999999999873   4456677889999999992     3   3699


Q ss_pred             chhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCE
Q psy13988        209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNI  286 (358)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Ni  286 (358)
                      ++++.|....      .++.++|+|+|+++.+|+..++..+ ..++...+.+|++|++.||.|||. +||+|.||||+||
T Consensus       146 ~LlD~FkhsG------pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENv  219 (590)
T KOG1290|consen  146 QLLDHFKHSG------PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENV  219 (590)
T ss_pred             eeeccceecC------CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCccee
Confidence            9999987643      5688999999999999999987544 458999999999999999999995 6999999999999


Q ss_pred             Ee
Q psy13988        287 LM  288 (358)
Q Consensus       287 ll  288 (358)
                      |+
T Consensus       220 Ll  221 (590)
T KOG1290|consen  220 LL  221 (590)
T ss_pred             ee
Confidence            99

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=3.3e-31  Score=230.51  Aligned_cols=198  Identities=28%  Similarity=0.401  Sum_probs=159.3

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccc---cCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLEN---EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      +|.+.+.||.|++|.||++.+..++..+++|.++...   ........+.+|+.+++.++||||+++++++.+       
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------   73 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-------   73 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-------
Confidence            5889999999999999999998887777777665432   222233456679999999999999999888765       


Q ss_pred             ccCCCeEEEEeeccccChHH-HHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        224 RKDKGSFYLVFEYMDHDLMG-LLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~-~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                         ....++|+||+.+..+. .+.   .....+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+||
T Consensus        74 ---~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          74 ---RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             ---CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeeccc
Confidence               34789999999874444 332   23457899999999999999999999999999999999999975 56999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |.+.........  .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||
T Consensus       150 g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~  205 (260)
T cd08222         150 GVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAF  205 (260)
T ss_pred             CceeecCCCccc--ccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            998766433221  12334588899999886544 788999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.7e-31  Score=259.74  Aligned_cols=149  Identities=24%  Similarity=0.337  Sum_probs=126.3

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...|.+++.||.|+||.||++.+..+++.||||++...... ......+..|+.+++.++|+||++++.++..       
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------   75 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-------   75 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-------
Confidence            35789999999999999999999999999999998754322 1223467789999999999999999766543       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ...+|+||||+.|+.+..+......+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||+++
T Consensus        76 ---~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          76 ---ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             ---CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence               55899999999875444444444568999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587|consensus

Probab=99.97  E-value=2.3e-31  Score=247.93  Aligned_cols=210  Identities=23%  Similarity=0.322  Sum_probs=175.4

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      .+.......+.|.+++|.|.+|.||++....+++.+|+|+.......   .+++..|.++++.. .|||++.++++|.-.
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34445667788999999999999999999999999999998765433   34667788999888 799999999998754


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhc--CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                      ..     ..++.+|||||||.|+....+.+  ....+.|..+.-|++.++.|+.+||++.++|||||-.|||++.++.+|
T Consensus        89 ~~-----~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   89 DP-----GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             cC-----CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEE
Confidence            32     45789999999999754443322  145799999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCC----CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||.+......-.  .....+|||.|||||++...    ..|+.++|+||||++..||--|.+|+
T Consensus       164 LvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl  228 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL  228 (953)
T ss_pred             Eeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc
Confidence            999999987754322  23456889999999999643    24778999999999999999999996

>KOG0196|consensus

Probab=99.97  E-value=1.6e-32  Score=252.44  Aligned_cols=203  Identities=24%  Similarity=0.400  Sum_probs=171.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCC---cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTD---ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ..+.-+|-++||.|.||.|+.++.+..+   ..||||.++..... .....|+.|..++-+++||||+++.++...    
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte-kqrrdFL~EAsIMGQFdHPNIIrLEGVVTk----  701 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIRLEGVVTK----  701 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH-HHHhhhhhhhhhcccCCCCcEEEEEEEEec----
Confidence            3344467789999999999999987766   57999999876433 345579999999999999999999999876    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            ...+.||+|||++ +|..++..+.++++..+...+++.|+.|++||-+.++|||||...|||++.+-.+|++||
T Consensus       702 ------s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDF  775 (996)
T KOG0196|consen  702 ------SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDF  775 (996)
T ss_pred             ------CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccc
Confidence                  3478999999996 566666778888999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccC-CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAED-RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++...+.. ...+..+.....+|.|||.+.-.+ ++.++||||+|++|||.++ |..||
T Consensus       776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             cceeecccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcc
Confidence            9999876554 222223333478999999998655 9999999999999999885 88886

>KOG0665|consensus

Probab=99.97  E-value=5.3e-32  Score=225.83  Aligned_cols=207  Identities=32%  Similarity=0.537  Sum_probs=177.9

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      +.-+...+|.-+..++.|.- .|.-+-|..+++.||+|+............+..+|..++..+.|+||++++.++.... 
T Consensus        11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~-   88 (369)
T KOG0665|consen   11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK-   88 (369)
T ss_pred             cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccc-
Confidence            44456678888999999998 8888999999999999998877555556667889999999999999999999987643 


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                         ....-..+|+|||+++.++-..+.   ..++-..+..++.|++.|+++||+.||+||||||+||++..+..+||.||
T Consensus        89 ---~l~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   89 ---TLEEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             ---cHHHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccc
Confidence               223345689999999998877765   35778888999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+++.....   ...+..+.|..|.|||++.+.. +...+||||+||++.||++|+..|
T Consensus       163 g~ar~e~~~---~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf  217 (369)
T KOG0665|consen  163 GLARTEDTD---FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLF  217 (369)
T ss_pred             hhhcccCcc---cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEe
Confidence            999876544   3345667799999999999887 899999999999999999998765

>KOG4257|consensus

Probab=99.97  E-value=4.2e-31  Score=237.74  Aligned_cols=195  Identities=24%  Similarity=0.345  Sum_probs=164.1

Q ss_pred             ccccccCCcceeeEeeeeec--CC--cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        150 LMEPLAAGGLSLNNFSVSLF--TD--ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~--~~--~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      +.+.||.|-||.||.+....  .|  --||||..+..... ...+.|+.|..+++.++||||+++++++.+.        
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e~--------  463 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ--------  463 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeecc--------
Confidence            45689999999999998743  23  35788877654433 3367899999999999999999999999864        


Q ss_pred             CCCeEEEEeeccc-cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                         ..|||||.+. |.|..+++.+...++......++.||+.||+|||+...|||||...|||+....=+||+|||+++.
T Consensus       464 ---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence               5899999998 567777777777899999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +......... ...-..-|||||.+.= +.++.++|||-||+++||+|. |..||
T Consensus       541 ~ed~~yYkaS-~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPf  593 (974)
T KOG4257|consen  541 LEDDAYYKAS-RGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPF  593 (974)
T ss_pred             ccccchhhcc-ccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcc
Confidence            8766544332 2233678999998764 449999999999999999885 88888

>KOG0670|consensus

Probab=99.97  E-value=2.1e-31  Score=235.00  Aligned_cols=203  Identities=31%  Similarity=0.412  Sum_probs=169.2

Q ss_pred             cccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCC------Ccccchh
Q psy13988        138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH------KNIVNLR  211 (358)
Q Consensus       138 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~  211 (358)
                      ..-.+....+|.+....|+|-|++|..|.|...|..||||+|.......   ..-++|+++|++|..      -|+++++
T Consensus       424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            3344566778888888999999999999999999999999998543221   234689999999943      3788887


Q ss_pred             hhhcccCcccccccCCCeEEEEeeccccChHHHHhcC--CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec
Q psy13988        212 EIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG--MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN  289 (358)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~  289 (358)
                      ..|..          .+++|||+|.+.-+|...++.-  +..+....++.++.|++.||..|-++||+|.||||+|||+.
T Consensus       501 r~F~h----------knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  501 RHFKH----------KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN  570 (752)
T ss_pred             HHhhh----------cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec
Confidence            66654          6699999999999888887643  33477788999999999999999999999999999999998


Q ss_pred             CCC-cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        290 NRG-EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       290 ~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.. .+||||||.|.....+..    +....+..|.|||++.|-. |+...|+||.||+||||.||+..|
T Consensus       571 E~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlF  635 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILF  635 (752)
T ss_pred             cCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceec
Confidence            765 689999999988765543    3445578899999999876 999999999999999999999876

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.6e-29  Score=214.76  Aligned_cols=199  Identities=37%  Similarity=0.539  Sum_probs=164.6

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      |.+.+.||.|++|.||++....+++.+++|.+...... .....+.+|++.++.++|+|++++++++..          .
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----------~   69 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED----------P   69 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec----------C
Confidence            56778999999999999999988999999998865433 134577889999999999999999777654          4


Q ss_pred             CeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       228 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ...++++|++++ ++.+.+......+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....
T Consensus        70 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       70 EPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIH  149 (225)
T ss_pred             CceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence            578999999998 5555554433228899999999999999999999999999999999999999999999999998775


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .... .......++..|++||.+.+...++.++|+|+||+++++|++|+.||
T Consensus       150 ~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf  200 (225)
T smart00221      150 RDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF  200 (225)
T ss_pred             Cccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence            4421 11233455788999998843344778999999999999999999998

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG2052|consensus

Probab=99.97  E-value=3.3e-30  Score=223.81  Aligned_cols=196  Identities=24%  Similarity=0.299  Sum_probs=155.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHH--hCCCCcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILR--QLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~~~  220 (358)
                      +....-.+.+.||+|.||.||.+..  -|+.||||+|......     ..++|.++.+  .|+|+||+.+++.-....  
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~-----SWfrEtEIYqTvmLRHENILgFIaaD~~~~--  278 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDER-----SWFRETEIYQTVMLRHENILGFIAADNKDN--  278 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchh-----hhhhHHHHHHHHHhccchhhhhhhccccCC--
Confidence            3445556889999999999998885  8999999999865443     3445555554  459999999987654422  


Q ss_pred             cccccCCCeEEEEeeccc-cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCEEecCC
Q psy13988        221 LDFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK--------RNFLHRDIKCSNILMNNR  291 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--------~~i~H~Dlkp~Nill~~~  291 (358)
                          ..-.++|||++|.+ |+|.+++..  ..++-....+++..++.||++||.        -.|.|||||+.|||+..+
T Consensus       279 ----gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  279 ----GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             ----CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence                12347999999998 688888866  468889999999999999999994        259999999999999999


Q ss_pred             CcEEEeecccceeccccC--CCCCCCCccccccccccccccCCCCC----C-CcchHHHHHHHHHHHhh
Q psy13988        292 GEVKLADFGLARLYNAED--RQRPYTNKVITLWYRPPELLLGEERY----G-PAIDVWSCGCILGELFV  353 (358)
Q Consensus       292 ~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~----~-~~~DiwslG~~l~~llt  353 (358)
                      +.+.|+|+|+|.......  ..-.....+||-+|||||++...-+.    + ..+||||||.++||+..
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            999999999998775542  22344567899999999999754321    1 25899999999999864

>KOG0199|consensus

Probab=99.97  E-value=6.9e-31  Score=239.02  Aligned_cols=201  Identities=22%  Similarity=0.334  Sum_probs=167.7

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCC---cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTD---ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+.+.||+|+||+|+.+.....+   -.||||.+....... ....|++|+.++.+|+|+|++++|++..+.    
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q----  183 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ----  183 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc----
Confidence            334457799999999999999875433   479999998765443 456899999999999999999999998753    


Q ss_pred             ccccCCCeEEEEeeccc-cChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        222 DFRKDKGSFYLVFEYMD-HDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ...+|+|+++ |+|++.+.. ....+-......++.||+.|+.||.++++|||||-..|+++-....+||+||
T Consensus       184 -------p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DF  256 (1039)
T KOG0199|consen  184 -------PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDF  256 (1039)
T ss_pred             -------hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecc
Confidence                   4679999999 578888866 4456778888899999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCC-ccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+.+.++.+...-.+.. ....+.|-|||.+.... ++.++|+|++||++|||+| |.-||
T Consensus       257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW  316 (1039)
T KOG0199|consen  257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPW  316 (1039)
T ss_pred             cceeccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCC
Confidence            99998876654433322 23377899999998655 9999999999999999998 66776

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=5.1e-30  Score=261.61  Aligned_cols=185  Identities=20%  Similarity=0.257  Sum_probs=150.3

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .+...+.||+|+||.||++.+..++..||||++.....      ....|++.+++++||||+++++++.+          
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~----------  754 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRS----------  754 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEc----------
Confidence            34556789999999999999999999999998864321      12356889999999999999887765          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH---KRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ....|+||||++++.+..+..   .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++..++. ++...
T Consensus       755 ~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        755 EKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             CCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            447899999999755444433   3788999999999999999999   6799999999999999998887765 55443


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....      ....+++.|+|||++.+.. ++.++|||||||++|||+||+.||
T Consensus       831 ~~~~~------~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~  878 (968)
T PLN00113        831 LLCTD------TKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPA  878 (968)
T ss_pred             ccccC------CCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCC
Confidence            32111      1235689999999987654 899999999999999999999997

>KOG1025|consensus

Probab=99.96  E-value=3.2e-30  Score=238.44  Aligned_cols=196  Identities=20%  Similarity=0.302  Sum_probs=168.4

Q ss_pred             ccccccCCcceeeEeeeeecCC----cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTD----ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..++||.|+||+||++.....|    .+||||++.... .....+++++|+.++.+++|||++++++++...        
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--------  770 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLS--------  770 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--------
Confidence            3468999999999999986555    478999876543 333456889999999999999999999998753        


Q ss_pred             CCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                         .+-||++|+++ .|++.++.....+..+..+.|+.||++|+.|||.+++|||||-..|||+.+-..+|+.|||+++.
T Consensus       771 ---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  771 ---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             ---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence               36799999994 78888888888899999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .......-........+-|||-|.+.... ++.++||||+||++||++| |..|+
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py  901 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPY  901 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCcc
Confidence            87766555555555578899999988655 9999999999999999998 77775

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.4e-29  Score=239.06  Aligned_cols=203  Identities=19%  Similarity=0.229  Sum_probs=141.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecC----CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFT----DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ....|.+.+.||+|+||.||++.+..+    +..||||++.....    .+....  +.+....+.++..+...+.... 
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~--e~l~~~~~~~~~~~~~~~~~~~-  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMN--ERVRRACPNSCADFVYGFLEPV-  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHH--HHHHhhchhhHHHHHHhhhccc-
Confidence            456799999999999999999999988    99999998763221    111111  1222223334444433333211 


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhcCCCC-------------------CChHHHHHHHHHHHHHHHHHHhCCceec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVD-------------------FNEVNNASIMRQLLDGLSYCHKRNFLHR  279 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~-------------------~~~~~~~~~~~qi~~al~~LH~~~i~H~  279 (358)
                        . ...+..+++|+||++++ |.+.+......                   ..+..+..++.||+.||+|||+++|+||
T Consensus       203 --~-~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        203 --S-SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             --c-cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence              1 34567899999999875 44444332211                   1233456799999999999999999999


Q ss_pred             CCCCCCEEecC-CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCC---------------------CCCC
Q psy13988        280 DIKCSNILMNN-RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE---------------------RYGP  337 (358)
Q Consensus       280 Dlkp~Nill~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~  337 (358)
                      ||||+|||++. ++.+||+|||+++....... .......+++.|+|||.+....                     .++.
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            99999999986 57999999999986543221 1223456789999999764221                     1344


Q ss_pred             cchHHHHHHHHHHHhhCCCC
Q psy13988        338 AIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       338 ~~DiwslG~~l~~lltg~~p  357 (358)
                      ++||||+||++|+|+++..|
T Consensus       359 k~DVwSlGviL~el~~~~~~  378 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLR  378 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCC
Confidence            67999999999999987654

>KOG4278|consensus

Probab=99.96  E-value=8.4e-30  Score=229.39  Aligned_cols=195  Identities=24%  Similarity=0.379  Sum_probs=163.8

Q ss_pred             cccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCC
Q psy13988        149 PLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       149 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      .+...||.|.||.||.+..+.-.-.||||.++.+.   ...++|+.|..+++.++|||+|+++++|...          -
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~E----------p  336 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE----------P  336 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccC----------C
Confidence            45678999999999999999999999999988543   4467899999999999999999998888764          4


Q ss_pred             eEEEEeeccc-cChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        229 SFYLVFEYMD-HDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       229 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      .+|||+||+. |+|++++...+ ..++..-.+.++.||..|++||..++++||||...|.|+.++..+||.|||+++++.
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            7899999987 68999986543 346666777889999999999999999999999999999999999999999999886


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ..... ...+..-..-|.|||-+.-+. ++.++|||+|||+|||+.| |--||
T Consensus       417 gDTYT-AHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPY  467 (1157)
T KOG4278|consen  417 GDTYT-AHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPY  467 (1157)
T ss_pred             CCcee-cccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCC
Confidence            54322 122222367899999887544 8999999999999999987 66664

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=9.9e-29  Score=229.40  Aligned_cols=213  Identities=24%  Similarity=0.313  Sum_probs=148.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee----------------cCCcEEEEEEeeccccCC------------CCchhHHH
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL----------------FTDELVALKKVRLENEKE------------GFPITAVR  194 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~----------------~~~~~vaiK~~~~~~~~~------------~~~~~~~~  194 (358)
                      ....+|.+.+.||+|+||.||++...                ..++.||||++.......            ...+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            35678999999999999999998752                345689999987543210            11122345


Q ss_pred             HHHHHHhCCCCcc-----cchhhhhcccCcccccccCCCeEEEEeeccccC-hHHHHhcCC-------------------
Q psy13988        195 EIKILRQLNHKNI-----VNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGM-------------------  249 (358)
Q Consensus       195 e~~~l~~l~h~ni-----v~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-------------------  249 (358)
                      |+.++.+++|.++     +++++++....  .+-....+..++||||++++ |.+.+....                   
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~--~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNT--ADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhccccc--ccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            7777777766554     56666654321  11112345789999999974 444333211                   


Q ss_pred             ----CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccc
Q psy13988        250 ----VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP  325 (358)
Q Consensus       250 ----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  325 (358)
                          ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.......... .....+++.|+|
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a  378 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP  378 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence                123566788899999999999999999999999999999999999999999997654332111 112234789999


Q ss_pred             cccccCCCC---------------------CCCcchHHHHHHHHHHHhhCCC-CC
Q psy13988        326 PELLLGEER---------------------YGPAIDVWSCGCILGELFVKKP-LF  358 (358)
Q Consensus       326 PE~~~~~~~---------------------~~~~~DiwslG~~l~~lltg~~-pF  358 (358)
                      ||.+.....                     ...+.||||+||++|+|++|.. ||
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~  433 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV  433 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence            998753220                     1234799999999999999874 43

>KOG1167|consensus

Probab=99.96  E-value=1e-29  Score=219.63  Aligned_cols=200  Identities=30%  Similarity=0.436  Sum_probs=166.3

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeec---CCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLF---TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      ......|.+++.||.|+|++||++.+..   ..++||+|.+.....    ...+..|+++|..+ .+.||+++.+++.. 
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn-  106 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN-  106 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc-
Confidence            3456778899999999999999999987   789999999876543    34788999999999 78999999777654 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~l  296 (358)
                               ++.+.+|+||++......+..   .++...++.+++.++.||.++|.+||+||||||.|++.+.. ++-.|
T Consensus       107 ---------nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  107 ---------NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             ---------CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceE
Confidence                     668999999999865555544   35688889999999999999999999999999999999865 67899


Q ss_pred             eecccceecccc------------------------------------------CCCCCCCCccccccccccccccCCCC
Q psy13988        297 ADFGLARLYNAE------------------------------------------DRQRPYTNKVITLWYRPPELLLGEER  334 (358)
Q Consensus       297 ~Dfg~~~~~~~~------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~  334 (358)
                      +|||++......                                          ..........||++|.|||++...+.
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            999998721100                                          00111234568999999999988888


Q ss_pred             CCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        335 YGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       335 ~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .+.++||||.|+|++.+++++.||
T Consensus       255 QttaiDiws~GVI~Lslls~~~PF  278 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPF  278 (418)
T ss_pred             cCCccceeeccceeehhhcccccc
Confidence            899999999999999999999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=2e-28  Score=210.21  Aligned_cols=185  Identities=42%  Similarity=0.630  Sum_probs=155.9

Q ss_pred             cceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEEEeecc
Q psy13988        158 GLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYM  237 (358)
Q Consensus       158 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  237 (358)
                      ++|.||++....+++.|++|++........ ...+.+|+..+++++|+|++++++.+..          ....++++|++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------~~~~~l~~e~~   69 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED----------EDKLYLVMEYC   69 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee----------CCEEEEEEeCC
Confidence            578999999988999999999876544322 4578899999999999999999887765          35899999999


Q ss_pred             cc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCC
Q psy13988        238 DH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN  316 (358)
Q Consensus       238 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  316 (358)
                      ++ ++...+.. ...++...+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......   ....
T Consensus        70 ~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~  145 (244)
T smart00220       70 DGGDLFDLLKK-RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTT  145 (244)
T ss_pred             CCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccc
Confidence            98 55554443 3348899999999999999999999999999999999999999999999999998775543   1233


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        317 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       317 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..++..|+|||...+.. ++.++|+||+|+++++|++|..||
T Consensus       146 ~~~~~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~  186 (244)
T smart00220      146 FVGTPEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPF  186 (244)
T ss_pred             ccCCcCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            44588899999887544 788999999999999999999887

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1345|consensus

Probab=99.96  E-value=6.7e-30  Score=208.78  Aligned_cols=196  Identities=25%  Similarity=0.346  Sum_probs=156.5

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....|.|.+.||+|.||.+-++++..+...+++|-+.....   ....|.+|...--.| .|.||+.-+++--+      
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq------   92 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQ------   92 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhh------
Confidence            45678999999999999999999999999999998875532   245788888766666 68899987765443      


Q ss_pred             cccCCCeEEEEeeccc-cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC--CcEEEeec
Q psy13988        223 FRKDKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR--GEVKLADF  299 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~--~~~~l~Df  299 (358)
                         ..+.+++++||++ |+|...+...  .+-|.....++.|++.|+.|||++++||||||.+||||-..  -++|||||
T Consensus        93 ---t~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   93 ---TSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             ---cCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeec
Confidence               3458999999998 5666666543  47788889999999999999999999999999999999543  38999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCC----CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |..+..+.--...     ..+..|-+||.....    -...+.+|+|.||+++|..|||++||
T Consensus       168 G~t~k~g~tV~~~-----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW  225 (378)
T KOG1345|consen  168 GLTRKVGTTVKYL-----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW  225 (378)
T ss_pred             ccccccCceehhh-----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence            9987654332221     126678899876422    12567899999999999999999998

>KOG1027|consensus

Probab=99.96  E-value=8.8e-30  Score=236.27  Aligned_cols=190  Identities=27%  Similarity=0.386  Sum_probs=153.1

Q ss_pred             cccccCCccee-eEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCCC
Q psy13988        151 MEPLAAGGLSL-NNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       151 ~~~lg~G~~g~-v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      .+.+|.|+.|+ ||++..  .++.||||++-.+.     ...+.+|+..|+.- +||||+++++.-          .++.
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E----------~d~q  576 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSE----------QDRQ  576 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeec----------cCCc
Confidence            46789998775 666654  78899999876432     23567999999888 799999996544          3467


Q ss_pred             eEEEEeeccccChHHHHhcC--CCCCCh-HHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CC--cEEEeecc
Q psy13988        229 SFYLVFEYMDHDLMGLLESG--MVDFNE-VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RG--EVKLADFG  300 (358)
Q Consensus       229 ~~~lv~e~~~~~l~~~~~~~--~~~~~~-~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~---~~--~~~l~Dfg  300 (358)
                      +.||..|.|..+|.+.++..  ...... ...+.++.|++.||++||+.+||||||||.||||+.   ++  +++|+|||
T Consensus       577 F~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  577 FLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             eEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            99999999999999998763  111222 456788999999999999999999999999999986   33  78999999


Q ss_pred             cceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhC-CCCC
Q psy13988        301 LARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK-KPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg-~~pF  358 (358)
                      +++.+..+... ....+..||.+|+|||++.... -+.++||||+||++|+.++| .+||
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpF  715 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPF  715 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCC
Confidence            99988655432 3345667899999999998765 57799999999999999986 8998

>KOG0200|consensus

Probab=99.95  E-value=9e-28  Score=230.46  Aligned_cols=203  Identities=26%  Similarity=0.401  Sum_probs=163.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeec-------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLF-------TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVT  215 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  215 (358)
                      ......+.+.||.|.||.|+++....       ....||||.++..... .....+..|+++++.+ +|+||+.+++++.
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            33344567799999999999998531       2468999998866544 4556788999999999 6999999988776


Q ss_pred             ccCcccccccCCCeEEEEeeccc-cChHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHHHhCCceec
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMD-HDLMGLLESGM---------------VDFNEVNNASIMRQLLDGLSYCHKRNFLHR  279 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~  279 (358)
                      .          .+.+++|+||+. |+|+..+....               ..++......++.||+.|++||++..++||
T Consensus       373 ~----------~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR  442 (609)
T KOG0200|consen  373 Q----------DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR  442 (609)
T ss_pred             c----------CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence            5          558999999998 57777776655               348888999999999999999999999999


Q ss_pred             CCCCCCEEecCCCcEEEeecccceeccccCCCC-CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCC
Q psy13988        280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPL  357 (358)
Q Consensus       280 Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~p  357 (358)
                      ||-..|||+..+..+||+|||+++......... ......-...|||||.+.. ..++.++||||+|+++||++| |..|
T Consensus       443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~P  521 (609)
T KOG0200|consen  443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTP  521 (609)
T ss_pred             hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCC
Confidence            999999999999999999999999654433222 1111113566999999987 449999999999999999998 6777


Q ss_pred             C
Q psy13988        358 F  358 (358)
Q Consensus       358 F  358 (358)
                      |
T Consensus       522 Y  522 (609)
T KOG0200|consen  522 Y  522 (609)
T ss_pred             C
Confidence            5

>KOG0576|consensus

Probab=99.95  E-value=4.6e-29  Score=226.21  Aligned_cols=201  Identities=27%  Similarity=0.368  Sum_probs=173.7

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+++.+|.|++|-||+++|..+++..|+|+++......  ..-..+|+-+++.++||||+.+++.|..      
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr------   83 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLR------   83 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhh------
Confidence            55678999999999999999999999999999999999876554  3345689999999999999999998876      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          +..+++.||||+|+.++.+...-+++++.++..+++..+++++|||+.|=+|||||-.||++++.|.+|+.|||.+
T Consensus        84 ----~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   84 ----RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             ----hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCch
Confidence                4479999999999888888788889999999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCcccccccccccccc--CCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLL--GEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      ..+.....  ..-.++||+.|||||+-.  ....|+..+|||++|++..|+---++|
T Consensus       160 aqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp  214 (829)
T KOG0576|consen  160 AQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP  214 (829)
T ss_pred             hhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence            87654322  234678899999999863  334589999999999999888654444

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.3e-26  Score=206.74  Aligned_cols=171  Identities=19%  Similarity=0.125  Sum_probs=129.6

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeec-CCcEEEEEEeecccc---CCCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLF-TDELVALKKVRLENE---KEGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      .......|.+.+.||+|+||.||++.+.. ++..||||++.....   .......+.+|+++++.++|+|+++.+..   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            33566789999999999999999999876 678889998653211   11123457899999999999999853211   


Q ss_pred             cCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEecCCCcEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI-KCSNILMNNRGEVK  295 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dl-kp~Nill~~~~~~~  295 (358)
                                .+..|+||||++|..+.....    ..   ...++.|+++||.|||++||+|||| ||+||+++.+++++
T Consensus        90 ----------~~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         90 ----------TGKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             ----------cCCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEE
Confidence                      125799999999876653311    11   2568899999999999999999999 99999999999999


Q ss_pred             EeecccceeccccCCCCC------CCCccccccccccccccC
Q psy13988        296 LADFGLARLYNAEDRQRP------YTNKVITLWYRPPELLLG  331 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~  331 (358)
                      |+|||+++.+........      .....+++.|+|||.+..
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999999997754431111      134456888999998854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1e-25  Score=188.87  Aligned_cols=185  Identities=38%  Similarity=0.610  Sum_probs=153.3

Q ss_pred             ccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEEE
Q psy13988        154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV  233 (358)
Q Consensus       154 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv  233 (358)
                      ||.|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++++++++++..          ....+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------~~~~~~~   69 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED----------ENHLYLV   69 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec----------CCeEEEE
Confidence            689999999999998889999999988654331 23568899999999999999999777765          3589999


Q ss_pred             eecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEeecccceeccccCCC
Q psy13988        234 FEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-RGEVKLADFGLARLYNAEDRQ  311 (358)
Q Consensus       234 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~-~~~~~l~Dfg~~~~~~~~~~~  311 (358)
                      +|+++| ++...+......++...+..++.++++++.+||+.|++|+||+|.||+++. ++.++|+|||.+........ 
T Consensus        70 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-  148 (215)
T cd00180          70 MEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-  148 (215)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence            999995 555555443346899999999999999999999999999999999999999 89999999999987654431 


Q ss_pred             CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHH
Q psy13988        312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL  351 (358)
Q Consensus       312 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l  351 (358)
                       ......+...|++||........+.++|+|++|+++++|
T Consensus       149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence             122344588899999887653578899999999999886

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1164|consensus

Probab=99.94  E-value=1.1e-25  Score=201.11  Aligned_cols=200  Identities=25%  Similarity=0.255  Sum_probs=161.8

Q ss_pred             CCcccccccCCcceeeEeeeeecCC-cEEEEEEeeccccCCCCchhHHHHHHHHHhCCC----CcccchhhhhcccCccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTD-ELVALKKVRLENEKEGFPITAVREIKILRQLNH----KNIVNLREIVTDKSDAL  221 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~  221 (358)
                      .|.+.+.||+|+||.||.+.+..++ ..+|+|...........  .+..|..++..+..    +++..+++...      
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~------   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR------   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc------
Confidence            8999999999999999999997775 68888887654333211  56678888888863    47777755552      


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-----CcEE
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-----GEVK  295 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-----~~~~  295 (358)
                         ..++..|+||+.++.+|.+...... ..++...+..++.|++.+|++||+.|++||||||+|+++...     ..+.
T Consensus        91 ---~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~  167 (322)
T KOG1164|consen   91 ---STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLY  167 (322)
T ss_pred             ---CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEE
Confidence               2356889999999999988775443 789999999999999999999999999999999999999865     3599


Q ss_pred             Eeecccce--eccccCC-----CCC-CCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLAR--LYNAEDR-----QRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~--~~~~~~~-----~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||+++  .+.....     ... .....||..|+|+.+..+.. .+++.|+||++.++.+++.|..||
T Consensus       168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW  237 (322)
T KOG1164|consen  168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPW  237 (322)
T ss_pred             EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCC
Confidence            99999998  4322211     111 23456899999999998766 899999999999999999999987

>KOG1163|consensus

Probab=99.93  E-value=5.3e-26  Score=183.06  Aligned_cols=201  Identities=26%  Similarity=0.294  Sum_probs=164.7

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCC-CcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH-KNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~  221 (358)
                      ...+.|++++.||.|+||.+|++....+|+.||||.-+.....    .++..|..+.+.+++ ..|..+..+..      
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~------   81 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGT------   81 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcc------
Confidence            4568899999999999999999999999999999976544332    256788999888865 34444433333      


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC---CcEEEee
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLAD  298 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~---~~~~l~D  298 (358)
                          +..+-.+|||.++.+|.+.+.--...++-..++-++-|++.-++|+|.++++||||||+|+|..-+   ..+.|+|
T Consensus        82 ----e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   82 ----EKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             ----ccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEe
Confidence                355789999999999888887666678999999999999999999999999999999999999644   4799999


Q ss_pred             cccceeccccCC-----CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDR-----QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+++.+.+...     ........||.+|+|--...+.. .+.+.|+-|+|.++.++.-|..||
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPW  221 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPW  221 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcc
Confidence            999998754322     23334567899999988877655 688999999999999999999998

>KOG1165|consensus

Probab=99.93  E-value=1.5e-25  Score=188.37  Aligned_cols=201  Identities=20%  Similarity=0.285  Sum_probs=171.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ..+..|++.+.||+|+||..+.+...-+++.||||.-......    -++..|.+..+.| ..+.|...          +
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~v----------Y   90 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQV----------Y   90 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCce----------e
Confidence            5677899999999999999999999999999999976554333    3667788888888 56777766          4


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-----cEEE
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-----EVKL  296 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-----~~~l  296 (358)
                      .+.+.+.+-.+|+|+++.+|.+.+.-....++...+.-++.||+.-++++|++.+|.|||||+|+||...+     .+.+
T Consensus        91 YFGqeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen   91 YFGQEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             eeccccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEE
Confidence            45556778899999999999998877777899999999999999999999999999999999999997544     5899


Q ss_pred             eecccceeccccCCC-----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQ-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||+|+.+.++...     +..-+..||.+||+---..+.. .+.+.|+-|||=++++.|-|..||
T Consensus       171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPW  236 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPW  236 (449)
T ss_pred             EeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCcc
Confidence            999999988765432     2223456799999998888776 799999999999999999999998

>KOG0590|consensus

Probab=99.92  E-value=1e-25  Score=213.68  Aligned_cols=263  Identities=24%  Similarity=0.345  Sum_probs=193.7

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCCCCCCCCCCCCchhhHHHHHHhhhcccCCCcccccccccccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQS  140 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (358)
                      ...+..+.+++.++|..+|..|.+..++-.++|+...+.......                   .......     ....
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n-------------------~~~~~~~-----~~~~  311 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSN-------------------PCADSLT-----IAKS  311 (601)
T ss_pred             ccCChhhhhcccccccCCchhcccccccccccccccccccccccc-------------------ccccccc-----cccC
Confidence            357789999999999999999999999999999986110000000                   0000000     0001


Q ss_pred             CCCCCCCC-cccccccCCcceeeEeeeeecCCcEEEEEEeecc----ccCCCCchhHHHHHHHHHhCCCCcccchhhhhc
Q psy13988        141 NSTNNSSR-PLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLE----NEKEGFPITAVREIKILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       141 ~~~~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  215 (358)
                      .......| .....+|.|.+|.|+.+......+.++.|.+...    .........+..|+.+-..+.|+|++.....+.
T Consensus       312 ~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~  391 (601)
T KOG0590|consen  312 PIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ  391 (601)
T ss_pred             ccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence            11112223 3457899999998888888777766666655421    111111122456777788889999988877776


Q ss_pred             ccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                      +..          ..+-+||||++++...+.. ...+...++..++.|++.|++|||+.||.|||+|++|+++..+|.+|
T Consensus       392 ~~~----------~~~~~mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lk  460 (601)
T KOG0590|consen  392 EID----------GILQSMEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILK  460 (601)
T ss_pred             hcc----------cchhhhhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceE
Confidence            533          2333499999955555544 35788999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCC--CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQ--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||.+.....+...  ....+.+|+..|+|||++.+...-....||||.|+++..|.+|+.||
T Consensus       461 i~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~W  525 (601)
T KOG0590|consen  461 IIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPW  525 (601)
T ss_pred             EeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcc
Confidence            9999999877655544  55677888999999999998875667899999999999999999997

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=1.9e-24  Score=177.64  Aligned_cols=142  Identities=16%  Similarity=0.134  Sum_probs=108.2

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC-------c-----------------hhHHHHHHHHHhCCCCc
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF-------P-----------------ITAVREIKILRQLNHKN  206 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-------~-----------------~~~~~e~~~l~~l~h~n  206 (358)
                      ...||+|++|.||++.+. +|+.||||+++........       .                 .....|+..+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999765321111       0                 12234899999998877


Q ss_pred             ccchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHH-HhCCceecCCCCCC
Q psy13988        207 IVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYC-HKRNFLHRDIKCSN  285 (358)
Q Consensus       207 iv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~L-H~~~i~H~Dlkp~N  285 (358)
                      +.....+..            ...++||||++|+.+.........+++..+..++.|++.+|.++ |+.||+||||||+|
T Consensus        81 v~~p~~~~~------------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~N  148 (190)
T cd05147          81 IPCPEPILL------------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYN  148 (190)
T ss_pred             CCCCcEEEe------------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence            643322111            12389999999865433322235789999999999999999999 79999999999999


Q ss_pred             EEecCCCcEEEeecccceecc
Q psy13988        286 ILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       286 ill~~~~~~~l~Dfg~~~~~~  306 (358)
                      |+++ ++.++|+|||++....
T Consensus       149 Ili~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             EEEE-CCcEEEEEccccccCC
Confidence            9998 5789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=6e-25  Score=218.95  Aligned_cols=153  Identities=21%  Similarity=0.245  Sum_probs=113.5

Q ss_pred             CCC-CcccchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecC
Q psy13988        202 LNH-KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD  280 (358)
Q Consensus       202 l~h-~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~D  280 (358)
                      ++| .||+++++++....  .+. .+...+++++|+++++|.+.+......+++.+++.+++||++||+|||++||+|||
T Consensus        29 ~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGN--LDG-LDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             hhHHHHHHHhhcccCCcc--ccc-cccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            345 57888877763322  011 12346888999999999888876566799999999999999999999999999999


Q ss_pred             CCCCCEEecCCCc-------------------EEEeecccceeccccCC--------------CCCCCCccccccccccc
Q psy13988        281 IKCSNILMNNRGE-------------------VKLADFGLARLYNAEDR--------------QRPYTNKVITLWYRPPE  327 (358)
Q Consensus       281 lkp~Nill~~~~~-------------------~~l~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE  327 (358)
                      |||+||||+..+.                   +|++|||+++.......              ........+|+.|+|||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            9999999965444                   45555555543211000              00011235688899999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        328 LLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       328 ~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.+.. ++.++|||||||++|||++|.+||
T Consensus       186 ~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~  215 (793)
T PLN00181        186 EDNGSS-SNCASDVYRLGVLLFELFCPVSSR  215 (793)
T ss_pred             hhccCC-CCchhhhhhHHHHHHHHhhCCCch
Confidence            988665 899999999999999999998875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2e-24  Score=179.33  Aligned_cols=182  Identities=10%  Similarity=0.099  Sum_probs=133.9

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC-chh------HHHHHHHHHhCCCCcccchhhhh
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF-PIT------AVREIKILRQLNHKNIVNLREIV  214 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~------~~~e~~~l~~l~h~niv~~~~~~  214 (358)
                      +...++|++++.||.|+||.||++.+  ++..+|||.+......... ...      +.+|+..+.++.|++|..+.+++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            34678999999999999999999655  5778999998754322211 112      56899999999999999998876


Q ss_pred             cccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcE
Q psy13988        215 TDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       215 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~  294 (358)
                      ....  ...+...+..++||||++|..+..+.    .+++    ....+++.++..+|+.|++|+|++|.||+++.+| +
T Consensus       105 ~~~~--~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        105 LLAE--RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             eecc--cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence            6532  22222345789999999996555442    2333    3466999999999999999999999999999988 9


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHH
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL  351 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l  351 (358)
                      +|+|||.........               |-+.+.....++.++|+||||+++..+
T Consensus       174 ~liDfg~~~~~~e~~---------------a~d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        174 RIIDLSGKRCTAQRK---------------AKDRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             EEEECCCcccccchh---------------hHHHHHHHhHhcccccccceeEeehHH
Confidence            999999876542111               111122233366899999999987654

>KOG1024|consensus

Probab=99.90  E-value=3.4e-24  Score=183.78  Aligned_cols=205  Identities=20%  Similarity=0.231  Sum_probs=158.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecC-----CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFT-----DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ....+.++...+-+|.||.||.+.....     .+.|.+|.++... .+-....++.|.-.+..+.|||+..+.++... 
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie-  358 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-  358 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEee-
Confidence            3445566777899999999999965332     3567777665442 22233466789899999999999999887764 


Q ss_pred             CcccccccCCCeEEEEeeccc-cChHHHHh-----c--CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec
Q psy13988        218 SDALDFRKDKGSFYLVFEYMD-HDLMGLLE-----S--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN  289 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~  289 (358)
                              +....++++.+.+ |+|..++.     +  .-..++..+...++.|++.|++|||+.|++|.||...|.+||
T Consensus       359 --------~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  359 --------DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID  430 (563)
T ss_pred             --------ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh
Confidence                    3446788888887 45555554     1  112367777888999999999999999999999999999999


Q ss_pred             CCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       290 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +.-++||+|=.+++-.-+.+..-..++......|||||.+.+.. |+.++|+||||+++|||+| |+.||
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~Py  499 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPY  499 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCc
Confidence            99999999999988665554443334445578899999998765 9999999999999999998 77775

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=3.2e-23  Score=171.07  Aligned_cols=142  Identities=17%  Similarity=0.147  Sum_probs=109.6

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC------------------------chhHHHHHHHHHhCCCC
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF------------------------PITAVREIKILRQLNHK  205 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~  205 (358)
                      +.+.||+|++|.||++.+. +|+.||||+++........                        .....+|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999998865321000                        11234688899999888


Q ss_pred             cccchhhhhcccCcccccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCC
Q psy13988        206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKC  283 (358)
Q Consensus       206 niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp  283 (358)
                      ++.....+...            ..|+||||++|. +...... ...++...+..++.|++.++.++|+ .||+|+||||
T Consensus        80 ~i~~p~~~~~~------------~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP  146 (190)
T cd05145          80 GVPVPEPILLK------------KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSE  146 (190)
T ss_pred             CCCCceEEEec------------CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCh
Confidence            87543222111            248999999986 3333222 2467888999999999999999999 9999999999


Q ss_pred             CCEEecCCCcEEEeecccceecc
Q psy13988        284 SNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       284 ~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      +||+++ ++.++|+|||++....
T Consensus       147 ~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         147 YNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             hhEEEE-CCCEEEEEcccceecC
Confidence            999999 8899999999998664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=1.9e-22  Score=181.09  Aligned_cols=198  Identities=36%  Similarity=0.514  Sum_probs=165.1

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCCCC-cccchhhhhcccCccccccc
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLNHK-NIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  225 (358)
                      |.+.+.||.|+|+.||.+.+.   ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+.+..         
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~---------   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD---------   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec---------
Confidence            678889999999999999987   8899999887655543 456788999999999988 79999777743         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCC---CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeeccc
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMV---DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGL  301 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg~  301 (358)
                       ....+++++++.+..+..+.....   .++......++.|++.++.++|+.+++|||+||+||+++..+ .++++|||.
T Consensus        70 -~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~  148 (384)
T COG0515          70 -EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGL  148 (384)
T ss_pred             -CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCc
Confidence             345899999999865554444332   689999999999999999999999999999999999999998 799999999


Q ss_pred             ceeccccCCCC----CCCCccccccccccccccCC--CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQR----PYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +..........    ......++..|++||.+.+.  ...+...|+||+|++++++++|..||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~  211 (384)
T COG0515         149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF  211 (384)
T ss_pred             ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            98655443221    34566789999999999874  45889999999999999999999885

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.7e-22  Score=164.27  Aligned_cols=186  Identities=18%  Similarity=0.069  Sum_probs=136.2

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC--chhHHHHHHHHHhCC-CCcccchhhhhcccCcccccccC
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF--PITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      +...|+.|+||+|+++..  .+.+++.+.+.........  ...+.+|+++|+++. ++++++++++             
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-------------   70 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-------------   70 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-------------
Confidence            567899999999997765  7889998877755432211  124678999999995 5778888553             


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEecCCCcEEEeecccceec
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI-KCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dl-kp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       +..+++|||+.|..+......       ....++.|++.+|+++|++||+|||| ||+||+++.++.++|+|||++...
T Consensus        71 -~~~~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         71 -DGRHLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             -cCEEEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence             146899999999665433211       12457889999999999999999999 799999999999999999999865


Q ss_pred             cccCCC----CC-------CCCccccccccccccccCCCCCC-CcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQ----RP-------YTNKVITLWYRPPELLLGEERYG-PAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~----~~-------~~~~~~~~~y~aPE~~~~~~~~~-~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......    ..       ......++.+++|+.-.-....+ .+.++++.|+-+|.++|+..|+
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            543311    00       00112377788887654322233 4678889999999999998764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.87  E-value=4.2e-22  Score=162.77  Aligned_cols=104  Identities=26%  Similarity=0.346  Sum_probs=90.4

Q ss_pred             cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCcc
Q psy13988        239 HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKV  318 (358)
Q Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  318 (358)
                      |+|.+.+......+++..++.++.|++.||.|||+.+      ||+||+++.++.+++  ||++.......       ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-------CC
Confidence            4566666655567999999999999999999999998      999999999999999  99988764322       24


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        319 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       319 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus        66 g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~  104 (176)
T smart00750       66 VDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPY  104 (176)
T ss_pred             CcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCc
Confidence            689999999998655 889999999999999999999997

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=3.2e-22  Score=171.16  Aligned_cols=206  Identities=20%  Similarity=0.216  Sum_probs=129.7

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCCC----------Ccccchhhhhcc
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLNH----------KNIVNLREIVTD  216 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h----------~niv~~~~~~~~  216 (358)
                      ....+.||.|+++.||.+.|..+++.+|+|++........ ..+.+.+|.-....+.+          -.++..++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            3456799999999999999999999999999877653322 22344455544444322          123333333322


Q ss_pred             cCcc--cccccCCC-----eEEEEeeccccChHHHHh---cCCCC---CChHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy13988        217 KSDA--LDFRKDKG-----SFYLVFEYMDHDLMGLLE---SGMVD---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC  283 (358)
Q Consensus       217 ~~~~--~~~~~~~~-----~~~lv~e~~~~~l~~~~~---~~~~~---~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp  283 (358)
                      ....  +....+..     ..+++|+-+.++|...+.   .....   +.......+..|+++.+++||+.|++|+||+|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~  173 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP  173 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence            2111  11111112     347888988888766652   11111   22333345668999999999999999999999


Q ss_pred             CCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCC-------CCCCCcchHHHHHHHHHHHhhCCC
Q psy13988        284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE-------ERYGPAIDVWSCGCILGELFVKKP  356 (358)
Q Consensus       284 ~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~~l~~lltg~~  356 (358)
                      +|++++.+|.++|+||+.....+.....     ...+..|.|||.....       -.++.+.|.|+||+++|.|.||..
T Consensus       174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999999999999988766543221     2235779999976432       236789999999999999999999


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       249 Pf  250 (288)
T PF14531_consen  249 PF  250 (288)
T ss_dssp             ST
T ss_pred             CC
Confidence            98

>KOG1166|consensus

Probab=99.86  E-value=4.1e-21  Score=186.31  Aligned_cols=205  Identities=18%  Similarity=0.162  Sum_probs=159.1

Q ss_pred             cccccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC---CCcccch
Q psy13988        134 AAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNL  210 (358)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~  210 (358)
                      ...+.......+..|.|-+.||+|+||.||.|.... |+.||+|+-+.....+.+.     =.+++.+|+   -+.|..+
T Consensus       686 ~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~  759 (974)
T KOG1166|consen  686 KLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHI  759 (974)
T ss_pred             ccCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHH
Confidence            334555666788889999999999999999999877 9999999866555443322     234444554   2344444


Q ss_pred             hhhhcccCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec
Q psy13988        211 REIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN  289 (358)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~  289 (358)
                      ...+.-          .+.-++|+||.+. +|++.+. ....+++..+..+..||+..+++||..+|||+||||+|+||.
T Consensus       760 ~~a~~~----------~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~  828 (974)
T KOG1166|consen  760 SSAHVF----------QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLR  828 (974)
T ss_pred             HHHHcc----------CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEee
Confidence            444433          3356899999985 5666554 667899999999999999999999999999999999999994


Q ss_pred             CC-------CcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCC
Q psy13988        290 NR-------GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP  356 (358)
Q Consensus       290 ~~-------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~  356 (358)
                      ..       .-++|+|||.+--+..-.....+...+.|-.+-.+|+..|.. |++.+|.|.|+.+++.||.|++
T Consensus       829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            32       358999999987554444444556667799999999988766 9999999999999999999974

>KOG0603|consensus

Probab=99.85  E-value=1.4e-22  Score=184.30  Aligned_cols=187  Identities=27%  Similarity=0.300  Sum_probs=155.8

Q ss_pred             cccCCcceeeEeeee---ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCcccccccCCC
Q psy13988        153 PLAAGGLSLNNFSVS---LFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       153 ~lg~G~~g~v~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      ++|.|.+|.|++++-   ...+.-||.|..++.............|..++..++ ||.++++...++.          .+
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt----------~~   70 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT----------DG   70 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc----------cc
Confidence            479999999998874   345778999988877655444445667888888886 9999999777665          55


Q ss_pred             eEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecccc
Q psy13988        229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE  308 (358)
Q Consensus       229 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~  308 (358)
                      ..++++++..|+.+-........+.+.....+...++.|++++|+.+++|+|+|++||+++.+|++++.|||.++..-..
T Consensus        71 kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   71 KLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             chhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence            88999999998555544455556788888889999999999999999999999999999999999999999999876544


Q ss_pred             CCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       309 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ...      +||..|||||++.+   ...++|.||+|+++++|+||..||
T Consensus       151 ~~~------cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf  191 (612)
T KOG0603|consen  151 KIA------CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPF  191 (612)
T ss_pred             hhc------ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCC
Confidence            322      77999999999972   678899999999999999999998

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=1.2e-20  Score=160.30  Aligned_cols=151  Identities=17%  Similarity=0.137  Sum_probs=112.0

Q ss_pred             CCCCcccccccCCcceeeEeee-eecCCcEEEEEEeeccccCCC----------------------CchhHHHHHHHHHh
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSV-SLFTDELVALKKVRLENEKEG----------------------FPITAVREIKILRQ  201 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~~vaiK~~~~~~~~~~----------------------~~~~~~~e~~~l~~  201 (358)
                      +.-|.+.+.||+|++|.||+|. +..+|+.||||+++.......                      ....+.+|+..+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3457888999999999999999 678999999999876532100                      00124579999999


Q ss_pred             CCCCcccchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCC-ceecC
Q psy13988        202 LNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN-FLHRD  280 (358)
Q Consensus       202 l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~D  280 (358)
                      +.+.. +....++..           ...++||||++|..+.........+....+..++.||+.++.+||+.| ++|+|
T Consensus       107 L~~~~-i~~p~~~~~-----------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~D  174 (237)
T smart00090      107 LYEAG-VPVPKPIAW-----------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGD  174 (237)
T ss_pred             HHhcC-CCCCeeeEe-----------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCC
Confidence            86532 222111111           124799999999654433322335666777899999999999999999 99999


Q ss_pred             CCCCCEEecCCCcEEEeecccceecccc
Q psy13988        281 IKCSNILMNNRGEVKLADFGLARLYNAE  308 (358)
Q Consensus       281 lkp~Nill~~~~~~~l~Dfg~~~~~~~~  308 (358)
                      |||+||+++ ++.++|+|||.+.....+
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhccCCc
Confidence            999999999 889999999998765443

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=4.5e-20  Score=153.00  Aligned_cols=138  Identities=20%  Similarity=0.240  Sum_probs=103.6

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-----CCCcccchhhhhcccCccccccc
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-----NHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+.||+|+++.||.  ++.++.. +||++......  ....+.+|+.+++.+     .||||+++++++.+..       
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~-------   74 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC-------   74 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC-------
Confidence            46899999999995  7667666 69988754322  245688999999999     5799999999887632       


Q ss_pred             CCCeEE-EEeeccc--c-ChHHHHhcCCCCCChHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCEEecCC----CcEEE
Q psy13988        226 DKGSFY-LVFEYMD--H-DLMGLLESGMVDFNEVNNASIMRQLLDGL-SYCHKRNFLHRDIKCSNILMNNR----GEVKL  296 (358)
Q Consensus       226 ~~~~~~-lv~e~~~--~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al-~~LH~~~i~H~Dlkp~Nill~~~----~~~~l  296 (358)
                      ..+.++ +|+||.+  + +|.+.+.+.  .+++.  ..++.|++.++ +|||+++|+||||||+||+++..    ++++|
T Consensus        75 g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         75 GTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             CCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence            123434 7899954  4 565666442  35555  35678888887 99999999999999999999743    37999


Q ss_pred             ee-ccccee
Q psy13988        297 AD-FGLARL  304 (358)
Q Consensus       297 ~D-fg~~~~  304 (358)
                      +| ||....
T Consensus       151 iDg~G~~~~  159 (210)
T PRK10345        151 CDNIGESTF  159 (210)
T ss_pred             EECCCCcce
Confidence            99 554443

>KOG4158|consensus

Probab=99.81  E-value=1.2e-19  Score=156.62  Aligned_cols=154  Identities=25%  Similarity=0.364  Sum_probs=116.4

Q ss_pred             CCCcccchhhhhcccCccc-----------------ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHH
Q psy13988        203 NHKNIVNLREIVTDKSDAL-----------------DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL  265 (358)
Q Consensus       203 ~h~niv~~~~~~~~~~~~~-----------------~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~  265 (358)
                      +|||||++...|.+.-..+                 .-..++..+|+||..++.+|...+..+  ..+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHH
Confidence            6999999999887753211                 112345689999999999988888654  356777788999999


Q ss_pred             HHHHHHHhCCceecCCCCCCEEec--CCC--cEEEeecccceeccccCCCCCC----CCccccccccccccccCCCCC--
Q psy13988        266 DGLSYCHKRNFLHRDIKCSNILMN--NRG--EVKLADFGLARLYNAEDRQRPY----TNKVITLWYRPPELLLGEERY--  335 (358)
Q Consensus       266 ~al~~LH~~~i~H~Dlkp~Nill~--~~~--~~~l~Dfg~~~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~--  335 (358)
                      +|+.|||++||.|||+|.+||++.  +++  .+.|.|||++..-........+    ...-|....||||+.......  
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999994  333  6899999998754443222222    122346668999988643211  


Q ss_pred             ---CCcchHHHHHHHHHHHhhCCCCC
Q psy13988        336 ---GPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       336 ---~~~~DiwslG~~l~~lltg~~pF  358 (358)
                         -.++|.|+.|.+.||+++..-||
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPF  457 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPF  457 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcc
Confidence               13799999999999999999888

>KOG1240|consensus

Probab=99.79  E-value=7.6e-20  Score=175.24  Aligned_cols=197  Identities=26%  Similarity=0.344  Sum_probs=147.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHH---HHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR---EIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+...+.||.+.|=.|.++.+..  -.|+||++-..... -....+.+   |+. ...+++||++++.-+-..       
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e--G~vVvKVFvk~~p~-~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t-------   92 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE--GLVVVKVFVKQDPT-ISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT-------   92 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC--ceEEEEEEeccCCC-CCchHHHHHHHHHH-HHhhcCCcccchHHHHHh-------
Confidence            67778999999999999888733  34999998765422 22233433   444 555699999999655433       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ++..|+|-+|+..+|.+.+..+ .-+...+..-|+-||+.||..+|..||+|+|||.+||||+.=+.+.|.||..-+
T Consensus        93 ---~kAAylvRqyvkhnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen   93 ---DKAAYLVRQYVKHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             ---hHHHHHHHHHHhhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC
Confidence               4567899999999999988544 357777888899999999999999999999999999999999999999998765


Q ss_pred             ecccc-----CCCCCCCCccccccccccccccCCC----------CCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        304 LYNAE-----DRQRPYTNKVITLWYRPPELLLGEE----------RYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       304 ~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~----------~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ..--+     +...-++.......|.|||.+....          ..+++-||||+||++.||++ |++||
T Consensus       169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF  239 (1431)
T KOG1240|consen  169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF  239 (1431)
T ss_pred             CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence            33111     1111122223356699999986421          25678999999999999998 68887

>KOG0659|consensus

Probab=99.79  E-value=9.6e-20  Score=149.09  Aligned_cols=95  Identities=40%  Similarity=0.669  Sum_probs=81.5

Q ss_pred             CCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         11 WANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        11 ~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ||++|+|||.+||++||||++++|+.++.+|.|..+..  ....++..+|+.++++++|||.+|+.+||.+|++|.|+|.
T Consensus       203 pG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~--~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  203 PGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ--FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             CCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc--CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            67888999999999999999999999999999987663  2234466799999999999999999999999999999999


Q ss_pred             CcccccCCCCCCCCCCCC
Q psy13988         91 SVWLKNVHPESMPPPQLP  108 (358)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~  108 (358)
                      |+||... |.++.+..+|
T Consensus       281 ~~yf~~~-P~pt~~~~lp  297 (318)
T KOG0659|consen  281 HPYFKSL-PLPTPPSKLP  297 (318)
T ss_pred             chhhhcC-CCCCChhhCc
Confidence            9999984 4444554444

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.1e-18  Score=145.07  Aligned_cols=139  Identities=18%  Similarity=0.213  Sum_probs=105.3

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC--------------------CchhHHHHHHHHHhCCCCc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG--------------------FPITAVREIKILRQLNHKN  206 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~h~n  206 (358)
                      .|.+.+.||.|++|.||.+... +|+.||||++........                    ......+|+.++..+.+++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4778899999999999999874 899999998765431100                    0112467888888887764


Q ss_pred             c--cchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy13988        207 I--VNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS  284 (358)
Q Consensus       207 i--v~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~  284 (358)
                      +  ...++              ....++||||++|..+..+..      ......++.+++.++.++|+.|++|+||+|+
T Consensus        95 i~v~~~~~--------------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~  154 (198)
T cd05144          95 FPVPKPID--------------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEF  154 (198)
T ss_pred             CCCCceee--------------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcc
Confidence            3  22211              124589999999866554422      1345678899999999999999999999999


Q ss_pred             CEEecCCCcEEEeecccceecc
Q psy13988        285 NILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       285 Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ||+++.++.++|+|||++....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2e-18  Score=145.22  Aligned_cols=138  Identities=18%  Similarity=0.227  Sum_probs=106.9

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC------chhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF------PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ++.||+|++|.||++..  .+..|++|+..........      ...+.+|+.++..+.|+++.....++.+        
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--------   70 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--------   70 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--------
Confidence            36799999999999986  7888999976543222111      1245679999999999988766544432        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ....++||||++|..+..+.....   . ....++.+++.+|.++|+.+++|+|++|.||+++ ++.++|+|||.+..
T Consensus        71 --~~~~~lv~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         71 --PENFIIVMEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             --CCCCEEEEEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence              346789999999855554433221   2 7788999999999999999999999999999999 78999999999875


Q ss_pred             c
Q psy13988        305 Y  305 (358)
Q Consensus       305 ~  305 (358)
                      .
T Consensus       144 ~  144 (211)
T PRK14879        144 S  144 (211)
T ss_pred             C
Confidence            3

>KOG0195|consensus

Probab=99.76  E-value=1.3e-18  Score=143.17  Aligned_cols=196  Identities=16%  Similarity=0.201  Sum_probs=151.9

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +...+...++..|.+...|..|+++.  .|..+++|+++...........|.+|.-.|+-+.||||+.+++.+..+.   
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp---  260 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP---  260 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC---
Confidence            34445556778899999999998885  6678888998887766666678889999999999999999998888765   


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                             .+.++..|++- +|...+... +...+..++.+++.++++|++|||+..  |.---|....|++|++...+|+
T Consensus       261 -------nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  261 -------NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             -------CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee
Confidence                   68899999985 555555432 334788899999999999999999864  5555688899999998765543


Q ss_pred             --ecccceeccccCCCCCCCCccccccccccccccCCCC--CCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 --DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 --Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                        |--++...         .+....|.||+||.+.....  .-.++|+|||++++|||-|...||
T Consensus       334 mad~kfsfqe---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf  389 (448)
T KOG0195|consen  334 MADTKFSFQE---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF  389 (448)
T ss_pred             cccceeeeec---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence              43333221         23334889999999975432  235799999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=6.6e-18  Score=139.29  Aligned_cols=135  Identities=19%  Similarity=0.204  Sum_probs=94.0

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhH----------------------HHHHHHHHhCCCCc-
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITA----------------------VREIKILRQLNHKN-  206 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~n-  206 (358)
                      +.+.||+|++|.||.+.+. +++.||||++.............                      ..|...+..+.+.. 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3568999999999999986 89999999987543221111111                      12333333332221 


Q ss_pred             -ccchhhhhcccCcccccccCCCeEEEEeeccccC-----hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceec
Q psy13988        207 -IVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-----LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHR  279 (358)
Q Consensus       207 -iv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-----l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~  279 (358)
                       +.++++              ....++||||++|+     .+.....      ...+..++.+++.++.++|+ .+++|+
T Consensus        80 ~~~~~~~--------------~~~~~lv~e~~~g~~~~~~~l~~~~~------~~~~~~~~~~~~~~l~~lh~~~~ivH~  139 (187)
T cd05119          80 PVPKPID--------------LNRHVLVMEFIGGDGIPAPRLKDVRL------LEDPEELYDQILELMRKLYREAGLVHG  139 (187)
T ss_pred             CCCceEe--------------cCCCEEEEEEeCCCCccChhhhhhhh------cccHHHHHHHHHHHHHHHhhccCcCcC
Confidence             111111              12358999999982     2222211      15678899999999999999 999999


Q ss_pred             CCCCCCEEecCCCcEEEeecccceecc
Q psy13988        280 DIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       280 Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ||||+||+++ ++.++|+|||.+....
T Consensus       140 Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         140 DLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCChhhEEEE-CCcEEEEECccccccc
Confidence            9999999999 8999999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=6.9e-18  Score=140.63  Aligned_cols=133  Identities=18%  Similarity=0.232  Sum_probs=100.3

Q ss_pred             cccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC------chhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        153 PLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF------PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       153 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .||+|++|.||++.  .++..|++|...........      ...+.+|++++..+.|+++.....++..          
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----------   68 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD----------   68 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE----------
Confidence            48999999999998  47789999986543222111      1345679999999988775544333222          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      ....++||||++|..+..+......       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus        69 ~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        69 PDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            3356899999998655544322111       7899999999999999999999999999999 889999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0660|consensus

Probab=99.74  E-value=1.1e-18  Score=149.11  Aligned_cols=106  Identities=30%  Similarity=0.378  Sum_probs=89.1

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCC-CCcccccccccccccCCChhHHHHHhhhcCCCCCC
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTI-KPKKIHRRRLREEFSLMPPGALDLLDKMLELDPER   81 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~   81 (358)
                      .|+.+|.  |++.++||.+|++++|||+++.+..+.+-.....+ +.++..+.+|..+||+++++|+|||.+||++||.+
T Consensus       223 ~gkplFp--G~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~k  300 (359)
T KOG0660|consen  223 TGKPLFP--GKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKK  300 (359)
T ss_pred             cCCCCCC--CCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccc
Confidence            5677774  57789999999999999999999887754333222 35667788999999999999999999999999999


Q ss_pred             cCCHhhhhcCcccccCCCCCCCCCCCCCc
Q psy13988         82 RITAEQALKSVWLKNVHPESMPPPQLPTW  110 (358)
Q Consensus        82 R~~~~~~l~~~~~~~~~~~~~~~~~~~~~  110 (358)
                      |+|++|||.|||+..++.+..+|.+.+.+
T Consensus       301 Rita~eAL~hPYl~~~hdp~dEP~~~~~~  329 (359)
T KOG0660|consen  301 RITAEEALAHPYLAPYHDPEDEPVCQPIF  329 (359)
T ss_pred             cCCHHHHhcChhhhhhcCCccCCCCCCCC
Confidence            99999999999999999888777555543

>KOG0606|consensus

Probab=99.72  E-value=4.8e-18  Score=162.70  Aligned_cols=167  Identities=28%  Similarity=0.400  Sum_probs=121.1

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ......+..++.+..|++|.||++++..+...+|+| +++.+.             +++     ||..+.          
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------------ilR-----nilt~a----------  129 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------------ILR-----NILTFA----------  129 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------------hhh-----cccccc----------
Confidence            345567889999999999999999999999999994 454321             111     132221          


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                            +..+.|     |+-...+ .+.++++..        ++.|++|||+.||+|||+||+|.+|..-|++|+.|||+
T Consensus       130 ------~npfvv-----gDc~tll-k~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgL  189 (1205)
T KOG0606|consen  130 ------GNPFVV-----GDCATLL-KNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGL  189 (1205)
T ss_pred             ------CCccee-----chhhhhc-ccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhh
Confidence                  122333     3322322 333344443        38899999999999999999999999999999999999


Q ss_pred             ceeccccCC------------CCCCC-CccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDR------------QRPYT-NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~------------~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.......            ..... ..++||.|.|||++...+ |...+|+|++|+|+|+.+-|+.||
T Consensus       190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpf  258 (1205)
T KOG0606|consen  190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPF  258 (1205)
T ss_pred             hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeec
Confidence            774321110            01111 236799999999998666 899999999999999999999998

>KOG0663|consensus

Probab=99.72  E-value=6.8e-18  Score=142.57  Aligned_cols=109  Identities=34%  Similarity=0.590  Sum_probs=91.5

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCC--ChhHHHHHhhhcCCCCC
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLM--PPGALDLLDKMLELDPE   80 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ll~~~l~~~p~   80 (358)
                      .++.+|+|  ++++|||.+||++||||++.+|+++..+|..+...++...-.+++..|+..  +..++|||..||.+||.
T Consensus       273 ~~kPlf~G--~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~  350 (419)
T KOG0663|consen  273 TQKPLFPG--KSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG  350 (419)
T ss_pred             hcCCCCCC--CchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc
Confidence            45666655  666999999999999999999999999998877777666667799999865  49999999999999999


Q ss_pred             CcCCHhhhhcCcccccCCCCCCCCCCCCCchhhH
Q psy13988         81 RRITAEQALKSVWLKNVHPESMPPPQLPTWQDCH  114 (358)
Q Consensus        81 ~R~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  114 (358)
                      +|+||.++|+|.||.+. |.+.+|...|+|+...
T Consensus       351 kR~tA~~~L~h~~F~e~-P~p~~P~~~Pt~P~k~  383 (419)
T KOG0663|consen  351 KRITAEDGLKHEYFRET-PLPIDPSMFPTWPAKS  383 (419)
T ss_pred             ccccHHHhhcccccccC-CCCCChhhcCCCcccc
Confidence            99999999999999984 4566666777775543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=4.1e-17  Score=155.66  Aligned_cols=142  Identities=15%  Similarity=0.165  Sum_probs=105.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC------CCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE------GFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ....|...+.||+|+||.||++...  +..+++|+........      .....+.+|+++++.++|++++....+..+ 
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-  407 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-  407 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-
Confidence            3444556789999999999998763  4445555432221111      112356789999999999998876544333 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                               ....++||||++|..+.....        ....++.+++.+|.+||+.|++||||||+||++ .++.++|+
T Consensus       408 ---------~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~li  469 (535)
T PRK09605        408 ---------PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLI  469 (535)
T ss_pred             ---------CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEE
Confidence                     335689999999855544432        356789999999999999999999999999999 67899999


Q ss_pred             ecccceecc
Q psy13988        298 DFGLARLYN  306 (358)
Q Consensus       298 Dfg~~~~~~  306 (358)
                      |||+++...
T Consensus       470 DFGla~~~~  478 (535)
T PRK09605        470 DFGLGKYSD  478 (535)
T ss_pred             eCcccccCC
Confidence            999998653

>KOG0600|consensus

Probab=99.72  E-value=1.6e-17  Score=147.45  Aligned_cols=124  Identities=44%  Similarity=0.686  Sum_probs=106.9

Q ss_pred             CCCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCC
Q psy13988          2 FSGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPER   81 (358)
Q Consensus         2 ~~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~   81 (358)
                      |.|+..+  +|++|++||.+|+++||+|+++.|+ ...+|.+.........+..+++.|...++.+++||..||.+||.+
T Consensus       314 ~~gkPI~--~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~k  390 (560)
T KOG0600|consen  314 FLGKPIL--QGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDK  390 (560)
T ss_pred             HcCCCCc--CCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccc
Confidence            4455555  4578899999999999999999999 888888777777777788899999999999999999999999999


Q ss_pred             cCCHhhhhcCcccccCCCCCCCCCCCCCchhhHHHHHHhhhcccCCCc
Q psy13988         82 RITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDP  129 (358)
Q Consensus        82 R~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  129 (358)
                      |.||.++|.|+||.. .+.++.++.+|.+.++++.+.+.++.+.+...
T Consensus       391 R~tA~~aL~seyF~t-~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~  437 (560)
T KOG0600|consen  391 RGTASSALQSEYFTT-EPLPCDPSSLPKYPPSHELDAKRRREQKRRNK  437 (560)
T ss_pred             cccHHHHhcCccccc-CCCCCCcccCCCCCcchhHHHHHHHHHhhccc
Confidence            999999999999954 56778888999999999999888776655543

>KOG0590|consensus

Probab=99.69  E-value=3.8e-18  Score=162.35  Aligned_cols=205  Identities=28%  Similarity=0.443  Sum_probs=165.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeee-cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSL-FTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  221 (358)
                      ....|.+.+.||+|+++.|-..... .....+|.|.+...............|..+-+.+. |.|++.+++...+     
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-----   92 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-----   92 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-----
Confidence            4677889999999999999888874 34567788877766534434445556777777776 9999999777765     


Q ss_pred             ccccCCCeEEEEeeccccC-hHHHH-hcCCCCCChHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEecCCC-cEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDHD-LMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCH-KRNFLHRDIKCSNILMNNRG-EVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~-l~~~~-~~~~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~Dlkp~Nill~~~~-~~~l~  297 (358)
                           ....++++++..|+ +.... .......+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.
T Consensus        93 -----~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~  167 (601)
T KOG0590|consen   93 -----PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIA  167 (601)
T ss_pred             -----CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCC
Confidence                 44789999998874 44444 333326777888899999999999999 99999999999999999999 99999


Q ss_pred             ecccceeccc-cCCCCCCCCccc-cccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNA-EDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||+|..+.. ..........+| ++.|+|||...+........|+||+|+++.-+++|..||
T Consensus       168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~  230 (601)
T KOG0590|consen  168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPW  230 (601)
T ss_pred             CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCc
Confidence            9999998876 444445556677 999999999987666778999999999999999999886

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=2.5e-16  Score=134.18  Aligned_cols=142  Identities=18%  Similarity=0.137  Sum_probs=101.3

Q ss_pred             cccc-CCcceeeEeeeeecCCcEEEEEEeecccc-----C------CCCchhHHHHHHHHHhCCCCcc--cchhhhhccc
Q psy13988        152 EPLA-AGGLSLNNFSVSLFTDELVALKKVRLENE-----K------EGFPITAVREIKILRQLNHKNI--VNLREIVTDK  217 (358)
Q Consensus       152 ~~lg-~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  217 (358)
                      ..|| .|+.|+||++..  .+..++||++.....     .      ......+.+|++++..+.|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4676 788888988876  478999998864321     1      1223457789999999988875  4554443221


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                      .      ......++|||+++| ..+..+... ..+++.    .+.+|+.++.+||++||+|+||||+|||++.++.++|
T Consensus       115 ~------~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 H------GLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             c------CcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEE
Confidence            1      001234699999997 344433322 244443    3678999999999999999999999999999999999


Q ss_pred             eecccceecc
Q psy13988        297 ADFGLARLYN  306 (358)
Q Consensus       297 ~Dfg~~~~~~  306 (358)
                      +|||.+....
T Consensus       184 IDfg~~~~~~  193 (239)
T PRK01723        184 IDFDRGELRT  193 (239)
T ss_pred             EECCCcccCC
Confidence            9999987643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1e-15  Score=121.52  Aligned_cols=132  Identities=20%  Similarity=0.223  Sum_probs=105.6

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCC--CcccchhhhhcccCcccccccCC
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH--KNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      +++.|+.|.++.||++....  ..+++|.+.....    ...+.+|+..++.+++  .++.+++.+...          .
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~----------~   65 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES----------D   65 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC----------C
Confidence            46789999999999999743  7899998765432    3467889999999976  477777554433          4


Q ss_pred             CeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR---NFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      +..+++|||+.|..+..+       +......++.+++.+++.+|..   +++|+|++|+||+++..+.++++||+.+..
T Consensus        66 ~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          66 GWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            578999999988544322       4556677899999999999985   799999999999999989999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1033|consensus

Probab=99.64  E-value=9.1e-17  Score=143.96  Aligned_cols=122  Identities=27%  Similarity=0.506  Sum_probs=102.4

Q ss_pred             CeEEEEeeccccC-hHHHHhc--CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        228 GSFYLVFEYMDHD-LMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       228 ~~~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .++||.|++|.-+ |-+++..  .....+......++.|++.|++|   ++.+|+|+||.||+...+..++|.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            4689999999964 4445532  22346777888999999999999   9999999999999999999999999999987


Q ss_pred             ccccC----CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh
Q psy13988        305 YNAED----RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV  353 (358)
Q Consensus       305 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt  353 (358)
                      .....    .....+..+||..||+||.+.+.. |+.++||||||++++||+.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLI  457 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHH
Confidence            76554    223456778899999999999876 9999999999999999987

>KOG0662|consensus

Probab=99.64  E-value=3.8e-16  Score=121.01  Aligned_cols=86  Identities=30%  Similarity=0.417  Sum_probs=77.0

Q ss_pred             CCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         11 WANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        11 ~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ||.|..|||.+|+++||+|+++.|+.++.+|.|.-...-. ....|.++.|..++.+.|||+++|.-+|.+|++|+.+|+
T Consensus       204 pg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~yp-attswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  204 PGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYP-ATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcc-ccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            6788899999999999999999999999999987654322 245699999999999999999999999999999999999


Q ss_pred             CcccccC
Q psy13988         91 SVWLKNV   97 (358)
Q Consensus        91 ~~~~~~~   97 (358)
                      ||||...
T Consensus       283 hpyf~d~  289 (292)
T KOG0662|consen  283 HPYFSDF  289 (292)
T ss_pred             Ccccccc
Confidence            9999864

>KOG0661|consensus

Probab=99.63  E-value=2.1e-16  Score=139.42  Aligned_cols=87  Identities=24%  Similarity=0.371  Sum_probs=78.2

Q ss_pred             CCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         11 WANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        11 ~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ||.+|+|||.+|.+|||||..+.|.....+...-.+.+|+....++..+++++++++++||.+||.|||.+||||+|+|+
T Consensus       211 PG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  211 PGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             CCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            67888999999999999999999999766655555667777788899999999999999999999999999999999999


Q ss_pred             CcccccC
Q psy13988         91 SVWLKNV   97 (358)
Q Consensus        91 ~~~~~~~   97 (358)
                      ||||+.-
T Consensus       291 ~pffq~~  297 (538)
T KOG0661|consen  291 HPFFQVG  297 (538)
T ss_pred             Ccccccc
Confidence            9999853

>KOG1023|consensus

Probab=99.58  E-value=3e-15  Score=136.55  Aligned_cols=150  Identities=28%  Similarity=0.452  Sum_probs=121.6

Q ss_pred             HHhCCCCcccchhhhhcccCcccccccCCCeEEEEeeccc-cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCc-
Q psy13988        199 LRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF-  276 (358)
Q Consensus       199 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i-  276 (358)
                      |+.+.|.|+.++++.+.+          +...++|.+||. |++.+.+......+++.-...++++|+.||.|||+..| 
T Consensus         1 l~~l~h~n~~~f~g~~~~----------~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~   70 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD----------GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIG   70 (484)
T ss_pred             CcccchhhhhhheeeEec----------CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcce
Confidence            356789999999888776          458899999998 57777777777788999999999999999999998766 


Q ss_pred             eecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCC------CCCCcchHHHHHHHHHH
Q psy13988        277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE------RYGPAIDVWSCGCILGE  350 (358)
Q Consensus       277 ~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~~l~~  350 (358)
                      .|+.+++.|.++|....+||.|||+....................-|.|||.+....      ..+.+.||||+|++++|
T Consensus        71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            999999999999999999999999987664311111112222366799999987631      14678999999999999


Q ss_pred             HhhCCCCC
Q psy13988        351 LFVKKPLF  358 (358)
Q Consensus       351 lltg~~pF  358 (358)
                      +++.+.||
T Consensus       151 i~~r~~~~  158 (484)
T KOG1023|consen  151 ILFRSGPF  158 (484)
T ss_pred             HHhccCcc
Confidence            99999887

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.57  E-value=3.5e-14  Score=115.69  Aligned_cols=140  Identities=15%  Similarity=0.145  Sum_probs=98.9

Q ss_pred             cccccCCcceeeEeeeeec------CCcEEEEEEeeccccC----------C-C--------C-c----hhHHHHHHHHH
Q psy13988        151 MEPLAAGGLSLNNFSVSLF------TDELVALKKVRLENEK----------E-G--------F-P----ITAVREIKILR  200 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~~----------~-~--------~-~----~~~~~e~~~l~  200 (358)
                      ...||.|.-+.||.+....      .+..+|||+++.....          + .        . .    ....+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998654      3589999997654210          0 0        0 0    12237888888


Q ss_pred             hCCC--CcccchhhhhcccCcccccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHH-HhCCc
Q psy13988        201 QLNH--KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYC-HKRNF  276 (358)
Q Consensus       201 ~l~h--~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~L-H~~~i  276 (358)
                      ++..  -++.+++.+              ..-++||||++++ +....... ..+++.+...++.+++.+|..| |+.|+
T Consensus        82 rl~~~Gv~vP~pi~~--------------~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVL--------------KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNL  146 (197)
T ss_pred             HHHHcCCCCCeEEEe--------------cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCe
Confidence            8843  344444332              2457999999874 22211111 2355566778889999999998 89999


Q ss_pred             eecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        277 LHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       277 ~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      +|+||++.||+++ ++.+.|+|||.+....
T Consensus       147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         147 VHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             ecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999999997 5789999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243|consensus

Probab=99.55  E-value=1.6e-13  Score=126.89  Aligned_cols=186  Identities=24%  Similarity=0.307  Sum_probs=134.1

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      -.|.+ +..+-++.+..-.+..+.++.+|.|..++....  .......+-+..++.++||||+++++.++.         
T Consensus        13 fpY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~---------   80 (690)
T KOG1243|consen   13 FPYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE---------   80 (690)
T ss_pred             CCccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc---------
Confidence            34555 444444444333466678899999998887655  334567788899999999999999777765         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH-KRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                       .+..|+|+|.+.. +-..+..    +......-.+.||+.||.||| +++++|++|.-+.|+++..|+.+|++|.++..
T Consensus        81 -~~~~ylvTErV~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~  154 (690)
T KOG1243|consen   81 -EGTLYLVTERVRP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSK  154 (690)
T ss_pred             -cCceEEEeecccc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence             5689999999976 2222221    235666777899999999997 67899999999999999999999999998865


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK  354 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg  354 (358)
                      .........  ...---.|..|+.+....   ...|.|.||+++++++.|
T Consensus       155 ~~~~~~~~~--~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  155 ASGFNAPAK--SLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccCCcccc--cchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCc
Confidence            543321111  111123356677554322   457999999999999998

>KOG0601|consensus

Probab=99.53  E-value=1.4e-14  Score=132.43  Aligned_cols=203  Identities=21%  Similarity=0.189  Sum_probs=163.0

Q ss_pred             CCCCCCcccccccC--CcceeeEeeee--ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        143 TNNSSRPLMEPLAA--GGLSLNNFSVS--LFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       143 ~~~~~~~~~~~lg~--G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      .....+.+.+.+|.  |.+|.+|.+..  ..++..+|+|+-+...........-++|+...+.+ .|+|.++.+..+.  
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e--  188 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE--  188 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc--
Confidence            34455667788999  99999999998  88999999998444433333333445677777777 6889998655554  


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCEEecCC-C
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLD----GLSYCHKRNFLHRDIKCSNILMNNR-G  292 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~----al~~LH~~~i~H~Dlkp~Nill~~~-~  292 (358)
                              ..+..|+-+|+++.++..........+++...+..+.++..    ||.++|+.+++|.|+||+||+...+ .
T Consensus       189 --------~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  189 --------GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             --------cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc
Confidence                    36689999999998888888777767899999999999999    9999999999999999999999999 7


Q ss_pred             cEEEeecccceeccccCCCCCCC---CccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        293 EVKLADFGLARLYNAEDRQRPYT---NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       293 ~~~l~Dfg~~~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      ..+++|||+...+..+.......   ...+...|++||...+.  ++.+.|+|++|.++.+..+|..+
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~  326 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHL  326 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhccc
Confidence            89999999999887765433221   12457789999988653  78899999999999998887654

>KOG0658|consensus

Probab=99.52  E-value=1.6e-14  Score=124.07  Aligned_cols=99  Identities=28%  Similarity=0.418  Sum_probs=83.4

Q ss_pred             CCCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccccccccccc-ccCCChhHHHHHhhhcCCCCC
Q psy13988          2 FSGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREE-FSLMPPGALDLLDKMLELDPE   80 (358)
Q Consensus         2 ~~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~~l~~~p~   80 (358)
                      +.|..+|+|  +|..|||++|++++|||+.+++..++  +.|....++.....+|.++ +...+++++||+.++|+++|.
T Consensus       220 l~g~plFpG--~s~~dQL~eIik~lG~Pt~e~I~~mn--~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~  295 (364)
T KOG0658|consen  220 LKGQPLFPG--DSSVDQLVEIIKVLGTPTREDIKSMN--PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPS  295 (364)
T ss_pred             hcCCcccCC--CCHHHHHHHHHHHhCCCCHHHHhhcC--cccccccCcccccccceeecccCCCHHHHHHHHHHhccChh
Confidence            467777766  77799999999999999999998876  5666666777777778774 467899999999999999999


Q ss_pred             CcCCHhhhhcCcccccCCCCCCCC
Q psy13988         81 RRITAEQALKSVWLKNVHPESMPP  104 (358)
Q Consensus        81 ~R~~~~~~l~~~~~~~~~~~~~~~  104 (358)
                      +|+++.|+|.||||..++.+....
T Consensus       296 ~R~~~~~~l~h~fFdelr~~~~~l  319 (364)
T KOG0658|consen  296 KRLSALEALAHPFFDELRDPNTKL  319 (364)
T ss_pred             hcCCHHHHhcchhhHHhhCcCccC
Confidence            999999999999999988764433

>KOG0594|consensus

Probab=99.51  E-value=2.5e-14  Score=122.68  Aligned_cols=95  Identities=31%  Similarity=0.473  Sum_probs=82.0

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      .++++|.|  .++++||.+|++++|||+++.|+++..++.|..........+++...++..++++.||+.+||+++|.+|
T Consensus       216 ~~~~LFpG--~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R  293 (323)
T KOG0594|consen  216 TRRPLFPG--DSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR  293 (323)
T ss_pred             hCCCCCCC--CcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence            45667755  5569999999999999999999999999999873333433778888889889999999999999999999


Q ss_pred             CCHhhhhcCcccccCCC
Q psy13988         83 ITAEQALKSVWLKNVHP   99 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~   99 (358)
                      +||..+|.||||.....
T Consensus       294 ~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  294 ISAKGALTHPYFSELPE  310 (323)
T ss_pred             cCHHHHhcChhhccccc
Confidence            99999999999997643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=2.8e-13  Score=109.78  Aligned_cols=128  Identities=16%  Similarity=0.178  Sum_probs=93.4

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccc-hhhhhcccCcccccccCCCe
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN-LREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~~~~  229 (358)
                      ++.|+.|.++.||.+..  .+..|++|.......   ......+|+.+++.+.+.++++ ++...            ...
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~------------~~~   65 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD------------PET   65 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe------------CCC
Confidence            46789999999999886  488999998754321   1234578999999886555443 32211            113


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF-----LHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i-----~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .++|||+++|..+...        .......+.+++++|+.||+.++     +|+|++|.||+++ ++.++++||+.+..
T Consensus        66 ~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          66 GVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            4799999998544321        11123467899999999999885     9999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=6.6e-13  Score=122.83  Aligned_cols=143  Identities=22%  Similarity=0.278  Sum_probs=91.0

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC------------------------c--------------hhHH
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF------------------------P--------------ITAV  193 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~--------------~~~~  193 (358)
                      +.||.|++|.||+|.. .+|+.||||+.+......-.                        .              ..+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999986 57999999997543211000                        0              0122


Q ss_pred             HHHHHHHhC----CCCcccchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhc-CCCCCChHHHHHHHHHHHH-H
Q psy13988        194 REIKILRQL----NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLD-G  267 (358)
Q Consensus       194 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~-a  267 (358)
                      +|...+.++    ++.+-+.+-.++.+         .....++||||++|..+..+.. .....   ....++.+++. .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~---------~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~  269 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWD---------RTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSF  269 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehh---------hcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHH
Confidence            233333333    12111122111111         1234689999999854443321 11112   23456666666 4


Q ss_pred             HHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccc
Q psy13988        268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA  307 (358)
Q Consensus       268 l~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~  307 (358)
                      +..+|..|++|+|++|.||+++.+++++++|||++..+..
T Consensus       270 l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       270 LNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            7889999999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=2.7e-13  Score=126.93  Aligned_cols=152  Identities=20%  Similarity=0.223  Sum_probs=93.6

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC---------------------C-----------CCchhHHH
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK---------------------E-----------GFPITAVR  194 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------------~-----------~~~~~~~~  194 (358)
                      .|.. +.||.|++|.||.|....+|+.||||+.......                     .           +....+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4444 7899999999999999888999999998744210                     0           00111223


Q ss_pred             HHHHHHhCCCCcccchhhhhcccCccc---ccccCCCeEEEEeeccccChHHHH---hcCCC---CCChHHHHHHHHHHH
Q psy13988        195 EIKILRQLNHKNIVNLREIVTDKSDAL---DFRKDKGSFYLVFEYMDHDLMGLL---ESGMV---DFNEVNNASIMRQLL  265 (358)
Q Consensus       195 e~~~l~~l~h~niv~~~~~~~~~~~~~---~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~---~~~~~~~~~~~~qi~  265 (358)
                      |+......  .|+.++...+.+.....   -+.+.....++||||++|.-+..+   .....   .+.+..+..++.|  
T Consensus       200 ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        200 ELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             hhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence            33333332  35555544443322100   001113456799999998544332   22211   1333333333344  


Q ss_pred             HHHHHHHhCCceecCCCCCCEEecCCC----cEEEeecccceecccc
Q psy13988        266 DGLSYCHKRNFLHRDIKCSNILMNNRG----EVKLADFGLARLYNAE  308 (358)
Q Consensus       266 ~al~~LH~~~i~H~Dlkp~Nill~~~~----~~~l~Dfg~~~~~~~~  308 (358)
                           +...|++|+|++|.||+++.++    +++++|||++..+...
T Consensus       276 -----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        276 -----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                 4469999999999999999988    9999999999877543

>KOG0666|consensus

Probab=99.37  E-value=3.1e-13  Score=113.69  Aligned_cols=82  Identities=38%  Similarity=0.598  Sum_probs=65.1

Q ss_pred             hHHHHHHHhhcCCCCCCccccccCCCCCCCCC--Ccc--ccccccccccc---CCChhHHHHHhhhcCCCCCCcCCHhhh
Q psy13988         16 LLQLEVISKLCGTPTPAVWPAVIKLPLWHTIK--PKK--IHRRRLREEFS---LMPPGALDLLDKMLELDPERRITAEQA   88 (358)
Q Consensus        16 ~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~---~~~~~~~~ll~~~l~~~p~~R~~~~~~   88 (358)
                      .|||.+|+++||+|+.+.|+.+..+|.|....  ++.  .....|.+.+.   .-++.++|||.+||++||.+|+|++||
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence            79999999999999999999999999984332  221  11222444442   245669999999999999999999999


Q ss_pred             hcCcccccC
Q psy13988         89 LKSVWLKNV   97 (358)
Q Consensus        89 l~~~~~~~~   97 (358)
                      |+|+||.+-
T Consensus       335 leh~yF~~d  343 (438)
T KOG0666|consen  335 LEHPYFTED  343 (438)
T ss_pred             hcccccccC
Confidence            999999874

>KOG0593|consensus

Probab=99.37  E-value=4.1e-13  Score=112.57  Aligned_cols=94  Identities=24%  Similarity=0.359  Sum_probs=83.0

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccc-ccccccccccCCChhHHHHHhhhcCCCCCC
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKI-HRRRLREEFSLMPPGALDLLDKMLELDPER   81 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~   81 (358)
                      +|++++  ||++|+|||..|.+.||.-.++...-+.+.+.|..+..|.+ ...+++..||.++.-++||+++||.+||.+
T Consensus       197 ~G~pL~--PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~  274 (396)
T KOG0593|consen  197 TGEPLW--PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDD  274 (396)
T ss_pred             cCCcCC--CCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccc
Confidence            455555  56788999999999999999998888888899988887755 477899999999999999999999999999


Q ss_pred             cCCHhhhhcCcccccCC
Q psy13988         82 RITAEQALKSVWLKNVH   98 (358)
Q Consensus        82 R~~~~~~l~~~~~~~~~   98 (358)
                      |++++|+|.|+||..+.
T Consensus       275 R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  275 RLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             cccHHHHhcChHHHHHH
Confidence            99999999999997653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.2e-11  Score=97.58  Aligned_cols=134  Identities=17%  Similarity=0.215  Sum_probs=93.3

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCc------hhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFP------ITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..+++|+-+.++.+..  -|..+++|.-..+.......      ....+|+.++.+++--.|....-+..+         
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD---------   70 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD---------   70 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc---------
Confidence            4678999999998843  55566777533322221111      234578888888865444433323333         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       .....|+|||++|.++.......       ...++..+-.-+.-||.+||+|+||++.||++...+ +.++|||++..-
T Consensus        71 -~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          71 -PDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             -CCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence             33567999999998877554332       255777888888899999999999999999997655 999999998743

>KOG3087|consensus

Probab=99.34  E-value=1.3e-11  Score=96.83  Aligned_cols=144  Identities=22%  Similarity=0.251  Sum_probs=102.2

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC------chhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF------PITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+..+-+|+-+.|+.+..  .|+...||.-..+......      ..+.++|++.|.++.--.|....-++.+       
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-------   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-------   81 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-------
Confidence            567889999998887764  8888888854433222211      2345679999988865444443333333       


Q ss_pred             ccCCCeEEEEeecccc--ChHHHHhcCCCCCChHH-HHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEe
Q psy13988        224 RKDKGSFYLVFEYMDH--DLMGLLESGMVDFNEVN-NASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EVKLA  297 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~-~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~~l~  297 (358)
                         ...-.++|||++|  .+.+++......-.+.. ...++++|-+.+.-||.++|+|+||+.+||++..++   .+.++
T Consensus        82 ---~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lI  158 (229)
T KOG3087|consen   82 ---TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILI  158 (229)
T ss_pred             ---cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEE
Confidence               3345799999999  55666654433333333 378999999999999999999999999999997766   35899


Q ss_pred             ecccceec
Q psy13988        298 DFGLARLY  305 (358)
Q Consensus       298 Dfg~~~~~  305 (358)
                      |||++..-
T Consensus       159 dfgls~~s  166 (229)
T KOG3087|consen  159 DFGLSSVS  166 (229)
T ss_pred             eecchhcc
Confidence            99998654

>KOG0601|consensus

Probab=99.26  E-value=3e-12  Score=117.28  Aligned_cols=198  Identities=21%  Similarity=0.149  Sum_probs=146.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeee-cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSL-FTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ...++..+..||.|.++.|+.+... .++..|++|.+..........+.-+.|+.+...+ .|.+++.+...+..     
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----
Confidence            4456678889999999999988765 7789999998776654433333445677777766 68888887665554     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~l~Dfg  300 (358)
                           .+..|+-.|||++........-..-+++...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.||+
T Consensus       338 -----~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  338 -----LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             -----cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccc
Confidence                 23556889999875444333333347888889999999999999999999999999999999887 788999999


Q ss_pred             cceeccccCCCCCCCCcccccccc-ccccccCCCCCCCcchHHHHHHHHHHHhhCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYR-PPELLLGEERYGPAIDVWSCGCILGELFVKKP  356 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~  356 (358)
                      +...+....     ......-++. ..|++.....+..+.|++|||..+.+.++|.+
T Consensus       413 ~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  413 CWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            987532111     1112233444 36666656668899999999999999988864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.26  E-value=4.9e-11  Score=96.95  Aligned_cols=127  Identities=20%  Similarity=0.240  Sum_probs=81.8

Q ss_pred             eEeeeeecCCcEEEEEEeeccccC-----------CC-------------CchhHHHHHHHHHhCCCC--cccchhhhhc
Q psy13988        162 NNFSVSLFTDELVALKKVRLENEK-----------EG-------------FPITAVREIKILRQLNHK--NIVNLREIVT  215 (358)
Q Consensus       162 v~~~~~~~~~~~vaiK~~~~~~~~-----------~~-------------~~~~~~~e~~~l~~l~h~--niv~~~~~~~  215 (358)
                      ||.|.. .+|..+|||+.......           ..             ......+|.+.|.++...  ++.+++.+. 
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            677776 56779999987654211           00             012446799999999765  344443322 


Q ss_pred             ccCcccccccCCCeEEEEeeccc--cChHHHHhcCCCCCChHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCEEecCCC
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMD--HDLMGLLESGMVDFNEVNNASIMRQLLDGLSY-CHKRNFLHRDIKCSNILMNNRG  292 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~-LH~~~i~H~Dlkp~Nill~~~~  292 (358)
                                   .-++||||++  |..+..+....  ++......++.+++..+.. +|+.||+|+||++.||+++++ 
T Consensus        80 -------------~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -------------RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -------------TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-
T ss_pred             -------------CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-
Confidence                         2369999999  75555554332  2245567788888885555 679999999999999999887 


Q ss_pred             cEEEeecccceecc
Q psy13988        293 EVKLADFGLARLYN  306 (358)
Q Consensus       293 ~~~l~Dfg~~~~~~  306 (358)
                      .+.++|||.+....
T Consensus       144 ~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 KVYIIDFGQAVDSS  157 (188)
T ss_dssp             CEEE--GTTEEETT
T ss_pred             eEEEEecCcceecC
Confidence            99999999887554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1.4e-10  Score=98.25  Aligned_cols=143  Identities=20%  Similarity=0.262  Sum_probs=100.0

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc--ccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN--IVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.|+.|..+.+|++... +|+.+++|........ .....+.+|+.+++.+.+.+  +.+++.+.....       ..+.
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-------~~~~   74 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-------VLGT   74 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-------ccCC
Confidence            67899999999999863 3689999987654321 23446788999999996533  455544433211       1236


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh------------------------------------
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK------------------------------------  273 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~------------------------------------  273 (358)
                      .++|||+++|..+...... ..+++.....++.+++++|..||+                                    
T Consensus        75 ~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          75 PFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             ceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            7899999998544333211 245666667777777777777773                                    


Q ss_pred             --------------------CCceecCCCCCCEEecC--CCcEEEeeccccee
Q psy13988        274 --------------------RNFLHRDIKCSNILMNN--RGEVKLADFGLARL  304 (358)
Q Consensus       274 --------------------~~i~H~Dlkp~Nill~~--~~~~~l~Dfg~~~~  304 (358)
                                          ..++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                24699999999999998  56789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.21  E-value=1.3e-10  Score=97.10  Aligned_cols=139  Identities=21%  Similarity=0.264  Sum_probs=102.5

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC--------------C------CCchhHHHHHHHHHhCCCC--
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK--------------E------GFPITAVREIKILRQLNHK--  205 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------------~------~~~~~~~~e~~~l~~l~h~--  205 (358)
                      +.+...||.|.-|.||.+.+. .|.++|||.-......              .      -......+|.++|..|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            346789999999999999985 8999999974433110              0      0113456799999988544  


Q ss_pred             cccchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy13988        206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN  285 (358)
Q Consensus       206 niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~N  285 (358)
                      .+.+.++              .+...+|||+++|-.+..+.     ++......++..|+.-+..+-..||+|+|+++-|
T Consensus       172 ~VP~P~~--------------~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefN  232 (304)
T COG0478         172 KVPKPIA--------------WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFN  232 (304)
T ss_pred             CCCCccc--------------cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchhe
Confidence            5555532              34678999999995554432     2344556677778887777779999999999999


Q ss_pred             EEecCCCcEEEeecccceecc
Q psy13988        286 ILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       286 ill~~~~~~~l~Dfg~~~~~~  306 (358)
                      |+++++|.+.++||--+....
T Consensus       233 IlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             EEEecCCCEEEEeCcccccCC
Confidence            999999999999998766543

>KOG3741|consensus

Probab=99.19  E-value=7.3e-10  Score=100.05  Aligned_cols=170  Identities=18%  Similarity=0.196  Sum_probs=130.2

Q ss_pred             cceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEEEeecc
Q psy13988        158 GLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYM  237 (358)
Q Consensus       158 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  237 (358)
                      -..+.|++....+|..|++|+++-..  .........-++.++++.|+|+|++.+++....      .++..+++|++|+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t------F~D~SlvlvYDYy  359 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT------FGDLSLVLVYDYY  359 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhc------cCcceEEEEEecC
Confidence            55789999999999999999994322  222223456788999999999999999997322      2466899999999


Q ss_pred             cc--ChHHHHhc--------------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        238 DH--DLMGLLES--------------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       238 ~~--~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                      ++  +|.+..-.              .+...+|...|.++.|+..||.++|+.|+..+-|.+.+|+++.+.+++|+..|+
T Consensus       360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i  439 (655)
T KOG3741|consen  360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGI  439 (655)
T ss_pred             CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccc
Confidence            96  56665421              123467899999999999999999999999999999999999999999998887


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK  355 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~  355 (358)
                      .........                |-+.+    -.+-|.=.||.+++.|.||.
T Consensus       440 ~Dvl~~d~~----------------~~le~----~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  440 MDVLQEDPT----------------EPLES----QQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             eeeecCCCC----------------cchhH----HhhhhHHHHHHHHHHHhhcc
Confidence            665432220                11211    12568888999999999984

>KOG0665|consensus

Probab=99.14  E-value=2e-11  Score=103.24  Aligned_cols=85  Identities=27%  Similarity=0.284  Sum_probs=60.9

Q ss_pred             CCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccC------------CChhHHHHHhhhcCCC
Q psy13988         11 WANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSL------------MPPGALDLLDKMLELD   78 (358)
Q Consensus        11 ~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~ll~~~l~~~   78 (358)
                      +|+|-+||..+|.+.||||.++.+..+.....-...+.++....++.+.||+            -...+.|||.+||..|
T Consensus       218 ~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~  297 (369)
T KOG0665|consen  218 PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID  297 (369)
T ss_pred             cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC
Confidence            5888999999999999999998877754321111112222222333333332            2356799999999999


Q ss_pred             CCCcCCHhhhhcCcccc
Q psy13988         79 PERRITAEQALKSVWLK   95 (358)
Q Consensus        79 p~~R~~~~~~l~~~~~~   95 (358)
                      |++|+|++++|+|||++
T Consensus       298 pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  298 PEKRISVDDALRHPYIK  314 (369)
T ss_pred             hhhcccHHHHhcCCeee
Confidence            99999999999999997

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.12  E-value=8.5e-10  Score=95.13  Aligned_cols=132  Identities=14%  Similarity=0.072  Sum_probs=89.1

Q ss_pred             ecCCcEEEEEEeeccccCC---------CCchhHHHHHHHHHhCCCCccc--chhhhhcccCcccccccCCCeEEEEeec
Q psy13988        168 LFTDELVALKKVRLENEKE---------GFPITAVREIKILRQLNHKNIV--NLREIVTDKSDALDFRKDKGSFYLVFEY  236 (358)
Q Consensus       168 ~~~~~~vaiK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~~~~~~lv~e~  236 (358)
                      ...|+.|.||.........         .-...+.+|...+..+..-+|.  .++.+.+...     ......-++|||+
T Consensus        42 ~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~-----~~~~~~s~LVte~  116 (268)
T PRK15123         42 ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS-----NPATRTSFIITED  116 (268)
T ss_pred             EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC-----CCccceeEEEEee
Confidence            3467789999764433111         0011467888888888443332  3333332211     0112357899999


Q ss_pred             cccC--hHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-------CCcEEEeeccccee
Q psy13988        237 MDHD--LMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-------RGEVKLADFGLARL  304 (358)
Q Consensus       237 ~~~~--l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~-------~~~~~l~Dfg~~~~  304 (358)
                      +++.  +.+.+... ..+.+......++.+++..+..||++||+|+|+++.|||++.       +..+.|+||+.+..
T Consensus       117 l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        117 LAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9983  44444321 234566778899999999999999999999999999999985       45899999998864

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.09  E-value=1.6e-09  Score=90.31  Aligned_cols=131  Identities=19%  Similarity=0.206  Sum_probs=89.8

Q ss_pred             cCCcEEEEEEeeccccCC-----CCchhHHHHHHHHHhCCCCc--ccchhhhhcccCcccccccCCCeEEEEeecccc--
Q psy13988        169 FTDELVALKKVRLENEKE-----GFPITAVREIKILRQLNHKN--IVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH--  239 (358)
Q Consensus       169 ~~~~~vaiK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~--  239 (358)
                      ..++.|.+|.........     .......+|...+..+....  +.+.+.+......      .....++|+|++++  
T Consensus        30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~------~~~~s~lite~l~~~~  103 (206)
T PF06293_consen   30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKG------GGYRSYLITEALPGAQ  103 (206)
T ss_pred             ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC------CceeEEEEEEeCCCcc
Confidence            455667777543322111     22346778888887774333  3344444333210      11356899999998  


Q ss_pred             ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEeecccceecc
Q psy13988        240 DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EVKLADFGLARLYN  306 (358)
Q Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~~l~Dfg~~~~~~  306 (358)
                      ++.+.+.. ....+......++.+++..+.-||++||+|+|+++.|||++.++   .+.++||+.++...
T Consensus       104 ~L~~~~~~-~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  104 DLRDLLQQ-WEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             cHHHHHHh-hcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            34444443 22367777889999999999999999999999999999999887   89999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0606|consensus

Probab=99.08  E-value=7.7e-11  Score=114.14  Aligned_cols=202  Identities=21%  Similarity=0.179  Sum_probs=141.0

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-CchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-FPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+.+.+.+-.|.++.++.+.-..+|...++|.......-.. ..+....+-+++-.-.+|.++...-.+          
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~----------  873 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF----------  873 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC----------
Confidence            334566788899999999888777776666665443321110 011222233333233456665543332          


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ......++|++|+.++.+..........+++.++..+..+..++++||+..+.|+|++|.|.+...++..++.||+....
T Consensus       874 ~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  874 PCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             CCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccc
Confidence            22457899999998744444444555678888888999999999999999999999999999999999999999984322


Q ss_pred             ccc---------------------cC--------CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCC
Q psy13988        305 YNA---------------------ED--------RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK  355 (358)
Q Consensus       305 ~~~---------------------~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~  355 (358)
                      ..-                     ..        .........+|+.|.+||...+.. ....+|+|+.|+++++.++|.
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCC
Confidence            110                     00        001123345699999999998776 778899999999999999999


Q ss_pred             CCC
Q psy13988        356 PLF  358 (358)
Q Consensus       356 ~pF  358 (358)
                      +||
T Consensus      1033 pp~ 1035 (1205)
T KOG0606|consen 1033 PPF 1035 (1205)
T ss_pred             CCC
Confidence            998

>KOG1266|consensus

Probab=99.05  E-value=7.5e-11  Score=100.36  Aligned_cols=189  Identities=19%  Similarity=0.230  Sum_probs=123.1

Q ss_pred             eeEeeeeecCCcEEEEEEeeccccCCCCc--hhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEEEeeccc
Q psy13988        161 LNNFSVSLFTDELVALKKVRLENEKEGFP--ITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD  238 (358)
Q Consensus       161 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~  238 (358)
                      .||++.+...|.+|+--.+.....+....  +....-+.-+-.+-|.|||+++.|+.+..     .++.-...+++||+.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K-----~~e~~rviFiteyms  155 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKK-----YEEKPRVIFITEYMS  155 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccc-----cccccceEEEEeccc
Confidence            36666666666665543332221111111  11222334555668999999999998744     234567889999998


Q ss_pred             c-ChHHHH---hcCCCCCChHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEecCCCcEEEeecccceecc--ccCC
Q psy13988        239 H-DLMGLL---ESGMVDFNEVNNASIMRQLLDGLSYCHKR--NFLHRDIKCSNILMNNRGEVKLADFGLARLYN--AEDR  310 (358)
Q Consensus       239 ~-~l~~~~---~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~--~~~~  310 (358)
                      . ++-+.+   ......+......+|+.||+.||.|||+.  -|+|+++.-+.|++..+|-+|+.--.-...-.  ....
T Consensus       156 sgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~  235 (458)
T KOG1266|consen  156 SGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTR  235 (458)
T ss_pred             chhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhh
Confidence            5 444444   34556788888899999999999999987  59999999999999999988775322111110  0111


Q ss_pred             CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCC
Q psy13988        311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK  355 (358)
Q Consensus       311 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~  355 (358)
                      ........+-++|.+||.-... ..+.++|||++|++.++|.-+.
T Consensus       236 ~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  236 EAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             HhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHHHhe
Confidence            1111223446788999854333 3667899999999999987553

>KOG0667|consensus

Probab=99.05  E-value=1.8e-10  Score=106.31  Aligned_cols=94  Identities=28%  Similarity=0.302  Sum_probs=62.5

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCC-C------------------------------Cccc
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTI-K------------------------------PKKI   51 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~-~------------------------------~~~~   51 (358)
                      .|..+|  ||++|.|||.+|++++|.|++..+........|... .                              ...+
T Consensus       383 tG~PLf--pG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P  460 (586)
T KOG0667|consen  383 TGEPLF--PGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGP  460 (586)
T ss_pred             cCcccc--CCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCC
Confidence            344444  678899999999999999987766553322111110 0                              0001


Q ss_pred             -cccccccccc-CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         52 -HRRRLREEFS-LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        52 -~~~~~~~~~~-~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                       ..+.+...++ ......+|||++||+|||.+|+|+.+||+|||+....
T Consensus       461 ~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  461 PGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS  509 (586)
T ss_pred             CCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence             1222333333 2334569999999999999999999999999998643

>KOG0668|consensus

Probab=99.05  E-value=5.2e-11  Score=96.30  Aligned_cols=86  Identities=27%  Similarity=0.365  Sum_probs=61.9

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccC---CCCCCCCCCcccccccccccccC-----CChhHHHHHhhhcCCCCCCcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIK---LPLWHTIKPKKIHRRRLREEFSL-----MPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      |+|+.|||.+|.++|||-....+-....   .|.|..+.. ...+++|....+.     ++++++|||.++|++|.+.|+
T Consensus       236 G~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~-~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl  314 (338)
T KOG0668|consen  236 GHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILG-RHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL  314 (338)
T ss_pred             CCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhh-ccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc
Confidence            5677999999999999875443332222   133333222 2335556655532     579999999999999999999


Q ss_pred             CHhhhhcCcccccCC
Q psy13988         84 TAEQALKSVWLKNVH   98 (358)
Q Consensus        84 ~~~~~l~~~~~~~~~   98 (358)
                      ||.+|+.||||..+.
T Consensus       315 TakEam~HpyF~~~~  329 (338)
T KOG0668|consen  315 TAKEAMAHPYFAPVR  329 (338)
T ss_pred             chHHHhcCchHHHHH
Confidence            999999999998653

>PRK09902 hypothetical protein; Provisional

Probab=99.04  E-value=6.8e-09  Score=84.95  Aligned_cols=142  Identities=13%  Similarity=0.132  Sum_probs=98.5

Q ss_pred             cCCcceeeEeeeeecCCcEEEEEEeeccccC----CCCchhHHHHHHHHHhCCCCc--ccchhhhhcccCcccccccCCC
Q psy13988        155 AAGGLSLNNFSVSLFTDELVALKKVRLENEK----EGFPITAVREIKILRQLNHKN--IVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       155 g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      |+||-|.|+....  .|..+-+|+-......    ..-...+.+|+..+..+..-+  +.++. ++....     .....
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k-----~~~~~   98 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK-----IEGEW   98 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec-----cCCce
Confidence            3477888887654  4446888865422111    122356889999999984332  33443 222111     01134


Q ss_pred             eEEEEeecccc--ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc--EEEeecccce
Q psy13988        229 SFYLVFEYMDH--DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE--VKLADFGLAR  303 (358)
Q Consensus       229 ~~~lv~e~~~~--~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~--~~l~Dfg~~~  303 (358)
                      .-+||+|-++|  +|.+.+.+. ..+.++.....++.+++.++.-||+.|+.|+|+-+.||+++.++.  ++++||.-++
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            57899999986  566655442 235678888899999999999999999999999999999987776  9999999776


Q ss_pred             e
Q psy13988        304 L  304 (358)
Q Consensus       304 ~  304 (358)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.01  E-value=1.2e-08  Score=90.14  Aligned_cols=195  Identities=12%  Similarity=0.058  Sum_probs=129.2

Q ss_pred             cccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccccccCC
Q psy13988        149 PLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       149 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      .....||+|+-+-+|-...   -..-+.|++......     .-.+.+..|... .||-+..-+..-+.    .-+..++
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa-----~~aqk~a~la~~p~~p~~~~rvaWPqa----~L~G~~~   81 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPA-----AQAQKVAELAATPDAPLLNYRVAWPQA----TLHGGRR   81 (637)
T ss_pred             CCCccccCCccceeeecch---hhchhheeecCCCch-----HHHHHHHHhccCCCCcchhhhhcccHH----HhhCCCc
Confidence            3557899999999885543   223355666644322     112233344444 56544331111111    2233334


Q ss_pred             Ce-EEEEeeccccC--hHHHH-----hcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        228 GS-FYLVFEYMDHD--LMGLL-----ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       228 ~~-~~lv~e~~~~~--l~~~~-----~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                      +. .-++|..+.|.  ....+     ........+.-.++.++.++.|.+.||+.|.+-+|+.++|+|+++++.+.|+|-
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc
Confidence            44 77899998872  22222     122234788888999999999999999999999999999999999999999986


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCC----CCCCCcchHHHHHHHHHHHhhC-CCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFVK-KPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~lltg-~~pF  358 (358)
                      ..-..-.   ....+...+|.+.|.+||...-.    -.-+..+|.|.||+++++||.| ++||
T Consensus       162 Dsfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPy  222 (637)
T COG4248         162 DSFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY  222 (637)
T ss_pred             cceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCC
Confidence            5443332   22334566789999999965411    1135679999999999999987 8997

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=98.95  E-value=1.1e-09  Score=96.60  Aligned_cols=89  Identities=24%  Similarity=0.374  Sum_probs=69.8

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      |+..|.  +.+..+++..|.+.+|+|..+.|+.+.....+.....+.....++....+..+++++|||++||++||.+|+
T Consensus       200 g~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~  277 (288)
T cd07871         200 GRPMFP--GSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI  277 (288)
T ss_pred             CCCCCC--CCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC
Confidence            444444  345578899999999999999999877666555444444434445455567899999999999999999999


Q ss_pred             CHhhhhcCccc
Q psy13988         84 TAEQALKSVWL   94 (358)
Q Consensus        84 ~~~~~l~~~~~   94 (358)
                      |++|+|+||||
T Consensus       278 t~~~~l~hp~f  288 (288)
T cd07871         278 SAEAALRHSYF  288 (288)
T ss_pred             CHHHHhcCCCC
Confidence            99999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.93  E-value=1.1e-08  Score=84.91  Aligned_cols=141  Identities=17%  Similarity=0.152  Sum_probs=95.6

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCc----------------------hhHHHHHHHHHhCCC--Cc
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFP----------------------ITAVREIKILRQLNH--KN  206 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~----------------------~~~~~e~~~l~~l~h--~n  206 (358)
                      ...|..|.-+.||+|.. .++..||+|++..........                      ....+|+.-|+++..  -.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34777888889999886 678999999987664221110                      123456666666522  23


Q ss_pred             ccchhhhhcccCcccccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCC
Q psy13988        207 IVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCS  284 (358)
Q Consensus       207 iv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~  284 (358)
                      +.+.+.+.              .-.+||||++.. ...-... ..++...++..+..++++.+.-|-. .++||+||+.-
T Consensus       132 vP~Pi~~~--------------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEy  196 (268)
T COG1718         132 VPEPIAFR--------------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEY  196 (268)
T ss_pred             CCCceeec--------------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhh
Confidence            33333222              347999999853 1111111 1123344678888999999998887 89999999999


Q ss_pred             CEEecCCCcEEEeecccceecccc
Q psy13988        285 NILMNNRGEVKLADFGLARLYNAE  308 (358)
Q Consensus       285 Nill~~~~~~~l~Dfg~~~~~~~~  308 (358)
                      |||+. ++.+.+||++-+....++
T Consensus       197 NiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         197 NILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             heEEE-CCeEEEEECccccccCCC
Confidence            99999 889999999998766544

>KOG0669|consensus

Probab=98.89  E-value=1.8e-09  Score=88.70  Aligned_cols=92  Identities=40%  Similarity=0.661  Sum_probs=72.3

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCc---ccccccccccccC--CChhHHHHHhhhcCC
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPK---KIHRRRLREEFSL--MPPGALDLLDKMLEL   77 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~ll~~~l~~   77 (358)
                      ++...++|  +++..||..|..+||+-++|.|+.+..+|-|..+..+   ....+.+.+....  -++++.||+.+||.+
T Consensus       224 trspimqg--nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~  301 (376)
T KOG0669|consen  224 TRSPIMQG--NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKL  301 (376)
T ss_pred             ccCccccC--ChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhcc
Confidence            34445554  6679999999999999999999999999888776443   2222233333321  378999999999999


Q ss_pred             CCCCcCCHhhhhcCccccc
Q psy13988         78 DPERRITAEQALKSVWLKN   96 (358)
Q Consensus        78 ~p~~R~~~~~~l~~~~~~~   96 (358)
                      ||.+|+.++++|.|.||..
T Consensus       302 DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  302 DPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CcccCcchHhhhchhhhhc
Confidence            9999999999999999985

>KOG0671|consensus

Probab=98.84  E-value=3.3e-09  Score=92.05  Aligned_cols=95  Identities=21%  Similarity=0.274  Sum_probs=61.6

Q ss_pred             CCCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCC--CCC-----------CcccccccccccccCCCh---
Q psy13988          2 FSGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWH--TIK-----------PKKIHRRRLREEFSLMPP---   65 (358)
Q Consensus         2 ~~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~--~~~-----------~~~~~~~~~~~~~~~~~~---   65 (358)
                      +.|.++|++.  ++.++|..+-++||.++...+........|.  .+.           ......+++...+...+.   
T Consensus       303 ytG~~LFqtH--en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~  380 (415)
T KOG0671|consen  303 YTGETLFQTH--ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV  380 (415)
T ss_pred             eccceecccC--CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence            4678888774  4599999999999955444333321111110  000           111112345544444443   


Q ss_pred             hHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         66 GALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        66 ~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      +.+|||++||++||.+|+|+.|||.||||....
T Consensus       381 ~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  381 QLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            569999999999999999999999999998643

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=98.81  E-value=5.5e-09  Score=93.16  Aligned_cols=95  Identities=25%  Similarity=0.420  Sum_probs=71.2

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      .|+..|.+  .+..+.+..|.+++|.|..+.|+.+.....+.....+......+....+.+++++.|||.+||.+||.+|
T Consensus       200 tg~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  277 (309)
T cd07872         200 SGRPLFPG--STVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKR  277 (309)
T ss_pred             hCCCCCCC--CChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhC
Confidence            34544543  4446888999999999999999887654444333333333344445566789999999999999999999


Q ss_pred             CCHhhhhcCcccccCCC
Q psy13988         83 ITAEQALKSVWLKNVHP   99 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~   99 (358)
                      +|+.+++.||||+....
T Consensus       278 ~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         278 ISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             CCHHHHhcChhhhhccc
Confidence            99999999999997643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00036 glycogen synthase kinase; Provisional

Probab=98.79  E-value=5.4e-09  Score=97.80  Aligned_cols=93  Identities=24%  Similarity=0.374  Sum_probs=71.2

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccccccccccccc-CCChhHHHHHhhhcCCCCCC
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS-LMPPGALDLLDKMLELDPER   81 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~~p~~   81 (358)
                      .|...|.|  .+..+++.+|.+++|+|+.+.+..+.  +.|....++......+...+| ..+++++|||.+||++||.+
T Consensus       266 tG~~pf~~--~~~~~~~~~i~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~  341 (440)
T PTZ00036        266 LGYPIFSG--QSSVDQLVRIIQVLGTPTEDQLKEMN--PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLK  341 (440)
T ss_pred             hCCCCCCC--CChHHHHHHHHHHhCCCCHHHHHHhc--hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhH
Confidence            34445544  45589999999999999988877643  344444444444455666676 47889999999999999999


Q ss_pred             cCCHhhhhcCcccccCCC
Q psy13988         82 RITAEQALKSVWLKNVHP   99 (358)
Q Consensus        82 R~~~~~~l~~~~~~~~~~   99 (358)
                      |+|+.++|.||||..+..
T Consensus       342 R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        342 RLNPIEALADPFFDDLRD  359 (440)
T ss_pred             CcCHHHHhCChhHHhhhc
Confidence            999999999999987654

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=98.75  E-value=2.1e-08  Score=89.43  Aligned_cols=98  Identities=34%  Similarity=0.581  Sum_probs=71.5

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.+..+++..|...+|.|....|+.+..++.......+...-..+...++..++++.|||.+||++||.+|+|+.+++.|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             CCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            45668899999999999999999887666554333332222223444555678999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCc
Q psy13988         92 VWLKNVHPESMPPPQLPTW  110 (358)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~  110 (358)
                      |||.... .+..+..+|++
T Consensus       291 ~~f~~~~-~~~~~~~~~~~  308 (309)
T cd07845         291 SYFKEKP-LPCEPEMMPTF  308 (309)
T ss_pred             hhhccCC-CCCCCCcCCCC
Confidence            9998643 23444455543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0615|consensus

Probab=98.72  E-value=8.7e-09  Score=90.38  Aligned_cols=36  Identities=42%  Similarity=0.720  Sum_probs=33.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+|.+++||+..||+.||.+|+|+++||+||||+..
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            478999999999999999999999999999999864

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.72  E-value=8.4e-08  Score=78.90  Aligned_cols=145  Identities=18%  Similarity=0.264  Sum_probs=85.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCc-------hhHHHHHHHHHhCCC---Ccccchhhh
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFP-------ITAVREIKILRQLNH---KNIVNLREI  213 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-------~~~~~e~~~l~~l~h---~niv~~~~~  213 (358)
                      ....|.+++.+-......|.+.  ..++..+++|.........+..       ....+.+..+..++.   .....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4566777777777665555444  4578999999866543221100       011233343333322   222222222


Q ss_pred             hcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE  293 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~  293 (358)
                      ....     .+.-....++||||++|--+..+.    .+++    .+...+.+++..||+.|+.|+|+.|.|++++.++ 
T Consensus       107 ~ekk-----~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  107 AEKK-----IFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeee-----eccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-
Confidence            2211     111123567899999994332221    1222    2446678889999999999999999999998554 


Q ss_pred             EEEeeccccee
Q psy13988        294 VKLADFGLARL  304 (358)
Q Consensus       294 ~~l~Dfg~~~~  304 (358)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=98.71  E-value=2.2e-08  Score=89.07  Aligned_cols=95  Identities=28%  Similarity=0.411  Sum_probs=68.0

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccccccccccccc--CCChhHHHHHhhhcCCCCCC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS--LMPPGALDLLDKMLELDPER   81 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~l~~~p~~   81 (358)
                      |+..|.+. ++..+++..+..++|+|....|+.....+.+............+.+.+.  ..++++.||+.+||++||.+
T Consensus       200 g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~  278 (303)
T cd07869         200 GVAAFPGM-KDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKN  278 (303)
T ss_pred             CCCCCCCC-ccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchh
Confidence            44455543 2346889999999999999999987766554322222222233333333  24678999999999999999


Q ss_pred             cCCHhhhhcCcccccCCC
Q psy13988         82 RITAEQALKSVWLKNVHP   99 (358)
Q Consensus        82 R~~~~~~l~~~~~~~~~~   99 (358)
                      |+|+.++|.||||..+.+
T Consensus       279 R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         279 RLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccCHHHHhcCcccccCCh
Confidence            999999999999997643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=98.66  E-value=3e-08  Score=87.23  Aligned_cols=84  Identities=31%  Similarity=0.557  Sum_probs=73.0

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.++.+++.++.+.+|.|....|+.+..++.+.....+.....++...++..+.++.+||.+||..+|.+|+|+++++.|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         203 GENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            45568899999999999999999998888887666666665666777888888999999999999999999999999999


Q ss_pred             cccc
Q psy13988         92 VWLK   95 (358)
Q Consensus        92 ~~~~   95 (358)
                      |||.
T Consensus       283 ~~~~  286 (286)
T cd07832         283 PYFT  286 (286)
T ss_pred             cCcC
Confidence            9983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=98.64  E-value=6.3e-08  Score=85.97  Aligned_cols=94  Identities=23%  Similarity=0.384  Sum_probs=68.0

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      |+..|.  +.+..+++..|..++|.|....|+.+.....+.....+......+...-+.+++++.|||.+||++||.+|+
T Consensus       201 g~~~f~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~  278 (301)
T cd07873         201 GRPLFP--GSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI  278 (301)
T ss_pred             CCCCCC--CCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc
Confidence            444443  344578899999999999999998765544443333333222223333356788999999999999999999


Q ss_pred             CHhhhhcCcccccCCC
Q psy13988         84 TAEQALKSVWLKNVHP   99 (358)
Q Consensus        84 ~~~~~l~~~~~~~~~~   99 (358)
                      |+.++|.||||..+..
T Consensus       279 t~~eil~h~~f~~~~~  294 (301)
T cd07873         279 SAEEAMKHPYFHCLGE  294 (301)
T ss_pred             CHHHHhcCcccccccc
Confidence            9999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.57  E-value=7.3e-07  Score=75.39  Aligned_cols=134  Identities=16%  Similarity=0.147  Sum_probs=77.6

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcc--cchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNI--VNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      ..||.|..+.||+.    .+..+++|......    ......+|.++++.+..-.+  .+.+.+.          .+.+.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~----------~~~~~   68 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLV----------EDGGR   68 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEE----------ecCCe
Confidence            57899999999973    35577889875422    23356789999988854333  3343332          33456


Q ss_pred             EEEEeeccccCh-HHHHh---------------------cCC--CCCChHHHH-HHHHH----------HHH-HHHHHH-
Q psy13988        230 FYLVFEYMDHDL-MGLLE---------------------SGM--VDFNEVNNA-SIMRQ----------LLD-GLSYCH-  272 (358)
Q Consensus       230 ~~lv~e~~~~~l-~~~~~---------------------~~~--~~~~~~~~~-~~~~q----------i~~-al~~LH-  272 (358)
                      ..+|||+++|.. .....                     ...  ......... .+..+          +.. ...+|. 
T Consensus        69 ~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~  148 (226)
T TIGR02172        69 LGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE  148 (226)
T ss_pred             eeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh
Confidence            788999999841 11000                     000  000100000 01000          111 112222 


Q ss_pred             ---hCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        273 ---KRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       273 ---~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                         ...++|+|+.|.||++++++ +.|+||+.+..
T Consensus       149 ~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       149 VPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence               12478999999999999888 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=98.54  E-value=8.7e-08  Score=85.74  Aligned_cols=79  Identities=28%  Similarity=0.430  Sum_probs=56.1

Q ss_pred             hHHHHHHHhhcCCCCCCccccccCCCCCCCCCC----ccccccc----ccccccCCChhHHHHHhhhcCCCCCCcCCHhh
Q psy13988         16 LLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKP----KKIHRRR----LREEFSLMPPGALDLLDKMLELDPERRITAEQ   87 (358)
Q Consensus        16 ~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~   87 (358)
                      .+|+.+|+.++|.|....|.....++.......    .......    +.......+++++|||.+||++||.+|+|++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e  310 (317)
T cd07868         231 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  310 (317)
T ss_pred             HHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHH
Confidence            589999999999999999988765543221110    0000001    11111235678999999999999999999999


Q ss_pred             hhcCccc
Q psy13988         88 ALKSVWL   94 (358)
Q Consensus        88 ~l~~~~~   94 (358)
                      +|+||||
T Consensus       311 ~l~hp~f  317 (317)
T cd07868         311 AMQDPYF  317 (317)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=98.54  E-value=7.6e-08  Score=87.92  Aligned_cols=95  Identities=24%  Similarity=0.289  Sum_probs=60.9

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCC--------CCCCCCCCccccc---cccc-ccccCCChhHHHHH
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKL--------PLWHTIKPKKIHR---RRLR-EEFSLMPPGALDLL   71 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~ll   71 (358)
                      |+..|.  +.+..+++.+|++.+|+|.++.+..+...        +.+..........   .++. ......+.++.|||
T Consensus       221 g~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  298 (364)
T cd07875         221 GGVLFP--GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL  298 (364)
T ss_pred             CCCCCC--CCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence            444443  45568999999999999988776654321        2121111100000   0000 01112356789999


Q ss_pred             hhhcCCCCCCcCCHhhhhcCcccccCCCC
Q psy13988         72 DKMLELDPERRITAEQALKSVWLKNVHPE  100 (358)
Q Consensus        72 ~~~l~~~p~~R~~~~~~l~~~~~~~~~~~  100 (358)
                      .+||++||.+|+|+.++|.||||..+..+
T Consensus       299 ~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  327 (364)
T cd07875         299 SKMLVIDASKRISVDEALQHPYINVWYDP  327 (364)
T ss_pred             HHhcCcCcccCCCHHHHhcCcccccccCc
Confidence            99999999999999999999999865443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=98.53  E-value=1.3e-07  Score=83.49  Aligned_cols=86  Identities=24%  Similarity=0.297  Sum_probs=65.2

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      |+..|.|  .++.+++.+|++.+|.|.++.|+.....+...   .......++.+..+.+++.+.+|+.+||+.||.+||
T Consensus       205 g~~~f~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  279 (290)
T cd07862         205 RKPLFRG--SSDVDQLGKILDVIGLPGEEDWPRDVALPRQA---FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI  279 (290)
T ss_pred             CCCCcCC--CCHHHHHHHHHHHhCCCChhhchhhhcccchh---ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC
Confidence            4444444  44589999999999999999887754443321   111223446666677899999999999999999999


Q ss_pred             CHhhhhcCccc
Q psy13988         84 TAEQALKSVWL   94 (358)
Q Consensus        84 ~~~~~l~~~~~   94 (358)
                      |+.++|+||||
T Consensus       280 s~~~~l~hp~f  290 (290)
T cd07862         280 SAYSALSHPYF  290 (290)
T ss_pred             CHHHHhcCCCC
Confidence            99999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.50  E-value=6.7e-07  Score=83.77  Aligned_cols=76  Identities=24%  Similarity=0.410  Sum_probs=53.4

Q ss_pred             CeEEEEeecccc---ChHHHHhcCCCCCChHHHHHHHHHHHHH-HHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        228 GSFYLVFEYMDH---DLMGLLESGMVDFNEVNNASIMRQLLDG-LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       228 ~~~~lv~e~~~~---~l~~~~~~~~~~~~~~~~~~~~~qi~~a-l~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      +.-.++|||++|   +....+...  .++.   ..++..++++ +..+-..|+.|.|.+|.||+++.+|++.+.|||+..
T Consensus       239 ~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~---k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g  313 (517)
T COG0661         239 TRRVLTMEWIDGIKISDIAALKSA--GIDR---KELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVG  313 (517)
T ss_pred             CCcEEEEEeeCCEecccHHHHHhc--CCCH---HHHHHHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCccee
Confidence            456899999999   333334332  2332   2333344433 344445899999999999999999999999999988


Q ss_pred             ecccc
Q psy13988        304 LYNAE  308 (358)
Q Consensus       304 ~~~~~  308 (358)
                      .+...
T Consensus       314 ~l~~~  318 (517)
T COG0661         314 RLDPK  318 (517)
T ss_pred             cCCHH
Confidence            77544

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=98.49  E-value=1.2e-07  Score=85.71  Aligned_cols=95  Identities=29%  Similarity=0.412  Sum_probs=66.7

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCC-CcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIK-PKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |+..|.|  .+..+++..+.+.+|+|+.+.+..+.......... .......++...++..++++.+|+.+||+.||.+|
T Consensus       204 g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  281 (338)
T cd07859         204 GKPLFPG--KNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDR  281 (338)
T ss_pred             CCCCCCC--CChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccC
Confidence            4444443  44588999999999999887776543322111000 01112234556677789999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPE  100 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~  100 (358)
                      ||+.+++.||||..+...
T Consensus       282 pt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         282 PTAEEALADPYFKGLAKV  299 (338)
T ss_pred             CCHHHHhcCchhhhcCcc
Confidence            999999999999876543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=98.49  E-value=1.7e-07  Score=82.40  Aligned_cols=82  Identities=33%  Similarity=0.433  Sum_probs=64.9

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.+..+++..|++.+|.|.+..|+.+...+.+..... ......+....+..++++.||+.+||..||.+|+|+++++.|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         203 GNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM-YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             CCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC-CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            4455789999999999999999988777666533222 112233556667789999999999999999999999999999


Q ss_pred             ccc
Q psy13988         92 VWL   94 (358)
Q Consensus        92 ~~~   94 (358)
                      |||
T Consensus       282 ~~f  284 (284)
T cd07839         282 PYF  284 (284)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=98.49  E-value=1.6e-07  Score=82.41  Aligned_cols=82  Identities=37%  Similarity=0.602  Sum_probs=67.2

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.+..+++.+|.+.+|+|.++.|..+..++.+ ....+......+...++..+.++.+++.+||..||.+|+++.+++.|
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         201 GDSEIDQLFKIFQILGTPTEESWPGVTKLPDY-KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             CccHHHHHHHHHHHhCCCcHHHHHhhcccccc-cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            34457889999999999999999988777733 33344444455666777789999999999999999999999999999


Q ss_pred             ccc
Q psy13988         92 VWL   94 (358)
Q Consensus        92 ~~~   94 (358)
                      |||
T Consensus       280 p~~  282 (282)
T cd07829         280 PYF  282 (282)
T ss_pred             cCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=98.45  E-value=2.7e-07  Score=83.06  Aligned_cols=94  Identities=30%  Similarity=0.420  Sum_probs=68.6

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCC-CCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTI-KPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      +.+..+++..|...+|.|+++.|............ ..+.....++...++..+.++.+|+.+||+++|.+||++++++.
T Consensus       209 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         209 GRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             CCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            34457889999999999998887643222111111 12233344566777888999999999999999999999999999


Q ss_pred             CcccccCCCCCCCCC
Q psy13988         91 SVWLKNVHPESMPPP  105 (358)
Q Consensus        91 ~~~~~~~~~~~~~~~  105 (358)
                      ||||..+..++...+
T Consensus       289 ~~~~~~~~~~~~~~~  303 (330)
T cd07834         289 HPYLAQLHDPEDEPV  303 (330)
T ss_pred             CccHHhhcccccCCC
Confidence            999998765544443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=98.44  E-value=2.9e-07  Score=81.37  Aligned_cols=89  Identities=36%  Similarity=0.550  Sum_probs=67.2

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCC--ChhHHHHHhhhcCCCCCC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLM--PPGALDLLDKMLELDPER   81 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ll~~~l~~~p~~   81 (358)
                      |+..+.+  .+..+.+.++++.+|.|..+.|+....++..............+...++..  +..+.+|+.+||..+|.+
T Consensus       203 g~~~f~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  280 (293)
T cd07843         203 KKPLFPG--KSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAK  280 (293)
T ss_pred             CCCCCCC--CChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccc
Confidence            4444443  334778899999999999999998776665543333333333455666654  888999999999999999


Q ss_pred             cCCHhhhhcCccc
Q psy13988         82 RITAEQALKSVWL   94 (358)
Q Consensus        82 R~~~~~~l~~~~~   94 (358)
                      |+|+.|++.||||
T Consensus       281 R~t~~ell~~~~f  293 (293)
T cd07843         281 RISAEDALKHPYF  293 (293)
T ss_pred             cCCHHHHhcCCCC
Confidence            9999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.44  E-value=1.2e-06  Score=74.53  Aligned_cols=141  Identities=23%  Similarity=0.238  Sum_probs=78.0

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc--ccchhhhhcccCcccccccCCC
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN--IVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      ++.|+.|..+.||++....  ..+++|.....    .....+.+|..+++.+....  +.+++.....       ....+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~-------~~~~~   68 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTS-------DEFNG   68 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE-------TEETS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccc-------ccccc
Confidence            4678999999999998744  59999986543    12345678888888884333  3344332211       11234


Q ss_pred             eEEEEeeccccChHHH--------------------HhcC---CCCCChHHH--H-------HH------------HHHH
Q psy13988        229 SFYLVFEYMDHDLMGL--------------------LESG---MVDFNEVNN--A-------SI------------MRQL  264 (358)
Q Consensus       229 ~~~lv~e~~~~~l~~~--------------------~~~~---~~~~~~~~~--~-------~~------------~~qi  264 (358)
                      ..+++|++++|..+..                    +...   .........  .       ..            ...+
T Consensus        69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (239)
T PF01636_consen   69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL  148 (239)
T ss_dssp             EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred             cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence            5899999999853333                    0111   011111000  0       00            0112


Q ss_pred             HH-HHHHHH-------hCCceecCCCCCCEEec-CCCcEEEeeccccee
Q psy13988        265 LD-GLSYCH-------KRNFLHRDIKCSNILMN-NRGEVKLADFGLARL  304 (358)
Q Consensus       265 ~~-al~~LH-------~~~i~H~Dlkp~Nill~-~~~~~~l~Dfg~~~~  304 (358)
                      .. .+..++       ...++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            22 233333       24599999999999999 666678999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=98.42  E-value=4.2e-07  Score=80.17  Aligned_cols=80  Identities=29%  Similarity=0.419  Sum_probs=63.8

Q ss_pred             hhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCC--hhHHHHHhhhcCCCCCCcCCHhhhhcCc
Q psy13988         15 ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMP--PGALDLLDKMLELDPERRITAEQALKSV   92 (358)
Q Consensus        15 ~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ll~~~l~~~p~~R~~~~~~l~~~   92 (358)
                      ..+|+..+.+.+|.|.++.|+.......+...........++...++..+  .++.+++.+||.++|.+|||+.+++.||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~  289 (291)
T cd07844         210 VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP  289 (291)
T ss_pred             HHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence            46889999999999999999888766655444443333444555555556  8899999999999999999999999999


Q ss_pred             cc
Q psy13988         93 WL   94 (358)
Q Consensus        93 ~~   94 (358)
                      ||
T Consensus       290 ~f  291 (291)
T cd07844         290 YF  291 (291)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=98.38  E-value=3e-07  Score=80.81  Aligned_cols=82  Identities=33%  Similarity=0.515  Sum_probs=63.3

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.++.+++.++.+.+|.|....|+.+...+.+.. .++......+....+.+++++.|+|.+||+.||.+||++++++.|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         203 GDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP-SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             CCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh-hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            4556788999999999998888887665554433 222222334555566788999999999999999999999999999


Q ss_pred             ccc
Q psy13988         92 VWL   94 (358)
Q Consensus        92 ~~~   94 (358)
                      |||
T Consensus       282 ~~f  284 (284)
T cd07860         282 PFF  284 (284)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG1290|consensus

Probab=98.37  E-value=3.4e-07  Score=82.29  Aligned_cols=88  Identities=26%  Similarity=0.269  Sum_probs=57.0

Q ss_pred             CCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCC---------cccccccccccc--cC-CChhHHHHHhhhcCCC
Q psy13988         11 WANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKP---------KKIHRRRLREEF--SL-MPPGALDLLDKMLELD   78 (358)
Q Consensus        11 ~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~--~~-~~~~~~~ll~~~l~~~   78 (358)
                      +++ +.|+|.+|+++||.-+.....+......|.....         +++...-|.+.+  +. ...+..|||..||+++
T Consensus       459 Y~r-DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~  537 (590)
T KOG1290|consen  459 YSR-DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFD  537 (590)
T ss_pred             CCc-cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcC
Confidence            666 4799999999999876665544332222211111         111111122222  21 2345688999999999


Q ss_pred             CCCcCCHhhhhcCcccccCCC
Q psy13988         79 PERRITAEQALKSVWLKNVHP   99 (358)
Q Consensus        79 p~~R~~~~~~l~~~~~~~~~~   99 (358)
                      |++|+||.++|+|||+..+..
T Consensus       538 PeKR~tA~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  538 PEKRPTAAQCLKHPWLNPVAG  558 (590)
T ss_pred             ccccccHHHHhcCccccCCCC
Confidence            999999999999999997543

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=98.37  E-value=9.5e-07  Score=79.69  Aligned_cols=84  Identities=37%  Similarity=0.618  Sum_probs=65.2

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.++.+++.+|.+.+|.|....|+.....+.+......  ....+...++..+.++.+|+.+||..+|.+|+|++++|.|
T Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcC--CcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            34458899999999999999888876655544332221  1233455566778999999999999999999999999999


Q ss_pred             cccccC
Q psy13988         92 VWLKNV   97 (358)
Q Consensus        92 ~~~~~~   97 (358)
                      |||+..
T Consensus       314 ~~~~~~  319 (335)
T PTZ00024        314 EYFKSD  319 (335)
T ss_pred             cccCCC
Confidence            999864

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=98.36  E-value=4e-07  Score=79.83  Aligned_cols=83  Identities=40%  Similarity=0.523  Sum_probs=64.9

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.+..+++.++.+.+|.|.++.|..+..+-.+.....+...........+.++.++.+|+.+||..||.+||++.+++.|
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         201 GKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             CCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            45568999999999999999999887654333333333333333445556788999999999999999999999999999


Q ss_pred             ccc
Q psy13988         92 VWL   94 (358)
Q Consensus        92 ~~~   94 (358)
                      |||
T Consensus       281 ~~~  283 (283)
T cd05118         281 PYF  283 (283)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=98.36  E-value=5.9e-07  Score=80.30  Aligned_cols=79  Identities=29%  Similarity=0.427  Sum_probs=56.7

Q ss_pred             hHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccc----ccccccccc----cCCChhHHHHHhhhcCCCCCCcCCHhh
Q psy13988         16 LLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKI----HRRRLREEF----SLMPPGALDLLDKMLELDPERRITAEQ   87 (358)
Q Consensus        16 ~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~   87 (358)
                      .+|+.+++.++|.|..+.|..+...+.+........    ....+...+    ...+..+.|||.+||+.||.+|+|+.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e  310 (317)
T cd07867         231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ  310 (317)
T ss_pred             HHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH
Confidence            578999999999999999988766554432221100    001111111    235677899999999999999999999


Q ss_pred             hhcCccc
Q psy13988         88 ALKSVWL   94 (358)
Q Consensus        88 ~l~~~~~   94 (358)
                      +|+||||
T Consensus       311 ~l~hp~f  317 (317)
T cd07867         311 ALQDPYF  317 (317)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0599|consensus

Probab=98.36  E-value=8.6e-08  Score=79.93  Aligned_cols=35  Identities=31%  Similarity=0.579  Sum_probs=32.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ++|++..||+.++|+.||.+|+|+.++|.||||..
T Consensus       254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             hccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            57889999999999999999999999999999964

>KOG2137|consensus

Probab=98.35  E-value=1.2e-07  Score=88.90  Aligned_cols=95  Identities=29%  Similarity=0.474  Sum_probs=72.4

Q ss_pred             HHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccceeccccCCC--CCC-----CCccccccccccccccCC
Q psy13988        261 MRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ--RPY-----TNKVITLWYRPPELLLGE  332 (358)
Q Consensus       261 ~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~--~~~-----~~~~~~~~y~aPE~~~~~  332 (358)
                      +.+.+.|+.|+|. .++||++|.|++|.++..+.+||+.|+++.....+...  ..+     ........|.|||.+...
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            3455689999996 58999999999999999999999999988765442211  111     111226789999998764


Q ss_pred             CCCCCcchHHHHHHHHHHHh-hCCC
Q psy13988        333 ERYGPAIDVWSCGCILGELF-VKKP  356 (358)
Q Consensus       333 ~~~~~~~DiwslG~~l~~ll-tg~~  356 (358)
                       ..+.++|+||+|+++|.+. .|+.
T Consensus       185 -~~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  185 -TNTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             -cccccccceeeeeEEEEEecCCcc
Confidence             4788999999999999888 4443

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=98.35  E-value=8.5e-07  Score=78.10  Aligned_cols=79  Identities=29%  Similarity=0.384  Sum_probs=60.1

Q ss_pred             CchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCc
Q psy13988         13 NIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSV   92 (358)
Q Consensus        13 ~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~   92 (358)
                      .+..+++.+|...+|.|..+.|+.....+...   .......++....+..+.++.||+.+||+.||.+|+|+.+++.||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp  286 (288)
T cd07863         210 NSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA---FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP  286 (288)
T ss_pred             CCHHHHHHHHHHHhCCCChhhCcccccccccc---cCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            34578899999999999888887644332211   111223345566677889999999999999999999999999999


Q ss_pred             cc
Q psy13988         93 WL   94 (358)
Q Consensus        93 ~~   94 (358)
                      ||
T Consensus       287 ~f  288 (288)
T cd07863         287 FF  288 (288)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.35  E-value=6.4e-06  Score=70.76  Aligned_cols=136  Identities=15%  Similarity=0.068  Sum_probs=76.8

Q ss_pred             ccccCCcc-eeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGL-SLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.|..|.. +.||.+..  .+..+.+|+.....     .....+|+++++.+. +--+.+++.+.          ..++.
T Consensus         4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~----------~~~~~   66 (244)
T cd05150           4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYG----------SDDGR   66 (244)
T ss_pred             eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEE----------ecCCc
Confidence            34555554 77888865  34788889875432     224567888888884 32233443332          22346


Q ss_pred             EEEEeeccccChHHHHh-------------------cC----CCCCChH--HHHHHHHH--------------------H
Q psy13988        230 FYLVFEYMDHDLMGLLE-------------------SG----MVDFNEV--NNASIMRQ--------------------L  264 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~-------------------~~----~~~~~~~--~~~~~~~q--------------------i  264 (358)
                      .++|||+++|..+....                   ..    ..++...  ........                    +
T Consensus        67 ~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (244)
T cd05150          67 AWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSA  146 (244)
T ss_pred             cEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCH
Confidence            78999999985333211                   00    0011100  00000000                    1


Q ss_pred             HHHHHHHH-------hCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        265 LDGLSYCH-------KRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       265 ~~al~~LH-------~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ...+..|-       ...++|+|+.|.||++++++...|+||+.+..
T Consensus       147 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         147 EELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            11111221       23489999999999999987789999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=98.34  E-value=2.8e-07  Score=83.99  Aligned_cols=94  Identities=24%  Similarity=0.318  Sum_probs=58.6

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccC--------CCCCCCCCCccccc----ccccccccCCChhHHHH
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIK--------LPLWHTIKPKKIHR----RRLREEFSLMPPGALDL   70 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~--------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l   70 (358)
                      .|+..|.+  .+..+++..+.+.+|+|..+.+.....        .+.+..........    ..........++++.+|
T Consensus       217 tg~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  294 (359)
T cd07876         217 KGSVIFQG--TDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL  294 (359)
T ss_pred             hCCCCCCC--CCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHH
Confidence            34445554  355899999999999998765544221        11111111000000    00001111246788999


Q ss_pred             HhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         71 LDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        71 l~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      |.+||++||.+|+|+.|+|.|||+....
T Consensus       295 i~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         295 LSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHHhccCcccCCCHHHHhcCchhhhhc
Confidence            9999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	358
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-53
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-53
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-53
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-52
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-43
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-43
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-43
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-43
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-43
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-43
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-43
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-43
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-43
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-43
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-43
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-43
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-43
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-43
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-42
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-42
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-42
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-42
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-42
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-42
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-42
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-42
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-42
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-42
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-42
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-42
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-42
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-42
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-42
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-42
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-42
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-42
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-42
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-42
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-42
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-42
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-42
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-42
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-42
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-41
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-41
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-41
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-41
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-40
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-39
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-35
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-34
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-34
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-34
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-34
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-34
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-34
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-33
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-32
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-31
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-31
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-31
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-30
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-30
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-30
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-29
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-29
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-29
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-29
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-29
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-28
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-28
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-28
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-28
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-28
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-28
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-28
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-28
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-28
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-28
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-28
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-28
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-28
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-28
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-28
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-28
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-28
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-28
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-28
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-28
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-28
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-28
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-28
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-28
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-28
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-26
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-26
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-26
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-26
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-26
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-25
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-25
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-25
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-25
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-25
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-25
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-25
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-25
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-25
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-25
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-25
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-25
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-25
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-25
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-25
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-24
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-24
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-24
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-24
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-24
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-24
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-24
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-24
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-24
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-24
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-24
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-24
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-24
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-24
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-24
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-24
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-24
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-24
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-24
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-24
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-24
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-24
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-24
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-24
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-24
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-24
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-24
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-23
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-23
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-23
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-23
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-23
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-23
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-23
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-23
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-23
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-23
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-23
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-23
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-23
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-23
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-23
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-23
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-23
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-23
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-23
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-23
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-23
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-23
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-23
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-23
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-23
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-23
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-23
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-23
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-23
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-23
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-23
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-23
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-23
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-23
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-23
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-23
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-23
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-23
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-23
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-23
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-23
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-23
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-23
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-23
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-23
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-22
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-22
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-22
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-22
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-22
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-21
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-21
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-21
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-21
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-21
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-21
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-21
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-21
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-21
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-21
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-21
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-21
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-21
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-21
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-21
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-21
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-21
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-21
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-21
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-21
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-21
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-20
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-20
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-20
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-20
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-20
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-19
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-19
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-19
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-19
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-19
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-19
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-19
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-19
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-19
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-19
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-19
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-19
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-19
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-19
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-19
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-19
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-17
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-17
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-16
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-16
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-16
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-16
3soa_A	444	Full-Length Human Camkii Length = 444		9e-16
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-16
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-15
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-15
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-15
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-15
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-15
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-15
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-15
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-15
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-15
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-15
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-15
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-15
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-13
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-12
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-12
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-12
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-12
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-12
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		9e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-07
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		4e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-06
3op5_A	364	Human Vaccinia-Related Kinase 1 Length = 364		1e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-06
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		2e-06
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-06

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 100/191 (52%), Positives = 135/191 (70%), Gaps = 4/191 (2%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VALKKV +ENEKEGFPITA+REIKIL+ L H+N+VNL EI   ++ A  + + KGS
Sbjct: 42  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC--RTKASPYNRCKGS 99
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLVF++ +HDL GLL + +V F       +M+ LL+GL Y H+   LHRD+K +N+L+ 
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 159
Query: 290 NRGEVKLADFGLARLYNAEDRQRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             G +KLADFGLAR ++     +P  Y N+V+TLWYRPPELLLGE  YGP ID+W  GCI
Sbjct: 160 RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 219
Query: 348 LGELFVKKPLF 358
           + E++ + P+ 
Sbjct: 220 MAEMWTRSPIM 230

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  204 bits (520), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 100/191 (52%), Positives = 135/191 (70%), Gaps = 4/191 (2%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VALKKV +ENEKEGFPITA+REIKIL+ L H+N+VNL EI   ++ A  + + KGS
Sbjct: 42  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC--RTKASPYNRCKGS 99
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLVF++ +HDL GLL + +V F       +M+ LL+GL Y H+   LHRD+K +N+L+ 
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 159
Query: 290 NRGEVKLADFGLARLYNAEDRQRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             G +KLADFGLAR ++     +P  Y N+V+TLWYRPPELLLGE  YGP ID+W  GCI
Sbjct: 160 RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 219
Query: 348 LGELFVKKPLF 358
           + E++ + P+ 
Sbjct: 220 MAEMWTRSPIM 230

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  204 bits (520), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 100/191 (52%), Positives = 135/191 (70%), Gaps = 4/191 (2%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VALKKV +ENEKEGFPITA+REIKIL+ L H+N+VNL EI   ++ A  + + KGS
Sbjct: 41  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC--RTKASPYNRCKGS 98
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLVF++ +HDL GLL + +V F       +M+ LL+GL Y H+   LHRD+K +N+L+ 
Sbjct: 99  IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 158
Query: 290 NRGEVKLADFGLARLYNAEDRQRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             G +KLADFGLAR ++     +P  Y N+V+TLWYRPPELLLGE  YGP ID+W  GCI
Sbjct: 159 RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 218
Query: 348 LGELFVKKPLF 358
           + E++ + P+ 
Sbjct: 219 MAEMWTRSPIM 229

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 99/191 (51%), Positives = 134/191 (70%), Gaps = 4/191 (2%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VALKKV +ENEKEGFPITA+REIKIL+ L H+N+VNL EI   ++ A  + + K S
Sbjct: 42  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC--RTKASPYNRCKAS 99
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLVF++ +HDL GLL + +V F       +M+ LL+GL Y H+   LHRD+K +N+L+ 
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 159
Query: 290 NRGEVKLADFGLARLYNAEDRQRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             G +KLADFGLAR ++     +P  Y N+V+TLWYRPPELLLGE  YGP ID+W  GCI
Sbjct: 160 RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 219
Query: 348 LGELFVKKPLF 358
           + E++ + P+ 
Sbjct: 220 MAEMWTRSPIM 230

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 86/187 (45%), Positives = 117/187 (62%), Gaps = 12/187 (6%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           E  ALKK+RLE E EG P T +REI IL++L H NIV L +++  K              
Sbjct: 27  ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK----------RLV 76
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           LVFE++D DL  LL+        V   S + QLL+G++YCH R  LHRD+K  N+L+N  
Sbjct: 77  LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136
Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           GE+K+ADFGLAR +    R+  YT++V+TLWYR P++L+G ++Y   ID+WS GCI  E+
Sbjct: 137 GELKIADFGLARAFGIPVRK--YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194
Query: 352 FVKKPLF 358
               PLF
Sbjct: 195 VNGTPLF 201

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 86/187 (45%), Positives = 117/187 (62%), Gaps = 12/187 (6%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           E  ALKK+RLE E EG P T +REI IL++L H NIV L +++  K              
Sbjct: 27  ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK----------RLV 76
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           LVFE++D DL  LL+        V   S + QLL+G++YCH R  LHRD+K  N+L+N  
Sbjct: 77  LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136
Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           GE+K+ADFGLAR +    R+  YT++V+TLWYR P++L+G ++Y   ID+WS GCI  E+
Sbjct: 137 GELKIADFGLARAFGIPVRK--YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194
Query: 352 FVKKPLF 358
               PLF
Sbjct: 195 VNGAPLF 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 85/187 (45%), Positives = 117/187 (62%), Gaps = 12/187 (6%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           E  ALKK+RLE E EG P T +REI IL++L H NIV L +++  K              
Sbjct: 27  ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK----------RLV 76
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           LVFE++D DL  LL+        V   S + QLL+G++YCH R  LHRD+K  N+L+N  
Sbjct: 77  LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136
Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           GE+K+ADFGLAR +    R+  YT++++TLWYR P++L+G ++Y   ID+WS GCI  E+
Sbjct: 137 GELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194
Query: 352 FVKKPLF 358
               PLF
Sbjct: 195 VNGTPLF 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 87/190 (45%), Positives = 118/190 (62%), Gaps = 13/190 (6%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    +  
Sbjct: 34  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTENK 83
Query: 230 FYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L+
Sbjct: 84  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 143
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI 
Sbjct: 144 NTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIF 201
Query: 349 GELFVKKPLF 358
            E+  ++ LF
Sbjct: 202 AEMVTRRALF 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 95/209 (45%), Positives = 127/209 (60%), Gaps = 15/209 (7%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++ L  G  +      S  TD LVALK++RLE+E EG P TA+RE+ +L+ L H NIV L
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTL 65
Query: 211 REIV-TDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
            +I+ T+KS             LVFEY+D DL   L+      N  N    + QLL GL+
Sbjct: 66  HDIIHTEKS-----------LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           YCH++  LHRD+K  N+L+N RGE+KLADFGLAR  +     + Y N+V+TLWYRPP++L
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDIL 172
Query: 330 LGEERYGPAIDVWSCGCILGELFVKKPLF 358
           LG   Y   ID+W  GCI  E+   +PLF
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 26  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 75
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 76  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 135
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 136 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCI 193
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 194 FAEMVTRRALF 204

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 88/191 (46%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 26  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 75
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GLS+CH    LHRD+K  N+L
Sbjct: 76  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLL 135
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 136 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 193
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 194 FAEMVTRRALF 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 25  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 74
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 75  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 135 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 192
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 193 FAEMVTRRALF 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 26  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 75
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 76  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 135
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 136 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 193
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 194 FAEMVTRRALF 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 27  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 76
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 77  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 136
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 137 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 194
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 195 FAEMVTRRALF 205

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 87/190 (45%), Positives = 118/190 (62%), Gaps = 13/190 (6%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    +  
Sbjct: 34  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTENK 83
Query: 230 FYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L+
Sbjct: 84  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 143
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI 
Sbjct: 144 NTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 201
Query: 349 GELFVKKPLF 358
            E+  ++ LF
Sbjct: 202 AEMVTRRALF 211

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 26  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 75
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 76  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 135
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 136 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 193
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 194 FAEMVTRRALF 204

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 25  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 74
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 75  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 135 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 192
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 193 FAEMVTRRALF 203

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 30  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 79
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 80  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 139
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 140 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 197
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 198 FAEMVTRRALF 208

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 29  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 78
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++D DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 79  KLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 138
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 139 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 196
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 197 FAEMVTRRALF 207

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/191 (45%), Positives = 118/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 25  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 74
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 75  KLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 135 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 192
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 193 FAEMVTRRALF 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 29  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 78
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 79  KLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 138
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 139 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 196
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 197 FAEMVTRRALF 207

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 29  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 78
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 79  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 138
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 139 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 196
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 197 FAEMVTRRALF 207

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 28  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 77
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 78  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 137
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 138 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 195
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 196 FAEMVTRRALF 206

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 26  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 75
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 76  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 135
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 136 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 193
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 194 FAEMVTRRALF 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 27  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 76
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 77  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 136
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 137 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 194
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 195 FAEMVTRRALF 205

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 26  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 75
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 76  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 135
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 136 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 193
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 194 FAEMVTRRALF 204

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 28  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 77
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 78  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 137
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 138 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 195
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 196 FAEMVTRRALF 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VAL K+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 26  LTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 75
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 76  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 135
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 136 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 193
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 194 FAEMVTRRALF 204

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VAL K+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 25  LTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 74
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 75  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 135 INTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 192
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 193 FAEMVTRRALF 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 25  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 74
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 75  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 135 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 192
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 193 FAEMVTRRALF 203

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 26  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 75
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 76  KLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLL 135
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +      R Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 136 INTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 193
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 194 FAEMVTRRALF 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 26  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 75
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 76  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 135
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +      R Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 136 INTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 193
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 194 FAEMVTRRALF 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 29  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 78
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 79  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 138
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 139 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 196
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 197 FAEMVTRRALF 207

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 25  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 74
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 75  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 135 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 192
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 193 FAEMVTRRALF 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 27  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 76
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 77  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 136
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 137 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 194
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 195 FAEMVTRRALF 205

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 30  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 79
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 80  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 139
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 140 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 197
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 198 FAEMVTRRALF 208

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 28  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 77
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 78  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLL 137
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 138 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 195
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 196 FAEMVTRRALF 206

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 29  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 78
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 79  KLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 138
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 139 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 196
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 197 FAEMVTRRALF 207

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/190 (45%), Positives = 117/190 (61%), Gaps = 13/190 (6%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    +  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTENK 76
Query: 230 FYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 136
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           N  G +KLADFGLAR +      R Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI 
Sbjct: 137 NTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 349 GELFVKKPLF 358
            E+  ++ LF
Sbjct: 195 AEMVTRRALF 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 27  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 76
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 77  KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLL 136
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 137 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 194
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 195 FAEMVTRRALF 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 28  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 77
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 78  KLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 137
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +      R Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 138 INTEGAIKLADFGLARAFGVP--VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 195
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 196 FAEMVTRRALF 206

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 29  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 78
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 79  KLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLL 138
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 139 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 196
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 197 FAEMVTRRALF 207

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 86/191 (45%), Positives = 117/191 (61%), Gaps = 13/191 (6%)
Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L          LD    + 
Sbjct: 27  LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL----------LDVIHTEN 76
Query: 229 SFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
             YLVFE++  DL   ++ S +         S + QLL GL++CH    LHRD+K  N+L
Sbjct: 77  KLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLL 136
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +N  G +KLADFGLAR +    R   Y ++V+TLWYR PE+LLG + Y  A+D+WS GCI
Sbjct: 137 INTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI 194
Query: 348 LGELFVKKPLF 358
             E+  ++ LF
Sbjct: 195 FAEMVTRRALF 205

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 89/190 (46%), Positives = 121/190 (63%), Gaps = 13/190 (6%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALK+VRL+++ EG P +A+REI +L++L HKNIV L +++           DK  
Sbjct: 26  THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL---------HSDK-K 75
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             LVFE+ D DL    +S   D +     S + QLL GL +CH RN LHRD+K  N+L+N
Sbjct: 76  LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             GE+KLADFGLAR +      R Y+ +V+TLWYRPP++L G + Y  +ID+WS GCI  
Sbjct: 136 RNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 350 ELF-VKKPLF 358
           EL    +PLF
Sbjct: 194 ELANAARPLF 203

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 78/186 (41%), Positives = 120/186 (64%), Gaps = 12/186 (6%)
Query: 173 LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           +VALK++RL+ E EG P TA+REI +L++L+H NIV+L +++  +              L
Sbjct: 47  IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER----------CLTL 96
Query: 233 VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           VFE+M+ DL  +L+       +      + QLL G+++CH+   LHRD+K  N+L+N+ G
Sbjct: 97  VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG 156
Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            +KLADFGLAR +      R YT++V+TLWYR P++L+G ++Y  ++D+WS GCI  E+ 
Sbjct: 157 ALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
Query: 353 VKKPLF 358
             KPLF
Sbjct: 215 TGKPLF 220

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 78/186 (41%), Positives = 120/186 (64%), Gaps = 12/186 (6%)
Query: 173 LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           +VALK++RL+ E EG P TA+REI +L++L+H NIV+L +++  +              L
Sbjct: 47  IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER----------CLTL 96
Query: 233 VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           VFE+M+ DL  +L+       +      + QLL G+++CH+   LHRD+K  N+L+N+ G
Sbjct: 97  VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG 156
Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            +KLADFGLAR +      R YT++V+TLWYR P++L+G ++Y  ++D+WS GCI  E+ 
Sbjct: 157 ALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
Query: 353 VKKPLF 358
             KPLF
Sbjct: 215 TGKPLF 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 88/190 (46%), Positives = 121/190 (63%), Gaps = 13/190 (6%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALK+VRL+++ EG P +A+REI +L++L HKNIV L +++           DK  
Sbjct: 26  THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL---------HSDK-K 75
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             LVFE+ D DL    +S   D +     S + QLL GL +CH RN LHRD+K  N+L+N
Sbjct: 76  LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             GE+KLA+FGLAR +      R Y+ +V+TLWYRPP++L G + Y  +ID+WS GCI  
Sbjct: 136 RNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 350 ELF-VKKPLF 358
           EL    +PLF
Sbjct: 194 ELANAGRPLF 203

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 87/221 (39%), Positives = 134/221 (60%), Gaps = 18/221 (8%)
Query: 143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL 202
           +++S    +E L  G  +     ++  T   VALK+V+L++E EG P TA+REI ++++L
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKEL 60
Query: 203 NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFN----EVNNA 258
            H+NIV L +++            +    LVFE+MD+DL   ++S  V       E+N  
Sbjct: 61  KHENIVRLYDVI----------HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 259 SIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNK 317
              + QLL GL++CH+   LHRD+K  N+L+N RG++KL DFGLAR +        ++++
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--VNTFSSE 168
Query: 318 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           V+TLWYR P++L+G   Y  +ID+WSCGCIL E+   KPLF
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 83/235 (35%), Positives = 135/235 (57%), Gaps = 20/235 (8%)
Query: 129 PMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF 188
           P  M  +A   + S +   R  +  L  G       ++   T+E VA+K++RLE+E+EG 
Sbjct: 19  PGSMSVSAAPSATSIDRYRR--ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV 76
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P TA+RE+ +L++L H+NI+ L+ ++                +L+FEY ++DL   ++  
Sbjct: 77  PGTAIREVSLLKELQHRNIIELKSVI----------HHNHRLHLIFEYAENDLKKYMDKN 126
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE-----VKLADFGLAR 303
             D +     S + QL++G+++CH R  LHRD+K  N+L++         +K+ DFGLAR
Sbjct: 127 -PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
Query: 304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            +    RQ  +T+++ITLWYRPPE+LLG   Y  ++D+WS  CI  E+ +K PLF
Sbjct: 186 AFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 79/191 (41%), Positives = 118/191 (61%), Gaps = 16/191 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  +VA+KK    ++ +     A+REIK+L+QL H+N+VNL E+           K K  
Sbjct: 49  TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC----------KKKKR 98
Query: 230 FYLVFEYMDHDLMGLLE--SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
           +YLVFE++DH ++  LE     +D+  V     + Q+++G+ +CH  N +HRDIK  NIL
Sbjct: 99  WYLVFEFVDHTILDDLELFPNGLDYQVVQ--KYLFQIINGIGFCHSHNIIHRDIKPENIL 156
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           ++  G VKL DFG AR   A      Y ++V T WYR PELL+G+ +YG A+DVW+ GC+
Sbjct: 157 VSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCL 214
Query: 348 LGELFVKKPLF 358
           + E+F+ +PLF
Sbjct: 215 VTEMFMGEPLF 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 117/193 (60%), Gaps = 19/193 (9%)
Query: 173 LVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREIVTDKSDALDFRKDKGS 229
            VALK+VR++  +EG P++ +RE+ +LR L    H N+V L ++ T        R D+ +
Sbjct: 39  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS------RTDRET 92
Query: 230 -FYLVFEYMDHDLMGLLESGMVDFNEVNNASI---MRQLLDGLSYCHKRNFLHRDIKCSN 285
              LVFE++D DL   L+   V    V   +I   M QLL GL + H    +HRD+K  N
Sbjct: 93  KLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 150
Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           IL+ + G++KLADFGLAR+Y+    Q   T+ V+TLWYR PE+LL +  Y   +D+WS G
Sbjct: 151 ILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVG 206
Query: 346 CILGELFVKKPLF 358
           CI  E+F +KPLF
Sbjct: 207 CIFAEMFRRKPLF 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 117/193 (60%), Gaps = 19/193 (9%)
Query: 173 LVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREIVTDKSDALDFRKDKGS 229
            VALK+VR++  +EG P++ +RE+ +LR L    H N+V L ++ T        R D+ +
Sbjct: 39  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS------RTDRET 92
Query: 230 -FYLVFEYMDHDLMGLLESGMVDFNEVNNASI---MRQLLDGLSYCHKRNFLHRDIKCSN 285
              LVFE++D DL   L+   V    V   +I   M QLL GL + H    +HRD+K  N
Sbjct: 93  KLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 150
Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           IL+ + G++KLADFGLAR+Y+    Q   T+ V+TLWYR PE+LL +  Y   +D+WS G
Sbjct: 151 ILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVG 206
Query: 346 CILGELFVKKPLF 358
           CI  E+F +KPLF
Sbjct: 207 CIFAEMFRRKPLF 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 117/193 (60%), Gaps = 19/193 (9%)
Query: 173 LVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREIVTDKSDALDFRKDKGS 229
            VALK+VR++  +EG P++ +RE+ +LR L    H N+V L ++ T        R D+ +
Sbjct: 39  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS------RTDRET 92
Query: 230 -FYLVFEYMDHDLMGLLESGMVDFNEVNNASI---MRQLLDGLSYCHKRNFLHRDIKCSN 285
              LVFE++D DL   L+   V    V   +I   M QLL GL + H    +HRD+K  N
Sbjct: 93  KLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 150
Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           IL+ + G++KLADFGLAR+Y+    Q   T+ V+TLWYR PE+LL +  Y   +D+WS G
Sbjct: 151 ILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVG 206
Query: 346 CILGELFVKKPLF 358
           CI  E+F +KPLF
Sbjct: 207 CIFAEMFRRKPLF 219

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/194 (42%), Positives = 116/194 (59%), Gaps = 15/194 (7%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREI-VTDKSDALDFRK 225
           +   VALK VR+ N +EG PI+ VRE+ +LR+L    H N+V L ++  T ++D    R+
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD----RE 83
Query: 226 DKGSFYLVFEYMDHDLMGLLESGMV-DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
            K +  LVFE++D DL   L+              +MRQ L GL + H    +HRD+K  
Sbjct: 84  IKVT--LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 141
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           NIL+ + G VKLADFGLAR+Y+ +    P    V+TLWYR PE+LL +  Y   +D+WS 
Sbjct: 142 NILVTSGGTVKLADFGLARIYSYQMALAPV---VVTLWYRAPEVLL-QSTYATPVDMWSV 197
Query: 345 GCILGELFVKKPLF 358
           GCI  E+F +KPLF
Sbjct: 198 GCIFAEMFRRKPLF 211

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/194 (42%), Positives = 116/194 (59%), Gaps = 15/194 (7%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREI-VTDKSDALDFRK 225
           +   VALK VR+ N +EG PI+ VRE+ +LR+L    H N+V L ++  T ++D    R+
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD----RE 83
Query: 226 DKGSFYLVFEYMDHDLMGLLESGMV-DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
            K +  LVFE++D DL   L+              +MRQ L GL + H    +HRD+K  
Sbjct: 84  IKVT--LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 141
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           NIL+ + G VKLADFGLAR+Y+ +    P    V+TLWYR PE+LL +  Y   +D+WS 
Sbjct: 142 NILVTSGGTVKLADFGLARIYSYQMALDPV---VVTLWYRAPEVLL-QSTYATPVDMWSV 197
Query: 345 GCILGELFVKKPLF 358
           GCI  E+F +KPLF
Sbjct: 198 GCIFAEMFRRKPLF 211

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 83/194 (42%), Positives = 116/194 (59%), Gaps = 15/194 (7%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREI-VTDKSDALDFRK 225
           +   VALK VR+ N +EG PI+ VRE+ +LR+L    H N+V L ++  T ++D    R+
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD----RE 83
Query: 226 DKGSFYLVFEYMDHDLMGLLESGMV-DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
            K +  LVFE++D DL   L+              +MRQ L GL + H    +HRD+K  
Sbjct: 84  IKVT--LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 141
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           NIL+ + G VKLADFGLAR+Y+ +    P    V+TLWYR PE+LL +  Y   +D+WS 
Sbjct: 142 NILVTSGGTVKLADFGLARIYSYQMALFPV---VVTLWYRAPEVLL-QSTYATPVDMWSV 197
Query: 345 GCILGELFVKKPLF 358
           GCI  E+F +KPLF
Sbjct: 198 GCIFAEMFRRKPLF 211

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 74/192 (38%), Positives = 116/192 (60%), Gaps = 15/192 (7%)
Query: 170 TDELVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T+++VA+KK++L      K+G   TA+REIK+L++L+H NI+ L          LD    
Sbjct: 34  TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL----------LDAFGH 83
Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           K +  LVF++M+ DL  +++   +     +  + M   L GL Y H+   LHRD+K +N+
Sbjct: 84  KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L++  G +KLADFGLA+ + + +R   Y ++V+T WYR PELL G   YG  +D+W+ GC
Sbjct: 144 LLDENGVLKLADFGLAKSFGSPNRA--YXHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 201
Query: 347 ILGELFVKKPLF 358
           IL EL ++ P  
Sbjct: 202 ILAELLLRVPFL 213

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 76/189 (40%), Positives = 107/189 (56%), Gaps = 12/189 (6%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++VA+KK     +       A+REI++L+QL H N+VNL E+         FR+ K  
Sbjct: 27  TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV---------FRR-KRR 76
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +LVFEY DH ++  L+       E    SI  Q L  +++CHK N +HRD+K  NIL+ 
Sbjct: 77  LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
               +KL DFG ARL         Y ++V T WYR PELL+G+ +YGP +DVW+ GC+  
Sbjct: 137 KHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194
Query: 350 ELFVKKPLF 358
           EL    PL+
Sbjct: 195 ELLSGVPLW 203

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/214 (38%), Positives = 121/214 (56%), Gaps = 10/214 (4%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++PL  GG  L   +V    D+ VA+KK+ L + +      A+REIKI+R+L+H NIV +
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS--VKHALREIKIIRRLDHDNIVKV 73
Query: 211 REIV----TDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLD 266
            EI+    +  +D +    +  S Y+V EYM+ DL  +LE G     E +    M QLL 
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG--PLLEEHARLFMYQLLR 131
Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEV-KLADFGLARLYNAEDRQRPYTNK-VITLWYR 324
           GL Y H  N LHRD+K +N+ +N    V K+ DFGLAR+ +     + + ++ ++T WYR
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 325 PPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            P LLL    Y  AID+W+ GCI  E+   K LF
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/197 (42%), Positives = 114/197 (57%), Gaps = 18/197 (9%)
Query: 170 TDELVALKKVRLENEKEG---FPITAVREIKILRQLN---HKNIVNLREI-VTDKSDALD 222
           +   VALK VR+ N   G    PI+ VRE+ +LR+L    H N+V L ++  T ++D   
Sbjct: 33  SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD--- 89
Query: 223 FRKDKGSFYLVFEYMDHDLMGLLESGMV-DFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
            R+ K +  LVFE++D DL   L+              +MRQ L GL + H    +HRD+
Sbjct: 90  -REIKVT--LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDL 146
Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           K  NIL+ + G VKLADFGLAR+Y+    Q   T  V+TLWYR PE+LL +  Y   +D+
Sbjct: 147 KPENILVTSGGTVKLADFGLARIYS---YQMALTPVVVTLWYRAPEVLL-QSTYATPVDM 202
Query: 342 WSCGCILGELFVKKPLF 358
           WS GCI  E+F +KPLF
Sbjct: 203 WSVGCIFAEMFRRKPLF 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 82/229 (35%), Positives = 121/229 (52%), Gaps = 30/229 (13%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIV 208
           L++ L  G   +   S+   T E+VA+KK+    +         REI IL +L+ H+NIV
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGL 268
           NL  ++   +D           YLVF+YM+ DL  ++ + +++   V+   ++ QL+  +
Sbjct: 73  NLLNVLRADNDR--------DVYLVFDYMETDLHAVIRANILE--PVHKQYVVYQLIKVI 122
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY-------------------NAED 309
            Y H    LHRD+K SNIL+N    VK+ADFGL+R +                   N +D
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            Q   T+ V T WYR PE+LLG  +Y   ID+WS GCILGE+   KP+F
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 72/197 (36%), Positives = 114/197 (57%), Gaps = 16/197 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK+    +K  F +  +REIKIL+   H+NI+ +  I   + D+ +   +   
Sbjct: 35  TGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIFNI--QRPDSFE---NFNE 88
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y++ E M  DL  ++ + M+  + +     + Q L  +   H  N +HRD+K SN+L+N
Sbjct: 89  VYIIQELMQTDLHRVISTQMLSDDHIQ--YFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146
Query: 290 NRGEVKLADFGLARLYN--AEDRQRP------YTNKVITLWYRPPELLLGEERYGPAIDV 341
           +  ++K+ DFGLAR+ +  A D   P       T  V T WYR PE++L   +Y  A+DV
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 342 WSCGCILGELFVKKPLF 358
           WSCGCIL ELF+++P+F
Sbjct: 207 WSCGCILAELFLRRPIF 223

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 72/197 (36%), Positives = 114/197 (57%), Gaps = 16/197 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK+    +K  F +  +REIKIL+   H+NI+ +  I   + D+ +   +   
Sbjct: 35  TGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIFNI--QRPDSFE---NFNE 88
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y++ E M  DL  ++ + M+  + +     + Q L  +   H  N +HRD+K SN+L+N
Sbjct: 89  VYIIQELMQTDLHRVISTQMLSDDHIQ--YFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146
Query: 290 NRGEVKLADFGLARLYN--AEDRQRP------YTNKVITLWYRPPELLLGEERYGPAIDV 341
           +  ++K+ DFGLAR+ +  A D   P       T  V T WYR PE++L   +Y  A+DV
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 342 WSCGCILGELFVKKPLF 358
           WSCGCIL ELF+++P+F
Sbjct: 207 WSCGCILAELFLRRPIF 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 70/186 (37%), Positives = 112/186 (60%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REI+IL +  H+N++ +R+I+  ++  L+  +D    Y+V
Sbjct: 71  VAIKKIS-PFEHQTYCQRTLREIQILLRFRHENVIGIRDIL--RASTLEAMRD---VYIV 124
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL+S  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 125 QDLMETDLYKLLKSQQLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD 182
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + E D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 183 LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242
Query: 353 VKKPLF 358
             +P+F
Sbjct: 243 SNRPIF 248

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 70/189 (37%), Positives = 106/189 (56%), Gaps = 12/189 (6%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + E VA+KK+    + E F   A RE+ +L+ + H+N++ L ++ T  S   +F      
Sbjct: 66  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY----D 121
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLV  +M  DL  ++  GM +F+E     ++ Q+L GL Y H    +HRD+K  N+ +N
Sbjct: 122 FYLVMPFMQTDLQKIM--GM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 178
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
              E+K+ DFGLAR  +AE      T  V+T WYR PE++L    Y   +D+WS GCI+ 
Sbjct: 179 EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 233
Query: 350 ELFVKKPLF 358
           E+   K LF
Sbjct: 234 EMLTGKTLF 242

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 114/197 (57%), Gaps = 16/197 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK+    +K  F +  +REIKIL+   H+NI+ +  I   + D+ +   +   
Sbjct: 35  TGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIFNI--QRPDSFE---NFNE 88
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y++ E M  DL  ++ + M+  + +     + Q L  +   H  N +HRD+K SN+L+N
Sbjct: 89  VYIIQELMQTDLHRVISTQMLSDDHIQ--YFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146
Query: 290 NRGEVKLADFGLARLYN--AEDRQRPYTNK------VITLWYRPPELLLGEERYGPAIDV 341
           +  ++K+ DFGLAR+ +  A D   P   +      V T WYR PE++L   +Y  A+DV
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 342 WSCGCILGELFVKKPLF 358
           WSCGCIL ELF+++P+F
Sbjct: 207 WSCGCILAELFLRRPIF 223

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 76/204 (37%), Positives = 115/204 (56%), Gaps = 39/204 (19%)
Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           ALK++    E  G  ++A REI +LR+L H N+++L+++    +D    RK     +L+F
Sbjct: 52  ALKQI----EGTGISMSACREIALLRELKHPNVISLQKVFLSHAD----RK----VWLLF 99
Query: 235 EYMDHDLMGLLESGMVDFNEVNNA-------------SIMRQLLDGLSYCHKRNFLHRDI 281
           +Y +HDL  +++     F+  + A             S++ Q+LDG+ Y H    LHRD+
Sbjct: 100 DYAEHDLWHIIK-----FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 154
Query: 282 KCSNILMNN----RGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEER 334
           K +NIL+      RG VK+AD G ARL+N+    +P  +    V+T WYR PELLLG   
Sbjct: 155 KPANILVMGEGPERGRVKIADMGFARLFNSP--LKPLADLDPVVVTFWYRAPELLLGARH 212
Query: 335 YGPAIDVWSCGCILGELFVKKPLF 358
           Y  AID+W+ GCI  EL   +P+F
Sbjct: 213 YTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 68/189 (35%), Positives = 104/189 (55%), Gaps = 12/189 (6%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + E VA+KK+    + E F   A RE+ +L+ + H+N++ L ++ T  S   +F      
Sbjct: 48  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY----D 103
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLV  +M  DL  ++    + F+E     ++ Q+L GL Y H    +HRD+K  N+ +N
Sbjct: 104 FYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
              E+K+ DFGLAR  +AE      T  V+T WYR PE++L    Y   +D+WS GCI+ 
Sbjct: 161 EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 350 ELFVKKPLF 358
           E+   K LF
Sbjct: 216 EMLTGKTLF 224

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G       +V   T   VA+KK+    + E F   A RE+++L+ + H+N++ L
Sbjct: 30  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      DF      FYLV  +M  DL  L++   +  + +    ++ Q+L GL Y
Sbjct: 90  LDVFTPDETLDDFT----DFYLVMPFMGTDLGKLMKHEKLGEDRIQ--FLVYQMLKGLRY 143
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K  N+ +N   E+K+ DFGLAR  ++E         V+T WYR PE++L
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
              RY   +D+WS GCI+ E+   K LF
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 55  VAIKKIS-PFEHQTYXQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 108
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 109 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD 166
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 353 VKKPLF 358
             +P+F
Sbjct: 227 SNRPIF 232

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 110/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL    H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 53  VAIKKIS-PFEHQTYCQRTLREIKILLAFRHENIIGINDII--RAPTIEQMKD---VYIV 106
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 107 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSD 164
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 165 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224
Query: 353 VKKPLF 358
             +P+F
Sbjct: 225 SNRPIF 230

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 51  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 104
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 105 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD 162
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 163 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 353 VKKPLF 358
             +P+F
Sbjct: 223 SNRPIF 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 68/186 (36%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 51  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 104
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 105 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD 162
Query: 294 VKLADFGLARLYNAEDRQRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + +     + T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 163 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 353 VKKPLF 358
             +P+F
Sbjct: 223 SNRPIF 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 51  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 104
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 105 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD 162
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 163 LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 353 VKKPLF 358
             +P+F
Sbjct: 223 SNRPIF 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 53  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 106
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 107 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 164
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 165 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224
Query: 353 VKKPLF 358
             +P+F
Sbjct: 225 SNRPIF 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 55  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 108
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 109 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD 166
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 353 VKKPLF 358
             +P+F
Sbjct: 227 SNRPIF 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 51  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 104
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 105 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 162
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 163 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 353 VKKPLF 358
             +P+F
Sbjct: 223 SNRPIF 228

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 68/186 (36%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 71  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 124
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 125 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 182
Query: 294 VKLADFGLARLYNAEDRQRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + +     + T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 183 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242
Query: 353 VKKPLF 358
             +P+F
Sbjct: 243 SNRPIF 248

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 70/186 (37%), Positives = 109/186 (58%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    YLV
Sbjct: 71  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYLV 124
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
              M  DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 125 THLMGADLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD 182
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 183 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242
Query: 353 VKKPLF 358
             +P+F
Sbjct: 243 SNRPIF 248

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 56  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 109
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 110 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 167
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 168 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227
Query: 353 VKKPLF 358
             +P+F
Sbjct: 228 SNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 57  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 110
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 111 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 168
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 169 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 228
Query: 353 VKKPLF 358
             +P+F
Sbjct: 229 SNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 48  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 101
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 102 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 159
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 160 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 219
Query: 353 VKKPLF 358
             +P+F
Sbjct: 220 SNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 55  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 108
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 109 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 353 VKKPLF 358
             +P+F
Sbjct: 227 SNRPIF 232

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 49  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 102
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 103 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 160
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 161 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 220
Query: 353 VKKPLF 358
             +P+F
Sbjct: 221 SNRPIF 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 59  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 112
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 113 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 170
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 171 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 230
Query: 353 VKKPLF 358
             +P+F
Sbjct: 231 SNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 51  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 104
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 105 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 162
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 163 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222
Query: 353 VKKPLF 358
             +P+F
Sbjct: 223 SNRPIF 228

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 110/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL    H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 53  VAIKKIS-PFEHQTYCQRTLREIKILLAFRHENIIGINDII--RAPTIEQMKD---VYIV 106
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 107 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 164
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 165 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224
Query: 353 VKKPLF 358
             +P+F
Sbjct: 225 SNRPIF 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 68/186 (36%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 49  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 102
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 103 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 160
Query: 294 VKLADFGLARLYNAEDRQRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + +     + T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 161 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 220
Query: 353 VKKPLF 358
             +P+F
Sbjct: 221 SNRPIF 226

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 111/212 (52%), Gaps = 9/212 (4%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           ++E +  G   + + +    T + VA+KK+    +        +RE+KIL+   H NI+ 
Sbjct: 59  IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIA 118
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGL 268
           +++I+       +F+    S Y+V + M+ DL  ++ S   +    V     + QLL GL
Sbjct: 119 IKDILRPTVPYGEFK----SVYVVLDLMESDLHQIIHSSQPLTLEHVRY--FLYQLLRGL 172
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY--TNKVITLWYRPP 326
            Y H    +HRD+K SN+L+N   E+K+ DFG+AR       +  Y  T  V T WYR P
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 327 ELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           EL+L    Y  AID+WS GCI GE+  ++ LF
Sbjct: 233 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 264

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 111/212 (52%), Gaps = 9/212 (4%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           ++E +  G   + + +    T + VA+KK+    +        +RE+KIL+   H NI+ 
Sbjct: 58  IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIA 117
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGL 268
           +++I+       +F+    S Y+V + M+ DL  ++ S   +    V     + QLL GL
Sbjct: 118 IKDILRPTVPYGEFK----SVYVVLDLMESDLHQIIHSSQPLTLEHVRY--FLYQLLRGL 171
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY--TNKVITLWYRPP 326
            Y H    +HRD+K SN+L+N   E+K+ DFG+AR       +  Y  T  V T WYR P
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 327 ELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           EL+L    Y  AID+WS GCI GE+  ++ LF
Sbjct: 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 69/186 (37%), Positives = 110/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 55  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 108
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL+   +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 109 QDLMETDLYKLLKCQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 353 VKKPLF 358
             +P+F
Sbjct: 227 SNRPIF 232

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 68/186 (36%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA++K+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 55  VAIRKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 108
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 109 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166
Query: 294 VKLADFGLARLYNAE-DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + + D     T  V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 353 VKKPLF 358
             +P+F
Sbjct: 227 SNRPIF 232

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 67/186 (36%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 55  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 108
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 109 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166
Query: 294 VKLADFGLARLYNAEDRQRPYTNK-VITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + +     +  + V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 167 LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 353 VKKPLF 358
             +P+F
Sbjct: 227 SNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 67/186 (36%), Positives = 111/186 (59%), Gaps = 9/186 (4%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KK+    E + +    +REIKIL +  H+NI+ + +I+  ++  ++  KD    Y+V
Sbjct: 56  VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDII--RAPTIEQMKD---VYIV 109
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            + M+ DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N   +
Sbjct: 110 QDLMETDLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 167
Query: 294 VKLADFGLARLYNAEDRQRPYTNK-VITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +K+ DFGLAR+ + +     +  + V T WYR PE++L  + Y  +ID+WS GCIL E+ 
Sbjct: 168 LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227
Query: 353 VKKPLF 358
             +P+F
Sbjct: 228 SNRPIF 233

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKTLEEFQ----DVYLVMELMDANLXQVIQ---MELDHERMSYLLYQMLXGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 82  LNVFTPQKTLEEFQ----DVYLVMELMDANLXQVIQ---MELDHERMSYLLYQMLXGIKH 134
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 191
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 192 G-MGYKENVDIWSVGCIMGEMVRHKILF 218

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKTLEEFQ----DVYLVMELMDANLXQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKTLEEFQ----DVYLVMELMDANLXQVIQ---MELDHERMSYLLYQMLXGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 61/165 (36%), Positives = 91/165 (55%), Gaps = 11/165 (6%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFN 253
           RE+++L+ L H+N++ L ++ T  +   DF +     YLV   M  DL  +++S  +   
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSE----VYLVTTLMGADLNNIVKSQALSDE 131
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            V    ++ QLL GL Y H    +HRD+K SN+ +N   E+++ DFGLAR  + E     
Sbjct: 132 HVQ--FLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----- 184
Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            T  V T WYR PE++L    Y   +D+WS GCI+ EL   K LF
Sbjct: 185 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 127 LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 179
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 236
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 237 G-MGYKENVDIWSVGCIMGEMVRHKILF 263

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 30  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 90  LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 142
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 199
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 200 G-MGYKENVDIWSVGCIMGEMVRHKILF 226

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 30  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 90  LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 142
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 199
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 200 G-MGYKENVDIWSVGCIMGEMVRHKILF 226

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 28  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 88  LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 141 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 197
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 198 G-MGYKENVDIWSVGCIMGEMVRHKILF 224

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 29  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 23  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 83  LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 135
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 192
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 193 G-MGYKENVDIWSVGCIMGEMVRHKILF 219

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 127 LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 179
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 236
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 237 G-MGYKENVDIWSVGCIMGEMVRHKILF 263

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 22  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 82  LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 134
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 191
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 192 G-MGYKENVDIWSVGCIMGEMVRHKILF 218

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++L
Sbjct: 23  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      YLV E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 83  LNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 135
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 192
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 193 G-MGYKENVDIWSVGCIMGEMVRHKILF 219

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 60/165 (36%), Positives = 90/165 (54%), Gaps = 11/165 (6%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFN 253
           RE+++L+ L H+N++ L ++ T  +   DF +     YLV   M  DL  +++   +   
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSE----VYLVTTLMGADLNNIVKCQALSDE 131
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            V    ++ QLL GL Y H    +HRD+K SN+ +N   E+++ DFGLAR  + E     
Sbjct: 132 HVQ--FLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----- 184
Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            T  V T WYR PE++L    Y   +D+WS GCI+ EL   K LF
Sbjct: 185 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 34  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 94  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 146
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 147 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 203
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 204 G-MGYKENVDLWSVGCIMGEMVCHKILF 230

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 60/165 (36%), Positives = 90/165 (54%), Gaps = 11/165 (6%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFN 253
           RE+++L+ L H+N++ L ++ T  +   DF +     YLV   M  DL  +++   +   
Sbjct: 68  RELRLLKHLKHENVIGLLDVFTPATSIEDFSE----VYLVTTLMGADLNNIVKCQALSDE 123
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            V    ++ QLL GL Y H    +HRD+K SN+ +N   E+++ DFGLAR  + E     
Sbjct: 124 HVQ--FLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE----- 176
Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            T  V T WYR PE++L    Y   +D+WS GCI+ EL   K LF
Sbjct: 177 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 23  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 83  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 135
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 192
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 193 G-MGYKENVDLWSVGCIMGEMVCHKILF 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLVGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         P   +V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP---EVVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMVCHKILF 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 23  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 83  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCAKLTDDHVQ--FLIYQILRGLKY 136
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 191
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 30  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 90  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 142
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 199
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 200 G-MGYKENVDIWSVGCIMGEMIKGGVLF 226

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         P   +V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP---EVVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+   K LF
Sbjct: 199 G-MGYKENVDLWSVGCIMGEMVCHKILF 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 33  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 93  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 146
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 201
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 46  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 106 LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 159
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 214
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 115/210 (54%), Gaps = 15/210 (7%)
Query: 151 MEPLAAG--GLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIV 208
           ++P+ +G  G+    F   L  +  VA+KK+    + +     A RE+ +L+ +NHKNI+
Sbjct: 27  LKPIGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNII 84
Query: 209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGL 268
           +L  + T +    +F+      YLV E MD +L  ++    ++ +    + ++ Q+L G+
Sbjct: 85  SLLNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGI 137
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            + H    +HRD+K SNI++ +   +K+ DFGLAR  +      PY   V+T +YR PE+
Sbjct: 138 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPY---VVTRYYRAPEV 194
Query: 329 LLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +LG   Y   +D+WS GCI+GEL     +F
Sbjct: 195 ILG-MGYKENVDIWSVGCIMGELVKGSVIF 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 47  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 107 LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 160
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 215
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 23  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 83  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 136
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 191
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 37  LAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 96
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 97  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 150
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 205
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 206 NWMHYNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NAMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++S  +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKSQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGL R  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 151 MEPLAAG--GLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIV 208
           ++P+ +G  G+    F   L  +  VA+KK+    + +     A RE+ +L+ +NHKNI+
Sbjct: 29  LKPIGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNII 86
Query: 209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGL 268
           +L  + T +    +F+      YLV E MD +L  ++    ++ +    + ++ Q+L G+
Sbjct: 87  SLLNVFTPQKTLEEFQ----DVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGI 139
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            + H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY---VVTRYYRAPEV 196
Query: 329 LLGEERYGPAIDVWSCGCILGEL 351
           +LG   Y   +D+WS GCI+GEL
Sbjct: 197 ILG-MGYAANVDIWSVGCIMGEL 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 33  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 93  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 146
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 201
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 29  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 89  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 142
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 197
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       S  + +   +A+KK+    +         RE+++L+ + H+N++ L
Sbjct: 56  LSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 115
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T  +   +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 116 LDVFTPATSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 169
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 224
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 225 NWMHYNMTVDIWSVGCIMAELLTGRTLF 252

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKXQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 32  LSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 92  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 145
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 200
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 31  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 91  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 143
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         P+   V+T +YR PE++L
Sbjct: 144 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPF---VVTRYYRAPEVIL 200
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 201 G-MGYKENVDIWSVGCIMGEMIKGGVLF 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 33  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 93  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 146
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 201
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 38  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 98  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 151
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 206
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 29  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 89  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 142
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 197
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 50  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 110 LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 163
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 218
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 32  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 92  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 145
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 200
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 46  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 106 LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 159
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 214
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 33  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 93  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 146
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 201
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 38  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 98  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 151
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 206
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 23  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 83  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 136
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 191
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 39  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 99  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 152
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 207
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 24  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 84  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 137
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 192
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 39  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 99  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 152
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 207
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 47  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 107 LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 160
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 215
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 29  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 89  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 142
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 197
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 94  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 147
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 202
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLVGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS G I+GE+     LF
Sbjct: 199 G-MGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 25  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 84
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 85  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 138
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 193
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 32  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 92  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 145
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 200
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 26  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 85
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 86  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 139
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 194
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 195 NWMHYNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKXQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 39  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 99  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 152
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 207
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 32  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 92  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 145
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 200
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 29  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 89  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 142
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 197
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/185 (36%), Positives = 92/185 (49%), Gaps = 31/185 (16%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF 252
           +REI IL +LNH ++V + +IV  K D   F       Y+V E  D D   L  +  V  
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPK-DVEKF----DELYVVLEIADSDFKKLFRTP-VYL 153
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN------ 306
            E++  +++  LL G+ Y H    LHRD+K +N L+N    VK+ DFGLAR  +      
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 307 -------------------AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
                               ++ +R  T  V+T WYR PEL+L +E Y  AIDVWS GCI
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 348 LGELF 352
             EL 
Sbjct: 274 FAELL 278

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLSQVIQ---MELDHERMSYLLYQMLVGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         PY   V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS G I+GE+     LF
Sbjct: 199 G-MGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 24  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 84  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 137
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E      T  V T WYR PE++L
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 192
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 47  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 107 LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 160
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + E         V T WYR PE++L
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAPEIML 215
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++P+ +G   +   +     +  VA+KK+    + +     A RE+ +++ +NHKNI+ L
Sbjct: 29  LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
             + T +    +F+      Y+V E MD +L  +++   ++ +    + ++ Q+L G+ +
Sbjct: 89  LNVFTPQKSLEEFQ----DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKH 141
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRD+K SNI++ +   +K+ DFGLAR         P   +V+T +YR PE++L
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---EVVTRYYRAPEVIL 198
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
           G   Y   +D+WS GCI+GE+     LF
Sbjct: 199 G-MGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 94  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 147
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR + A++     T  V T WYR PE++L
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM----TGYVATRWYRAPEIML 202
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 94  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 147
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR + A++     T  V T WYR PE++L
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM----TGYVATRWYRAPEIML 202
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 50  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 110 LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 163
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + +D    Y   V T WYR PE++L
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGY---VATRWYRAPEIML 218
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + +D    +   V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGF---VATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 94  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 147
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR + A++     T  V T WYR PE++L
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM----TGYVATRWYRAPEIML 202
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + +D    +   V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGF---VATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 23  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 83  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 136
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DFGLAR  + +D    +   V T WYR PE++L
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGF---VATRWYRAPEIML 191
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ D+GLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ DF LAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+  FGLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ D GLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ D GLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           + P+ +G       +    T   VA+KK+    +         RE+++L+ + H+N++ L
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            ++ T      +F       YLV   M  DL  +++   +  + V    ++ Q+L GL Y
Sbjct: 87  LDVFTPARSLEEF----NDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKY 140
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H  + +HRD+K SN+ +N   E+K+ D GLAR  + E      T  V T WYR PE++L
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
               Y   +D+WS GCI+ EL   + LF
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 103/203 (50%), Gaps = 26/203 (12%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T++ VA+KKV    E        +REI IL +L    I+ L +++    D L F      
Sbjct: 50  TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII-PDDLLKF----DE 104
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y+V E  D DL  L ++ +    E +  +I+  LL G ++ H+   +HRD+K +N L+N
Sbjct: 105 LYIVLEIADSDLKKLFKTPIF-LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163
Query: 290 NRGEVKLADFGLARLYNAE--------------------DRQRPYTNKVITLWYRPPELL 329
               VK+ DFGLAR  N+E                    + ++  T+ V+T WYR PEL+
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223
Query: 330 LGEERYGPAIDVWSCGCILGELF 352
           L +E Y  +ID+WS GCI  EL 
Sbjct: 224 LLQENYTKSIDIWSTGCIFAELL 246

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 109/191 (57%), Gaps = 24/191 (12%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           ++++ ++V+ + +KE      +RE+++L+QL+H NI+ L E          F +DKG FY
Sbjct: 80  KVISKRQVKQKTDKESL----LREVQLLKQLDHPNIMKLYE----------FFEDKGYFY 125
Query: 232 LVFE-YMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           LV E Y   +L   + S    F+EV+ A I+RQ+L G++Y HK   +HRD+K  N+L+ +
Sbjct: 126 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 184
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + +   +++ DFGL+  + A  + +   +K+ T +Y  PE+L G   Y    DVWS G I
Sbjct: 185 KSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHG--TYDEKCDVWSTGVI 239
Query: 348 LGELFVKKPLF 358
           L  L    P F
Sbjct: 240 LYILLSGCPPF 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 109/191 (57%), Gaps = 24/191 (12%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           ++++ ++V+ + +KE      +RE+++L+QL+H NI+ L E          F +DKG FY
Sbjct: 81  KVISKRQVKQKTDKESL----LREVQLLKQLDHPNIMKLYE----------FFEDKGYFY 126
Query: 232 LVFE-YMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           LV E Y   +L   + S    F+EV+ A I+RQ+L G++Y HK   +HRD+K  N+L+ +
Sbjct: 127 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 185
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + +   +++ DFGL+  + A  + +   +K+ T +Y  PE+L G   Y    DVWS G I
Sbjct: 186 KSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHG--TYDEKCDVWSTGVI 240
Query: 348 LGELFVKKPLF 358
           L  L    P F
Sbjct: 241 LYILLSGCPPF 251

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 109/191 (57%), Gaps = 24/191 (12%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           ++++ ++V+ + +KE      +RE+++L+QL+H NI+ L E          F +DKG FY
Sbjct: 57  KVISKRQVKQKTDKESL----LREVQLLKQLDHPNIMKLYE----------FFEDKGYFY 102
Query: 232 LVFE-YMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           LV E Y   +L   + S    F+EV+ A I+RQ+L G++Y HK   +HRD+K  N+L+ +
Sbjct: 103 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 161
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + +   +++ DFGL+  + A  + +   +K+ T +Y  PE+L G   Y    DVWS G I
Sbjct: 162 KSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHG--TYDEKCDVWSTGVI 216
Query: 348 LGELFVKKPLF 358
           L  L    P F
Sbjct: 217 LYILLSGCPPF 227

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 29/202 (14%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KKV    E        +REI IL +L    I+ L +++  + D L F       Y+V
Sbjct: 56  VAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPE-DLLKF----DELYIV 110
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            E  D DL  L ++ +    E +  +I+  LL G  + H+   +HRD+K +N L+N    
Sbjct: 111 LEIADSDLKKLFKTPIF-LTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCS 169
Query: 294 VKLADFGLARLYNAE-----------------------DRQRPYTNKVITLWYRPPELLL 330
           VK+ DFGLAR  N++                       + ++  T+ V+T WYR PEL+L
Sbjct: 170 VKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 229
Query: 331 GEERYGPAIDVWSCGCILGELF 352
            +E Y  +ID+WS GCI  EL 
Sbjct: 230 LQENYTNSIDIWSTGCIFAELL 251

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 110/191 (57%), Gaps = 24/191 (12%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           ++++ ++V+ + +KE    + +RE+++L+QL+H NI+ L E          F +DKG FY
Sbjct: 63  KVISKRQVKQKTDKE----SLLREVQLLKQLDHPNIMKLYE----------FFEDKGYFY 108
Query: 232 LVFE-YMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           LV E Y   +L   + S    F+EV+ A I+RQ+L G++Y HK   +HRD+K  N+L+ +
Sbjct: 109 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 167
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + +   +++ DFGL+  + A  + +   +K+ T +Y  PE+L G   Y    DVWS G I
Sbjct: 168 KSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPEVLHGT--YDEKCDVWSTGVI 222
Query: 348 LGELFVKKPLF 358
           L  L    P F
Sbjct: 223 LYILLSGCPPF 233

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 108/191 (56%), Gaps = 24/191 (12%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           ++++ ++V+ + +KE      +RE+++L+QL+H NI  L E          F +DKG FY
Sbjct: 57  KVISKRQVKQKTDKESL----LREVQLLKQLDHPNIXKLYE----------FFEDKGYFY 102
Query: 232 LVFE-YMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           LV E Y   +L   + S    F+EV+ A I+RQ+L G++Y HK   +HRD+K  N+L+ +
Sbjct: 103 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLES 161
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + +   +++ DFGL+  + A  + +   +K+ T +Y  PE+L G   Y    DVWS G I
Sbjct: 162 KSKDANIRIIDFGLSTHFEASKKXK---DKIGTAYYIAPEVLHG--TYDEKCDVWSTGVI 216
Query: 348 LGELFVKKPLF 358
           L  L    P F
Sbjct: 217 LYILLSGCPPF 227

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 170 TDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           + ELVA+KKV    R +N          RE++I+R+L+H NIV LR       +    +K
Sbjct: 78  SGELVAIKKVLQDKRFKN----------RELQIMRKLDHCNIVRLRYFFYSSGE----KK 123
Query: 226 DKGSFYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
           D+    LV +Y+   +  +             +     M QL   L+Y H     HRDIK
Sbjct: 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 283 CSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
             N+L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDV
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDV 240
Query: 342 WSCGCILGELFVKKPLF 358
           WS GC+L EL + +P+F
Sbjct: 241 WSAGCVLAELLLGQPIF 257

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 170 TDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           + ELVA+KKV    R +N          RE++I+R+L+H NIV LR       +    +K
Sbjct: 123 SGELVAIKKVLQDKRFKN----------RELQIMRKLDHCNIVRLRYFFYSSGE----KK 168
Query: 226 DKGSFYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
           D+    LV +Y+   +  +             +     M QL   L+Y H     HRDIK
Sbjct: 169 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 228
Query: 283 CSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
             N+L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDV
Sbjct: 229 PQNLLLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDV 285
Query: 342 WSCGCILGELFVKKPLF 358
           WS GC+L EL + +P+F
Sbjct: 286 WSAGCVLAELLLGQPIF 302

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 170 TDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           + ELVA+KKV    R +N          RE++I+R+L+H NIV LR       +    +K
Sbjct: 72  SGELVAIKKVLQDKRFKN----------RELQIMRKLDHCNIVRLRYFFYSSGE----KK 117
Query: 226 DKGSFYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
           D+    LV +Y+   +  +             +     M QL   L+Y H     HRDIK
Sbjct: 118 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 177
Query: 283 CSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
             N+L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDV
Sbjct: 178 PQNLLLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDV 234
Query: 342 WSCGCILGELFVKKPLF 358
           WS GC+L EL + +P+F
Sbjct: 235 WSAGCVLAELLLGQPIF 251

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 170 TDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           + ELVA+KKV    R +N          RE++I+R+L+H NIV LR       +    +K
Sbjct: 82  SGELVAIKKVLQDKRFKN----------RELQIMRKLDHCNIVRLRYFFYSSGE----KK 127
Query: 226 DKGSFYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
           D+    LV +Y+   +  +             +     M QL   L+Y H     HRDIK
Sbjct: 128 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 187
Query: 283 CSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
             N+L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDV
Sbjct: 188 PQNLLLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDV 244
Query: 342 WSCGCILGELFVKKPLF 358
           WS GC+L EL + +P+F
Sbjct: 245 WSAGCVLAELLLGQPIF 261

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/179 (35%), Positives = 98/179 (54%), Gaps = 24/179 (13%)
Query: 186 EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLL 245
           E F      EI +L+ L+H NI+ L           D  +DK  FYLV E+ +    G L
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKL----------FDVFEDKKYFYLVTEFYEG---GEL 133
Query: 246 ESGMVD---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADF 299
              +++   F+E + A+IM+Q+L G+ Y HK N +HRDIK  NIL+ N+     +K+ DF
Sbjct: 134 FEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           GL+  ++ + + R   +++ T +Y  PE+L  +++Y    DVWSCG I+  L    P F
Sbjct: 194 GLSSFFSKDYKLR---DRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 170 TDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           + ELVA+KKV    R +N          RE++I+R+L+H NIV LR       +    +K
Sbjct: 80  SGELVAIKKVLQDKRFKN----------RELQIMRKLDHCNIVRLRYFFYSSGE----KK 125
Query: 226 DKGSFYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
           D+    LV +Y+   +  +             +     M QL   L+Y H     HRDIK
Sbjct: 126 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 185
Query: 283 CSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
             N+L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDV
Sbjct: 186 PQNLLLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDV 242
Query: 342 WSCGCILGELFVKKPLF 358
           WS GC+L EL + +P+F
Sbjct: 243 WSAGCVLAELLLGQPIF 259

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 170 TDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           + ELVA+KKV    R +N          RE++I+R+L+H NIV LR       +    +K
Sbjct: 78  SGELVAIKKVLQDKRFKN----------RELQIMRKLDHCNIVRLRYFFYSSGE----KK 123
Query: 226 DKGSFYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
           D+    LV +Y+   +  +             +     M QL   L+Y H     HRDIK
Sbjct: 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183
Query: 283 CSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
             N+L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDV
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDV 240
Query: 342 WSCGCILGELFVKKPLF 358
           WS GC+L EL + +P+F
Sbjct: 241 WSAGCVLAELLLGQPIF 257

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 170 TDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           + ELVA+KKV    R +N          RE++I+R+L+H NIV LR       +    +K
Sbjct: 49  SGELVAIKKVLQDKRFKN----------RELQIMRKLDHCNIVRLRYFFYSSGE----KK 94
Query: 226 DKGSFYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
           D+    LV +Y+   +  +             +     M QL   L+Y H     HRDIK
Sbjct: 95  DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 154
Query: 283 CSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
             N+L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDV
Sbjct: 155 PQNLLLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDV 211
Query: 342 WSCGCILGELFVKKPLF 358
           WS GC+L EL + +P+F
Sbjct: 212 WSAGCVLAELLLGQPIF 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 56  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 105
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 106 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 165
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 166 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 222
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 223 CVLAELLLGQPIF 235

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 56  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 105
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 106 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 165
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 166 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 222
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 223 CVLAELLLGQPIF 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 63  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 112
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 113 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 172
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 173 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 229
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 230 CVLAELLLGQPIF 242

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 52  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 101
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 102 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 161
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 162 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 218
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 219 CVLAELLLGQPIF 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 44  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 93
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 44  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 93
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 48  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 97
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 98  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 157
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 158 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 214
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 215 CVLAELLLGQPIF 227

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 45  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 94
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 95  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 154
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 155 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 211
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 212 CVLAELLLGQPIF 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 57  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 106
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 107 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 166
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 167 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 223
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 224 CVLAELLLGQPIF 236

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 44  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 93
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD   
Sbjct: 44  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDVVY 93
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 98/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV    + + F     RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 44  SGELVAIKKVL---QGKAF---KNRELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 93
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 98/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV    + + F     RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 44  SGELVAIKKVL---QGKAF---KNRELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 93
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 94  LNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 98/193 (50%), Gaps = 17/193 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV    + + F     RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 44  SGELVAIKKVL---QGKAF---KNRELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 93
Query: 230 FYLVFEYMDHDLMGL---LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 211 CVLAELLLGQPIF 223

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 33/207 (15%)
Query: 164 FSVSLFTDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD 219
           F   L   + VA+KKV    R +N          RE++I+R + H N+V+L+       D
Sbjct: 57  FQAKLVESDEVAIKKVLQDKRFKN----------RELQIMRIVKHPNVVDLKAFFYSNGD 106
Query: 220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNAS-------IMRQLLDGLSYCH 272
               +KD+    LV EY+   +          + ++            M QLL  L+Y H
Sbjct: 107 ----KKDEVFLNLVLEYVPETVY----RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 273 KRNFLHRDIKCSNILMNN-RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG 331
                HRDIK  N+L++   G +KL DFG A++  A +   P  + + + +YR PEL+ G
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSXICSRYYRAPELIFG 215
Query: 332 EERYGPAIDVWSCGCILGELFVKKPLF 358
              Y   ID+WS GC++ EL   +PLF
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 8/167 (4%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
            +REI++L   +H NI+ LR+I     +           YLV E M  DL  ++    + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPA-----MHKLYLVTELMRTDLAQVIHDQRIV 130
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
            +  +    M  +L GL   H+   +HRD+   NIL+ +  ++ + DF LAR   A+  +
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
              T+ V   WYR PEL++  + +   +D+WS GC++ E+F +K LF
Sbjct: 191 ---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 8/167 (4%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
            +REI++L   +H NI+ LR+I     +           YLV E M  DL  ++    + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPA-----MHKLYLVTELMRTDLAQVIHDQRIV 130
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
            +  +    M  +L GL   H+   +HRD+   NIL+ +  ++ + DF LAR   A+  +
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
              T+ V   WYR PEL++  + +   +D+WS GC++ E+F +K LF
Sbjct: 191 ---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNHENVVK 69
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 70  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 69
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 70  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/170 (34%), Positives = 96/170 (56%), Gaps = 20/170 (11%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE-YMDHDLMGLLESGMVD 251
           + E+ +L+ L+H NI+ L           DF +DK ++YLV E Y   +L   +   M  
Sbjct: 84  LEEVAVLKLLDHPNIMKL----------YDFFEDKRNYYLVMECYKGGELFDEIIHRM-K 132
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLYNAE 308
           FNEV+ A I++Q+L G++Y HK N +HRD+K  N+L+ ++ +   +K+ DFGL+ ++   
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--- 189
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + Q+    ++ T +Y  PE+L   ++Y    DVWS G IL  L    P F
Sbjct: 190 ENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 69
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 70  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 69
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 70  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 69
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 70  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 67
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 68  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 116
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLA 201

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 69
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 70  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 103/193 (53%), Gaps = 20/193 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T +  A+K +   + K     T +RE+++L++L+H NI+ L EI+ D S          S
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----------S 95
Query: 230 FYLVFE-YMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           FY+V E Y   +L   +      F+E + A I++Q+  G++Y HK N +HRD+K  NIL+
Sbjct: 96  FYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 289 NNRG---EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
            ++    ++K+ DFGL+  +    + +   +++ T +Y  PE+L G   Y    DVWS G
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRG--TYDEKCDVWSAG 209
Query: 346 CILGELFVKKPLF 358
            IL  L    P F
Sbjct: 210 VILYILLSGTPPF 222

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIKKEICINKMLNHENVVK 69
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 70  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/170 (35%), Positives = 93/170 (54%), Gaps = 24/170 (14%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE-YMDHDLMG--LLESGMVD 251
           E+ +L+QL+H NI+ L E          F +DK ++YLV E Y   +L    +L      
Sbjct: 71  EVAVLKQLDHPNIMKLYE----------FFEDKRNYYLVMEVYRGGELFDEIILRQ---K 117
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLYNAE 308
           F+EV+ A IM+Q+L G +Y HK N +HRD+K  N+L+ ++     +K+ DFGL+  +   
Sbjct: 118 FSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG 177
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            + +    ++ T +Y  PE+L   ++Y    DVWSCG IL  L    P F
Sbjct: 178 GKMK---ERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I + LNH+N+V 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIKKEICINKMLNHENVVK 68
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 69  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 117
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 103/193 (53%), Gaps = 20/193 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T +  A+K +   + K     T +RE+++L++L+H NI+ L EI+ D S          S
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----------S 95
Query: 230 FYLVFE-YMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           FY+V E Y   +L   +      F+E + A I++Q+  G++Y HK N +HRD+K  NIL+
Sbjct: 96  FYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 289 NNR---GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
            ++    ++K+ DFGL+  +    + +   +++ T +Y  PE+L G   Y    DVWS G
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRGT--YDEKCDVWSAG 209
Query: 346 CILGELFVKKPLF 358
            IL  L    P F
Sbjct: 210 VILYILLSGTPPF 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 103/193 (53%), Gaps = 20/193 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T +  A+K +   + K     T +RE+++L++L+H NI+ L EI+ D S          S
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----------S 95
Query: 230 FYLVFE-YMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           FY+V E Y   +L   +      F+E + A I++Q+  G++Y HK N +HRD+K  NIL+
Sbjct: 96  FYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 289 NNR---GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
            ++    ++K+ DFGL+  +    + +   +++ T +Y  PE+L G   Y    DVWS G
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRG--TYDEKCDVWSAG 209
Query: 346 CILGELFVKKPLF 358
            IL  L    P F
Sbjct: 210 VILYILLSGTPPF 222

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 48  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 99
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 100 ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 155
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 210
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPF 232

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/170 (35%), Positives = 93/170 (54%), Gaps = 24/170 (14%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE-YMDHDLMG--LLESGMVD 251
           E+ +L+QL+H NI+ L E          F +DK ++YLV E Y   +L    +L      
Sbjct: 54  EVAVLKQLDHPNIMKLYE----------FFEDKRNYYLVMEVYRGGELFDEIILRQ---K 100
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLYNAE 308
           F+EV+ A IM+Q+L G +Y HK N +HRD+K  N+L+ ++     +K+ DFGL+  +   
Sbjct: 101 FSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG 160
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            + +    ++ T +Y  PE+L   ++Y    DVWSCG IL  L    P F
Sbjct: 161 GKMKE---RLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     + F   L  L K +LE  KEG      REI+I   L H NI+ +      
Sbjct: 28  GNVYLAREKQNKFIMALKVLFKSQLE--KEGVEHQLRREIEIQSHLRHPNILRM------ 79
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                ++  D+   YL+ E+     +         F+E  +A+ M +L D L YCH+R  
Sbjct: 80  ----YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+LM  +GE+K+ADFG + ++    R+R       TL Y PPE++ G+  + 
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCG---TLDYLPPEMIEGKT-HD 190
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+W  G +  E  V  P F
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPF 212

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ L  G       +V+  T+E VA+K V ++   +  P    +EI I   LNH+N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINAMLNHENVVK 69
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
                         R++    YL  EY    +L   +E   +   E +      QL+ G+
Sbjct: 70  F----------YGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGV 118
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
            Y H     HRDIK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 329 LLGEERYGPAIDVWSCGCILGELFV 353
           L   E +   +DVWSCG +L  +  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     + F   L  L K +LE  KEG      REI+I   L H NI+ +      
Sbjct: 29  GNVYLAREKQNKFIMALKVLFKSQLE--KEGVEHQLRREIEIQSHLRHPNILRM------ 80
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                ++  D+   YL+ E+     +         F+E  +A+ M +L D L YCH+R  
Sbjct: 81  ----YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 136
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+LM  +GE+K+ADFG + ++    R+R       TL Y PPE++ G+  + 
Sbjct: 137 IHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCG---TLDYLPPEMIEGKT-HD 191
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+W  G +  E  V  P F
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 22  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 73
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 74  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T+   TL Y PPE++ G   + 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TDLCGTLDYLPPEMIEG-RMHD 184
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 27  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 78
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 79  ----YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 189
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 23  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 74
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 75  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T+   TL Y PPE++ G   + 
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TDLCGTLDYLPPEMIEG-RMHD 185
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 27  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 78
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 79  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T+   TL Y PPE++ G   + 
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TDLCGTLDYLPPEMIEG-RMHD 189
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPF 211

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 39  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 90
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 91  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 146
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 147 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 201
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPF 223

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 22  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 73
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 74  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 184
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 25  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 76
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 77  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 187
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 22  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 73
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 74  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T+   TL Y PPE++ G   + 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TDLCGTLDYLPPEMIEG-RMHD 184
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 27  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 78
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 79  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 189
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 22  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 73
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 74  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TELCGTLDYLPPEMIEG-RMHD 184
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 21  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 72
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 73  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 128
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 129 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 183
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPF 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 26  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 77
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 78  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 133
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 134 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 188
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPF 210

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 25  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 76
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 77  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 187
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 23  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 74
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 75  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRR--TTLSGTLDYLPPEMIEG-RMHD 185
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 22  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 73
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 74  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TXLCGTLDYLPPEMIEG-RMHD 184
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 27  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 78
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 79  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE + G   + 
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEXIEGRX-HD 189
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 48  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 99
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 100 ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 155
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R   +   TL Y PPE++ G   + 
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--DDLCGTLDYLPPEMIEG-RMHD 210
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 27  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 78
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 79  ----YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG + ++    R+        TL Y PPE++ G   + 
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXG---TLDYLPPEMIEG-RMHD 189
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 25  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 76
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 77  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG + ++    R+        TL Y PPE++ G   + 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCG---TLDYLPPEMIEG-RMHD 187
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/187 (32%), Positives = 94/187 (50%), Gaps = 16/187 (8%)
Query: 173 LVALKKV-RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           ++ALK + + + EK G      RE++I   L H NI+ L            +  D    Y
Sbjct: 32  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----------YGYFHDATRVY 81
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           L+ EY     +      +  F+E   A+ + +L + LSYCH +  +HRDIK  N+L+ + 
Sbjct: 82  LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA 141
Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   +   +D+WS G +  E 
Sbjct: 142 GELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 196
Query: 352 FVKKPLF 358
            V KP F
Sbjct: 197 LVGKPPF 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 22  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 73
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 74  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG + ++    R+        TL Y PPE++ G   + 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCG---TLDYLPPEMIEG-RMHD 184
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 24  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 75
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 76  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 131
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+A+FG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 132 IHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 186
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPF 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 24  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 75
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 76  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 131
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG + ++    R+        TL Y PPE++ G   + 
Sbjct: 132 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCG---TLDYLPPEMIEG-RMHD 186
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 25  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 76
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 77  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+A+FG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 133 IHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 187
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 23  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 74
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 75  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG + ++    R+        TL Y PPE++ G   + 
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCG---TLDYLPPEMIEG-RMHD 185
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 25  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 76
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 77  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R   +   TL Y PPE++ G   + 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRR--DDLCGTLDYLPPEMIEG-RMHD 187
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 22  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 73
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 74  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG + ++    R+        TL Y PPE++ G   + 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCG---TLDYLPPEMIEG-RMHD 184
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 22  GNVYLAREKNSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 73
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 74  ----YGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKV 129
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG + ++    R+        TL Y PPE++ G   + 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCG---TLDYLPPEMIEG-RMHD 184
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 25  GNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 76
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 77  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG + ++    R+        TL Y PPE++ G   + 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCG---TLDYLPPEMIEG-RMHD 187
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V KP F
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVN 209
           +  G      F+  +   E+VA+KK+    +  NEK       ++E++ L++L H N + 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQKLRHPNTIQ 118
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
            R     +  A          +LV EY       LLE       EV  A++    L GL+
Sbjct: 119 YRGCYLREHTA----------WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           Y H  N +HRD+K  NIL++  G VKL DFG A +        P    V T ++  PE++
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVI 222
Query: 330 LG--EERYGPAIDVWSCGCILGELFVKKP 356
           L   E +Y   +DVWS G    EL  +KP
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKV----RLENEKEGFPITAVREIKILRQLNHKNIVN 209
           +  G      F+  +   E+VA+KK+    +  NEK       ++E++ L++L H N + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQKLRHPNTIQ 79
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
            R     +  A          +LV EY       LLE       EV  A++    L GL+
Sbjct: 80  YRGCYLREHTA----------WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           Y H  N +HRD+K  NIL++  G VKL DFG A +        P    V T ++  PE++
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVI 183
Query: 330 LG--EERYGPAIDVWSCGCILGELFVKKP 356
           L   E +Y   +DVWS G    EL  +KP
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ +  G  +    +  + T + VA+K +              RE++I++ LNH NIV 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L E++  +           + YLV EY     +           E    +  RQ++  + 
Sbjct: 78  LFEVIETEK----------TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW----YRP 325
           YCH++  +HRD+K  N+L++    +K+ADFG +  +        + NK+ T      Y  
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------FGNKLDTFCGSPPYAA 180
Query: 326 PELLLGEERYGPAIDVWSCGCILGEL 351
           PEL  G++  GP +DVWS G IL  L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTL 206

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ +  G  +    +  + T + VA+K +              RE++I++ LNH NIV 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L E++  +           + YLV EY     +           E    +  RQ++  + 
Sbjct: 78  LFEVIETEK----------TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW----YRP 325
           YCH++  +HRD+K  N+L++    +K+ADFG +  +        + NK+ T      Y  
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------FGNKLDTFCGSPPYAA 180
Query: 326 PELLLGEERYGPAIDVWSCGCILGEL 351
           PEL  G++  GP +DVWS G IL  L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTL 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 26  GNVYLARERQSKFILALKVLFKTQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 77
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 78  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG +   +A   +R  T    TL Y PPE++ G   + 
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRR--TTLCGTLDYLPPEMIEG-RMHD 188
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V  P F
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L E +  G  S+    V L T    A K +  +           RE +I R L H NIV 
Sbjct: 8   LYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVR 67
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD---FNEVNNASIMRQLLD 266
           L + ++++          G  YLVF+ +     G L   +V    ++E + +  ++Q+L+
Sbjct: 68  LHDSISEE----------GFHYLVFDLVT---GGELFEDIVAREYYSEADASHCIQQILE 114
Query: 267 GLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
            + +CH+   +HRD+K  N+L+ ++     VKLADFGLA     +  Q+ +     T  Y
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGY 172
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             PE+L  +E YG  +D+W+CG IL  L V  P F
Sbjct: 173 LSPEVLR-KEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ +  G  +    +  + T + VA++ +              RE++I++ LNH NIV 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L E++  +           + YLV EY     +           E    +  RQ++  + 
Sbjct: 78  LFEVIETEK----------TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW----YRP 325
           YCH++  +HRD+K  N+L++    +K+ADFG +  +        + NK+ T      Y  
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------FGNKLDTFCGSPPYAA 180
Query: 326 PELLLGEERYGPAIDVWSCGCILGEL 351
           PEL  G++  GP +DVWS G IL  L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTL 206

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 83/163 (50%), Gaps = 22/163 (13%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-----HDLMGLLESG 248
           RE  I   L H +IV L E  T  SD        G  Y+VFE+MD      +++   ++G
Sbjct: 75  REASICHMLKHPHIVELLE--TYSSD--------GMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLADFGLARLY 305
            V ++E   +  MRQ+L+ L YCH  N +HRD+K  N+L+    N   VKL DFG+A   
Sbjct: 125 FV-YSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA--I 181
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              +       +V T  +  PE ++  E YG  +DVW CG IL
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVIL 223

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ +  G  +    +  + T + VA+K +              RE++I++ LNH NIV 
Sbjct: 11  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 70
Query: 210 LREIV-TDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGL 268
           L E++ T+K+  L      G    VF+Y       L+  G +   E    +  RQ++  +
Sbjct: 71  LFEVIETEKTLYLVMEYASGG--EVFDY-------LVAHGWMKEKEAR--AKFRQIVSAV 119
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW----YR 324
            YCH++  +HRD+K  N+L++    +K+ADFG +  +        + NK+ T      Y 
Sbjct: 120 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------FGNKLDTFCGSPPYA 172
Query: 325 PPELLLGEERYGPAIDVWSCGCILGEL 351
            PEL  G++  GP +DVWS G IL  L
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTL 199

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ +  G  +    +  + T + VA+K +              RE++I++ LNH NIV 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L E++  +           + YLV EY     +           E    +  RQ++  + 
Sbjct: 78  LFEVIETEK----------TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW----YRP 325
           YCH++  +HRD+K  N+L++    +K+ADFG +  +        + NK+        Y  
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------FGNKLDAFCGAPPYAA 180
Query: 326 PELLLGEERYGPAIDVWSCGCILGEL 351
           PEL  G++  GP +DVWS G IL  L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTL 206

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH 204
            S   L E L  G  S+    V +   +  A K +  +           RE +I R L H
Sbjct: 21  QSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 80
Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD---FNEVNNASIM 261
            NIV L + ++++          G  YL+F+ +     G L   +V    ++E + +  +
Sbjct: 81  PNIVRLHDSISEE----------GHHYLIFDLVT---GGELFEDIVAREYYSEADASHCI 127
Query: 262 RQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAEDRQRPYTNKV 318
           +Q+L+ + +CH+   +HRD+K  N+L+ ++     VKLADFGLA     E  Q+ +    
Sbjct: 128 QQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFA 185
Query: 319 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            T  Y  PE+L  ++ YG  +D+W+CG IL  L V  P F
Sbjct: 186 GTPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFN 253
           RE++I++ LNH NIV L E++  +           + YLV EY     +           
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEK----------TLYLVMEYASGGEVFDYLVAHGRMK 112
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
           E    +  RQ++  + YCH++  +HRD+K  N+L++    +K+ADFG +  +        
Sbjct: 113 EKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTV------ 166
Query: 314 YTNKVITLW----YRPPELLLGEERYGPAIDVWSCGCILGEL 351
             NK+ T      Y  PEL  G++  GP +DVWS G IL  L
Sbjct: 167 -GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ +  G  +    +  + T   VA+K +              RE++I++ LNH NIV 
Sbjct: 16  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 75
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L E++  +           + YL+ EY     +           E    S  RQ++  + 
Sbjct: 76  LFEVIETEK----------TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 125
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           YCH++  +HRD+K  N+L++    +K+ADFG +  +    +   +     +  Y  PEL 
Sbjct: 126 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCG---SPPYAAPELF 182
Query: 330 LGEERYGPAIDVWSCGCIL 348
            G++  GP +DVWS G IL
Sbjct: 183 QGKKYDGPEVDVWSLGVIL 201

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD 216
           G + L     S F   L  L K +LE  K G      RE++I   L H NI+ L      
Sbjct: 26  GNVYLARERQSKFILALKVLFKTQLE--KAGVEHQLRREVEIQSHLRHPNILRL------ 77
Query: 217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                 +  D    YL+ EY     +      +  F+E   A+ + +L + LSYCH +  
Sbjct: 78  ----YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRDIK  N+L+ + GE+K+ADFG + ++    R+        TL Y PPE++ G   + 
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCG---TLDYLPPEMIEG-RMHD 188
Query: 337 PAIDVWSCGCILGELFVKKPLF 358
             +D+WS G +  E  V  P F
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ +  G  +    +  + T   VA+K +              RE++I++ LNH NIV 
Sbjct: 19  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L E++  +           + YL+ EY     +           E    S  RQ++  + 
Sbjct: 79  LFEVIETEK----------TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           YCH++  +HRD+K  N+L++    +K+ADFG +  +    +   +        Y  PEL 
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG---APPYAAPELF 185
Query: 330 LGEERYGPAIDVWSCGCILGEL 351
            G++  GP +DVWS G IL  L
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTL 207

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 91/176 (51%), Gaps = 22/176 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVD 251
           V E+ +LR+L H NIV   + + D+++         + Y+V EY +  DL  ++  G  +
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNT--------TLYIVMEYCEGGDLASVITKGTKE 104
Query: 252 FNEVNNASIMR---QLLDGLSYCHKRN-----FLHRDIKCSNILMNNRGEVKLADFGLAR 303
              ++   ++R   QL   L  CH+R+      LHRD+K +N+ ++ +  VKL DFGLAR
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 304 LYNA-EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + N  ED  + +   V T +Y  PE  +    Y    D+WS GC+L EL    P F
Sbjct: 165 ILNHDEDFAKEF---VGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ +  G  +    +  + T + VA++ +              RE++I++ LNH NIV 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVK 77
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L E++  +           + YLV EY     +           E    +  RQ++  + 
Sbjct: 78  LFEVIETEK----------TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 127
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           YCH++  +HRD+K  N+L++    +K+ADFG +  +   ++   +     +  Y  PEL 
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG---SPPYAAPELF 184
Query: 330 LGEERYGPAIDVWSCGCILGEL 351
            G++  GP +DVWS G IL  L
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTL 206

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ +  G  +    +  + T + VA+K +              RE++I + LNH NIV 
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVK 77
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L E++  +           + YLV EY     +           E    +  RQ++  + 
Sbjct: 78  LFEVIETEK----------TLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ 127
Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW----YRP 325
           YCH++  +HRD+K  N+L++    +K+ADFG +  +        + NK+        Y  
Sbjct: 128 YCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFT-------FGNKLDAFCGAPPYAA 180
Query: 326 PELLLGEERYGPAIDVWSCGCILGEL 351
           PEL  G++  GP +DVWS G IL  L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTL 206

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL 202
           T++    L + L  G   +      + + +  ALKKV  +      P    RE+ I++ L
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD------PRYKNRELDIMKVL 57
Query: 203 NHKNIVNLREIVTDKSDAL--------DFRKDKGS--------------------FYLVF 234
           +H NI+ L +      D          D  K  G                       ++ 
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 235 EYMDHDLMGLLESGMVDFNEV--NNASI-MRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           EY+   L  +L+S +     +  N  SI + QL   + + H     HRDIK  N+L+N++
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 292 -GEVKLADFGLAR-LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
              +KL DFG A+ L  +E    P    + + +YR PEL+LG   Y P+ID+WS GC+ G
Sbjct: 178 DNTLKLCDFGSAKKLIPSE----PSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 350 ELFVKKPLF 358
           EL + KPLF
Sbjct: 234 ELILGKPLF 242

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L E L  G  S+    + + T +  A K +  +           RE +I R L H NIV 
Sbjct: 8   LFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVR 67
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD---FNEVNNASIMRQLLD 266
           L + ++++          G  YLVF+ +     G L   +V    ++E + +  ++Q+L+
Sbjct: 68  LHDSISEE----------GFHYLVFDLVTG---GELFEDIVAREYYSEADASHCIQQILE 114
Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWY 323
            +++CH    +HRD+K  N+L+ ++ +   VKLADFGLA     +  Q+ +     T  Y
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGY 172
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             PE+L  ++ YG  +D+W+CG IL  L V  P F
Sbjct: 173 LSPEVLR-KDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L E L  G  S+    + + T +  A K +  +           RE +I R L H NIV 
Sbjct: 8   LFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVR 67
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD---FNEVNNASIMRQLLD 266
           L + ++++          G  YLVF+ +     G L   +V    ++E + +  ++Q+L+
Sbjct: 68  LHDSISEE----------GFHYLVFDLVTG---GELFEDIVAREYYSEADASHCIQQILE 114
Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWY 323
            +++CH    +HRD+K  N+L+ ++ +   VKLADFGLA     +  Q+ +     T  Y
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGY 172
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             PE+L  ++ YG  +D+W+CG IL  L V  P F
Sbjct: 173 LSPEVLR-KDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 152 EPLAAGGLSLNNFSVSLFTDELVALKKV-RLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           E L  G       +    T + VALK + R   +K    +   REI  L+ L H +I+ L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
            +++T  +D +          +V EY   +L   +        E       +Q++  + Y
Sbjct: 75  YDVITTPTDIV----------MVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEY 123
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
           CH+   +HRD+K  N+L+++   VK+ADFGL+ +    +  +       +  Y  PE++ 
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVIN 180
Query: 331 GEERYGPAIDVWSCGCILGELFVKK 355
           G+   GP +DVWSCG +L  + V +
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVD 251
           V E+ +LR+L H NIV   + + D+++         + Y+V EY +  DL  ++  G  +
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNT--------TLYIVMEYCEGGDLASVITKGTKE 104
Query: 252 FNEVNNASIMR---QLLDGLSYCHKRN-----FLHRDIKCSNILMNNRGEVKLADFGLAR 303
              ++   ++R   QL   L  CH+R+      LHRD+K +N+ ++ +  VKL DFGLAR
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + N +         V T +Y  PE  +    Y    D+WS GC+L EL    P F
Sbjct: 165 ILNHDTSFAK--TFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALK----KVRLENEKEGFPITAVREIKILRQLNHK 205
           +++ L  G       +    T + VALK    KV  +++ +G      REI  LR L H 
Sbjct: 8   IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG---RIEREISYLRLLRHP 64
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           +I+ L +++          K K    +V EY  ++L   +       +E       +Q++
Sbjct: 65  HIIKLYDVI----------KSKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQII 113
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
             + YCH+   +HRD+K  N+L++    VK+ADFGL+ +    +  +       +  Y  
Sbjct: 114 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAA 170
Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKK 355
           PE++ G+   GP +DVWSCG IL  +  ++
Sbjct: 171 PEVISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALK----KVRLENEKEGFPITAVREIKILRQLNHK 205
           +++ L  G       +    T + VALK    KV  +++ +G      REI  LR L H 
Sbjct: 18  IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG---RIEREISYLRLLRHP 74
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           +I+ L +++          K K    +V EY  ++L   +       +E       +Q++
Sbjct: 75  HIIKLYDVI----------KSKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQII 123
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
             + YCH+   +HRD+K  N+L++    VK+ADFGL+ +    +  +       +  Y  
Sbjct: 124 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAA 180
Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKK 355
           PE++ G+   GP +DVWSCG IL  +  ++
Sbjct: 181 PEVISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALK----KVRLENEKEGFPITAVREIKILRQLNHK 205
           +++ L  G       +    T + VALK    KV  +++ +G      REI  LR L H 
Sbjct: 17  IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG---RIEREISYLRLLRHP 73
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           +I+ L +++          K K    +V EY  ++L   +       +E       +Q++
Sbjct: 74  HIIKLYDVI----------KSKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQII 122
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
             + YCH+   +HRD+K  N+L++    VK+ADFGL+ +    +  +       +  Y  
Sbjct: 123 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAA 179
Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKK 355
           PE++ G+   GP +DVWSCG IL  +  ++
Sbjct: 180 PEVISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALK----KVRLENEKEGFPITAVREIKILRQLNHK 205
           +++ L  G       +    T + VALK    KV  +++ +G      REI  LR L H 
Sbjct: 12  IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG---RIEREISYLRLLRHP 68
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           +I+ L +++          K K    +V EY  ++L   +       +E       +Q++
Sbjct: 69  HIIKLYDVI----------KSKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQII 117
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
             + YCH+   +HRD+K  N+L++    VK+ADFGL+ +    +  +       +  Y  
Sbjct: 118 SAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAA 174
Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKK 355
           PE++ G+   GP +DVWSCG IL  +  ++
Sbjct: 175 PEVISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVD 251
           V E+ +LR+L H NIV   + + D+++         + Y+V EY +  DL  ++  G  +
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNT--------TLYIVMEYCEGGDLASVITKGTKE 104
Query: 252 FNEVNNASIMR---QLLDGLSYCHKRN-----FLHRDIKCSNILMNNRGEVKLADFGLAR 303
              ++   ++R   QL   L  CH+R+      LHRD+K +N+ ++ +  VKL DFGLAR
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 304 LYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + N +     +    + T +Y  PE  +    Y    D+WS GC+L EL    P F
Sbjct: 165 ILNHDT---SFAKAFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 19/218 (8%)
Query: 145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLE-NEKEGFPITAVREIKILRQLN 203
           N    +++ L  GG+S    +     +  VA+K + +   EKE       RE+    QL+
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 204 HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIM 261
           H+NIV++          +D  ++   +YLV EY++   L   +ES G +  +   N +  
Sbjct: 70  HQNIVSM----------IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT-- 117
Query: 262 RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-T 320
            Q+LDG+ + H    +HRDIK  NIL+++   +K+ DFG+A+  +  +     TN V+ T
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGT 175
Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + Y  PE   GE       D++S G +L E+ V +P F
Sbjct: 176 VQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPF 212

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 90/173 (52%), Gaps = 27/173 (15%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVD 251
           RE +I R+L H NIV L + + ++S               F Y+  DL+  G L   +V 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEES---------------FHYLVFDLVTGGELFEDIVA 98
Query: 252 ---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLY 305
              ++E + +  ++Q+L+ ++YCH    +HR++K  N+L+ ++ +   VKLADFGLA   
Sbjct: 99  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           N  +    +     T  Y  PE +L ++ Y   +D+W+CG IL  L V  P F
Sbjct: 159 NDSEAWHGFAG---TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 90/173 (52%), Gaps = 27/173 (15%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVD 251
           RE +I R+L H NIV L + + ++S               F Y+  DL+  G L   +V 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEES---------------FHYLVFDLVTGGELFEDIVA 98
Query: 252 ---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLY 305
              ++E + +  ++Q+L+ ++YCH    +HR++K  N+L+ ++ +   VKLADFGLA   
Sbjct: 99  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           N  +    +     T  Y  PE +L ++ Y   +D+W+CG IL  L V  P F
Sbjct: 159 NDSEAWHGFAG---TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 82/171 (47%), Gaps = 24/171 (14%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD-- 251
           +EI+I++ L+H NI+ L E   D +D           YLV E       G L   +V   
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTD----------IYLVMELCTG---GELFERVVHKR 101
Query: 252 -FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLADFGLARLYNA 307
            F E + A IM+ +L  ++YCHK N  HRD+K  N L    +    +KL DFGLA  +  
Sbjct: 102 VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
               R    KV T +Y  P++L G   YGP  D WS G ++  L    P F
Sbjct: 162 GKMMR---TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 82/171 (47%), Gaps = 24/171 (14%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD-- 251
           +EI+I++ L+H NI+ L E   D +D           YLV E       G L   +V   
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTD----------IYLVMELCTG---GELFERVVHKR 118
Query: 252 -FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLADFGLARLYNA 307
            F E + A IM+ +L  ++YCHK N  HRD+K  N L    +    +KL DFGLA  +  
Sbjct: 119 VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 178
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
               R    KV T +Y  P++L G   YGP  D WS G ++  L    P F
Sbjct: 179 GKMMR---TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 90/173 (52%), Gaps = 27/173 (15%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVD 251
           RE +I R+L H NIV L + + ++S               F Y+  DL+  G L   +V 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEES---------------FHYLVFDLVTGGELFEDIVA 121
Query: 252 ---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLY 305
              ++E + +  ++Q+L+ ++YCH    +HR++K  N+L+ ++ +   VKLADFGLA   
Sbjct: 122 REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           N  +    +     T  Y  PE +L ++ Y   +D+W+CG IL  L V  P F
Sbjct: 182 NDSEAWHGFAG---TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 90/173 (52%), Gaps = 27/173 (15%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVD 251
           RE +I R+L H NIV L + + ++S               F Y+  DL+  G L   +V 
Sbjct: 53  REARICRKLQHPNIVRLHDSIQEES---------------FHYLVFDLVTGGELFEDIVA 97
Query: 252 ---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLY 305
              ++E + +  ++Q+L+ ++YCH    +HR++K  N+L+ ++ +   VKLADFGLA   
Sbjct: 98  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 157
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           N  +    +     T  Y  PE +L ++ Y   +D+W+CG IL  L V  P F
Sbjct: 158 NDSEAWHGFAG---TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 96/187 (51%), Gaps = 16/187 (8%)
Query: 173 LVALKKV-RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           +VALK + + + EKEG      REI+I   L+H NI+ L           ++  D+   Y
Sbjct: 50  IVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL----------YNYFYDRRRIY 99
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           L+ EY     +         F+E   A+IM +L D L YCH +  +HRDIK  N+L+  +
Sbjct: 100 LILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLK 159
Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           GE+K+ADFG + ++    R++       TL Y PPE++ G   +   +D+W  G +  EL
Sbjct: 160 GELKIADFGWS-VHAPSLRRKTMCG---TLDYLPPEMIEG-RMHNEKVDLWCIGVLCYEL 214
Query: 352 FVKKPLF 358
            V  P F
Sbjct: 215 LVGNPPF 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 12/216 (5%)
Query: 142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQ 201
           S N     L E + +G  ++   +      E VA+K++ LE  +       ++EI+ + Q
Sbjct: 6   SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQ 64
Query: 202 LNHKNIVNLREIVTDKSDALDFRK--DKGSFYLVFEYMDHDLM-GLLESGMVDFNEVNNA 258
            +H NIV+       K +     K    GS   V + + H +  G  +SG++D  E   A
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGS---VLDIIKHIVAKGEHKSGVLD--ESTIA 119
Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTNK 317
           +I+R++L+GL Y HK   +HRD+K  NIL+   G V++ADFG+ A L    D  R    K
Sbjct: 120 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 179
Query: 318 --VITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             V T  +  PE++     Y    D+WS G    EL
Sbjct: 180 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 215

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 81/163 (49%), Gaps = 22/163 (13%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-----HDLMGLLESG 248
           RE  I   L H +IV L E  T  SD        G  Y+VFE+MD      +++   ++G
Sbjct: 77  REASICHMLKHPHIVELLE--TYSSD--------GMLYMVFEFMDGADLCFEIVKRADAG 126
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLADFGLARLY 305
            V ++E   +  MRQ+L+ L YCH  N +HRD+K   +L+    N   VKL  FG+A   
Sbjct: 127 FV-YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--I 183
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              +       +V T  +  PE ++  E YG  +DVW CG IL
Sbjct: 184 QLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVIL 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 12/216 (5%)
Query: 142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQ 201
           S N     L E + +G  ++   +      E VA+K++ LE  +       ++EI+ + Q
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQ 69
Query: 202 LNHKNIVNLREIVTDKSDALDFRK--DKGSFYLVFEYMDHDLM-GLLESGMVDFNEVNNA 258
            +H NIV+       K +     K    GS   V + + H +  G  +SG++D  E   A
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGS---VLDIIKHIVAKGEHKSGVLD--ESTIA 124
Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTNK 317
           +I+R++L+GL Y HK   +HRD+K  NIL+   G V++ADFG+ A L    D  R    K
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 318 --VITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             V T  +  PE++     Y    D+WS G    EL
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L E L  G  S+    V +   +  A   +  +           RE +I R L H NIV 
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD---FNEVNNASIMRQLLD 266
           L + ++++          G  YL+F+ +     G L   +V    ++E + +  ++Q+L+
Sbjct: 75  LHDSISEE----------GHHYLIFDLVT---GGELFEDIVAREYYSEADASHCIQQILE 121
Query: 267 GLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
            + +CH+   +HR++K  N+L+ ++     VKLADFGLA     E  Q+ +     T  Y
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGY 179
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             PE+L  ++ YG  +D+W+CG IL  L V  P F
Sbjct: 180 LSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 91/168 (54%), Gaps = 17/168 (10%)
Query: 194 REIKILRQLNHK-NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF 252
           REIKIL  L    NI+ L +IV D            +  LVFE++++     L   + D+
Sbjct: 80  REIKILENLRGGPNIITLADIVKDPVSR--------TPALVFEHVNNTDFKQLYQTLTDY 131
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQ 311
           +       M ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     
Sbjct: 132 D---IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---G 185
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           + Y  +V + +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 81/163 (49%), Gaps = 22/163 (13%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-----HDLMGLLESG 248
           RE  I   L H +IV L E  T  SD        G  Y+VFE+MD      +++   ++G
Sbjct: 75  REASICHMLKHPHIVELLE--TYSSD--------GMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLADFGLARLY 305
            V ++E   +  MRQ+L+ L YCH  N +HRD+K   +L+    N   VKL  FG+A   
Sbjct: 125 FV-YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--I 181
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              +       +V T  +  PE ++  E YG  +DVW CG IL
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVIL 223

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 77/129 (59%), Gaps = 8/129 (6%)
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           LVFEY+++     L   + DF+       M +LL  L YCH +  +HRD+K  N++++++
Sbjct: 112 LVFEYINNTDFKQLYQILTDFD---IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 292 -GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
             +++L D+GLA  Y+     + Y  +V + +++ PELL+  + Y  ++D+WS GC+L  
Sbjct: 169 QKKLRLIDWGLAEFYHPA---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 225
Query: 351 L-FVKKPLF 358
           + F ++P F
Sbjct: 226 MIFRREPFF 234

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVD 251
           REI+ L+   H +I+ L ++++  +D          F++V EY+    +   + + G V+
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD----------FFMVMEYVSGGELFDYICKHGRVE 109
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
             E+    + +Q+L  + YCH+   +HRD+K  N+L++     K+ADFGL+ + +  +  
Sbjct: 110 --EMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           R       +  Y  PE++ G    GP +D+WSCG IL  L 
Sbjct: 168 RTSCG---SPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 77/129 (59%), Gaps = 8/129 (6%)
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           LVFEY+++     L   + DF+       M +LL  L YCH +  +HRD+K  N++++++
Sbjct: 117 LVFEYINNTDFKQLYQILTDFD---IRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 292 -GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
             +++L D+GLA  Y+     + Y  +V + +++ PELL+  + Y  ++D+WS GC+L  
Sbjct: 174 QKKLRLIDWGLAEFYHPA---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 230
Query: 351 L-FVKKPLF 358
           + F ++P F
Sbjct: 231 MIFRREPFF 239

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 85/161 (52%), Gaps = 17/161 (10%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVD 251
           REI+ L+   H +I+ L ++++  +D          F++V EY+    +   + + G V+
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD----------FFMVMEYVSGGELFDYICKHGRVE 109
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
             E+    + +Q+L  + YCH+   +HRD+K  N+L++     K+ADFGL+ + +  +  
Sbjct: 110 --EMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           R   +   +  Y  PE++ G    GP +D+WSCG IL  L 
Sbjct: 168 R---DSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 42/271 (15%)
Query: 95  KNVHPESM-PPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEP 153
           +N++ +SM P  +LP W    E + K   + + G  +       +   + +  +  +ME 
Sbjct: 70  ENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLRE 212
            A                    L   +LE  +E       RE  ILRQ+  H +I+ L  
Sbjct: 130 TAE------------------RLSPEQLEEVREA----TRRETHILRQVAGHPHIITL-- 165
Query: 213 IVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH 272
                   +D  +     +LVF+ M    +    +  V  +E    SIMR LL+ +S+ H
Sbjct: 166 --------IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 273 KRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL--- 329
             N +HRD+K  NIL+++  +++L+DFG +      ++ R       T  Y  PE+L   
Sbjct: 218 ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG---TPGYLAPEILKCS 274
Query: 330 LGEER--YGPAIDVWSCGCILGELFVKKPLF 358
           + E    YG  +D+W+CG IL  L    P F
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 26/244 (10%)
Query: 127 GDPMEMQAAAPIQSNSTNNSSRPLMEPLAA-GGLSLNNFSVSLFTDELVALKKVRLENEK 185
           G  M + AAA     S     R  +E +A  G            T   VA+KKV  +   
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD--- 59
Query: 186 EGFPITAVREIKILRQL---NHKNIVNLREIVTDKSDALDFRKDKGSFYL--VFEYMDHD 240
              P    RE++I++ L   +H NIV L+       +     +D+   YL  V EY+   
Sbjct: 60  ---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE-----RDRRDIYLNVVMEYVPDT 111
Query: 241 LMGLLES---GMVDFNEVNNASIMRQLLDGLSYCH--KRNFLHRDIKCSNILMNNR-GEV 294
           L     +     V    +     + QL+  +   H    N  HRDIK  N+L+N   G +
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171
Query: 295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           KL DFG A+  +  +   P    + + +YR PEL+ G + Y  A+D+WS GCI  E+ + 
Sbjct: 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
Query: 355 KPLF 358
           +P+F
Sbjct: 229 EPIF 232

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD-- 251
           RE +I R L H NIV L + ++++          G  YLVF+ +     G L   +V   
Sbjct: 79  REARICRLLKHPNIVRLHDSISEE----------GFHYLVFDLVT---GGELFEDIVARE 125
Query: 252 -FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNA 307
            ++E + +  + Q+L+ +++ H+ + +HRD+K  N+L+ ++     VKLADFGLA     
Sbjct: 126 YYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEV 183
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +  Q+ +     T  Y  PE+L  ++ YG  +D+W+CG IL  L V  P F
Sbjct: 184 QGEQQAWFGFAGTPGYLSPEVLR-KDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 41  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 90
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L++     + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 91  LKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 150
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 151 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 208
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 209 VLYELFT 215

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 87  NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYDI---RYYIYELL 135
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 192
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 108 NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYDI---RYYIYELL 156
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 157 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 213
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 214 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 248

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 88  NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYDI---RYYIYELL 136
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 137 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 193
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 194 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 228

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 87  NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYDI---RYYIYELL 135
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 192
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 88  NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYDI---RYYIYELL 136
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 137 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 193
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 194 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 228

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 89  NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELL 137
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 138 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 194
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 195 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 229

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 87  NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYDI---RYYIYELL 135
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 192
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 87  NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYDI---RYYIYELL 135
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 192
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 87  NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYDI---RYYIYELL 135
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 192
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NIV L +IV D+           +  L+FEY+++    +L   + D++       + +LL
Sbjct: 87  NIVKLLDIVRDQHSK--------TPSLIFEYVNNTDFKVLYPTLTDYD---IRYYIYELL 135
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH +  +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFK 192
Query: 325 PPELLLGEERYGPAIDVWSCGCIL-GELFVKKPLF 358
            PELL+  + Y  ++D+WS GC+  G +F K+P F
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 69  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 118
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 179 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 236
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 237 VLYELFT 243

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 36  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 85
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 86  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 145
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 146 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 203
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 204 VLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 38  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 87
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 148 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 205
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 206 VLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 37  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 86
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 87  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 146
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 147 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 204
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 205 VLYELFT 211

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV ++  K G   P + + E +I+++L H  +V L  +V+++             Y+V E
Sbjct: 35  KVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEP-----------IYIVTE 83
Query: 236 YMDH-DLMGLLESGMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
           YM+   L+  L+ G     ++ N   +  Q+  G++Y  + N++HRD++ +NIL+ N   
Sbjct: 84  YMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLI 143
Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
            K+ADFGLARL    +       K    W  P   L G  R+    DVWS G +L EL  
Sbjct: 144 CKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVT 201
Query: 354 K 354
           K
Sbjct: 202 K 202

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 41  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 90
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 91  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 150
Query: 289 NNRGEVKLADFGLARL--YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 151 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 208
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 209 VLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 44  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 93
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 94  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 153
Query: 289 NNRGEVKLADFGLARL--YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 154 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 211
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 212 VLYELFT 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 42  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 91
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 92  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 151
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 152 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 209
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 210 VLYELFT 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 45  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 94
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 95  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 154
Query: 289 NNRGEVKLADFGLARL--YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 155 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 212
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 213 VLYELFT 219

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 43  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 92
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 93  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 152
Query: 289 NNRGEVKLADFGLARL--YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 153 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 210
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 211 VLYELFT 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 56  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 105
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 106 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 165
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 166 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 223
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 224 VLYELFT 230

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 38  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 87
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 148 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 205
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 206 VLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 56  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 105
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 106 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 165
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 166 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 223
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 224 VLYELFT 230

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLR 211
           E +  G       ++ + T + VA++++ L+ + +   I  + EI ++R+  + NIVN  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY- 82
Query: 212 EIVTDKSDALDFRKDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
                    LD        ++V EY+    L  ++    +D  ++  A++ R+ L  L +
Sbjct: 83  ---------LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEF 131
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRDIK  NIL+   G VKL DFG       E  +R  +  V T ++  PE++ 
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT 189
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
             + YGP +D+WS G +  E+   +P +
Sbjct: 190 -RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLR 211
           E +  G       ++ + T + VA++++ L+ + +   I  + EI ++R+  + NIVN  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY- 82
Query: 212 EIVTDKSDALDFRKDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
                    LD        ++V EY+    L  ++    +D  ++  A++ R+ L  L +
Sbjct: 83  ---------LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEF 131
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRDIK  NIL+   G VKL DFG       E  +R  +  V T ++  PE++ 
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVT 189
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
             + YGP +D+WS G +  E+   +P +
Sbjct: 190 -RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLR 211
           E +  G       ++ + T + VA++++ L+ + +   I  + EI ++R+  + NIVN  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY- 82
Query: 212 EIVTDKSDALDFRKDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
                    LD        ++V EY+    L  ++    +D  ++  A++ R+ L  L +
Sbjct: 83  ---------LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEF 131
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRDIK  NIL+   G VKL DFG       E  +R  +  V T ++  PE++ 
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVT 189
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
             + YGP +D+WS G +  E+   +P +
Sbjct: 190 -RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLR 211
           E +  G       ++ + T + VA++++ L+ + +   I  + EI ++R+  + NIVN  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY- 83
Query: 212 EIVTDKSDALDFRKDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
                    LD        ++V EY+    L  ++    +D  ++  A++ R+ L  L +
Sbjct: 84  ---------LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEF 132
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HRDIK  NIL+   G VKL DFG       E  +R  +  V T ++  PE++ 
Sbjct: 133 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVT 190
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
             + YGP +D+WS G +  E+   +P +
Sbjct: 191 -RKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES 247
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVIEYMSKGSLLDFLKG 105
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+      K+ADFGLARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 166 DNEXTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 211

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES 247
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVIEYMSKGSLLDFLKG 105
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+      K+ADFGLARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 211

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVD 251
           REI+ L+   H +I+ L ++++  SD           ++V EY+    +   + ++G +D
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSD----------IFMVMEYVSGGELFDYICKNGRLD 114
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
             E  +  + +Q+L G+ YCH+   +HRD+K  N+L++     K+ADFGL+ + +  +  
Sbjct: 115 --EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           R       +  Y  PE++ G    GP +D+WS G IL  L 
Sbjct: 173 RXSCG---SPNYAAPEVISGRLYAGPEVDIWSSGVILYALL 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 38  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 87
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 205
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 206 VLYELFT 212

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ EY+     + LLE G +D  E   A+I+R++L GL Y H    +HRDIK +N+L+
Sbjct: 80  LWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 137
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  GEVKLADFG+A      D Q      V T ++  PE ++ +  Y    D+WS G   
Sbjct: 138 SEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGITA 194
Query: 349 GELFVKKP 356
            EL   +P
Sbjct: 195 IELARGEP 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ EY+     + LLE G +D  E   A+I+R++L GL Y H    +HRDIK +N+L+
Sbjct: 100 LWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 157
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  GEVKLADFG+A      D Q      V T ++  PE ++ +  Y    D+WS G   
Sbjct: 158 SEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGITA 214
Query: 349 GELFVKKP 356
            EL   +P
Sbjct: 215 IELARGEP 222

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLES 247
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVMEYMSKGCLLDFLKG 105
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+      K+ADFGLARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 211

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES 247
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 46  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMSKGSLLDFLKG 94
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+      K+ADFGLARL  
Sbjct: 95  EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 154
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 155 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 200

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES 247
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMSKGSLLDFLKG 105
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+      K+ADFGLARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 211

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ EY+     + LLE G +D  E   A+I+R++L GL Y H    +HRDIK +N+L+
Sbjct: 95  LWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 152
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  GEVKLADFG+A      D Q      V T ++  PE ++ +  Y    D+WS G   
Sbjct: 153 SEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGITA 209
Query: 349 GELFVKKP 356
            EL   +P
Sbjct: 210 IELARGEP 217

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 91/188 (48%), Gaps = 16/188 (8%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VALK VR  NEK  F   A  EI+IL  L  ++  N   ++    +   FR       + 
Sbjct: 125 VALKMVR--NEKR-FHRQAAEEIRILEHLRKQDKDNTMNVI-HMLENFTFRN---HICMT 177
Query: 234 FEYMDHDLMGLLESGMVD-FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           FE +  +L  L++      F+          +L  L   HK   +H D+K  NIL+  +G
Sbjct: 178 FELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237
Query: 293 E--VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              +K+ DFG +      + QR YT  + + +YR PE++LG  RYG  ID+WS GCIL E
Sbjct: 238 RSGIKVIDFGSS----CYEHQRVYT-XIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAE 291
Query: 351 LFVKKPLF 358
           L    PL 
Sbjct: 292 LLTGYPLL 299

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 90/191 (47%), Gaps = 21/191 (10%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           +A+K++   + +   P+    EI + + L HKNIV            L    + G   + 
Sbjct: 50  IAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQY----------LGSFSENGFIKIF 97
Query: 234 FEYM-DHDLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
            E +    L  LL S  G +  NE       +Q+L+GL Y H    +HRDIK  N+L+N 
Sbjct: 98  MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
Query: 291 -RGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELL-LGEERYGPAIDVWSCGCI 347
             G +K++DFG + RL         +T    TL Y  PE++  G   YG A D+WS GC 
Sbjct: 158 YSGVLKISDFGTSKRLAGINPCTETFTG---TLQYMAPEIIDKGPRGYGKAADIWSLGCT 214
Query: 348 LGELFVKKPLF 358
           + E+   KP F
Sbjct: 215 IIEMATGKPPF 225

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 41  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 90
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ E++ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NIL+
Sbjct: 91  LKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 150
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 151 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 208
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 209 VLYELFT 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES 247
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 48  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMSKGSLLDFLKG 96
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+      K+ADFGLARL  
Sbjct: 97  EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 156
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 157 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 202

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ EY+     + LLE G +D  E   A+I+R++L GL Y H    +HRDIK +N+L+
Sbjct: 80  LWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 137
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  GEVKLADFG+A      D Q      V T ++  PE ++ +  Y    D+WS G   
Sbjct: 138 SEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGITA 194
Query: 349 GELFVKKP 356
            EL   +P
Sbjct: 195 IELARGEP 202

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES 247
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVCEYMSKGSLLDFLKG 105
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+      K+ADFGLARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 211

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 91/188 (48%), Gaps = 16/188 (8%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VALK VR  NEK  F   A  EI+IL  L  ++  N   ++    +   FR       + 
Sbjct: 125 VALKMVR--NEKR-FHRQAAEEIRILEHLRKQDKDNTMNVI-HMLENFTFRN---HICMT 177
Query: 234 FEYMDHDLMGLLESGMVD-FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           FE +  +L  L++      F+          +L  L   HK   +H D+K  NIL+  +G
Sbjct: 178 FELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237
Query: 293 E--VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              +K+ DFG +      + QR YT  + + +YR PE++LG  RYG  ID+WS GCIL E
Sbjct: 238 RSGIKVIDFGSS----CYEHQRVYT-XIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAE 291
Query: 351 LFVKKPLF 358
           L    PL 
Sbjct: 292 LLTGYPLL 299

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 93  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 138
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+L+++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 195
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM-VD 251
           RE+ +L  + H NIV  RE            ++ GS Y+V +Y +  DL   + +   V 
Sbjct: 72  REVAVLANMKHPNIVQYRESF----------EENGSLYIVMDYCEGGDLFKRINAQKGVL 121
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F E        Q+   L + H R  LHRDIK  NI +   G V+L DFG+AR+ N+    
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 + T +Y  PE+   +  Y    D+W+ GC+L EL   K  F
Sbjct: 182 ARAC--IGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAF 225

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLR 211
           E +  G       ++ + T + VA++++ L+ + +   I  + EI ++R+  + NIVN  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY- 83
Query: 212 EIVTDKSDALDFRKDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSY 270
                    LD        ++V EY+    L  ++    +D  ++  A++ R+ L  L +
Sbjct: 84  ---------LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEF 132
Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
            H    +HR+IK  NIL+   G VKL DFG       E  +R  +  V T ++  PE++ 
Sbjct: 133 LHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT 190
Query: 331 GEERYGPAIDVWSCGCILGELFVKKPLF 358
             + YGP +D+WS G +  E+   +P +
Sbjct: 191 -RKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLES 247
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMSKGCLLDFLKG 105
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+      K+ADFGLARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 211

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 93  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLRQTLTDYD---IRFYMY 138
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 195
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 84/155 (54%), Gaps = 16/155 (10%)
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLL 265
           NI+ L +IV D            +  LVFE++++     L   + D++       M ++L
Sbjct: 93  NIITLADIVKDPV--------SRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEIL 141
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
             L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + +++
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFK 198
Query: 325 PPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
            PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES 247
           P   ++E ++++++ H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 57  PEAFLQEAQVMKKIRHEKLVQLYAVVSEEP-----------IYIVTEYMSKGSLLDFLKG 105
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+      K+ADFGLARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 211

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 90/191 (47%), Gaps = 21/191 (10%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           +A+K++   + +   P+    EI + + L HKNIV            L    + G   + 
Sbjct: 36  IAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQY----------LGSFSENGFIKIF 83
Query: 234 FEYM-DHDLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
            E +    L  LL S  G +  NE       +Q+L+GL Y H    +HRDIK  N+L+N 
Sbjct: 84  MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 143
Query: 291 -RGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELL-LGEERYGPAIDVWSCGCI 347
             G +K++DFG + RL         +T    TL Y  PE++  G   YG A D+WS GC 
Sbjct: 144 YSGVLKISDFGTSKRLAGINPCTETFTG---TLQYMAPEIIDKGPRGYGKAADIWSLGCT 200
Query: 348 LGELFVKKPLF 358
           + E+   KP F
Sbjct: 201 IIEMATGKPPF 211

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 29/175 (16%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM+       +  
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMN-------KGS 95
Query: 249 MVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           ++DF +      +R         Q+  G++Y  + N++HRD++ +NIL+      K+ADF
Sbjct: 96  LLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 155
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           GLARL    +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 156 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES 247
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM    L+  L+ 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMSKGSLLDFLKG 105
Query: 248 GMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            M  +  +     +  Q+  G++Y  + N++HRD+  +NIL+      K+ADFGLARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIE 165
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
             +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 211

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 29/175 (16%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM        +  
Sbjct: 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMS-------KGS 347
Query: 249 MVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           ++DF +      +R         Q+  G++Y  + N++HRD++ +NIL+      K+ADF
Sbjct: 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 407
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           GLARL    +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 408 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 460

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 93  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 138
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 195
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 93  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 138
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 195
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 92  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 137
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 194
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 93  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 138
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 195
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 93  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 138
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 195
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 93  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 138
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 195
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 93  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 138
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 195
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 16/160 (10%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLES-GMVDF 252
           +EI++LR+L HKN++ L +++        + ++K   Y+V EY    +  +L+S     F
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVL--------YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRF 106
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL---YNAED 309
                     QL+DGL Y H +  +H+DIK  N+L+   G +K++  G+A     + A+D
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166
Query: 310 RQRPYTNKVITLWYRPPELLLGEERY-GPAIDVWSCGCIL 348
             R       +  ++PPE+  G + + G  +D+WS G  L
Sbjct: 167 TCRTSQG---SPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+KK  L++  E       REI+IL+ L H NIV  + +         +   + +
Sbjct: 39  TGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC--------YSAGRRN 88
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HR++   NIL+
Sbjct: 89  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILV 148
Query: 289 NNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
            N   VK+ DFGL ++   + E  +     +    WY P  L   E ++  A DVWS G 
Sbjct: 149 ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGV 206
Query: 347 ILGELFV 353
           +L ELF 
Sbjct: 207 VLYELFT 213

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 93  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 138
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 195
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 233

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 91  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 136
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 137 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 193
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 98  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 143
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 144 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 200
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 201 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 238

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 22/158 (13%)
Query: 206 NIVNLREIVTD---KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMR 262
           NI+ L +IV D   ++ AL           VFE++++     L   + D++       M 
Sbjct: 92  NIITLADIVKDPVSRTPAL-----------VFEHVNNTDFKQLYQTLTDYD---IRFYMY 137
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           ++L  L YCH    +HRD+K  N+++++   +++L D+GLA  Y+     + Y  +V + 
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASR 194
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGEL-FVKKPLF 358
           +++ PELL+  + Y  ++D+WS GC+L  + F K+P F
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 29/175 (16%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM        +  
Sbjct: 50  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMS-------KGS 91
Query: 249 MVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           ++DF +      +R         Q+  G++Y  + N++HRD++ +NIL+      K+ADF
Sbjct: 92  LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 151
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           GLARL    +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 152 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 204

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 29/175 (16%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM+       +  
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMN-------KGS 95
Query: 249 MVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           ++DF +      +R         Q+  G++Y  + N++HRD++ +NIL+      K+ADF
Sbjct: 96  LLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 155
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           GLARL    +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 156 GLARLIEDNEWTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 208

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 189 PITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLES 247
           PI  V +EI IL++L+H N+V L E++ D ++           Y+VFE ++   +  + +
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE--------DHLYMVFELVNQGPVMEVPT 130
Query: 248 GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA 307
            +   +E       + L+ G+ Y H +  +HRDIK SN+L+   G +K+ADFG++  +  
Sbjct: 131 -LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERY--GPAIDVWSCGCIL 348
            D     +N V T  +  PE L    +   G A+DVW+ G  L
Sbjct: 190 SDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 29/175 (16%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM        +  
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMS-------KGS 264
Query: 249 MVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           ++DF +      +R         Q+  G++Y  + N++HRD++ +NIL+      K+ADF
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 324
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           GLARL    +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 325 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 377

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 29/175 (16%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM        +  
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVTEYMS-------KGS 264
Query: 249 MVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           ++DF +      +R         Q+  G++Y  + N++HRD++ +NIL+      K+ADF
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 324
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           GLARL    +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 325 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 377

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 18/183 (9%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++  N     P   ++E +++++L H+ +V L  +V+++             Y+V
Sbjct: 212 VAIKTLKPGNMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIV 257
Query: 234 FEYMDH-DLMGLLESGMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
            EYM    L+  L+  M  +  +     +  Q+  G++Y  + N++HRD++ +NIL+   
Sbjct: 258 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 317
Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
              K+ADFGL RL    +       K    W  P   L G  R+    DVWS G +L EL
Sbjct: 318 LVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTEL 375
Query: 352 FVK 354
             K
Sbjct: 376 TTK 378

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 29/175 (16%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P   ++E +++++L H+ +V L  +V+++             Y+V EYM        +  
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYIVGEYMS-------KGS 264
Query: 249 MVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           ++DF +      +R         Q+  G++Y  + N++HRD++ +NIL+      K+ADF
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 324
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           GLARL    +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 325 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 377

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/188 (33%), Positives = 90/188 (47%), Gaps = 16/188 (8%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VALK VR  NEK  F   A  EI+IL  L  ++  N   ++    +   FR       + 
Sbjct: 125 VALKMVR--NEKR-FHRQAAEEIRILEHLRKQDKDNTMNVI-HMLENFTFRN---HICMT 177
Query: 234 FEYMDHDLMGLLESGMVD-FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           FE +  +L  L++      F+          +L  L   HK   +H D+K  NIL+  +G
Sbjct: 178 FELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237
Query: 293 E--VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              +K+ DFG +      + QR Y   + + +YR PE++LG  RYG  ID+WS GCIL E
Sbjct: 238 RSGIKVIDFGSS----CYEHQRVYX-XIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAE 291
Query: 351 LFVKKPLF 358
           L    PL 
Sbjct: 292 LLTGYPLL 299

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/132 (34%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 227 KGS-FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KGS  +++ EY+     + LL +G   F+E   A++++++L GL Y H    +HRDIK +
Sbjct: 92  KGSKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 149
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++ +G+VKLADFG+A      D Q      V T ++  PE ++ +  Y    D+WS 
Sbjct: 150 NVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADIWSL 206
Query: 345 GCILGELFVKKP 356
           G    EL   +P
Sbjct: 207 GITAIELAKGEP 218

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 47  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 95
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 96  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 148
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 149 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 206
Query: 347 ILGEL 351
           +L E+
Sbjct: 207 LLTEI 211

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ + +G   +        ++ELVA+K +      E       REI   R L H NIV 
Sbjct: 23  LVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIAANVKREIINHRSLRHPNIVR 79
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
            +E++   +             +V EY     +         F+E       +QL+ G+S
Sbjct: 80  FKEVILTPT----------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 270 YCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPE 327
           YCH     HRD+K  N L++      +K+ DFG ++      + +   + V T  Y  PE
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 186
Query: 328 LLLGEERYGPAIDVWSCGCILGELFV 353
           +LL +E  G   DVWSCG  L  + V
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLV 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 39  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 87
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 88  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 141 LVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 198
Query: 347 ILGEL 351
           +L E+
Sbjct: 199 LLTEI 203

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 48  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 96
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 97  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 149
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 150 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 207
Query: 347 ILGEL 351
           +L E+
Sbjct: 208 LLTEI 212

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 45  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 93
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 94  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 146
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 204
Query: 347 ILGEL 351
           +L E+
Sbjct: 205 LLTEI 209

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 49  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 97
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 98  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 150
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 151 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 208
Query: 347 ILGEL 351
           +L E+
Sbjct: 209 LLTEI 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 39  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 87
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 88  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 198
Query: 347 ILGEL 351
           +L E+
Sbjct: 199 LLTEI 203

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 41  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 89
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 90  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 142
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 143 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 200
Query: 347 ILGEL 351
           +L E+
Sbjct: 201 LLTEI 205

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 28/239 (11%)
Query: 130 MEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFP 189
           +E++  A  +   +   S   M PL +G       +V    ++ V +K ++ E   E   
Sbjct: 10  VELEGLAACEGEYSQKYST--MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 190 I------TAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG 243
           I          EI IL ++ H NI+ +          LD  +++G F LV   M+    G
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKV----------LDIFENQGFFQLV---MEKHGSG 114
Query: 244 LLESGMVD----FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           L     +D     +E   + I RQL+  + Y   ++ +HRDIK  NI++     +KL DF
Sbjct: 115 LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDF 174
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           G A      +R + +     T+ Y  PE+L+G    GP +++WS G  L  L  ++  F
Sbjct: 175 GSAAYL---ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 44  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 92
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 93  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 145
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 146 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 203
Query: 347 ILGEL 351
           +L E+
Sbjct: 204 LLTEI 208

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 33/230 (14%)
Query: 141 NSTNN-SSRPLM---EPLAAGGLSL------NNFSVSLFTDELVALKKVRLENEKEGFPI 190
           N TNN   RP+      +  GG  +      NN +V++   +L A+  +  E  K+ F  
Sbjct: 22  NVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAV--KKLAAMVDITTEELKQQFD- 78
Query: 191 TAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH----DLMGLLE 246
              +EIK++ +  H+N+V L          L F  D     LV+ YM +    D +  L+
Sbjct: 79  ---QEIKVMAKCQHENLVEL----------LGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 247 SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            G    +      I +   +G+++ H+ + +HRDIK +NIL++     K++DFGLAR   
Sbjct: 126 -GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP 356
              +    +  V T  Y  PE L GE    P  D++S G +L E+    P
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLP 232

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 40  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 88
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 89  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 141
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 142 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 199
Query: 347 ILGEL 351
           +L E+
Sbjct: 200 LLTEI 204

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 45  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 93
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 94  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 146
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 204
Query: 347 ILGEL 351
           +L E+
Sbjct: 205 LLTEI 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 39  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 87
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 88  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 198
Query: 347 ILGEL 351
           +L E+
Sbjct: 199 LLTEI 203

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPI--TAVREIKILRQLNHKNI 207
            ++ + +G   +        T ELVA+K +     + G  I     REI   R L H NI
Sbjct: 24  FVKDIGSGNFGVARLMRDKLTKELVAVKYI-----ERGAAIDENVQREIINHRSLRHPNI 78
Query: 208 VNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDG 267
           V  +E++   +             ++ EY     +         F+E       +QLL G
Sbjct: 79  VRFKEVILTPT----------HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG 128
Query: 268 LSYCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
           +SYCH     HRD+K  N L++      +K+ DFG ++      + +   + V T  Y  
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 185
Query: 326 PELLLGEERYGPAIDVWSCGCILGELFV 353
           PE+LL +E  G   DVWSCG  L  + V
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLV 213

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           ++E L  G       ++   T ++VA+K+V +E++ +      ++EI I++Q +  ++V 
Sbjct: 33  VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IKEISIMQQCDSPHVVK 88
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLL 265
                   +D           ++V EY       D++ L    + + +E+  A+I++  L
Sbjct: 89  YYGSYFKNTD----------LWIVMEYCGAGSVSDIIRLRNKTLTE-DEI--ATILQSTL 135
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYR 324
            GL Y H    +HRDIK  NIL+N  G  KLADFG+A        +R   N VI T ++ 
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKR---NXVIGTPFWM 192
Query: 325 PPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            PE ++ E  Y    D+WS G    E+   KP +
Sbjct: 193 APE-VIQEIGYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 39  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 87
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 88  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 198
Query: 347 ILGEL 351
           +L E+
Sbjct: 199 LLTEI 203

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE- 212
           +  G   +   +    + +LVA+KK+ L  ++    +    E+ I+R   H+N+V +   
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 216
Query: 213 -IVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYC 271
            +V D+             ++V E+++   +  + +     NE   A++   +L  LS  
Sbjct: 217 YLVGDE------------LWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVL 263
Query: 272 HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG 331
           H +  +HRDIK  +IL+ + G VKL+DFG     + E  +R     V T ++  PE L+ 
Sbjct: 264 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPE-LIS 320
Query: 332 EERYGPAIDVWSCGCILGELFVKKPLF 358
              YGP +D+WS G ++ E+   +P +
Sbjct: 321 RLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 34  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 82
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HRD++ +NI
Sbjct: 83  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 135
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 136 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 193
Query: 347 ILGEL 351
           +L E+
Sbjct: 194 LLTEI 198

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 19/222 (8%)
Query: 135 AAPIQSNSTNNSSR-PLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAV 193
           A P+     ++S R  L++ + AG   +         +ELVA+K +      E       
Sbjct: 7   AGPMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE---RGEKIDENVK 63
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFN 253
           REI   R L H NIV  +E++   +             +V EY     +         F+
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPT----------HLAIVMEYASGGELFERICNAGRFS 113
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDRQ 311
           E       +QL+ G+SY H     HRD+K  N L++      +K+ADFG ++      + 
Sbjct: 114 EDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP 173
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +   + V T  Y  PE+LL +E  G   DVWSCG  L  + V
Sbjct: 174 K---SAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 29/175 (16%)
Query: 189 PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           P   ++E +++++L H+ +V L  +V+++              +V EYM        +  
Sbjct: 47  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-----------IXIVTEYMS-------KGS 88
Query: 249 MVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
           ++DF +      +R         Q+  G++Y  + N++HRD++ +NIL+      K+ADF
Sbjct: 89  LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 148
Query: 300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           GLARL    +       K    W  P   L G  R+    DVWS G +L EL  K
Sbjct: 149 GLARLIEDNEXTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTK 201

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 33/230 (14%)
Query: 141 NSTNN-SSRPLM---EPLAAGGLSL------NNFSVSLFTDELVALKKVRLENEKEGFPI 190
           N TNN   RP+      +  GG  +      NN +V++   +L A+  +  E  K+ F  
Sbjct: 16  NVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAV--KKLAAMVDITTEELKQQFD- 72
Query: 191 TAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH----DLMGLLE 246
              +EIK++ +  H+N+V L          L F  D     LV+ YM +    D +  L+
Sbjct: 73  ---QEIKVMAKCQHENLVEL----------LGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 119
Query: 247 SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            G    +      I +   +G+++ H+ + +HRDIK +NIL++     K++DFGLAR   
Sbjct: 120 -GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP 356
              +       V T  Y  PE L GE    P  D++S G +L E+    P
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLP 226

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 33/230 (14%)
Query: 141 NSTNN-SSRPLM---EPLAAGGLSL------NNFSVSLFTDELVALKKVRLENEKEGFPI 190
           N TNN   RP+      +  GG  +      NN +V++   +L A+  +  E  K+ F  
Sbjct: 22  NVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAV--KKLAAMVDITTEELKQQFD- 78
Query: 191 TAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH----DLMGLLE 246
              +EIK++ +  H+N+V L          L F  D     LV+ YM +    D +  L+
Sbjct: 79  ---QEIKVMAKCQHENLVEL----------LGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 247 SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            G    +      I +   +G+++ H+ + +HRDIK +NIL++     K++DFGLAR   
Sbjct: 126 -GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP 356
              +       V T  Y  PE L GE    P  D++S G +L E+    P
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLP 232

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 26/224 (11%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L+  L  G  S    +  +  +  VA+K VR +   + +   A  EIK+L+++N  +  N
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDAD--N 77
Query: 210 LREIVTDKSDAL---DFRKDKG----SFYLVFEYMDHDLMGLLES-GMVDFNEVNNASIM 261
            +E     +  L   D    KG       +VFE +  +L+ L++         +    I 
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 262 RQLLDGLSYCHKR-NFLHRDIKCSNILMN------NRGEVKLADFGLARLYNAEDRQRPY 314
           +QLL GL Y H+R   +H DIK  N+LM       N  ++K+AD G A  Y+       Y
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----Y 192
Query: 315 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           TN + T  YR PE+LLG   +G   D+WS  C++ EL     LF
Sbjct: 193 TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF 235

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ + +G   +        ++ELVA+K +      E       REI   R L H NIV 
Sbjct: 22  LVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLRHPNIVR 78
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
            +E++   +             +V EY     +         F+E       +QL+ G+S
Sbjct: 79  FKEVILTPT----------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 128
Query: 270 YCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPE 327
           YCH     HRD+K  N L++      +K+ DFG ++      + +   + V T  Y  PE
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 185
Query: 328 LLLGEERYGPAIDVWSCGCILGELFV 353
           +LL +E  G   DVWSCG  L  + V
Sbjct: 186 VLLKKEYDGKVADVWSCGVTLYVMLV 211

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 122
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     F+HRD+   NIL+N
Sbjct: 123 -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILIN 181
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 182 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 238
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 239 VLWEVM 244

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 26/224 (11%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L+  L  G  S    +  +  +  VA+K VR +   + +   A  EIK+L+++N  +  N
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDAD--N 77
Query: 210 LREIVTDKSDAL---DFRKDKG----SFYLVFEYMDHDLMGLLES-GMVDFNEVNNASIM 261
            +E     +  L   D    KG       +VFE +  +L+ L++         +    I 
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 262 RQLLDGLSYCHKR-NFLHRDIKCSNILMN------NRGEVKLADFGLARLYNAEDRQRPY 314
           +QLL GL Y H+R   +H DIK  N+LM       N  ++K+AD G A  Y+       Y
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----Y 192
Query: 315 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           TN + T  YR PE+LLG   +G   D+WS  C++ EL     LF
Sbjct: 193 TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF 235

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLR 211
           E L  G  S    +    T +L A+K +  +  K G   +   EI +LR++ H+NIV L 
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALK-GKESSIENEIAVLRKIKHENIVALE 86
Query: 212 EIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVDFNEVNNASIMRQLLDGLS 269
           +I           +     YLV + +    +   ++E G   + E + ++++RQ+LD + 
Sbjct: 87  DIY----------ESPNHLYLVMQLVSGGELFDRIVEKGF--YTEKDASTLIRQVLDAVY 134
Query: 270 YCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPP 326
           Y H+   +HRD+K  N+L  ++ E   + ++DFGL+++   E +    +    T  Y  P
Sbjct: 135 YLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAP 191
Query: 327 ELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           E +L ++ Y  A+D WS G I   L    P F
Sbjct: 192 E-VLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 152 EPLAAGGLSLNNFSVSLFTDELVALKKV--RLENEKEGFPITAVREIKILRQLNHKNIVN 209
           +PL  G  S+    V   +++  A+K +  R+E   +   ITA++  +      H NIV 
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK-EITALKLCE-----GHPNIVK 70
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L E+  D+             +LV E ++   +         F+E   + IMR+L+  +S
Sbjct: 71  LHEVFHDQLHT----------FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS 120
Query: 270 YCHKRNFLHRDIKCSNILM---NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPP 326
           + H    +HRD+K  N+L    N+  E+K+ DFG ARL   ++  +P      TL Y  P
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAP 178
Query: 327 ELLLGEERYGPAIDVWSCGCIL 348
           E LL +  Y  + D+WS G IL
Sbjct: 179 E-LLNQNGYDESCDLWSLGVIL 199

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 122
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 123 -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGLAR+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 182 SNLVCKVSDFGLARVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 238
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 239 VLWEVM 244

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE- 212
           +  G   +   +    + +LVA+KK+ L  ++    +    E+ I+R   H+N+V +   
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 139
Query: 213 -IVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYC 271
            +V D+             ++V E+++   +  + +     NE   A++   +L  LS  
Sbjct: 140 YLVGDE------------LWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVL 186
Query: 272 HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG 331
           H +  +HRDIK  +IL+ + G VKL+DFG     + E  +R     V T ++  PE L+ 
Sbjct: 187 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPE-LIS 243
Query: 332 EERYGPAIDVWSCGCILGELFVKKPLF 358
              YGP +D+WS G ++ E+   +P +
Sbjct: 244 RLPYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 20/191 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE--IVTDKSDALDFRKDK 227
           + +LVA+KK+ L  ++    +    E+ I+R   H+N+V +    +V D+          
Sbjct: 55  SGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNSYLVGDE---------- 102
Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              ++V E+++   +  + +     NE   A++   +L  LS  H +  +HRDIK  +IL
Sbjct: 103 --LWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 159
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + + G VKL+DFG     + E  +R     V T ++  PE L+    YGP +D+WS G +
Sbjct: 160 LTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIM 216
Query: 348 LGELFVKKPLF 358
           + E+   +P +
Sbjct: 217 VIEMVDGEPPY 227

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE- 212
           +  G   +   +    + +LVA+KK+ L  ++    +    E+ I+R   H+N+V +   
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 94
Query: 213 -IVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYC 271
            +V D+             ++V E+++   +  + +     NE   A++   +L  LS  
Sbjct: 95  YLVGDE------------LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVL 141
Query: 272 HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG 331
           H +  +HRDIK  +IL+ + G VKL+DFG     + E  +R     V T ++  PE L+ 
Sbjct: 142 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LIS 198
Query: 332 EERYGPAIDVWSCGCILGELFVKKPLF 358
              YGP +D+WS G ++ E+   +P +
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 191 TAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM 249
             ++E+ ILR+++ H NI+ L+          D  +    F+LVF+ M    +    +  
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLK----------DTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
           V  +E     IMR LL+ +   HK N +HRD+K  NIL+++   +KL DFG +   +  +
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 310 RQRPYTNKVITLWYRPPELLL-----GEERYGPAIDVWSCGCILGELFVKKPLF 358
           + R       T  Y  PE++          YG  +D+WS G I+  L    P F
Sbjct: 179 KLRSVCG---TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 19/193 (9%)
Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA---LDFRKDKGSFY 231
           A+KK+R   EK     T + E+ +L  LNH+ +V       ++ +    +   K K + +
Sbjct: 35  AIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF 91
Query: 232 LVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           +  EY ++  L  L+ S  ++        + RQ+L+ LSY H +  +HRD+K  NI ++ 
Sbjct: 92  IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151
Query: 291 RGEVKLADFGLAR-------LYNAEDRQRP-----YTNKVITLWYRPPELLLGEERYGPA 338
              VK+ DFGLA+       +   + +  P      T+ + T  Y   E+L G   Y   
Sbjct: 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK 211
Query: 339 IDVWSCGCILGEL 351
           ID++S G I  E+
Sbjct: 212 IDMYSLGIIFFEM 224

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 17/166 (10%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I R L H+++V              F +D    ++V E      +  L        E
Sbjct: 91  EISIHRSLAHQHVVGFH----------GFFEDNDFVFVVLELCRRRSLLELHKRRKALTE 140
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                 +RQ++ G  Y H+   +HRD+K  N+ +N   EVK+ DFGLA     +  ++  
Sbjct: 141 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-- 198
Query: 315 TNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             KV+  T  Y  PE +L ++ +   +DVWS GCI+  L V KP F
Sbjct: 199 --KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 20/191 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE--IVTDKSDALDFRKDK 227
           + +LVA+KK+ L  ++    +    E+ I+R   H+N+V +    +V D+          
Sbjct: 44  SGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNSYLVGDE---------- 91
Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              ++V E+++   +  + +     NE   A++   +L  LS  H +  +HRDIK  +IL
Sbjct: 92  --LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 148
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + + G VKL+DFG     + E  +R     V T ++  PE L+    YGP +D+WS G +
Sbjct: 149 LTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIM 205
Query: 348 LGELFVKKPLF 358
           + E+   +P +
Sbjct: 206 VIEMVDGEPPY 216

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 19/193 (9%)
Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA---LDFRKDKGSFY 231
           A+KK+R   EK     T + E+ +L  LNH+ +V       ++ +    +   K K + +
Sbjct: 35  AIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF 91
Query: 232 LVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           +  EY ++  L  L+ S  ++        + RQ+L+ LSY H +  +HRD+K  NI ++ 
Sbjct: 92  IQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151
Query: 291 RGEVKLADFGLAR-------LYNAEDRQRP-----YTNKVITLWYRPPELLLGEERYGPA 338
              VK+ DFGLA+       +   + +  P      T+ + T  Y   E+L G   Y   
Sbjct: 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK 211
Query: 339 IDVWSCGCILGEL 351
           ID++S G I  E+
Sbjct: 212 IDMYSLGIIFFEM 224

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 107
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 108 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 167
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             P   K    W  P  L     ++    DVW+ G +L E+
Sbjct: 168 TAPAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 206

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 20/191 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE--IVTDKSDALDFRKDK 227
           + +LVA+KK+ L  ++    +    E+ I+R   H+N+V +    +V D+          
Sbjct: 48  SGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNSYLVGDE---------- 95
Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              ++V E+++   +  + +     NE   A++   +L  LS  H +  +HRDIK  +IL
Sbjct: 96  --LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL 152
Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + + G VKL+DFG     + E  +R     V T ++  PE L+    YGP +D+WS G +
Sbjct: 153 LTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIM 209
Query: 348 LGELFVKKPLF 358
           + E+   +P +
Sbjct: 210 VIEMVDGEPPY 220

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 17/166 (10%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I R L H+++V              F +D    ++V E      +  L        E
Sbjct: 89  EISIHRSLAHQHVVGFH----------GFFEDNDFVFVVLELCRRRSLLELHKRRKALTE 138
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                 +RQ++ G  Y H+   +HRD+K  N+ +N   EVK+ DFGLA     +  ++  
Sbjct: 139 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-- 196
Query: 315 TNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             KV+  T  Y  PE +L ++ +   +DVWS GCI+  L V KP F
Sbjct: 197 --KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 108
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 109 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 168
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             P   K    W  P  L     ++    DVW+ G +L E+
Sbjct: 169 TAPAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 207

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 191 TAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM 249
             ++E+ ILR+++ H NI+ L+          D  +    F+LVF+ M    +    +  
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLK----------DTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
           V  +E     IMR LL+ +   HK N +HRD+K  NIL+++   +KL DFG +   +  +
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 310 RQRPYTNKVITLWYRPPELLL-----GEERYGPAIDVWSCGCILGELFVKKPLF 358
           + R       T  Y  PE++          YG  +D+WS G I+  L    P F
Sbjct: 179 KLREVCG---TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I R L H+++V              F +D    ++V E      +  L        E
Sbjct: 71  EISIHRSLAHQHVVGFH----------GFFEDNDFVFVVLELCRRRSLLELHKRRKALTE 120
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL--YNAEDRQR 312
                 +RQ++ G  Y H+   +HRD+K  N+ +N   EVK+ DFGLA    Y+ E ++ 
Sbjct: 121 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK- 179
Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                  T  Y  PE +L ++ +   +DVWS GCI+  L V KP F
Sbjct: 180 ---TLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 191 TAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM 249
             ++E+ ILR+++ H NI+ L+          D  +    F+LVF+ M    +    +  
Sbjct: 56  ATLKEVDILRKVSGHPNIIQLK----------DTYETNTFFFLVFDLMKKGELFDYLTEK 105
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
           V  +E     IMR LL+ +   HK N +HRD+K  NIL+++   +KL DFG +   +  +
Sbjct: 106 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 165
Query: 310 RQRPYTNKVITLWYRPPELLL-----GEERYGPAIDVWSCGCILGELFVKKPLF 358
           + R       T  Y  PE++          YG  +D+WS G I+  L    P F
Sbjct: 166 KLREVCG---TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 47  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 93
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 94  -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 152
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 153 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 209
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 210 VLWEVM 215

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 64  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 110
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 111 -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 169
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 170 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 226
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 227 VLWEVM 232

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 17/166 (10%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I R L H+++V              F +D    ++V E      +  L        E
Sbjct: 65  EISIHRSLAHQHVVGFH----------GFFEDNDFVFVVLELCRRRSLLELHKRRKALTE 114
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                 +RQ++ G  Y H+   +HRD+K  N+ +N   EVK+ DFGLA     +  ++  
Sbjct: 115 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-- 172
Query: 315 TNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             KV+  T  Y  PE +L ++ +   +DVWS GCI+  L V KP F
Sbjct: 173 --KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 178 KVRLENEKEGF--PITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFE 235
           KV +++ K+G   P   + E  +++QL H+ +V L  +VT +             Y++ E
Sbjct: 35  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-----------IYIITE 83
Query: 236 YMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           YM++         +VDF +  +           +  Q+ +G+++  +RN++HR+++ +NI
Sbjct: 84  YMEN-------GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANI 136
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+++    K+ADFGLARL    +       K    W  P  +  G   +    DVWS G 
Sbjct: 137 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGI 194
Query: 347 ILGEL 351
           +L E+
Sbjct: 195 LLTEI 199

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I R L H+++V              F +D    ++V E      +  L        E
Sbjct: 67  EISIHRSLAHQHVVGFH----------GFFEDNDFVFVVLELCRRRSLLELHKRRKALTE 116
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL--YNAEDRQR 312
                 +RQ++ G  Y H+   +HRD+K  N+ +N   EVK+ DFGLA    Y+ E ++ 
Sbjct: 117 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK- 175
Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                  T  Y  PE +L ++ +   +DVWS GCI+  L V KP F
Sbjct: 176 ---TLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 122
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 123 -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 182 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 238
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 239 VLWEVM 244

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I R L H+++V              F +D    ++V E      +  L        E
Sbjct: 67  EISIHRSLAHQHVVGFH----------GFFEDNDFVFVVLELCRRRSLLELHKRRKALTE 116
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL--YNAEDRQR 312
                 +RQ++ G  Y H+   +HRD+K  N+ +N   EVK+ DFGLA    Y+ E ++ 
Sbjct: 117 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK- 175
Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                  T  Y  PE +L ++ +   +DVWS GCI+  L V KP F
Sbjct: 176 ---TLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 74  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 120
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 121 -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 179
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 180 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 236
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 237 VLWEVM 242

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+   Y    Y  +  +      +  
Sbjct: 79  VTRERDVMSRLDHPFFVKLY---------FTFQDDE-KLYFGLSYAKNGCLLKYIRKIGS 128
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 129 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
               + V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 189 ARANSFVGTAQYVSPELLT-EKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 38/198 (19%)
Query: 170 TDELVALKKVRLE---NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E+VA+K ++ +     + G+     +EI ILR L H++I+  +    D   A      
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWK----QEIDILRTLYHEHIIKYKGCCEDAGAA------ 108
Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKC 283
             S  LV EY+    +G L    +  + +  A ++   +Q+ +G++Y H ++++HRD+  
Sbjct: 109 --SLQLVMEYVP---LGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAA 162
Query: 284 SNILMNNRGEVKLADFGLAR-------LYNA-EDRQRPYTNKVITLWYRPPELLLGEERY 335
            N+L++N   VK+ DFGLA+        Y   ED   P        WY P    L E ++
Sbjct: 163 RNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP------VFWYAPE--CLKEYKF 214
Query: 336 GPAIDVWSCGCILGELFV 353
             A DVWS G  L EL  
Sbjct: 215 YYASDVWSFGVTLYELLT 232

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 122
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 123 -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 182 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 238
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 239 VLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 122
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 123 -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 182 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 238
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 239 VLWEVM 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 122
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 123 -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 182 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 238
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 239 VLWEVM 244

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 89/194 (45%), Gaps = 15/194 (7%)
Query: 167 SLFTDELVALKKV-RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           S+ T   VA+K + +    K G       E+KI  QL H +I+ L           ++ +
Sbjct: 32  SIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL----------YNYFE 81
Query: 226 DKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           D    YLV E   +  M   L++ +  F+E      M Q++ G+ Y H    LHRD+  S
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L+     +K+ADFGLA        ++ YT    T  Y  PE +     +G   DVWS 
Sbjct: 142 NLLLTRNMNIKIADFGLATQLKMP-HEKHYT-LCGTPNYISPE-IATRSAHGLESDVWSL 198
Query: 345 GCILGELFVKKPLF 358
           GC+   L + +P F
Sbjct: 199 GCMFYTLLIGRPPF 212

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 122
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 123 -IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 182 SNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 238
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 239 VLWEVM 244

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 6/128 (4%)
Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ EY+     + LL+ G ++  E   A+I+R++L GL Y H    +HRDIK +N+L+
Sbjct: 92  LWIIMEYLGGGSALDLLKPGPLE--ETYIATILREILKGLDYLHSERKIHRDIKAANVLL 149
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           + +G+VKLADFG+A      D Q      V T ++  PE ++ +  Y    D+WS G   
Sbjct: 150 SEQGDVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDFKADIWSLGITA 206
Query: 349 GELFVKKP 356
            EL   +P
Sbjct: 207 IELAKGEP 214

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 39/227 (17%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           +E + +GG      +      +   +++V+  NEK      A RE+K L +L+H NIV+ 
Sbjct: 17  IELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEK------AEREVKALAKLDHVNIVHY 70
Query: 211 R----------EIVTDKSDALDF---------RKDKGSFYLVFEYMDHDLMGLLESGMVD 251
                      E   D  ++ D+         R      ++  E+ D    G LE  +  
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK---GTLEQWIEK 127
Query: 252 -----FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL-ARLY 305
                 ++V    +  Q+  G+ Y H +  +HRD+K SNI + +  +VK+ DFGL   L 
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLK 187
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           N   R R       TL Y  PE +  ++ YG  +D+++ G IL EL 
Sbjct: 188 NDGKRTRSKG----TLRYMSPEQISSQD-YGKEVDLYALGLILAELL 229

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 80  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 129
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 130 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 189
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
               + V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 190 ARANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVD 251
           + E K++  L+H+ +V L  + T +             +++ EYM +  L+  L      
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQR----------PIFIITEYMANGCLLNYLREMRHR 116
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F       + + + + + Y   + FLHRD+   N L+N++G VK++DFGL+R Y  +D +
Sbjct: 117 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEE 175
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
                    + + PPE+L+   ++    D+W+ G ++ E++
Sbjct: 176 TSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIY 215

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ + +G   +        ++ELVA+K +      E       REI   R L H NIV 
Sbjct: 23  LVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLRHPNIVR 79
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
            +E++   +             +V EY     +         F+E       +QL+ G+S
Sbjct: 80  FKEVILTPT----------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 270 YCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPE 327
           YCH     HRD+K  N L++      +K+  FG ++      + +   + V T  Y  PE
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK---DTVGTPAYIAPE 186
Query: 328 LLLGEERYGPAIDVWSCGCILGELFV 353
           +LL +E  G   DVWSCG  L  + V
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLV 212

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L++ + +G   +        ++ELVA+K +      E       REI   R L H NIV 
Sbjct: 23  LVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKREIINHRSLRHPNIVR 79
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
            +E++   +             +V EY     +         F+E       +QL+ G+S
Sbjct: 80  FKEVILTPT----------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 270 YCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPE 327
           YCH     HRD+K  N L++      +K+  FG ++      + +   + V T  Y  PE
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK---STVGTPAYIAPE 186
Query: 328 LLLGEERYGPAIDVWSCGCILGELFV 353
           +LL +E  G   DVWSCG  L  + V
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLV 212

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 33/230 (14%)
Query: 141 NSTNN-SSRPLM---EPLAAGGLSL------NNFSVSLFTDELVALKKVRLENEKEGFPI 190
           N TNN   RP+         GG  +      NN +V++   +L A+  +  E  K+ F  
Sbjct: 13  NVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAV--KKLAAMVDITTEELKQQFD- 69
Query: 191 TAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH----DLMGLLE 246
              +EIK+  +  H+N+V L          L F  D     LV+ Y  +    D +  L+
Sbjct: 70  ---QEIKVXAKCQHENLVEL----------LGFSSDGDDLCLVYVYXPNGSLLDRLSCLD 116
Query: 247 SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
            G    +      I +   +G+++ H+ + +HRDIK +NIL++     K++DFGLAR   
Sbjct: 117 -GTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP 356
              +    +  V T  Y  PE L GE    P  D++S G +L E+    P
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPEALRGE--ITPKSDIYSFGVVLLEIITGLP 223

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 84/182 (46%), Gaps = 21/182 (11%)
Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
            LK    E ++  F    + E  I+ Q +H N+++L  +VT  +  +          ++ 
Sbjct: 68  TLKSGYTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKSTPVM----------IIT 113
Query: 235 EYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
           E+M++  L   L      F  +    ++R +  G+ Y    N++HRD+   NIL+N+   
Sbjct: 114 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV 173
Query: 294 VKLADFGLARLYNAEDRQRPYTN----KVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
            K++DFGL+R    +     YT+    K+   W  P  +     ++  A DVWS G ++ 
Sbjct: 174 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMW 231
Query: 350 EL 351
           E+
Sbjct: 232 EV 233

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE- 212
           +  G   +   +    T + VA+KK+ L  ++    +    E+ I+R  +H N+V++   
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHDNVVDMYSS 110
Query: 213 -IVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYC 271
            +V D+             ++V E+++   +  + +     NE   A++   +L  LSY 
Sbjct: 111 YLVGDE------------LWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYL 157
Query: 272 HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG 331
           H +  +HRDIK  +IL+ + G +KL+DFG     + E  +R     V T ++  PE ++ 
Sbjct: 158 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL--VGTPYWMAPE-VIS 214
Query: 332 EERYGPAIDVWSCGCILGELFVKKP 356
              YG  +D+WS G ++ E+   +P
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMIDGEP 239

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF 252
            RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  F
Sbjct: 80  TRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGSF 129
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
           +E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q 
Sbjct: 130 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189
Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 190 RANXFVGTAQYVSPELLT-EKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIV 208
           L E L  GG+S  + +  L     VA+K +R +  ++  F +   RE +    LNH  IV
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 209 NLREIVTDKSDALDFRKDKGSF-YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDG 267
                V D  +A       G   Y+V EY+D   +  +              ++      
Sbjct: 76  ----AVYDTGEA---ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPP 326
           L++ H+   +HRD+K +NIL++    VK+ DFG+AR           T  VI T  Y  P
Sbjct: 129 LNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSP 188
Query: 327 ELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           E   G+     + DV+S GC+L E+   +P F
Sbjct: 189 EQARGDSVDARS-DVYSLGCVLYEVLTGEPPF 219

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 83/161 (51%), Gaps = 22/161 (13%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMV--- 250
           EI++L+ L+H NI+ + E+           +D  + Y+V E  +  +L+  + S      
Sbjct: 70  EIEVLKSLDHPNIIKIFEVF----------EDYHNMYIVMETCEGGELLERIVSAQARGK 119
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEVKLADFGLARLYNA 307
             +E   A +M+Q+++ L+Y H ++ +H+D+K  NIL  +      +K+ DFGLA L+ +
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           ++     TN   T  Y  PE+   +  +    D+WS G ++
Sbjct: 180 DEHS---TNAAGTALYMAPEVFKRDVTF--KCDIWSAGVVM 215

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I + L++ ++V              F +D    Y+V E      +  L        E
Sbjct: 92  EIAIHKSLDNPHVVGFH----------GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE 141
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                 MRQ + G+ Y H    +HRD+K  N+ +N+  +VK+ DFGLA     +  ++  
Sbjct: 142 PEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK-- 199
Query: 315 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            +   T  Y  PE+L  ++ +   +D+WS GCIL  L V KP F
Sbjct: 200 KDLCGTPNYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 80  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 129
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 130 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 189
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 190 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 24/185 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI++L  +VT     +         
Sbjct: 53  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIHLEGVVTKSKPVM--------- 99
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L+     F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 100 -IVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILIN 158
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P  +     ++  A DVWS G 
Sbjct: 159 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTAPEAIAF--RKFTSASDVWSYGI 215
Query: 347 ILGEL 351
           ++ E+
Sbjct: 216 VMWEV 220

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF 252
            RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  F
Sbjct: 83  TRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGSF 132
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
           +E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q 
Sbjct: 133 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 192
Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 193 RANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 79  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 128
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 129 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 189 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF 252
            RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  F
Sbjct: 80  TRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGSF 129
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
           +E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q 
Sbjct: 130 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189
Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 190 RANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I + L++ ++V              F +D    Y+V E      +  L        E
Sbjct: 92  EIAIHKSLDNPHVVGFH----------GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE 141
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNAEDRQRP 313
                 MRQ + G+ Y H    +HRD+K  N+ +N+  +VK+ DFGLA ++    +R++ 
Sbjct: 142 PEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT 201
Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 T  Y  PE+L  ++ +   +D+WS GCIL  L V KP F
Sbjct: 202 LCG---TPNYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIV 208
            ME L +G  S         T +L ALK ++   +   F  +++  EI +L+++ H+NIV
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIK---KSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLD 266
            L +I    +           +YLV + +    +   +LE G+  + E + + +++Q+L 
Sbjct: 70  TLEDIYESTTH----------YYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLS 117
Query: 267 GLSYCHKRNFLHRDIKCSNILM---NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
            + Y H+   +HRD+K  N+L        ++ + DFGL+++    ++    +    T  Y
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGY 173
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             PE +L ++ Y  A+D WS G I   L    P F
Sbjct: 174 VAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREI 213
           L  G  S    +    T +LVA+K +  E   EG   +   EI +L ++ H NIV L +I
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEA-LEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 214 VTDKSDALDFRKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDGLSYC 271
                      +  G  YL+ + +    +   ++E G   + E + + ++ Q+LD + Y 
Sbjct: 85  Y----------ESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYL 132
Query: 272 HKRNFLHRDIKCSNIL---MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
           H    +HRD+K  N+L   ++   ++ ++DFGL+++   ED     +    T  Y  PE 
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPE- 188
Query: 329 LLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +L ++ Y  A+D WS G I   L    P F
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 77  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 126
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 187 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 77  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 126
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 187 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 87/195 (44%), Gaps = 30/195 (15%)
Query: 170 TDELVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T E VA+K   L+ E  G  I  ++ EI+ILR L H+NIV  + I T+         D G
Sbjct: 49  TGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---------DGG 97
Query: 229 S-FYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           +   L+ E++    L   L       N         Q+  G+ Y   R ++HRD+   N+
Sbjct: 98  NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 157
Query: 287 LMNNRGEVKLADFGLARLYNA--------EDRQRPYTNKVITLWYRPPELLLGEERYGPA 338
           L+ +  +VK+ DFGL +            +DR  P        WY P  L+  + ++  A
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP------VFWYAPECLM--QSKFYIA 209
Query: 339 IDVWSCGCILGELFV 353
            DVWS G  L EL  
Sbjct: 210 SDVWSFGVTLHELLT 224

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I + L++ ++V              F +D    Y+V E      +  L        E
Sbjct: 92  EIAIHKSLDNPHVVGFH----------GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE 141
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNAEDRQRP 313
                 MRQ + G+ Y H    +HRD+K  N+ +N+  +VK+ DFGLA ++    +R++ 
Sbjct: 142 PEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX 201
Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 T  Y  PE+L  ++ +   +D+WS GCIL  L V KP F
Sbjct: 202 LCG---TPNYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREI 213
           L  G  S    +    T +LVA+K +  E   EG   +   EI +L ++ H NIV L +I
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEA-LEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 214 VTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVDFNEVNNASIMRQLLDGLSYC 271
                      +  G  YL+ + +    +   ++E G   + E + + ++ Q+LD + Y 
Sbjct: 85  Y----------ESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYL 132
Query: 272 HKRNFLHRDIKCSNIL---MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
           H    +HRD+K  N+L   ++   ++ ++DFGL+++   ED     +    T  Y  PE 
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPE- 188
Query: 329 LLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +L ++ Y  A+D WS G I   L    P F
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 79  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 128
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 129 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 189 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 79  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 128
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 129 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 189 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF 252
            RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  F
Sbjct: 78  TRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGSF 127
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
           +E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q 
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 188 RANAFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 77  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 126
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 187 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVD 251
           + E K++  L+H+ +V L  + T +             +++ EYM +  L+  L      
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQR----------PIFIITEYMANGCLLNYLREMRHR 116
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F       + + + + + Y   + FLHRD+   N L+N++G VK++DFGL+R Y  +D  
Sbjct: 117 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEY 175
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
                    + + PPE+L+   ++    D+W+ G ++ E++
Sbjct: 176 TSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIY 215

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           +E + +GG      +      +   +K+V+  NEK      A RE+K L +L+H NIV+ 
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVNIVHY 69
Query: 211 R------EIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD-----FNEVNNAS 259
                  +   + S     R      ++  E+ D    G LE  +        ++V    
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDK---GTLEQWIEKRRGEKLDKVLALE 126
Query: 260 IMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTNKV 318
           +  Q+  G+ Y H +  ++RD+K SNI + +  +VK+ DFGL   L N   R R      
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKG--- 183
Query: 319 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            TL Y  PE +  ++ YG  +D+++ G IL EL 
Sbjct: 184 -TLRYMSPEQISSQD-YGKEVDLYALGLILAELL 215

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIIIEFMTYGNLLDYLRECNRQ 107
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 108 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX 167
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 168 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 206

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREI 213
           L  G  S    +    T +LVA+K +  E   EG   +   EI +L ++ H NIV L +I
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEA-LEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 214 VTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVDFNEVNNASIMRQLLDGLSYC 271
                      +  G  YL+ + +    +   ++E G   + E + + ++ Q+LD + Y 
Sbjct: 85  Y----------ESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYL 132
Query: 272 HKRNFLHRDIKCSNIL---MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
           H    +HRD+K  N+L   ++   ++ ++DFGL+++   ED     +    T  Y  PE 
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPE- 188
Query: 329 LLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +L ++ Y  A+D WS G I   L    P F
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI I + L++ ++V              F +D    Y+V E      +  L        E
Sbjct: 76  EIAIHKSLDNPHVVGFH----------GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE 125
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                 MRQ + G+ Y H    +HRD+K  N+ +N+  +VK+ DFGLA     +  ++  
Sbjct: 126 PEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK-- 183
Query: 315 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            +   T  Y  PE+L  ++ +   +D+WS GCIL  L V KP F
Sbjct: 184 KDLCGTPNYIAPEVLC-KKGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 57  VTRERDVMSRLDHPFFVKL---------YFTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 106
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 107 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 166
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 167 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREI 213
           L  G  S    +    T +LVA+K +  +   EG   +   EI +L ++ H NIV L +I
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 214 VTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVDFNEVNNASIMRQLLDGLSYC 271
                      +  G  YL+ + +    +   ++E G   + E + + ++ Q+LD + Y 
Sbjct: 85  Y----------ESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYL 132
Query: 272 HKRNFLHRDIKCSNIL---MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPEL 328
           H    +HRD+K  N+L   ++   ++ ++DFGL+++   ED     +    T  Y  PE 
Sbjct: 133 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPE- 188
Query: 329 LLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +L ++ Y  A+D WS G I   L    P F
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 87/195 (44%), Gaps = 30/195 (15%)
Query: 170 TDELVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T E VA+K   L+ E  G  I  ++ EI+ILR L H+NIV  + I T+         D G
Sbjct: 37  TGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---------DGG 85
Query: 229 S-FYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           +   L+ E++    L   L       N         Q+  G+ Y   R ++HRD+   N+
Sbjct: 86  NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 145
Query: 287 LMNNRGEVKLADFGLARLYNA--------EDRQRPYTNKVITLWYRPPELLLGEERYGPA 338
           L+ +  +VK+ DFGL +            +DR  P        WY P  L+  + ++  A
Sbjct: 146 LVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP------VFWYAPECLM--QSKFYIA 197
Query: 339 IDVWSCGCILGELFV 353
            DVWS G  L EL  
Sbjct: 198 SDVWSFGVTLHELLT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +  E E F    ++E  +++++ H N+V L  + T +            FY+
Sbjct: 46  VAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYI 91
Query: 233 VFEYMDHD--LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           + E+M +   L  L E    + N V    +  Q+   + Y  K+NF+HRD+   N L+  
Sbjct: 92  IIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 151
Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              VK+ADFGL+RL   +        K    W  P  L     ++    DVW+ G +L E
Sbjct: 152 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWE 209
Query: 351 L 351
           +
Sbjct: 210 I 210

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 18/183 (9%)
Query: 174 VALKKVRLENEKEGFP-ITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VALKKV++ +  +       ++EI +L+QLNH N++       + ++            +
Sbjct: 60  VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE----------LNI 109
Query: 233 VFEYMDH-DLMGLLESGMVDFNEVNNASIMR---QLLDGLSYCHKRNFLHRDIKCSNILM 288
           V E  D  DL  +++        +   ++ +   QL   L + H R  +HRDIK +N+ +
Sbjct: 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 169
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              G VKL D GL R +++  +     + V T +Y  PE  + E  Y    D+WS GC+L
Sbjct: 170 TATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLL 226
Query: 349 GEL 351
            E+
Sbjct: 227 YEM 229

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 56  VTRERDVMSRLDHPFFVKL---------YFTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 105
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 106 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 165
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 166 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 30/197 (15%)
Query: 170 TDELVALKK-VRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T E++ +K+ +R + E +    T ++E+K++R L H N++    ++  K   L+F     
Sbjct: 34  TGEVMVMKELIRFDEETQR---TFLKEVKVMRCLEHPNVLKFIGVLY-KDKRLNF----- 84
Query: 229 SFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
               + EY+    L G+++S    +      S  + +  G++Y H  N +HRD+   N L
Sbjct: 85  ----ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCL 140
Query: 288 MNNRGEVKLADFGLARLYNAE-------------DRQRPYTNKVITLWYRPPELLLGEER 334
           +     V +ADFGLARL   E             DR++ YT  V   ++  PE++ G   
Sbjct: 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT-VVGNPYWMAPEMINGRS- 198
Query: 335 YGPAIDVWSCGCILGEL 351
           Y   +DV+S G +L E+
Sbjct: 199 YDEKVDVFSFGIVLCEI 215

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 76  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 125
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 126 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 185
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
               + V T  Y  PE LL E+    + D+W+ GCI+ +L    P F
Sbjct: 186 ARANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 38/198 (19%)
Query: 170 TDELVALKKVRLE---NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E+VA+K ++ +     + G+     +EI ILR L H++I+  +    D+ +       
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWK----QEIDILRTLYHEHIIKYKGCCEDQGEK------ 91
Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKC 283
             S  LV EY+    +G L    +  + +  A ++   +Q+ +G++Y H ++++HR++  
Sbjct: 92  --SLQLVMEYVP---LGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAA 145
Query: 284 SNILMNNRGEVKLADFGLAR-------LYNA-EDRQRPYTNKVITLWYRPPELLLGEERY 335
            N+L++N   VK+ DFGLA+        Y   ED   P        WY P    L E ++
Sbjct: 146 RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAPE--CLKEYKF 197
Query: 336 GPAIDVWSCGCILGELFV 353
             A DVWS G  L EL  
Sbjct: 198 YYASDVWSFGVTLYELLT 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIV 208
           L E L  GG+S  + +  L     VA+K +R +  ++  F +   RE +    LNH  IV
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 209 NLREIVTDKSDALDFRKDKGSF-YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDG 267
                V D  +A       G   Y+V EY+D   +  +              ++      
Sbjct: 76  ----AVYDTGEA---ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPP 326
           L++ H+   +HRD+K +NI+++    VK+ DFG+AR           T  VI T  Y  P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 327 ELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           E   G+     + DV+S GC+L E+   +P F
Sbjct: 189 EQARGDSVDARS-DVYSLGCVLYEVLTGEPPF 219

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVD 251
           + E K++  L+H+ +V L  + T +             +++ EYM +  L+  L      
Sbjct: 51  IEEAKVMMNLSHEKLVQLYGVCTKQR----------PIFIITEYMANGCLLNYLREMRHR 100
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F       + + + + + Y   + FLHRD+   N L+N++G VK++DFGL+R Y  +D  
Sbjct: 101 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEY 159
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
                    + + PPE+L+   ++    D+W+ G ++ E++
Sbjct: 160 TSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIY 199

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 38/198 (19%)
Query: 170 TDELVALKKVRLE---NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E+VA+K ++ +     + G+     +EI ILR L H++I+  +    D+ +       
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWK----QEIDILRTLYHEHIIKYKGCCEDQGEK------ 91
Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKC 283
             S  LV EY+    +G L    +  + +  A ++   +Q+ +G++Y H ++++HR++  
Sbjct: 92  --SLQLVMEYVP---LGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAA 145
Query: 284 SNILMNNRGEVKLADFGLAR-------LYNA-EDRQRPYTNKVITLWYRPPELLLGEERY 335
            N+L++N   VK+ DFGLA+        Y   ED   P        WY P    L E ++
Sbjct: 146 RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAPE--CLKEYKF 197
Query: 336 GPAIDVWSCGCILGELFV 353
             A DVWS G  L EL  
Sbjct: 198 YYASDVWSFGVTLYELLT 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIV 208
           L E L  GG+S  + +  L     VA+K +R +  ++  F +   RE +    LNH  IV
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 209 NLREIVTDKSDALDFRKDKGSF-YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDG 267
                V D  +A       G   Y+V EY+D   +  +              ++      
Sbjct: 76  ----AVYDTGEA---ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPP 326
           L++ H+   +HRD+K +NI+++    VK+ DFG+AR           T  VI T  Y  P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 327 ELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           E   G+     + DV+S GC+L E+   +P F
Sbjct: 189 EQARGDSVDARS-DVYSLGCVLYEVLTGEPPF 219

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 54  VTRERDVMSRLDHPFFVKL---------YFTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 103
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 104 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 163
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 164 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIV 208
           L E L  GG+S  + +  L     VA+K +R +  ++  F +   RE +    LNH  IV
Sbjct: 16  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 209 NLREIVTDKSDALDFRKDKGSF-YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDG 267
                V D  +A       G   Y+V EY+D   +  +              ++      
Sbjct: 76  ----AVYDTGEA---ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPP 326
           L++ H+   +HRD+K +NI+++    VK+ DFG+AR           T  VI T  Y  P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 327 ELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           E   G+     + DV+S GC+L E+   +P F
Sbjct: 189 EQARGDSVDARS-DVYSLGCVLYEVLTGEPPF 219

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVD 251
           + E K++  L+H+ +V L  + T +             +++ EYM +  L+  L      
Sbjct: 58  IEEAKVMMNLSHEKLVQLYGVCTKQR----------PIFIITEYMANGCLLNYLREMRHR 107
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F       + + + + + Y   + FLHRD+   N L+N++G VK++DFGL+R Y  +D  
Sbjct: 108 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEY 166
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
                    + + PPE+L+   ++    D+W+ G ++ E++
Sbjct: 167 TSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIY 206

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVD 251
           + E K++  L+H+ +V L  + T +             +++ EYM +  L+  L      
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQR----------PIFIITEYMANGCLLNYLREMRHR 96
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F       + + + + + Y   + FLHRD+   N L+N++G VK++DFGL+R Y  +D  
Sbjct: 97  FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEY 155
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
                    + + PPE+L+   ++    D+W+ G ++ E++
Sbjct: 156 TSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIY 195

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 55  VTRERDVMSRLDHPFFVKL---------YFTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 104
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 105 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 165 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +  E E F    ++E  +++++ H N+V L  + T +            FY+
Sbjct: 46  VAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYI 91
Query: 233 VFEYMDHD--LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           + E+M +   L  L E    + N V    +  Q+   + Y  K+NF+HRD+   N L+  
Sbjct: 92  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 151
Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              VK+ADFGL+RL   +        K    W  P  L     ++    DVW+ G +L E
Sbjct: 152 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWE 209
Query: 351 L 351
           +
Sbjct: 210 I 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +  E E F    ++E  +++++ H N+V L  + T +            FY+
Sbjct: 46  VAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYI 91
Query: 233 VFEYMDHD--LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           + E+M +   L  L E    + N V    +  Q+   + Y  K+NF+HRD+   N L+  
Sbjct: 92  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 151
Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              VK+ADFGL+RL   +        K    W  P  L     ++    DVW+ G +L E
Sbjct: 152 NHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWE 209
Query: 351 L 351
           +
Sbjct: 210 I 210

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 84  VTRERDVMSRLDHPFFVKLY---------FCFQDDEKLYFGLSYAKNGELLKYIRK-IGS 133
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 134 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 193
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PELL  E+    + D+W+ GCI+ +L    P F
Sbjct: 194 ARANXFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 111
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 112 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 172 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 210

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVD 251
           + E K++  L+H+ +V L  + T +             +++ EYM +  L+  L      
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQR----------PIFIITEYMANGCLLNYLREMRHR 101
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F       + + + + + Y   + FLHRD+   N L+N++G VK++DFGL+R Y  +D  
Sbjct: 102 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEY 160
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
                    + + PPE+L+   ++    D+W+ G ++ E++
Sbjct: 161 TSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIY 200

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 173 LVALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           LVA+K ++   E+ ++ F     RE ++L  L H++IV    + T+    L         
Sbjct: 73  LVAVKALKEASESARQDFQ----REAELLTMLQHQHIVRFFGVCTEGRPLL--------- 119
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNA--------------SIMRQLLDGLSYCHKRN 275
            +VFEYM H DL   L S   D   +                 ++  Q+  G+ Y    +
Sbjct: 120 -MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178
Query: 276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           F+HRD+   N L+     VK+ DFG++R   + D  R     ++ + + PPE +L   ++
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKF 237
Query: 336 GPAIDVWSCGCILGELFV--KKPLF 358
               DVWS G +L E+F   K+P +
Sbjct: 238 TTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 172 ELVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           ++++ +K  + + +E  P   V  EI+IL++LNH  I+ ++              D   +
Sbjct: 47  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-----------DAEDY 95
Query: 231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           Y+V E M+   +     G     E        Q+L  + Y H+   +HRD+K  N+L+++
Sbjct: 96  YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 155
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL--LGEERYGPAIDVWSCG 345
           + E   +K+ DFG +++       R       T  Y  PE+L  +G   Y  A+D WS G
Sbjct: 156 QEEDCLIKITDFGHSKILGETSLMRTLCG---TPTYLAPEVLVSVGTAGYNRAVDCWSLG 212
Query: 346 CIL 348
            IL
Sbjct: 213 VIL 215

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 61  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 110
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 111 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 170
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PE LL E+    + D+W+ GCI+ +L    P F
Sbjct: 171 ARANXFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 47  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 93
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V E M++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 94  -IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 152
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 153 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 209
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 210 VLWEVM 215

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 110
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 111 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 171 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 108
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 109 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 168
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 169 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 207

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIV 208
           L E L  GG+S  + +  L     VA+K +R +  ++  F +   RE +    LNH  IV
Sbjct: 33  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 92
Query: 209 NLREIVTDKSDALDFRKDKGSF-YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDG 267
                V D  +A       G   Y+V EY+D   +  +              ++      
Sbjct: 93  ----AVYDTGEA---ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 145
Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPP 326
           L++ H+   +HRD+K +NI+++    VK+ DFG+AR           T  VI T  Y  P
Sbjct: 146 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 205
Query: 327 ELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           E   G+     + DV+S GC+L E+   +P F
Sbjct: 206 EQARGDSVDARS-DVYSLGCVLYEVLTGEPPF 236

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 108
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 109 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 168
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 169 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 207

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 32/203 (15%)
Query: 173 LVALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           LVA+K ++   +N ++ F     RE ++L  L H++IV    +  +    +         
Sbjct: 45  LVAVKTLKDASDNARKDFH----REAELLTNLQHEHIVKFYGVCVEGDPLI--------- 91
Query: 231 YLVFEYMDH-DLMGLLESGMVD------------FNEVNNASIMRQLLDGLSYCHKRNFL 277
            +VFEYM H DL   L +   D              +     I +Q+  G+ Y   ++F+
Sbjct: 92  -MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFV 150
Query: 278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGP 337
           HRD+   N L+     VK+ DFG++R   + D  R   + ++ + + PPE ++   ++  
Sbjct: 151 HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTT 209
Query: 338 AIDVWSCGCILGELFV--KKPLF 358
             DVWS G +L E+F   K+P +
Sbjct: 210 ESDVWSLGVVLWEIFTYGKQPWY 232

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 172 ELVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           ++++ +K  + + +E  P   V  EI+IL++LNH  I+ ++              D   +
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-----------DAEDY 89
Query: 231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           Y+V E M+   +     G     E        Q+L  + Y H+   +HRD+K  N+L+++
Sbjct: 90  YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL--LGEERYGPAIDVWSCG 345
           + E   +K+ DFG +++       R       T  Y  PE+L  +G   Y  A+D WS G
Sbjct: 150 QEEDCLIKITDFGHSKILGETSLMRTLCG---TPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 346 CIL 348
            IL
Sbjct: 207 VIL 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 106
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 107 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 167 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 205

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 172 ELVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           ++++ +K  + + +E  P   V  EI+IL++LNH  I+ ++              D   +
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-----------DAEDY 89
Query: 231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           Y+V E M+   +     G     E        Q+L  + Y H+   +HRD+K  N+L+++
Sbjct: 90  YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL--LGEERYGPAIDVWSCG 345
           + E   +K+ DFG +++       R       T  Y  PE+L  +G   Y  A+D WS G
Sbjct: 150 QEEDCLIKITDFGHSKILGETSLMRTLCG---TPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 346 CIL 348
            IL
Sbjct: 207 VIL 209

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVD 251
           + E K++  L+H+ +V L  + T +             +++ EYM +  L+  L      
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQR----------PIFIITEYMANGCLLNYLREMRHR 101
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F       + + + + + Y   + FLHRD+   N L+N++G VK++DFGL+R Y  +D  
Sbjct: 102 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEY 160
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
                    + + PPE+L+   ++    D+W+ G ++ E++
Sbjct: 161 TSSRGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIY 200

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 122
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V E M++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 123 -IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 182 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 238
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 239 VLWEVM 244

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             RE  ++ +L+H   V L            F+ D+  ++ +    + +L+  +   +  
Sbjct: 76  VTRERDVMSRLDHPFFVKLY---------FTFQDDEKLYFGLSYAKNGELLKYIRK-IGS 125
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E        +++  L Y H +  +HRD+K  NIL+N    +++ DFG A++ + E +Q
Sbjct: 126 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 185
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                 V T  Y  PE LL E+    + D+W+ GCI+ +L    P F
Sbjct: 186 ARANXFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 106
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 107 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 167 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 205

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 35/188 (18%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++ +   + F    + E  ++ QL H N+V L  ++ +         +KG  Y+V
Sbjct: 47  VAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVE---------EKGGLYIV 93
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCS 284
            EYM        +  +VD+      S++           + + + Y    NF+HRD+   
Sbjct: 94  TEYM-------AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 146
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++     K++DFGL +    E      T K+   W  P  L   E+++    DVWS 
Sbjct: 147 NVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALR--EKKFSTKSDVWSF 200
Query: 345 GCILGELF 352
           G +L E++
Sbjct: 201 GILLWEIY 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 19/192 (9%)
Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD---FRKDKGSFY 231
           A+KK+R   EK     T + E+ +L  LNH+ +V       ++ + +      K K + +
Sbjct: 35  AIKKIRHTEEKLS---TILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLF 91
Query: 232 LVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           +  EY ++  L  L+ S  ++        + RQ+L+ LSY H +  +HR++K  NI ++ 
Sbjct: 92  IQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDE 151
Query: 291 RGEVKLADFGLAR-------LYNAEDRQRP-----YTNKVITLWYRPPELLLGEERYGPA 338
              VK+ DFGLA+       +   + +  P      T+ + T  Y   E+L G   Y   
Sbjct: 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEK 211
Query: 339 IDVWSCGCILGE 350
           ID +S G I  E
Sbjct: 212 IDXYSLGIIFFE 223

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 39/191 (20%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKS---------------DALDFRKDKGSFYLVF----- 234
           E++++++L+H NI  L E+  D+                D L+   D  +          
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 235 ----------EYMDHDLMGLLESGMVDFNEVNN--ASIMRQLLDGLSYCHKRNFLHRDIK 282
                     E ++  + G  ES  +DF +     ++IMRQ+   L Y H +   HRDIK
Sbjct: 138 QICPCPECNEEAINGSIHGFRES--LDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195
Query: 283 CSNILM--NNRGEVKLADFGLARLYNAEDRQRPY--TNKVITLWYRPPELL-LGEERYGP 337
             N L   N   E+KL DFGL++ +   +    Y  T K  T ++  PE+L    E YGP
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 338 AIDVWSCGCIL 348
             D WS G +L
Sbjct: 256 KCDAWSAGVLL 266

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 172 ELVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           ++++ +K  + + +E  P   V  EI+IL++LNH  I+ ++              D   +
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-----------DAEDY 89
Query: 231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           Y+V E M+   +     G     E        Q+L  + Y H+   +HRD+K  N+L+++
Sbjct: 90  YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL--LGEERYGPAIDVWSCG 345
           + E   +K+ DFG +++       R       T  Y  PE+L  +G   Y  A+D WS G
Sbjct: 150 QEEDCLIKITDFGHSKILGETSLMRTLCG---TPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 346 CIL 348
            IL
Sbjct: 207 VIL 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 35/188 (18%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++ +   + F    + E  ++ QL H N+V L  ++ +         +KG  Y+V
Sbjct: 32  VAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVE---------EKGGLYIV 78
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCS 284
            EYM        +  +VD+      S++           + + + Y    NF+HRD+   
Sbjct: 79  TEYM-------AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 131
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++     K++DFGL +    E      T K+   W  P  L   E+++    DVWS 
Sbjct: 132 NVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALR--EKKFSTKSDVWSF 185
Query: 345 GCILGELF 352
           G +L E++
Sbjct: 186 GILLWEIY 193

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 35/188 (18%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++ +   + F    + E  ++ QL H N+V L  ++ +         +KG  Y+V
Sbjct: 219 VAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVE---------EKGGLYIV 265
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCS 284
            EYM        +  +VD+      S++           + + + Y    NF+HRD+   
Sbjct: 266 TEYM-------AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++     K++DFGL +    E      T K+   W  P  L   E+++    DVWS 
Sbjct: 319 NVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALR--EKKFSTKSDVWSF 372
Query: 345 GCILGELF 352
           G +L E++
Sbjct: 373 GILLWEIY 380

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 173 LVALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           LVA+K ++   E+ ++ F     RE ++L  L H++IV    + T+    L         
Sbjct: 50  LVAVKALKEASESARQDFQ----REAELLTMLQHQHIVRFFGVCTEGRPLL--------- 96
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNA--------------SIMRQLLDGLSYCHKRN 275
            +VFEYM H DL   L S   D   +                 ++  Q+  G+ Y    +
Sbjct: 97  -MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 155
Query: 276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           F+HRD+   N L+     VK+ DFG++R   + D  R     ++ + + PPE +L   ++
Sbjct: 156 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKF 214
Query: 336 GPAIDVWSCGCILGELFV--KKPLF 358
               DVWS G +L E+F   K+P +
Sbjct: 215 TTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 70  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 119
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 120 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 179
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 180 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 218

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 31/167 (18%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG----- 248
           E  +++ L H  +V L  +VT           K   Y++ E+M    L+  L+S      
Sbjct: 60  EANVMKTLQHDKLVKLHAVVT-----------KEPIYIITEFMAKGSLLDFLKSDEGSKQ 108
Query: 249 ----MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL 304
               ++DF+         Q+ +G+++  +RN++HRD++ +NIL++     K+ADFGLAR+
Sbjct: 109 PLPKLIDFSA--------QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 160
Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
               +       K    W  P  +  G   +    DVWS G +L E+
Sbjct: 161 IEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEI 205

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 172 ELVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           ++++ +K  + + +E  P   V  EI+IL++LNH  I+ ++              D   +
Sbjct: 40  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-----------DAEDY 88
Query: 231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           Y+V E M+   +     G     E        Q+L  + Y H+   +HRD+K  N+L+++
Sbjct: 89  YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 148
Query: 291 RGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL--LGEERYGPAIDVWSCG 345
           + E   +K+ DFG +++       R       T  Y  PE+L  +G   Y  A+D WS G
Sbjct: 149 QEEDCLIKITDFGHSKILGETSLMRTLCG---TPTYLAPEVLVSVGTAGYNRAVDCWSLG 205
Query: 346 CIL 348
            IL
Sbjct: 206 VIL 208

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 173 LVALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           LVA+K ++   E+ ++ F     RE ++L  L H++IV    + T+    L         
Sbjct: 44  LVAVKALKEASESARQDFQ----REAELLTMLQHQHIVRFFGVCTEGRPLL--------- 90
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNA--------------SIMRQLLDGLSYCHKRN 275
            +VFEYM H DL   L S   D   +                 ++  Q+  G+ Y    +
Sbjct: 91  -MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 149
Query: 276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           F+HRD+   N L+     VK+ DFG++R   + D  R     ++ + + PPE +L   ++
Sbjct: 150 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKF 208
Query: 336 GPAIDVWSCGCILGELFV--KKPLF 358
               DVWS G +L E+F   K+P +
Sbjct: 209 TTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 33/185 (17%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH------------DL 241
           RE ++L  L H++IV    +  D    +          +VFEYM H            D 
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLI----------MVFEYMKHGDLNKFLRAHGPDA 115
Query: 242 MGLLES------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
           M L++       G +  +++ +  I  Q+  G+ Y   ++F+HRD+   N L+     VK
Sbjct: 116 MILVDGQPRQAKGELGLSQMLH--IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 173
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-- 353
           + DFG++R   + D  R   + ++ + + PPE ++   ++    DVWS G IL E+F   
Sbjct: 174 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYG 232
Query: 354 KKPLF 358
           K+P F
Sbjct: 233 KQPWF 237

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 85/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK RL + + G     + RE+ ILR++ H NI+ L +I  +K+D +          L+ 
Sbjct: 45  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV----------LIL 94
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+LDG+ Y H +   H D+K  NI++ +
Sbjct: 95  ELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 150
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +      +KL DFG+A    A +    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 151 KNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 206
Query: 347 I 347
           I
Sbjct: 207 I 207

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 9/211 (4%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIV 208
           L E L  GG+S  + +  L     VA+K +R +  ++  F +   RE +    LNH  IV
Sbjct: 16  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGL 268
            +      ++ A          Y+V EY+D   +  +              ++      L
Sbjct: 76  AVYATGEAETPAGPLP------YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 269 SYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPE 327
           ++ H+   +HRD+K +NI+++    VK+ DFG+AR           T  VI T  Y  PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 328 LLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
              G+     + DV+S GC+L E+   +P F
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPF 219

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIIIEFMTYGNLLDYLRECNRQ 104
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + + V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 105 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX 164
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 165 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 203

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM--GLLESGMVDF 252
           EI +L +L+H NI+ L+EI    ++            LV E +    +   ++E G   +
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTE----------ISLVLELVTGGELFDRIVEKGY--Y 145
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEVKLADFGLARLYNAED 309
           +E + A  ++Q+L+ ++Y H+   +HRD+K  N+L         +K+ADFGL+++   + 
Sbjct: 146 SERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             +       T  Y  PE+L G   YGP +D+WS G I
Sbjct: 206 LMKTVCG---TPGYCAPEILRGCA-YGPEVDMWSVGII 239

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+K ++ E           REI+ILR L H++IV  +    D+ +         S
Sbjct: 37  TGEMVAVKALK-EGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEK--------S 87
Query: 230 FYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             LV EY+    L   L    V   ++      +Q+ +G++Y H ++++HR +   N+L+
Sbjct: 88  VQLVMEYVPLGSLRDYLPRHCVGLAQL--LLFAQQICEGMAYLHAQHYIHRALAARNVLL 145
Query: 289 NNRGEVKLADFGLAR-------LYNA-EDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +N   VK+ DFGLA+        Y   ED   P        WY P    L E ++  A D
Sbjct: 146 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAPE--CLKECKFYYASD 197
Query: 341 VWSCGCILGELFV 353
           VWS G  L EL  
Sbjct: 198 VWSFGVTLYELLT 210

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 85/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK RL + + G     + RE+ ILR++ H NI+ L +I  +K+D +          L+ 
Sbjct: 38  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV----------LIL 87
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+LDG+ Y H +   H D+K  NI++ +
Sbjct: 88  ELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +      +KL DFG+A    A +    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 144 KNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 199
Query: 347 I 347
           I
Sbjct: 200 I 200

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/135 (36%), Positives = 70/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E M+   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 79  LDWFERPDSFVLILERMEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 136
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 137 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 192
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 193 RSAAVWSLGILLYDM 207

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 1/93 (1%)
Query: 260 IMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI 319
           I RQ+  G++Y  +R F+HRD+   N L+     VK+ADFGL+R   + D  +   N  I
Sbjct: 179 IARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 238
Query: 320 TLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            + + PPE +    RY    DVW+ G +L E+F
Sbjct: 239 PIRWMPPESIF-YNRYTTESDVWAYGVVLWEIF 270

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VA+K ++ E           REI+ILR L H++IV  +    D+ +         S
Sbjct: 36  TGEMVAVKALK-EGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEK--------S 86
Query: 230 FYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             LV EY+    L   L    V   ++      +Q+ +G++Y H ++++HR +   N+L+
Sbjct: 87  VQLVMEYVPLGSLRDYLPRHCVGLAQL--LLFAQQICEGMAYLHAQHYIHRALAARNVLL 144
Query: 289 NNRGEVKLADFGLAR-------LYNA-EDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +N   VK+ DFGLA+        Y   ED   P        WY P    L E ++  A D
Sbjct: 145 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAPE--CLKECKFYYASD 196
Query: 341 VWSCGCILGELFV 353
           VWS G  L EL  
Sbjct: 197 VWSFGVTLYELLT 209

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 83/183 (45%), Gaps = 21/183 (11%)
Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
            LK    E ++  F    + E  I+ Q +H N+++L  +VT  +  +          ++ 
Sbjct: 42  TLKSGYTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKSTPVM----------IIT 87
Query: 235 EYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
           E+M++  L   L      F  +    ++R +  G+ Y    N++HR +   NIL+N+   
Sbjct: 88  EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLV 147
Query: 294 VKLADFGLARLYNAEDRQRPYTN----KVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
            K++DFGL+R    +     YT+    K+   W  P  +     ++  A DVWS G ++ 
Sbjct: 148 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMW 205
Query: 350 ELF 352
           E+ 
Sbjct: 206 EVM 208

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIIIEFMTYGNLLDYLRECNRQ 106
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + + V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 107 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 167 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIIIEFMTYGNLLDYLRECNRQ 106
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + + V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 107 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 167 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 205

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 31/167 (18%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG----- 248
           E  +++ L H  +V L  +VT           K   Y++ E+M    L+  L+S      
Sbjct: 233 EANVMKTLQHDKLVKLHAVVT-----------KEPIYIITEFMAKGSLLDFLKSDEGSKQ 281
Query: 249 ----MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL 304
               ++DF+         Q+ +G+++  +RN++HRD++ +NIL++     K+ADFGLAR+
Sbjct: 282 PLPKLIDFSA--------QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
               +       K    W  P  +  G   +    DVWS G +L E+
Sbjct: 334 IEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEI 378

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 85/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK RL + + G     + RE+ ILR++ H NI+ L +I  +K+D +          L+ 
Sbjct: 59  IKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV----------LIL 108
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+LDG+ Y H +   H D+K  NI++ +
Sbjct: 109 ELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 164
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +      +KL DFG+A    A +    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 165 KNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 220
Query: 347 I 347
           I
Sbjct: 221 I 221

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 104
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + + V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 105 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX 164
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 165 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 203

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 20/182 (10%)
Query: 173 LVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           +++ +K  + + +E  P   V  EI+IL++LNH  I+ ++              D   +Y
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-----------DAEDYY 215
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           +V E M+   +     G     E        Q+L  + Y H+   +HRD+K  N+L++++
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275
Query: 292 GE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL--LGEERYGPAIDVWSCGC 346
            E   +K+ DFG +++       R       T  Y  PE+L  +G   Y  A+D WS G 
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMRTLCG---TPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 347 IL 348
           IL
Sbjct: 333 IL 334

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 35/188 (18%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++ +   + F    + E  ++ QL H N+V L  ++ +         +KG  Y+V
Sbjct: 38  VAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVE---------EKGGLYIV 84
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMR---------QLLDGLSYCHKRNFLHRDIKCS 284
            EYM        +  +VD+      S++           + + + Y    NF+HRD+   
Sbjct: 85  TEYM-------AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 137
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++     K++DFGL +    E      T K+   W  P  L   E  +    DVWS 
Sbjct: 138 NVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALR--EAAFSTKSDVWSF 191
Query: 345 GCILGELF 352
           G +L E++
Sbjct: 192 GILLWEIY 199

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 20/182 (10%)
Query: 173 LVALKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           +++ +K  + + +E  P   V  EI+IL++LNH  I+ ++              D   +Y
Sbjct: 181 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-----------DAEDYY 229
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           +V E M+   +     G     E        Q+L  + Y H+   +HRD+K  N+L++++
Sbjct: 230 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 289
Query: 292 GE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL--LGEERYGPAIDVWSCGC 346
            E   +K+ DFG +++       R       T  Y  PE+L  +G   Y  A+D WS G 
Sbjct: 290 EEDCLIKITDFGHSKILGETSLMRTLCG---TPTYLAPEVLVSVGTAGYNRAVDCWSLGV 346
Query: 347 IL 348
           IL
Sbjct: 347 IL 348

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 111
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + + V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 112 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 172 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 17/163 (10%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG-LLESGMVDFN 253
           E  I+ Q +H NI+ L  +++     +          ++ EYM++  +   L     +F+
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMM----------IITEYMENGALDKFLREKDGEFS 145
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            +    ++R +  G+ Y    N++HRD+   NIL+N+    K++DFGL+R+   +D +  
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAT 204
Query: 314 YTN---KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           YT    K+   W  P    +   ++  A DVWS G ++ E+  
Sbjct: 205 YTTSGGKIPIRWTAPEA--ISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 68/132 (51%), Gaps = 14/132 (10%)
Query: 231 YLVFEYMDHD-------LMGLLESGMVDFNEVNN-ASIMRQLLDGLSYCH-KRNFLHRDI 281
           Y+++EYM++D          +L+     F  +     I++ +L+  SY H ++N  HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY-GPAID 340
           K SNILM+  G VKL+DFG +  Y  + + +       T  + PPE    E  Y G  +D
Sbjct: 179 KPSNILMDKNGRVKLSDFGESE-YMVDKKIKGSRG---TYEFMPPEFFSNESSYNGAKVD 234
Query: 341 VWSCGCILGELF 352
           +WS G  L  +F
Sbjct: 235 IWSLGICLYVMF 246

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 82/181 (45%), Gaps = 19/181 (10%)
Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +  E E F    ++E  +++++ H N+V L  + T +            FY+
Sbjct: 60  VAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTLEP----------PFYI 105
Query: 233 VFEYMDHD--LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           V EYM +   L  L E    +   V    +  Q+   + Y  K+NF+HRD+   N L+  
Sbjct: 106 VTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 165
Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              VK+ADFGL+RL   +        K    W  P    L    +    DVW+ G +L E
Sbjct: 166 NHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES--LAYNTFSIKSDVWAFGVLLWE 223
Query: 351 L 351
           +
Sbjct: 224 I 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 24/188 (12%)
Query: 171 DELVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           D  VA+K +++   E ++  F    + E  I+ Q +H N+V+L  +VT     +      
Sbjct: 71  DVAVAIKTLKVGYTEKQRRDF----LCEASIMGQFDHPNVVHLEGVVTRGKPVM------ 120
Query: 228 GSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
               +V E+M++  L   L      F  +    ++R +  G+ Y     ++HRD+   NI
Sbjct: 121 ----IVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNI 176
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWS 343
           L+N+    K++DFGL+R+   +D +  YT    K+   W  P  +     ++  A DVWS
Sbjct: 177 LVNSNLVCKVSDFGLSRVIE-DDPEAVYTTTGGKIPVRWTAPEAIQY--RKFTSASDVWS 233
Query: 344 CGCILGEL 351
            G ++ E+
Sbjct: 234 YGIVMWEV 241

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD----HDLMGLLESGM 249
           RE+ ILRQ+ H N++ L ++  +++D +          L+ E +      D +   ES  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVV----------LILELVSGGELFDFLAQKES-- 111
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EVKLADFGLARLY 305
              +E    S ++Q+LDG++Y H +   H D+K  NI++ ++      +KL DFGLA  +
Sbjct: 112 --LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--H 167
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             ED    + N   T  +  PE ++  E  G   D+WS G I
Sbjct: 168 EIEDGVE-FKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVI 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 106
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + + V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 107 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 167 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 106
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + + V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 107 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 167 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 104
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + + V    +  Q+   + Y  K+NF+HRD+   N L+     VK+ADFGL+RL   +  
Sbjct: 105 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF 164
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 165 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 203

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 174 VALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +++   E ++  F    + E  I+ Q +H NI+ L  +VT     +         
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSKPVM--------- 122
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V E M++  L   L      F  +    ++R +  G+ Y      +HRD+   NIL+N
Sbjct: 123 -IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILIN 181
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    K++DFGL+R+   +D +  YT    K+   W  P    +   ++  A DVWS G 
Sbjct: 182 SNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPEA--IAYRKFTSASDVWSYGI 238
Query: 347 ILGELF 352
           +L E+ 
Sbjct: 239 VLWEVM 244

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 80/161 (49%), Gaps = 15/161 (9%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFN 253
           E  I+ Q +H NI++L  +VT     +          ++ EYM++  L   L      F 
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKCKPVM----------IITEYMENGSLDAFLRKNDGRFT 108
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            +    ++R +  G+ Y    +++HRD+   NIL+N+    K++DFG++R+   +D +  
Sbjct: 109 VIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAA 167
Query: 314 YTNK--VITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           YT +   I + +  PE  +   ++  A DVWS G ++ E+ 
Sbjct: 168 YTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVM 207

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 17/171 (9%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSD---ALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           A+ E KIL +++ + IV+L      K+D    +         Y ++  +D D  G     
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPG----- 285
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNA 307
              F E        Q++ GL + H+RN ++RD+K  N+L+++ G V+++D GLA  L   
Sbjct: 286 ---FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + + + Y     T  +  PELLLGEE Y  ++D ++ G  L E+   +  F
Sbjct: 343 QTKTKGYAG---TPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMV 250
           ++E  +++++ H N+V L  + T +            FY++ E+M +   L  L E    
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYIITEFMTYGNLLDYLRECNRQ 352
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
           + N V    +  Q+   + Y  K+NF+HR++   N L+     VK+ADFGL+RL   +  
Sbjct: 353 EVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 412
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                 K    W  P  L     ++    DVW+ G +L E+
Sbjct: 413 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEI 451

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L +   
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 137
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 138 PGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 198 IADFGLARDINNIDXXKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 17/171 (9%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSD---ALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           A+ E KIL +++ + IV+L      K+D    +         Y ++  +D D  G     
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPG----- 285
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNA 307
              F E        Q++ GL + H+RN ++RD+K  N+L+++ G V+++D GLA  L   
Sbjct: 286 ---FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + + + Y     T  +  PELLLGEE Y  ++D ++ G  L E+   +  F
Sbjct: 343 QTKTKGYAG---TPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 17/171 (9%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSD---ALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           A+ E KIL +++ + IV+L      K+D    +         Y ++  +D D  G     
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPG----- 285
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNA 307
              F E        Q++ GL + H+RN ++RD+K  N+L+++ G V+++D GLA  L   
Sbjct: 286 ---FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + + + Y     T  +  PELLLGEE Y  ++D ++ G  L E+   +  F
Sbjct: 343 QTKTKGYAG---TPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 80/161 (49%), Gaps = 15/161 (9%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFN 253
           E  I+ Q +H NI++L  +VT     +          ++ EYM++  L   L      F 
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPVM----------IITEYMENGSLDAFLRKNDGRFT 114
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            +    ++R +  G+ Y    +++HRD+   NIL+N+    K++DFG++R+   +D +  
Sbjct: 115 VIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAA 173
Query: 314 YTNK--VITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           YT +   I + +  PE  +   ++  A DVWS G ++ E+ 
Sbjct: 174 YTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVM 213

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L +   
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 137
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 198 IADFGLARDINNIDXXKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 17/171 (9%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSD---ALDFRKDKGSFYLVFEYMDHDLMGLLESG 248
           A+ E KIL +++ + IV+L      K+D    +         Y ++  +D D  G     
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPG----- 285
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNA 307
              F E        Q++ GL + H+RN ++RD+K  N+L+++ G V+++D GLA  L   
Sbjct: 286 ---FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + + + Y     T  +  PELLLGEE Y  ++D ++ G  L E+   +  F
Sbjct: 343 QTKTKGYAG---TPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD----HDLMGLLESGM 249
           RE+ ILRQ+ H N++ L ++  +++D +          L+ E +      D +   ES  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVV----------LILELVSGGELFDFLAQKES-- 111
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EVKLADFGLARLY 305
              +E    S ++Q+LDG++Y H +   H D+K  NI++ ++      +KL DFGLA  +
Sbjct: 112 --LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--H 167
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             ED    + N   T  +  PE ++  E  G   D+WS G I
Sbjct: 168 EIED-GVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVI 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 18/163 (11%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH----DLMGLLESG 248
           + E  +++ L H  +V L  +VT +             Y++ EYM      D +   E G
Sbjct: 56  LEEANLMKTLQHDKLVRLYAVVTREE----------PIYIITEYMAKGSLLDFLKSDEGG 105
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
            V   ++ + S   Q+ +G++Y  ++N++HRD++ +N+L++     K+ADFGLAR+    
Sbjct: 106 KVLLPKLIDFSA--QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 163
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +       K    W  P  +  G   +    DVWS G +L E+
Sbjct: 164 EYTAREGAKFPIKWTAPEAINFG--CFTIKSDVWSFGILLYEI 204

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L +   
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 183
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 12/191 (6%)
Query: 179 VRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD----ALDFR-KDKGSFYLV 233
           V+L+N  + F +  + + ++L++         R+++ +        L +  +D  + YLV
Sbjct: 93  VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152
Query: 234 FEY-MDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            +Y +  DL+ LL        E      + +++  +   H+ +++HRDIK  NILM+  G
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL----GEERYGPAIDVWSCG-CI 347
            ++LADFG + L   ED     +  V T  Y  PE+L     G+ RYGP  D WS G C+
Sbjct: 213 HIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271
Query: 348 LGELFVKKPLF 358
              L+ + P +
Sbjct: 272 YEMLYGETPFY 282

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF-- 252
           EI IL   +H NIV L          LD    + + +++ E+      G +++ M++   
Sbjct: 84  EIDILASCDHPNIVKL----------LDAFYYENNLWILIEFC---AGGAVDAVMLELER 130
Query: 253 --NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
              E     + +Q LD L+Y H    +HRD+K  NIL    G++KLADFG++   N    
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTI 189
Query: 311 QRPYTNKVITLWYRPPELLLGEER----YGPAIDVWSCGCILGELFVKKP 356
           QR   + + T ++  PE+++ E      Y    DVWS G  L E+   +P
Sbjct: 190 QR-RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD----HDLMGLLESGM 249
           RE+ ILRQ+ H N++ L ++  +++D +          L+ E +      D +   ES  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVV----------LILELVSGGELFDFLAQKES-- 111
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EVKLADFGLARLY 305
              +E    S ++Q+LDG++Y H +   H D+K  NI++ ++      +KL DFGLA  +
Sbjct: 112 --LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--H 167
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             ED    + N   T  +  PE ++  E  G   D+WS G I
Sbjct: 168 EIED-GVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD----HDLMGLLESGM 249
           RE+ ILRQ+ H N++ L ++  +++D +          L+ E +      D +   ES  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVV----------LILELVSGGELFDFLAQKES-- 111
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EVKLADFGLARLY 305
              +E    S ++Q+LDG++Y H +   H D+K  NI++ ++      +KL DFGLA  +
Sbjct: 112 --LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--H 167
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             ED    + N   T  +  PE ++  E  G   D+WS G I
Sbjct: 168 EIED-GVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD----HDLMGLLESGM 249
           RE+ ILRQ+ H N++ L ++  +++D +          L+ E +      D +   ES  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVV----------LILELVSGGELFDFLAQKES-- 111
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EVKLADFGLARLY 305
              +E    S ++Q+LDG++Y H +   H D+K  NI++ ++      +KL DFGLA  +
Sbjct: 112 --LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--H 167
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             ED    + N   T  +  PE ++  E  G   D+WS G I
Sbjct: 168 EIED-GVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVI 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 29/197 (14%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +  +E      V E+++++ +  HKNI+NL    T            G  Y+
Sbjct: 70  VAVKMLKDDATEEDLS-DLVSEMEMMKMIGKHKNIINLLGACTQD----------GPLYV 118
Query: 233 VFEYMDH-DLMGLLES----GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNF 276
           + EY    +L   L +    GM    D N V        +  S   QL  G+ Y   +  
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178
Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRD+   N+L+     +K+ADFGLAR  N  D  +  TN  + + +  PE L  +  Y 
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYT 237
Query: 337 PAIDVWSCGCILGELFV 353
              DVWS G ++ E+F 
Sbjct: 238 HQSDVWSFGVLMWEIFT 254

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF-- 252
           EI IL   +H NIV L          LD    + + +++ E+      G +++ M++   
Sbjct: 84  EIDILASCDHPNIVKL----------LDAFYYENNLWILIEFC---AGGAVDAVMLELER 130
Query: 253 --NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
              E     + +Q LD L+Y H    +HRD+K  NIL    G++KLADFG++   N    
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRXI 189
Query: 311 QRPYTNKVITLWYRPPELLLGEER----YGPAIDVWSCGCILGELFVKKP 356
           QR   + + T ++  PE+++ E      Y    DVWS G  L E+   +P
Sbjct: 190 QR-RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 21/183 (11%)
Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           ALK    E ++  F    + E  I+ Q +H NI+ L  +VT    A+          +V 
Sbjct: 84  ALKAGYTERQRRDF----LSEASIMGQFDHPNIIRLEGVVTRGRLAM----------IVT 129
Query: 235 EYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
           EYM++  L   L +    F  +    ++R +  G+ Y     ++HRD+   N+L+++   
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV 189
Query: 294 VKLADFGLARLYNAEDRQRPYTN---KVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
            K++DFGL+R+   +D    YT    K+   W  P  +      +  A DVWS G ++ E
Sbjct: 190 CKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWE 246
Query: 351 LFV 353
           +  
Sbjct: 247 VLA 249

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L +   
Sbjct: 77  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 126
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 127 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 186
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 187 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 56/116 (48%), Gaps = 8/116 (6%)
Query: 246 ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLA 302
           E G   F E   A IMR +   + + H  N  HRD+K  N+L  ++ +   +KL DFG A
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
Query: 303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +    E  Q        T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 179 K----ETTQNALQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD----HDLMGLLESGM 249
           RE+ ILRQ+ H NI+ L ++  +++D +          L+ E +      D +   ES  
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVV----------LILELVSGGELFDFLAQKES-- 111
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EVKLADFGLARLY 305
              +E    S ++Q+LDG++Y H +   H D+K  NI++ ++      +KL DFGLA  +
Sbjct: 112 --LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--H 167
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             ED    + N   T  +  PE ++  E  G   D+WS G I
Sbjct: 168 EIED-GVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVI 207

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L +   
Sbjct: 75  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 124
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 125 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMK 184
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 185 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L +   
Sbjct: 80  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 129
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 130 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 189
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 190 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 56/116 (48%), Gaps = 8/116 (6%)
Query: 246 ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLA 302
           E G   F E   A IMR +   + + H  N  HRD+K  N+L  ++ +   +KL DFG A
Sbjct: 100 ERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 159
Query: 303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +    E  Q        T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 160 K----ETTQNALQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 25/160 (15%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFN 253
           EI ++ QL+H N++ L +    K+D +          LV EY+D  +L   +     +  
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIV----------LVMEYVDGGELFDRIIDESYNLT 185
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG--EVKLADFGLARLYNAEDRQ 311
           E++    M+Q+ +G+ + H+   LH D+K  NIL  NR   ++K+ DFGLAR Y   ++ 
Sbjct: 186 ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244
Query: 312 RPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCI 347
                  + + +  PE L  E    +      D+WS G I
Sbjct: 245 -------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLM-GLLESGMVDFN 253
           E  I+ Q  H NI+ L  +VT+    +          ++ E+M++  +   L      F 
Sbjct: 65  EASIMGQFEHPNIIRLEGVVTNSMPVM----------ILTEFMENGALDSFLRLNDGQFT 114
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            +    ++R +  G+ Y  + +++HRD+   NIL+N+    K++DFGL+R          
Sbjct: 115 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 174
Query: 314 YTN----KVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKPLF 358
           YT+    K+   W  P  +     ++  A D WS G ++ E+  F ++P +
Sbjct: 175 YTSSLGGKIPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVMSFGERPYW 223

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 23/170 (13%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDF-- 252
           EI IL   +H NIV L          LD    + + +++ E+      G +++ M++   
Sbjct: 84  EIDILASCDHPNIVKL----------LDAFYYENNLWILIEFC---AGGAVDAVMLELER 130
Query: 253 --NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
              E     + +Q LD L+Y H    +HRD+K  NIL    G++KLADFG++       +
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ 190
Query: 311 QRPYTNKVITLWYRPPELLLGEER----YGPAIDVWSCGCILGELFVKKP 356
           +R     + T ++  PE+++ E      Y    DVWS G  L E+   +P
Sbjct: 191 RRDXF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           E VA+K ++    K+ F   A  E+++L  +N K+   ++  +        FR       
Sbjct: 80  EWVAIKIIK---NKKAFLNQAQIEVRLLELMN-KHDTEMKYYIVHLKRHFMFR---NHLC 132
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVN---NASIMRQLLDGLSYCH--KRNFLHRDIKCSNI 286
           LVFE + ++L  LL +   +F  V+        +Q+   L +    + + +H D+K  NI
Sbjct: 133 LVFEMLSYNLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 287 LMNN--RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           L+ N  R  +K+ DFG +     +  QR Y   + + +YR PE+LLG   Y  AID+WS 
Sbjct: 191 LLCNPKRSAIKIVDFGSS----CQLGQRIY-QXIQSRFYRSPEVLLGMP-YDLAIDMWSL 244
Query: 345 GCILGELFVKKPLF 358
           GCIL E+   +PLF
Sbjct: 245 GCILVEMHTGEPLF 258

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L +   
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 137
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 198 IADFGLARDINNIDYYKNTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  LVA+K+++     +       REI+IL+ L+   IV  R         + +   + S
Sbjct: 38  TGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDFIVKYR--------GVSYGPGRQS 87
Query: 230 FYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             LV EY+    L   L+      +         Q+  G+ Y   R  +HRD+   NIL+
Sbjct: 88  LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 147
Query: 289 NNRGEVKLADFGLARLYNAEDR----QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
            +   VK+ADFGLA+L   +      + P  + +   WY P    L +  +    DVWS 
Sbjct: 148 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI--FWYAPES--LSDNIFSRQSDVWSF 203
Query: 345 GCILGELFV 353
           G +L ELF 
Sbjct: 204 GVVLYELFT 212

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           E VA+K ++    K+ F   A  E+++L  +N K+   ++  +        FR       
Sbjct: 61  EWVAIKIIK---NKKAFLNQAQIEVRLLELMN-KHDTEMKYYIVHLKRHFMFR---NHLC 113
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVN---NASIMRQLLDGLSYCH--KRNFLHRDIKCSNI 286
           LVFE + ++L  LL +   +F  V+        +Q+   L +    + + +H D+K  NI
Sbjct: 114 LVFEMLSYNLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 171
Query: 287 LMNN--RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           L+ N  R  +K+ DFG +     +  QR Y   + + +YR PE+LLG   Y  AID+WS 
Sbjct: 172 LLCNPKRSAIKIVDFGSS----CQLGQRIY-QXIQSRFYRSPEVLLGMP-YDLAIDMWSL 225
Query: 345 GCILGELFVKKPLF 358
           GCIL E+   +PLF
Sbjct: 226 GCILVEMHTGEPLF 239

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  LVA+K+++     +       REI+IL+ L+   IV  R         + +   + S
Sbjct: 39  TGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDFIVKYR--------GVSYGPGRQS 88
Query: 230 FYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             LV EY+    L   L+      +         Q+  G+ Y   R  +HRD+   NIL+
Sbjct: 89  LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 148
Query: 289 NNRGEVKLADFGLARLYNAEDR----QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
            +   VK+ADFGLA+L   +      + P  + +   WY P    L +  +    DVWS 
Sbjct: 149 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI--FWYAPES--LSDNIFSRQSDVWSF 204
Query: 345 GCILGELFV 353
           G +L ELF 
Sbjct: 205 GVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  LVA+K+++     +       REI+IL+ L+   IV  R         + +   + S
Sbjct: 51  TGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDFIVKYR--------GVSYGPGRQS 100
Query: 230 FYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             LV EY+    L   L+      +         Q+  G+ Y   R  +HRD+   NIL+
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 160
Query: 289 NNRGEVKLADFGLARLYNAEDR----QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
            +   VK+ADFGLA+L   +      + P  + +   WY P    L +  +    DVWS 
Sbjct: 161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI--FWYAPES--LSDNIFSRQSDVWSF 216
Query: 345 GCILGELFV 353
           G +L ELF 
Sbjct: 217 GVVLYELFT 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 17/181 (9%)
Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           ALK    E ++  F    + E  I+ Q +H NI+ L  +VT    A+          +V 
Sbjct: 84  ALKAGYTERQRRDF----LSEASIMGQFDHPNIIRLEGVVTRGRLAM----------IVT 129
Query: 235 EYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
           EYM++  L   L +    F  +    ++R +  G+ Y     ++HRD+   N+L+++   
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV 189
Query: 294 VKLADFGLAR-LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            K++DFGL+R L +  D     T   I + +  PE  +    +  A DVWS G ++ E+ 
Sbjct: 190 CKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVL 248
Query: 353 V 353
Sbjct: 249 A 249

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 75  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNXGVL 132
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 188
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 189 RSAAVWSLGILLYDM 203

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +  E E F    ++E  +++++ H N+V L  + T +            FY+
Sbjct: 248 VAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP----------PFYI 293
Query: 233 VFEYMDHD--LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           + E+M +   L  L E    + + V    +  Q+   + Y  K+NF+HR++   N L+  
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE 353
Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              VK+ADFGL+RL   +        K    W  P  L     ++    DVW+ G +L E
Sbjct: 354 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWE 411
Query: 351 L 351
           +
Sbjct: 412 I 412

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFN 253
           E  I+ Q +H NI++L  +VT     +          ++ EYM++  L   L      F 
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTKCKPVM----------IITEYMENGSLDAFLRKNDGRFT 129
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
            +    ++R +  G+ Y    + +HRD+   NIL+N+    K++DFG++R+   +D +  
Sbjct: 130 VIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAA 188
Query: 314 YTNK--VITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           YT +   I + +  PE  +   ++  A DVWS G ++ E+ 
Sbjct: 189 YTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 74/134 (55%), Gaps = 7/134 (5%)
Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           K + + V EY++  DLM  ++S    F+         +++ GL + H +  ++RD+K  N
Sbjct: 91  KENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 149
Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSC 344
           IL++  G +K+ADFG+ +     D +   TN+   T  Y  PE+LLG ++Y  ++D WS 
Sbjct: 150 ILLDKDGHIKIADFGMCKENMLGDAK---TNEFCGTPDYIAPEILLG-QKYNHSVDWWSF 205
Query: 345 GCILGELFVKKPLF 358
           G +L E+ + +  F
Sbjct: 206 GVLLYEMLIGQSPF 219

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L +   
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 137
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     ++
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMR 197
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 25/195 (12%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  L A K +  ++E+E      + EI+IL   +H  IV L          L      G 
Sbjct: 35  TGALAAAKVIETKSEEELE--DYIVEIEILATCDHPYIVKL----------LGAYYHDGK 82
Query: 230 FYLVFEYMDHDLMGLLESGMVDFN----EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
            +++ E+      G +++ M++ +    E     + RQ+L+ L++ H +  +HRD+K  N
Sbjct: 83  LWIMIEFCPG---GAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 139
Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER----YGPAIDV 341
           +LM   G+++LADFG++   N +  Q+   + + T ++  PE+++ E      Y    D+
Sbjct: 140 VLMTLEGDIRLADFGVSA-KNLKTLQK-RDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 197
Query: 342 WSCGCILGELFVKKP 356
           WS G  L E+   +P
Sbjct: 198 WSLGITLIEMAQIEP 212

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 122 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 179
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 180 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 235
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 236 RSAAVWSLGILLYDM 250

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 22/194 (11%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           E VA+K ++    K+ F   A  E+++L  +N K+   ++  +        FR       
Sbjct: 80  EWVAIKIIK---NKKAFLNQAQIEVRLLELMN-KHDTEMKYYIVHLKRHFMFR---NHLC 132
Query: 232 LVFEYMDHDLMGLLESGMVDFNEVN---NASIMRQLLDGLSYCH--KRNFLHRDIKCSNI 286
           LVFE + ++L  LL +   +F  V+        +Q+   L +    + + +H D+K  NI
Sbjct: 133 LVFEMLSYNLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 287 LMNN--RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           L+ N  R  +K+ DFG +     +  QR Y   + + +YR PE+LLG   Y  AID+WS 
Sbjct: 191 LLCNPKRXAIKIVDFGSS----CQLGQRIY-QXIQSRFYRSPEVLLGMP-YDLAIDMWSL 244
Query: 345 GCILGELFVKKPLF 358
           GCIL E+   +PLF
Sbjct: 245 GCILVEMHTGEPLF 258

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 94  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 151
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 152 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 207
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 208 RSAAVWSLGILLYDM 222

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 79  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 136
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 137 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 192
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 193 RSAAVWSLGILLYDM 207

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 80  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 137
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 138 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 193
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 194 RSAAVWSLGILLYDM 208

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 107 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 164
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 165 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 220
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 221 RSAAVWSLGILLYDM 235

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 94  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 151
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 152 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 207
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 208 RSAAVWSLGILLYDM 222

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 122 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 179
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 180 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 235
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 236 RSAAVWSLGILLYDM 250

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 107 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 164
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 165 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 220
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 221 RSAAVWSLGILLYDM 235

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 80  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 137
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 138 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 193
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 194 RSAAVWSLGILLYDM 208

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 108 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 165
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 166 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 221
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 222 RSAAVWSLGILLYDM 236

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 107 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 164
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 165 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 220
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 221 RSAAVWSLGILLYDM 235

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 108 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 165
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 166 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 221
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 222 RSAAVWSLGILLYDM 236

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 108 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 165
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 166 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 221
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 222 RSAAVWSLGILLYDM 236

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 25/195 (12%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  L A K +  ++E+E      + EI+IL   +H  IV L          L      G 
Sbjct: 43  TGALAAAKVIETKSEEELE--DYIVEIEILATCDHPYIVKL----------LGAYYHDGK 90
Query: 230 FYLVFEYMDHDLMGLLESGMVDFN----EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
            +++ E+      G +++ M++ +    E     + RQ+L+ L++ H +  +HRD+K  N
Sbjct: 91  LWIMIEFCPG---GAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 147
Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER----YGPAIDV 341
           +LM   G+++LADFG++   N +  Q+   + + T ++  PE+++ E      Y    D+
Sbjct: 148 VLMTLEGDIRLADFGVSA-KNLKTLQK-RDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 205
Query: 342 WSCGCILGELFVKKP 356
           WS G  L E+   +P
Sbjct: 206 WSLGITLIEMAQIEP 220

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 95  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 152
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 153 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 208
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 209 RSAAVWSLGILLYDM 223

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 108 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 165
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 166 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 221
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 222 RSAAVWSLGILLYDM 236

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 107 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 164
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 165 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 220
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 221 RSAAVWSLGILLYDM 235

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 95  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 152
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 153 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 208
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 209 RSAAVWSLGILLYDM 223

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 95  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 152
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 153 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 208
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 209 RSAAVWSLGILLYDM 223

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 127 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 184
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 185 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 240
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 241 RSAAVWSLGILLYDM 255

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 80  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 137
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 138 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 193
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 194 RSAAVWSLGILLYDM 208

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 22/196 (11%)
Query: 164 FSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
           F VS     LV  +K+     K       +RE+++L + N   IV              F
Sbjct: 85  FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA---------F 135
Query: 224 RKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDGLSYC-HKRNFLHRD 280
             D G   +  E+MD   +   L ++G +    +   SI   ++ GL+Y   K   +HRD
Sbjct: 136 YSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHKIMHRD 192
Query: 281 IKCSNILMNNRGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAI 339
           +K SNIL+N+RGE+KL DFG++ +L ++        + V T  Y  PE L G   Y    
Sbjct: 193 VKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQG-THYSVQS 246
Query: 340 DVWSCGCILGELFVKK 355
           D+WS G  L E+ V +
Sbjct: 247 DIWSMGLSLVEMAVGR 262

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 114 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 171
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 227
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 228 RSAAVWSLGILLYDM 242

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 122 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 179
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 180 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 235
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 236 RSAAVWSLGILLYDM 250

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 69/130 (53%), Gaps = 2/130 (1%)
Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +L+ +Y++   +    S    F E      + +++  L + HK   ++RDIK  NIL++
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 193
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL-GEERYGPAIDVWSCGCIL 348
           + G V L DFGL++ + A++ +R Y +   T+ Y  P+++  G+  +  A+D WS G ++
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252
Query: 349 GELFVKKPLF 358
            EL      F
Sbjct: 253 YELLTGASPF 262

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 73/134 (54%), Gaps = 7/134 (5%)
Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           K + + V EY++  DLM  ++S    F+         +++ GL + H +  ++RD+K  N
Sbjct: 90  KENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 148
Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSC 344
           IL++  G +K+ADFG+ +     D +   TN    T  Y  PE+LLG ++Y  ++D WS 
Sbjct: 149 ILLDKDGHIKIADFGMCKENMLGDAK---TNXFCGTPDYIAPEILLG-QKYNHSVDWWSF 204
Query: 345 GCILGELFVKKPLF 358
           G +L E+ + +  F
Sbjct: 205 GVLLYEMLIGQSPF 218

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 78  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 135
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 136 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 191
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 192 RSAAVWSLGILLYDM 206

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 102 LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 159
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 160 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 215
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 216 RSAAVWSLGILLYDM 230

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 28/169 (16%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG------ 248
           E+ I+R   H N+V + +                  YLV E +   LM  L+ G      
Sbjct: 92  EVVIMRDYQHFNVVEMYK-----------------SYLVGEEL-WVLMEFLQGGALTDIV 133
Query: 249 -MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA 307
             V  NE   A++   +L  L+Y H +  +HRDIK  +IL+   G VKL+DFG     + 
Sbjct: 134 SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKP 356
           +  +R     V T ++  PE ++    Y   +D+WS G ++ E+   +P
Sbjct: 194 DVPKRKXL--VGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEP 239

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 75  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 132
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 188
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 189 RSAAVWSLGILLYDM 203

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 41/167 (24%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG----- 248
           E  +++ L H  +V L  +VT           K   Y++ E+M    L+  L+S      
Sbjct: 227 EANVMKTLQHDKLVKLHAVVT-----------KEPIYIITEFMAKGSLLDFLKSDEGSKQ 275
Query: 249 ----MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL 304
               ++DF+         Q+ +G+++  +RN++HRD++ +NIL++     K+ADFGLAR+
Sbjct: 276 PLPKLIDFSA--------QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 327
Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                       K    W  P  +  G   +    DVWS G +L E+
Sbjct: 328 ----------GAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEI 362

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 17/166 (10%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMVDF 252
           E  IL ++ H  IV+L          +   +  G  YL+ EY+      M L   G+  F
Sbjct: 71  ERNILEEVKHPFIVDL----------IYAFQTGGKLYLILEYLSGGELFMQLEREGI--F 118
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
            E      + ++   L + H++  ++RD+K  NI++N++G VKL DFGL +  +  D   
Sbjct: 119 MEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTV 177
Query: 313 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            +T    T+ Y  PE+L+    +  A+D WS G ++ ++    P F
Sbjct: 178 THTF-CGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           + E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L++   
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLQARRP 130
Query: 248 -GM-VDFNEVNN----------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+   FN  +N           S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 131 PGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 191 IADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 221 LDFRKDKGSFYLVFEYMD--HDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
           LD+ +   SF L+ E  +   DL   + E G +   E    S   Q+L+ + +CH    L
Sbjct: 75  LDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAVRHCHNCGVL 132
Query: 278 HRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           HRDIK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHG 188
Query: 337 PAIDVWSCGCILGEL 351
            +  VWS G +L ++
Sbjct: 189 RSAAVWSLGILLYDM 203

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI++L    T            G  Y++ EY    +L   L +   
Sbjct: 88  VSEMEMMKMIGKHKNIIHLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 137
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+ L    T            G  Y++ EY    +L   L +   
Sbjct: 88  VSEMEMMKMIGKHKNIITLLGACTQD----------GPLYVIVEYASKGNLREYLRARRP 137
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++  Y    +L   L +   
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVAYASKGNLREYLRARRP 137
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 82/189 (43%), Gaps = 19/189 (10%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  LVA+K+++     +       REI+IL+ L+   IV  R         + +   +  
Sbjct: 35  TGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDFIVKYR--------GVSYGPGRPE 84
Query: 230 FYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             LV EY+    L   L+      +         Q+  G+ Y   R  +HRD+   NIL+
Sbjct: 85  LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 144
Query: 289 NNRGEVKLADFGLARLYNAEDR----QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
            +   VK+ADFGLA+L   +      + P  + +   WY P    L +  +    DVWS 
Sbjct: 145 ESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI--FWYAPES--LSDNIFSRQSDVWSF 200
Query: 345 GCILGELFV 353
           G +L ELF 
Sbjct: 201 GVVLYELFT 209

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 37/186 (19%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +             
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI------------- 90
Query: 235 EYMDHDLMGLLESG--MVDF-------NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
                 L+G L +G  + DF        E      ++Q+L+G+ Y H     H D+K  N
Sbjct: 91  ------LIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 144
Query: 286 ILMNNRG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           I++ +R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+
Sbjct: 145 IMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADM 200
Query: 342 WSCGCI 347
           WS G I
Sbjct: 201 WSIGVI 206

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 18/163 (11%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH----DLMGLLESG 248
           + E  +++ L H  +V L  +VT +             Y++ E+M      D +   E G
Sbjct: 55  LEEANLMKTLQHDKLVRLYAVVTKEE----------PIYIITEFMAKGSLLDFLKSDEGG 104
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
            V   ++ + S   Q+ +G++Y  ++N++HRD++ +N+L++     K+ADFGLAR+    
Sbjct: 105 KVLLPKLIDFS--AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 162
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +       K    W  P  +  G   +    +VWS G +L E+
Sbjct: 163 EYTAREGAKFPIKWTAPEAINFG--CFTIKSNVWSFGILLYEI 203

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 29/214 (13%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFP-----ITAVREIKILRQLN-- 203
           + PL   G     F+    TD L    KV   N   G+      +T   E+ +L ++   
Sbjct: 35  LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 204 --HKNIVNLREIVTDKSDALDFRKDKGSFYLVFE--YMDHDLMGLL-ESGMVDFNEVNNA 258
             H  ++ L          LD+ + +  F LV E      DL   + E G     E  + 
Sbjct: 95  GGHPGVIRL----------LDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSR 142
Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNK 317
               Q++  + +CH R  +HRDIK  NIL++  RG  KL DFG   L + E    PYT+ 
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDF 198
Query: 318 VITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             T  Y PPE +   + +     VWS G +L ++
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDM 232

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 164 FSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
           F VS     LV  +K+     K       +RE+++L + N   IV              F
Sbjct: 23  FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA---------F 73
Query: 224 RKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDGLSYC-HKRNFLHRD 280
             D G   +  E+MD   +   L ++G +    +   SI   ++ GL+Y   K   +HRD
Sbjct: 74  YSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHKIMHRD 130
Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +K SNIL+N+RGE+KL DFG++     +       + V T  Y  PE L G   Y    D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG-THYSVQSD 185
Query: 341 VWSCGCILGELFVKK 355
           +WS G  L E+ V +
Sbjct: 186 IWSMGLSLVEMAVGR 200

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 25/228 (10%)
Query: 132 MQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDE-LVALKKVRLENEKEGFPI 190
           +  A P      N+    L E +  G      FS  L  D  LVA+K  R E        
Sbjct: 100 LHRAVPKDKWVLNHEDLVLGEQIGRGNFG-EVFSGRLRADNTLVAVKSCR-ETLPPDLKA 157
Query: 191 TAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM 249
             ++E +IL+Q +H NIV L  + T K             Y+V E +   D +  L +  
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQ----------PIYIVMELVQGGDFLTFLRTEG 207
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-----L 304
                     ++     G+ Y   +  +HRD+   N L+  +  +K++DFG++R     +
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           Y A    R    +V   W  P  L  G  RY    DVWS G +L E F
Sbjct: 268 YAASGGLR----QVPVKWTAPEALNYG--RYSSESDVWSFGILLWETF 309

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           V E+++++ +  HKNI+NL    T            G  Y++  Y    +L   L +   
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVGYASKGNLREYLRARRP 137
Query: 248 -GM---VDFNEV--------NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            GM    D N V        +  S   QL  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  N  D  +  TN  + + +  PE L  +  Y    DVWS G ++ E+F 
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           ++E L +G   + +  V   T  +   K +      + +  T   EI I+ QL+H  ++N
Sbjct: 55  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKLIN 112
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
           L +   DK + +          L+ E++   +L   + +     +E    + MRQ  +GL
Sbjct: 113 LHDAFEDKYEMV----------LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 162
Query: 269 SYCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPP 326
            + H+ + +H DIK  NI+   +    VK+ DFGLA   N ++  +  T    T  +  P
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAP 219
Query: 327 ELLLGEERYGPAIDVWSCGCI 347
           E ++  E  G   D+W+ G +
Sbjct: 220 E-IVDREPVGFYTDMWAIGVL 239

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 22/196 (11%)
Query: 164 FSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
           F VS     LV  +K+     K       +RE+++L + N   IV              F
Sbjct: 26  FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA---------F 76
Query: 224 RKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDGLSYC-HKRNFLHRD 280
             D G   +  E+MD   +   L ++G +    +   SI   ++ GL+Y   K   +HRD
Sbjct: 77  YSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHKIMHRD 133
Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAI 339
           +K SNIL+N+RGE+KL DFG++     E       N+ + T  Y  PE L G   Y    
Sbjct: 134 VKPSNILVNSRGEIKLCDFGVSGQLIDE-----MANEFVGTRSYMSPERLQG-THYSVQS 187
Query: 340 DVWSCGCILGELFVKK 355
           D+WS G  L E+ V +
Sbjct: 188 DIWSMGLSLVEMAVGR 203

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 70/130 (53%), Gaps = 7/130 (5%)
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           Y V EY++  DLM  ++  +  F E        ++  GL + HKR  ++RD+K  N++++
Sbjct: 96  YFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLD 154
Query: 290 NRGEVKLADFGLARLYNAED-RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           + G +K+ADFG+ + +  +    R +     T  Y  PE ++  + YG ++D W+ G +L
Sbjct: 155 SEGHIKIADFGMCKEHMMDGVTTREFCG---TPDYIAPE-IIAYQPYGKSVDWWAYGVLL 210
Query: 349 GELFVKKPLF 358
            E+   +P F
Sbjct: 211 YEMLAGQPPF 220

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 164 FSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
           F VS     LV  +K+     K       +RE+++L + N   IV              F
Sbjct: 23  FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA---------F 73
Query: 224 RKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDGLSYC-HKRNFLHRD 280
             D G   +  E+MD   +   L ++G +    +   SI   ++ GL+Y   K   +HRD
Sbjct: 74  YSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHKIMHRD 130
Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +K SNIL+N+RGE+KL DFG++     +       + V T  Y  PE L G   Y    D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG-THYSVQSD 185
Query: 341 VWSCGCILGELFVKK 355
           +WS G  L E+ V +
Sbjct: 186 IWSMGLSLVEMAVGR 200

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 92
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 93  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 149 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 204
Query: 347 I 347
           I
Sbjct: 205 I 205

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG--LLESGMV 250
           +RE+++L + N   IV              F  D G   +  E+MD   +   L E+  +
Sbjct: 62  IRELQVLHECNSPYIVGFYGA---------FYSD-GEISICMEHMDGGSLDQVLKEAKRI 111
Query: 251 DFNEVNNASIMRQLLDGLSYC-HKRNFLHRDIKCSNILMNNRGEVKLADFGLA-RLYNAE 308
               +   SI   +L GL+Y   K   +HRD+K SNIL+N+RGE+KL DFG++ +L ++ 
Sbjct: 112 PEEILGKVSI--AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 169
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK 355
                  + V T  Y  PE L G   Y    D+WS G  L EL V +
Sbjct: 170 -----ANSFVGTRSYMAPERLQG-THYSVQSDIWSMGLSLVELAVGR 210

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPAFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG--LLESGMV 250
           +RE+++L + N   IV              F  D G   +  E+MD   +   L ++G +
Sbjct: 79  IRELQVLHECNSPYIVGFYGA---------FYSD-GEISICMEHMDGGSLDQVLKKAGRI 128
Query: 251 DFNEVNNASIMRQLLDGLSYC-HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
               +   SI   ++ GL+Y   K   +HRD+K SNIL+N+RGE+KL DFG++     + 
Sbjct: 129 PEQILGKVSI--AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQL 182
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK 355
                 + V T  Y  PE L G   Y    D+WS G  L E+ V +
Sbjct: 183 IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 118 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 177
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 178 NS---LTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 92
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 93  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 149 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 204
Query: 347 I 347
           I
Sbjct: 205 I 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 164 FSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
           F VS     LV  +K+     K       +RE+++L + N   IV              F
Sbjct: 23  FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA---------F 73
Query: 224 RKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDGLSYC-HKRNFLHRD 280
             D G   +  E+MD   +   L ++G +    +   SI   ++ GL+Y   K   +HRD
Sbjct: 74  YSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHKIMHRD 130
Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +K SNIL+N+RGE+KL DFG++     +       + V T  Y  PE L G   Y    D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG-THYSVQSD 185
Query: 341 VWSCGCILGELFVKK 355
           +WS G  L E+ V +
Sbjct: 186 IWSMGLSLVEMAVGR 200

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 164 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 223
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 224 N---SLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 119 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 178
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 179 NS---LTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 128 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 187
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 188 NS---LTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 120 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 179
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 180 NS---LTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 112 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 171
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 172 NS---LTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 173
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 174 N---SLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 218 N---SLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 113 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 172
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 173 NS---LTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 173
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 174 N---SLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA   +  D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFGLARLYNAE 308
           F E   + IM+ + + + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + 
Sbjct: 112 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 171
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +     T    T +Y  PE +LG E+Y  + D+WS G I+  L    P F
Sbjct: 172 NS---LTEPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 27/181 (14%)
Query: 176 LKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +KK R ++ + G     + RE+ IL+++ H N++ L E+  +K+D +          L+ 
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI----------LIL 93
Query: 235 EYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           E +      D +   ES      E      ++Q+L+G+ Y H     H D+K  NI++ +
Sbjct: 94  ELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 291 RG----EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           R      +K+ DFGLA      D    + N   T  +  PE ++  E  G   D+WS G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGV 205
Query: 347 I 347
           I
Sbjct: 206 I 206

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 164 FSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
           F VS     LV  +K+     K       +RE+++L + N   IV              F
Sbjct: 23  FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA---------F 73
Query: 224 RKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDGLSYC-HKRNFLHRD 280
             D G   +  E+MD   +   L ++G +    +   SI   ++ GL+Y   K   +HRD
Sbjct: 74  YSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHKIMHRD 130
Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +K SNIL+N+RGE+KL DFG++     +       + V T  Y  PE L G   Y    D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG-THYSVQSD 185
Query: 341 VWSCGCILGELFVKK 355
           +WS G  L E+ V +
Sbjct: 186 IWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 164 FSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF 223
           F VS     LV  +K+     K       +RE+++L + N   IV              F
Sbjct: 23  FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA---------F 73
Query: 224 RKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDGLSYC-HKRNFLHRD 280
             D G   +  E+MD   +   L ++G +    +   SI   ++ GL+Y   K   +HRD
Sbjct: 74  YSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHKIMHRD 130
Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +K SNIL+N+RGE+KL DFG++     +       + V T  Y  PE L G   Y    D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG-THYSVQSD 185
Query: 341 VWSCGCILGELFVKK 355
           +WS G  L E+ V +
Sbjct: 186 IWSMGLSLVEMAVGR 200

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           + E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L++   
Sbjct: 73  ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLQARRP 122
Query: 248 -GM-VDFNEVNN----------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+   +N  +N           S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 123 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 182
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 183 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRL-ENEKEGFPITAVREIKILRQLNH 204
           S    ++ + +G   L +    L  D+ VA+K +R     +E F    + E +++ +L+H
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDF----IEEAEVMMKLSH 61
Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQ 263
             +V L  +  +++             LVFE+M+H  +   L +    F       +   
Sbjct: 62  PKLVQLYGVCLEQAPIC----------LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
           + +G++Y  + + +HRD+   N L+     +K++DFG+ R +  +D+    T     + +
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKW 170
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELF 352
             PE +    RY    DVWS G ++ E+F
Sbjct: 171 ASPE-VFSFSRYSSKSDVWSFGVLMWEVF 198

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           + E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L++   
Sbjct: 70  ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLQARRP 119
Query: 248 -GM-VDFNEVNN----------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+   +N  +N           S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 120 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 179
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 180 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           + E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L++   
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLQAREP 130
Query: 248 -GM-VDFNEVNN----------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+   +N  +N           S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 131 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           + E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L++   
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLQARRP 130
Query: 248 -GM-VDFNEVNN----------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+   +N  +N           S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 131 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           + E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L++   
Sbjct: 74  ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLQARRP 123
Query: 248 -GM-VDFNEVNN----------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+   +N  +N           S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 124 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 183
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 184 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG--LLESGMV 250
           +RE+++L + N   IV              F  D G   +  E+MD   +   L ++G +
Sbjct: 71  IRELQVLHECNSPYIVGFYGA---------FYSD-GEISICMEHMDGGSLDQVLKKAGRI 120
Query: 251 DFNEVNNASIMRQLLDGLSYC-HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
               +   SI   ++ GL+Y   K   +HRD+K SNIL+N+RGE+KL DFG++     + 
Sbjct: 121 PEQILGKVSI--AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQL 174
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK 355
                 + V T  Y  PE L G   Y    D+WS G  L E+ V +
Sbjct: 175 IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD--LMGLLESGMVDF 252
           E  IL ++ H  IV+L          +   +  G  YL+ EY+      M L   G+  F
Sbjct: 71  ERNILEEVKHPFIVDL----------IYAFQTGGKLYLILEYLSGGELFMQLEREGI--F 118
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
            E      + ++   L + H++  ++RD+K  NI++N++G VKL DFGL +         
Sbjct: 119 MEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDG 175
Query: 313 PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             T+    T+ Y  PE+L+    +  A+D WS G ++ ++    P F
Sbjct: 176 TVTHXFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFN 253
           E  I+ Q  H NI+ L  +VT+    +          ++ E+M++  L   L      F 
Sbjct: 67  EASIMGQFEHPNIIRLEGVVTNSMPVM----------ILTEFMENGALDSFLRLNDGQFT 116
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY--NAEDRQ 311
            +    ++R +  G+ Y  + +++HRD+   NIL+N+    K++DFGL+R    N+ D  
Sbjct: 117 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 176
Query: 312 RPYT--NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
              +   K+   W  P  +     ++  A D WS G ++ E+  F ++P
Sbjct: 177 ETSSLGGKIPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYM-DHDLMGLLESGMVDFN 253
           E  IL  +NH  +V L              + +G  YL+ +++   DL   L S  V F 
Sbjct: 80  ERDILADVNHPFVVKLHYAF----------QTEGKLYLILDFLRGGDLFTRL-SKEVMFT 128
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
           E +    + +L  GL + H    ++RD+K  NIL++  G +KL DFGL++   A D ++ 
Sbjct: 129 EEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKK 186
Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
             +   T+ Y  PE ++  + +  + D WS G ++ E+  
Sbjct: 187 AYSFCGTVEYMAPE-VVNRQGHSHSADWWSYGVLMFEMLT 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++   EK       +RE +I+ QL++  IV L  +   ++  L      G     
Sbjct: 40  VAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHK 98
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
           F      L+G  E   V     N A ++ Q+  G+ Y  ++NF+HRD+   N+L+ NR  
Sbjct: 99  F------LVGKREEIPVS----NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY 148
Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLW---YRPPELLLGEERYGPAIDVWSCGCILGE 350
            K++DFGL++   A+D    YT +    W   +  PE  +   ++    DVWS G  + E
Sbjct: 149 AKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWE 205

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           + E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L++   
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLQARRP 171
Query: 248 -GM-VDFNEVNN----------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+   +N  +N           S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 231
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 65/138 (47%), Gaps = 7/138 (5%)
Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D    Y+V EYM   DL+ L+ +   D  E        +++  L   H   F+HRD+K 
Sbjct: 144 QDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 201
Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---GEERYGPAID 340
            N+L++  G +KLADFG     N E   R  T  V T  Y  PE+L    G+  YG   D
Sbjct: 202 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECD 260
Query: 341 VWSCGCILGELFVKKPLF 358
            WS G  L E+ V    F
Sbjct: 261 WWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 65/138 (47%), Gaps = 7/138 (5%)
Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D    Y+V EYM   DL+ L+ +   D  E        +++  L   H   F+HRD+K 
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196
Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---GEERYGPAID 340
            N+L++  G +KLADFG     N E   R  T  V T  Y  PE+L    G+  YG   D
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 341 VWSCGCILGELFVKKPLF 358
            WS G  L E+ V    F
Sbjct: 256 WWSVGVFLYEMLVGDTPF 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 65/138 (47%), Gaps = 7/138 (5%)
Query: 225 KDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D    Y+V EYM   DL+ L+ +   D  E        +++  L   H   F+HRD+K 
Sbjct: 144 QDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 201
Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---GEERYGPAID 340
            N+L++  G +KLADFG     N E   R  T  V T  Y  PE+L    G+  YG   D
Sbjct: 202 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECD 260
Query: 341 VWSCGCILGELFVKKPLF 358
            WS G  L E+ V    F
Sbjct: 261 WWSVGVFLYEMLVGDTPF 278

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL 210
           ++ L  GG  +   + +   D   A+K++RL N +E      +RE+K L +L H  IV  
Sbjct: 10  IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRY 68
Query: 211 REIVTDK--SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNA---SIMRQLL 265
                +K  ++ L     K   Y+  +    + +    +G     E   +    I  Q+ 
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP----------YT 315
           + + + H +  +HRD+K SNI       VK+ DFGL    + ++ ++           +T
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 316 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            +V T  Y  PE + G   Y   +D++S G IL EL 
Sbjct: 189 GQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRL-ENEKEGFPITAVREIKILRQLNH 204
           S    ++ + +G   L +    L  D+ VA+K +R     +E F    + E +++ +L+H
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDF----IEEAEVMMKLSH 64
Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQ 263
             +V L  +  +++             LVFE+M+H  +   L +    F       +   
Sbjct: 65  PKLVQLYGVCLEQAPIC----------LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 114
Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
           + +G++Y  +   +HRD+   N L+     +K++DFG+ R +  +D+    T     + +
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKW 173
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELF 352
             PE +    RY    DVWS G ++ E+F
Sbjct: 174 ASPE-VFSFSRYSSKSDVWSFGVLMWEVF 201

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRL-ENEKEGFPITAVREIKILRQLNH 204
           S    ++ + +G   L +    L  D+ VA+K +R     +E F    + E +++ +L+H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDF----IEEAEVMMKLSH 59
Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQ 263
             +V L  +  +++             LVFE+M+H  +   L +    F       +   
Sbjct: 60  PKLVQLYGVCLEQAPIC----------LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
           + +G++Y  +   +HRD+   N L+     +K++DFG+ R +  +D+    T     + +
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKW 168
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELF 352
             PE +    RY    DVWS G ++ E+F
Sbjct: 169 ASPE-VFSFSRYSSKSDVWSFGVLMWEVF 196

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRL-ENEKEGFPITAVREIKILRQLNH 204
           S    ++ + +G   L +    L  D+ VA+K +R     +E F    + E +++ +L+H
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDF----IEEAEVMMKLSH 61
Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQ 263
             +V L  +  +++             LVFE+M+H  +   L +    F       +   
Sbjct: 62  PKLVQLYGVCLEQAPIC----------LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
           + +G++Y  +   +HRD+   N L+     +K++DFG+ R +  +D+    T     + +
Sbjct: 112 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKW 170
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELF 352
             PE +    RY    DVWS G ++ E+F
Sbjct: 171 ASPE-VFSFSRYSSKSDVWSFGVLMWEVF 198

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR---EIKILRQLNHKN 206
           + E L  GG       +   T E VA+K+ R    +E  P    R   EI+I+++LNH N
Sbjct: 19  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNHPN 74
Query: 207 IVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLES--GMVDFNEVNNASIMRQ 263
           +V+ RE+     D L          L  EY +  DL   L          E    +++  
Sbjct: 75  VVSAREV----PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 130
Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMN---NRGEVKLADFGLARLYNAEDRQRPYTNKVIT 320
           +   L Y H+   +HRD+K  NI++     R   K+ D G A+     D+    T  V T
Sbjct: 131 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGT 187
Query: 321 LWYRPPELLLGEERYGPAIDVWSCG-----CILG 349
           L Y  PE LL +++Y   +D WS G     CI G
Sbjct: 188 LQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 17/180 (9%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++   EK       +RE +I+ QL++  IV L  +   ++  L      G     
Sbjct: 366 VAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHK 424
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
           F      L+G  E   V     N A ++ Q+  G+ Y  ++NF+HR++   N+L+ NR  
Sbjct: 425 F------LVGKREEIPVS----NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY 474
Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLW---YRPPELLLGEERYGPAIDVWSCGCILGE 350
            K++DFGL++   A+D    YT +    W   +  PE  +   ++    DVWS G  + E
Sbjct: 475 AKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWE 531

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           + E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L++   
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLQARRP 115
Query: 248 -GM-VDFNEVNN----------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+   +N  +N           S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 116 PGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 175
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHK 205
           S    ++ + +G   L +    L  D+ VA+K ++  +  E      + E +++ +L+H 
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIKEGSMSED---DFIEEAEVMMKLSHP 82
Query: 206 NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQL 264
            +V L  +  +++             LVFE+M+H  +   L +    F       +   +
Sbjct: 83  KLVQLYGVCLEQAPIC----------LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 132
Query: 265 LDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
            +G++Y  +   +HRD+   N L+     +K++DFG+ R +  +D+    T     + + 
Sbjct: 133 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWA 191
Query: 325 PPELLLGEERYGPAIDVWSCGCILGELF 352
            PE +    RY    DVWS G ++ E+F
Sbjct: 192 SPE-VFSFSRYSSKSDVWSFGVLMWEVF 218

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR---EIKILRQLNHKN 206
           + E L  GG       +   T E VA+K+ R    +E  P    R   EI+I+++LNH N
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNHPN 73
Query: 207 IVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLES--GMVDFNEVNNASIMRQ 263
           +V+ RE+     D L          L  EY +  DL   L          E    +++  
Sbjct: 74  VVSAREV----PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMN---NRGEVKLADFGLARLYNAEDRQRPYTNKVIT 320
           +   L Y H+   +HRD+K  NI++     R   K+ D G A+     D+    T  V T
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGT 186
Query: 321 LWYRPPELLLGEERYGPAIDVWSCG-----CILG 349
           L Y  PE LL +++Y   +D WS G     CI G
Sbjct: 187 LQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 193 VREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES--- 247
           + E+++++ +  HKNI+NL    T            G  Y++ EY    +L   L++   
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQD----------GPLYVIVEYASKGNLREYLQARRP 130
Query: 248 -GM-VDFNEVNN----------ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
            G+   +N  +N           S   Q+  G+ Y   +  +HRD+   N+L+     +K
Sbjct: 131 PGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           +ADFGLAR  +  D  +  TN  + + +  PE L  +  Y    DVWS G +L E+F 
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 7/140 (5%)
Query: 225 KDKGSFYLVFEY-MDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D+   YLV +Y +  DL+ LL        E      + +++  +   H+ +++HRDIK 
Sbjct: 144 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKP 203
Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE----RYGPAI 339
            N+L++  G ++LADFG     N +D     +  V T  Y  PE+L   E    +YGP  
Sbjct: 204 DNVLLDVNGHIRLADFGSCLKMN-DDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 262
Query: 340 DVWSCG-CILGELFVKKPLF 358
           D WS G C+   L+ + P +
Sbjct: 263 DWWSLGVCMYEMLYGETPFY 282

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 7/140 (5%)
Query: 225 KDKGSFYLVFEY-MDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +D+   YLV +Y +  DL+ LL        E      + +++  +   H+ +++HRDIK 
Sbjct: 160 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKP 219
Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE----RYGPAI 339
            N+L++  G ++LADFG     N +D     +  V T  Y  PE+L   E    +YGP  
Sbjct: 220 DNVLLDVNGHIRLADFGSCLKMN-DDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 278
Query: 340 DVWSCG-CILGELFVKKPLF 358
           D WS G C+   L+ + P +
Sbjct: 279 DWWSLGVCMYEMLYGETPFY 298

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 89/224 (39%), Gaps = 17/224 (7%)
Query: 132 MQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDE-LVALKKVRLENEKEGFPI 190
           +  A P      N+    L E +  G      FS  L  D  LVA+K  R E        
Sbjct: 100 LHRAVPKDKWVLNHEDLVLGEQIGRGNFG-EVFSGRLRADNTLVAVKSCR-ETLPPDLKA 157
Query: 191 TAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM 249
             ++E +IL+Q +H NIV L  + T K             Y+V E +   D +  L +  
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQ----------PIYIVMELVQGGDFLTFLRTEG 207
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE 308
                     ++     G+ Y   +  +HRD+   N L+  +  +K++DFG++R   +  
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
                   +V   W  P  L  G  RY    DVWS G +L E F
Sbjct: 268 XAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETF 309

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 23/189 (12%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K++  E+E++ F    + E++ L ++NH NIV L     +    +    + GS Y V
Sbjct: 35  VAIKQIESESERKAF----IVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNV 90
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK---RNFLHRDIKCSNILMNN 290
               +          +  +   +  S   Q   G++Y H    +  +HRD+K  N+L+  
Sbjct: 91  LHGAE---------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 141
Query: 291 RGEV-KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
            G V K+ DFG      A D Q   TN   +  +  PE+  G   Y    DV+S G IL 
Sbjct: 142 GGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILW 195
Query: 350 ELFVKKPLF 358
           E+  ++  F
Sbjct: 196 EVITRRKPF 204

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 16/169 (9%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DL-MGLLESGM 249
           A+ E +IL ++N + +V+L     +  DAL          LV   M+  DL   +   G 
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDAL---------CLVLTLMNGGDLKFHIYHMGQ 280
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
             F E        ++  GL   H+   ++RD+K  NIL+++ G ++++D GLA ++  E 
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEG 339
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +      +V T+ Y  PE ++  ERY  + D W+ GC+L E+   +  F
Sbjct: 340 QT--IKGRVGTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+     +T  + A+  +  +GS           L   L      F  
Sbjct: 82  EVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGS----------SLYKHLHVQETKFQM 131
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA----RLYNAEDR 310
                I RQ   G+ Y H +N +HRD+K +NI ++    VK+ DFGLA    R   ++  
Sbjct: 132 FQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 311 QRPYTNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFV 353
           ++P T  V  LW  P  + + +   +    DV+S G +L EL  
Sbjct: 192 EQP-TGSV--LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 16/169 (9%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DL-MGLLESGM 249
           A+ E +IL ++N + +V+L     +  DAL          LV   M+  DL   +   G 
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDAL---------CLVLTLMNGGDLKFHIYHMGQ 280
Query: 250 VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
             F E        ++  GL   H+   ++RD+K  NIL+++ G ++++D GLA ++  E 
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEG 339
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +      +V T+ Y  PE ++  ERY  + D W+ GC+L E+   +  F
Sbjct: 340 QT--IKGRVGTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EYM    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +K+ADFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIKVADFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EYM    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +K+ADFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIKVADFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRL--ENEKEGFPITAVREIKILRQLNHKNI 207
           + E L  G   + +      T    A K V    E++KE    T  +EI+ +  L H  +
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE----TVRKEIQTMSVLRHPTL 216
Query: 208 VNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLD 266
           VNL +   D ++ +          +++E+M   +L   +       +E      MRQ+  
Sbjct: 217 VNLHDAFEDDNEMV----------MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 267 GLSYCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
           GL + H+ N++H D+K  NI+   +   E+KL DFGL    + +   +  T    T  + 
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG---TAEFA 323
Query: 325 PPELLLGEERYGPAIDVWSCGCI 347
            PE+  G+   G   D+WS G +
Sbjct: 324 APEVAEGKP-VGYYTDMWSVGVL 345

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 23/189 (12%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K++  E+E++ F    + E++ L ++NH NIV L     +    +    + GS Y V
Sbjct: 34  VAIKQIESESERKAF----IVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNV 89
Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK---RNFLHRDIKCSNILMNN 290
               +          +  +   +  S   Q   G++Y H    +  +HRD+K  N+L+  
Sbjct: 90  LHGAE---------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 140
Query: 291 RGEV-KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
            G V K+ DFG      A D Q   TN   +  +  PE+  G   Y    DV+S G IL 
Sbjct: 141 GGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILW 194
Query: 350 ELFVKKPLF 358
           E+  ++  F
Sbjct: 195 EVITRRKPF 203

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRL--ENEKEGFPITAVREIKILRQLNHKNI 207
           + E L  G   + +      T    A K V    E++KE    T  +EI+ +  L H  +
Sbjct: 55  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE----TVRKEIQTMSVLRHPTL 110
Query: 208 VNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLD 266
           VNL +   D ++ +          +++E+M   +L   +       +E      MRQ+  
Sbjct: 111 VNLHDAFEDDNEMV----------MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 160
Query: 267 GLSYCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
           GL + H+ N++H D+K  NI+   +   E+KL DFGL    + +   +  T    T  + 
Sbjct: 161 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG---TAEFA 217
Query: 325 PPELLLGEERYGPAIDVWSCGCI 347
            PE+  G+   G   D+WS G +
Sbjct: 218 APEVAEGKP-VGYYTDMWSVGVL 239

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 8/104 (7%)
Query: 258 ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTN 316
           A I R++L GLS+ H+   +HRDIK  N+L+    EVKL DFG+ A+L     R+  +  
Sbjct: 132 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-- 189
Query: 317 KVITLWYRPPELLLGEER----YGPAIDVWSCGCILGELFVKKP 356
            + T ++  PE++  +E     Y    D+WS G    E+    P
Sbjct: 190 -IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 206 -NIVNLREIVTDKSDAL-------------DFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
            N+VNL    T     L              + + K + ++ ++ +  D + L       
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDR 310
           F          Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D 
Sbjct: 151 F----------QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 201 VRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 240

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 104
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L+++   VKL DFGL+R     
Sbjct: 105 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 165 TXXKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 207

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 206 -NIVNLREIVTDKSDAL-------------DFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
            N+VNL    T     L              + + K + ++ ++ +  D + L       
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDR 310
           F          Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D 
Sbjct: 151 F----------QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 311 QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 201 VRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 240

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 87  LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 132
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L+++   VKL DFGL+R     
Sbjct: 133 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 192
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 193 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 235

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 109
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L+++   VKL DFGL+R     
Sbjct: 110 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 170 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 61  LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 106
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L+++   VKL DFGL+R     
Sbjct: 107 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 166
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 167 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 209

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 104
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L+++   VKL DFGL+R     
Sbjct: 105 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 165 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 207

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 33/225 (14%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 206 -NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNA----- 258
            N+VNL    T         K  G   ++ E+    +L   L S   +F     A     
Sbjct: 93  LNVVNLLGACT---------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLY 143
Query: 259 ----------SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNA 307
                         Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y  
Sbjct: 144 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 203
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
            D  R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 204 PDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 246

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 104
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L+++   VKL DFGL+R     
Sbjct: 105 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 165 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 207

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 62  LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 107
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L+++   VKL DFGL+R     
Sbjct: 108 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 167
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 168 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 210

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 56  LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 101
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L+++   VKL DFGL+R     
Sbjct: 102 KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 162 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 204

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYM-DHDLMGLLESGMVDFN 253
           E  IL ++NH  IV L              + +G  YL+ +++   DL   L S  V F 
Sbjct: 76  ERDILVEVNHPFIVKLHYAF----------QTEGKLYLILDFLRGGDLFTRL-SKEVMFT 124
Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
           E +    + +L   L + H    ++RD+K  NIL++  G +KL DFGL++   + D ++ 
Sbjct: 125 EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKK 182
Query: 314 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
             +   T+ Y  PE ++    +  + D WS G ++ E+  
Sbjct: 183 AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLRE 212
           LA GG +    +  + +    ALK++ L NE+E      ++E+  +++L+ H NIV    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEK-NRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 213 IVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLES----GMVDFNEVNNASIMRQLLDGL 268
             +   +  D    +  F L+ E     L+  L+     G +  + V    I  Q    +
Sbjct: 94  AASIGKEESD--TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV--LKIFYQTCRAV 149
Query: 269 SYCHKRN--FLHRDIKCSNILMNNRGEVKLADFGLARL------YNAEDRQRPYTNKVIT 320
            + H++    +HRD+K  N+L++N+G +KL DFG A        Y+   ++R    + IT
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 321 L----WYRPPEL--LLGEERYGPAIDVWSCGCIL 348
                 YR PE+  L      G   D+W+ GCIL
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 176 LKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           LK     +EKE      + E+KI+  L  H+NIVNL    T            G   ++ 
Sbjct: 84  LKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHG----------GPVLVIT 129
Query: 235 EYMDH-DLMGLL--ESGMVD----FNEVNNASIMRQLL-------DGLSYCHKRNFLHRD 280
           EY  + DL+  L  +S +++    F   N+ +  R LL        G+++   +N +HRD
Sbjct: 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +   N+L+ N    K+ DFGLAR    +       N  + + +  PE +  +  Y    D
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSD 248
Query: 341 VWSCGCILGELF 352
           VWS G +L E+F
Sbjct: 249 VWSYGILLWEIF 260

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 103
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA + +       +
Sbjct: 104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 32/199 (16%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILR-QLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           + VA+K   L+++ EG      R   +LR +L H N+V L  +VT         KD+   
Sbjct: 57  QAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT---------KDQ-PL 104
Query: 231 YLVFEYMDH-DLMGLL-------ESGMVDFNEVNNASI--------MRQLLDGLSYCHKR 274
            ++F Y  H DL   L       + G  D +    +++        + Q+  G+ Y    
Sbjct: 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 164
Query: 275 NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGEE 333
           + +H+D+   N+L+ ++  VK++D GL R   A D  +   N ++ + W  P  ++ G  
Sbjct: 165 HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-- 222
Query: 334 RYGPAIDVWSCGCILGELF 352
           ++    D+WS G +L E+F
Sbjct: 223 KFSIDSDIWSYGVVLWEVF 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 143 IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 187
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ +   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           D     T   + + +   E  L  +++    DVWS G +L EL  +
Sbjct: 248 DSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTR 292

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 56  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 105
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA + +       +
Sbjct: 106 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 165
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 166 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 83  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 127
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 128 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEX 187
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 188 XSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 232

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 59  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 108
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA + +       +
Sbjct: 109 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 103 IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 147
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 148 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 207
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 208 YSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 252

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 59  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 108
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA + +       +
Sbjct: 109 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 17/135 (12%)
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           + V E+++  DLM  ++     F+E        +++  L + H +  ++RD+K  N+L++
Sbjct: 100 FFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLW------YRPPELLLGEERYGPAIDVWS 343
           + G  KLADFG+ +            N V T        Y  PE +L E  YGPA+D W+
Sbjct: 159 HEGHCKLADFGMCK--------EGICNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWA 209
Query: 344 CGCILGELFVKKPLF 358
            G +L E+      F
Sbjct: 210 MGVLLYEMLCGHAPF 224

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 7/118 (5%)
Query: 244 LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLADFG 300
           + + G   F E   + I + + + + Y H  N  HRD+K  N+L  ++     +KL DFG
Sbjct: 150 IQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209
Query: 301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            A+   + +     T    T +Y  PE +LG E+Y  + D WS G I   L    P F
Sbjct: 210 FAKETTSHN---SLTTPCYTPYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 103
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA + +       +
Sbjct: 104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +K+ADFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIKVADFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 206 -NIVNLREIVTDKSDAL-------------DFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
            N+VNL    T     L              + + K + ++ ++    DL         D
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-------D 143
Query: 252 FNEVNNASIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAED 309
           F  + +      Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
             R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 204 XVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 244

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 32/199 (16%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILR-QLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           + VA+K   L+++ EG      R   +LR +L H N+V L  +VT         KD+   
Sbjct: 40  QAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT---------KDQ-PL 87
Query: 231 YLVFEYMDH-DLMGLL-------ESGMVDFNEVNNASI--------MRQLLDGLSYCHKR 274
            ++F Y  H DL   L       + G  D +    +++        + Q+  G+ Y    
Sbjct: 88  SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 147
Query: 275 NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGEE 333
           + +H+D+   N+L+ ++  VK++D GL R   A D  +   N ++ + W  P  ++ G  
Sbjct: 148 HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-- 205
Query: 334 RYGPAIDVWSCGCILGELF 352
           ++    D+WS G +L E+F
Sbjct: 206 KFSIDSDIWSYGVVLWEVF 224

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 76  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 120
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 121 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 180
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 181 YSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 225

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 102 IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 146
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 147 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 206
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 207 YSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 251

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           +L A+K ++    K    +    E  IL ++NH  IV L              + +G  Y
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF----------QTEGKLY 102
Query: 232 LVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           L+ +++   DL   L S  V F E +    + +L   L + H    ++RD+K  NIL++ 
Sbjct: 103 LILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE 161
Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
            G +KL DFGL++   + D ++   +   T+ Y  PE ++    +  + D WS G ++ E
Sbjct: 162 EGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFE 218
Query: 351 LFV 353
           +  
Sbjct: 219 MLT 221

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           +L A+K ++    K    +    E  IL ++NH  IV L              + +G  Y
Sbjct: 54  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF----------QTEGKLY 103
Query: 232 LVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           L+ +++   DL   L S  V F E +    + +L   L + H    ++RD+K  NIL++ 
Sbjct: 104 LILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE 162
Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
            G +KL DFGL++   + D ++   +   T+ Y  PE ++    +  + D WS G ++ E
Sbjct: 163 EGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFE 219
Query: 351 LFV 353
           +  
Sbjct: 220 MLT 222

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 84  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 128
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ +   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 129 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           D     T   + + +   E  L  +++    DVWS G +L EL  +
Sbjct: 189 DSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTR 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 89  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 133
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ +   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 134 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 193
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           D     T   + + +   E  L  +++    DVWS G +L EL  +
Sbjct: 194 DSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTR 238

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 81  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 125
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 126 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 185
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 186 YSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 230

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 68  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 206 -NIVNLREIVTDKSDAL-------------DFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
            N+VNL    T     L              + + K + ++ ++    DL         D
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-------D 180
Query: 252 FNEVNNASIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAED 309
           F  + +      Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D
Sbjct: 181 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 240
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
             R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 241 YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 281

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 82  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 126
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 127 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 186
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 187 YSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 231

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 84  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 128
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 129 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 188
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 189 YSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 233

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 15/216 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 206 -NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLL------ESGMVDFNEVNNA 258
            N+VNL    T     L    +   F  +  Y+       +      E    DF  + + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 259 SIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTN 316
                Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D  R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 317 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 202 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 235

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 82  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 126
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ +   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 127 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 186
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           D     T   + + +   E  L  +++    DVWS G +L EL  +
Sbjct: 187 DSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTR 231

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 84  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 128
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ +   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 129 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           D     T   + + +   E  L  +++    DVWS G +L EL  +
Sbjct: 189 DSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTR 233

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 18/165 (10%)
Query: 193 VREIKILRQLNHKNIVNLREIV-TDKSDALDFRKDKGSFY-LVFEYMDHDLMGLLESGMV 250
           +RE+  +  L+H+N++ L  +V T     +      GS    + ++  H L+G L    V
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
                       Q+ +G+ Y   + F+HRD+   N+L+  R  VK+ DFGL R     D 
Sbjct: 129 ------------QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
Query: 311 QRPYTN--KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
                   KV   W  P    L    +  A D W  G  L E+F 
Sbjct: 177 HXVMQEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 15/216 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 206 -NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLL------ESGMVDFNEVNNA 258
            N+VNL    T     L    +   F  +  Y+       +      E    DF  + + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 259 SIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTN 316
                Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D  R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 317 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 202 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 84  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 128
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 129 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 188
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 189 YSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 233

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 206 -NIVNLREIVTDKSDAL-------------DFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
            N+VNL    T     L              + + K + ++ ++    DL         D
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-------D 143
Query: 252 FNEVNNASIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAED 309
           F  + +      Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
             R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 204 YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 244

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRL-ENEKEGFPITAVREIKILRQLNH 204
           S    ++ + +G   L +    L  D+ VA+K +R     +E F    + E +++ +L+H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDF----IEEAEVMMKLSH 62
Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQ 263
             +V L  +  +++             LV E+M+H  +   L +    F       +   
Sbjct: 63  PKLVQLYGVCLEQAPIC----------LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
           + +G++Y  +   +HRD+   N L+     +K++DFG+ R +  +D+    T     + +
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKW 171
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELF 352
             PE +    RY    DVWS G ++ E+F
Sbjct: 172 ASPE-VFSFSRYSSKSDVWSFGVLMWEVF 199

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 85  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 129
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ +   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 130 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 189
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           D     T   + + +   E  L  +++    DVWS G +L EL  +
Sbjct: 190 DSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTR 234

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 21/185 (11%)
Query: 177 KKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY 236
           K   L+N KE F   AV    I++ L+H +IV L  I+ ++             +++ E 
Sbjct: 62  KDCTLDN-KEKFMSEAV----IMKNLDHPHIVKLIGIIEEEPT-----------WIIMEL 105
Query: 237 MDHDLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
             +  +G  LE        +       Q+   ++Y    N +HRDI   NIL+ +   VK
Sbjct: 106 YPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVK 165
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL--FV 353
           L DFGL+R    ED  +    ++   W  P  +     R+  A DVW     + E+  F 
Sbjct: 166 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFG 223
Query: 354 KKPLF 358
           K+P F
Sbjct: 224 KQPFF 228

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLL--ESGMV 250
           +RE+ I+++L H NIV     VT   +            +V EY+    +  L  +SG  
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPN----------LSIVTEYLSRGSLYRLLHKSGAR 131
Query: 251 D-FNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNNRGEVKLADFGLARLYNA 307
           +  +E    S+   +  G++Y H RN   +HRD+K  N+L++ +  VK+ DFGL+RL  A
Sbjct: 132 EQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KA 190
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                         W  P   +L +E      DV+S G IL EL
Sbjct: 191 SXFLXSKXAAGTPEWMAPE--VLRDEPSNEKSDVYSFGVILWEL 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 83  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 127
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 128 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 187
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 188 YSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 79  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 123
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE- 308
           N ++        Q+  G+ Y   + F+HRD+   N +++ +  VK+ADFGLAR +Y+ E 
Sbjct: 124 NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 309 -DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
                    K+   W       L  +++    DVWS G +L EL  +
Sbjct: 184 YSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTR 228

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 81  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 130
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA + +       +
Sbjct: 131 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 190
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 191 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 231

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 131
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA + +       +
Sbjct: 132 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 191
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 192 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS           L   L +    F  
Sbjct: 58  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS----------SLYHHLHASETKFEM 107
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA + +       +
Sbjct: 108 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQF 167
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  ++   Y    DV++ G +L EL  
Sbjct: 168 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 208

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 170 TDELVALKKVRLE--NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           TD + A+K V+ E  N+ E        +    +  NH  +V L      +S         
Sbjct: 33  TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--------- 83
Query: 228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
              + V EY++  DLM  ++       E +      ++   L+Y H+R  ++RD+K  N+
Sbjct: 84  -RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI---TLWYRPPELLLGEERYGPAIDVWS 343
           L+++ G +KL D+G+ +     +  RP         T  Y  PE+L GE+ YG ++D W+
Sbjct: 142 LLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSVDWWA 195
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+   +  F
Sbjct: 196 LGVLMFEMMAGRSPF 210

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 59/101 (58%), Gaps = 4/101 (3%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E +      +++ GL + H R  ++RD+K +NIL++  G V+++D GLA  ++   ++
Sbjct: 288 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KK 344
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +P+ + V T  Y  PE+L     Y  + D +S GC+L +L 
Sbjct: 345 KPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 484
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L+++   VKL DFGL+R     
Sbjct: 485 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 545 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 587

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 59/101 (58%), Gaps = 4/101 (3%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E +      +++ GL + H R  ++RD+K +NIL++  G V+++D GLA  ++   ++
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KK 345
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +P+ + V T  Y  PE+L     Y  + D +S GC+L +L 
Sbjct: 346 KPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 59/101 (58%), Gaps = 4/101 (3%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E +      +++ GL + H R  ++RD+K +NIL++  G V+++D GLA  ++   ++
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KK 345
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +P+ + V T  Y  PE+L     Y  + D +S GC+L +L 
Sbjct: 346 KPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 18/165 (10%)
Query: 193 VREIKILRQLNHKNIVNLREIV-TDKSDALDFRKDKGSFY-LVFEYMDHDLMGLLESGMV 250
           +RE+  +  L+H+N++ L  +V T     +      GS    + ++  H L+G L    V
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
                       Q+ +G+ Y   + F+HRD+   N+L+  R  VK+ DFGL R     D 
Sbjct: 119 ------------QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166
Query: 311 QRPYTN--KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
                   KV   W  P    L    +  A D W  G  L E+F 
Sbjct: 167 HXVMQEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +K+ADFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLLIDQQGYIKVADFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 59/101 (58%), Gaps = 4/101 (3%)
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F+E +      +++ GL + H R  ++RD+K +NIL++  G V+++D GLA  ++   ++
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KK 345
Query: 312 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           +P+ + V T  Y  PE+L     Y  + D +S GC+L +L 
Sbjct: 346 KPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 18/165 (10%)
Query: 193 VREIKILRQLNHKNIVNLREIV-TDKSDALDFRKDKGSFY-LVFEYMDHDLMGLLESGMV 250
           +RE+  +  L+H+N++ L  +V T     +      GS    + ++  H L+G L    V
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
                       Q+ +G+ Y   + F+HRD+   N+L+  R  VK+ DFGL R     D 
Sbjct: 129 ------------QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
Query: 311 QRPYTN--KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
                   KV   W  P    L    +  A D W  G  L E+F 
Sbjct: 177 HYVMQEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 104
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L++    VKL DFGL+R     
Sbjct: 105 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS 164
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 165 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 207

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 18/165 (10%)
Query: 193 VREIKILRQLNHKNIVNLREIV-TDKSDALDFRKDKGSFY-LVFEYMDHDLMGLLESGMV 250
           +RE+  +  L+H+N++ L  +V T     +      GS    + ++  H L+G L    V
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 122
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
                       Q+ +G+ Y   + F+HRD+   N+L+  R  VK+ DFGL R     D 
Sbjct: 123 ------------QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 170
Query: 311 QRPYTN--KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
                   KV   W  P    L    +  A D W  G  L E+F 
Sbjct: 171 HYVMQEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 27/221 (12%)
Query: 144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN 203
           +N     ++ L  GG S  +    L      ALK++    +++     A RE  + R  N
Sbjct: 27  DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFN 84
Query: 204 HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQ 263
           H NI+ L       +  L  R  K   +L+  +      G L + +    +  N     Q
Sbjct: 85  HPNILRL------VAYCLRERGAKHEAWLLLPFFKR---GTLWNEIERLKDKGNFLTEDQ 135
Query: 264 LL-------DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG---LARLYNAEDRQ-- 311
           +L        GL   H + + HRD+K +NIL+ + G+  L D G    A ++    RQ  
Sbjct: 136 ILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 312 --RPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCIL 348
             + +  +  T+ YR PEL   +         DVWS GC+L
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 35/184 (19%)
Query: 193 VREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMV 250
           + E+K++ QL +H+NIVNL    T            G  YL+FEY  + DL+  L S   
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLS----------GPIYLIFEYCCYGDLLNYLRSKRE 145
Query: 251 DFNE----------------------VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            F+E                       +      Q+  G+ +   ++ +HRD+   N+L+
Sbjct: 146 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 205
Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
            +   VK+ DFGLAR   ++       N  + + +  PE L  E  Y    DVWS G +L
Sbjct: 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILL 264
Query: 349 GELF 352
            E+F
Sbjct: 265 WEIF 268

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 21/185 (11%)
Query: 177 KKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY 236
           K   L+N KE F   AV    I++ L+H +IV L  I+ ++             +++ E 
Sbjct: 50  KDCTLDN-KEKFMSEAV----IMKNLDHPHIVKLIGIIEEEPT-----------WIIMEL 93
Query: 237 MDHDLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
             +  +G  LE        +       Q+   ++Y    N +HRDI   NIL+ +   VK
Sbjct: 94  YPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVK 153
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL--FV 353
           L DFGL+R    ED  +    ++   W  P  +     R+  A DVW     + E+  F 
Sbjct: 154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFG 211
Query: 354 KKPLF 358
           K+P F
Sbjct: 212 KQPFF 216

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI---TLWY 323
            L+Y H+R  ++RD+K  N+L+++ G +KL D+G+ +     +  RP         T  Y
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNY 219
Query: 324 RPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             PE+L GE+ YG ++D W+ G ++ E+   +  F
Sbjct: 220 IAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 170 TDELVALKKVRLE--NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           TD + A+K V+ E  N+ E        +    +  NH  +V L      +S         
Sbjct: 29  TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--------- 79
Query: 228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
              + V EY++  DLM  ++       E +      ++   L+Y H+R  ++RD+K  N+
Sbjct: 80  -RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 137
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI---TLWYRPPELLLGEERYGPAIDVWS 343
           L+++ G +KL D+G+ +     +  RP         T  Y  PE+L GE+ YG ++D W+
Sbjct: 138 LLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSVDWWA 191
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+   +  F
Sbjct: 192 LGVLMFEMMAGRSPF 206

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 170 TDELVALKKVRLE--NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           TD + A+K V+ E  N+ E        +    +  NH  +V L      +S         
Sbjct: 44  TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--------- 94
Query: 228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
              + V EY++  DLM  ++       E +      ++   L+Y H+R  ++RD+K  N+
Sbjct: 95  -RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 152
Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI---TLWYRPPELLLGEERYGPAIDVWS 343
           L+++ G +KL D+G+ +     +  RP         T  Y  PE+L GE+ YG ++D W+
Sbjct: 153 LLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAPEILRGED-YGFSVDWWA 206
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+   +  F
Sbjct: 207 LGVLMFEMMAGRSPF 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 21/185 (11%)
Query: 177 KKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY 236
           K   L+N KE F   AV    I++ L+H +IV L  I+ ++             +++ E 
Sbjct: 46  KDCTLDN-KEKFMSEAV----IMKNLDHPHIVKLIGIIEEEPT-----------WIIMEL 89
Query: 237 MDHDLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK 295
             +  +G  LE        +       Q+   ++Y    N +HRDI   NIL+ +   VK
Sbjct: 90  YPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVK 149
Query: 296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL--FV 353
           L DFGL+R    ED  +    ++   W  P  +     R+  A DVW     + E+  F 
Sbjct: 150 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFG 207
Query: 354 KKPLF 358
           K+P F
Sbjct: 208 KQPFF 212

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 18/165 (10%)
Query: 193 VREIKILRQLNHKNIVNLREIV-TDKSDALDFRKDKGSFY-LVFEYMDHDLMGLLESGMV 250
           +RE+  +  L+H+N++ L  +V T     +      GS    + ++  H L+G L    V
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 122
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
                       Q+ +G+ Y   + F+HRD+   N+L+  R  VK+ DFGL R     D 
Sbjct: 123 ------------QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 170
Query: 311 QRPYTN--KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
                   KV   W  P    L    +  A D W  G  L E+F 
Sbjct: 171 HYVMQEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 18/165 (10%)
Query: 193 VREIKILRQLNHKNIVNLREIV-TDKSDALDFRKDKGSFY-LVFEYMDHDLMGLLESGMV 250
           +RE+  +  L+H+N++ L  +V T     +      GS    + ++  H L+G L    V
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
                       Q+ +G+ Y   + F+HRD+   N+L+  R  VK+ DFGL R     D 
Sbjct: 119 ------------QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166
Query: 311 QRPYTN--KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
                   KV   W  P    L    +  A D W  G  L E+F 
Sbjct: 167 HYVMQEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLL--ESGMV 250
           +RE+ I+++L H NIV     VT   +            +V EY+    +  L  +SG  
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPN----------LSIVTEYLSRGSLYRLLHKSGAR 131
Query: 251 D-FNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNNRGEVKLADFGLARLYNA 307
           +  +E    S+   +  G++Y H RN   +HR++K  N+L++ +  VK+ DFGL+RL  A
Sbjct: 132 EQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KA 190
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
                  +      W  P   +L +E      DV+S G IL EL
Sbjct: 191 STFLSSKSAAGTPEWMAPE--VLRDEPSNEKSDVYSFGVILWEL 232

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 18/165 (10%)
Query: 193 VREIKILRQLNHKNIVNLREIV-TDKSDALDFRKDKGSFY-LVFEYMDHDLMGLLESGMV 250
           +RE+  +  L+H+N++ L  +V T     +      GS    + ++  H L+G L    V
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDR 310
                       Q+ +G+ Y   + F+HRD+   N+L+  R  VK+ DFGL R     D 
Sbjct: 119 ------------QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166
Query: 311 QRPYTN--KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
                   KV   W  P    L    +  A D W  G  L E+F 
Sbjct: 167 HYVMQEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 175 ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           +L ++    + E F    +RE  ++R LNH N++ L  I+            +G  +++ 
Sbjct: 56  SLSRITEMQQVEAF----LREGLLMRGLNHPNVLALIGIMLPP---------EGLPHVLL 102
Query: 235 EYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
            YM H DL+  + S   +    +  S   Q+  G+ Y  ++ F+HRD+   N +++    
Sbjct: 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT 162
Query: 294 VKLADFGLARLYNAEDR-----QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           VK+ADFGLAR  +  DR     Q+    ++   W       L   R+    DVWS G +L
Sbjct: 163 VKVADFGLAR--DILDREYYSVQQHRHARLPVKWTALES--LQTYRFTTKSDVWSFGVLL 218
Query: 349 GELFVK 354
            EL  +
Sbjct: 219 WELLTR 224

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL 321
           Q+  G+ +   R  +HRD+   NIL++    VK+ DFGLAR +Y   D  R    ++   
Sbjct: 207 QVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLK 266
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           W  P  +   ++ Y    DVWS G +L E+F
Sbjct: 267 WMAPESIF--DKIYSTKSDVWSYGVLLWEIF 295

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 20/165 (12%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VD 251
           ++E   +RQ +H +IV L  ++T+                V+  M+   +G L S + V 
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVITENP--------------VWIIMELCTLGELRSFLQVR 484
Query: 252 FNEVNNASIM---RQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
              ++ AS++    QL   L+Y   + F+HRDI   N+L++    VKL DFGL+R     
Sbjct: 485 KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS 544
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
              +    K+   W  P  +     R+  A DVW  G  + E+ +
Sbjct: 545 TYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILM 587

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 176 LKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           LK     +EKE      + E+KI+  L  H+NIVNL    T            G   ++ 
Sbjct: 84  LKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHG----------GPVLVIT 129
Query: 235 EYMDH-DLMGLL--ESGMVD----FNEVNNASIMRQLL-------DGLSYCHKRNFLHRD 280
           EY  + DL+  L  +S +++    F   N+    R LL        G+++   +N +HRD
Sbjct: 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +   N+L+ N    K+ DFGLAR    +       N  + + +  PE +  +  Y    D
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSD 248
Query: 341 VWSCGCILGELF 352
           VWS G +L E+F
Sbjct: 249 VWSYGILLWEIF 260

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 31/223 (13%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 206 -NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMR- 262
            N+VNL    T         K  G   ++ E+    +L   L S   +F       + + 
Sbjct: 93  LNVVNLLGACT---------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 263 ------------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAED 309
                       Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +    D
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
             R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 204 XVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 244

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 103
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA   +       +
Sbjct: 104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 163
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +K+ DFGLA+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLMIDQQGYIKVTDFGLAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 26/188 (13%)
Query: 176 LKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           LK     +EKE      + E+KI+  L  H+NIVNL    T            G   ++ 
Sbjct: 76  LKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHG----------GPVLVIT 121
Query: 235 EYMDH-DLMGLLE-SGMVDFNEVNNASI-MRQLL-------DGLSYCHKRNFLHRDIKCS 284
           EY  + DL+  L      D ++ +   + +R LL        G+++   +N +HRD+   
Sbjct: 122 EYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 181
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L+ N    K+ DFGLAR    +       N  + + +  PE +  +  Y    DVWS 
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSY 240
Query: 345 GCILGELF 352
           G +L E+F
Sbjct: 241 GILLWEIF 248

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 71/162 (43%), Gaps = 15/162 (9%)
Query: 192 AVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
             +E++I++ L H  +VNL     D+ D          F +V   +  DL   L+   V 
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQDEEDM---------FMVVDLLLGGDLRYHLQQN-VH 111
Query: 252 FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ 311
           F E      + +L+  L Y   +  +HRD+K  NIL++  G V + DF +A +     R+
Sbjct: 112 FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRE 168
Query: 312 RPYTNKVITLWYRPPELLLGEE--RYGPAIDVWSCGCILGEL 351
              T    T  Y  PE+    +   Y  A+D WS G    EL
Sbjct: 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 74  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 123
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA   +       +
Sbjct: 124 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 183
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 184 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 224

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 64/134 (47%), Gaps = 6/134 (4%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++ +G +++ DFG A+           T +     Y  PE++L  + Y  A+D W+ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPE-----YLAPEIILS-KGYNKAVDWWAL 224
Query: 345 GCILGELFVKKPLF 358
           G ++ E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 259 SIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNN-RGEVKLADFGLARLYNAEDRQRPYT 315
           S  RQ+L GL + H R    +HRD+KC NI +    G VK+ D GLA L  A      + 
Sbjct: 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-----SFA 187
Query: 316 NKVI-TLWYRPPELLLGEERYGPAIDVWSCG-CIL 348
             VI T  +  PE    EE+Y  ++DV++ G C L
Sbjct: 188 KAVIGTPEFXAPEXY--EEKYDESVDVYAFGXCXL 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 6/134 (4%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++ +G +++ DFG A+      + R +T    T  Y  PE++L  + Y  A+D W+ 
Sbjct: 172 NLLIDQQGYIQVTDFGFAK----RVKGRTWT-LCGTPEYLAPEIILS-KGYNKAVDWWAL 225
Query: 345 GCILGELFVKKPLF 358
           G ++ E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 26/188 (13%)
Query: 176 LKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           LK     +EKE      + E+KI+  L  H+NIVNL    T            G   ++ 
Sbjct: 84  LKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHG----------GPVLVIT 129
Query: 235 EYMDH-DLMGLLE-SGMVDFNEVNNASI-MRQLL-------DGLSYCHKRNFLHRDIKCS 284
           EY  + DL+  L      D ++ +   + +R LL        G+++   +N +HRD+   
Sbjct: 130 EYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 189
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L+ N    K+ DFGLAR    +       N  + + +  PE +  +  Y    DVWS 
Sbjct: 190 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSY 248
Query: 345 GCILGELF 352
           G +L E+F
Sbjct: 249 GILLWEIF 256

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS           L   L +    F  
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS----------SLYHHLHASETKFEM 119
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA   +       +
Sbjct: 120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  ++   Y    DV++ G +L EL  
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 6/134 (4%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 97  KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 156
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++ +G +++ DFG A+      + R +T    T  Y  PE++L  + Y  A+D W+ 
Sbjct: 157 NLLIDQQGYIQVTDFGFAK----RVKGRTWT-LCGTPEYLAPEIILS-KGYNKAVDWWAL 210
Query: 345 GCILGELFVKKPLF 358
           G ++ E+    P F
Sbjct: 211 GVLIYEMAAGYPPF 224

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS       + H L  ++E+    F  
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGS------SLYHHLH-IIET---KFEM 131
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
           +    I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA   +       +
Sbjct: 132 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 191
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  +++  Y    DV++ G +L EL  
Sbjct: 192 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 12/161 (7%)
Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           E+ +LR+  H NI+      T    A+  +  +GS           L   L +    F  
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGS----------SLYHHLHASETKFEM 119
Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                I RQ   G+ Y H ++ +HRD+K +NI ++    VK+ DFGLA   +       +
Sbjct: 120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 315 TNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFV 353
                ++ +  PE++  ++   Y    DV++ G +L EL  
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLXGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 132 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 192 NLLIDQQGYIQVTDFGFAK------RVKGATWTLCGTPEYLAPEIILS-KGYNKAVDWWA 244
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 245 LGVLIYEMAAGYPPF 259

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL 321
           Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D  R    ++   
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           W  P  +   +  Y    DVWS G +L E+F
Sbjct: 261 WMAPETIF--DRVYTIQSDVWSFGVLLWEIF 289

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 193 VREIKILRQLNHKNIVNLREI---VTDKSDALDFRKDK-GSFYLVFEYMDHDLMGLLESG 248
           +RE ++L++LNHKNIV L  I    T +   L       GS Y V E    +  GL ES 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESE 113
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM----NNRGEVKLADFGLAR- 303
            +         ++R ++ G+++  +   +HR+IK  NI+     + +   KL DFG AR 
Sbjct: 114 FL--------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 304 ---------LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
                    LY  E+   P       ++ R       +++YG  +D+WS G   
Sbjct: 166 LEDDEQFVSLYGTEEYLHP------DMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL 321
           Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D  R    ++   
Sbjct: 199 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 258
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           W  P  +   +  Y    DVWS G +L E+F
Sbjct: 259 WMAPETIF--DRVYTIQSDVWSFGVLLWEIF 287

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL 321
           Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D  R    ++   
Sbjct: 206 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 265
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           W  P  +   +  Y    DVWS G +L E+F
Sbjct: 266 WMAPETIF--DRVYTIQSDVWSFGVLLWEIF 294

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+ +G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 122 QIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 182 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL 321
           Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +Y   D  R    ++   
Sbjct: 208 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 267
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           W  P  +   +  Y    DVWS G +L E+F
Sbjct: 268 WMAPETIF--DRVYTIQSDVWSFGVLLWEIF 296

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 64/140 (45%), Gaps = 8/140 (5%)
Query: 223 FRKDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
           F+ DK   Y+V EYM   DL+ L+ +   D  E        +++  L   H    +HRD+
Sbjct: 144 FQDDK-YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 200
Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---GEERYGPA 338
           K  N+L++  G +KLADFG     + E         V T  Y  PE+L    G+  YG  
Sbjct: 201 KPDNMLLDKHGHLKLADFGTCMKMD-ETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRE 259
Query: 339 IDVWSCGCILGELFVKKPLF 358
            D WS G  L E+ V    F
Sbjct: 260 CDWWSVGVFLFEMLVGDTPF 279

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 132 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 192 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 244
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 245 LGVLIYEMAAGYPPF 259

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 32/194 (16%)
Query: 176 LKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVF 234
           LK     +EKE      + E+KI+  L  H+NIVNL    T     L          ++ 
Sbjct: 84  LKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHGGPVL----------VIT 129
Query: 235 EYMDH-DLMGLLES----GM-VDFNEVNNAS----------IMRQLLDGLSYCHKRNFLH 278
           EY  + DL+  L      G+   +N  +N               Q+  G+++   +N +H
Sbjct: 130 EYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIH 189
Query: 279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPA 338
           RD+   N+L+ N    K+ DFGLAR    +       N  + + +  PE +  +  Y   
Sbjct: 190 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQ 248
Query: 339 IDVWSCGCILGELF 352
            DVWS G +L E+F
Sbjct: 249 SDVWSYGILLWEIF 262

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +K+ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVN 256
           I++  +H N+++L  I           + +GS  +V  YM H DL   +       NE +
Sbjct: 85  IMKDFSHPNVLSLLGICL---------RSEGSPLVVLPYMKHGDLRNFIR------NETH 129
Query: 257 NASIMR------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR--LYNAE 308
           N ++        Q+  G+ +   + F+HRD+   N +++ +  VK+ADFGLAR  L    
Sbjct: 130 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEF 189
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
           D     T   + + +   E  L  +++    DVWS G +L EL  +
Sbjct: 190 DSVHNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTR 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +K+ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 193 VREIKILRQLNHKNIVNL---REIVTDKSDALDFR-KDKGSFYLVFEYMDHDLMGLLESG 248
           +RE ++L++LNHKNIV L    E  T +   L       GS Y V E    +  GL ES 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESE 113
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM----NNRGEVKLADFGLAR- 303
            +         ++R ++ G+++  +   +HR+IK  NI+     + +   KL DFG AR 
Sbjct: 114 FL--------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 304 ---------LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
                    LY  E+   P       ++ R       +++YG  +D+WS G   
Sbjct: 166 LEDDEQFVXLYGTEEYLHP------DMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H R+ ++RDIK  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGT 168
Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 169 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 104 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 163
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 164 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 216
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 217 LGVLIYEMAAGYPPF 231

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +K+ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +K+ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H R+ ++RDIK  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 116 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGT 171
Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 172 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 201

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 98  KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 157
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 158 NLLIDEQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 210
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 211 LGVLIYEMAAGYPPF 225

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 206 -NIVNLREIVTDKSDAL-------------DFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
            N+VNL    T     L              + + K + ++ ++    DL         D
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-------D 134
Query: 252 FNEVNNASIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAED 309
           F  + +      Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +    D
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
             R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 195 XVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +++ DFGLA+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLMIDQQGYIQVTDFGLAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 206 -NIVNLREIVTDKSDAL-------------DFRKDKGSFYLVFEYMDHDLMGLLESGMVD 251
            N+VNL    T     L              + + K + ++ ++    DL         D
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-------D 143
Query: 252 FNEVNNASIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAED 309
           F  + +      Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +    D
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
             R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 204 XVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 244

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 186 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 185 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 15/216 (6%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 206 -NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLL------ESGMVDFNEVNNA 258
            N+VNL    T     L    +   F  +  Y+       +      E    DF  + + 
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 259 SIMR-QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTN 316
                Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +    D  R    
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 317 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 202 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 235

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H R+ ++RDIK  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGT 168
Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 169 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 32/224 (14%)
Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR----EIKILRQLNHK 205
           L +PL  G       + +   D+    + V ++  KEG   +  R    E+KIL  + H 
Sbjct: 32  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 206 -NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMR- 262
            N+VNL    T         K  G   ++ E+    +L   L S   +F        +  
Sbjct: 92  LNVVNLLGACT---------KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYK 142
Query: 263 -------------QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR-LYNAE 308
                        Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR +    
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 309 DRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           D  R    ++   W  P  +   +  Y    DVWS G +L E+F
Sbjct: 203 DXVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIF 244

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 192 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 131 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 191 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 192 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 192 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 132 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 192 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 244
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 245 LGVLIYEMAAGYPPF 259

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 188 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 188 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 106 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 165
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 166 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 218
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 219 LGVLIYEMAAGYPPF 233

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 129 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 189 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 185 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 185 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 187 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 188 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 186 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 188 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 40/261 (15%)
Query: 119 KKRRRQLRGDPMEMQA-AAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALK 177
           KKR+R  RG     ++  A I +   +  +  + E +   G S        F    VA+K
Sbjct: 4   KKRKRGSRGGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVK 63
Query: 178 KVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY 236
           ++ ++     F   A+ EIK+L + + H N++  R   ++ +D           Y+  E 
Sbjct: 64  RMLID-----FCDIALMEIKLLTESDDHPNVI--RYYCSETTDRF--------LYIALEL 108
Query: 237 MDHDLMGLLESGMV-DFN-----EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
            + +L  L+ES  V D N     E N  S++RQ+  G+++ H    +HRD+K  NIL++ 
Sbjct: 109 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 168
Query: 291 RG-------------EVKLADFGLARLYNAEDR--QRPYTNKVITLWYRPPELL--LGEE 333
                           + ++DFGL +  ++     +    N   T  +R PELL    + 
Sbjct: 169 SSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKR 228
Query: 334 RYGPAIDVWSCGCILGELFVK 354
           R   +ID++S GC+   +  K
Sbjct: 229 RLTRSIDIFSMGCVFYYILSK 249

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 135 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 195 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 159 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 219 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 185 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 187 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 150 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 210 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H R+ ++RDIK  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 118 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGT 173
Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 174 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 203

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 179 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H R+ ++RDIK  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGT 168
Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 169 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFGLA+L  AE+++       + + 
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 185 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 40/261 (15%)
Query: 119 KKRRRQLRGDPMEMQA-AAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALK 177
           KKR+R  RG     ++  A I +   +  +  + E +   G S        F    VA+K
Sbjct: 4   KKRKRGSRGGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVK 63
Query: 178 KVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY 236
           ++ ++     F   A+ EIK+L + + H N++  R   ++ +D           Y+  E 
Sbjct: 64  RMLID-----FCDIALMEIKLLTESDDHPNVI--RYYCSETTDRF--------LYIALEL 108
Query: 237 MDHDLMGLLESGMV-DFN-----EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
            + +L  L+ES  V D N     E N  S++RQ+  G+++ H    +HRD+K  NIL++ 
Sbjct: 109 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 168
Query: 291 RG-------------EVKLADFGLARLYNAEDR--QRPYTNKVITLWYRPPELL--LGEE 333
                           + ++DFGL +  ++     +    N   T  +R PELL    + 
Sbjct: 169 SSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKR 228
Query: 334 RYGPAIDVWSCGCILGELFVK 354
           R   +ID++S GC+   +  K
Sbjct: 229 RLTRSIDIFSMGCVFYYILSK 249

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H R+ ++RDIK  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGT 168
Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 169 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 33/205 (16%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VALK +R   +   +   A  EI +L+++  K+  N + +    SD  +F    G   + 
Sbjct: 48  VALKIIRNVGK---YREAARLEINVLKKIKEKDKEN-KFLCVLMSDWFNFH---GHMCIA 100
Query: 234 FEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-- 290
           FE +  +    L E+    +   +   +  QL   L + H+    H D+K  NIL  N  
Sbjct: 101 FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160
Query: 291 -----------------RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE 333
                               +++ADFG A           +T  V T  YRPPE++L E 
Sbjct: 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATF-----DHEHHTTIVATRHYRPPEVIL-EL 214
Query: 334 RYGPAIDVWSCGCILGELFVKKPLF 358
            +    DVWS GCIL E +    LF
Sbjct: 215 GWAQPCDVWSIGCILFEYYRGFTLF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +K+ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           Y V EY++  DLM  ++  +  F E +      ++  GL +   +  ++RD+K  N++++
Sbjct: 97  YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 155
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + G +K+ADFG+ +    E+     T K    T  Y  PE ++  + YG ++D W+ G +
Sbjct: 156 SEGHIKIADFGMCK----ENIWDGVTTKXFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVL 210
Query: 348 LGELFVKKPLF 358
           L E+   +  F
Sbjct: 211 LYEMLAGQAPF 221

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 33/205 (16%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VALK +R   +   +   A  EI +L+++  K+  N + +    SD  +F    G   + 
Sbjct: 57  VALKIIRNVGK---YREAARLEINVLKKIKEKDKEN-KFLCVLMSDWFNFH---GHMCIA 109
Query: 234 FEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-- 290
           FE +  +    L E+    +   +   +  QL   L + H+    H D+K  NIL  N  
Sbjct: 110 FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 169
Query: 291 -----------------RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE 333
                               +++ADFG A           +T  V T  YRPPE++L E 
Sbjct: 170 FETLYNEHKSCEEKSVKNTSIRVADFGSATF-----DHEHHTTIVATRHYRPPEVIL-EL 223
Query: 334 RYGPAIDVWSCGCILGELFVKKPLF 358
            +    DVWS GCIL E +    LF
Sbjct: 224 GWAQPCDVWSIGCILFEYYRGFTLF 248

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           +++  L Y H R+ ++RDIK  N++++  G +K+ DFGL +    E      T K    T
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGT 168
Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGEL 351
             Y  PE +L +  YG A+D W  G ++ E+
Sbjct: 169 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +K+ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 172 NLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 224
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 225 LGVLIYEMAAGYPPF 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           Y V EY++  DLM  ++  +  F E +      ++  GL +   +  ++RD+K  N++++
Sbjct: 418 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476
Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCI 347
           + G +K+ADFG+ +    E+     T K    T  Y  PE ++  + YG ++D W+ G +
Sbjct: 477 SEGHIKIADFGMCK----ENIWDGVTTKXFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVL 531
Query: 348 LGELFVKKPLF 358
           L E+   +  F
Sbjct: 532 LYEMLAGQAPF 542

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F E +      Q++    Y H  + ++RD+K  
Sbjct: 104 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 163
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 164 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 216
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 217 LGVLIYEMAAGYPPF 231

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 33/205 (16%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VALK +R   +   +   A  EI +L+++  K+  N + +    SD  +F    G   + 
Sbjct: 80  VALKIIRNVGK---YREAARLEINVLKKIKEKDKEN-KFLCVLMSDWFNFH---GHMCIA 132
Query: 234 FEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-- 290
           FE +  +    L E+    +   +   +  QL   L + H+    H D+K  NIL  N  
Sbjct: 133 FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 192
Query: 291 -----------------RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE 333
                               +++ADFG A           +T  V T  YRPPE++L E 
Sbjct: 193 FETLYNEHKSCEEKSVKNTSIRVADFGSATF-----DHEHHTTIVATRHYRPPEVIL-EL 246
Query: 334 RYGPAIDVWSCGCILGELFVKKPLF 358
            +    DVWS GCIL E +    LF
Sbjct: 247 GWAQPCDVWSIGCILFEYYRGFTLF 271

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ ++    P F
Sbjct: 224 LGVLIYQMAAGYPPF 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 6/134 (4%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L++ +G +++ DFG A+           T + +      PE++L  + Y  A+D W+ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALA-----PEIILS-KGYNKAVDWWAL 224
Query: 345 GCILGELFVKKPLF 358
           G ++ E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +++ DFG A+      R +  T  +  T  Y  PE+++  + Y  A+D W+
Sbjct: 171 NLIIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIIIS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY     M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N++++ +G +++ DFG A+      R +  T  +  T  Y  PE++L  + Y  A+D W+
Sbjct: 171 NLMIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 79/191 (41%), Gaps = 19/191 (9%)
Query: 176 LKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKS------------DALD 222
           LK     +EKE      + E+KI+  L  H+NIVNL    T               D L+
Sbjct: 69  LKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 124
Query: 223 FRKDKGSFYLVFEYM-DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
           F + K    L        D  GL +         +      Q+  G+++   +N +HRD+
Sbjct: 125 FLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDV 184
Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
              N+L+ N    K+ DFGLAR    +       N  + + +  PE +  +  Y    DV
Sbjct: 185 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDV 243
Query: 342 WSCGCILGELF 352
           WS G +L E+F
Sbjct: 244 WSYGILLWEIF 254

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 27/221 (12%)
Query: 152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAV-REIKILRQLN-HKNIVN 209
           E L  G  +    +VSL   +  A+K +    ++ G   + V RE++ L Q   +KNI+ 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIE---KQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L          ++F +D   FYLVFE +    +         FNE   + ++R +   L 
Sbjct: 76  L----------IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALD 125
Query: 270 YCHKRNFLHRDIKCSNILMNN---RGEVKLADFGLARLYNAEDRQRPYTNKVITL----- 321
           + H +   HRD+K  NIL  +      VK+ DF L       +   P T   +T      
Sbjct: 126 FLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 322 WYRPPELLL----GEERYGPAIDVWSCGCILGELFVKKPLF 358
            Y  PE++         Y    D+WS G +L  +    P F
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 22/192 (11%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E V ++++ LE            E+ + +  NH NIV  R      ++          
Sbjct: 51  TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE---------- 100
Query: 230 FYLVFEYMDH-DLMGLLESGMVD-FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
            ++V  +M +     L+ +  +D  NE+  A I++ +L  L Y H   ++HR +K S+IL
Sbjct: 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL 160
Query: 288 MNNRGEVKLADF--GLARLYNAEDRQR------PYTNKVITLWYRPPELLLGEERYGPAI 339
           ++  G+V L+     L+ + + + RQR       Y+ KV+  W  P  L    + Y    
Sbjct: 161 ISVDGKVYLSGLRSNLSMISHGQ-RQRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKS 218
Query: 340 DVWSCGCILGEL 351
           D++S G    EL
Sbjct: 219 DIYSVGITACEL 230

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 22/192 (11%)
Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E V ++++ LE            E+ + +  NH NIV  R      ++          
Sbjct: 35  TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE---------- 84
Query: 230 FYLVFEYMDH-DLMGLLESGMVD-FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
            ++V  +M +     L+ +  +D  NE+  A I++ +L  L Y H   ++HR +K S+IL
Sbjct: 85  LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL 144
Query: 288 MNNRGEVKLADF--GLARLYNAEDRQR------PYTNKVITLWYRPPELLLGEERYGPAI 339
           ++  G+V L+     L+ + + + RQR       Y+ KV+  W  P  L    + Y    
Sbjct: 145 ISVDGKVYLSGLRSNLSMISHGQ-RQRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKS 202
Query: 340 DVWSCGCILGEL 351
           D++S G    EL
Sbjct: 203 DIYSVGITACEL 214

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 13/188 (6%)
Query: 179 VRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD-----ALDFR-KDKGSFYL 232
            R + E+  + +  +++  IL++   K+I++ R ++           L F  +     Y 
Sbjct: 57  ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116
Query: 233 VFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           V +Y++   +         F E        ++   L Y H  N ++RD+K  NIL++++G
Sbjct: 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG 176
Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
            + L DFGL +    E+ +   T      T  Y  PE +L ++ Y   +D W  G +L E
Sbjct: 177 HIVLTDFGLCK----ENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYE 231
Query: 351 LFVKKPLF 358
           +    P F
Sbjct: 232 MLYGLPPF 239

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 195 EIKIL-RQLNHKNIVNLREIVTDKSDALDFRKDKGSF-YLVFEYMDHD--LMGLLESGMV 250
           EI+IL R   H NI+ L+++            D G + Y+V E M     L  +L     
Sbjct: 65  EIEILLRYGQHPNIITLKDVY-----------DDGKYVYVVTELMKGGELLDKILRQKF- 112
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM----NNRGEVKLADFGLARLYN 306
            F+E   ++++  +   + Y H +  +HRD+K SNIL      N   +++ DFG A+   
Sbjct: 113 -FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           AE+          T  +  PE +L  + Y  A D+WS G +L
Sbjct: 172 AENGL--LMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLL 210

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 43/209 (20%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K++ ++     F   A+ EIK+L + + H N++  R   ++ +D           Y+
Sbjct: 42  VAVKRMLID-----FCDIALMEIKLLTESDDHPNVI--RYYCSETTDRF--------LYI 86
Query: 233 VFEYMDHDLMGLLESGMV-DFN-----EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             E  + +L  L+ES  V D N     E N  S++RQ+  G+++ H    +HRD+K  NI
Sbjct: 87  ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNI 146
Query: 287 LMNNRG-------------EVKLADFGLA-RLYNAEDRQRP-YTNKVITLWYRPPEL--- 328
           L++                 + ++DFGL  +L + +   R    N   T  +R PEL   
Sbjct: 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206
Query: 329 ---LLGEERYGPAIDVWSCGCILGELFVK 354
              L  + R   +ID++S GC+   +  K
Sbjct: 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           KD  + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           N+L++ +G +++ DFG A+      R +  T  +  T  Y  P ++L  + Y  A+D W+
Sbjct: 171 NLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPAIILS-KGYNKAVDWWA 223
Query: 344 CGCILGELFVKKPLF 358
            G ++ E+    P F
Sbjct: 224 LGVLIYEMAAGYPPF 238

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 103/273 (37%), Gaps = 60/273 (21%)
Query: 137 PIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREI 196
           P++     N    ++  L  G  S       +     VA+K V+     + +  TA+ EI
Sbjct: 22  PVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVK---SAQHYTETALDEI 78
Query: 197 KILRQLNHKNIVNL-REIVTDKSDALDFRKDKG-SFYLVFEYMDHDLMG-LLESGMVDFN 253
           K+L+ +   +  +  +++V    D        G    +VFE + H L+  +++S      
Sbjct: 79  KLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLP 138
Query: 254 EVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILM------------------------ 288
                SI+RQ+L GL Y H +   +H DIK  NILM                        
Sbjct: 139 VRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPP 198
Query: 289 -----------------------NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
                                   ++  VK+AD G     NA    + +T  + T  YR 
Sbjct: 199 PSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLG-----NACWVHKHFTEDIQTRQYRS 253
Query: 326 PELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            E+L+G     PA D+WS  C+  EL     LF
Sbjct: 254 IEVLIGAGYSTPA-DIWSTACMAFELATGDYLF 285

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 67/145 (46%), Gaps = 16/145 (11%)
Query: 225 KDKGSFYLVFEY-MDHDLMGLLESGMVDFNEVNNASIMR----QLLDGLSYCHKRNFLHR 279
           +D+   YLV EY +  DL+ LL      F E   A + R    +++  +   H+  ++HR
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSK----FGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG------EE 333
           DIK  NIL++  G ++LADFG      A+   R     V T  Y  PE+L          
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTG 245
Query: 334 RYGPAIDVWSCGCILGELFVKKPLF 358
            YGP  D W+ G    E+F  +  F
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 11/103 (10%)
Query: 260 IMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR------- 312
           I  Q+ + + + H +  +HRD+K SNI       VK+ DFGL    + ++ ++       
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 313 ---PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
               +  +V T  Y  PE + G   Y   +D++S G IL EL 
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 470 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 530 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 566

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 27/196 (13%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           E VA+K     +EK  F  T +    +LR   H+NI+    I +D +     R      +
Sbjct: 61  ENVAVKIFSSRDEKSWFRETELYNTVMLR---HENILGF--IASDMTS----RHSSTQLW 111
Query: 232 LVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNF--------LHRDIK 282
           L+  Y  H++  L +   +   + V+   I+  +  GL++ H   F         HRD+K
Sbjct: 112 LITHY--HEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 169
Query: 283 CSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN--KVITLWYRPPELLLGEERYG---- 336
             NIL+   G+  +AD GLA +++    Q    N  +V T  Y  PE+L    +      
Sbjct: 170 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 229
Query: 337 -PAIDVWSCGCILGEL 351
              +D+W+ G +L E+
Sbjct: 230 YKRVDIWAFGLVLWEV 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 27/196 (13%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           E VA+K     +EK  F  T +    +LR   H+NI+    I +D +     R      +
Sbjct: 32  ENVAVKIFSSRDEKSWFRETELYNTVMLR---HENILGF--IASDMTS----RHSSTQLW 82
Query: 232 LVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNF--------LHRDIK 282
           L+  Y  H++  L +   +   + V+   I+  +  GL++ H   F         HRD+K
Sbjct: 83  LITHY--HEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 283 CSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN--KVITLWYRPPELLLGEERYG---- 336
             NIL+   G+  +AD GLA +++    Q    N  +V T  Y  PE+L    +      
Sbjct: 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200
Query: 337 -PAIDVWSCGCILGEL 351
              +D+W+ G +L E+
Sbjct: 201 YKRVDIWAFGLVLWEV 216

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 128 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 187
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 188 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 224

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 128 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 187
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 188 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 43/209 (20%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K++ ++     F   A+ EIK+L + + H N++  R   ++ +D           Y+
Sbjct: 42  VAVKRMLID-----FCDIALMEIKLLTESDDHPNVI--RYYCSETTDRF--------LYI 86
Query: 233 VFEYMDHDLMGLLESGMV-DFN-----EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             E  + +L  L+ES  V D N     E N  S++RQ+  G+++ H    +HRD+K  NI
Sbjct: 87  ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNI 146
Query: 287 LMNNRG-------------EVKLADFGLARLYNAEDR--QRPYTNKVITLWYRPPEL--- 328
           L++                 + ++DFGL +  ++     +    N   T  +R PEL   
Sbjct: 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEE 206
Query: 329 ---LLGEERYGPAIDVWSCGCILGELFVK 354
              L  + R   +ID++S GC+   +  K
Sbjct: 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           ++ DG++Y + + F+HRD+   N ++ +   VK+ DFG+ R     D  R     ++ + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +  PE  L +  +  + D+WS G +L E+
Sbjct: 198 WMAPE-SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 471 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 530
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 531 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 567

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 126 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 185
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 186 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 222

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           ++ DG++Y + + F+HRD+   N ++ +   VK+ DFG+ R     D  R     ++ + 
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +  PE  L +  +  + D+WS G +L E+
Sbjct: 195 WMAPE-SLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 30/231 (12%)
Query: 138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIK 197
           +Q  S N S++ +   L  GG     +   L    LVA+K+++ E   +G  +    E++
Sbjct: 33  LQVASDNFSNKNI---LGRGGFG-KVYKGRLADGTLVAVKRLK-EERXQGGELQFQTEVE 87
Query: 198 ILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVN- 256
           ++    H+N++ LR      ++ L          LV+ YM +   G + S + +  E   
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERL----------LVYPYMAN---GSVASCLRERPESQP 134
Query: 257 ------NASIMRQLLDGLSYCHKR---NFLHRDIKCSNILMNNRGEVKLADFGLARLYNA 307
                    I      GL+Y H       +HRD+K +NIL++   E  + DFGLA+L + 
Sbjct: 135 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 194
Query: 308 EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +D       +  T+ +  PE  L   +     DV+  G +L EL   +  F
Sbjct: 195 KDXHVXXAVRG-TIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 27/196 (13%)
Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           E VA+K     +EK  F  T +    +LR   H+NI+    I +D +     R      +
Sbjct: 32  ENVAVKIFSSRDEKSWFRETELYNTVMLR---HENILGF--IASDMTS----RHSSTQLW 82
Query: 232 LVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNF--------LHRDIK 282
           L+  Y  H++  L +   +   + V+   I+  +  GL++ H   F         HRD+K
Sbjct: 83  LITHY--HEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 283 CSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN--KVITLWYRPPELLLGEERYG---- 336
             NIL+   G+  +AD GLA +++    Q    N  +V T  Y  PE+L    +      
Sbjct: 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200
Query: 337 -PAIDVWSCGCILGEL 351
              +D+W+ G +L E+
Sbjct: 201 YKRVDIWAFGLVLWEV 216

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 118 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 178 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 214

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 193 VREIKILRQL-NHKNIVNL---------REIVTDK---SDALDF-RKDKGSFYLVFEYMD 238
           + E+K+L  L NH NIVNL           ++T+     D L+F R+ + SF        
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC-----S 151
Query: 239 HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD 298
                ++E   +  +  +  S   Q+  G+++   +N +HRD+   NIL+ +    K+ D
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 211
Query: 299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           FGLAR    +       N  + + +  PE +     Y    DVWS G  L ELF
Sbjct: 212 FGLARHIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELF 264

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           ++ DG++Y + + F+HRD+   N ++ +   VK+ DFG+ R     D  R     ++ + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +  PE  L +  +  + D+WS G +L E+
Sbjct: 198 WMAPE-SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G+SY      +HRD+   N+L+ +   VK+ DFGLARL + ++ +       + + 
Sbjct: 127 QIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 186
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L   R+    DVWS G  + EL  F  KP
Sbjct: 187 WMALESIL-RRRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 112 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ 171
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 172 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 208

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 25/162 (15%)
Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDF 252
           +EI IL    H+NI++L E      + +          ++FE++   D+   + +   + 
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELV----------MIFEFISGLDIFERINTSAFEL 99
Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR--GEVKLADFGLARLYNAEDR 310
           NE    S + Q+ + L + H  N  H DI+  NI+   R    +K+ +FG AR     D 
Sbjct: 100 NEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 311 QRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCIL 348
            R        L +  PE    E    +    A D+WS G ++
Sbjct: 160 FR--------LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 108 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 168 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 204

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN-KVITL 321
           Q+  G+ Y  +   +HR++   N+L+ +  +V++ADFG+A L   +D+Q  Y+  K    
Sbjct: 141 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 200
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           W     +  G  +Y    DVWS G  + EL  
Sbjct: 201 WMALESIHFG--KYTHQSDVWSYGVTVWELMT 230

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 112 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 171
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 172 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 208

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNA-EDRQRPY 314
           N   ++ Q+  G+ Y  + NF+HRD+   N+L+  +   K++DFGL++   A E+  +  
Sbjct: 106 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 165
Query: 315 TN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           T+ K    WY P    +   ++    DVWS G ++ E F
Sbjct: 166 THGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAF 202

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFG A+L  AE+++       + + 
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 192 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 193 VREIKILRQL-NHKNIVNL---------REIVTDK---SDALDF-RKDKGSFYLVFEYMD 238
           + E+K+L  L NH NIVNL           ++T+     D L+F R+ + SF        
Sbjct: 90  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC-----S 144
Query: 239 HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD 298
                ++E   +  +  +  S   Q+  G+++   +N +HRD+   NIL+ +    K+ D
Sbjct: 145 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 204
Query: 299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           FGLAR    +       N  + + +  PE +     Y    DVWS G  L ELF
Sbjct: 205 FGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELF 257

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 193 VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF---YLVFEYMDH-DLMGLLESG 248
           +RE   +++ +H ++  L   V+ +S A      KG      ++  +M H DL   L + 
Sbjct: 73  LREAACMKEFDHPHVAKLVG-VSLRSRA------KGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 249 MVDFNEVNN--ASIMRQLLD---GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR 303
            +  N  N    +++R ++D   G+ Y   RNF+HRD+   N ++     V +ADFGL+R
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 304 -LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK 354
            +Y+ +  ++   +K+   W       L +  Y    DVW+ G  + E+  +
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALES--LADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 56/128 (43%), Gaps = 7/128 (5%)
Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           ++ G  YL  E     L    E+      E      +R  L  L++ H +  +H D+K +
Sbjct: 127 EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186
Query: 285 NILMNNRGEVKLADFG-LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
           NI +  RG  KL DFG L  L  A   +    +      Y  PELL G   YG A DV+S
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR----YMAPELLQGS--YGTAADVFS 240
Query: 344 CGCILGEL 351
            G  + E+
Sbjct: 241 LGLTILEV 248

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 88/214 (41%), Gaps = 51/214 (23%)
Query: 174 VALKKVR-LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VALK ++ +E  KE     A  EI +L ++N K+  N + +     D  D+    G   +
Sbjct: 62  VALKIIKNVEKYKEA----ARLEINVLEKINEKDPDN-KNLCVQMFDWFDYH---GHMCI 113
Query: 233 VFEYMDHDLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRDIKC 283
            FE     L+GL      DF + NN           +  QL   + + H     H D+K 
Sbjct: 114 SFE-----LLGL---STFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKP 165
Query: 284 SNILMNN------------RGE-------VKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
            NIL  N            R E       V++ DFG A           ++  V T  YR
Sbjct: 166 ENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF-----DHEHHSTIVSTRHYR 220
Query: 325 PPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            PE++L E  +    DVWS GCI+ E +V   LF
Sbjct: 221 APEVIL-ELGWSQPCDVWSIGCIIFEYYVGFTLF 253

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFG A+L  AE+++       + + 
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 187 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFG A+L  AE+++       + + 
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 185 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFG A+L  AE+++       + + 
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 187 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFG A+L  AE+++       + + 
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 187 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G++Y   R  +HRD+   N+L+     VK+ DFG A+L  AE+++       + + 
Sbjct: 129 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E +L    Y    DVWS G  + EL  F  KP
Sbjct: 189 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN-KVITL 321
           Q+  G+ Y  +   +HR++   N+L+ +  +V++ADFG+A L   +D+Q  Y+  K    
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           W     +  G  +Y    DVWS G  + EL  
Sbjct: 183 WMALESIHFG--KYTHQSDVWSYGVTVWELMT 212

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 21/230 (9%)
Query: 139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKI 198
           QS S       +++ + +GG S   F V     ++ A+K V LE        +   EI  
Sbjct: 21  QSMSVKGRIYSILKQIGSGGSS-KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 199 LRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNA 258
           L +L   +   +R          D+       Y+V E  + DL   L+      +     
Sbjct: 80  LNKLQQHSDKIIR--------LYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERK 130
Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKV 318
           S  + +L+ +   H+   +H D+K +N L+ + G +KL DFG+A     +       ++V
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 319 ITLWYRPPELL--LGEERYG--------PAIDVWSCGCILGELFVKKPLF 358
            T+ Y PPE +  +   R          P  DVWS GCIL  +   K  F
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 193 VREIKILRQL-NHKNIVNL---------REIVTDK---SDALDF-RKDKGSFYLVFEYMD 238
           + E+K+L  L NH NIVNL           ++T+     D L+F R+ + SF        
Sbjct: 92  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC-----S 146
Query: 239 HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD 298
                ++E   +  +  +  S   Q+  G+++   +N +HRD+   NIL+ +    K+ D
Sbjct: 147 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 206
Query: 299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           FGLAR    +       N  + + +  PE +     Y    DVWS G  L ELF
Sbjct: 207 FGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELF 259

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 193 VREIKILRQL-NHKNIVNL---------REIVTDK---SDALDF-RKDKGSFYLVFEYMD 238
           + E+K+L  L NH NIVNL           ++T+     D L+F R+ + SF        
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC-----S 151
Query: 239 HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD 298
                ++E   +  +  +  S   Q+  G+++   +N +HRD+   NIL+ +    K+ D
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 211
Query: 299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           FGLAR    +       N  + + +  PE +     Y    DVWS G  L ELF
Sbjct: 212 FGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELF 264

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           ++ DG++Y + + F+HRD+   N ++ +   VK+ DFG+ R     D  R     ++ + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +  PE  L +  +  + D+WS G +L E+
Sbjct: 198 WMAPE-SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 25/218 (11%)
Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLRE 212
           L  G  +     ++L T +  A+K +  E +         RE+++L Q   H+N++ L E
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 213 IVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH 272
              ++            FYLVFE M    +         FNE+  + +++ +   L + H
Sbjct: 79  FFEEED----------RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 273 KRNFLHRDIKCSNILM---NNRGEVKLADFGLARLYNAEDRQRPYTNKVI-----TLWYR 324
            +   HRD+K  NIL    N    VK+ DFGL           P +   +     +  Y 
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 325 PPELL--LGEER--YGPAIDVWSCGCILGELFVKKPLF 358
            PE++    EE   Y    D+WS G IL  L    P F
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 193 VREIKILRQL-NHKNIVNL---------REIVTDK---SDALDF-RKDKGSFYLVFEYMD 238
           + E+K+L  L NH NIVNL           ++T+     D L+F R+ + SF        
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC-----S 128
Query: 239 HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD 298
                ++E   +  +  +  S   Q+  G+++   +N +HRD+   NIL+ +    K+ D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           FGLAR    +       N  + + +  PE +     Y    DVWS G  L ELF
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELF 241

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 18/190 (9%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA--------LDFRK 225
           VA+K ++L+N  +      + E   ++  +H N++ L  +  + S          L F K
Sbjct: 65  VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
             G  +    Y        LE+G            M  +  G+ Y   RNFLHRD+   N
Sbjct: 125 -YGDLHTYLLY------SRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177
Query: 286 ILMNNRGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
            ++ +   V +ADFGL+ ++Y+ +  ++    K+   W       L +  Y    DVW+ 
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES--LADRVYTSKSDVWAF 235
Query: 345 GCILGELFVK 354
           G  + E+  +
Sbjct: 236 GVTMWEIATR 245

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 249 MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEVKLADFGLARLY 305
           MV  N+V    +++Q+L+G+ Y H+ N +H D+K  NIL+++    G++K+ DFG++R  
Sbjct: 127 MVSENDV--IRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGP---AIDVWSCGCI 347
                 R       T  Y  PE+L     Y P   A D+W+ G I
Sbjct: 185 GHACELREIMG---TPEYLAPEIL----NYDPITTATDMWNIGII 222

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 21/230 (9%)
Query: 139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKI 198
           QS S       +++ + +GG S   F V     ++ A+K V LE        +   EI  
Sbjct: 21  QSMSVKGRIYSILKQIGSGGSS-KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 199 LRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNA 258
           L +L   +   +R          D+       Y+V E  + DL   L+      +     
Sbjct: 80  LNKLQQHSDKIIR--------LYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERK 130
Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKV 318
           S  + +L+ +   H+   +H D+K +N L+ + G +KL DFG+A     +       ++V
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDXXXVVKDSQV 189
Query: 319 ITLWYRPPELL--LGEERYG--------PAIDVWSCGCILGELFVKKPLF 358
            T+ Y PPE +  +   R          P  DVWS GCIL  +   K  F
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           ++ DG++Y + + F+HRD+   N ++ +   VK+ DFG+ R     D  R     ++ + 
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +  PE  L +  +  + D+WS G +L E+
Sbjct: 197 WMAPE-SLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 79/179 (44%), Gaps = 41/179 (22%)
Query: 195 EIKILRQLNHK-NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMV-- 250
           E+++L +L H  NI+NL          L   + +G  YL  EY  H +L+  L    V  
Sbjct: 75  ELEVLCKLGHHPNIINL----------LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124
Query: 251 ---DFNEVNN-ASIM--RQLLD-------GLSYCHKRNFLHRDIKCSNILMNNRGEVKLA 297
               F   N+ AS +  +QLL        G+ Y  ++ F+HRD+   NIL+      K+A
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184
Query: 298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER-----YGPAIDVWSCGCILGEL 351
           DFGL+R       Q  Y  K +    R P   +  E      Y    DVWS G +L E+
Sbjct: 185 DFGLSR------GQEVYVKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 2/87 (2%)
Query: 231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN- 289
           +++ +    DL  + E+    F+      +  ++LD L Y H+  ++H DIK SN+L+N 
Sbjct: 128 FMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187
Query: 290 -NRGEVKLADFGLARLYNAEDRQRPYT 315
            N  +V L D+GLA  Y  E   + Y 
Sbjct: 188 KNPDQVYLVDYGLAYRYCPEGVHKAYA 214

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 79/179 (44%), Gaps = 41/179 (22%)
Query: 195 EIKILRQLNHK-NIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMV-- 250
           E+++L +L H  NI+NL          L   + +G  YL  EY  H +L+  L    V  
Sbjct: 65  ELEVLCKLGHHPNIINL----------LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 114
Query: 251 ---DFNEVNN-ASIM--RQLLD-------GLSYCHKRNFLHRDIKCSNILMNNRGEVKLA 297
               F   N+ AS +  +QLL        G+ Y  ++ F+HRD+   NIL+      K+A
Sbjct: 115 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 174
Query: 298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER-----YGPAIDVWSCGCILGEL 351
           DFGL+R       Q  Y  K +    R P   +  E      Y    DVWS G +L E+
Sbjct: 175 DFGLSR------GQEVYVKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 24/180 (13%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
            A+KKVRLE       +  V E+     L+   IV L   V +           G +  +
Sbjct: 86  CAVKKVRLE-------VFRVEELVACAGLSSPRIVPLYGAVRE-----------GPWVNI 127
Query: 234 F-EYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           F E ++   +G L   M    E      + Q L+GL Y H R  LH D+K  N+L+++ G
Sbjct: 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG 187
Query: 293 E-VKLADFGLARLYNAEDRQRP-YTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCIL 348
               L DFG A     +   +   T   I  T  +  PE+++G+      +D+WS  C++
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMM 246

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 24/180 (13%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
            A+KKVRLE       +  V E+     L+   IV L   V +           G +  +
Sbjct: 102 CAVKKVRLE-------VFRVEELVACAGLSSPRIVPLYGAVRE-----------GPWVNI 143
Query: 234 F-EYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           F E ++   +G L   M    E      + Q L+GL Y H R  LH D+K  N+L+++ G
Sbjct: 144 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG 203
Query: 293 E-VKLADFGLARLYNAEDRQRP-YTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCIL 348
               L DFG A     +   +   T   I  T  +  PE+++G+      +D+WS  C++
Sbjct: 204 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMM 262

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 104/267 (38%), Gaps = 62/267 (23%)
Query: 145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH 204
           N    ++  L  G  S    S  +   + VA+K V+     E +  TA+ EI++L+ + +
Sbjct: 20  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRN 76
Query: 205 KNIVNL-REIVTDKSDALDFRKDKGS-FYLVFEYMDHDLMG-LLESGMVDFNEVNNASIM 261
            +  +  RE+V    D        G+   +VFE + H L+  +++S            I+
Sbjct: 77  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 136
Query: 262 RQLLDGLSYCHKR-NFLHRDIKCSNILMN------------------------------- 289
           +Q+L GL Y H +   +H DIK  NIL++                               
Sbjct: 137 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 196
Query: 290 ------------------NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG 331
                              + +VK+AD G     NA    + +T  + T  YR  E+L+G
Sbjct: 197 APATAGNFLVNPLEPKNAEKLKVKIADLG-----NACWVHKHFTEDIQTRQYRSLEVLIG 251
Query: 332 EERYGPAIDVWSCGCILGELFVKKPLF 358
                PA D+WS  C+  EL     LF
Sbjct: 252 SGYNTPA-DIWSTACMAFELATGDYLF 277

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 1/89 (1%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           ++ DG++Y +   F+HRD+   N ++     VK+ DFG+ R     D  R     ++ + 
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +  PE  L +  +    DVWS G +L E+
Sbjct: 200 WMSPE-SLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 24/180 (13%)
Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
            A+KKVRLE       +  V E+     L+   IV L   V +           G +  +
Sbjct: 100 CAVKKVRLE-------VFRVEELVACAGLSSPRIVPLYGAVRE-----------GPWVNI 141
Query: 234 F-EYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
           F E ++   +G L   M    E      + Q L+GL Y H R  LH D+K  N+L+++ G
Sbjct: 142 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG 201
Query: 293 E-VKLADFGLARLYNAEDRQRP-YTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCIL 348
               L DFG A     +   +   T   I  T  +  PE+++G+      +D+WS  C++
Sbjct: 202 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMM 260

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 1/89 (1%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           ++ DG++Y +   F+HRD+   N ++     VK+ DFG+ R     D  R     ++ + 
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL 351
           +  PE  L +  +    DVWS G +L E+
Sbjct: 191 WMSPE-SLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 8/174 (4%)
Query: 180 RLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVF-EYMD 238
           R+E+++ GF   AV++++ L     + ++    + + +   L     +G +  +F E ++
Sbjct: 111 RMEDKQTGFQC-AVKKVR-LEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLE 168
Query: 239 HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLA 297
              +G L        E      + Q L+GL Y H R  LH D+K  N+L+++ G    L 
Sbjct: 169 GGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALC 228
Query: 298 DFGLARLYNAEDRQRP-YTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           DFG A     +   +   T   I  T  +  PE++LG       +DVWS  C++
Sbjct: 229 DFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMM 281

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 104/267 (38%), Gaps = 62/267 (23%)
Query: 145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH 204
           N    ++  L  G  S    S  +   + VA+K V+     E +  TA+ EI++L+ + +
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRN 92
Query: 205 KNIVNL-REIVTDKSDALDFRKDKGS-FYLVFEYMDHDLMG-LLESGMVDFNEVNNASIM 261
            +  +  RE+V    D        G+   +VFE + H L+  +++S            I+
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 262 RQLLDGLSYCHKR-NFLHRDIKCSNILMN------------------------------- 289
           +Q+L GL Y H +   +H DIK  NIL++                               
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 290 ------------------NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG 331
                              + +VK+AD G     NA    + +T  + T  YR  E+L+G
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLG-----NACWVHKHFTEDIQTRQYRSLEVLIG 267
Query: 332 EERYGPAIDVWSCGCILGELFVKKPLF 358
                PA D+WS  C+  EL     LF
Sbjct: 268 SGYNTPA-DIWSTACMAFELATGDYLF 293

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 2/97 (2%)
Query: 220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
            L  +  K   +++ +    DL  + E+    F+      +  ++LD L Y H+  ++H 
Sbjct: 117 GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHG 176
Query: 280 DIKCSNILMN--NRGEVKLADFGLARLYNAEDRQRPY 314
           DIK SN+L+N  N  +V L D+GLA  Y  E   + Y
Sbjct: 177 DIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKEY 213

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 231 YLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN- 289
           +++ +    DL  + E+    F+      +  ++LD L Y H+  ++H DIK SN+L+N 
Sbjct: 128 FMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187
Query: 290 -NRGEVKLADFGLARLYNAEDRQRPY 314
            N  +V L D+GLA  Y  E   + Y
Sbjct: 188 KNPDQVYLVDYGLAYRYCPEGVHKEY 213

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 90/190 (47%), Gaps = 24/190 (12%)
Query: 168 LFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKD 226
           +F +  VA+K++      E F   A RE+++LR+ + H N++  R   T+K        D
Sbjct: 45  MFDNRDVAVKRIL----PECFSF-ADREVQLLRESDEHPNVI--RYFCTEK--------D 89
Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           +   Y+  E     L   +E        +   ++++Q   GL++ H  N +HRD+K  NI
Sbjct: 90  RQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 287 LM---NNRGEVK--LADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGP--A 338
           L+   N  G++K  ++DFGL +            + V  T  +  PE+L  + +  P   
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 339 IDVWSCGCIL 348
           +D++S GC+ 
Sbjct: 210 VDIFSAGCVF 219

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 24/162 (14%)
Query: 195 EIKIL-RQLNHKNIVNLREIVTDKSDALDFRKDKGSF-YLVFEYMDHD--LMGLLESGMV 250
           EI+IL R   H NI+ L+++            D G + Y+V E       L  +L     
Sbjct: 65  EIEILLRYGQHPNIITLKDVY-----------DDGKYVYVVTELXKGGELLDKILRQKF- 112
Query: 251 DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM----NNRGEVKLADFGLARLYN 306
            F+E   ++++  +   + Y H +  +HRD+K SNIL      N   +++ DFG A+   
Sbjct: 113 -FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           AE+          T  +  PE +L  + Y  A D+WS G +L
Sbjct: 172 AENGL--LXTPCYTANFVAPE-VLERQGYDAACDIWSLGVLL 210

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW 322
           Q+  G+ Y  +R  +HRD+   N+L+ +   VK+ DFGLARL   ++++       + + 
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGEL--FVKKP 356
           +   E  +   ++    DVWS G  + EL  F  KP
Sbjct: 185 WMALE-CIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	358
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-119
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-40
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-107
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-106
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-105
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-105
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-103
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-31
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-103
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-26
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-103
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-103
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-102
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-32
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-102
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-101
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-29
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-99
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-90
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-29
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-65
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-64
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-62
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-60
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-59
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-58
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-58
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-58
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-58
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-57
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-57
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-57
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-56
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-56
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-55
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-54
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-54
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-11
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-49
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-06
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-48
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-04
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-46
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-06
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-06
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-44
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-06
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-44
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-05
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-42
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-04
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-42
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-05
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-42
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-05
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-42
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-42
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-05
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-41
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-39
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-06
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-04
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-39
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-07
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-38
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-09
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-38
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-07
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-38
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-38
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-37
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-07
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-37
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-08
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-37
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-06
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-37
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-37
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-07
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-37
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-05
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-37
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-08
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-37
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-07
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-37
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-37
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-05
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-36
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-36
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-07
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-36
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-36
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-07
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-36
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-07
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-36
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-07
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-36
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-36
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-07
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-35
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-35
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-05
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-35
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-09
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-35
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-06
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-35
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-06
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-35
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-35
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-07
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-35
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-35
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-07
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-05
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-35
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-07
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-35
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-35
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-07
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-35
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-35
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-35
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-06
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-35
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-34
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-08
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-34
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-08
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-34
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-07
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-07
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-34
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-33
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-06
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-33
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-05
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-33
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-07
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-32
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-32
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-07
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-32
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-32
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-07
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-32
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-32
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-07
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-32
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-32
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-06
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-32
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-05
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-31
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-31
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-31
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-31
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-06
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-31
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-06
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-31
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-30
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-07
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-30
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-08
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-29
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-29
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-07
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-29
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-28
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-08
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-28
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-06
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-26
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-26
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-05
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-25
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-25
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-07
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-24
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-23
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-23
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-22
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-19
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-18
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-17
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  348 bits (894), Expect = e-119
 Identities = 100/191 (52%), Positives = 133/191 (69%), Gaps = 4/191 (2%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VALKKV +ENEKEGFPITA+REIKIL+ L H+N+VNL EI    + A  + + KGS
Sbjct: 41  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR--TKASPYNRCKGS 98

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLVF++ +HDL GLL + +V F       +M+ LL+GL Y H+   LHRD+K +N+L+ 
Sbjct: 99  IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 158

Query: 290 NRGEVKLADFGLARLYNAEDR--QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             G +KLADFGLAR ++         YTN+V+TLWYRPPELLLGE  YGP ID+W  GCI
Sbjct: 159 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 218

Query: 348 LGELFVKKPLF 358
           + E++ + P+ 
Sbjct: 219 MAEMWTRSPIM 229

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  145 bits (368), Expect = 1e-40
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 5/116 (4%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS--LMPPGALDLLD 72
           E  QL +IS+LCG+ TP VWP V    L+  ++  K  +R++++     +  P ALDL+D
Sbjct: 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 293

Query: 73  KMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPT--WQDCHELWSKKRRRQLR 126
           K+L LDP +RI ++ AL   +  +  P       + +       E  +  RR+   
Sbjct: 294 KLLVLDPAQRIDSDDALNHDFFWS-DPMPSDLKGMLSTHLTSMFEYLAPPRRKHHH 348

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  314 bits (808), Expect = e-107
 Identities = 78/189 (41%), Positives = 120/189 (63%), Gaps = 12/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
              +VALK++RL+ E EG P TA+REI +L++L+H NIV+L +++  +            
Sbjct: 44  QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER----------C 93

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             LVFE+M+ DL  +L+       +      + QLL G+++CH+   LHRD+K  N+L+N
Sbjct: 94  LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN 153

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           + G +KLADFGLAR +      R YT++V+TLWYR P++L+G ++Y  ++D+WS GCI  
Sbjct: 154 SDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211

Query: 350 ELFVKKPLF 358
           E+   KPLF
Sbjct: 212 EMITGKPLF 220

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  111 bits (279), Expect = 3e-28
 Identities = 27/86 (31%), Positives = 41/86 (47%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           +  QL  I  + GTP P  WP V +LPLW     +   ++             +DLL  M
Sbjct: 225 DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNM 284

Query: 75  LELDPERRITAEQALKSVWLKNVHPE 100
           L  DP +RI+A  A+   + K++ P+
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDLDPQ 310

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  312 bits (802), Expect = e-106
 Identities = 85/189 (44%), Positives = 116/189 (61%), Gaps = 12/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             E  ALKK+RLE E EG P T +REI IL++L H NIV L +++  K            
Sbjct: 25  YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK----------R 74

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             LVFE++D DL  LL+        V   S + QLL+G++YCH R  LHRD+K  N+L+N
Sbjct: 75  LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             GE+K+ADFGLAR +      R YT++++TLWYR P++L+G ++Y   ID+WS GCI  
Sbjct: 135 REGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFA 192

Query: 350 ELFVKKPLF 358
           E+    PLF
Sbjct: 193 EMVNGTPLF 201

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  103 bits (259), Expect = 1e-25
 Identities = 29/83 (34%), Positives = 40/83 (48%), Gaps = 1/83 (1%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E  QL  I ++ GTP    WP V +LP +                   +    +DLL KM
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY-EPLPWESFLKGLDESGIDLLSKM 264

Query: 75  LELDPERRITAEQALKSVWLKNV 97
           L+LDP +RITA+QAL+  + K  
Sbjct: 265 LKLDPNQRITAKQALEHAYFKEN 287

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  309 bits (793), Expect = e-105
 Identities = 86/190 (45%), Positives = 119/190 (62%), Gaps = 13/190 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALK+VRL+++ EG P +A+REI +L++L HKNIV L +++               
Sbjct: 26  THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK----------K 75

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             LVFE+ D DL    +S   D +     S + QLL GL +CH RN LHRD+K  N+L+N
Sbjct: 76  LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             GE+KLA+FGLAR +      R Y+ +V+TLWYRPP++L G + Y  +ID+WS GCI  
Sbjct: 136 RNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193

Query: 350 ELFVK-KPLF 358
           EL    +PLF
Sbjct: 194 ELANAGRPLF 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  105 bits (265), Expect = 2e-26
 Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 6/91 (6%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
              QL+ I +L GTPT   WP++ KLP +    P       L      +     DLL  +
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY-PMYPATTSLVNVVPKLNATGRDLLQNL 266

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPPP 105
           L+ +P +RI+AE+AL+  +  +       PP
Sbjct: 267 LKCNPVQRISAEEALQHPYFSDF-----CPP 292

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  108 bits (272), Expect = 2e-27
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 2/93 (2%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E+ QL  I +  GTP   VWP V  +P +    PK   R+   +    +      LL +M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW-ARQDFSKVVPPLDEDGRSLLSQM 267

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPPPQL 107
           L  DP +RI+A+ AL   + ++V  + +P  +L
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV-TKPVPHLRL 299

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  306 bits (787), Expect = e-103
 Identities = 90/189 (47%), Positives = 119/189 (62%), Gaps = 13/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           TD LVALK++RLE+E EG P TA+RE+ +L+ L H NIV L +I+  +           S
Sbjct: 26  TDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK----------S 74

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             LVFEY+D DL   L+      N  N    + QLL GL+YCH++  LHRD+K  N+L+N
Sbjct: 75  LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN 134

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
            RGE+KLADFGLAR  +     + Y N+V+TLWYRPP++LLG   Y   ID+W  GCI  
Sbjct: 135 ERGELKLADFGLARAKS--IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFY 192

Query: 350 ELFVKKPLF 358
           E+   +PLF
Sbjct: 193 EMATGRPLF 201

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  120 bits (302), Expect = 2e-31
 Identities = 26/110 (23%), Positives = 43/110 (39%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
              QL  I ++ GTPT   WP ++    + T    K     L      +     DLL K+
Sbjct: 206 VEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKL 265

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQ 124
           L+ +   RI+AE A+K  +  ++       P   +     E+  +K    
Sbjct: 266 LQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKEASL 315

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  306 bits (787), Expect = e-103
 Identities = 77/189 (40%), Positives = 115/189 (60%), Gaps = 12/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  +VA+KK    ++ +     A+REIK+L+QL H+N+VNL E+           K K  
Sbjct: 49  TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC----------KKKKR 98

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           +YLVFE++DH ++  LE      +       + Q+++G+ +CH  N +HRDIK  NIL++
Sbjct: 99  WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS 158

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             G VKL DFG AR   A      Y ++V T WYR PELL+G+ +YG A+DVW+ GC++ 
Sbjct: 159 QSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVT 216

Query: 350 ELFVKKPLF 358
           E+F+ +PLF
Sbjct: 217 EMFMGEPLF 225

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  106 bits (266), Expect = 2e-26
 Identities = 19/95 (20%), Positives = 36/95 (37%), Gaps = 1/95 (1%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIK-PKKIHRRRLREEFSLMPPGALDLLDK 73
           ++ QL  I    G   P       K P++  ++ P+   R  L   +  +    +DL  K
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289

Query: 74  MLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
            L +DP++R    + L   + +          +L 
Sbjct: 290 CLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQ 324

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  305 bits (784), Expect = e-103
 Identities = 75/194 (38%), Positives = 121/194 (62%), Gaps = 18/194 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T+E VA+K++RLE+E+EG P TA+RE+ +L++L H+NI+ L+ ++               
Sbjct: 58  TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH----------R 107

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +L+FEY ++DL   ++    D +     S + QL++G+++CH R  LHRD+K  N+L++
Sbjct: 108 LHLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166

Query: 290 -----NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
                    +K+ DFGLAR +    R   +T+++ITLWYRPPE+LLG   Y  ++D+WS 
Sbjct: 167 VSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSI 224

Query: 345 GCILGELFVKKPLF 358
            CI  E+ +K PLF
Sbjct: 225 ACIWAEMLMKTPLF 238

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  106 bits (266), Expect = 3e-26
 Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 3/90 (3%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E+ QL  I ++ G P    WP V  LP W    PK   +   R   +L+    LDLL  M
Sbjct: 243 EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAM 302

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPP 104
           LE+DP +RI+A+ AL+  +  +       P
Sbjct: 303 LEMDPVKRISAKNALEHPYFSHNDF---DP 329

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  304 bits (781), Expect = e-103
 Identities = 81/194 (41%), Positives = 120/194 (61%), Gaps = 18/194 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T   VALK+V+L++E EG P TA+REI ++++L H+NIV L +++  ++           
Sbjct: 29  TGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTEN----------K 77

Query: 230 FYLVFEYMDHDLMGLLESGMV-----DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
             LVFE+MD+DL   ++S  V                 QLL GL++CH+   LHRD+K  
Sbjct: 78  LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQ 137

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           N+L+N RG++KL DFGLAR +        ++++V+TLWYR P++L+G   Y  +ID+WSC
Sbjct: 138 NLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSC 195

Query: 345 GCILGELFVKKPLF 358
           GCIL E+   KPLF
Sbjct: 196 GCILAEMITGKPLF 209

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  106 bits (268), Expect = 1e-26
 Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 6/105 (5%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS-----LMPPGALD 69
           +  QL++I  + GTP  ++WP+V KLP ++    ++   R LR+         +    +D
Sbjct: 214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQR-PPRDLRQVLQPHTKEPLDGNLMD 272

Query: 70  LLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCH 114
            L  +L+L+P+ R++A+QAL   W    +  +            H
Sbjct: 273 FLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGGSRSHHHHHH 317

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  304 bits (781), Expect = e-102
 Identities = 76/193 (39%), Positives = 110/193 (56%), Gaps = 13/193 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREIVTDKSDALDFRKD 226
               VALK+VR++  +EG P++ +RE+ +LR L    H N+V L ++ T           
Sbjct: 36  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-----DR 90

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNA-SIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           +    LVFE++D DL   L+              +M QLL GL + H    +HRD+K  N
Sbjct: 91  ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 150

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           IL+ + G++KLADFGLAR+Y+ +      T+ V+TLWYR PE+LL    Y   +D+WS G
Sbjct: 151 ILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVG 206

Query: 346 CILGELFVKKPLF 358
           CI  E+F +KPLF
Sbjct: 207 CIFAEMFRRKPLF 219

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  121 bits (307), Expect = 4e-32
 Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 4/103 (3%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           ++ QL  I  + G P    WP  + LP            + + +  + +     DLL K 
Sbjct: 224 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA---QPIEKFVTDIDELGKDLLLKC 280

Query: 75  LELDPERRITAEQALKSVWLKNV-HPESMPPPQLPTWQDCHEL 116
           L  +P +RI+A  AL   + +++   +      LP  Q+  EL
Sbjct: 281 LTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSEL 323

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  303 bits (779), Expect = e-102
 Identities = 74/189 (39%), Positives = 105/189 (55%), Gaps = 12/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++VA+KK     +       A+REI++L+QL H N+VNL E+           + K  
Sbjct: 27  TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF----------RRKRR 76

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +LVFEY DH ++  L+       E    SI  Q L  +++CHK N +HRD+K  NIL+ 
Sbjct: 77  LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
               +KL DFG ARL         Y ++V T WYR PELL+G+ +YGP +DVW+ GC+  
Sbjct: 137 KHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194

Query: 350 ELFVKKPLF 358
           EL    PL+
Sbjct: 195 ELLSGVPLW 203

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  108 bits (272), Expect = 3e-27
 Identities = 24/102 (23%), Positives = 38/102 (37%), Gaps = 2/102 (1%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIK-PKKIHRRRLREEFSLMPPGALDLLDK 73
           ++ QL +I K  G   P           +  +K P       L  +F  +   AL LL  
Sbjct: 208 DVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKG 267

Query: 74  MLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHE 115
            L +DP  R+T EQ L   + +N+  E     +       + 
Sbjct: 268 CLHMDPTERLTCEQLLHHPYFENI-REIEDLAKEHDKPAENL 308

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  301 bits (772), Expect = e-101
 Identities = 74/192 (38%), Positives = 118/192 (61%), Gaps = 15/192 (7%)

Query: 170 TDELVALKKVRLENE---KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T+++VA+KK++L +    K+G   TA+REIK+L++L+H NI+ L +    KS        
Sbjct: 34  TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-------- 85

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             +  LVF++M+ DL  +++   +     +  + M   L GL Y H+   LHRD+K +N+
Sbjct: 86  --NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L++  G +KLADFGLA+ + + +  R YT++V+T WYR PELL G   YG  +D+W+ GC
Sbjct: 144 LLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 201

Query: 347 ILGELFVKKPLF 358
           IL EL ++ P  
Sbjct: 202 ILAELLLRVPFL 213

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  114 bits (288), Expect = 3e-29
 Identities = 37/112 (33%), Positives = 47/112 (41%), Gaps = 3/112 (2%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           +L QL  I +  GTPT   WP +  LP + T K        L   FS      LDL+  +
Sbjct: 218 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGL 275

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLR 126
              +P  RITA QALK  +  N  P   P  QLP      E   ++    L 
Sbjct: 276 FLFNPCARITATQALKMKYFSNR-PGPTPGCQLPRPNCPVETLKEQSNPALA 326

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  295 bits (758), Expect = 2e-99
 Identities = 79/196 (40%), Positives = 105/196 (53%), Gaps = 16/196 (8%)

Query: 170 TDELVALKKVRLENEKEG---FPITAVREIKILRQLN---HKNIVNLREIVTDKSDALDF 223
           +   VALK VR+ N   G    PI+ VRE+ +LR+L    H N+V L ++          
Sbjct: 33  SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR----- 87

Query: 224 RKDKGSFYLVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
              +    LVFE++D DL   L+              +MRQ L GL + H    +HRD+K
Sbjct: 88  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 147

Query: 283 CSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
             NIL+ + G VKLADFGLAR+Y     Q   T  V+TLWYR PE+LL    Y   +D+W
Sbjct: 148 PENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMW 203

Query: 343 SCGCILGELFVKKPLF 358
           S GCI  E+F +KPLF
Sbjct: 204 SVGCIFAEMFRRKPLF 219

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  101 bits (255), Expect = 6e-25
 Identities = 24/85 (28%), Positives = 34/85 (40%), Gaps = 3/85 (3%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E  QL  I  L G P    WP  + LP            R ++     M      LL +M
Sbjct: 224 EADQLGKIFDLIGLPPEDDWPRDVSLPRG---AFPPRGPRPVQSVVPEMEESGAQLLLEM 280

Query: 75  LELDPERRITAEQALKSVWLKNVHP 99
           L  +P +RI+A +AL+  +L     
Sbjct: 281 LTFNPHKRISAFRALQHSYLHKDEG 305

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  275 bits (705), Expect = 3e-90
 Identities = 72/202 (35%), Positives = 109/202 (53%), Gaps = 25/202 (12%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            D+  ALK++    E  G  ++A REI +LR+L H N+++L+++    +D          
Sbjct: 47  DDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQKVFLSHADR--------K 94

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNA--------SIMRQLLDGLSYCHKRNFLHRDI 281
            +L+F+Y +HDL  +++                    S++ Q+LDG+ Y H    LHRD+
Sbjct: 95  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 154

Query: 282 KCSNILM----NNRGEVKLADFGLARLYNAEDRQRP-YTNKVITLWYRPPELLLGEERYG 336
           K +NIL+      RG VK+AD G ARL+N+  +        V+T WYR PELLLG   Y 
Sbjct: 155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 214

Query: 337 PAIDVWSCGCILGELFVKKPLF 358
            AID+W+ GCI  EL   +P+F
Sbjct: 215 KAIDIWAIGCIFAELLTSEPIF 236

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  114 bits (288), Expect = 5e-29
 Identities = 31/144 (21%), Positives = 52/144 (36%), Gaps = 14/144 (9%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKK--------IHRRRLREEFSLMPPGALD 69
           QL+ I  + G P    W  + K+P   T+               + + +        A  
Sbjct: 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 312

Query: 70  LLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDP 129
           LL K+L +DP +RIT+EQA++  +         P P    +  C   + K+       +P
Sbjct: 313 LLQKLLTMDPIKRITSEQAMQDPYFLE-----DPLPTSDVFAGCQIPYPKREFLT-EEEP 366

Query: 130 MEMQAAAPIQSNSTNNSSRPLMEP 153
            +       Q    NN +     P
Sbjct: 367 DDKGDKKNQQQQQGNNHTNGTGHP 390

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  211 bits (538), Expect = 4e-65
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 17/193 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 78  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 127

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNA---SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +          +        M QL   L+Y H     HRDIK  N+
Sbjct: 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 187

Query: 287 LMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++ +   +KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 188 LLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 244

Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 245 CVLAELLLGQPIF 257

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 37/147 (25%), Positives = 52/147 (35%), Gaps = 21/147 (14%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAV------IKLPLWHTIKPKKIHRRRLREEFSLMPPGAL 68
            + QL  I K+ GTPT      +       K P        K+ R R        PP A+
Sbjct: 262 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR-------TPPEAI 314

Query: 69  DLLDKMLELDPERRITAEQALKSVWLKNVH------PESMPPPQLPTWQDCHELWSKKR- 121
            L  ++LE  P  R+T  +A    +   +       P     P L  +    EL S    
Sbjct: 315 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTT-QELSSNPPL 373

Query: 122 RRQLRGDPMEMQAAAPIQSNSTNNSSR 148
              L      +QAAA   +N+T  S  
Sbjct: 374 ATILIPPHARIQAAASTPTNATAASDA 400

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  209 bits (534), Expect = 1e-64
 Identities = 60/189 (31%), Positives = 88/189 (46%), Gaps = 17/189 (8%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+KKV  +   +       RE++I+R + H N+V+L+       D  D         LV
Sbjct: 67  VAIKKVLQDKRFKN------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF----LNLV 116

Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASI---MRQLLDGLSYCHKRNFLHRDIKCSNILMN- 289
            EY+   +             +    I   M QLL  L+Y H     HRDIK  N+L++ 
Sbjct: 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP 176

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             G +KL DFG A+         P  + + + +YR PEL+ G   Y   ID+WS GC++ 
Sbjct: 177 PSGVLKLIDFGSAK---ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233

Query: 350 ELFVKKPLF 358
           EL   +PLF
Sbjct: 234 ELMQGQPLF 242

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 23/144 (15%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAV------IKLPLWHTIKPKKIHRRRLREEFSLMPPGAL 68
            + QL  I K+ GTP+      +       K P        K+ R R        PP A+
Sbjct: 247 GIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPR-------TPPDAI 299

Query: 69  DLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWS-KKRRRQLRG 127
           DL+ ++LE  P  R+TA +AL   +   +        ++P  ++   L++  K    +R 
Sbjct: 300 DLISRLLEYTPSARLTAIEALCHPFFDELRT---GEARMPNGRELPPLFNWTKEELSVRP 356

Query: 128 D------PMEMQAAAPIQSNSTNN 145
           D      P   +A    +    +N
Sbjct: 357 DLISRLVPQHAEAELLSRGIDVHN 380

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  205 bits (524), Expect = 1e-62
 Identities = 75/225 (33%), Positives = 104/225 (46%), Gaps = 42/225 (18%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
              +VA+KK+    E        +REI IL +LNH ++V + +IV  K D   F +    
Sbjct: 77  EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK-DVEKFDE---- 131

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y+V E  D D   L  +  V   E++  +++  LL G+ Y H    LHRD+K +N L+N
Sbjct: 132 LYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190

Query: 290 NRGEVKLADFGLARLYNAEDR-------------------------QRPYTNKVITLWYR 324
               VK+ DFGLAR  +  +                          +R  T  V+T WYR
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR 250

Query: 325 PPELLLGEERYGPAIDVWSCGCILGELF-----------VKKPLF 358
            PEL+L +E Y  AIDVWS GCI  EL             + PLF
Sbjct: 251 APELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 29/98 (29%), Positives = 42/98 (42%), Gaps = 8/98 (8%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIK--PKKIHRRRLREEFSLMPPGALDLLDKML 75
           QL VI  + GTP+     A+ K      I+  PK+     L E F      A+ LL +ML
Sbjct: 323 QLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR-EGTDLAERFPASSADAIHLLKRML 381

Query: 76  ELDPERRITAEQALKSVWLKNVH-----PESMPPPQLP 108
             +P +RIT  + L   + K V        +    +LP
Sbjct: 382 VFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLP 419

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  195 bits (499), Expect = 2e-60
 Identities = 75/195 (38%), Positives = 107/195 (54%), Gaps = 10/195 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            D+ VA+KK+ L + +      A+REIKI+R+L+H NIV + EI+      L       +
Sbjct: 35  CDKRVAIKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92

Query: 230 ----FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
                Y+V EYM+ DL  +LE G     E +    M QLL GL Y H  N LHRD+K +N
Sbjct: 93  ELNSVYIVQEYMETDLANVLEQG--PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN 150

Query: 286 ILMNNRG-EVKLADFGLARLYNAEDRQRPY-TNKVITLWYRPPELLLGEERYGPAIDVWS 343
           + +N     +K+ DFGLAR+ +     + + +  ++T WYR P LLL    Y  AID+W+
Sbjct: 151 LFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210

Query: 344 CGCILGELFVKKPLF 358
            GCI  E+   K LF
Sbjct: 211 AGCIFAEMLTGKTLF 225

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 14/81 (17%), Positives = 33/81 (40%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLEL 77
           Q+++I +            ++ +   +         + L +    +   A+D L+++L  
Sbjct: 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292

Query: 78  DPERRITAEQALKSVWLKNVH 98
            P  R+TAE+AL   ++    
Sbjct: 293 SPMDRLTAEEALSHPYMSIYS 313

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  194 bits (496), Expect = 2e-59
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 17/198 (8%)

Query: 170 TDELVALKKVRLENEKEGFPIT---------AVREIKILRQLNHKNIVNLREIVTDKSDA 220
               VA+K+V                      +REI++L   +H NI+ LR+I     + 
Sbjct: 45  EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104

Query: 221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
               K     YLV E M  DL  ++    +  +  +    M  +L GL   H+   +HRD
Sbjct: 105 -AMHK----LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRD 159

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +   NIL+ +  ++ + DF LAR   A+  +  Y   V   WYR PEL++  + +   +D
Sbjct: 160 LHPGNILLADNNDITICDFNLAREDTADANKTHY---VTHRWYRAPELVMQFKGFTKLVD 216

Query: 341 VWSCGCILGELFVKKPLF 358
           +WS GC++ E+F +K LF
Sbjct: 217 MWSAGCVMAEMFNRKALF 234

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 3/111 (2%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIK--PKKIHRRRLREEFSLMPPGALDLLDKML 75
           QL  I ++ GTP                ++     +  R          P ALDL+ KML
Sbjct: 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKML 301

Query: 76  ELDPERRITAEQALKSVWLKNVH-PESMPPPQLPTWQDCHELWSKKRRRQL 125
           E +P+RRI+ EQAL+  + +++  P  +       +     +       ++
Sbjct: 302 EFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKI 352

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  190 bits (486), Expect = 2e-58
 Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 30/196 (15%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKG 228
            +E V +K ++   +K+       REIKIL  L    NI+ L +IV D            
Sbjct: 60  NNEKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITLADIVKDPVSRTP------ 108

Query: 229 SFYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
              LVFE+++      L   L    + F        M ++L  L YCH    +HRD+K  
Sbjct: 109 --ALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDYCHSMGIMHRDVKPH 159

Query: 285 NILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
           N++++    +++L D+GLA  Y+     + Y  +V + +++ PELL+  + Y  ++D+WS
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 216

Query: 344 CGCILGEL-FVKKPLF 358
            GC+L  + F K+P F
Sbjct: 217 LGCMLASMIFRKEPFF 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 7/88 (7%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLR-------EEFSLMPPGALDL 70
           QL  I+K+ GT     +     + L            R R       E   L+ P ALD 
Sbjct: 240 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 299

Query: 71  LDKMLELDPERRITAEQALKSVWLKNVH 98
           LDK+L  D + R+TA +A++  +   V 
Sbjct: 300 LDKLLRYDHQSRLTAREAMEHPYFYTVV 327

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  191 bits (487), Expect = 4e-58
 Identities = 68/190 (35%), Positives = 109/190 (57%), Gaps = 9/190 (4%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
               VA+KK+    E + +    +REIKIL +  H+NI+ + +I+   +  ++  KD   
Sbjct: 51  NKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT--IEQMKD--- 104

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y+V + M+ DL  LL++     +  +    + Q+L GL Y H  N LHRD+K SN+L+N
Sbjct: 105 VYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162

Query: 290 NRGEVKLADFGLARLYNAEDRQRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              ++K+ DFGLAR+ + +     + T  V T WYR PE++L  + Y  +ID+WS GCIL
Sbjct: 163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222

Query: 349 GELFVKKPLF 358
            E+   +P+F
Sbjct: 223 AEMLSNRPIF 232

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 4/94 (4%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIK--PKKIHRRRLREEFSLMPPGALDLLDKML 75
           QL  I  + G+P+      +I L   + +   P K ++      F      ALDLLDKML
Sbjct: 240 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKML 298

Query: 76  ELDPERRITAEQALKSVWLKNVH-PESMPPPQLP 108
             +P +RI  EQAL   +L+  + P   P  + P
Sbjct: 299 TFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP 332

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  191 bits (487), Expect = 4e-58
 Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 11/209 (5%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
            ++P+ +G       +V   T   VA+KK+    + E F   A RE+++L+ + H+N++ 
Sbjct: 29  DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88

Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L ++ T      DF      FYLV  +M  DL  L++       E     ++ Q+L GL 
Sbjct: 89  LLDVFTPDETLDDFT----DFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 142

Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           Y H    +HRD+K  N+ +N   E+K+ DFGLAR  ++E      T  V+T WYR PE++
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVI 197

Query: 330 LGEERYGPAIDVWSCGCILGELFVKKPLF 358
           L   RY   +D+WS GCI+ E+   K LF
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 28/111 (25%), Positives = 51/111 (45%), Gaps = 4/111 (3%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIK--PKKIHRRRLREEFSLMPPGALDLLDKML 75
           QL+ I K+ GTP       +      + +K  P+   ++      +   P A++LL+KML
Sbjct: 234 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL-EKKDFASILTNASPLAVNLLEKML 292

Query: 76  ELDPERRITAEQALKSVWLKNVH-PESMPPPQLPTWQDCHELWSKKRRRQL 125
            LD E+R+TA +AL   + +++H  E  P  Q           +    +++
Sbjct: 293 VLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 343

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  190 bits (485), Expect = 7e-58
 Identities = 68/189 (35%), Positives = 103/189 (54%), Gaps = 12/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + E VA+KK+    + E F   A RE+ +L+ + H+N++ L ++ T  S   +F      
Sbjct: 48  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD---- 103

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           FYLV  +M  DL  ++      F+E     ++ Q+L GL Y H    +HRD+K  N+ +N
Sbjct: 104 FYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
              E+K+ DFGLAR  +AE      T  V+T WYR PE++L    Y   +D+WS GCI+ 
Sbjct: 161 EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215

Query: 350 ELFVKKPLF 358
           E+   K LF
Sbjct: 216 EMLTGKTLF 224

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 31/94 (32%), Positives = 43/94 (45%), Gaps = 4/94 (4%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIK--PKKIHRRRLREEFSLMPPGALDLLDKML 75
           QL  I K+ G P       +        I+  P+   R+   + F    P A DLL+KML
Sbjct: 232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQAADLLEKML 290

Query: 76  ELDPERRITAEQALKSVWLKNVH-PESMPPPQLP 108
           ELD ++R+TA QAL   + +    PE     Q P
Sbjct: 291 ELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP 324

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  188 bits (480), Expect = 4e-57
 Identities = 57/198 (28%), Positives = 86/198 (43%), Gaps = 21/198 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVRE---IKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T   VA+KKV  +      P    RE   ++ L  L+H NIV L+       +     + 
Sbjct: 47  TGMSVAIKKVIQD------PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER---DRR 97

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNA---SIMRQLLDGLSYCHKR--NFLHRDI 281
                +V EY+   L     +                + QL+  +   H    N  HRDI
Sbjct: 98  DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDI 157

Query: 282 KCSNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           K  N+L+N   G +KL DFG A+         P    + + +YR PEL+ G + Y  A+D
Sbjct: 158 KPHNVLVNEADGTLKLCDFGSAKKL---SPSEPNVAYICSRYYRAPELIFGNQHYTTAVD 214

Query: 341 VWSCGCILGELFVKKPLF 358
           +WS GCI  E+ + +P+F
Sbjct: 215 IWSVGCIFAEMMLGEPIF 232

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 10/94 (10%)

Query: 18  QLEVISKLCGTPTPAVWPAV------IKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLL 71
           QL  I ++ G P+  V   +      + L      K          +        A DLL
Sbjct: 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLY---NSKGIPWSNV-FSDHSLKDAKEAYDLL 295

Query: 72  DKMLELDPERRITAEQALKSVWLKNVHPESMPPP 105
             +L+  PE R+   +AL   +   +H  +   P
Sbjct: 296 SALLQYLPEERMKPYEALCHPYFDELHDPATKLP 329

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  188 bits (480), Expect = 5e-57
 Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 11/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T   VA+KK+    +         RE+++L+ + H+N++ L ++ T      +F      
Sbjct: 53  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN----D 108

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLV   M  DL  +++       + +   ++ Q+L GL Y H  + +HRD+K SN+ +N
Sbjct: 109 VYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 166

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
              E+K+ DFGLAR    E      T  V T WYR PE++L    Y   +D+WS GCI+ 
Sbjct: 167 EDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221

Query: 350 ELFVKKPLF 358
           EL   + LF
Sbjct: 222 ELLTGRTLF 230

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 4/92 (4%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIK--PKKIHRRRLREEFSLMPPGALDLLDKML 75
           QL++I +L GTP   +   +      + I+   +   +      F    P A+DLL+KML
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQM-PKMNFANVFIGANPLAVDLLEKML 296

Query: 76  ELDPERRITAEQALKSVWLKNVH-PESMPPPQ 106
            LD ++RITA QAL   +    H P+  P   
Sbjct: 297 VLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 328

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  188 bits (480), Expect = 8e-57
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 41/221 (18%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF------ 223
           + +  ALKKV  +      P    RE+ I++ L+H NI+ L +      D          
Sbjct: 31  SGKRFALKKVLQD------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84

Query: 224 ----------------------RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASI- 260
                                         ++ EY+   L  +L+S +     +    I 
Sbjct: 85  DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLIS 144

Query: 261 --MRQLLDGLSYCHKRNFLHRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNK 317
             + QL   + + H     HRDIK  N+L+N     +KL DFG A+         P    
Sbjct: 145 IYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL---IPSEPSVAY 201

Query: 318 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + + +YR PEL+LG   Y P+ID+WS GC+ GEL + KPLF
Sbjct: 202 ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 18/93 (19%), Positives = 37/93 (39%), Gaps = 3/93 (3%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEF-SLMPPGALDLLDKMLE 76
           QL  I ++ GTPT      +             +  +  R+      P  A+DLL+++L 
Sbjct: 250 QLVRIIQIMGTPTKEQMIRMNPHYTEVRFP--TLKAKDWRKILPEGTPSLAIDLLEQILR 307

Query: 77  LDPERRITAEQALKSVWLKNVHPESMPPPQLPT 109
            +P+ RI   +A+   +  ++        +  +
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNS 340

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  187 bits (477), Expect = 1e-56
 Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 24/201 (11%)

Query: 170 TDELVALKKVR-LENEKEGFPITA---VREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T E+VA+KK+   +      P+ A   +REIKIL+   H+NI+ +  I   + D+ +   
Sbjct: 35  TGEIVAIKKIEPFDK-----PLFALRTLREIKILKHFKHENIITIFNIQ--RPDSFENFN 87

Query: 226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           +    Y++ E M  DL  ++ +     ++ +    + Q L  +   H  N +HRD+K SN
Sbjct: 88  E---VYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN 142

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPY--------TNKVITLWYRPPELLLGEERYGP 337
           +L+N+  ++K+ DFGLAR+ +                   V T WYR PE++L   +Y  
Sbjct: 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSR 202

Query: 338 AIDVWSCGCILGELFVKKPLF 358
           A+DVWSCGCIL ELF+++P+F
Sbjct: 203 AMDVWSCGCILAELFLRRPIF 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 31/99 (31%), Positives = 44/99 (44%), Gaps = 9/99 (9%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTI---KPKKIHRRRLREEFSLMPPGALDLLDKM 74
           QL +I  + GTP        I+ P         P       L + F  + P  +DLL +M
Sbjct: 231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY-PAAPLEKMFPRVNPKGIDLLQRM 289

Query: 75  LELDPERRITAEQALKSVWLKNVH-----PESMPPPQLP 108
           L  DP +RITA++AL+  +L+  H     PE  P P   
Sbjct: 290 LVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSF 328

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  190 bits (484), Expect = 1e-56
 Identities = 63/189 (33%), Positives = 104/189 (55%), Gaps = 11/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            D  VA+KK+    + +     A RE+ +++ +NHKNI++L  + T +    +F+     
Sbjct: 86  LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ----D 141

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLV E MD +L  +++  +        + ++ Q+L G+ + H    +HRD+K SNI++ 
Sbjct: 142 VYLVMELMDANLCQVIQMELDH---ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           +   +K+ DFGLAR         PY   V+T +YR PE++LG   Y   +D+WS GCI+G
Sbjct: 199 SDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMG 254

Query: 350 ELFVKKPLF 358
           E+   K LF
Sbjct: 255 EMVRHKILF 263

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 24/105 (22%), Positives = 38/105 (36%), Gaps = 14/105 (13%)

Query: 18  QLEVISKLCGTPTPAVWPA--------VIKLPL-----WHTIKPKKIHRRRLREEFSLMP 64
           Q   + +  GTP P             V   P      +  + P  +      E   L  
Sbjct: 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL-FPADSEHNKLKA 329

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPT 109
             A DLL KML +DP +RI+ + AL+  ++   +  +      P 
Sbjct: 330 SQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQ 374

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  185 bits (471), Expect = 1e-55
 Identities = 60/189 (31%), Positives = 103/189 (54%), Gaps = 11/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            +  VA+KK+    + +     A RE+ +++ +NHKNI+ L  + T +    +F+     
Sbjct: 49  LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ----D 104

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y+V E MD +L  +++    + +    + ++ Q+L G+ + H    +HRD+K SNI++ 
Sbjct: 105 VYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           +   +K+ DFGLAR         PY   V+T +YR PE++LG   Y   +D+WS GCI+G
Sbjct: 162 SDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMG 217

Query: 350 ELFVKKPLF 358
           E+     LF
Sbjct: 218 EMIKGGVLF 226

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 25/108 (23%), Positives = 39/108 (36%), Gaps = 14/108 (12%)

Query: 18  QLEVISKLCGTPTPAVWPA--------VIKLPL-----WHTIKPKKIHRRRLREEFSLMP 64
           Q   + +  GTP P             V   P      +  + P  +      E   L  
Sbjct: 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA-DSEHNKLKA 292

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQD 112
             A DLL KML +D  +RI+ ++AL+  ++   +  S      P   D
Sbjct: 293 SQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD 340

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  184 bits (468), Expect = 1e-54
 Identities = 70/220 (31%), Positives = 103/220 (46%), Gaps = 37/220 (16%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T++ VA+KKV    E        +REI IL +L    I+ L +++      L    +   
Sbjct: 50  TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD--LLKFDE--- 104

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            Y+V E  D DL  L ++ +    E +  +I+  LL G ++ H+   +HRD+K +N L+N
Sbjct: 105 LYIVLEIADSDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163

Query: 290 NRGEVKLADFGLARLYNAEDRQRPY--------------------TNKVITLWYRPPELL 329
               VK+ DFGLAR  N+E                          T+ V+T WYR PEL+
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223

Query: 330 LGEERYGPAIDVWSCGCILGELFV-----------KKPLF 358
           L +E Y  +ID+WS GCI  EL             + PLF
Sbjct: 224 LLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 8/98 (8%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIK--PKKIHRRRLREEFSLMPPGALDLLDKML 75
           QL +I  + GTPT      + K  +   IK  P +     L++++  +    ++LL+ ML
Sbjct: 288 QLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR-KPINLKQKYPSISDDGINLLESML 346

Query: 76  ELDPERRITAEQALKSVWLKNVH-----PESMPPPQLP 108
           + +P +RIT +QAL   +LK+V        S     LP
Sbjct: 347 KFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILP 384

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  182 bits (463), Expect = 3e-54
 Identities = 77/209 (36%), Positives = 109/209 (52%), Gaps = 30/209 (14%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKG 228
           T E+VA+KK+    +         REI IL +L+ H+NIVNL  ++   +D     +D  
Sbjct: 33  TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND-----RD-- 85

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             YLVF+YM+ DL  ++ +       V+   ++ QL+  + Y H    LHRD+K SNIL+
Sbjct: 86  -VYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPY-------------------TNKVITLWYRPPELL 329
           N    VK+ADFGL+R +    R                       T+ V T WYR PE+L
Sbjct: 143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202

Query: 330 LGEERYGPAIDVWSCGCILGELFVKKPLF 358
           LG  +Y   ID+WS GCILGE+   KP+F
Sbjct: 203 LGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 24/113 (21%), Positives = 41/113 (36%), Gaps = 22/113 (19%)

Query: 18  QLEVISKLCGTPTPAV---------------WPAVIKLPLWHTIKPKKIHRRRLREEF-- 60
           QLE I  +   P+                      +++   +        +  L +    
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 61  SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH-----PESMPPPQLP 108
           +     ALDLLDK+L+ +P +RI+A  ALK  ++   H     P       +P
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIP 351

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  165 bits (421), Expect = 4e-49
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 19/198 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD---FRKD 226
                A+KK+R   EK     T + E+ +L  LNH+ +V       ++ + +      K 
Sbjct: 30  DSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86

Query: 227 KGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           K + ++  EY +   L  L+ S  ++        + RQ+L+ LSY H +  +HRD+K  N
Sbjct: 87  KSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMN 146

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI------------TLWYRPPELLLGEE 333
           I ++    VK+ DFGLA+  +         ++ +            T  Y   E+L G  
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206

Query: 334 RYGPAIDVWSCGCILGEL 351
            Y   ID++S G I  E+
Sbjct: 207 HYNEKIDMYSLGIIFFEM 224

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 9/38 (23%), Positives = 17/38 (44%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESM 102
                ++  +++ DP +R  A   L S WL   H + +
Sbjct: 258 KVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV 295

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  163 bits (414), Expect = 4e-48
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 19/198 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLRE------IVTDKSDALDF 223
             +   +K+V+  NEK      A RE+K L +L+H NIV+            + S     
Sbjct: 35  DGKTYVIKRVKYNNEK------AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88

Query: 224 RKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
           R      ++  E+ D   L   +E       ++V    +  Q+  G+ Y H +  ++RD+
Sbjct: 89  RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDL 148

Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           K SNI + +  +VK+ DFGL      + +    T    TL Y  PE +  ++ YG  +D+
Sbjct: 149 KPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQD-YGKEVDL 204

Query: 342 WSCGCILGELF-VKKPLF 358
           ++ G IL EL  V    F
Sbjct: 205 YALGLILAELLHVCDTAF 222

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 11/52 (21%), Positives = 20/52 (38%), Gaps = 3/52 (5%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPE 100
             +    + + F         LL K+L   PE R    + L+++ +    PE
Sbjct: 229 TDLRDGIISDIFD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  159 bits (405), Expect = 1e-46
 Identities = 50/201 (24%), Positives = 81/201 (40%), Gaps = 24/201 (11%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN--IVNLREIVTDKSDALDFRKDK 227
             ++ A+K V LE        +   EI  L +L   +  I+ L           D+    
Sbjct: 51  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL----------YDYEITD 100

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              Y+V E  + DL   L+      +     S  + +L+ +   H+   +H D+K +N L
Sbjct: 101 QYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 159

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----------ERYGP 337
           + + G +KL DFG+A     +       ++V T+ Y PPE +              +  P
Sbjct: 160 IVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218

Query: 338 AIDVWSCGCILGELFVKKPLF 358
             DVWS GCIL  +   K  F
Sbjct: 219 KSDVWSLGCILYYMTYGKTPF 239

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 46.5 bits (111), Expect = 5e-06
 Identities = 10/47 (21%), Positives = 23/47 (48%), Gaps = 3/47 (6%)

Query: 61  SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQL 107
            +      D+L   L+ DP++RI+  + L   +++    ++ P  Q+
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ---IQTHPVNQM 306

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  154 bits (391), Expect = 7e-45
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 22/199 (11%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             +++  K++   +  E      V E+ +LR+L H NIV   + + D+++         +
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN--------TT 81

Query: 230 FYLVFEYMDH-DLMGLLESGMVD---FNEVNNASIMRQLLDGLSYCHKRNF-----LHRD 280
            Y+V EY +  DL  ++  G  +    +E     +M QL   L  CH+R+      LHRD
Sbjct: 82  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAI 339
           +K +N+ ++ +  VKL DFGLAR+ N +     +    + T +Y  PE +     Y    
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKTFVGTPYYMSPEQMNR-MSYNEKS 197

Query: 340 DVWSCGCILGELFVKKPLF 358
           D+WS GC+L EL    P F
Sbjct: 198 DIWSLGCLLYELCALMPPF 216

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  157 bits (398), Expect = 8e-45
 Identities = 64/284 (22%), Positives = 103/284 (36%), Gaps = 41/284 (14%)

Query: 98  HPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRP------LM 151
           H        +P      E  + K  RQ    P          S+S N           ++
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61

Query: 152 EPLAAGGLS-----LNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN 206
           + + +GG S     LN         ++ A+K V LE        +   EI  L +L   +
Sbjct: 62  KQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 207 --IVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQL 264
             I+ L           D+       Y+V E  + DL   L+      +     S  + +
Sbjct: 116 DKIIRL----------YDYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNM 164

Query: 265 LDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
           L+ +   H+   +H D+K +N L+ + G +KL DFG+A     +       ++V  + Y 
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 325 PPELLLGE----------ERYGPAIDVWSCGCILGELFVKKPLF 358
           PPE +              +  P  DVWS GCIL  +   K  F
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 14/88 (15%), Positives = 34/88 (38%), Gaps = 3/88 (3%)

Query: 61  SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKK 120
            +      D+L   L+ DP++RI+  + L   +++    ++ P  Q+         +   
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ---IQTHPVNQMAKGTTEEMKYVLG 347

Query: 121 RRRQLRGDPMEMQAAAPIQSNSTNNSSR 148
           +   L      ++AA  +  + +   S 
Sbjct: 348 QLVGLNSPNSILKAAKTLYEHYSGGESH 375

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  155 bits (394), Expect = 1e-44
 Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 24/201 (11%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN--IVNLREIVTDKSDALDFRKDK 227
             ++ A+K V LE        +   EI  L +L   +  I+ L           D+    
Sbjct: 32  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL----------YDYEITD 81

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              Y+V E  + DL   L+      +     S  + +L+ +   H+   +H D+K +N L
Sbjct: 82  QYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 140

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG----------EERYGP 337
           + + G +KL DFG+A     +       ++V T+ Y PPE +            + +  P
Sbjct: 141 IVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 199

Query: 338 AIDVWSCGCILGELFVKKPLF 358
             DVWS GCIL  +   K  F
Sbjct: 200 KSDVWSLGCILYYMTYGKTPF 220

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 14/88 (15%), Positives = 34/88 (38%), Gaps = 3/88 (3%)

Query: 61  SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKK 120
            +      D+L   L+ DP++RI+  + L   +++    ++ P  Q+         +   
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ---IQTHPVNQMAKGTTEEMKYVLG 300

Query: 121 RRRQLRGDPMEMQAAAPIQSNSTNNSSR 148
           +   L      ++AA  +  + +   S 
Sbjct: 301 QLVGLNSPNSILKAAKTLYEHYSGGESH 328

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  154 bits (391), Expect = 4e-44
 Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 17/192 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
                 +K++ +          + RE+ +L  + H NIV  RE            ++ GS
Sbjct: 48  DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF----------EENGS 97

Query: 230 FYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
            Y+V +Y +  DL   + +   V F E        Q+   L + H R  LHRDIK  NI 
Sbjct: 98  LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 157

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGC 346
           +   G V+L DFG+AR+ N+           I T +Y  PE+    + Y    D+W+ GC
Sbjct: 158 LTKDGTVQLGDFGIARVLNSTV---ELARACIGTPYYLSPEICEN-KPYNNKSDIWALGC 213

Query: 347 ILGELFVKKPLF 358
           +L EL   K  F
Sbjct: 214 VLYELCTLKHAF 225

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 18/95 (18%), Positives = 41/95 (43%), Gaps = 6/95 (6%)

Query: 69  DLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGD 128
            L+ ++ + +P  R +    L+  ++     E    PQL   + C + +SK   +     
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAK-RIEKFLSPQLIAEEFCLKTFSKFGSQ----- 308

Query: 129 PMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNN 163
           P+  +  A  Q++ +   ++ + +P A  G+ L  
Sbjct: 309 PIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAY 343

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  149 bits (379), Expect = 1e-42
 Identities = 46/195 (23%), Positives = 68/195 (34%), Gaps = 26/195 (13%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKG 228
              L A+K+              + E+    ++  H   V L +            ++ G
Sbjct: 81  DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW----------EEGG 130

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             YL  E     L    E+      E      +R  L  L++ H +  +H D+K +NI +
Sbjct: 131 ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190

Query: 289 NNRGEVKLADFGLARLYNAEDRQR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
             RG  KL DFGL                P         Y  PELL  +  YG A DV+S
Sbjct: 191 GPRGRCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPELL--QGSYGTAADVFS 240

Query: 344 CGCILGELFVKKPLF 358
            G  + E+     L 
Sbjct: 241 LGLTILEVACNMELP 255

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 2/58 (3%)

Query: 40  LPLWHTIKP-KKIHRRRLREEF-SLMPPGALDLLDKMLELDPERRITAEQALKSVWLK 95
           + L H  +  +++ +  L  EF + +      +L  MLE DP+ R TAE  L    L+
Sbjct: 252 MELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  149 bits (377), Expect = 2e-42
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 23/202 (11%)

Query: 170 TDELVALKKVRL---ENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD--FR 224
            D   A+K++RL   E  +E      +RE+K L +L H  IV       +K+        
Sbjct: 29  DDCNYAIKRIRLPNRELARE----KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84

Query: 225 KDKGSFYLVFEYMDH-DLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
             K   Y+  +     +L   +     + +        I  Q+ + + + H +  +HRD+
Sbjct: 85  SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDL 144

Query: 282 KCSNILMNNRGEVKLADFGLARLYNAED----------RQRPYTNKVITLWYRPPELLLG 331
           K SNI       VK+ DFGL    + ++              +T +V T  Y  PE + G
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204

Query: 332 EERYGPAIDVWSCGCILGELFV 353
              Y   +D++S G IL EL  
Sbjct: 205 -NSYSHKVDIFSLGLILFELLY 225

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 7/56 (12%), Positives = 18/56 (32%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPP 104
             +   +    F+   P    ++  ML   P  R  A   +++   +++       
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  152 bits (385), Expect = 2e-42
 Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 24/192 (12%)

Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDK 227
           F +  VA+K++  E         A RE+++LR+ + H N++                KD+
Sbjct: 46  FDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRY----------FCTEKDR 90

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              Y+  E     L   +E        +   ++++Q   GL++ H  N +HRD+K  NIL
Sbjct: 91  QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNIL 150

Query: 288 MNNRGE-----VKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGE--ERYGPAI 339
           ++           ++DFGL +            + V  T  +  PE+L  +  E     +
Sbjct: 151 ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV 210

Query: 340 DVWSCGCILGEL 351
           D++S GC+   +
Sbjct: 211 DIFSAGCVFYYV 222

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 10/34 (29%), Positives = 22/34 (64%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKNVH 98
             A +L++KM+ +DP++R +A+  LK  +  ++ 
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  147 bits (374), Expect = 5e-42
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)

Query: 170 TDELVALKKVRLEN-----EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
               VALKKV++ +      +       ++EI +L+QLNH N++                
Sbjct: 56  DGVPVALKKVQIFDLMDAKARA----DCIKEIDLLKQLNHPNVIKYYASF---------- 101

Query: 225 KDKGSFYLVFEYMDH-DLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
            +     +V E  D  DL  +++          E        QL   L + H R  +HRD
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRD 161

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           IK +N+ +   G VKL D GL R ++++     ++  V T +Y  PE +     Y    D
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHS-LVGTPYYMSPERIHENG-YNFKSD 218

Query: 341 VWSCGCILGELFVKKPLF 358
           +WS GC+L E+   +  F
Sbjct: 219 IWSLGCLLYEMAALQSPF 236

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  146 bits (371), Expect = 6e-42
 Identities = 56/195 (28%), Positives = 84/195 (43%), Gaps = 23/195 (11%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T   VA+K   K  +   K G       E+KI  QL H +I+ L     D +        
Sbjct: 35  TGLEVAIKMIDKKAMY--KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY------- 85

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
               YLV E   + ++   L++ +  F+E      M Q++ G+ Y H    LHRD+  SN
Sbjct: 86  ---VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSN 142

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWS 343
           +L+     +K+ADFGLA        +       +  T  Y  PE+      +G   DVWS
Sbjct: 143 LLLTRNMNIKIADFGLATQLKMPHEKH----YTLCGTPNYISPEIATRSA-HGLESDVWS 197

Query: 344 CGCILGELFVKKPLF 358
            GC+   L + +P F
Sbjct: 198 LGCMFYTLLIGRPPF 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 42.5 bits (101), Expect = 8e-05
 Identities = 10/57 (17%), Positives = 26/57 (45%), Gaps = 4/57 (7%)

Query: 49  KKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKSVWL-KNVHPES 101
           K    + +  ++ +   +   A DL+ ++L  +P  R++    L   ++ +N   +S
Sbjct: 218 KNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKS 274

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  146 bits (370), Expect = 2e-41
 Identities = 43/202 (21%), Positives = 75/202 (37%), Gaps = 21/202 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
                ALK++    +++     A RE  + R  NH NI+ L      +         K  
Sbjct: 53  DGHFYALKRILCHEQQD--REEAQREADMHRLFNHPNILRLVAYCLRERG------AKHE 104

Query: 230 FYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
            +L+  +       + +  L+       E     ++  +  GL   H + + HRD+K +N
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN 164

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQR-------PYTNKVITLWYRPPELLLGEER--YG 336
           IL+ + G+  L D G                    +  +  T+ YR PEL   +      
Sbjct: 165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224

Query: 337 PAIDVWSCGCILGELFVKKPLF 358
              DVWS GC+L  +   +  +
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGPY 246

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  140 bits (356), Expect = 1e-39
 Identities = 57/196 (29%), Positives = 86/196 (43%), Gaps = 26/196 (13%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E+ A K   K  L    +   ++   EI I R L H+++V       D          
Sbjct: 39  TKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDNDF------- 89

Query: 227 KGSFYLVFEYMDH-DLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
               ++V E      L+ L      +   E      +RQ++ G  Y H+   +HRD+K  
Sbjct: 90  ---VFVVLELCRRRSLLELHKRRKALTEPEA--RYYLRQIVLGCQYLHRNRVIHRDLKLG 144

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVW 342
           N+ +N   EVK+ DFGLA     +  ++    KV+  T  Y  PE+L  +  +   +DVW
Sbjct: 145 NLFLNEDLEVKIGDFGLATKVEYDGERK----KVLCGTPNYIAPEVLSKKG-HSFEVDVW 199

Query: 343 SCGCILGELFVKKPLF 358
           S GCI+  L V KP F
Sbjct: 200 SIGCIMYTLLVGKPPF 215

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 4/65 (6%)

Query: 49  KKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKSVWL-KNVHPESMPP 104
           K+ + R  + E+S+   + P A  L+ KML+ DP  R T  + L   +      P  +P 
Sbjct: 221 KETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPI 280

Query: 105 PQLPT 109
             L  
Sbjct: 281 TCLTI 285

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  140 bits (354), Expect = 4e-39
 Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 32/206 (15%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T +L A+K    +      +      +RE ++L++LNHKNIV L  I  + +        
Sbjct: 33  TGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKLNHKNIVKLFAIEEETT-------- 80

Query: 227 KGSFYLVFEYMDH-DLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
                L+ E+     L  +LE         E     ++R ++ G+++  +   +HR+IK 
Sbjct: 81  TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140

Query: 284 SNILM----NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG-------E 332
            NI+     + +   KL DFG AR    ++    + +   T  Y  P++          +
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQ 197

Query: 333 ERYGPAIDVWSCGCILGELFVKKPLF 358
           ++YG  +D+WS G            F
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPF 223

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 8/34 (23%), Positives = 12/34 (35%), Gaps = 4/34 (11%)

Query: 69  DLLDKMLELDPERRITAEQALKSVW----LKNVH 98
            +L  +LE D E+    +Q            N H
Sbjct: 281 PVLANILEADQEKCWGFDQFFAETSDILHRGNSH 314

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  140 bits (354), Expect = 8e-39
 Identities = 57/196 (29%), Positives = 84/196 (42%), Gaps = 26/196 (13%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E+ A K   K  L    +   ++   EI I R L H+++V       D          
Sbjct: 65  TKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDNDF------- 115

Query: 227 KGSFYLVFEYMDH-DLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
               ++V E      L+ L      +   E      +RQ++ G  Y H+   +HRD+K  
Sbjct: 116 ---VFVVLELCRRRSLLELHKRRKALTEPEA--RYYLRQIVLGCQYLHRNRVIHRDLKLG 170

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVW 342
           N+ +N   EVK+ DFGLA      D +R      +  T  Y  PE+L  +  +   +DVW
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEY-DGERKKV---LCGTPNYIAPEVLSKKG-HSFEVDVW 225

Query: 343 SCGCILGELFVKKPLF 358
           S GCI+  L V KP F
Sbjct: 226 SIGCIMYTLLVGKPPF 241

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 21/84 (25%), Positives = 34/84 (40%), Gaps = 7/84 (8%)

Query: 49  KKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKSVWL-KNVHPESMPP 104
           K+ + R  + E+S+   + P A  L+ KML+ DP  R T  + L   +      P  +P 
Sbjct: 247 KETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPI 306

Query: 105 PQL---PTWQDCHELWSKKRRRQL 125
             L   P +           R+ L
Sbjct: 307 TCLTIPPRFSIAPSSLDPSNRKPL 330

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  139 bits (352), Expect = 3e-38
 Identities = 30/213 (14%), Positives = 60/213 (28%), Gaps = 29/213 (13%)

Query: 170 TDELVALKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREI--VTDKSDALDFRKD 226
             E  ALK   +  E     +  +        +L  ++    R+   +   SDA+  +  
Sbjct: 86  RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145

Query: 227 K--------------GSFYLVFEYMDHDLMGLLE------SGMVDFNEVNNASIMRQLLD 266
                           ++ L+      DL  L            D   +    +  QL+ 
Sbjct: 146 PPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIR 205

Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPP 326
             +    +  +H      N+ +   G + L D                    + + Y P 
Sbjct: 206 LAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPR 260

Query: 327 ELLLGEER-YGPAIDVWSCGCILGELFVKKPLF 358
           E L      +  A++ W  G  +  ++     F
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 14/88 (15%), Positives = 27/88 (30%), Gaps = 4/88 (4%)

Query: 25  LCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLR-EEFSLMPPGALDLLDKMLELDPERRI 83
            C    P           W     +      L     + +P     L+ + L  D  RR+
Sbjct: 287 WCLFL-PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345

Query: 84  TAEQALKSVWLKNVHPESMPPPQLPTWQ 111
              +A+++     +  ++     L T Q
Sbjct: 346 LPLEAMETPEFLQL--QNEISSSLSTGQ 371

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  136 bits (345), Expect = 4e-38
 Identities = 46/189 (24%), Positives = 87/189 (46%), Gaps = 29/189 (15%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           +     +K   K R +   E        EI++L+ L+H NI+ + E+           +D
Sbjct: 46  SGLERVIKTINKDRSQVPMEQI----EAEIEVLKSLDHPNIIKIFEVF----------ED 91

Query: 227 KGSFYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
             + Y+V E  +     + +   ++     +E   A +M+Q+++ L+Y H ++ +H+D+K
Sbjct: 92  YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK 151

Query: 283 CSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAI 339
             NIL  +      +K+ DFGLA L+ +++     TN   T  Y  PE+           
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKR--DVTFKC 206

Query: 340 DVWSCGCIL 348
           D+WS G ++
Sbjct: 207 DIWSAGVVM 215

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 48.8 bits (117), Expect = 9e-07
 Identities = 17/32 (53%), Positives = 20/32 (62%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKN 96
           P A+DLL +ML  DPERR +A Q L   W K 
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  138 bits (350), Expect = 9e-38
 Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 32/206 (15%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T +L A+K    +      +      +RE ++L++LNHKNIV L  I  + +        
Sbjct: 33  TGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKLNHKNIVKLFAIEEETT-------- 80

Query: 227 KGSFYLVFEYMDH-DLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
                L+ E+     L  +LE         E     ++R ++ G+++  +   +HR+IK 
Sbjct: 81  TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140

Query: 284 SNILM----NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG-------E 332
            NI+     + +   KL DFG AR     +    + +   T  Y  P++          +
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197

Query: 333 ERYGPAIDVWSCGCILGELFVKKPLF 358
           ++YG  +D+WS G            F
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPF 223

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  139 bits (351), Expect = 9e-38
 Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 29/192 (15%)

Query: 170 TDELVALK-----KVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDF 223
           T + VA++     K  + + +E  P   V  EI+IL++LNH  I+ ++     +      
Sbjct: 159 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----- 213

Query: 224 RKDKGSFYLVFEYMDH-DLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
                 +Y+V E M+  +L   ++ +      E        Q+L  + Y H+   +HRD+
Sbjct: 214 ------YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDL 265

Query: 282 KCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER--YG 336
           K  N+L++++ E   +K+ DFG +++               T  Y  PE+L+      Y 
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPEVLVSVGTAGYN 322

Query: 337 PAIDVWSCGCIL 348
            A+D WS G IL
Sbjct: 323 RAVDCWSLGVIL 334

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 20/83 (24%), Positives = 35/83 (42%), Gaps = 18/83 (21%)

Query: 25  LCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPP-------GALDLLDKMLEL 77
           L G P           P         +  +    +++ +P         ALDL+ K+L +
Sbjct: 338 LSGYP-----------PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 386

Query: 78  DPERRITAEQALKSVWLKNVHPE 100
           DP+ R T E+AL+  WL++   +
Sbjct: 387 DPKARFTTEEALRHPWLQDEDMK 409

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  137 bits (347), Expect = 1e-37
 Identities = 58/193 (30%), Positives = 82/193 (42%), Gaps = 31/193 (16%)

Query: 170 TDELVALK--KVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T +  A+K   V       G     + RE  I   L H +IV L E              
Sbjct: 48  TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY----------SS 97

Query: 227 KGSFYLVFEYMDHDLMG--LLE------SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLH 278
            G  Y+VFE+MD    G  L             ++E   +  MRQ+L+ L YCH  N +H
Sbjct: 98  DGMLYMVFEFMD----GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 153

Query: 279 RDIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           RD+K   +L+ ++     VKL  FG+A      +       +V T  +  PE++  E  Y
Sbjct: 154 RDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPEVVKREP-Y 210

Query: 336 GPAIDVWSCGCIL 348
           G  +DVW CG IL
Sbjct: 211 GKPVDVWGCGVIL 223

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 21/79 (26%), Positives = 33/79 (41%), Gaps = 20/79 (25%)

Query: 25  LCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPP-------GALDLLDKMLEL 77
           L G             P + T   +++    ++ ++ + P         A DL+ +ML L
Sbjct: 227 LSGCL-----------PFYGT--KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLML 273

Query: 78  DPERRITAEQALKSVWLKN 96
           DP  RIT  +AL   WLK 
Sbjct: 274 DPAERITVYEALNHPWLKE 292

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  136 bits (344), Expect = 2e-37
 Identities = 50/196 (25%), Positives = 86/196 (43%), Gaps = 37/196 (18%)

Query: 170 TDELVALK-----KVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDF 223
           T + VA+K     K  + + +E  P   V  EI+IL++LNH  I+ ++     +      
Sbjct: 34  TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----- 88

Query: 224 RKDKGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFL 277
                 +Y+V E M+    G      ++ +      E        Q+L  + Y H+   +
Sbjct: 89  ------YYIVLELME----GGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGII 136

Query: 278 HRDIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER 334
           HRD+K  N+L++++ E   +K+ DFG +++               T  Y  PE+L+    
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTYLAPEVLVSVGT 193

Query: 335 --YGPAIDVWSCGCIL 348
             Y  A+D WS G IL
Sbjct: 194 AGYNRAVDCWSLGVIL 209

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 18/90 (20%)

Query: 25  LCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPP-------GALDLLDKMLEL 77
           L G P           P         +  +    +++ +P         ALDL+ K+L +
Sbjct: 213 LSGYP-----------PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 261

Query: 78  DPERRITAEQALKSVWLKNVHPESMPPPQL 107
           DP+ R T E+AL+  WL++   +      L
Sbjct: 262 DPKARFTTEEALRHPWLQDEDMKRKFQDLL 291

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  134 bits (339), Expect = 3e-37
 Identities = 59/191 (30%), Positives = 84/191 (43%), Gaps = 38/191 (19%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T    A K   K  +E+          +EI+I++ L+H NI+ L E   D +D       
Sbjct: 33  TRIRRAAKKIPKYFVEDVDRFK-----QEIEIMKSLDHPNIIRLYETFEDNTD------- 80

Query: 227 KGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
               YLV E       G      ++   +  F E + A IM+ +L  ++YCHK N  HRD
Sbjct: 81  ---IYLVMELCT----GGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRD 131

Query: 281 IKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGP 337
           +K  N L         +KL DFGLA  +           KV T +Y  P++L G   YGP
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEG--LYGP 186

Query: 338 AIDVWSCGCIL 348
             D WS G ++
Sbjct: 187 ECDEWSAGVMM 197

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 13/40 (32%), Positives = 21/40 (52%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPP 104
           P A  L+ ++L   P++RIT+ QAL+  W +     S   
Sbjct: 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  136 bits (344), Expect = 3e-37
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 39/214 (18%)

Query: 170 TDELVALK---KVRLENEKEGFPITAV------------REIKILRQLNHKNIVNLREIV 214
            ++  ALK   K  LE +++                    E++I+  + ++  +    I+
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112

Query: 215 TDKSDALDFRKDKGSFYLVFEYMD--------HDLMGLLESGMVDFNEVNNASIMRQLLD 266
           T+  +           Y+++EYM+             L ++            I++ +L+
Sbjct: 113 TNYDE----------VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLN 162

Query: 267 GLSYCH-KRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
             SY H ++N  HRD+K SNILM+  G VKL+DFG +      D++        T  + P
Sbjct: 163 SFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKI--KGSRGTYEFMP 218

Query: 326 PELLLGEERY-GPAIDVWSCGCILGELFVKKPLF 358
           PE    E  Y G  +D+WS G  L  +F     F
Sbjct: 219 PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 20/87 (22%), Positives = 36/87 (41%), Gaps = 7/87 (8%)

Query: 36  AVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLK 95
             I+ PL        +  ++     + +    +D L   L  +P  RIT+E ALK  WL 
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327

Query: 96  NVHPESMPPPQLPTWQDCHELWSKKRR 122
           + + E +            EL+ K+++
Sbjct: 328 DTNIEDLREFS-------KELYKKRKK 347

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  134 bits (340), Expect = 3e-37
 Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 34/193 (17%)

Query: 170 TDELVALK---KVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T +  A K   K RL + + G     + RE+ ILR++ H NI+ L +I  +K+D      
Sbjct: 29  TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD------ 82

Query: 226 DKGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
                 L+ E +     G      L E       E      ++Q+LDG+ Y H +   H 
Sbjct: 83  ----VVLILELVS----GGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHF 132

Query: 280 DIKCSNILMNNRGE----VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           D+K  NI++ ++      +KL DFG+A    A +    + N   T  +  PE++   E  
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNY-EPL 188

Query: 336 GPAIDVWSCGCIL 348
           G   D+WS G I 
Sbjct: 189 GLEADMWSIGVIT 201

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 49.5 bits (119), Expect = 5e-07
 Identities = 15/48 (31%), Positives = 26/48 (54%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPP 104
            E FS     A D + ++L  DP+RR+T  Q+L+  W+K +   ++  
Sbjct: 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  137 bits (347), Expect = 4e-37
 Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 43/208 (20%)

Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDK 227
           F    VA+K++ ++         A+ EIK+L +  +H N++                   
Sbjct: 37  FQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHPNVIRY----------YCSETTD 81

Query: 228 GSFYLVFEYMDHDLM------GLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
              Y+  E  + +L        + +  +    E N  S++RQ+  G+++ H    +HRD+
Sbjct: 82  RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDL 141

Query: 282 KCSNIL-------------MNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPP 326
           K  NIL                   + ++DFGL +  ++              T  +R P
Sbjct: 142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP 201

Query: 327 ELLLGE------ERYGPAIDVWSCGCIL 348
           ELL          R   +ID++S GC+ 
Sbjct: 202 ELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 10/32 (31%), Positives = 17/32 (53%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKN 96
             A DL+ +M++ DP +R TA + L+      
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  138 bits (349), Expect = 5e-37
 Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 30/198 (15%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T    A+K +R  +         + E+ +L+ L+H NI+ L +            +DK +
Sbjct: 61  THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF----------EDKRN 110

Query: 230 FYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +YLV E       G      ++      FNEV+ A I++Q+L G++Y HK N +HRD+K 
Sbjct: 111 YYLVMECYK----GGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKP 164

Query: 284 SNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
            N+L+ ++ +   +K+ DFGL+ ++   + Q+    ++ T +Y  PE+L    +Y    D
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPEVLRK--KYDEKCD 219

Query: 341 VWSCGCILGELFVKKPLF 358
           VWS G IL  L    P F
Sbjct: 220 VWSIGVILFILLAGYPPF 237

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 43/194 (22%), Positives = 79/194 (40%), Gaps = 23/194 (11%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHEL 116
             E+  +  GA DL+ +ML+ D +RRI+A+QAL+  W+K +  +     +LP+  +  E 
Sbjct: 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIEN 317

Query: 117 WSK-KRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSL---NNFSVSLFTDE 172
             K +  ++L       QAA  +   ++  +S+   + L      +    +  +     E
Sbjct: 318 MRKFQNSQKLA------QAA--LLYMASKLTSQEETKELTDIFRHIDKNGDGQLDR--QE 367

Query: 173 LV-ALKKVRLENEKEGFPITAVREI-KILRQL--NHKNIVNLREIVTDKSDALDFRK--D 226
           L+    K+  E            E+  IL     +    ++  E VT    A+D +    
Sbjct: 368 LIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVT---VAMDRKSLLS 424

Query: 227 KGSFYLVFEYMDHD 240
           K      F+  D D
Sbjct: 425 KDKLESAFQKFDQD 438

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  138 bits (349), Expect = 5e-37
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 31/199 (15%)

Query: 170 TDELVALKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T +  A+K +     K+     ++ RE+++L+QL+H NI+ L E            +DKG
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF----------EDKG 99

Query: 229 SFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
            FYLV E       G      ++      F+EV+ A I+RQ+L G++Y HK   +HRD+K
Sbjct: 100 YFYLVGEVYT----GGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153

Query: 283 CSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAI 339
             N+L+ ++ +   +++ DFGL+  + A        +K+ T +Y  PE+L G   Y    
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG--TYDEKC 208

Query: 340 DVWSCGCILGELFVKKPLF 358
           DVWS G IL  L    P F
Sbjct: 209 DVWSTGVILYILLSGCPPF 227

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 36/194 (18%), Positives = 68/194 (35%), Gaps = 21/194 (10%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHEL 116
             ++  +   A DL+ KML   P  RI+A  AL   W++    E +             +
Sbjct: 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNI 307

Query: 117 WSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLN-NFSVSLFTDELV- 174
              +  ++L       QAA  +    +  +S+   + L A    ++ N    L   EL+ 
Sbjct: 308 RQFQGTQKLA------QAA--LLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIE 359

Query: 175 ALKKVRLENEKEGFPITAVREIKILRQL------NHKNIVNLREIVTDKSDALDFRK--D 226
             K++     ++   + A      + Q+      +    +   E VT    A+D +    
Sbjct: 360 GYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVT---VAMDRKTLLS 416

Query: 227 KGSFYLVFEYMDHD 240
           +      F   D D
Sbjct: 417 RERLERAFRMFDSD 430

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  133 bits (337), Expect = 7e-37
 Identities = 36/219 (16%), Positives = 67/219 (30%), Gaps = 44/219 (20%)

Query: 166 VSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFR 224
           V      + A+K+ +           A+RE+     L  H ++V                
Sbjct: 31  VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW---------- 80

Query: 225 KDKGSFYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
            +     +  EY +     D +      M  F E     ++ Q+  GL Y H  + +H D
Sbjct: 81  AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMD 140

Query: 281 IKCSNILMNNRGE-------------------VKLADFGLARLYNAEDRQR--PYTNKVI 319
           IK SNI ++                        K+ D G     ++   +          
Sbjct: 141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR----- 195

Query: 320 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
              +   E+L     + P  D+++    +      +PL 
Sbjct: 196 ---FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  133 bits (338), Expect = 7e-37
 Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 15/158 (9%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDF 252
           +EI IL++L+H N+V L E++ D +        +   Y+VFE ++   +M +        
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPN--------EDHLYMVFELVNQGPVMEVPTLK--PL 134

Query: 253 NEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
           +E       + L+ G+ Y H +  +HRDIK SN+L+   G +K+ADFG++  +   D   
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194

Query: 313 PYTNKVITLWYRPPELLLGEER-Y-GPAIDVWSCGCIL 348
             +N V T  +  PE L    + + G A+DVW+ G  L
Sbjct: 195 --SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 12/48 (25%), Positives = 21/48 (43%), Gaps = 1/48 (2%)

Query: 49  KKIHRRRLR-EEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLK 95
            KI  + L   +   +     DL+ +ML+ +PE RI   +     W+ 
Sbjct: 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (336), Expect = 1e-36
 Identities = 60/193 (31%), Positives = 89/193 (46%), Gaps = 21/193 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
               +A+K++   + +   P+    EI + + L HKNIV            L    + G 
Sbjct: 46  NQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQY----------LGSFSENGF 93

Query: 230 FYLVFEYMDHD-LMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             +  E +    L  LL S  G +  NE       +Q+L+GL Y H    +HRDIK  N+
Sbjct: 94  IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNV 153

Query: 287 LMNNR-GEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELLLGEER-YGPAIDVWS 343
           L+N   G +K++DFG + RL         +T    TL Y  PE++    R YG A D+WS
Sbjct: 154 LINTYSGVLKISDFGTSKRLAGINPCTETFTG---TLQYMAPEIIDKGPRGYGKAADIWS 210

Query: 344 CGCILGELFVKKP 356
            GC + E+   KP
Sbjct: 211 LGCTIIEMATGKP 223

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  137 bits (346), Expect = 1e-36
 Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 30/198 (15%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T +  A+K +   + K     T +RE+++L++L+H NI+ L EI           +D  S
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI---------L-EDSSS 95

Query: 230 FYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           FY+V E       G      +++     F+E + A I++Q+  G++Y HK N +HRD+K 
Sbjct: 96  FYIVGELYT----GGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149

Query: 284 SNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
            NIL+ ++ +   +K+ DFGL+  +    +     +++ T +Y  PE+L G   Y    D
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG--TYDEKCD 204

Query: 341 VWSCGCILGELFVKKPLF 358
           VWS G IL  L    P F
Sbjct: 205 VWSAGVILYILLSGTPPF 222

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 17/52 (32%), Positives = 25/52 (48%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
             ++  +   A DL+ KML   P  RITA Q L+  W++    E+     LP
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLP 294

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  132 bits (335), Expect = 1e-36
 Identities = 58/192 (30%), Positives = 99/192 (51%), Gaps = 38/192 (19%)

Query: 170 TDELVALK---KVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T +  A+K   K   +N +        +RE+++L++L+H NI+ L EI+          +
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTI----LREVELLKKLDHPNIMKLFEIL----------E 91

Query: 226 DKGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           D  SFY+V E       G      +++     F+E + A I++Q+  G++Y HK N +HR
Sbjct: 92  DSSSFYIVGELYT----GGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHR 145

Query: 280 DIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           D+K  NIL+ ++ +   +K+ DFGL+  +    +     +++ T +Y  PE+L G   Y 
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG--TYD 200

Query: 337 PAIDVWSCGCIL 348
              DVWS G IL
Sbjct: 201 EKCDVWSAGVIL 212

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 49.5 bits (119), Expect = 6e-07
 Identities = 14/32 (43%), Positives = 18/32 (56%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKN 96
             A DL+ KML   P  RITA Q L+  W++ 
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  132 bits (334), Expect = 3e-36
 Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 38/191 (19%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T +L ALK   K     +          EI +L+++ H+NIV L +I    +        
Sbjct: 33  TGKLFALKCIKKSPAFRDSS-----LENEIAVLKKIKHENIVTLEDIYESTT-------- 79

Query: 227 KGSFYLVFEYM------DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
              +YLV + +      D     +LE G+  + E + + +++Q+L  + Y H+   +HRD
Sbjct: 80  --HYYLVMQLVSGGELFDR----ILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRD 131

Query: 281 IKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGP 337
           +K  N+L     E   + + DFGL+++          +    T  Y  PE+L   + Y  
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQ-KPYSK 186

Query: 338 AIDVWSCGCIL 348
           A+D WS G I 
Sbjct: 187 AVDCWSIGVIT 197

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 49.5 bits (119), Expect = 5e-07
 Identities = 12/32 (37%), Positives = 16/32 (50%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKN 96
             A D +  +LE DP  R T E+AL   W+  
Sbjct: 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  136 bits (344), Expect = 3e-36
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 41/209 (19%)

Query: 170 TDELVALK---KVRLENEKEGFPITAV--------REIKILRQLNHKNIVNLREIVTDKS 218
                A+K   K + +  +       +         EI +L+ L+H NI+ L ++     
Sbjct: 60  GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV----- 114

Query: 219 DALDFRKDKGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCH 272
               F +DK  FYLV E+ +    G      ++      F+E + A+IM+Q+L G+ Y H
Sbjct: 115 ----F-EDKKYFYLVTEFYE----GGELFEQIINRHK--FDECDAANIMKQILSGICYLH 163

Query: 273 KRNFLHRDIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           K N +HRDIK  NIL+ N+     +K+ DFGL+  ++ + +     +++ T +Y  PE+L
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVL 220

Query: 330 LGEERYGPAIDVWSCGCILGELFVKKPLF 358
               +Y    DVWSCG I+  L    P F
Sbjct: 221 KK--KYNEKCDVWSCGVIMYILLCGYPPF 247

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 36/191 (18%), Positives = 67/191 (35%), Gaps = 18/191 (9%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHEL 116
             ++  +   A +L+  ML  D  +R TAE+AL S W+K          Q         +
Sbjct: 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNM 327

Query: 117 WSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLN-NFSVSLFTDELV- 174
              +  ++L       QAA  I    +  ++    + L      L+ N    L   EL+ 
Sbjct: 328 RKFEGSQKLA------QAA--ILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIE 379

Query: 175 ALKKVRLENEKEGFPITAVREI-KILRQL--NHKNIVNLREIVTDKSDALDFRK--DKGS 229
               +R    + G       E+  IL+++  +    +   E ++     +D +    +  
Sbjct: 380 GYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFIS---VCMDKQILFSEER 436

Query: 230 FYLVFEYMDHD 240
               F   D D
Sbjct: 437 LRRAFNLFDTD 447

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  131 bits (332), Expect = 4e-36
 Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 29/164 (17%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG------LLES 247
           RE +I R+L H NIV L + +          +++   YLVF+ +     G      ++  
Sbjct: 54  REARICRKLQHPNIVRLHDSI----------QEESFHYLVFDLVT----GGELFEDIVAR 99

Query: 248 GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARL 304
               ++E + +  ++Q+L+ ++YCH    +HR++K  N+L+ ++ +   VKLADFGLA  
Sbjct: 100 EF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157

Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
               +    +     T  Y  PE+L   + Y   +D+W+CG IL
Sbjct: 158 V---NDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVIL 197

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 49.9 bits (120), Expect = 4e-07
 Identities = 17/32 (53%), Positives = 24/32 (75%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKN 96
           P A  L+D ML ++P++RITA+QALK  W+ N
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICN 267

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  132 bits (334), Expect = 4e-36
 Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 34/193 (17%)

Query: 170 TDELVALK---KVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T    A K   K +    + G     + RE+ ILRQ+ H N++ L ++  +++D      
Sbjct: 36  TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD------ 89

Query: 226 DKGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
                 L+ E +     G      L +      +E    S ++Q+LDG++Y H +   H 
Sbjct: 90  ----VVLILELVS----GGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHF 139

Query: 280 DIKCSNILMNNRGE----VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           D+K  NI++ ++      +KL DFGLA           + N   T  +  PE++   E  
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNY-EPL 195

Query: 336 GPAIDVWSCGCIL 348
           G   D+WS G I 
Sbjct: 196 GLEADMWSIGVIT 208

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 13/52 (25%), Positives = 24/52 (46%)

Query: 58  EEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPT 109
           E FS     A D + K+L  +  +R+T ++AL+  W+  V  +     +   
Sbjct: 240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  132 bits (334), Expect = 9e-36
 Identities = 51/193 (26%), Positives = 83/193 (43%), Gaps = 34/193 (17%)

Query: 170 TDELVALK---KVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T    A K   K +    + G     + RE+ ILRQ+ H NI+ L ++  +++D      
Sbjct: 36  TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD------ 89

Query: 226 DKGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
                 L+ E +     G      L +      +E    S ++Q+LDG++Y H +   H 
Sbjct: 90  ----VVLILELVS----GGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHF 139

Query: 280 DIKCSNILMNNRGE----VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           D+K  NI++ ++      +KL DFGLA           + N   T  +  PE++   E  
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNY-EPL 195

Query: 336 GPAIDVWSCGCIL 348
           G   D+WS G I 
Sbjct: 196 GLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 13/52 (25%), Positives = 24/52 (46%)

Query: 58  EEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPT 109
           E FS     A D + K+L  +  +R+T ++AL+  W+  V  +     +   
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  131 bits (332), Expect = 1e-35
 Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 34/193 (17%)

Query: 170 TDELVALK---KVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T    A K   K R ++ + G     + RE+ IL+++ H N++ L E+  +K+D      
Sbjct: 35  TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD------ 88

Query: 226 DKGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
                 L+ E +     G      L E       E      ++Q+L+G+ Y H     H 
Sbjct: 89  ----VILILELVA----GGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHF 138

Query: 280 DIKCSNILMNNRGE----VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           D+K  NI++ +R      +K+ DFGLA   +  +    + N   T  +  PE++   E  
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNY-EPL 194

Query: 336 GPAIDVWSCGCIL 348
           G   D+WS G I 
Sbjct: 195 GLEADMWSIGVIT 207

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 13/45 (28%), Positives = 24/45 (53%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPES 101
            E FS     A D + ++L  DP++R+T + +L+  W+K    + 
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  133 bits (336), Expect = 1e-35
 Identities = 58/265 (21%), Positives = 104/265 (39%), Gaps = 41/265 (15%)

Query: 99  PESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGG 158
           P   PPPQ PT    H           +     +++   I+ N+  +  +   + L  G 
Sbjct: 15  PAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLG- 73

Query: 159 LSLNNFSV-----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLRE 212
                        +  T E  ALK ++ +  K        RE+++  +     +IV + +
Sbjct: 74  ----INGKVLQIFNKRTQEKFALKMLQ-DCPKAR------REVELHWRASQCPHIVRIVD 122

Query: 213 IVTDKSDALDFRKDKGSFYLVFEYM------DHDLMGLLESGMVDFNEVNNASIMRQLLD 266
           +  +          +    +V E +            + + G   F E   + IM+ + +
Sbjct: 123 VYENLYAG------RKCLLIVMECLDGGELFSR----IQDRGDQAFTEREASEIMKSIGE 172

Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWY 323
            + Y H  N  HRD+K  N+L  ++     +KL DFG A+   + +     T    T +Y
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYY 229

Query: 324 RPPELLLGEERYGPAIDVWSCGCIL 348
             PE +LG E+Y  + D+WS G I+
Sbjct: 230 VAPE-VLGPEKYDKSCDMWSLGVIM 253

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 6/32 (18%), Positives = 15/32 (46%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKN 96
                L+  +L+ +P +R+T  + +   W+  
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  130 bits (329), Expect = 1e-35
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 38/198 (19%)

Query: 170 TDELVALK-------KVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDAL 221
           T +  A+K             E +      ++E+ ILR+++ H NI+ L++     +   
Sbjct: 41  TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF-- 98

Query: 222 DFRKDKGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRN 275
                   F+LVF+ M            L E      +E     IMR LL+ +   HK N
Sbjct: 99  --------FFLVFDLMK----KGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLN 144

Query: 276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG---- 331
            +HRD+K  NIL+++   +KL DFG +   +  ++         T  Y  PE++      
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMND 201

Query: 332 -EERYGPAIDVWSCGCIL 348
               YG  +D+WS G I+
Sbjct: 202 NHPGYGKEVDMWSTGVIM 219

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 19/87 (21%)

Query: 25  LCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPP-------GALDLLDKMLEL 77
           L G+P           P WH  K   + R  +   +    P          DL+ + L +
Sbjct: 223 LAGSP-----------PFWHR-KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV 270

Query: 78  DPERRITAEQALKSVWLKNVHPESMPP 104
            P++R TAE+AL   + +    E +  
Sbjct: 271 QPQKRYTAEEALAHPFFQQYVVEEVRH 297

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  130 bits (329), Expect = 2e-35
 Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 43/205 (20%)

Query: 166 VSLFTDELVALK---KVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL 221
           ++L T +  A+K   K               RE+++L Q   H+N++ L E   ++    
Sbjct: 33  INLITSQEYAVKIIEKQPGHIRSR-----VFREVEMLYQCQGHRNVLELIEFFEEED--- 84

Query: 222 DFRKDKGSFYLVFEYM------DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN 275
                   FYLVFE M       H    + +     FNE+  + +++ +   L + H + 
Sbjct: 85  -------RFYLVFEKMRGGSILSH----IHKRRH--FNELEASVVVQDVASALDFLHNKG 131

Query: 276 FLHRDIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVI-----TLWYRPPE 327
             HRD+K  NIL  +  +   VK+ DF L           P +   +     +  Y  PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 328 LLLG----EERYGPAIDVWSCGCIL 348
           ++         Y    D+WS G IL
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 16/87 (18%), Positives = 29/87 (33%), Gaps = 10/87 (11%)

Query: 25  LCGTP---TPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPP-------GALDLLDKM 74
           L G P                        +       ++             A DL+ K+
Sbjct: 220 LSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKL 279

Query: 75  LELDPERRITAEQALKSVWLKNVHPES 101
           L  D ++R++A Q L+  W++   PE+
Sbjct: 280 LVRDAKQRLSAAQVLQHPWVQGCAPEN 306

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  130 bits (330), Expect = 2e-35
 Identities = 42/165 (25%), Positives = 68/165 (41%), Gaps = 25/165 (15%)

Query: 194 REIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYM------DHDLMGLLE 246
           +E+    Q     +IV + ++  +          K    ++ E M            + E
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHG------KRCLLIIMECMEGGELFSR----IQE 119

Query: 247 SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLAR 303
            G   F E   A IMR +   + + H  N  HRD+K  N+L  ++ +   +KL DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

Query: 304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
                           T +Y  PE +LG E+Y  + D+WS G I+
Sbjct: 180 ETTQN----ALQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIM 219

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 17/70 (24%), Positives = 28/70 (40%), Gaps = 8/70 (11%)

Query: 67  ALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLR 126
           A  L+  +L+ DP  R+T  Q +   W+     +SM  PQ P     H     +  +   
Sbjct: 264 AKQLIRLLLKTDPTERLTITQFMNHPWIN----QSMVVPQTPL----HTARVLQEDKDHW 315

Query: 127 GDPMEMQAAA 136
            +  E   +A
Sbjct: 316 DEVKEEMTSA 325

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  135 bits (341), Expect = 2e-35
 Identities = 54/189 (28%), Positives = 81/189 (42%), Gaps = 17/189 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T E VA+K+ R E   +         EI+I+++LNH N+V+ RE+               
Sbjct: 38  TGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL----APND 91

Query: 229 SFYLVFEYMDH-DLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
              L  EY +  DL   L          E    +++  +   L Y H+   +HRD+K  N
Sbjct: 92  LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151

Query: 286 ILM---NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
           I++     R   K+ D G A+     D+    T  V TL Y  PELL   ++Y   +D W
Sbjct: 152 IVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYW 207

Query: 343 SCGCILGEL 351
           S G +  E 
Sbjct: 208 SFGTLAFEC 216

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  131 bits (332), Expect = 2e-35
 Identities = 57/197 (28%), Positives = 85/197 (43%), Gaps = 37/197 (18%)

Query: 170 TDELVALK-----KVRLENEKEGFPITAV-REIKILRQL-NHKNIVNLREIVTDKSDALD 222
           T    A+K       RL  E+      A  RE  ILRQ+  H +I+ L +     S    
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF--- 174

Query: 223 FRKDKGSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                   +LVF+ M            L E      +E    SIMR LL+ +S+ H  N 
Sbjct: 175 -------MFLVFDLMR----KGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNI 221

Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG----- 331
           +HRD+K  NIL+++  +++L+DFG +      ++         T  Y  PE+L       
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDET 278

Query: 332 EERYGPAIDVWSCGCIL 348
              YG  +D+W+CG IL
Sbjct: 279 HPGYGKEVDLWACGVIL 295

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 21/78 (26%), Positives = 36/78 (46%), Gaps = 19/78 (24%)

Query: 25  LCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPP-------GALDLLDKMLEL 77
           L G+P           P WH  +   + R  +  ++    P          DL+ ++L++
Sbjct: 299 LAGSP-----------PFWHR-RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQV 346

Query: 78  DPERRITAEQALKSVWLK 95
           DPE R+TAEQAL+  + +
Sbjct: 347 DPEARLTAEQALQHPFFE 364

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  130 bits (329), Expect = 3e-35
 Identities = 44/195 (22%), Positives = 74/195 (37%), Gaps = 30/195 (15%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T    A+KKVRLE  +         E+     L+   IV L              ++   
Sbjct: 82  TGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPL----------YGAVREGPW 124

Query: 230 FYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
             +  E ++      L+   + G     E      + Q L+GL Y H R  LH D+K  N
Sbjct: 125 VNIFMELLEGGSLGQLIK--QMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADN 180

Query: 286 ILMNNRG-EVKLADFGLARLYNAEDRQRPYTNK---VITLWYRPPELLLGEERYGPAIDV 341
           +L+++ G    L DFG A     +   +          T  +  PE+++G +     +D+
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDI 239

Query: 342 WSCGCILGELFVKKP 356
           WS  C++  +     
Sbjct: 240 WSSCCMMLHMLNGCH 254

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  132 bits (335), Expect = 3e-35
 Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 28/164 (17%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG------LLES 247
           RE +I R L H NIV L + +           ++G  YL+F+ +     G      ++  
Sbjct: 59  REARICRLLKHPNIVRLHDSI----------SEEGHHYLIFDLVT----GGELFEDIVAR 104

Query: 248 GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARL 304
               ++E + +  ++Q+L+ + +CH+   +HR++K  N+L+ ++ +   VKLADFGLA  
Sbjct: 105 EY--YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162

Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              E  Q+ +     T  Y  PE+L   + YG  +D+W+CG IL
Sbjct: 163 VEGE--QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVIL 203

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 16/32 (50%), Positives = 24/32 (75%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKN 96
           P A DL++KML ++P +RITA +ALK  W+ +
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISH 273

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  128 bits (325), Expect = 3e-35
 Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 26/195 (13%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           +  ++ALK   K +LE       +   RE++I   L H NI+ L     D +        
Sbjct: 33  SKFILALKVLFKAQLEKAGVEHQLR--REVEIQSHLRHPNILRLYGYFHDATR------- 83

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
               YL+ EY     +   L+  +  F+E   A+ + +L + LSYCH +  +HRDIK  N
Sbjct: 84  ---VYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 139

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWS 343
           +L+ + GE+K+ADFG +         R      +  TL Y PPE++ G   +   +D+WS
Sbjct: 140 LLLGSAGELKIADFGWSVH---APSSRRTD---LCGTLDYLPPEMIEGRM-HDEKVDLWS 192

Query: 344 CGCILGELFVKKPLF 358
            G +  E  V KP F
Sbjct: 193 LGVLCYEFLVGKPPF 207

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 43.7 bits (104), Expect = 4e-05
 Identities = 13/57 (22%), Positives = 29/57 (50%), Gaps = 3/57 (5%)

Query: 48  PKKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPES 101
            ++ ++R  R EF+    +  GA DL+ ++L+ +P +R    + L+  W+     + 
Sbjct: 212 YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  130 bits (328), Expect = 4e-35
 Identities = 54/237 (22%), Positives = 85/237 (35%), Gaps = 58/237 (24%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T  + A+K   K ++             E++++++L+H NI  L E+           +D
Sbjct: 50  TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY----------ED 99

Query: 227 KGSFYLVFEYM----------------------------------------DHDLMGLLE 246
           +    LV E                                          +  + G  E
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159

Query: 247 SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE--VKLADFGLARL 304
           S      E   ++IMRQ+   L Y H +   HRDIK  N L +      +KL DFGL++ 
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219

Query: 305 YNAEDRQRPYTNKVI--TLWYRPPELLLGEER-YGPAIDVWSCGCILGELFVKKPLF 358
           +   +    Y       T ++  PE+L      YGP  D WS G +L  L +    F
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 11/46 (23%), Positives = 22/46 (47%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESM 102
              ++++ P A DLL  +L  + + R  A +AL+  W+     +  
Sbjct: 297 NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIY 342

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  129 bits (327), Expect = 4e-35
 Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 40/192 (20%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRK 225
           +++  A+K   K    N +        +EI  L+    H NIV L E+            
Sbjct: 35  SNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNIVKLHEVF----------H 76

Query: 226 DKGSFYLVFEYM------DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           D+   +LV E +      +     + +     F+E   + IMR+L+  +S+ H    +HR
Sbjct: 77  DQLHTFLVMELLNGGELFER----IKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHR 130

Query: 280 DIKCSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           D+K  N+L  +  +   +K+ DFG ARL   ++  +P      TL Y  PELL     Y 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNG-YD 187

Query: 337 PAIDVWSCGCIL 348
            + D+WS G IL
Sbjct: 188 ESCDLWSLGVIL 199

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 46.5 bits (111), Expect = 6e-06
 Identities = 12/42 (28%), Positives = 20/42 (47%)

Query: 67  ALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
           A DL+  +L +DP +R+       + WL++    S  P   P
Sbjct: 247 AKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTP 288

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  130 bits (329), Expect = 4e-35
 Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 29/164 (17%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG------LLES 247
           RE +I R+L H NIV L + +          +++   YLVF+ +     G      ++  
Sbjct: 77  REARICRKLQHPNIVRLHDSI----------QEESFHYLVFDLVT----GGELFEDIVAR 122

Query: 248 GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLADFGLARL 304
               ++E + +  ++Q+L+ ++YCH    +HR++K  N+L+ ++ +   VKLADFGLA  
Sbjct: 123 EF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
               +    +     T  Y  PE+L   + Y   +D+W+CG IL
Sbjct: 181 V---NDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVIL 220

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 17/32 (53%), Positives = 24/32 (75%)

Query: 65  PGALDLLDKMLELDPERRITAEQALKSVWLKN 96
           P A  L+D ML ++P++RITA+QALK  W+ N
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICN 290

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  129 bits (325), Expect = 5e-35
 Identities = 53/195 (27%), Positives = 80/195 (41%), Gaps = 25/195 (12%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T   VA  +++     +        E ++L+ L H NIV                K K  
Sbjct: 50  TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF------YDSWESTVKGKKC 103

Query: 230 FYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKC 283
             LV E M          L    ++    +   S  RQ+L GL + H R    +HRD+KC
Sbjct: 104 IVLVTELMTSGTLKTY--LKRFKVMKIKVL--RSWCRQILKGLQFLHTRTPPIIHRDLKC 159

Query: 284 SNILMNNR-GEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDV 341
            NI +    G VK+ D GLA L  A   +      VI T  +  PE+   EE+Y  ++DV
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRASFAKA-----VIGTPEFMAPEM--YEEKYDESVDV 212

Query: 342 WSCGCILGELFVKKP 356
           ++ G  + E+   + 
Sbjct: 213 YAFGMCMLEMATSEY 227

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  130 bits (330), Expect = 5e-35
 Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 23/184 (12%)

Query: 170 TDELVALK--KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T  +   K        +K         EI I+ QL+H  ++NL +   DK          
Sbjct: 75  TGRVFVAKFINTPYPLDKYTV----KNEISIMNQLHHPKLINLHDAFEDKY--------- 121

Query: 228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
               L+ E++   +L   + +     +E    + MRQ  +GL + H+ + +H DIK  NI
Sbjct: 122 -EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 180

Query: 287 LMNNRGE--VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           +   +    VK+ DFGLA   N ++          T  +  PE++  E   G   D+W+ 
Sbjct: 181 MCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREP-VGFYTDMWAI 236

Query: 345 GCIL 348
           G + 
Sbjct: 237 GVLG 240

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 22/103 (21%), Positives = 38/103 (36%), Gaps = 4/103 (3%)

Query: 58  EEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELW 117
           + FS + P A D +  +L+ +P +R+T   AL+  WLK  H               +   
Sbjct: 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN----LTSRIPSSRYNKI 327

Query: 118 SKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLS 160
            +K + +    P    A   I + S+    RP    +      
Sbjct: 328 RQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFD 370

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  128 bits (325), Expect = 8e-35
 Identities = 42/187 (22%), Positives = 74/187 (39%), Gaps = 30/187 (16%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + +    K V+++   +       +EI IL    H+NI++L E      +          
Sbjct: 29  SKKTYMAKFVKVKGTDQV---LVKKEISILNIARHRNILHLHESFESMEE---------- 75

Query: 230 FYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
             ++FE++     G      +  S   + NE    S + Q+ + L + H  N  H DI+ 
Sbjct: 76  LVMIFEFIS----GLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130

Query: 284 SNILMNNRGE--VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
            NI+   R    +K+ +FG AR     D    +        Y  PE+   +     A D+
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDV-VSTATDM 186

Query: 342 WSCGCIL 348
           WS G ++
Sbjct: 187 WSLGTLV 193

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 14/40 (35%), Positives = 24/40 (60%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN 96
            E F  +   A+D +D++L  + + R+TA +AL+  WLK 
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  133 bits (335), Expect = 9e-35
 Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 23/184 (12%)

Query: 170 TDELVALK--KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T    A K      E++KE       +EI+ +  L H  +VNL +   D +         
Sbjct: 181 TGNNFAAKFVMTPHESDKETV----RKEIQTMSVLRHPTLVNLHDAFEDDN--------- 227

Query: 228 GSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
               +++E+M   +L   +       +E      MRQ+  GL + H+ N++H D+K  NI
Sbjct: 228 -EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 286

Query: 287 LMNNRGE--VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           +   +    +KL DFGL    + +           T  +  PE+  G+   G   D+WS 
Sbjct: 287 MFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKP-VGYYTDMWSV 342

Query: 345 GCIL 348
           G + 
Sbjct: 343 GVLS 346

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 52.9 bits (127), Expect = 8e-08
 Identities = 25/141 (17%), Positives = 44/141 (31%), Gaps = 7/141 (4%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHEL 116
              FS +     D + K+L  DP  R+T  QAL+  WL           Q+P+    +  
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP-GNAPGRDSQIPS--SRYTK 433

Query: 117 WSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRP----LMEPLAAGGLSLNNFSVSLFTDE 172
                + +    P  +     I + S+    RP    + +       +   F V  +  E
Sbjct: 434 IRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTE 493

Query: 173 LVALKKVRLENEKEGFPITAV 193
           +   +               V
Sbjct: 494 VGEGQSANFYCRVIASSPPVV 514

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  127 bits (322), Expect = 1e-34
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 16/185 (8%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T    A+K   K +L     G      +EI++LR+L HKN++ L +++ ++         
Sbjct: 29  TLCRRAVKILKKKKLRRIPNGEA-NVKKEIQLLRRLRHKNVIQLVDVLYNEE-------- 79

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVD--FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           K   Y+V EY    +  +L+S + +  F          QL+DGL Y H +  +H+DIK  
Sbjct: 80  KQKMYMVMEYCVCGMQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG 138

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY-GPAIDVWS 343
           N+L+   G +K++  G+A   +             +  ++PPE+  G + + G  +D+WS
Sbjct: 139 NLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWS 198

Query: 344 CGCIL 348
            G  L
Sbjct: 199 AGVTL 203

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 18/72 (25%), Positives = 31/72 (43%), Gaps = 7/72 (9%)

Query: 49  KKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPP 105
           + I     +  +++     P   DLL  MLE +P +R +  Q  +  W +  HP +  P 
Sbjct: 223 ENI----GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

Query: 106 QLPTWQDCHELW 117
            +P   D  + W
Sbjct: 279 PIPPSPDTKDRW 290

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  128 bits (324), Expect = 2e-34
 Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 33/188 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T +  ALK ++   +K+        EI +L +L+H NI+ L+EI    +           
Sbjct: 77  TQKPYALKVLKKTVDKKIV----RTEIGVLLRLSHPNIIKLKEIFETPT----------E 122

Query: 230 FYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
             LV E +     G      ++E G   ++E + A  ++Q+L+ ++Y H+   +HRD+K 
Sbjct: 123 ISLVLELVT----GGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIVHRDLKP 176

Query: 284 SNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
            N+L         +K+ADFGL+++    + Q        T  Y  PE+L G   YGP +D
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPEILRG-CAYGPEVD 232

Query: 341 VWSCGCIL 348
           +WS G I 
Sbjct: 233 MWSVGIIT 240

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 22/92 (23%), Positives = 36/92 (39%), Gaps = 18/92 (19%)

Query: 25  LCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPP-------GALDLLDKMLEL 77
           LCG             P +     + + RR L  E+  + P        A DL+ K++ L
Sbjct: 244 LCGFE-----------PFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292

Query: 78  DPERRITAEQALKSVWLKNVHPESMPPPQLPT 109
           DP++R+T  QAL+  W+       +       
Sbjct: 293 DPKKRLTTFQALQHPWVTGKAANFVHMDTAQK 324

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  128 bits (323), Expect = 3e-34
 Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 42/193 (21%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRK 225
           T+   A+K   K + +            EI+IL +   H NI+ L+++            
Sbjct: 46  TNMEFAVKIIDKSKRDPT---------EEIEILLRYGQHPNIITLKDVY----------D 86

Query: 226 DKGSFYLVFEYM------DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           D    Y+V E M      D     +L      F+E   ++++  +   + Y H +  +HR
Sbjct: 87  DGKYVYVVTELMKGGELLDK----ILRQKF--FSEREASAVLFTITKTVEYLHAQGVVHR 140

Query: 280 DIKCSNILMNNRGE----VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           D+K SNIL  +       +++ DFG A+   AE+          T  +  PE+L   + Y
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLER-QGY 197

Query: 336 GPAIDVWSCGCIL 348
             A D+WS G +L
Sbjct: 198 DAACDIWSLGVLL 210

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 22/91 (24%), Positives = 33/91 (36%), Gaps = 20/91 (21%)

Query: 25  LCGTPTPAVWPAVIKLPLWHTIK--PKKIHRRRLREEFSLMPP-------GALDLLDKML 75
           L G             P  +     P++I  R    +FSL           A DL+ KML
Sbjct: 214 LTGYT-----------PFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKML 262

Query: 76  ELDPERRITAEQALKSVWLKNVHPESMPPPQ 106
            +DP +R+TA   L+  W+ +          
Sbjct: 263 HVDPHQRLTAALVLRHPWIVHWDQLPQYQLN 293

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  125 bits (317), Expect = 5e-34
 Identities = 63/197 (31%), Positives = 95/197 (48%), Gaps = 30/197 (15%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
              ++ALK   K +LE E     +   REI+I   L H NI+ +     D+         
Sbjct: 38  NKFIMALKVLFKSQLEKEGVEHQLR--REIEIQSHLRHPNILRMYNYFHDRKR------- 88

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVD---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
               YL+ E+      G L   +     F+E  +A+ M +L D L YCH+R  +HRDIK 
Sbjct: 89  ---IYLMLEFAPR---GELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKP 142

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDV 341
            N+LM  +GE+K+ADFG +    A   +R    + +  TL Y PPE++ G+  +   +D+
Sbjct: 143 ENLLMGYKGELKIADFGWSVH--APSLRR----RTMCGTLDYLPPEMIEGKT-HDEKVDL 195

Query: 342 WSCGCILGELFVKKPLF 358
           W  G +  E  V  P F
Sbjct: 196 WCAGVLCYEFLVGMPPF 212

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 49.1 bits (118), Expect = 8e-07
 Identities = 14/58 (24%), Positives = 28/58 (48%), Gaps = 3/58 (5%)

Query: 49  KKIHRRRLREEF-SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPP 105
           ++I    L+  F   +  G+ DL+ K+L   P +R+  +  ++  W+K      +PP 
Sbjct: 222 RRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  127 bits (322), Expect = 6e-34
 Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 33/189 (17%)

Query: 170 TDELVALK--KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T   +A K  K R   +KE        EI ++ QL+H N++ L +    K+D        
Sbjct: 113 TGLKLAAKIIKTRGMKDKEEV----KNEISVMNQLDHANLIQLYDAFESKND-------- 160

Query: 228 GSFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
               LV EY+D    G      +++    +  E++    M+Q+ +G+ + H+   LH D+
Sbjct: 161 --IVLVMEYVD----GGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDL 213

Query: 282 KCSNILMNNRGE--VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAI 339
           K  NIL  NR    +K+ DFGLAR Y   +          T  +  PE++  +       
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDF-VSFPT 269

Query: 340 DVWSCGCIL 348
           D+WS G I 
Sbjct: 270 DMWSVGVIA 278

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 16/50 (32%), Positives = 24/50 (48%)

Query: 58  EEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQL 107
           EEF  +   A + + K+L  +   RI+A +ALK  WL +    S    Q 
Sbjct: 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQK 359

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  125 bits (317), Expect = 1e-33
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 26/189 (13%)

Query: 170 TDELVALK---KVRLENEKEGFPITAV-REIKILRQLNHK--NIVNLREIVTDKSDALDF 223
            +  VA+K   K R+ +  E    T V  E+ +L++++     ++ L +           
Sbjct: 67  DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS---- 122

Query: 224 RKDKGSFYLVFEYMDH--DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
                 F L+ E  +   DL   +   G +   E    S   Q+L+ + +CH    LHRD
Sbjct: 123 ------FVLILERPEPVQDLFDFITERGALQ--EELARSFFWQVLEAVRHCHNCGVLHRD 174

Query: 281 IKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAI 339
           IK  NIL++ NRGE+KL DFG   L     +   YT+   T  Y PPE +     +G + 
Sbjct: 175 IKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 230

Query: 340 DVWSCGCIL 348
            VWS G +L
Sbjct: 231 AVWSLGILL 239

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 2/62 (3%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH-PESMPPPQL 107
           ++I R ++      +      L+   L L P  R T E+     W+++V  P+      L
Sbjct: 253 EEIIRGQVFFRQR-VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHL 311

Query: 108 PT 109
            +
Sbjct: 312 HS 313

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  126 bits (317), Expect = 1e-33
 Identities = 50/247 (20%), Positives = 81/247 (32%), Gaps = 62/247 (25%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLR------------------ 211
            D   A+K++RL N +       +RE+K L +L H  IV                     
Sbjct: 30  DDCNYAIKRIRLPNRELARE-KVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88

Query: 212 ----------------------EIVTDKSDALDF-------RKDKGSFYLVFEYMDH-DL 241
                                 +I      +             K   Y+  +     +L
Sbjct: 89  WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENL 148

Query: 242 MGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF 299
              +     + D        I  Q+ + + + H +  +HRD+K SNI       VK+ DF
Sbjct: 149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 208

Query: 300 GLARLYNAED----------RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           GL    + ++              +T +V T  Y  PE + G   Y   +D++S G IL 
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILF 267

Query: 350 ELFVKKP 356
           EL     
Sbjct: 268 ELLYSFS 274

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 8/49 (16%), Positives = 18/49 (36%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV 97
             +   +    F+   P    ++  ML   P  R  A   +++   +N+
Sbjct: 284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  125 bits (316), Expect = 2e-33
 Identities = 43/187 (22%), Positives = 78/187 (41%), Gaps = 24/187 (12%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNH-KNIVNLREIVTDKSDALDFRKDKG 228
           T +  A K ++     +      + EI +L        ++NL E+  + S+         
Sbjct: 53  TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE--------- 103

Query: 229 SFYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
              L+ EY        L   L       +E +   +++Q+L+G+ Y H+ N +H D+K  
Sbjct: 104 -IILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQ 160

Query: 285 NILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           NIL+++      +K+ DFG++R              + T  Y  PE+L   +    A D+
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNY-DPITTATDM 216

Query: 342 WSCGCIL 348
           W+ G I 
Sbjct: 217 WNIGIIA 223

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 17/53 (32%), Positives = 27/53 (50%)

Query: 57  REEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPT 109
            E FS +   A D +  +L  +PE+R TAE  L   WL+    E++  P+  +
Sbjct: 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETS 306

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (311), Expect = 2e-32
 Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 34/198 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E V ++++ LE            E+ + +  NH NIV                  + +
Sbjct: 51  TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY----------------RAT 94

Query: 230 F------YLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           F      ++V  +M      DL+          NE+  A I++ +L  L Y H   ++HR
Sbjct: 95  FIADNELWVVTSFMAYGSAKDLICTHFMDG--MNELAIAYILQGVLKALDYIHHMGYVHR 152

Query: 280 DIKCSNILMNNRGEVKLADFG-LARLYNAEDRQR----PYTNKVITLWYRPPELLLGEER 334
            +K S+IL++  G+V L+       + +   RQR         V  L +  PE+L    +
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212

Query: 335 -YGPAIDVWSCGCILGEL 351
            Y    D++S G    EL
Sbjct: 213 GYDAKSDIYSVGITACEL 230

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  122 bits (308), Expect = 3e-32
 Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 25/187 (13%)

Query: 168 LFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           + T   VA+K +              RE++I++ LNH NIV L E++  +          
Sbjct: 37  ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT-------- 88

Query: 228 GSFYLVFEY------MDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
              YL+ EY       D+    L+  G +   E    S  RQ++  + YCH++  +HRD+
Sbjct: 89  --LYLIMEYASGGEVFDY----LVAHGRM--KEKEARSKFRQIVSAVQYCHQKRIVHRDL 140

Query: 282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           K  N+L++    +K+ADFG +  +      +          Y  PEL  G++  GP +DV
Sbjct: 141 KAENLLLDADMNIKIADFGFSNEF--TVGGKLDA-FCGAPPYAAPELFQGKKYDGPEVDV 197

Query: 342 WSCGCIL 348
           WS G IL
Sbjct: 198 WSLGVIL 204

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 49.2 bits (118), Expect = 7e-07
 Identities = 20/70 (28%), Positives = 33/70 (47%), Gaps = 3/70 (4%)

Query: 49  KKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPP 105
           K++  R LR ++ +   M     +LL + L L+P +R T EQ +K  W+   H E    P
Sbjct: 220 KELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP 279

Query: 106 QLPTWQDCHE 115
            +    D  +
Sbjct: 280 FVEPELDISD 289

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  121 bits (306), Expect = 3e-32
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 39/191 (20%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  L A K +  ++E+E      + EI+IL   +H  IV L                 G+
Sbjct: 43  TGALAAAKVIETKSEEELEDY--IVEIEILATCDHPYIVKL----------------LGA 84

Query: 230 FY------LVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           +Y      ++ E+        +M  L+ G+    E     + RQ+L+ L++ H +  +HR
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVVCRQMLEALNFLHSKRIIHR 141

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEER---- 334
           D+K  N+LM   G+++LADFG++       ++R   +  I T ++  PE+++ E      
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR---DSFIGTPYWMAPEVVMCETMKDTP 198

Query: 335 YGPAIDVWSCG 345
           Y    D+WS G
Sbjct: 199 YDYKADIWSLG 209

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  120 bits (304), Expect = 4e-32
 Identities = 57/188 (30%), Positives = 83/188 (44%), Gaps = 29/188 (15%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T+E VA+K     R  +  E       +EI I + LNH+N+V       + +        
Sbjct: 31  TEEAVAVKIVDMKRAVDCPENI----KKEICINKMLNHENVVKFYGHRREGNI------- 79

Query: 227 KGSFYLVFEYM------DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
               YL  EY       D     +         E +      QL+ G+ Y H     HRD
Sbjct: 80  ---QYLFLEYCSGGELFDR----IEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRD 130

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           IK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PELL   E +   +D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190

Query: 341 VWSCGCIL 348
           VWSCG +L
Sbjct: 191 VWSCGIVL 198

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 16/71 (22%), Positives = 23/71 (32%), Gaps = 5/71 (7%)

Query: 40  LPLWHTIKPKKIHRRRLREEFSLMP-----PGALDLLDKMLELDPERRITAEQALKSVWL 94
           LP        + +     ++  L P        L LL K+L  +P  RIT     K  W 
Sbjct: 206 LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265

Query: 95  KNVHPESMPPP 105
                +    P
Sbjct: 266 NKPLKKGAKRP 276

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (305), Expect = 5e-32
 Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 38/239 (15%)

Query: 118 SKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALK 177
           S +  +       +++                ++E L  G       ++   T ++VA+K
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 178 KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY------ 231
           +V +E++ +      ++EI I++Q +  ++V                   GS++      
Sbjct: 61  QVPVESDLQEI----IKEISIMQQCDSPHVVKY----------------YGSYFKNTDLW 100

Query: 232 LVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
           +V EY       D++ L    +    E   A+I++  L GL Y H    +HRDIK  NIL
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTL---TEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL 157

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCG 345
           +N  G  KLADFG+A        +R   N VI T ++  PE++  E  Y    D+WS G
Sbjct: 158 LNTEGHAKLADFGVAGQLTDTMAKR---NTVIGTPFWMAPEVIQ-EIGYNCVADIWSLG 212

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  123 bits (311), Expect = 5e-32
 Identities = 65/195 (33%), Positives = 91/195 (46%), Gaps = 22/195 (11%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             + VALK VR  NEK  F   A  EI+IL  L  ++  N   ++    +   FR     
Sbjct: 121 VHQHVALKMVR--NEKR-FHRQAAEEIRILEHLRKQDKDNTMNVIHML-ENFTFR---NH 173

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNA---SIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             + FE +  +L  L++     F   +          +L  L   HK   +H D+K  NI
Sbjct: 174 ICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231

Query: 287 LMNN--RGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 343
           L+    R  +K+ DFG +      + QR YT   I + +YR PE++LG  RYG  ID+WS
Sbjct: 232 LLKQQGRSGIKVIDFGSS----CYEHQRVYT--YIQSRFYRAPEVILGA-RYGMPIDMWS 284

Query: 344 CGCILGELFVKKPLF 358
            GCIL EL    PL 
Sbjct: 285 LGCILAELLTGYPLL 299

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 18/70 (25%), Positives = 25/70 (35%), Gaps = 4/70 (5%)

Query: 41  PLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPE 100
                ++     R           P  LD L + LE DP  R+T  QAL+  WL+     
Sbjct: 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR----R 414

Query: 101 SMPPPQLPTW 110
            +P P     
Sbjct: 415 RLPKPPTGEK 424

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  120 bits (303), Expect = 6e-32
 Identities = 42/182 (23%), Positives = 75/182 (41%), Gaps = 14/182 (7%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K + +             E+ +LR+  H NI+      T                +V
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----------APQLAIV 97

Query: 234 FEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            ++ +   L   L +    F       I RQ   G+ Y H ++ +HRD+K +NI ++   
Sbjct: 98  TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN 157

Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE--RYGPAIDVWSCGCILGE 350
            VK+ DFGLA   +       +     ++ +  PE++  ++   Y    DV++ G +L E
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217

Query: 351 LF 352
           L 
Sbjct: 218 LM 219

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 7e-32
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 21/206 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKG 228
           +    ALK++    E++      ++E+  +++L  H NIV      +   +  D    + 
Sbjct: 52  SGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD--TGQA 107

Query: 229 SFYLVFEYMDHDLMGLLESGMVD--FNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCS 284
            F L+ E     L+  L+        +      I  Q    + + H++    +HRD+K  
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167

Query: 285 NILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI----------TLWYRPPEL--LLGE 332
           N+L++N+G +KL DFG A   +          +            T  YR PE+  L   
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227

Query: 333 ERYGPAIDVWSCGCILGELFVKKPLF 358
              G   D+W+ GCIL  L  ++  F
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPF 253

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  120 bits (304), Expect = 7e-32
 Identities = 50/193 (25%), Positives = 76/193 (39%), Gaps = 28/193 (14%)

Query: 168 LFTDELVALK---KVRLENEKEGFPITAV-REIKILRQLN----HKNIVNLREIVTDKSD 219
           L     VA+K   + R+              E+ +L ++     H  ++ L +    +  
Sbjct: 53  LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEG 112

Query: 220 ALDFRKDKGSFYLVFEYMDH--DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
                     F LV E      DL   +   G +   E  +     Q++  + +CH R  
Sbjct: 113 ----------FMLVLERPLPAQDLFDYITEKGPLG--EGPSRCFFGQVVAAIQHCHSRGV 160

Query: 277 LHRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           +HRDIK  NIL++  RG  KL DFG   L        PYT+   T  Y PPE +   + +
Sbjct: 161 VHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTRVYSPPEWISRHQYH 216

Query: 336 GPAIDVWSCGCIL 348
                VWS G +L
Sbjct: 217 ALPATVWSLGILL 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 11/60 (18%), Positives = 21/60 (35%), Gaps = 1/60 (1%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
           ++I    L      + P    L+ + L   P  R + E+ L   W++    +    P   
Sbjct: 243 QEILEAELHFPAH-VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  120 bits (304), Expect = 9e-32
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 22/189 (11%)

Query: 168 LFTDELVALK-----KVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDAL 221
              ++ V +K     KV  +   E   +  V  EI IL ++ H NI+ + +I  ++    
Sbjct: 46  KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF-- 103

Query: 222 DFRKDKGSFYLVFEYMDH--DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
                   F LV E      DL   ++      +E   + I RQL+  + Y   ++ +HR
Sbjct: 104 --------FQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHR 154

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAI 339
           DIK  NI++     +KL DFG A     E  +  YT    T+ Y  PE+L+G    GP +
Sbjct: 155 DIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTF-CGTIEYCAPEVLMGNPYRGPEL 211

Query: 340 DVWSCGCIL 348
           ++WS G  L
Sbjct: 212 EMWSLGVTL 220

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 10/67 (14%), Positives = 26/67 (38%), Gaps = 3/67 (4%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
           ++     +   +  +    + L+  +L+  PERR T E+ +   W+    P ++      
Sbjct: 234 EETVEAAIHPPYL-VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT--QPVNLADYTWE 290

Query: 109 TWQDCHE 115
                ++
Sbjct: 291 EVFRVNK 297

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  120 bits (302), Expect = 2e-31
 Identities = 57/188 (30%), Positives = 83/188 (44%), Gaps = 29/188 (15%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T+E VA+K     R  +  E       +EI I + LNH+N+V       + +        
Sbjct: 31  TEEAVAVKIVDMKRAVDCPENI----KKEICINKMLNHENVVKFYGHRREGNI------- 79

Query: 227 KGSFYLVFEYM------DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
               YL  EY       D     +         E +      QL+ G+ Y H     HRD
Sbjct: 80  ---QYLFLEYCSGGELFDR----IEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRD 130

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           IK  N+L++ R  +K++DFGLA ++   +R+R       TL Y  PELL   E +   +D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190

Query: 341 VWSCGCIL 348
           VWSCG +L
Sbjct: 191 VWSCGIVL 198

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 17/99 (17%), Positives = 31/99 (31%), Gaps = 5/99 (5%)

Query: 53  RRRLREEFSLMP-----PGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQL 107
                ++  L P        L LL K+L  +P  RIT     K  W      +    P++
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 278

Query: 108 PTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNS 146
            +           +  Q   D   + +A+    +  +  
Sbjct: 279 TSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKE 317

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  119 bits (301), Expect = 3e-31
 Identities = 53/190 (27%), Positives = 91/190 (47%), Gaps = 31/190 (16%)

Query: 168 LFTDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
             T + VALK   +  L+       +   REI  L+ L H +I+ L +++T  +D     
Sbjct: 31  YKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLYDVITTPTD----- 83

Query: 225 KDKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
                  +V EY   +L   ++E   +  +E       +Q++  + YCH+   +HRD+K 
Sbjct: 84  -----IVMVIEYAGGELFDYIVEKKRMTEDEGRR--FFQQIICAIEYCHRHKIVHRDLKP 136

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQR-----PYTNKVITLWYRPPELLLGEERYGPA 338
            N+L+++   VK+ADFGL+ +    +  +     P         Y  PE++ G+   GP 
Sbjct: 137 ENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN--------YAAPEVINGKLYAGPE 188

Query: 339 IDVWSCGCIL 348
           +DVWSCG +L
Sbjct: 189 VDVWSCGIVL 198

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 13/63 (20%), Positives = 29/63 (46%), Gaps = 3/63 (4%)

Query: 49  KKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPP 105
             + ++     + +   + PGA  L+ +M+  DP +RIT ++  +  W     P+ + P 
Sbjct: 214 PNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPM 273

Query: 106 QLP 108
           +  
Sbjct: 274 EEV 276

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  118 bits (297), Expect = 5e-31
 Identities = 41/189 (21%), Positives = 72/189 (38%), Gaps = 52/189 (27%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKG 228
           T E  ALK ++   +         RE+++  +     +IV + ++  +          + 
Sbjct: 42  TQEKFALKMLQDCPKAR-------REVELHWRASQCPHIVRIVDVYENLYAG------RK 88

Query: 229 SFYLVFEYMDHDLMG------LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
              +V E +D    G      + + G   F E   + IM+ + + + Y H  N  HRD+K
Sbjct: 89  CLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 144

Query: 283 CSNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAI 339
             N+L  ++     +KL DFG A                        E     E+Y  + 
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFA-----------------------KETT--GEKYDKSC 179

Query: 340 DVWSCGCIL 348
           D+WS G I+
Sbjct: 180 DMWSLGVIM 188

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 46.5 bits (111), Expect = 5e-06
 Identities = 14/90 (15%), Positives = 27/90 (30%), Gaps = 21/90 (23%)

Query: 25  LCGTPTPAVWPAVIKLPLW---HTIKPKKIHRRRLREEFSLMPP-------GALDLLDKM 74
           LCG P           P +          +  R    ++    P           L+  +
Sbjct: 192 LCGYP-----------PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 240

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPP 104
           L+ +P +R+T  + +   W+         P
Sbjct: 241 LKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  117 bits (296), Expect = 6e-31
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 40/193 (20%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T   VA+K   + ++ +      I   REI+ L+   H +I+ L ++++  +D       
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKLYQVISTPTD------- 85

Query: 227 KGSFYLVFEYM------DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
              F++V EY+      D+    + + G V   E+    + +Q+L  + YCH+   +HRD
Sbjct: 86  ---FFMVMEYVSGGELFDY----ICKHGRV--EEMEARRLFQQILSAVDYCHRHMVVHRD 136

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQR-----PYTNKVITLWYRPPELLLGEERY 335
           +K  N+L++     K+ADFGL+ + +  +  R     P         Y  PE++ G    
Sbjct: 137 LKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--------YAAPEVISGRLYA 188

Query: 336 GPAIDVWSCGCIL 348
           GP +D+WSCG IL
Sbjct: 189 GPEVDIWSCGVIL 201

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 11/63 (17%)

Query: 49  KKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPP 105
           KKI        F +   +      LL  ML++DP +R T +   +  W K    + +P  
Sbjct: 221 KKI----RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK----QDLPSY 272

Query: 106 QLP 108
             P
Sbjct: 273 LFP 275

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  119 bits (299), Expect = 7e-31
 Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 33/186 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
             E+VA+KK+    ++       + +E++ L++L H N +                  +G
Sbjct: 78  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY----------------RG 121

Query: 229 SFY------LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
            +       LV EY       LLE       EV  A++    L GL+Y H  N +HRD+K
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181

Query: 283 CSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEER--YGPAI 339
             NIL++  G VKL DFG A    +        N  + T ++  PE++L  +   Y   +
Sbjct: 182 AGNILLSEPGLVKLGDFGSA----SIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKV 234

Query: 340 DVWSCG 345
           DVWS G
Sbjct: 235 DVWSLG 240

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  117 bits (296), Expect = 2e-30
 Identities = 58/186 (31%), Positives = 84/186 (45%), Gaps = 28/186 (15%)

Query: 170 TDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T ELVA+K   +    +E         REI   R L H NIV  +E++   +        
Sbjct: 44  TKELVAVKYIERGAAIDEN------VQREIINHRSLRHPNIVRFKEVILTPTH------- 90

Query: 227 KGSFYLVFEYMDH-DLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
                ++ EY    +L   +  +G   F+E       +QLL G+SYCH     HRD+K  
Sbjct: 91  ---LAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145

Query: 285 NILM--NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
           N L+  +    +K+ DFG ++        +P +  V T  Y  PE+LL +E  G   DVW
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSS--VLHSQPKS-TVGTPAYIAPEVLLRQEYDGKIADVW 202

Query: 343 SCGCIL 348
           SCG  L
Sbjct: 203 SCGVTL 208

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 15/66 (22%), Positives = 28/66 (42%), Gaps = 6/66 (9%)

Query: 49  KKIHRRRLREEFSL-----MPPGALDLLDKMLELDPERRITAEQALKSVW-LKNVHPESM 102
           +K  +R L  ++S+     + P    L+ ++   DP  RI+  +     W LKN+  + M
Sbjct: 228 RKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLM 287

Query: 103 PPPQLP 108
                 
Sbjct: 288 NESNTG 293

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  116 bits (292), Expect = 3e-30
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 32/184 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VA++++ L+ + +   I  + EI ++R+  + NIVN                   S
Sbjct: 44  TGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY----------------LDS 85

Query: 230 FY------LVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
           +       +V EY+    L  ++       +E   A++ R+ L  L + H    +HRDIK
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143

Query: 283 CSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDV 341
             NIL+   G VKL DFG       E  +R   + ++ T ++  PE++  +  YGP +D+
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKA-YGPKVDI 199

Query: 342 WSCG 345
           WS G
Sbjct: 200 WSLG 203

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (292), Expect = 4e-30
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 34/199 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             E VA+K++ LE  +       ++EI+ + Q +H NIV+                   S
Sbjct: 39  KKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHPNIVSY----------------YTS 81

Query: 230 F------YLVFEYMD----HDLMGLLESGMVD----FNEVNNASIMRQLLDGLSYCHKRN 275
           F      +LV + +      D++  + +         +E   A+I+R++L+GL Y HK  
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141

Query: 276 FLHRDIKCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTNK--VITLWYRPPELLLGE 332
            +HRD+K  NIL+   G V++ADFG+ A L    D  R    K  V T  +  PE++   
Sbjct: 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV 201

Query: 333 ERYGPAIDVWSCGCILGEL 351
             Y    D+WS G    EL
Sbjct: 202 RGYDFKADIWSFGITAIEL 220

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  116 bits (292), Expect = 4e-30
 Identities = 44/187 (23%), Positives = 81/187 (43%), Gaps = 38/187 (20%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           +   VA+K + L  ++    +    E+ I+R   H N+V +                  S
Sbjct: 69  SGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHFNVVEM----------------YKS 110

Query: 230 FY------LVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           +       ++ E++      D++       V  NE   A++   +L  L+Y H +  +HR
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPA 338
           DIK  +IL+   G VKL+DFG     + +  +R     ++ T ++  PE++     Y   
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISRSL-YATE 221

Query: 339 IDVWSCG 345
           +D+WS G
Sbjct: 222 VDIWSLG 228

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (290), Expect = 6e-30
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDEL----VALKKVRLE-NEKEGFPITAVREIKILRQLNH 204
           +++ L  GG+S    +V L  D +    VA+K + +   EKE       RE+    QL+H
Sbjct: 15  IVDKLGGGGMS----TVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLL-ESGMVDFNEVNNASIMR 262
           +NIV++          +D  ++   +YLV EY++   L   +   G +  +     +   
Sbjct: 71  QNIVSM----------IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTA--INFTN 118

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TL 321
           Q+LDG+ + H    +HRDIK  NIL+++   +K+ DFG+A+  +     +  TN V+ T+
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTV 176

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            Y  PE   GE       D++S G +L E+ V +P F
Sbjct: 177 QYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPF 212

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  115 bits (290), Expect = 8e-30
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 32/191 (16%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVN-----LREIVTDKSDALDF 223
           T +L A+K + +  ++E       +EI +L++  +H+NI       +++      D L  
Sbjct: 48  TGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL-- 102

Query: 224 RKDKGSFYLVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
                  +LV E+       DL+   +       E   A I R++L GLS+ H+   +HR
Sbjct: 103 -------WLVMEFCGAGSVTDLIKNTKGNT--LKEEWIAYICREILRGLSHLHQHKVIHR 153

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEER---- 334
           DIK  N+L+    EVKL DFG++   +    +R   N  I T ++  PE++  +E     
Sbjct: 154 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR---NTFIGTPYWMAPEVIACDENPDAT 210

Query: 335 YGPAIDVWSCG 345
           Y    D+WS G
Sbjct: 211 YDFKSDLWSLG 221

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  116 bits (292), Expect = 1e-29
 Identities = 31/221 (14%), Positives = 67/221 (30%), Gaps = 40/221 (18%)

Query: 170 TDELVALKKVRLENEKEGFPITAVRE----IKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T E   +             I  ++E    +++LR + ++    +        D +   +
Sbjct: 97  TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156

Query: 226 DKG--------------SFYLVFEYMDHDLMGLLE------SGMVDFNEVNNASIMRQLL 265
            K               S + ++  M  +L    E      S            +  Q++
Sbjct: 157 KKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 216

Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
             L+  H    +H  ++  +I+++ RG V L  F       A           ++  + P
Sbjct: 217 RLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVSRGFEP 270

Query: 326 PELL----------LGEERYGPAIDVWSCGCILGELFVKKP 356
           PEL                   + D W+ G ++  ++    
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 13/62 (20%), Positives = 23/62 (37%), Gaps = 7/62 (11%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
           + I R         +P     LL+  L    E R+   QA+++   + +  E      LP
Sbjct: 323 EWIFRSCKN-----IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL--SAALP 375

Query: 109 TW 110
            +
Sbjct: 376 LY 377

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  113 bits (285), Expect = 3e-29
 Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 37/193 (19%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T ++VA+K + LE  ++       +EI +L Q +   +                    GS
Sbjct: 46  TQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKY----------------YGS 88

Query: 230 FY------LVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR 279
           +       ++ EY+      DL+   E G    +E   A+I+R++L GL Y H    +HR
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLL---EPGP--LDETQIATILREILKGLDYLHSEKKIHR 143

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPA 338
           DIK +N+L++  GEVKLADFG+A        +R   N  + T ++  PE++  +  Y   
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIK-QSAYDSK 199

Query: 339 IDVWSCGCILGEL 351
            D+WS G    EL
Sbjct: 200 ADIWSLGITAIEL 212

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  114 bits (287), Expect = 5e-29
 Identities = 61/194 (31%), Positives = 94/194 (48%), Gaps = 18/194 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             E VA+K ++  N K+ F   A  E+++L  +N  +      IV  K     FR     
Sbjct: 78  EQEWVAIKIIK--N-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK-RHFMFR---NH 130

Query: 230 FYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCH--KRNFLHRDIKCSNI 286
             LVFE + ++L  LL  +     +        +Q+   L +    + + +H D+K  NI
Sbjct: 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190

Query: 287 LMNN--RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 344
           L+ N  R  +K+ DFG +     +  QR Y   + + +YR PE+LLG   Y  AID+WS 
Sbjct: 191 LLCNPKRSAIKIVDFGSS----CQLGQRIYQ-YIQSRFYRSPEVLLGM-PYDLAIDMWSL 244

Query: 345 GCILGELFVKKPLF 358
           GCIL E+   +PLF
Sbjct: 245 GCILVEMHTGEPLF 258

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 15/64 (23%), Positives = 23/64 (35%), Gaps = 7/64 (10%)

Query: 37  VIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN 96
           V           +  H      +F        DL+ +ML+ DP+ RI    AL+  + K 
Sbjct: 326 VETGGPGGRRAGESGHTVADYLKF-------KDLILRMLDYDPKTRIQPYYALQHSFFKK 378

Query: 97  VHPE 100
              E
Sbjct: 379 TADE 382

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  115 bits (289), Expect = 7e-29
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 40/195 (20%)

Query: 168 LFTDELVALK---KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
             T   VA+K   + ++ +      I   REI+ L+   H +I+ L ++++  SD     
Sbjct: 38  ELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKLYQVISTPSD----- 90

Query: 225 KDKGSFYLVFEYM------DHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLH 278
                 ++V EY+      D+    + ++G +  +E  +  + +Q+L G+ YCH+   +H
Sbjct: 91  -----IFMVMEYVSGGELFDY----ICKNGRL--DEKESRRLFQQILSGVDYCHRHMVVH 139

Query: 279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLW-----YRPPELLLGEE 333
           RD+K  N+L++     K+ADFGL+ + +          + +        Y  PE++ G  
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMS--------DGEFLRTSCGSPNYAAPEVISGRL 191

Query: 334 RYGPAIDVWSCGCIL 348
             GP +D+WS G IL
Sbjct: 192 YAGPEVDIWSSGVIL 206

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 17/61 (27%), Positives = 26/61 (42%), Gaps = 7/61 (11%)

Query: 49  KKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPP 105
           KKI        F     + P  + LL  ML++DP +R T +   +  W K   P+ + P 
Sbjct: 226 KKI----CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPE 281

Query: 106 Q 106
            
Sbjct: 282 D 282

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  112 bits (283), Expect = 2e-28
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 36/209 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLN-----------HKNIVNLREIVTDKS 218
            +  VA+K VR     + +   A  EIK+L+++N             +I+ L        
Sbjct: 43  NNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL------- 92

Query: 219 DALDFRKDKGSFY-LVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKR-N 275
           D  + +   G    +VFE +  +L+ L+ +        +    I +QLL GL Y H+R  
Sbjct: 93  DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 152

Query: 276 FLHRDIKCSNILMNN------RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
            +H DIK  N+LM          ++K+AD G A  Y+       YTN + T  YR PE+L
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVL 207

Query: 330 LGEERYGPAIDVWSCGCILGELFVKKPLF 358
           LG   +G   D+WS  C++ EL     LF
Sbjct: 208 LGA-PWGCGADIWSTACLIFELITGDFLF 235

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 26/123 (21%), Positives = 40/123 (32%), Gaps = 15/123 (12%)

Query: 2   FSGGRGNSGWANIELLQLEVISKLCGTPTP-----AVWPAVI--KLPLWHTIKPKKIHRR 54
           F    G+S   + +   +  I +L G           +         L   I   K    
Sbjct: 235 FEPDEGHSYTKDDD--HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292

Query: 55  R--LREEFSLMPPGA---LDLLDKMLELDPERRITAEQALKSVWLKNVHP-ESMPPPQLP 108
              L E++      A    D L  ML+LDP +R  A   +   WLK+    E +  P   
Sbjct: 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRE 352

Query: 109 TWQ 111
            + 
Sbjct: 353 LYG 355

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (282), Expect = 2e-28
 Identities = 29/205 (14%), Positives = 61/205 (29%), Gaps = 29/205 (14%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             +   LK  +  N  E +  T  + ++ L+       +                  +  
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGT--QLMERLKPSMQHMFMKFYSAH----------LFQNG 141

Query: 230 FYLVFEYMDH-DLMGLLESGMV----DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
             LV E   +  L+  +            +    S   ++L  +   H    +H DIK  
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201

Query: 285 NILMNNR-----------GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE 333
           N ++ N              + L D G +       +   +T K  T  ++  E+L   +
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-K 260

Query: 334 RYGPAIDVWSCGCILGELFVKKPLF 358
            +   ID +     +  +     + 
Sbjct: 261 PWNYQIDYFGVAATVYCMLFGTYMK 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  111 bits (279), Expect = 2e-28
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 29/191 (15%)

Query: 169 FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           +  + VA+K++  E+E++ F    + E++ L ++NH NIV L     +            
Sbjct: 29  WRAKDVAIKQIESESERKAF----IVELRQLSRVNHPNIVKLYGACLNP----------- 73

Query: 229 SFYLVFEYMDH-DLMGLL--ESGMVDFNEVNNASIMRQLLDGLSYCHKRN---FLHRDIK 282
              LV EY +   L  +L     +  +   +  S   Q   G++Y H       +HRD+K
Sbjct: 74  -VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132

Query: 283 CSNILMNNRGEV-KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
             N+L+   G V K+ DFG A            TN   +  +  PE+  G   Y    DV
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEG-SNYSEKCDV 186

Query: 342 WSCGCILGELF 352
           +S G IL E+ 
Sbjct: 187 FSWGIILWEVI 197

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  111 bits (279), Expect = 3e-28
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 21/217 (9%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDEL----VALKKVRLE-NEKEGFPITAVREIKILRQLNH 204
           L E L  GG+S     V L  D      VA+K +R +      F +   RE +    LNH
Sbjct: 16  LGEILGFGGMS----EVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLL-ESGMVDFNEVNNASIMR 262
             IV + +    ++ A          Y+V EY+D   L  ++   G +         ++ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLP------YIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVIA 123

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TL 321
                L++ H+   +HRD+K +NI+++    VK+ DFG+AR           T  VI T 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            Y  PE   G+       DV+S GC+L E+   +P F
Sbjct: 184 QYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPF 219

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  108 bits (273), Expect = 2e-27
 Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 27/217 (12%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDEL----VALKKVRLE-NEKEGFPITAVREIKILRQLNH 204
           L   +  GG+      V    D +    VALK +    +    F     RE +   +L  
Sbjct: 38  LRRLVGRGGMG----DVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93

Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLL-ESGMVDFNEVNNASIMR 262
            ++V +           DF +  G  Y+    ++  DL  +L   G +        +I+R
Sbjct: 94  PHVVPI----------HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA--VAIVR 141

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TL 321
           Q+   L   H     HRD+K  NIL++      L DFG+A      D +       + TL
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTL 199

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +Y  PE            D+++  C+L E     P +
Sbjct: 200 YYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPY 235

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  109 bits (274), Expect = 2e-27
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 35/197 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           +  ++A K + LE +        +RE+++L + N   IV              F    G+
Sbjct: 57  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIV-------------GF---YGA 99

Query: 230 FY------LVFEYMDHDLMGLLESGMVD---FNEVNNASIMRQLLDGLSYCH-KRNFLHR 279
           FY      +  E+MD    G L+  +       E     +   ++ GL+Y   K   +HR
Sbjct: 100 FYSDGEISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAI 339
           D+K SNIL+N+RGE+KL DFG++      D      + V T  Y  PE L G   Y    
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG--QLIDSMA--NSFVGTRSYMSPERLQG-THYSVQS 211

Query: 340 DVWSCGCILGELFVKKP 356
           D+WS G  L E+ V + 
Sbjct: 212 DIWSMGLSLVEMAVGRY 228

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (276), Expect = 2e-27
 Identities = 27/218 (12%), Positives = 64/218 (29%), Gaps = 31/218 (14%)

Query: 170 TDELVALKKVRLENEKEGFPITAVRE----IKILRQLNHKNIVNLREIVTDKSDAL---- 221
           T E   +             I  ++E    +++LR + ++    +        D +    
Sbjct: 102 TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161

Query: 222 ----------DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNN-------ASIMRQL 264
                     +      S + ++  M  +L    E  ++  +  +          +  Q+
Sbjct: 162 KKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV-LLSHSSTHKSLVHHARLQLTLQV 220

Query: 265 LDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYR 324
           +  L+  H    +H  ++  +I+++ RG V L  F             P           
Sbjct: 221 IRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-ASAVSPIGRGFAPPETT 279

Query: 325 PPELLLGEE----RYGPAIDVWSCGCILGELFVKKPLF 358
              +L   +        A D W+ G  +  ++      
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 11/49 (22%), Positives = 21/49 (42%), Gaps = 2/49 (4%)

Query: 63  MPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQ 111
           +P     LL+  L    E R+   QA+++   + +   +     LP +Q
Sbjct: 336 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL--RTELSAALPLYQ 382

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  107 bits (270), Expect = 4e-27
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 30/198 (15%)

Query: 170 TDELVALKKVRLENEK--EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T E++ +K++   +E+    F    ++E+K++R L H N++    ++             
Sbjct: 34  TGEVMVMKELIRFDEETQRTF----LKEVKVMRCLEHPNVLKFIGVLYKD---------- 79

Query: 228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
                + EY+    L G+++S    +      S  + +  G++Y H  N +HRD+   N 
Sbjct: 80  KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNC 139

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP------------PELLLGEER 334
           L+     V +ADFGLARL   E  Q      +     +             PE++ G   
Sbjct: 140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RS 198

Query: 335 YGPAIDVWSCGCILGELF 352
           Y   +DV+S G +L E+ 
Sbjct: 199 YDEKVDVFSFGIVLCEII 216

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  107 bits (269), Expect = 7e-27
 Identities = 39/191 (20%), Positives = 75/191 (39%), Gaps = 23/191 (12%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA++ + +E + E       RE+   RQ  H+N+V                       ++
Sbjct: 58  VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP----------PHLAII 107

Query: 234 FEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
                   L  ++    +  +      I ++++ G+ Y H +  LH+D+K  N+  +N G
Sbjct: 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-G 166

Query: 293 EVKLADFGLARL---YNAEDRQRPYTNKVITLWYRPPELL--------LGEERYGPAIDV 341
           +V + DFGL  +     A  R+     +   L +  PE++          +  +    DV
Sbjct: 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226

Query: 342 WSCGCILGELF 352
           ++ G I  EL 
Sbjct: 227 FALGTIWYELH 237

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (268), Expect = 1e-26
 Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 19/188 (10%)

Query: 170 TDELVALK--KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T E+VA+K  +   E     F     REI+IL+ L H NIV  + +             +
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSA--------GR 116

Query: 228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
            +  L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NI
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 176

Query: 287 LMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL-WYRPPELLLGEERYGPAIDVWSC 344
           L+ N   VK+ DFGL + L   ++  +        + WY  PE L  E ++  A DVWS 
Sbjct: 177 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLT-ESKFSVASDVWSF 234

Query: 345 GCILGELF 352
           G +L ELF
Sbjct: 235 GVVLYELF 242

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (275), Expect = 1e-26
 Identities = 46/216 (21%), Positives = 80/216 (37%), Gaps = 30/216 (13%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDEL-----VALKKVRLENEKEGFPITAVREIKILRQLNH 204
           +   +A GGL      + L  D       V LK +    +       A+ E + L ++ H
Sbjct: 84  VKGCIAHGGLG----WIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVH 138

Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQ 263
            +IV +   V       D        Y+V EY+    L       +    E    + + +
Sbjct: 139 PSIVQIFNFVEHTDRHGD-----PVGYIVMEYVGGQSLKRSKGQKL-PVAEA--IAYLLE 190

Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLW 322
           +L  LSY H    ++ D+K  NI++     +KL D G     N+          +  T  
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINS-------FGYLYGTPG 242

Query: 323 YRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           ++ PE++        A D+++ G  L  L +  P  
Sbjct: 243 FQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTR 276

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  105 bits (264), Expect = 2e-26
 Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 31/196 (15%)

Query: 171 DELVALKKVRLENEKEGFPITA--VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
            + VA+K  R + +++         +E K+   L H NI+ LR +   + +         
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN--------- 80

Query: 229 SFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN---FLHRDIKCS 284
              LV E+     L  +L    +  + +   +   Q+  G++Y H       +HRD+K S
Sbjct: 81  -LCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137

Query: 285 NILMNNRGE--------VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           NIL+  + E        +K+ DFGLAR    E  +    +      +  PE++     + 
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPEVIRA-SMFS 192

Query: 337 PAIDVWSCGCILGELF 352
              DVWS G +L EL 
Sbjct: 193 KGSDVWSYGVLLWELL 208

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (264), Expect = 2e-26
 Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 19/188 (10%)

Query: 170 TDELVALK--KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T E+VA+K  +   E     F     REI+IL+ L H NIV  + +             +
Sbjct: 38  TGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSA--------GR 85

Query: 228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
            +  L+ EY+ +  L   L+      + +       Q+  G+ Y   + ++HRD+   NI
Sbjct: 86  RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 145

Query: 287 LMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL-WYRPPELLLGEERYGPAIDVWSC 344
           L+ N   VK+ DFGL + L   ++  +        + WY  PE L  E ++  A DVWS 
Sbjct: 146 LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLT-ESKFSVASDVWSF 203

Query: 345 GCILGELF 352
           G +L ELF
Sbjct: 204 GVVLYELF 211

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  105 bits (263), Expect = 5e-26
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 18/187 (9%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
              VA+K +  ++         +RE+ I+++L H NIV     VT   +           
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN----------L 109

Query: 231 YLVFEYMDH-DLMGLL--ESGMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSN 285
            +V EY+    L  LL         +E    S+   +  G++Y H RN   +HR++K  N
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPN 169

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +L++ +  VK+ DFGL+RL  +        +   T  +  PE+L   E      DV+S G
Sbjct: 170 LLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRD-EPSNEKSDVYSFG 226

Query: 346 CILGELF 352
            IL EL 
Sbjct: 227 VILWELA 233

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  104 bits (262), Expect = 6e-26
 Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 20/189 (10%)

Query: 170 TDELVALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E VA+K ++     N          +EI+ILR L H+NIV  + I T+          
Sbjct: 49  TGEQVAVKSLKPESGGNHIADL----KKEIEILRNLYHENIVKYKGICTEDGGN------ 98

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
                L+ E++    L   L       N         Q+  G+ Y   R ++HRD+   N
Sbjct: 99  --GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN 156

Query: 286 ILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL-WYRPPELLLGEERYGPAIDVWS 343
           +L+ +  +VK+ DFGL + +   ++      ++   + WY  PE L+ + ++  A DVWS
Sbjct: 157 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-APECLM-QSKFYIASDVWS 214

Query: 344 CGCILGELF 352
            G  L EL 
Sbjct: 215 FGVTLHELL 223

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  103 bits (260), Expect = 7e-26
 Identities = 44/197 (22%), Positives = 76/197 (38%), Gaps = 31/197 (15%)

Query: 170 TDELVALKKVRLENEKEGFPITAV-----REIKILRQLNHKNIVNLREIVTDKSDALDFR 224
              +VA+K + L + +    +        RE+ I+  LNH NIV L  ++ +        
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP------- 95

Query: 225 KDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDI 281
                  +V E++   DL   L              +M  +  G+ Y   +N   +HRD+
Sbjct: 96  -----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150

Query: 282 KCSNILMNNRGE-----VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE-ERY 335
           +  NI + +  E      K+ADFGL++           +  +    +  PE +  E E Y
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESY 205

Query: 336 GPAIDVWSCGCILGELF 352
               D +S   IL  + 
Sbjct: 206 TEKADTYSFAMILYTIL 222

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  104 bits (262), Expect = 7e-26
 Identities = 46/195 (23%), Positives = 76/195 (38%), Gaps = 34/195 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKIL-RQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T  ++A+K++R    KE      + ++ ++ +  +   IV                +  G
Sbjct: 49  TGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYIV----------------QCFG 91

Query: 229 SFY------LVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH-KRNFLHRDI 281
           +F       +  E M      L +       E     +   ++  L Y   K   +HRD+
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV 151

Query: 282 KCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTNKVITLWYRPPE----LLLGEERYG 336
           K SNIL++ RG++KL DFG+  RL + + +            Y  PE        +  Y 
Sbjct: 152 KPSNILLDERGQIKLCDFGISGRLVDDKAK----DRSAGCAAYMAPERIDPPDPTKPDYD 207

Query: 337 PAIDVWSCGCILGEL 351
              DVWS G  L EL
Sbjct: 208 IRADVWSLGISLVEL 222

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  104 bits (261), Expect = 8e-26
 Identities = 55/189 (29%), Positives = 91/189 (48%), Gaps = 22/189 (11%)

Query: 170 TDELVALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T E+VA+K ++       + G+     +EI ILR L H++I+  +    D          
Sbjct: 59  TGEMVAVKALKADAGPQHRSGW----KQEIDILRTLYHEHIIKYKGCCEDA--------G 106

Query: 227 KGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
             S  LV EY+    L   L    +   ++      +Q+ +G++Y H ++++HRD+   N
Sbjct: 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQL--LLFAQQICEGMAYLHAQHYIHRDLAARN 164

Query: 286 ILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL-WYRPPELLLGEERYGPAIDVWS 343
           +L++N   VK+ DFGLA+ +    +  R   +    + WY  PE L  E ++  A DVWS
Sbjct: 165 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK-EYKFYYASDVWS 222

Query: 344 CGCILGELF 352
            G  L EL 
Sbjct: 223 FGVTLYELL 231

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  104 bits (262), Expect = 8e-26
 Identities = 45/199 (22%), Positives = 77/199 (38%), Gaps = 39/199 (19%)

Query: 170 TDELVALKKVRLE-NEKEGFPITAVREIKI-LRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           + +++A+K++R   +EKE   +  + ++ + +R  +   IV              F    
Sbjct: 46  SGQIMAVKRIRSTVDEKEQKQL--LMDLDVVMRSSDCPYIV-------------QF---Y 87

Query: 228 GSFY------LVFEYMD----HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH-KRNF 276
           G+ +      +  E M          +         E     I    +  L++       
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147

Query: 277 LHRDIKCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTNKVITLWYRPPELLLGEER- 334
           +HRDIK SNIL++  G +KL DFG+  +L ++  +    T       Y  PE +      
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPERIDPSASR 203

Query: 335 --YGPAIDVWSCGCILGEL 351
             Y    DVWS G  L EL
Sbjct: 204 QGYDVRSDVWSLGITLYEL 222

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  103 bits (259), Expect = 1e-25
 Identities = 42/198 (21%), Positives = 77/198 (38%), Gaps = 38/198 (19%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKI-LRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           + +++A+K++R     +      + ++ I +R ++    V              F    G
Sbjct: 31  SGQIMAVKRIRATVNSQEQK-RLLMDLDISMRTVDCPFTV-------------TF---YG 73

Query: 229 SFY------LVFEYMD---HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH-KRNFLH 278
           + +      +  E MD         +        E     I   ++  L + H K + +H
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133

Query: 279 RDIKCSNILMNNRGEVKLADFGL-ARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEER-- 334
           RD+K SN+L+N  G+VK+ DFG+   L +   +     +       Y  PE +  E    
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-----DIDAGCKPYMAPERINPELNQK 188

Query: 335 -YGPAIDVWSCGCILGEL 351
            Y    D+WS G  + EL
Sbjct: 189 GYSVKSDIWSLGITMIEL 206

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  104 bits (262), Expect = 1e-25
 Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 52/221 (23%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNH-----KNIVNLREIVTDKSDALDFR 224
             +  A+K VR  N  + +  +A  E  IL+++ +      NIV              + 
Sbjct: 59  NKKYYAVKVVR--N-IKKYTRSAKIEADILKKIQNDDINNNNIVKYH-------GKFMYY 108

Query: 225 KDKGSFYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
                  L+FE +   L  ++  +    F+  +      ++L  L+Y  K +  H D+K 
Sbjct: 109 ---DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKP 165

Query: 284 SNILMNN-------------------------RGEVKLADFGLARLYNAEDRQRPYTNKV 318
            NIL+++                            +KL DFG A            +  +
Sbjct: 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TFKSDYHGS--I 219

Query: 319 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           I T  YR PE++L    +  + D+WS GC+L EL+    LF
Sbjct: 220 INTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLF 259

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 12/51 (23%), Positives = 23/51 (45%)

Query: 45  TIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLK 95
           +I   K  ++ L     +      D L  +L++DP  R +  + LK  +L+
Sbjct: 310 SINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  104 bits (261), Expect = 1e-25
 Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 35/210 (16%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
               VA+K V+  N    +   A  EI++L  LN  +  +    V    +  +     G 
Sbjct: 39  GGRHVAVKIVK--NVDR-YCEAARSEIQVLEHLNTTDPNSTFRCVQML-EWFEHH---GH 91

Query: 230 FYLVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             +VFE +       ++  G + F   +   +  Q+   +++ H     H D+K  NIL 
Sbjct: 92  ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151

Query: 289 NN-------------------RGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPEL 328
                                  ++K+ DFG A      D +   T  ++ T  YR PE+
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----TYDDEHHST--LVSTRHYRAPEV 205

Query: 329 LLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +L    +    DVWS GCIL E ++   +F
Sbjct: 206 ILAL-GWSQPCDVWSIGCILIEYYLGFTVF 234

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 14/28 (50%), Positives = 18/28 (64%)

Query: 68  LDLLDKMLELDPERRITAEQALKSVWLK 95
            DL+ KMLE DP +RIT  +ALK  +  
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFD 333

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  104 bits (261), Expect = 2e-25
 Identities = 56/210 (26%), Positives = 84/210 (40%), Gaps = 35/210 (16%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
               VALK +R  N    +   A  EI +L+++  K+  N    V    D  +F    G 
Sbjct: 44  GKSQVALKIIR--N-VGKYREAARLEINVLKKIKEKDKENKFLCVLMS-DWFNFH---GH 96

Query: 230 FYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             + FE +  +    L E+    +   +   +  QL   L + H+    H D+K  NIL 
Sbjct: 97  MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156

Query: 289 NN-------------------RGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPEL 328
            N                      +++ADFG A      D +   T  ++ T  YRPPE+
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTT--IVATRHYRPPEV 210

Query: 329 LLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +L    +    DVWS GCIL E +    LF
Sbjct: 211 ILEL-GWAQPCDVWSIGCILFEYYRGFTLF 239

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 17/58 (29%), Positives = 29/58 (50%), Gaps = 1/58 (1%)

Query: 44  HTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPES 101
           +  +  K  +  + ++ SL      DL+ +MLE DP +RIT  +AL   +   + PE 
Sbjct: 288 YVKENCKPLKSYMLQD-SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (261), Expect = 5e-25
 Identities = 51/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++      E F    ++E +++++L H+ +V L  +V+++             Y+
Sbjct: 211 VAIKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYI 255

Query: 233 VFEYMDH-DLMGLLESGMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           V EYM    L+  L+     +  +     +  Q+  G++Y  + N++HRD++ +NIL+  
Sbjct: 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 315

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
               K+ADFGLARL    +       K    W  P   L G  R+    DVWS G +L E
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTE 373

Query: 351 LF 352
           L 
Sbjct: 374 LT 375

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  101 bits (253), Expect = 8e-25
 Identities = 45/198 (22%), Positives = 73/198 (36%), Gaps = 27/198 (13%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
            E VA+K     +EK         E+     L H+NI+                      
Sbjct: 31  GENVAVKIFSSRDEKS---WFRETELYNTVMLRHENILGFIASDMTSRH------SSTQL 81

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH--------KRNFLHRDI 281
           +L+  Y +   L   L+   +D        I+  +  GL++ H        K    HRD+
Sbjct: 82  WLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139

Query: 282 KCSNILMNNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGE-----ER 334
           K  NIL+   G+  +AD GLA ++  +          +V T  Y  PE+L          
Sbjct: 140 KSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFD 199

Query: 335 YGPAIDVWSCGCILGELF 352
               +D+W+ G +L E+ 
Sbjct: 200 SYKRVDIWAFGLVLWEVA 217

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  103 bits (259), Expect = 1e-24
 Identities = 51/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++      E F    ++E +++++L H+ +V L  +V+++             Y+
Sbjct: 294 VAIKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEP-----------IYI 338

Query: 233 VFEYMDH-DLMGLLESGMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           V EYM    L+  L+     +  +     +  Q+  G++Y  + N++HRD++ +NIL+  
Sbjct: 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 398

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
               K+ADFGLARL    +       K    W  P   L G  R+    DVWS G +L E
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTE 456

Query: 351 LF 352
           L 
Sbjct: 457 LT 458

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  101 bits (253), Expect = 1e-24
 Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 26/196 (13%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           +E VA+K   +++++         E+  L  + H+NI+    I  +K             
Sbjct: 47  NEYVAVKIFPIQDKQSWQ---NEYEVYSLPGMKHENILQF--IGAEKRG----TSVDVDL 97

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH----------KRNFLHR 279
           +L+  + +   L   L++ +V +NE+    I   +  GL+Y H          K    HR
Sbjct: 98  WLITAFHEKGSLSDFLKANVVSWNEL--CHIAETMARGLAYLHEDIPGLKDGHKPAISHR 155

Query: 280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG----EERY 335
           DIK  N+L+ N     +ADFGLA  + A         +V T  Y  PE+L G    +   
Sbjct: 156 DIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDA 215

Query: 336 GPAIDVWSCGCILGEL 351
              ID+++ G +L EL
Sbjct: 216 FLRIDMYAMGLVLWEL 231

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  100 bits (251), Expect = 2e-24
 Identities = 56/188 (29%), Positives = 82/188 (43%), Gaps = 19/188 (10%)

Query: 170 TDELVALK--KVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T  LVA+K  +    +++  F     REI+IL+ L+   IV  R +             +
Sbjct: 51  TGALVAVKQLQHSGPDQQRDF----QREIQILKALHSDFIVKYRGVSYGP--------GR 98

Query: 228 GSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
            S  LV EY+    L   L+      +         Q+  G+ Y   R  +HRD+   NI
Sbjct: 99  QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 158

Query: 287 LMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL-WYRPPELLLGEERYGPAIDVWSC 344
           L+ +   VK+ADFGLA+ L   +D           + WY  PE L  +  +    DVWS 
Sbjct: 159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLS-DNIFSRQSDVWSF 216

Query: 345 GCILGELF 352
           G +L ELF
Sbjct: 217 GVVLYELF 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  102 bits (256), Expect = 3e-24
 Identities = 48/182 (26%), Positives = 86/182 (47%), Gaps = 19/182 (10%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +  E E F    ++E  +++++ H N+V L  + T +            FY+
Sbjct: 248 VAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTRE----------PPFYI 293

Query: 233 VFEYMDH-DLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           + E+M + +L+  L E    + + V    +  Q+   + Y  K+NF+HR++   N L+  
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE 353

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
              VK+ADFGL+RL   +        K    W  P  L     ++    DVW+ G +L E
Sbjct: 354 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWE 411

Query: 351 LF 352
           + 
Sbjct: 412 IA 413

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  100 bits (251), Expect = 3e-24
 Identities = 44/198 (22%), Positives = 71/198 (35%), Gaps = 27/198 (13%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
            E VA+K      E+         EI     L H+NI+         +            
Sbjct: 65  GEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNG------TWTQL 115

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH--------KRNFLHRDI 281
           +LV +Y +H  L   L    V    +    +      GL++ H        K    HRD+
Sbjct: 116 WLVSDYHEHGSLFDYLNRYTVTVEGMIK--LALSTASGLAHLHMEIVGTQGKPAIAHRDL 173

Query: 282 KCSNILMNNRGEVKLADFGLARLYNA--EDRQRPYTNKVITLWYRPPELLLGE-----ER 334
           K  NIL+   G   +AD GLA  +++  +       ++V T  Y  PE+L          
Sbjct: 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233

Query: 335 YGPAIDVWSCGCILGELF 352
                D+++ G +  E+ 
Sbjct: 234 SFKRADIYAMGLVFWEIA 251

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  100 bits (250), Expect = 4e-24
 Identities = 49/198 (24%), Positives = 77/198 (38%), Gaps = 27/198 (13%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
            E VA+K      E   F      EI     + H+NI+         + +          
Sbjct: 60  GEKVAVKVFFTTEEASWF---RETEIYQTVLMRHENILGFIAADIKGTGS------WTQL 110

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH--------KRNFLHRDI 281
           YL+ +Y ++  L   L+S  +D   +    +    + GL + H        K    HRD+
Sbjct: 111 YLITDYHENGSLYDYLKSTTLDAKSMLK--LAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168

Query: 282 KCSNILMNNRGEVKLADFGLARLY--NAEDRQRPYTNKVITLWYRPPELLLGE-----ER 334
           K  NIL+   G   +AD GLA  +  +  +   P   +V T  Y PPE+L         +
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228

Query: 335 YGPAIDVWSCGCILGELF 352
                D++S G IL E+ 
Sbjct: 229 SYIMADMYSFGLILWEVA 246

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  100 bits (252), Expect = 8e-24
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 25/183 (13%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++ +   + F    + E  ++ QL H N+V L  ++          ++KG  Y+V
Sbjct: 219 VAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIV---------EEKGGLYIV 265

Query: 234 FEYMDH-DLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
            EYM    L+  L   G               + + + Y    NF+HRD+   N+L++  
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 325

Query: 292 GEVKLADFGLAR-LYNAEDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
              K++DFGL +   + +D  + P   K    W   PE L  E+++    DVWS G +L 
Sbjct: 326 NVAKVSDFGLTKEASSTQDTGKLPV--K----WT-APEALR-EKKFSTKSDVWSFGILLW 377

Query: 350 ELF 352
           E++
Sbjct: 378 EIY 380

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 97.7 bits (244), Expect = 1e-23
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 27/187 (14%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K ++    + + E      +RE +I+ QL++  IV L  +   ++            
Sbjct: 40  VAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEA-----------L 84

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            LV E      L   L     +    N A ++ Q+  G+ Y  ++NF+HRD+   N+L+ 
Sbjct: 85  MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 144

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSCG 345
           NR   K++DFGL++   A+D    YT +        WY P  +     ++    DVWS G
Sbjct: 145 NRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYG 200

Query: 346 CILGELF 352
             + E  
Sbjct: 201 VTMWEAL 207

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 96.9 bits (242), Expect = 2e-23
 Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 26/185 (14%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K +R     +E F    + E +++ +L+H  +V L  +  ++              L
Sbjct: 35  VAIKTIREGAMSEEDF----IEEAEVMMKLSHPKLVQLYGVCLEQ----------APICL 80

Query: 233 VFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           V E+M+H  L   L +    F       +   + +G++Y  +   +HRD+   N L+   
Sbjct: 81  VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 140

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSCGCI 347
             +K++DFG+ R    +     YT+   T     W   PE+     RY    DVWS G +
Sbjct: 141 QVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWA-SPEVFS-FSRYSSKSDVWSFGVL 194

Query: 348 LGELF 352
           + E+F
Sbjct: 195 MWEVF 199

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 22/186 (11%)

Query: 174 VA---LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
            A   L ++    E   F    + E  I++  +H N+++L  I             +GS 
Sbjct: 56  CAVKSLNRITDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLR---------SEGSP 102

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V  YM H DL   + +   +    +      Q+  G+ Y   + F+HRD+   N +++
Sbjct: 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITL---WYRPPELLLGEERYGPAIDVWSCGC 346
            +  VK+ADFGLAR    ++    +      L   W    E L   +++    DVWS G 
Sbjct: 163 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQ-TQKFTTKSDVWSFGV 220

Query: 347 ILGELF 352
           +L EL 
Sbjct: 221 LLWELM 226

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 26/187 (13%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K ++    E ++  F    + E  I+ Q +H NI+ L  +VT               
Sbjct: 80  VAIKALKAGYTERQRRDF----LSEASIMGQFDHPNIIRLEGVVTRGR----------LA 125

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L +    F  +    ++R +  G+ Y     ++HRD+   N+L++
Sbjct: 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD 185

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN----KVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +    K++DFGL+R+   ED           K+   W   PE +     +  A DVWS G
Sbjct: 186 SNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWT-APEAIA-FRTFSSASDVWSFG 241

Query: 346 CILGELF 352
            ++ E+ 
Sbjct: 242 VVMWEVL 248

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 21/184 (11%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K  R     + K  F    ++E +IL+Q +H NIV L  + T K             
Sbjct: 142 VAVKSCRETLPPDLKAKF----LQEARILKQYSHPNIVRLIGVCTQKQ----------PI 187

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           Y+V E +   D +  L +            ++     G+ Y   +  +HRD+   N L+ 
Sbjct: 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT 247

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGEERYGPAIDVWSCGCIL 348
            +  +K++DFG++R             + + + W   PE L    RY    DVWS G +L
Sbjct: 248 EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APEALN-YGRYSSESDVWSFGILL 305

Query: 349 GELF 352
            E F
Sbjct: 306 WETF 309

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 96.5 bits (241), Expect = 3e-23
 Identities = 41/185 (22%), Positives = 81/185 (43%), Gaps = 26/185 (14%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++  +  ++ F     +E + + +L+H  +V    + + +             Y+
Sbjct: 35  VAVKMIKEGSMSEDEF----FQEAQTMMKLSHPKLVKFYGVCSKE----------YPIYI 80

Query: 233 VFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           V EY+ +  L+  L S            +   + +G+++     F+HRD+   N L++  
Sbjct: 81  VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD 140

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSCGCI 347
             VK++DFG+ R    +     Y + V T     W   PE+     +Y    DVW+ G +
Sbjct: 141 LCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWS-APEVFH-YFKYSSKSDVWAFGIL 194

Query: 348 LGELF 352
           + E+F
Sbjct: 195 MWEVF 199

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 27/186 (14%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +  E E F    ++E  +++++ H N+V L  + T +            FY+
Sbjct: 41  VAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTRE----------PPFYI 86

Query: 233 VFEYMDH-DLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           + E+M + +L+  L E    + + V    +  Q+   + Y  K+NF+HRD+   N L+  
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSCGC 346
              VK+ADFGL+RL   +     YT          W   PE L    ++    DVW+ G 
Sbjct: 147 NHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWT-APESLA-YNKFSIKSDVWAFGV 200

Query: 347 ILGELF 352
           +L E+ 
Sbjct: 201 LLWEIA 206

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.8 bits (244), Expect = 4e-23
 Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 26/187 (13%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K ++    E ++  F    + E  I+ Q +H NI+ L  +VT               
Sbjct: 76  VAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVTKSK----------PV 121

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V EYM++  L   L      F  +    ++R +  G+ Y     ++HRD+   NIL+N
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN----KVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +    K++DFGL R+   ED           K+   W   PE +    ++  A DVWS G
Sbjct: 182 SNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWT-SPEAIA-YRKFTSASDVWSYG 237

Query: 346 CILGELF 352
            +L E+ 
Sbjct: 238 IVLWEVM 244

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.1 bits (240), Expect = 4e-23
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 21/183 (11%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K  +    ++ +E F    ++E   +RQ +H +IV L  ++T+              
Sbjct: 46  VAIKTCKNCTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITENP-----------V 90

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           +++ E     +L   L+      +  +      QL   L+Y   + F+HRDI   N+L++
Sbjct: 91  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 150

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           +   VKL DFGL+R        +    K+   W  P  +     R+  A DVW  G  + 
Sbjct: 151 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMW 208

Query: 350 ELF 352
           E+ 
Sbjct: 209 EIL 211

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 96.1 bits (240), Expect = 5e-23
 Identities = 46/185 (24%), Positives = 92/185 (49%), Gaps = 26/185 (14%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++  +  ++ F    + E K++  L+H+ +V L  + T +             ++
Sbjct: 51  VAIKMIKEGSMSEDEF----IEEAKVMMNLSHEKLVQLYGVCTKQ----------RPIFI 96

Query: 233 VFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           + EYM +  L+  L      F       + + + + + Y   + FLHRD+   N L+N++
Sbjct: 97  ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 156

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSCGCI 347
           G VK++DFGL+R    ++    YT+ V +     W  PPE+L+   ++    D+W+ G +
Sbjct: 157 GVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWS-PPEVLM-YSKFSSKSDIWAFGVL 210

Query: 348 LGELF 352
           + E++
Sbjct: 211 MWEIY 215

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 96.9 bits (242), Expect = 5e-23
 Identities = 41/184 (22%), Positives = 74/184 (40%), Gaps = 22/184 (11%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K++R        +      + E  ++  +++ ++  L  I    +            
Sbjct: 47  VAIKELREATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTST-----------V 91

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            L+ + M    L+  +     +       +   Q+  G++Y   R  +HRD+   N+L+ 
Sbjct: 92  QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 151

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN-KVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
               VK+ DFGLA+L  AE+++      KV   W     +L     Y    DVWS G  +
Sbjct: 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTV 209

Query: 349 GELF 352
            EL 
Sbjct: 210 WELM 213

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 95.7 bits (239), Expect = 6e-23
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 25/183 (13%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K ++ +   + F    + E  ++ QL H N+V L  ++          ++KG  Y+V
Sbjct: 47  VAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIV---------EEKGGLYIV 93

Query: 234 FEYMDH-DLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
            EYM    L+  L   G               + + + Y    NF+HRD+   N+L++  
Sbjct: 94  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 153

Query: 292 GEVKLADFGLAR-LYNAEDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
              K++DFGL +   + +D  + P   K    W   PE L  E+++    DVWS G +L 
Sbjct: 154 NVAKVSDFGLTKEASSTQDTGKLPV--K----WT-APEALR-EKKFSTKSDVWSFGILLW 205

Query: 350 ELF 352
           E++
Sbjct: 206 EIY 208

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 48/187 (25%), Positives = 87/187 (46%), Gaps = 26/187 (13%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K ++    E ++  F    + E  I+ Q +H NI+ L  +++               
Sbjct: 76  VAIKTLKAGYTEKQRVDF----LGEAGIMGQFSHHNIIRLEGVISKYK----------PM 121

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            ++ EYM++  L   L     +F+ +    ++R +  G+ Y    N++HRD+   NIL+N
Sbjct: 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN----KVITLWYRPPELLLGEERYGPAIDVWSCG 345
           +    K++DFGL+R+   ED           K+   W   PE +    ++  A DVWS G
Sbjct: 182 SNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWT-APEAIS-YRKFTSASDVWSFG 237

Query: 346 CILGELF 352
            ++ E+ 
Sbjct: 238 IVMWEVM 244

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.9 bits (246), Expect = 7e-23
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 27/187 (14%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K ++    + + E      +RE +I+ QL++  IV L  +   ++            
Sbjct: 366 VAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEA-----------L 410

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            LV E      L   L     +    N A ++ Q+  G+ Y  ++NF+HR++   N+L+ 
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV 470

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYT----NKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           NR   K++DFGL++   A+D    YT     K    WY P  +     ++    DVWS G
Sbjct: 471 NRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYG 526

Query: 346 CILGELF 352
             + E  
Sbjct: 527 VTMWEAL 533

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 45/185 (24%), Positives = 74/185 (40%), Gaps = 21/185 (11%)

Query: 174 VALKKVRLENEKEGFPITA-VREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ +   +   +   +RE+  +  L+H+N++ L  +V                 +
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-----------MKM 97

Query: 233 VFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR 291
           V E      L+  L      F     +    Q+ +G+ Y   + F+HRD+   N+L+  R
Sbjct: 98  VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR 157

Query: 292 GEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSCGCI 347
             VK+ DFGL R     D    Y  +        W   PE L     +  A D W  G  
Sbjct: 158 DLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC-APESLK-TRTFSHASDTWMFGVT 213

Query: 348 LGELF 352
           L E+F
Sbjct: 214 LWEMF 218

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 95.0 bits (237), Expect = 1e-22
 Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 29/187 (15%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K  +     + KE F    + E  I++ L+H +IV L  I+            +   
Sbjct: 43  VAVKTCKKDCTLDNKEKF----MSEAVIMKNLDHPHIVKLIGIIE-----------EEPT 87

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           +++ E   + +L   LE        +       Q+   ++Y    N +HRDI   NIL+ 
Sbjct: 88  WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA 147

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSCG 345
           +   VKL DFGL+R    ED    Y    +T     W   PE +    R+  A DVW   
Sbjct: 148 SPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWM-SPESIN-FRRFTTASDVWMFA 201

Query: 346 CILGELF 352
             + E+ 
Sbjct: 202 VCMWEIL 208

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 46/188 (24%), Positives = 84/188 (44%), Gaps = 29/188 (15%)

Query: 174 VALKKVRLE----NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++ E      K+      + E  +++QL++  IV +  I   +S           
Sbjct: 47  VAVKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAES----------- 91

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           + LV E  +   L   L+       + N   ++ Q+  G+ Y  + NF+HRD+   N+L+
Sbjct: 92  WMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 150

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSC 344
             +   K++DFGL++   A++    Y  +        WY  PE +    ++    DVWS 
Sbjct: 151 VTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWY-APECIN-YYKFSSKSDVWSF 206

Query: 345 GCILGELF 352
           G ++ E F
Sbjct: 207 GVLMWEAF 214

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 25/187 (13%), Positives = 66/187 (35%), Gaps = 25/187 (13%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           + +K +++ +           E   LR  +H N++ +                     L+
Sbjct: 36  IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP--------PAPHPTLI 87

Query: 234 FEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLD---GLSYCHKRNF--LHRDIKCSNIL 287
             +M +  L  +L  G      V+ +  ++  LD   G+++ H          +   +++
Sbjct: 88  THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCG 345
           ++     +++   +   + +         ++    +  PE L  +  +    + D+WS  
Sbjct: 146 IDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198

Query: 346 CILGELF 352
            +L EL 
Sbjct: 199 VLLWELV 205

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 21/183 (11%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K  +    ++ +E F    ++E   +RQ +H +IV L  ++T+              
Sbjct: 421 VAIKTCKNCTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITENP-----------V 465

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           +++ E     +L   L+      +  +      QL   L+Y   + F+HRDI   N+L++
Sbjct: 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 525

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
           +   VKL DFGL+R        +    K+   W  P  +     R+  A DVW  G  + 
Sbjct: 526 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMW 583

Query: 350 ELF 352
           E+ 
Sbjct: 584 EIL 586

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 39/184 (21%), Positives = 71/184 (38%), Gaps = 22/184 (11%)

Query: 174 VA---LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           V    ++        +         +  +  L+H +IV L  +    S            
Sbjct: 45  VCIKVIEDKSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGSS-----------L 89

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            LV +Y+    L+  +             +   Q+  G+ Y  +   +HR++   N+L+ 
Sbjct: 90  QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK 149

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN-KVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  +V++ADFG+A L   +D+Q  Y+  K    W    E +    +Y    DVWS G  +
Sbjct: 150 SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALESIH-FGKYTHQSDVWSYGVTV 207

Query: 349 GELF 352
            EL 
Sbjct: 208 WELM 211

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 93.1 bits (232), Expect = 6e-22
 Identities = 39/190 (20%), Positives = 70/190 (36%), Gaps = 31/190 (16%)

Query: 174 VALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFY 231
           V LK +     N  E F         ++ +L+HK++V    +                  
Sbjct: 43  VLLKVLDKAHRNYSESF----FEAASMMSKLSHKHLVLNYGVCVCGD----------ENI 88

Query: 232 LVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           LV E++    L   L+      N +    + +QL   + +  +   +H ++   NIL+  
Sbjct: 89  LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIR 148

Query: 291 RGE--------VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
             +        +KL+D G++     +D       + I  W  PPE +   +    A D W
Sbjct: 149 EEDRKTGNPPFIKLSDPGISITVLPKD----ILQERIP-WV-PPECIENPKNLNLATDKW 202

Query: 343 SCGCILGELF 352
           S G  L E+ 
Sbjct: 203 SFGTTLWEIC 212

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 22/186 (11%)

Query: 174 VA---LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
            A   L ++    E   F    + E  I++  +H N+++L  I             +GS 
Sbjct: 120 CAVKSLNRITDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRS---------EGSP 166

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            +V  YM H DL   + +   +    +      Q+  G+ +   + F+HRD+   N +++
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 226

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITL---WYRPPELLLGEERYGPAIDVWSCGC 346
            +  VK+ADFGLAR    ++    +      L   W    E L   +++    DVWS G 
Sbjct: 227 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQ-TQKFTTKSDVWSFGV 284

Query: 347 ILGELF 352
           +L EL 
Sbjct: 285 LLWELM 290

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 93.8 bits (233), Expect = 9e-22
 Identities = 51/204 (25%), Positives = 80/204 (39%), Gaps = 32/204 (15%)

Query: 171 DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           +  VA+K     N +        + I  +  + H NI     IV D+    D R +   +
Sbjct: 36  ERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARF--IVGDERVTADGRME---Y 87

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH---------KRNFLHRD 280
            LV EY  +  L   L     D+       +   +  GL+Y H         K    HRD
Sbjct: 88  LLVMEYYPNGSLXKYLSLHTSDWVSS--CRLAHSVTRGLAYLHTELPRGDHYKPAISHRD 145

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY------TNKVITLWYRPPELLLGE-- 332
           +   N+L+ N G   ++DFGL+         RP        ++V T+ Y  PE+L G   
Sbjct: 146 LNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN 205

Query: 333 ----ERYGPAIDVWSCGCILGELF 352
               E     +D+++ G I  E+F
Sbjct: 206 LRDXESALKQVDMYALGLIYWEIF 229

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 22/186 (11%)

Query: 174 VA---LKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
            A   L ++    + E F    +RE  ++R LNH N++ L  I+            +G  
Sbjct: 52  CAIKSLSRITEMQQVEAF----LREGLLMRGLNHPNVLALIGIMLPP---------EGLP 98

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           +++  YM H DL+  + S   +    +  S   Q+  G+ Y  ++ F+HRD+   N +++
Sbjct: 99  HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD 158

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITL---WYRPPELLLGEERYGPAIDVWSCGC 346
               VK+ADFGLAR     +      ++   L   W    E L    R+    DVWS G 
Sbjct: 159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALESLQ-TYRFTTKSDVWSFGV 216

Query: 347 ILGELF 352
           +L EL 
Sbjct: 217 LLWELL 222

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 42/184 (22%), Positives = 75/184 (40%), Gaps = 22/184 (11%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K++R        +      + E  ++  +++ ++  L  I    +            
Sbjct: 47  VAIKELREATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTST-----------V 91

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            L+ + M    L+  +     +       +   Q+  G++Y   R  +HRD+   N+L+ 
Sbjct: 92  QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 151

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTN-KVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
               VK+ DFGLA+L  AE+++      KV   W    E +L    Y    DVWS G  +
Sbjct: 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESIL-HRIYTHQSDVWSYGVTV 209

Query: 349 GELF 352
            EL 
Sbjct: 210 WELM 213

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 30/194 (15%)

Query: 174 VALKKVRLEN----EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++L+N    E E F    + E   ++  +H N++ L  +  + S      +    
Sbjct: 65  VAVKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLGVCIEMSS-----QGIPK 115

Query: 230 FYLVFEYMDH-DLMGLL-----ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
             ++  +M + DL   L     E+G            M  +  G+ Y   RNFLHRD+  
Sbjct: 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAA 175

Query: 284 SNILMNNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPA 338
            N ++ +   V +ADFGL++ +Y+ +     Y    I      W    E L  +  Y   
Sbjct: 176 RNCMLRDDMTVCVADFGLSKKIYSGDY----YRQGRIAKMPVKWI-AIESLA-DRVYTSK 229

Query: 339 IDVWSCGCILGELF 352
            DVW+ G  + E+ 
Sbjct: 230 SDVWAFGVTMWEIA 243

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 44/190 (23%), Positives = 78/190 (41%), Gaps = 21/190 (11%)

Query: 174 VALKKVR----LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++      ++ E F    +RE   +++ +H ++  L  +          +     
Sbjct: 54  VAVKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVGVSLRSRA----KGRLPI 105

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNA-----SIMRQLLDGLSYCHKRNFLHRDIKC 283
             ++  +M H DL   L +  +  N  N         M  +  G+ Y   RNF+HRD+  
Sbjct: 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGEERYGPAIDVW 342
            N ++     V +ADFGL+R   + D  R      + + W    E L  +  Y    DVW
Sbjct: 166 RNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL-ALESLA-DNLYTVHSDVW 223

Query: 343 SCGCILGELF 352
           + G  + E+ 
Sbjct: 224 AFGVTMWEIM 233

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 43/192 (22%), Positives = 76/192 (39%), Gaps = 28/192 (14%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K V       E+  F    + E  ++++ N  ++V L  +V+               
Sbjct: 58  VAIKTVNEAASMRERIEF----LNEASVMKEFNCHHVVRLLGVVSQG----------QPT 103

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNA---------SIMRQLLDGLSYCHKRNFLHRD 280
            ++ E M   DL   L S                     +  ++ DG++Y +   F+HRD
Sbjct: 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRD 163

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +   N ++     VK+ DFG+ R     D  R     ++ + +  PE L  +  +    D
Sbjct: 164 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSD 222

Query: 341 VWSCGCILGELF 352
           VWS G +L E+ 
Sbjct: 223 VWSFGVVLWEIA 234

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 90.3 bits (225), Expect = 5e-21
 Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 28/186 (15%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++  +   + F    + E  +++QL H+ +V L  +VT +             Y+
Sbjct: 40  VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAVVTQEP-----------IYI 84

Query: 233 VFEYMDH-DLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           + EYM++  L+  L     +         +  Q+ +G+++  +RN++HRD++ +NIL+++
Sbjct: 85  ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 144

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSCGC 346
               K+ADFGLARL    +    YT +        W   PE +     +    DVWS G 
Sbjct: 145 TLSCKIADFGLARLIEDNE----YTAREGAKFPIKWT-APEAIN-YGTFTIKSDVWSFGI 198

Query: 347 ILGELF 352
           +L E+ 
Sbjct: 199 LLTEIV 204

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 92.5 bits (230), Expect = 7e-21
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 28/186 (15%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++  +   E F    + E  +++ L H  +V L  +VT +             Y+
Sbjct: 215 VAVKTMKPGSMSVEAF----LAEANVMKTLQHDKLVKLHAVVTKEP-----------IYI 259

Query: 233 VFEYMDH-DLMGLLESGMVDFNEVNN-ASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           + E+M    L+  L+S       +        Q+ +G+++  +RN++HRD++ +NIL++ 
Sbjct: 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 319

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELLLGEERYGPAIDVWSCGC 346
               K+ADFGLAR+    +    YT +        W  P  +  G   +    DVWS G 
Sbjct: 320 SLVCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGI 373

Query: 347 ILGELF 352
           +L E+ 
Sbjct: 374 LLMEIV 379

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 90.4 bits (225), Expect = 9e-21
 Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 28/192 (14%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +     E ++  F    + E  I+ + NH+NIV    +                 
Sbjct: 63  VAVKTLPEVCSEQDELDF----LMEALIISKFNHQNIVRCIGVSLQS----------LPR 108

Query: 231 YLVFEYMDH-DLMGLL------ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +++ E M   DL   L       S       ++   + R +  G  Y  + +F+HRDI  
Sbjct: 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 168

Query: 284 SNILMNNRGE---VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
            N L+   G     K+ DFG+AR        R     ++ + + PPE  + E  +    D
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTD 227

Query: 341 VWSCGCILGELF 352
            WS G +L E+F
Sbjct: 228 TWSFGVLLWEIF 239

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 49/205 (23%), Positives = 79/205 (38%), Gaps = 54/205 (26%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K +     E ++  F    + E  I+ + NH+NIV    +                 
Sbjct: 104 VAVKTLPEVCSEQDELDF----LMEALIISKFNHQNIVRCIGVSLQS----------LPR 149

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNN------ASIMRQLLDGLSYCHKRNFLHRDIKC 283
           +++ E M   DL   L       ++ ++        + R +  G  Y  + +F+HRDI  
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 209

Query: 284 SNILMNNRGE---VKLADFGLAR-LYNAEDRQRPYTNKVITLWYR------------PPE 327
            N L+   G     K+ DFG+AR +Y A              +YR            PPE
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAG-------------YYRKGGCAMLPVKWMPPE 256

Query: 328 LLLGEERYGPAIDVWSCGCILGELF 352
             + E  +    D WS G +L E+F
Sbjct: 257 AFM-EGIFTSKTDTWSFGVLLWEIF 280

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 34/198 (17%)

Query: 173 LVALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           LVA+K ++   E+ ++ F     RE ++L  L H++IV    + T+              
Sbjct: 73  LVAVKALKEASESARQDF----QREAELLTMLQHQHIVRFFGVCTEG----------RPL 118

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNA--------------SIMRQLLDGLSYCHKRN 275
            +VFEYM H DL   L S   D   +                 ++  Q+  G+ Y    +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178

Query: 276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGEER 334
           F+HRD+   N L+     VK+ DFG++R   + D  R     ++ + W  PPE +L   +
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-PPESIL-YRK 236

Query: 335 YGPAIDVWSCGCILGELF 352
           +    DVWS G +L E+F
Sbjct: 237 FTTESDVWSFGVVLWEIF 254

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 87.3 bits (217), Expect = 9e-20
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 35/199 (17%)

Query: 173 LVALKKVR--LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           LVA+K ++      ++ F     RE ++L  L H++IV    +  D              
Sbjct: 47  LVAVKALKDPTLAARKDF----QREAELLTNLQHEHIVKFYGVCGDG----------DPL 92

Query: 231 YLVFEYMDH-DLMGLLESGMVDFNEVNNA---------------SIMRQLLDGLSYCHKR 274
            +VFEYM H DL   L +   D   + +                 I  Q+  G+ Y   +
Sbjct: 93  IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ 152

Query: 275 NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGEE 333
           +F+HRD+   N L+     VK+ DFG++R   + D  R   + ++ + W  PPE ++   
Sbjct: 153 HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPESIM-YR 210

Query: 334 RYGPAIDVWSCGCILGELF 352
           ++    DVWS G IL E+F
Sbjct: 211 KFTTESDVWSFGVILWEIF 229

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 60/256 (23%), Positives = 98/256 (38%), Gaps = 51/256 (19%)

Query: 130 MEMQAAAPIQSNSTNNSSRPLMEPLAAGGLSLNNFSV----------------SLFTDEL 173
           M+  AA P     +   ++P   P         +F                   L T   
Sbjct: 1   MDGTAAEPRPGAGSLQHAQP---PPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSRE 57

Query: 174 VALK---KVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            A+K   K  +  E +   +  V  E  ++ +L+H   V L            F +D   
Sbjct: 58  YAIKILEKRHIIKENK---VPYVTRERDVMSRLDHPFFVKLY---------FTF-QDDEK 104

Query: 230 FYLVFEYMDH-DLMGLLE-SGMVDFNEVNNASIMR----QLLDGLSYCHKRNFLHRDIKC 283
            Y    Y  + +L+  +   G   F+E    +  R    +++  L Y H +  +HRD+K 
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGS--FDE----TCTRFYTAEIVSALEYLHGKGIIHRDLKP 158

Query: 284 SNILMNNRGEVKLADFGLA-RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
            NIL+N    +++ DFG A  L     + R  +  V T  Y  PELL  +     + D+W
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSPELLTEKS-ACKSSDLW 216

Query: 343 SCGCILGELFVKKPLF 358
           + GCI+ +L    P F
Sbjct: 217 ALGCIIYQLVAGLPPF 232

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 45/200 (22%), Positives = 82/200 (41%), Gaps = 36/200 (18%)

Query: 173 LVALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            VA+K ++       +E F      E  +  +L H N+V L  +VT              
Sbjct: 41  AVAIKTLKDKAEGPLREEF----RHEAMLRARLQHPNVVCLLGVVTKD----------QP 86

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNA---------------SIMRQLLDGLSYCHK 273
             ++F Y  H DL   L       +  +                  ++ Q+  G+ Y   
Sbjct: 87  LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146

Query: 274 RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGE 332
            + +H+D+   N+L+ ++  VK++D GL R   A D  +   N ++ + W   PE ++  
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM-APEAIM-Y 204

Query: 333 ERYGPAIDVWSCGCILGELF 352
            ++    D+WS G +L E+F
Sbjct: 205 GKFSIDSDIWSYGVVLWEVF 224

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 84.6 bits (210), Expect = 9e-19
 Identities = 54/201 (26%), Positives = 81/201 (40%), Gaps = 37/201 (18%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++      E+E      + E+K+L  L NH NIVNL    T            G 
Sbjct: 56  VAVKMLKPSAHLTEREAL----MSELKVLSYLGNHMNIVNLLGACTIG----------GP 101

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASI----------MRQLLD-------GLSYC 271
             ++ EY  + DL+  L      F     +            +  LL        G+++ 
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 272 HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG 331
             +N +HRD+   NIL+ +    K+ DFGLAR    +       N  + + +  PE +  
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF- 220

Query: 332 EERYGPAIDVWSCGCILGELF 352
              Y    DVWS G  L ELF
Sbjct: 221 NCVYTFESDVWSYGIFLWELF 241

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 37/200 (18%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++    E +        V E+++++ +  HKNI+NL    T            G 
Sbjct: 70  VAVKMLKDDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGACTQD----------GP 115

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNA---------------SIMRQLLDGLSYCHK 273
            Y++ EY    +L   L +      E +                 S   QL  G+ Y   
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 274 RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGE 332
           +  +HRD+   N+L+     +K+ADFGLAR  N  D  +  TN  + + W   PE L  +
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALF-D 233

Query: 333 ERYGPAIDVWSCGCILGELF 352
             Y    DVWS G ++ E+F
Sbjct: 234 RVYTHQSDVWSFGVLMWEIF 253

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 53/168 (31%), Positives = 72/168 (42%), Gaps = 17/168 (10%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFN 253
           E  I+   N   +V L            F +D    Y+V EYM   DL+ L+ +   D  
Sbjct: 119 ERDIMAFANSPWVVQLF---------YAF-QDDRYLYMVMEYMPGGDLVNLMSNY--DVP 166

Query: 254 EVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRP 313
           E        +++  L   H   F+HRD+K  N+L++  G +KLADFG     N E   R 
Sbjct: 167 EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226

Query: 314 YTNKVITLWYRPPELLLGE---ERYGPAIDVWSCGCILGELFVKKPLF 358
            T  V T  Y  PE+L  +     YG   D WS G  L E+ V    F
Sbjct: 227 DT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 26/208 (12%), Positives = 49/208 (23%), Gaps = 53/208 (25%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDEL----VALKKVRLE-NEKEGFPITAVREIKILRQLNH 204
           L+                   D      VAL  V  +    +      +     L +++ 
Sbjct: 35  LLIFHGGVPPL----QFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQ 263
             +  +          LD    +    +V E++    L  + ++             M+ 
Sbjct: 91  PGVARV----------LDVVHTRAGGLVVAEWIRGGSLQEVADTSP-SPVGA--IRAMQS 137

Query: 264 LLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
           L       H+          S + ++  G+V LA                          
Sbjct: 138 LAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------T 175

Query: 324 RPPELLLGEERYGPAIDVWSCGCILGEL 351
            P           P  D+   G  L  L
Sbjct: 176 MPDA--------NPQDDIRGIGASLYAL 195

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 33/197 (16%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++     +EKE      + E+KI+  L  H+NIVNL    T            G 
Sbjct: 79  VAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHG----------GP 124

Query: 230 FYLVFEYMDH-DLMGLL-----ESGMVDFNEVNNASI-MRQLLD-------GLSYCHKRN 275
             ++ EY  + DL+  L              + N++   R LL        G+++   +N
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184

Query: 276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
            +HRD+   N+L+ N    K+ DFGLAR    +       N  + + +  PE +  +  Y
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVY 243

Query: 336 GPAIDVWSCGCILGELF 352
               DVWS G +L E+F
Sbjct: 244 TVQSDVWSYGILLWEIF 260

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 44/207 (21%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF 230
           VA+K ++     +E        + E  +L+Q+NH +++ L    +            G  
Sbjct: 56  VAVKMLKENASPSELRDL----LSEFNVLKQVNHPHVIKLYGACSQD----------GPL 101

Query: 231 YLVFEYMDH-DLMG-LLESGMVDFNEVNNA----------------------SIMRQLLD 266
            L+ EY  +  L G L ES  V    + +                       S   Q+  
Sbjct: 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQ 161

Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRP 325
           G+ Y  +   +HRD+   NIL+    ++K++DFGL+R    ED     +   I + W   
Sbjct: 162 GMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM-A 220

Query: 326 PELLLGEERYGPAIDVWSCGCILGELF 352
            E L  +  Y    DVWS G +L E+ 
Sbjct: 221 IESLF-DHIYTTQSDVWSFGVLLWEIV 246

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 34/199 (17%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++     +E        + E+KIL  + +H N+VNL    T            G 
Sbjct: 60  VAVKMLKEGATHSEHRAL----MSELKILIHIGHHLNVVNLLGACTKPG---------GP 106

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNA---------------SIMRQLLDGLSYCHK 273
             ++ E+    +L   L S   +F     A                   Q+  G+ +   
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166

Query: 274 RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE 333
           R  +HRD+   NIL++ +  VK+ DFGLAR    +       +  + L +  PE +  + 
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DR 225

Query: 334 RYGPAIDVWSCGCILGELF 352
            Y    DVWS G +L E+F
Sbjct: 226 VYTIQSDVWSFGVLLWEIF 244

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 37/200 (18%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++    E +        V E+++++ +  HKNI+NL    T            G 
Sbjct: 116 VAVKMLKDDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGACTQD----------GP 161

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNA---------------SIMRQLLDGLSYCHK 273
            Y++ EY    +L   L +      E +                 S   QL  G+ Y   
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 274 RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYRPPELLLGE 332
           +  +HRD+   N+L+     +K+ADFGLAR  N  D  +  TN  + + W   PE L  +
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM-APEALF-D 279

Query: 333 ERYGPAIDVWSCGCILGELF 352
             Y    DVWS G ++ E+F
Sbjct: 280 RVYTHQSDVWSFGVLMWEIF 299

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 50/170 (29%), Positives = 74/170 (43%), Gaps = 18/170 (10%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFN 253
           E  +L   + K I  L            F +D  + YLV +Y    DL+ LL        
Sbjct: 124 ERDVLVNGDSKWITTLH---------YAF-QDDNNLYLVMDYYVGGDLLTLLSKFEDRLP 173

Query: 254 EVNNASI-MRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQR 312
           E   A   + +++  +   H+ +++HRDIK  NILM+  G ++LADFG       +   +
Sbjct: 174 E-EMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 313 PYTNKVITLWYRPPELLLGEE----RYGPAIDVWSCGCILGELFVKKPLF 358
                V T  Y  PE+L   E    RYGP  D WS G  + E+   +  F
Sbjct: 233 SSV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 27/201 (13%)

Query: 170 TDELVALKKVR----LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T ++ A+K +     L+  +         E  +L   + + I  L            F +
Sbjct: 85  TGQVYAMKIMNKWDMLKRGEVSCFRE---ERDVLVNGDRRWITQLH---------FAF-Q 131

Query: 226 DKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASI-MRQLLDGLSYCHKRNFLHRDIKC 283
           D+   YLV EY    DL+ LL            A   + +++  +   H+  ++HRDIK 
Sbjct: 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPA-EMARFYLAEIVMAIDSVHRLGYVHRDIKP 190

Query: 284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE------RYGP 337
            NIL++  G ++LADFG      A+   R     V T  Y  PE+L           YGP
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGP 249

Query: 338 AIDVWSCGCILGELFVKKPLF 358
             D W+ G    E+F  +  F
Sbjct: 250 ECDWWALGVFAYEMFYGQTPF 270

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 82.4 bits (204), Expect = 9e-18
 Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 43/203 (21%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++    E +        + E+++++ +  HKNI+NL    T            G 
Sbjct: 104 VAVKMLKSDATEKDLSDL----ISEMEMMKMIGKHKNIINLLGACTQD----------GP 149

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNA---------------SIMRQLLDGLSYCHK 273
            Y++ EY    +L   L++      E +                 S   Q+  G+ Y   
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 274 RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL----WYRPPELL 329
           +  +HRD+   N+L+     +K+ADFGLAR  +  D    Y           W   PE L
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY---YKKTTNGRLPVKWM-APEAL 265

Query: 330 LGEERYGPAIDVWSCGCILGELF 352
             +  Y    DVWS G +L E+F
Sbjct: 266 F-DRIYTHQSDVWSFGVLLWEIF 287

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 61/258 (23%), Positives = 98/258 (37%), Gaps = 62/258 (24%)

Query: 154 LAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNL-RE 212
           L  G  S    S  +   + VA+K V+     E +  TA+ EI++L+ + + +  +  RE
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 213 IVTDKSDALDFRKDKGSFY-LVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSY 270
           +V    D        G+   +VFE + H L+  +  S            I++Q+L GL Y
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 271 CHKR-NFLHRDIKCSNILMN---------------------------------------- 289
            H +   +H DIK  NIL++                                        
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Query: 290 ---------NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
                     + +VK+AD G A   +     + +T  + T  YR  E+L+G   Y    D
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVH-----KHFTEDIQTRQYRSLEVLIGSG-YNTPAD 275

Query: 341 VWSCGCILGELFVKKPLF 358
           +WS  C+  EL     LF
Sbjct: 276 IWSTACMAFELATGDYLF 293

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 43.4 bits (102), Expect = 7e-05
 Identities = 14/29 (48%), Positives = 18/29 (62%)

Query: 68  LDLLDKMLELDPERRITAEQALKSVWLKN 96
            D L  MLEL PE+R TA + L+  WL +
Sbjct: 369 TDFLLPMLELIPEKRATAAECLRHPWLNS 397

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 81.1 bits (199), Expect = 2e-17
 Identities = 35/215 (16%), Positives = 59/215 (27%), Gaps = 50/215 (23%)

Query: 170 TDELVALKKVRLEN------EKEGFPITAVREIKILRQL---------NHKNIVNLRE-- 212
               VA+K + +E         +      + EI I ++L           +  + L    
Sbjct: 42  DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101

Query: 213 IVTDKSDAL------DFRKDKGS------------FYLVFEYMDHDLMGLLESGMVDFNE 254
            V      L       +   KGS             ++V E+     + L +      + 
Sbjct: 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG-IDLEQMRTKLSSL 160

Query: 255 VNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED---- 309
               SI+ QL   L+       F HRD+   N+L+      KL      +          
Sbjct: 161 ATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQ 220

Query: 310 ---------RQRPYTNKVITLWYRPPELLLGEERY 335
                    R       V        +L  G+  Y
Sbjct: 221 VSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDY 255

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 44/208 (21%)

Query: 173 LVALKKVR---LENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           +VA+K ++     + +  F     RE  ++ + ++ NIV L  +                
Sbjct: 79  MVAVKMLKEEASADMQADF----QREAALMAEFDNPNIVKLLGVCAVG----------KP 124

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNA-----------------------SIMRQLL 265
             L+FEYM + DL   L S         +                         I RQ+ 
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184

Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITL-WYR 324
            G++Y  +R F+HRD+   N L+     VK+ADFGL+R   + D  +   N  I + W  
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM- 243

Query: 325 PPELLLGEERYGPAIDVWSCGCILGELF 352
           PPE +    RY    DVW+ G +L E+F
Sbjct: 244 PPESIF-YNRYTTESDVWAYGVVLWEIF 270

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 42/206 (20%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS 229
           VA+K ++     +E+E      + E+K++ QL +H+NIVNL    T            G 
Sbjct: 78  VAVKMLKEKADSSEREAL----MSELKMMTQLGSHENIVNLLGACTLS----------GP 123

Query: 230 FYLVFEYMDH-DL---------------MGLLESGMVDFNEVNNASIMRQLL-------D 266
            YL+FEY  + DL               +       ++  E  N      LL        
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183

Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPP 326
           G+ +   ++ +HRD+   N+L+ +   VK+ DFGLAR   ++       N  + + +  P
Sbjct: 184 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243

Query: 327 ELLLGEERYGPAIDVWSCGCILGELF 352
           E L  E  Y    DVWS G +L E+F
Sbjct: 244 ESLF-EGIYTIKSDVWSYGILLWEIF 268

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 19/193 (9%)

Query: 170 TDELVALKKVRLEN--EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T ++ A KK+  +   +++G  +    E +IL ++N + +V+L         A  + + K
Sbjct: 208 TGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSRFVVSL---------AYAY-ETK 256

Query: 228 GSFYLVFEYMDH-DLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
            +  LV   M+  DL   +   G   F E        ++  GL   H+   ++RD+K  N
Sbjct: 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           IL+++ G ++++D GLA   +  + Q     +V T+ Y  PE++   ERY  + D W+ G
Sbjct: 317 ILLDDHGHIRISDLGLAV--HVPEGQTIKG-RVGTVGYMAPEVVKN-ERYTFSPDWWALG 372

Query: 346 CILGELFVKKPLF 358
           C+L E+   +  F
Sbjct: 373 CLLYEMIAGQSPF 385

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 76/339 (22%), Positives = 131/339 (38%), Gaps = 52/339 (15%)

Query: 54  RRLREEF---SLMPPGALDLLDKMLE---LDPERRITAEQALKSVWLKNVHPESMPPPQL 107
           +RL ++F         AL L   + +    D   R    QAL++ +L+            
Sbjct: 69  KRLFQQFLRTHEQHGPALQLWKDIEDYDTADDALRPQKAQALRAAYLEPQAQLFCSFLDA 128

Query: 108 PTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQS--NSTNNSSRPLMEPLAAGGLSLNNFS 165
            T             + L    +     AP Q   +S         + L A  +  + F 
Sbjct: 129 ETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFL 188

Query: 166 ------------VSL----FTDELVALKKVRLEN--EKEGFPITAVREIKILRQLNHKNI 207
                       V       T +L A KK+  +   +++G+    V E KIL +++ + I
Sbjct: 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-EKKILAKVHSRFI 247

Query: 208 VNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLM---GLLESGMVDFNEVNNASIMR- 262
           V+L         A  F + K    LV   M+  D+      ++     F E         
Sbjct: 248 VSL---------AYAF-ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE----PRAIF 293

Query: 263 ---QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI 319
              Q++ GL + H+RN ++RD+K  N+L+++ G V+++D GLA       + +       
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTKTKG-YAG 351

Query: 320 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           T  +  PELLLG E Y  ++D ++ G  L E+   +  F
Sbjct: 352 TPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 38/199 (19%)

Query: 174 VALKKVR---LENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGS 229
            A+K+++    +++   F      E+++L +L +H NI+NL      +          G 
Sbjct: 55  AAIKRMKEYASKDDHRDF----AGELEVLCKLGHHPNIINLLGACEHR----------GY 100

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASI--------MRQLLD-------GLSYCHK 273
            YL  EY  H +L+  L    V   +   A           +QLL        G+ Y  +
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160

Query: 274 RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE 333
           + F+HRD+   NIL+      K+ADFGL+R    ++     T   + + +   E L    
Sbjct: 161 KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLN-YS 216

Query: 334 RYGPAIDVWSCGCILGELF 352
            Y    DVWS G +L E+ 
Sbjct: 217 VYTTNSDVWSYGVLLWEIV 235

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 47/196 (23%), Positives = 86/196 (43%), Gaps = 24/196 (12%)

Query: 170 TDELVA---LKKVRLENEKEGFPITAVREIKILRQLNHKN---IVNLREIVTDKSDALDF 223
           T ++ A   L K R++ ++      A+ E  +L  ++  +   IV +         +  F
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGE--TLALNERIMLSLVSTGDCPFIVCM---------SYAF 261

Query: 224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIK 282
                    + + M+  DL   L      F+E +      +++ GL + H R  ++RD+K
Sbjct: 262 -HTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319

Query: 283 CSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVW 342
            +NIL++  G V+++D GLA    ++ +       V T  Y  PE+L     Y  + D +
Sbjct: 320 PANILLDEHGHVRISDLGLAC-DFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWF 375

Query: 343 SCGCILGELFVKKPLF 358
           S GC+L +L      F
Sbjct: 376 SLGCMLFKLLRGHSPF 391

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 37/178 (20%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF------YLVFEYMDH-DLMGLLE 246
           +E++I++ L H  +VNL                  SF      ++V + +   DL   L+
Sbjct: 64  KELQIMQGLEHPFLVNLW----------------YSFQDEEDMFMVVDLLLGGDLRYHLQ 107

Query: 247 SGMVDFNEVNNASIMR----QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA 302
              V F E      ++    +L+  L Y   +  +HRD+K  NIL++  G V + DF +A
Sbjct: 108 Q-NVHFKE----ETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162

Query: 303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFVKKPLF 358
            +       +  T    T  Y  PE+    +   Y  A+D WS G    EL   +  +
Sbjct: 163 AML--PRETQITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 24/125 (19%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNE 254
           EI+ L    H ++V+L          + F  ++    L+++YM++   G L+  +  +  
Sbjct: 85  EIETLSFCRHPHLVSL----------IGFCDERNEMILIYKYMEN---GNLKRHL--YGS 129

Query: 255 VNNASIM--RQLLD-------GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY 305
                 M   Q L+       GL Y H R  +HRD+K  NIL++     K+ DFG+++  
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189

Query: 306 NAEDR 310
              D+
Sbjct: 190 TELDQ 194

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.8 bits (177), Expect = 2e-14
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 37/196 (18%)

Query: 171 DELVALKKVRLENEKEG------FPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           +  VA+KK+    +         F     +EIK++ +  H+N+V L    +D  D     
Sbjct: 54  NTTVAVKKLAAMVDITTEELKQQF----DQEIKVMAKCQHENLVELLGFSSDGDDLC--- 106

Query: 225 KDKGSFYLVFEYM-----DHDLMGLLESGMVDFNEVNNASIMRQLLD---GLSYCHKRNF 276
                  LV+ YM        L  L  +  + ++        +       G+++ H+ + 
Sbjct: 107 -------LVYVYMPNGSLLDRLSCLDGTPPLSWH-----MRCKIAQGAANGINFLHENHH 154

Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERY 335
           +HRDIK +NIL++     K++DFGLAR      +    T++++ T  Y  PE L G    
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV-MTSRIVGTTAYMAPEALRG--EI 211

Query: 336 GPAIDVWSCGCILGEL 351
            P  D++S G +L E+
Sbjct: 212 TPKSDIYSFGVVLLEI 227

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 26/169 (15%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFN 253
           E +IL+ +N   +V L            F KD  + Y+V EY+   ++   L   +  F+
Sbjct: 91  EKRILQAVNFPFLVKLE---------FSF-KDNSNLYMVMEYVAGGEMFSHLRR-IGRFS 139

Query: 254 EVNNASIMR----QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED 309
           E       R    Q++    Y H  + ++RD+K  N+L++ +G +++ DFG A+      
Sbjct: 140 E----PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RV 191

Query: 310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + R +T    T     PE++L  + Y  A+D W+ G ++ E+    P F
Sbjct: 192 KGRTWT-LCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF 238

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 37/177 (20%), Positives = 68/177 (38%), Gaps = 22/177 (12%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA--------- 220
             E  A   V++E ++ G       E+K  +++  K+ +                     
Sbjct: 61  KPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117

Query: 221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
           L   K +   ++V E +  DL  +       F +     +  ++LD L Y H+  ++H D
Sbjct: 118 LTEFKGRSYRFMVMERLGIDLQKISGQNGT-FKKSTVLQLGIRMLDVLEYIHENEYVHGD 176

Query: 281 IKCSNILM--NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           IK +N+L+   N  +V LAD+GL+  Y      + Y          P +   G   +
Sbjct: 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ-------ENPRKGHNGTIEF 226

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 44/174 (25%), Positives = 66/174 (37%), Gaps = 25/174 (14%)

Query: 166 VSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH-KNIVNLREIVTDKSDALDFR 224
             +   E VA+K    E  K   P     E KI + +     I  +R             
Sbjct: 29  TDIAAGEEVAIKL---ECVKTKHP-QLHIESKIYKMMQGGVGIPTIR----------WCG 74

Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
            +     +V E +   L  L       F+      +  Q++  + Y H +NF+HRD+K  
Sbjct: 75  AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 134

Query: 285 NILM---NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           N LM        V + DFGLA+ Y     +   T++ I   YR  + L G  RY
Sbjct: 135 NFLMGLGKKGNLVYIIDFGLAKKY-----RDARTHQHIP--YRENKNLTGTARY 181

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 57/181 (31%)

Query: 173 LVALKKVRLE----NEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           LVA+K+++ E     E + F      E++++    H+N++ LR      ++ L       
Sbjct: 56  LVAVKRLKEERTQGGELQ-F----QTEVEMISMAVHRNLLRLRGFCMTPTERL------- 103

Query: 229 SFYLVFEYM-----DHDLMGLLESGMVDFNEVNNASIMRQLLD-------------GLSY 270
              LV+ YM        L    ES              +  LD             GL+Y
Sbjct: 104 ---LVYPYMANGSVASCLRERPES--------------QPPLDWPKRQRIALGSARGLAY 146

Query: 271 CHKR---NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPP 326
            H       +HRD+K +NIL++   E  + DFGLA+L   + +    T  V  T+ +  P
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAP 204

Query: 327 E 327
           E
Sbjct: 205 E 205

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.3 bits (168), Expect = 4e-13
 Identities = 41/172 (23%), Positives = 75/172 (43%), Gaps = 32/172 (18%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMD-HDLMGLLE-SGMVDF 252
           E  +L  + H  I+ +            F +D    +++ +Y++  +L  LL  S    F
Sbjct: 56  ERLMLSIVTHPFIIRMW---------GTF-QDAQQIFMIMDYIEGGELFSLLRKSQR--F 103

Query: 253 NEVNNASIMR----QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAE 308
                  + +    ++   L Y H ++ ++RD+K  NIL++  G +K+ DFG A+     
Sbjct: 104 PN----PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK----Y 155

Query: 309 DRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                YT   +  T  Y  PE++   + Y  +ID WS G ++ E+      F
Sbjct: 156 VPDVTYT---LCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPF 203

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 11/132 (8%)

Query: 231 YLVFEYMDH-DLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           Y V EY++  DLM  + + G   F E +      ++  GL +   +  ++RD+K  N+++
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGC 346
           ++ G +K+ADFG+ +  N  D     T      T  Y  PE++  +  YG ++D W+ G 
Sbjct: 476 DSEGHIKIADFGMCKE-NIWDGVTTKT---FCGTPDYIAPEIIAYQP-YGKSVDWWAFGV 530

Query: 347 ILGELFVKKPLF 358
           +L E+   +  F
Sbjct: 531 LLYEMLAGQAPF 542

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 36/181 (19%), Positives = 63/181 (34%), Gaps = 29/181 (16%)

Query: 167 SLFTDELVALK----KVRLENEKEGFPITA----VREIKILRQLNHKNIVNLREIVTDKS 218
           S    +  +LK      RL NE+  F   A    V + K L       I           
Sbjct: 71  SGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM------- 123

Query: 219 DALDFRKDKGSF-YLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNF 276
               F   +  + +LV   +   L   L+ S     +E +   +  +LLD L + H+  +
Sbjct: 124 ---GFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY 180

Query: 277 LHRDIKCSNILM--NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER 334
           +H ++   NI +   ++ +V LA +G A  Y    +   Y                G+  
Sbjct: 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV-------EGSRSPHEGDLE 233

Query: 335 Y 335
           +
Sbjct: 234 F 234

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 47/192 (24%), Positives = 74/192 (38%), Gaps = 27/192 (14%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIV 208
           + + +  G         +L+T+E VA+K   LE  K   P     E +  +QL +   I 
Sbjct: 13  VGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAP-QLHLEYRFYKQLGSGDGIP 68

Query: 209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGL 268
            +            F        +V E +   L  L +     F+      I  QL+  +
Sbjct: 69  QVY----------YFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118

Query: 269 SYCHKRNFLHRDIKCSNILM-----NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWY 323
            Y H +N ++RD+K  N L+       +  + + DF LA+ Y       P T K I   Y
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY-----IDPETKKHIP--Y 171

Query: 324 RPPELLLGEERY 335
           R  + L G  RY
Sbjct: 172 REHKSLTGTARY 183

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 68.0 bits (167), Expect = 6e-13
 Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 40/203 (19%)

Query: 170 TDELVA---LKKVRLENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T    A   L+K  +  + E   +     E ++L+   H  +  L               
Sbjct: 29  TGRYYAMKILRKEVIIAKDE---VAHTVTESRVLQNTRHPFLTAL--------------- 70

Query: 226 DKGSF------YLVFEYMDH-DLMGLLESGMVDFNEVNNASI-MRQLLDGLSYCHKRNFL 277
            K +F        V EY +  +L   L    V F E   A     +++  L Y H R+ +
Sbjct: 71  -KYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTE-ERARFYGAEIVSALEYLHSRDVV 127

Query: 278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERY 335
           +RDIK  N++++  G +K+ DFGL +     D     T      T  Y  PE+L   + Y
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKT---FCGTPEYLAPEVLEDND-Y 182

Query: 336 GPAIDVWSCGCILGELFVKKPLF 358
           G A+D W  G ++ E+   +  F
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 67.2 bits (165), Expect = 9e-13
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 43/205 (20%)

Query: 170 TDELVALKKVR----LENEKEGFPITAVR-EIKILRQLNHKNIVNLREIVTDKSDALDFR 224
           T ++ A+K ++    + N K+       + E  IL ++ H  IV+L              
Sbjct: 44  TGKIFAMKVLKKAMIVRNAKD---TAHTKAERNILEEVKHPFIVDL-------------- 86

Query: 225 KDKGSF------YLVFEYMDH-DLMGLLE-SGMVDFNEVNNASI-MRQLLDGLSYCHKRN 275
               +F      YL+ EY+   +L   LE  G+  F E + A   + ++   L + H++ 
Sbjct: 87  --IYAFQTGGKLYLILEYLSGGELFMQLEREGI--FME-DTACFYLAEISMALGHLHQKG 141

Query: 276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEE 333
            ++RD+K  NI++N++G VKL DFGL +  +  D    +T      T+ Y  PE+L+   
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHT---FCGTIEYMAPEILMRSG 197

Query: 334 RYGPAIDVWSCGCILGELFVKKPLF 358
            +  A+D WS G ++ ++    P F
Sbjct: 198 -HNRAVDWWSLGALMYDMLTGAPPF 221

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 33/153 (21%), Positives = 57/153 (37%), Gaps = 18/153 (11%)

Query: 194 REIKILRQLNHKNIVNLREIVTDKSDA---------LDFRKDKGSFYLVFEYMDHDLMGL 244
            E+K  ++      +                     L  +  K   +++ +    DL  +
Sbjct: 82  TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKI 141

Query: 245 LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN--NRGEVKLADFGLA 302
            E+    F+      +  ++LD L Y H+  ++H DIK SN+L+N  N  +V L D+GLA
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

Query: 303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
             Y  E   + Y          P     G   +
Sbjct: 202 YRYCPEGVHKAYA-------ADPKRCHDGTIEF 227

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 35/175 (20%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF------YLVFEYMDH-DLMGLLE- 246
           E  IL ++NH  IV L                  +F      YL+ +++   DL   L  
Sbjct: 76  ERDILVEVNHPFIVKL----------------HYAFQTEGKLYLILDFLRGGDLFTRLSK 119

Query: 247 SGMVDFNEVNNASI-MRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY 305
             M  F E  +    + +L   L + H    ++RD+K  NIL++  G +KL DFGL++  
Sbjct: 120 EVM--FTE-EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE- 175

Query: 306 NAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           + +  ++ Y+      T+ Y  PE++     +  + D WS G ++ E+      F
Sbjct: 176 SIDHEKKAYS---FCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPF 226

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 49/174 (28%), Positives = 74/174 (42%), Gaps = 25/174 (14%)

Query: 166 VSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFR 224
            ++ T+E VA+K    EN K   P   + E KI R L     I N+R           F 
Sbjct: 27  TNIQTNEEVAIKL---ENVKTKHP-QLLYESKIYRILQGGTGIPNVR----------WFG 72

Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
            +     LV + +   L  L        +      +  Q+++ + + H ++FLHRDIK  
Sbjct: 73  VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132

Query: 285 NILM---NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           N LM       +V + DFGLA+ Y     +   T++ I   YR  + L G  RY
Sbjct: 133 NFLMGLGRRANQVYIIDFGLAKKY-----RDTSTHQHIP--YRENKNLTGTARY 179

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 11/132 (8%)

Query: 231 YLVFEYMDH-DLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           Y V EY++  DLM  + + G   F E +      ++  GL +   +  ++RD+K  N+++
Sbjct: 97  YFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGC 346
           ++ G +K+ADFG+ +  N  D     T      T  Y  PE++  +  YG ++D W+ G 
Sbjct: 155 DSEGHIKIADFGMCKE-NIWDGVTTKT---FCGTPDYIAPEIIAYQP-YGKSVDWWAFGV 209

Query: 347 ILGELFVKKPLF 358
           +L E+   +  F
Sbjct: 210 LLYEMLAGQAPF 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 12/134 (8%)

Query: 231 YLVFEYMDH-DLMGLLE-SGMVDFNEVNNASI-MRQLLDGLSYCHKRNFLHRDIKCSNIL 287
           +L+ +Y++  +L   L       F E +   I + +++  L + HK   ++RDIK  NIL
Sbjct: 135 HLILDYINGGELFTHLSQRER--FTE-HEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEER-YGPAIDVWSC 344
           +++ G V L DFGL++ + A++ +R Y       T+ Y  P+++ G +  +  A+D WS 
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYD---FCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248

Query: 345 GCILGELFVKKPLF 358
           G ++ EL      F
Sbjct: 249 GVLMYELLTGASPF 262

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.3 bits (160), Expect = 5e-12
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 7/130 (5%)

Query: 231 YLVFEYMDH-DLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           + V EY++  DLM  +       F+         +++ GL + H +  ++RD+K  NIL+
Sbjct: 94  FFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  G +K+ADFG+ +  N     +  T    T  Y  PE+LLG++ Y  ++D WS G +L
Sbjct: 152 DKDGHIKIADFGMCKE-NMLGDAKTNT-FCGTPDYIAPEILLGQK-YNHSVDWWSFGVLL 208

Query: 349 GELFVKKPLF 358
            E+ + +  F
Sbjct: 209 YEMLIGQSPF 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 29/101 (28%), Positives = 53/101 (52%), Gaps = 13/101 (12%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYT-----NK 317
           ++   L+Y H+R  ++RD+K  N+L+++ G +KL D+G+ +           T     N 
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPN- 175

Query: 318 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
                Y  PE+L GE+ YG ++D W+ G ++ E+   +  F
Sbjct: 176 -----YIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 210

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 11/132 (8%)

Query: 231 YLVFEYMDH-DLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           + V E+++  DLM  + +S    F+E        +++  L + H +  ++RD+K  N+L+
Sbjct: 100 FFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGC 346
           ++ G  KLADFG+ +     +     T      T  Y  PE+L     YGPA+D W+ G 
Sbjct: 158 DHEGHCKLADFGMCKE-GICNGVTTAT---FCGTPDYIAPEILQEML-YGPAVDWWAMGV 212

Query: 347 ILGELFVKKPLF 358
           +L E+      F
Sbjct: 213 LLYEMLCGHAPF 224

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 41/176 (23%), Positives = 71/176 (40%), Gaps = 27/176 (15%)

Query: 166 VSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFR 224
            +L  ++ VA+K    E  +   P     E +  + L     I N+            F 
Sbjct: 30  TNLLNNQQVAIKF---EPRRSDAP-QLRDEYRTYKLLAGCTGIPNVY----------YFG 75

Query: 225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCS 284
           ++     LV + +   L  LL+     F+    A   +Q+L  +   H+++ ++RDIK  
Sbjct: 76  QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 135

Query: 285 NILM-----NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERY 335
           N L+      N   + + DFG+ + Y     + P T + I   YR  + L G  RY
Sbjct: 136 NFLIGRPNSKNANMIYVVDFGMVKFY-----RDPVTKQHIP--YREKKNLSGTARY 184

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 28/172 (16%)

Query: 195 EIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSF------YLVFEYMDH-DLMGLLES 247
           E ++L+   H  +  L                K SF        V EY +  +L   L  
Sbjct: 198 ENRVLQNSRHPFLTAL----------------KYSFQTHDRLCFVMEYANGGELFFHLSR 241

Query: 248 GMVDFNEVNNASIMRQLLDGLSYCH-KRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN 306
             V F+E        +++  L Y H ++N ++RD+K  N++++  G +K+ DFGL +   
Sbjct: 242 ERV-FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-G 299

Query: 307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            +D     T    T  Y  PE+L   + YG A+D W  G ++ E+   +  F
Sbjct: 300 IKDGATMKT-FCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF 349

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 13/97 (13%)

Query: 267 GLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYT-----NKVITL 321
            L+Y H+R  ++RD+K  N+L+++ G +KL D+G+ +           T     N     
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPN----- 218

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            Y  PE+L GE+ YG ++D W+ G ++ E+   +  F
Sbjct: 219 -YIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 253

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 7/98 (7%)

Query: 263 QLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVI--T 320
           ++   L Y H  N ++RD+K  NIL++++G + L DFGL +  N E      T      T
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTST---FCGT 202

Query: 321 LWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
             Y  PE+L  +  Y   +D W  G +L E+    P F
Sbjct: 203 PEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPF 239

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 1/94 (1%)

Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKV 318
               Q+  G+ +   R  +HRD+   NIL++ +  VK+ DFGLAR    +       +  
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256

Query: 319 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
           + L +  PE +  +  Y    DVWS G +L E+F
Sbjct: 257 LPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIF 289

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 4e-06
 Identities = 50/339 (14%), Positives = 92/339 (27%), Gaps = 107/339 (31%)

Query: 40  LPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPER-----RITAEQ------- 87
           L  +   +P+      L  E     P  L ++ + +            +  ++       
Sbjct: 307 LLKYLDCRPQD-----LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361

Query: 88  ---ALKSVWLKN------VHPESMP-PPQ-LPTWQDCHELWSKKRRRQLRGDPMEMQAAA 136
               L+    +       V P S   P   L        +W    +     D M +    
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL------IWFDVIKS----DVMVV---- 407

Query: 137 PIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREI 196
               N  +  S      L          ++S+    +    KV+LENE            
Sbjct: 408 ---VNKLHKYS------LVEK--QPKESTISI--PSIYLELKVKLENEY----------- 443

Query: 197 KILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVN 256
                L H++IV+   I     D+ D        Y  + ++ H L  +     +      
Sbjct: 444 ----AL-HRSIVDHYNI-PKTFDSDDLIPPYLDQY-FYSHIGHHLKNIEHPERMTL---- 492

Query: 257 NASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK--LADFGLARLYNAEDRQRPY 314
                R +   L +     FL + I+  +   N  G +   L      + Y      +PY
Sbjct: 493 ----FRMVF--LDF----RFLEQKIRHDSTAWNASGSILNTLQQL---KFY------KPY 533

Query: 315 TNKVITLWYRPPELLLGE-----ERYGPAIDVWSCGCIL 348
               I       E L+        +    +       +L
Sbjct: 534 ----ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLL 568

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 1e-04
 Identities = 55/383 (14%), Positives = 113/383 (29%), Gaps = 124/383 (32%)

Query: 41  PLWHTIKP-KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRIT------------AEQ 87
            L++  +   K +  RL+          L L   +LEL P + +             A  
Sbjct: 118 RLYNDNQVFAKYNVSRLQPY--------LKLRQALLELRPAKNVLIDGVLGSGKTWVALD 169

Query: 88  ALKSV-----------WLK--NVH-PESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQ 133
              S            WL   N + PE++        +  +++         R D     
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML---QKLLYQI---DPNWTSRSDHSS-- 221

Query: 134 AAAPIQSNSTNNSSRPLM--EPLAAGGLSLNN---------FSVS---LFT-------DE 172
               ++ +S     R L+  +P     L L N         F++S   L T       D 
Sbjct: 222 -NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDF 280

Query: 173 LVAL--KKVRLENEKEGF----------------------------P-----ITAVREIK 197
           L A     + L++                                 P     I       
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340

Query: 198 ILR--QLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-----DLMGLL----- 245
           +       H N   L  I+    + L+  + +  F  +  +         L+ L+     
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVI 400

Query: 246 -ESGMVDFNEVNNAS-IMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEV--KLAD-FG 300
               MV  N+++  S + +Q  +          ++ ++K     + N   +   + D + 
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPS---IYLELKVK---LENEYALHRSIVDHYN 454

Query: 301 LARLYNAEDRQRPYTNKVITLWY 323
           + + ++++D   PY ++     +
Sbjct: 455 IPKTFDSDDLIPPYLDQYF-YSH 476

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	358
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.2
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.11
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.08
3niz_A	311	Rhodanese family protein; structural genomics, str	99.04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.02
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	98.97
3o0g_A	292	Cell division protein kinase 5; kinase activator c	98.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	98.96
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	98.95
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	98.95
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	98.94
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	98.87
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	98.84
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	98.83
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	98.78
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	98.77
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	98.76
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	98.75
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	98.73
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	98.72
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	98.71
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	98.7
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	98.61
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.6
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	98.59
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	98.53
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	98.51
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.48
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	98.47
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	98.45
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	98.43
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.38
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	98.37
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	98.35
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.34
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	98.29
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	98.26
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	98.24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	98.21
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.21
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	98.19
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	98.14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	98.11
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	98.1
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	98.04
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	98.03
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	97.91
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	97.89
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	97.86
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.84
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	97.82
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	97.8
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	97.78
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.78
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.77
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	97.72
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.72
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	97.6
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.57
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	97.55
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	97.54
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	97.5
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	97.48
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.47
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	97.47
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.45
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.44
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.44
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	97.41
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	97.4
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	97.39
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	97.34
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	97.32
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	97.32
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	97.31
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	97.29
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	97.29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	97.28
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	97.28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	97.28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	97.28
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.26
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	97.25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	97.23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	97.22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	97.22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	97.21
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	97.19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	97.19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	97.19
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	97.18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	97.17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	97.16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	97.15
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	97.14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	97.14
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	97.14
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	97.13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	97.12
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	97.12
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	97.11
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	97.11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	97.1
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	97.1
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	97.1
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	97.1
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	97.09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	97.09
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	97.09
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	97.08
3fme_A	290	Dual specificity mitogen-activated protein kinase;	97.07
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	97.07
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	97.05
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	97.05
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	97.04
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	97.04
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	97.02
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	97.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	96.98
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	96.98
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	96.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	96.94
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	96.93
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	96.86
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	96.85
3bhy_A	283	Death-associated protein kinase 3; death associate	96.84
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	96.83
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	96.83
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	96.82
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	96.81
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	96.81
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	96.81
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	96.77
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	96.75
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	96.75
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	96.75
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.75
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	96.74
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	96.72
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.71
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	96.71
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	96.69
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	96.69
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.66
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	96.65
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	96.64
3an0_A	340	Dual specificity mitogen-activated protein kinase;	96.64
2dyl_A	318	Dual specificity mitogen-activated protein kinase	96.63
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	96.63
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	96.6
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	96.59
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	96.57
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	96.47
3aln_A	327	Dual specificity mitogen-activated protein kinase;	96.45
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	96.44
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	96.43
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	96.37
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	96.32
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	96.31
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	96.3
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	96.29
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	96.29
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	96.2
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	96.16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	96.16
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	96.06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	96.04
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	95.94
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	95.92
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	95.84
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	95.59
3ork_A	311	Serine/threonine protein kinase; structural genomi	95.34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	94.29
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	92.99
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	92.82
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	92.78
2a19_B	284	Interferon-induced, double-stranded RNA-activated	92.54
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	92.43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	92.2
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	92.12
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	91.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	91.82
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	91.81
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	91.79
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	91.77
4aoj_A	329	High affinity nerve growth factor receptor; transf	91.69
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	91.6
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	91.58
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	91.52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	91.39
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	91.36
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	91.29
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	91.19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	91.12
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	91.11
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	91.06
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	90.98
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	90.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	90.93
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	90.93
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	90.79
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	90.68
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	90.64
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	90.45
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	90.39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	90.35
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	90.27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	90.25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	90.17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	89.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	89.94
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	89.86
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	89.86
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	89.82
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	89.81
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	89.72
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	89.7
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	89.66
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	89.46
3q4u_A	301	Activin receptor type-1; structural genomics conso	89.46
3soc_A	322	Activin receptor type-2A; structural genomics cons	89.39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	89.36
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	89.28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	89.18
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	89.16
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	89.07
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	89.07
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	88.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	88.8
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	88.48
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	88.32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	88.26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	88.17

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.7e-54  Score=375.50  Aligned_cols=201  Identities=26%  Similarity=0.414  Sum_probs=176.7

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|++++.||+|+||.||+|.+..+++.||||+++.... .......+.+|++++++++|||||++++++.+        
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------  103 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--------  103 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--------
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--------
Confidence            469999999999999999999999999999999976532 23345678899999999999999999877765        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ++.+|+||||++| +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus       104 --~~~~yivmEy~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~  180 (311)
T 4aw0_A          104 --DEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK  180 (311)
T ss_dssp             --SSEEEEEECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             --CCEEEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence              5689999999997 5555554 44579999999999999999999999999999999999999999999999999999


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .+............+||+.|||||++.+.. |+.++|||||||++|+|+||++||
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF  234 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPF  234 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence            876554444455678999999999998765 899999999999999999999998

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-52  Score=360.98  Aligned_cols=201  Identities=27%  Similarity=0.505  Sum_probs=162.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .-++|++++.||+|+||.||+|.+..+++.||||+++..... ......+.+|+.+++.++||||+++++++.+      
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~------   84 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS------   84 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE------
Confidence            346899999999999999999999999999999999765433 2334568899999999999999999877765      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ++.+|+||||++|+|++.+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|
T Consensus        85 ----~~~~~ivmEy~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla  159 (275)
T 3hyh_A           85 ----KDEIIMVIEYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS  159 (275)
T ss_dssp             ----SSEEEEEEECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred             ----CCEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCC
Confidence                5589999999999988888654 47999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.......   ....+||+.|||||++.+..+++.++||||+||++|+|+||++||
T Consensus       160 ~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF  212 (275)
T 3hyh_A          160 NIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF  212 (275)
T ss_dssp             ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCC
Confidence            87654332   234678999999999988775678999999999999999999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.4e-52  Score=371.02  Aligned_cols=200  Identities=26%  Similarity=0.426  Sum_probs=174.0

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .....|++++.||+|+||.||+|.+..+|+.||||+++.....  ..+.+.+|+.+++.++|||||++++++.+      
T Consensus        71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~------  142 (346)
T 4fih_A           71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV------  142 (346)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE------
T ss_pred             ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE------
Confidence            3456799999999999999999999999999999999765433  35578899999999999999999887765      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ++.+|||||||+|+.+..+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|
T Consensus       143 ----~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla  217 (346)
T 4fih_A          143 ----GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC  217 (346)
T ss_dssp             ----TTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ----CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCc
Confidence                5589999999997544444333 36999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.+.....  .....+||+.|||||++.+.. |+.++|||||||++|+|++|++||
T Consensus       218 ~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF  270 (346)
T 4fih_A          218 AQVSKEVP--RRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPY  270 (346)
T ss_dssp             EECCSSSC--CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eecCCCCC--cccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence            97754332  234567899999999998665 899999999999999999999998

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.1e-53  Score=375.00  Aligned_cols=200  Identities=29%  Similarity=0.460  Sum_probs=168.6

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++++.||+|+||.||+|++..+|+.||||+++.........+.+.+|+.++++++|||||++++++.+         
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~---------   94 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE---------   94 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---------
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE---------
Confidence            58999999999999999999999999999999998765444445678899999999999999999877765         


Q ss_pred             CCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                       ++.+|||||||+| +|.+.+.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus        95 -~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  173 (350)
T 4b9d_A           95 -NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR  173 (350)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccce
Confidence             5689999999986 66666654 34468999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  .....+||+.|||||++.+.. |+.++|||||||++|+|+||++||
T Consensus       174 ~~~~~~~--~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF  225 (350)
T 4b9d_A          174 VLNSTVE--LARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAF  225 (350)
T ss_dssp             CCCHHHH--HHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eecCCcc--cccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence            7653321  123456899999999998765 899999999999999999999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-51  Score=373.34  Aligned_cols=203  Identities=26%  Similarity=0.415  Sum_probs=176.2

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      +.+.....|++++.||+|+||.||+|.+..+|+.||||++.....  ...+.+.+|+.+++.++|||||++++++.+   
T Consensus       145 ~~~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~---  219 (423)
T 4fie_A          145 DPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV---  219 (423)
T ss_dssp             CSSCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred             CCCChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEE---
Confidence            444556789999999999999999999999999999999986543  235578899999999999999999887765   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ++.+|||||||+|+.+..+... ..+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+||
T Consensus       220 -------~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DF  291 (423)
T 4fie_A          220 -------GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF  291 (423)
T ss_dssp             -------TTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCC
T ss_pred             -------CCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecC
Confidence                   5589999999997544444333 36999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|+.+.....  .....+||+.|||||++.+.. |+.++|||||||++|+|++|++||
T Consensus       292 Gla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF  347 (423)
T 4fie_A          292 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPY  347 (423)
T ss_dssp             TTCEECCSSCC--CBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccceECCCCCc--cccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99997754332  234568999999999998665 899999999999999999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.4e-52  Score=363.44  Aligned_cols=200  Identities=25%  Similarity=0.317  Sum_probs=164.3

Q ss_pred             CCCcccccccCCcceeeEeeeee---cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ++|++++.||+|+||.||+|++.   .+++.||||+++...........+.+|+.++++++|||||++++++.+      
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------   97 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT------   97 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE------
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE------
Confidence            57999999999999999999874   467899999998664433334467889999999999999999877765      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ++.+|+||||++|+.+..+......+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|
T Consensus        98 ----~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A           98 ----EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             ----TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             ----CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence                5689999999997544444344457999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.......  .....+||+.|||||++.+.. |+.++|||||||++|+|+||++||
T Consensus       174 ~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF  226 (304)
T 3ubd_A          174 KESIDHEK--KAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPF  226 (304)
T ss_dssp             EC-----C--CCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eeccCCCc--cccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCC
Confidence            86543322  234567899999999998765 899999999999999999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-51  Score=357.33  Aligned_cols=202  Identities=24%  Similarity=0.310  Sum_probs=170.5

Q ss_pred             CCCC-cccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        145 NSSR-PLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .++| ++.+.||+|+||.||+|.+..++..||||++..........+.+.+|+.++++++|||||++++++.+..     
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-----   98 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-----   98 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-----
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-----
Confidence            3444 6778899999999999999999999999999866544444567889999999999999999999886532     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecC-CCcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNN-RGEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~~-~~~~~l~Dfg  300 (358)
                       ..+..+||||||++|+.+..+......+++..++.++.||+.||+|||+++  |+||||||+|||++. ++.+||+|||
T Consensus        99 -~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A           99 -KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             -TTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             -CCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence             224578999999997555544444567999999999999999999999998  999999999999985 7899999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+.....    .....+||+.|||||++.+  .|+.++|||||||++|+|+||++||
T Consensus       178 la~~~~~~----~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf  229 (290)
T 3fpq_A          178 LATLKRAS----FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPY  229 (290)
T ss_dssp             GGGGCCTT----SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCEeCCCC----ccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99754322    2234578999999999864  3899999999999999999999998

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4e-51  Score=362.11  Aligned_cols=195  Identities=25%  Similarity=0.306  Sum_probs=164.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||+++....       ..+|+.+++.++|||||++++++.+         
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~---------  121 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVRE---------  121 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEE---------
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEE---------
Confidence            457888999999999999999999999999999975422       2479999999999999999877765         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg~~~~  304 (358)
                       ++.+||||||++|+.+..+....+.+++.+++.++.||+.||+|||++||+||||||+|||++.+| ++||+|||+|+.
T Consensus       122 -~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          122 -GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             -TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             -CCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence             558999999999754444444445799999999999999999999999999999999999999998 699999999998


Q ss_pred             ccccCCCC---CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQR---PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........   .....+||+.|||||++.+.. |+.++|||||||++|+|+||++||
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf  256 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPW  256 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCC
Confidence            75443221   123357899999999998765 899999999999999999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=369.16  Aligned_cols=210  Identities=33%  Similarity=0.560  Sum_probs=180.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+.+|.+++.||+|+||.||+|.+..+|+.||||+++...........+.+|+.+|+.++|||||++++++....    .
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~  127 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV----P  127 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS----C
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc----c
Confidence            456899999999999999999999999999999999765443333456789999999999999999999887632    3


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      +.+.+.+||||||++|+|.+.+.. ...+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       128 ~~~~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          128 YGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            455678999999999988877754 4579999999999999999999999999999999999999999999999999998


Q ss_pred             eccccC--CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAED--RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .+....  ........+||+.|+|||++.+...++.++||||+||++|+|++|++||
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF  263 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF  263 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC
Confidence            764332  2223456788999999999988777899999999999999999999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-50  Score=352.77  Aligned_cols=203  Identities=23%  Similarity=0.317  Sum_probs=166.3

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +....++.+.+.||+|+||.||++...   ..||||+++.........+.+.+|+.++++++|||||++++++.+     
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----  103 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-----  103 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-----
Confidence            445677889999999999999999753   469999987654444445678899999999999999999887642     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            +.+||||||++| +|.+.+......+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus       104 ------~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          104 ------DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             ------SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             ------CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeecc
Confidence                  357999999996 5666666666789999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCC--CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+..............+||+.|||||++.+.  ..++.++|||||||++|||+||++||
T Consensus       178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf  237 (307)
T 3omv_A          178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY  237 (307)
T ss_dssp             SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence            99876544433344556789999999998643  34889999999999999999999998

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9e-50  Score=350.12  Aligned_cols=201  Identities=26%  Similarity=0.446  Sum_probs=167.3

Q ss_pred             CCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..+|.+.+.||+|+||.||+|...     .++..||||+++....  ...+.+.+|++++++++|||||++++++.+   
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~---   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVE---   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--HHHHHHHHHHHHHHhCCCCCCccEEEEEee---
Confidence            356888999999999999999864     4678999999975432  234578899999999999999999887765   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcC------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESG------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI  286 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Ni  286 (358)
                             ++.+|+||||+++ +|.+.+...            ...+++.++..++.||+.||+|||+++|+||||||+||
T Consensus        87 -------~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NI  159 (299)
T 4asz_A           87 -------GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC  159 (299)
T ss_dssp             -------SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             -------CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhE
Confidence                   4579999999996 555555432            24699999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       287 ll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |++.++.+||+|||+|+...............||+.|||||++.+.. ++.++|||||||++|||+| |++||
T Consensus       160 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf  231 (299)
T 4asz_A          160 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPW  231 (299)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999998765544433344556899999999998655 8999999999999999998 89998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-48  Score=344.46  Aligned_cols=202  Identities=23%  Similarity=0.356  Sum_probs=169.1

Q ss_pred             CCCCcccccccCCcceeeEeeee-----ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVS-----LFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ...+++++.||+|+||.||+|..     ..+++.||||+++... .....+.+.+|+.++++++|||||++++++.+   
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---  100 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK---  100 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE---
Confidence            34577889999999999999985     3567899999997543 33345678999999999999999999887765   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC  283 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp  283 (358)
                             ++.+++||||+++ +|.+.+...               ...+++..+..++.||+.||+|||+++|+||||||
T Consensus       101 -------~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~  173 (308)
T 4gt4_A          101 -------DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLAT  173 (308)
T ss_dssp             -------SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             -------CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence                   4578999999996 555555332               23589999999999999999999999999999999


Q ss_pred             CCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       284 ~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +|||++.++.+||+|||+++...............||+.|||||++.+.. ++.++|||||||++|||+| |++||
T Consensus       174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf  248 (308)
T 4gt4_A          174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPY  248 (308)
T ss_dssp             GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCC
Confidence            99999999999999999999776555444455667899999999998655 9999999999999999998 89998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=347.94  Aligned_cols=200  Identities=28%  Similarity=0.397  Sum_probs=158.6

Q ss_pred             CCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .++.+.+.||+|+||.||+|...     .++..||||+++....  ...+.+.+|++++++++|||||++++++.+    
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----  114 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTMLQHQHIVRFFGVCTE----  114 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence            45677889999999999999853     4688999999975432  234578899999999999999999887765    


Q ss_pred             cccccCCCeEEEEeeccccC-hHHHHhcC--------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy13988        221 LDFRKDKGSFYLVFEYMDHD-LMGLLESG--------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN  285 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~--------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~N  285 (358)
                            .+.+||||||++++ |.+.+...              ..++++.++..++.||+.||+|||+++|+||||||+|
T Consensus       115 ------~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N  188 (329)
T 4aoj_A          115 ------GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN  188 (329)
T ss_dssp             ------SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             ------CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence                  45799999999975 55554332              2468999999999999999999999999999999999


Q ss_pred             EEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       286 ill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||++.++.+||+|||+++...............||+.|||||++.+.. ++.++|||||||++|||+| |+.||
T Consensus       189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf  261 (329)
T 4aoj_A          189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPW  261 (329)
T ss_dssp             EEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCC
Confidence            999999999999999998775554444445567899999999998765 8999999999999999999 89998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-48  Score=343.45  Aligned_cols=205  Identities=26%  Similarity=0.371  Sum_probs=154.6

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc--cccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA--LDFR  224 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--~~~~  224 (358)
                      +|++++.||+|+||.||+|.+..+++.||||+++.... ....+.+.+|+.++++++|||||++++++.+.+..  +...
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            48899999999999999999999999999999976532 22335678999999999999999999998764321  1112


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCC---CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVD---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                      ....++|+||||++|+.+..+......   .++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl  164 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL  164 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence            234568999999997544444333333   34556889999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCC----------CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh
Q psy13988        302 ARLYNAEDRQ----------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV  353 (358)
Q Consensus       302 ~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt  353 (358)
                      |+........          ......+||+.|||||++.+.. |+.++|||||||++|||++
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~  225 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY  225 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc
Confidence            9877543221          1223457899999999998765 8999999999999999997

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.7e-47  Score=340.69  Aligned_cols=197  Identities=24%  Similarity=0.365  Sum_probs=165.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeee---cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSD  219 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  219 (358)
                      ..++|++.+.||+|+||.||+|.+.   .+++.||||++....    ....+.+|+++++.+ +||||+++++++.+   
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~---   91 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK---   91 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE---
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE---
Confidence            4467999999999999999999875   457899999886432    234678999999998 69999999877765   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEe
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLA  297 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~l~  297 (358)
                             ++++|+||||++| +|.+.+    ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+
T Consensus        92 -------~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~  160 (361)
T 4f9c_A           92 -------NDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALV  160 (361)
T ss_dssp             -------TTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             -------CCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEEC
Confidence                   5689999999986 555555    258999999999999999999999999999999999999887 799999


Q ss_pred             ecccceeccccCC--------------------------CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHH
Q psy13988        298 DFGLARLYNAEDR--------------------------QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL  351 (358)
Q Consensus       298 Dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l  351 (358)
                      |||+|+.......                          .......+||+.|+|||++.+...++.++||||+||++|+|
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el  240 (361)
T 4f9c_A          161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL  240 (361)
T ss_dssp             CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred             cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence            9999986543211                          11123457899999999998776789999999999999999


Q ss_pred             hhCCCCC
Q psy13988        352 FVKKPLF  358 (358)
Q Consensus       352 ltg~~pF  358 (358)
                      +||++||
T Consensus       241 l~G~~Pf  247 (361)
T 4f9c_A          241 LSGRYPF  247 (361)
T ss_dssp             HHTCSSS
T ss_pred             HHCCCCC
Confidence            9999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.5e-47  Score=361.14  Aligned_cols=202  Identities=21%  Similarity=0.257  Sum_probs=169.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHH---HHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVR---EIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ..-.+|.+++.||+|+||.||+|++..+|+.||||+++..... ......+.+   ++.+++.++|||||++++++.+  
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~--  263 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--  263 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE--
Confidence            3446799999999999999999999999999999999765322 112223333   4566777899999999877765  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                              .+.+|+||||+.|+.+..+....+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|
T Consensus       264 --------~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~D  335 (689)
T 3v5w_A          264 --------PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD  335 (689)
T ss_dssp             --------SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             --------CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecc
Confidence                    558999999999755544444456799999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+|+......    ....+||+.|||||++.+...|+.++|||||||++|+|++|++||
T Consensus       336 FGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF  391 (689)
T 3v5w_A          336 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF  391 (689)
T ss_dssp             CTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99998765432    234678999999999975555899999999999999999999998

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.7e-47  Score=338.98  Aligned_cols=205  Identities=25%  Similarity=0.354  Sum_probs=169.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCC-----cEEEEEEeeccccCCCCchhHHHHHHHHHhCCC-Ccccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTD-----ELVALKKVRLENEKEGFPITAVREIKILRQLNH-KNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~  216 (358)
                      ....+|++.+.||+|+||.||+|.+..++     +.||||+++..... .....+.+|+.++++++| ||||++++++.+
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            34467899999999999999999976543     68999998754322 223468899999999965 999999887754


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecC
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD  280 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~D  280 (358)
                      .         ++.+|+|||||++ +|.+.+...               ...+++.++..++.||+.||+|||+++|+|||
T Consensus       140 ~---------~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD  210 (353)
T 4ase_A          140 P---------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD  210 (353)
T ss_dssp             T---------TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             c---------CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence            2         3468999999996 555555432               23489999999999999999999999999999


Q ss_pred             CCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       281 lkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |||+|||++.++.+||+|||+|+...............||+.|||||++.+.. ++.++|||||||++|||+| |++||
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCC
Confidence            99999999999999999999998765444333344567899999999998655 8999999999999999998 99998

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.8e-46  Score=327.89  Aligned_cols=200  Identities=23%  Similarity=0.248  Sum_probs=157.3

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|.+.+.||+|+||.||++..  +|+.||||+++.....   ......|+..+.+++|||||++++++.+...      
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~------   71 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNG------   71 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS------
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC------
Confidence            4577889999999999999986  7899999998754321   1122346666678899999999998875321      


Q ss_pred             CCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEecCCCcEEE
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR--------NFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--------~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                      ....+||||||+++ +|.+.+...  .+++..+.+++.|++.||+|||++        +|+||||||+|||++.++++||
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence            12368999999996 555555443  689999999999999999999987        9999999999999999999999


Q ss_pred             eecccceeccccCCC--CCCCCccccccccccccccCCC-----CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQ--RPYTNKVITLWYRPPELLLGEE-----RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||+++........  ......+||+.|||||++.+..     .++.++|||||||++|||+||++||
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            999999877544322  2223457899999999987542     2567899999999999999998765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.4e-45  Score=350.04  Aligned_cols=199  Identities=26%  Similarity=0.373  Sum_probs=174.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+++.||+|+||.||+|.+..+|+.||||++......  ..+.+.+|+.+|+.++|||||++++++.+       
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-------  225 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED-------  225 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEC-------
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCCCCCCCeEEEEEEE-------
Confidence            345799999999999999999999999999999999765322  23567899999999999999999877765       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC--CcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR--GEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~--~~~~l~Dfg  300 (358)
                         ++.+|+||||++| +|.+.+......+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||
T Consensus       226 ---~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          226 ---DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             ---SSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             ---CCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeecc
Confidence               5689999999986 6667776666789999999999999999999999999999999999999865  799999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.+......   ...+||+.|||||++.+.. |+.++|||||||++|+|++|.+||
T Consensus       303 ~a~~~~~~~~~---~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf  356 (573)
T 3uto_A          303 LTAHLDPKQSV---KVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPF  356 (573)
T ss_dssp             SCEECCTTSEE---EEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred             ceeEccCCCce---eeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99987644322   3456899999999998765 899999999999999999999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.4e-43  Score=315.36  Aligned_cols=203  Identities=28%  Similarity=0.504  Sum_probs=174.3

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ....++|++++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++..     
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----   85 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----   85 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----
Confidence            345578999999999999999999999999999999998665443344567899999999999999999777654     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           .+..|+||||++| ++.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        86 -----~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           86 -----EKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             -----SSEEEEEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             -----CCEEEEEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeecc
Confidence                 5589999999986 45555543 3579999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........   .....||+.|+|||++.+....+.++|||||||++|+|++|++||
T Consensus       160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  214 (328)
T 3fe3_A          160 FSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF  214 (328)
T ss_dssp             CCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence            9986654332   234567999999999987764567999999999999999999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-42  Score=306.44  Aligned_cols=201  Identities=42%  Similarity=0.737  Sum_probs=178.6

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++++.||+|+||.||++.+..+++.||||++............+.+|+.++++++||||+++++++.+         
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS---------   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE---------
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe---------
Confidence            47999999999999999999999999999999998766555555678899999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++.+++||||++++++..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus        73 -~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           73 -DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             -TTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             -CCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence             5689999999999999998877778999999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  .......+|+.|+|||++.+...++.++||||||+++|+|++|..||
T Consensus       152 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~  202 (292)
T 3o0g_A          152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence            5332  22344567999999999987666899999999999999999988774

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-42  Score=308.96  Aligned_cols=206  Identities=39%  Similarity=0.742  Sum_probs=176.4

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ..+....+|++++.||+|+||.||++.+. +++.||+|++............+.+|+.+++.++||||+++++++.+   
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   90 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS---   90 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc---
Confidence            44567789999999999999999999984 59999999998665554445678899999999999999999777654   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ++..++||||+++++.+.+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+||
T Consensus        91 -------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df  163 (311)
T 3niz_A           91 -------ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADF  163 (311)
T ss_dssp             -------SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             -------CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccC
Confidence                   5589999999999999988877778999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........  ......+|+.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       164 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  220 (311)
T 3niz_A          164 GLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF  220 (311)
T ss_dssp             TTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC
Confidence            99987653322  2334567999999999987666899999999999999999999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.6e-42  Score=311.30  Aligned_cols=213  Identities=48%  Similarity=0.843  Sum_probs=183.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..++|.+++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++....  ..+
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~   92 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA--SPY   92 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc--ccc
Confidence            457899999999999999999999999999999999877666656667889999999999999999999887644  222


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ...++.+|+||||+++++...+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus        93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             ----CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            33466899999999999999988877789999999999999999999999999999999999999999999999999998


Q ss_pred             eccccC--CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAED--RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  .........+|+.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  229 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM  229 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence            765332  2223345567999999999987666899999999999999999999997

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-42  Score=310.10  Aligned_cols=201  Identities=23%  Similarity=0.331  Sum_probs=171.5

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..+|.+++.||+|+||.||++.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++.+       
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-------   76 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-------   76 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-------
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-------
Confidence            3578999999999999999999999999999999976532 23345567899999999999999999777765       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         .+.+|+||||++|+.+.........+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus        77 ---~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           77 ---HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             ---SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ---CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchh
Confidence               55899999999985554444444579999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  .......||+.|+|||++.+.. ++.++||||||+++|+|++|++||
T Consensus       154 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf  205 (337)
T 1o6l_A          154 EGISDG--ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             CSCCTT--CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             hcccCC--CcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCC
Confidence            643222  1234567899999999997655 899999999999999999999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.2e-42  Score=304.17  Aligned_cols=200  Identities=44%  Similarity=0.793  Sum_probs=172.8

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|.+++.||+|+||.||++.+ .+++.||+|++............+.+|+.+++.++||||+++++++.+         
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT---------   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC---------
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc---------
Confidence            4799999999999999999998 789999999998765555555678899999999999999999877754         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       .+..++|||++++++.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        72 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           72 -KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             -SSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             -CCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence             4589999999999888888776678999999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  ......+|+.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       151 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  201 (288)
T 1ob3_A          151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF  201 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             Ccccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            43321  2234467999999999987666899999999999999999999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.8e-42  Score=302.72  Aligned_cols=204  Identities=25%  Similarity=0.426  Sum_probs=174.4

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ...+....+|++++.||+|+||.||++.+..+++.||||++......  ....+.+|+.+++.++||||+++++++..  
T Consensus        13 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   88 (297)
T 3fxz_A           13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--   88 (297)
T ss_dssp             SBSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred             cCcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE--
Confidence            34556678999999999999999999999999999999998765433  24567899999999999999999877765  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                              ++.+|+||||++|+.+..+.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|
T Consensus        89 --------~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~D  159 (297)
T 3fxz_A           89 --------GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTD  159 (297)
T ss_dssp             --------TTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECC
T ss_pred             --------CCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEee
Confidence                    55899999999875444443332 589999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++........  ......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       160 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf  216 (297)
T 3fxz_A          160 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPY  216 (297)
T ss_dssp             CTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCceecCCccc--ccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999987654432  223456799999999998765 899999999999999999999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-42  Score=315.77  Aligned_cols=204  Identities=39%  Similarity=0.637  Sum_probs=165.0

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..+|.+++.||+|+||.||++.+..+++.||||++............+.+|+.+++.+. ||||+++++++...      
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------   81 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD------   81 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT------
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC------
Confidence            46899999999999999999999999999999998754333333456778999999996 99999998887643      


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        +...+|+||||+++++...+...  .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus        82 --~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           82 --NDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             --TSSCEEEEEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             --CCCEEEEEecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence              24579999999999888877653  68999999999999999999999999999999999999999999999999998


Q ss_pred             eccccC-------------------CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAED-------------------RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......                   ........++|+.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            764311                   1122344578999999999987666899999999999999999999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.5e-42  Score=311.53  Aligned_cols=205  Identities=22%  Similarity=0.342  Sum_probs=175.8

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ......+|.+++.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+   
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~---   86 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD---   86 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe---
Confidence            34556789999999999999999999999999999999876532 23334577899999999999999999777765   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             .+.+|+||||+.|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+||
T Consensus        87 -------~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           87 -------EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             -------SSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             -------CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEecc
Confidence                   5589999999988655555555667999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCC--CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........   .....||+.|+|||++.+.  ..++.++|||||||++|+|++|++||
T Consensus       160 G~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf  217 (384)
T 4fr4_A          160 NIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY  217 (384)
T ss_dssp             TTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence            99987654332   2455679999999998642  34889999999999999999999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.6e-42  Score=319.95  Aligned_cols=207  Identities=34%  Similarity=0.519  Sum_probs=162.3

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|.+++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++....   
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  125 (458)
T 3rp9_A           49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD---  125 (458)
T ss_dssp             CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC---
T ss_pred             CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC---
Confidence            34568899999999999999999999999999999998754333333456789999999999999999998886432   


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                        .+....+|+|||++++++...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       126 --~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          126 --VEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             --TTTCCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             --cccCceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence              123467999999999888877754 45799999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCC-------------------------CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhC
Q psy13988        302 ARLYNAEDRQ-------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK  354 (358)
Q Consensus       302 ~~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg  354 (358)
                      ++........                         ......+||+.|+|||++.....++.++|||||||++|+|++|
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            9876432211                         1234557799999999876556699999999999999999993

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.6e-41  Score=302.77  Aligned_cols=201  Identities=41%  Similarity=0.773  Sum_probs=160.6

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+        
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------   74 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHT--------   74 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--------
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE--------
Confidence            467999999999999999999999999999999997654 23344678899999999999999999777654        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcC-----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESG-----MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                        ++.+|+||||+++++.+.+...     ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus        75 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  152 (317)
T 2pmi_A           75 --ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDF  152 (317)
T ss_dssp             --TTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             --CCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcC
Confidence              5689999999999888877542     235899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........  ......+|+.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus       153 g~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  209 (317)
T 2pmi_A          153 GLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF  209 (317)
T ss_dssp             SSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99987653322  2234567999999999987666899999999999999999999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.2e-42  Score=312.72  Aligned_cols=203  Identities=22%  Similarity=0.331  Sum_probs=171.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  220 (358)
                      ....+|.+++.||+|+||.||++++..+++.||+|+++..... ......+.+|..++.++ +||||+++++++.+    
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----  124 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----  124 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC----
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE----
Confidence            3456799999999999999999999999999999999865432 22344677899999887 89999999877765    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       125 ------~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          125 ------ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             ------SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ------CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecc
Confidence                  55899999999985554444444579999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++......  ......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       199 la~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf  253 (396)
T 4dc2_A          199 MCKEGLRPG--DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF  253 (396)
T ss_dssp             TCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eeeecccCC--CccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCC
Confidence            998532222  2234567899999999998765 899999999999999999999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.8e-41  Score=306.86  Aligned_cols=203  Identities=25%  Similarity=0.354  Sum_probs=173.6

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC----CchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG----FPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ......|.+.+.||+|+||.||++.+..+|+.||+|++........    ....+.+|+.+++.++||||+++++++.+ 
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-   86 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-   86 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-
Confidence            3456789999999999999999999999999999999986643322    23567899999999999999999777654 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----c
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----E  293 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~----~  293 (358)
                               .+.+|+||||++|+.+..+......+++..+..++.||+.||.|||++||+||||||+||+++.++    .
T Consensus        87 ---------~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~  157 (361)
T 2yab_A           87 ---------RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH  157 (361)
T ss_dssp             ---------SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCC
T ss_pred             ---------CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccC
Confidence                     558999999998654444444556799999999999999999999999999999999999998877    7


Q ss_pred             EEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       294 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++|+|||++........   .....||+.|+|||++.+.. ++.++||||||+++|+|++|.+||
T Consensus       158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf  218 (361)
T 2yab_A          158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPF  218 (361)
T ss_dssp             EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999987754332   23456799999999987654 899999999999999999999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=312.15  Aligned_cols=203  Identities=22%  Similarity=0.334  Sum_probs=166.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  220 (358)
                      ....+|.+++.||+|+||.||++.+..+++.||||+++.... .......+.+|..+++.+ +||||+++++++.+    
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----   95 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----   95 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe----
Confidence            455789999999999999999999999999999999976421 222345677899999988 79999999777765    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        96 ------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           96 ------PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             ------SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ------CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcccc
Confidence                  55899999999975554444444579999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++......  ......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       170 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf  224 (353)
T 3txo_A          170 MCKEGICNG--VTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPF  224 (353)
T ss_dssp             TCBCSCC-----------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ceeecccCC--ccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCC
Confidence            998543222  2234557899999999987655 899999999999999999999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.8e-42  Score=319.73  Aligned_cols=204  Identities=31%  Similarity=0.524  Sum_probs=172.0

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++....    .
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~  135 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK----T  135 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC----S
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC----c
Confidence            457899999999999999999999999999999999865444444557789999999999999999999887632    2


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      .++...+|+||||+++++.+.+..   .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus       136 ~~~~~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             TTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             cccCCeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            234567899999999998887753   48999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF  263 (464)
T 3ttj_A          213 TAGTSF---MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILF  263 (464)
T ss_dssp             ----CC---CC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ecCCCc---ccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCC
Confidence            765432   234567799999999998765 899999999999999999999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.8e-42  Score=307.72  Aligned_cols=204  Identities=22%  Similarity=0.348  Sum_probs=170.2

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSD  219 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  219 (358)
                      .....+|.+.+.||+|+||.||++.+..+++.||||+++.... .......+..|..++..+ +||||+++++++.+   
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~---   89 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT---   89 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC---
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe---
Confidence            4456789999999999999999999999999999999976532 123345677899999877 99999999777765   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+||
T Consensus        90 -------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           90 -------KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             -------SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             -------CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEC
Confidence                   5589999999987544444344457999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+++......  .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       163 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf  218 (345)
T 1xjd_A          163 GMCKENMLGD--AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPF  218 (345)
T ss_dssp             TTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             hhhhhcccCC--CcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCC
Confidence            9998643222  1234557899999999998765 899999999999999999999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.3e-42  Score=305.96  Aligned_cols=204  Identities=29%  Similarity=0.446  Sum_probs=172.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|+||.||++.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+       
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------   76 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE-------   76 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec-------
Confidence            457899999999999999999999999999999998755332 223567899999999999999999776654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ++..|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus        77 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~  153 (323)
T 3tki_A           77 ---GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT  153 (323)
T ss_dssp             ---SSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ---CCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccc
Confidence               56899999999875554444555679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .+.............||+.|+|||++.+...++.++||||||+++|+|++|+.||
T Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  208 (323)
T 3tki_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  208 (323)
T ss_dssp             ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence            7654443334445678999999999987665578999999999999999999998

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.1e-42  Score=306.47  Aligned_cols=202  Identities=27%  Similarity=0.489  Sum_probs=175.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ...++|.+.+.||+|+||.||++.+..+++.||||++..... .......+.+|+.+++.++||||+++++++..     
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----
Confidence            345789999999999999999999999999999999875432 22334578899999999999999999877765     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           .+..++||||++|++++.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        81 -----~~~~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~  154 (336)
T 3h4j_B           81 -----PTDIVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL  154 (336)
T ss_dssp             -----SSEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred             -----CCEEEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecc
Confidence                 4589999999998888887654 4699999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.........   ....||+.|+|||++.+....+.++||||||+++|+|++|+.||
T Consensus       155 s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf  208 (336)
T 3h4j_B          155 SNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF  208 (336)
T ss_dssp             TBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence            9876544322   34567999999999987764578999999999999999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-42  Score=303.82  Aligned_cols=198  Identities=21%  Similarity=0.307  Sum_probs=170.3

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..+|.+++.||+|+||.||++.+..+++.||+|+++.... .......+.+|+.+++.++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------   77 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-------   77 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-------
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-------
Confidence            4578999999999999999999999999999999976532 22334567789999999999999999777654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ...+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus        78 ---~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           78 ---AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             ---SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ---CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcce
Confidence               55899999999975444444444579999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....     .....||+.|+|||++.+.. ++.++||||||+++|+|++|++||
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf  203 (318)
T 1fot_A          155 YVPDV-----TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPF  203 (318)
T ss_dssp             ECSSC-----BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecCCc-----cccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCC
Confidence            76432     23456799999999998655 899999999999999999999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.5e-41  Score=305.91  Aligned_cols=202  Identities=23%  Similarity=0.336  Sum_probs=170.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||+|++....... .....+.+|..+++.+ +||||+++++++.+     
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----   81 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----   81 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----
Confidence            3457999999999999999999999999999999998654322 1234567899999988 89999999877755     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus        82 -----~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           82 -----ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             -----SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             -----CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccc
Confidence                 558999999998754444433445799999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++......  .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       157 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf  210 (345)
T 3a8x_A          157 CKEGLRPG--DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF  210 (345)
T ss_dssp             CBCSCCTT--CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccccCCC--CcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCc
Confidence            98643222  1234557899999999998755 899999999999999999999998

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-41  Score=314.73  Aligned_cols=204  Identities=26%  Similarity=0.355  Sum_probs=172.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||+|+++.... .......+.+|+.++..++||||+++++++.+      
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~------  145 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD------  145 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC------
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee------
Confidence            34579999999999999999999999999999999975322 22223457889999999999999999777665      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          ++.+|+||||+.| +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       146 ----~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          146 ----DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             ----SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ----CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence                5689999999976 56666655466899999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCcccccccccccccc----CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLL----GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++....... ......+||+.|+|||++.    +...++.++|||||||++|+|++|++||
T Consensus       222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf  281 (437)
T 4aw2_A          222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF  281 (437)
T ss_dssp             CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC
Confidence            987644322 1223457899999999986    2345899999999999999999999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.5e-41  Score=299.67  Aligned_cols=206  Identities=26%  Similarity=0.405  Sum_probs=168.8

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ......+|++++.||+|+||.||++.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++.+   
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~---   82 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE---   82 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC---
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee---
Confidence            4456789999999999999999999999999999999986543322 223467889999999999999999776654   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ++..|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+||
T Consensus        83 -------~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Df  155 (294)
T 4eqm_A           83 -------DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDF  155 (294)
T ss_dssp             -------SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             -------CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeC
Confidence                   5689999999988555544444457999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........ .......||+.|+|||++.+.. ++.++||||||+++|+|+||+.||
T Consensus       156 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf  212 (294)
T 4eqm_A          156 GIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPF  212 (294)
T ss_dssp             SSSTTC--------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCccccccccc-cccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence            99986643322 1223446799999999998755 889999999999999999999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.2e-41  Score=313.08  Aligned_cols=212  Identities=32%  Similarity=0.487  Sum_probs=174.1

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .-....+|.+++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++....  
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--   98 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD--   98 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC--
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC--
Confidence            445678999999999999999999999999999999999755333333456789999999999999999998886532  


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                         ......+|+|||+++++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        99 ---~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A           99 ---LLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             ---TTTCCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ---CCcCCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence               112357999999999988777754 4579999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCC--------------------CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQ--------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++........                    ......++|+.|+|||++.....++.++|||||||++|+|++|..||
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            99876543221                    12356678999999999766666999999999999999999865443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-41  Score=308.30  Aligned_cols=205  Identities=21%  Similarity=0.309  Sum_probs=164.2

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHH-HHhCCCCcccchhhhhcccC
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKI-LRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~  218 (358)
                      ......+|.+++.||+|+||.||++.+..+++.||||++....... .....+.+|..+ ++.++||||+++++++.+  
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--  110 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--  110 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--
Confidence            3445678999999999999999999999999999999998664322 223345667666 567899999999777655  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                              .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|
T Consensus       111 --------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~D  182 (373)
T 2r5t_A          111 --------ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTD  182 (373)
T ss_dssp             --------SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             --------CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEee
Confidence                    558999999999754444434445789999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+++......  ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus       183 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf  239 (373)
T 2r5t_A          183 FGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPF  239 (373)
T ss_dssp             CCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CccccccccCC--CccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCC
Confidence            99998643222  2234557899999999998655 899999999999999999999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-41  Score=305.22  Aligned_cols=199  Identities=22%  Similarity=0.338  Sum_probs=171.7

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ....+|.+++.||+|+||.||++.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+     
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----  112 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----
Confidence            345689999999999999999999999999999999976532 22334567889999999999999999777654     


Q ss_pred             ccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           +..+|+||||++|+ |.+.+. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||
T Consensus       113 -----~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          113 -----NSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             -----SSEEEEEEECCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             -----CCEEEEEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccc
Confidence                 55899999999864 545544 34579999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.....     .....||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf  238 (350)
T 1rdq_E          187 FAKRVKGR-----TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             TCEECSSC-----BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cceeccCC-----cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCC
Confidence            99876433     23457899999999998655 899999999999999999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-41  Score=312.79  Aligned_cols=203  Identities=27%  Similarity=0.349  Sum_probs=171.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ....+|.+++.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+     
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----  140 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----  140 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----
Confidence            345679999999999999999999999999999999975321 22234467899999999999999999777764     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           .+.+|+||||++| +|.+.+..  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus       141 -----~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 -----DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             -----SSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             -----CCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccc
Confidence                 5689999999976 55555543  368999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCC---CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEE---RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++........ .....+||+.|+|||++.+..   .++.++|||||||++|+|++|++||
T Consensus       214 ~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf  273 (410)
T 3v8s_A          214 TCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  273 (410)
T ss_dssp             TCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence            99876543221 223557899999999997543   2778999999999999999999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.7e-41  Score=301.40  Aligned_cols=201  Identities=20%  Similarity=0.252  Sum_probs=173.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ..+.+|.+.+.||+|+||.||++.+..+++.||||++.....    ...+.+|+.+++.+ +||||+++++++..     
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----   76 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPC-----   76 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----
Confidence            356789999999999999999999999999999999875532    23678999999999 99999999776654     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc-----EEE
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE-----VKL  296 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~-----~~l  296 (358)
                           ++..++||||++++|.+.+......+++..++.++.||+.||+|||++||+||||||+||+++.++.     ++|
T Consensus        77 -----~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           77 -----GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             -----TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             -----CCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEE
Confidence                 5589999999977787777765668999999999999999999999999999999999999998887     999


Q ss_pred             eecccceeccccCCCC-----CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++..........     ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf  217 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPW  217 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCc
Confidence            9999999765433211     124567899999999998755 899999999999999999999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.2e-41  Score=305.06  Aligned_cols=200  Identities=30%  Similarity=0.477  Sum_probs=170.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|.+.+.||+|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++.+       
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-------   99 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-------   99 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-------
Confidence            4467999999999999999999999999999999998654433334567899999999999999999777654       


Q ss_pred             ccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEeec
Q psy13988        224 RKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EVKLADF  299 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~~l~Df  299 (358)
                         ++..|+||||+.|+ |.+.+. ....+++..+..++.||+.||.|||++||+||||||+||+++.++   .+||+||
T Consensus       100 ---~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A          100 ---ESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             ---SSEEEEEECCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             ---CCEEEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence               56899999999975 445554 445799999999999999999999999999999999999998654   5999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........   .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus       176 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf  230 (362)
T 2bdw_A          176 GLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPF  230 (362)
T ss_dssp             TTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CcceEecCCcc---cccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCC
Confidence            99987654322   23456799999999997654 899999999999999999999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-41  Score=305.72  Aligned_cols=203  Identities=21%  Similarity=0.311  Sum_probs=170.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  220 (358)
                      ....+|.+++.||+|+||.||++.+..+++.||||+++.... .......+..|..++..+ +||||+++++++.+    
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----   92 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----   92 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----
Confidence            345689999999999999999999999999999999976532 223345677899999888 89999999777765    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||
T Consensus        93 ------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           93 ------MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             ------SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ------CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence                  55899999999875444443334579999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++......  .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       167 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf  221 (353)
T 2i0e_A          167 MCKENIWDG--VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPF  221 (353)
T ss_dssp             TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccccCC--cccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCC
Confidence            998643222  1234557899999999998655 899999999999999999999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=312.83  Aligned_cols=202  Identities=29%  Similarity=0.483  Sum_probs=170.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+.+.||+|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++.+      
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------   81 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE------   81 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC------
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE------
Confidence            34567999999999999999999999999999999998665433334567899999999999999999777654      


Q ss_pred             cccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEee
Q psy13988        223 FRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEVKLAD  298 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~---~~~~~l~D  298 (358)
                          ++..|+||||+.|+ |.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.   ++.+||+|
T Consensus        82 ----~~~~~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           82 ----EGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             ----SSEEEEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             ----CCEEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEcc
Confidence                56899999999874 5555544 457999999999999999999999999999999999999984   57899999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++........  ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus       157 FG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf  213 (444)
T 3soa_A          157 FGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPF  213 (444)
T ss_dssp             CSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CceeEEecCCCc--eeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCC
Confidence            999987654322  223457899999999997654 899999999999999999999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-41  Score=305.44  Aligned_cols=205  Identities=34%  Similarity=0.581  Sum_probs=169.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+++.||+|+||.||++.+..+|+.||||++............+.+|+.+++.++||||+++++++....    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----   97 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE----   97 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS----
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC----
Confidence            3467899999999999999999999999999999998765433333456789999999999999999999887642    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      ...+...+|+||||+++++.+.+..  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            1122356799999997777776655  36899999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.....     .....+|+.|+|||++.+...++.++||||+||++|+|++|++||
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  226 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF  226 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence            876432     234567999999999987556899999999999999999999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=302.56  Aligned_cols=200  Identities=46%  Similarity=0.799  Sum_probs=167.3

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|.+++.||+|+||.||++.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.+         
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------   71 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT---------   71 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC---------
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee---------
Confidence            4799999999999999999999999999999998755432 222345679999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++..++||||+++++.+.+......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        72 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           72 -EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             -SSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             -CCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence             5589999999999999988877778999999999999999999999999999999999999999999999999999865


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  .......+|+.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       151 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  201 (324)
T 3mtl_A          151 SIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF  201 (324)
T ss_dssp             --------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            4332  22234567999999999987666899999999999999999999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=298.71  Aligned_cols=202  Identities=37%  Similarity=0.638  Sum_probs=170.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|++++.||+|++|.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.+        
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------   73 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--------   73 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--------
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--------
Confidence            357999999999999999999999999999999987654433334567789999999999999999877754        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        .+..++||||++++++..+......+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++..
T Consensus        74 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           74 --KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             --TTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             --CCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence              558999999999988888777667899999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......+|+.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  203 (311)
T 4agu_A          152 LTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW  203 (311)
T ss_dssp             CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence            653322  2234567999999999987666899999999999999999999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=311.06  Aligned_cols=204  Identities=25%  Similarity=0.336  Sum_probs=171.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||||+++.... .......+.+|..++..++||||+++++++.+      
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~------  132 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD------  132 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC------
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee------
Confidence            44679999999999999999999999999999999975321 11223457889999999999999999777765      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          .+.+|+||||+.| +|...+......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus       133 ----~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          133 ----ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             ----SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ----CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence                5589999999976 56666655445799999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccC------CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........ .....+||+.|+|||++..      ...++.++|||||||++|+|++|++||
T Consensus       209 a~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf  270 (412)
T 2vd5_A          209 CLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF  270 (412)
T ss_dssp             CEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             heeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence            9876543221 1234578999999999862      234899999999999999999999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=295.91  Aligned_cols=202  Identities=24%  Similarity=0.343  Sum_probs=172.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC----CchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG----FPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      .....|.+.+.||+|+||.||++.+..+++.||+|++........    ....+.+|+.+++.++||||+++++++.+  
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   85 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--   85 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--
Confidence            445679999999999999999999999999999999986543321    24567899999999999999999777654  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----cE
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EV  294 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~----~~  294 (358)
                              ....++||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||+++.++    .+
T Consensus        86 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  157 (326)
T 2y0a_A           86 --------KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI  157 (326)
T ss_dssp             --------SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCE
T ss_pred             --------CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCE
Confidence                    558999999998755544444556799999999999999999999999999999999999999887    89


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++|.+||
T Consensus       158 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf  217 (326)
T 2y0a_A          158 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPF  217 (326)
T ss_dssp             EECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             EEEECCCCeECCCCCc---cccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCC
Confidence            9999999987754332   23456799999999987654 899999999999999999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.9e-41  Score=302.65  Aligned_cols=205  Identities=38%  Similarity=0.752  Sum_probs=165.5

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ......+|.+++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.+    
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  104 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH----  104 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE----
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec----
Confidence            4455678999999999999999999999999999999998765555455667899999999999999999777654    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-----CCCcEE
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN-----NRGEVK  295 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~-----~~~~~~  295 (358)
                            ++.+++||||+++++.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++     .++.++
T Consensus       105 ------~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          105 ------NHRLHLIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             ------TTEEEEEEECCSEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred             ------CCEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEE
Confidence                  5689999999999888877654 3699999999999999999999999999999999999994     445699


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++........  ......+|+.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus       178 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  238 (329)
T 3gbz_A          178 IGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF  238 (329)
T ss_dssp             ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            999999987643322  2234566999999999987666899999999999999999999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.4e-41  Score=305.20  Aligned_cols=201  Identities=14%  Similarity=0.112  Sum_probs=167.8

Q ss_pred             CCCCCCCcccccccCCcceeeEee-----eeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC---CCcccchhhh
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFS-----VSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN---HKNIVNLREI  213 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~  213 (358)
                      .....+|.+.+.||+|+||.||+|     .+..+++.||||++...     ....+.+|+.+++.++   |+||++++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            345678999999999999999999     46788999999998643     2346778888888886   8999999777


Q ss_pred             hcccCcccccccCCCeEEEEeecccc-ChHHHHhc----CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLES----GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM  288 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill  288 (358)
                      +..          ++..|+||||++| +|.+.+..    ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus       136 ~~~----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll  205 (365)
T 3e7e_A          136 HLF----------QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL  205 (365)
T ss_dssp             EEC----------SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE
T ss_pred             eec----------CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEe
Confidence            654          5578999999986 55555543    35579999999999999999999999999999999999999


Q ss_pred             cC-----------CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        289 NN-----------RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       289 ~~-----------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      +.           ++.+||+|||+++.+.............||+.|+|||++.+.. ++.++|||||||++|+|+||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p  284 (365)
T 3e7e_A          206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYM  284 (365)
T ss_dssp             CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCC
T ss_pred             cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCc
Confidence            98           8999999999998765433333445567899999999998765 89999999999999999999999


Q ss_pred             C
Q psy13988        358 F  358 (358)
Q Consensus       358 F  358 (358)
                      |
T Consensus       285 f  285 (365)
T 3e7e_A          285 K  285 (365)
T ss_dssp             C
T ss_pred             c
Confidence            7

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=296.65  Aligned_cols=205  Identities=26%  Similarity=0.445  Sum_probs=167.9

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC------------------------CCchhHHHHHHH
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE------------------------GFPITAVREIKI  198 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~e~~~  198 (358)
                      ...++|.+.+.||+|+||.||++.+..+++.||||++.......                        ...+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            34578999999999999999999999999999999997653211                        123467899999


Q ss_pred             HHhCCCCcccchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCcee
Q psy13988        199 LRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLH  278 (358)
Q Consensus       199 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H  278 (358)
                      ++.++||||+++++++.+..        ++.+|+||||++++.+..+.. ...+++..++.++.||+.||+|||++||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~~~--------~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  160 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPN--------EDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIH  160 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSS--------SSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHhCCCCCCCeEEEEEEcCC--------CCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            99999999999988876532        568999999999765554433 347999999999999999999999999999


Q ss_pred             cCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCC--CCCcchHHHHHHHHHHHhhCCC
Q psy13988        279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFVKKP  356 (358)
Q Consensus       279 ~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~lltg~~  356 (358)
                      +||||+||+++.++.++|+|||++........  ......+|+.|+|||++.+...  ++.++||||||+++|+|++|+.
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            99999999999999999999999987654322  1234567999999999876542  4678999999999999999999


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       239 pf  240 (298)
T 2zv2_A          239 PF  240 (298)
T ss_dssp             SS
T ss_pred             CC
Confidence            98

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=296.06  Aligned_cols=208  Identities=39%  Similarity=0.668  Sum_probs=171.0

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc---CCCCchhHHHHHHHHHhCC---CCcccchhhhhc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE---KEGFPITAVREIKILRQLN---HKNIVNLREIVT  215 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~  215 (358)
                      +...++|++++.||+|+||.||++.+..+++.||||++.....   .......+.+|+.+++.++   ||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            3456799999999999999999999999999999999875532   2223346678888877774   999999998886


Q ss_pred             ccCcccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcE
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~  294 (358)
                      ....     .....+++|||++++++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+
T Consensus        85 ~~~~-----~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           85 TSRT-----DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             ECCS-----SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred             ccCC-----CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence            5321     1123689999999998888876543 349999999999999999999999999999999999999999999


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       160 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf  219 (308)
T 3g33_A          160 KLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLF  219 (308)
T ss_dssp             EECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSC
T ss_pred             EEeeCccccccCCCcc---cCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCC
Confidence            9999999986643322   23456799999999998665 899999999999999999999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.5e-41  Score=306.82  Aligned_cols=207  Identities=24%  Similarity=0.331  Sum_probs=173.8

Q ss_pred             CCCCCCCcccccccCC--cceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        142 STNNSSRPLMEPLAAG--GLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      -...++|++++.||+|  +||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.+   
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---   97 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---   97 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE---
Confidence            3566789999999999  99999999999999999999998765444444567789999999999999999877765   


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                             ++.+|+||||++++ +.+.+... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+
T Consensus        98 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~  170 (389)
T 3gni_B           98 -------DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS  170 (389)
T ss_dssp             -------TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             -------CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEc
Confidence                   55899999999975 44444332 3569999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCC-----CCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDR-----QRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||.+........     ........+|+.|+|||++.+. ..++.++|||||||++|+|++|++||
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  237 (389)
T 3gni_B          171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  237 (389)
T ss_dssp             CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence            9999875533221     1112234679999999999864 45899999999999999999999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-41  Score=299.08  Aligned_cols=198  Identities=23%  Similarity=0.367  Sum_probs=171.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+.+.||+|+||.||++.+..+++.||+|.+.....   ....+.+|+.+++.++||||+++++++.+       
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------   72 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFES-------   72 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEE-------
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc---cHHHHHHHHHHHHhCCCCCCCeEeEEEec-------
Confidence            45789999999999999999999999999999999875422   23457899999999999999999877755       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC--CCcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN--RGEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~--~~~~~l~Dfg  300 (358)
                         .+.+++||||++| +|.+.+......+++..++.++.||+.||.|||++||+||||||+||+++.  ++.++|+|||
T Consensus        73 ---~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           73 ---MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             ---TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             ---CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence               5589999999987 566666655567999999999999999999999999999999999999987  7899999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++|.+||
T Consensus       150 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf  203 (321)
T 1tki_A          150 QARQLKPGDN---FRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPF  203 (321)
T ss_dssp             TCEECCTTCE---EEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCeECCCCCc---cccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9987754332   23345799999999997654 789999999999999999999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-41  Score=302.51  Aligned_cols=213  Identities=25%  Similarity=0.365  Sum_probs=168.0

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ...+....+|.+.+.||+|+||.||++.+..+++.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   84 (311)
T 3ork_A            5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   84 (311)
T ss_dssp             CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred             CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence            345567789999999999999999999999999999999997653322 1224577899999999999999999887653


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                      ..      .+...|+||||++|+.+..+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+
T Consensus        85 ~~------~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           85 TP------AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             ET------TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEEC
T ss_pred             CC------CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEe
Confidence            31      123569999999874444443444579999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++......... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf  219 (311)
T 3ork_A          159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPF  219 (311)
T ss_dssp             CCSCC------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eccCcccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence            99999876543222 2223456799999999998664 899999999999999999999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=297.65  Aligned_cols=205  Identities=26%  Similarity=0.353  Sum_probs=171.8

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ...+.+|.+.+.||+|+||.||++.+..+++.||||++...... .....+.+|+.+++.++||||+++++++....   
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   80 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---   80 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCC---
Confidence            45678899999999999999999999999999999999765432 23456789999999999999999988776532   


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCCCcE
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGM--VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM----NNRGEV  294 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill----~~~~~~  294 (358)
                           ....++||||+++ +|.+.+....  ..+++..++.++.||+.||+|||++||+|+||||+||++    +.++.+
T Consensus        81 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           81 -----TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             -----TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred             -----CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceE
Confidence                 4578999999986 5555554322  238999999999999999999999999999999999999    777889


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccC-------CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG-------EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+|||+++.......   .....+|+.|+|||++..       ...++.++|||||||++|+|++|+.||
T Consensus       156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  223 (319)
T 4euu_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF  223 (319)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSE
T ss_pred             EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999987754432   234467999999998852       245889999999999999999999997

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-41  Score=297.79  Aligned_cols=203  Identities=25%  Similarity=0.245  Sum_probs=168.0

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSD  219 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  219 (358)
                      .+....+|++++.||+|+||+||++.+..+++.||||++...............|+..+..+ +||||+++++++.+   
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~---  128 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE---  128 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe---
Confidence            33444679999999999999999999999999999999865433332233445566655555 99999999777654   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ++.+|+|||++++++.+.+......+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+||
T Consensus       129 -------~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          129 -------GGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             -------TTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCC
T ss_pred             -------CCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccc
Confidence                   5689999999999999888777778999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........   .....||+.|+|||++.+  .++.++||||||+++|+|++|..||
T Consensus       202 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~  255 (311)
T 3p1a_A          202 GLLVELGTAGA---GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELP  255 (311)
T ss_dssp             TTCEECC---------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred             eeeeecccCCC---CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99987654332   234457999999999875  4899999999999999999996654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-40  Score=301.83  Aligned_cols=201  Identities=28%  Similarity=0.438  Sum_probs=161.7

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|.+++.||+|+||.||++.+..+++.||||++.....   ....+.+|+.+++.++||||+++++++.+     
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----   87 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILT-----   87 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEee-----
Confidence            3456789999999999999999999999999999999975432   24567899999999999999999877765     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc--EEEeec
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE--VKLADF  299 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~--~~l~Df  299 (358)
                           .+.+|+||||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+||
T Consensus        88 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           88 -----PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             -----SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             -----CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeec
Confidence                 5589999999987444444333457999999999999999999999999999999999999987765  999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+++.......   .....||+.|+|||++.+....+.++|||||||++|+|++|++||
T Consensus       163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf  218 (361)
T 3uc3_A          163 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF  218 (361)
T ss_dssp             CCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCC
Confidence            99875432222   234467999999999987663445599999999999999999998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-40  Score=299.32  Aligned_cols=203  Identities=38%  Similarity=0.674  Sum_probs=171.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.+       
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------   95 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-------   95 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-------
Confidence            3467999999999999999999999999999999987654433334456789999999999999999777654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         .+..|+||||++++++..+......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus        96 ---~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  172 (331)
T 4aaa_A           96 ---KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR  172 (331)
T ss_dssp             ---TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             ---CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence               56899999999999888887766789999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......+++.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       173 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  225 (331)
T 4aaa_A          173 TLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF  225 (331)
T ss_dssp             -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC
Confidence            6644322  2234567999999999987656899999999999999999999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-40  Score=299.56  Aligned_cols=202  Identities=31%  Similarity=0.453  Sum_probs=170.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc---CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE---KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ....|++.+.||+|+||.||++.+..+++.||||++.....   .......+.+|+.+++.++||||+++++++.+    
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----   97 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----   97 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            45679999999999999999999999999999999875432   12234578899999999999999999777654    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---  293 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~---  293 (358)
                            ++.+|+||||++| +|.+.+..   ....+++..+..++.||+.||+|||++||+||||||+||+++.++.   
T Consensus        98 ------~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~  171 (351)
T 3c0i_A           98 ------DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAP  171 (351)
T ss_dssp             ------TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCC
T ss_pred             ------CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCc
Confidence                  5689999999996 55455532   3345899999999999999999999999999999999999987664   


Q ss_pred             EEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       294 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++|+|||++........  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf  233 (351)
T 3c0i_A          172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPF  233 (351)
T ss_dssp             EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCC
Confidence            99999999987754322  223456899999999998655 899999999999999999999998

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=294.02  Aligned_cols=202  Identities=26%  Similarity=0.383  Sum_probs=169.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++.+       
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------   78 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-------   78 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-------
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCcCcccEEEEEec-------
Confidence            3467899999999999999999999999999999885432  2234567899999999999999999877764       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         ++..++||||+++ +|.+.+......+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++
T Consensus        79 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           79 ---DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             ---TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             ---CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccc
Confidence               5689999999987 565666665678999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCC------------CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQR------------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ..........            ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~  222 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNAD  222 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSS
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCC
Confidence            8765433211            111456799999999998654 899999999999999999999886

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-40  Score=297.88  Aligned_cols=202  Identities=26%  Similarity=0.366  Sum_probs=160.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee---cCCcEEEEEEeecccc--CCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENE--KEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ....+|.+++.||+|+||.||++.+.   .+++.||+|+++....  .......+.+|+.+++.++||||+++++++.. 
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   92 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-   92 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-
Confidence            45578999999999999999999985   6899999999976532  12233456789999999999999999777654 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                               ++.+|+||||++| +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus        93 ---------~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl  162 (327)
T 3a62_A           93 ---------GGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKL  162 (327)
T ss_dssp             ---------SSCEEEEEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEE
T ss_pred             ---------CCEEEEEEeCCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEE
Confidence                     5689999999986 4555554 3456899999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||+++.......  ......||+.|+|||++.+.. ++.++||||||+++|+|++|++||
T Consensus       163 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf  221 (327)
T 3a62_A          163 TDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPF  221 (327)
T ss_dssp             CCCSCC------------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             EeCCcccccccCCc--cccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCC
Confidence            99999876433221  123456799999999997655 899999999999999999999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=299.65  Aligned_cols=205  Identities=36%  Similarity=0.685  Sum_probs=169.3

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC---CCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK---EGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      +....+|.+++.||+|+||.||++.+..+++.||||++......   ......+.+|+.+++.++||||+++++++.+  
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   83 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--   83 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--
Confidence            34567899999999999999999999999999999998754322   1223467899999999999999999777654  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                              .+..++||||+++++...+......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|
T Consensus        84 --------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  155 (346)
T 1ua2_A           84 --------KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLAD  155 (346)
T ss_dssp             --------TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             --------CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEe
Confidence                    557899999999988888877777899999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++........  ......+|+.|+|||++.+...++.++||||||+++|+|++|.+||
T Consensus       156 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~  213 (346)
T 1ua2_A          156 FGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL  213 (346)
T ss_dssp             CGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            999987653322  2344567999999999976666889999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.9e-41  Score=303.35  Aligned_cols=205  Identities=30%  Similarity=0.520  Sum_probs=159.0

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|++++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++....    
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----  101 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR----  101 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS----
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC----
Confidence            3457899999999999999999999999999999998765433333456789999999999999999999886532    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                      ...+...+|+|+|+++++|.+.+..  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          102 SLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             SGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             ccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            1223457899999998777666654  46999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.....     .....+|+.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  230 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  230 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            865432     234567999999999987566899999999999999999999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-40  Score=300.28  Aligned_cols=199  Identities=30%  Similarity=0.473  Sum_probs=172.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....|.+++.||+|+||.||++.+..+++.||||++...... ......+.+|+.++++++||||+++++++.+      
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------  125 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR------  125 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE------
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE------
Confidence            345688999999999999999999999999999999754322 1123467899999999999999999877765      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ++..++||||+.|++.+.+......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus       126 ----~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  201 (348)
T 1u5q_A          126 ----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA  201 (348)
T ss_dssp             ----TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             ----CCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCc
Confidence                4589999999999988888766678999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......      ....+|+.|+|||++.+  ...++.++||||||+++|+|++|++||
T Consensus       202 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  253 (348)
T 1u5q_A          202 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  253 (348)
T ss_dssp             BSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            765432      23467999999999853  345899999999999999999999997

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-40  Score=302.01  Aligned_cols=204  Identities=29%  Similarity=0.512  Sum_probs=166.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++....    .
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~   98 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK----S   98 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC----S
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc----c
Confidence            457899999999999999999999999999999999865433333456789999999999999999999887532    2


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ..+....|+||||+++++.+.+..   .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        99 ~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A           99 LEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             TTTCCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             cccccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            234458999999999988887753   58999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf  226 (371)
T 2xrw_A          176 TAGTSF---MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLF  226 (371)
T ss_dssp             -----------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccc---ccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence            765332   123456799999999998754 899999999999999999999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-40  Score=310.75  Aligned_cols=205  Identities=24%  Similarity=0.417  Sum_probs=174.8

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      .....++|.+.+.||+|+||.||++.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++..   
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~---   87 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST---   87 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence            345567899999999999999999999999999999999765322 2234567899999999999999999877765   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus        88 -------~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           88 -------PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             -------SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             -------CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEec
Confidence                   4589999999987544444445567999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........   .....||+.|+|||++.+....+.++|||||||++|+|++|+.||
T Consensus       161 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf  216 (476)
T 2y94_A          161 GLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF  216 (476)
T ss_dssp             SSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC
Confidence            99987754432   234567999999999987665578999999999999999999998

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3e-40  Score=305.36  Aligned_cols=203  Identities=31%  Similarity=0.509  Sum_probs=169.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+.+.||+|+||.||++.+..+++.||||++.....      ...+|+++++.++||||+++++++....    
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~----  120 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSG----  120 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEE----
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccC----
Confidence            344579999999999999999999999999999999875321      2347999999999999999988875422    


Q ss_pred             cccCCCeEEEEeeccccChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEee
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVKLAD  298 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~l~D  298 (358)
                      ...+...+++||||+++++...+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus       121 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             TTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             CCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEecc
Confidence            112234578999999997766553   345679999999999999999999999999999999999999965 5789999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+++.......   .....+|+.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus       201 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf  257 (420)
T 1j1b_A          201 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF  257 (420)
T ss_dssp             CTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             chhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence            999987654332   234567999999999977656899999999999999999999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=296.35  Aligned_cols=203  Identities=27%  Similarity=0.394  Sum_probs=172.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC------CchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG------FPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      ....+|.+++.||+|+||.||++.+..+++.||||++........      ....+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            455689999999999999999999999999999999987643221      33467789999999999999999777654


Q ss_pred             cCcccccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                                .+.+++|||++.++ .+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++
T Consensus       101 ----------~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k  170 (335)
T 3dls_A          101 ----------QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK  170 (335)
T ss_dssp             ----------SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred             ----------CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEE
Confidence                      56899999998653 4444444555799999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++........   .....+|+.|+|||++.+....+.++||||||+++|+|++|+.||
T Consensus       171 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  230 (335)
T 3dls_A          171 LIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF  230 (335)
T ss_dssp             ECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             EeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCch
Confidence            999999987754432   233457999999999987764588999999999999999999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.5e-40  Score=293.78  Aligned_cols=202  Identities=27%  Similarity=0.355  Sum_probs=160.5

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +....+|++.+.||+|+||.||++.+  ++..||||++............+.+|+.++++++||||+++++++.+     
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----  105 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----  105 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----
Confidence            34567899999999999999999976  78899999987655443334567899999999999999999777654     


Q ss_pred             ccccCCCeEEEEeeccccC-hHHHHhcCC--CCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEEE
Q psy13988        222 DFRKDKGSFYLVFEYMDHD-LMGLLESGM--VDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~~~~~~~l  296 (358)
                           .+.+++||||++++ |.+.+....  ..+++..++.++.||+.||+|||+.|  |+||||||+||+++.++.++|
T Consensus       106 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          106 -----PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             -----TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             -----CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEE
Confidence                 45789999999874 545454332  13899999999999999999999999  999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||+++.......  ......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       181 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf  239 (309)
T 3p86_A          181 CDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPW  239 (309)
T ss_dssp             CCCC-------------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCCCCCcccccccc--ccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999986543321  223456799999999998665 899999999999999999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.3e-40  Score=311.61  Aligned_cols=205  Identities=27%  Similarity=0.315  Sum_probs=173.7

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      .......|.+++.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+   
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~---  256 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET---  256 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee---
Confidence            345567899999999999999999999999999999999765322 2234567889999999999999999777655   


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhcC---CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLESG---MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                             ...+|+||||++|+ |...+...   ...+++..++.++.||+.||+|||++||+||||||+||+++.+|.+|
T Consensus       257 -------~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vk  329 (543)
T 3c4z_A          257 -------KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR  329 (543)
T ss_dssp             -------SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred             -------CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEE
Confidence                   55899999999975 44444332   34699999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||+++.......  ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       330 L~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF  389 (543)
T 3c4z_A          330 ISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPF  389 (543)
T ss_dssp             ECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EeecceeeeccCCCc--ccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCC
Confidence            999999987654332  123457899999999998754 899999999999999999999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.6e-40  Score=288.91  Aligned_cols=203  Identities=19%  Similarity=0.219  Sum_probs=174.0

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSD  219 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  219 (358)
                      .....++|.+.+.||+|++|.||++.+..+++.||||++.....    ...+.+|+.+++.+ +|+|++++++++.+   
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~---   77 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQE---   77 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE---
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCC---
Confidence            34567889999999999999999999999999999999875432    23678899999999 89999999766543   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc-----E
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE-----V  294 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~-----~  294 (358)
                             +...++||||++++|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.++.     +
T Consensus        78 -------~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~  150 (298)
T 1csn_A           78 -------GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI  150 (298)
T ss_dssp             -------TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             -------CceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeE
Confidence                   5689999999977788887766667999999999999999999999999999999999999987775     9


Q ss_pred             EEeecccceeccccCCC-----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQ-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++.........     .......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf  218 (298)
T 1csn_A          151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPW  218 (298)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCc
Confidence            99999999877544322     1234556799999999987655 899999999999999999999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.7e-40  Score=297.81  Aligned_cols=207  Identities=32%  Similarity=0.591  Sum_probs=176.5

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+.+|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++....     
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----   98 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT-----   98 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS-----
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC-----
Confidence            4578999999999999999999999999999999987432 2222356789999999999999999998886532     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      .......|+|||++++++.+.+...  .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus        99 ~~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccccceEEEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            1234578999999999888877654  58999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........ .......+|+.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  232 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF  232 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence            77544322 22344578999999999876666899999999999999999999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6e-40  Score=287.94  Aligned_cols=202  Identities=30%  Similarity=0.478  Sum_probs=172.5

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|.+.+.||.|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++.+     
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   76 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----   76 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----
Confidence            346788999999999999999999999999999999998765444344567889999999999999999777654     


Q ss_pred             ccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---EEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~---~~l~  297 (358)
                           ++..++||||+.++ +...+.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.   ++|+
T Consensus        77 -----~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           77 -----ESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             -----SSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             -----CCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence                 55889999999875 4455543 356999999999999999999999999999999999999987665   9999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++........   .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       151 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf  207 (284)
T 3kk8_A          151 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPF  207 (284)
T ss_dssp             CCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eceeeEEcccCcc---ccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCC
Confidence            9999987654432   23456799999999998655 899999999999999999999997

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.2e-40  Score=300.98  Aligned_cols=210  Identities=19%  Similarity=0.234  Sum_probs=169.1

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecC-----CcEEEEEEeeccccCC---------CCchhHHHHHHHHHhCCCCcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFT-----DELVALKKVRLENEKE---------GFPITAVREIKILRQLNHKNI  207 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni  207 (358)
                      +....+|.+.+.||+|+||.||++.+..+     ++.||||++.......         ........|+..++.++||||
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            35667999999999999999999998664     5899999987543110         001123345566777789999


Q ss_pred             cchhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy13988        208 VNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL  287 (358)
Q Consensus       208 v~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nil  287 (358)
                      +++++++....      ......|+||||++++|.+.+......+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       111 v~~~~~~~~~~------~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nil  184 (364)
T 3op5_A          111 PKYWGSGLHDK------NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL  184 (364)
T ss_dssp             CCEEEEEEEEE------TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CeEEeeeeecc------CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEE
Confidence            99998886532      123568999999966777777766678999999999999999999999999999999999999


Q ss_pred             ec--CCCcEEEeecccceeccccCCCC-----CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        288 MN--NRGEVKLADFGLARLYNAEDRQR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       288 l~--~~~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++  .++.+||+|||+++.+.......     ......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCc
Confidence            99  88999999999998775443221     123345899999999998765 899999999999999999999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.7e-40  Score=297.46  Aligned_cols=203  Identities=25%  Similarity=0.384  Sum_probs=173.9

Q ss_pred             ccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-----CCcccchh
Q psy13988        137 PIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-----HKNIVNLR  211 (358)
Q Consensus       137 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~  211 (358)
                      .........++|.+++.||+|+||.||++.+..+++.||||++....   .....+..|+.+++.+.     ||||++++
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            45556677889999999999999999999999999999999987432   12345677999999996     99999998


Q ss_pred             hhhcccCcccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC
Q psy13988        212 EIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN  290 (358)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~  290 (358)
                      +++..          .+..++|||+++++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus       103 ~~~~~----------~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  172 (360)
T 3llt_A          103 GKFMY----------YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD  172 (360)
T ss_dssp             EEEEE----------TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred             ceeeE----------CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence            77765          45899999999778888776543 45899999999999999999999999999999999999975


Q ss_pred             -------------------------CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHH
Q psy13988        291 -------------------------RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG  345 (358)
Q Consensus       291 -------------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  345 (358)
                                               ++.++|+|||++.......     ....+|+.|+|||++.+.. ++.++||||||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG  246 (360)
T 3llt_A          173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLG-WDVSSDMWSFG  246 (360)
T ss_dssp             TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCC-CCTTHHHHHHH
T ss_pred             ccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCC-CCCccchHHHH
Confidence                                     7899999999998654322     3456799999999998765 89999999999


Q ss_pred             HHHHHHhhCCCCC
Q psy13988        346 CILGELFVKKPLF  358 (358)
Q Consensus       346 ~~l~~lltg~~pF  358 (358)
                      |++|+|++|++||
T Consensus       247 ~il~ell~g~~pf  259 (360)
T 3llt_A          247 CVLAELYTGSLLF  259 (360)
T ss_dssp             HHHHHHHHSSCSC
T ss_pred             HHHHHHHHCCCCC
Confidence            9999999999998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.3e-40  Score=312.38  Aligned_cols=203  Identities=25%  Similarity=0.343  Sum_probs=172.7

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .....+|.+++.||+|+||.||++.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+    
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----  255 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----  255 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee----
Confidence            3556779999999999999999999999999999999976532 22234567899999999999999999777654    


Q ss_pred             cccccCCCeEEEEeeccccC-hHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        221 LDFRKDKGSFYLVFEYMDHD-LMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                            .+.+|+||||++|+ |...+... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|
T Consensus       256 ------~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~D  329 (576)
T 2acx_A          256 ------KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD  329 (576)
T ss_dssp             ------SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             ------CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEe
Confidence                  55899999999875 44445433 23499999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++........   .....||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF  385 (576)
T 2acx_A          330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPF  385 (576)
T ss_dssp             CTTCEECCTTCC---EECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccceecccCcc---ccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCC
Confidence            999987654322   23457899999999998755 899999999999999999999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.3e-40  Score=298.79  Aligned_cols=205  Identities=27%  Similarity=0.423  Sum_probs=170.1

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeee-------cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhh
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSL-------FTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREI  213 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  213 (358)
                      .....+|.+.+.||+|+||.||++.+.       .++..||||+++... .......+.+|+.+++.+ +||||++++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            345578999999999999999999975       345689999987542 222234678999999999 89999999777


Q ss_pred             hcccCcccccccCCCeEEEEeecccc-ChHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHHHhCCce
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM---------------VDFNEVNNASIMRQLLDGLSYCHKRNFL  277 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~i~  277 (358)
                      +.+          .+.+|+||||+++ +|.+.+....               ..+++..+..++.||+.||+|||++||+
T Consensus       156 ~~~----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  225 (370)
T 2psq_A          156 CTQ----------DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI  225 (370)
T ss_dssp             ECS----------SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             Ecc----------CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            654          5579999999987 5655554432               3478999999999999999999999999


Q ss_pred             ecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCC
Q psy13988        278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKP  356 (358)
Q Consensus       278 H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~  356 (358)
                      ||||||+||+++.++.+||+|||+++...............+++.|+|||++.+.. ++.++|||||||++|+|+| |..
T Consensus       226 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~  304 (370)
T 2psq_A          226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGS  304 (370)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999998776544433444556688999999998655 8999999999999999999 999


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       305 p~  306 (370)
T 2psq_A          305 PY  306 (370)
T ss_dssp             SS
T ss_pred             CC
Confidence            87

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-40  Score=301.27  Aligned_cols=201  Identities=25%  Similarity=0.368  Sum_probs=171.2

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +.....|.+++.||+|+||.||++.+..+++.||+|++......  ....+.+|+.+++.++||||+++++++.+     
T Consensus        47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----  119 (387)
T 1kob_A           47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFED-----  119 (387)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----
T ss_pred             CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--hHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----
Confidence            34556899999999999999999999999999999998754322  13467889999999999999999777754     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC--CCcEEEee
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN--RGEVKLAD  298 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~--~~~~~l~D  298 (358)
                           .+.+++||||+.| +|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.  .+.++|+|
T Consensus       120 -----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~D  194 (387)
T 1kob_A          120 -----KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID  194 (387)
T ss_dssp             -----SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             -----CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEe
Confidence                 5689999999987 566666655567999999999999999999999999999999999999974  46799999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++........   .....+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus       195 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf  250 (387)
T 1kob_A          195 FGLATKLNPDEI---VKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPF  250 (387)
T ss_dssp             CTTCEECCTTSC---EEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred             cccceecCCCcc---eeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCC
Confidence            999987754322   22345799999999997654 899999999999999999999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-40  Score=311.10  Aligned_cols=202  Identities=21%  Similarity=0.314  Sum_probs=162.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+      
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------  219 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT------  219 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE------
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee------
Confidence            44679999999999999999999999999999999976432 22233466789999999999999999777765      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          .+.+|+||||++|+.+.........+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus       220 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          220 ----HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             ----TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             ----CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCC
Confidence                55899999999985555444444579999999999999999999998 9999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++......  .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       296 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf  349 (446)
T 4ejn_A          296 CKEGIKDG--ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  349 (446)
T ss_dssp             CCTTCC-------CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ceeccCCC--cccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCC
Confidence            97543222  1224457899999999997655 899999999999999999999998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-39  Score=297.67  Aligned_cols=207  Identities=29%  Similarity=0.492  Sum_probs=169.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc-
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL-  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~-  221 (358)
                      ....+|.+++.||+|+||.||++.+..+++.||||++.....      ...+|+.+++.++||||+++++++....... 
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            456789999999999999999999999999999999875422      2347999999999999999999886532100 


Q ss_pred             ---------------------------ccccCCCeEEEEeeccccChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHH
Q psy13988        222 ---------------------------DFRKDKGSFYLVFEYMDHDLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYC  271 (358)
Q Consensus       222 ---------------------------~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~L  271 (358)
                                                 ....++..+++||||+++++.+.+.   .....+++..++.++.||+.||+||
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                       0003455789999999998666553   4556799999999999999999999


Q ss_pred             HhCCceecCCCCCCEEec-CCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHH
Q psy13988        272 HKRNFLHRDIKCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE  350 (358)
Q Consensus       272 H~~~i~H~Dlkp~Nill~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~  350 (358)
                      |++||+||||||+||+++ .++.++|+|||+++........   ....+|+.|+|||++.+...++.++||||+||++|+
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            999999999999999998 5789999999999876544322   344669999999998876668999999999999999


Q ss_pred             HhhCCCCC
Q psy13988        351 LFVKKPLF  358 (358)
Q Consensus       351 lltg~~pF  358 (358)
                      |++|++||
T Consensus       235 ll~g~~pf  242 (383)
T 3eb0_A          235 LILGKPLF  242 (383)
T ss_dssp             HHHSSCSS
T ss_pred             HHhCCCCC
Confidence            99999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-39  Score=290.11  Aligned_cols=206  Identities=23%  Similarity=0.268  Sum_probs=171.6

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ........+|.+.+.||+|+||.||++.+ .+++.||||++....  ......+.+|+.+++.++||||+++++++.+  
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--  106 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--  106 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence            34455678999999999999999999996 478999999877543  2234567899999999999999999777654  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCC---CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcE
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGM---VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~  294 (358)
                              ++..++||||+++ +|.+.+....   ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.+
T Consensus       107 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~  178 (321)
T 2qkw_B          107 --------RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP  178 (321)
T ss_dssp             --------TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCE
T ss_pred             --------CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCE
Confidence                    5578999999987 4544443322   358999999999999999999999999999999999999999999


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++................+|+.|+|||++.+.. ++.++||||||+++|+|+||+.||
T Consensus       179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~  241 (321)
T 2qkw_B          179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAI  241 (321)
T ss_dssp             EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTC
T ss_pred             EEeecccccccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcc
Confidence            999999998765443333334556799999999987654 899999999999999999999987

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3e-40  Score=311.29  Aligned_cols=206  Identities=31%  Similarity=0.511  Sum_probs=173.4

Q ss_pred             ccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        137 PIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       137 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      |....+....+|.+++.||+|+||.||++.+..+++.||||++............+.+|+.++++++||||+++++++.+
T Consensus        13 ~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             -CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            33445567788999999999999999999999999999999997665444456678899999999999999999777654


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CC
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RG  292 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~---~~  292 (358)
                                .+.+|+||||+.| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.   ++
T Consensus        93 ----------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~  161 (486)
T 3mwu_A           93 ----------SSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDC  161 (486)
T ss_dssp             ----------SSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTC
T ss_pred             ----------CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCC
Confidence                      5689999999987 45555543 347999999999999999999999999999999999999954   55


Q ss_pred             cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       293 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .+||+|||++........   .....||+.|+|||++.+  .++.++|||||||++|+|++|.+||
T Consensus       162 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf  222 (486)
T 3mwu_A          162 DIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF  222 (486)
T ss_dssp             CEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            799999999986654332   234567999999999875  3889999999999999999999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.8e-39  Score=289.78  Aligned_cols=196  Identities=23%  Similarity=0.392  Sum_probs=168.2

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|...+.||+|+||.||++.+..+|+.||||++.....  .....+.+|+.+++.++||||+++++++..          
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------  113 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV----------  113 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE----------
Confidence            46677899999999999999999999999999875432  234567899999999999999999877765          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      .+..++||||++++.+..+... ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus       114 ~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          114 GEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  192 (321)
T ss_dssp             TTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence            4589999999998666555443 369999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf  241 (321)
T 2c30_A          193 KDVP--KRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPY  241 (321)
T ss_dssp             SSSC--CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCcc--ccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            4322  223456799999999997654 899999999999999999999997

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.1e-40  Score=295.35  Aligned_cols=199  Identities=27%  Similarity=0.366  Sum_probs=155.3

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +.....|.+.+.||+|+||.||++.+..+++.||||++.....    ...+.+|+.+++.++||||+++++++.+     
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~-----  119 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFET-----  119 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEec-----
Confidence            3456679999999999999999999999999999999985432    2356789999999999999999777754     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEee
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEVKLAD  298 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~---~~~~~l~D  298 (358)
                           .+..++||||++++.+.........+++..+..++.||+.||.|||++||+||||||+||+++.   ++.++|+|
T Consensus       120 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          120 -----PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             -----SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             -----CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEcc
Confidence                 5589999999987544444344557999999999999999999999999999999999999976   78999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+++.......   .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus       195 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf  250 (349)
T 2w4o_A          195 FGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPF  250 (349)
T ss_dssp             CC-------------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CccccccCcccc---cccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCC
Confidence            999987654322   23456799999999998655 899999999999999999999997

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.5e-40  Score=292.61  Aligned_cols=203  Identities=21%  Similarity=0.301  Sum_probs=169.0

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcE----EEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDEL----VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ....+|++++.||+|+||.||++.+..+++.    ||+|.+.... .......+.+|+.+++.++||||+++++++.   
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---   85 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---   85 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---
Confidence            3467899999999999999999999888875    7778775443 2233456778999999999999999988764   


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                              ++..++||||+.+ ++.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+
T Consensus        86 --------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~  157 (325)
T 3kex_A           86 --------GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVA  157 (325)
T ss_dssp             --------BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEEC
T ss_pred             --------CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEEC
Confidence                    2358899999985 6767776655679999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |||+++...............+++.|+|||++.+.. ++.++||||||+++|+|+| |+.||
T Consensus       158 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~  218 (325)
T 3kex_A          158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPY  218 (325)
T ss_dssp             SCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCc
Confidence            999999876554444445556688999999997654 8999999999999999999 99998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.9e-39  Score=294.72  Aligned_cols=207  Identities=29%  Similarity=0.474  Sum_probs=169.7

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC---------chhHHHHHHHHHhCCCCcccchhhh
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF---------PITAVREIKILRQLNHKNIVNLREI  213 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~  213 (358)
                      ...++|.+.+.||.|+||.||++.+.. ++.||||++.........         ...+.+|+.+++.++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            456789999999999999999999854 999999998765433222         1567899999999999999999988


Q ss_pred             hcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE  293 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~  293 (358)
                      +.....     .....+|+||||++|++.+.+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus        98 ~~~~~~-----~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~  172 (362)
T 3pg1_A           98 FVHFEE-----PAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND  172 (362)
T ss_dssp             EEECCT-----TTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred             EEeccC-----CCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence            754321     234578999999999999999877778999999999999999999999999999999999999999999


Q ss_pred             EEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       294 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++|+|||++........   .....+|+.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       173 ~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  234 (362)
T 3pg1_A          173 ITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF  234 (362)
T ss_dssp             EEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             EEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence            99999999975543322   234466899999999987566899999999999999999999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-39  Score=317.20  Aligned_cols=202  Identities=21%  Similarity=0.314  Sum_probs=171.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||||+++.... .......+..|..++..+ +||+|+++++++.+     
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-----  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-----
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-----
Confidence            45679999999999999999999999999999999986421 233345678899999988 79999999777654     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       414 -----~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGl  488 (674)
T 3pfq_A          414 -----MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM  488 (674)
T ss_dssp             -----SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred             -----CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecce
Confidence                 558999999999755554444445799999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++......  .......||+.|+|||++.+.. ++.++||||||+++|+|++|++||
T Consensus       489 a~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf  542 (674)
T 3pfq_A          489 CKENIWDG--VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPF  542 (674)
T ss_dssp             CEECCCTT--CCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eeccccCC--cccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCC
Confidence            98643222  2234567899999999997665 899999999999999999999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=296.84  Aligned_cols=203  Identities=26%  Similarity=0.393  Sum_probs=165.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCC--CcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH--KNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~  220 (358)
                      ..+..|.+++.||+|+||.||++.+ .+++.||||++............+.+|+.+++.++|  +||+++++++.+    
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----   80 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----   80 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee----
Confidence            4677899999999999999999998 568999999998665443334567889999999976  999999777654    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            ++..|+|||+.+++|.+.+... ..+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||
T Consensus        81 ------~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           81 ------DQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             ------SSEEEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             ------CCEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecc
Confidence                  5689999998777888777654 5799999999999999999999999999999999999997 6889999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccC----------CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLG----------EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++................||+.|+|||++.+          ...++.++||||||+++|+|++|+.||
T Consensus       153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf  220 (343)
T 3dbq_A          153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  220 (343)
T ss_dssp             SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcc
Confidence            9987755443333345678999999999853          244788999999999999999999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.4e-39  Score=291.95  Aligned_cols=211  Identities=25%  Similarity=0.358  Sum_probs=166.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc-----
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA-----  220 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-----  220 (358)
                      .+|.+++.||+|+||.||++.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++.+....     
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            46889999999999999999999999999999997654 233446788999999999999999999987653310     


Q ss_pred             ------------------------------------------cccccCCCeEEEEeeccccC-hHHHHhcCC--CCCChH
Q psy13988        221 ------------------------------------------LDFRKDKGSFYLVFEYMDHD-LMGLLESGM--VDFNEV  255 (358)
Q Consensus       221 ------------------------------------------~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~--~~~~~~  255 (358)
                                                                +.........++||||++|+ +.+.+....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                      00112234689999999985 444444322  224555


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCC----------CCCCCccccccccc
Q psy13988        256 NNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQ----------RPYTNKVITLWYRP  325 (358)
Q Consensus       256 ~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~~~y~a  325 (358)
                      .++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.........          .......+|+.|+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            68999999999999999999999999999999999999999999999877654221          22244568999999


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        326 PELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       326 PE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++.+.. ++.++||||||+++|+|++|..|+
T Consensus       245 PE~~~~~~-~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          245 PEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             HHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             hHHhcCCC-CcchhhHHHHHHHHHHHHHcCCCh
Confidence            99998765 899999999999999999998764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.3e-39  Score=288.30  Aligned_cols=202  Identities=25%  Similarity=0.353  Sum_probs=172.0

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC----CchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG----FPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      .....|.+.+.||+|+||.||++.+..+++.||+|++........    ....+.+|+.+++.++||||+++++++.+  
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   86 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--   86 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence            445679999999999999999999999999999999986643322    24567899999999999999999777654  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----cE
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EV  294 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~----~~  294 (358)
                              .+..++||||++++.+..+......+++..++.++.||+.||+|||++||+|+||||+||+++.++    .+
T Consensus        87 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~  158 (321)
T 2a2a_A           87 --------RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI  158 (321)
T ss_dssp             --------SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred             --------CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCE
Confidence                    558999999998754444444456799999999999999999999999999999999999999888    79


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus       159 kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  218 (321)
T 2a2a_A          159 KLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPF  218 (321)
T ss_dssp             EECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             EEccCccceecCcccc---ccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCC
Confidence            9999999987654332   23446799999999987654 899999999999999999999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.5e-40  Score=301.25  Aligned_cols=203  Identities=25%  Similarity=0.379  Sum_probs=165.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC--CCcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN--HKNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~  220 (358)
                      ..+..|.+++.||+|+||.||++.+.. ++.||||++............+.+|+.+++.++  ||||+++++++..    
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~----  127 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----  127 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec----
Confidence            345669999999999999999999864 899999999866544334457789999999996  5999999776654    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            ++.+|+|||+.+++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus       128 ------~~~~~lv~E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG  199 (390)
T 2zmd_A          128 ------DQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG  199 (390)
T ss_dssp             ------SSEEEEEEECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred             ------CCEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecC
Confidence                  5579999997767777777654 4789999999999999999999999999999999999995 5899999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCC----------CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGE----------ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.+.............||+.|+|||++.+.          ..++.++|||||||++|+|++|++||
T Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf  267 (390)
T 2zmd_A          200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  267 (390)
T ss_dssp             SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcc
Confidence            99877544333333455789999999998652          34788999999999999999999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-39  Score=284.56  Aligned_cols=202  Identities=30%  Similarity=0.459  Sum_probs=171.7

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++++.||+|++|.||++.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.+         
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------   76 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE---------   76 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE---------
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc---------
Confidence            4688999999999999999999999999999998755332 234567899999999999999999777654         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++..|+||||++++.+..+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        77 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           77 -GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             -TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -CCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence             5689999999987444444444557999999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .............+++.|+|||++.+....+.++||||||+++|+|++|+.||
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  208 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  208 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence            54433333345567999999999987664577999999999999999999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.9e-40  Score=293.49  Aligned_cols=206  Identities=23%  Similarity=0.373  Sum_probs=168.8

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCc---EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDE---LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ......+|.+.+.||+|+||.||++.+..++.   .||||+++.... ......+.+|+.+++.++||||+++++++.+ 
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-  121 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-  121 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-
Confidence            34566789999999999999999999986655   499999875422 2223467899999999999999999877654 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                               ++..|+||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|
T Consensus       122 ---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl  192 (325)
T 3kul_A          122 ---------GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV  192 (325)
T ss_dssp             ---------GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred             ---------CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEE
Confidence                     4578999999987 555666566668999999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        297 ADFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +|||++......... .......+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||
T Consensus       193 ~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~  255 (325)
T 3kul_A          193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPY  255 (325)
T ss_dssp             CCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCCcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCc
Confidence            999999877543221 1223334577899999997654 8899999999999999999 99997

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.2e-39  Score=305.52  Aligned_cols=204  Identities=31%  Similarity=0.553  Sum_probs=170.2

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-----------CCchhHHHHHHHHHhCCCCcc
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-----------GFPITAVREIKILRQLNHKNI  207 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~ni  207 (358)
                      ...+....+|.+++.||+|+||.||+|.+..+++.||||++.......           .....+.+|+.+++.++||||
T Consensus        29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  108 (504)
T 3q5i_A           29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNI  108 (504)
T ss_dssp             EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTB
T ss_pred             ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCC
Confidence            345567789999999999999999999999999999999997654221           234567899999999999999


Q ss_pred             cchhhhhcccCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy13988        208 VNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI  286 (358)
Q Consensus       208 v~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Ni  286 (358)
                      +++++++.+          .+.+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus       109 v~~~~~~~~----------~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni  177 (504)
T 3q5i_A          109 IKLFDVFED----------KKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI  177 (504)
T ss_dssp             CCEEEEEEC----------SSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CeEEEEEEc----------CCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence            999777754          5689999999987 45555543 35799999999999999999999999999999999999


Q ss_pred             EecCCC---cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        287 LMNNRG---EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       287 ll~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.++   .++|+|||++........   .....||+.|+|||++.+  .++.++|||||||++|+|++|.+||
T Consensus       178 l~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf  247 (504)
T 3q5i_A          178 LLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF  247 (504)
T ss_dssp             EESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC
Confidence            999876   699999999987754432   234567999999999864  3899999999999999999999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-39  Score=296.49  Aligned_cols=204  Identities=33%  Similarity=0.581  Sum_probs=170.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+.+.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.....   
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  115 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS---  115 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS---
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC---
Confidence            35678999999999999999999999999999999998654443334567899999999999999999998876432   


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                       ......+|+||||+++++...+.   ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus       116 -~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          116 -LRNFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             -STTCCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             -cccceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence             11122459999999998777663   34899999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......     .....+|+.|+|||++.+...++.++||||||+++|+|++|+.||
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  242 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF  242 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence            865433     234566999999999987566899999999999999999999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-39  Score=307.52  Aligned_cols=201  Identities=30%  Similarity=0.517  Sum_probs=166.8

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +.....|++++.||+|+||.||++.+..++..||||++............+.+|+.+++.++||||+++++++.+     
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----  107 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----  107 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----
Confidence            345567999999999999999999999999999999998765555556678899999999999999999877754     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC---CcEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR---GEVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~---~~~~l~  297 (358)
                           .+.+|+||||+.| ++.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++..   +.+||+
T Consensus       108 -----~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          108 -----KRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             -----SSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             -----CCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEE
Confidence                 5589999999987 45555543 3579999999999999999999999999999999999999764   459999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++........   .....||+.|+|||++.+  .++.++||||+||++|+|++|.+||
T Consensus       182 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf  237 (494)
T 3lij_A          182 DFGLSAVFENQKK---MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPF  237 (494)
T ss_dssp             CCTTCEECBTTBC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ECCCCeECCCCcc---ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCC
Confidence            9999987754432   234567999999999863  4899999999999999999999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-39  Score=283.84  Aligned_cols=199  Identities=32%  Similarity=0.456  Sum_probs=170.0

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +....+|.+.+.||+|+||.||++.+..++..||+|++......  ....+.+|+.+++.++||||+++++++.+     
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   77 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED-----   77 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            34567899999999999999999999999999999998765332  35678899999999999999999777654     


Q ss_pred             ccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill---~~~~~~~l~  297 (358)
                           ++..++||||++++ +.+.+. ....+++..++.++.|++.||+|||++|++|+||||+||++   +.++.++|+
T Consensus        78 -----~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~  151 (277)
T 3f3z_A           78 -----NTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLI  151 (277)
T ss_dssp             -----SSEEEEEEECCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             -----CCeEEEEEeccCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEE
Confidence                 56899999999875 444444 34568999999999999999999999999999999999999   778899999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++........   .....+|+.|+|||++.+.  ++.++||||||+++|+|++|+.||
T Consensus       152 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~  207 (277)
T 3f3z_A          152 DFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPF  207 (277)
T ss_dssp             CCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ecccceeccCccc---hhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCC
Confidence            9999987654432   2344579999999998653  899999999999999999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.5e-39  Score=297.18  Aligned_cols=199  Identities=26%  Similarity=0.376  Sum_probs=159.6

Q ss_pred             CCCCCCccc-ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHH-HhCCCCcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLM-EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKIL-RQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .....|.+. +.||.|+||.||++.+..+++.||||++...       ..+.+|+.++ +..+||||+++++++...   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~---  127 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL---  127 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE---
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeec---
Confidence            344556666 7899999999999999999999999998632       3567888887 445899999998887541   


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEE
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEVK  295 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~---~~~~~  295 (358)
                         ..+.+++|+||||++| +|.+.+... ...+++..++.++.||+.||+|||++||+||||||+||+++.   ++.+|
T Consensus       128 ---~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~k  204 (400)
T 1nxk_A          128 ---YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK  204 (400)
T ss_dssp             ---ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEE
T ss_pred             ---ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEE
Confidence               2235579999999986 666666543 246999999999999999999999999999999999999998   78899


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||+++.......   .....+|+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       205 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf  263 (400)
T 1nxk_A          205 LTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF  263 (400)
T ss_dssp             ECCCTTCEECC--------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSC
T ss_pred             EEecccccccCCCCc---cccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCC
Confidence            999999987653322   23456799999999987654 899999999999999999999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-39  Score=293.58  Aligned_cols=211  Identities=33%  Similarity=0.573  Sum_probs=175.1

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      .......+|.+.+.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   81 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPD--   81 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS--
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc--
Confidence            34467789999999999999999999999999999999986432 222234567899999999999999998877642  


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                         .+......|+|||++++++.+.+...  .+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+||
T Consensus        82 ---~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           82 ---SFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             ---CSTTCCCEEEEECCCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred             ---ccCccceEEEEEeccCccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEec
Confidence               22345689999999999888777653  6899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCC--------CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQR--------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++..........        ......+|+.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  223 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF  223 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC
Confidence            9998765332111        1233467999999999876556899999999999999999999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.5e-40  Score=294.09  Aligned_cols=196  Identities=26%  Similarity=0.429  Sum_probs=164.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      .....|.+.+.||+|+||.||++.+..+++.||||++.....      ...+|++++.++ +||||+++++++.+     
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~-----   87 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDD-----   87 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEEC-----
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEc-----
Confidence            345679999999999999999999999999999999975432      235788888888 89999999777654     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-C---cEEE
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-G---EVKL  296 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~---~~~l  296 (358)
                           ++.+|+||||++| ++.+.+. ....+++..+..++.||+.||+|||++||+||||||+||++..+ +   .+||
T Consensus        88 -----~~~~~lv~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           88 -----GKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             -----SSEEEEEECCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             -----CCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEE
Confidence                 5689999999987 5555554 44579999999999999999999999999999999999998543 3   5999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++........  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus       162 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf  220 (342)
T 2qr7_A          162 CDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPF  220 (342)
T ss_dssp             CCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EECCCcccCcCCCC--ceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCC
Confidence            99999987654322  223456799999999987654 788999999999999999999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-39  Score=298.59  Aligned_cols=205  Identities=30%  Similarity=0.502  Sum_probs=170.7

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      .......+|.+.+.||+|+||.||++.+..+++ ||+|++.....      ...+|+.+++.++||||+++++++.... 
T Consensus        34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~-  105 (394)
T 4e7w_A           34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNG-  105 (394)
T ss_dssp             SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEES-
T ss_pred             CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecC-
Confidence            344566789999999999999999999877666 88888764322      2247999999999999999998886533 


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEE
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN-NRGEVK  295 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~-~~~~~~  295 (358)
                         ...+...+++||||++++++..+.   .....+++..++.++.||+.||+|||++||+||||||+||+++ .++.+|
T Consensus       106 ---~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          106 ---DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             ---SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred             ---CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEE
Confidence               113345689999999998776553   3355799999999999999999999999999999999999999 789999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||+++........   ....+|+.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus       183 L~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  242 (394)
T 4e7w_A          183 LIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF  242 (394)
T ss_dssp             ECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999876544322   34566999999999987666899999999999999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.4e-39  Score=288.51  Aligned_cols=205  Identities=25%  Similarity=0.410  Sum_probs=164.5

Q ss_pred             CCCCCCCCccc-ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccC
Q psy13988        141 NSTNNSSRPLM-EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKS  218 (358)
Q Consensus       141 ~~~~~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  218 (358)
                      .+.....|.+. +.||+|+||.||++.+..+++.||||++....  ......+.+|+.++.++ +||||+++++++.+  
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--   82 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--   82 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--
Confidence            45567788885 78999999999999999999999999997543  23356788999999985 79999999777654  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---E
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---V  294 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~---~  294 (358)
                              ++.+|+||||+++ ++.+.+.. ...+++..+..++.||+.||+|||++||+|+||||+||+++.++.   +
T Consensus        83 --------~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~  153 (316)
T 2ac3_A           83 --------EDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV  153 (316)
T ss_dssp             --------TTEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSE
T ss_pred             --------CCEEEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCce
Confidence                    5589999999986 55555543 357899999999999999999999999999999999999998775   9


Q ss_pred             EEeecccceeccccCC-----CCCCCCccccccccccccccCC----CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDR-----QRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++........     ........+|+.|+|||++.+.    ..++.++||||||+++|+|++|++||
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  226 (316)
T 2ac3_A          154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF  226 (316)
T ss_dssp             EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCC
Confidence            9999999876543221     1112234579999999998641    23788999999999999999999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.9e-40  Score=299.41  Aligned_cols=205  Identities=24%  Similarity=0.351  Sum_probs=171.0

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|.+.+.||+|+||.||++.+..+++.||||.++... .......+.+|+.+++.++||||+++++++.+     
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----  183 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----  183 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----
Confidence            345678889999999999999999999999999999987542 11223467899999999999999999877754     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           ++..|+||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus       184 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          184 -----KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             -----CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence                 4578999999985 6666666555568999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++...............+++.|+|||++.+.. ++.++||||||+++|+|+| |..||
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~  316 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPY  316 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence            998654433222222334578899999987554 8899999999999999998 99987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-39  Score=290.81  Aligned_cols=188  Identities=31%  Similarity=0.530  Sum_probs=144.8

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCcccccccCCCeE
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKGSF  230 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~~~~  230 (358)
                      +.||+|+||.||++.+..+++.||||++....     .....+|+.+++.+. ||||+++++++.+          +...
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~----------~~~~   81 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHD----------QLHT   81 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------SSEE
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEc----------CCEE
Confidence            68999999999999999999999999987532     346778999999996 9999999777754          5689


Q ss_pred             EEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEeecccceecc
Q psy13988        231 YLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EVKLADFGLARLYN  306 (358)
Q Consensus       231 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~~l~Dfg~~~~~~  306 (358)
                      |+||||++|+ |.+.+. ....+++..++.++.||+.||+|||++||+||||||+||+++.++   .++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           82 FLVMELLNGGELFERIK-KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEEECCCCSCBHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEEEccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            9999999874 555554 446799999999999999999999999999999999999998766   89999999998765


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  ......+|+.|+|||++.+.. ++.++||||||+++|+|++|++||
T Consensus       161 ~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf  209 (325)
T 3kn6_A          161 PDNQ--PLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPF  209 (325)
T ss_dssp             C------------------------CC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCC--cccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCC
Confidence            4322  223456799999999987655 899999999999999999999998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.2e-40  Score=289.17  Aligned_cols=204  Identities=20%  Similarity=0.282  Sum_probs=158.4

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +....+|++++.||+|+||.||++.+..+++.||||++............+.++...++.++||||+++++++.+     
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----   77 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----   77 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----
Confidence            445678999999999999999999999999999999987653332222334455556888899999999777764     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                           ++..++||||++|++.+.+.   .....+++..++.++.||+.||+|||++ |++|+||||+||+++.++.++|+
T Consensus        78 -----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~  152 (290)
T 3fme_A           78 -----EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC  152 (290)
T ss_dssp             -----SSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBC
T ss_pred             -----cCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEe
Confidence                 55799999999998766553   3556799999999999999999999998 99999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCcccccccccccccc---CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++.........   ....+|+.|+|||++.   ....++.++||||||+++|+|++|+.||
T Consensus       153 Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  213 (290)
T 3fme_A          153 DFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY  213 (290)
T ss_dssp             CC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred             ecCCcccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            99999876543322   2335799999999973   3445888999999999999999999997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=299.45  Aligned_cols=200  Identities=36%  Similarity=0.629  Sum_probs=154.7

Q ss_pred             CCcc-cccccCCcceeeEeeeee--cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        147 SRPL-MEPLAAGGLSLNNFSVSL--FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~-~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .|.+ .+.||+|+||.||++.+.  .+++.||||++....    ....+.+|+.+++.++||||+++++++...      
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------   90 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH------   90 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEET------
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecC------
Confidence            4555 458999999999999965  578999999987432    234678999999999999999998887542      


Q ss_pred             ccCCCeEEEEeeccccChHHHHhc--------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCC
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLES--------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM----NNR  291 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill----~~~  291 (358)
                        .+..+|+||||+++++.+.+..        ....+++..++.++.||+.||+|||++||+||||||+|||+    +.+
T Consensus        91 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           91 --ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             --TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred             --CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence              2568999999999988887742        12248999999999999999999999999999999999999    677


Q ss_pred             CcEEEeecccceeccccCC-CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        292 GEVKLADFGLARLYNAEDR-QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       292 ~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.+||+|||+++....... ........+|+.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  236 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  236 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence            8999999999987654322 122344567999999999987666899999999999999999999998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.8e-40  Score=293.42  Aligned_cols=213  Identities=20%  Similarity=0.271  Sum_probs=154.2

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCc---EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDE---LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ......+|.+.+.||+|+||.||++.+..++.   .||||++............+.+|+.+++.++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            34566789999999999999999999887775   899999976544444456788999999999999999999888653


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcC-----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESG-----MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR  291 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~  291 (358)
                      ..    .......++||||+.+ ++.+.+...     ...+++..++.++.||+.||+|||++||+|+||||+||+++.+
T Consensus        98 ~~----~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           98 RA----KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             -----------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred             cc----ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence            31    1111235999999997 455544321     2258999999999999999999999999999999999999999


Q ss_pred             CcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       292 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +.++|+|||++................+++.|+|||++.+.. ++.++||||||+++|+|++ |.+||
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~  240 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPY  240 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCc
Confidence            999999999998775554433344455688999999987654 8999999999999999999 89987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-40  Score=302.79  Aligned_cols=207  Identities=15%  Similarity=0.159  Sum_probs=164.4

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHH---HHHHhCCCCcccchhhhhccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREI---KILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~  217 (358)
                      +....+|.+.+.||+|+||.||++.+..+++.||||++..... .......+.+|+   .+++.++||||+++++.+...
T Consensus        69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            3456789999999999999999999999999999999986532 222345678899   455555899999998655432


Q ss_pred             CcccccccCCC-----------------eEEEEeeccccChHHHHhcCCCCCC-------hHHHHHHHHHHHHHHHHHHh
Q psy13988        218 SDALDFRKDKG-----------------SFYLVFEYMDHDLMGLLESGMVDFN-------EVNNASIMRQLLDGLSYCHK  273 (358)
Q Consensus       218 ~~~~~~~~~~~-----------------~~~lv~e~~~~~l~~~~~~~~~~~~-------~~~~~~~~~qi~~al~~LH~  273 (358)
                      .   +++++.+                 ..|+||||++|+|.+.+.... .++       +..+..++.||+.||+|||+
T Consensus       149 ~---~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          149 F---DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             S---EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             h---hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence            1   2222221                 378999999888888775432 233       47888899999999999999


Q ss_pred             CCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCC----------CCCCCcchHHH
Q psy13988        274 RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----------ERYGPAIDVWS  343 (358)
Q Consensus       274 ~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~Diws  343 (358)
                      +||+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++.+.          ..++.++||||
T Consensus       225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS  298 (377)
T 3byv_A          225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA  298 (377)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred             CCeecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence            99999999999999999999999999999864332     233456 899999999765          24899999999


Q ss_pred             HHHHHHHHhhCCCCC
Q psy13988        344 CGCILGELFVKKPLF  358 (358)
Q Consensus       344 lG~~l~~lltg~~pF  358 (358)
                      |||++|+|++|+.||
T Consensus       299 lG~il~elltg~~Pf  313 (377)
T 3byv_A          299 LGLVIYWIWCADLPI  313 (377)
T ss_dssp             HHHHHHHHHHSSCCC
T ss_pred             HHHHHHHHHHCCCCC
Confidence            999999999999998

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.6e-40  Score=294.65  Aligned_cols=204  Identities=24%  Similarity=0.301  Sum_probs=169.2

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      -....+|++.+.||+|+||.||++.+  .++.||||++......   .....+|+.++++++||||+++++++.+...  
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--   92 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTS--   92 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred             ccchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchH---HHHHHHHHHHHhcCCCCCchhhcceeccCCC--
Confidence            34567899999999999999999986  4899999998754322   2345668889999999999999998876431  


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCCEEecC
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR----------NFLHRDIKCSNILMNN  290 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----------~i~H~Dlkp~Nill~~  290 (358)
                          ....+++||||+++ +|.+.+...  .+++..++.++.||+.||+|||+.          ||+||||||+||+++.
T Consensus        93 ----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           93 ----VDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             ----SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             ----CCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence                13468999999987 555555443  589999999999999999999999          9999999999999999


Q ss_pred             CCcEEEeecccceeccccCCCCCCCCccccccccccccccCC----CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.+||+|||+++...............+|+.|+|||++.+.    ..++.++|||||||++|+|+||++||
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf  238 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA  238 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred             CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence            999999999999887655544444556789999999998763    23566889999999999999999887

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.5e-40  Score=290.40  Aligned_cols=207  Identities=26%  Similarity=0.427  Sum_probs=167.1

Q ss_pred             CCCCCCCCcccccccCCcceeeEeee----eecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSV----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      ......+|++++.||+|+||.||++.    +..+++.||||++.....  .....+.+|+.+++.++||||+++++++..
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34567889999999999999999998    677899999999875422  223567899999999999999999887754


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                      ..        ...+++||||+++ +|.+.+......+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++
T Consensus        83 ~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~k  154 (295)
T 3ugc_A           83 AG--------RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK  154 (295)
T ss_dssp             HH--------HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred             CC--------CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEE
Confidence            22        3468999999976 66666666555699999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++......... .......++..|+|||++.+.. ++.++||||||+++|+|+||..||
T Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~  217 (295)
T 3ugc_A          155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKS  217 (295)
T ss_dssp             ECCCCSCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             EccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhccccc
Confidence            9999999876543221 2223334577899999987655 899999999999999999998876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=295.51  Aligned_cols=197  Identities=26%  Similarity=0.372  Sum_probs=162.6

Q ss_pred             CCCcc--cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        146 SSRPL--MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       146 ~~~~~--~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..|.+  .+.||+|+||.||++.+..+++.||+|++......  ....+.+|+.+++.++||||+++++++.+       
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------  157 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFES-------  157 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEE-------
Confidence            34544  56899999999999999999999999999864322  23567899999999999999999777754       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe--cCCCcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM--NNRGEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill--~~~~~~~l~Dfg  300 (358)
                         .+.+++||||+++ +|.+.+......+++..++.++.||+.||+|||+.||+||||||+||++  +.++.++|+|||
T Consensus       158 ---~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG  234 (373)
T 2x4f_A          158 ---KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG  234 (373)
T ss_dssp             ---SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred             ---CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCC
Confidence               5589999999986 5667776666679999999999999999999999999999999999999  566789999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       235 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf  288 (373)
T 2x4f_A          235 LARRYKPREKL---KVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPF  288 (373)
T ss_dssp             SCEECCTTCBC---CCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CceecCCcccc---ccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCC
Confidence            99877544322   3346799999999987554 889999999999999999999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-39  Score=286.87  Aligned_cols=206  Identities=21%  Similarity=0.299  Sum_probs=159.3

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ...+...++|++.+.||+|+||.||++.+.   ..||+|+++...........+.+|+.+++.++||||++++++..   
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---   90 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---   90 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---
Confidence            345678889999999999999999999863   35999999866544444456889999999999999999977542   


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                              ....++||||+++ ++.+.+......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+
T Consensus        91 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~  162 (289)
T 3og7_A           91 --------APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIG  162 (289)
T ss_dssp             --------SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             --------CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEc
Confidence                    3467999999986 5666665666779999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++................+|+.|+|||++..  ...++.++||||||+++|+|++|+.||
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  225 (289)
T 3og7_A          163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY  225 (289)
T ss_dssp             CCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence            9999986654333333445567999999999862  334788999999999999999999998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.8e-40  Score=292.73  Aligned_cols=203  Identities=21%  Similarity=0.323  Sum_probs=162.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcE----EEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDEL----VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ....+|++++.||+|+||.||++.+..+++.    ||+|.+.... .......+.+|+.++++++||||+++++++.+. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence            3456799999999999999999998877765    5788776432 223445788999999999999999998877642 


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                                ..++|+|++.+ ++.+.+......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus        90 ----------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~  159 (327)
T 3poz_A           90 ----------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             ----------SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred             ----------CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEc
Confidence                      36788888875 6777777666789999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |||+++...............+|+.|+|||++.+.. ++.++||||||+++|+|+| |+.||
T Consensus       160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~  220 (327)
T 3poz_A          160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPY  220 (327)
T ss_dssp             CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cCcceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCc
Confidence            999998776554444444555688999999988654 8999999999999999999 99997

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=301.21  Aligned_cols=205  Identities=26%  Similarity=0.339  Sum_probs=171.1

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ...+.+|.+.+.||+|+||.||++.+..+++.||||++...... .....+.+|+++++.++||||+++++++....   
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---   80 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---   80 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---
Confidence            45678999999999999999999999999999999999754332 23456779999999999999999988776532   


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcC--CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCCCcE
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESG--MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM----NNRGEV  294 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill----~~~~~~  294 (358)
                           ....++||||++| +|.+.+...  ...+++..++.++.||+.||+|||++||+||||||+||++    +.++.+
T Consensus        81 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           81 -----TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             -----TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             -----CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeE
Confidence                 4478999999986 555555432  2238999999999999999999999999999999999999    777789


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCC-------CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE-------ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+|||+++........   ....+|+.|+|||++.+.       ..++.++|||||||++|+|++|+.||
T Consensus       156 kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf  223 (396)
T 4eut_A          156 KLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF  223 (396)
T ss_dssp             EECCGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred             EEecCCCceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999877544322   345679999999988541       33678999999999999999999997

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-39  Score=287.67  Aligned_cols=210  Identities=25%  Similarity=0.383  Sum_probs=171.9

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeee----eecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhh
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSV----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIV  214 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  214 (358)
                      .........|++++.||+|+||.||++.    +..+++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus        14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (302)
T 4e5w_A           14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGIC   92 (302)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            3344456678999999999999999998    67889999999987654 233446788999999999999999998887


Q ss_pred             cccCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q psy13988        215 TDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE  293 (358)
Q Consensus       215 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~  293 (358)
                      .+..        ...+++||||+++ +|.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.
T Consensus        93 ~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~  164 (302)
T 4e5w_A           93 TEDG--------GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ  164 (302)
T ss_dssp             EC-----------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred             ecCC--------CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC
Confidence            6532        3578999999987 666666566667999999999999999999999999999999999999999999


Q ss_pred             EEEeecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        294 VKLADFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       294 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++|+|||++......... .......+|..|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCC
Confidence            999999999877544321 2223445688899999987654 788999999999999999998874

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-40  Score=296.85  Aligned_cols=205  Identities=23%  Similarity=0.327  Sum_probs=167.1

Q ss_pred             CCCCCCCcccccccCCcceeeEeee-----eecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSV-----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      +....+|.+++.||+|+||.||++.     +..+++.||||+++.... ......+.+|+.+++.++||||+++++++.+
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            4456789999999999999999999     556788999999864322 2223467889999999999999999777654


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCC------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN  289 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~  289 (358)
                                .+..++||||+.| +|.+.+....      ..+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus       146 ----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  215 (367)
T 3l9p_A          146 ----------SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT  215 (367)
T ss_dssp             ----------SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             ----------CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEe
Confidence                      4577999999976 6666664432      3589999999999999999999999999999999999999


Q ss_pred             CCC---cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        290 NRG---EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       290 ~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .++   .+||+|||+++...............+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||
T Consensus       216 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf  287 (367)
T 3l9p_A          216 CPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPY  287 (367)
T ss_dssp             CSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            655   59999999998665444333344556789999999987654 8999999999999999998 99987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.1e-39  Score=283.58  Aligned_cols=206  Identities=24%  Similarity=0.299  Sum_probs=172.6

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ....+..|++.+.||+|+||.||++.+..++..||+|.+............+.+|+.+++.++||||+++++++....  
T Consensus        21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--   98 (290)
T 1t4h_A           21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV--   98 (290)
T ss_dssp             ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES--
T ss_pred             cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc--
Confidence            345667789999999999999999999999999999999866544444556789999999999999999998876432  


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEec-CCCcEEEe
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMN-NRGEVKLA  297 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~-~~~~~~l~  297 (358)
                          .++..+++||||++++.+..+......+++..++.++.||+.||.|||+.+  ++|+||||+||+++ .++.++|+
T Consensus        99 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A           99 ----KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             ----SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             ----CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence                235679999999987544444444457899999999999999999999999  99999999999998 78899999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++.......    .....+++.|+|||++.+  .++.++||||||+++|+|++|+.||
T Consensus       175 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf  229 (290)
T 1t4h_A          175 DLGLATLKRASF----AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPY  229 (290)
T ss_dssp             CTTGGGGCCTTS----BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eCCCcccccccc----cccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCC
Confidence            999997543322    223457999999998864  3899999999999999999999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.1e-39  Score=282.69  Aligned_cols=202  Identities=22%  Similarity=0.240  Sum_probs=168.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...++|.+.+.||+|+||.||++.+..+++.||||++......    ..+.+|+.+++.++|++++..+..+..      
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~------   75 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA------   75 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEE------
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecC------
Confidence            3567899999999999999999999999999999987655433    357889999999999888877655432      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEeec
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLADF  299 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill---~~~~~~~l~Df  299 (358)
                         ++...++|||++++++.+.+......+++..+..++.||+.||.|||++||+|+||||+||++   +.++.++|+||
T Consensus        76 ---~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Df  152 (296)
T 4hgt_A           76 ---EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             ---ETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred             ---CCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecC
Confidence               356889999999778888877666679999999999999999999999999999999999999   78899999999


Q ss_pred             ccceeccccCCC-----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQ-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++.........     .......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 4hgt_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCC
Confidence            999877544321     1223456799999999998665 899999999999999999999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6e-40  Score=297.61  Aligned_cols=206  Identities=25%  Similarity=0.344  Sum_probs=169.1

Q ss_pred             CCCCCCCcccccccCCcceeeEeee-----eecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSV-----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVT  215 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  215 (358)
                      .....+|.+.+.||+|+||.||++.     +..+++.||||+++..... .....+.+|+.+++++ +||||+++++++.
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH-HHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            3456789999999999999999999     5566799999999754222 2234678999999999 8899999988876


Q ss_pred             ccCcccccccCCCeEEEEeecccc-ChHHHHhcCCC--------------------------------------------
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMV--------------------------------------------  250 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------------------------------------  250 (358)
                      +.         +..+++||||+.+ +|.+.+.....                                            
T Consensus        97 ~~---------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           97 KP---------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             ST---------TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             cC---------CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            53         3458999999987 55555543321                                            


Q ss_pred             ---------------------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        251 ---------------------DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       251 ---------------------~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                                           .+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                                 18999999999999999999999999999999999999999999999999998765444


Q ss_pred             CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        310 RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       310 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .........+|+.|+|||++.+.. ++.++||||||+++|+|+| |..||
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~  296 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPY  296 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             cchhccccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCC
Confidence            333344556789999999987654 8999999999999999998 99997

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-39  Score=298.12  Aligned_cols=207  Identities=28%  Similarity=0.426  Sum_probs=176.0

Q ss_pred             ccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC--------CCccc
Q psy13988        137 PIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN--------HKNIV  208 (358)
Q Consensus       137 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv  208 (358)
                      ++...+...++|.+++.||+|+||.||++.+..+++.||||++....   .....+.+|+.+++.++        |+||+
T Consensus        28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            44555667789999999999999999999999999999999987432   22346788999999985        78899


Q ss_pred             chhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCE
Q psy13988        209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNI  286 (358)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Ni  286 (358)
                      ++++++....      .++..+|+|||++++++++.+.... ..+++..++.++.||+.||+|||++ ||+||||||+||
T Consensus       105 ~~~~~~~~~~------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NI  178 (397)
T 1wak_A          105 QLLDDFKISG------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI  178 (397)
T ss_dssp             CEEEEEEEEE------TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGE
T ss_pred             eeecceeecC------CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHe
Confidence            9988776321      1345899999999999999886543 5699999999999999999999998 999999999999


Q ss_pred             EecCCC-------------------------------------------------cEEEeecccceeccccCCCCCCCCc
Q psy13988        287 LMNNRG-------------------------------------------------EVKLADFGLARLYNAEDRQRPYTNK  317 (358)
Q Consensus       287 ll~~~~-------------------------------------------------~~~l~Dfg~~~~~~~~~~~~~~~~~  317 (358)
                      |++.++                                                 .++|+|||++......     ....
T Consensus       179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~  253 (397)
T 1wak_A          179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTED  253 (397)
T ss_dssp             EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSC
T ss_pred             eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccC
Confidence            999775                                                 7999999999876533     2345


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        318 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       318 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .+|+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       254 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf  293 (397)
T 1wak_A          254 IQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLF  293 (397)
T ss_dssp             CSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCC
Confidence            6799999999998765 899999999999999999999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.6e-39  Score=282.21  Aligned_cols=200  Identities=24%  Similarity=0.347  Sum_probs=169.8

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC-----chhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF-----PITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      .....+|.+.+.||+|+||.||++.+..+++.||||++.........     ...+.+|+.+++.++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            35568899999999999999999999999999999998765433221     1567899999999999999999887754


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCc
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNNRGE  293 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~~~~~  293 (358)
                      .            .++||||+++ ++.+.+......+++..+..++.|++.||+|||++|  |+|+||||+||+++.++.
T Consensus        95 ~------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~  162 (287)
T 4f0f_A           95 P------------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE  162 (287)
T ss_dssp             T------------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT
T ss_pred             C------------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC
Confidence            2            2699999985 676777777778999999999999999999999999  999999999999988776


Q ss_pred             -----EEEeecccceeccccCCCCCCCCccccccccccccccC-CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        294 -----VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG-EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       294 -----~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                           ++|+|||++......     .....+|+.|+|||++.. ...++.++||||||+++|+|++|+.||
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  228 (287)
T 4f0f_A          163 NAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF  228 (287)
T ss_dssp             TCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence                 999999999754332     234567999999999843 334788999999999999999999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-39  Score=306.61  Aligned_cols=202  Identities=33%  Similarity=0.525  Sum_probs=171.9

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ......+|++.+.||+|+||.||++.+..+++.||||++...... ......+.+|+.++++++||||+++++++.+   
T Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---   97 (484)
T 3nyv_A           21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED---   97 (484)
T ss_dssp             CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred             CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe---
Confidence            345567899999999999999999999999999999999765433 3334568899999999999999999777654   


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEE
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVK  295 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill---~~~~~~~  295 (358)
                             .+.+|+||||+.|+ +.+.+. ....+++..++.++.||+.||.|||++||+||||||+||++   +.++.++
T Consensus        98 -------~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  169 (484)
T 3nyv_A           98 -------KGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIR  169 (484)
T ss_dssp             -------SSEEEEEECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEE
T ss_pred             -------CCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEE
Confidence                   56899999999875 545554 44579999999999999999999999999999999999999   4678999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++........   .....||+.|+|||++.+  .++.++|||||||++|+|++|++||
T Consensus       170 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf  227 (484)
T 3nyv_A          170 IIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPF  227 (484)
T ss_dssp             ECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EEeeeeeEEcccccc---cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCC
Confidence            999999987654322   233467999999999875  3899999999999999999999998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=281.57  Aligned_cols=202  Identities=29%  Similarity=0.430  Sum_probs=153.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+|.+.+.||+|+||.||++.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+      
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   82 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED------   82 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC------
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc------
Confidence            44579999999999999999999999999999999975532 22334567899999999999999999777654      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          .+..++||||+++ ++.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus        83 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~  158 (278)
T 3cok_A           83 ----SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGL  158 (278)
T ss_dssp             ----SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred             ----CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecc
Confidence                5689999999986 55556665556899999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.........  .....+++.|+|||++.+.. ++.++||||||+++|+|++|++||
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  212 (278)
T 3cok_A          159 ATQLKMPHEK--HYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPF  212 (278)
T ss_dssp             CEECC-------------------------------CTHHHHHHHHHHHHHHSSCSS
T ss_pred             eeeccCCCCc--ceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9876533221  22345799999999987654 789999999999999999999997

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.2e-39  Score=283.45  Aligned_cols=204  Identities=27%  Similarity=0.334  Sum_probs=173.0

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .....+|.+.+.||+|+||.||++.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----   86 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----   86 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc----
Confidence            456678999999999999999999999999999999987653222 223467789999999999999999777654    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            ++..++||||++++.+..+......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus        87 ------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  160 (294)
T 2rku_A           87 ------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG  160 (294)
T ss_dssp             ------SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ------CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEecc
Confidence                  55899999999975555554444579999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~  215 (294)
T 2rku_A          161 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPF  215 (294)
T ss_dssp             TCEECCSTTC--CBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CceecccCcc--ccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9987653322  123345799999999987654 889999999999999999999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=287.15  Aligned_cols=213  Identities=38%  Similarity=0.598  Sum_probs=168.9

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc-
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA-  220 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-  220 (358)
                      ....++|.+++.||+|++|.||++.+..+++.||||++.....  .....+.+|+.+++.++||||+++++++...... 
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh--HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            3567899999999999999999999999999999999875432  2245678999999999999999999887653321 


Q ss_pred             ---cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEEE
Q psy13988        221 ---LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN-NRGEVKL  296 (358)
Q Consensus       221 ---~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~-~~~~~~l  296 (358)
                         .+.+.+....|+||||++|++.+.+..  ..+++..++.++.||+.||+|||++||+|+||||+||+++ .++.++|
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CC----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence               233455678999999999987777754  4689999999999999999999999999999999999997 4669999


Q ss_pred             eecccceeccccCC-CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDR-QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++........ ........+++.|+|||++.+...++.++||||||+++|+|++|+.||
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  225 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF  225 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC
Confidence            99999987643321 122234456899999999876556899999999999999999999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.9e-39  Score=297.77  Aligned_cols=201  Identities=24%  Similarity=0.372  Sum_probs=160.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC------CCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK------EGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ...+|.+.+.||+|+||.||++.+..+++.||||++......      ......+.+|+.++++++||||+++++++.  
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--  210 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--  210 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence            457899999999999999999999999999999999765321      112235789999999999999999987764  


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EV  294 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~  294 (358)
                               ....|+||||++++.+.........+++..+..++.||+.||+|||++||+||||||+||+++.++   .+
T Consensus       211 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~  281 (419)
T 3i6u_A          211 ---------AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI  281 (419)
T ss_dssp             ---------SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred             ---------cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceE
Confidence                     235799999998755544444556799999999999999999999999999999999999997654   59


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+|||+++.......   .....||+.|+|||++.+  ...++.++||||||+++|+|++|.+||
T Consensus       282 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf  344 (419)
T 3i6u_A          282 KITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF  344 (419)
T ss_dssp             EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            9999999987654322   234567999999999853  344788999999999999999999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.1e-39  Score=288.73  Aligned_cols=205  Identities=27%  Similarity=0.336  Sum_probs=173.5

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ......+|.+.+.||+|+||.||++.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+   
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---  112 (335)
T 2owb_A           36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED---  112 (335)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence            3456678999999999999999999999999999999987653222 223467789999999999999999777654   


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ++..|+||||++++.+..+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+||
T Consensus       113 -------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          113 -------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             -------SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred             -------CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeec
Confidence                   5689999999997555545444457999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       186 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  241 (335)
T 2owb_A          186 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPF  241 (335)
T ss_dssp             TTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCceecccCcc--cccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCC
Confidence            99987653322  123456799999999998655 889999999999999999999997

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=286.21  Aligned_cols=207  Identities=24%  Similarity=0.373  Sum_probs=172.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC--CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK--EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++......  ......+.+|+.+++.++||||+++++++...    
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   78 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE----   78 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC----
Confidence            457899999999999999999999999999999999765321  23345678999999999999999998877432    


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                          +....|+||||+++++.+.+.. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||
T Consensus        79 ----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           79 ----EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             -------CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ----CCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccc
Confidence                2557899999999987776654 34569999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCC-CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++................+++.|+|||++.+.. .++.++||||||+++|+|++|+.||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  213 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF  213 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence            998765443333334556799999999987543 2467999999999999999999997

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=292.20  Aligned_cols=203  Identities=33%  Similarity=0.581  Sum_probs=169.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+.+.||.|+||.||++.+..+|+.||||++............+.+|+.+++.++||||+++++++.....    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----   97 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS----   97 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS----
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc----
Confidence            4578999999999999999999999999999999997654333334567899999999999999999988876431    


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ......+|+||||+++++...+.   ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.
T Consensus        98 ~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             GGGCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             cccceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            11223569999999987766553   248999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....     .....+|+.|+|||++.+...++.++||||||+++|+|++|+.||
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  224 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF  224 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            65432     234466999999999987566899999999999999999999998

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.7e-39  Score=298.02  Aligned_cols=200  Identities=30%  Similarity=0.486  Sum_probs=170.8

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC------CCCcccchhhh
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL------NHKNIVNLREI  213 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~  213 (358)
                      ..+....+|.+++.||+|+||.||++.+..+++.||||++.....   ....+.+|+.+++.+      .|+||++++++
T Consensus        91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc---hHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            345667889999999999999999999999999999999875321   224566788888777      56799999776


Q ss_pred             hcccCcccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG  292 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~  292 (358)
                      +..          .+.+++|||++++++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus       168 ~~~----------~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~  237 (429)
T 3kvw_A          168 FTF----------RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG  237 (429)
T ss_dssp             EEE----------TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT
T ss_pred             ccc----------CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC
Confidence            654          56899999999999888886543 4589999999999999999999999999999999999999998


Q ss_pred             c--EEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        293 E--VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       293 ~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .  +||+|||++......     .....+|+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       238 ~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf  299 (429)
T 3kvw_A          238 RSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLL  299 (429)
T ss_dssp             SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCC
Confidence            7  999999999765432     23456799999999998765 899999999999999999999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-39  Score=283.17  Aligned_cols=205  Identities=24%  Similarity=0.381  Sum_probs=169.0

Q ss_pred             cccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       138 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ....++...+|.+.+.||+|+||.||++.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.+ 
T Consensus        14 ~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   91 (285)
T 3is5_A           14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-   91 (285)
T ss_dssp             CEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             CCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec-
Confidence            34455677889999999999999999999999999999999986542 2334678899999999999999999777654 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cC
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NN  290 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill---~~  290 (358)
                               ....++||||+++ ++.+.+..   ....+++..++.++.||+.||+|||++||+|+||||+||++   +.
T Consensus        92 ---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~  162 (285)
T 3is5_A           92 ---------YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSP  162 (285)
T ss_dssp             ---------SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSST
T ss_pred             ---------CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCC
Confidence                     5589999999987 56665532   34679999999999999999999999999999999999999   44


Q ss_pred             CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.++|+|||++........   .....+++.|+|||++.+  .++.++||||||+++|+|++|+.||
T Consensus       163 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf  225 (285)
T 3is5_A          163 HSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPF  225 (285)
T ss_dssp             TCCEEECCCCCCCC-------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCEEEEeeecceecCCccc---CcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCC
Confidence            57899999999987654322   234457999999999863  3789999999999999999999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-38  Score=281.18  Aligned_cols=201  Identities=22%  Similarity=0.239  Sum_probs=171.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..++|++.+.||+|++|.||++.+..+++.||||++.....    ...+.+|+.+++.++|++++..+..+..       
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~-------   75 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA-------   75 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEE-------
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccC-------
Confidence            46789999999999999999999999999999999875533    2367899999999999988777554432       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill---~~~~~~~l~Dfg  300 (358)
                        .+...++||||++++|.+.+......+++..++.++.||+.||+|||++||+|+||||+||++   +.++.++|+|||
T Consensus        76 --~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           76 --EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             --ETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             --CCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence              356889999999778888877666689999999999999999999999999999999999999   478899999999


Q ss_pred             cceeccccCCC-----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQ-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.........     .......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCC
Confidence            99877554321     1224456799999999998655 889999999999999999999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-39  Score=292.91  Aligned_cols=204  Identities=24%  Similarity=0.348  Sum_probs=167.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee---cCCcEEEEEEeecccc--CCCCchhHHHHHHHHHhC-CCCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENE--KEGFPITAVREIKILRQL-NHKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  216 (358)
                      ....+|.+++.||+|+||.||++.+.   .+++.||||+++....  .......+.+|+.+++.+ +||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            34478999999999999999999984   5899999999875432  222344567899999999 79999999777654


Q ss_pred             cCcccccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                                ++.+++||||++++ |.+.+. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++
T Consensus       131 ----------~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k  199 (355)
T 1vzo_A          131 ----------ETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV  199 (355)
T ss_dssp             ----------TTEEEEEECCCCSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             ----------CceEEEEeecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEE
Confidence                      55899999999874 545444 345799999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||+++........ ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus       200 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf  262 (355)
T 1vzo_A          200 LTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF  262 (355)
T ss_dssp             ESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999876433221 22345679999999999753 34788999999999999999999998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-39  Score=286.03  Aligned_cols=206  Identities=23%  Similarity=0.324  Sum_probs=160.0

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ..+...++|.+.+.||+|+||.||++.+..+++.||||++....... .....+.+|+.+++.++||||+++++++..  
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--  105 (309)
T 2h34_A           28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--  105 (309)
T ss_dssp             ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--
T ss_pred             CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--
Confidence            34556688999999999999999999999999999999987653322 123567889999999999999999777654  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                              ++..|+||||++| +|.+.+. ....+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+
T Consensus       106 --------~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~  176 (309)
T 2h34_A          106 --------DGQLYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLV  176 (309)
T ss_dssp             --------TTEEEEEEECCCCEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             --------CCeEEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEe
Confidence                    5689999999997 5555444 34579999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++........ .......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       177 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  235 (309)
T 2h34_A          177 DFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPY  235 (309)
T ss_dssp             SCCC-----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred             cCccCcccccccc-ccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCC
Confidence            9999986654321 1223456799999999987654 889999999999999999999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3e-39  Score=282.80  Aligned_cols=200  Identities=30%  Similarity=0.458  Sum_probs=165.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+|.+.+.||+|++|.||++.+..++..||+|++...... ......+.+|+.+++.++||||+++++++.+      
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD------   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC------
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec------
Confidence            346799999999999999999999999999999998654322 2234567889999999999999999777654      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          .+..++||||++++.+.........+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++
T Consensus        81 ----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~  156 (279)
T 3fdn_A           81 ----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS  156 (279)
T ss_dssp             ----SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred             ----CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecccc
Confidence                5589999999997444443333457999999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......    .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus       157 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  207 (279)
T 3fdn_A          157 VHAPSSR----RTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF  207 (279)
T ss_dssp             SCC------------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCccc----ccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCC
Confidence            6543322    23346699999999987654 789999999999999999999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-38  Score=285.60  Aligned_cols=197  Identities=29%  Similarity=0.532  Sum_probs=169.9

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  221 (358)
                      ....+|++++.||+|+||.||++.+..+++.||||++....     ...+.+|+.+++.++ ||||+++++++.+..   
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---  104 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPV---  104 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---
Confidence            34578999999999999999999999999999999987432     356889999999996 999999988876532   


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg  300 (358)
                           ....++||||+.++.+..+..   .+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||
T Consensus       105 -----~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          105 -----SRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             -----TCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             -----CCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence                 557899999999765555543   388999999999999999999999999999999999999777 89999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........   .....+++.|+|||++.+...++.++||||||+++|+|++|+.||
T Consensus       177 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~  231 (330)
T 3nsz_A          177 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF  231 (330)
T ss_dssp             TCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             CceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9987654432   234467999999999987566899999999999999999999997

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-39  Score=292.90  Aligned_cols=206  Identities=27%  Similarity=0.429  Sum_probs=171.7

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCC-------cEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhh
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTD-------ELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLRE  212 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  212 (358)
                      ......+|.+.+.||+|+||.||++.+..++       ..||||++..... ......+.+|+++++.+ +||||+++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            3456678999999999999999999976433       5799999875422 22235678999999999 9999999977


Q ss_pred             hhcccCcccccccCCCeEEEEeecccc-ChHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHHHhCCc
Q psy13988        213 IVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM---------------VDFNEVNNASIMRQLLDGLSYCHKRNF  276 (358)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~i  276 (358)
                      ++.+          ++..++||||+++ +|.+.+....               ..+++..++.++.||+.||+|||++||
T Consensus       143 ~~~~----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  212 (382)
T 3tt0_A          143 ACTQ----------DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC  212 (382)
T ss_dssp             EECS----------SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             eecc----------CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            7654          5578999999987 5655554432               358999999999999999999999999


Q ss_pred             eecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CC
Q psy13988        277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KK  355 (358)
Q Consensus       277 ~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~  355 (358)
                      +||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+.. ++.++||||||+++|+|++ |.
T Consensus       213 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             CCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999998776554444445556689999999998654 8999999999999999999 99


Q ss_pred             CCC
Q psy13988        356 PLF  358 (358)
Q Consensus       356 ~pF  358 (358)
                      .||
T Consensus       292 ~p~  294 (382)
T 3tt0_A          292 SPY  294 (382)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.4e-39  Score=288.15  Aligned_cols=207  Identities=23%  Similarity=0.337  Sum_probs=170.2

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhh
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIV  214 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  214 (358)
                      .......+|.+.+.||+|+||.||++.+.     .++..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            34456678999999999999999999984     455899999987542 222235678899999999999999997776


Q ss_pred             cccCcccccccCCCeEEEEeecccc-ChHHHHhcCC-----------------------CCCChHHHHHHHHHHHHHHHH
Q psy13988        215 TDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM-----------------------VDFNEVNNASIMRQLLDGLSY  270 (358)
Q Consensus       215 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~al~~  270 (358)
                      .+          ++..++||||+++ +|.+.+....                       ..+++..++.++.||+.||.|
T Consensus        96 ~~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  165 (314)
T 2ivs_A           96 SQ----------DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY  165 (314)
T ss_dssp             CS----------SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHH
T ss_pred             ec----------CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHH
Confidence            54          5578999999986 5555554322                       238899999999999999999


Q ss_pred             HHhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHH
Q psy13988        271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE  350 (358)
Q Consensus       271 LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~  350 (358)
                      ||++||+|+||||+||+++.++.++|+|||++................+++.|+|||++.+.. ++.++||||||+++|+
T Consensus       166 lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e  244 (314)
T 2ivs_A          166 LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWE  244 (314)
T ss_dssp             HHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHH
T ss_pred             HHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHH
Confidence            999999999999999999999999999999998775443333334445688999999987654 8899999999999999


Q ss_pred             Hhh-CCCCC
Q psy13988        351 LFV-KKPLF  358 (358)
Q Consensus       351 llt-g~~pF  358 (358)
                      |++ |..||
T Consensus       245 l~t~g~~p~  253 (314)
T 2ivs_A          245 IVTLGGNPY  253 (314)
T ss_dssp             HHTTSCCSS
T ss_pred             HHhCCCCCC
Confidence            999 99987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-38  Score=288.66  Aligned_cols=206  Identities=27%  Similarity=0.436  Sum_probs=162.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+.+.||+|+||.||++.+..+++.||||++....   .......+++..++.++||||+++++++.....   .
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~---~   94 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE---R   94 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS---S
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc---c
Confidence            3467999999999999999999999999999999986542   223456788888899999999999998865321   1


Q ss_pred             ccCCCeEEEEeeccccChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEecC-CCcEEEe
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCH--KRNFLHRDIKCSNILMNN-RGEVKLA  297 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~Dlkp~Nill~~-~~~~~l~  297 (358)
                      ......+++||||+++++...+.   .....+++..+..++.||+.||.|||  ++||+||||||+||+++. ++.++|+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence            12234589999999998776553   35567899999999999999999999  999999999999999997 8999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++........   .....+|+.|+|||++.+...++.++||||||+++|+|++|++||
T Consensus       175 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf  232 (360)
T 3e3p_A          175 DFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF  232 (360)
T ss_dssp             CCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc
Confidence            9999987654432   234466999999999977666899999999999999999999998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=290.92  Aligned_cols=208  Identities=15%  Similarity=0.165  Sum_probs=171.0

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeec--------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhh
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLF--------TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIV  214 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  214 (358)
                      ..+.+|.+.+.||+|+||.||++.+..        .++.||||++...       ..+.+|+.+++.++||||+++++..
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence            346899999999999999999999987        4899999998743       3678999999999999999987765


Q ss_pred             cccCc-----ccccccC-CCeEEEEeeccccChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy13988        215 TDKSD-----ALDFRKD-KGSFYLVFEYMDHDLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL  287 (358)
Q Consensus       215 ~~~~~-----~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nil  287 (358)
                      .....     .++++.. ++..|+||||++++|.+.+... ...+++..++.++.||+.||+|||++||+||||||+||+
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence            44221     1333333 6789999999966777777654 357999999999999999999999999999999999999


Q ss_pred             ecCCC--cEEEeecccceeccccCCC-----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        288 MNNRG--EVKLADFGLARLYNAEDRQ-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       288 l~~~~--~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.++  .++|+|||+++........     .......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCc
Confidence            99998  8999999999876543321     1223446799999999998654 899999999999999999999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.3e-39  Score=281.11  Aligned_cols=201  Identities=31%  Similarity=0.490  Sum_probs=170.9

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .....+|.+.+.||+|++|.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.+    
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   85 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----   85 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc----
Confidence            34456799999999999999999999999999999998754322 2234567899999999999999999777654    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            ++..++||||+++ ++.+.+... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+||
T Consensus        86 ------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           86 ------RKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             ------SSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             ------CCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecc
Confidence                  5689999999986 565555443 46899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++.......    .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus       159 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  212 (284)
T 2vgo_A          159 GWSVHAPSLR----RRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPF  212 (284)
T ss_dssp             TTCEECSSSC----BCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccccCcccc----cccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCC
Confidence            9987654322    23345799999999988655 899999999999999999999997

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=291.57  Aligned_cols=206  Identities=26%  Similarity=0.400  Sum_probs=169.8

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  215 (358)
                      ......+|.+++.||+|+||.||++.+.     .+++.||||+++.... ......+.+|+.+++.++||||+++++++.
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3455678999999999999999999997     4558999999875432 222346789999999999999999977765


Q ss_pred             ccCcccccccCCCeEEEEeecccc-ChHHHHhcC-----------------------CCCCChHHHHHHHHHHHHHHHHH
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG-----------------------MVDFNEVNNASIMRQLLDGLSYC  271 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~al~~L  271 (358)
                      +          ++..|+||||+++ +|.+.+...                       ...+++..++.++.||+.||.||
T Consensus       121 ~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L  190 (343)
T 1luf_A          121 V----------GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL  190 (343)
T ss_dssp             S----------SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             c----------CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            4          5578999999987 555555432                       15689999999999999999999


Q ss_pred             HhCCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHH
Q psy13988        272 HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL  351 (358)
Q Consensus       272 H~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l  351 (358)
                      |++||+|+||||+||+++.++.++|+|||++................+++.|+|||++.+.. ++.++||||||+++|+|
T Consensus       191 H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el  269 (343)
T 1luf_A          191 SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI  269 (343)
T ss_dssp             HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHH
T ss_pred             HhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHH
Confidence            99999999999999999999999999999998765443333334556789999999987654 89999999999999999


Q ss_pred             hh-CCCCC
Q psy13988        352 FV-KKPLF  358 (358)
Q Consensus       352 lt-g~~pF  358 (358)
                      +| |..||
T Consensus       270 ~t~g~~p~  277 (343)
T 1luf_A          270 FSYGLQPY  277 (343)
T ss_dssp             HTTTCCTT
T ss_pred             HhcCCCcC
Confidence            99 99987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=282.14  Aligned_cols=201  Identities=26%  Similarity=0.395  Sum_probs=166.1

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .......|.+++.||.|+||.||++.+..+++.||||.+....    ....+.+|+.+++.++||||+++++++..    
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   95 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK----   95 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE----
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe----
Confidence            3456778999999999999999999999999999999987542    24578899999999999999999877654    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            .+..|+||||+++ ++.+.+......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus        96 ------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df  169 (314)
T 3com_A           96 ------NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF  169 (314)
T ss_dssp             ------TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             ------CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeec
Confidence                  5589999999987 555555545667999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       170 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  225 (314)
T 3com_A          170 GVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPY  225 (314)
T ss_dssp             TTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccchhhhhhcc--ccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCC
Confidence            99987654322  123446799999999987654 899999999999999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-39  Score=290.83  Aligned_cols=205  Identities=28%  Similarity=0.404  Sum_probs=165.0

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc---CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE---KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ...+|.+.+.||+|+||.||++.+..+++.||+|++.....   .......+.+|+.+++.++||||+++++++.+    
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----   99 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED----   99 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc----
Confidence            45679999999999999999999999999999999875432   23334578899999999999999999777754    


Q ss_pred             cccccCCCeEEEEeeccccC-hHHHHhcC---------------------------------------CCCCChHHHHHH
Q psy13988        221 LDFRKDKGSFYLVFEYMDHD-LMGLLESG---------------------------------------MVDFNEVNNASI  260 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~---------------------------------------~~~~~~~~~~~~  260 (358)
                            .+..++||||++|+ |.+.+...                                       ...+++..++.+
T Consensus       100 ------~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A          100 ------EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             ------SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ------CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence                  56899999999875 44444210                                       112467788899


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCCEEecCCC--cEEEeecccceeccccCCC--CCCCCccccccccccccccCC-CCC
Q psy13988        261 MRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG--EVKLADFGLARLYNAEDRQ--RPYTNKVITLWYRPPELLLGE-ERY  335 (358)
Q Consensus       261 ~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~--~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~  335 (358)
                      +.||+.||+|||++||+|+||||+||+++.++  .++|+|||++..+......  .......+|+.|+|||++.+. ..+
T Consensus       174 ~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          174 MRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            99999999999999999999999999998776  8999999999876432221  123455679999999998652 458


Q ss_pred             CCcchHHHHHHHHHHHhhCCCCC
Q psy13988        336 GPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       336 ~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.++||||||+++|+|++|+.||
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf  276 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPF  276 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCC
Confidence            89999999999999999999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.2e-39  Score=279.33  Aligned_cols=199  Identities=23%  Similarity=0.424  Sum_probs=168.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|+||.||++.+. +++.||+|++......   ...+.+|+.++++++||||+++++++.+       
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------   76 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE-------   76 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS-------
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEec-------
Confidence            4567999999999999999999985 5778999999754322   3568899999999999999999777654       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         ++..++||||+++ ++.+.+......+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        77 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           77 ---QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             ---SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             ---CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccc
Confidence               5579999999987 455566566667999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ......... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |++||
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~  208 (269)
T 4hcu_A          154 RFVLDDQYT-SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPY  208 (269)
T ss_dssp             GGBCCHHHH-STTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccccccc-cccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCC
Confidence            866433221 223344578899999987554 8899999999999999999 99997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.9e-39  Score=295.61  Aligned_cols=209  Identities=17%  Similarity=0.174  Sum_probs=152.9

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhC--CCCcccchhhhhcccCccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQL--NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~  221 (358)
                      ...|.+.+.||+|+||.||++.+..+++.||||++....... .....+.+|+.+++.+  +||||++++..+..+.+.+
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            445899999999999999999999999999999998754321 2233456675444444  6999988664443110000


Q ss_pred             cc---------ccC-----CCeEEEEeeccccChHHHHhcCCCCCChHHH------HHHHHHHHHHHHHHHhCCceecCC
Q psy13988        222 DF---------RKD-----KGSFYLVFEYMDHDLMGLLESGMVDFNEVNN------ASIMRQLLDGLSYCHKRNFLHRDI  281 (358)
Q Consensus       222 ~~---------~~~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~------~~~~~qi~~al~~LH~~~i~H~Dl  281 (358)
                      ..         ...     ...+|+||||++++|.+.+......+++..+      ..++.||+.||+|||++||+||||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            00         000     1458999999999888888764445556656      677899999999999999999999


Q ss_pred             CCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       282 kp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+. ..++.++|||||||++|+|+||++||
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999998764332     134457999999999752 34899999999999999999999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.9e-38  Score=277.10  Aligned_cols=199  Identities=26%  Similarity=0.372  Sum_probs=165.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC----CchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG----FPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .+|.+.+.||+|+||.||++.+..+++.||+|.+........    ....+.+|+.+++.++||||+++++++.+     
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-----   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence            468899999999999999999999999999999986643322    24567899999999999999999777654     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----cEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~----~~~l~  297 (358)
                           ....++||||+++..+..+......+++..+..++.||+.||.|||++|++|+||||+||+++.++    .++|+
T Consensus        80 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 -----KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             -----SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             -----CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEE
Confidence                 558999999998644444433345799999999999999999999999999999999999998877    89999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++........   .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus       155 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  211 (283)
T 3bhy_A          155 DFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPF  211 (283)
T ss_dssp             CCTTCEECC-----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecccceeccCCCc---ccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCC
Confidence            9999987654332   23445799999999987654 899999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-38  Score=284.78  Aligned_cols=206  Identities=38%  Similarity=0.678  Sum_probs=173.0

Q ss_pred             CCCCCcccccccCCcceeeEeeeee-cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC---CCCcccchhhhhcccCc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSL-FTDELVALKKVRLENEKEGFPITAVREIKILRQL---NHKNIVNLREIVTDKSD  219 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~  219 (358)
                      ...+|.+++.||+|+||.||++.+. .+++.||+|++............+.+|+.+++.+   +||||+++++++.... 
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~-   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR-   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE-
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc-
Confidence            4578999999999999999999995 6789999999986654444445677888877766   8999999988876311 


Q ss_pred             ccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                          .......++|||+++|++.+.+.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|
T Consensus        88 ----~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 ----TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             ----CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ----cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence                12356899999999998888876543 4589999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++........   .....+++.|+|||++.+.. ++.++||||||+++|+|++|++||
T Consensus       164 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  219 (326)
T 1blx_A          164 FGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLF  219 (326)
T ss_dssp             CCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CcccccccCCCC---ccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCC
Confidence            999987653322   23456799999999997655 899999999999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.1e-39  Score=288.30  Aligned_cols=212  Identities=24%  Similarity=0.349  Sum_probs=161.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  221 (358)
                      ....+|++.+.||+|+||.||++.+..+++.||||++.....  .....+.+|+.+++++. ||||+++++++....  .
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--~  100 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK--E  100 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT--T
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhccccccccc--c
Confidence            445689999999999999999999999999999999864422  22346788999999995 999999998885432  1


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhc--CCCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                      ........+++||||++|+|.+.+..  ....+++..++.++.||+.||+|||+.|  |+|+||||+||+++.++.++|+
T Consensus       101 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             TSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             ccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence            22344667999999999988887754  4557999999999999999999999999  9999999999999999999999


Q ss_pred             ecccceeccccCCCC----------CCCCcccccccccccccc--CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQR----------PYTNKVITLWYRPPELLL--GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++..........          ......+|+.|+|||++.  ....++.++||||||+++|+|++|+.||
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            999998765432211          112345799999999984  2334788999999999999999999997

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.7e-39  Score=290.14  Aligned_cols=210  Identities=20%  Similarity=0.245  Sum_probs=165.9

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeec---CCcEEEEEEeeccccCC---------CCchhHHHHHHHHHhCCCCccc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLF---TDELVALKKVRLENEKE---------GFPITAVREIKILRQLNHKNIV  208 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv  208 (358)
                      .+..+.+|.+.+.||+|+||.||++.+..   ++..||||++.......         .....+.+|+..++.++||||+
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            34566889999999999999999999987   88999999987553210         0122456788889999999999


Q ss_pred             chhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe
Q psy13988        209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM  288 (358)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill  288 (358)
                      ++++++....      .+....|+||||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||++
T Consensus       112 ~~~~~~~~~~------~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  184 (345)
T 2v62_A          112 LFYGSGLTEF------KGRSYRFMVMERLGIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL  184 (345)
T ss_dssp             CEEEEEEEES------SSCEEEEEEEECEEEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             eeeccccccc------CCCcEEEEEEeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE
Confidence            9988876521      235689999999955666665443 379999999999999999999999999999999999999


Q ss_pred             cCCC--cEEEeecccceeccccCCCC-----CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        289 NNRG--EVKLADFGLARLYNAEDRQR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       289 ~~~~--~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.++  .++|+|||+++.+.......     ......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCc
Confidence            9887  99999999998775433211     113456799999999998654 899999999999999999999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-38  Score=277.83  Aligned_cols=200  Identities=20%  Similarity=0.352  Sum_probs=168.2

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|++++.||+|+||.||++.+. ++..||+|++.....   ....+.+|+.+++.++||||+++++++.+      
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------   74 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSK------   74 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEcc------
Confidence            35578999999999999999999764 677899999875432   23568899999999999999999776654      


Q ss_pred             cccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          ++..++||||++++ +.+.+......+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+
T Consensus        75 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~  150 (268)
T 3sxs_A           75 ----EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGM  150 (268)
T ss_dssp             ----SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred             ----CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcc
Confidence                55799999999864 6666655555699999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +......... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~  206 (268)
T 3sxs_A          151 TRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPY  206 (268)
T ss_dssp             EEECCTTCEE-ECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ceecchhhhh-cccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCc
Confidence            9876544322 123344578899999987655 8899999999999999999 99997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.7e-39  Score=280.12  Aligned_cols=203  Identities=26%  Similarity=0.469  Sum_probs=164.5

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ....++|.+.+.||+|++|.||++.+..+++.||||++..... .......+.+|+.+++.++||||+++++++..    
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   82 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----   82 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec----
Confidence            3455789999999999999999999999999999999876532 22334577899999999999999999777654    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            .+..|+|||++++ +|.+.+. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+||
T Consensus        83 ------~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           83 ------PTDFFMVMEYVSGGELFDYIC-KHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             ------SSEEEEEEECCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCC
T ss_pred             ------CCeEEEEEeccCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeec
Confidence                  5589999999987 5555554 3356899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........   .....+++.|+|||++.+....+.++||||||+++|+|++|+.||
T Consensus       156 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          156 GLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF  211 (276)
T ss_dssp             CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            99987654322   233456999999999987654568999999999999999999997

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.2e-38  Score=279.57  Aligned_cols=201  Identities=26%  Similarity=0.379  Sum_probs=171.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .....|.+++.||+|+||.||++.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.+      
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   91 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK------   91 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE------
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence            3456799999999999999999999999999999999865432 345678899999999999999999877764      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          ++..++||||++++.+..+... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        92 ----~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           92 ----DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             ----TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ----CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccc
Confidence                5589999999997544444333 46899999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........  ......+++.|+|||++.+.. ++.++||||||+++|+|++|++||
T Consensus       167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  219 (303)
T 3a7i_A          167 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPH  219 (303)
T ss_dssp             EECBTTBC--CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eecCcccc--ccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCC
Confidence            87654332  123456799999999997654 889999999999999999999997

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.1e-39  Score=291.60  Aligned_cols=204  Identities=24%  Similarity=0.400  Sum_probs=157.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee---cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL---FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ....+|.+.+.||+|+||.||++.+.   .++..||||+++... .......+.+|+.++++++||||+++++++.+   
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  117 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK---  117 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee---
Confidence            45568999999999999999999986   467789999987542 22223467899999999999999999777654   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                             .+..++||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|
T Consensus       118 -------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D  190 (373)
T 2qol_A          118 -------SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSD  190 (373)
T ss_dssp             -------SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             -------CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECc
Confidence                   5578999999976 66666666566799999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        299 FGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||+++........ .......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~  251 (373)
T 2qol_A          191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPY  251 (373)
T ss_dssp             C----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTT
T ss_pred             CccccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCC
Confidence            9999876543221 1122233477899999987654 8999999999999999998 99997

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-38  Score=279.36  Aligned_cols=199  Identities=19%  Similarity=0.212  Sum_probs=167.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||||++............+.+|+..+..+ +||||+++++++.+      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~------   82 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE------   82 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE------
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec------
Confidence            34578999999999999999999999999999999987654444456778999999999 99999999877754      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcC---CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-------
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESG---MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-------  291 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-------  291 (358)
                          .+..++||||+++ +|.+.+...   ...+++..++.++.||+.||+|||++||+|+||||+||+++.+       
T Consensus        83 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           83 ----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             ----TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred             ----CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccc
Confidence                5589999999987 565555432   2568999999999999999999999999999999999999844       


Q ss_pred             ------------CcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        292 ------------GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       292 ------------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                                  ..++|+|||.+.......      ...+|+.|+|||++.+...++.++||||||+++|+|++|.+||
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                        479999999998765432      2347999999999987655778999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-38  Score=279.34  Aligned_cols=203  Identities=22%  Similarity=0.443  Sum_probs=167.1

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      .......+|++++.||+|+||.||++.+. ++..||||++......   ...+.+|+.+++.++||||+++++++.+   
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   90 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK---   90 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEec---
Confidence            33456678999999999999999999774 6778999999754322   3568899999999999999999777654   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                             ++..++||||+++ ++.+.+......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|
T Consensus        91 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~D  163 (283)
T 3gen_A           91 -------QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSD  163 (283)
T ss_dssp             -------SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECS
T ss_pred             -------CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcc
Confidence                   5579999999976 56666655456799999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||++......... ......+|+.|+|||++.+.. ++.++||||||+++|+|+| |+.||
T Consensus       164 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~  222 (283)
T 3gen_A          164 FGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPY  222 (283)
T ss_dssp             TTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ccccccccccccc-cccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCc
Confidence            9999866443221 223344578899999987654 8899999999999999998 99997

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-39  Score=288.17  Aligned_cols=204  Identities=26%  Similarity=0.358  Sum_probs=167.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  216 (358)
                      ....+|.+.+.||+|+||.||++.+.     .++..||||++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            45578899999999999999999973     456789999997543 233456788999999999 99999999777654


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCC----------------------CCChHHHHHHHHHHHHHHHHHHh
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMV----------------------DFNEVNNASIMRQLLDGLSYCHK  273 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------~~~~~~~~~~~~qi~~al~~LH~  273 (358)
                                .+..++||||+++ +|.+.+.....                      .+++..++.++.||+.||+|||+
T Consensus       121 ----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  190 (344)
T 1rjb_A          121 ----------SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF  190 (344)
T ss_dssp             ----------SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ----------CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence                      4578999999986 66666654332                      37899999999999999999999


Q ss_pred             CCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh
Q psy13988        274 RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV  353 (358)
Q Consensus       274 ~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt  353 (358)
                      +||+|+||||+||+++.++.++|+|||++................+|+.|+|||++.+.. ++.++||||||+++|+|+|
T Consensus       191 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          191 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTT
T ss_pred             CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHc
Confidence            999999999999999999999999999998775444333334455688999999987654 8999999999999999998


Q ss_pred             -CCCCC
Q psy13988        354 -KKPLF  358 (358)
Q Consensus       354 -g~~pF  358 (358)
                       |..||
T Consensus       270 ~g~~p~  275 (344)
T 1rjb_A          270 LGVNPY  275 (344)
T ss_dssp             TSCCSS
T ss_pred             CCCCCc
Confidence             99997

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.2e-38  Score=294.45  Aligned_cols=201  Identities=23%  Similarity=0.266  Sum_probs=170.0

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||||++......    ..+.+|+.+++.++|.+++..+..+.        
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~--------   72 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG--------   72 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE--------
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE--------
Confidence            467899999999999999999999999999999988765433    35789999999998865554443332        


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill---~~~~~~~l~Dfg  300 (358)
                       ......++||||+.++|.+.+......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||
T Consensus        73 -~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           73 -VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             -EETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             -eeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence             2356889999999778888887666789999999999999999999999999999999999999   688899999999


Q ss_pred             cceeccccCCC-----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQ-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.+......     .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf  213 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPW  213 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCC
Confidence            99877654321     1223556899999999998765 899999999999999999999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.1e-38  Score=283.75  Aligned_cols=203  Identities=25%  Similarity=0.336  Sum_probs=167.8

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|.+.+.||+|+||.||++.+ .+++.||||++....... ....+.+|+.+++.++||||+++++++.+     
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   98 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMT-----   98 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----
T ss_pred             HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEec-----
Confidence            45667899999999999999999985 468999999987654332 23367899999999999999999777754     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcC---CCCCChHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEecCCCcE
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESG---MVDFNEVNNASIMRQLLDGLSYCHKR---NFLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~Dlkp~Nill~~~~~~  294 (358)
                           .+..++||||+++ ++.+.+...   ...+++..+..++.|++.||+|||+.   ||+|+||||+||+++.++.+
T Consensus        99 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           99 -----PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             -----SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             -----CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence                 4578999999987 555555432   23489999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++........ .......+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       174 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  235 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAF  235 (326)
T ss_dssp             EECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred             EeccCccccccCcccc-cccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcc
Confidence            9999999987654332 2223445799999999987655 899999999999999999999997

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=284.48  Aligned_cols=203  Identities=21%  Similarity=0.323  Sum_probs=161.7

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEE----EEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELV----ALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ....+|++++.||+|+||.||++.+..+++.|    |+|.+.... .......+.+|+.+++.++||||+++++++... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence            35678999999999999999999998888755    666665332 333456788999999999999999998877642 


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                                ..++|++++.+ ++.+.+......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+
T Consensus        90 ----------~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~  159 (327)
T 3lzb_A           90 ----------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             ----------SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred             ----------CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEc
Confidence                      36788888875 6777777666789999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |||++................+|+.|+|||++.+.. ++.++||||||+++|+|++ |.+||
T Consensus       160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~  220 (327)
T 3lzb_A          160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPY  220 (327)
T ss_dssp             CTTC----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cCcceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCC
Confidence            999998776554444444555688999999998654 8999999999999999999 99997

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-38  Score=283.71  Aligned_cols=213  Identities=22%  Similarity=0.273  Sum_probs=161.1

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeec---CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLF---TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      .......+|.+.+.||+|+||.||++.+..   ++..||+|++............+.+|+.++++++||||+++++++.+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            344566789999999999999999998765   45689999998664444344567899999999999999999988876


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHh-----cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLE-----SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN  290 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~  290 (358)
                      ...     ......++||||+++ ++.+.+.     .....+++..++.++.||+.||.|||++||+|+||||+||+++.
T Consensus       108 ~~~-----~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          108 MSS-----QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             ------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred             ccc-----cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence            331     112356999999997 4555442     23456999999999999999999999999999999999999999


Q ss_pred             CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++.++|+|||++................+++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~  250 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPY  250 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCC
Confidence            9999999999998765443333333445688999999997654 8899999999999999999 88887

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.3e-38  Score=286.58  Aligned_cols=201  Identities=29%  Similarity=0.450  Sum_probs=168.2

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC------CchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG------FPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      ..+|.+.+.||.|++|.||++.+..+|+.||||++........      ....+.+|+.+++.+ +||||+++++++.. 
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  171 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-  171 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence            3568899999999999999999999999999999876532211      123567899999999 89999999777654 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                               .+..|+||||++|+.+..+......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+
T Consensus       172 ---------~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          172 ---------SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             ---------SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             ---------CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEE
Confidence                     55899999999985444443344579999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccC-----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG-----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++........   .....||+.|+|||++.+     ...++.++||||||+++|+|++|..||
T Consensus       243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf  305 (365)
T 2y7j_A          243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF  305 (365)
T ss_dssp             CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence            9999987754432   234567999999998853     234788999999999999999999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.9e-39  Score=285.35  Aligned_cols=207  Identities=27%  Similarity=0.405  Sum_probs=150.9

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ......+|.+.+.||+|++|.||++.+..+++.||||++...... .....+.+|+.+++.++||||+++++++..    
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   84 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVV----   84 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES----
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEee----
Confidence            455678999999999999999999999999999999998755322 234467789999999999999999877765    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhc-------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLES-------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG  292 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~  292 (358)
                            .+..++||||+++ ++.+.+..       ....+++..++.++.||+.||.|||++|++|+||||+||+++.++
T Consensus        85 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~  158 (303)
T 2vwi_A           85 ------KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG  158 (303)
T ss_dssp             ------SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC
T ss_pred             ------cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC
Confidence                  4578999999986 55555432       245689999999999999999999999999999999999999999


Q ss_pred             cEEEeecccceeccccCCC---CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        293 EVKLADFGLARLYNAEDRQ---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       293 ~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .++|+|||++.........   .......+|+.|+|||++.+...++.++||||||+++|+|++|+.||
T Consensus       159 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  227 (303)
T 2vwi_A          159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY  227 (303)
T ss_dssp             CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999998766433211   11234467999999999875444889999999999999999999997

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.3e-39  Score=292.13  Aligned_cols=202  Identities=27%  Similarity=0.345  Sum_probs=169.9

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ......+|.+++.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+    
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  102 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----  102 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE----
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE----
Confidence            4456678999999999999999999999999999999987652 22223567899999999999999999877764    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            ++..++||||++|+.+..+......+++..+..++.|++.||.|||+. ||+|+||||+||+++.++.++|+||
T Consensus       103 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Df  176 (360)
T 3eqc_A          103 ------DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF  176 (360)
T ss_dssp             ------TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ------CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEEC
Confidence                  558999999998754444434445799999999999999999999996 9999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++.......    .....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       177 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  230 (360)
T 3eqc_A          177 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPI  230 (360)
T ss_dssp             CCCHHHHHHC--------CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCS
T ss_pred             CCCccccccc----ccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9987654332    12346799999999998654 899999999999999999999997

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.5e-38  Score=276.50  Aligned_cols=206  Identities=29%  Similarity=0.451  Sum_probs=169.7

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC-------CchhHHHHHHHHHhCC-CCcccch
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG-------FPITAVREIKILRQLN-HKNIVNL  210 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~e~~~l~~l~-h~niv~~  210 (358)
                      .+......+|.+.+.||+|++|.||++.+..+++.||||++........       ....+.+|+.+++++. ||||+++
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (298)
T 1phk_A           10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   89 (298)
T ss_dssp             -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            3445677899999999999999999999999999999999976542211       1235678999999995 9999999


Q ss_pred             hhhhcccCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec
Q psy13988        211 REIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN  289 (358)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~  289 (358)
                      ++++..          ++..++||||+++ +|.+.+. ....+++..+..++.||+.||.|||++|++|+||||+||+++
T Consensus        90 ~~~~~~----------~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~  158 (298)
T 1phk_A           90 KDTYET----------NTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD  158 (298)
T ss_dssp             EEEEEC----------SSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             eeeecc----------CCeEEEEEeccCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc
Confidence            777654          5689999999986 4555554 345799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeecccceeccccCCCCCCCCcccccccccccccc-----CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL-----GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       290 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .++.++|+|||++........   .....+++.|+|||++.     ....++.++||||||+++|+|++|..||
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  229 (298)
T 1phk_A          159 DDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF  229 (298)
T ss_dssp             TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCC
Confidence            999999999999987654432   23445799999999885     2344788999999999999999999997

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-38  Score=281.05  Aligned_cols=204  Identities=24%  Similarity=0.362  Sum_probs=166.7

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .......|++++.||.|+||.||++.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++..    
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   87 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH----   87 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee----
Confidence            3456788999999999999999999999999999999987543  2335678899999999999999999777654    


Q ss_pred             cccccCCCeEEEEeeccccChHH-HHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            ++..++||||++++.+. .+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+||
T Consensus        88 ------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  161 (302)
T 2j7t_A           88 ------DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF  161 (302)
T ss_dssp             ------C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCC
T ss_pred             ------CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEEC
Confidence                  45899999999875444 44444567999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCcccccccccccccc----CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLL----GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++........  ......+++.|+|||++.    ....++.++||||||+++|+|++|..||
T Consensus       162 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  222 (302)
T 2j7t_A          162 GVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH  222 (302)
T ss_dssp             HHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCC
Confidence            98764322211  112345799999999884    3344889999999999999999999997

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.2e-39  Score=280.36  Aligned_cols=204  Identities=22%  Similarity=0.334  Sum_probs=158.2

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecC---CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFT---DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ......+|++.+.||+|+||.||++.+..+   +..||+|.+.... .......+.+|+.+++.++||||+++++++.  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT--   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc--
Confidence            345667899999999999999999998654   4579999876532 2223346789999999999999999987763  


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                               ++..|+||||+++ ++.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|
T Consensus        87 ---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  157 (281)
T 1mp8_A           87 ---------ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL  157 (281)
T ss_dssp             ---------SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred             ---------cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEE
Confidence                     2367899999997 666666666567999999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +|||++......... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |.+||
T Consensus       158 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf  218 (281)
T 1mp8_A          158 GDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPF  218 (281)
T ss_dssp             CC--------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CccccccccCccccc-ccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCC
Confidence            999999876543221 122334578899999987554 8899999999999999996 99987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.5e-38  Score=282.32  Aligned_cols=203  Identities=24%  Similarity=0.362  Sum_probs=167.7

Q ss_pred             CCCCCCCccc-ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCc
Q psy13988        142 STNNSSRPLM-EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSD  219 (358)
Q Consensus       142 ~~~~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  219 (358)
                      +....+|.+. +.||+|+||.||++.+..+++.||||++............+.+|+.+++.+ .||||+++++++.+   
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~---  100 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN---  100 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe---
Confidence            3455667777 899999999999999999999999999987655544556788999999999 56999999777654   


Q ss_pred             ccccccCCCeEEEEeeccccC-hHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcE
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD-LMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEV  294 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~---~~~~  294 (358)
                             .+..++||||+.++ +.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||+++.   ++.+
T Consensus       101 -------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A          101 -------TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             -------SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCE
T ss_pred             -------CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcE
Confidence                   55899999999874 5444432 2357999999999999999999999999999999999999988   7899


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++.........   ....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       174 kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf  233 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPF  233 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EEeeCccccccCCcccc---ccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999877544322   3346799999999997655 899999999999999999999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.9e-38  Score=280.03  Aligned_cols=198  Identities=27%  Similarity=0.440  Sum_probs=166.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|.+.+.||+|+||.||++.+..+++.||+|++......  ....+.+|+.+++.++||||+++++++.+      
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   77 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYES------   77 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhccc------
Confidence            4456799999999999999999999999999999999854322  23467899999999999999999777654      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEee
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM---NNRGEVKLAD  298 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill---~~~~~~~l~D  298 (358)
                          .+..|+||||+++ ++.+.+.. ...+++..+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|
T Consensus        78 ----~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           78 ----TTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             ----SSEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             ----CCEEEEEEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEcc
Confidence                5589999999986 55555543 3478999999999999999999999999999999999999   7788999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++......    ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus       153 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  207 (304)
T 2jam_A          153 FGLSKMEQNG----IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPF  207 (304)
T ss_dssp             CSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCcceecCCC----ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCC
Confidence            9998754332    122345799999999987654 889999999999999999999997

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-38  Score=285.10  Aligned_cols=206  Identities=27%  Similarity=0.419  Sum_probs=168.0

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeee-------cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhh
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSL-------FTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLRE  212 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  212 (358)
                      ......+|.+.+.||+|+||.||++.+.       .++..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            3455678999999999999999999975       467899999987543 222234678899999999 9999999977


Q ss_pred             hhcccCcccccccCCCeEEEEeecccc-ChHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHHHhCCc
Q psy13988        213 IVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM---------------VDFNEVNNASIMRQLLDGLSYCHKRNF  276 (358)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~i  276 (358)
                      ++.+          .+..|+||||+++ +|.+.+....               ..+++..++.++.||+.||+|||++||
T Consensus       109 ~~~~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  178 (334)
T 2pvf_A          109 ACTQ----------DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC  178 (334)
T ss_dssp             EECS----------SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEcc----------CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            7654          5578999999987 5555554432               248899999999999999999999999


Q ss_pred             eecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CC
Q psy13988        277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KK  355 (358)
Q Consensus       277 ~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~  355 (358)
                      +|+||||+||+++.++.++|+|||++................+++.|+|||++.+.. ++.++||||||+++|+|++ |.
T Consensus       179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~  257 (334)
T 2pvf_A          179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGG  257 (334)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             eCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999998776544333334445688999999987654 8899999999999999999 99


Q ss_pred             CCC
Q psy13988        356 PLF  358 (358)
Q Consensus       356 ~pF  358 (358)
                      .||
T Consensus       258 ~p~  260 (334)
T 2pvf_A          258 SPY  260 (334)
T ss_dssp             CSS
T ss_pred             CCc
Confidence            987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-38  Score=282.80  Aligned_cols=204  Identities=26%  Similarity=0.333  Sum_probs=170.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeee-----ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVS-----LFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  216 (358)
                      ....+|.+.+.||+|+||.||++.+     ..+++.||||++...... ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            4556899999999999999999985     456789999998754321 2235678999999999 99999999777654


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCC-----------------CCChHHHHHHHHHHHHHHHHHHhCCcee
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMV-----------------DFNEVNNASIMRQLLDGLSYCHKRNFLH  278 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------~~~~~~~~~~~~qi~~al~~LH~~~i~H  278 (358)
                                ++..++||||+++ +|.+.+.....                 .+++..++.++.||+.||.|||++|++|
T Consensus        99 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  168 (313)
T 1t46_A           99 ----------GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH  168 (313)
T ss_dssp             ----------SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ----------CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence                      4578999999987 66666654332                 4899999999999999999999999999


Q ss_pred             cCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCC
Q psy13988        279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPL  357 (358)
Q Consensus       279 ~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~p  357 (358)
                      +||||+||+++.++.++|+|||++................+++.|+|||++.+.. ++.++||||||+++|+|+| |+.|
T Consensus       169 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p  247 (313)
T 1t46_A          169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP  247 (313)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             CCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998776554333334455688999999987654 8899999999999999999 9998


Q ss_pred             C
Q psy13988        358 F  358 (358)
Q Consensus       358 F  358 (358)
                      |
T Consensus       248 ~  248 (313)
T 1t46_A          248 Y  248 (313)
T ss_dssp             S
T ss_pred             C
Confidence            7

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-38  Score=280.23  Aligned_cols=197  Identities=19%  Similarity=0.233  Sum_probs=165.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCC-------cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTD-------ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  215 (358)
                      ....+|.+.+.||+|+||.||++.+..++       ..||+|++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            34568999999999999999999998887       4799999865432  23457889999999999999999977776


Q ss_pred             ccCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc-
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE-  293 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~-  293 (358)
                      +          ++..++||||+++ +|.+.+......+++..+..++.||+.||.|||++||+||||||+||+++.++. 
T Consensus        83 ~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~  152 (289)
T 4fvq_A           83 C----------GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR  152 (289)
T ss_dssp             C----------TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBG
T ss_pred             e----------CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcc
Confidence            5          4578999999986 666666655555999999999999999999999999999999999999998887 


Q ss_pred             -------EEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        294 -------VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       294 -------~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                             ++|+|||++......      ....+++.|+|||++.+...++.++||||||+++|+|++|..|
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~  217 (289)
T 4fvq_A          153 KTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK  217 (289)
T ss_dssp             GGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence                   999999998654322      2234688899999998755689999999999999999996543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.4e-38  Score=282.52  Aligned_cols=207  Identities=28%  Similarity=0.405  Sum_probs=170.9

Q ss_pred             ccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC----CCchhHHHHHHHHHhCC--CCcccch
Q psy13988        137 PIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE----GFPITAVREIKILRQLN--HKNIVNL  210 (358)
Q Consensus       137 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~~  210 (358)
                      +....+....+|++.+.||+|+||.||++.+..+++.||||++.......    .....+.+|+.+++.++  |+||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            44556678889999999999999999999999999999999998664332    12345678999999996  5999999


Q ss_pred             hhhhcccCcccccccCCCeEEEEeeccc--cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe
Q psy13988        211 REIVTDKSDALDFRKDKGSFYLVFEYMD--HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM  288 (358)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill  288 (358)
                      ++++..          .+..++|||++.  +++.+.+.. ...+++..++.++.||+.||+|||++||+|+||||+||++
T Consensus       114 ~~~~~~----------~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  182 (320)
T 3a99_A          114 LDWFER----------PDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI  182 (320)
T ss_dssp             EEEEEC----------SSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             EEEEec----------CCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEE
Confidence            777654          558999999997  456666544 4578999999999999999999999999999999999999


Q ss_pred             c-CCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        289 N-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       289 ~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      + .++.++|+|||++.......    .....+|+.|+|||++.+....+.++||||||+++|+|++|+.||
T Consensus       183 ~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  249 (320)
T 3a99_A          183 DLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF  249 (320)
T ss_dssp             ETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence            9 67899999999998765432    234457999999999876664578899999999999999999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.2e-39  Score=283.60  Aligned_cols=204  Identities=29%  Similarity=0.476  Sum_probs=168.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||+++++++.+.      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   77 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR------   77 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG------
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC------
Confidence            34679999999999999999999999999999999986654433445678999999999999999998876432      


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEecCCCcE
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKRN-----FLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~Dlkp~Nill~~~~~~  294 (358)
                        .++..|+||||+++ +|.+.+..   ....+++..++.++.||+.||+|||+.+     ++|+||||+||+++.++.+
T Consensus        78 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~  155 (279)
T 2w5a_A           78 --TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV  155 (279)
T ss_dssp             --GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred             --CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence              24589999999986 66665543   2345899999999999999999999999     9999999999999999999


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++.........  .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       156 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  216 (279)
T 2w5a_A          156 KLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPF  216 (279)
T ss_dssp             EECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EEecCchheeecccccc--ccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCC
Confidence            99999999865432211  12235689999999998654 889999999999999999999997

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.6e-39  Score=286.34  Aligned_cols=204  Identities=26%  Similarity=0.375  Sum_probs=170.6

Q ss_pred             CCCCCcccccccCCcceeeEeee----eecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSV----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  219 (358)
                      ...+|++++.||+|+||.||++.    +..+++.||||++.....  .....+.+|+.+++.++||||+++++++...  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   96 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--DQQRDFQREIQILKALHSDFIVKYRGVSYGP--   96 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecC--
Confidence            45689999999999999999998    677899999999875432  2234578999999999999999998876542  


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                            +.+..++||||+++ +|.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|
T Consensus        97 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~D  170 (327)
T 3lxl_A           97 ------GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD  170 (327)
T ss_dssp             ------SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             ------CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcc
Confidence                  35679999999976 56556655455799999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||++......... .......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~  230 (327)
T 3lxl_A          171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKS  230 (327)
T ss_dssp             GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             cccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCC
Confidence            9999876543321 1223445688899999987654 788999999999999999999886

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.5e-38  Score=282.71  Aligned_cols=199  Identities=26%  Similarity=0.441  Sum_probs=162.3

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc------CCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE------KEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ..+|.+.+.||+|+||.||++.+..+++.||||++.....      .......+.+|+.+++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            4578999999999999999999999999999999875432      11223357889999999999999999877643  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---E
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---V  294 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~---~  294 (358)
                               ...|+||||+++ ++.+.+ .....+++..+..++.||+.||.|||++||+|+||||+||+++.++.   +
T Consensus        87 ---------~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           87 ---------EDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             ---------SSEEEEEECCTTEETHHHH-STTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCE
T ss_pred             ---------CceEEEEecCCCCcHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeE
Confidence                     238999999987 555544 44567999999999999999999999999999999999999987664   9


Q ss_pred             EEeecccceeccccCCCCCCCCcccccccccccccc--CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL--GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++........   .....+|+.|+|||++.  +...++.++||||||+++|+|++|..||
T Consensus       157 kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  219 (322)
T 2ycf_A          157 KITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF  219 (322)
T ss_dssp             EECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999987643321   12335689999999974  3345889999999999999999999997

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-38  Score=280.00  Aligned_cols=198  Identities=25%  Similarity=0.341  Sum_probs=160.5

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHh--CCCCcccchhhhhcccCc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQ--LNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~  219 (358)
                      .....+|++++.||+|+||.||++.+  +++.||||++....     ...+.+|.+++..  ++||||+++++++...  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~--   74 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTS--   74 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE--
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccc--
Confidence            34567899999999999999999987  79999999986532     2345667777766  7999999998876542  


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEecC
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH--------KRNFLHRDIKCSNILMNN  290 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--------~~~i~H~Dlkp~Nill~~  290 (358)
                          .......++||||+++ +|.+.+..  ..+++..+..++.||+.||+|||        +.+|+||||||+||+++.
T Consensus        75 ----~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~  148 (301)
T 3q4u_A           75 ----RHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK  148 (301)
T ss_dssp             ----ETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECT
T ss_pred             ----cCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcC
Confidence                2234578999999997 55555532  36999999999999999999999        999999999999999999


Q ss_pred             CCcEEEeecccceeccccCCC--CCCCCccccccccccccccCCCC-----CCCcchHHHHHHHHHHHhhC
Q psy13988        291 RGEVKLADFGLARLYNAEDRQ--RPYTNKVITLWYRPPELLLGEER-----YGPAIDVWSCGCILGELFVK  354 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~~lltg  354 (358)
                      ++.+||+|||++.........  .......+|+.|+|||++.+...     ++.++||||||+++|+|+||
T Consensus       149 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            999999999999876543322  11233467999999999976532     44689999999999999999

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.2e-38  Score=277.49  Aligned_cols=203  Identities=23%  Similarity=0.370  Sum_probs=171.8

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ......+|++.+.||+|++|.||++.+..++..||+|.+....   .....+.+|+.+++.++||||+++++++.+    
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   80 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----   80 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence            3456678999999999999999999999999999999987432   234578899999999999999999777654    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                            ++..++||||+++ ++.+.+.. ....+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|
T Consensus        81 ------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~D  154 (288)
T 3kfa_A           81 ------EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD  154 (288)
T ss_dssp             ------SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             ------CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEcc
Confidence                  5579999999995 66666654 345699999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||++........ .......+++.|+|||++.+.. ++.++||||||+++|+|++ |.+||
T Consensus       155 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~  213 (288)
T 3kfa_A          155 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY  213 (288)
T ss_dssp             CCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CccceeccCCcc-ccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999987653322 2223445578899999987654 8899999999999999999 98887

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-38  Score=283.39  Aligned_cols=204  Identities=26%  Similarity=0.376  Sum_probs=164.8

Q ss_pred             CCCCCC-cccccccCCcceeeEee----eeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        143 TNNSSR-PLMEPLAAGGLSLNNFS----VSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       143 ~~~~~~-~~~~~lg~G~~g~v~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ....+| ++++.||+|+||.||++    .+..+++.||||++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            345556 99999999999999665    4566889999999975422 22234678999999999999999998887653


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                      .        ...+++||||+++ +|.+.+...  .+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|
T Consensus       106 ~--------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl  175 (318)
T 3lxp_A          106 G--------AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI  175 (318)
T ss_dssp             T--------TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred             C--------CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEE
Confidence            2        4578999999987 455555433  4899999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++......... .......+++.|+|||++.+.. ++.++||||||+++|+|+||+.||
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~  237 (318)
T 3lxp_A          176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSS  237 (318)
T ss_dssp             CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             CCccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcc
Confidence            999999877544321 1223345688899999997654 788999999999999999999886

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.8e-38  Score=279.39  Aligned_cols=203  Identities=28%  Similarity=0.418  Sum_probs=158.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ....+|++.+.||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++..     
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----  103 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----  103 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence            3446799999999999999999999999999999998754322 2223467889999999999999999777664     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                           ++..++||||+++ +|.+.+.   .....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+
T Consensus       104 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~  178 (310)
T 2wqm_A          104 -----DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLG  178 (310)
T ss_dssp             -----TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             -----CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEE
Confidence                 5589999999997 4444443   245578999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       179 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~  236 (310)
T 2wqm_A          179 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPF  236 (310)
T ss_dssp             CC--------------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eccceeeecCCCc--cccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999886643322  123345789999999987654 889999999999999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.2e-38  Score=282.98  Aligned_cols=202  Identities=25%  Similarity=0.407  Sum_probs=169.5

Q ss_pred             cccCCCCCCCCcccccccCCcceeeEeeee-ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc------ccch
Q psy13988        138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVS-LFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN------IVNL  210 (358)
Q Consensus       138 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~  210 (358)
                      ....+....+|++++.||+|+||.||++.+ ..+++.||||+++...   .....+.+|+.+++.++|++      ++++
T Consensus         6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A            6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            345566788999999999999999999998 5688999999987432   22346778999999987665      7777


Q ss_pred             hhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec
Q psy13988        211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN  289 (358)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~  289 (358)
                      ++++.          +.+..++||||+++++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus        83 ~~~~~----------~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  152 (339)
T 1z57_A           83 LEWFE----------HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFV  152 (339)
T ss_dssp             EEEEE----------ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred             ecccc----------cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence            55554          466899999999888888886543 4689999999999999999999999999999999999998


Q ss_pred             C-------------------CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHH
Q psy13988        290 N-------------------RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE  350 (358)
Q Consensus       290 ~-------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~  350 (358)
                      .                   ++.++|+|||++......     .....+|+.|+|||++.+.. ++.++||||||+++|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~e  226 (339)
T 1z57_A          153 QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIE  226 (339)
T ss_dssp             CCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHH
T ss_pred             ccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHH
Confidence            7                   668999999999865432     23446799999999998655 8999999999999999


Q ss_pred             HhhCCCCC
Q psy13988        351 LFVKKPLF  358 (358)
Q Consensus       351 lltg~~pF  358 (358)
                      |++|..||
T Consensus       227 l~~g~~pf  234 (339)
T 1z57_A          227 YYLGFTVF  234 (339)
T ss_dssp             HHHSSCSC
T ss_pred             HHhCCCCC
Confidence            99999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-38  Score=281.17  Aligned_cols=206  Identities=23%  Similarity=0.394  Sum_probs=162.7

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCC----cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTD----ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      .+....+|.+.+.||+|+||.||++.+..++    ..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            3456788999999999999999999987654    459999987543 22223467899999999999999999777654


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                                .+..++||||+++ +|.+.+......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++
T Consensus       118 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k  187 (333)
T 1mqb_A          118 ----------YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCK  187 (333)
T ss_dssp             ----------SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred             ----------CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEE
Confidence                      5589999999987 66666666666899999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        296 LADFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+|||++......... .......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf  251 (333)
T 1mqb_A          188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPY  251 (333)
T ss_dssp             ECCCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ECCCCcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCc
Confidence            9999999876543221 1122334578899999987654 8899999999999999999 99997

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.3e-39  Score=284.63  Aligned_cols=205  Identities=25%  Similarity=0.347  Sum_probs=168.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeee-----ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVS-----LFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  216 (358)
                      ....+|.+.+.||+|+||.||++.+     ..+++.||||++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            4567899999999999999999985     356789999998754321 2234678899999999 79999999887754


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCC---------------CCChHHHHHHHHHHHHHHHHHHhCCceecC
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMV---------------DFNEVNNASIMRQLLDGLSYCHKRNFLHRD  280 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~qi~~al~~LH~~~i~H~D  280 (358)
                      .         ++.+++||||+++ +|.+.+.....               .+++..++.++.||+.||.|||++||+|+|
T Consensus       103 ~---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d  173 (316)
T 2xir_A          103 P---------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD  173 (316)
T ss_dssp             T---------TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             C---------CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence            2         3468999999997 56555544332               288999999999999999999999999999


Q ss_pred             CCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       281 lkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |||+||+++.++.++|+|||++................+|+.|+|||++.+.. ++.++||||||+++|+|+| |..||
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999998765443333334456688999999987654 8899999999999999998 99987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.5e-38  Score=284.81  Aligned_cols=203  Identities=25%  Similarity=0.416  Sum_probs=171.0

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCc---------------hhHHHHHHHHHhCCC
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFP---------------ITAVREIKILRQLNH  204 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~---------------~~~~~e~~~l~~l~h  204 (358)
                      ......++|.+.+.||+|+||.||++.+  +++.||||.+..........               ..+.+|+.+++.++|
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  102 (348)
T 2pml_X           25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN  102 (348)
T ss_dssp             SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred             hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence            3445567999999999999999999998  99999999998664332221               678899999999999


Q ss_pred             CcccchhhhhcccCcccccccCCCeEEEEeecccc-ChHHH------HhcC-CCCCChHHHHHHHHHHHHHHHHHHh-CC
Q psy13988        205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGL------LESG-MVDFNEVNNASIMRQLLDGLSYCHK-RN  275 (358)
Q Consensus       205 ~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~------~~~~-~~~~~~~~~~~~~~qi~~al~~LH~-~~  275 (358)
                      |||+++++++.+          .+..++||||+++ +|.+.      +... ...+++..++.++.||+.||.|||+ +|
T Consensus       103 ~~i~~~~~~~~~----------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~  172 (348)
T 2pml_X          103 EYCLTCEGIITN----------YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN  172 (348)
T ss_dssp             TTBCCCSEEEES----------SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC
T ss_pred             CCcceEEEEEee----------CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence            999999777754          5589999999998 44444      3221 5679999999999999999999999 99


Q ss_pred             ceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCC-cchHHHHHHHHHHHhhC
Q psy13988        276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGP-AIDVWSCGCILGELFVK  354 (358)
Q Consensus       276 i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~~l~~lltg  354 (358)
                      ++|+||||+||+++.++.++|+|||++......    ......+++.|+|||++.+...++. ++||||||+++|+|++|
T Consensus       173 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  248 (348)
T 2pml_X          173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN  248 (348)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred             EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence            999999999999999999999999999876443    2234567999999999987644555 99999999999999999


Q ss_pred             CCCC
Q psy13988        355 KPLF  358 (358)
Q Consensus       355 ~~pF  358 (358)
                      ..||
T Consensus       249 ~~pf  252 (348)
T 2pml_X          249 VVPF  252 (348)
T ss_dssp             SCSS
T ss_pred             CCCC
Confidence            9998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=278.81  Aligned_cols=209  Identities=24%  Similarity=0.339  Sum_probs=166.9

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSD  219 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  219 (358)
                      .....++|.+++.||.|+||.||++.+..+++.||||++.....   ....+.+|+.+++.+ +||||+++++++.... 
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-   94 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN-   94 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc-
Confidence            34567889999999999999999999999999999999875432   345788999999999 8999999998887532 


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                         .....+..|+||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+
T Consensus        95 ---~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           95 ---PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             -----CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             ---CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence               11124689999999987 566665443 3568999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++........  ......+++.|+|||++..    ...++.++||||||+++|+|++|..||
T Consensus       172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  234 (326)
T 2x7f_A          172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL  234 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence            9999887643321  1233467999999999863    234889999999999999999999997

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=281.73  Aligned_cols=207  Identities=24%  Similarity=0.372  Sum_probs=167.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|+||.||++.+..+++.||||++.....  .....+.+|+.+++.++||||+++++++....     
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----   99 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRER-----   99 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-----
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-----
Confidence            45789999999999999999999999999999999865422  22456789999999999999999988876321     


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhc---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLES---GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                       ......++||||+.+ +|.+.+..   ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+||
T Consensus       100 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          100 -GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             -TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             -CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence             124578999999997 55555543   4567999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCC-------CCCCccccccccccccccCCC--CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQR-------PYTNKVITLWYRPPELLLGEE--RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |++..........       ......+|+.|+|||++.+..  .++.++||||||+++|+|++|+.||
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  246 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY  246 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCCh
Confidence            9987653221110       011234588999999986543  2688999999999999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.4e-38  Score=275.10  Aligned_cols=202  Identities=32%  Similarity=0.532  Sum_probs=171.4

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .+....+|++++.||+|++|.||++.+..+++.||||++............+.+|+.++++++||||+++++++.+    
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   92 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----   92 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC----
Confidence            3445568999999999999999999999999999999998765555556678899999999999999999777654    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEE
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG---EVKL  296 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~---~~~l  296 (358)
                            .+..++|||++.+ ++.+.+.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++   .++|
T Consensus        93 ------~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL  165 (287)
T 2wei_A           93 ------SSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI  165 (287)
T ss_dssp             ------SSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             ------CCeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEE
Confidence                  5589999999986 45555543 34689999999999999999999999999999999999997644   6999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++........   .....+++.|+|||++.+.  ++.++||||||+++|+|++|..||
T Consensus       166 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~  222 (287)
T 2wei_A          166 IDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPF  222 (287)
T ss_dssp             CSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eccCcceeecCCCc---cccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCC
Confidence            99999986643322   2344579999999998753  789999999999999999999997

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.9e-38  Score=283.58  Aligned_cols=205  Identities=25%  Similarity=0.352  Sum_probs=169.5

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCc-----EEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDE-----LVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVT  215 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  215 (358)
                      .....+|.+.+.||.|+||.||++.+..++.     .||+|.+...... .....+.+|+.+++.+ +||||+++++++.
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4456789999999999999999999876654     7999998754321 2235678999999999 8999999977765


Q ss_pred             ccCcccccccCCCeEEEEeecccc-ChHHHHhcC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG-------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI  281 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dl  281 (358)
                      +          ++..++||||+++ +|.+.+...             ...+++..++.++.||+.||+|||++||+|+||
T Consensus       121 ~----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  190 (333)
T 2i1m_A          121 H----------GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDV  190 (333)
T ss_dssp             S----------SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             c----------CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCc
Confidence            4          5578999999987 666655432             345899999999999999999999999999999


Q ss_pred             CCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       282 kp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||+||+++.++.++|+|||++................+++.|+|||++.+.. ++.++||||||+++|+|+| |..||
T Consensus       191 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~  267 (333)
T 2i1m_A          191 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPY  267 (333)
T ss_dssp             SGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999998765443333334455688999999987654 8899999999999999998 88887

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.2e-37  Score=274.75  Aligned_cols=199  Identities=28%  Similarity=0.402  Sum_probs=165.1

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc--CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE--KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..|...+.||+|+||.||++.+  +++.||||++.....  .......+.+|+.+++.++||||+++++++.+       
T Consensus        31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------  101 (307)
T 2nru_A           31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-------  101 (307)
T ss_dssp             BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-------
T ss_pred             cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-------
Confidence            3455678999999999999986  689999999875432  22234567899999999999999999777654       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhc--CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLES--GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                         ++..++||||+++ ++.+.+..  ....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus       102 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg  178 (307)
T 2nru_A          102 ---GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFG  178 (307)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ---CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence               5578999999976 55555542  34468999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++................+++.|+|||++.+.  ++.++||||||+++|+|++|.+||
T Consensus       179 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~  234 (307)
T 2nru_A          179 LARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAV  234 (307)
T ss_dssp             TCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred             cccccccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCc
Confidence            99876544333233445679999999988653  789999999999999999999997

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.6e-38  Score=282.61  Aligned_cols=205  Identities=22%  Similarity=0.344  Sum_probs=168.9

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      .....+|.+.+.||+|+||.||++.+.     .+++.||||.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            455678999999999999999999986     4678999999875422 1223457889999999999999999777654


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcC---------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESG---------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI  286 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Ni  286 (358)
                                ++..++||||+++ +|.+.+...         ...+++..++.++.||+.||.|||++||+|+||||+||
T Consensus       100 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NI  169 (322)
T 1p4o_A          100 ----------GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC  169 (322)
T ss_dssp             ----------SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred             ----------CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceE
Confidence                      5578999999986 555555331         14578999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       287 ll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++.++.++|+|||++................+++.|+|||++.+.. ++.++||||||+++|+|++ |..||
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~  241 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPY  241 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCcc
Confidence            99999999999999998665443333334456688999999987654 8899999999999999999 88887

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.9e-38  Score=282.11  Aligned_cols=206  Identities=22%  Similarity=0.314  Sum_probs=162.1

Q ss_pred             CCCCCCCCcccccccCCcceeeEeee-----eecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSV-----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  215 (358)
                      ......+|.+++.||+|+||.||++.     +..+++.||||.+.... .......+.+|+.+++.++||||+++++++.
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            34567899999999999999999999     56778999999986432 2222346788999999999999999977765


Q ss_pred             ccCcccccccCCCeEEEEeecccc-ChHHHHhcCC------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM  288 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill  288 (358)
                      +          .+..|+||||+++ +|.+.+....      ..+++..++.++.||+.||.|||++||+|+||||+||++
T Consensus       104 ~----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli  173 (327)
T 2yfx_A          104 Q----------SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL  173 (327)
T ss_dssp             S----------SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             C----------CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEE
Confidence            4          4578999999975 6666665432      348899999999999999999999999999999999999


Q ss_pred             cCC---CcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        289 NNR---GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       289 ~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +.+   ..++|+|||++................+++.|+|||++.+.. ++.++||||||+++|+|+| |..||
T Consensus       174 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~  246 (327)
T 2yfx_A          174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPY  246 (327)
T ss_dssp             SCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCC
Confidence            854   469999999998665443333334456688999999987654 8899999999999999998 88887

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-37  Score=272.87  Aligned_cols=205  Identities=25%  Similarity=0.395  Sum_probs=169.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCc----
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSD----  219 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  219 (358)
                      ...+|.+++.||+|+||.||++.+..+++.||+|++....      ..+.+|+.+++.++||||+++++++.....    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            4467899999999999999999999999999999987542      356789999999999999999988754110    


Q ss_pred             --ccccccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        220 --ALDFRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       220 --~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                        ..........+++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence              00111234578999999997 56665543 335799999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++........   .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus       163 l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          163 IGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             ECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             ECcchhheecccccc---ccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcc
Confidence            999999987754432   23345799999999998655 899999999999999999998875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.2e-38  Score=274.89  Aligned_cols=200  Identities=12%  Similarity=0.179  Sum_probs=167.0

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +....+|.+.+.||+|+||.||++.+  +++.||||++............+.+|+.+++.++||||+++++++.+..   
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   80 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---   80 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---
Confidence            44567899999999999999999998  4899999999876544444456889999999999999999988876532   


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCC-CCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMV-DFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                           .+..++||||+++ +|.+.+..... .+++..++.++.||+.||.|||+.+  ++|+||||+||+++.++.++|+
T Consensus        81 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~  155 (271)
T 3kmu_A           81 -----APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS  155 (271)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred             -----CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEE
Confidence                 3578999999986 66666654332 5899999999999999999999999  9999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCC--CCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++.....       ....+|+.|+|||++.+...  ++.++||||||+++|+|++|+.||
T Consensus       156 ~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  211 (271)
T 3kmu_A          156 MADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF  211 (271)
T ss_dssp             GGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTT
T ss_pred             eccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9998754322       23456999999999976542  233799999999999999999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7e-38  Score=283.39  Aligned_cols=202  Identities=26%  Similarity=0.396  Sum_probs=169.2

Q ss_pred             cccCCCCCCCCcccccccCCcceeeEeeeeecCC-cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc------ccch
Q psy13988        138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTD-ELVALKKVRLENEKEGFPITAVREIKILRQLNHKN------IVNL  210 (358)
Q Consensus       138 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~  210 (358)
                      ....+....+|.+++.||+|+||.||++.+..++ ..||||+++...   .....+.+|+.+++.++|++      ++.+
T Consensus        11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A           11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            3345567789999999999999999999998777 799999987432   12346678999999997766      6666


Q ss_pred             hhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe-
Q psy13988        211 REIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM-  288 (358)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill-  288 (358)
                      .+++          ...+..++|||++++++++.+.... ..+++..++.++.||+.||+|||++||+||||||+||++ 
T Consensus        88 ~~~~----------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~  157 (355)
T 2eu9_A           88 SDWF----------NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFV  157 (355)
T ss_dssp             EEEE----------EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEES
T ss_pred             eeee----------eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence            4444          3466899999999999998886544 569999999999999999999999999999999999999 


Q ss_pred             ------------------cCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHH
Q psy13988        289 ------------------NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE  350 (358)
Q Consensus       289 ------------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~  350 (358)
                                        +.++.++|+|||++.......     ....+|+.|+|||++.+.. ++.++||||||+++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~e  231 (355)
T 2eu9_A          158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFE  231 (355)
T ss_dssp             CCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHH
Confidence                              567899999999998654322     3446799999999998655 8999999999999999


Q ss_pred             HhhCCCCC
Q psy13988        351 LFVKKPLF  358 (358)
Q Consensus       351 lltg~~pF  358 (358)
                      |++|.+||
T Consensus       232 l~~g~~pf  239 (355)
T 2eu9_A          232 YYRGFTLF  239 (355)
T ss_dssp             HHHSSCSC
T ss_pred             HHhCCCCC
Confidence            99999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.4e-38  Score=281.18  Aligned_cols=208  Identities=22%  Similarity=0.271  Sum_probs=153.8

Q ss_pred             ccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHH-HHHhCCCCcccchhhhhc
Q psy13988        137 PIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIK-ILRQLNHKNIVNLREIVT  215 (358)
Q Consensus       137 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~  215 (358)
                      +.........+|++++.||+|+||.||++.+..+++.||||++....... ....+.+|+. +++.++||||+++++++.
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            33445566789999999999999999999999999999999997653221 2234455555 677789999999987776


Q ss_pred             ccCcccccccCCCeEEEEeeccccChHHHHhc----CCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecC
Q psy13988        216 DKSDALDFRKDKGSFYLVFEYMDHDLMGLLES----GMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNN  290 (358)
Q Consensus       216 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~  290 (358)
                      +          .+..++||||+++++.+.+..    ....+++..+..++.|++.||.|||++ ||+|+||||+||+++.
T Consensus        92 ~----------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~  161 (327)
T 3aln_A           92 R----------EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR  161 (327)
T ss_dssp             C----------SSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEET
T ss_pred             e----------CCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcC
Confidence            4          458999999999987766642    345789999999999999999999999 9999999999999999


Q ss_pred             CCcEEEeecccceeccccCCCCCCCCcccccccccccccc---CCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---GEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.+||+|||++........   .....+|+.|+|||++.   ....++.++||||||+++|+|++|+.||
T Consensus       162 ~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (327)
T 3aln_A          162 SGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY  229 (327)
T ss_dssp             TTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCS
T ss_pred             CCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            99999999999987644322   22335799999999984   2334889999999999999999999997

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.9e-38  Score=272.55  Aligned_cols=197  Identities=26%  Similarity=0.392  Sum_probs=154.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC--CCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK--EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      ...+|.+.+.||+|+||.||++.+  +++.||||++......  ......+.+|+.+++.++||||+++++++.+     
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   77 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----   77 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----
T ss_pred             chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----
Confidence            457899999999999999999997  5899999998765332  2234567889999999999999999777654     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEecC--------
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN---FLHRDIKCSNILMNN--------  290 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~Dlkp~Nill~~--------  290 (358)
                           ++..++||||++++.+..+... ..+++..++.++.|++.||+|||++|   ++|+||||+||+++.        
T Consensus        78 -----~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           78 -----EPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             -----C--CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             -----CCceEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence                 5578999999987666555443 47999999999999999999999999   899999999999986        


Q ss_pred             CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       291 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.++|+|||++........    ....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~  214 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPF  214 (271)
T ss_dssp             SCCEEECCCCC-----------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CcceEEccCCcccccccccc----cCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence            67899999999986654322    2345799999999987654 889999999999999999999998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.2e-38  Score=279.05  Aligned_cols=203  Identities=22%  Similarity=0.340  Sum_probs=163.2

Q ss_pred             CCCCCcccc-cccCCcceeeEeeee--ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLME-PLAAGGLSLNNFSVS--LFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~-~lg~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ...+|.+.+ .||+|+||.||++.+  ..+++.||||++............+.+|+.+++.++||||+++++++.     
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   88 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----   88 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence            456788888 999999999999954  566789999999866444433567889999999999999999988763     


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            .+..++|||+++++.+..+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus        89 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           89 ------AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             ------SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             ------CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence                  34689999999865444443444579999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++......... .......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~  221 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPY  221 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCC
Confidence            99876543221 1122334578899999987554 7889999999999999999 99997

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.2e-38  Score=294.41  Aligned_cols=201  Identities=23%  Similarity=0.375  Sum_probs=169.8

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      .....|.+.+.||+|+||.||++.+..++..||||.++...   .....+.+|+.++++++||||+++++++.+      
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------  287 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR------  287 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEec------
Confidence            34556788999999999999999999999999999987543   235678899999999999999999777654      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                          ...+|+||||+.+ +|.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       288 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          288 ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             ----CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecc
Confidence                4578999999985 66666654 34568999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++....... .......+++.|+|||++.+.. ++.++||||||+++|+|+| |..||
T Consensus       364 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~  420 (495)
T 1opk_A          364 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY  420 (495)
T ss_dssp             CEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cceeccCCce-eecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCC
Confidence            9987653322 1223344578899999987654 8999999999999999999 88887

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.1e-38  Score=280.41  Aligned_cols=201  Identities=23%  Similarity=0.341  Sum_probs=163.8

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEE--EEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELV--ALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSD  219 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  219 (358)
                      ...++|.+.+.||+|+||.||++.+..++..+  |+|.+.... .......+.+|+.+++++ +||||+++++++.+   
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---   97 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH---   97 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE---
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee---
Confidence            34468999999999999999999999999865  999887543 223345688999999999 99999999777654   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcCC---------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESGM---------------VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKC  283 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp  283 (358)
                             .+..|+||||+++ +|.+.+....               ..+++..++.++.||+.||.|||++||+|+||||
T Consensus        98 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp  170 (327)
T 1fvr_A           98 -------RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA  170 (327)
T ss_dssp             -------TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             -------CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCcc
Confidence                   5689999999986 5666554332               4699999999999999999999999999999999


Q ss_pred             CCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        284 SNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       284 ~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +||+++.++.++|+|||++........   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       171 ~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf  242 (327)
T 1fvr_A          171 RNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPY  242 (327)
T ss_dssp             GGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCC
Confidence            999999999999999999875432221   12334578899999987554 7899999999999999998 99997

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.7e-38  Score=276.83  Aligned_cols=207  Identities=24%  Similarity=0.341  Sum_probs=164.9

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCC---cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTD---ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      .+....+|++.+.||+|+||.||++.+..++   ..||+|.+.... .......+.+|+.++++++||||+++++++.. 
T Consensus        20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-   97 (298)
T 3f66_A           20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-   97 (298)
T ss_dssp             CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-
T ss_pred             cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-
Confidence            3445567999999999999999999975443   468999887532 22233567899999999999999999887543 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                              .++..++||||+++ +|.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|
T Consensus        98 --------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl  169 (298)
T 3f66_A           98 --------SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKV  169 (298)
T ss_dssp             --------SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEE
T ss_pred             --------CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEE
Confidence                    24578999999997 666666666667899999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCC--CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        297 ADFGLARLYNAEDR--QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +|||++........  ........+|+.|+|||.+.+.. ++.++||||||+++|+|++ |.+||
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~  233 (298)
T 3f66_A          170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPY  233 (298)
T ss_dssp             CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CcccccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999987654332  12223445688999999987654 8899999999999999999 55555

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.5e-38  Score=272.05  Aligned_cols=199  Identities=23%  Similarity=0.408  Sum_probs=167.9

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++.+.||+|++|.||++.+. +++.||+|++......   .+.+.+|+.+++.++||||+++++++.+       
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------   74 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE-------   74 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS-------
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc-------
Confidence            3467899999999999999999985 6789999998764322   3578899999999999999999777654       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         ++..++|||++++ ++.+.+......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        75 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           75 ---QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             ---SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             ---CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccc
Confidence               4578999999986 566666666667999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ........ .......+++.|+|||++.+.. ++.++||||||+++|+|++ |++||
T Consensus       152 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~  206 (267)
T 3t9t_A          152 RFVLDDQY-TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPY  206 (267)
T ss_dssp             GGBCCHHH-HSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccccccc-cccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCC
Confidence            86643221 1123344578899999987554 7899999999999999999 89987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-37  Score=273.67  Aligned_cols=201  Identities=24%  Similarity=0.311  Sum_probs=164.1

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCc---EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDE---LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ..|.+.+.||+|+||.||++.+..++.   .||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.     
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   94 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-----   94 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-----
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-----
Confidence            356677999999999999999766554   799999875322 22235678999999999999999998887653     


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                          ++..++|||++.+ ++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus        95 ----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A           95 ----EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             ----SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             ----CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence                2345899999975 66666766667799999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccC--CCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        302 ARLYNAED--RQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       302 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      +.......  .........+++.|+|||.+.+.. ++.++||||||+++|+|++|..|
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~  227 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAP  227 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCC
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCC
Confidence            98664432  122233445689999999997655 88999999999999999996544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-38  Score=280.96  Aligned_cols=206  Identities=26%  Similarity=0.430  Sum_probs=169.8

Q ss_pred             CCCCCCCcccccccCCcceeeEeee----eecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSV----SLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      .....+|++++.||+|+||.||++.    +..+++.||||++....  ......+.+|+.+++.++||||+++++++...
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            3456779999999999999999998    56789999999987532  22345678999999999999999998876542


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                      .        ...+++||||+++ +|.+.+......+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|
T Consensus       115 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL  186 (326)
T 2w1i_A          115 G--------RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI  186 (326)
T ss_dssp             -----------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred             C--------CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEE
Confidence            2        3478999999986 666667666667999999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++......... .......++..|+|||++.+.. ++.++||||||+++|+|+||..||
T Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~  248 (326)
T 2w1i_A          187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKS  248 (326)
T ss_dssp             CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred             ecCcchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCC
Confidence            999999877543321 1122334577899999987654 788999999999999999998875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1e-37  Score=285.23  Aligned_cols=202  Identities=27%  Similarity=0.443  Sum_probs=168.4

Q ss_pred             cccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCc-----ccchh
Q psy13988        138 IQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKN-----IVNLR  211 (358)
Q Consensus       138 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n-----iv~~~  211 (358)
                      ....+....+|.+.+.||+|+||.||++.+..+++.||||+++...   .....+..|+.+++.++ |++     |++++
T Consensus        46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            3445566789999999999999999999999999999999987432   12345667888888884 554     66665


Q ss_pred             hhhcccCcccccccCCCeEEEEeeccccChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEe
Q psy13988        212 EIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCH--KRNFLHRDIKCSNILM  288 (358)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~Dlkp~Nill  288 (358)
                      +++.          ..+..|+|||++++++.+.+.... ..+++..++.++.||+.||.|||  +.||+||||||+||++
T Consensus       123 ~~~~----------~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll  192 (382)
T 2vx3_A          123 RHFM----------FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL  192 (382)
T ss_dssp             EEEE----------ETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEE
T ss_pred             eeec----------cCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEE
Confidence            5554          356899999999999888886543 46899999999999999999999  5799999999999999


Q ss_pred             c--CCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        289 N--NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       289 ~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +  .++.+||+|||+++.....     .....+|+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       193 ~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf  258 (382)
T 2vx3_A          193 CNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLF  258 (382)
T ss_dssp             SSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence            5  4678999999999876432     23456799999999998765 899999999999999999999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-37  Score=289.76  Aligned_cols=196  Identities=23%  Similarity=0.415  Sum_probs=164.4

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|++.+.||+|+||.||++..  .++.||||+++...    ....+.+|+.++++++||||+++++++.+.    
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----  258 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----  258 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----
Confidence            45567889999999999999999986  47899999987543    346789999999999999999998876542    


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCC-CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMV-DFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                           .+..|+||||+++ +|.+.+..... .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+||
T Consensus       259 -----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          259 -----KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             -----TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCC
T ss_pred             -----CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeC
Confidence                 3478999999986 66666654433 4799999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++......     ....+++.|+|||++.+.. ++.++||||||+++|+|+| |+.||
T Consensus       334 G~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~  387 (450)
T 1k9a_A          334 GLTKEASSTQ-----DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPY  387 (450)
T ss_dssp             TTCEECC-----------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCcccccccc-----cCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9998553221     1224578899999998655 8999999999999999998 99997

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-38  Score=284.78  Aligned_cols=204  Identities=24%  Similarity=0.347  Sum_probs=156.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCC---cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTD---ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ....|.+.+.||+|+||.||++.+..++   ..||+|.++... .......+.+|+.++++++||||+++++++..    
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----  161 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----  161 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----
Confidence            3445778899999999999999986543   468999886432 22234567899999999999999999887543    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                           .++..++||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus       162 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DF  236 (373)
T 3c1x_A          162 -----SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF  236 (373)
T ss_dssp             -----CSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             -----CCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeec
Confidence                 23478999999987 666666666667899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCC--CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQ--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++........  .......+++.|+|||++.+.. ++.++||||||+++|+|+| |.+||
T Consensus       237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~  297 (373)
T 3c1x_A          237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPY  297 (373)
T ss_dssp             ---------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             cccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCC
Confidence            999866433221  1223345578899999987654 8999999999999999999 67776

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=274.02  Aligned_cols=202  Identities=24%  Similarity=0.361  Sum_probs=166.2

Q ss_pred             CCCCCcccc-cccCCcceeeEeeeee--cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLME-PLAAGGLSLNNFSVSL--FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~-~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ...+|.+.+ .||+|+||.||++.+.  .++..||||++.... .......+.+|+.+++.++||||+++++++.     
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----   80 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----   80 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----
Confidence            345677777 9999999999999853  567889999987642 2223456789999999999999999988773     


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            .+..++|||++++ +|.+.+......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus        81 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           81 ------AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             ------SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred             ------CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcc
Confidence                  2358999999997 555556555667999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |++......... .......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~  214 (287)
T 1u59_A          155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPY  214 (287)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cceeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCc
Confidence            999877543321 2223344588999999987554 8899999999999999998 99997

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=275.88  Aligned_cols=191  Identities=27%  Similarity=0.393  Sum_probs=154.5

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+.+.||+|+||.||++.+  .++.||||++...    .....+.+|+.++++++||||+++++++.+       
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------   72 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN-------   72 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------
Confidence            346788999999999999999986  5789999998643    224567899999999999999999887653       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCC--CCChHHHHHHHHHHHHHHHHHHh---CCceecCCCCCCEEecCCCc-EEE
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMV--DFNEVNNASIMRQLLDGLSYCHK---RNFLHRDIKCSNILMNNRGE-VKL  296 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~i~H~Dlkp~Nill~~~~~-~~l  296 (358)
                           ..++||||+++ +|.+.+.....  .+++..+..++.||+.||+|||+   +||+|+||||+||+++.++. +||
T Consensus        73 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl  147 (307)
T 2eva_A           73 -----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI  147 (307)
T ss_dssp             -----TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred             -----CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence                 36899999987 55555543322  47889999999999999999999   89999999999999998886 799


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||++.......     ....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus       148 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~  203 (307)
T 2eva_A          148 CDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPF  203 (307)
T ss_dssp             CCCCC-----------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred             ccccccccccccc-----ccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCc
Confidence            9999997654321     2345799999999998654 899999999999999999999997

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-38  Score=279.77  Aligned_cols=204  Identities=26%  Similarity=0.378  Sum_probs=160.8

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC----CCchhHHHHHHHHHhC----CCCcccchh
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE----GFPITAVREIKILRQL----NHKNIVNLR  211 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~~~  211 (358)
                      ..+...++|++.+.||+|+||.||++.+..+++.||||++.......    .....+.+|+.+++++    +|+||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34566788999999999999999999999999999999997653321    1223456799999998    899999998


Q ss_pred             hhhcccCcccccccCCCeEEEEeec-ccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec
Q psy13988        212 EIVTDKSDALDFRKDKGSFYLVFEY-MDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN  289 (358)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~lv~e~-~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~  289 (358)
                      +++..          .+..++|||+ +.+ ++.+.+.. ...+++..++.++.||+.||+|||++||+|+||||+||+++
T Consensus       105 ~~~~~----------~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  173 (312)
T 2iwi_A          105 DWFET----------QEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID  173 (312)
T ss_dssp             EEC---------------CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE
T ss_pred             EEEec----------CCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe
Confidence            77654          4578999998 555 56555544 44699999999999999999999999999999999999999


Q ss_pred             -CCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        290 -NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       290 -~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                       .++.++|+|||++.......    .....+++.|+|||++.+....+.++||||||+++|+|++|+.||
T Consensus       174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  239 (312)
T 2iwi_A          174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF  239 (312)
T ss_dssp             TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCC
Confidence             78999999999998765432    234457999999999876554456899999999999999999997

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=276.95  Aligned_cols=208  Identities=20%  Similarity=0.281  Sum_probs=167.3

Q ss_pred             ccccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        137 PIQSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       137 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      ..........+|++.+.||+|+||.||++.+..   .||+|+++...........+.+|+.+++.++||||+++++++.+
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            344556677899999999999999999998743   59999998765555555677889999999999999999877765


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                                .+..++||||++| ++.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++ ++.++
T Consensus       101 ----------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~  169 (319)
T 2y4i_B          101 ----------PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV  169 (319)
T ss_dssp             ----------SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCE
T ss_pred             ----------CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEE
Confidence                      4579999999986 55555555555799999999999999999999999999999999999998 68999


Q ss_pred             EeecccceeccccC---CCCCCCCccccccccccccccC--------CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAED---RQRPYTNKVITLWYRPPELLLG--------EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++.......   .........+++.|+|||++.+        ...++.++||||||+++|+|++|+.||
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  243 (319)
T 2y4i_B          170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF  243 (319)
T ss_dssp             ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999987653221   1122234457999999999864        234788999999999999999999997

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.6e-38  Score=278.48  Aligned_cols=206  Identities=26%  Similarity=0.386  Sum_probs=164.8

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC--CCcccchhhhhccc
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN--HKNIVNLREIVTDK  217 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~  217 (358)
                      +....+.+|.+++.||+|+||.||++.+. +++.||||++............+.+|+.+++.++  |+||+++++++.. 
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-   99 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-   99 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-
Confidence            34456678999999999999999999984 5899999999765444334456789999999996  5999999776654 


Q ss_pred             CcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                               ++..|+|||+.+++|.+.+... ..+++..+..++.||+.||.|||++||+|+||||+||+++ ++.++|+
T Consensus       100 ---------~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~  168 (313)
T 3cek_A          100 ---------DQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLI  168 (313)
T ss_dssp             ---------SSEEEEEECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEEC
T ss_pred             ---------CCEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEe
Confidence                     5589999997777887777654 4789999999999999999999999999999999999996 4899999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCC----------CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----------ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||++................+++.|+|||++.+.          ..++.++||||||+++|+|++|+.||
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  239 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence            99999876544333333445679999999998652          34788999999999999999999997

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=286.89  Aligned_cols=198  Identities=23%  Similarity=0.286  Sum_probs=159.2

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..+|.+.+.||+|+||+|+ .....+++.||||++....     ...+.+|+.+++.+ +||||+++++++.+       
T Consensus        23 ~~~y~~~~~LG~G~~G~V~-~~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-------   89 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKD-------   89 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEE-EEEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEE-------
T ss_pred             cEEEecCCeeecCcCEEEE-EEEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec-------
Confidence            3468899999999999976 4556789999999986432     23467899999999 89999999776654       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-----CcEEEee
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-----GEVKLAD  298 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-----~~~~l~D  298 (358)
                         ....|+|||+++|++.+.+........+..+..++.||+.||+|||++||+||||||+||+++.+     ..++|+|
T Consensus        90 ---~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           90 ---RQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             ---TTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             ---CCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence               56899999999999999888777677777889999999999999999999999999999999532     3588999


Q ss_pred             cccceeccccCC-CCCCCCccccccccccccccC--CCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        299 FGLARLYNAEDR-QRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ||+++....... ........||+.|+|||++.+  ...++.++|||||||++|+|+| |.+||
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf  230 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF  230 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence            999987654321 122344568999999999874  2347789999999999999999 88887

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=278.11  Aligned_cols=202  Identities=21%  Similarity=0.241  Sum_probs=151.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|.+++.||.|+||.||++.+..+++.||||++............+.++..+++.++||||+++++++.+       
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-------   95 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-------   95 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-------
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-------
Confidence            3467889999999999999999999999999999998654332222233445557788899999999877765       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         ++..++||||+++.+..........+++..+..++.||+.||.|||++ |++|+||||+||+++.++.++|+|||++
T Consensus        96 ---~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A           96 ---NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             ---SSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ---CCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence               558999999996555444444456799999999999999999999995 9999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........   .....+++.|+|||++..    ...++.++||||||+++|+|++|+.||
T Consensus       173 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (318)
T 2dyl_A          173 GRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY  229 (318)
T ss_dssp             -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             hhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCC
Confidence            76644322   233457999999999852    344788999999999999999999997

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-37  Score=273.24  Aligned_cols=204  Identities=24%  Similarity=0.281  Sum_probs=164.7

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecC---CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFT---DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      .+....+|.+.+.||+|+||.||++.+...   +..||+|.+..... ......+.+|+.+++.++||||+++++++.+ 
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence            345667899999999999999999987543   35699999875422 1224567889999999999999999887643 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                                +..|+|||++++ ++.+.+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|
T Consensus        85 ----------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  154 (281)
T 3cc6_A           85 ----------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKL  154 (281)
T ss_dssp             ----------SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEE
T ss_pred             ----------CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEe
Confidence                      246899999996 566666555567999999999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +|||++......... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       155 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~  215 (281)
T 3cc6_A          155 GDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPF  215 (281)
T ss_dssp             CCCCGGGCC----------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CccCCCccccccccc-ccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCc
Confidence            999999876543221 122334578899999987554 8899999999999999998 99997

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-37  Score=271.64  Aligned_cols=200  Identities=26%  Similarity=0.451  Sum_probs=165.0

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|++++.||+|+||.||++.+. ++..||||.+....   .....+.+|+++++.++||||+++++++.+     
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   79 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----   79 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----
Confidence            445678999999999999999999964 66789999987543   234578899999999999999999877642     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            +..++||||+++ +|.+.+... ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+||
T Consensus        80 ------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           80 ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             ------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ------CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCC
Confidence                  357899999986 455554332 126899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |++......... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       154 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~  211 (279)
T 1qpc_A          154 GLARLIEDNEYT-AREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPY  211 (279)
T ss_dssp             TTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccCcccc-cccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCC
Confidence            999877543221 123344578899999987544 7889999999999999999 89887

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-37  Score=274.22  Aligned_cols=206  Identities=26%  Similarity=0.398  Sum_probs=163.7

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc---cc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA---LD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---~~  222 (358)
                      .+|.+++.||+|+||.||++.+..+++.||||++....   .....+.+|+.+++.++||||+++++++.+....   .+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            46889999999999999999999999999999986432   2235678899999999999999999887653221   22


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                      .....+..|+||||+++ +|.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence            33446789999999986 66666665666788899999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCC------------CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhC
Q psy13988        302 ARLYNAEDR------------QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK  354 (358)
Q Consensus       302 ~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg  354 (358)
                      +........            ........+++.|+|||++.+...++.++||||||+++|+|+++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p  227 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP  227 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc
Confidence            986643211            11223456799999999998765689999999999999999983

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8.7e-38  Score=302.09  Aligned_cols=195  Identities=22%  Similarity=0.351  Sum_probs=158.2

Q ss_pred             ccccCCcceeeEeeee--ecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVS--LFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||++.+  ..+++.||||+++...........+.+|+.+++.++||||+++++++..           ..
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----------~~  443 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----------ES  443 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----------SS
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----------CC
Confidence            3799999999999955  4567899999998765544445678899999999999999999887643           25


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      .++||||+.++.+..+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            78999999975444444445679999999999999999999999999999999999999999999999999998765433


Q ss_pred             C-CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        310 R-QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       310 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      . ........+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf  573 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPY  573 (635)
T ss_dssp             -----------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            2 12223344578899999997654 8999999999999999998 99998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=271.05  Aligned_cols=198  Identities=29%  Similarity=0.435  Sum_probs=161.5

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|.....||+|+||.||++.+..++..||||.+....  ......+.+|+.+++.++||||+++++++..          
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------   90 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE----------   90 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE----------
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe----------
Confidence            3444558999999999999999999999999987643  2335678899999999999999999777654          


Q ss_pred             CCeEEEEeecccc-ChHHHHhcCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEeecccc
Q psy13988        227 KGSFYLVFEYMDH-DLMGLLESGM--VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-RGEVKLADFGLA  302 (358)
Q Consensus       227 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~-~~~~~l~Dfg~~  302 (358)
                      .+..++|||++++ ++.+.+....  ..+++..+..++.||+.||.|||++|++|+||||+||+++. ++.++|+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A           91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence            5589999999976 5555554432  34678889999999999999999999999999999999988 889999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........  ......+++.|+|||++.+. ..++.++||||||+++|+|++|+.||
T Consensus       171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  225 (295)
T 2clq_A          171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF  225 (295)
T ss_dssp             EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTT
T ss_pred             cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            87653321  12344679999999998643 23788999999999999999999997

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-37  Score=289.65  Aligned_cols=200  Identities=25%  Similarity=0.395  Sum_probs=165.7

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|.+.+.||+|+||.||++.+. ++..||||+++...   ...+.+.+|+.+++.++||||+++++++.      
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------  253 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT------  253 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------
Confidence            445667889999999999999999874 57889999987543   23567899999999999999999987764      


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                           ....|+||||+.+ +|.+.+... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus       254 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          254 -----KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             -----SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECST
T ss_pred             -----CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeC
Confidence                 2358999999986 566666532 236888999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++........ ......+++.|+|||++.... ++.++||||||+++|+|+| |+.||
T Consensus       329 G~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~  386 (454)
T 1qcf_A          329 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPY  386 (454)
T ss_dssp             TGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCceEcCCCcee-ccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCC
Confidence            999876433211 112334578899999987554 8999999999999999999 99997

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.8e-37  Score=282.73  Aligned_cols=200  Identities=33%  Similarity=0.513  Sum_probs=168.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-----------CCcccchhh
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-----------HKNIVNLRE  212 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~  212 (358)
                      ...+|.+.+.||+|+||.||++.+..+++.||||++.....   ....+.+|+.+++.++           |+||+++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc---chhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            56789999999999999999999999999999999874321   2345678999998886           789999988


Q ss_pred             hhcccCcccccccCCCeEEEEeeccccChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecC
Q psy13988        213 IVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKR-NFLHRDIKCSNILMNN  290 (358)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~Dlkp~Nill~~  290 (358)
                      ++....      .+...+++|||++++++.+.+... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.
T Consensus        94 ~~~~~~------~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           94 HFNHKG------PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  167 (373)
T ss_dssp             EEEEEE------TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             HhhccC------CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence            876532      123478999999977888887653 34699999999999999999999998 9999999999999953


Q ss_pred             ------CCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        291 ------RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       291 ------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                            .+.++|+|||++......     .....+|+.|+|||++.+.. ++.++||||||+++|+|+||+.||
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf  235 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF  235 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence                  347999999999876533     23446799999999998765 899999999999999999999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.1e-37  Score=295.08  Aligned_cols=208  Identities=28%  Similarity=0.359  Sum_probs=168.8

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +...++|.+.+.||.|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++..    .
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~----~   84 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDG----L   84 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT----T
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecc----c
Confidence            344578999999999999999999999999999999987542 22223467889999999999999999888765    2


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---EE
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGM--VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE---VK  295 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~---~~  295 (358)
                      ..+..++..|+||||++| +|.+.+....  ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.   ++
T Consensus        85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred             ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEE
Confidence            334456788999999976 5555554322  26899999999999999999999999999999999999997764   89


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus       165 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf  223 (676)
T 3qa8_A          165 IIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPF  223 (676)
T ss_dssp             ECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred             Ecccccccccccccc---cccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCC
Confidence            999999987654432   23456799999999987654 899999999999999999999997

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=279.06  Aligned_cols=204  Identities=24%  Similarity=0.335  Sum_probs=158.4

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHH--HHhCCCCcccchhhhhcccC
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKI--LRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~  218 (358)
                      ......+|++++.||+|+||.||++.+  +++.||||++.....     ..+..|.++  +..++||||+++++.+... 
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-   79 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERV-   79 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheeccccc-
Confidence            345668899999999999999999965  789999999875432     233344444  4558999999998755431 


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR---------NFLHRDIKCSNILM  288 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---------~i~H~Dlkp~Nill  288 (358)
                          .......+++||||+++ +|.+.+...  ..++..+..++.||+.||+|||+.         ||+||||||+||++
T Consensus        80 ----~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill  153 (336)
T 3g2f_A           80 ----TADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV  153 (336)
T ss_dssp             ----CTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred             ----ccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence                22335578999999976 555555443  458889999999999999999999         99999999999999


Q ss_pred             cCCCcEEEeecccceeccccCC------CCCCCCccccccccccccccCC------CCCCCcchHHHHHHHHHHHhhCCC
Q psy13988        289 NNRGEVKLADFGLARLYNAEDR------QRPYTNKVITLWYRPPELLLGE------ERYGPAIDVWSCGCILGELFVKKP  356 (358)
Q Consensus       289 ~~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~~lltg~~  356 (358)
                      +.++.+||+|||++..+.....      ........||+.|+|||++.+.      ..++.++|||||||++|+|++|..
T Consensus       154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            9999999999999987654321      1222345679999999998763      235678999999999999999976


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       234 p~  235 (336)
T 3g2f_A          234 DL  235 (336)
T ss_dssp             GG
T ss_pred             cC
Confidence            54

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-37  Score=296.25  Aligned_cols=198  Identities=24%  Similarity=0.370  Sum_probs=159.0

Q ss_pred             Ccccc-cccCCcceeeEeeeeec--CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        148 RPLME-PLAAGGLSLNNFSVSLF--TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       148 ~~~~~-~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      +.+.+ .||+|+||.||++.+..  ++..||||+++... .....+.+.+|+.+++.++||||+++++++..        
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--------  407 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--------  407 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--------
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--------
Confidence            33444 79999999999998763  45679999997653 33345678999999999999999999887753        


Q ss_pred             cCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ..+++||||+.++ |.+.+......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus       408 ---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          408 ---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             ---SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             ---CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence               2589999999875 555565556679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        304 LYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       304 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ........ .......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf  540 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPY  540 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            76433221 1112233468899999987554 8999999999999999998 99998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-37  Score=271.81  Aligned_cols=195  Identities=24%  Similarity=0.420  Sum_probs=157.0

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|++.+.||+|++|.||++.+  +++.||||+++...    ..+.+.+|+.+++.++||||+++++++..      
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------   85 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE------   85 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECC------
T ss_pred             CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEc------
Confidence            4557899999999999999999986  58999999987432    34578899999999999999999887543      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                         ..+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus        86 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           86 ---EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             ---C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             ---CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecc
Confidence               23478999999987 6666664432 237899999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++.......     ....+++.|+|||++.+.. ++.++||||||+++|+|+| |+.||
T Consensus       163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~  215 (278)
T 1byg_A          163 LTKEASSTQ-----DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPY  215 (278)
T ss_dssp             C-----------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             ccccccccc-----cCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCC
Confidence            987654332     2234578899999987554 8899999999999999998 99987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.5e-37  Score=276.76  Aligned_cols=206  Identities=25%  Similarity=0.355  Sum_probs=149.7

Q ss_pred             ccccccCCCCCCCCcccc-cccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHH-HHHHhCCCCcccchhh
Q psy13988        135 AAPIQSNSTNNSSRPLME-PLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREI-KILRQLNHKNIVNLRE  212 (358)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~-~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~~  212 (358)
                      +.|.........+|.+++ .||+|+||.||++.+..+++.||||++....       ...+|+ ..++.++||||+++++
T Consensus        17 ~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~   89 (336)
T 3fhr_A           17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILD   89 (336)
T ss_dssp             ---CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHH
Confidence            344455556778899865 6999999999999999999999999986431       223333 4466779999999998


Q ss_pred             hhcccCcccccccCCCeEEEEeecccc-ChHHHHhcCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC
Q psy13988        213 IVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM-VDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN  290 (358)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~  290 (358)
                      ++....      ..+..+++||||++| +|.+.+.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.
T Consensus        90 ~~~~~~------~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~  163 (336)
T 3fhr_A           90 VYENMH------HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTS  163 (336)
T ss_dssp             EEEEEE------TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred             HHhhcc------CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEe
Confidence            876522      224568999999987 6666665443 46999999999999999999999999999999999999986


Q ss_pred             C---CcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        291 R---GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       291 ~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +   +.++|+|||++.......    .....+|+.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus       164 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  229 (336)
T 3fhr_A          164 KEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPF  229 (336)
T ss_dssp             SSTTCCEEECCCTTCEEC--------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCC
Confidence            4   459999999998665332    23345699999999986554 788999999999999999999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-37  Score=279.30  Aligned_cols=201  Identities=16%  Similarity=0.177  Sum_probs=161.2

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC------CCCchhHHHHHHHHHhCC---------------
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK------EGFPITAVREIKILRQLN---------------  203 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~---------------  203 (358)
                      ..+|.+++.||+|+||.||++.+  +++.||||++......      ......+.+|+.+++.++               
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  7899999999876422      222356789999999886               


Q ss_pred             -----------CCcccchhhhhcccCccc---ccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHH
Q psy13988        204 -----------HKNIVNLREIVTDKSDAL---DFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGL  268 (358)
Q Consensus       204 -----------h~niv~~~~~~~~~~~~~---~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al  268 (358)
                                 ||||+++++++.+.....   ....+.+.+|+||||+.++ +++.+..  ..+++..++.++.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence                       677777777766421000   0011256899999999764 6666644  4689999999999999999


Q ss_pred             HHHH-hCCceecCCCCCCEEecCCC--------------------cEEEeecccceeccccCCCCCCCCccccccccccc
Q psy13988        269 SYCH-KRNFLHRDIKCSNILMNNRG--------------------EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPE  327 (358)
Q Consensus       269 ~~LH-~~~i~H~Dlkp~Nill~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  327 (358)
                      +||| ++||+||||||+|||++.++                    .+||+|||+++.....       ...||+.|+|||
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE  247 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSG
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChh
Confidence            9999 99999999999999999887                    8999999999876532       236799999999


Q ss_pred             cccCCCCCCCcchHHHHHHH-HHHHhhCCCCC
Q psy13988        328 LLLGEERYGPAIDVWSCGCI-LGELFVKKPLF  358 (358)
Q Consensus       328 ~~~~~~~~~~~~DiwslG~~-l~~lltg~~pF  358 (358)
                      ++.+..  +.++||||++++ .+++++|..||
T Consensus       248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~  277 (336)
T 2vuw_A          248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPY  277 (336)
T ss_dssp             GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred             hhcCCC--ccceehhhhhCCCCcccccccCCC
Confidence            998654  789999998777 77788898886

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-36  Score=282.79  Aligned_cols=200  Identities=28%  Similarity=0.391  Sum_probs=154.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  221 (358)
                      .....|.+.+.||+|+||+||.+ ...+|+.||||++....     ...+.+|+.+++.+ +||||+++++++.+     
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----   80 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETT-----   80 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----
T ss_pred             hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec-----
Confidence            45566777789999999999865 55789999999987532     23567899999876 89999999776654     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCC------CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC----
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVD------FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR----  291 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~------~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~----  291 (358)
                           ++.+|+||||++|+|.+.+......      .++..++.++.||+.||+|||++||+||||||+||+++.+    
T Consensus        81 -----~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~  155 (434)
T 2rio_A           81 -----DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFT  155 (434)
T ss_dssp             -----SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHH
T ss_pred             -----CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccc
Confidence                 5689999999999888877544321      1344567899999999999999999999999999999754    


Q ss_pred             ---------CcEEEeecccceeccccCCC--CCCCCccccccccccccccC------CCCCCCcchHHHHHHHHHHHhh-
Q psy13988        292 ---------GEVKLADFGLARLYNAEDRQ--RPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFV-  353 (358)
Q Consensus       292 ---------~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~llt-  353 (358)
                               +.++|+|||++.........  .......||+.|+|||++.+      ...++.++|||||||++|+|+| 
T Consensus       156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~  235 (434)
T 2rio_A          156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK  235 (434)
T ss_dssp             SCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence                     48999999999987544321  11234568999999999865      2458899999999999999999 


Q ss_pred             CCCCC
Q psy13988        354 KKPLF  358 (358)
Q Consensus       354 g~~pF  358 (358)
                      |++||
T Consensus       236 g~~Pf  240 (434)
T 2rio_A          236 GKHPF  240 (434)
T ss_dssp             SCCTT
T ss_pred             CCCCC
Confidence            89997

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.7e-37  Score=286.04  Aligned_cols=200  Identities=26%  Similarity=0.405  Sum_probs=160.5

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|++.+.||+|+||.||++.+.. +..||||+++...   ...+.+.+|+.++++++||||+++++++.+     
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----  250 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----  250 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence            3455678899999999999999999854 4679999987543   224578999999999999999999877643     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            +..|+||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+||
T Consensus       251 ------~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          251 ------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             ------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             ------CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCC
Confidence                  357999999986 56666643 2346899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++....... .......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       325 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~  382 (452)
T 1fmk_A          325 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY  382 (452)
T ss_dssp             CTTC---------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             ccceecCCCce-ecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCC
Confidence            99987653321 1122334578899999987554 8999999999999999999 89987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.1e-37  Score=271.59  Aligned_cols=204  Identities=23%  Similarity=0.354  Sum_probs=157.8

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeec-CCc--EEEEEEeeccccC-CCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLF-TDE--LVALKKVRLENEK-EGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~--~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ....+|++.+.||+|+||.||++.+.. ++.  .||||+++..... ......+.+|+.+++.++||||+++++++... 
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   93 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-   93 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-
Confidence            456789999999999999999998654 333  6899998755322 22345678999999999999999998877542 


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                                ..++|||++.+ ++.+.+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+
T Consensus        94 ----------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~  163 (291)
T 1u46_A           94 ----------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG  163 (291)
T ss_dssp             ----------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred             ----------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEc
Confidence                      37899999985 6777676555679999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        298 DFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |||++......... .......+++.|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~  225 (291)
T 1u46_A          164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPW  225 (291)
T ss_dssp             CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCc
Confidence            99999876543321 1122334578899999987654 7889999999999999999 99997

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-36  Score=271.41  Aligned_cols=200  Identities=24%  Similarity=0.327  Sum_probs=157.9

Q ss_pred             ccCCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC--CCCcccchhhhhcc
Q psy13988        139 QSNSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQL--NHKNIVNLREIVTD  216 (358)
Q Consensus       139 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~  216 (358)
                      ........+|++++.||+|+||.||++.+  +++.||||++....     .....+|.+++..+  +||||+++++++..
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            34455667899999999999999999987  48999999986432     22445566666554  99999999888765


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR--------NFLHRDIKCSNIL  287 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--------~i~H~Dlkp~Nil  287 (358)
                      ..      ......|+||||+++ +|.+.+...  .+++..++.++.|++.||+|||+.        ||+||||||+||+
T Consensus       103 ~~------~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nil  174 (337)
T 3mdy_A          103 GT------GSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL  174 (337)
T ss_dssp             SC------GGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEE
T ss_pred             CC------CCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEE
Confidence            32      112579999999987 566666443  689999999999999999999998        9999999999999


Q ss_pred             ecCCCcEEEeecccceeccccCCCC--CCCCccccccccccccccCCCCCCC------cchHHHHHHHHHHHhhC
Q psy13988        288 MNNRGEVKLADFGLARLYNAEDRQR--PYTNKVITLWYRPPELLLGEERYGP------AIDVWSCGCILGELFVK  354 (358)
Q Consensus       288 l~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~~DiwslG~~l~~lltg  354 (358)
                      ++.++.+||+|||++..........  ......||+.|+|||++.+.. .+.      ++|||||||++|+|+||
T Consensus       175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhc
Confidence            9999999999999998765433221  123456799999999997654 333      39999999999999999

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.7e-36  Score=263.85  Aligned_cols=178  Identities=15%  Similarity=0.091  Sum_probs=148.0

Q ss_pred             ccCC-CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcc
Q psy13988        139 QSNS-TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTD  216 (358)
Q Consensus       139 ~~~~-~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  216 (358)
                      .... ...++|++.+.||+|+||.||++.+..+++.||||++....... .....+.+|+.+++.++||||+++++++.+
T Consensus        23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  102 (286)
T 3uqc_A           23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT  102 (286)
T ss_dssp             CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence            3344 57789999999999999999999999999999999998653321 223567899999999999999999777654


Q ss_pred             cCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l  296 (358)
                                ++..|+||||++|+.+..+....  ....++..++.||+.||+|||++||+||||||+||+++.++.++|
T Consensus       103 ----------~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl  170 (286)
T 3uqc_A          103 ----------RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVL  170 (286)
T ss_dssp             ----------TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEE
T ss_pred             ----------CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEE
Confidence                      56899999999875444443332  456678999999999999999999999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++++                      |++|        ++.++||||||+++|+|+||+.||
T Consensus       171 ~~~~----------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf  202 (286)
T 3uqc_A          171 AYPA----------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPL  202 (286)
T ss_dssp             CSCC----------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECS
T ss_pred             Eecc----------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCC
Confidence            7433                      3332        678999999999999999999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-36  Score=289.28  Aligned_cols=200  Identities=26%  Similarity=0.405  Sum_probs=165.4

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .....+|++.+.||+|+||.||++.+.. +..||||+++...   ...+.+.+|+.+++.++||||+++++++.+     
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----  333 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----  333 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-----
Confidence            3456678899999999999999999854 4679999987543   224578999999999999999999877643     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            +..|+||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus       334 ------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          334 ------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             ------SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             ------ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccc
Confidence                  357999999986 66666643 2346899999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++....... .......++..|+|||++.+.. ++.++||||||+++|+|++ |+.||
T Consensus       408 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~  465 (535)
T 2h8h_A          408 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY  465 (535)
T ss_dssp             TSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSS
T ss_pred             ccceecCCCce-ecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99986643221 1112334578899999987554 8999999999999999999 89987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.6e-37  Score=298.28  Aligned_cols=202  Identities=20%  Similarity=0.269  Sum_probs=165.1

Q ss_pred             cCCCCCCCCcccccccCCcceeeEeeeeec-CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        140 SNSTNNSSRPLMEPLAAGGLSLNNFSVSLF-TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       140 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ..+...++|++.+.||+|+||.||++.+.. +++.||||++..... ......+.+|+.++++++||||+++++++....
T Consensus        74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            445567899999999999999999999976 789999998864322 222346778999999999999999998887643


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                      .     ......|+||||++|+.+......  .+++.+++.++.||+.||.|||++||+||||||+||+++.+ .+||+|
T Consensus       153 ~-----~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          153 R-----HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             T-----TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECC
T ss_pred             C-----CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEe
Confidence            1     111236999999998555544333  68999999999999999999999999999999999999875 899999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+++.....      ....||+.|+|||++.+.  ++.++||||||+++|+|++|.+||
T Consensus       225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~  276 (681)
T 2pzi_A          225 LGAVSRINSF------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTR  276 (681)
T ss_dssp             CTTCEETTCC------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEE
T ss_pred             cccchhcccC------CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCC
Confidence            9999876433      344679999999998653  488999999999999999998875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-36  Score=277.45  Aligned_cols=209  Identities=17%  Similarity=0.128  Sum_probs=158.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCC-Ccccchhhh--------
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNH-KNIVNLREI--------  213 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~~~~~--------  213 (358)
                      ....|.+.+.||+|+||.||++.+..+|+.||||++..... .....+.+.+|+.+++.++| .|+.....+        
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            33457788999999999999999999999999999884432 22335678899999999977 433333222        


Q ss_pred             -hcccCc--ccccccC-----CCeEEEEeeccccChHHHHh------cCCCCCChHHHHHHHHHHHHHHHHHHhCCceec
Q psy13988        214 -VTDKSD--ALDFRKD-----KGSFYLVFEYMDHDLMGLLE------SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHR  279 (358)
Q Consensus       214 -~~~~~~--~~~~~~~-----~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~  279 (358)
                       ......  .......     ...++++|+++.+++.+.+.      .....+++..+..++.||+.||+|||++||+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence             000000  0000011     23578999999988877763      224457888899999999999999999999999


Q ss_pred             CCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCcccccccccccccc---------CCCCCCCcchHHHHHHHHHH
Q psy13988        280 DIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL---------GEERYGPAIDVWSCGCILGE  350 (358)
Q Consensus       280 Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DiwslG~~l~~  350 (358)
                      ||||+|||++.++.+||+|||+++.....     .....| +.|+|||++.         ....++.++|||||||++|+
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            99999999999999999999998876543     234456 9999999983         33347889999999999999


Q ss_pred             HhhCCCCC
Q psy13988        351 LFVKKPLF  358 (358)
Q Consensus       351 lltg~~pF  358 (358)
                      |+||+.||
T Consensus       310 lltg~~Pf  317 (413)
T 3dzo_A          310 IWCADLPN  317 (413)
T ss_dssp             HHHSSCCC
T ss_pred             HHHCCCCC
Confidence            99999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.6e-36  Score=290.46  Aligned_cols=203  Identities=22%  Similarity=0.344  Sum_probs=163.7

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecC---CcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFT---DELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      .....+|.+.+.||+|+||.||++.+..+   +..||||.+.... .....+.+.+|+.+++.++||||+++++++.+  
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--  462 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE--  462 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence            34456788999999999999999998654   4679999876432 22223567899999999999999999887632  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                               +..|+||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus       463 ---------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~  533 (656)
T 2j0j_A          463 ---------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG  533 (656)
T ss_dssp             ---------SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             ---------CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEE
Confidence                     357999999996 5666666555679999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |||++......... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |.+||
T Consensus       534 DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf  593 (656)
T 2j0j_A          534 DFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPF  593 (656)
T ss_dssp             CCCCCCSCCC-----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCC
Confidence            99999876543221 122344578999999987554 8999999999999999997 99997

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3e-35  Score=264.93  Aligned_cols=197  Identities=24%  Similarity=0.284  Sum_probs=161.1

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHh--CCCCcccchhhhhcccCcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQ--LNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~  220 (358)
                      ....+|.+.+.||+|+||.||++.+  +++.||||++....     ...+.+|.+++..  ++||||+++++++....  
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~--  109 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDN--  109 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC--
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC--
Confidence            3456899999999999999999987  69999999986432     3456788888887  79999999988876532  


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEecCC
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH--------KRNFLHRDIKCSNILMNNR  291 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--------~~~i~H~Dlkp~Nill~~~  291 (358)
                          ......++||||+++ +|.+.+..  ..+++..++.++.||+.||.|||        +.+|+|+||||+||+++.+
T Consensus       110 ----~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          110 ----GTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             ----SSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred             ----CccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence                112378999999997 56665644  36899999999999999999999        8999999999999999999


Q ss_pred             CcEEEeecccceeccccCCCC--CCCCccccccccccccccCCCC-----CCCcchHHHHHHHHHHHhhC
Q psy13988        292 GEVKLADFGLARLYNAEDRQR--PYTNKVITLWYRPPELLLGEER-----YGPAIDVWSCGCILGELFVK  354 (358)
Q Consensus       292 ~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~~lltg  354 (358)
                      +.++|+|||++..........  ......+|+.|+|||++.+...     ++.++||||||+++|+|+||
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999999998765443211  2234567999999999876432     23689999999999999999

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.1e-34  Score=252.72  Aligned_cols=179  Identities=26%  Similarity=0.382  Sum_probs=149.9

Q ss_pred             CCCCCCCccc-ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHH-HhCCCCcccchhhhhcccCc
Q psy13988        142 STNNSSRPLM-EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKIL-RQLNHKNIVNLREIVTDKSD  219 (358)
Q Consensus       142 ~~~~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~  219 (358)
                      +.....|.++ +.||+|+||.||++.+..+++.||||++...       ....+|+.++ +.++||||+++++++..   
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~---   82 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYEN---   82 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEE---
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhh---
Confidence            3455667776 7899999999999999999999999998632       3567889887 66699999999888754   


Q ss_pred             ccccccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcE
Q psy13988        220 ALDFRKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEV  294 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~---~~~~  294 (358)
                         ...++...++||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+|+||||+||+++.   ++.+
T Consensus        83 ---~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           83 ---LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             ---EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCE
T ss_pred             ---hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcE
Confidence               12235679999999987 666666543 346999999999999999999999999999999999999998   7889


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|+|||++.....                         ..++.++||||||+++|+|++|++||
T Consensus       160 kl~Dfg~a~~~~~-------------------------~~~~~~~DiwslG~il~el~tg~~pf  198 (299)
T 3m2w_A          160 KLTDFGFAKETTG-------------------------EKYDKSCDMWSLGVIMYILLCGYPPF  198 (299)
T ss_dssp             EECCCTTCEECTT-------------------------CGGGGHHHHHHHHHHHHHHHHSSCSC
T ss_pred             EEecccccccccc-------------------------ccCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999864321                         22677899999999999999999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.5e-33  Score=267.27  Aligned_cols=186  Identities=20%  Similarity=0.092  Sum_probs=127.9

Q ss_pred             cccCCcceeeEeeeeecCCcEEEEEEeeccccCC--------CCchhHHHHHHHHHhC-CCCcccchhhhhcccCccccc
Q psy13988        153 PLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE--------GFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       153 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|+.|.+..++....|+.|++|++.......        ...+++.+|+++|+++ .|+||++++++++        
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e--------  312 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE--------  312 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE--------
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--------
Confidence            4667888888888888899999999997653221        1124578899999999 7999999966665        


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        +++.+||||||++|+.+..+.....++++.   +|+.||+.||+|+|++||+||||||+|||++.+|++||+|||+++
T Consensus       313 --d~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr  387 (569)
T 4azs_A          313 --NAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIV  387 (569)
T ss_dssp             --CSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred             --ECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCe
Confidence              467999999999996555555555677664   589999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK  355 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~  355 (358)
                      .......  .....+||+.|+|||++.+.  +..++|+||+|++++++.++.
T Consensus       388 ~~~~~~~--~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          388 TTPQDCS--WPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             SCC---C--CSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eCCCCCc--cccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence            7654322  23456789999999999764  567899999999988776653

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.1e-28  Score=231.99  Aligned_cols=186  Identities=17%  Similarity=0.192  Sum_probs=136.0

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC------chhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF------PITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..+.||+|+||.||++  ...+..+++|+..........      .+.+.+|++++++++||||+++..++..       
T Consensus       340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-------  410 (540)
T 3en9_A          340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-------  410 (540)
T ss_dssp             --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-------
T ss_pred             CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-------
Confidence            3568999999999999  457889999987543322111      2346899999999999999955433332       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         ....|+||||++| +|.+.+..         +..++.||+.||+|||++||+||||||+||+++.  ++||+|||++
T Consensus       411 ---~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          411 ---LDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             ---TTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             ---CCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccC
Confidence               3356999999986 55555443         5689999999999999999999999999999998  9999999999


Q ss_pred             eeccccCCCC-----CCCCccccccccccccccCC-CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQR-----PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.........     ......||+.|+|||++... ..|+..+|+||..+-.++.+.++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9875432211     11245679999999998751 22677889999998888887776554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=3.1e-25  Score=193.45  Aligned_cols=162  Identities=15%  Similarity=0.114  Sum_probs=121.6

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC----------------CchhHHHHHHHHHhCCCCccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG----------------FPITAVREIKILRQLNHKNIV  208 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~niv  208 (358)
                      +..|.+.+.||.|++|.||++.+ .+|+.||||.++.......                ....+.+|+.+++.++  | +
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~  164 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L  164 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence            34566779999999999999999 8899999999875432111                1245789999999998  5 6


Q ss_pred             chhhhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe
Q psy13988        209 NLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM  288 (358)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill  288 (358)
                      ++.+++..           +..|+||||++|+.+..+.       ......++.|++.||.+||+.||+||||||+||++
T Consensus       165 ~v~~~~~~-----------~~~~lvmE~~~g~~L~~l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl  226 (282)
T 1zar_A          165 AVPKVYAW-----------EGNAVLMELIDAKELYRVR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             SSCCEEEE-----------ETTEEEEECCCCEEGGGCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred             CcCeEEec-----------cceEEEEEecCCCcHHHcc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE
Confidence            66554422           3569999999874333331       13356799999999999999999999999999999


Q ss_pred             cCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCC---------CCCCCcchHHHH
Q psy13988        289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE---------ERYGPAIDVWSC  344 (358)
Q Consensus       289 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------~~~~~~~Diwsl  344 (358)
                      + ++.++|+|||+++.               +..++|||.+...         ..+...+|+|.+
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            9 99999999999874               3346788877431         125666777764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=4.9e-22  Score=171.16  Aligned_cols=144  Identities=15%  Similarity=0.215  Sum_probs=107.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcE--EEEEEeeccccCCC----------------------CchhHHHHHHHHHh
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDEL--VALKKVRLENEKEG----------------------FPITAVREIKILRQ  201 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~----------------------~~~~~~~e~~~l~~  201 (358)
                      ..|.+.+.||.|+||.||++.+..+|+.  ||||+++.......                      ....+.+|+..+..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999999889999  99998754321100                      01256789999999


Q ss_pred             CCCCcccchhhhhcccCcccccccCCCeEEEEeecccc-----ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHH-hCC
Q psy13988        202 LNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-----DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH-KRN  275 (358)
Q Consensus       202 l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-----~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~~  275 (358)
                      +.|+++.-..-+.            .+..++||||+++     ..+..+..   ..++..+..++.||+.||.+|| +.|
T Consensus       127 l~~~~i~~p~~~~------------~~~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~g  191 (258)
T 1zth_A          127 AKEAGVSVPQPYT------------YMKNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQEAE  191 (258)
T ss_dssp             HHHTTCCCCCEEE------------EETTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred             HHhCCCCCCeEEE------------cCCCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCC
Confidence            9887642211111            0246899999953     13333321   1345678899999999999999 999


Q ss_pred             ceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        276 FLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       276 i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      |+||||||+|||++.  .++|+|||++....
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            999999999999998  99999999998653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=5.6e-20  Score=164.53  Aligned_cols=151  Identities=15%  Similarity=0.044  Sum_probs=106.7

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC------------CchhHHHHHHHHHhCCCCcccchhhh
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG------------FPITAVREIKILRQLNHKNIVNLREI  213 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~~~~~  213 (358)
                      .-|.+...||.|++|.||+|.+ .+|+.||||+++.......            .......+..++....|+|+.+++..
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            3489999999999999999998 4799999999765422111            01122334444444467777777655


Q ss_pred             hcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-  292 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-  292 (358)
                      .......++.    ...++||||++|..+..+..      ......++.||+.+|.+||++|||||||||.|||+++++ 
T Consensus       174 gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          174 GFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             TCSCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence            4433222221    12379999999865543321      224567899999999999999999999999999998876 


Q ss_pred             ---------cEEEeecccceeccc
Q psy13988        293 ---------EVKLADFGLARLYNA  307 (358)
Q Consensus       293 ---------~~~l~Dfg~~~~~~~  307 (358)
                               .+.|+||+-+....+
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEETTS
T ss_pred             cccccccccceEEEEeCCcccCCC
Confidence                     389999998766543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=1e-12  Score=113.17  Aligned_cols=140  Identities=16%  Similarity=0.099  Sum_probs=105.0

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|.+...++.|+.+.||++..  .+..+++|+.......  ....+.+|+.+++.+. +..+.++++++.          
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~----------   80 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFER----------   80 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEE----------
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEe----------
Confidence            477888888899999999875  4789999988653211  1235788999999984 555666654443          


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh--------------------------------
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK--------------------------------  273 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--------------------------------  273 (358)
                      +.+..|+|||+++|..+.....     +......++.+++.+|..||+                                
T Consensus        81 ~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           81 HDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             cCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            3568899999999965554311     223345788999999999998                                


Q ss_pred             ---------------------------CCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        274 ---------------------------RNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       274 ---------------------------~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                                                 ..++|+|++|.||+++.++.+.|+||+.+..-
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                                       45899999999999987656679999987643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.32  E-value=1.2e-12  Score=119.02  Aligned_cols=104  Identities=27%  Similarity=0.299  Sum_probs=76.7

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCC-CCcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTI-KPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |+..|.  |+++.+|+.+|++.+|+|+.+.|............ ..+.....+|...++.++++++|||.+||++||.+|
T Consensus       259 G~~pF~--g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R  336 (398)
T 4b99_A          259 RRQLFP--GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSAR  336 (398)
T ss_dssp             TSCSSC--CSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTS
T ss_pred             CCCCCC--CCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHC
Confidence            455554  56789999999999999999988775443322111 223344567888899999999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCCCCCCCCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPESMPPPQLPT  109 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~  109 (358)
                      +|++|+|+||||...+.+...+...+.
T Consensus       337 ~ta~e~L~Hp~f~~~~~p~~~p~~~~~  363 (398)
T 4b99_A          337 ISAAAALRHPFLAKYHDPDDEPDCAPP  363 (398)
T ss_dssp             CCHHHHTTSGGGTTTCCGGGSCCCSSC
T ss_pred             cCHHHHhcCHhhCcCCCCccccCCCCC
Confidence            999999999999987765544443333

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.26  E-value=1.4e-11  Score=105.69  Aligned_cols=135  Identities=14%  Similarity=0.060  Sum_probs=93.9

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcc--cchhhhhcccCcccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNI--VNLREIVTDKSDALDFR  224 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~  224 (358)
                      .+.+....+.|..+.||++.. .+|..+++|.....     ....+.+|+.+++.+.+.++  .+++.+..         
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~---------   85 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT---------   85 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE---------
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEecc---------
Confidence            344433334666789998864 56788999986543     12356789999998854443  34544332         


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN-----------------------------  275 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-----------------------------  275 (358)
                       +++..++|||+++|..+. . .   ..   ....++.+++.+|..||+..                             
T Consensus        86 -~~~~~~~v~e~i~G~~l~-~-~---~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (264)
T 1nd4_A           86 -EAGRDWLLLGEVPGQDLL-S-S---HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  156 (264)
T ss_dssp             -CSSCEEEEEECCSSEETT-T-S---CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             -CCCCCEEEEEecCCcccC-c-C---cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence             345789999999985543 1 1   11   12357788888888888753                             


Q ss_pred             -----------------------------ceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        276 -----------------------------FLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       276 -----------------------------i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                                                   ++|+|++|.||+++.++.+.|+||+.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                         999999999999987766779999997654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.20  E-value=6.1e-11  Score=106.79  Aligned_cols=143  Identities=13%  Similarity=0.221  Sum_probs=101.2

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEee--ccccCCCCchhHHHHHHHHHhCCC--CcccchhhhhcccCccccccc
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVR--LENEKEGFPITAVREIKILRQLNH--KNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .++.|+.|.++.||++..  .+..+++|+..  .... ......+.+|+.+++.+..  ..+.+++.++.+..       
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~-------  111 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES-------  111 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT-------
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC-------
Confidence            467899999999999876  35688899765  3221 1123467789999999964  34566655544321       


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh--------------------------------
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK--------------------------------  273 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--------------------------------  273 (358)
                      ..+..|+|||+++|..+..  .....++..+...++.+++.+|..||+                                
T Consensus       112 ~~g~~~~vme~v~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          112 VIGRAFYIMEFVSGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             TTSSCEEEEECCCCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEecCCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            1256899999999844321  112246788888999999999999997                                


Q ss_pred             --------------------------CCceecCCCCCCEEecCCCc--EEEeeccccee
Q psy13988        274 --------------------------RNFLHRDIKCSNILMNNRGE--VKLADFGLARL  304 (358)
Q Consensus       274 --------------------------~~i~H~Dlkp~Nill~~~~~--~~l~Dfg~~~~  304 (358)
                                                .+++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                      36899999999999997753  68999998875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.11  E-value=2e-11  Score=109.66  Aligned_cols=93  Identities=29%  Similarity=0.365  Sum_probs=58.6

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccC--------CCCCC---------C--CCCccc-----cccccccc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIK--------LPLWH---------T--IKPKKI-----HRRRLREE   59 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~--------~~~~~---------~--~~~~~~-----~~~~~~~~   59 (358)
                      |+.-|.+ |+++.+||.+|++++|+|....+.....        .+...         .  ...+..     ........
T Consensus       243 G~~Pf~~-~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  321 (361)
T 4f9c_A          243 GRYPFYK-ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG  321 (361)
T ss_dssp             TCSSSSC-CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred             CCCCCCC-CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence            3333433 7788999999999999875443332111        01000         0  000000     00011123


Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +..++++++|||.+||++||.+|+||+|+|+||||+++
T Consensus       322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            45689999999999999999999999999999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=2.4e-11  Score=106.81  Aligned_cols=187  Identities=14%  Similarity=0.098  Sum_probs=115.5

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcc--cchhhhhcccCcccccccCC
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNI--VNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~~  227 (358)
                      ++.++.|..+.||++.     ..+++|+....    .....+.+|.++++.+. +..+  .+++......       ...
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~-------~~~   88 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS-------ETY   88 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC-------SSC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC-------CCC
Confidence            3568999999999875     56889975432    12346788999998883 3332  2222221110       011


Q ss_pred             CeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh----------------------------------
Q psy13988        228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK----------------------------------  273 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~----------------------------------  273 (358)
                      ...|+||++++|..+.....  ..++..+...++.+++..+..||+                                  
T Consensus        89 ~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (304)
T 3sg8_A           89 QMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK  166 (304)
T ss_dssp             SCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred             CcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence            34589999999954432111  246777778888888888888885                                  


Q ss_pred             ------------------------CCceecCCCCCCEEecC--CCcEEEeecccceeccccCCCCCCCCc---cc-----
Q psy13988        274 ------------------------RNFLHRDIKCSNILMNN--RGEVKLADFGLARLYNAEDRQRPYTNK---VI-----  319 (358)
Q Consensus       274 ------------------------~~i~H~Dlkp~Nill~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~---~~-----  319 (358)
                                              ..++|+|++|.||+++.  ...+.|+||+.+..-............   .+     
T Consensus       167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred             cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence                                    23799999999999998  456789999998754322110000000   00     


Q ss_pred             ----cccccc-cccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        320 ----TLWYRP-PELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       320 ----~~~y~a-PE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                          ...... |+....   .....+.|+++.++|.+.+|.++|
T Consensus       247 ~~l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence                000111 221110   112368999999999999998764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.08  E-value=4.7e-11  Score=110.29  Aligned_cols=88  Identities=27%  Similarity=0.433  Sum_probs=68.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccccccCCCCCCCC-CCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcc
Q psy13988         15 ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTI-KPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVW   93 (358)
Q Consensus        15 ~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~   93 (358)
                      +.+||..|++++|+|+.+.|..+......... ..+.....++...++.++++++|||.+||++||.+|+|++|+|+|||
T Consensus       285 ~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  364 (432)
T 3n9x_A          285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPY  364 (432)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred             hHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChh
Confidence            58999999999999999888765432111111 12233345577788899999999999999999999999999999999


Q ss_pred             cccCCCCCC
Q psy13988         94 LKNVHPESM  102 (358)
Q Consensus        94 ~~~~~~~~~  102 (358)
                      |..++.+..
T Consensus       365 f~~~~~~~~  373 (432)
T 3n9x_A          365 LKDVRKKKL  373 (432)
T ss_dssp             GTTTCCTTT
T ss_pred             hhhccCccc
Confidence            998765543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.04  E-value=1.5e-10  Score=102.08  Aligned_cols=93  Identities=30%  Similarity=0.513  Sum_probs=75.2

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      |+..|.|  .++.+++..|..++|+|.+..|+....++.+...........++....+..++++.|||.+||++||.+||
T Consensus       216 g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  293 (311)
T 3niz_A          216 GKPLFPG--VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI  293 (311)
T ss_dssp             SSCSCCC--SSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC
T ss_pred             CCCCCCC--CChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC
Confidence            4444444  44578899999999999999999887776554444444445567777788999999999999999999999


Q ss_pred             CHhhhhcCcccccCC
Q psy13988         84 TAEQALKSVWLKNVH   98 (358)
Q Consensus        84 ~~~~~l~~~~~~~~~   98 (358)
                      |+.++|+||||+++.
T Consensus       294 t~~ell~hp~f~~~~  308 (311)
T 3niz_A          294 SARDAMNHPYFKDLD  308 (311)
T ss_dssp             CHHHHHTSGGGTTSC
T ss_pred             CHHHHhcCcccccCC
Confidence            999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.02  E-value=1e-10  Score=108.83  Aligned_cols=86  Identities=29%  Similarity=0.337  Sum_probs=67.5

Q ss_pred             hhHHHHHHHhhcCCCCCCccccccCCCCCC-CCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcc
Q psy13988         15 ELLQLEVISKLCGTPTPAVWPAVIKLPLWH-TIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVW   93 (358)
Q Consensus        15 ~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~   93 (358)
                      +.+|+..|++++|+|+.+.|..+....... ....+......+...++.++++++|||.+||++||.+|+|++|+|+|||
T Consensus       320 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~  399 (458)
T 3rp9_A          320 NRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF  399 (458)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             CHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence            489999999999999998887654321110 0112333345677888899999999999999999999999999999999


Q ss_pred             cccCCCC
Q psy13988         94 LKNVHPE  100 (358)
Q Consensus        94 ~~~~~~~  100 (358)
                      |..++.+
T Consensus       400 f~~~~~~  406 (458)
T 3rp9_A          400 FKEVRIA  406 (458)
T ss_dssp             GTTTCCG
T ss_pred             hhhcCCC
Confidence            9987653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=98.97  E-value=1.2e-10  Score=105.15  Aligned_cols=96  Identities=28%  Similarity=0.362  Sum_probs=71.8

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCC-CCCcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHT-IKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |+..|.  |.+..+|+.+|++++|+|+.+.|..+........ ...+...+.++...++.+++++.|||.+||++||.+|
T Consensus       226 g~~pf~--~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R  303 (367)
T 2fst_X          226 GRTLFP--GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR  303 (367)
T ss_dssp             SSCSCC--CSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGS
T ss_pred             CCCCCC--CCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccC
Confidence            444554  4566999999999999999888876543211000 0112223445777888899999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPES  101 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~~  101 (358)
                      +|+.++|.||||...+.+.
T Consensus       304 ~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          304 ITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             CCHHHHHTSGGGTTTCCGG
T ss_pred             cCHHHHhcChhhhhccCCC
Confidence            9999999999999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=98.96  E-value=1.6e-09  Score=94.41  Aligned_cols=86  Identities=30%  Similarity=0.427  Sum_probs=69.3

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.+..+++..|++.+|+|+.+.|+.....+.+...... .....+....+..++++.|||.+||++||.+|+|++|+|+|
T Consensus       205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY-PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC-CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccc-cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            56668999999999999999999988877766433221 12233555667789999999999999999999999999999


Q ss_pred             cccccCC
Q psy13988         92 VWLKNVH   98 (358)
Q Consensus        92 ~~~~~~~   98 (358)
                      |||+++.
T Consensus       284 p~f~~~~  290 (292)
T 3o0g_A          284 PYFSDFC  290 (292)
T ss_dssp             GGGTTC-
T ss_pred             cccccCC
Confidence            9999754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=98.96  E-value=6.9e-10  Score=101.18  Aligned_cols=94  Identities=27%  Similarity=0.374  Sum_probs=73.6

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccccccccccccc-CCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS-LMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |+..|.  |.+..+|+..|++++|+|+.+.|..+.  +.+.....+.....++...++ ..++++.|||.+||++||.+|
T Consensus       238 g~~pf~--~~~~~~~l~~i~~~~g~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (394)
T 4e7w_A          238 GQPLFP--GESGIDQLVEIIKVLGTPSREQIKTMN--PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR  313 (394)
T ss_dssp             SSCSSC--CSSHHHHHHHHHHHHCCCCHHHHHHHC--GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             CCCCCC--CCCHHHHHHHHHHHhCCCCHHHHHhhC--hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhC
Confidence            444444  456689999999999999998887654  344444445555566777675 489999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPES  101 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~~  101 (358)
                      +|+.+++.||||..++...
T Consensus       314 ~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          314 LTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             CCHHHHHTSGGGSTTTSSC
T ss_pred             CCHHHHhcChhhhhhcccc
Confidence            9999999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=98.95  E-value=6.6e-10  Score=98.52  Aligned_cols=90  Identities=26%  Similarity=0.396  Sum_probs=70.6

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.+..+++..|.+++|+|.++.|+.......+.....+......+....+.+++++.|||.+||++||.+|+|++|+|+|
T Consensus       203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          203 GSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            45568999999999999999999987655444333333333334445567789999999999999999999999999999


Q ss_pred             cccccCCCCC
Q psy13988         92 VWLKNVHPES  101 (358)
Q Consensus        92 ~~~~~~~~~~  101 (358)
                      |||..+....
T Consensus       283 p~f~~~~~~~  292 (324)
T 3mtl_A          283 PFFLSLGERI  292 (324)
T ss_dssp             GGGGGGCSTT
T ss_pred             hhhhhccccc
Confidence            9999876543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=98.95  E-value=2.7e-10  Score=102.88  Aligned_cols=97  Identities=26%  Similarity=0.325  Sum_probs=70.6

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCC-CCcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTI-KPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |+..|.  |.+..+|+.+|++++|+|+.+.+..+......... ..+...+..+...++.+++++.|||.+||++||.+|
T Consensus       222 g~~pf~--~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R  299 (367)
T 1cm8_A          222 GKTLFK--GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR  299 (367)
T ss_dssp             SSCSSC--CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred             CCCCCC--CCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHC
Confidence            444454  45669999999999999998887765432111000 112233456777888899999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPESM  102 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~~~  102 (358)
                      +|+.++|.||||..++.+..
T Consensus       300 ~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          300 VTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             CCHHHHHHSGGGTTTC----
T ss_pred             CCHHHHhcChHHHhhcCCcc
Confidence            99999999999998765443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=98.94  E-value=9.1e-10  Score=101.24  Aligned_cols=94  Identities=26%  Similarity=0.351  Sum_probs=74.8

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccccccccccccc-CCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS-LMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |+..|.|  .+..+|+.+|++++|+|+.+.|..+.  +.+....++.....+|...++ ..++++.|||.+||++||.+|
T Consensus       253 G~~pf~~--~~~~~~l~~i~~~lg~p~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R  328 (420)
T 1j1b_A          253 GQPIFPG--DSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR  328 (420)
T ss_dssp             SSCSSCC--SSHHHHHHHHHHHHCSCCHHHHHHHC--SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred             CCCCCCC--CCHHHHHHHHHHHhCCCCHHHHHhhC--hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHC
Confidence            4444544  55689999999999999999987764  444444555555666777774 578999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPES  101 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~~  101 (358)
                      +|+.++|.||||..++.+.
T Consensus       329 ~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          329 LTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             CCHHHHHTSGGGGGGGCTT
T ss_pred             CCHHHHhCCHhhccccccc
Confidence            9999999999998876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=98.87  E-value=2.4e-10  Score=106.40  Aligned_cols=94  Identities=21%  Similarity=0.174  Sum_probs=63.2

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccC------------CChhHHHHH
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSL------------MPPGALDLL   71 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~ll   71 (358)
                      |+..|.  |.+..+|+.+|++.+|+|+++.|..+...........+......+...++.            .++++.|||
T Consensus       259 g~~pF~--g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  336 (464)
T 3ttj_A          259 HKILFP--GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL  336 (464)
T ss_dssp             SSCSSC--CSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred             CCCCCC--CCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHH
Confidence            445554  566799999999999999988876643110000001111112223333322            156799999


Q ss_pred             hhhcCCCCCCcCCHhhhhcCcccccCCC
Q psy13988         72 DKMLELDPERRITAEQALKSVWLKNVHP   99 (358)
Q Consensus        72 ~~~l~~~p~~R~~~~~~l~~~~~~~~~~   99 (358)
                      .+||++||.+|+|++|+|+||||..+..
T Consensus       337 ~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          337 SKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HHHcCCChhhCCCHHHHhcChhhhhccC
Confidence            9999999999999999999999987553

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=98.84  E-value=9.3e-09  Score=91.94  Aligned_cols=85  Identities=35%  Similarity=0.474  Sum_probs=70.7

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      |.++.+++.+|++.+|+|+.+.|+..+..+.+...  ......++...++.+++++.+||.+||+.||.+|||+.|+|+|
T Consensus       215 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          215 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF--KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC--CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHHcCCCChhhhhhhccCcccccc--cccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            45678999999999999999999998887766432  2222345666778889999999999999999999999999999


Q ss_pred             cccccCC
Q psy13988         92 VWLKNVH   98 (358)
Q Consensus        92 ~~~~~~~   98 (358)
                      |||....
T Consensus       293 ~~f~~~~  299 (346)
T 1ua2_A          293 KYFSNRP  299 (346)
T ss_dssp             GGGTSSS
T ss_pred             hhhhcCC
Confidence            9998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=98.83  E-value=9.9e-10  Score=99.91  Aligned_cols=96  Identities=27%  Similarity=0.319  Sum_probs=64.8

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCC-C---ccccccccccccc-------------CCChh
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIK-P---KKIHRRRLREEFS-------------LMPPG   66 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~-------------~~~~~   66 (358)
                      |+..|.  |.+..+|+.+|+.++|+|+.+.+..+.......... .   .......+...|+             .++++
T Consensus       227 g~~pf~--~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (388)
T 3oz6_A          227 GKPIFP--GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE  304 (388)
T ss_dssp             SSCSCC--CSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHH
T ss_pred             CCCCCC--CCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHH
Confidence            444554  466799999999999999988876644221100000 0   0000112222222             67899


Q ss_pred             HHHHHhhhcCCCCCCcCCHhhhhcCcccccCCCCC
Q psy13988         67 ALDLLDKMLELDPERRITAEQALKSVWLKNVHPES  101 (358)
Q Consensus        67 ~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~~~  101 (358)
                      +.|||.+||++||.+|+|++|+|+||||..++.+.
T Consensus       305 ~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~  339 (388)
T 3oz6_A          305 ALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN  339 (388)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGG
T ss_pred             HHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCc
Confidence            99999999999999999999999999998766543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=98.78  E-value=3.7e-09  Score=95.91  Aligned_cols=91  Identities=23%  Similarity=0.372  Sum_probs=71.5

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccC-CChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSL-MPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |+..|.  |.+..+|+.+|++++|+|+.+.|..+.  +.|....++......|...++. .++++.|||.+||++||.+|
T Consensus       238 g~~pf~--~~~~~~~~~~i~~~~g~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          238 GKPLFS--GETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             SSCSSC--CSSHHHHHHHHHHHHCCCCHHHHHHHC--TTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             CCCCCC--CCChHHHHHHHHHHhCCCCHHHHHHhC--cccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            444444  456699999999999999999887754  4455555555556667777764 78999999999999999999


Q ss_pred             CCHhhhhcCcccccCC
Q psy13988         83 ITAEQALKSVWLKNVH   98 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~   98 (358)
                      +|+.|+|+||||..++
T Consensus       314 ~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          314 INPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CCHHHHHTSGGGHHHH
T ss_pred             CCHHHHhcCHHHHHHH
Confidence            9999999999998653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=98.77  E-value=1.2e-08  Score=88.66  Aligned_cols=90  Identities=34%  Similarity=0.472  Sum_probs=70.0

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      |+..|.+  .++.+++.+|.+.+|+|....|+.....+.+... .......++......+++++.+||.+||+.||.+||
T Consensus       197 g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  273 (288)
T 1ob3_A          197 GTPLFPG--VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN-FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI  273 (288)
T ss_dssp             SSCSCCC--SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT-CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC
T ss_pred             CCCCCCC--CCHHHHHHHHHHHHCCCChhhchhhhcccccccc-cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC
Confidence            3444443  4568899999999999999999887766654321 222233456666678899999999999999999999


Q ss_pred             CHhhhhcCccccc
Q psy13988         84 TAEQALKSVWLKN   96 (358)
Q Consensus        84 ~~~~~l~~~~~~~   96 (358)
                      |+.++|+||||++
T Consensus       274 t~~e~l~hp~f~~  286 (288)
T 1ob3_A          274 TAKQALEHAYFKE  286 (288)
T ss_dssp             CHHHHHTSGGGGC
T ss_pred             CHHHHhcCcchhh
Confidence            9999999999985

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=98.76  E-value=2.1e-08  Score=87.50  Aligned_cols=87  Identities=30%  Similarity=0.489  Sum_probs=70.3

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.++.+++.+|++.+|+|....|+....++.+.. ..+......+....+..++++.+||.+||..||.+|||+.+++.|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~~l~h  284 (299)
T 2r3i_A          206 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  284 (299)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CccHHHHHHHHHHHhCCCchhhhhHhhcCcccch-hhhcccchhhHhhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            4556899999999999999999998877766543 222333344566667789999999999999999999999999999


Q ss_pred             cccccCCC
Q psy13988         92 VWLKNVHP   99 (358)
Q Consensus        92 ~~~~~~~~   99 (358)
                      |||..+..
T Consensus       285 p~~~~~~~  292 (299)
T 2r3i_A          285 PFFQDVTK  292 (299)
T ss_dssp             GGGTTCCC
T ss_pred             hhhhcCCC
Confidence            99997653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=98.75  E-value=1.4e-08  Score=89.20  Aligned_cols=90  Identities=28%  Similarity=0.311  Sum_probs=68.3

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          3 SGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         3 ~~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      .|+..|.  +.++.+++.+|++.+|.|..+.|+.....+...   ++.....++....+.+++++.+||.+||++||.+|
T Consensus       214 ~g~~pf~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  288 (308)
T 3g33_A          214 RRKPLFC--GNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA---FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKR  288 (308)
T ss_dssp             TSSCSCC--CSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGG---SCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTS
T ss_pred             hCCCCCC--CCCHHHHHHHHHHHhCCCChhhccchhhccccc---cCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccC
Confidence            3444444  455689999999999999999998766554321   22223445666778899999999999999999999


Q ss_pred             CCHhhhhcCcccccC
Q psy13988         83 ITAEQALKSVWLKNV   97 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~   97 (358)
                      +|+.++|+||||...
T Consensus       289 ~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          289 ISAFRALQHSYLHKD  303 (308)
T ss_dssp             CCHHHHHTSTTC---
T ss_pred             CCHHHHhcCccccCC
Confidence            999999999999863

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=98.73  E-value=4.3e-09  Score=94.85  Aligned_cols=89  Identities=29%  Similarity=0.370  Sum_probs=67.8

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCC-CCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHT-IKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      |.+..+++..|..++|+|+.+.|........... ...+.....++...++..++++.+||.+||++||.+|+|+.++|+
T Consensus       234 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            4556899999999999999888776443221110 112233345577778889999999999999999999999999999


Q ss_pred             CcccccCCCC
Q psy13988         91 SVWLKNVHPE  100 (358)
Q Consensus        91 ~~~~~~~~~~  100 (358)
                      ||||.....+
T Consensus       314 hp~~~~~~~~  323 (364)
T 3qyz_A          314 HPYLEQYYDP  323 (364)
T ss_dssp             SGGGTTTCCG
T ss_pred             CcchhhccCc
Confidence            9999976543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=98.72  E-value=2.1e-08  Score=88.47  Aligned_cols=87  Identities=30%  Similarity=0.557  Sum_probs=66.2

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccc-----cCCChhHHHHHhhhcCCCCCCcCCHh
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEF-----SLMPPGALDLLDKMLELDPERRITAE   86 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ll~~~l~~~p~~R~~~~   86 (358)
                      +.++.+++..|++.+|+|....|+.+..++.+..... ......+...+     ...+.++.|||.+||+.||.+|+|+.
T Consensus       211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  289 (317)
T 2pmi_A          211 GTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQ-QRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK  289 (317)
T ss_dssp             CSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCC-CCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccc-cccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHH
Confidence            4556889999999999999999998877766543221 11122222222     24788999999999999999999999


Q ss_pred             hhhcCcccccCCC
Q psy13988         87 QALKSVWLKNVHP   99 (358)
Q Consensus        87 ~~l~~~~~~~~~~   99 (358)
                      |+|+||||.....
T Consensus       290 e~l~hp~f~~~~~  302 (317)
T 2pmi_A          290 QALHHPWFAEYYH  302 (317)
T ss_dssp             HHTTSGGGGGGCC
T ss_pred             HHhCChhhhcccc
Confidence            9999999998643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=98.71  E-value=2.4e-08  Score=88.55  Aligned_cols=86  Identities=34%  Similarity=0.580  Sum_probs=67.9

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccccccccccccc-CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS-LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      +.++.+++.+|++.+|.|....|+.....+.+... .+......+...++ ..++++.|||.+||++||.+|+|+.|+|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          240 GDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT-CCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhh-hhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            45668999999999999999999988777766432 22222333444443 37899999999999999999999999999


Q ss_pred             CcccccCC
Q psy13988         91 SVWLKNVH   98 (358)
Q Consensus        91 ~~~~~~~~   98 (358)
                      ||||+...
T Consensus       319 hp~f~~~~  326 (329)
T 3gbz_A          319 HPYFSHND  326 (329)
T ss_dssp             SGGGSSSC
T ss_pred             CcccCCCC
Confidence            99998753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=98.70  E-value=1.6e-08  Score=92.45  Aligned_cols=84  Identities=26%  Similarity=0.375  Sum_probs=61.0

Q ss_pred             hHHHHHHHhhcCCCCCCccccccCCCCCCCCCC----ccccccc----ccccccCCChhHHHHHhhhcCCCCCCcCCHhh
Q psy13988         16 LLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKP----KKIHRRR----LREEFSLMPPGALDLLDKMLELDPERRITAEQ   87 (358)
Q Consensus        16 ~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~   87 (358)
                      .+|+.+|+.++|+|+.+.|..+..++.+.....    .......    +.......+++++|||.+||++||.+|+|++|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            699999999999999999998876664321110    0000001    11111234789999999999999999999999


Q ss_pred             hhcCcccccCCC
Q psy13988         88 ALKSVWLKNVHP   99 (358)
Q Consensus        88 ~l~~~~~~~~~~   99 (358)
                      +|+||||.....
T Consensus       331 ~L~hp~f~~~~~  342 (405)
T 3rgf_A          331 AMQDPYFLEDPL  342 (405)
T ss_dssp             HHTSGGGTSSSC
T ss_pred             HhcChhhccCCC
Confidence            999999987543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=1.1e-07  Score=81.90  Aligned_cols=135  Identities=13%  Similarity=0.044  Sum_probs=91.2

Q ss_pred             ccccCCcce-eeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCC-CcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLS-LNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH-KNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.+..|..+ .||+......+..+++|+-....     ...+.+|...|+.+.. --+.+++          .++.+.+.
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-----~~~~~~E~~~l~~l~~~vPVP~v~----------~~~~~~~~   94 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSV-----ANDVTDEMVRLNWLTAFMPLPTIK----------HFIRTPDD   94 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETHH-----HHHHHHHHHHHHHHTTTSCCCCEE----------EEEEETTE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCCC-----HhHHHHHHHHHHHhccCCCcCeEE----------EEEEECCe
Confidence            345555544 68988877778899999865331     3356789999988842 1233343          33344668


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh------------------------------------
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK------------------------------------  273 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~------------------------------------  273 (358)
                      .|+|||+++|..+......    .......+..+++..|..||+                                    
T Consensus        95 ~~lvme~l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A           95 AWLLTTAIPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             EEEEEECCCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             EEEEEEeeCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            8999999999544433221    122334566667777777763                                    


Q ss_pred             ----------------------CCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        274 ----------------------RNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       274 ----------------------~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                                            ..++|+|+.+.||+++.++.+-|+||+.+..-
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                                  02789999999999998777789999988754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=98.61  E-value=2.2e-08  Score=89.92  Aligned_cols=88  Identities=22%  Similarity=0.243  Sum_probs=64.5

Q ss_pred             CchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccC----CChhHHHHHhhhcCCCCCCcCCHhhh
Q psy13988         13 NIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSL----MPPGALDLLDKMLELDPERRITAEQA   88 (358)
Q Consensus        13 ~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ll~~~l~~~p~~R~~~~~~   88 (358)
                      .+..+++..|.+.+|.|+.+.|..+....  ...........+|...++.    .++++.+||.+||++||.+|||+.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  312 (360)
T 3e3p_A          235 DNSAGQLHEIVRVLGCPSREVLRKLNPSH--TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA  312 (360)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CChHHHHHHHHHHcCCCCHHHHHhcccch--hhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence            45588999999999999988887654221  1111222223345555543    56789999999999999999999999


Q ss_pred             hcCcccccCCCCCC
Q psy13988         89 LKSVWLKNVHPESM  102 (358)
Q Consensus        89 l~~~~~~~~~~~~~  102 (358)
                      |+||||.....+..
T Consensus       313 l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          313 LCHPYFDELHDPAT  326 (360)
T ss_dssp             TTSGGGGGGGCTTC
T ss_pred             hcCccccccCCccc
Confidence            99999998765443

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.60  E-value=1.6e-07  Score=82.35  Aligned_cols=136  Identities=15%  Similarity=0.149  Sum_probs=89.4

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc---ccchhhhhcccCcccccccCC
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN---IVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~~  227 (358)
                      ++.++.|....||++     +..+++|+-...    .....+.+|..+++.+.+..   +.+.+.+..         ...
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~---------~~~   85 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGK---------RSD   85 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE---------CTT
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc---------cCC
Confidence            456788888899887     577888874321    12346788999999996531   233322221         124


Q ss_pred             CeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhC---------------------------------
Q psy13988        228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKR---------------------------------  274 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---------------------------------  274 (358)
                      +..|+|||+++|..+....-  ..++..+...++.++...|..||+.                                 
T Consensus        86 g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~  163 (306)
T 3tdw_A           86 GNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL  163 (306)
T ss_dssp             SCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred             CceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence            56789999999954443211  1244555556666666666666642                                 


Q ss_pred             ---------------------------CceecCCCCCCEEecC---CCc-EEEeecccceecc
Q psy13988        275 ---------------------------NFLHRDIKCSNILMNN---RGE-VKLADFGLARLYN  306 (358)
Q Consensus       275 ---------------------------~i~H~Dlkp~Nill~~---~~~-~~l~Dfg~~~~~~  306 (358)
                                                 .++|+|+++.||+++.   ++. +.|+||+.+..-.
T Consensus       164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                                       3599999999999987   455 4899999887543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=98.59  E-value=4.2e-08  Score=87.78  Aligned_cols=92  Identities=36%  Similarity=0.599  Sum_probs=67.3

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccccccccccccc--CCChhHHHHHhhhcCCCCCC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS--LMPPGALDLLDKMLELDPER   81 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~l~~~p~~   81 (358)
                      |+..+.  |.++.+++..|..++|.++++.|+.......+............+...+.  ..++++.+||.+||++||.+
T Consensus       225 g~~pf~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  302 (351)
T 3mi9_A          225 RSPIMQ--GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ  302 (351)
T ss_dssp             SSCSCC--CSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGG
T ss_pred             CCCCCC--CCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhh
Confidence            344444  35568999999999999999999887665544443332222222333222  25788999999999999999


Q ss_pred             cCCHhhhhcCcccccC
Q psy13988         82 RITAEQALKSVWLKNV   97 (358)
Q Consensus        82 R~~~~~~l~~~~~~~~   97 (358)
                      |+|++|+|+||||...
T Consensus       303 R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          303 RIDSDDALNHDFFWSD  318 (351)
T ss_dssp             SCCHHHHHTSGGGGSS
T ss_pred             CCCHHHHhCCCCcCCC
Confidence            9999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=98.53  E-value=2e-08  Score=90.63  Aligned_cols=95  Identities=28%  Similarity=0.312  Sum_probs=66.4

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCC-CCCcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHT-IKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |+..|.  +.+..+++..|.+.+|.|..+.+..+........ ...+......+...++..++++.+||.+||++||.+|
T Consensus       238 g~~pf~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  315 (371)
T 4exu_A          238 GKTLFK--GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR  315 (371)
T ss_dssp             SSCSCC--CSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTS
T ss_pred             CCCCCC--CCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhc
Confidence            344443  3556899999999999998776665432110000 0011222334556677889999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPE  100 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~  100 (358)
                      +|+.++|+||||..+..+
T Consensus       316 pt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          316 LTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             CCHHHHHTSGGGTTTCCG
T ss_pred             CCHHHHhcCcccccCCCc
Confidence            999999999999876543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=98.51  E-value=3.3e-08  Score=88.54  Aligned_cols=95  Identities=29%  Similarity=0.334  Sum_probs=65.9

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCC-CCCcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHT-IKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |...+.|  .+..+++..|.+.+|.|..+.+..+........ ...+......+...++.+++++.+||.+||..||.+|
T Consensus       220 g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  297 (353)
T 3coi_A          220 GKTLFKG--KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR  297 (353)
T ss_dssp             SSCSSBS--SCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTS
T ss_pred             CCCCCCC--CCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccC
Confidence            3444443  445889999999999998776665432110000 0111222334556667789999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPE  100 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~  100 (358)
                      +|+.++|.||||.....+
T Consensus       298 pt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          298 LTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             CCHHHHHTSGGGTTTCCG
T ss_pred             CCHHHHhcCcchhhccCc
Confidence            999999999999876543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=98.49  E-value=9.1e-09  Score=92.94  Aligned_cols=85  Identities=25%  Similarity=0.328  Sum_probs=58.5

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccC--------CCCCCCCCCcccccccccccccC------------C
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIK--------LPLWHTIKPKKIHRRRLREEFSL------------M   63 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~------------~   63 (358)
                      |...|.  |.+..+++.+|++.+|+|.++.|..+..        .+.+..        ..+...++.            .
T Consensus       222 g~~pf~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~  291 (371)
T 2xrw_A          222 GGVLFP--GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAG--------YSFEKLFPDVLFPADSEHNKLK  291 (371)
T ss_dssp             SSCSSC--CSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCC--------CCHHHHSCGGGSCCSSHHHHHH
T ss_pred             CCCCCC--CCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccc--------cchhhhcccccCcccccccccc
Confidence            344443  4566899999999999999887765421        121111        112222211            2


Q ss_pred             ChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         64 PPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        64 ~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ++++.|||.+||++||.+|+|++++|+||||....
T Consensus       292 ~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          292 ASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             cHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence            56789999999999999999999999999998643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=98.47  E-value=2.8e-07  Score=81.32  Aligned_cols=85  Identities=24%  Similarity=0.344  Sum_probs=65.2

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.++.+++.+|.+.+|.|..+.|+.....+....   ......++....+.+++++.+||.+||..||.+|+|+.+++.|
T Consensus       221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          221 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF---HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS---CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHHcCCCCcccCccccccchhhh---cccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            3456889999999999999999986544332211   1112233555667789999999999999999999999999999


Q ss_pred             cccccCCC
Q psy13988         92 VWLKNVHP   99 (358)
Q Consensus        92 ~~~~~~~~   99 (358)
                      |||..+..
T Consensus       298 p~~~~~~~  305 (326)
T 1blx_A          298 PYFQDLER  305 (326)
T ss_dssp             GGGTTCCC
T ss_pred             ccccccch
Confidence            99987653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=98.45  E-value=2.3e-07  Score=82.94  Aligned_cols=90  Identities=29%  Similarity=0.353  Sum_probs=61.2

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCC--CCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhh
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHT--IKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQAL   89 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l   89 (358)
                      +.+..+++..|..++|+|...........+....  ...+.....++...++.+++++.+||.+||..||.+|||+.+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  304 (353)
T 2b9h_A          225 GRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL  304 (353)
T ss_dssp             CSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            3455788999999999986433222111000000  00111123345566778899999999999999999999999999


Q ss_pred             cCcccccCCCCC
Q psy13988         90 KSVWLKNVHPES  101 (358)
Q Consensus        90 ~~~~~~~~~~~~  101 (358)
                      +||||.....+.
T Consensus       305 ~hp~~~~~~~~~  316 (353)
T 2b9h_A          305 EHPYLQTYHDPN  316 (353)
T ss_dssp             TSGGGTTTCCTT
T ss_pred             cCccccccCCcc
Confidence            999999876544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=98.43  E-value=1e-07  Score=87.69  Aligned_cols=86  Identities=29%  Similarity=0.396  Sum_probs=57.3

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCC---------CCCCCCC-------------------Cccccccccccccc-C
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKL---------PLWHTIK-------------------PKKIHRRRLREEFS-L   62 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~---------~~~~~~~-------------------~~~~~~~~~~~~~~-~   62 (358)
                      |.++.+++..|++++|.|+.+.+......         +.+....                   ........|...++ .
T Consensus       301 ~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  380 (429)
T 3kvw_A          301 GEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGC  380 (429)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTC
T ss_pred             CCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcccc
Confidence            45678999999999999987665442211         1110000                   00011222333333 3


Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .++++.|||.+||++||.+|+|++|+|+||||+..
T Consensus       381 ~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          381 DDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             chHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence            57889999999999999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=98.37  E-value=3.6e-07  Score=80.09  Aligned_cols=88  Identities=25%  Similarity=0.317  Sum_probs=61.6

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccc-ccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKI-HRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      +.+..+++..+.+.+|.+.+..+........+.....+.. ...++...++..+.++.+|+.+||.+||.+|||++++++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          205 GKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            4556788888888888876655443332222222222211 122345556788999999999999999999999999999


Q ss_pred             CcccccCCC
Q psy13988         91 SVWLKNVHP   99 (358)
Q Consensus        91 ~~~~~~~~~   99 (358)
                      ||||..+..
T Consensus       285 hp~f~~~~~  293 (311)
T 4agu_A          285 HPYFENIRE  293 (311)
T ss_dssp             SGGGTTCC-
T ss_pred             ChHHHhccC
Confidence            999998653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=98.35  E-value=1.4e-07  Score=84.63  Aligned_cols=94  Identities=27%  Similarity=0.311  Sum_probs=65.2

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCC--CCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLP--LWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPER   81 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~   81 (358)
                      |+..+.|  .+..+++..|.+.+|+|..+.+.......  .+............+....+..++.+.+||.+||++||.+
T Consensus       230 g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  307 (362)
T 3pg1_A          230 RKALFRG--STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR  307 (362)
T ss_dssp             SSCSCCC--SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred             CCCCCCC--CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence            4444443  44588999999999999877654432210  1111111112233455666778999999999999999999


Q ss_pred             cCCHhhhhcCcccccCCC
Q psy13988         82 RITAEQALKSVWLKNVHP   99 (358)
Q Consensus        82 R~~~~~~l~~~~~~~~~~   99 (358)
                      |||+.++|+||||+.+..
T Consensus       308 Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          308 RISTEQALRHPYFESLFD  325 (362)
T ss_dssp             SCCHHHHHTSGGGTTTCC
T ss_pred             CCCHHHHHcCchhhhccC
Confidence            999999999999997643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.34  E-value=1.7e-06  Score=78.64  Aligned_cols=78  Identities=15%  Similarity=0.024  Sum_probs=47.7

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEeecccc-----CCCCchhHHHHHHHHHhCCC--Cccc-chhhhhcccCccc
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-----KEGFPITAVREIKILRQLNH--KNIV-NLREIVTDKSDAL  221 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h--~niv-~~~~~~~~~~~~~  221 (358)
                      -++.||.|..+.||++....+++.|+||.......     .......+..|.++++.+..  +..+ +++.+  +     
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d-----  106 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D-----  106 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E-----
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c-----
Confidence            35689999999999998766778999997653211     01223456779988888732  3333 33221  1     


Q ss_pred             ccccCCCeEEEEeecccc
Q psy13988        222 DFRKDKGSFYLVFEYMDH  239 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~  239 (358)
                           ....++|||+++|
T Consensus       107 -----~~~~~lvmE~l~g  119 (397)
T 2olc_A          107 -----TEMAVTVMEDLSH  119 (397)
T ss_dssp             -----TTTTEEEECCCTT
T ss_pred             -----CCccEEEEEeCCC
Confidence                 2235799999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=98.29  E-value=1.2e-07  Score=83.51  Aligned_cols=89  Identities=18%  Similarity=0.182  Sum_probs=59.8

Q ss_pred             CchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCc
Q psy13988         13 NIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSV   92 (358)
Q Consensus        13 ~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~   92 (358)
                      .++.+++..|.+.++.+..+.+..+....+............++....+.+++++.+||.+||..||.+|||+.++|+||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (320)
T 2i6l_A          228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP  307 (320)
T ss_dssp             SSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred             CCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence            34577788888877777666665543321110000001112335556677899999999999999999999999999999


Q ss_pred             ccccCCCCC
Q psy13988         93 WLKNVHPES  101 (358)
Q Consensus        93 ~~~~~~~~~  101 (358)
                      ||.....+.
T Consensus       308 ~~~~~~~p~  316 (320)
T 2i6l_A          308 YMSIYSFPM  316 (320)
T ss_dssp             HHHTTCC--
T ss_pred             ccccccCcc
Confidence            999765443

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=1.9e-06  Score=77.22  Aligned_cols=83  Identities=10%  Similarity=0.115  Sum_probs=50.4

Q ss_pred             cccc-cCCcceeeEeeeeec------CCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCC---CcccchhhhhcccCc
Q psy13988        151 MEPL-AAGGLSLNNFSVSLF------TDELVALKKVRLENE-KEGFPITAVREIKILRQLNH---KNIVNLREIVTDKSD  219 (358)
Q Consensus       151 ~~~l-g~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~  219 (358)
                      ++.| +.|..+.+|++....      ++..+++|+...... .......+.+|+.+++.+..   -.+.+++.+..+.. 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~-  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD-  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence            4677 888889999887531      267889997654321 01012356788888888732   23445544433211 


Q ss_pred             ccccccCCCeEEEEeeccccC
Q psy13988        220 ALDFRKDKGSFYLVFEYMDHD  240 (358)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~  240 (358)
                            ..+..|+|||+++|.
T Consensus       104 ------~~g~~~~v~e~l~G~  118 (357)
T 3ats_A          104 ------VLGTPFFLMDYVEGV  118 (357)
T ss_dssp             ------TTSSCEEEEECCCCB
T ss_pred             ------ccCCceEEEEecCCC
Confidence                  014568999999883

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=98.26  E-value=4e-07  Score=82.45  Aligned_cols=33  Identities=33%  Similarity=0.482  Sum_probs=30.2

Q ss_pred             hhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         65 PGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        65 ~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +++.|||.+||++||.+|||+.|+|+||||...
T Consensus       347 ~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          347 LKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             HHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence            368999999999999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=98.24  E-value=2.2e-07  Score=79.79  Aligned_cols=35  Identities=31%  Similarity=0.716  Sum_probs=33.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      .+|+++.|||.+||+.||.+|+|++|+|+||||+.
T Consensus       234 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          234 FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            47899999999999999999999999999999974

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=98.21  E-value=5.5e-07  Score=79.78  Aligned_cols=85  Identities=21%  Similarity=0.323  Sum_probs=61.4

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccc-ccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKI-HRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      +.++.+++..|...+|.+.+..+..+...+.+.....+.. ...++...++.+++++.+||.+||..||.+|||+.++|+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          227 GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            3456788888888888876655544433333332222221 233455566778999999999999999999999999999


Q ss_pred             Cccccc
Q psy13988         91 SVWLKN   96 (358)
Q Consensus        91 ~~~~~~   96 (358)
                      ||||+.
T Consensus       307 hp~f~~  312 (331)
T 4aaa_A          307 HDFFQM  312 (331)
T ss_dssp             SHHHHG
T ss_pred             Cchhcc
Confidence            999985

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.21  E-value=6.5e-06  Score=73.08  Aligned_cols=31  Identities=19%  Similarity=0.369  Sum_probs=28.1

Q ss_pred             CCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        274 RNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       274 ~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5799999999999998888999999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=98.19  E-value=4.4e-07  Score=79.16  Aligned_cols=38  Identities=29%  Similarity=0.423  Sum_probs=34.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhh------hcCcccccCCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQA------LKSVWLKNVHP   99 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~------l~~~~~~~~~~   99 (358)
                      .+++++.|||.+||+.||.+|+|++|+      ++||||+++..
T Consensus       256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw  299 (311)
T 4aw0_A          256 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  299 (311)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence            578999999999999999999999985      88999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=98.14  E-value=2e-06  Score=74.38  Aligned_cols=35  Identities=9%  Similarity=0.353  Sum_probs=32.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..++++.|||.+||+.||.+|||++|+|+||||+.
T Consensus       254 ~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            46789999999999999999999999999999974

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=98.11  E-value=1e-06  Score=77.95  Aligned_cols=86  Identities=29%  Similarity=0.404  Sum_probs=55.1

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCC---CCCCCCCCcccccccccccc-----cCCChhHHHHHhhhcCCCCCCcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKL---PLWHTIKPKKIHRRRLREEF-----SLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      +.++.+++..|.+.+|++....+......   +.+... ........|...+     ..+++++.+||.+||.+||.+|+
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  312 (330)
T 3nsz_A          234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL  312 (330)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHH-HCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC
T ss_pred             CCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhh-hhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC
Confidence            55678999999999997654333221111   000000 0001111222222     23789999999999999999999


Q ss_pred             CHhhhhcCcccccCC
Q psy13988         84 TAEQALKSVWLKNVH   98 (358)
Q Consensus        84 ~~~~~l~~~~~~~~~   98 (358)
                      |++++|+||||..+.
T Consensus       313 ta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          313 TAREAMEHPYFYTVV  327 (330)
T ss_dssp             CHHHHHTSGGGTTCC
T ss_pred             CHHHHhcCccHhhhc
Confidence            999999999999764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=98.10  E-value=8.3e-07  Score=78.75  Aligned_cols=35  Identities=11%  Similarity=0.256  Sum_probs=33.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      .+++++.|||.+||+.||.+|+|++|+|+||||..
T Consensus       248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          248 HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            57899999999999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=98.04  E-value=1.9e-06  Score=78.13  Aligned_cols=82  Identities=29%  Similarity=0.356  Sum_probs=51.6

Q ss_pred             hhHHHHHHHhhcCCCCCCccccccCCCCCCCCCC-----ccccc----ccccccc---cCCChhHHHHHhhhcCCCCCCc
Q psy13988         15 ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKP-----KKIHR----RRLREEF---SLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus        15 ~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~-----~~~~~----~~~~~~~---~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      +.+++..|.+++|.++.+.+........+.....     .....    ..+...+   ...++++.+||.+||+.||.+|
T Consensus       304 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  383 (397)
T 1wak_A          304 DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR  383 (397)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGS
T ss_pred             hHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhc
Confidence            5789999999999987665533221111110000     00000    0011111   1234678899999999999999


Q ss_pred             CCHhhhhcCccccc
Q psy13988         83 ITAEQALKSVWLKN   96 (358)
Q Consensus        83 ~~~~~~l~~~~~~~   96 (358)
                      ||+.|+|+||||++
T Consensus       384 pt~~e~l~hp~~~~  397 (397)
T 1wak_A          384 ATAAECLRHPWLNS  397 (397)
T ss_dssp             CCHHHHHTSGGGGC
T ss_pred             CCHHHHhhCccccC
Confidence            99999999999973

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=98.03  E-value=5.5e-07  Score=78.41  Aligned_cols=37  Identities=22%  Similarity=0.504  Sum_probs=33.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCH-----hhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITA-----EQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~-----~~~l~~~~~~~~~   98 (358)
                      .+|+++.|||.+||+.||.+|+|+     +|+++||||+++.
T Consensus       248 ~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          248 FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            478999999999999999999995     7999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=97.91  E-value=6.5e-06  Score=72.62  Aligned_cols=44  Identities=25%  Similarity=0.320  Sum_probs=37.0

Q ss_pred             ccccccCCChhHHHHHhhhcCCCCCCcCCHhhh-------------hcCcccccCCC
Q psy13988         56 LREEFSLMPPGALDLLDKMLELDPERRITAEQA-------------LKSVWLKNVHP   99 (358)
Q Consensus        56 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~-------------l~~~~~~~~~~   99 (358)
                      +.++.+.+++++.|||.+||+.||.+|+|+.|+             |+|||+.....
T Consensus       275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence            344556789999999999999999999999985             78999987654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=97.89  E-value=2.9e-05  Score=73.92  Aligned_cols=41  Identities=34%  Similarity=0.542  Sum_probs=36.6

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCCC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPE  100 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~~  100 (358)
                      ++.+|+++.|||.+||+.||.+|+|+.|+|+||||+....+
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            45679999999999999999999999999999999875543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=97.86  E-value=8.5e-06  Score=72.15  Aligned_cols=38  Identities=32%  Similarity=0.489  Sum_probs=34.8

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ..+++++.|||.+||+.||.+|+|++|+|+||||....
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            35789999999999999999999999999999998643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.84  E-value=0.00011  Score=63.88  Aligned_cols=30  Identities=20%  Similarity=0.351  Sum_probs=25.5

Q ss_pred             CceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        275 NFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       275 ~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      .++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            4899999999999 56678899999987643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=97.82  E-value=9.2e-06  Score=72.98  Aligned_cols=84  Identities=24%  Similarity=0.263  Sum_probs=52.8

Q ss_pred             hhHHHHHHHhhcCCCCCCccccccCC-------CCCCCCCC-cc-cccccccccc---cCCChhHHHHHhhhcCCCCCCc
Q psy13988         15 ELLQLEVISKLCGTPTPAVWPAVIKL-------PLWHTIKP-KK-IHRRRLREEF---SLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus        15 ~~~ql~~i~~~lGtp~~~~~~~~~~~-------~~~~~~~~-~~-~~~~~~~~~~---~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      +.+++..|.+++|.++...|......       ........ .. .....+...+   +..+.++.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence            57889999999999876555432110       00000000 00 0000111111   1245678999999999999999


Q ss_pred             CCHhhhhcCcccccCC
Q psy13988         83 ITAEQALKSVWLKNVH   98 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~   98 (358)
                      ||+.++|+||||....
T Consensus       326 pt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          326 ADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             BCHHHHHTCGGGTTCT
T ss_pred             CCHHHHhhChhhhccc
Confidence            9999999999998743

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=97.80  E-value=3.9e-06  Score=74.74  Aligned_cols=86  Identities=21%  Similarity=0.225  Sum_probs=52.7

Q ss_pred             CchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccc-----------cccccccccc---CCChhHHHHHhhhcCCC
Q psy13988         13 NIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKI-----------HRRRLREEFS---LMPPGALDLLDKMLELD   78 (358)
Q Consensus        13 ~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~---~~~~~~~~ll~~~l~~~   78 (358)
                      .+..+++..+.+++|.++.+.+........+........           ...++.....   ..+.++.+||.+||..|
T Consensus       242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            345778888999999877655544321111100000000           0001111111   12457889999999999


Q ss_pred             CCCcCCHhhhhcCcccccCC
Q psy13988         79 PERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        79 p~~R~~~~~~l~~~~~~~~~   98 (358)
                      |.+|||+.++|+||||..+.
T Consensus       322 P~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          322 PAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             TTTSCCHHHHTTSGGGGGCC
T ss_pred             hhhCcCHHHHhcChhhcCCC
Confidence            99999999999999999754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=97.78  E-value=6.3e-06  Score=73.78  Aligned_cols=33  Identities=27%  Similarity=0.368  Sum_probs=30.5

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcccc
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLK   95 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~   95 (358)
                      .++++.+||.+||++||.+|||+.++|+||||+
T Consensus       328 ~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          328 KHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             hHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            357788999999999999999999999999985

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.78  E-value=0.00011  Score=67.29  Aligned_cols=33  Identities=9%  Similarity=0.278  Sum_probs=28.7

Q ss_pred             HhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        272 HKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       272 H~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      +...++|+|+++.||+++.++ +.|+||+.+..-
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            456799999999999998776 999999988754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=97.78  E-value=6e-06  Score=72.97  Aligned_cols=87  Identities=23%  Similarity=0.305  Sum_probs=53.3

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccc-----------ccccccccc---cCCChhHHHHHhhhcCC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKI-----------HRRRLREEF---SLMPPGALDLLDKMLEL   77 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~---~~~~~~~~~ll~~~l~~   77 (358)
                      +.+..+++..+.+++|.++.+.+........+........           ...++....   ...++++.+||.+||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence            3445778888889999877655544321111100000000           000111111   12346788999999999


Q ss_pred             CCCCcCCHhhhhcCcccccCC
Q psy13988         78 DPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        78 ~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ||.+|||+.++++||||..++
T Consensus       316 dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          316 DPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             STTTSCCHHHHTTSGGGGGGG
T ss_pred             CcccccCHHHHhcCHHHHHHh
Confidence            999999999999999998754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.77  E-value=0.00013  Score=63.67  Aligned_cols=73  Identities=18%  Similarity=0.148  Sum_probs=52.3

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCC---CcccchhhhhcccCcccccccCC
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH---KNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      ++.|+.|....+|++..  ++..+++|+....     ....+..|.+.|+.+..   ..+.+++...          ...
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~----------~~~  103 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIG----------NSQ  103 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEE----------ECS
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEe----------ecC
Confidence            46789999999999875  5778899986532     13457789888888832   3455554433          234


Q ss_pred             CeEEEEeeccccC
Q psy13988        228 GSFYLVFEYMDHD  240 (358)
Q Consensus       228 ~~~~lv~e~~~~~  240 (358)
                      +..|+|||+++|.
T Consensus       104 g~~~lvme~l~G~  116 (312)
T 3jr1_A          104 GHSFLLLEALNKS  116 (312)
T ss_dssp             SEEEEEEECCCCC
T ss_pred             CceEEEEEeccCC
Confidence            6799999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=97.72  E-value=2.1e-05  Score=71.51  Aligned_cols=37  Identities=32%  Similarity=0.514  Sum_probs=34.5

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..+++++.|||.+||+.||.+|+|++|+|+||||...
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            3578999999999999999999999999999999864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.72  E-value=8e-05  Score=65.44  Aligned_cols=144  Identities=12%  Similarity=0.072  Sum_probs=77.1

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc--ccchhhhhcccCcccccccCCC
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN--IVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      ++.|+.|....+|++..  ++..+++|+.....    ....+..|+.+++.+....  +.+++... + +.  .+...++
T Consensus        27 ~~~i~~G~~n~~~~v~~--~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~-g~--~~~~~~g   96 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHT--TKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRK-D-GE--LLGELSG   96 (322)
T ss_dssp             EEEECC---EEEEEEEE--SSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-T-CC--SCEEETT
T ss_pred             eeccCCCcccceEEEEe--CCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCC-C-CC--EEEEECC
Confidence            46778888889998875  23478899876421    1235567888877773222  22332111 1 10  0111245


Q ss_pred             eEEEEeeccccChH---------------HHHhcC--C--CC----CChHHHHH---------------HHHHHHHHHHH
Q psy13988        229 SFYLVFEYMDHDLM---------------GLLESG--M--VD----FNEVNNAS---------------IMRQLLDGLSY  270 (358)
Q Consensus       229 ~~~lv~e~~~~~l~---------------~~~~~~--~--~~----~~~~~~~~---------------~~~qi~~al~~  270 (358)
                      ..++|+++++|...               ..+...  .  .+    ........               +...+...++.
T Consensus        97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~  176 (322)
T 2ppq_A           97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY  176 (322)
T ss_dssp             EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred             EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence            67999999987311               111110  0  00    00000000               00113344555


Q ss_pred             HHh-------CCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        271 CHK-------RNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       271 LH~-------~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      +++       .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            542       3699999999999998876668999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=97.60  E-value=4.2e-05  Score=69.18  Aligned_cols=39  Identities=18%  Similarity=0.397  Sum_probs=33.7

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHP   99 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~   99 (358)
                      ..+++++.+||.+||++||.+|||+.++|+||||+.+..
T Consensus       304 ~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          304 RTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             --CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             cccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence            457899999999999999999999999999999997643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.57  E-value=0.00022  Score=64.05  Aligned_cols=137  Identities=16%  Similarity=0.108  Sum_probs=77.5

Q ss_pred             cccccCCcceeeEeeeeec-------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcc-cchhhhhcccCcccc
Q psy13988        151 MEPLAAGGLSLNNFSVSLF-------TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNI-VNLREIVTDKSDALD  222 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~  222 (358)
                      ++.|..|-...+|++....       +++.|++|+.-..   ........+|..+++.+....+ .++++.+        
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--------  123 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVF--------  123 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--------
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEc--------
Confidence            4577778888888887642       3578999985321   1223455689999888843333 3343222        


Q ss_pred             cccCCCeEEEEeeccccChHH------------------HHhcCCCC----CC--hHHHHHHHHHHHH------------
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMG------------------LLESGMVD----FN--EVNNASIMRQLLD------------  266 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~------------------~~~~~~~~----~~--~~~~~~~~~qi~~------------  266 (358)
                        .+    .+||||++|..+.                  .+.....+    ..  ..++.++..++..            
T Consensus       124 --~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~  197 (379)
T 3feg_A          124 --PE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLL  197 (379)
T ss_dssp             --TT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHH
T ss_pred             --CC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhh
Confidence              21    2899999872111                  11111111    11  2344455544322            


Q ss_pred             -------HHHHHH----h----CCceecCCCCCCEEecCC----CcEEEeeccccee
Q psy13988        267 -------GLSYCH----K----RNFLHRDIKCSNILMNNR----GEVKLADFGLARL  304 (358)
Q Consensus       267 -------al~~LH----~----~~i~H~Dlkp~Nill~~~----~~~~l~Dfg~~~~  304 (358)
                             .++.|.    +    ..++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       198 ~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          198 EMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                   223332    2    258999999999999876    6899999998875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=97.55  E-value=4e-05  Score=67.08  Aligned_cols=37  Identities=30%  Similarity=0.533  Sum_probs=32.5

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      .+++++.+||.+||..||.+|||+.++|+||||....
T Consensus       267 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            4788999999999999999999999999999998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=97.54  E-value=2.3e-05  Score=68.15  Aligned_cols=37  Identities=16%  Similarity=0.244  Sum_probs=33.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ..++++.+||.+||+.||.+|||+.|+|+||||.++.
T Consensus       251 ~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          251 QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            4567789999999999999999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=97.50  E-value=0.00011  Score=64.53  Aligned_cols=38  Identities=29%  Similarity=0.433  Sum_probs=34.5

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ..+++++.+||.+||+.||.+|+|+.|+++||||....
T Consensus       232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            45788999999999999999999999999999998643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=97.48  E-value=0.00012  Score=64.67  Aligned_cols=37  Identities=35%  Similarity=0.588  Sum_probs=34.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ..++++.+||.+||..||.+|+|++++++||||....
T Consensus       236 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          236 YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            3688999999999999999999999999999998654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.47  E-value=0.00042  Score=59.80  Aligned_cols=74  Identities=9%  Similarity=-0.081  Sum_probs=49.4

Q ss_pred             cccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc---ccchhhhhcccCccccccc
Q psy13988        149 PLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN---IVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       149 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~  225 (358)
                      .-++.+|.|..+.||++.. .+|+.|++|+.....  ......+..|...|+.+....   +.+++.+            
T Consensus        18 ~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~------------   82 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW------------   82 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE------------
T ss_pred             EEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec------------
Confidence            3467899999999999874 678999999765332  122335678999999884322   2222221            


Q ss_pred             CCCeEEEEeecccc
Q psy13988        226 DKGSFYLVFEYMDH  239 (358)
Q Consensus       226 ~~~~~~lv~e~~~~  239 (358)
                        +.-++|||++.+
T Consensus        83 --~~~~lv~e~l~~   94 (288)
T 3f7w_A           83 --DDRTLAMEWVDE   94 (288)
T ss_dssp             --ETTEEEEECCCC
T ss_pred             --cCceEEEEeecc
Confidence              123789999875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=97.47  E-value=7.9e-05  Score=65.64  Aligned_cols=40  Identities=35%  Similarity=0.513  Sum_probs=35.6

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHP   99 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~   99 (358)
                      ++..++.+.+||.+||+.||.+|||++++|+||||+....
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            3457889999999999999999999999999999987543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.45  E-value=0.00049  Score=60.70  Aligned_cols=32  Identities=34%  Similarity=0.467  Sum_probs=27.7

Q ss_pred             CCceecCCCCCCEEecCC----CcEEEeecccceec
Q psy13988        274 RNFLHRDIKCSNILMNNR----GEVKLADFGLARLY  305 (358)
Q Consensus       274 ~~i~H~Dlkp~Nill~~~----~~~~l~Dfg~~~~~  305 (358)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            479999999999999875    68999999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.44  E-value=0.00061  Score=62.38  Aligned_cols=71  Identities=15%  Similarity=0.064  Sum_probs=45.5

Q ss_pred             cccccCCcceeeEeeeeec-------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcc-cchhhhhcccCcccc
Q psy13988        151 MEPLAAGGLSLNNFSVSLF-------TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNI-VNLREIVTDKSDALD  222 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~  222 (358)
                      ++.|+.|....+|++....       .+..|++|+....    .....+.+|..+++.+...++ .++++.+        
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~--------  145 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIF--------  145 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEE--------
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEe--------
Confidence            4678888889999987642       3578999987421    111355679888888843333 3443322        


Q ss_pred             cccCCCeEEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDH  239 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~  239 (358)
                        . +   .+|+||++|
T Consensus       146 --~-~---g~v~e~l~G  156 (429)
T 1nw1_A          146 --S-G---GRLEEYIPS  156 (429)
T ss_dssp             --T-T---EEEECCCCE
T ss_pred             --C-C---CEEEEEeCC
Confidence              1 1   288999986

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.44  E-value=0.00087  Score=58.88  Aligned_cols=78  Identities=14%  Similarity=0.081  Sum_probs=47.2

Q ss_pred             ccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc--ccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN--IVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.|+ |....||++.. .+|+.+++|..+...   .....+..|..+++.+....  +.+++..  +..   .....++.
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~---~~~~~~g~  101 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQ---TLLNHQGF  101 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTB---SCEEETTE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeec--CCc---EEEEECCE
Confidence            4566 77788887764 356689999876331   12345667888887773222  3344332  111   11123567


Q ss_pred             EEEEeecccc
Q psy13988        230 FYLVFEYMDH  239 (358)
Q Consensus       230 ~~lv~e~~~~  239 (358)
                      .++||++++|
T Consensus       102 ~~~l~~~i~G  111 (328)
T 1zyl_A          102 YFAVFPSVGG  111 (328)
T ss_dssp             EEEEEECCCC
T ss_pred             EEEEEEecCC
Confidence            8899999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=97.41  E-value=8.8e-05  Score=66.40  Aligned_cols=38  Identities=32%  Similarity=0.555  Sum_probs=34.7

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ++.+++++.|||.+||..||.+|+|+.++|+||||...
T Consensus       242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            34678999999999999999999999999999999854

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=97.40  E-value=7.9e-05  Score=64.76  Aligned_cols=40  Identities=33%  Similarity=0.602  Sum_probs=35.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCCCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPES  101 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~~~  101 (358)
                      ..+++..+||.+||..||.+|+|+.++++||||....++.
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence            4678899999999999999999999999999998765543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=97.39  E-value=0.00013  Score=65.59  Aligned_cols=38  Identities=32%  Similarity=0.524  Sum_probs=34.8

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ++.+++++.+||.+||+.||.+|+|+.++|+||||...
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            45678999999999999999999999999999999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=97.34  E-value=0.0001  Score=64.84  Aligned_cols=38  Identities=24%  Similarity=0.458  Sum_probs=34.7

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      +.+++++.+||.+||+.||.+|+|+.+++.||||....
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            35789999999999999999999999999999998744

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=97.32  E-value=0.00014  Score=62.57  Aligned_cols=35  Identities=49%  Similarity=0.802  Sum_probs=32.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..++++.+||.+||..||.+|||+.|+|.||||+.
T Consensus       250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            36889999999999999999999999999999974

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=97.32  E-value=0.00014  Score=62.53  Aligned_cols=38  Identities=45%  Similarity=0.754  Sum_probs=34.4

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ...++++.+|+.+||..||.+|||+.++++||||....
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            35688999999999999999999999999999998643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=97.31  E-value=6.7e-05  Score=66.94  Aligned_cols=37  Identities=16%  Similarity=0.399  Sum_probs=33.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCH------hhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITA------EQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~------~~~l~~~~~~~~~   98 (358)
                      ..++++.+||++||+.||.+|+++      +++++||||+.+.
T Consensus       246 ~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            378899999999999999999998      8999999998753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=97.29  E-value=0.00019  Score=63.63  Aligned_cols=37  Identities=35%  Similarity=0.610  Sum_probs=34.2

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +.+++++.+||.+||..||.+|+|+.++++||||...
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            4578999999999999999999999999999999764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=97.29  E-value=0.00017  Score=61.57  Aligned_cols=37  Identities=30%  Similarity=0.461  Sum_probs=34.0

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ...+++..+||.+||..||.+|||+.++++||||...
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            3578899999999999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=97.28  E-value=0.00016  Score=63.19  Aligned_cols=36  Identities=33%  Similarity=0.321  Sum_probs=33.4

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ...++++.+|+.+||+.||.+|||+.++|+||||+.
T Consensus       275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          275 AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            357889999999999999999999999999999974

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=97.28  E-value=0.00012  Score=63.60  Aligned_cols=38  Identities=18%  Similarity=0.401  Sum_probs=34.6

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ..+++++.+||.+||..||.+|||+.++++||||....
T Consensus       227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            35789999999999999999999999999999998643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=97.28  E-value=0.00018  Score=63.69  Aligned_cols=35  Identities=31%  Similarity=0.693  Sum_probs=33.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..++++.+||.+||+.||.+|||++++++||||..
T Consensus       230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            46889999999999999999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=97.28  E-value=7.9e-05  Score=65.52  Aligned_cols=38  Identities=34%  Similarity=0.622  Sum_probs=34.9

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ++.+++++.+|+.+||..||.+|||+.++|+||||...
T Consensus       227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            34678999999999999999999999999999999864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.26  E-value=0.0039  Score=55.05  Aligned_cols=32  Identities=25%  Similarity=0.397  Sum_probs=28.3

Q ss_pred             CCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        274 RNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       274 ~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      ..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            46999999999999998888999999887654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=97.23  E-value=0.00014  Score=64.04  Aligned_cols=37  Identities=32%  Similarity=0.618  Sum_probs=34.1

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ++..++++.+||.+||+.||.+|||+.++|.||||..
T Consensus       241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            3467889999999999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=97.22  E-value=0.00011  Score=65.89  Aligned_cols=37  Identities=19%  Similarity=0.346  Sum_probs=34.4

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +.+++++.+||.+||..||.+|||+.++|+||||..+
T Consensus       323 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          323 TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             SCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            4678999999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=97.22  E-value=0.00016  Score=66.06  Aligned_cols=37  Identities=41%  Similarity=0.771  Sum_probs=34.2

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ++.+++++.+|+.+||..||.+|+|++++|+||||..
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            3457899999999999999999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=97.21  E-value=0.00016  Score=62.72  Aligned_cols=34  Identities=26%  Similarity=0.496  Sum_probs=32.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLK   95 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~   95 (358)
                      .+++++.+||.+||..||.+|||+.++++||||.
T Consensus       264 ~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          264 DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             ccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            4788999999999999999999999999999985

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.21  E-value=0.0016  Score=58.32  Aligned_cols=29  Identities=31%  Similarity=0.582  Sum_probs=24.4

Q ss_pred             CceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        275 NFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       275 ~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .++|+|+.+.||+++.++ +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            589999999999997654 89999998764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=97.19  E-value=0.00016  Score=62.09  Aligned_cols=38  Identities=24%  Similarity=0.578  Sum_probs=34.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHP   99 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~   99 (358)
                      ..+.+..+||.+||..||.+|+|+.+++.||||.....
T Consensus       234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            46889999999999999999999999999999986543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=97.19  E-value=0.00047  Score=62.26  Aligned_cols=39  Identities=38%  Similarity=0.758  Sum_probs=35.2

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      +..+++++.+||.+||..||.+|+|+.++|+||||....
T Consensus       274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            345789999999999999999999999999999998643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.18  E-value=0.0023  Score=58.97  Aligned_cols=72  Identities=18%  Similarity=0.121  Sum_probs=44.6

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCccc-chhhhhcccCcccccccCCCe
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIV-NLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      ++.|+.|-...+|++.....+..|++|+.....  . ....-.+|..+++.+...++. ++++.+          . +  
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~-~~idR~~E~~vl~~L~~~gl~P~ll~~~----------~-~--  176 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--D-EIINREREKKISCILYNKNIAKKIYVFF----------T-N--  176 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--C-SCSCHHHHHHHHHHHTTSSSBCCEEEEE----------T-T--
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--h-hhcCHHHHHHHHHHHHhcCCCCCEEEEe----------C-C--
Confidence            567888989999998864445789999864321  1 111225799999988655553 343332          1 1  


Q ss_pred             EEEEeecccc
Q psy13988        230 FYLVFEYMDH  239 (358)
Q Consensus       230 ~~lv~e~~~~  239 (358)
                       .+||||++|
T Consensus       177 -G~v~e~I~G  185 (458)
T 2qg7_A          177 -GRIEEFMDG  185 (458)
T ss_dssp             -EEEEECCCS
T ss_pred             -eEEEEeeCC
Confidence             259999987

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=97.18  E-value=0.00026  Score=61.37  Aligned_cols=36  Identities=31%  Similarity=0.412  Sum_probs=33.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            467889999999999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=97.17  E-value=0.00021  Score=62.66  Aligned_cols=37  Identities=30%  Similarity=0.504  Sum_probs=34.1

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +..++++.+||.+||..||.+|||+.+++.||||..+
T Consensus       243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            4578899999999999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=97.16  E-value=0.00024  Score=62.83  Aligned_cols=38  Identities=29%  Similarity=0.544  Sum_probs=34.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHP   99 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~   99 (358)
                      .+++++.+||.+||..||.+||++.++|+||||+.+..
T Consensus       302 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          302 VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             GSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            46889999999999999999999999999999997643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=97.15  E-value=0.00021  Score=65.82  Aligned_cols=36  Identities=44%  Similarity=0.831  Sum_probs=33.6

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      +.+++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus       238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            457899999999999999999999999999999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=97.14  E-value=0.00024  Score=60.92  Aligned_cols=35  Identities=31%  Similarity=0.404  Sum_probs=31.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..+++..+|+.+||..||.+|||+.++++||||..
T Consensus       251 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          251 VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             ccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence            57889999999999999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=97.14  E-value=0.00028  Score=62.78  Aligned_cols=37  Identities=35%  Similarity=0.591  Sum_probs=34.2

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +.++.++.+||.+||..||.+|||+.++|+||||...
T Consensus       276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             hhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            4578899999999999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=97.14  E-value=0.00019  Score=66.99  Aligned_cols=38  Identities=37%  Similarity=0.611  Sum_probs=34.9

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      +.+++++.+||.+||+.||.+|||+.++|.||||....
T Consensus       247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            45789999999999999999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=97.13  E-value=0.00016  Score=64.59  Aligned_cols=35  Identities=20%  Similarity=0.313  Sum_probs=32.8

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+.++.+||.+||.+||.+|||++++|+||||+..
T Consensus       297 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          297 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence            57889999999999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=97.12  E-value=0.00018  Score=63.60  Aligned_cols=37  Identities=27%  Similarity=0.492  Sum_probs=34.1

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..+++++.+||.+||..||.+|||+.++|+||||...
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            3578899999999999999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=97.12  E-value=0.00024  Score=61.23  Aligned_cols=35  Identities=9%  Similarity=0.353  Sum_probs=31.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..+++..+||.+||..||.+|||+.++++||||++
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            35678999999999999999999999999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=97.11  E-value=0.00018  Score=61.68  Aligned_cols=37  Identities=24%  Similarity=0.563  Sum_probs=33.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ..++++.+||.+||..||.+|||+.++++||||....
T Consensus       229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          229 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            3678899999999999999999999999999998743

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=97.11  E-value=0.0002  Score=63.77  Aligned_cols=37  Identities=46%  Similarity=0.677  Sum_probs=34.1

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +.+++++.+||.+||..||.+|+|+.++|+||||...
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            4578899999999999999999999999999999863

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=97.10  E-value=0.00021  Score=67.01  Aligned_cols=38  Identities=37%  Similarity=0.531  Sum_probs=35.0

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      +.+++++.+||.+||++||.+|||+.++|.||||+...
T Consensus       272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            45789999999999999999999999999999998753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=97.10  E-value=0.00028  Score=62.57  Aligned_cols=37  Identities=35%  Similarity=0.671  Sum_probs=33.8

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +..++++.+||.+||..||.+|||+.++++||||...
T Consensus       293 ~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          293 NFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             -CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            4578899999999999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=97.10  E-value=0.00012  Score=64.31  Aligned_cols=36  Identities=19%  Similarity=0.303  Sum_probs=32.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..+++..+|+.+||..||.+|||+.++|+||||+.+
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            356788999999999999999999999999999853

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=97.10  E-value=0.00023  Score=66.31  Aligned_cols=38  Identities=34%  Similarity=0.547  Sum_probs=34.8

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      +.+++++.+||.+||+.||.+|||+.++|.||||....
T Consensus       252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            35789999999999999999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=97.09  E-value=0.00019  Score=61.39  Aligned_cols=35  Identities=34%  Similarity=0.631  Sum_probs=33.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..++++.+|+.+||..||.+|+|+.++|+||||..
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            57889999999999999999999999999999976

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=97.09  E-value=0.00028  Score=63.07  Aligned_cols=36  Identities=19%  Similarity=0.461  Sum_probs=33.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+++++.+||.+||+.||.+|+|+.+++.||||...
T Consensus       246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            368899999999999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=97.09  E-value=0.00028  Score=61.03  Aligned_cols=38  Identities=26%  Similarity=0.421  Sum_probs=34.3

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      +..+.+..+||.+||..||.+|||+.++++||||....
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            35678899999999999999999999999999998643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=97.08  E-value=0.0003  Score=61.67  Aligned_cols=36  Identities=42%  Similarity=0.759  Sum_probs=33.6

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ...++++.+|+.+||..||.+|||+.++|+||||..
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            457889999999999999999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=97.07  E-value=0.0002  Score=61.65  Aligned_cols=35  Identities=11%  Similarity=0.193  Sum_probs=32.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..++++.+|+.+||..||.+|||+.++++||||..
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            46789999999999999999999999999999985

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=97.07  E-value=0.00031  Score=62.88  Aligned_cols=35  Identities=37%  Similarity=0.612  Sum_probs=32.5

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLK   95 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~   95 (358)
                      ...++++.+||.+||..||.+|||+.++|+||||.
T Consensus       330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            35678899999999999999999999999999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=97.05  E-value=0.00025  Score=66.29  Aligned_cols=37  Identities=43%  Similarity=0.791  Sum_probs=34.2

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +.+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus       262 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          262 KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            4578999999999999999999999999999999763

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=97.05  E-value=0.00032  Score=60.76  Aligned_cols=38  Identities=21%  Similarity=0.336  Sum_probs=32.0

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ...+.+..+|+.+||..||.+|||+.++++||||....
T Consensus       258 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          258 KKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             hhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            45678899999999999999999999999999998643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=97.04  E-value=0.00043  Score=59.96  Aligned_cols=37  Identities=24%  Similarity=0.328  Sum_probs=33.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ..+.+..+||.+||..||.+|||+.+++.||||....
T Consensus       247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            4678899999999999999999999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=97.04  E-value=0.0002  Score=61.66  Aligned_cols=38  Identities=37%  Similarity=0.611  Sum_probs=34.4

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ..+++++.+||.+||..||.+|||+.+++.||||....
T Consensus       247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            35788999999999999999999999999999998643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=97.02  E-value=0.00044  Score=59.59  Aligned_cols=36  Identities=31%  Similarity=0.382  Sum_probs=33.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..++++.+|+.+||..||.+|||+.+++.||||...
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            468899999999999999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=97.00  E-value=0.00035  Score=59.75  Aligned_cols=35  Identities=20%  Similarity=0.454  Sum_probs=32.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..+.++.+|+.+||..||.+|||+.+++.||||..
T Consensus       234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence            46789999999999999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=96.98  E-value=0.00026  Score=63.68  Aligned_cols=37  Identities=22%  Similarity=0.294  Sum_probs=34.5

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +.+++++.+||.+||..||.+|||+.++++||||..+
T Consensus       330 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          330 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            4678999999999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=96.98  E-value=0.00027  Score=63.22  Aligned_cols=36  Identities=47%  Similarity=0.811  Sum_probs=33.4

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..+++++.+||.+||..||.+|+|+.++|+||||..
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            357889999999999999999999999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=96.97  E-value=0.00033  Score=63.60  Aligned_cols=37  Identities=19%  Similarity=0.415  Sum_probs=34.0

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..+++++.+||.+||..||.+|+|+.+++.||||...
T Consensus       292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            3578899999999999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=96.94  E-value=0.00036  Score=60.61  Aligned_cols=37  Identities=32%  Similarity=0.548  Sum_probs=34.0

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +..++++.+||.+||..||.+|||+.+++.||||...
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          232 DDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            3568899999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=96.93  E-value=0.00057  Score=59.94  Aligned_cols=36  Identities=33%  Similarity=0.512  Sum_probs=33.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..++++.+|+.+||..||.+|||+.+++.||||...
T Consensus       266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          266 KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            467889999999999999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=96.86  E-value=0.0006  Score=59.74  Aligned_cols=36  Identities=25%  Similarity=0.410  Sum_probs=33.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+++++.+|+.+||..||.+|||+.++++||||...
T Consensus       265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence            478899999999999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=96.85  E-value=0.00051  Score=60.70  Aligned_cols=35  Identities=29%  Similarity=0.551  Sum_probs=32.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      .+++++.+||.+||..||.+|||+.+++.||||..
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence            36889999999999999999999999999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=96.84  E-value=0.00033  Score=60.04  Aligned_cols=39  Identities=36%  Similarity=0.638  Sum_probs=35.0

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ++..++.+.+|+.+||..||.+|||+.+++.||||..++
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          235 FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            346788899999999999999999999999999998653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=96.83  E-value=0.00067  Score=65.10  Aligned_cols=37  Identities=24%  Similarity=0.464  Sum_probs=34.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCC-----HhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRIT-----AEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~-----~~~~l~~~~~~~~~   98 (358)
                      .+|+++.|||.+||+.||.+|++     +++++.||||+.+.
T Consensus       416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            57999999999999999999998     79999999998764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=96.83  E-value=0.00054  Score=59.13  Aligned_cols=37  Identities=30%  Similarity=0.421  Sum_probs=33.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ..+++..+|+.+||..||.+|||+.+++.||||....
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence            4678899999999999999999999999999998643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=96.82  E-value=0.00063  Score=58.72  Aligned_cols=34  Identities=24%  Similarity=0.373  Sum_probs=31.3

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      .+..+.+|+.+||..||.+|||+.++++||||..
T Consensus       256 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          256 KMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             TSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             chHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            4567899999999999999999999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=96.81  E-value=0.00067  Score=61.40  Aligned_cols=37  Identities=22%  Similarity=0.387  Sum_probs=33.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCH------hhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITA------EQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~------~~~l~~~~~~~~~   98 (358)
                      .+++++.+||.+||+.||.+|+++      ++++.||||+.+.
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            478999999999999999999996      7999999998764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=96.81  E-value=0.00045  Score=58.92  Aligned_cols=36  Identities=28%  Similarity=0.472  Sum_probs=33.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..+.+..+|+.+||..||.+|||+.+++.||||+..
T Consensus       233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          233 YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            357889999999999999999999999999999863

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=96.81  E-value=0.00081  Score=61.89  Aligned_cols=36  Identities=25%  Similarity=0.543  Sum_probs=33.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcC-----CHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~-----~~~~~l~~~~~~~~   97 (358)
                      .+++++.+||.+||..||.+|+     ++.++++||||..+
T Consensus       371 ~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            4788999999999999999999     99999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=96.77  E-value=0.00084  Score=59.57  Aligned_cols=37  Identities=22%  Similarity=0.387  Sum_probs=33.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCH------hhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITA------EQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~------~~~l~~~~~~~~~   98 (358)
                      .+++++.+||.+||+.||.+|+++      .+++.||||..+.
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            478899999999999999999996      7999999998754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=96.75  E-value=0.00085  Score=58.39  Aligned_cols=36  Identities=22%  Similarity=0.457  Sum_probs=33.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .++++..+|+.+||..||.+|+|+.+++.||||...
T Consensus       255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            468899999999999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=96.75  E-value=0.00062  Score=59.64  Aligned_cols=36  Identities=14%  Similarity=0.223  Sum_probs=33.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..+.+..+||.+||..||.+||++.++++||||...
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            467889999999999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=96.75  E-value=0.001  Score=58.82  Aligned_cols=37  Identities=24%  Similarity=0.545  Sum_probs=33.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcC-----CHhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~-----~~~~~l~~~~~~~~~   98 (358)
                      .+++++.+||.+||+.||.+|+     +++++++||||..+.
T Consensus       227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            4789999999999999999999     899999999998653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=96.74  E-value=0.001  Score=61.77  Aligned_cols=36  Identities=31%  Similarity=0.632  Sum_probs=33.5

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+++++.+||.+||+.||.+|||+.+++.||||...
T Consensus       238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            368899999999999999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=96.72  E-value=0.00083  Score=59.46  Aligned_cols=35  Identities=23%  Similarity=0.318  Sum_probs=32.0

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+.++.+||.+||..||.+|||+.++|.||||...
T Consensus       246 ~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            45688999999999999999999999999999853

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.71  E-value=0.0054  Score=55.76  Aligned_cols=30  Identities=20%  Similarity=0.557  Sum_probs=26.5

Q ss_pred             CceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        275 NFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       275 ~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                      .++|+|+.+.||+ +.++.+.|+||..+..-
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            4899999999999 77889999999998743

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=96.71  E-value=0.0011  Score=58.07  Aligned_cols=37  Identities=24%  Similarity=0.484  Sum_probs=33.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcC-----CHhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~-----~~~~~l~~~~~~~~~   98 (358)
                      ..++++.+||.+||+.||.+|+     ++++++.||||+.+.
T Consensus       225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            4788999999999999999999     899999999998753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=96.69  E-value=0.00081  Score=58.59  Aligned_cols=35  Identities=23%  Similarity=0.318  Sum_probs=32.3

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+.+..+|+.+||..||.+|||+.+++.||||...
T Consensus       265 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             chHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            46788999999999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=96.69  E-value=0.0006  Score=62.52  Aligned_cols=34  Identities=29%  Similarity=0.527  Sum_probs=30.9

Q ss_pred             ChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         64 PPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        64 ~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +..+.+||.+||+.||.+|||+.++++||||..+
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            4457899999999999999999999999999763

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.66  E-value=0.0066  Score=49.28  Aligned_cols=96  Identities=19%  Similarity=0.049  Sum_probs=63.4

Q ss_pred             ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCcc
Q psy13988        240 DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKV  318 (358)
Q Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  318 (358)
                      +|...+...+.+++|+++|.++.|.+.+|..+-. ..-..+=+.|..|++..+|.+...+ ..+.              .
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~   98 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A   98 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence            5777777788899999999999999999888732 1112334456889999999887653 1110              0


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHh
Q psy13988        319 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELF  352 (358)
Q Consensus       319 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll  352 (358)
                      ....+.|||...  ...+.+.=|||||+++|..+
T Consensus        99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~AL  130 (229)
T 2yle_A           99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKAL  130 (229)
T ss_dssp             --------CCSS--SSSCHHHHHHHHHHHHHHHH
T ss_pred             cccCCCChhhcc--ccchHHHHHHHHHHHHHHHh
Confidence            123456888653  22467889999999999876

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=96.65  E-value=0.00078  Score=59.76  Aligned_cols=37  Identities=22%  Similarity=0.400  Sum_probs=34.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHh-hhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAE-QALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~-~~l~~~~~~~~~   98 (358)
                      .+++++.+||.+||+.||.+|+++. +++.||||+.+.
T Consensus       240 ~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          240 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            4789999999999999999999998 999999998764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=96.64  E-value=0.00096  Score=58.07  Aligned_cols=35  Identities=26%  Similarity=0.393  Sum_probs=32.8

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+.+..+||.+||..||.+|||+.+++.||||...
T Consensus       251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            57889999999999999999999999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=96.63  E-value=0.00091  Score=58.29  Aligned_cols=36  Identities=14%  Similarity=0.179  Sum_probs=33.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .++++..+|+.+||..||.+||++.+++.||||...
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            367899999999999999999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=96.63  E-value=0.0011  Score=58.24  Aligned_cols=36  Identities=22%  Similarity=0.428  Sum_probs=33.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcC-----CHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~-----~~~~~l~~~~~~~~   97 (358)
                      .+++++.+||.+||+.||.+|+     ++.+++.||||+.+
T Consensus       243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            4688999999999999999999     88999999999865

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=96.60  E-value=0.0012  Score=58.17  Aligned_cols=36  Identities=31%  Similarity=0.453  Sum_probs=33.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..+++..+||.+||..||.+|+|+.+++.||||...
T Consensus       263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            467889999999999999999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=96.59  E-value=0.00079  Score=61.77  Aligned_cols=33  Identities=30%  Similarity=0.403  Sum_probs=30.8

Q ss_pred             ChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         64 PPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        64 ~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ++++.+|+.+||+.||.+|||+.++++||||..
T Consensus       269 ~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          269 IAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            467899999999999999999999999999974

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=96.57  E-value=0.001  Score=60.06  Aligned_cols=35  Identities=23%  Similarity=0.318  Sum_probs=32.2

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+.++.+||.+||..||.+|||+.++|.||||...
T Consensus       293 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             chHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            46788999999999999999999999999999853

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=96.47  E-value=0.0017  Score=59.63  Aligned_cols=39  Identities=15%  Similarity=0.182  Sum_probs=34.9

Q ss_pred             cCCChhHHHHHhhhcCCCCCC--cCCHhhhhcCcccccCCC
Q psy13988         61 SLMPPGALDLLDKMLELDPER--RITAEQALKSVWLKNVHP   99 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~--R~~~~~~l~~~~~~~~~~   99 (358)
                      +.+++++.|||++||+.+|.+  |++++++++||||+.+..
T Consensus       307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w  347 (437)
T 4aw2_A          307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW  347 (437)
T ss_dssp             CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred             ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence            347899999999999999999  999999999999987643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=96.45  E-value=0.0012  Score=57.93  Aligned_cols=36  Identities=17%  Similarity=0.277  Sum_probs=33.5

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..++++.+|+.+||..||.+|||+.++++||||...
T Consensus       257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            478899999999999999999999999999999764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=96.44  E-value=0.0014  Score=58.11  Aligned_cols=36  Identities=22%  Similarity=0.192  Sum_probs=33.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..+++..+||.+||..||.+|||+.++++|||+...
T Consensus       277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            467889999999999999999999999999999863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=96.43  E-value=0.0021  Score=57.06  Aligned_cols=36  Identities=19%  Similarity=0.414  Sum_probs=33.5

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCC-----HhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRIT-----AEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~-----~~~~l~~~~~~~~   97 (358)
                      .+++++.+||.+||+.||.+|++     +++++.||||..+
T Consensus       260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            47899999999999999999998     9999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=96.37  E-value=0.00056  Score=59.85  Aligned_cols=32  Identities=19%  Similarity=0.100  Sum_probs=28.6

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCccc
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWL   94 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~   94 (358)
                      .+....+||.+||++||.+|+|++|+|+||-=
T Consensus       275 ~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          275 LQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            45677899999999999999999999999863

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=96.32  E-value=0.0016  Score=59.32  Aligned_cols=37  Identities=22%  Similarity=0.294  Sum_probs=34.1

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +.+++++.+||.+||+.||.+|+++.++++||||..+
T Consensus       334 ~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          334 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            3578999999999999999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=96.31  E-value=0.0023  Score=56.85  Aligned_cols=36  Identities=25%  Similarity=0.531  Sum_probs=33.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcC-----CHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~-----~~~~~l~~~~~~~~   97 (358)
                      .+++.+.+||.+||..||.+|+     +++++++||||..+
T Consensus       288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            4678899999999999999999     99999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=96.30  E-value=0.0024  Score=56.79  Aligned_cols=37  Identities=11%  Similarity=0.320  Sum_probs=33.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCC-----HhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRIT-----AEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~-----~~~~l~~~~~~~~~   98 (358)
                      .+++++.+||.+||+.||.+|++     +++++.||||+.+.
T Consensus       243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            47899999999999999999995     69999999998653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=96.29  E-value=0.0017  Score=56.20  Aligned_cols=36  Identities=19%  Similarity=0.243  Sum_probs=33.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      ..+.+..+|+.+||..||.+|||+.++++||||...
T Consensus       242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            467889999999999999999999999999999753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=96.29  E-value=0.0019  Score=61.22  Aligned_cols=36  Identities=25%  Similarity=0.407  Sum_probs=33.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcC-----CHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~-----~~~~~l~~~~~~~~   97 (358)
                      .+++++.+||.+||+.||.+|+     ++++++.||||+.+
T Consensus       411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            4789999999999999999999     88999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=96.20  E-value=0.004  Score=56.60  Aligned_cols=37  Identities=22%  Similarity=0.301  Sum_probs=33.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcC---CHhhhhcCcccccCCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRI---TAEQALKSVWLKNVHP   99 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~---~~~~~l~~~~~~~~~~   99 (358)
                      .+++++.|||++||+ +|.+|+   ++++++.||||+.+..
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w  336 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW  336 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence            578999999999999 999984   8999999999987654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=96.16  E-value=0.0031  Score=56.76  Aligned_cols=37  Identities=19%  Similarity=0.439  Sum_probs=33.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCC-HhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRIT-AEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~-~~~~l~~~~~~~~~   98 (358)
                      ..++++.+||.+||..||.+|++ +++++.||||..+.
T Consensus       242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            46889999999999999999998 89999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=96.16  E-value=0.0034  Score=57.03  Aligned_cols=37  Identities=22%  Similarity=0.229  Sum_probs=34.1

Q ss_pred             CCChhHHHHHhhhcCCCCCC--cCCHhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPER--RITAEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~--R~~~~~~l~~~~~~~~~   98 (358)
                      .+++++.+||.+||+.+|.+  |++++++++||||+.+.
T Consensus       299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            47899999999999999988  99999999999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.07  E-value=0.024  Score=51.22  Aligned_cols=30  Identities=30%  Similarity=0.530  Sum_probs=25.4

Q ss_pred             ceecCCCCCCEEe------cCCCcEEEeecccceec
Q psy13988        276 FLHRDIKCSNILM------NNRGEVKLADFGLARLY  305 (358)
Q Consensus       276 i~H~Dlkp~Nill------~~~~~~~l~Dfg~~~~~  305 (358)
                      ++|+|+.+.||++      +++..+.++||..|..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            6799999999999      34567999999998753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=96.06  E-value=0.00044  Score=61.04  Aligned_cols=74  Identities=11%  Similarity=0.051  Sum_probs=45.5

Q ss_pred             HHHHHHHhhcCCCCCCccccccCCCCCC---CC----C-CcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhh
Q psy13988         17 LQLEVISKLCGTPTPAVWPAVIKLPLWH---TI----K-PKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQA   88 (358)
Q Consensus        17 ~ql~~i~~~lGtp~~~~~~~~~~~~~~~---~~----~-~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~   88 (358)
                      ++..-|..++|+|..+.|.+........   ..    . ............++.+++++.|||.+||++|     |++|+
T Consensus       254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~  328 (336)
T 2vuw_A          254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDL  328 (336)
T ss_dssp             SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHH
T ss_pred             ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHH
Confidence            4556677778888888887643221100   00    0 0000011111223456789999999999987     99999


Q ss_pred             h-cCcccc
Q psy13988         89 L-KSVWLK   95 (358)
Q Consensus        89 l-~~~~~~   95 (358)
                      | +||||+
T Consensus       329 l~~Hp~f~  336 (336)
T 2vuw_A          329 LCQHSLFK  336 (336)
T ss_dssp             HHHCGGGC
T ss_pred             HhcCCCcC
Confidence            9 999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=96.04  E-value=0.0037  Score=60.65  Aligned_cols=37  Identities=11%  Similarity=0.325  Sum_probs=34.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCH-----hhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITA-----EQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~-----~~~l~~~~~~~~~   98 (358)
                      .+++++.+||.+||+.||.+|+++     ++++.||||+.+.
T Consensus       564 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            478999999999999999999998     9999999998764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=95.94  E-value=0.0042  Score=52.85  Aligned_cols=35  Identities=17%  Similarity=0.265  Sum_probs=32.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..+++..+|+.+||..||.+|||+.+++.|+|+..
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            46789999999999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=95.92  E-value=0.0015  Score=62.97  Aligned_cols=35  Identities=17%  Similarity=0.076  Sum_probs=29.2

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .++++.+||.+||.+||.+|||+.+++.||||..+
T Consensus       270 ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          270 LAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             GHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence            56788999999999999999999999999999754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=95.84  E-value=0.005  Score=55.18  Aligned_cols=38  Identities=21%  Similarity=0.338  Sum_probs=33.9

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCH----hhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITA----EQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~----~~~l~~~~~~~~~   98 (358)
                      +.+++++.+||.+||+.||.+|+++    .+++.||||+.+.
T Consensus       260 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            3578999999999999999999997    5899999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=95.59  E-value=0.0063  Score=57.35  Aligned_cols=37  Identities=19%  Similarity=0.469  Sum_probs=33.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCC-----HhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRIT-----AEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~-----~~~~l~~~~~~~~~   98 (358)
                      .+++++.+||.+||+.||.+|++     +++++.||||+.+.
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence            57899999999999999999995     58999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=95.34  E-value=0.0067  Score=52.66  Aligned_cols=38  Identities=13%  Similarity=0.182  Sum_probs=34.2

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      +.++++..+|+.+||..||.+|+++.+++.|+|++...
T Consensus       244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            34788999999999999999999999999999998543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=94.29  E-value=0.022  Score=49.55  Aligned_cols=37  Identities=19%  Similarity=0.213  Sum_probs=28.0

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCC-------HhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRIT-------AEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~-------~~~~l~~~~~~~~   97 (358)
                      +..+++..+|+.+||..||.+|||       .++++.|+|+...
T Consensus       262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            356789999999999999999999       6788999999763

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=92.99  E-value=0.055  Score=46.86  Aligned_cols=33  Identities=21%  Similarity=0.159  Sum_probs=28.0

Q ss_pred             cccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         59 EFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        59 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+.+++++.+|+.+||+.||.+|||+.+++.+
T Consensus       262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            344578899999999999999999999987544

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=92.82  E-value=0.048  Score=47.28  Aligned_cols=31  Identities=16%  Similarity=0.244  Sum_probs=28.0

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ...+.+..+|+.+||..||.+|||+.+++.+
T Consensus       263 ~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          263 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3567889999999999999999999999876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=92.54  E-value=0.04  Score=46.72  Aligned_cols=35  Identities=23%  Similarity=0.365  Sum_probs=31.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..+.+..+|+.+||..||.+|||+.+++.+.+...
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            36788999999999999999999999999987654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=92.43  E-value=0.054  Score=47.95  Aligned_cols=30  Identities=13%  Similarity=0.187  Sum_probs=28.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+++++.+|+.+|+..||.+|||+.+++.|
T Consensus       312 ~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          312 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            478899999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=92.20  E-value=0.061  Score=45.27  Aligned_cols=30  Identities=20%  Similarity=0.286  Sum_probs=27.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+|+.+||..||.+|||+.+++++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            467889999999999999999999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=92.12  E-value=0.051  Score=47.31  Aligned_cols=35  Identities=14%  Similarity=0.159  Sum_probs=31.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..+++..+|+.+||..||.+||++.+++.+.++..
T Consensus       269 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          269 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            46788999999999999999999999999988753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=91.97  E-value=0.066  Score=45.06  Aligned_cols=29  Identities=14%  Similarity=0.257  Sum_probs=26.8

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+++..+|+.+||..||.+|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            57889999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=91.82  E-value=0.084  Score=45.21  Aligned_cols=29  Identities=21%  Similarity=0.397  Sum_probs=26.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      .++++..+|+.+||..||.+|||+.++++
T Consensus       267 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          267 NCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            56789999999999999999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=91.81  E-value=0.059  Score=46.62  Aligned_cols=35  Identities=11%  Similarity=0.224  Sum_probs=29.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc--Cccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK--SVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~--~~~~~~   96 (358)
                      .++++..+|+.+||..||.+|||+.++++  .+++..
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            57889999999999999999999999986  456554

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=91.79  E-value=0.054  Score=48.71  Aligned_cols=29  Identities=21%  Similarity=0.194  Sum_probs=24.5

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+....+||.+||++||.+|+++++++.+
T Consensus       275 ~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          275 LQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             HHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            34567899999999999999999987443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=91.77  E-value=0.07  Score=46.09  Aligned_cols=31  Identities=23%  Similarity=0.366  Sum_probs=28.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSV   92 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~   92 (358)
                      ..+++..+||.+||..||.+|||+.+++.+-
T Consensus       271 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          271 RHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            4678999999999999999999999999863

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=91.69  E-value=0.091  Score=45.99  Aligned_cols=30  Identities=13%  Similarity=0.341  Sum_probs=27.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+++++.+|+.+|+..||.+|||+.+++.+
T Consensus       284 ~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          284 ACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             TCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            478899999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=91.60  E-value=0.072  Score=44.75  Aligned_cols=29  Identities=24%  Similarity=0.216  Sum_probs=26.8

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+++..+|+.+||..||.+|||+.+++.+
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            57789999999999999999999999876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=91.58  E-value=0.077  Score=46.16  Aligned_cols=30  Identities=13%  Similarity=0.135  Sum_probs=27.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .++++..+|+.+||..||.+|||+.+++.+
T Consensus       268 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          268 ACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            467899999999999999999999999654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=91.52  E-value=0.06  Score=47.00  Aligned_cols=33  Identities=27%  Similarity=0.486  Sum_probs=27.5

Q ss_pred             ChhHHHHHhhhcCCCCCCcCCHhhh------hcCccccc
Q psy13988         64 PPGALDLLDKMLELDPERRITAEQA------LKSVWLKN   96 (358)
Q Consensus        64 ~~~~~~ll~~~l~~~p~~R~~~~~~------l~~~~~~~   96 (358)
                      ++++.+||.+||..||.+|||+.++      +.++|-+.
T Consensus       285 ~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          285 VRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            3468999999999999999999998      55677665

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=91.39  E-value=0.1  Score=43.79  Aligned_cols=29  Identities=17%  Similarity=0.293  Sum_probs=26.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..+++..+|+.+||..||.+|||+.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            47889999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=91.36  E-value=0.083  Score=46.55  Aligned_cols=30  Identities=13%  Similarity=0.187  Sum_probs=27.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..++++.+|+.+||..||.+|||+.+++.|
T Consensus       320 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          320 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            467899999999999999999999999876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=91.29  E-value=0.11  Score=44.25  Aligned_cols=30  Identities=20%  Similarity=0.212  Sum_probs=27.0

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..++++..+|+.+||..||.+|||+.+++.
T Consensus       252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          252 SNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            456788999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=91.19  E-value=0.1  Score=44.23  Aligned_cols=29  Identities=21%  Similarity=0.299  Sum_probs=26.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..+++..+|+.+||..||.+|||+.++++
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          254 DCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            46788999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=91.12  E-value=0.065  Score=45.57  Aligned_cols=30  Identities=10%  Similarity=0.341  Sum_probs=27.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+|+.+||..||.+|||+.+++++
T Consensus       240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          240 PKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            457788999999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=91.11  E-value=0.084  Score=45.93  Aligned_cols=30  Identities=23%  Similarity=0.182  Sum_probs=27.5

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+|+.+||..||.+|||+.+++.+
T Consensus       265 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          265 NCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            467899999999999999999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=91.06  E-value=0.095  Score=44.42  Aligned_cols=31  Identities=26%  Similarity=0.358  Sum_probs=27.5

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.++++..+|+.+||..||.+|||+.+++.+
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3578899999999999999999999998753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=90.98  E-value=0.098  Score=44.31  Aligned_cols=30  Identities=27%  Similarity=0.421  Sum_probs=27.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+|+.+||..||.+|||+.+++.+
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            467889999999999999999999998864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=90.96  E-value=0.097  Score=45.05  Aligned_cols=30  Identities=13%  Similarity=0.154  Sum_probs=27.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .++++..+|+.+||..||.+|||+.+++.+
T Consensus       276 ~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          276 NCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            578899999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=90.93  E-value=0.1  Score=44.44  Aligned_cols=33  Identities=15%  Similarity=0.078  Sum_probs=29.4

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVW   93 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~   93 (358)
                      +..+++..+|+.+||..||.+||++.+++.+.+
T Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            357889999999999999999999999988753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=90.93  E-value=0.093  Score=44.45  Aligned_cols=29  Identities=10%  Similarity=0.076  Sum_probs=26.7

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+++..+|+.+||..||.+|||+.+++.|
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            57888999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=90.79  E-value=0.1  Score=44.91  Aligned_cols=30  Identities=23%  Similarity=0.372  Sum_probs=27.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+|+.+||..||.+|||+.+++++
T Consensus       272 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            467889999999999999999999998864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=90.68  E-value=0.11  Score=44.83  Aligned_cols=30  Identities=13%  Similarity=0.187  Sum_probs=27.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+++.+||..||.+|||+.+++.|
T Consensus       275 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          275 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            467899999999999999999999999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=90.64  E-value=0.13  Score=43.84  Aligned_cols=30  Identities=10%  Similarity=-0.042  Sum_probs=26.9

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..++++..+|+.+||..||.+|||+.++++
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            456889999999999999999999998865

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=90.45  E-value=0.14  Score=43.72  Aligned_cols=29  Identities=7%  Similarity=0.014  Sum_probs=26.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      .++++..+|+.+||..||.+|||+.+++.
T Consensus       256 ~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          256 GCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            46788999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=90.39  E-value=0.14  Score=43.42  Aligned_cols=29  Identities=14%  Similarity=0.237  Sum_probs=26.5

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..+++..+|+.+||..||.+|||+.++++
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            46788999999999999999999999865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=90.35  E-value=0.097  Score=46.49  Aligned_cols=34  Identities=15%  Similarity=0.159  Sum_probs=30.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLK   95 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~   95 (358)
                      .++++..+|+.+||..||.+|||+.+++++.++.
T Consensus       310 ~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          310 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            4678899999999999999999999999998764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=90.27  E-value=0.14  Score=43.55  Aligned_cols=30  Identities=10%  Similarity=-0.042  Sum_probs=26.9

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      +.++++..+|+.+||..||.+|||+.+++.
T Consensus       244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            457889999999999999999999988764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=90.25  E-value=0.12  Score=43.20  Aligned_cols=30  Identities=17%  Similarity=0.293  Sum_probs=26.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+|+.+||..||.+|||+.+++.+
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            357889999999999999999999998864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=90.17  E-value=0.12  Score=45.12  Aligned_cols=32  Identities=6%  Similarity=0.032  Sum_probs=28.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVW   93 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~   93 (358)
                      ..+++..+|+.+||..||.+|||+.+++.+-.
T Consensus       299 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          299 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            46789999999999999999999999987654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=89.96  E-value=0.13  Score=43.57  Aligned_cols=29  Identities=17%  Similarity=0.145  Sum_probs=26.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..+++..+++.+||..||.+|||+.+++.
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            46789999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=89.94  E-value=0.16  Score=43.97  Aligned_cols=29  Identities=21%  Similarity=0.243  Sum_probs=26.5

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      .++++..+|+.+||..||.+|||+.+++.
T Consensus       275 ~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          275 KCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            46789999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=89.86  E-value=0.14  Score=44.13  Aligned_cols=30  Identities=13%  Similarity=-0.019  Sum_probs=27.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .++++..+|+.+||..||.+|||+.+++.+
T Consensus       273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            467889999999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=89.86  E-value=0.15  Score=43.96  Aligned_cols=31  Identities=23%  Similarity=0.354  Sum_probs=27.8

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..++++..+|+.+||..||.+|||+++++++
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            4578899999999999999999999998774

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=89.82  E-value=0.14  Score=43.69  Aligned_cols=33  Identities=6%  Similarity=-0.095  Sum_probs=28.1

Q ss_pred             cccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         59 EFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        59 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+.++++..+|+.+||..||.+||++++++..
T Consensus       245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            334678899999999999999999999987643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=89.81  E-value=0.096  Score=45.61  Aligned_cols=29  Identities=21%  Similarity=0.211  Sum_probs=25.6

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ++++..+|+.+||..||.+|||+.+++++
T Consensus       297 ~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          297 CLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            34568899999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=89.72  E-value=0.21  Score=42.49  Aligned_cols=29  Identities=21%  Similarity=0.121  Sum_probs=26.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..+++..+|+.+||..||.+|||+.+++.
T Consensus       244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          244 GCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            46889999999999999999999998864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=89.70  E-value=0.12  Score=44.75  Aligned_cols=33  Identities=6%  Similarity=-0.015  Sum_probs=28.4

Q ss_pred             ChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         64 PPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        64 ~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      +.+..+|+.+||..||.+|||+.++++|-.-..
T Consensus       278 ~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          278 VEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            357899999999999999999999998875443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=89.66  E-value=0.18  Score=43.49  Aligned_cols=33  Identities=18%  Similarity=0.263  Sum_probs=28.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      .+++++.+|+.+|++.||.+|||+.++  ++++..
T Consensus       254 ~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          254 TCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             cchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            478899999999999999999999998  456654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=89.46  E-value=0.15  Score=45.43  Aligned_cols=30  Identities=13%  Similarity=0.098  Sum_probs=27.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .++++..+|+.+||..||.+|||+.+++++
T Consensus       317 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          317 NCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            468899999999999999999999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=89.46  E-value=0.13  Score=44.02  Aligned_cols=27  Identities=22%  Similarity=0.245  Sum_probs=24.4

Q ss_pred             ChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         64 PPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        64 ~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      +++..+|+.+||..||.+|||+.++++
T Consensus       269 ~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          269 LTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            457899999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=89.39  E-value=0.16  Score=44.14  Aligned_cols=26  Identities=15%  Similarity=0.188  Sum_probs=23.6

Q ss_pred             hhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         65 PGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        65 ~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      +++.+|+.+||..||.+|||+.++++
T Consensus       286 ~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          286 AMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            45899999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=89.36  E-value=0.19  Score=42.82  Aligned_cols=30  Identities=20%  Similarity=0.280  Sum_probs=26.5

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+|+.+||..||.+|||+.+++..
T Consensus       252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            367889999999999999999999988753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=89.28  E-value=0.16  Score=43.89  Aligned_cols=30  Identities=17%  Similarity=0.073  Sum_probs=27.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .++++..+|+.+|+..||.+|||+.+++.+
T Consensus       271 ~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          271 DCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            578889999999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=89.18  E-value=0.14  Score=44.46  Aligned_cols=31  Identities=19%  Similarity=0.350  Sum_probs=27.8

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcc
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVW   93 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~   93 (358)
                      .+....+|+.+||..||.+|||+.+++.+-.
T Consensus       274 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          274 QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            5677899999999999999999999998854

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=89.16  E-value=0.16  Score=43.58  Aligned_cols=30  Identities=17%  Similarity=0.226  Sum_probs=26.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+|+.+||..||.+|||+.+++.+
T Consensus       262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          262 HYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            467889999999999999999999998853

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=89.07  E-value=0.19  Score=43.26  Aligned_cols=30  Identities=23%  Similarity=0.366  Sum_probs=27.3

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      +.++++..+|+.+||..||.+|||+.+++.
T Consensus       246 ~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            357889999999999999999999999876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=89.07  E-value=0.21  Score=42.17  Aligned_cols=29  Identities=21%  Similarity=0.280  Sum_probs=26.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..+++..+|+.+||..||.+|||+.+++.
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          238 GCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            46788999999999999999999998874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=88.96  E-value=0.21  Score=43.36  Aligned_cols=29  Identities=7%  Similarity=0.014  Sum_probs=26.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      .++++..+|+.+||..||.+|||+.+++.
T Consensus       287 ~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          287 GCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            46789999999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=88.80  E-value=0.13  Score=44.65  Aligned_cols=30  Identities=23%  Similarity=0.079  Sum_probs=26.2

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCc
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSV   92 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~   92 (358)
                      .+.+..+|+.+||..||.+|||+.+++.+-
T Consensus       281 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             HHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            345678999999999999999999998764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=88.48  E-value=0.24  Score=43.57  Aligned_cols=30  Identities=10%  Similarity=-0.005  Sum_probs=26.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .++++..+|+.+||..||.+|||+.+++..
T Consensus       301 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          301 RPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             CCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            458899999999999999999999988653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=88.32  E-value=0.24  Score=42.15  Aligned_cols=29  Identities=14%  Similarity=0.149  Sum_probs=26.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..+++..+|+.+||..||.+|||+.+++.
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            35788999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=88.26  E-value=0.21  Score=43.43  Aligned_cols=28  Identities=21%  Similarity=0.361  Sum_probs=25.9

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      .+++..+|+.+||..||.+|||+.+++.
T Consensus       292 ~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          292 APKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            5788899999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=88.17  E-value=0.23  Score=43.20  Aligned_cols=30  Identities=10%  Similarity=0.152  Sum_probs=26.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+.+..+|+.+||..||.+|||+.+++..
T Consensus       243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            467889999999999999999999998863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	358
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-52
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-15
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-06
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-07
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-07
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-06
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-07
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-09
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-08
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-16
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-10
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-12
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-43
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-09
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-10
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-14
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-14
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-42
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-05
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-14
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-10
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-15
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-14
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-12
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-06
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-07
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-05
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	0.002
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-36
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-36
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-36
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-14
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-08
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-06
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-06
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-08
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-12
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-07
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-34
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-33
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-12
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-04
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-06
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-06
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	0.004
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	0.004
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-31
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-31
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-04
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-27
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	0.003
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-26
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-19

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 7e-52
 Identities = 100/191 (52%), Positives = 134/191 (70%), Gaps = 4/191 (2%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VALKKV +ENEKEGFPITA+REIKIL+ L H+N+VNL EI   K+    + + KGS
Sbjct: 34  TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS--PYNRCKGS 91

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLVF++ +HDL GLL + +V F       +M+ LL+GL Y H+   LHRD+K +N+L+ 
Sbjct: 92  IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 151

Query: 290 NRGEVKLADFGLARLYNA--EDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
             G +KLADFGLAR ++     +   YTN+V+TLWYRPPELLLGE  YGP ID+W  GCI
Sbjct: 152 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211

Query: 348 LGELFVKKPLF 358
           + E++ + P+ 
Sbjct: 212 MAEMWTRSPIM 222

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.6 bits (177), Expect = 5e-15
 Identities = 33/88 (37%), Positives = 52/88 (59%), Gaps = 2/88 (2%)

Query: 11  WANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS--LMPPGAL 68
             N E  QL +IS+LCG+ TP VWP V    L+  ++  K  +R++++     +  P AL
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282

Query: 69  DLLDKMLELDPERRITAEQALKSVWLKN 96
           DL+DK+L LDP +RI ++ AL   +  +
Sbjct: 283 DLIDKLLVLDPAQRIDSDDALNHDFFWS 310

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 7e-51
 Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 11/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T+E VA+K V ++   +  P    +EI I + LNH+N+V               R++   
Sbjct: 29  TEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKF----------YGHRREGNI 77

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YL  EY     +       +   E +      QL+ G+ Y H     HRDIK  N+L++
Sbjct: 78  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
            R  +K++DFGLA ++   +R+R       TL Y  PELL   E +   +DVWSCG +L 
Sbjct: 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 197

Query: 350 ELFVKKPLF 358
            +   +  +
Sbjct: 198 AMLAGELPW 206

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 11/47 (23%), Positives = 17/47 (36%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLK 95
               ++     +  +    L LL K+L  +P  RIT     K  W  
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 6e-48
 Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 17/190 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           +  ++A K + LE  K       +RE+++L + N   IV                   G 
Sbjct: 30  SGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----------GE 78

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN-FLHRDIKCSNILM 288
             +  E+MD   +  +        E     +   ++ GL+Y  +++  +HRD+K SNIL+
Sbjct: 79  ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           N+RGE+KL DFG++             + V T  Y  PE L G   Y    D+WS G  L
Sbjct: 139 NSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSL 193

Query: 349 GELFVKKPLF 358
            E+ V +   
Sbjct: 194 VEMAVGRYPI 203

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 16/96 (16%), Positives = 28/96 (29%), Gaps = 9/96 (9%)

Query: 16  LLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPG--------- 66
           +   +V      TP     P           +P       L    +  PP          
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273

Query: 67  ALDLLDKMLELDPERRITAEQALKSVWLKNVHPESM 102
             D ++K L  +P  R   +Q +   ++K    E +
Sbjct: 274 FQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (402), Expect = 3e-47
 Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 16/190 (8%)

Query: 170 TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           +  ++ALK +     EK G      RE++I   L H NI+ L            +  D  
Sbjct: 30  SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL----------YGYFHDAT 79

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             YL+ EY     +      +  F+E   A+ + +L + LSYCH +  +HRDIK  N+L+
Sbjct: 80  RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
            + GE+K+ADFG +    +  R         TL Y PPE++ G   +   +D+WS G + 
Sbjct: 140 GSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEMIEG-RMHDEKVDLWSLGVLC 194

Query: 349 GELFVKKPLF 358
            E  V KP F
Sbjct: 195 YEFLVGKPPF 204

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (116), Expect = 3e-07
 Identities = 14/65 (21%), Positives = 33/65 (50%), Gaps = 3/65 (4%)

Query: 34  WPAVIKLPLWHTIKPKKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALK 90
           +  ++  P +     ++ ++R  R EF+    +  GA DL+ ++L+ +P +R    + L+
Sbjct: 195 YEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

Query: 91  SVWLK 95
             W+ 
Sbjct: 255 HPWIT 259

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-46
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 20/198 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             +++  K++   +  E      V E+ +LR+L H NIV   + + D+++         +
Sbjct: 28  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN--------TT 79

Query: 230 FYLVFEYMDH-DLMGLLESGMVD---FNEVNNASIMRQLLDGLSYCHKRN-----FLHRD 280
            Y+V EY +  DL  ++  G  +    +E     +M QL   L  CH+R+      LHRD
Sbjct: 80  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +K +N+ ++ +  VKL DFGLAR+ N +         V T +Y  PE +     Y    D
Sbjct: 140 LKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMNR-MSYNEKSD 196

Query: 341 VWSCGCILGELFVKKPLF 358
           +WS GC+L EL    P F
Sbjct: 197 IWSLGCLLYELCALMPPF 214

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (104), Expect = 9e-06
 Identities = 9/46 (19%), Positives = 19/46 (41%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWL 94
            KI   + R           +++ +ML L    R + E+ L++  +
Sbjct: 224 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-46
 Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 19/194 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  L A K +  ++E+E      + EI IL   +H NIV L          LD    + +
Sbjct: 36  TSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKL----------LDAFYYENN 83

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ E+     +  ++        E     + +Q LD L+Y H    +HRD+K  NIL 
Sbjct: 84  LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF 143

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSC 344
              G++KLADFG++       ++R   + + T ++  PE+++ E      Y    DVWS 
Sbjct: 144 TLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 201

Query: 345 GCILGELFVKKPLF 358
           G  L E+   +P  
Sbjct: 202 GITLIEMAEIEPPH 215

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (116), Expect = 3e-07
 Identities = 22/104 (21%), Positives = 34/104 (32%), Gaps = 13/104 (12%)

Query: 6   RGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKL-------PLWHTIKPKKIHRRRLRE 58
            G   W   E++  E            VW   I L       P  H + P ++  +  + 
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230

Query: 59  EF------SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN 96
           E       S       D L K LE + + R T  Q L+  ++  
Sbjct: 231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 3e-45
 Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 14/188 (7%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K + +             E+ +LR+  H NI+      T                +V
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----------PQLAIV 81

Query: 234 FEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG 292
            ++ +   L   L      F  +    I RQ   G+ Y H ++ +HRD+K +NI ++   
Sbjct: 82  TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141

Query: 293 EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGE 350
            VK+ DFGLA + +       +     ++ +  PE++  +++  Y    DV++ G +L E
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201

Query: 351 LFVKKPLF 358
           L   +  +
Sbjct: 202 LMTGQLPY 209

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (391), Expect = 4e-45
 Identities = 59/192 (30%), Positives = 89/192 (46%), Gaps = 19/192 (9%)

Query: 170 TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
             E+VA+KK+     +        ++E++ L++L H N +  R     +           
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----------H 88

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           + +LV EY       LLE       EV  A++    L GL+Y H  N +HRD+K  NIL+
Sbjct: 89  TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGC 346
           +  G VKL DFG A +        P  + V T ++  PE++L   E +Y   +DVWS G 
Sbjct: 149 SEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202

Query: 347 ILGELFVKKPLF 358
              EL  +KP  
Sbjct: 203 TCIELAERKPPL 214

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 11/78 (14%), Positives = 27/78 (34%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
                     +         + +D  L+  P+ R T+E  LK  ++    P ++    + 
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284

Query: 109 TWQDCHELWSKKRRRQLR 126
             +D        + R+++
Sbjct: 285 RTKDAVRELDNLQYRKMK 302

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 54/190 (28%), Positives = 94/190 (49%), Gaps = 18/190 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T + VA++++ L+ + +   I  + EI ++R+  + NIVN           LD       
Sbjct: 44  TGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY----------LDSYLVGDE 91

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            ++V EY+    L  ++    +D  ++  A++ R+ L  L + H    +HRDIK  NIL+
Sbjct: 92  LWVVMEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              G VKL DFG       E  +R  +  V T ++  PE++   + YGP +D+WS G + 
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMA 206

Query: 349 GELFVKKPLF 358
            E+   +P +
Sbjct: 207 IEMIEGEPPY 216

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.1 bits (127), Expect = 1e-08
 Identities = 15/75 (20%), Positives = 32/75 (42%), Gaps = 5/75 (6%)

Query: 39  KLPLWHTIKPKKIHRRRLREEFSL-----MPPGALDLLDKMLELDPERRITAEQALKSVW 93
           + P  +    + ++         L     +     D L++ L++D E+R +A++ L+  +
Sbjct: 213 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272

Query: 94  LKNVHPESMPPPQLP 108
           LK   P S   P + 
Sbjct: 273 LKIAKPLSSLTPLIA 287

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 6e-44
 Identities = 75/192 (39%), Positives = 117/192 (60%), Gaps = 15/192 (7%)

Query: 170 TDELVALKKVRLEN---EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD 226
           T+++VA+KK++L +    K+G   TA+REIK+L++L+H NI+ L          LD    
Sbjct: 22  TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL----------LDAFGH 71

Query: 227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
           K +  LVF++M+ DL  +++   +     +  + M   L GL Y H+   LHRD+K +N+
Sbjct: 72  KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 131

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L++  G +KLADFGLA+ + +    R YT++V+T WYR PELL G   YG  +D+W+ GC
Sbjct: 132 LLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189

Query: 347 ILGELFVKKPLF 358
           IL EL ++ P  
Sbjct: 190 ILAELLLRVPFL 201

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.6 bits (190), Expect = 1e-16
 Identities = 35/94 (37%), Positives = 43/94 (45%), Gaps = 3/94 (3%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           +L QL  I +  GTPT   WP +  LP + T K        L   FS      LDL+  +
Sbjct: 206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK--SFPGIPLHHIFSAAGDDLLDLIQGL 263

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
              +P  RITA QALK  +  N  P   P  QLP
Sbjct: 264 FLFNPCARITATQALKMKYFSN-RPGPTPGCQLP 296

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 12/190 (6%)

Query: 170 TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T    A+K +   +  KE       RE  ++ +L+H   V L     D            
Sbjct: 32  TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD----------E 81

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             Y    Y  +  +      +  F+E        +++  L Y H +  +HRD+K  NIL+
Sbjct: 82  KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 141

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           N    +++ DFG A++ + E +Q    + V T  Y  PELL   +    + D+W+ GCI+
Sbjct: 142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCII 200

Query: 349 GELFVKKPLF 358
            +L    P F
Sbjct: 201 YQLVAGLPPF 210

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.3 bits (138), Expect = 6e-10
 Identities = 22/109 (20%), Positives = 42/109 (38%), Gaps = 21/109 (19%)

Query: 20  EVISKLCGTPTPAVWPAVIKL-------PLWHTIKPKKIHRRRLREEFSL---MPPGALD 69
           E++++     +  +W     +       P +       I ++ ++ E+       P A D
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239

Query: 70  LLDKMLELDPERRITAEQALKSVWLKNVHP----------ESMPPPQLP 108
           L++K+L LD  +R+  E+      LK  HP              PP+L 
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKA-HPFFESVTWENLHQQTPPKLT 287

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  149 bits (377), Expect = 2e-43
 Identities = 84/189 (44%), Positives = 112/189 (59%), Gaps = 12/189 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             E  ALKK+RLE E EG P T +REI IL++L H NIV L           D    K  
Sbjct: 25  YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL----------YDVIHTKKR 74

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             LVFE++D DL  LL+        V   S + QLL+G++YCH R  LHRD+K  N+L+N
Sbjct: 75  LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             GE+K+ADFGLAR +    R+  +   ++TLWYR P++L+G ++Y   ID+WS GCI  
Sbjct: 135 REGELKIADFGLARAFGIPVRKYTHE--IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFA 192

Query: 350 ELFVKKPLF 358
           E+    PLF
Sbjct: 193 EMVNGTPLF 201

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 64.9 bits (157), Expect = 1e-12
 Identities = 28/78 (35%), Positives = 39/78 (50%), Gaps = 1/78 (1%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLEL 77
           QL  I ++ GTP    WP V +LP +                   +    +DLL KML+L
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY-EPLPWESFLKGLDESGIDLLSKMLKL 267

Query: 78  DPERRITAEQALKSVWLK 95
           DP +RITA+QAL+  + K
Sbjct: 268 DPNQRITAKQALEHAYFK 285

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 19/192 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T    A K V   +E +    T  +EI+ +  L H  +VNL +   D             
Sbjct: 50  TGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDD----------NE 97

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             +++E+M   +L   +       +E      MRQ+  GL + H+ N++H D+K  NI+ 
Sbjct: 98  MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 157

Query: 289 NNR--GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
             +   E+KL DFGL    + +   +  T       +  PE+  G +  G   D+WS G 
Sbjct: 158 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGT---AEFAAPEVAEG-KPVGYYTDMWSVGV 213

Query: 347 ILGELFVKKPLF 358
           +   L      F
Sbjct: 214 LSYILLSGLSPF 225

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 54.7 bits (131), Expect = 5e-09
 Identities = 23/99 (23%), Positives = 35/99 (35%), Gaps = 7/99 (7%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
           K          FS +     D + K+L  DP  R+T  QAL+  WL   +       Q+P
Sbjct: 238 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG-RDSQIP 296

Query: 109 TWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSS 147
           + +        K R  ++          P     +N SS
Sbjct: 297 SSR------YTKIRDSIKTKYDAWPEPLPPLGRISNYSS 329

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  150 bits (381), Expect = 4e-43
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 19/192 (9%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T  +   K +      + +  T   EI I+ QL+H  ++NL           D  +DK  
Sbjct: 53  TGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKLINL----------HDAFEDKYE 100

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             L+ E++   +L   + +     +E    + MRQ  +GL + H+ + +H DIK  NI+ 
Sbjct: 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 160

Query: 289 --NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
                  VK+ DFGLA   N ++  +       T  +  PE++   E  G   D+W+ G 
Sbjct: 161 ETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDR-EPVGFYTDMWAIGV 216

Query: 347 ILGELFVKKPLF 358
           +   L      F
Sbjct: 217 LGYVLLSGLSPF 228

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 27/125 (21%), Positives = 49/125 (39%), Gaps = 9/125 (7%)

Query: 25  LCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRIT 84
           L G      +     L     +K  +       + FS + P A D +  +L+ +P +R+T
Sbjct: 222 LSGLSP---FAGEDDLETLQNVK--RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 276

Query: 85  AEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTN 144
              AL+  WLK  H       ++P+ +  +    +K + +    P    A   I + S+ 
Sbjct: 277 VHDALEHPWLKGDHSN--LTSRIPSSR--YNKIRQKIKEKYADWPAPQPAIGRIANFSSL 332

Query: 145 NSSRP 149
              RP
Sbjct: 333 RKHRP 337

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 8e-43
 Identities = 68/190 (35%), Positives = 104/190 (54%), Gaps = 9/190 (4%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
               VA+KK+    E + +    +REIKIL +  H+NI+ + +I+   +      +    
Sbjct: 32  NKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI-----EQMKD 85

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLV   M  DL  LL++  +  + +     + Q+L GL Y H  N LHRD+K SN+L+N
Sbjct: 86  VYLVTHLMGADLYKLLKTQHLSNDHI--CYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 143

Query: 290 NRGEVKLADFGLARLYN-AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
              ++K+ DFGLAR+ +   D     T  V T WYR PE++L  + Y  +ID+WS GCIL
Sbjct: 144 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 203

Query: 349 GELFVKKPLF 358
            E+   +P+F
Sbjct: 204 AEMLSNRPIF 213

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.6 bits (172), Expect = 3e-14
 Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 3/118 (2%)

Query: 11  WANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTI-KPKKIHRRRLREEFSLMPPGALD 69
                L QL  I  + G+P+      +I L   + +      ++      F      ALD
Sbjct: 214 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 273

Query: 70  LLDKMLELDPERRITAEQALKSVWLKNVH-PESMPPPQLPTWQDCH-ELWSKKRRRQL 125
           LLDKML  +P +RI  EQAL   +L+  + P   P  + P   D   +   K++ ++L
Sbjct: 274 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 331

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-42
 Identities = 85/190 (44%), Positives = 118/190 (62%), Gaps = 13/190 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALKK+RL+ E EG P TA+REI +L++LNH NIV L           D    +  
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL----------DVIHTENK 75

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNA-SIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            YLVFE++  DL   +++  +    +    S + QLL GL++CH    LHRD+K  N+L+
Sbjct: 76  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           N  G +KLADFGLAR +    R   YT++V+TLWYR PE+LLG + Y  A+D+WS GCI 
Sbjct: 136 NTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193

Query: 349 GELFVKKPLF 358
            E+  ++ LF
Sbjct: 194 AEMVTRRALF 203

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (169), Expect = 5e-14
 Identities = 30/93 (32%), Positives = 44/93 (47%), Gaps = 4/93 (4%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKM 74
           E+ QL  I +  GTP   VWP V  +P +    PK   R+   +    +      LL +M
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA-RQDFSKVVPPLDEDGRSLLSQM 266

Query: 75  LELDPERRITAEQALKSVWLKNVHPESMPPPQL 107
           L  DP +RI+A+ AL   + ++V     P P L
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDVTK---PVPHL 296

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-42
 Identities = 50/192 (26%), Positives = 77/192 (40%), Gaps = 15/192 (7%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T   VA  +++     +        E ++L+ L H NIV   +            K K  
Sbjct: 33  TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV------KGKKC 86

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNIL 287
             LV E M    +                S  RQ+L GL + H R    +HRD+KC NI 
Sbjct: 87  IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 146

Query: 288 MNNR-GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           +    G VK+ D GLA L  A          + T  +  PE+   EE+Y  ++DV++ G 
Sbjct: 147 ITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGM 200

Query: 347 ILGELFVKKPLF 358
            + E+   +  +
Sbjct: 201 CMLEMATSEYPY 212

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (102), Expect = 2e-05
 Identities = 7/62 (11%), Positives = 22/62 (35%), Gaps = 5/62 (8%)

Query: 39  KLPLWHTIKPKKIHRRRLREEF-----SLMPPGALDLLDKMLELDPERRITAEQALKSVW 93
           + P        +I+RR            +  P   ++++  +  + + R + +  L   +
Sbjct: 209 EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268

Query: 94  LK 95
            +
Sbjct: 269 FQ 270

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 4e-41
 Identities = 69/209 (33%), Positives = 112/209 (53%), Gaps = 11/209 (5%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
            ++P+ +G       +V   T   VA+KK+    + E F   A RE+++L+ + H+N++ 
Sbjct: 22  DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81

Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L ++ T      +   D   FYLV  +M  DL  L++   +  + +    ++ Q+L GL 
Sbjct: 82  LLDVFTPD----ETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI--QFLVYQMLKGLR 135

Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           Y H    +HRD+K  N+ +N   E+K+ DFGLAR  ++E      T  V+T WYR PE++
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVI 190

Query: 330 LGEERYGPAIDVWSCGCILGELFVKKPLF 358
           L   RY   +D+WS GCI+ E+   K LF
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLF 219

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.8 bits (175), Expect = 1e-14
 Identities = 28/106 (26%), Positives = 54/106 (50%), Gaps = 2/106 (1%)

Query: 11  WANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPK-KIHRRRLREEFSLMPPGALD 69
             +  L QL+ I K+ GTP       +      + +K   ++ ++      +   P A++
Sbjct: 220 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVN 279

Query: 70  LLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHE 115
           LL+KML LD E+R+TA +AL   + +++H ++   PQ+  + D  +
Sbjct: 280 LLEKMLVLDAEQRVTAGEALAHPYFESLH-DTEDEPQVQKYDDSFD 324

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-40
 Identities = 46/212 (21%), Positives = 85/212 (40%), Gaps = 20/212 (9%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           + E L  G   + +  V   + +    K V+++   +   +   +EI IL    H+NI++
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRNILH 65

Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGL 268
           L           +  +      ++FE++   D+   + +   + NE    S + Q+ + L
Sbjct: 66  L----------HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 269 SYCHKRNFLHRDIKCSNILMNNRGE--VKLADFGLARLYNAEDRQRPYTNKVITLWYRPP 326
            + H  N  H DI+  NI+   R    +K+ +FG AR     D    +        Y  P
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAP 172

Query: 327 ELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           E+    +    A D+WS G ++  L      F
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGINPF 203

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.1 bits (140), Expect = 3e-10
 Identities = 21/115 (18%), Positives = 46/115 (40%), Gaps = 13/115 (11%)

Query: 41  PLWHTIKPKKIHRRRLREEFSL-------MPPGALDLLDKMLELDPERRITAEQALKSVW 93
             +     ++I    +  E++        +   A+D +D++L  + + R+TA +AL+  W
Sbjct: 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260

Query: 94  LKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSR 148
           LK    E +    + T +       +     ++ D   + +AA I       S +
Sbjct: 261 LKQ-KIERVSTKVIRTLKH-----RRYYHTLIKKDLNMVVSAARISCGGAIRSQK 309

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-40
 Identities = 64/193 (33%), Positives = 96/193 (49%), Gaps = 17/193 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           + ELVA+KKV  +   +       RE++I+R+L+H NIV LR       +    +KD+  
Sbjct: 44  SGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE----KKDEVY 93

Query: 230 FYLVFEYMDHDLMGLLESGMVD---FNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
             LV +Y+   +  +             +     M QL   L+Y H     HRDIK  N+
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153

Query: 287 LMNNRGEV-KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           L++    V KL DFG A+      R  P  + + + +YR PEL+ G   Y  +IDVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210

Query: 346 CILGELFVKKPLF 358
           C+L EL + +P+F
Sbjct: 211 CVLAELLLGQPIF 223

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.4 bits (182), Expect = 2e-15
 Identities = 27/123 (21%), Positives = 46/123 (37%), Gaps = 5/123 (4%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLEL 77
           QL  I K+ GTPT      +          P+       +      PP A+ L  ++LE 
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKF-PQIKAHPWTKVFRPRTPPEAIALCSRLLEY 289

Query: 78  DPERRITAEQALKSVWLKNVHPESMPPPQLPTWQDCHELWSKKRRRQLRGDPMEMQAAAP 137
            P  R+T  +A    +   +     P  +LP  +D   L++    ++L  +P       P
Sbjct: 290 TPTARLTPLEACAHSFFDELRD---PNVKLPNGRDTPALFNFT-TQELSSNPPLATILIP 345

Query: 138 IQS 140
             +
Sbjct: 346 PHA 348

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-40
 Identities = 86/190 (45%), Positives = 116/190 (61%), Gaps = 13/190 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T E+VALK+VRL+++ EG P +A+REI +L++L HKNIV             D       
Sbjct: 26  THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR----------LHDVLHSDKK 75

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             LVFE+ D DL    +S   D +     S + QLL GL +CH RN LHRD+K  N+L+N
Sbjct: 76  LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
             GE+KLA+FGLAR +      R Y+ +V+TLWYRPP++L G + Y  +ID+WS GCI  
Sbjct: 136 RNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193

Query: 350 ELFV-KKPLF 358
           EL    +PLF
Sbjct: 194 ELANAGRPLF 203

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.4 bits (171), Expect = 2e-14
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 1/82 (1%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLEL 77
           QL+ I +L GTPT   WP++ KLP +    P       L      +     DLL  +L+ 
Sbjct: 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKC 269

Query: 78  DPERRITAEQALKSVWLKNVHP 99
           +P +RI+AE+AL+  +  +  P
Sbjct: 270 NPVQRISAEEALQHPYFSDFCP 291

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 7e-40
 Identities = 77/193 (39%), Positives = 109/193 (56%), Gaps = 13/193 (6%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQL---NHKNIVNLREIVTDKSDALDFRKD 226
               VALK+VR++  +EG P++ +RE+ +LR L    H N+V L ++ T           
Sbjct: 32  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-----DR 86

Query: 227 KGSFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
           +    LVFE++D DL   L+              +M QLL GL + H    +HRD+K  N
Sbjct: 87  ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146

Query: 286 ILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
           IL+ + G++KLADFGLAR+Y     Q   T+ V+TLWYR PE+LL    Y   +D+WS G
Sbjct: 147 ILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVG 202

Query: 346 CILGELFVKKPLF 358
           CI  E+F +KPLF
Sbjct: 203 CIFAEMFRRKPLF 215

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.4 bits (153), Expect = 6e-12
 Identities = 20/80 (25%), Positives = 31/80 (38%), Gaps = 3/80 (3%)

Query: 18  QLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLEL 77
           QL  I  + G P    WP  + LP             +   +         DLL K L  
Sbjct: 223 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTF 279

Query: 78  DPERRITAEQALKSVWLKNV 97
           +P +RI+A  AL   + +++
Sbjct: 280 NPAKRISAYSALSHPYFQDL 299

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  139 bits (352), Expect = 1e-39
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 28/203 (13%)

Query: 170 TDELVALKKVRLEN-------EKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDAL 221
           T +  A+K + +         E +      ++E+ ILR+++ H NI+ L           
Sbjct: 27  TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL----------K 76

Query: 222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
           D  +    F+LVF+ M   +L   L    V  +E     IMR LL+ +   HK N +HRD
Sbjct: 77  DTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRD 135

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE-----RY 335
           +K  NIL+++   +KL DFG +   +  ++         T  Y  PE++          Y
Sbjct: 136 LKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGY 192

Query: 336 GPAIDVWSCGCILGELFVKKPLF 358
           G  +D+WS G I+  L    P F
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSPPF 215

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 46.6 bits (110), Expect = 2e-06
 Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 7/62 (11%)

Query: 41  PLWHTIKPKKIHRRRLREEFSL-------MPPGALDLLDKMLELDPERRITAEQALKSVW 93
           P +   K   + R  +   +               DL+ + L + P++R TAE+AL   +
Sbjct: 213 PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272

Query: 94  LK 95
            +
Sbjct: 273 FQ 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-38
 Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 21/185 (11%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
               VA+K ++ +   + F    + E  ++ QL H N+V L  ++ +         +KG 
Sbjct: 29  RGNKVAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVE---------EKGG 75

Query: 230 FYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
            Y+V EYM    L+  L S G               + + + Y    NF+HRD+   N+L
Sbjct: 76  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 135

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           ++     K++DFGL +  ++           + + +  PE L   +++    DVWS G +
Sbjct: 136 VSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGIL 189

Query: 348 LGELF 352
           L E++
Sbjct: 190 LWEIY 194

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (344), Expect = 3e-38
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 20/193 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T +LVA+K +  +   EG   +   EI +L ++ H NIV L +I              G 
Sbjct: 33  TQKLVAIKCIAKKA-LEGKEGSMENEIAVLHKIKHPNIVALDDIYESG----------GH 81

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL- 287
            YL+ + +   +L   +      + E + + ++ Q+LD + Y H    +HRD+K  N+L 
Sbjct: 82  LYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLY 140

Query: 288 --MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 345
             ++   ++ ++DFGL+++   ED     +    T  Y  PE+L   + Y  A+D WS G
Sbjct: 141 YSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIG 196

Query: 346 CILGELFVKKPLF 358
            I   L    P F
Sbjct: 197 VIAYILLCGYPPF 209

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.0 bits (119), Expect = 1e-07
 Identities = 19/78 (24%), Positives = 33/78 (42%), Gaps = 7/78 (8%)

Query: 41  PLWHTIKPKKIHRRRLREEFSL-------MPPGALDLLDKMLELDPERRITAEQALKSVW 93
           P ++     K+  + L+ E+         +   A D +  ++E DPE+R T EQAL+  W
Sbjct: 207 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266

Query: 94  LKNVHPESMPPPQLPTWQ 111
           +           Q  + Q
Sbjct: 267 IAGDTALDKNIHQSVSEQ 284

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  136 bits (343), Expect = 1e-37
 Identities = 45/220 (20%), Positives = 88/220 (40%), Gaps = 34/220 (15%)

Query: 159 LSLNNFSV----------------SLFTDELVALKKVRLE----NEKEGFPITAVREIKI 198
           L++N+FSV                   T ++ A+K +  +     + E   +     + +
Sbjct: 1   LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 199 LRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNA 258
           +   +   IV +                      + + M+   +    S    F+E +  
Sbjct: 61  VSTGDCPFIVCM----------SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 110

Query: 259 SIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKV 318
               +++ GL + H R  ++RD+K +NIL++  G V+++D GLA  ++    ++     V
Sbjct: 111 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASV 166

Query: 319 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            T  Y  PE+L     Y  + D +S GC+L +L      F
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 42.8 bits (100), Expect = 4e-05
 Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 10/70 (14%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRIT-----AEQALKSVWLKNV-----H 98
            ++      E      P    LL+ +L+ D  RR+      A++  +S + +++      
Sbjct: 218 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF 277

Query: 99  PESMPPPQLP 108
            +  PPP +P
Sbjct: 278 LQKYPPPLIP 287

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  132 bits (333), Expect = 6e-37
 Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 9/191 (4%)

Query: 170 TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
               VA+K +R +      F +   RE +    LNH  IV + +    ++ A        
Sbjct: 31  LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL----- 85

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             Y+V EY+D   +  +              ++      L++ H+   +HRD+K +NI++
Sbjct: 86  -PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 144

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +    VK+ DFG+AR           T  VI T  Y  PE   G+       DV+S GC+
Sbjct: 145 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCV 203

Query: 348 LGELFVKKPLF 358
           L E+   +P F
Sbjct: 204 LYEVLTGEPPF 214

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 9/62 (14%), Positives = 23/62 (37%), Gaps = 7/62 (11%)

Query: 41  PLWHTIKPKKIHRRRLREEFSL-------MPPGALDLLDKMLELDPERRITAEQALKSVW 93
           P +    P  +  + +RE+          +      ++ K L  +PE R      +++  
Sbjct: 212 PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

Query: 94  LK 95
           ++
Sbjct: 272 VR 273

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-36
 Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 19/211 (9%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L+E L AG      +         VA+K ++   +    P   + E  +++QL H+ +V 
Sbjct: 17  LVERLGAGQFG-EVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMG--LLESGMVDFNEVNNASIMRQLLDG 267
           L  +VT               Y++ EYM++  +   L     +         +  Q+ +G
Sbjct: 73  LYAVVTQ-----------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 268 LSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPE 327
           +++  +RN++HRD++ +NIL+++    K+ADFGLARL    +       K    W  P  
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 328 LLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           +  G   +    DVWS G +L E+     + 
Sbjct: 182 INYG--TFTIKSDVWSFGILLTEIVTHGRIP 210

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-36
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 15/185 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
               VA+K ++   EK       +RE +I+ QL++  IV L  +   ++           
Sbjct: 35  KQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLIGVCQAEA----------- 82

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             LV E      L   L     +    N A ++ Q+  G+ Y  ++NF+HRD+   N+L+
Sbjct: 83  LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL 142

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCI 347
            NR   K++DFGL++   A+D      +     L +  PE +    ++    DVWS G  
Sbjct: 143 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVT 201

Query: 348 LGELF 352
           + E  
Sbjct: 202 MWEAL 206

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-36
 Identities = 60/189 (31%), Positives = 97/189 (51%), Gaps = 11/189 (5%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
           T   VA+KK+    +         RE+++L+ + H+N++ L ++ T         ++   
Sbjct: 42  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA----RSLEEFND 97

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
            YLV   M  DL  +++   +  + V    ++ Q+L GL Y H  + +HRD+K SN+ +N
Sbjct: 98  VYLVTHLMGADLNNIVKCQKLTDDHV--QFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 155

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 349
              E+K+ DFGLAR  +        T  V T WYR PE++L    Y   +D+WS GCI+ 
Sbjct: 156 EDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210

Query: 350 ELFVKKPLF 358
           EL   + LF
Sbjct: 211 ELLTGRTLF 219

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.1 bits (173), Expect = 2e-14
 Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 1/95 (1%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIK-PKKIHRRRLREEFSLMPPGALDLLDK 73
            + QL++I +L GTP   +   +      + I+   ++ +      F    P A+DLL+K
Sbjct: 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283

Query: 74  MLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
           ML LD ++RITA QAL   +    H     P   P
Sbjct: 284 MLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 318

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 3e-36
 Identities = 40/184 (21%), Positives = 79/184 (42%), Gaps = 13/184 (7%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             + VA+K ++ E          + E  +++QL++  IV +  I            +  S
Sbjct: 33  VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-----------EAES 81

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
           + LV E  +   +           + N   ++ Q+  G+ Y  + NF+HRD+   N+L+ 
Sbjct: 82  WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 141

Query: 290 NRGEVKLADFGLARLYNAEDRQRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCIL 348
            +   K++DFGL++   A++            + +  PE +    ++    DVWS G ++
Sbjct: 142 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLM 200

Query: 349 GELF 352
            E F
Sbjct: 201 WEAF 204

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 4e-36
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 23/195 (11%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKIL-RQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T E  ALK ++   +         RE+++  R     +IV + ++  +          + 
Sbjct: 36  TQEKFALKMLQDCPKAR-------REVELHWRASQCPHIVRIVDVYEN------LYAGRK 82

Query: 229 SFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
              +V E +D  +L   ++  G   F E   + IM+ + + + Y H  N  HRD+K  N+
Sbjct: 83  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 142

Query: 287 LMN---NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 343
           L         +KL DFG A+   + +          T +Y  PE+L   E+Y  + D+WS
Sbjct: 143 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP-EKYDKSCDMWS 198

Query: 344 CGCILGELFVKKPLF 358
            G I+  L    P F
Sbjct: 199 LGVIMYILLCGYPPF 213

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (127), Expect = 2e-08
 Identities = 15/105 (14%), Positives = 34/105 (32%), Gaps = 1/105 (0%)

Query: 47  KPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQ 106
           + +         E+S +      L+  +L+ +P +R+T  + +   W+         P  
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 287

Query: 107 LPTW-QDCHELWSKKRRRQLRGDPMEMQAAAPIQSNSTNNSSRPL 150
                ++  E W   +                I+     ++S PL
Sbjct: 288 TSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPL 332

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 1e-35
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 24/198 (12%)

Query: 170 TDELVALKKVRLENEKEGFPIT----AVREIKILRQLN--HKNIVNLREIVTDKSDALDF 223
            +  VA+K V  +   +   +        E+ +L++++     ++ L          LD+
Sbjct: 28  DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL----------LDW 77

Query: 224 RKDKGSFYLVFEYMD--HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI 281
            +   SF L+ E  +   DL   +        E    S   Q+L+ + +CH    LHRDI
Sbjct: 78  FERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLHRDI 136

Query: 282 KCSNILMN-NRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           K  NIL++ NRGE+KL DFG   L         YT+   T  Y PPE +     +G +  
Sbjct: 137 KDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 192

Query: 341 VWSCGCILGELFVKKPLF 358
           VWS G +L ++      F
Sbjct: 193 VWSLGILLYDMVCGDIPF 210

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.8 bits (108), Expect = 3e-06
 Identities = 9/36 (25%), Positives = 15/36 (41%)

Query: 63  MPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH 98
           +      L+   L L P  R T E+     W+++V 
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 42/191 (21%), Positives = 85/191 (44%), Gaps = 15/191 (7%)

Query: 170 TDELVALKKVRLEN--EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T++  A+K ++ +     +    T V +  +     H  + ++              + K
Sbjct: 26  TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM----------FCTFQTK 75

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
            + + V EY++   +         F+         +++ GL + H +  ++RD+K  NIL
Sbjct: 76  ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 135

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           ++  G +K+ADFG+ +     D +        T  Y  PE+LLG ++Y  ++D WS G +
Sbjct: 136 LDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVL 192

Query: 348 LGELFVKKPLF 358
           L E+ + +  F
Sbjct: 193 LYEMLIGQSPF 203

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (106), Expect = 6e-06
 Identities = 13/77 (16%), Positives = 29/77 (37%), Gaps = 9/77 (11%)

Query: 41  PLWHTIKPKKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRITAEQALKS-VWLKN 96
             +H    +++      +       +   A DLL K+   +PE+R+     ++     + 
Sbjct: 201 SPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260

Query: 97  VHPE-----SMPPPQLP 108
           ++ E      + PP  P
Sbjct: 261 INWEELERKEIDPPFRP 277

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 6e-35
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 37/210 (17%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++ E          + E+K++ QL +H+NIVNL          L      G  YL
Sbjct: 70  VAVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNL----------LGACTLSGPIYL 118

Query: 233 VFEYMDH-DLMGLLESGMVDFNEVNN----------------------ASIMRQLLDGLS 269
           +FEY  + DL+  L S    F+E                              Q+  G+ 
Sbjct: 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178

Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           +   ++ +HRD+   N+L+ +   VK+ DFGLAR   ++       N  + + +  PE L
Sbjct: 179 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238

Query: 330 LGEERYGPAIDVWSCGCILGELF-VKKPLF 358
                Y    DVWS G +L E+F +    +
Sbjct: 239 FE-GIYTIKSDVWSYGILLWEIFSLGVNPY 267

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 6e-35
 Identities = 46/197 (23%), Positives = 82/197 (41%), Gaps = 22/197 (11%)

Query: 170 TDELVALKKVR---LENEKEGFPITAV-REIKILRQLNHKNIVNLREIVTDKSDALDFRK 225
           T    A K ++    ++ + G     + RE+ IL+++ H N++ L E+  +K        
Sbjct: 34  TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-------- 85

Query: 226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSN 285
                 L+ E +    +    +      E      ++Q+L+G+ Y H     H D+K  N
Sbjct: 86  --TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 143

Query: 286 ILMNNRGE----VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
           I++ +R      +K+ DFGLA   +  +    + N   T  +  PE++   E  G   D+
Sbjct: 144 IMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNY-EPLGLEADM 199

Query: 342 WSCGCILGELFVKKPLF 358
           WS G I   L      F
Sbjct: 200 WSIGVITYILLSGASPF 216

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.7 bits (123), Expect = 3e-08
 Identities = 15/66 (22%), Positives = 29/66 (43%), Gaps = 5/66 (7%)

Query: 47  KPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPE-----S 101
               ++     E FS     A D + ++L  DP++R+T + +L+  W+K    +     +
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSA 286

Query: 102 MPPPQL 107
              PQ 
Sbjct: 287 WSHPQF 292

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-34
 Identities = 43/184 (23%), Positives = 86/184 (46%), Gaps = 16/184 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
               VA+K ++  +  E      + E K++  L+H+ +V L  + T +            
Sbjct: 27  GQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVCTKQ----------RP 73

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ EYM +  L+  L      F       + + + + + Y   + FLHRD+   N L+
Sbjct: 74  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 133

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           N++G VK++DFGL+R    +D           + + PPE+L+   ++    D+W+ G ++
Sbjct: 134 NDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLM 191

Query: 349 GELF 352
            E++
Sbjct: 192 WEIY 195

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-34
 Identities = 44/190 (23%), Positives = 82/190 (43%), Gaps = 16/190 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             + VA+K +R     E      + E +++ +L+H  +V L               ++  
Sbjct: 28  NKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQL----------YGVCLEQAP 74

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             LVFE+M+H  L   L +    F       +   + +G++Y  +   +HRD+   N L+
Sbjct: 75  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
                +K++DFG+ R    +D+    T     + +  PE+     RY    DVWS G ++
Sbjct: 135 GENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLM 192

Query: 349 GELFVKKPLF 358
            E+F +  + 
Sbjct: 193 WEVFSEGKIP 202

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (318), Expect = 2e-34
 Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 21/191 (10%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRKDKG 228
            +E V +K ++   +K+       REIKIL  L    NI+ L +IV D            
Sbjct: 59  NNEKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITLADIVKDP--------VSR 105

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           +  LVFE++++      +       + +    M ++L  L YCH    +HRD+K  N+++
Sbjct: 106 TPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162

Query: 289 NNRG-EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           ++   +++L D+GLA  Y+       Y  +V + +++ PELL+  + Y  ++D+WS GC+
Sbjct: 163 DHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 219

Query: 348 LGELFVKKPLF 358
           L  +  +K  F
Sbjct: 220 LASMIFRKEPF 230

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 63.3 bits (153), Expect = 7e-12
 Identities = 25/90 (27%), Positives = 38/90 (42%), Gaps = 7/90 (7%)

Query: 15  ELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIK-------PKKIHRRRLREEFSLMPPGA 67
              QL  I+K+ GT     +     + L             K+  R    E   L+ P A
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 295

Query: 68  LDLLDKMLELDPERRITAEQALKSVWLKNV 97
           LD LDK+L  D + R+TA +A++  +   V
Sbjct: 296 LDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  125 bits (316), Expect = 4e-34
 Identities = 38/190 (20%), Positives = 73/190 (38%), Gaps = 17/190 (8%)

Query: 170 TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
                A+K ++ E   +         E  +L  + H  I+ +              +D  
Sbjct: 28  NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM----------WGTFQDAQ 77

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             +++ +Y++   +  L      F          ++   L Y H ++ ++RD+K  NIL+
Sbjct: 78  QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  G +K+ DFG A+                T  Y  PE++   + Y  +ID WS G ++
Sbjct: 138 DKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILI 191

Query: 349 GELFVKKPLF 358
            E+      F
Sbjct: 192 YEMLAGYTPF 201

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 49.7 bits (118), Expect = 2e-07
 Identities = 18/118 (15%), Positives = 38/118 (32%), Gaps = 15/118 (12%)

Query: 7   GNSGWANIELLQLEVISKLCGTPTPAV--WPAVIKLPLWHTIKPKKIHRRRLREEFSL-- 62
           G   +   E++  +  +K     +  +  +  +     ++     K + + L  E     
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 222

Query: 63  -MPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNVHPE-----SMPPPQLPT 109
                  DLL +++  D  +R+       E      W K V  E     ++  P  P 
Sbjct: 223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  125 bits (314), Expect = 5e-34
 Identities = 37/219 (16%), Positives = 72/219 (32%), Gaps = 24/219 (10%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           +   +  G   +     +L  ++ VA+K     ++          E +  + L     + 
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLAGCTGIP 64

Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
                        F ++     LV + +   L  LL+     F+    A   +Q+L  + 
Sbjct: 65  N---------VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115

Query: 270 YCHKRNFLHRDIKCSNILMNN-----RGEVKLADFGLARLYNAED-----RQRPYTNKVI 319
             H+++ ++RDIK  N L+          + + DFG+ + Y           R   N   
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 320 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
           T  Y      LG E      D+ + G +          +
Sbjct: 176 TARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPW 213

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (312), Expect = 9e-34
 Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 36/207 (17%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
              +VA+K ++ E           RE  ++ + ++ NIV            L        
Sbjct: 42  PFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVK----------LLGVCAVGKP 90

Query: 230 FYLVFEYMDH-DLMGLLES-----------------------GMVDFNEVNNASIMRQLL 265
             L+FEYM + DL   L S                       G    +      I RQ+ 
Sbjct: 91  MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150

Query: 266 DGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP 325
            G++Y  +R F+HRD+   N L+     VK+ADFGL+R   + D  +   N  I + + P
Sbjct: 151 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP 210

Query: 326 PELLLGEERYGPAIDVWSCGCILGELF 352
           PE +    RY    DVW+ G +L E+F
Sbjct: 211 PESIFY-NRYTTESDVWAYGVVLWEIF 236

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-33
 Identities = 41/185 (22%), Positives = 69/185 (37%), Gaps = 13/185 (7%)

Query: 170 TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
               VA+K ++ +   +       +RE+  +  L+H+N++ L  +V              
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----------P 83

Query: 229 SFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              +V E      L+  L      F     +    Q+ +G+ Y   + F+HRD+   N+L
Sbjct: 84  PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +  R  VK+ DFGL R     D            +       L    +  A D W  G  
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203

Query: 348 LGELF 352
           L E+F
Sbjct: 204 LWEMF 208

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-33
 Identities = 45/205 (21%), Positives = 73/205 (35%), Gaps = 27/205 (13%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             E VA+K      E+  F      EI     L H+NI+         +           
Sbjct: 25  RGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENILGFIAADNKDNGTWTQ------ 75

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCH--------KRNFLHRD 280
            +LV +Y +H  L   L    V    +    +      GL++ H        K    HRD
Sbjct: 76  LWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY--TNKVITLWYRPPELLLGE-----E 333
           +K  NIL+   G   +AD GLA  +++          ++V T  Y  PE+L         
Sbjct: 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 193

Query: 334 RYGPAIDVWSCGCILGELFVKKPLF 358
                 D+++ G +  E+  +  + 
Sbjct: 194 ESFKRADIYAMGLVFWEIARRCSIG 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (313), Expect = 2e-33
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
            ++P+ +G   +   +     D  VA+KK+    + +     A RE+ +++ +NHKNI++
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 210 LREIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLS 269
           L  + T +       ++    YLV E MD     L +   ++ +    + ++ Q+L G+ 
Sbjct: 81  LLNVFTPQ----KTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIK 133

Query: 270 YCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELL 329
           + H    +HRD+K SNI++ +   +K+ DFGLAR           T  V+T +YR PE++
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVI 190

Query: 330 LGEERYGPAIDVWSCGCILGELFVKKPLF 358
           LG   Y   +D+WS GCI+GE+   K LF
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILF 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.7 bits (159), Expect = 1e-12
 Identities = 29/130 (22%), Positives = 49/130 (37%), Gaps = 15/130 (11%)

Query: 11  WANIELLQLEVISKLCGTPTPAVWPAVIK--------LPLWHTIKPKKIHRRRL----RE 58
                + Q   + +  GTP P     +           P +  +   K+    L     E
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278

Query: 59  EFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH---PESMPPPQLPTWQDCHE 115
              L    A DLL KML +DP +RI+ + AL+  ++   +       PPPQ+   Q    
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDER 338

Query: 116 LWSKKRRRQL 125
             + +  ++L
Sbjct: 339 EHTIEEWKEL 348

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 3e-33
 Identities = 45/187 (24%), Positives = 87/187 (46%), Gaps = 16/187 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            +  VA+K ++    ++      + E  I+ Q +H N+++L  +VT              
Sbjct: 53  REIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNVIHLEGVVTKS----------TP 101

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             ++ E+M++  L   L      F  +    ++R +  G+ Y    N++HRD+   NIL+
Sbjct: 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV 161

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKV---ITLWYRPPELLLGEERYGPAIDVWSCG 345
           N+    K++DFGL+R    +     YT+ +   I + +  PE +    ++  A DVWS G
Sbjct: 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYG 220

Query: 346 CILGELF 352
            ++ E+ 
Sbjct: 221 IVMWEVM 227

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 5e-33
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)

Query: 174 VALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
           VA+K ++      E F    ++E +++++L H+ +V L  +V++              Y+
Sbjct: 44  VAIKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSE-----------EPIYI 88

Query: 233 VFEYMDHDLMGLL--ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN 290
           V EYM    +                   +  Q+  G++Y  + N++HRD++ +NIL+  
Sbjct: 89  VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 148

Query: 291 RGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 350
               K+ADFGLARL   ++           + +  PE  L   R+    DVWS G +L E
Sbjct: 149 NLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTE 206

Query: 351 LFVKKPLF 358
           L  K  + 
Sbjct: 207 LTTKGRVP 214

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (92), Expect = 3e-04
 Identities = 12/61 (19%), Positives = 21/61 (34%), Gaps = 2/61 (3%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSV--WLKNVHPESMPPPQ 106
            ++ R          P    DL+ +    +PE R T E     +  +  +  P+  P   
Sbjct: 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284

Query: 107 L 107
           L
Sbjct: 285 L 285

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (306), Expect = 6e-33
 Identities = 42/197 (21%), Positives = 67/197 (34%), Gaps = 22/197 (11%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
             E VA+K   ++ +          E KI + +     +                 +   
Sbjct: 31  AGEEVAIKLECVKTKHPQL----HIESKIYKMMQGGVGIPTIR---------WCGAEGDY 77

Query: 230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN 289
             +V E +   L  L       F+      +  Q++  + Y H +NF+HRD+K  N LM 
Sbjct: 78  NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137

Query: 290 NRG---EVKLADFGLARLY-----NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDV 341
                  V + DFGLA+ Y     +     R   N   T  Y      LG E      D+
Sbjct: 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDL 196

Query: 342 WSCGCILGELFVKKPLF 358
            S G +L    +    +
Sbjct: 197 ESLGYVLMYFNLGSLPW 213

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 7e-33
 Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 14/190 (7%)

Query: 170 TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           T    A+K +R E    +      V E ++L+   H  +  L+             +   
Sbjct: 29  TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK----------YAFQTHD 78

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
               V EY +   +    S    F E        +++  L Y H R+ ++RDIK  N+++
Sbjct: 79  RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           +  G +K+ DFGL +   ++           T  Y  PE+L     YG A+D W  G ++
Sbjct: 139 DKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVLED-NDYGRAVDWWGLGVVM 195

Query: 349 GELFVKKPLF 358
            E+   +  F
Sbjct: 196 YEMMCGRLPF 205

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (109), Expect = 2e-06
 Identities = 15/82 (18%), Positives = 35/82 (42%), Gaps = 13/82 (15%)

Query: 41  PLWHTIKPKKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRI-----TAEQALKSV 92
             ++    +++    L EE      + P A  LL  +L+ DP++R+      A++ ++  
Sbjct: 203 LPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262

Query: 93  WLKNV-----HPESMPPPQLPT 109
           +  ++       + + PP  P 
Sbjct: 263 FFLSINWQDVVQKKLLPPFKPQ 284

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-32
 Identities = 42/191 (21%), Positives = 82/191 (42%), Gaps = 11/191 (5%)

Query: 170 TDELVALKKVRLEN--EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
           T +L A+K ++     +K         E ++L  +     +                + +
Sbjct: 51  TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL---------HYAFQTE 101

Query: 228 GSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL 287
              +L+ +Y++   +    S    F E      + +++  L + HK   ++RDIK  NIL
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 161

Query: 288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           +++ G V L DFGL++ + A++ +R Y       +  P  +  G+  +  A+D WS G +
Sbjct: 162 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221

Query: 348 LGELFVKKPLF 358
           + EL      F
Sbjct: 222 MYELLTGASPF 232

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.8 bits (110), Expect = 2e-06
 Identities = 17/75 (22%), Positives = 35/75 (46%), Gaps = 13/75 (17%)

Query: 48  PKKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNVHP 99
             +I RR L+ E      M   A DL+ ++L  DP++R+      A++  + ++ + ++ 
Sbjct: 241 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300

Query: 100 E-----SMPPPQLPT 109
           +      +P P  P 
Sbjct: 301 DDLAAKKVPAPFKPV 315

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 5e-32
 Identities = 37/185 (20%), Positives = 72/185 (38%), Gaps = 12/185 (6%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLV 233
           VA+K++R     +      + E  ++  +++ ++  L  I    +             + 
Sbjct: 41  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTV----------QLIT 89

Query: 234 FEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGE 293
                  L+  +     +       +   Q+  G++Y   R  +HRD+   N+L+     
Sbjct: 90  QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH 149

Query: 294 VKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV 353
           VK+ DFGLA+L  AE+++       + + +   E +L    Y    DVWS G  + EL  
Sbjct: 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMT 208

Query: 354 KKPLF 358
                
Sbjct: 209 FGSKP 213

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.3 bits (83), Expect = 0.004
 Identities = 5/60 (8%), Positives = 16/60 (26%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHPESMPPPQLP 108
             + +     +  +       ++ K   +D + R    + +         P+     Q  
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 283

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-31
 Identities = 42/185 (22%), Positives = 78/185 (42%), Gaps = 15/185 (8%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
               VA+K  +     +      ++E   +RQ +H +IV L  ++T+             
Sbjct: 34  PALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----------NP 81

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
            +++ E     +L   L+      +  +      QL   L+Y   + F+HRDI   N+L+
Sbjct: 82  VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 141

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           ++   VKL DFGL+R        +  +   + + +  PE +    R+  A DVW  G  +
Sbjct: 142 SSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCM 199

Query: 349 GELFV 353
            E+ +
Sbjct: 200 WEILM 204

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.3 bits (83), Expect = 0.004
 Identities = 9/42 (21%), Positives = 12/42 (28%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALK 90
            +I            PP    L+ K    DP RR    +   
Sbjct: 220 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-31
 Identities = 44/192 (22%), Positives = 82/192 (42%), Gaps = 14/192 (7%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
                A+K +    +  G     + E  I++  +H N+++L  I             +GS
Sbjct: 54  KKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR---------SEGS 103

Query: 230 FYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             +V  YM H DL   + +   +    +      Q+  G+ +   + F+HRD+   N ++
Sbjct: 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 163

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPY--TNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           + +  VK+ADFGLAR    ++    +  T   + + +   E L   +++    DVWS G 
Sbjct: 164 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGV 222

Query: 347 ILGELFVKKPLF 358
           +L EL  +    
Sbjct: 223 LLWELMTRGAPP 234

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (295), Expect = 2e-31
 Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 19/192 (9%)

Query: 170 TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
               VA+K ++ +  E E F    ++E  +++++ H N+V L  + T +           
Sbjct: 41  YSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTRE----------P 86

Query: 229 SFYLVFEYMDH--DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI 286
            FY++ E+M +   L  L E    + + V    +  Q+   + Y  K+NF+HRD+   N 
Sbjct: 87  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146

Query: 287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 346
           L+     VK+ADFGL+RL    D    +      + +  PE L    ++    DVW+ G 
Sbjct: 147 LVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGV 204

Query: 347 ILGELFVKKPLF 358
           +L E+       
Sbjct: 205 LLWEIATYGMSP 216

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-30
 Identities = 43/191 (22%), Positives = 83/191 (43%), Gaps = 14/191 (7%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS 229
            +  VA+K ++     E   +  + E  I+ Q +H NI+                     
Sbjct: 35  KEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNIIR----------LEGVISKYKP 83

Query: 230 FYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
             ++ EYM++  +   L     +F+ +    ++R +  G+ Y    N++HRD+   NIL+
Sbjct: 84  MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 143

Query: 289 NNRGEVKLADFGLAR-LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 347
           N+    K++DFGL+R L +  +     +   I + +  PE +    ++  A DVWS G +
Sbjct: 144 NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIV 202

Query: 348 LGELFVKKPLF 358
           + E+       
Sbjct: 203 MWEVMTYGERP 213

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  113 bits (283), Expect = 4e-29
 Identities = 43/190 (22%), Positives = 80/190 (42%), Gaps = 17/190 (8%)

Query: 170 TDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKG 228
           +    A+K +  +   K       + E +IL+ +N   +V L              KD  
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL----------EFSFKDNS 114

Query: 229 SFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILM 288
           + Y+V EY+    M      +  F+E +      Q++    Y H  + ++RD+K  N+L+
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174

Query: 289 NNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 348
           + +G +++ DFG A+                T     PE++L  + Y  A+D W+ G ++
Sbjct: 175 DQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIILS-KGYNKAVDWWALGVLI 228

Query: 349 GELFVKKPLF 358
            E+    P F
Sbjct: 229 YEMAAGYPPF 238

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 39.4 bits (91), Expect = 4e-04
 Identities = 12/85 (14%), Positives = 28/85 (32%), Gaps = 13/85 (15%)

Query: 41  PLWHTIKPKKIHRRRLREEFSL---MPPGALDLLDKMLELDPERRI-----TAEQALKSV 92
           P +   +P +I+ + +  +            DLL  +L++D  +R               
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295

Query: 93  WLKNV-----HPESMPPPQLPTWQD 112
           W         +   +  P +P ++ 
Sbjct: 296 WFATTDWIAIYQRKVEAPFIPKFKG 320

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 8e-29
 Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 31/202 (15%)

Query: 170 TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKG 228
               VA+K ++            + E+K+L  L NH NIVNL          L      G
Sbjct: 52  AAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNL----------LGACTIGG 100

Query: 229 SFYLVFEYMDH-DLMGLL-----------------ESGMVDFNEVNNASIMRQLLDGLSY 270
              ++ EY  + DL+  L                 E   +  +  +  S   Q+  G+++
Sbjct: 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160

Query: 271 CHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLL 330
              +N +HRD+   NIL+ +    K+ DFGLAR    +       N  + + +  PE + 
Sbjct: 161 LASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220

Query: 331 GEERYGPAIDVWSCGCILGELF 352
               Y    DVWS G  L ELF
Sbjct: 221 N-CVYTFESDVWSYGIFLWELF 241

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 2e-27
 Identities = 48/202 (23%), Positives = 80/202 (39%), Gaps = 32/202 (15%)

Query: 174 VALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSFYL 232
            A+K+++    K+        E+++L +L +H NI+NL          L   + +G  YL
Sbjct: 40  AAIKRMKEYASKDDHRDF-AGELEVLCKLGHHPNIINL----------LGACEHRGYLYL 88

Query: 233 VFEYMDH-DLMGLLESGMVD---------------FNEVNNASIMRQLLDGLSYCHKRNF 276
             EY  H +L+  L    V                 +          +  G+ Y  ++ F
Sbjct: 89  AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 148

Query: 277 LHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYG 336
           +HRD+   NIL+      K+ADFGL+R      ++   T   + + +   E L     Y 
Sbjct: 149 IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNY-SVYT 204

Query: 337 PAIDVWSCGCILGELFVKKPLF 358
              DVWS G +L E+       
Sbjct: 205 TNSDVWSYGVLLWEIVSLGGTP 226

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 1e-26
 Identities = 45/218 (20%), Positives = 81/218 (37%), Gaps = 27/218 (12%)

Query: 150 LMEPLAAGG-----LSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH 204
           +   L  G        +    V    +  VA+K V  E       I  + E  ++++ N 
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNC 82

Query: 205 KNIVNLREIVTDKSDALDFRKDKGSFYLVFEYMDH-DLMGLL---------ESGMVDFNE 254
            ++V L  +V+                ++ E M   DL   L            +   + 
Sbjct: 83  HHVVRLLGVVSQG----------QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 255 VNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPY 314
                +  ++ DG++Y +   F+HRD+   N ++     VK+ DFG+ R     D  R  
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 315 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 352
              ++ + +  PE L     +    DVWS G +L E+ 
Sbjct: 193 GKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIA 229

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.4 bits (83), Expect = 0.003
 Identities = 6/43 (13%), Positives = 18/43 (41%)

Query: 49  KKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS 91
           + +    L ++    P    +L+    + +P+ R +  + + S
Sbjct: 246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 6e-26
 Identities = 42/192 (21%), Positives = 71/192 (36%), Gaps = 8/192 (4%)

Query: 168 LFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK 227
             T   VA+K ++                 ++   +H N+VNL    T     L    + 
Sbjct: 40  TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 99

Query: 228 GSFYLVFEYMDHDLMGLLESGMVD-------FNEVNNASIMRQLLDGLSYCHKRNFLHRD 280
             F  +  Y+       +   +             +      Q+  G+ +   R  +HRD
Sbjct: 100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 159

Query: 281 IKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAID 340
           +   NIL++ +  VK+ DFGLAR    +       +  + L +  PE +     Y    D
Sbjct: 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSD 218

Query: 341 VWSCGCILGELF 352
           VWS G +L E+F
Sbjct: 219 VWSFGVLLWEIF 230

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 2e-25
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 29/204 (14%)

Query: 172 ELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALDFRKDKGSF 230
             VA+K ++ +  ++      + E+++++ +  HKNI+N           L      G  
Sbjct: 46  TKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIIN----------LLGACTQDGPL 94

Query: 231 YLVFEYMDH-DLMGLLE---------------SGMVDFNEVNNASIMRQLLDGLSYCHKR 274
           Y++ EY    +L   L+               +     +  +  S   Q+  G+ Y   +
Sbjct: 95  YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 154

Query: 275 NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEER 334
             +HRD+   N+L+     +K+ADFGLAR  +  D  +  TN  + + +  PE L     
Sbjct: 155 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RI 213

Query: 335 YGPAIDVWSCGCILGELFVKKPLF 358
           Y    DVWS G +L E+F      
Sbjct: 214 YTHQSDVWSFGVLLWEIFTLGGSP 237

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (249), Expect = 2e-24
 Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 12/217 (5%)

Query: 150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVN 209
           L+  L  G  S    +  +  +  VA+K VR +   + +   A  EIK+L+++N  +   
Sbjct: 17  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTK 73

Query: 210 L-----REIVTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQ 263
                   I+           +     +VFE +  + L  + +        +    I +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 264 LLDGLSYCH-KRNFLHRDIKCSNILMNNRG-EVKLADFGLARLYNAEDRQRPYTNKVITL 321
           LL GL Y H +   +H DIK  N+LM        L    +A L NA      YTN + T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 322 WYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF 358
            YR PE+LLG   +G   D+WS  C++ EL     LF
Sbjct: 194 EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLF 229

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 58.9 bits (141), Expect = 2e-10
 Identities = 21/124 (16%), Positives = 39/124 (31%), Gaps = 15/124 (12%)

Query: 2   FSGGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLR---- 57
           F    G+S   + +   +  I +L G     +         +   +    +  +L+    
Sbjct: 229 FEPDEGHSYTKDDD--HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 286

Query: 58  --------EEFSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHP-ESMPPPQLP 108
                   +          D L  ML+LDP +R  A   +   WLK+    E +  P   
Sbjct: 287 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRE 346

Query: 109 TWQD 112
            +  
Sbjct: 347 LYGS 350

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 6e-19
 Identities = 21/190 (11%), Positives = 61/190 (32%), Gaps = 32/190 (16%)

Query: 164 FSVSLFTDELVALKKVRLEN--------EKEGFPITAVREIKILRQLNHKNIVNLREIVT 215
           F+          +K  ++ +        +++   +          +   + +  L+ +  
Sbjct: 17  FNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 76

Query: 216 DKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN 275
            K     +  +     ++ E +D   +             N   ++  +L+ ++  + R 
Sbjct: 77  PKV--YAWEGN----AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG 123

Query: 276 FLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTN--KVITLWYRPPELLLGEE 333
            +H D+   N+L++  G + + DF  +     E  +       + I  ++          
Sbjct: 124 IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS--------R 174

Query: 334 RYGPAIDVWS 343
            Y    D+ S
Sbjct: 175 TYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	358
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.31
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.1
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.05
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.04
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.04
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.02
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	98.92
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	98.89
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	98.84
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	98.82
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.65
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	98.63
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	98.59
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	98.52
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.22
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	98.2
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	98.11
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.08
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	98.06
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	97.88
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	97.85
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	97.83
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	97.81
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	97.74
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	97.7
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	97.7
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	97.68
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	97.67
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	97.66
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	97.62
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.59
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	97.53
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	97.52
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	97.52
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	97.48
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	97.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.41
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	97.39
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.38
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	97.26
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	97.21
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	97.2
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	95.84
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	94.69
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	94.57
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	94.56
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	94.46
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	94.43
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	94.17
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	94.03
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	93.8
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	93.67
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	93.66
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	93.59
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	93.45
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	93.14
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	93.09
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	92.64
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	92.63
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	92.24
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	91.92
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	91.88
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	91.73
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	91.53
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	90.47
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	87.29
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	85.84

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-52  Score=356.63  Aligned_cols=203  Identities=30%  Similarity=0.453  Sum_probs=173.5

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|++++.||+|+||.||+|.+..+++.||||+++..... ...+.+.+|+.++++++||||+++++++.+        
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--------   74 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--------   74 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--------
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeecc--------
Confidence            34699999999999999999999999999999999765432 234568899999999999999999877765        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ++.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.
T Consensus        75 --~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~  152 (271)
T d1nvra_          75 --GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV  152 (271)
T ss_dssp             --TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             --CceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence              558999999999744444444556799999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .............+||+.|+|||++.+...++.++|||||||++|+|+||++||
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf  206 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  206 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCC
Confidence            765544444556788999999999987765578899999999999999999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=351.32  Aligned_cols=202  Identities=25%  Similarity=0.430  Sum_probs=175.5

Q ss_pred             CCCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        141 NSTNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       141 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      .+....+|.+++.||+|+||.||+|.+..+|+.||||+++.....  ..+.+.+|+.++++++||||+++++++.+    
T Consensus        15 ~~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~----   88 (293)
T d1yhwa1          15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV----   88 (293)
T ss_dssp             SSCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             CCCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE----
Confidence            344567899999999999999999999999999999999865433  34578899999999999999999877765    


Q ss_pred             cccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                            ++.+|+||||++|+.+..+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||
T Consensus        89 ------~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG  161 (293)
T d1yhwa1          89 ------GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG  161 (293)
T ss_dssp             ------TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ------CCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccch
Confidence                  5589999999998665555443 369999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.......  ......||+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       162 ~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf  216 (293)
T d1yhwa1         162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPY  216 (293)
T ss_dssp             TCEECCSTTC--CBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             hheeeccccc--cccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCC
Confidence            9997754332  234557899999999998755 899999999999999999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=352.77  Aligned_cols=202  Identities=26%  Similarity=0.377  Sum_probs=170.7

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|++++.||+|+||.||+|.+..+++.||||+++.... .......+.+|++++++++||||+++++++.+        
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------   79 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--------   79 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--------
Confidence            469999999999999999999999999999999976532 23345678899999999999999999777765        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ++.+|+||||++|+.+..+......+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+|+.
T Consensus        80 --~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          80 --DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             --SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             --CCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEeccccccee
Confidence              568999999999754444444445799999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.............||+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf  210 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPF  210 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCC
Confidence            76554444445567899999999998765 899999999999999999999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=345.42  Aligned_cols=198  Identities=31%  Similarity=0.468  Sum_probs=171.8

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|.+++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+        
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--------   77 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--------   77 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--------
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--------
Confidence            468999999999999999999999999999999875432 23345567899999999999999999877765        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ++.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..
T Consensus        78 --~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          78 --ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             --CCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeee
Confidence              568999999999755554444445799999999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....    .....||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       156 ~~~~~----~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf  204 (263)
T d2j4za1         156 APSSR----RTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF  204 (263)
T ss_dssp             CCCCC----CEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCc----ccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCC
Confidence            54332    23456899999999998765 899999999999999999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=344.42  Aligned_cols=199  Identities=25%  Similarity=0.354  Sum_probs=170.8

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      ..|++++.||+|+||.||+|.+..+++.||||+++....  ...+.+.+|++++++++||||+++++++.+         
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~---------   80 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYY---------   80 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEE---------
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEee---------
Confidence            468999999999999999999999999999999976532  235678899999999999999999887765         


Q ss_pred             CCCeEEEEeeccccChHHH-HhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMDHDLMGL-LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                       ++.+|+||||++|+.+.. +......+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus        81 -~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~  159 (288)
T d2jfla1          81 -ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK  159 (288)
T ss_dssp             -TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             -CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhc
Confidence             558999999999755544 455556799999999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCCCCCCCccccccccccccccC----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......||+.|+|||++..    ...++.++|||||||++|+|+||++||
T Consensus       160 ~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf  215 (288)
T d2jfla1         160 NTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH  215 (288)
T ss_dssp             CHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCC
Confidence            543321  1234567999999999852    334789999999999999999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=352.70  Aligned_cols=199  Identities=27%  Similarity=0.348  Sum_probs=171.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|+||+||+|.+..+|+.||+|+++... .......+.+|+.+++.++|||||++++++.+       
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------   75 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------   75 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-------
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-------
Confidence            3567999999999999999999999999999999997653 23334578899999999999999999887765       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                         .+.+|+||||++|+.+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++.++++||+|||+|
T Consensus        76 ---~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla  152 (322)
T d1s9ja_          76 ---DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS  152 (322)
T ss_dssp             ---SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             ---CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence               55899999999975555544444579999999999999999999997 59999999999999999999999999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +......    ....+||+.|+|||++.+.. ++.++||||+||++|+|++|+.||
T Consensus       153 ~~~~~~~----~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf  203 (322)
T d1s9ja_         153 GQLIDSM----ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPI  203 (322)
T ss_dssp             HHHHHHT----C---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCS
T ss_pred             cccCCCc----cccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence            8765432    23457899999999998765 999999999999999999999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-50  Score=344.05  Aligned_cols=202  Identities=29%  Similarity=0.482  Sum_probs=161.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++++.||+|+||.||++.+..+|+.||||.+......+...+.+.+|++++++++||||+++++++.+..       
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-------   76 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT-------   76 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---------
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC-------
Confidence            4699999999999999999999999999999999876544444556889999999999999999998876532       


Q ss_pred             CCCeEEEEeecccc-ChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEecCCCcEEE
Q psy13988        226 DKGSFYLVFEYMDH-DLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRN-----FLHRDIKCSNILMNNRGEVKL  296 (358)
Q Consensus       226 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~Dlkp~Nill~~~~~~~l  296 (358)
                       ++.+|+||||++| +|.+.+.   .....+++..++.++.||+.||+|||+.+     |+||||||+|||++.++.+||
T Consensus        77 -~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl  155 (269)
T d2java1          77 -NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  155 (269)
T ss_dssp             ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred             -CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence             4578999999987 4555443   23457999999999999999999999876     999999999999999999999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||+++........  .....||+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       156 ~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf  214 (269)
T d2java1         156 GDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPF  214 (269)
T ss_dssp             CCHHHHHHC-------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eeccceeecccCCCc--cccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCC
Confidence            999999876543322  23457799999999997655 899999999999999999999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-49  Score=346.04  Aligned_cols=198  Identities=30%  Similarity=0.467  Sum_probs=172.9

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...|.+++.||+|+||.||+|.+..+++.||||+++...... .....+.+|+.++++++|||||++++++.+       
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-------   86 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-------   86 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-------
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-------
Confidence            346899999999999999999999999999999997654322 223457899999999999999999887765       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ++.+|+||||+.++++..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.
T Consensus        87 ---~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~  163 (309)
T d1u5ra_          87 ---EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (309)
T ss_dssp             ---TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             ---CCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccccc
Confidence               55899999999998887776666789999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCC--CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....      ....||+.|+|||++.+.  ..++.++|||||||++|+|++|++||
T Consensus       164 ~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf  214 (309)
T d1u5ra_         164 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  214 (309)
T ss_dssp             SSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence            65432      345689999999998643  34899999999999999999999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=347.81  Aligned_cols=200  Identities=23%  Similarity=0.336  Sum_probs=174.6

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ++|.+++.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--------   76 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--------   76 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--------
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--------
Confidence            469999999999999999999999999999999976532 23345678899999999999999999877765        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ++.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus        77 --~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          77 --HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             --ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccc
Confidence              568999999999866655555556799999999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  .....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       155 ~~~~~~--~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf  205 (337)
T d1o6la_         155 GISDGA--TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             SCCTTC--CBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccCCc--ccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCC
Confidence            643322  234567899999999998766 899999999999999999999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-49  Score=338.29  Aligned_cols=200  Identities=25%  Similarity=0.303  Sum_probs=169.2

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .|++.+.||+|+||+||+|.+..++..||+|++..........+.+.+|++++++++||||+++++++.+..      ..
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~   83 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV------KG   83 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES------SS
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc------cc
Confidence            346778899999999999999999999999999876544434556889999999999999999999886532      23


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEec-CCCcEEEeecccce
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRN--FLHRDIKCSNILMN-NRGEVKLADFGLAR  303 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~Dlkp~Nill~-~~~~~~l~Dfg~~~  303 (358)
                      +..+|+||||++|+.+..+......+++..++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+++
T Consensus        84 ~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            5678999999998655555444557999999999999999999999998  99999999999996 47899999999997


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......    .....||+.|+|||++.+  .++.++|||||||++|+|++|++||
T Consensus       164 ~~~~~~----~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf  212 (270)
T d1t4ha_         164 LKRASF----AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPY  212 (270)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eccCCc----cCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCC
Confidence            543321    234578999999999865  3899999999999999999999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.7e-49  Score=345.44  Aligned_cols=197  Identities=21%  Similarity=0.317  Sum_probs=174.5

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|++++.||+|+||.||+|++..+|+.||||+++.... .....+.+.+|+.+++.++||||+++++++.+        
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--------   75 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--------   75 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--------
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--------
Confidence            468999999999999999999999999999999975532 23345678899999999999999999877765        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.
T Consensus        76 --~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          76 --AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             --SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             --CCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceE
Confidence              568999999999877777766667889999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....     ....||+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       154 ~~~~~-----~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf  201 (316)
T d1fota_         154 VPDVT-----YTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPF  201 (316)
T ss_dssp             CSSCB-----CCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecccc-----ccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCC
Confidence            65432     3457899999999998665 899999999999999999999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-48  Score=342.92  Aligned_cols=201  Identities=26%  Similarity=0.409  Sum_probs=156.7

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      +.....|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.++++++||||+++++++.+     
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----   78 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES-----   78 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence            345567999999999999999999999999999999998654332 23467799999999999999999777754     


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec---CCCcEEEe
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN---NRGEVKLA  297 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~---~~~~~~l~  297 (358)
                           ++.+|+||||++| +|.+.+. ....+++.++..++.||+.||+|||++||+||||||+||++.   .++.+||+
T Consensus        79 -----~~~~~lvmE~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~  152 (307)
T d1a06a_          79 -----GGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS  152 (307)
T ss_dssp             -----SSEEEEEECCCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             -----CCEEEEEEeccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEe
Confidence                 5689999999996 4555554 456799999999999999999999999999999999999995   46899999


Q ss_pred             ecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||+++.......   ....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||
T Consensus       153 DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf  209 (307)
T d1a06a_         153 DFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPF  209 (307)
T ss_dssp             CC---------------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccceeEEccCCCe---eeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCC
Confidence            9999987654432   23456899999999998765 899999999999999999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=337.25  Aligned_cols=202  Identities=21%  Similarity=0.312  Sum_probs=166.9

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...++|.+.+.||+|+||.||++..   +..||||+++.........+.+.+|+.++++++||||+++++++.+      
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------   75 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------   75 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------
Confidence            4567899999999999999999974   3469999998765555556778899999999999999999876532      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           ..+++||||++| +|.+.+......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus        76 -----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGl  150 (276)
T d1uwha_          76 -----PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL  150 (276)
T ss_dssp             -----SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred             -----cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccc
Confidence                 357999999996 66666666667799999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCC--CCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++...............||+.|+|||++.+.  ..++.++|||||||++|||+||+.||
T Consensus       151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf  209 (276)
T d1uwha_         151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY  209 (276)
T ss_dssp             SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence            9877554443444556789999999998643  34788999999999999999999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=334.90  Aligned_cols=202  Identities=24%  Similarity=0.343  Sum_probs=172.8

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCC----CchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEG----FPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ....+|.+++.||+|+||.||+|.+..+|+.||||+++.......    ..+.+.+|+.++++++||||+++++++.+  
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--   84 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--   84 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence            345689999999999999999999999999999999976543222    23567899999999999999999877765  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----cE
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG----EV  294 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~----~~  294 (358)
                              .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||+++|+||||||+||+++.++    .+
T Consensus        85 --------~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~v  156 (293)
T d1jksa_          85 --------KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI  156 (293)
T ss_dssp             --------SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCE
T ss_pred             --------CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccce
Confidence                    568999999999755544444445799999999999999999999999999999999999998876    59


Q ss_pred             EEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+|||++........   .....+|+.|+|||++.+.. ++.++||||+||++|+|+||++||
T Consensus       157 kl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf  216 (293)
T d1jksa_         157 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPF  216 (293)
T ss_dssp             EECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCC
Confidence            9999999988754433   23456799999999998654 899999999999999999999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-48  Score=345.01  Aligned_cols=197  Identities=22%  Similarity=0.318  Sum_probs=172.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccc-cCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLEN-EKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.+        
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--------  112 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--------  112 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--------
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--------
Confidence            57999999999999999999999999999999987543 223345578899999999999999999777765        


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                        ...+++||||+.|+.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       113 --~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         113 --NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             --ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence              558999999999865555544455799999999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....     ....||+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       191 ~~~~~-----~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf  238 (350)
T d1rdqe_         191 VKGRT-----WTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             CSSCB-----CCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccc-----ccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCC
Confidence            75332     3467899999999998765 899999999999999999999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.6e-48  Score=344.81  Aligned_cols=199  Identities=26%  Similarity=0.381  Sum_probs=172.6

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ....|++++.||+|+||.||+|.+..+|+.||||+++......  ...+.+|+.++++++||||+++++++.+       
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~-------   97 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFED-------   97 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEEC-------
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEE-------
Confidence            4457999999999999999999999999999999987653222  3467789999999999999999777765       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec--CCCcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMN--NRGEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~--~~~~~~l~Dfg  300 (358)
                         ++.+|+||||++| +|.+.+......+++.+++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||
T Consensus        98 ---~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_          98 ---KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             ---SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             ---CCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecc
Confidence               5689999999997 45566666666799999999999999999999999999999999999998  56899999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........   .....+|+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       175 la~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf  228 (352)
T d1koba_         175 LATKLNPDEI---VKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPF  228 (352)
T ss_dssp             TCEECCTTSC---EEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred             cceecCCCCc---eeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCC
Confidence            9998765432   23446699999999998765 899999999999999999999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=337.07  Aligned_cols=197  Identities=38%  Similarity=0.714  Sum_probs=169.1

Q ss_pred             ccccccCCcceeeEeeeeecCCcEEEEEEeeccccC---CCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccC
Q psy13988        150 LMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK---EGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKD  226 (358)
Q Consensus       150 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  226 (358)
                      .++.||+|+||+||+|.+..+|+.||||+++.....   ......+.+|+.++++++||||+++++++.+          
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~----------   71 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----------   71 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----------
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc----------
Confidence            468999999999999999999999999999765432   2224568899999999999999999777765          


Q ss_pred             CCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        227 KGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       227 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      ++.+|+||||+.++++..+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        72 ~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          72 KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             CCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccC
Confidence            55899999999998888887777789999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....  .....++|+.|+|||++.....++.++||||+||++|+|+||.+||
T Consensus       152 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf  201 (299)
T d1ua2a_         152 SPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL  201 (299)
T ss_dssp             SCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC
Confidence            4432  2234578999999999977666899999999999999999999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.2e-48  Score=343.86  Aligned_cols=199  Identities=26%  Similarity=0.369  Sum_probs=172.4

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .-.+|.+++.||+|+||.||+|.+..+|+.||||++......  ..+.+.+|+.++++++||||+++++++.+       
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~-------   94 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED-------   94 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEE-------
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEE-------
Confidence            345899999999999999999999999999999998754332  23567899999999999999999877765       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC--CCcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN--RGEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~--~~~~~l~Dfg  300 (358)
                         ++.+|+||||++| +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||
T Consensus        95 ---~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2          95 ---DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             ---TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             ---CCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecc
Confidence               5689999999986 566666666668999999999999999999999999999999999999964  5789999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++.......   .....||+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       172 ~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf  225 (350)
T d1koaa2         172 LTAHLDPKQS---VKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPF  225 (350)
T ss_dssp             TCEECCTTSC---EEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             hheecccccc---cceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCC
Confidence            9987754432   23456799999999998765 889999999999999999999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=334.52  Aligned_cols=201  Identities=43%  Similarity=0.801  Sum_probs=174.1

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++++.||+|+||.||+|.+..+++.||||+++...........+.+|++++++++||||+++++++.+         
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~---------   72 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT---------   72 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE---------
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc---------
Confidence            47999999999999999999999999999999997765555556788999999999999999999877765         


Q ss_pred             CCCeEEEEeeccccChHHHHh-cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                       ++.+|+||||++++++..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        73 -~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          73 -ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             -TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             -ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCccee
Confidence             55899999999998777764 4456799999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ......+|+.|+|||++.....++.++||||+||++|+|++|++||
T Consensus       152 ~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf  203 (298)
T d1gz8a_         152 FGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF  203 (298)
T ss_dssp             HCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC
Confidence            654332  2345578999999999887777789999999999999999999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-47  Score=332.64  Aligned_cols=208  Identities=25%  Similarity=0.365  Sum_probs=168.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC-CCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE-GFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ...+|++.+.||+|+||.||+|.+..+++.||||+++...... .....+.+|+.+++.++||||+++++++....    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~----   80 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET----   80 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC----
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc----
Confidence            4578999999999999999999999999999999997654332 22346789999999999999999998887533    


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                        .....+|+||||++|+.+.........+++.+++.++.||+.||+|||++||+||||||+||+++.++..+|+|||.+
T Consensus        81 --~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          81 --PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             --SSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             --CCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhh
Confidence              123468999999998665555555567999999999999999999999999999999999999999999999999998


Q ss_pred             eeccccCC-CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDR-QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........ ........||+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf  214 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPF  214 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCC
Confidence            76543322 22334567899999999998654 899999999999999999999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.9e-47  Score=340.46  Aligned_cols=199  Identities=22%  Similarity=0.266  Sum_probs=167.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccC-CCCchhHHH---HHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEK-EGFPITAVR---EIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .+|.+++.||+|+||.||+|.+..+|+.||||++...... ......+.+   ++.+++.++||||+++++++.+     
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-----   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-----
Confidence            5799999999999999999999999999999998754321 111223333   4667777899999999777765     


Q ss_pred             ccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        222 DFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                           .+.+|+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        79 -----~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          79 -----PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             -----SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             -----CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeece
Confidence                 558999999999755555444456789999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+......    .....||+.|+|||++.+...++.++|||||||++|+|+||++||
T Consensus       154 a~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf  206 (364)
T d1omwa3         154 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF  206 (364)
T ss_dssp             CEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCC
Confidence            98765432    234568999999999976656899999999999999999999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5e-47  Score=330.08  Aligned_cols=201  Identities=23%  Similarity=0.359  Sum_probs=170.4

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|++.+.||+|+||.||+|.+..+++.||||+++...   ...+.+.+|+.++++++|||||++++++.+      
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~------   84 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR------   84 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEee------
Confidence            34457889999999999999999999999999999987543   234678999999999999999999887765      


Q ss_pred             cccCCCeEEEEeecccc-ChHHHHhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDH-DLMGLLES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                          ++.+|+||||+++ ++...+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        85 ----~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          85 ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ----CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence                4578999999996 55555543 45578999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++....... .......+++.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus       161 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~  216 (287)
T d1opja_         161 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP  216 (287)
T ss_dssp             CTTTCCSSSS-EEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ceeecCCCCc-eeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCC
Confidence            9987654322 2233445789999999988655 899999999999999999976664

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=331.47  Aligned_cols=212  Identities=48%  Similarity=0.843  Sum_probs=178.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .++|++++.||+|+||+||+|.+..+|+.||||++......+.....+.+|+.++++++||||+++++++....  ..+.
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~--~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA--SPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc--cccc
Confidence            47899999999999999999999999999999999877666666778899999999999999999999887644  2334


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ..++..|+|||+++++++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence            45678999999999999888888778899999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCC--CCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDR--QRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  ........+|+.|+|||++.+...++.++||||+||++|+|++|++||
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf  222 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM  222 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence            654322  223344568999999999987767899999999999999999999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=331.32  Aligned_cols=200  Identities=23%  Similarity=0.363  Sum_probs=170.0

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeecccc-CCCCchhHHHHHHHHH-hCCCCcccchhhhhcccCccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENE-KEGFPITAVREIKILR-QLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+|.+++.||+|+||+||+|.+..+++.||||+++.... .......+..|..++. .++||||+++++++.+       
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-------   74 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-------   74 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-------
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-------
Confidence            468999999999999999999999999999999975432 2333445667777665 6899999999777765       


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                         ++.+|+||||++|+.+..+......+++.+++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+++
T Consensus        75 ---~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          75 ---KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             ---SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ---CCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhh
Confidence               56899999999986555555555679999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .......  ......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||
T Consensus       152 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF  203 (320)
T d1xjda_         152 ENMLGDA--KTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPF  203 (320)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             hcccccc--cccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCC
Confidence            6543322  234457899999999998765 899999999999999999999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.9e-46  Score=322.34  Aligned_cols=200  Identities=29%  Similarity=0.456  Sum_probs=171.5

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCc-------hhHHHHHHHHHhCC-CCcccchhhhhcc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFP-------ITAVREIKILRQLN-HKNIVNLREIVTD  216 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~  216 (358)
                      ..+|++.+.||+|+||+||+|++..+++.||||+++.........       +.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            468999999999999999999999999999999998765433221       34778999999996 9999999777765


Q ss_pred             cCcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVK  295 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~  295 (358)
                                ++.+|+||||++| +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+|
T Consensus        82 ----------~~~~~ivmE~~~~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~k  150 (277)
T d1phka_          82 ----------NTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK  150 (277)
T ss_dssp             ----------SSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             ----------CcceEEEEEcCCCchHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeE
Confidence                      5689999999987 5555554 455799999999999999999999999999999999999999999999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccC-----CCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLG-----EERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||+++.......   .....||+.|+|||++.+     ...++.++||||+||++|+|+||++||
T Consensus       151 l~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf  215 (277)
T d1phka_         151 LTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF  215 (277)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC
Confidence            999999998765432   234567999999999852     334788999999999999999999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.4e-47  Score=330.54  Aligned_cols=203  Identities=22%  Similarity=0.403  Sum_probs=157.0

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCc---EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDE---LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ..++|++.+.||+|+||.||+|.+..+++   .||||.+...... .....+.+|+.++++++|||||++++++.+    
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----   98 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTK----   98 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEee----
Confidence            34678899999999999999999877664   5889987654322 223468899999999999999999887755    


Q ss_pred             cccccCCCeEEEEeeccccChHH-HHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                            ++.+|+||||++++.+. .+......+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus        99 ------~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_          99 ------STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             ------SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             ------CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCc
Confidence                  45789999999975554 45555667999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCC---CCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRP---YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++..........   .....+|+.|+|||++.+.. ++.++|||||||++|||+| |++||
T Consensus       173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf  234 (299)
T d1jpaa_         173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPY  234 (299)
T ss_dssp             -----------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCC
Confidence            99987754433222   22345689999999988654 8999999999999999998 89998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-47  Score=326.31  Aligned_cols=201  Identities=26%  Similarity=0.343  Sum_probs=169.0

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCC----CCchhHHHHHHHHHhCC--CCcccchhhhhccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKE----GFPITAVREIKILRQLN--HKNIVNLREIVTDK  217 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~  217 (358)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.......    .....+.+|+.++++++  ||||+++++++.+ 
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-   80 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-   80 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-
Confidence            4678999999999999999999999999999999997653221    12235678999999996  8999999877765 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR-GEVK  295 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~-~~~~  295 (358)
                               .+..|+|||++.+ +++..+......+++.+++.++.||+.||+|||++||+||||||+||+++.+ +.+|
T Consensus        81 ---------~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vk  151 (273)
T d1xwsa_          81 ---------PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK  151 (273)
T ss_dssp             ---------SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred             ---------CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEE
Confidence                     5589999999975 3444443344579999999999999999999999999999999999999865 7999


Q ss_pred             EeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        296 LADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       296 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+|||+++......    .....||+.|+|||++.+...++.++|||||||++|+|+||+.||
T Consensus       152 l~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf  210 (273)
T d1xwsa_         152 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF  210 (273)
T ss_dssp             ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCC
Confidence            99999998764332    234578999999999987665677899999999999999999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=321.49  Aligned_cols=198  Identities=23%  Similarity=0.424  Sum_probs=158.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .++|++++.||+|+||.||++.+. +++.||||+++...   ...+.+.+|+.++++++||||+++++++.+        
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--------   71 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--------   71 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--------
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceecc--------
Confidence            467899999999999999999974 57789999987543   234678999999999999999999887765        


Q ss_pred             cCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ++.+++||||++++ |.+.+......+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++
T Consensus        72 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          72 --QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             --CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchhe
Confidence              45789999999875 555566666778999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhC-CCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK-KPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg-~~pF  358 (358)
                      ........ ......||+.|+|||++.+.. ++.++|||||||++|||+|+ .+||
T Consensus       150 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~  203 (263)
T d1sm2a_         150 FVLDDQYT-SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPY  203 (263)
T ss_dssp             ----------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             eccCCCce-eecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCC
Confidence            76544322 223456799999999998765 89999999999999999995 5554

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.1e-46  Score=326.01  Aligned_cols=200  Identities=44%  Similarity=0.793  Sum_probs=175.7

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++++.||+|+||+||+|++. +++.||||+++...........+.+|+.++++++||||+++++++.+         
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~---------   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT---------   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC---------
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc---------
Confidence            47999999999999999999985 78999999998776556666788999999999999999999777665         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ++..+++||++.++++..+......+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||.+...
T Consensus        72 -~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          72 -KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             -SSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             -CCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence             5689999999999999999888889999999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  ......+++.|+|||.+.+...++.++|||||||++|+|++|++||
T Consensus       151 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf  201 (286)
T d1ob3a_         151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF  201 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC
Confidence            54332  2234457999999999987777899999999999999999999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=330.46  Aligned_cols=198  Identities=24%  Similarity=0.384  Sum_probs=171.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .-.+|.+++.||+|+||+||+|.+..+++.||||+++.....   ...+.+|+.+++.++||||+++++++.+       
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~-------   72 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFES-------   72 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEE-------
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEE-------
Confidence            456799999999999999999999999999999999765322   3457799999999999999999877765       


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC--CcEEEeecc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR--GEVKLADFG  300 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~--~~~~l~Dfg  300 (358)
                         ++.+|+||||++| +|.+.+......+++.+++.++.||+.||+|||++||+||||||+|||++.+  ..++|+|||
T Consensus        73 ---~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          73 ---MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             ---TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             ---CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccc
Confidence               5689999999997 5666666666689999999999999999999999999999999999999855  489999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........   .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|.+||
T Consensus       150 ~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf  203 (321)
T d1tkia_         150 QARQLKPGDN---FRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPF  203 (321)
T ss_dssp             TCEECCTTCE---EEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             hhhccccCCc---ccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCC
Confidence            9987654332   23345699999999987665 899999999999999999999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=325.97  Aligned_cols=195  Identities=22%  Similarity=0.352  Sum_probs=159.3

Q ss_pred             ccccCCcceeeEeeeee--cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCe
Q psy13988        152 EPLAAGGLSLNNFSVSL--FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGS  229 (358)
Q Consensus       152 ~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~  229 (358)
                      +.||+|+||.||+|...  .+++.||||+++.........+.+.+|+.++++++|||||++++++..           ..
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----------~~   81 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----------ES   81 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----------SS
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----------CC
Confidence            36999999999999864  456789999997655444445678899999999999999999887643           24


Q ss_pred             EEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceeccccC
Q psy13988        230 FYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYNAED  309 (358)
Q Consensus       230 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~  309 (358)
                      .++||||++++.+..+......+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            78999999986555555555679999999999999999999999999999999999999999999999999998765433


Q ss_pred             CC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        310 RQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       310 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      .. .......||+.|+|||++.+.. ++.++|||||||++|||+| |++||
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf  211 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPY  211 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCC
Confidence            22 2233456799999999987655 8999999999999999998 89998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=314.23  Aligned_cols=198  Identities=22%  Similarity=0.446  Sum_probs=171.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      .+.|++++.||+|+||.||++.. .++..||||+++....   ..+.+.+|+.++++++||||+++++++.+        
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--------   70 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTK--------   70 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECC--------
T ss_pred             hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEee--------
Confidence            46889999999999999999997 4788999999986533   34678999999999999999999887764        


Q ss_pred             cCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        225 KDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                        ++.+++||||+++ ++...+......+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus        71 --~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          71 --QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             --SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             --CCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhe
Confidence              4579999999986 5555656666789999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ....... .......+|+.|+|||++.+.. ++.++||||||+++|||+| |+.||
T Consensus       149 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf  202 (258)
T d1k2pa_         149 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPY  202 (258)
T ss_dssp             BCSSSSC-CCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             eccCCCc-eeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCC
Confidence            7654432 2334567899999999998655 8999999999999999998 89997

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=329.56  Aligned_cols=203  Identities=27%  Similarity=0.372  Sum_probs=167.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCc-----EEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDE-----LVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      ...+|.+.+.||+|+||.||+|.+..+++     .||+|.+..... ......+.+|+.+++++ +|||||++++++.+ 
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-  112 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTL-  112 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-
Confidence            34578899999999999999999876554     699998875433 33455788999999998 89999999877765 


Q ss_pred             CcccccccCCCeEEEEeecccc-ChHHHHhcCC----------------------CCCChHHHHHHHHHHHHHHHHHHhC
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDH-DLMGLLESGM----------------------VDFNEVNNASIMRQLLDGLSYCHKR  274 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------~~~~~~~~~~~~~qi~~al~~LH~~  274 (358)
                               .+.+|+||||+++ +|.+.+....                      ..+++..++.++.||+.||+|||++
T Consensus       113 ---------~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~  183 (325)
T d1rjba_         113 ---------SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK  183 (325)
T ss_dssp             ---------SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ---------CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                     4578999999987 5555554332                      2488999999999999999999999


Q ss_pred             CceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-
Q psy13988        275 NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-  353 (358)
Q Consensus       275 ~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-  353 (358)
                      +|+||||||+||+++.++.+||+|||+|+...............+|+.|+|||++.+.. ++.++|||||||++|||+| 
T Consensus       184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTT
T ss_pred             CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhC
Confidence            99999999999999999999999999998776554443344566799999999987655 8999999999999999998 


Q ss_pred             CCCCC
Q psy13988        354 KKPLF  358 (358)
Q Consensus       354 g~~pF  358 (358)
                      |++||
T Consensus       263 g~~Pf  267 (325)
T d1rjba_         263 GVNPY  267 (325)
T ss_dssp             SCCSS
T ss_pred             CCCCC
Confidence            89998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=330.57  Aligned_cols=204  Identities=34%  Similarity=0.584  Sum_probs=171.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|+||+||+|.+..+|+.||||+++...........+.+|+.+|+.++|||||++++++...+    .
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~----~   91 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE----T   91 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS----S
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc----c
Confidence            567899999999999999999999999999999999865444444557789999999999999999999987643    2


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ......+|+||||+++++......  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||+++
T Consensus        92 ~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          92 LDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccccceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccccee
Confidence            334567899999997666665543  369999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....     .....+|+.|+|||++.+...++.++||||+||++|+|++|++||
T Consensus       170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf  219 (346)
T d1cm8a_         170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF  219 (346)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC
Confidence            76533     245567999999999987776899999999999999999999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-46  Score=321.20  Aligned_cols=199  Identities=25%  Similarity=0.374  Sum_probs=164.8

Q ss_pred             CCccccc-ccCCcceeeEeeeeec--CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        147 SRPLMEP-LAAGGLSLNNFSVSLF--TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       147 ~~~~~~~-lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+.+.+. ||+|+||.||+|.+..  ++..||||+++.... ....+.+.+|++++++++|||||++++++.+       
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------   80 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-------   80 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-------
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC-HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-------
Confidence            4556674 9999999999997654  455899999875432 2234578899999999999999999887743       


Q ss_pred             ccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~  302 (358)
                          +.+|+||||++++ |.+.+......+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus        81 ----~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          81 ----EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             ----SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             ----CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhh
Confidence                2579999999974 55555566668999999999999999999999999999999999999999999999999999


Q ss_pred             eeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        303 RLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +........ .......+|+.|+|||++.+.. ++.++|||||||++|||+| |++||
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf  213 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPY  213 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             hcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCC
Confidence            987544322 2233446789999999987654 8999999999999999998 89998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=323.89  Aligned_cols=205  Identities=38%  Similarity=0.683  Sum_probs=173.7

Q ss_pred             CCCCcccccccCCcceeeEeeeeecC-CcEEEEEEeeccccCCCCchhHHHHHHHHHhC---CCCcccchhhhhcccCcc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFT-DELVALKKVRLENEKEGFPITAVREIKILRQL---NHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~  220 (358)
                      ..+|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+++.+   +||||+++++++....  
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~--   83 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR--   83 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE--
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc--
Confidence            46899999999999999999999765 67899999987665555555677888887766   8999999998886422  


Q ss_pred             cccccCCCeEEEEeeccccChHHHH-hcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDHDLMGLL-ESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                         ......++++||+++++++... ......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus        84 ---~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          84 ---TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             ---CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             ---cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence               1235689999999999877654 445567999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |+++.......   .....||+.|+|||++.+.. ++.++||||+||++|+|+||++||
T Consensus       161 g~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf  215 (305)
T d1blxa_         161 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLF  215 (305)
T ss_dssp             CSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             hhhhhhccccc---CCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCC
Confidence            99886544332   34567799999999998765 899999999999999999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-46  Score=319.92  Aligned_cols=198  Identities=25%  Similarity=0.433  Sum_probs=164.6

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|++.+.||+|+||.||+|.+. ++..||||+++...   ...+.+.+|+.++++++|||||++++++.+      
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------   79 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------   79 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------
Confidence            34567899999999999999999974 67899999987543   234578999999999999999999887643      


Q ss_pred             cccCCCeEEEEeeccccChHHH-Hhc-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGL-LES-GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~-~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           +.+|+||||++++.+.. +.. ....+++..+..++.||++||.|||+++|+||||||+|||++.++.+||+|||
T Consensus        80 -----~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          80 -----EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             -----SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             -----CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeecccc
Confidence                 35789999999765544 322 22358999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPL  357 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~p  357 (358)
                      +++....... .......+|+.|+|||++.+.. ++.++|||||||++|||+||..|
T Consensus       155 la~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~  209 (272)
T d1qpca_         155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRI  209 (272)
T ss_dssp             TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ceEEccCCcc-ccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCC
Confidence            9998754432 2233456789999999987654 89999999999999999996544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=327.58  Aligned_cols=201  Identities=31%  Similarity=0.511  Sum_probs=171.6

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|+.+++||+|+||+||+|++..+|+.||||++.....      ...+|++++++++||||+++++++....    ..
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~----~~   88 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSG----EK   88 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC------C
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecC----cc
Confidence            3479999999999999999999999999999999975432      2357999999999999999999886532    22


Q ss_pred             cCCCeEEEEeeccccChHHHHh---cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeecc
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLE---SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFG  300 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg  300 (358)
                      .+..++|+||||+++++...+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus        89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence            3456789999999988766553   3556799999999999999999999999999999999999999876 89999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++........   .....+++.|+|||++.+...++.++||||+||++|+|++|++||
T Consensus       169 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf  223 (350)
T d1q5ka_         169 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF  223 (350)
T ss_dssp             TCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred             chhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC
Confidence            9987754433   234567999999999887667999999999999999999999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=324.59  Aligned_cols=200  Identities=21%  Similarity=0.325  Sum_probs=162.8

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCc----EEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDE----LVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  221 (358)
                      .+|++++.||+|+||.||+|.+..+|+    +||+|+++... .....+.+.+|+.++++++|||||++++++.+.    
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            469999999999999999999987775    68888886543 333456789999999999999999998887642    


Q ss_pred             ccccCCCeEEEEeeccc-cChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        222 DFRKDKGSFYLVFEYMD-HDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                             ..++++|++. |++++.+......+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus        84 -------~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          84 -------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             -------SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             -------CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccc
Confidence                   3556666666 57888787777789999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      +++...............||+.|+|||++.+.. ++.++|||||||++|||+| |.+||
T Consensus       157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~  214 (317)
T d1xkka_         157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPY  214 (317)
T ss_dssp             HHHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCC
Confidence            999876554444444556799999999988654 8999999999999999998 78887

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=318.83  Aligned_cols=204  Identities=22%  Similarity=0.375  Sum_probs=160.3

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCC----cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTD----ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ...+.|.+.+.||+|+||.||+|....++    ..||||+++..... .....+.+|+.++++++|||||++++++.+  
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--   80 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISK--   80 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh-HHHHHHHHHHHHHHhcCCCCEeeeeEEEec--
Confidence            34567889999999999999999987655    47999998754322 223467899999999999999999877765  


Q ss_pred             cccccccCCCeEEEEeeccccChH-HHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLM-GLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLA  297 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~  297 (358)
                              .+..++||||+.++++ ..+......+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus        81 --------~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~  152 (283)
T d1mqba_          81 --------YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS  152 (283)
T ss_dssp             --------SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             --------CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEc
Confidence                    4578999999997544 4455666789999999999999999999999999999999999999999999999


Q ss_pred             ecccceeccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||+++........ .......||+.|+|||++.+.. ++.++|||||||++|||+||..||
T Consensus       153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~  213 (283)
T d1mqba_         153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERP  213 (283)
T ss_dssp             CCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccchhhcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCc
Confidence            99999876543322 2233456799999999998655 899999999999999999965553

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=325.76  Aligned_cols=198  Identities=26%  Similarity=0.367  Sum_probs=167.1

Q ss_pred             CCCCCcccc-cccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHh-CCCCcccchhhhhcccCccc
Q psy13988        144 NNSSRPLME-PLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQ-LNHKNIVNLREIVTDKSDAL  221 (358)
Q Consensus       144 ~~~~~~~~~-~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~  221 (358)
                      ....|.+++ .||+|+||.||+|.+..+++.||||+++..       ..+.+|+.++.+ .+||||++++++|.+..   
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~---   78 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY---   78 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE---
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc---
Confidence            345788875 699999999999999999999999998632       356789998655 58999999999886521   


Q ss_pred             ccccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEE
Q psy13988        222 DFRKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEVKL  296 (358)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~---~~~~~l  296 (358)
                         ..+..+|+|||||+| +|.+.+... ...+++.+++.++.||+.||+|||++||+||||||+||+++.   .+.+||
T Consensus        79 ---~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          79 ---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             ---TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred             ---cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccc
Confidence               234679999999986 676766553 346999999999999999999999999999999999999986   457999


Q ss_pred             eecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        297 ADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       297 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +|||+++.......   .....||+.|+|||++.+.. ++.++|||||||++|+|+||++||
T Consensus       156 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf  213 (335)
T d2ozaa1         156 TDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF  213 (335)
T ss_dssp             CCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred             cccceeeeccCCCc---cccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCC
Confidence            99999987765433   24456899999999987655 899999999999999999999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=324.25  Aligned_cols=207  Identities=32%  Similarity=0.582  Sum_probs=173.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+.+|.+++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++....     
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~-----   79 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT-----   79 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS-----
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc-----
Confidence            4568999999999999999999999999999999987543 2223456789999999999999999998886532     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccce
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLAR  303 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~  303 (358)
                      ......+|+|+++++|+|.+.+...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          80 IEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             TTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            2334567888888878888877654  69999999999999999999999999999999999999999999999999998


Q ss_pred             eccccCCC-CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        304 LYNAEDRQ-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       304 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ........ ......++|+.|+|||++.....++.++||||+||++|+|++|++||
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf  213 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF  213 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC
Confidence            76544322 22345678999999999877666899999999999999999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-44  Score=314.61  Aligned_cols=201  Identities=42%  Similarity=0.738  Sum_probs=178.9

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .+|++++.||+|+||+||+|.+..+++.||||+++...........+.+|+.+++.++||||+++++++.+         
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~---------   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS---------   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---------
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc---------
Confidence            47999999999999999999999999999999998776555566788899999999999999999777765         


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                       ....++|++++.++++..+......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++..
T Consensus        73 -~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          73 -DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             -SSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -ccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcc
Confidence             5589999999999888888777788999999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        306 NAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       306 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......  .....+++.|+|||++.+...++.++||||+||++|+|++|+.||
T Consensus       152 ~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  202 (292)
T d1unla_         152 GIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             CSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence            544332  233455888999999987776899999999999999999999886

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3e-44  Score=313.88  Aligned_cols=200  Identities=19%  Similarity=0.209  Sum_probs=172.3

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCC-CcccchhhhhcccCcccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH-KNIVNLREIVTDKSDALD  222 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~  222 (358)
                      .+++|++.+.||+|+||.||+|.+..+++.||||+++.....    ..+.+|++.++.++| +|++.+++++..      
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~------   72 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE------   72 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE------
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec------
Confidence            467899999999999999999999999999999988654322    356789999999965 899988666544      


Q ss_pred             cccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-----CCcEEEe
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN-----RGEVKLA  297 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~-----~~~~~l~  297 (358)
                          ++..++|||++++++.+.+......+++..+..++.|++.||+|||++||+||||||+||+++.     ++.++|+
T Consensus        73 ----~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          73 ----GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             ----TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             ----CCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEc
Confidence                6689999999999988888777778999999999999999999999999999999999999974     5689999


Q ss_pred             ecccceeccccCCC-----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        298 DFGLARLYNAEDRQ-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       298 Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      |||+++.+......     .......||+.|+|||++.+.. ++.++||||||+++|+|+||+.||
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf  213 (293)
T d1csna_         149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPW  213 (293)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcC
Confidence            99999987543221     2233457899999999998765 899999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-43  Score=311.67  Aligned_cols=200  Identities=22%  Similarity=0.239  Sum_probs=170.2

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      +++|++++.||+|+||.||+|.+..+++.||||++......    ..+..|+++++.++|+|++..+..+.         
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~---------   72 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCG---------   72 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEE---------
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEE---------
Confidence            46899999999999999999999999999999998765332    35788999999998887666644332         


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEeeccc
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNN---RGEVKLADFGL  301 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~---~~~~~l~Dfg~  301 (358)
                      .+++..++||||+++++...+......+++..+..++.|++.||+|||++||+||||||+||+++.   +..++|+|||+
T Consensus        73 ~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~  152 (299)
T d1ckia_          73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  152 (299)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred             ecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCc
Confidence            235689999999999998888777778999999999999999999999999999999999999864   45799999999


Q ss_pred             ceeccccCCC-----CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        302 ARLYNAEDRQ-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ++.+......     .......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~  213 (299)
T d1ckia_         153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPW  213 (299)
T ss_dssp             CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcc
Confidence            9987544321     2234557899999999998765 899999999999999999999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=312.67  Aligned_cols=201  Identities=22%  Similarity=0.345  Sum_probs=156.1

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCC---cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTD---ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ...+|++.+.||+|+||.||+|.+..++   ..||||.++... .......+.+|+.++++++||||+++++++.+    
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----   79 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE----   79 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----
Confidence            3467999999999999999999886543   568899876432 22234568899999999999999999887743    


Q ss_pred             cccccCCCeEEEEeeccccC-hHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDHD-LMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             +.+|+||||++++ +...+......+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+||
T Consensus        80 -------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~Df  152 (273)
T d1mp8a_          80 -------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF  152 (273)
T ss_dssp             -------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             -------CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccc
Confidence                   3689999999964 55555666678999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++........ ......+|+.|+|||++.+.. ++.++|||||||++|||+| |.+||
T Consensus       153 G~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~  210 (273)
T d1mp8a_         153 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPF  210 (273)
T ss_dssp             -------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             hhheeccCCcce-eccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCC
Confidence            999876543322 223456789999999997654 8999999999999999998 89987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=318.26  Aligned_cols=203  Identities=31%  Similarity=0.536  Sum_probs=167.1

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|++++.||+|+||+||+|++..+|+.||||++............+.+|+.++++++||||+++++++....    ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~----~~   91 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK----TL   91 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC----ST
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc----cc
Confidence            36799999999999999999999999999999999866544434456789999999999999999999887532    23


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      +....+|+||||+.++++..+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||+++.
T Consensus        92 ~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          92 EEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             TTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             ccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence            4567999999999999888774   3589999999999999999999999999999999999999999999999999886


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ......   .....+|+.|+|||++.+.. ++.++||||+||++|+|++|++||
T Consensus       169 ~~~~~~---~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF  218 (355)
T d2b1pa1         169 AGTSFM---MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccc---cccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCC
Confidence            654432   23446799999999998754 899999999999999999999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=311.14  Aligned_cols=199  Identities=26%  Similarity=0.389  Sum_probs=158.8

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  222 (358)
                      ....+|++.+.||+|+||.||+|.+..+ ..||||+++....   ..+.+.+|+.++++++|||||++++++.+      
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------   83 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------   83 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec------
Confidence            3456799999999999999999998544 6799999975432   24678999999999999999999887643      


Q ss_pred             cccCCCeEEEEeeccccChHH-HHh-cCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecc
Q psy13988        223 FRKDKGSFYLVFEYMDHDLMG-LLE-SGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFG  300 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~l~~-~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg  300 (358)
                           +.+++||||++++.+. .+. .....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        84 -----~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfG  158 (285)
T d1fmka3          84 -----EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG  158 (285)
T ss_dssp             -----SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             -----CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccc
Confidence                 3578999999976444 443 233468999999999999999999999999999999999999999999999999


Q ss_pred             cceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        301 LARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +++....... .......+|+.|+|||++.+.. ++.++||||||+++|||+||..||
T Consensus       159 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~  214 (285)
T d1fmka3         159 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVP  214 (285)
T ss_dssp             TTC---------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             hhhhccCCCc-eeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCC
Confidence            9987654332 2234456799999999997655 899999999999999999976554

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=317.53  Aligned_cols=203  Identities=31%  Similarity=0.533  Sum_probs=169.1

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFR  224 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  224 (358)
                      ..+|++++.||+|+||+||+|++..+|+.||||+++...........+.+|+.++++++||||+++++++....    ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~----~~   92 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR----SL   92 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS----ST
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc----cc
Confidence            46899999999999999999999999999999999865444434456789999999999999999998886532    22


Q ss_pred             cCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        225 KDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       225 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      ++.+.+++++++.+|+|.+.+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+..
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             ccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence            34456677766666677666543  3699999999999999999999999999999999999999999999999999976


Q ss_pred             ccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        305 YNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ....     .....|++.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus       171 ~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF  219 (348)
T d2gfsa1         171 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  219 (348)
T ss_dssp             CTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC
Confidence            5433     244567999999999887777899999999999999999999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.7e-43  Score=313.33  Aligned_cols=195  Identities=29%  Similarity=0.530  Sum_probs=168.9

Q ss_pred             CCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccccc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  223 (358)
                      ..+|++++.||+|+||+||+|++..+++.||||+++...     ...+.+|+++++.++ ||||+++++++....     
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~-----  103 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPV-----  103 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT-----
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecC-----
Confidence            357999999999999999999999999999999986432     356789999999995 999999988876532     


Q ss_pred             ccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEeecccc
Q psy13988        224 RKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRG-EVKLADFGLA  302 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~-~~~l~Dfg~~  302 (358)
                         ...+++||||++++.+..+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++
T Consensus       104 ---~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         104 ---SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             ---TCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             ---CCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccc
Confidence               45799999999987665443   3699999999999999999999999999999999999999765 6899999999


Q ss_pred             eeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        303 RLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.......   .....+|+.|+|||.+.+...++.++||||+||++|+|++|+.||
T Consensus       178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf  230 (328)
T d3bqca1         178 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF  230 (328)
T ss_dssp             EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             eeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCC
Confidence            87754432   244567999999999987777899999999999999999999997

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-44  Score=308.89  Aligned_cols=202  Identities=23%  Similarity=0.352  Sum_probs=157.4

Q ss_pred             CCCCcccccccCCcceeeEeeeeecC-C--cEEEEEEeeccccCCC-CchhHHHHHHHHHhCCCCcccchhhhhcccCcc
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVSLFT-D--ELVALKKVRLENEKEG-FPITAVREIKILRQLNHKNIVNLREIVTDKSDA  220 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~~~~-~--~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  220 (358)
                      ..+|++++.||+|+||.||+|....+ +  ..||||+++....... ..+.+.+|+.++++++||||+++++++.+    
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----   82 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   82 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----
Confidence            35699999999999999999986533 3  4789999876543332 23578899999999999999999887754    


Q ss_pred             cccccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeec
Q psy13988        221 LDFRKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADF  299 (358)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Df  299 (358)
                             ...++||||+++ ++.+.+......+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+||
T Consensus        83 -------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          83 -------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             -------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             -------cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence                   246899999986 566666666667999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccccCCCC-CCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        300 GLARLYNAEDRQR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       300 g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      |+++......... ......++..|+|||++.+.. ++.++||||||+++|||+| |++||
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf  215 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPW  215 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCC
Confidence            9999875443322 222334588999999998654 8999999999999999998 89998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-43  Score=311.47  Aligned_cols=203  Identities=27%  Similarity=0.414  Sum_probs=166.7

Q ss_pred             CCCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccC
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKS  218 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  218 (358)
                      ...+|.+++.||+|+||.||+|+..     .+++.||||+++.... ......+.+|+.++++++||||+++++++.+  
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAV--   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeecc--
Confidence            3457999999999999999999975     3568999999875432 2234568899999999999999999877765  


Q ss_pred             cccccccCCCeEEEEeecccc-ChHHHHhcC-----------------------CCCCChHHHHHHHHHHHHHHHHHHhC
Q psy13988        219 DALDFRKDKGSFYLVFEYMDH-DLMGLLESG-----------------------MVDFNEVNNASIMRQLLDGLSYCHKR  274 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~al~~LH~~  274 (358)
                              .+..++|||++++ ++.+.+...                       ...+++..+..++.||+.||+|||++
T Consensus        88 --------~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~  159 (301)
T d1lufa_          88 --------GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER  159 (301)
T ss_dssp             --------SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             --------CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence                    4578999999986 455544322                       12488899999999999999999999


Q ss_pred             CceecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhC
Q psy13988        275 NFLHRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK  354 (358)
Q Consensus       275 ~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg  354 (358)
                      +++||||||+||+++.++.+||+|||+++...............+++.|+|||.+.+.. ++.++|||||||++|||++|
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHcc
Confidence            99999999999999999999999999998776555444455667789999999998655 89999999999999999998


Q ss_pred             C-CCC
Q psy13988        355 K-PLF  358 (358)
Q Consensus       355 ~-~pF  358 (358)
                      . +||
T Consensus       239 ~~~p~  243 (301)
T d1lufa_         239 GLQPY  243 (301)
T ss_dssp             TCCTT
T ss_pred             CCCCC
Confidence            5 666

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=310.48  Aligned_cols=204  Identities=25%  Similarity=0.347  Sum_probs=156.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeec-----CCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLF-----TDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDK  217 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  217 (358)
                      ...+|++.+.||+|+||.||+|.+..     +++.||||+++..... .....+.+|...+.++ +|+||+.+++++.. 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTK-   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-
Confidence            34579999999999999999999754     3468999998754322 2234566777777776 78999999776654 


Q ss_pred             CcccccccCCCeEEEEeeccccC-hHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHD-LMGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDI  281 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dl  281 (358)
                              ++..+++||||++++ |.+.+...               ...+++.++..++.||+.||+|||+++|+||||
T Consensus        89 --------~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDl  160 (299)
T d1ywna1          89 --------PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL  160 (299)
T ss_dssp             --------TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             --------CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcC
Confidence                    245789999999964 55555332               234889999999999999999999999999999


Q ss_pred             CCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhC-CCCC
Q psy13988        282 KCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVK-KPLF  358 (358)
Q Consensus       282 kp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg-~~pF  358 (358)
                      ||+|||++.++.+||+|||+++...............||+.|+|||++.+.. ++.++|||||||++|||+|| .+||
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~  237 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPY  237 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCC
Confidence            9999999999999999999998776554444445667899999999998654 89999999999999999987 4566

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-43  Score=307.47  Aligned_cols=205  Identities=26%  Similarity=0.429  Sum_probs=165.7

Q ss_pred             CCCCCCCcccccccCCcceeeEeeeeecCC-------cEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhh
Q psy13988        142 STNNSSRPLMEPLAAGGLSLNNFSVSLFTD-------ELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREI  213 (358)
Q Consensus       142 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  213 (358)
                      +....+|.+.+.||+|+||.||+|.+..++       ..||||+++..... .....+.+|...+.++ +||||++++++
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh-HHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            345678999999999999999999986654       47999998754322 2235677888888888 89999999877


Q ss_pred             hcccCcccccccCCCeEEEEeeccccC-hHHHHhcC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCce
Q psy13988        214 VTDKSDALDFRKDKGSFYLVFEYMDHD-LMGLLESG---------------MVDFNEVNNASIMRQLLDGLSYCHKRNFL  277 (358)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~  277 (358)
                      +.+          ++..++||||++++ +.+.+...               ...+++..++.++.||+.||+|||+++|+
T Consensus        88 ~~~----------~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~iv  157 (299)
T d1fgka_          88 CTQ----------DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI  157 (299)
T ss_dssp             ECS----------SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             ccc----------CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEE
Confidence            765          55789999999975 54444332               23589999999999999999999999999


Q ss_pred             ecCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCC
Q psy13988        278 HRDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKP  356 (358)
Q Consensus       278 H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~  356 (358)
                      ||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+.. ++.++||||||+++|+|+| |.+
T Consensus       158 HrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~  236 (299)
T d1fgka_         158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGS  236 (299)
T ss_dssp             CSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCC
Confidence            99999999999999999999999999887665555556667899999999997654 8999999999999999998 688


Q ss_pred             CC
Q psy13988        357 LF  358 (358)
Q Consensus       357 pF  358 (358)
                      ||
T Consensus       237 p~  238 (299)
T d1fgka_         237 PY  238 (299)
T ss_dssp             SS
T ss_pred             CC
Confidence            87

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-43  Score=309.90  Aligned_cols=203  Identities=24%  Similarity=0.331  Sum_probs=168.2

Q ss_pred             CCCCcccccccCCcceeeEeeee---ecCCcEEEEEEeecccc--CCCCchhHHHHHHHHHhCCC-CcccchhhhhcccC
Q psy13988        145 NSSRPLMEPLAAGGLSLNNFSVS---LFTDELVALKKVRLENE--KEGFPITAVREIKILRQLNH-KNIVNLREIVTDKS  218 (358)
Q Consensus       145 ~~~~~~~~~lg~G~~g~v~~~~~---~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~  218 (358)
                      -.+|++++.||+|+||.||+|.+   ..+|+.||||+++....  .....+.+.+|++++++++| |||+++++++.+  
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--  100 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  100 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence            36699999999999999999987   44789999999875432  22334567899999999966 899999777665  


Q ss_pred             cccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEee
Q psy13988        219 DALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLAD  298 (358)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~D  298 (358)
                              ...+++||||+.++.+.........+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|
T Consensus       101 --------~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         101 --------ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             --------TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             --------CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEee
Confidence                    558999999999865555544555788999999999999999999999999999999999999999999999


Q ss_pred             cccceeccccCCCCCCCCccccccccccccccCCC-CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        299 FGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       299 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+++.+....... .....+++.|+|||.+.+.. .++.++|||||||++|+|++|+.||
T Consensus       173 FG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF  232 (322)
T d1vzoa_         173 FGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF  232 (322)
T ss_dssp             SSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence            99998765433222 23456799999999987543 4788999999999999999999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-43  Score=301.83  Aligned_cols=194  Identities=24%  Similarity=0.425  Sum_probs=155.8

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      ...+|++++.||+|+||.||+|..  +|..||||+++.+.    ..+.+.+|++++++++||||+++++++.+.      
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------   72 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE------   72 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC------
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec------
Confidence            345688999999999999999987  58899999986432    345788999999999999999998877542      


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeeccc
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESG-MVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGL  301 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~  301 (358)
                         .+.+|+||||+++ ++.+.+... ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||+
T Consensus        73 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          73 ---KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             -----CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             ---CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence               3468999999987 555555332 23589999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCCC
Q psy13988        302 ARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPLF  358 (358)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~pF  358 (358)
                      ++......     ....+++.|+|||++.+.. ++.++||||||+++|||+| |++||
T Consensus       150 s~~~~~~~-----~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~  201 (262)
T d1byga_         150 TKEASSTQ-----DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPY  201 (262)
T ss_dssp             -----------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             ceecCCCC-----ccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCC
Confidence            98654332     2334588999999997654 8999999999999999998 68776

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=305.86  Aligned_cols=204  Identities=26%  Similarity=0.336  Sum_probs=168.5

Q ss_pred             CCCCCCcccccccCCcceeeEeeeee-----cCCcEEEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSL-----FTDELVALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTD  216 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  216 (358)
                      ....+|.+.+.||+|+||.||+|...     .+++.||||+++..... .....+.+|+.+++++ +|||||++++++.+
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-HHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            44568889999999999999999853     46689999999754322 2344678999999999 79999999887765


Q ss_pred             cCcccccccCCCeEEEEeeccccC-hHHHHhcC-----------------CCCCChHHHHHHHHHHHHHHHHHHhCCcee
Q psy13988        217 KSDALDFRKDKGSFYLVFEYMDHD-LMGLLESG-----------------MVDFNEVNNASIMRQLLDGLSYCHKRNFLH  278 (358)
Q Consensus       217 ~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~-----------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H  278 (358)
                                ...+++||||++++ +...+...                 ...+++..+..++.||+.||+|||+++++|
T Consensus        99 ----------~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH  168 (311)
T d1t46a_          99 ----------GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH  168 (311)
T ss_dssp             ----------SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ----------CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence                      45789999999974 44444322                 235899999999999999999999999999


Q ss_pred             cCCCCCCEEecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhh-CCCC
Q psy13988        279 RDIKCSNILMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFV-KKPL  357 (358)
Q Consensus       279 ~Dlkp~Nill~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~llt-g~~p  357 (358)
                      |||||+||+++.++.++++|||.++...............+|+.|+|||++.+.. ++.++||||||+++|+|+| |.+|
T Consensus       169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCC
Confidence            9999999999999999999999999876554444455677899999999997654 8999999999999999999 5555


Q ss_pred             C
Q psy13988        358 F  358 (358)
Q Consensus       358 F  358 (358)
                      |
T Consensus       248 ~  248 (311)
T d1t46a_         248 Y  248 (311)
T ss_dssp             S
T ss_pred             C
Confidence            4

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-42  Score=300.86  Aligned_cols=197  Identities=23%  Similarity=0.318  Sum_probs=161.9

Q ss_pred             cccccCCcceeeEeeeeecCC---cEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCC
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTD---ELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDK  227 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  227 (358)
                      .+.||+|+||+||+|.+..++   ..||||+++... .......+.+|++++++++||||+++++++.+.         +
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---------~  101 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---------E  101 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET---------T
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec---------C
Confidence            578999999999999986543   368999987432 222345789999999999999999998876542         4


Q ss_pred             CeEEEEeeccccChHHH-HhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeecccceecc
Q psy13988        228 GSFYLVFEYMDHDLMGL-LESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNRGEVKLADFGLARLYN  306 (358)
Q Consensus       228 ~~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~~  306 (358)
                      +..++||||++++.+.. +......+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++...
T Consensus       102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            57899999999765554 55566678888999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCC--CCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        307 AEDRQ--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       307 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      .....  .......+|+.|+|||.+.+.. ++.++||||||+++|||+||..||
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~  234 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPP  234 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCC
Confidence            44322  2223456799999999987655 899999999999999999987775

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-42  Score=302.25  Aligned_cols=198  Identities=24%  Similarity=0.351  Sum_probs=161.2

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcE--EEEEEeeccccCCCCchhHHHHHHHHHhC-CCCcccchhhhhcccCcccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDEL--VALKKVRLENEKEGFPITAVREIKILRQL-NHKNIVNLREIVTDKSDALD  222 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  222 (358)
                      .+|++.+.||+|+||.||+|.+..++..  ||||+++..... ...+.+.+|+++++++ +||||+++++++.+      
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~------   82 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEH------   82 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE------
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEec------
Confidence            5788899999999999999999988864  677877544322 3345789999999999 79999999887765      


Q ss_pred             cccCCCeEEEEeeccccC-hHHHHhc---------------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy13988        223 FRKDKGSFYLVFEYMDHD-LMGLLES---------------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNI  286 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~-l~~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Ni  286 (358)
                          ++.+++||||++++ |.+.+..               ....+++..+..++.||+.||.|||+++|+||||||+||
T Consensus        83 ----~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NI  158 (309)
T d1fvra_          83 ----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI  158 (309)
T ss_dssp             ----TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             ----CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceE
Confidence                55899999999964 5554432               235689999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCC-CCC
Q psy13988        287 LMNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK-PLF  358 (358)
Q Consensus       287 ll~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~-~pF  358 (358)
                      |++.++.+||+|||+++........   ....+|..|+|||.+.+.. ++.++||||||+++|||++|. +||
T Consensus       159 L~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~  227 (309)
T d1fvra_         159 LVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPY  227 (309)
T ss_dssp             EECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             EEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCC
Confidence            9999999999999999865443322   2345689999999998655 899999999999999999975 555

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-42  Score=300.62  Aligned_cols=198  Identities=23%  Similarity=0.253  Sum_probs=157.0

Q ss_pred             CCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHH--HHHHHHhCCCCcccchhhhhcccCccccc
Q psy13988        146 SSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVR--EIKILRQLNHKNIVNLREIVTDKSDALDF  223 (358)
Q Consensus       146 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~~~~~~~~~~~~~~~  223 (358)
                      .+|.+.+.||+|+||.||++..  +|+.||||+++....     ..+.+  |+..+..++||||+++++++.+..     
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-----   70 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDN-----   70 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-----
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-----
Confidence            4677889999999999999985  789999999875422     23334  455556789999999999887533     


Q ss_pred             ccCCCeEEEEeecccc-ChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCEEecCCCcE
Q psy13988        224 RKDKGSFYLVFEYMDH-DLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK--------RNFLHRDIKCSNILMNNRGEV  294 (358)
Q Consensus       224 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--------~~i~H~Dlkp~Nill~~~~~~  294 (358)
                       .....+|+||||+.+ +|.+.+...  .+++..+..++.|++.||.|||+        +||+||||||+|||++.++.+
T Consensus        71 -~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          71 -GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             -SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             -CcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence             123468999999987 555555443  68999999999999999999996        599999999999999999999


Q ss_pred             EEeecccceeccccCCC--CCCCCccccccccccccccCCC-----CCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        295 KLADFGLARLYNAEDRQ--RPYTNKVITLWYRPPELLLGEE-----RYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       295 ~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      ||+|||+++........  .......||+.|+|||++.+..     .++.++|||||||++|||+||.+||
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~  218 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence            99999999877544322  2234567899999999987542     1466899999999999999998775

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-42  Score=301.00  Aligned_cols=204  Identities=22%  Similarity=0.332  Sum_probs=168.2

Q ss_pred             CCCCCCcccccccCCcceeeEeeeeec-----CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhccc
Q psy13988        143 TNNSSRPLMEPLAAGGLSLNNFSVSLF-----TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDK  217 (358)
Q Consensus       143 ~~~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  217 (358)
                      ....+|.+.+.||+|+||.||+|.+..     ++..||||+++... .......+.+|+.++++++||||+++++++.. 
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-   94 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-   94 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-
Confidence            445688899999999999999998753     45789999987543 22233467899999999999999999887764 


Q ss_pred             CcccccccCCCeEEEEeeccccC-hHHHHhc---------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy13988        218 SDALDFRKDKGSFYLVFEYMDHD-LMGLLES---------GMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNIL  287 (358)
Q Consensus       218 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nil  287 (358)
                               +...++||||+.++ +.+.+..         ....+++..+..++.|+++||.|||+++|+||||||+|||
T Consensus        95 ---------~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiL  165 (308)
T d1p4oa_          95 ---------GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM  165 (308)
T ss_dssp             ---------SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred             ---------CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCcee
Confidence                     45789999999875 4443321         1234688899999999999999999999999999999999


Q ss_pred             ecCCCcEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCC-CCC
Q psy13988        288 MNNRGEVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKK-PLF  358 (358)
Q Consensus       288 l~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~-~pF  358 (358)
                      ++.++++||+|||+++...............+|+.|+|||.+.+.. ++.++||||||+++|||+||. +||
T Consensus       166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~  236 (308)
T d1p4oa_         166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPY  236 (308)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCC
Confidence            9999999999999998776555444445567899999999988655 888999999999999999985 665

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.9e-37  Score=277.27  Aligned_cols=198  Identities=30%  Similarity=0.467  Sum_probs=158.2

Q ss_pred             CCCCCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCC-----------Ccccchhh
Q psy13988        144 NNSSRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNH-----------KNIVNLRE  212 (358)
Q Consensus       144 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-----------~niv~~~~  212 (358)
                      .+++|++++.||+|+||+||+|.+..+|+.||||+++....   ....+.+|+.+++.+.|           +||+++++
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            34679999999999999999999999999999999975432   23456789998888864           66777776


Q ss_pred             hhcccCcccccccCCCeEEEEeecccc--ChHH-HHhcCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEe
Q psy13988        213 IVTDKSDALDFRKDKGSFYLVFEYMDH--DLMG-LLESGMVDFNEVNNASIMRQLLDGLSYCHK-RNFLHRDIKCSNILM  288 (358)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~-~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~Dlkp~Nill  288 (358)
                      ++....        ....+++++++.+  +... ........+++..+..++.||+.||+|||+ .||+||||||+|||+
T Consensus        88 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll  159 (362)
T d1q8ya_          88 HFNHKG--------PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM  159 (362)
T ss_dssp             EEEEEE--------TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred             Eeeecc--------ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence            664322        3355566665543  3233 234455678999999999999999999998 899999999999999


Q ss_pred             cCCC------cEEEeecccceeccccCCCCCCCCccccccccccccccCCCCCCCcchHHHHHHHHHHHhhCCCCC
Q psy13988        289 NNRG------EVKLADFGLARLYNAEDRQRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFVKKPLF  358 (358)
Q Consensus       289 ~~~~------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~lltg~~pF  358 (358)
                      +.++      .++++|||.+.......     ....+|+.|+|||++.+.. ++.++||||+||++++|++|+.||
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF  229 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF  229 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             eccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCC
Confidence            8765      39999999998654332     3456799999999998665 899999999999999999999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=3.6e-26  Score=186.06  Aligned_cols=166  Identities=14%  Similarity=0.082  Sum_probs=118.9

Q ss_pred             CcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCC----------------chhHHHHHHHHHhCCCCcccchh
Q psy13988        148 RPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGF----------------PITAVREIKILRQLNHKNIVNLR  211 (358)
Q Consensus       148 ~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~niv~~~  211 (358)
                      +.+.+.||+|+||.||+|.+ .+|+.||||+++........                .....+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            45778999999999999998 47899999987643211000                12234578888999999988775


Q ss_pred             hhhcccCcccccccCCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC
Q psy13988        212 EIVTDKSDALDFRKDKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHKRNFLHRDIKCSNILMNNR  291 (358)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~Dlkp~Nill~~~  291 (358)
                      ++.              ..++|||++++....       .++...+..++.|++.++++||++||+||||||+|||++++
T Consensus        81 ~~~--------------~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~  139 (191)
T d1zara2          81 AWE--------------GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             EEE--------------TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT
T ss_pred             Eec--------------CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC
Confidence            332              126999999984332       24556678899999999999999999999999999999865


Q ss_pred             CcEEEeecccceeccccCCCCCCCCccccccccc------cccccCCCCCCCcchHHHHHHHH
Q psy13988        292 GEVKLADFGLARLYNAEDRQRPYTNKVITLWYRP------PELLLGEERYGPAIDVWSCGCIL  348 (358)
Q Consensus       292 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~~DiwslG~~l  348 (358)
                       .++|+|||.+.....+..          ..|..      .+.+.  +.|+.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGW----------REILERDVRNIITYFS--RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence             589999999976543321          11111      12221  3378899999986544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.31  E-value=2.3e-12  Score=110.95  Aligned_cols=84  Identities=36%  Similarity=0.483  Sum_probs=70.6

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      |.++.+|+.+|.+++|+|+.+.|+.....+.+...  ......++...++..+++++|||.+||++||.+|+||+|+|+|
T Consensus       203 ~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF--KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC--CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHhcCCCChhhccchhccchhhhh--ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            56679999999999999999999987766654332  2223455777788899999999999999999999999999999


Q ss_pred             cccccC
Q psy13988         92 VWLKNV   97 (358)
Q Consensus        92 ~~~~~~   97 (358)
                      |||++.
T Consensus       281 p~f~~~  286 (299)
T d1ua2a_         281 KYFSNR  286 (299)
T ss_dssp             GGGTSS
T ss_pred             HhhCCC
Confidence            999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=1.1e-10  Score=99.95  Aligned_cols=87  Identities=31%  Similarity=0.459  Sum_probs=70.7

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      |.+..+++.+|....|+|....|+.....+.+........ ........+..++++.|||.+||++||.+|+||+|+|+|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA-TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCT-TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccc-cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            6677899999999999999999988777666544333222 233555667789999999999999999999999999999


Q ss_pred             cccccCCC
Q psy13988         92 VWLKNVHP   99 (358)
Q Consensus        92 ~~~~~~~~   99 (358)
                      |||+++.+
T Consensus       284 p~f~~~~~  291 (292)
T d1unla_         284 PYFSDFCP  291 (292)
T ss_dssp             GGGSSCSC
T ss_pred             hhhcCCCC
Confidence            99998754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.05  E-value=2.2e-10  Score=98.28  Aligned_cols=94  Identities=28%  Similarity=0.416  Sum_probs=75.0

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      |+.-|.  |.++.+++.+|.+.+|.|.+..|+.....+.+.. ..+......+...++.+++++.|||++||+.||.+|+
T Consensus       199 G~~Pf~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~  275 (298)
T d1gz8a_         199 RRALFP--GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP-SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI  275 (298)
T ss_dssp             SSCSCC--CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred             CCCCCC--CCCHHHHHHHHHHhcCCCchhhcccccccccccc-ccccccccchhhhccCCCHHHHHHHHHHccCChhHCc
Confidence            444443  4667899999999999999999988776665433 2333334556677788999999999999999999999


Q ss_pred             CHhhhhcCcccccCCCC
Q psy13988         84 TAEQALKSVWLKNVHPE  100 (358)
Q Consensus        84 ~~~~~l~~~~~~~~~~~  100 (358)
                      |++|+|+||||+++..|
T Consensus       276 t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         276 SAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CHHHHHTSGGGTTCCCC
T ss_pred             CHHHHhCCHhhccCCCC
Confidence            99999999999987544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.04  E-value=2.4e-10  Score=97.45  Aligned_cols=90  Identities=33%  Similarity=0.463  Sum_probs=71.3

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      |...|.  +.++.+++.+|.+.+|+|....|+.....+.+.. ........++...++.+++++.|||++||++||.+|+
T Consensus       197 G~~pf~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~  273 (286)
T d1ob3a_         197 GTPLFP--GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP-NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI  273 (286)
T ss_dssp             SSCSCC--CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC
T ss_pred             CCCCCC--CCCHHHHHHHHHHhhCCCChhhccchhhhhhccc-ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc
Confidence            444443  3556899999999999999999988776665432 2223334556677788999999999999999999999


Q ss_pred             CHhhhhcCccccc
Q psy13988         84 TAEQALKSVWLKN   96 (358)
Q Consensus        84 ~~~~~l~~~~~~~   96 (358)
                      |+.|+|+||||++
T Consensus       274 s~~ell~Hp~f~~  286 (286)
T d1ob3a_         274 TAKQALEHAYFKE  286 (286)
T ss_dssp             CHHHHHTSGGGGC
T ss_pred             CHHHHhcCcccCc
Confidence            9999999999973

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.04  E-value=2.1e-10  Score=98.72  Aligned_cols=90  Identities=22%  Similarity=0.279  Sum_probs=69.7

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      |+..|.  |.++.+++.+|++++|+|..+.|+.....+.....   .....++....+.+++++.|||.+||++||.+|+
T Consensus       211 g~~pf~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~  285 (305)
T d1blxa_         211 RKPLFR--GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH---SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI  285 (305)
T ss_dssp             SSCSCC--CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC---CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC
T ss_pred             CCCCCC--CCCHHHHHHHHHHhhCCCchhcccccccchhhhhc---cccccchhhccccCCHHHHHHHHHHCcCChhHCc
Confidence            455554  45679999999999999999999876554433221   1122335555667899999999999999999999


Q ss_pred             CHhhhhcCcccccCC
Q psy13988         84 TAEQALKSVWLKNVH   98 (358)
Q Consensus        84 ~~~~~l~~~~~~~~~   98 (358)
                      |++|+|+||||+++.
T Consensus       286 sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         286 SAYSALSHPYFQDLE  300 (305)
T ss_dssp             CHHHHHTSGGGTTCC
T ss_pred             CHHHHhcChhhcCch
Confidence            999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.02  E-value=1.5e-10  Score=101.55  Aligned_cols=93  Identities=25%  Similarity=0.332  Sum_probs=68.5

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCcccccccccccc-cCCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEF-SLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |+..|.  +.++.+|+.+|++++|+|..+.|....  +.+.....+.....++.... +..++++.|||.+||++||.+|
T Consensus       219 g~~pf~--~~~~~~~l~~i~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R  294 (350)
T d1q5ka_         219 GQPIFP--GDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR  294 (350)
T ss_dssp             TSCSSC--CSSHHHHHHHHHHHHCCCCHHHHHHHC--C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred             CCCCCC--CCCHHHHHHHHHHHhCCChHHhhhhhc--cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHC
Confidence            444554  455689999999999999988887654  22333333333334444433 4678999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPE  100 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~  100 (358)
                      +|+.|+|+||||+++..+
T Consensus       295 ~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         295 LTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             CCHHHHHTSGGGGGGGCT
T ss_pred             cCHHHHhcCHhhccccCC
Confidence            999999999999987654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.92  E-value=6.5e-10  Score=96.19  Aligned_cols=91  Identities=36%  Similarity=0.617  Sum_probs=65.4

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCCCCCccccccccccccc--CCChhHHHHHhhhcCCCCCC
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHTIKPKKIHRRRLREEFS--LMPPGALDLLDKMLELDPER   81 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~l~~~p~~   81 (358)
                      |+..|.  |.++.+++..|.+++|+|.++.+........+............+...++  ..+++++|||.+||++||.+
T Consensus       218 g~~pf~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~  295 (318)
T d3blha1         218 RSPIMQ--GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ  295 (318)
T ss_dssp             SSCSCC--CSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTT
T ss_pred             CCCCCC--CCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhH
Confidence            444454  46678999999999999999988887665554443333332333434333  35889999999999999999


Q ss_pred             cCCHhhhhcCccccc
Q psy13988         82 RITAEQALKSVWLKN   96 (358)
Q Consensus        82 R~~~~~~l~~~~~~~   96 (358)
                      |+|++|+|.||||+.
T Consensus       296 R~sa~elL~Hpff~~  310 (318)
T d3blha1         296 RIDSDDALNHDFFWS  310 (318)
T ss_dssp             SCCHHHHHHSGGGSS
T ss_pred             CcCHHHHHcChhhcc
Confidence            999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=2.8e-10  Score=99.73  Aligned_cols=96  Identities=26%  Similarity=0.322  Sum_probs=69.0

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccCCCCCCC-CCCcccccccccccccCCChhHHHHHhhhcCCCCCCc
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHT-IKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERR   82 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R   82 (358)
                      |...+.  +.++.+++.++.++.|+|+.+.|........... ...+......+...++.++++++|||.+||++||.+|
T Consensus       215 g~~pf~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R  292 (346)
T d1cm8a_         215 GKTLFK--GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR  292 (346)
T ss_dssp             SSCSSC--CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred             CcCCCC--CCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHC
Confidence            344443  4567899999999999998887765432111100 0112233455777778899999999999999999999


Q ss_pred             CCHhhhhcCcccccCCCCC
Q psy13988         83 ITAEQALKSVWLKNVHPES  101 (358)
Q Consensus        83 ~~~~~~l~~~~~~~~~~~~  101 (358)
                      +|+.|+|+||||+.++.+.
T Consensus       293 ~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         293 VTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             CCHHHHHHSGGGTTTC---
T ss_pred             cCHHHHhcChhhCcCCCcc
Confidence            9999999999999876543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=98.84  E-value=1e-09  Score=95.36  Aligned_cols=86  Identities=29%  Similarity=0.385  Sum_probs=59.7

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCC---CCCCCCccccccccccc-----ccCCChhHHHHHhhhcCCCCCCcC
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPL---WHTIKPKKIHRRRLREE-----FSLMPPGALDLLDKMLELDPERRI   83 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ll~~~l~~~p~~R~   83 (358)
                      +.++.+|+..|.+++|+|....|........   +..... ......+...     ...++++++|||++||++||.+|+
T Consensus       233 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~  311 (328)
T d3bqca1         233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG-RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL  311 (328)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCC-CCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC
T ss_pred             CchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcc-cccccchhhcccccccccCCHHHHHHHHHHccCChhHCc
Confidence            5667899999999999987666554332221   111111 1111112222     234789999999999999999999


Q ss_pred             CHhhhhcCcccccCC
Q psy13988         84 TAEQALKSVWLKNVH   98 (358)
Q Consensus        84 ~~~~~l~~~~~~~~~   98 (358)
                      |++|+|+||||+.+.
T Consensus       312 ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         312 TAREAMEHPYFYTVV  326 (328)
T ss_dssp             CHHHHHTSGGGTTSC
T ss_pred             CHHHHhcCcccCCCC
Confidence            999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.82  E-value=7.5e-10  Score=97.03  Aligned_cols=93  Identities=28%  Similarity=0.350  Sum_probs=67.3

Q ss_pred             CCCchhHHHHHHHhhcCCCCCCccccccCCCCCCC-CCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhh
Q psy13988         11 WANIELLQLEVISKLCGTPTPAVWPAVIKLPLWHT-IKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQAL   89 (358)
Q Consensus        11 ~g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l   89 (358)
                      +|.++.++...|.+..|.|..+.+........... ..........+...+..++++++|||.+||++||.+|+|+.|+|
T Consensus       220 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL  299 (348)
T d2gfsa1         220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL  299 (348)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence            35667899999999999988766654322111000 01122234456677788999999999999999999999999999


Q ss_pred             cCcccccCCCCCCC
Q psy13988         90 KSVWLKNVHPESMP  103 (358)
Q Consensus        90 ~~~~~~~~~~~~~~  103 (358)
                      +||||+.++.+..+
T Consensus       300 ~Hp~f~~~~~~~~~  313 (348)
T d2gfsa1         300 AHAYFAQYHDPDDE  313 (348)
T ss_dssp             TSGGGTTTCCTTSC
T ss_pred             cCHhhCCCCCCccC
Confidence            99999987654433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.65  E-value=9.5e-08  Score=79.67  Aligned_cols=140  Identities=16%  Similarity=0.107  Sum_probs=88.2

Q ss_pred             CCcccccccCCcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCC-CCcccchhhhhcccCccccccc
Q psy13988        147 SRPLMEPLAAGGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLN-HKNIVNLREIVTDKSDALDFRK  225 (358)
Q Consensus       147 ~~~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  225 (358)
                      .|++++..+.++.+.||++.  .++..+++|+.......  ....+.+|...+..+. +--+.+++          .+..
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl----------~~~~   80 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVL----------HFER   80 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEE----------EEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEE----------EEEe
Confidence            45556655556667888775  46677888877644322  2345678888887774 22233443          2333


Q ss_pred             CCCeEEEEeeccccChHHHHhcCCCCCChHHHHHHHHHHHHHHHHHHh--------------------------------
Q psy13988        226 DKGSFYLVFEYMDHDLMGLLESGMVDFNEVNNASIMRQLLDGLSYCHK--------------------------------  273 (358)
Q Consensus       226 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--------------------------------  273 (358)
                      +++..++||++++|..+......     ......++.+++..+..||+                                
T Consensus        81 ~~~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          81 HDGWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             cCCceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            46688999999998554332211     11123344455555555552                                


Q ss_pred             ---------------------------CCceecCCCCCCEEecCCCcEEEeecccceec
Q psy13988        274 ---------------------------RNFLHRDIKCSNILMNNRGEVKLADFGLARLY  305 (358)
Q Consensus       274 ---------------------------~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~~  305 (358)
                                                 ..++|+|+.|.||++++++...|+||+.+..-
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                                       12789999999999997766789999988753

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.63  E-value=1.6e-09  Score=95.15  Aligned_cols=93  Identities=25%  Similarity=0.288  Sum_probs=61.3

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCCCccccccC--------CCCCCCCCCcccccccc----cccccCCChhHHHHH
Q psy13988          4 GGRGNSGWANIELLQLEVISKLCGTPTPAVWPAVIK--------LPLWHTIKPKKIHRRRL----REEFSLMPPGALDLL   71 (358)
Q Consensus         4 ~~~~~~~~g~~~~~ql~~i~~~lGtp~~~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ll   71 (358)
                      |+..|.  |.++.+++.+|+..+++|.++.|.....        .+.+.....+.......    .......+++++|||
T Consensus       214 g~~pF~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll  291 (355)
T d2b1pa1         214 HKILFP--GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL  291 (355)
T ss_dssp             SSCSSC--CSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred             CCCCCC--CCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHH
Confidence            455554  4567999999999999998888866322        11111111111000000    000112467899999


Q ss_pred             hhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         72 DKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        72 ~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ++||++||.+|+||+|+|+||||+...
T Consensus       292 ~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         292 SKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.59  E-value=9.3e-09  Score=89.75  Aligned_cols=89  Identities=29%  Similarity=0.372  Sum_probs=64.3

Q ss_pred             CCchhHHHHHHHhhcCCCCCCccccccCCCCCC-CCCCcccccccccccccCCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         12 ANIELLQLEVISKLCGTPTPAVWPAVIKLPLWH-TIKPKKIHRRRLREEFSLMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        12 g~~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      +.++.++...+..+++.|..+............ ....+.....++...++.++++++|||.+||++||.+|+|+.|+|+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            355688899999999988766544322211100 0112233345577778889999999999999999999999999999


Q ss_pred             CcccccCCCC
Q psy13988         91 SVWLKNVHPE  100 (358)
Q Consensus        91 ~~~~~~~~~~  100 (358)
                      ||||+....+
T Consensus       295 hpf~~~~~~~  304 (345)
T d1pmea_         295 HPYLEQYYDP  304 (345)
T ss_dssp             SGGGTTTCCG
T ss_pred             CHhhccCCCC
Confidence            9999876543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.52  E-value=3.3e-08  Score=86.77  Aligned_cols=84  Identities=20%  Similarity=0.225  Sum_probs=54.1

Q ss_pred             chhHHHHHHHhhcCCCCCCccccccCCCCCCC-----CCCcccccccccc----c---ccCCChhHHHHHhhhcCCCCCC
Q psy13988         14 IELLQLEVISKLCGTPTPAVWPAVIKLPLWHT-----IKPKKIHRRRLRE----E---FSLMPPGALDLLDKMLELDPER   81 (358)
Q Consensus        14 ~~~~ql~~i~~~lGtp~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~----~---~~~~~~~~~~ll~~~l~~~p~~   81 (358)
                      .+.+++.++++++|+++.+.+........+..     .........++..    .   ....++++.|||.+||++||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence            35788999999999987666544221110000     0000000111111    1   1235678999999999999999


Q ss_pred             cCCHhhhhcCcccccC
Q psy13988         82 RITAEQALKSVWLKNV   97 (358)
Q Consensus        82 R~~~~~~l~~~~~~~~   97 (358)
                      |||++|+|+||||++.
T Consensus       319 Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         319 RADAGGLVNHPWLKDT  334 (362)
T ss_dssp             CBCHHHHHTCGGGTTC
T ss_pred             CcCHHHHhcCcccCCC
Confidence            9999999999999864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.22  E-value=1.8e-06  Score=76.22  Aligned_cols=77  Identities=14%  Similarity=-0.020  Sum_probs=46.1

Q ss_pred             cccccCCcceeeEeeeeecCCcEEEEEEeeccc-----cCCCCchhHHHHHHHHHhC-CC-C-cccchhhhhcccCcccc
Q psy13988        151 MEPLAAGGLSLNNFSVSLFTDELVALKKVRLEN-----EKEGFPITAVREIKILRQL-NH-K-NIVNLREIVTDKSDALD  222 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h-~-niv~~~~~~~~~~~~~~  222 (358)
                      .+.||.|....||++.+..+++.|+||.-....     .......+...|.+.++.+ .+ | .+.+++.+.        
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--------  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--------  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--------
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--------
Confidence            467899999999999988888999999643211     1112234556788888776 22 2 233343221        


Q ss_pred             cccCCCeEEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDH  239 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~  239 (358)
                          ....++|||++++
T Consensus       103 ----~~~~~lvmE~L~~  115 (392)
T d2pula1         103 ----TEMAVTVMEDLSH  115 (392)
T ss_dssp             ----TTTTEEEECCCTT
T ss_pred             ----CCCCEEEEeccCC
Confidence                2245789999976

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.20  E-value=2.9e-07  Score=79.12  Aligned_cols=35  Identities=20%  Similarity=0.313  Sum_probs=32.7

Q ss_pred             CChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         63 MPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        63 ~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .|+++.|||.+||++||.+|||++|+|+||||+..
T Consensus       270 ~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         270 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             BCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence            57899999999999999999999999999999853

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=98.11  E-value=4.6e-06  Score=72.21  Aligned_cols=40  Identities=35%  Similarity=0.560  Sum_probs=36.0

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCCC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVHP   99 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~~   99 (358)
                      ++.+++++.|||.+||+.||.+|+|++|+|.||||+....
T Consensus       249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            3467899999999999999999999999999999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.08  E-value=7.4e-06  Score=67.40  Aligned_cols=73  Identities=10%  Similarity=-0.018  Sum_probs=44.9

Q ss_pred             ccccCCcc-eeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCc--ccchhhhhcccCcccccccCCC
Q psy13988        152 EPLAAGGL-SLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKN--IVNLREIVTDKSDALDFRKDKG  228 (358)
Q Consensus       152 ~~lg~G~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~~~  228 (358)
                      +.+..|.. +.||++.. .++..+++|......     ...+..|...++.+....  +.+++.+          ..+++
T Consensus        16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~----------~~~~~   79 (255)
T d1nd4a_          16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDV----------VTEAG   79 (255)
T ss_dssp             EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEE----------EECSS
T ss_pred             EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeee----------ccccc
Confidence            34555543 56787764 456678888754321     224677888888774333  3334322          23456


Q ss_pred             eEEEEeeccccC
Q psy13988        229 SFYLVFEYMDHD  240 (358)
Q Consensus       229 ~~~lv~e~~~~~  240 (358)
                      ..++||++++|.
T Consensus        80 ~~~~v~~~i~G~   91 (255)
T d1nd4a_          80 RDWLLLGEVPGQ   91 (255)
T ss_dssp             CEEEEEECCSSE
T ss_pred             ceEEEEEeeecc
Confidence            789999999873

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=98.06  E-value=6.3e-06  Score=71.37  Aligned_cols=39  Identities=38%  Similarity=0.758  Sum_probs=35.3

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccCC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNVH   98 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~~   98 (358)
                      ++.+++++.|||.+||+.||.+|+|++|+|.||||+...
T Consensus       252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            346789999999999999999999999999999998744

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.88  E-value=3.9e-06  Score=69.94  Aligned_cols=36  Identities=31%  Similarity=0.491  Sum_probs=33.8

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      +.+++++.|||.+||+.||.+|||++|+|+||||+.
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            457899999999999999999999999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=97.85  E-value=3.5e-06  Score=70.50  Aligned_cols=37  Identities=27%  Similarity=0.451  Sum_probs=34.4

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +.+|+++.||+.+||+.||.+|+|++|+|+||||+..
T Consensus       240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            4689999999999999999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.83  E-value=3.8e-06  Score=70.15  Aligned_cols=36  Identities=25%  Similarity=0.410  Sum_probs=34.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+|+++.|||.+||+.||.+|||++|+|+||||++.
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            578999999999999999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.81  E-value=2.2e-06  Score=73.83  Aligned_cols=36  Identities=25%  Similarity=0.539  Sum_probs=33.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCC-----HhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRIT-----AEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~-----~~~~l~~~~~~~~   97 (358)
                      .+|+++.|||.+||+.||.+|++     ++++++||||..+
T Consensus       227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            58999999999999999999995     8999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.74  E-value=5.1e-06  Score=70.11  Aligned_cols=37  Identities=30%  Similarity=0.539  Sum_probs=34.0

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      +..++++.|||++||+.||.+|||++|+|+||||+..
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            4678999999999999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.70  E-value=8.3e-06  Score=67.85  Aligned_cols=34  Identities=9%  Similarity=0.354  Sum_probs=31.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLK   95 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~   95 (358)
                      ..++++.|||.+||..||.+|||++|+|+||||+
T Consensus       237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            4678999999999999999999999999999995

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.70  E-value=5.2e-06  Score=68.84  Aligned_cols=35  Identities=26%  Similarity=0.618  Sum_probs=32.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      .+++++.|||.+||+.||.+|+|++|+|+||||.+
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            47899999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.68  E-value=1.2e-05  Score=67.66  Aligned_cols=36  Identities=28%  Similarity=0.405  Sum_probs=33.5

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      +.+++++.|||.+||+.||.+|+|++|+|+||||+.
T Consensus       240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            347899999999999999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.67  E-value=9.5e-06  Score=68.84  Aligned_cols=36  Identities=36%  Similarity=0.674  Sum_probs=33.8

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      +.+|+++.|||.+||+.||.+|+|++|+|+||||+.
T Consensus       234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             cCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            457899999999999999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.66  E-value=1.2e-05  Score=67.53  Aligned_cols=36  Identities=28%  Similarity=0.296  Sum_probs=33.3

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      +.+++++.|||.+||+.||.+|+|++|+|+||||..
T Consensus       239 ~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            357899999999999999999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.62  E-value=2.6e-05  Score=66.48  Aligned_cols=37  Identities=35%  Similarity=0.654  Sum_probs=34.3

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ++.+|+++.|||.+||+.||.+|+|++|+|+||||..
T Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            3468999999999999999999999999999999975

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.59  E-value=8.3e-05  Score=63.39  Aligned_cols=76  Identities=12%  Similarity=0.026  Sum_probs=45.9

Q ss_pred             CcceeeEeeeeecCCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCcccchhhhhcccCcccccccCCCeEEEEeec
Q psy13988        157 GGLSLNNFSVSLFTDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIVNLREIVTDKSDALDFRKDKGSFYLVFEY  236 (358)
Q Consensus       157 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~lv~e~  236 (358)
                      +.-..||++.. .+|..|++|+.....   ....++..|...+..|....+.-..-......   .....++..+.|+++
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~---~~~~~~~~~~~l~~~  105 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQ---TLLNHQGFYFAVFPS  105 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTB---SCEEETTEEEEEEEC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCC---eeeeeeeEEEEEEee
Confidence            33467998886 678899999876432   23456778888888774322211111111111   122346788999999


Q ss_pred             ccc
Q psy13988        237 MDH  239 (358)
Q Consensus       237 ~~~  239 (358)
                      ++|
T Consensus       106 ~~G  108 (325)
T d1zyla1         106 VGG  108 (325)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.53  E-value=2.3e-05  Score=65.70  Aligned_cols=37  Identities=30%  Similarity=0.479  Sum_probs=33.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhh------hcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQA------LKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~------l~~~~~~~~~   98 (358)
                      .+++++.|||.+||+.||.+|+|++|+      ++||||+++.
T Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            578999999999999999999999984      7899998764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.52  E-value=1.8e-05  Score=67.05  Aligned_cols=35  Identities=23%  Similarity=0.215  Sum_probs=32.9

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~   96 (358)
                      ..++++.|||.+||+.||.+|||++|+|+||||..
T Consensus       238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            36889999999999999999999999999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.52  E-value=1.9e-05  Score=67.79  Aligned_cols=36  Identities=17%  Similarity=0.406  Sum_probs=33.5

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~~~   97 (358)
                      .+|+++.|||.+||+.||.+|+|+.|+|.||||...
T Consensus       243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            478999999999999999999999999999999753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.48  E-value=2.7e-05  Score=64.59  Aligned_cols=33  Identities=18%  Similarity=0.293  Sum_probs=31.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSVWL   94 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~   94 (358)
                      .+++++.+||.+||+.||.+|||++|+|+|||+
T Consensus       237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            578999999999999999999999999999995

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.47  E-value=3.7e-05  Score=66.73  Aligned_cols=36  Identities=25%  Similarity=0.473  Sum_probs=33.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCC-----HhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRIT-----AEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~-----~~~~l~~~~~~~~   97 (358)
                      .+++++.|||.+||+.||.+|+|     |++++.||||+.+
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            57899999999999999999999     7999999999875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.41  E-value=0.0002  Score=60.53  Aligned_cols=31  Identities=23%  Similarity=0.243  Sum_probs=27.8

Q ss_pred             CCceecCCCCCCEEecCCCcEEEeeccccee
Q psy13988        274 RNFLHRDIKCSNILMNNRGEVKLADFGLARL  304 (358)
Q Consensus       274 ~~i~H~Dlkp~Nill~~~~~~~l~Dfg~~~~  304 (358)
                      .|++|+|+.++||+++.+...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            4799999999999999888889999998764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.39  E-value=4.4e-05  Score=65.05  Aligned_cols=37  Identities=24%  Similarity=0.518  Sum_probs=33.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCC-----HhhhhcCcccccCC
Q psy13988         62 LMPPGALDLLDKMLELDPERRIT-----AEQALKSVWLKNVH   98 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~-----~~~~l~~~~~~~~~   98 (358)
                      ..++++.+||.+||+.||.+|+|     ++|+++||||+.+.
T Consensus       258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            57899999999999999999994     89999999998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.38  E-value=0.00028  Score=61.80  Aligned_cols=71  Identities=15%  Similarity=0.086  Sum_probs=45.7

Q ss_pred             cccccCCcceeeEeeeeec-------CCcEEEEEEeeccccCCCCchhHHHHHHHHHhCCCCccc-chhhhhcccCcccc
Q psy13988        151 MEPLAAGGLSLNNFSVSLF-------TDELVALKKVRLENEKEGFPITAVREIKILRQLNHKNIV-NLREIVTDKSDALD  222 (358)
Q Consensus       151 ~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~  222 (358)
                      ++.|+.|-.-.+|++....       ..+.|.+++.- ..   .......+|..+++.+.-.++. ++++++.+      
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG------  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------
Confidence            4678888889999988643       24567777754 21   1223456788888888433443 44443321      


Q ss_pred             cccCCCeEEEEeecccc
Q psy13988        223 FRKDKGSFYLVFEYMDH  239 (358)
Q Consensus       223 ~~~~~~~~~lv~e~~~~  239 (358)
                              .+|+||++|
T Consensus       117 --------g~I~efi~g  125 (395)
T d1nw1a_         117 --------GRLEEYIPS  125 (395)
T ss_dssp             --------EEEECCCCE
T ss_pred             --------ceEEEEecc
Confidence                    588999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.26  E-value=5.6e-05  Score=64.34  Aligned_cols=36  Identities=22%  Similarity=0.400  Sum_probs=33.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHh-hhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAE-QALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~-~~l~~~~~~~~   97 (358)
                      .+++++.|||.+||+.||.+|+|+. ++++||||+.+
T Consensus       225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             cCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            4789999999999999999999995 89999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.21  E-value=0.0001  Score=63.44  Aligned_cols=36  Identities=19%  Similarity=0.414  Sum_probs=33.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcC-----CHhhhhcCcccccC
Q psy13988         62 LMPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNV   97 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~-----~~~~~l~~~~~~~~   97 (358)
                      .+++++.|||++||+.||.+|+     |++++++||||+..
T Consensus       260 ~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            5789999999999999999995     89999999999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.20  E-value=0.0001  Score=62.50  Aligned_cols=37  Identities=24%  Similarity=0.505  Sum_probs=33.9

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcC-----CHhhhhcCcccccC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRI-----TAEQALKSVWLKNV   97 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~-----~~~~~l~~~~~~~~   97 (358)
                      +.+++++.|||.+||+.||.+|+     |++++++||||+++
T Consensus       222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            35789999999999999999997     89999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.84  E-value=0.0031  Score=52.11  Aligned_cols=38  Identities=21%  Similarity=0.245  Sum_probs=33.1

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhc--CcccccCC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALK--SVWLKNVH   98 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~--~~~~~~~~   98 (358)
                      +.+++++.+|+.+||+.||.+|||+++++.  ++||....
T Consensus       237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            357889999999999999999999999876  88887643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.69  E-value=0.0064  Score=49.79  Aligned_cols=31  Identities=26%  Similarity=0.358  Sum_probs=28.4

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      +.+++++.+||.+||..||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            4578999999999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.57  E-value=0.0047  Score=50.59  Aligned_cols=35  Identities=17%  Similarity=0.160  Sum_probs=31.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc--Cccccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK--SVWLKN   96 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~--~~~~~~   96 (358)
                      .+++++.+|+.+||..||.+|||++++++  ++||.+
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            47889999999999999999999999987  788753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.56  E-value=0.007  Score=50.22  Aligned_cols=30  Identities=13%  Similarity=0.187  Sum_probs=28.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..++++.+|+.+||+.||.+|||++|+++|
T Consensus       261 ~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         261 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            478899999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=94.46  E-value=0.0065  Score=49.86  Aligned_cols=36  Identities=14%  Similarity=0.218  Sum_probs=29.7

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcCcccc
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKSVWLK   95 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~~~~   95 (358)
                      .+.+|+++.+||.+||+.||.+|++..+.+.|++.+
T Consensus       238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            356889999999999999999999666666677654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.43  E-value=0.0072  Score=49.60  Aligned_cols=34  Identities=21%  Similarity=0.259  Sum_probs=29.1

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhh---hcCcccc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQA---LKSVWLK   95 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~---l~~~~~~   95 (358)
                      .+++++.+|+.+||..||.+|||++++   |+|+|+.
T Consensus       234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            468899999999999999999999987   5566653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.17  E-value=0.0091  Score=50.22  Aligned_cols=30  Identities=7%  Similarity=0.058  Sum_probs=27.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+++++.+|+.+||+.||.+|||++|++.|
T Consensus       291 ~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         291 YATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            478899999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.03  E-value=0.0098  Score=48.20  Aligned_cols=30  Identities=13%  Similarity=0.118  Sum_probs=27.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..+++..+|+.+|++.||.+|||+++++.|
T Consensus       225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         225 LASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            357788999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.80  E-value=0.013  Score=47.60  Aligned_cols=30  Identities=20%  Similarity=0.273  Sum_probs=27.2

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..++++.+|+.+|+..||.+|||+.+++++
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            467899999999999999999999998764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.67  E-value=0.012  Score=48.96  Aligned_cols=30  Identities=23%  Similarity=0.182  Sum_probs=28.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+++++.+||.+||..||.+|||+.+++.+
T Consensus       250 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         250 NCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            468899999999999999999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.66  E-value=0.016  Score=47.41  Aligned_cols=32  Identities=25%  Similarity=0.187  Sum_probs=28.6

Q ss_pred             ccCCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         60 FSLMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        60 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ...++++..+|+.+||..||.+|||+++++.+
T Consensus       235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            34578899999999999999999999999876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.59  E-value=0.011  Score=48.72  Aligned_cols=35  Identities=14%  Similarity=0.190  Sum_probs=30.6

Q ss_pred             cCCChhHHHHHhhhcCCCCCCcCCHhhh---hcCcccc
Q psy13988         61 SLMPPGALDLLDKMLELDPERRITAEQA---LKSVWLK   95 (358)
Q Consensus        61 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~---l~~~~~~   95 (358)
                      +.+++++.+|+.+||..||.+|||+.++   |+|+|+.
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            3578899999999999999999999877   7788875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.45  E-value=0.014  Score=47.38  Aligned_cols=30  Identities=17%  Similarity=0.302  Sum_probs=27.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      ..++++.+|+.+||+.||.+|||++++++|
T Consensus       226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            357889999999999999999999999876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.14  E-value=0.017  Score=47.97  Aligned_cols=29  Identities=14%  Similarity=0.229  Sum_probs=27.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      .+++++.+|+.+|+..||.+|||+.++++
T Consensus       259 ~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         259 NCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            46789999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.09  E-value=0.022  Score=47.10  Aligned_cols=29  Identities=14%  Similarity=0.095  Sum_probs=26.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      .+++++.+|+.+||..||.+|||+.++++
T Consensus       261 ~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         261 NCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            46889999999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=92.64  E-value=0.029  Score=46.06  Aligned_cols=29  Identities=14%  Similarity=0.237  Sum_probs=26.7

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      .+++++.+|+.+||..||.+|||++++++
T Consensus       240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         240 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            47889999999999999999999999865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.63  E-value=0.027  Score=46.85  Aligned_cols=29  Identities=24%  Similarity=0.409  Sum_probs=26.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..++++.+||.+||..||.+|||+++++.
T Consensus       272 ~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            46789999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.24  E-value=0.025  Score=47.16  Aligned_cols=31  Identities=10%  Similarity=0.120  Sum_probs=28.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcCc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKSV   92 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~~   92 (358)
                      .+++++.+|+.+|+..||.+|||+.+++.|-
T Consensus       237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            4678999999999999999999999998873

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=91.92  E-value=0.039  Score=45.53  Aligned_cols=30  Identities=17%  Similarity=0.148  Sum_probs=27.0

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+++++.+|+.+||..||.+|||+.+++.+
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            467889999999999999999999988754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.88  E-value=0.039  Score=44.86  Aligned_cols=28  Identities=18%  Similarity=0.144  Sum_probs=25.8

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhh
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQAL   89 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l   89 (358)
                      .+++++.+|+.+||..||.+|||+.+++
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            5788999999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.73  E-value=0.034  Score=46.17  Aligned_cols=30  Identities=13%  Similarity=0.142  Sum_probs=27.6

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhcC
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALKS   91 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~~   91 (358)
                      .+++++.+|+.+|+..||.+|||+.|++.|
T Consensus       258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            467899999999999999999999999877

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=91.53  E-value=0.044  Score=45.21  Aligned_cols=29  Identities=14%  Similarity=0.052  Sum_probs=26.4

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      .++++..+|+.+|++.||.+|||+.|+++
T Consensus       266 ~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         266 NCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            57889999999999999999999999854

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.47  E-value=0.072  Score=43.42  Aligned_cols=29  Identities=14%  Similarity=0.185  Sum_probs=26.3

Q ss_pred             CCChhHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         62 LMPPGALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        62 ~~~~~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ..+.+..+|+.+||..||.+|||+.+++.
T Consensus       237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            46788999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.29  E-value=0.098  Score=43.06  Aligned_cols=25  Identities=16%  Similarity=0.105  Sum_probs=22.8

Q ss_pred             hHHHHHhhhcCCCCCCcCCHhhhhc
Q psy13988         66 GALDLLDKMLELDPERRITAEQALK   90 (358)
Q Consensus        66 ~~~~ll~~~l~~~p~~R~~~~~~l~   90 (358)
                      ...+|+.+||+.||.+|||+.|++.
T Consensus       266 ~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         266 VMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             HHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHH
Confidence            4789999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=85.84  E-value=0.16  Score=41.50  Aligned_cols=38  Identities=11%  Similarity=0.090  Sum_probs=31.2

Q ss_pred             cccCCChhHHHHHhhhcCCCCCCcCCHh---hhhcCccccc
Q psy13988         59 EFSLMPPGALDLLDKMLELDPERRITAE---QALKSVWLKN   96 (358)
Q Consensus        59 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~---~~l~~~~~~~   96 (358)
                      ..+.+++++.+|+.+|+..+|.+||+++   ++|+|+|.+.
T Consensus       240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            3456789999999999999999999986   5577877654